FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Mao, XJ
   Hou, YL
   Fang, C
   Ma, K
   Zhang, SX
   Guo, ZF
   Kang, N
   Niu, KX
   Shen, XG
   Li, YW
   Jiang, YN
   Song, YH
   Wang, L
   Li, HR
   Chang, LP
   Wei, C
   Wu, YL
   Li, MN
AF Mao, Xinjing
   Hou, Yunlong
   Fang, Chao
   Ma, Kun
   Zhang, Shixiong
   Guo, Zhifang
   Kang, Ning
   Niu, Kunxu
   Shen, Xiaogang
   Li, Yawen
   Jiang, Yuning
   Song, Yahui
   Wang, Lu
   Li, Hongrong
   Chang, Liping
   Wei, Cong
   Wu, Yiling
   Li, Mengnan
TI Bazi Bushen mitigates epigenetic aging and extends healthspan in
   naturally aging mice
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Traditional Chinese Medicine; Epigenetic rejuvenation; Methylation
   clock; Frailty Index; Genome stability
ID DNA METHYLATION; CHINESE MEDICINE; SKELETAL-MUSCLE; STEM-CELLS;
   SENESCENCE; HALLMARKS; RAPAMYCIN; GENE; MECHANISMS; EXPRESSION
AB Bazi Bushen (BZBS), a traditional Chinese medicine, has been proven effective in the treatment of age-related disease in mouse models. However, whether its therapeutic effects are due to antiaging mechanism has not yet been explored. In the present study, we investigated the antiaging effects of BZBS in naturally aging mice by using behavioral tests, liver DNA methylome sequencing, methylation age estimation, and frailty index assess-ment. The methylome analysis revealed a decrease of mCpG levels in the aged mouse liver. BZBS treatment tended to restore age-associated methylation decline and prune the methylation pattern toward that of young mice. More importantly, BZBS significantly rejuvenated methylation age of the aged mice, which was computed by an upgraded DNA methylation clock. These results were consistent with enhanced memory and muscular endurance, as well as decreased frailty score and liver pathological changes. KEGG analysis together with aging-related database screening identified methylation-targeted pathways upon BZBS treatment, including oxidative stress, DNA repair, MAPK signaling, and inflammation. Upregulation of key effectors and their downstream effects on elevating Sod2 expression and diminishing DNA damage were further investigated. Finally, in vitro experiments with senescent HUVECs proved a direct effect of BZBS extracts on the regulation of methylation enzymes during cellular aging. In summary, our work has revealed for the first time the antiaging effects of BZBS by slowing the methylation aging. These results suggest that BZBS might have great potential to extend healthspan and also explored the mechanism of BZBS action in the treatment of age-related diseases.
C1 [Mao, Xinjing; Zhang, Shixiong; Jiang, Yuning; Wu, Yiling] Nanjing Univ Chinese Med, Coll Tradit Chinese Med, Coll Integrated Tradit Chinese & Western Med, Nanjing 210023, Peoples R China.
   [Hou, Yunlong; Wu, Yiling; Li, Mengnan] Natl Key Lab Luobing Res & Innovat Chinese Med, Shijiazhuang 050035, Peoples R China.
   [Hou, Yunlong; Guo, Zhifang; Kang, Ning; Shen, Xiaogang; Wang, Lu] Key Lab State Adm TCM Cardiocerebral Vessel Collat, Shijiazhuang 050035, Peoples R China.
   [Fang, Chao] LC BIO Technol CO LTD, Hangzhou 310018, Peoples R China.
   [Ma, Kun; Song, Yahui] Hebei Univ Chinese Med, Grad Sch, Shijiazhuang 050091, Peoples R China.
   [Ma, Kun; Guo, Zhifang; Kang, Ning; Song, Yahui; Chang, Liping; Wei, Cong] Hebei Prov Key Lab Luobing, Shijiazhuang 050035, Peoples R China.
   [Zhang, Shixiong; Li, Yawen; Li, Hongrong; Wei, Cong] Key Disciplines State Adm TCM Luobing, Shijiazhuang 050035, Peoples R China.
   [Niu, Kunxu; Shen, Xiaogang; Li, Yawen] Hebei Med Univ, Grad Sch, Shijiazhuang 050017, Peoples R China.
   [Niu, Kunxu; Jiang, Yuning; Wang, Lu; Li, Mengnan] Shijiazhuang Cpd Tradit Chinese Med Technol Innova, Shijiazhuang 050035, Peoples R China.
   [Li, Hongrong; Chang, Liping] Hebei Clin Res Ctr Cardiovasc Dis Tradit Chinese M, Shijiazhuang 050035, Peoples R China.
C3 Nanjing University of Chinese Medicine; Hebei University of Chinese
   Medicine; Hebei Medical University
RP Wu, YL; Li, MN (corresponding author), Natl Key Lab Luobing Res & Innovat Chinese Med, Shijiazhuang 050035, Peoples R China.
EM professorylw@163.com; Limengnan413@163.com
RI Li, Mengnan/HNI-4978-2023; Liu, Yiwei/JUF-2477-2023; wang,
   jiaqi/JSL-7112-2023
FU Strategic Consulting Project of the Chinese Academy of
   Engineering-Strategic Research on Anti-aging Effects of Traditional
   Chinese Medicine [2022-XY-45]; S&T Program of Hebei [22372502D];
   High-level S & T Innovation and Entrepre-neurship Talent Project of
   Shijiazhuang [07202203]; Scientific Research Project of Hebei Provincial
   Administration of Traditional Chinese Medicine [2023172]; Natural
   Science Foundation of Hebei Province of China [H2022106065]
FX This work was supported by the Strategic Consulting Project of the
   Chinese Academy of Engineering-Strategic Research on Anti-aging Effects
   of Traditional Chinese Medicine (2022-XY-45) , S & T Program of Hebei
   (No. 22372502D) , High-level S & T Innovation and Entrepreneurship
   Talent Project of Shijiazhuang (No. 07202203) , Scientific Research
   Project of Hebei Provincial Administration of Traditional Chinese
   Medicine (NO. 2023172) , The Natural Science Foundation of Hebei
   Province of China (NO. H2022106065) .
CR Agolini E, 2021, CLIN GENET, V99, P842, DOI 10.1111/cge.13957
   Avgustinova A, 2016, NAT REV MOL CELL BIO, V17, P643, DOI 10.1038/nrm.2016.76
   Bacalini MG, 2019, J GERONTOL A-BIOL, V74, P1, DOI 10.1093/gerona/gly048
   Bell CG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1824-y
   Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003
   Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010
   Blättler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008
   Bysani M, 2017, EPIGENOMICS-UK, V9, P105, DOI 10.2217/epi-2016-0087
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Chen DP, 2016, BRIEF FUNCT GENOMICS, V15, P485, DOI 10.1093/bfgp/elw018
   Chen WD, 2019, AGING DIS, V10, P578, DOI 10.14336/AD.2018.0604
   Ciechomska M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8090953
   Compe E., 2022, PHYS LETT B, V8, P33
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174
   De Winter G, 2015, MED HEALTH CARE PHIL, V18, P237, DOI 10.1007/s11019-014-9600-y
   Dong XR, 2015, RADIAT RES, V183, P82, DOI 10.1667/RR13682.1
   Folgueras AR, 2018, CIRC RES, V123, P905, DOI 10.1161/CIRCRESAHA.118.312204
   Gems D, 2014, EXP GERONTOL, V58, P14, DOI 10.1016/j.exger.2014.07.003
   Hahn O., 2017, GENOME BIOL, P18
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Huang D., 2021, FRONT PHARMACOL, P12
   Huang D, 2020, ANN PALLIAT MED, V9, P1073, DOI 10.21037/apm-20-906
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Jia LJ, 2011, J BIOL CHEM, V286, P3379, DOI 10.1074/jbc.M110.188425
   Jiang M, 2011, PLANTA MED, V77, P873, DOI 10.1055/s-0030-1270983
   Jiang SS, 2011, AGING-US, V3, P672, DOI 10.18632/aging.100355
   Kim CH, 2016, AGING CELL, V15, P1074, DOI 10.1111/acel.12513
   Kinde B, 2016, P NATL ACAD SCI USA, V113, P15114, DOI 10.1073/pnas.1618737114
   Koltai E, 2018, REDOX BIOL, V19, P46, DOI 10.1016/j.redox.2018.07.022
   Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001
   Kunze S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125304
   Law PP, 2019, ESSAYS BIOCHEM, V63, P717, DOI 10.1042/EBC20190031
   Lee J, 2018, CHEM-BIOL INTERACT, V279, P27, DOI 10.1016/j.cbi.2017.11.004
   Levine M.E., AGING-US
   Li L., PHYS REV LETT
   Li L., 2021, J ETHNOPHARMACOL, P271
   Liu ZP, 2022, CELL DISCOV, V8, DOI 10.1038/s41421-021-00361-3
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lowe R., 2018, GENOME BIOL, P19
   Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427
   McDaniel K, 2017, HEPATOLOGY, V65, P544, DOI 10.1002/hep.28831
   Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3
   Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112
   Moreira BP, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071633
   Nakaoka T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061111
   Noroozi R., 2021, AGEING RES REV, P68
   Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007
   Sanders JL, 2021, AM J RESP CRIT CARE, V203, P1149, DOI 10.1164/rccm.202007-2993OC
   Schulz MA, 2020, NAT COMMUN, V11, DOI [10.1038/s41467-020-18037-z, 10.1038/s41467-020-18446-0]
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Stallone G, 2009, TRANSPLANTATION, V87, pS23, DOI 10.1097/TP.0b013e3181a05b7a
   Stubbs T.M., 2017, GENOME BIOL, P18
   Tabibzadeh S, 2021, FRONT BIOSCI-LANDMRK, V26, P50, DOI 10.2741/4889
   Takasugi M, 2013, MECH AGEING DEV, V134, P331, DOI 10.1016/j.mad.2013.05.003
   Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x
   Tubita A., CANCER RES
   Wahl D, 2020, J GERONTOL A-BIOL, V75, P1643, DOI 10.1093/gerona/glz135
   [王启荣 Wang Qirong], 2012, [中国运动医学杂志, Chinese Journal of Sports Medicine], V31, P1054
   Wang T., 2017, GENOME BIOL, P18
   Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x
   Xu H., 2020, Front. Chem., P8
   Yang YJ, 2020, LIVER INT, V40, P141, DOI 10.1111/liv.14262
   Yi YX, 2018, AGING-US, V10, P212, DOI 10.18632/aging.101383
   Zhang B, 2013, AGE, V35, P2237, DOI 10.1007/s11357-013-9520-4
   Zhang M, 2017, J TOXICOL ENV HEAL A, V80, P1199, DOI 10.1080/15287394.2017.1367133
   Zhang WQ, 2020, NAT REV MOL CELL BIO, V21, P137, DOI 10.1038/s41580-019-0204-5
   Zheng J, 2014, BRIT J NUTR, V112, P1850, DOI 10.1017/S0007114514002827
   Zhou L., 2022, CELLS-BASEL, V11, P16
   Zhu D., 2022, FRONT PHARMACOL, P13
NR 72
TC 4
Z9 4
U1 9
U2 21
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD APR
PY 2023
VL 160
AR 114384
DI 10.1016/j.biopha.2023.114384
EA FEB 2023
PG 14
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 9A4SA
UT WOS:000934048300001
PM 36764132
OA gold
DA 2024-02-19
ER

PT J
AU Asokan, SM
   Wang, T
   Wang, MF
   Lin, WT
AF Asokan, Shibu Marthandam
   Wang, Ting
   Wang, Ming-Fu
   Lin, Wan-Teng
TI A novel dipeptide from potato protein hydrolysate augments the effects
   of exercise training against high-fat diet-induced damages in
   senescence-accelerated mouse-prone 8 by boosting pAMPK / SIRT1/PGC-1α/
   pFOXO3 pathway
SO AGING-US
LA English
DT Article
DE bioactive peptides; alcalase; longevity; cardio-protection;
   hepato-protection
ID LIPOLYSIS-STIMULATING PEPTIDE; LIVER-DISEASE; SIRT1 PROTECTS;
   PGC-1-ALPHA; APOPTOSIS; OBESITY; HEART; EXPRESSION; ASSOCIATION;
   PREVENTION
AB The pathological effects of obesity are often severe in aging condition. Although exercise training is found to be advantageous, the intensity of exercise performed is limited in aging condition. Therefore in this study we assessed the effect of a combined treatment regimen with a short-peptide IF isolated from alcalase potato-protein hydrolysates and a moderate exercise training for 15 weeks in a 6 month old HFD induced obese senescence-accelerated mouse-prone 8 (SAMP8) mice model. Animals were divided into 6 groups (n=6) (C:Control+BSA); (HF:HFD+BSA); (EX:Control+ BSA+Exercise); (HF+IF:HFD+ IF); (HF+EX:HFD+Exercise); (HF+EX+IF:HFD+Exercise+IF). A moderate incremental swimming exercise training was provided for 6 weeks and after 3 weeks of exercise, IF was orally administered (1 mg/kg body Weight). The results show that combined administration of IF and exercise provides a better protection to aging animals by reducing body weight and regulated tissue damage. IF intake and exercise training provided protection against cardiac hypertrophy and maintains the tissue homeostasis in the heart and liver sections. Interestingly, IF and exercise training showed an effective upregulation in pAMPK/ SIRT1/PGC-1 alpha/ pFOXO3 mechanism of cellular longevity. Therefore, exercise training with IF intake is a possible strategy for anti-obesity benefits and superior cardiac and hepatic protection in aging condition.
C1 [Asokan, Shibu Marthandam] Buddhist Tzu Chi Hosp, Cardiovasc & Mitochondria Related Dis Res Ctr, Hualien, Taiwan.
   [Asokan, Shibu Marthandam] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.
   [Wang, Ting; Lin, Wan-Teng] Tunghai Univ, Dept Hospitality Management, Coll Agr, Taichung, Taiwan.
   [Wang, Ming-Fu] Providence Univ, Dept Food & Nutr, Taichung, Taiwan.
   [Lin, Wan-Teng] Tunghai Univ, Coll Agr, Dept Senior Wellness & Sport Sci, Taichung, Taiwan.
C3 Buddhist Tzu Chi General Hospital; China Medical University Taiwan;
   Tunghai University; Providence University - Taiwan; Tunghai University
RP Lin, WT (corresponding author), Tunghai Univ, Dept Hospitality Management, Coll Agr, Taichung, Taiwan.; Lin, WT (corresponding author), Tunghai Univ, Coll Agr, Dept Senior Wellness & Sport Sci, Taichung, Taiwan.
EM 040770@thu.edu.tw
RI wang, ming/ITV-5378-2023; Liu, Yixuan/JFJ-2820-2023; li,
   tong/JYO-7530-2024; wang, ming/HPC-6329-2023; Marthandam Asokan,
   Shibu/F-6137-2018
OI Lin, Wan-Teng/0000-0001-7700-3398; Marthandam Asokan,
   Shibu/0000-0001-6381-3525
FU Ministry of Science and Technology of Taiwan [MOST108-2410-H-029-050,
   MOST-106-2410-H-029-047-MY2]
FX This Research was financially supported by a grant from the Ministry of
   Science and Technology of Taiwan MOST108-2410-H-029-050 and
   MOST-106-2410-H-029-047-MY2.
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   ADHIHETTY PJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE74, DOI DOI 10.1152/AJPEND0.00311.2006
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Ashton K, 2016, LANCET, V388, P21
   Asokan SM, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2700-8
   Asokan SM, 2018, J MED FOOD, V21, P225, DOI 10.1089/jmf.2017.3941
   Asokan SM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040779
   Asokan SM, 2018, BIOMED PHARMACOTHER, V107, P1667, DOI 10.1016/j.biopha.2018.08.070
   Buckley AJ, 2018, DIABETES RES CLIN PR, V144, P144, DOI 10.1016/j.diabres.2018.08.011
   Chen WK, 2018, AGING-US, V10, P4166, DOI 10.18632/aging.101714
   Cheng KC, 2016, BIOMEDICINE-TAIWAN, V6, DOI 10.7603/s40681-016-0016-2
   Chiang WD, 2016, FOOD NUTR RES, V60, DOI [10.3402/fnr.v60.30511, 10.3402/fnr.v60.31417]
   Chiang WD, 2014, J FUNCT FOODS, V11, P482, DOI 10.1016/j.jff.2014.08.003
   Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562
   Clark Keith, 2003, J Insur Med, V35, P59
   Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x
   Coviello Jessica S, 2003, J Cardiovasc Nurs, V18, P360
   D'Onofrio N, 2018, ANTIOXID REDOX SIGN, V28, P711, DOI 10.1089/ars.2017.7178
   Ding RJ, 2017, ADV EXP MED BIOL, V1000, P31, DOI 10.1007/978-981-10-4304-8_3
   Dumeus S, 2018, CELL PHYSIOL BIOCHEM, V48, P1942, DOI 10.1159/000492518
   Fan LM, 2017, FREE RADICAL BIO MED, V108, P940, DOI 10.1016/j.freeradbiomed.2017.05.008
   Gill C, 2017, AM J CARDIOL, V119, P1717, DOI 10.1016/j.amjcard.2017.03.010
   Guo YC, 2018, CHINESE MED J-PEKING, V131, P2269, DOI 10.4103/0366-6999.241797
   Guyenet SJ, 2012, J CLIN ENDOCR METAB, V97, P745, DOI 10.1210/jc.2011-2525
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Hu WS, 2015, INT J MOL SCI, V16, P10158, DOI 10.3390/ijms160510158
   Huang CC, 2016, INT J MED SCI, V13, P260, DOI 10.7150/ijms.14586
   Huang CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/275431
   Huang CY, 2015, J FUNCT FOODS, V12, P389, DOI 10.1016/j.jff.2014.11.027
   Keating SE, 2012, J HEPATOL, V57, P157, DOI 10.1016/j.jhep.2012.02.023
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kwak HB, 2006, FASEB J, V20, P791, DOI 10.1096/fj.05-5116fje
   Kwon S, 2017, J BIOL CHEM, V292, P17312, DOI 10.1074/jbc.M117.778720
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lanza IR, 2008, DIABETES, V57, P2933, DOI 10.2337/db08-0349
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Leick L, 2010, EXP GERONTOL, V45, P336, DOI 10.1016/j.exger.2010.01.011
   Lin CH, 2014, AGE, V36, DOI 10.1007/s11357-014-9705-5
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Liu YS, 2008, MOL CELL PROTEOMICS, V7, P1737, DOI 10.1074/mcp.M800109-MCP200
   Massie BM, 2002, NEW ENGL J MED, V347, P358, DOI 10.1056/NEJMe020065
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   Mendis S, 2015, STROKE, V46, pE121, DOI 10.1161/STROKEAHA.115.008097
   Meng XF, 2017, CELL MOL NEUROBIOL, V37, P17, DOI 10.1007/s10571-016-0355-2
   Nair KS, 2005, AM J CLIN NUTR, V81, P953
   Nehra V, 2001, DIGEST DIS SCI, V46, P2347, DOI 10.1023/A:1012338828418
   Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719
   Nunes-Souza V, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1987960
   Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035
   Ok DP, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0852-z
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Piguet AC, 2019, HEPATOL RES, V49, P637, DOI 10.1111/hepr.13323
   Prola A, 2017, CELL DEATH DIFFER, V24, P343, DOI 10.1038/cdd.2016.138
   Reed AL, 2011, AM J PHYSIOL-HEART C, V301, pH824, DOI 10.1152/ajpheart.00407.2010
   Roh J, 2016, CIRC RES, V118, P279, DOI 10.1161/CIRCRESAHA.115.305250
   Sakamoto J, 2004, FEBS LETT, V556, P281, DOI 10.1016/S0014-5793(03)01444-3
   Salvestrini V, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00266
   Shanmugam G, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00068
   Asokan SM, 2018, J FOOD BIOCHEM, V42, DOI 10.1111/jfbc.12638
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   Tonkin J, 2012, CURR OPIN PHARMACOL, V12, P372, DOI 10.1016/j.coph.2012.02.010
   Vilà L, 2007, J GERONTOL A-BIOL, V62, P1219, DOI 10.1093/gerona/62.11.1219
   Waldman M, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0754-4
   Wang B, 2017, CAN J PHYSIOL PHARM, V95, P667, DOI 10.1139/cjpp-2016-0611
   Warburton DER, 2006, CAN MED ASSOC J, V174, P961, DOI 10.1503/cmaj.1040750
   Wu XD, 2008, HEPATOLOGY, V47, P1905, DOI 10.1002/hep.22239
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yatsuya H, 2014, CIRC J, V78, P2807, DOI 10.1253/circj.CJ-14-0850
   Ye X, 2004, HISTOL HISTOPATHOL, V19, P1141, DOI 10.14670/HH-19.1141
   Zhang FY, 2016, EBIOMEDICINE, V13, P157, DOI 10.1016/j.ebiom.2016.10.013
NR 70
TC 16
Z9 17
U1 0
U2 19
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD APR 30
PY 2020
VL 12
IS 8
BP 7334
EP 7349
DI 10.18632/aging.103081
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LK5DW
UT WOS:000530887200051
PM 32335547
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Sha, JY
   Li, JH
   Zhou, YD
   Yang, JY
   Liu, W
   Jiang, S
   Wang, YP
   Zhang, R
   Di, P
   Li, W
AF Sha, Ji-yue
   Li, Jian-hao
   Zhou, Yan-dan
   Yang, Jia-yu
   Liu, Wei
   Jiang, Shuang
   Wang, Ying-ping
   Zhang, Rui
   Di, Peng
   Li, Wei
TI The p53/p21/p16 and PI3K/Akt signaling pathways are involved in the
   ameliorative effects of maltol on D-galactose-induced liver and kidney
   aging and injury
SO PHYTOTHERAPY RESEARCH
LA English
DT Article; Early Access
DE apoptosis; D&#8208; galactose; maltol; oxidative stress; p53; p21; p16;
   PI3K; Akt pathway
ID CISPLATIN-INDUCED NEPHROTOXICITY; LOTUS SEEDPOD PROANTHOCYANIDINS;
   OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; SENESCENT CELLS; MICE; BRAIN;
   DEFICITS; MATRINE; DAMAGE
AB Successive evidence has established that maltol, a flavor-enhancing agent, could provide resistance to oxidative stress-induced tissue injury in various animal models though its benefits for aging-induced liver and kidney injuries are still undetermined. In the present work, for demonstrating maltol's ameliorative effect and probable mechanism against aging-induced liver and kidney injuries, D-galactose (D-Gal)-induced animal in vivo and HEK293 cells in vitro models were established and results demonstrated that long-term D-Gal treatment increases the accumulation of advanced glycation end products (AGEs) in liver and kidney tissues, mitigates cell viability, and arrests the cycle. Interestingly, 4-weeks maltol treatment at 50 and 100 mg/kg activated aging-associated proteins including p53, p21, and p16 followed by inhibiting malondialdehyde (MDA)'s over-production and increasing the levels of antioxidant enzymes. Therefore, decreases in cytochrome P450 E1 (CYP2E1) and 4-hydroxydecene (4-HNE)'s immunofluorescence expression levels are confirmed. Furthermore, maltol improved oxidative stress injury by activating the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt) signaling pathway. In conclusion, the purpose of the present study was to estimate the mechanistic insights into maltol's role as an antioxidant in liver and kidney cell senescence and injury, which will reflect potential of therapeutic strategy for antiaging and aging-related disease treatment.
C1 [Sha, Ji-yue; Li, Jian-hao; Zhou, Yan-dan; Yang, Jia-yu; Liu, Wei; Jiang, Shuang; Wang, Ying-ping; Zhang, Rui; Di, Peng; Li, Wei] Jilin Agr Univ, Coll Chinese Med Mat, Changchun 130118, Peoples R China.
   [Li, Jian-hao] Chinese Inst Jilin Ginseng, Plant Chem Lab, Changchun, Peoples R China.
   [Wang, Ying-ping; Di, Peng; Li, Wei] Natl & Local Joint Engn Res Ctr Ginseng Breeding, Changchun, Peoples R China.
C3 Jilin Agricultural University
RP Li, W (corresponding author), Jilin Agr Univ, Coll Chinese Med Mat, Changchun 130118, Peoples R China.
EM liwei7727@126.com
RI wang, KiKi/JFZ-3334-2023; Di, Peng/E-4751-2013
OI , wei/0000-0002-2988-4298; Di, Peng/0000-0002-8537-9245
FU Innovation Leadership Program in Sciences and Technologies for Young and
   Middle-aged Scientists in Jilin Province [20200201083YY]
FX This work was supported by the grants of Innovation Leadership Program
   in Sciences and Technologies for Young and Middle-aged Scientists in
   Jilin Province (No. 20200201083YY).
CR Abdelmegeed MA, 2017, FOOD CHEM TOXICOL, V109, P48, DOI 10.1016/j.fct.2017.08.022
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Brück K, 2016, J AM SOC NEPHROL, V27, P2135, DOI 10.1681/ASN.2015050542
   Chen HL, 2011, BRIT J NUTR, V105, P805, DOI 10.1017/S000711451000437X
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Conti V, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00024
   Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408
   Ferenbach David A, 2016, Nephrol Ther, V12 Suppl 1, pS41, DOI 10.1016/j.nephro.2016.02.005
   Gong YS, 2016, EXP GERONTOL, V74, P21, DOI 10.1016/j.exger.2015.11.020
   Gong YS, 2008, BEHAV BRAIN RES, V194, P100, DOI 10.1016/j.bbr.2008.06.029
   Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20
   Haider S, 2015, LIFE SCI, V124, P110, DOI 10.1016/j.lfs.2015.01.016
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Huang JL, 2019, AGING-US, V11, P8542, DOI 10.18632/aging.102337
   Jian Jie, 2015, Drug Des Devel Ther, V9, P5933, DOI 10.2147/DDDT.S92549
   Kim YB, 2004, NUTR NEUROSCI, V7, P33, DOI 10.1080/10284150310001653604
   Krüsemann EJZ, 2021, TOB CONTROL, V30, P185, DOI 10.1136/tobaccocontrol-2019-055447
   Li CZ, 2019, FREE RADICAL BIO MED, V130, P512, DOI 10.1016/j.freeradbiomed.2018.11.006
   Li RY, 2019, J AGR FOOD CHEM, V67, P5754, DOI 10.1021/acs.jafc.9b00540
   Li W, 2016, NUTRIENTS, V8, DOI 10.3390/nu8090566
   Li XB, 2012, J PHARM PHARMACOL, V64, P1107, DOI 10.1111/j.2042-7158.2012.01502.x
   Liao CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010098
   Liman N, 2013, REPROD DOMEST ANIM, V48, P33, DOI 10.1111/j.1439-0531.2012.02021.x
   Liu BH, 2018, AGING-US, V10, P4197, DOI 10.18632/aging.101723
   Liu C, 2019, AM J PHYSIOL-RENAL, V317, pF1122, DOI 10.1152/ajprenal.00202.2019
   Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007
   Ma ZN, 2017, FOOD CHEM TOXICOL, V110, P62, DOI 10.1016/j.fct.2017.10.006
   Meng FH, 2017, ONCOL LETT, V13, P296, DOI 10.3892/ol.2016.5383
   Mi XJ, 2019, J AGR FOOD CHEM, V67, P1392, DOI 10.1021/acs.jafc.8b05943
   Mi XJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34156-6
   Miao JH, 2019, AGING CELL, V18, DOI 10.1111/acel.13004
   Minutolo R, 2015, AM J KIDNEY DIS, V66, P184, DOI 10.1053/j.ajkd.2015.05.004
   Newgard CB, 2013, J CLIN INVEST, V123, P946, DOI 10.1172/JCI68833
   Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Schröter D, 2018, CURR PHARM DESIGN, V24, P5245, DOI 10.2174/1381612825666190130145549
   Sha JY, 2019, J AGR FOOD CHEM, V67, P10342, DOI 10.1021/acs.jafc.9b04614
   Shin Kyung Rim, 2003, Nurs Health Sci, V5, P245, DOI 10.1046/j.1442-2018.2003.00161.x
   Shirato T, 2017, ARCH TOXICOL, V91, P1319, DOI 10.1007/s00204-016-1785-9
   Shwe T, 2018, EXP GERONTOL, V101, P13, DOI 10.1016/j.exger.2017.10.029
   Sun KY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7108604
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Wang PP, 2017, J ETHNOPHARMACOL, V203, P252, DOI 10.1016/j.jep.2017.03.050
   Wang Z, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090395
   Wei A, 2001, J AGR FOOD CHEM, V49, P4097, DOI 10.1021/jf010325e
   Wu W, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5707830
   Ye Qinyuan, 2012, Hepatobiliary Surg Nutr, V1, P5
   Yu YH, 2015, MOL CELL BIOCHEM, V403, P287, DOI 10.1007/s11010-015-2358-6
   Yzydorczyk C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112796
   Zhang JY, 2017, INT IMMUNOPHARMACOL, V45, P26, DOI 10.1016/j.intimp.2017.01.028
   Zhang R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0610-1
   Zhao P, 2015, INT J MOL MED, V36, P633, DOI 10.3892/ijmm.2015.2260
   Zhuang YL, 2017, FOOD CHEM TOXICOL, V108, P554, DOI 10.1016/j.fct.2017.01.022
   Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013
NR 54
TC 27
Z9 29
U1 13
U2 38
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-418X
EI 1099-1573
J9 PHYTOTHER RES
JI Phytother. Res.
PD 2021 AUG
PY 2021
VL 35
IS 8
BP 4411
EP 4424
DI 10.1002/ptr.7142
EA MAY 2021
PG 14
WC Chemistry, Medicinal; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA UA0GE
UT WOS:000653153300001
PM 34028092
DA 2024-02-19
ER

PT S
AU Le Couteur, DG
   Cogger, VC
   McCuskey, RS
   De Cabo, R
   Smedsrod, B
   Sorensen, KK
   Warren, A
   Fraser, R
AF Le Couteur, David G.
   Cogger, Victoria C.
   McCuskey, Robert S.
   De Cabo, Rafael
   Smedsrod, Bard
   Sorensen, Karen K.
   Warren, Alessandra
   Fraser, Robin
BE Weller, NJ
   Rattan, SIS
TI Age-related changes in the liver sinusoidal endothelium - A mechanism
   for dyslipidemia
SO HEALTHY AGING AND LONGEVITY
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Healthy Aging and Longevity
CY OCT 13-15, 2006
CL Melbourne, AUSTRALIA
DE liver; aging; liver sinusoidal endothelial cell; chylomicron remnant;
   endocytosis; caloric restriction
ID CALORIC RESTRICTION; AGING LIVER; PSEUDOCAPILLARIZATION;
   ATHEROSCLEROSIS; CLEARANCE; LIPOPROTEINS; METABOLISM; KUPFFER; SIEVE;
   CELLS
AB The liver sinusoidal endothelial cell (LSEC) influences the transfer of substrates between the sinusoidal blood and hepatocytes and has a major role in endocytosis; therefore, changes in the LSEC have significant implications for hepatic function. There are major morphological changes in the LSEC in old age called pseudocapillarization. These changes include increased LSEC thickness and reduced numbers of pores in the LSEC, which are called fenestrations. Pseudocapillarization has been found in old humans, rats, mice, and nonhuman primates. In addition, old age is associated with impaired LSEC endocytosis and increased leukocyte adhesion, which contributes to reduced hepatic perfusion. Given that fenestrations in the endothelium allow passage of some lipoproteins, including chylomicron remnants, age-related reduction in fenestrations impairs hepatic lipoprotein metabolism. In old rats, caloric restriction was associated with complete preservation of LSEC morphology find fenestrations. In conclusion, pseudocapillarization of the LSEC is a newly discovered aging change that, through its effects on lipoproteins, contributes to the association between old age, dyslipidemia, and vascular disease.
C1 [Le Couteur, David G.; Cogger, Victoria C.; Warren, Alessandra] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
   [Le Couteur, David G.; Cogger, Victoria C.; Warren, Alessandra] Concord RG Hosp, Sydney, NSW 2139, Australia.
   [McCuskey, Robert S.] Univ Arizona, Coll Med, Dept Anat & Cell Biol, Tucson, AZ USA.
   [McCuskey, Robert S.; Smedsrod, Bard; Sorensen, Karen K.] Univ Tromso, Inst Med Biol, Dept Cell Biol & Histol, Tromso, Norway.
   [De Cabo, Rafael] NIA, Lab Expt Gerontol, Baltimore, MD 21224 USA.
   [Fraser, Robin] Univ Otago, Christchurch Sch Med, Christchurch, New Zealand.
C3 University of Sydney; Concord Repatriation General Hospital; University
   of Arizona; UiT The Arctic University of Tromso; National Institutes of
   Health (NIH) - USA; NIH National Institute on Aging (NIA); University of
   Otago
RP Le Couteur, DG (corresponding author), Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW 2139, Australia.
EM dlecouteur@med.usyd.edu.au
RI de Cabo, Rafael Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI de Cabo, Rafael Carlos/0000-0003-2830-5693; Le Couteur,
   David/0000-0002-4227-5817; de Cabo, Rafael/0000-0002-3354-2442
FU NIA NIH HHS [R21 AG-02582] Funding Source: Medline
CR Carpenter B, 2005, DEVELOPMENT, V132, P3293, DOI 10.1242/dev.01902
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2006, ATHEROSCLEROSIS, V189, P273, DOI 10.1016/j.atherosclerosis.2005.12.025
   COHN JS, 1988, J LIPID RES, V29, P469
   Everitt AV, 2005, AGE, V27, P39, DOI 10.1007/s11357-005-3284-4
   FLOREN CH, 1984, SCAND J GASTROENTERO, V19, P473, DOI 10.1080/00365521.1984.12005755
   Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   FRASER R, 1978, ATHEROSCLEROSIS, V29, P113, DOI 10.1016/0021-9150(78)90001-1
   Gerstenblith G, 2006, J AM COLL CARDIOL, V47, P403, DOI 10.1016/j.jacc.2005.10.030
   Hansen B, 2005, EXP CELL RES, V303, P160, DOI 10.1016/j.yexcr.2004.09.017
   HARDONK MJ, 1985, HISTOCHEMISTRY, V83, P473, DOI 10.1007/BF00509211
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hilmer SN, 2004, DRUG METAB DISPOS, V32, P794, DOI 10.1124/dmd.32.8.794
   Huet PM, 2005, HEPATOLOGY, V42, P1248, DOI 10.1002/hep.20991
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 1998, CLIN PHARMACOKINET, V34, P359, DOI 10.2165/00003088-199834050-00003
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Le Couteur DG, 2006, NEW RES ATHEROSCLERO, P19
   Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020
   Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Meyer TE, 2006, J AM COLL CARDIOL, V47, P398, DOI 10.1016/j.jacc.2005.08.069
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Romero EL, 1999, FEBS LETT, V448, P193, DOI 10.1016/S0014-5793(99)00364-6
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Seternes T, 2002, P NATL ACAD SCI USA, V99, P7594, DOI 10.1073/pnas.102173299
   Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019
   Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567
   SMEDSROD B, 1994, GUT, V35, P1509, DOI 10.1136/gut.35.11.1509
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Weintraub MS, 1996, BRIT MED J, V312, P935, DOI 10.1136/bmj.312.7036.935
   WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4
   Yokomori H, 2001, LIVER, V21, P198, DOI 10.1034/j.1600-0676.2001.021003198.x
   Yu KCW, 2001, FRONT BIOSCI-LANDMRK, V6, pD332, DOI 10.2741/Yu
   Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024
NR 40
TC 38
Z9 42
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER STREET, HOBOKEN, NJ, UNITED STATES
SN 0077-8923
BN 978-1-57331-680-4
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2007
VL 1114
BP 79
EP 87
DI 10.1196/annals.1396.003
PG 9
WC Geriatrics & Gerontology; Multidisciplinary Sciences; Physiology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Science & Technology - Other Topics;
   Physiology
GA BHA05
UT WOS:000251775900010
PM 17804522
DA 2024-02-19
ER

PT J
AU SPEARMAN, ME
   LEIBMAN, KC
AF SPEARMAN, ME
   LEIBMAN, KC
TI EFFECTS OF AGING ON HEPATIC AND PULMONARY GLUTATHIONE S-TRANSFERASE
   ACTIVITIES IN MALE AND FEMALE FISCHER 344 RATS
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
C1 UNIV FLORIDA,J HILLIS MILLER HLTH CTR,DEPT PHARMACOL & THERAPEUT,GAINESVILLE,FL 32610.
C3 State University System of Florida; University of Florida
FU NCRR NIH HHS [RR05362] Funding Source: Medline; NIEHS NIH HHS [ES02895]
   Funding Source: Medline; NIOSH CDC HHS [OH00316] Funding Source: Medline
CR BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158
   BIRNBAUM LS, 1979, CHEM-BIOL INTERACT, V26, P245, DOI 10.1016/0009-2797(79)90028-0
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887
   FJELLSTEDT TA, 1973, J BIOL CHEM, V248, P3702
   FLEISCHNER G, 1972, J CLIN INVEST, V51, P677, DOI 10.1172/JCI106856
   HABIG WH, 1974, P NATL ACAD SCI USA, V71, P3879, DOI 10.1073/pnas.71.10.3879
   HABIG WH, 1976, ARCH BIOCHEM BIOPHYS, V175, P710, DOI 10.1016/0003-9861(76)90563-4
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HALES BF, 1976, BIOCHEM J, V160, P231, DOI 10.1042/bj1600231
   HALES BF, 1976, BIOCHEM J, V160, P223, DOI 10.1042/bj1600223
   HAYAKAWA T, 1975, ARCH BIOCHEM BIOPHYS, V170, P438, DOI 10.1016/0003-9861(75)90139-3
   HEMMINKI K, 1980, CHEM-BIOL INTERACT, V30, P259, DOI 10.1016/0009-2797(80)90049-6
   HESSE S, 1982, CARCINOGENESIS, V3, P757, DOI 10.1093/carcin/3.7.757
   IRWIN C, 1980, ARCH BIOCHEM BIOPHYS, V205, P122, DOI 10.1016/0003-9861(80)90090-9
   JAMES MO, 1977, DRUG METAB DISPOS, V5, P19
   JAMES SP, 1978, XENOBIOTICA, V8, P207, DOI 10.3109/00498257809056142
   KAPITULNIK J, 1978, CANCER RES, V38, P354
   KEEN JH, 1976, J BIOL CHEM, V251, P6183
   KITAHARA A, 1982, LIVER AGING 1982, P135
   PATEL JM, 1980, DRUG METAB DISPOS, V8, P305
   PROHASKA JR, 1980, BIOCHIM BIOPHYS ACTA, V611, P87, DOI 10.1016/0005-2744(80)90045-5
   SPEARMAN ME, 1983, LIFE SCI, V33, P2615, DOI 10.1016/0024-3205(83)90345-4
   STOHS SJ, 1982, GEN PHARMACOL, V13, P519, DOI 10.1016/0306-3623(82)90028-3
NR 24
TC 55
Z9 55
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PY 1984
VL 33
IS 8
BP 1309
EP 1313
DI 10.1016/0006-2952(84)90185-0
PG 5
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA SR434
UT WOS:A1984SR43400019
PM 6712736
DA 2024-02-19
ER

PT J
AU Ortu, G
   Rivabene, R
   Cantafora, A
   Bravo, E
AF Ortu, G
   Rivabene, R
   Cantafora, A
   Bravo, E
TI Age-related variations in hepatic biosynthesis of phosphatidylcholine: A
   study of choline metabolism with perfused rat liver
SO PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
ID BILE-ACID METABOLISM; MALE WISTAR RATS; DIACYLGLYCEROL ACYLTRANSFERASE;
   TRIACYLGLYCEROL SYNTHESIS; DIETARY RESTRICTION; CHOLESTEROL;
   HEPATOCYTES; LIPIDS; PHOSPHOLIPIDS; LIPOPROTEIN
AB This study investigated the age-related increase in phospholipid secretion previously described in perfused rat livers, The hypothesis of this study was that the increased secretion is mainly due to an enhanced hepatic biosynthesis of phosphatidylcholine (PC). Specifically, we evaluated the contribution to this increase of the major hepatic pathway of phosphatidylcholine formation (i.e., the conversion of choline into phosphatidylcholine via cytidine diphosphate [CDP]-choline),
   The measurements of [H-3]choline incorporation into phosphatidylcholine and its precursors in liver and bile throughout the 2-hr duration of the experiments showed significant differences in the amount of newly synthesized labeled PC secreted in the bile produced by adult and young rat livers. However, the present findings do not support the idea that the age-related increase in phosphatidylcholine hepatic secretion was due only to a strong increase in phosphatidylcholine synthesis by via CDP-choline.
   Conversely, they suggest that future research should be directed towards the mechanisms regulating the diacylglycerol metabolism in the hepatocytes, as the alteration of the splitting ratio of hepatic diacylglycerol flow could leed to an age-related increase in conversion of diacylglycerol into phosphatidylcholine, rather than into triacylglycerol, This, in turn, may decrease the availability of triacylglycerol for hepatic very low density lipoprotein (VLDL) assembly and contribute to altered VLDL synthesis, as previously observed in the aging process.
C1 IST SUPER SANITA, LAB METAB & PATHOL BIOCHEM, I-00161 ROME, ITALY.
C3 Istituto Superiore di Sanita (ISS)
RI Bravo, Elena/K-2170-2012; Ortu, Giuseppina/AAD-6151-2021; Rivabene,
   Roberto/AAB-6097-2022; Bravo, Elena/AAH-7512-2021
OI Bravo, Elena/0000-0002-3473-6767; Rivabene, Roberto/0000-0002-3687-969X;
   Bravo, Elena/0000-0002-3473-6767; Ortu, Giuseppina/0000-0001-9234-756X
CR ANSELL GB, 1982, PHOSPHOLIPIDS, P1, DOI DOI 10.1016/S0167-7306(08)60005-8
   BERTOLOTTI M, 1993, J LIPID RES, V34, P1001
   BJORNSTAD P, 1966, J LIPID RES, V7, P38
   BRAVO E, 1993, METABOLISM, V42, P609, DOI 10.1016/0026-0495(93)90220-I
   Bravo E, 1996, J BIOCHEM-TOKYO, V119, P240, DOI 10.1093/oxfordjournals.jbchem.a021229
   BRINDLEY DN, 1988, PHOSPHATIDATE PHOSPH, P1
   CANTAFORA A, 1993, ARCH GERONTOL GERIAT, V16, P249, DOI 10.1016/0167-4943(93)90036-H
   CHANUSSOT F, 1990, BIOCHEM J, V270, P691, DOI 10.1042/bj2700691
   FERLAND G, 1989, LIPIDS, V24, P842, DOI 10.1007/BF02535757
   HAAGSMAN HP, 1981, BIOCHIM BIOPHYS ACTA, V664, P74, DOI 10.1016/0005-2760(81)90029-1
   KAWAMOTO T, 1980, BIOCHIM BIOPHYS ACTA, V619, P20
   LACKO AG, 1979, J AM GERIATR SOC, V27, P212, DOI 10.1111/j.1532-5415.1979.tb06034.x
   MARKOVSKA TT, 1990, EXP GERONTOL, V25, P55, DOI 10.1016/0531-5565(90)90009-Q
   MASELLA R, 1995, COMP BIOCHEM PHYS B, V111, P319, DOI 10.1016/0305-0491(94)00217-I
   MAYOREK N, 1989, EUR J BIOCHEM, V182, P395, DOI 10.1111/j.1432-1033.1989.tb14844.x
   MURAWSKI U, 1990, COMP BIOCHEM PHYS B, V96, P271, DOI 10.1016/0305-0491(90)90375-4
   PETKOVA DH, 1988, EXP GERONTOL, V23, P19, DOI 10.1016/0531-5565(88)90016-2
   RIVABENE R, 1972, BIOSCI REPORT, V12, P425
   ROBINS SJ, 1982, J LIPID RES, V23, P604
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   SUNDLER R, 1975, J BIOL CHEM, V250, P3359
   SUNDLER R, 1972, BIOCHIM BIOPHYS ACTA, V280, P559, DOI 10.1016/0005-2760(72)90136-1
   TAKAYAMA M, 1977, CLIN CHIM ACTA, V79, P93, DOI 10.1016/0009-8981(77)90465-X
   TUCHWEBER B, 1987, LIFE SCI, V41, P2091, DOI 10.1016/0024-3205(87)90526-1
   UCHIDA K, 1978, J LIPID RES, V19, P544
   VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172
   VANCE DE, 1991, BIOCH LIPIDS LIPOPRO, P205
   VANLENTEN BJ, 1982, J LIPID RES, V23, P1187
NR 28
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0037-9727
J9 P SOC EXP BIOL MED
JI Proc. Soc. Exp. Biol. Med.
PD OCT
PY 1997
VL 216
IS 1
BP 44
EP 51
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA XX281
UT WOS:A1997XX28100004
PM 9316609
DA 2024-02-19
ER

PT J
AU Trak-Smayra, V
   Contreras, J
   Dondero, F
   Durand, F
   Dubois, S
   Sommacale, D
   Marcellin, P
   Belghiti, J
   Degott, C
   Paradis, V
AF Trak-Smayra, V
   Contreras, J
   Dondero, F
   Durand, F
   Dubois, S
   Sommacale, D
   Marcellin, P
   Belghiti, J
   Degott, C
   Paradis, V
TI Role of replicative senescence in the progression of fibrosis in
   hepatitis C virus (HCV) recurrence after liver transplantation
SO TRANSPLANTATION
LA English
DT Article
ID TELOMERE LENGTH; INFECTION; CAPACITY; CELLS
AB Background. Although hepatitis C virus (HCV) recurrence is almost universal after orthotopic liver transplantation (OLT), the impact of viral infection on liver graft is highly variable and difficult to predict. Because of the possible relationship between replicative senescence (RS) and the accelerated development of liver fibrosis, we aimed to assess the potential role of RS in the severity of HCV-related chronic hepatitis recurrence after OLT.
   Methods. One hundred three liver biopsies from 56 patients receiving transplants for HCV-related cirrhosis were studied, including 30 revascularization biopsies and 52 and 21 biopsies performed during and beyond the first year of OLT, respectively. The presence of senescent cells in liver grafts was assessed by the senescence-associated beta-galactosidase (SA-beta-Gal) staining method. Chronic hepatitis was defined by fibrosis stage and necrotico-inflammatory activity grade using the METAVIR score.
   Results. A total of 34 of the 103 (33%) frozen liver biopsies displayed SA-beta-Gal-positive cells, including 6 (20%) of the revascularization biopsies, 14 (34%) of the biopsies performed within the first year, and 10 (46%) of the biopsies performed beyond 1 year of follow-up. The presence of senescent cells in revascularization biopsies was significantly associated with the degree of ischemic necrosis at time of OLT (P = 0.01) and hepatitis C recurrence in the first year after OLT (P = 0.05). Furthermore, the presence of RS in the biopsy performed within the first year was associated with further development of fibrosis (P = 0.05).
   Conclusions. These data show that RS has a significant impact upon the course of liver transplantation, especially in the long-term progression of fibrosis observed in HCV-infected patients.
C1 Hop Beaujon, Serv Anat Pathol, F-92118 Clichy, France.
   Hop Beaujon, Serv Hepatol, F-92118 Clichy, France.
   Hop Beaujon, Serv Chirurg Viscerale, F-92118 Clichy, France.
   CNRS, FRE 2443, Fac Pharm, Paris, France.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Beaujon - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Beaujon - APHP;
   Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Beaujon - APHP; Centre National de la Recherche
   Scientifique (CNRS)
RP Paradis, V (corresponding author), Hop Beaujon, Serv Anat Pathol, 100 Bd Gen Leclerc, F-92118 Clichy, France.
EM vparadis@teaser.fr
RI Paradis, Valerie/X-9097-2019
OI Durand, Francois/0000-0002-0357-1090; Paradis,
   Valerie/0000-0003-3142-3762
CR ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   BEDOSSA P, 1994, HEPATOLOGY, V20, P15
   Berenguer M, 2003, HEPATOLOGY, V38, P34, DOI 10.1053/jhep.2003.50278
   Berenguer M, 2001, J HEPATOL, V35, P666, DOI 10.1016/S0168-8278(01)00179-9
   Cane EJ, 1996, NEW ENGL J MED, V334, P815, DOI 10.1056/NEJM199603283341302
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   Chopra KB, 2003, TRANSPLANTATION, V76, P1487, DOI 10.1097/01.TP.0000088668.28950.7C
   Demetris AJ, 1997, HEPATOLOGY, V25, P658
   DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X
   FERAY C, 1994, HEPATOLOGY, V20, P1137, DOI 10.1002/hep.1840200506
   Féray C, 1999, GASTROENTEROLOGY, V117, P619, DOI 10.1016/S0016-5085(99)70454-3
   Ferlicot S, 2003, HUM PATHOL, V34, P924, DOI 10.1016/S0046-8177(03)00340-X
   GarciaSamaniego J, 1997, AM J GASTROENTEROL, V92, P1130
   Ghobrial RM, 2001, ANN SURG, V234, P384, DOI 10.1097/00000658-200109000-00012
   GOLDSTEIN S, 1979, J CLIN INVEST, V63, P358, DOI 10.1172/JCI109311
   Halloran PF, 1999, J AM SOC NEPHROL, V10, P167
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Pol S, 1998, J HEPATOL, V29, P12, DOI 10.1016/S0168-8278(98)80173-6
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   WRIGHT TL, 1992, GASTROENTEROLOGY, V103, P317, DOI 10.1016/0016-5085(92)91129-R
NR 26
TC 21
Z9 23
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD JUN 15
PY 2004
VL 77
IS 11
BP 1755
EP 1760
DI 10.1097/01.TP.0000131172.75294.A9
PG 6
WC Immunology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Surgery; Transplantation
GA 830AP
UT WOS:000222094300022
PM 15201678
OA Bronze
DA 2024-02-19
ER

PT J
AU Cavallini, G
   Donati, A
   Gori, Z
   Pollera, M
   Bergamini, E
AF Cavallini, G
   Donati, A
   Gori, Z
   Pollera, M
   Bergamini, E
TI The protection of rat liver autophagic proteolysis from the age-related
   decline co-varies with the duration of anti-ageing food restriction
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE ageing; rat liver; autophagy lysosomal proteolysis; food restriction
ID LIPOFUSCIN-LIKE SUBSTANCES; CALORIC RESTRICTION; DIETARY RESTRICTION;
   PROTEIN-DEGRADATION; OXIDATIVE DAMAGE; LEUPEPTIN CAUSES; CANCER
   INCIDENCE; YOUNG-RATS; LIFE-SPAN; ACCUMULATION
AB Restricting caloric intake (CR) well below that of ad libitum (AL) fed animals retards and/or delays many characteristics of ageing and the occurrence and progression of age-associated diseases, efficacy depending on duration. The hypothesis that the anti-ageing effect of CR might involve stimulation of the cell-repair mechanism autophagy was tested. The effects of ageing and duration of anti-ageing CR on liver autophagic proteolysis (AP) were explored in male AL Sprague-Dawley rats aged 2-, 6-, 12- and 24-months; and 24-month-old rats on a CR diet initiated at 2-, 6- and 12-month of age or initiated at age 2-months and interrupted at age 18 months. The age-related changes in the regulation of AP were studied by monitoring the rate of valine release in the incubation medium from isolated liver cells by an HPLC procedure. Results show that the maximum attainable rate and the regulation of AP decline with increasing age; that changes are prevented by anti-ageing CR initiated at young age, that the protective effects of CR change with the duration of diet. It is concluded that the data are compatible with the hypothesis that AP and improved membrane maintenance might be involved in the antiageing mechanism of CR. (C) 2001 Elsevier Science Inc. All rights reserved.
C1 Biotecnol Med Infettivol & Epidemiol, Dipartimento Patol Sperimentale, I-56126 Pisa, Italy.
RP Bergamini, E (corresponding author), Biotecnol Med Infettivol & Epidemiol, Dipartimento Patol Sperimentale, Via Roma 55, I-56126 Pisa, Italy.
CR BEAUCHENE RE, 1986, J GERONTOL, V41, P13, DOI 10.1093/geronj/41.1.13
   Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374
   BERGAMINI E, 1999, AGING CLIN EXP RES
   Bergamini E., 1990, PROTEIN METABOLISM A, V9, P361
   BERTRAND HA, 1999, METHODS AGING RES, P271
   Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x
   CONCONI M, 1996, ARCH BIOCHEM BIOPHYS, V309, P24
   COTRAN SC, 1999, ROBBINS PATHOLOGIC B, P25
   DONATI A, 2001, IN PRESS J GERONTOL
   HIGAMI Y, 1994, J GERONTOL, V49, pB239, DOI 10.1093/geronj/49.5.B239
   IVY GO, 1991, MECH AGEING DEV, V57, P213, DOI 10.1016/0047-6374(91)90048-5
   Ivy GO, 1996, ANN NY ACAD SCI, V786, P12, DOI 10.1111/j.1749-6632.1996.tb39048.x
   IVY GO, 1984, SCIENCE, V226, P985, DOI 10.1126/science.6505679
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lipman RD, 1998, AGING CLIN EXP RES, V10, P463, DOI 10.1007/BF03340160
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   Masoro Edward J., 1995, P3
   Masoro EJ, 1996, TOXICOL PATHOL, V24, P738, DOI 10.1177/019262339602400617
   MASORO EJ, 1995, EXP GERONTOL, V30, P291, DOI 10.1016/0531-5565(94)00028-2
   MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543
   MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105
   Pugh TD, 1999, CANCER RES, V59, P1642
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   SEGLEN PO, 1980, BIOCHIM BIOPHYS ACTA, V630, P103, DOI 10.1016/0304-4165(80)90141-5
   Sell DR, 1996, P NATL ACAD SCI USA, V93, P485, DOI 10.1073/pnas.93.1.485
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   TAPHUI Y, 1981, ANAL BIOCHEM, V115, P123
   VENERANDO R, 1994, AM J PHYSIOL, V266, P455
   Vittorini S, 1995, AGING-CLIN EXP RES, V7, P476, DOI 10.1007/BF03324376
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   Yu Byung P., 1995, P613
NR 35
TC 60
Z9 63
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAR
PY 2001
VL 36
IS 3
BP 497
EP 506
DI 10.1016/S0531-5565(00)00224-2
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 412BG
UT WOS:000167533700010
PM 11250121
DA 2024-02-19
ER

PT J
AU Barogi, S
   Baracca, A
   Castelli, GP
   Bovina, C
   Formiggini, G
   Marchetti, M
   Solaini, G
   Lenaz, G
AF Barogi, S
   Baracca, A
   Castelli, GP
   Bovina, C
   Formiggini, G
   Marchetti, M
   Solaini, G
   Lenaz, G
TI Lack of major changes in ATPase activity in mitochondria from liver,
   heart, and skeletal muscle of rats upon ageing
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE ageing; ATPase; mitochondria
ID CYTOCHROME-C-OXIDASE; ADENOSINE-TRIPHOSPHATASE; INHIBITOR PROTEIN;
   KINETIC MECHANISM; DEPENDENT CHANGES; CARDIAC-MUSCLE; DNA DAMAGE;
   SYNTHASE; DELETION; DISEASE
AB ATP hydrolase activity has been investigated in mitochondria from liver, heart, and skeletal muscle from adult (6 months) and aged (24 months) rats. No significant changes in total ATPase activity were observed in the three tissues, but the oligomycin sensitivity was slightly decreased in heart mitochondria of aged rats. The bicarbonate-induced stimulation of hydrolytic activity was somewhat decreased in mitochondria from aged rats, particularly in liver. No significant change was observed in ATPase activity after release of the endogenous inhibitor protein, IF1. It is concluded that no activity changes to be directly ascribed to the catalytic sector F-1 of the enzyme occur upon ageing, but it cannot be excluded that changes in the membrane sector F-0 occur as a consequence of mtDNA mutations.
C1 SCUOLA SUPER SANT ANNA, PISA, ITALY.
C3 Scuola Superiore Sant'Anna
RP Barogi, S (corresponding author), UNIV BOLOGNA, DEPT BIOCHIM G MORUZZI, VIA IRNERIO 48, I-40126 BOLOGNA, ITALY.
OI SOLAINI, GIANCARLO/0000-0001-7825-0446; BARACCA,
   ALESSANDRA/0000-0002-0490-1776
CR AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   BARACCA A, 1994, BIOCHEM BIOPH RES CO, V199, P99, DOI 10.1006/bbrc.1994.1200
   BEYER RE, 1987, CHEM SCRIPTA, V27, P145
   BRADLEY MO, 1976, J BIOL CHEM, V251, P3521
   CASTELLUCCIO C, 1994, MECH AGEING DEV, V76, P73, DOI 10.1016/0047-6374(94)91583-0
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   CRETIN F, 1991, BIOCHIM BIOPHYS ACTA, V1058, P141, DOI 10.1016/S0005-2728(05)80230-0
   DAS AM, 1989, FEBS LETT, V256, P97, DOI 10.1016/0014-5793(89)81725-9
   DiMauro S., 1993, Mitochondrial DNA in Human Pathology
   DIVITA G, 1992, BIOCHEMISTRY-US, V31, P5791, DOI 10.1021/bi00140a015
   EBEL RE, 1975, J BIOL CHEM, V250, P191
   FEARNLEY IM, 1986, EMBO J, V5, P2003, DOI 10.1002/j.1460-2075.1986.tb04456.x
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   GUERRIERI F, 1994, BIOCHEM MOL BIOL INT, V33, P117
   GUERRIERI F, 1992, ARCH GERONTOL GERIAT, V14, P299, DOI 10.1016/0167-4943(92)90029-4
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561
   HOLT IJ, 1990, AM J HUM GENET, V46, P428
   Kun E, 1979, Methods Enzymol, V55, P115
   LEE CP, 1968, EUR J BIOCHEM, V3, P391, DOI 10.1111/j.1432-1033.1967.tb19542.x
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LIPPE G, 1993, BIOCHEM MOL BIOL INT, V30, P1061
   LIPPE G, 1991, BIOCHEM BIOPH RES CO, V181, P764, DOI 10.1016/0006-291X(91)91256-C
   MANZELMANN MS, 1987, MECH AGEING DEV, V39, P281, DOI 10.1016/0047-6374(87)90067-4
   MARINETTI GV, 1962, J LIPID RES, V3, P1
   MILGROM YM, 1991, EUR J BIOCHEM, V200, P789, DOI 10.1111/j.1432-1033.1991.tb16246.x
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MIQUEL J, 1984, EXP GERONTOL, V19, P31, DOI 10.1016/0531-5565(84)90029-9
   MULLERHOCKER J, 1992, MUTAT RES, V275, P115, DOI 10.1016/0921-8734(92)90016-I
   MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510X(90)90006-9
   MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167
   MUNSCHER C, 1993, FEBS LETT, V317, P27, DOI 10.1016/0014-5793(93)81484-H
   PENEFSKY HS, 1985, P NATL ACAD SCI USA, V82, P1589, DOI 10.1073/pnas.82.6.1589
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   ROBINSON BH, 1992, EUR J PEDIATR, V151, P347, DOI 10.1007/BF02113256
   ROBINSON BH, 1994, J BIOENERG BIOMEMBR, V26, P311, DOI 10.1007/BF00763102
   ROUSLIN W, 1989, ARCH BIOCHEM BIOPHYS, V275, P385, DOI 10.1016/0003-9861(89)90386-X
   ROUSLIN W, 1991, J BIOENERG BIOMEMBR, V23, P873, DOI 10.1007/BF00786006
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SOLAINI G, 1993, EUR J BIOCHEM, V214, P729, DOI 10.1111/j.1432-1033.1993.tb17974.x
   STADTMAN ER, 1991, J BIOL CHEM, V266, P2005
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0
   TZAGOLOFF A, 1986, ANNU REV BIOCHEM, V55, P249, DOI 10.1146/annurev.biochem.55.1.249
   VASILYEVA EA, 1982, BIOCHEM J, V202, P15, DOI 10.1042/bj2020015
   VASILYEVA EA, 1982, BIOCHEM J, V202, P9, DOI 10.1042/bj2020009
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
NR 52
TC 23
Z9 25
U1 0
U2 4
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD OCT 13
PY 1995
VL 84
IS 2
BP 139
EP 150
DI 10.1016/0047-6374(95)01640-6
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TN372
UT WOS:A1995TN37200005
PM 8788241
DA 2024-02-19
ER

PT J
AU Weiskirchen, R
   Tacke, F
AF Weiskirchen, Ralf
   Tacke, Frank
TI Liver Fibrosis: From Pathogenesis to Novel Therapies
SO DIGESTIVE DISEASES
LA English
DT Article
DE Liver fibrosis; Macrophages; Chemokine; Matrix; Regression;
   Translational medicine; Hepatic stellate cell; Myofibroblast; Gut-liver
   axis; Microbiome
ID HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; MACROPHAGE
   INFILTRATION; TGF-BETA; PHARMACOLOGICAL INHIBITION; CELLULAR SENESCENCE;
   CRYSTAL-STRUCTURE; TISSUE INHIBITOR; INJURED LIVER; MICE
AB Chronic liver injury is accompanied by a dysbalanced scarring process, termed fibrosis. This process is mainly driven by chronic inflammation and an altered activity of a multitude of different chemokines and cytokines, resulting in the infiltration by immune cells (especially macrophages) and increase of matrix-expressing cell types. These processes might lead to cirrhosis representing the end-stage of fibrosis. Recent clinical studies comprising patients successfully treated for viral hepatitis showed that liver fibrogenesis and even cirrhosis may be reverted. The hepatic capacity to remodel scar tissue and to revert into a normal liver follows specific mechanistic principles that include the termination of chronic tissue damage, shifting the cellular bias from inflammation to resolution, initiation of myofibroblast apoptosis or senescence and, finally, fibrinolysis of excess scar tissue. The plurality of molecular and cellular triggers involved in initiation, progression and resolution of hepatic fibrogenesis offers an infinite number of therapeutic possibilities. For instance, inflammatory macrophages can be targeted via inhibition of chemokine CCL2 or its receptor CCR2 (e.g., by cenicriviroc) as well as by transfer of restorative macrophage subsets. Another target is galectin-3 that acts at various stages along the continuum from acute to chronic inflammation. Profibrogenic cytokines (e.g., transforming growth factor-beta), matricellular proteins (e.g., CCN1/CYR61) or signaling pathways involved in fibrogenesis offer further possible targets. Other options are the application of therapeutic antibodies directed against components involved in biogenesis or remodeling of connective tissue such as lysyl oxidase-like-2 or synthetic bile acids like obeticholic acid that activate the farnesoid X receptor and was antifibrotic in a phase 2 study (FLINT trial). Factors affecting the gut barrier function or the intestinal microbiome further expanded the repertoire of drug targets. In this review, we discuss novel concepts in resolution of hepatic fibrosis and focus on drug targets that might be suitable to trigger resolution of fibrosis. (C) 2016 S. Karger AG, Basel
C1 [Weiskirchen, Ralf] RWTH Univ Hosp Aachen, Inst Mol Pathobiochem Expt Gene Therapy & Clin Ch, Aachen, Germany.
   [Tacke, Frank] Univ Hosp Aachen, Dept Med 3, Pauwelsstr 30, DE-52074 Aachen, Germany.
C3 RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen
   University; RWTH Aachen University Hospital
RP Tacke, F (corresponding author), Univ Hosp Aachen, Dept Med 3, Pauwelsstr 30, DE-52074 Aachen, Germany.
EM frank.tacke@gmx.net
RI Weiskirchen, Ralf/O-1734-2018; Tacke, Frank/ABF-2212-2020
OI Weiskirchen, Ralf/0000-0003-3888-0931; 
FU German Research Foundation (DFG) [SFB/TRR57, TA434/3-1];
   Interdisciplinary Centre for Clinical Research within the Faculty of
   Medicine at the RWTH Aachen University
FX This work was supported by the German Research Foundation (DFG;
   SFB/TRR57, TA434/3-1) and grants from the Interdisciplinary Centre for
   Clinical Research within the Faculty of Medicine at the RWTH Aachen
   University.
CR Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783
   Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304
   Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208
   Benyon RC, 1996, GASTROENTEROLOGY, V110, P821, DOI 10.1053/gast.1996.v110.pm8608892
   Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732
   Bian ZL, 2013, J LIPID RES, V54, P44, DOI 10.1194/jlr.M026013
   Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023
   Bryant CE, 2015, MOL IMMUNOL, V63, P162, DOI 10.1016/j.molimm.2014.06.033
   Coombes JD, 2015, GUT, V64, P1120, DOI 10.1136/gutjnl-2013-306484
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   de Moura PR, 2009, FEBS LETT, V583, P1072, DOI 10.1016/j.febslet.2009.03.006
   Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675
   Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020
   Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294
   Ehling J, 2013, HEPATOLOGY, V58, P1517, DOI 10.1002/hep.26326
   Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024
   Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4
   Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713
   Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x
   Guillot A, 2014, HEPATOLOGY, V59, P296, DOI 10.1002/hep.26598
   Hammerich L, 2014, HEPATOLOGY, V59, P630, DOI 10.1002/hep.26697
   Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x
   Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477
   Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599
   Iredale JP, 2013, BBA-MOL BASIS DIS, V1832, P876, DOI 10.1016/j.bbadis.2012.11.002
   Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1053/jhep.1996.v24.pm0008707259
   Issa R, 2002, FASEB J, V16, P47, DOI 10.1096/fj.02-0494fje
   Jiao JJ, 2012, HEPATOLOGY, V55, P243, DOI 10.1002/hep.24621
   Kantari-Mimoun C, 2015, HEPATOLOGY, V61, P2042, DOI 10.1002/hep.27635
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   King A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007700
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1
   Li LC, 2014, J PHARMACOL EXP THER, V351, P336, DOI 10.1124/jpet.114.218370
   Liaskou E, 2013, HEPATOLOGY, V57, P385, DOI 10.1002/hep.26016
   Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018
   Mallat A, 2013, J HEPATOL, V59, P891, DOI 10.1016/j.jhep.2013.03.032
   Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1
   Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043
   Mazagova M, 2015, FASEB J, V29, P1043, DOI 10.1096/fj.14-259515
   Mehal WZ, 2015, SEMIN LIVER DIS, V35, P184, DOI 10.1055/s-0035-1550055
   Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020
   Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4
   Oberthür D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7923
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Pellicoro A, 2012, HEPATOLOGY, V55, P1965, DOI 10.1002/hep.25567
   POWELL WJ, 1968, AM J MED, V44, P406, DOI 10.1016/0002-9343(68)90111-3
   Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109
   Ratziu V, 2015, J HEPATOL, V62, pS65, DOI 10.1016/j.jhep.2015.02.041
   Rocky D, 1997, HEPATOLOGY, V25, P2, DOI 10.1002/hep.510250102
   Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com
   Roeb E, 2015, Z GASTROENTEROL, V53, P668, DOI 10.1055/s-0035-1553193
   Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151
   Schneider KM, 2015, HEPATOLOGY, V62, P1405, DOI 10.1002/hep.27982
   Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332
   Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691
   Seki E, 2011, HEPATOL RES, V41, P597, DOI 10.1111/j.1872-034X.2011.00822.x
   Sertorio M, 2015, HEPATOLOGY, V61, P1321, DOI 10.1002/hep.27629
   Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641
   Tacke F, 2015, J HEPATOL, V63, P1038, DOI 10.1016/j.jhep.2015.03.039
   Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025
   Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551
   Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315
   Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115
   Traber PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075361
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Weiskirchen R, 2011, FRONT BIOSCI-LANDMRK, V16, P1939, DOI 10.2741/3832
   Wong CCL, 2014, HEPATOLOGY, V60, P1645, DOI 10.1002/hep.27320
   Yang L, 2014, GASTROENTEROLOGY, V146, P1339, DOI 10.1053/j.gastro.2014.01.061
   Yatime L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7481
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200
NR 81
TC 107
Z9 125
U1 2
U2 42
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0257-2753
EI 1421-9875
J9 DIGEST DIS
JI Dig. Dis.
PY 2016
VL 34
IS 4
BP 410
EP 422
DI 10.1159/000444556
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DL6WS
UT WOS:000375781300017
PM 27170396
DA 2024-02-19
ER

PT J
AU Ong, QR
   Chan, ES
   Lim, ML
   Wong, BS
AF Ong, Qi-Rui
   Chan, Elizabeth S.
   Lim, Mei-Li
   Wong, Boon-Seng
TI Expression of human apolipoprotein E4 reduces insulin-receptor substrate
   1 expression and Akt phosphorylation in the ageing liver
SO FEBS OPEN BIO
LA English
DT Article
DE Liver insulin signaling; ApoE; Akt signaling; Ageing
ID APOE GENOTYPE; ALZHEIMERS-DISEASE; TRANSPORT PROTEIN; LIFE-SPAN; BRAIN;
   MICE; GLUCOSE; ATHEROSCLEROSIS; SENSITIVITY; HOMEOSTASIS
AB The diabetic drug rosiglitazone was reported to improve glucose tolerance in insulin-resistant ApoE3 but not ApoE4 knock-in mice. We therefore examined whether apolipoprotein E (ApoE) has genotype-specific effects on liver insulin function. At 12 weeks, no difference in liver insulin signaling was detected between fasting ApoE3 and ApoE4 mice. At 72 weeks however, ApoE4 mice had lower IRS-1 and PI3K expression, and reduced Akt phosphorylation. This decline was associated with lower insulin and higher glucose in ApoE4 mouse liver. Liver cholesterol was not affected. These results show that ApoE4 expression reduces liver insulin signaling and insulin levels, leading to higher glucose content. (C) 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This is an open access article under the CC BY-NC-ND license.
C1 [Ong, Qi-Rui; Chan, Elizabeth S.; Lim, Mei-Li; Wong, Boon-Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.
C3 National University of Singapore
RP Wong, BS (corresponding author), Natl Univ Singapore, Dept Physiol, 2 Med Dr MD9, Singapore 117597, Singapore.
EM bswong@nus.edu.sg
RI Wong, Boon-Seng/G-2759-2012
OI Wong, Boon-Seng/0000-0002-7118-8077
FU National Medical Research Council [NMRC/1148/2008]; Biomedical Research
   Council [BMRC/05/1/21/19/401]; Singapore Ministry of Education
FX This work was supported by grants to BSW from the National Medical
   Research Council (NMRC/1148/2008) and the Biomedical Research Council
   (BMRC/05/1/21/19/401). QRO and ESC were supported by graduate
   scholarships from Singapore Ministry of Education. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Arbones-Mainar JM, 2010, FASEB J, V24, P3809, DOI 10.1096/fj.10-159517
   Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239
   Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319
   Chua LM, 2012, J ALZHEIMERS DIS, V29, P783, DOI 10.3233/JAD-2012-111880
   Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8
   Elosua R, 2003, OBES RES, V11, P1502, DOI 10.1038/oby.2003.201
   Haan MN, 1999, JAMA-J AM MED ASSOC, V282, P40, DOI 10.1001/jama.282.1.40
   Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005
   Jagust WJ, 2011, TRENDS COGN SCI, V15, P520, DOI 10.1016/j.tics.2011.09.004
   Johnson LA, 2011, DIABETES, V60, P2285, DOI 10.2337/db11-0466
   Ketterer C, 2011, DIABETES RES CLIN PR, V93, pS47, DOI 10.1016/S0168-8227(11)70013-4
   Liu F, 2010, NEUROBIOL AGING, V31, P1831, DOI 10.1016/j.neurobiolaging.2008.09.015
   Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507
   MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935
   Mosconi L, 2004, PSYCHIAT RES-NEUROIM, V130, P141, DOI 10.1016/j.pscychresns.2003.12.005
   Ong QR, 2014, SCI REP-UK, V4, DOI 10.1038/srep03754
   Ong QR, 2012, BIOCHEM BIOPH RES CO, V424, P482, DOI 10.1016/j.bbrc.2012.06.139
   Ott V, 2012, DIABETES OBES METAB, V14, P214, DOI 10.1111/j.1463-1326.2011.01490.x
   Pendse AA, 2009, J LIPID RES, V50, pS178, DOI 10.1194/jlr.R800070-JLR200
   RALL SC, 1982, J BIOL CHEM, V257, P4171
   Reger MA, 2006, NEUROBIOL AGING, V27, P451, DOI 10.1016/j.neurobiolaging.2005.03.016
   Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008
   Samuraki M, 2012, NEUROBIOL AGING, V33, P2321, DOI 10.1016/j.neurobiolaging.2011.11.020
   Shen L, 2011, PHYSIOL BEHAV, V105, P124, DOI 10.1016/j.physbeh.2011.04.018
   Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011
   Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972
   Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179
   To AWM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016991
   ZANNIS VI, 1982, J BIOL CHEM, V257, P536
   ZANNIS VI, 1984, J BIOL CHEM, V259, P5495
NR 30
TC 8
Z9 9
U1 0
U2 6
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 2211-5463
J9 FEBS OPEN BIO
JI FEBS Open Bio
PY 2014
VL 4
BP 260
EP 265
DI 10.1016/j.fob.2014.02.011
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AW4WL
UT WOS:000346278200032
PM 24649407
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Malatesta, M
   Bertoni-Freddari, C
   Fattoretti, P
   Caporaloni, C
   Fakan, S
   Gazzanelli, G
AF Malatesta, M
   Bertoni-Freddari, C
   Fattoretti, P
   Caporaloni, C
   Fakan, S
   Gazzanelli, G
TI Altered RNA structural constituents in aging and vitamin E deficiency
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; vitamin E-deficiency; hepatocyte; nucleus; nucleolus; RNA
ID RAT-LIVER; RIBONUCLEOPROTEIN CONSTITUENTS; PERICHROMATIN FIBRILS;
   NUCLEUS; NUCLEOLUS; CELLS; TRANSCRIPTION; ACCUMULATION; NEURONS; DAMAGE
AB Ribonucleoprotein (RNP) containing structural constituents in hepatocyte nuclei of adult, old and adult, vitamin E-deficient rats were investigated to assess the effect of aging and increased oxidative stress on nuclear functions. Fibrillar centres (FCs), dense fibrillar (DFC) and granular (GC) components of nucleoli as well as perichromatin granules (PGs) in the nucleoplasm were preferentially evidenced by the ethylenediaminetetracetic acid (EDTA) method and measured by computer-assisted morphometric procedures. FCs size and the percentage of nucleolar surface occupied by FCs significantly decreased during aging and vitamin E-deficiency. The percentage of nucleolar surface occupied by GC and DFC remained unchanged in adult and old rats, but in vitamin E-deficient animals GC increased and DFC decreased significantly. PG density significantly changed in aging and vitamin E-deficiency. Functionally, FCs, DFC and GC constitute sites of transcription and processing of ribosomal RNA while PGs are involved in intranuclear storage and transport of messenger RNA. Thus, the present structural changes during aging and vitamin E-deficiency correlate with a decay of nuclear responsiveness to cellular metabolic needs. Considering the antioxidant action of alpha-tocopherol, our data lend further support to the importance of free radical production and control in the aging process. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
C1 INRCA Res Dept, Neurobiol Aging Lab, I-60121 Ancona, Italy.
   Univ Urbino, Ist Istol & Analisi Lab, I-61029 Urbino, Italy.
   Univ Lausanne, Ctr Electron Microscopy, Lausanne, Switzerland.
C3 IRCCS INRCA; University of Urbino; University of Lausanne
RP Bertoni-Freddari, C (corresponding author), INRCA Res Dept, Neurobiol Aging Lab, Via Birarelli 8, I-60121 Ancona, Italy.
EM c.bertoni@inrca.it
RI Fattoretti, Patrizia/A-8152-2011
OI Fattoretti, Patrizia/0000-0003-1998-0080; MALATESTA,
   Manuela/0000-0001-8196-9232
CR BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X
   Bertoni-Freddari C, 1997, CELL BIOL INT, V21, P671, DOI 10.1006/cbir.1997.0154
   BERTONIFREDDARI C, 1995, SCANNING MICROSCOPY, V9, P289
   BERTONIFREDDARI C, 1984, MECH AGEING DEV, V24, P225, DOI 10.1016/0047-6374(84)90073-3
   Biggiogera M, 2001, J CELL SCI, V114, P3199
   BRUST R, 1986, MOL BIOL REP, V11, P213, DOI 10.1007/BF00419599
   BURTON GW, 1989, ANN NY ACAD SCI, V570, P7
   Cmarko D, 2000, HISTOCHEM CELL BIOL, V113, P181, DOI 10.1007/s004180050437
   DOWSON JH, 1992, ARCH GERONTOL GERIAT, V14, P239, DOI 10.1016/0167-4943(92)90024-X
   Evstigneeva R P, 1998, Membr Cell Biol, V12, P151
   Fakan S, 1980, Int Rev Cytol, V65, P255
   Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5
   FRAGA CG, 1989, ARCH BIOCHEM BIOPHYS, V270, P84, DOI 10.1016/0003-9861(89)90010-6
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Imai S, 1998, EXP GERONTOL, V33, P555
   JIMENEZGARCIA LF, 1993, EXP CELL RES, V207, P220, DOI 10.1006/excr.1993.1186
   LAFARGA M, 1993, ANAT EMBRYOL, V187, P363
   MA HJ, 1990, CELL MOL BIOL, V36, P589
   MONNERON A, 1969, J ULTRA MOL STRUCT R, V27, P266, DOI 10.1016/S0022-5320(69)80017-1
   PARK GH, 1990, GERONTOLOGY, V36, P61
   PARK GH, 1990, GERONTOLOGY, V36, P76
   PUVION E, 1977, BIOL CELLULAIRE, V29, P81
   Puvion E, 1996, EXP CELL RES, V229, P217, DOI 10.1006/excr.1996.0363
   PUVIONDUTILLEUI F, 1981, J ULTRA MOL STRUCT R, V74, P341, DOI 10.1016/S0022-5320(81)80125-6
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   SCHWARZACHER HG, 1993, ANAT EMBRYOL, V188, P515
   Shaw PJ, 1995, ANNU REV CELL DEV BI, V11, P93, DOI 10.1146/annurev.cellbio.11.1.93
   Spector DL, 1996, EXP CELL RES, V229, P189, DOI 10.1006/excr.1996.0358
   SUMMERFIELD FW, 1984, ARCH BIOCHEM BIOPHYS, V233, P408, DOI 10.1016/0003-9861(84)90462-4
   VAZQUEZNIN GH, 1979, BIOL CELLULAIRE, V35, P221
   Villeponteau B, 1997, EXP GERONTOL, V32, P383, DOI 10.1016/S0531-5565(96)00155-6
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   ZANCANARO C, 1993, BIOL CELL, V79, P55, DOI 10.1016/0248-4900(93)90263-E
NR 33
TC 22
Z9 23
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD FEB
PY 2003
VL 124
IS 2
BP 175
EP 181
AR PII S0047-6374(02)00117-3
DI 10.1016/S0047-6374(02)00117-3
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 665BM
UT WOS:000182099800005
PM 12633937
DA 2024-02-19
ER

PT J
AU Carrier, N
   Connat, JL
AF Carrier, N
   Connat, JL
TI CGRP innervation and receptors during aging of male and female hepatic
   rat portal veins
SO NEUROBIOLOGY OF AGING
LA English
DT Article
DE aging; innervation; calcitonin gene-related peptide; gender; histamine;
   portal vein; rat; pharmacology; substance P
ID GENE-RELATED PEPTIDE; VASCULAR SMOOTH-MUSCLE; MESSENGER-RNA EXPRESSION;
   NERVE GROWTH-FACTOR; CALCITONIN-GENE; GUINEA-PIG; ENDOTHELIAL-CELLS;
   BINDING-SITES; SUBSTANCE-P; IMMUNOREACTIVITY
AB Calcitonin gene-related peptide (CGRP) innervation and binding sites were studied on hepatic portal veins of male and female rats from 19 days to 22 months of age. CGRP containing nerve fibers were present both in adventitial and medial nerve plexuses, closely apposing to or penetrating into the muscular layers. The density of CGRP innervation was estimated on whole mount preparations and compared during aging. In females, aging did not affect the number of fibers per unit length, although the vessel circumference decreased after 6 months of age. In males, the vessel circumference remained constant during aging, while the density of innervation significantly decreased. Whatever the age or sex of the animals was, no CGRP binding sites were found on portal veins sections by autoradiography. CGRP had no effect on spontaneous contractions of perfused portal veins. The difference observed in the evolution of CGRP innervation density between males and females suggests that CGRP innervation in the rat portal vein may be influenced by gonadal steroids during aging.
C1 CNRS, URA DEV 674, DEPT ANIM BIOL, F-21000 DIJON, FRANCE.
C3 Centre National de la Recherche Scientifique (CNRS)
RI Goodman, Jack M/C-4607-2015
OI Goodman, Jack M/0000-0003-1487-4975; Connat,
   Jean-Louis/0000-0002-2885-2323
CR AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0
   AMARA SG, 1985, SCIENCE, V229, P1094, DOI 10.1126/science.2994212
   BELAI A, 1987, GASTROENTEROLOGY, V92, P730, DOI 10.1016/0016-5085(87)90025-4
   BENY JL, 1989, REGUL PEPTIDES, V25, P25, DOI 10.1016/0167-0115(89)90245-0
   BRAIN SD, 1985, NATURE, V313, P54, DOI 10.1038/313054a0
   BRATVEIT M, 1987, ACTA PHYSIOL SCAND, V130, P593, DOI 10.1111/j.1748-1716.1987.tb08181.x
   BRATVEIT M, 1991, REGUL PEPTIDES, V33, P331, DOI 10.1016/0167-0115(91)90235-9
   Burnstock G., 1974, DYNAMICS DEGENERATIO, P509
   CLAGUE JR, 1985, NEUROSCI LETT, V56, P63, DOI 10.1016/0304-3940(85)90441-0
   CONNAT JL, 1992, ANN NY ACAD SCI, V657, P444, DOI 10.1111/j.1749-6632.1992.tb22795.x
   CORR LA, 1991, J CARDIOVASC PHARM, V18, P144, DOI 10.1097/00005344-199107000-00019
   CREEDON D, 1991, HYPERTENSION, V18, P730, DOI 10.1161/01.HYP.18.6.730
   DENISDONINI S, 1989, NATURE, V339, P701, DOI 10.1038/339701a0
   DHALL U, 1986, J AUTONOM NERV SYST, V16, P109, DOI 10.1016/0165-1838(86)90003-2
   DHITAL KK, 1988, BRAIN RES, V444, P33, DOI 10.1016/0006-8993(88)90910-9
   DOBIE DJ, 1992, BRAIN RES, V583, P247, DOI 10.1016/S0006-8993(10)80030-7
   FISHER LA, 1983, NATURE, V305, P534, DOI 10.1038/305534a0
   GILLARDON F, 1991, NEUROSCI LETT, V125, P77, DOI 10.1016/0304-3940(91)90135-G
   GON G, 1990, ENDOCRINOLOGY, V127, P2618, DOI 10.1210/endo-127-6-2618
   GULBENKIAN S, 1986, J NEUROCYTOL, V15, P535, DOI 10.1007/BF01611735
   HAEGERSTRAND A, 1990, P NATL ACAD SCI USA, V87, P3299, DOI 10.1073/pnas.87.9.3299
   HIRATA Y, 1988, BIOCHEM BIOPH RES CO, V151, P1113, DOI 10.1016/S0006-291X(88)80481-9
   KAWASAKI H, 1990, CIRC RES, V67, P733, DOI 10.1161/01.RES.67.3.733
   KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513
   LEFEVRE J, 1988, BIOL REPROD, V38, P780, DOI 10.1095/biolreprod38.4.780
   LENNETTE DA, 1978, AM J CLIN PATHOL, V69, P647
   LJUNG B, 1975, ACTA PHYSIOL SCAND, V94, P112, DOI 10.1111/j.1748-1716.1975.tb05867.x
   MULDERRY PK, 1985, NEUROSCIENCE, V14, P947, DOI 10.1016/0306-4522(85)90156-3
   NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0
   ODY M, 1993, CELL TISSUE RES, V272, P303, DOI 10.1007/BF00302735
   POPPER P, 1990, MOL BRAIN RES, V8, P159, DOI 10.1016/0169-328X(90)90060-Q
   ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0
   SASAKI Y, 1986, HEPATOLOGY, V6, P676, DOI 10.1002/hep.1840060423
   SIGRIST S, 1986, ENDOCRINOLOGY, V119, P381, DOI 10.1210/endo-119-1-381
   THIEVENT A, 1993, J AUTONOM NERV SYST, V44, P233, DOI 10.1016/0165-1838(93)90036-T
   THOM SM, 1987, BRIT J CLIN PHARMACO, V24, P139, DOI 10.1111/j.1365-2125.1987.tb03154.x
   TSAO C, 1971, ANAT RECORD, V171, P457, DOI 10.1002/ar.1091710403
   UMEDA Y, 1992, ANN NY ACAD SCI, V657, P552, DOI 10.1111/j.1749-6632.1992.tb22832.x
   WHARTON J, 1986, J AUTONOM NERV SYST, V16, P289, DOI 10.1016/0165-1838(86)90035-4
   WIMALAWANSA SJ, 1987, NEUROENDOCRINOLOGY, V46, P131, DOI 10.1159/000124809
   ZHANG A, 1992, BRIT J PHARMACOL, V105, P305, DOI 10.1111/j.1476-5381.1992.tb14250.x
NR 41
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0197-4580
EI 1558-1497
J9 NEUROBIOL AGING
JI Neurobiol. Aging
PD JAN-FEB
PY 1996
VL 17
IS 1
BP 53
EP 60
DI 10.1016/0197-4580(95)02027-6
PG 8
WC Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Neurosciences & Neurology
GA TK807
UT WOS:A1996TK80700008
PM 8786803
DA 2024-02-19
ER

PT J
AU Grigorash, BB
   van Essen, D
   Liang, GX
   Grosse, L
   Emelyanov, A
   Kang, ZX
   Korablev, A
   Kanzler, B
   Molina, C
   Lopez, E
   Demidov, ON
   Garrido, C
   Liu, F
   Saccani, S
   Bulavin, DV
AF Grigorash, Bogdan B.
   van Essen, Dominic
   Liang, Guixian
   Grosse, Laurent
   Emelyanov, Alexander
   Kang, Zhixin
   Korablev, Alexey
   Kanzler, Benoit
   Molina, Clement
   Lopez, Elsa
   Demidov, Oleg N.
   Garrido, Carmen
   Liu, Feng
   Saccani, Simona
   Bulavin, Dmitry V.
TI p16<SUP>High</SUP> senescence restricts cellular plasticity during
   somatic cell reprogramming
SO NATURE CELL BIOLOGY
LA English
DT Article; Early Access
ID STEM-CELLS; MOUSE; RETROTRANSPOSITION
AB Despite advances in four-factor (4F)-induced reprogramming (4FR) in vitro and in vivo, how 4FR interconnects with senescence remains largely under investigated. Here, using genetic and chemical approaches to manipulate senescent cells, we show that removal of p16High cells resulted in the 4FR of somatic cells into totipotent-like stem cells. These cells expressed markers of both pluripotency and the two-cell embryonic state, readily formed implantation-competent blastoids and, following morula aggregation, contributed to embryonic and extraembryonic lineages. We identified senescence-dependent regulation of nicotinamide N-methyltransferase as a key mechanism controlling the S-adenosyl-l-methionine levels during 4FR that was required for expression of the two-cell genes and acquisition of an extraembryonic potential. Importantly, a partial 4F epigenetic reprogramming in old mice was able to reverse several markers of liver aging only in conjunction with the depletion of p16High cells. Our results show that the presence of p16High senescent cells limits cell plasticity, whereas their depletion can promote a totipotent-like state and histopathological tissue rejuvenation during 4F reprogramming.
C1 [Grigorash, Bogdan B.; van Essen, Dominic; Grosse, Laurent; Emelyanov, Alexander; Korablev, Alexey; Molina, Clement; Saccani, Simona; Bulavin, Dmitry V.] Univ Cote Azur, Inst Res Canc & Aging Nice IRCAN, CNRS, INSERM, Nice, France.
   [Grigorash, Bogdan B.; Demidov, Oleg N.; Garrido, Carmen] Univ Burgundy Franche Comte, INSERM, UMR1231, LipSTIC, Dijon, France.
   [Liang, Guixian; Kang, Zhixin; Liu, Feng] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Stem Cell & Regenerat, State Key Lab Membrane Biol,Inst Zool, Beijing, Peoples R China.
   [Liang, Guixian; Kang, Zhixin; Liu, Feng] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China.
   [Kanzler, Benoit; Lopez, Elsa] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany.
   [Demidov, Oleg N.] RAS, Inst Cytol, St Petersburg, Russia.
   [Demidov, Oleg N.] Sirius Univ, Soci, Russia.
   [Liu, Feng] Shandong Univ, Sch Life Sci, Qingdao, Peoples R China.
C3 Centre National de la Recherche Scientifique (CNRS); Universite Cote
   d'Azur; Institut National de la Sante et de la Recherche Medicale
   (Inserm); Universite de Bourgogne; Institut Agro; AgroSup Dijon;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Chinese Academy of Sciences; University of Chinese Academy of Sciences,
   CAS; Chinese Academy of Sciences; Max Planck Society; Russian Academy of
   Sciences; St. Petersburg Scientific Centre of the Russian Academy of
   Sciences; Institute of Cytology RAS; Shandong University
RP Bulavin, DV (corresponding author), Univ Cote Azur, Inst Res Canc & Aging Nice IRCAN, CNRS, INSERM, Nice, France.
EM Dmitry.Bulavin@unice.fr
RI Alexey, Korablev/AAD-5621-2020; Demidov, Oleg/AAC-4462-2021; Garrido,
   Carmen/G-1633-2018; Grigorash, Bogdan/I-7436-2017
OI Alexey, Korablev/0000-0002-0571-6935; Demidov, Oleg/0000-0003-4323-7174;
   Garrido, Carmen/0000-0003-1368-1493; Grigorash,
   Bogdan/0000-0002-3836-7217
FU Ulysseus European University; Foundation FRM; ANR; INSERM programme
   'Agemed'; Agence Nationale de la Recherche; National Natural Science
   Foundation of China [31830061, 32030032]; RSF [19-75-20128]
FX B.B.G. is a recipient of the Vernadski bourse' scholarship given by the
   French government and a postdoctoral fellowship from Ulysseus European
   University. Research in the laboratory of D.V.B. is supported by the
   Foundation FRM, ANR and INSERM programme Agemed'. Research in the
   laboratory of S.S. is supported by the Agence Nationale de la Recherche,
   research in the laboratory of F.L. was supported by grants from the
   National Natural Science Foundation of China (31830061, 32030032) and
   research in the laboratory of O.N.D. was supported by RSF grant
   19-75-20128. We thank M. Serrano and H. Li for providing i4F mouse
   strains<SUP>19</SUP>. We thank W. Li (Institute of Zoology, Institute
   for Stem Cell and Regeneration, Beijing) and L. Chao (Institute of
   Zoology, Institute for Stem Cell and Regeneration, Beijing) for their
   assistance in morula aggregation and transplantation. We thank S. R.
   Jaffrey (Department of Pharmacology, Weill Medical College, Cornell
   University, New York, NY, USA) for providing SAM sensor
   plasmids<SUP>35</SUP>. We acknowledge the ImagingCore Facility (PICMI),
   histology, genomic and animal housing facilities of IRCAN supported by
   le Canceropole PACA, la Region PACA, le Conseil Departementale 06,
   l'INSERM, ARC, IBiSA and the Conseil Departemental 06 de la Region PACA.
CR Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609
   Chen TX, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00275
   Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116
   Chondronasiou D, 2022, AGING CELL, V21, DOI 10.1111/acel.13578
   Dey SK, 2022, NAT CHEM BIOL, V18, P180, DOI 10.1038/s41589-021-00925-0
   Fragola G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003292
   Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105
   Genet M, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.189688
   Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Hall BM, 2017, AGING-US, V9, P1867, DOI 10.18632/aging.101268
   Hishida T, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110730
   Huang Y, 2017, ELIFE, V6, DOI 10.7554/eLife.22345
   Jachowicz JW, 2017, NAT GENET, V49, P1502, DOI 10.1038/ng.3945
   Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290
   Li RH, 2019, CELL, V179, P687, DOI 10.1016/j.cell.2019.09.029
   Martinez-Val A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22181-5
   Morgani SM, 2013, CELL REP, V3, P1945, DOI 10.1016/j.celrep.2013.04.034
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052
   Posfai E, 2021, NAT CELL BIOL, V23, DOI 10.1038/s41556-020-00609-2
   Reddy P, 2021, CELL STEM CELL, V28, P5, DOI 10.1016/j.stem.2020.12.006
   Richardson SR, 2017, GENOME RES, V27, P1395, DOI 10.1101/gr.219022.116
   Ritschka B, 2020, GENE DEV, V34, P489, DOI 10.1101/gad.332643.119
   Riveiro AR, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.189845
   Roberti A, 2021, MOL METAB, V45, DOI 10.1016/j.molmet.2021.101165
   Shen H, 2021, CELL, V184, P2843, DOI 10.1016/j.cell.2021.04.020
   Sozen B, 2019, DEV CELL, V51, P698, DOI 10.1016/j.devcel.2019.11.014
   Sozen B, 2018, NAT CELL BIOL, V20, P979, DOI 10.1038/s41556-018-0147-7
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072
   Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285
   Vitullo P, 2012, MOL REPROD DEV, V79, P118, DOI 10.1002/mrd.22003
   Wyatt CDR, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abn4935
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yang MZ, 2022, CELL STEM CELL, V29, P400, DOI 10.1016/j.stem.2022.01.010
   Zhao J, 2021, NAT METAB, V3, P1372, DOI 10.1038/s42255-021-00464-x
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 42
TC 0
Z9 0
U1 3
U2 3
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1465-7392
EI 1476-4679
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD 2023 AUG 31
PY 2023
DI 10.1038/s41556-023-01214-9
EA AUG 2023
PG 35
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA R6EH6
UT WOS:001065260200001
PM 37652981
DA 2024-02-19
ER

PT J
AU Gohlke, S
   Mishto, M
   Textoris-Taube, K
   Keller, C
   Giannini, C
   Vasuri, F
   Capizzi, E
   D'Errico-Grigioni, A
   Kloetzel, PM
   Dahlmann, B
AF Gohlke, Sabrina
   Mishto, Michele
   Textoris-Taube, Kathrin
   Keller, Christin
   Giannini, Carolin
   Vasuri, Francesco
   Capizzi, Elisa
   D'Errico-Grigioni, Antonia
   Kloetzel, Peter-Michael
   Dahlmann, Burkhardt
TI Molecular alterations in proteasomes of rat liver during aging result in
   altered proteolytic activities
SO AGE
LA English
DT Article
DE Rat liver; Aging; Proteasome; Proteasome subpopulations; Proteasome
   subunits; Proteolytic activity
ID AGE-RELATED-CHANGES; OXIDATIVE STRESS; INTERFERON-GAMMA; 2-DIMENSIONAL
   ELECTROPHORESIS; CONSTITUTIVE PROTEASOME; AUTOPHAGIC PROTEOLYSIS;
   PEPTIDASE ACTIVITIES; PROTEIN-DEGRADATION; SUBUNIT COMPOSITION;
   FUNCTIONAL-ASPECTS
AB Aging induces alterations of tissue protein homoeostasis. To investigate one of the major systems catalysing intracellular protein degradation we have purified 20S proteasomes from rat liver of young (2 months) and aged (23 months) animals and separated them into three subpopulations containing different types of intermediate proteasomes with standard- and immuno-subunits. The smallest subpopulation I (TM) I (TM) I (TM) and the major subpopulation I (TM) comprised proteasomes containing immuno-subunits beta 1i and beta 5i beside small amounts of standard-subunits, whereas proteasomes of subpopulation I (TM) I (TM) contained only beta 5i beside standard-subunits. In favour of a relative increase of the major subpopulation I (TM), subpopulation I (TM) I (TM) and I (TM) I (TM) I (TM) were reduced for about 55 % and 80 %, respectively, in aged rats. Furthermore, in all three 20S proteasome subpopulations from aged animals standard-active site subunits were replaced by immuno-subunits. Overall, this transformation resulted in a relative increase of immuno-subunit-containing proteasomes, paralleled by reduced activity towards short fluorogenic peptide substrates. However, depending on the substrate their hydrolysing activity of long polypeptide substrates was significantly higher or unchanged. Furthermore, our data revealed an altered MHC class I antigen-processing efficiency of 20S proteasomes from liver of aged rats. We therefore suggest that the age-related intramolecular alteration of hepatic proteasomes modifies its cleavage preferences without a general decrease of its activity. Such modifications could have implications on protein homeostasis as well as on MHC class I antigen presentation as part of the immunosenescence process.
C1 [Gohlke, Sabrina; Mishto, Michele; Textoris-Taube, Kathrin; Keller, Christin; Giannini, Carolin; Kloetzel, Peter-Michael; Dahlmann, Burkhardt] Charite, CCM, ChariteCrossOver, Inst Biochem, D-10117 Berlin, Germany.
   [Mishto, Michele] Univ Bologna, Ctr Interdipartimentale Ric Canc Giorgio Prodi, Bologna, Italy.
   [Vasuri, Francesco; Capizzi, Elisa; D'Errico-Grigioni, Antonia] Univ Bologna, S Orsola Malpighi Hosp, F Addarii Inst Oncol & Transplant Pathol, Bologna, Italy.
C3 Free University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; University of Bologna; University of
   Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna
RP Dahlmann, B (corresponding author), Charite, CCM, ChariteCrossOver, Inst Biochem, Charitepl 1, D-10117 Berlin, Germany.
EM burkhardt.dahlmann@charite.de
RI Vasuri, Francesco/K-5418-2016; D'ERRICO, ANTONIETTA/HGU-1912-2022;
   mishto, michele/A-5592-2010
OI Vasuri, Francesco/0000-0002-1145-6025; D'ERRICO,
   ANTONIETTA/0000-0003-2747-3732; mishto, michele/0000-0003-3042-2792
FU Sonnenfeld-Stiftung, Berlin; Berliner Krebsgesellschaft [SEFF200907]
FX The authors thank Dr. P. Henklein for providing us with synthesized
   polypeptides, and Alexander Kloss and Andrea Lehmann for technical
   assistance. S.G. was supported by a PhD studentship from the
   Sonnenfeld-Stiftung, Berlin. B.D. was supported by the Berliner
   Krebsgesellschaft (SEFF200907).
CR Bardag-Gorce F, 2004, LIFE SCI, V75, P585, DOI 10.1016/j.lfs.2003.12.027
   BOES B, 1994, J EXP MED, V179, P901, DOI 10.1084/jem.179.3.901
   Breusing N, 2009, MECH AGEING DEV, V130, P748, DOI 10.1016/j.mad.2009.09.004
   Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155
   Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7
   Chapiro J, 2006, J IMMUNOL, V176, P1053, DOI 10.4049/jimmunol.176.2.1053
   Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004
   Conconi M, 1996, ARCH BIOCHEM BIOPHYS, V331, P232, DOI 10.1006/abbi.1996.0303
   Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57
   DAHLMANN B, 1985, BIOCHEM J, V228, P161, DOI 10.1042/bj2280161
   Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185
   Dasuri K, 2009, MECH AGEING DEV, V130, P777, DOI 10.1016/j.mad.2009.10.003
   DAVID H, 1985, EXP PATHOL-JENA, P1
   De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055
   Dechavanne V, 2013, PROTEIN EXPRES PURIF, V87, P100, DOI 10.1016/j.pep.2012.10.009
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB288, DOI 10.1093/gerona/56.7.B288
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   French BA, 2011, EXP MOL PATHOL, V90, P252, DOI 10.1016/j.yexmp.2011.01.004
   GACZYNSKA M, 1994, P NATL ACAD SCI USA, V91, P9213, DOI 10.1073/pnas.91.20.9213
   Gaczynska M, 2001, MECH AGEING DEV, V122, P235, DOI 10.1016/S0047-6374(00)00246-3
   Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034
   Gavilán MP, 2009, J NEUROCHEM, V108, P260, DOI 10.1111/j.1471-4159.2008.05762.x
   GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531
   Goto S, 1997, AGE, V20, P81, DOI 10.1007/s11357-997-0008-y
   Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020
   Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107
   Hayashi T, 1998, MECH AGEING DEV, V102, P55, DOI 10.1016/S0047-6374(98)00011-6
   Hubbard VM, 2012, BIOGERONTOLOGY, V13, P21, DOI 10.1007/s10522-011-9331-x
   Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030
   Huber N, 2009, HEPATOLOGY, V49, P1718, DOI 10.1002/hep.22840
   Husom AD, 2004, ARCH BIOCHEM BIOPHYS, V421, P67, DOI 10.1016/j.abb.2003.10.010
   Hussong SA, 2010, J NEUROCHEM, V113, P1481, DOI 10.1111/j.1471-4159.2010.06688.x
   IKEDA T, 1992, ARCH GERONTOL GERIAT, V15, P181, DOI 10.1016/0167-4943(92)90017-X
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V277, P189, DOI 10.1016/0003-9861(90)90568-J
   ISHIGAMI A, 1988, MECH AGEING DEV, V46, P125, DOI 10.1016/0047-6374(88)90120-0
   Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3
   Khan S, 2001, J IMMUNOL, V167, P6859, DOI 10.4049/jimmunol.167.12.6859
   Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200
   KITANI K, 1994, ARCH GERONTOL GERIAT, V19, P145, DOI 10.1016/0167-4943(94)90036-1
   Kitani K, 2007, AGE, V29, P1, DOI 10.1007/s11357-006-9014-8
   Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038
   Kloss A, 2010, CARDIOVASC RES, V85, P367, DOI 10.1093/cvr/cvp217
   Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x
   Krüger E, 2012, CURR OPIN IMMUNOL, V24, P77, DOI 10.1016/j.coi.2012.01.005
   Liepe J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000830
   Merker K, 2001, MECH AGEING DEV, V122, P595, DOI 10.1016/S0047-6374(01)00219-6
   Millward DJ, 1997, AM J CLIN NUTR, V66, P774, DOI 10.1093/ajcn/66.4.774
   Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004
   Mishto M, 2003, AGEING RES REV, V2, P419, DOI 10.1016/S1568-1637(03)00030-8
   Mishto M, 2008, J MOL BIOL, V377, P1607, DOI 10.1016/j.jmb.2008.01.086
   Mishto M, 2012, MOL CELL PROTEOMICS, V11, P1008, DOI 10.1074/mcp.M112.020164
   Mishto M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009287
   OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3
   Palmer A, 1996, BIOCHEM J, V316, P401, DOI 10.1042/bj3160401
   Petersen A, 2010, CURR GERONTOL GERIAT, V2010, P1, DOI DOI 10.1155/2010/230697
   Puente XS, 2004, GENOME RES, V14, P609, DOI 10.1101/gr.1946304
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003
   RIVETT AJ, 1992, J HISTOCHEM CYTOCHEM, V40, P1165, DOI 10.1177/40.8.1619280
   Rodriguez KA, 2010, MECH AGEING DEV, V131, P144, DOI 10.1016/j.mad.2010.01.002
   SAHAKIAN JA, 1995, ARCH BIOCHEM BIOPHYS, V318, P411, DOI 10.1006/abbi.1995.1248
   Schmidt F, 2006, PROTEOMICS, V6, P4622, DOI 10.1002/pmic.200500920
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   Scrofano MM, 1998, MECH AGEING DEV, V101, P277, DOI 10.1016/S0047-6374(97)00178-4
   Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036
   Shibatani T, 1996, J GERONTOL A-BIOL, V51, pB316, DOI 10.1093/gerona/51A.5.B316
   Short K R, 2000, Curr Opin Clin Nutr Metab Care, V3, P39, DOI 10.1097/00075197-200001000-00007
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Singh P, 2011, J GERONTOL A-BIOL, V66, P944, DOI 10.1093/gerona/glr094
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   Stolzing A, 2001, CLIN EXP DERMATOL, V26, P566, DOI 10.1046/j.1365-2230.2001.00867.x
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   TANAKA K, 1986, J BIOL CHEM, V261, P5197
   TANAKA K, 1989, J CELL PHYSIOL, V139, P34, DOI 10.1002/jcp.1041390107
   Ueno T, 2012, BBA-PROTEINS PROTEOM, V1824, P51, DOI 10.1016/j.bbapap.2011.06.019
   USTRELL V, 1995, P NATL ACAD SCI USA, V92, P584, DOI 10.1073/pnas.92.2.584
   Vasuri F, 2010, BIOCHEM BIOPH RES CO, V397, P301, DOI 10.1016/j.bbrc.2010.05.104
   Vernace VA, 2007, AGING CELL, V6, P599, DOI 10.1111/j.1474-9726.2007.00329.x
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   WARD WF, 1988, J GERONTOL, V43, pB121, DOI 10.1093/geronj/43.5.B121
   WEEKE B, 1973, SCAND J IMMUNOL, V2, P37, DOI 10.1111/j.1365-3083.1973.tb03777.x
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
   Zong CG, 2008, PROTEOMICS, V8, P5025, DOI 10.1002/pmic.200800387
NR 84
TC 19
Z9 20
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD FEB
PY 2014
VL 36
IS 1
BP 57
EP 72
DI 10.1007/s11357-013-9543-x
PG 16
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 283EE
UT WOS:000329227500006
PM 23690132
OA Green Published
DA 2024-02-19
ER

PT J
AU Ribarac-Stepic, N
   Vulovic, M
   Koricanac, G
   Isenovic, E
AF Ribarac-Stepic, N
   Vulovic, M
   Koricanac, G
   Isenovic, E
TI Basal and glucocorticoid induced changes of hepatic glucocorticoid
   receptor during aging: relation to activities of tyrosine
   aminotransferase and tryptophan oxygenase
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; glucocorticoid receptor; glucocorticoid resistance; thyrosine
   aminotransferase; tryptophan oxygenase
ID AGE-RELATED-CHANGES; DOWN-REGULATION; CORTICOSTEROID RECEPTORS;
   RAT-LIVER; MESSENGER-RNA; PROINFLAMMATORY CYTOKINES; DEXAMETHASONE
   TREATMENT; ENZYME-INDUCTION; GENE-EXPRESSION; HORMONE-BINDING
AB The characteristics of glucocorticoid receptors, their sensitivity to glucocorticoid as well as the basal and glucocorticoid induced thyrosine aminotranferase (TAT) and tryptophan oxygenase (TO) activities were studied in rat liver during aging. The concentration (N) and dissociation constant (K-d) of glucocorticoid receptor (GR) significantly change during the aging both in untreated and dexamethasone treated animals. The level of receptors was lower in dexamethasone treated rats of all analyzed aged groups compared to untreated animals. In comparison to untreated groups, there was no correlation between the changes of N and K-d during the lifespan. According to immunochemical analysis, the decline of receptor protein content occurs during lifespan. Dexamethasone treatment reduced the level of receptor protein compare to respective age group of untreated rats. The glucocorticoid-receptor (G-R) complexes from both untreated and treated animals underwent thermal activation, although the extent of activation was more pronounced in the case of untreated groups compared to treated animals. The magnitude of heat activation of receptor complexes was more pronounced in the liver of the youngest untreated rats compared to elderly ones, while the receptor activation between treated groups of studied ages has shown less significant differences. Besides, basal as well as induced TAT and TO activities after dexamethasone injection also showed age-related alterations. The observed alterations in GR might play a role in the changes of the cell responses to glucocorticoid during the age. This presumption is supported by detected changes in basal and dexamethasone induced TAT and TO activities during aging.
C1 Vinca Inst Nucl Sci, Dept Mol Biol & Endocrinol, YU-11001 Belgrade, Serbia Monteneg.
C3 University of Belgrade
RP Ribarac-Stepic, N (corresponding author), Vinca Inst Nucl Sci, Dept Mol Biol & Endocrinol, POB 522, YU-11001 Belgrade, Serbia Monteneg.
EM nrs@rt270.vin.bg.ac.yu
RI Korićanac, Goran/ABF-6544-2021; Isenovic, Esma/D-3017-2009
OI Isenovic, Esma/0000-0002-0012-2636; Koricanac,
   Goran/0000-0002-9852-3330; Stojiljkovic, Mojca/0000-0002-9041-7947
CR ARMANINI D, 1993, J STEROID BIOCHEM, V45, P191, DOI 10.1016/0960-0760(93)90141-I
   BAILLY A, 1977, J BIOL CHEM, V252, P858
   Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245
   Beato M, 1996, STEROIDS, V61, P240, DOI 10.1016/0039-128X(96)00030-X
   BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086
   BOLLA R, 1980, MECH AGEING DEV, V12, P249, DOI 10.1016/0047-6374(80)90048-2
   BOLLA RI, 1982, LIFE SCI, V31, P615, DOI 10.1016/0024-3205(82)90762-7
   BRENNAN MJ, 1985, EXP GERONTOL, V20, P285, DOI 10.1016/0531-5565(85)90054-3
   BRONNEGARD M, 1995, TRENDS ENDOCRIN MET, V6, P160, DOI 10.1016/1043-2760(95)00078-V
   BURNSTEIN KL, 1991, STEROIDS, V56, P52, DOI 10.1016/0039-128X(91)90124-E
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   CHANG WC, 1979, J STEROID BIOCHEM, V11, P889
   DANIELSEN M, 1984, MOL CELL BIOL, V4, P449, DOI 10.1128/MCB.4.3.449
   DELAP L, 1978, BIOCHEM BIOPH RES CO, V82, P142, DOI 10.1016/0006-291X(78)90588-0
   DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X
   Djordjevic-Markovic R, 1999, EXP GERONTOL, V34, P971, DOI 10.1016/S0531-5565(99)00067-4
   Dutta D, 2004, BIOGERONTOLOGY, V5, P177, DOI 10.1023/B:BGEN.0000031155.60748.0a
   EVANS PJ, 1981, BIOCHIM BIOPHYS ACTA, V677, P433, DOI 10.1016/0304-4165(81)90257-9
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   Felszeghy K, 1996, J NEUROENDOCRINOL, V8, P493, DOI 10.1046/j.1365-2826.1996.04822.x
   GEHRING U, 1984, MOL CELL ENDOCRINOL, V36, P107, DOI 10.1016/0303-7207(84)90089-3
   Grasso G, 1997, LIFE SCI, V61, P301, DOI 10.1016/S0024-3205(97)00386-X
   GREENSPAN SL, 1993, J GERONTOL, V48, pM72, DOI 10.1093/geronj/48.3.M72
   GROTE H, 1983, BIOCHEM J, V212, P305, DOI 10.1042/bj2120305
   HERMAN JP, 1993, CELL MOL NEUROBIOL, V13, P349, DOI 10.1007/BF00711577
   Hirano T, 1997, IMMUNOPHARMACOLOGY, V36, P57, DOI 10.1016/S0162-3109(96)00163-4
   HIROTA T, 1981, LIFE SCI, V28, P2161, DOI 10.1016/0024-3205(81)90623-8
   HIROTA T, 1985, ENDOCRINOLOGY, V117, P1788, DOI 10.1210/endo-117-5-1788
   Ivanisevic-Milovanovic Olivera K., 1997, Acta Physiologica Hungarica, V85, P65
   JACOBS S, 1976, BIOCHIM BIOPHYS ACTA, V433, P482, DOI 10.1016/0005-2736(76)90275-3
   KALIMI M, 1988, ANN NY ACAD SCI, V521, P149, DOI 10.1111/j.1749-6632.1988.tb35273.x
   KALIMI M, 1975, J BIOL CHEM, V250, P1080
   KANAZIR DT, 1978, J STEROID BIOCHEM, V9, P467, DOI 10.1016/0022-4731(78)90617-9
   Kanungo MS, 1980, BIOCH AGEING CHANGES, P79
   Kellendonk C, 1999, J STEROID BIOCHEM, V69, P253, DOI 10.1016/S0960-0760(99)00041-2
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEAKE RE, 1987, STEROID HORMONES PRA
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKOVIC RD, 1980, ARCH BIOCHEM BIOPHYS, V202, P374, DOI 10.1016/0003-9861(80)90440-3
   MENDEL DB, 1986, NATURE, V324, P478, DOI 10.1038/324478a0
   MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8
   MILGROM E, 1973, BIOCHEMISTRY-US, V12, P5198, DOI 10.1021/bi00749a029
   MIYABE S, 1983, ENDOCRINOLOGY, V112, P2174, DOI 10.1210/endo-112-6-2174
   MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25
   NAKAMURA T, 1980, J BIOL CHEM, V255, P7533
   Nichols NR, 1998, INTERD T GERONT GERI, V29, P1
   Oakley Robert H., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P63
   OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899
   PETROVIC J, 1972, ARCH BIOL SCI, V24, P1
   POLLET RJ, 1977, J BIOL CHEM, V252, P5828
   PRATT WB, 1993, J BIOL CHEM, V268, P21455
   Ranhotra HS, 2001, BIOGERONTOLOGY, V2, P245, DOI 10.1023/A:1013218528102
   REUL JMHM, 1987, J ENDOCRINOL, V115, P459, DOI 10.1677/joe.0.1150459
   Rhouma Khemais Ben, 1994, Archives Internationales de Physiologie de Biochimie et de Biophysique, V102, P97, DOI 10.3109/13813459408996113
   Ribarac-Stepic N, 2001, CLIN EXP MED, V1, P179, DOI 10.1007/s102380100001
   ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581
   ROTH GS, 1982, MECH AGEING DEV, V20, P175, DOI 10.1016/0047-6374(82)90086-0
   ROTH GS, 1974, ENDOCRINOLOGY, V94, P82, DOI 10.1210/endo-94-1-82
   ROTH GS, 1979, MECH AGEING DEV, V9, P497, DOI 10.1016/0047-6374(79)90090-3
   ROTH GS, 1988, ANN NY ACAD SCI, V521, P170
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   SCHMIDT TJ, 1985, J BIOL CHEM, V260, P6255
   SCHWEIZERGROYER G, 1992, J STEROID BIOCHEM, V41, P747, DOI 10.1016/0960-0760(92)90416-G
   Sevaljevic L, 2001, BIOL SIGNAL RECEPT, V10, P299
   SHARMA R, 1987, BIOCHIM BIOPHYS ACTA, V930, P237, DOI 10.1016/0167-4889(87)90036-X
   SHARMA R, 1987, MECH AGEING DEV, V37, P249, DOI 10.1016/0047-6374(86)90042-4
   SHIRWANY TA, 1986, BIOCHIM BIOPHYS ACTA, V886, P162, DOI 10.1016/0167-4889(86)90222-3
   SILVA CM, 1994, STEROIDS, V59, P436, DOI 10.1016/0039-128X(94)90013-2
   SINGER S, 1971, ENDOCRINOLOGY, V88, P1448, DOI 10.1210/endo-88-6-1448
   SINGH LS, 1995, MECH AGEING DEV, V80, P85, DOI 10.1016/0047-6374(94)01560-9
   STEVENS J, 1983, BIOCHEM ACTION HORM, P385
   TANAKA H, 1991, CLIN CHEM, V37, P1715
   VANDERBILT JN, 1987, MOL ENDOCRINOL, V1, P68, DOI 10.1210/mend-1-1-68
   VANEEKELEN JAM, 1992, NEUROBIOL AGING, V13, P159, DOI 10.1016/0197-4580(92)90024-R
   VULOVIC M, 2003, ARCH BIOL SCI, V55, pP1
   WEBER A, 1980, BIOCHIM BIOPHYS ACTA, V631, P412, DOI 10.1016/0304-4165(80)90017-3
   Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098
   Werner S, 1996, STEROIDS, V61, P216, DOI 10.1016/0039-128X(96)00017-7
   YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.ge.19.120185.001233
   Zovato S, 1996, AGING CLIN EXP RES, V8, P360, DOI 10.1007/BF03339594
NR 80
TC 7
Z9 7
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD MAR
PY 2005
VL 6
IS 2
BP 113
EP 131
DI 10.1007/s10522-005-3498-y
PG 19
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 948GX
UT WOS:000230705200004
PM 16034679
DA 2024-02-19
ER

PT J
AU Okun, JG
   Rusu, PM
   Chan, AY
   Wu, YQ
   Yap, YW
   Sharkie, T
   Schumacher, J
   Schmidt, KV
   Roberts-Thomson, KM
   Russell, RD
   Zota, A
   Hille, S
   Jungmann, A
   Maggi, L
   Lee, Y
   Blüher, M
   Herzig, S
   Keske, MA
   Heikenwalder, M
   Müller, OJ
   Rose, AJ
AF Okun, Juergen G.
   Rusu, Patricia M.
   Chan, Andrea Y.
   Wu, Yuqin
   Yap, Yann W.
   Sharkie, Thomas
   Schumacher, Jonas
   Schmidt, Kathrin V.
   Roberts-Thomson, Katherine M.
   Russell, Ryan D.
   Zota, Annika
   Hille, Susanne
   Jungmann, Andreas
   Maggi, Ludovico
   Lee, Young
   Bluher, Matthias
   Herzig, Stephan
   Keske, Michelle A.
   Heikenwalder, Mathias
   Mueller, Oliver J.
   Rose, Adam J.
TI Liver alanine catabolism promotes skeletal muscle atrophy and
   hyperglycaemia in type 2 diabetes
SO NATURE METABOLISM
LA English
DT Article
AB Elevated hepatic alanine catabolism is shown to promote hyperglycaemia and reduce skeletal muscle protein synthesis, thereby linking sarcopenia with hyperglycaemia in the context of type 2 diabetes.
   Both obesity and sarcopenia are frequently associated in ageing, and together may promote the progression of related conditions such as diabetes and frailty. However, little is known about the pathophysiological mechanisms underpinning this association. Here we show that systemic alanine metabolism is linked to glycaemic control. We find that expression of alanine aminotransferases is increased in the liver in mice with obesity and diabetes, as well as in humans with type 2 diabetes. Hepatocyte-selective silencing of both alanine aminotransferase enzymes in mice with obesity and diabetes retards hyperglycaemia and reverses skeletal muscle atrophy through restoration of skeletal muscle protein synthesis. Mechanistically, liver alanine catabolism driven by chronic glucocorticoid and glucagon signalling promotes hyperglycaemia and skeletal muscle wasting. We further provide evidence for amino acid-induced metabolic cross-talk between the liver and skeletal muscle in ex vivo experiments. Taken together, we reveal a metabolic inter-tissue cross-talk that links skeletal muscle atrophy and hyperglycaemia in type 2 diabetes.
C1 [Okun, Juergen G.; Schmidt, Kathrin V.] Univ Childrens Hosp, Div Inherited Metab Dis, Heidelberg, Germany.
   [Rusu, Patricia M.; Chan, Andrea Y.; Wu, Yuqin; Yap, Yann W.; Sharkie, Thomas; Rose, Adam J.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.
   [Schumacher, Jonas; Zota, Annika; Maggi, Ludovico; Herzig, Stephan; Rose, Adam J.] German Canc Res Ctr, Div Mol Metab Control, Heidelberg, Germany.
   [Roberts-Thomson, Katherine M.; Keske, Michelle A.] Deakin Univ, Inst Phys Act & Nutr, Sch Exercise & Nutr Sci, Geelong, Vic, Australia.
   [Russell, Ryan D.] Univ Texas Rio Grande Valley, Dept Hlth & Human Performance, Coll Hlth Profess, Brownsville, TX USA.
   [Zota, Annika] Tech Univ Munich, Inst Diabet & Canc IDC, Heidelberg Univ Hosp,Helmholtz Ctr Munich, Joint Heidelberg IDC Translat Diabet Program,Inne, Neuherberg, Germany.
   [Zota, Annika] Tech Univ Munich, Chair Mol Metab Control, Neuherberg, Germany.
   [Hille, Susanne; Mueller, Oliver J.] Univ Kiel, Dept Internal Med 3, Kiel, Germany.
   [Hille, Susanne; Jungmann, Andreas; Mueller, Oliver J.] German Ctr Cardiovasc Res DZHK, Heidelberg & Kiel Sites, Heidelberg, Germany.
   [Jungmann, Andreas] Univ Hosp Heidelberg, Dept Internal Med 3, Heidelberg, Germany.
   [Lee, Young] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX USA.
   [Bluher, Matthias] Univ Leipzig, Helmholtz Inst Metab Obes & Vasc Res HI MAG, Helmholtz Zentrum Munchen, Leipzig, Germany.
   [Heikenwalder, Mathias] German Canc Res Ctr, Div Chron Inflammat & Canc, Heidelberg, Germany.
C3 Ruprecht Karls University Heidelberg; University of Hamburg; University
   Medical Center Hamburg-Eppendorf; Monash University; Helmholtz
   Association; German Cancer Research Center (DKFZ); Deakin University;
   University of Texas System; University of Texas Rio Grande Valley;
   Helmholtz Association; Helmholtz-Center Munich - German Research Center
   for Environmental Health; Ruprecht Karls University Heidelberg;
   Technical University of Munich; Technical University of Munich;
   University of Kiel; German Centre for Cardiovascular Research; Ruprecht
   Karls University Heidelberg; University of Texas System; University of
   Texas Southwestern Medical Center Dallas; Leipzig University; Helmholtz
   Association; Helmholtz-Center Munich - German Research Center for
   Environmental Health; Helmholtz Association; German Cancer Research
   Center (DKFZ)
RP Rose, AJ (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.; Rose, AJ (corresponding author), German Canc Res Ctr, Div Mol Metab Control, Heidelberg, Germany.
EM adam.rose@monash.edu
RI Rusu, Patricia/AAI-7106-2020; Rose, Adam John/AAC-6274-2019
OI Rusu, Patricia/0000-0001-7210-1976; Rose, Adam John/0000-0001-9132-8244;
   Hille, Susanne/0000-0002-9809-4636; Keske, Michelle/0000-0003-4214-7628;
   Wu, Yuqin/0000-0002-1762-1896
CR Albrechtsen NJW, 2019, ENDOCR REV, V40, P1353, DOI 10.1210/er.2018-00251
   Bell JA, 2006, J NUTR, V136, P1249, DOI 10.1093/jn/136.5.1249
   Bentzinger CF, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-6
   Bujak AL, 2015, CELL METAB, V21, P883, DOI 10.1016/j.cmet.2015.05.016
   Castets P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11227-4
   Celis K, 2015, J INHERIT METAB DIS, V38, P941, DOI 10.1007/s10545-015-9824-x
   CHRISTENSEN HN, 1982, PHYSIOL REV, V62, P1193, DOI 10.1152/physrev.1982.62.4.1193
   de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111
   DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667
   Deng HF, 2016, ACS MED CHEM LETT, V7, P379, DOI 10.1021/acsmedchemlett.5b00389
   Drey M, 2017, ENDOCRINE, V57, P481, DOI 10.1007/s12020-017-1370-x
   FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2
   FELIG P, 1970, SCIENCE, V167, P1003, DOI 10.1126/science.167.3920.1003
   FELIG P, 1974, J CLIN INVEST, V53, P582, DOI 10.1172/JCI107593
   Fuhrmeister J, 2016, EMBO MOL MED, V8, P654, DOI 10.15252/emmm.201505801
   Gilbert ER, 2011, EXP DIABETES RES, DOI 10.1155/2011/416254
   Graham T., 2008, GENET VACCINES THER, V6
   Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027
   Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002
   Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106
   Habegger KM, 2013, DIABETES, V62, P1453, DOI 10.2337/db12-1116
   Halvatsiotis P, 2002, DIABETES, V51, P2395, DOI 10.2337/diabetes.51.8.2395
   Halvatsiotis PG, 2002, DIABETES NUTR METAB, V15, P136
   Harvey I, 2018, ENDOCRINOLOGY, V159, P2275, DOI 10.1210/en.2018-00147
   Hirata Y, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124952
   Houten SM, 2013, HUM MOL GENET, V22, P5249, DOI 10.1093/hmg/ddt382
   Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770
   Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S
   Jadaho SB, 2004, HEPATOLOGY, V39, P1297, DOI 10.1002/hep.20182
   James HA, 2017, CELL METAB, V26, P310, DOI 10.1016/j.cmet.2017.06.010
   Jungmann A, 2017, HUM GENE THER METHOD, V28, P235, DOI 10.1089/hgtb.2017.192
   Just PA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19490-6
   Kalyani RR, 2015, DIABETES CARE, V38, P82, DOI 10.2337/dc14-1166
   Kim J, 2017, CELL METAB, V25, P1348, DOI 10.1016/j.cmet.2017.05.006
   Kim T, 2018, DIABETES, V67, P1773, DOI 10.2337/db17-1502
   Klöting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009
   Kob R, 2015, BIOGERONTOLOGY, V16, P15, DOI 10.1007/s10522-014-9539-7
   Lam T, 2017, EUR J ENDOCRINOL, V176, P489, DOI 10.1530/EJE-16-0868
   Lee YH, 2016, DIABETOLOGIA, V59, P1372, DOI 10.1007/s00125-016-3965-9
   Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001
   Lin HV, 2011, CELL METAB, V14, P9, DOI 10.1016/j.cmet.2011.06.003
   Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0
   Madiraju AK, 2016, P NATL ACAD SCI USA, V113, pE3423, DOI 10.1073/pnas.1606022113
   Maida A, 2017, MOL METAB, V6, P873, DOI 10.1016/j.molmet.2017.06.009
   Maida A, 2016, J CLIN INVEST, V126, P3263, DOI 10.1172/JCI85946
   McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028
   Miller RA, 2016, DIABETOLOGIA, V59, P1376, DOI 10.1007/s00125-016-3955-y
   Müller TD, 2017, PHYSIOL REV, V97, P721, DOI 10.1152/physrev.00025.2016
   Nilsson MI, 2013, FASEB J, V27, P3905, DOI 10.1096/fj.12-224006
   Okun JG, 2015, MOL METAB, V4, P732, DOI 10.1016/j.molmet.2015.07.006
   Ostertag A, 2010, DIABETES, V59, P1991, DOI 10.2337/db09-1537
   Ostler JE, 2014, AM J PHYSIOL-ENDOC M, V306, pE592, DOI 10.1152/ajpendo.00277.2013
   Ouyang Q, 2016, P NATL ACAD SCI USA, V113, pE5598, DOI 10.1073/pnas.1609221113
   Park SW, 2009, DIABETES CARE, V32, P1993, DOI 10.2337/dc09-0264
   Parr EB, 2013, MATURITAS, V74, P109, DOI 10.1016/j.maturitas.2012.10.014
   Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326
   Qian K, 2015, DIABETES-METAB RES, V31, P562, DOI 10.1002/dmrr.2655
   Reagan WJ, 2012, TOXICOL PATHOL, V40, P1117, DOI 10.1177/0192623312447550
   Rose AJ, 2011, CELL METAB, V14, P123, DOI 10.1016/j.cmet.2011.04.010
   Rose AJ, 2010, J STEROID BIOCHEM, V122, P10, DOI 10.1016/j.jsbmb.2010.02.010
   Rose AJ, 2009, J PHYSIOL-LONDON, V587, P1547, DOI 10.1113/jphysiol.2008.167528
   Sandhu S, 2020, GLUCAGONOMA SYNDROME
   Sauer SW, 2006, J NEUROCHEM, V97, P899, DOI 10.1111/j.1471-4159.2006.03813.x
   Short KR, 2012, J CLIN ENDOCR METAB, V97, P4733, DOI 10.1210/jc.2012-2533
   Shpilberg Y, 2012, DIS MODEL MECH, V5, P671, DOI 10.1242/dmm.008912
   Sivabalan S., 2008, INT ARCH MED, V1
   SNELL K, 1985, BIOCHEM J, V225, P737, DOI 10.1042/bj2250737
   Snell K, 1982, Prog Clin Biol Res, V102 Pt C, P279
   Solloway MJ, 2015, CELL REP, V12, P495, DOI 10.1016/j.celrep.2015.06.034
   Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805
   Tian SM, 2016, GERIATR GERONTOL INT, V16, P155, DOI 10.1111/ggi.12579
   Vary Thomas C., 2008, V447, P343, DOI 10.1007/978-1-59745-242-7_22
   WAHREN J, 1976, J CLIN INVEST, V57, P987, DOI 10.1172/JCI108375
   WAHREN J, 1972, J CLIN INVEST, V51, P1870, DOI 10.1172/JCI106989
   Wahren J, 1976, Journ Annu Diabetol Hotel Dieu, P7
   Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806
   Watson ML, 2012, AM J PHYSIOL-ENDOC M, V302, pE1210, DOI 10.1152/ajpendo.00512.2011
   WISE JK, 1973, J CLIN INVEST, V52, P2774, DOI 10.1172/JCI107473
   Wu Chaodong, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P51, DOI 10.2174/1568008053174769
   Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009
   Yang JX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-281
   Yang RZ, 2009, HEPATOLOGY, V49, P598, DOI 10.1002/hep.22657
   Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002
NR 83
TC 39
Z9 42
U1 3
U2 31
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2522-5812
J9 NAT METAB
JI Nat. Metab.
PD MAR
PY 2021
VL 3
IS 3
BP 394
EP U181
DI 10.1038/s42255-021-00369-9
PG 28
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA RF4DX
UT WOS:000634791100013
PM 33758419
DA 2024-02-19
ER

PT J
AU Castro, MD
   Suarez, E
   Kraiselburd, E
   Isidro, A
   Paz, J
   Ferder, L
   Ayala-Torres, S
AF Castro, Maria del R.
   Suarez, Edu
   Kraiselburd, Edmundo
   Isidro, Angel
   Paz, Jose
   Ferder, Leon
   Ayala-Torres, Sylvette
TI Aging increases mitochondrial DNA damage and oxidative stress in liver
   of rhesus monkeys
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Mitochondrial DNA; Aging; Mitochondria; Antioxidant enzymes; Rhesus
   monkey; Liver
ID TERM CALORIC RESTRICTION; SKELETAL-MUSCLE; RAT-LIVER; RESPIRATORY-CHAIN;
   ELECTRON-TRANSFER; APURINIC/APYRIMIDINIC ENDONUCLEASE; AGE; BRAIN; MICE;
   DEFECTS
AB While the mechanisms of cellular aging remain controversial, a leading hypothesis is that mitochondrial oxidative stress and mitochondrial dysfunction play a critical role in this process. Here, we provide data in aging rhesus macaques supporting the hypothesis that increased oxidative stress is a major characteristic of aging and may be responsible for the age-associated increase in mitochondrial dysfunction. We measured mitochondrial DNA (mtDNA) damage by quantitative PCR in liver and peripheral blood mononuclear cells of young, middle age, and old monkeys and show that older monkeys have increases in the number of mtDNA lesions. There was a direct correlation between the amount of mtDNA lesions and age, supporting the role of mtDNA damage in the process of aging. Liver from older monkeys showed significant increases in lipid peroxidation, protein carbonylations and reduced antioxidant enzyme activity. Similarly, peripheral blood mononuclear cells from the middle age group showed increased levels in carbonylated proteins, indicative of high levels of oxidative stress. Together, these results suggest that the aging process is associated with defective mitochondria, where increased production of reactive oxygen species results in extensive damage at the mtDNA and protein levels. This study provides valuable data based on the rhesus macaque model further validating age-related mitochondrial functional decline with increasing age and suggesting that mtDNA damage might be a good biomarker of aging. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Castro, Maria del R.; Ayala-Torres, Sylvette] Univ Puerto Rico, Dept Pharmacol & Toxicol, San Juan, PR 00936 USA.
   [Suarez, Edu; Isidro, Angel; Paz, Jose; Ferder, Leon] Ponce Sch Med, Dept Physiol & Pharmacol, Ponce, PR USA.
   [Suarez, Edu] Univ Puerto Rico, Dept Biol, Ponce, PR USA.
   [Kraiselburd, Edmundo] Univ Puerto Rico, Dept Microbiol, San Juan, PR 00936 USA.
   [Kraiselburd, Edmundo; Ayala-Torres, Sylvette] Univ Puerto Rico, Caribbean Primate Res Ctr, Sabana Seca, PR USA.
C3 University of Puerto Rico; University of Puerto Rico; University of
   Puerto Rico; University of Puerto Rico Mayaguez
RP Ayala-Torres, S (corresponding author), Univ Puerto Rico, Dept Pharmacol & Toxicol, Med Sci Campus,POB 365067, San Juan, PR 00936 USA.
EM sylvette.ayala@upr.edu
FU National Institutes of Health [P40RR003640, G12RR-03051,
   1U54RR026139-01A1]
FX This work was supported by the National Institutes of Health
   P40RR003640, G12RR-03051 and 1U54RR026139-01A1 grants. The authors thank
   Mrs. Sandra Gascot for technical assistance, Dr. Luis Montaner and Dr.
   Carlos A. Torres-Ramos for critical reading of this manuscript.
CR Acevedo-Torres K, 2009, ENVIRON MOL MUTAGEN, V50, P317, DOI 10.1002/em.20462
   Acevedo-Torres K, 2009, DNA REPAIR, V8, P126, DOI 10.1016/j.dnarep.2008.09.004
   ALEMANY J, 1988, EXP GERONTOL, V23, P25, DOI 10.1016/0531-5565(88)90017-4
   Ayala-Torres S., 2000, METHODS COMPANION ME
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BENZI G, 1992, NEUROBIOL AGING, V13, P361, DOI 10.1016/0197-4580(92)90109-B
   Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   Brunk UT, 2002, FREE RADICAL BIO MED, V33, P611, DOI 10.1016/S0891-5849(02)00959-0
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1
   Ferreira FM, 2006, TOXICOL MECH METHOD, V16, P323, DOI 10.1080/15376520600616925
   Forster MJ, 2000, J GERONTOL A-BIOL, V55, pB522, DOI 10.1093/gerona/55.11.B522
   Gokey NG, 2004, AGING CELL, V3, P319, DOI 10.1111/j.1474-9728.2004.00122.x
   Gredilla R, 2005, ENDOCRINOLOGY, V146, P3713, DOI 10.1210/en.2005-0378
   Gredilla R, 2001, J BIOENERG BIOMEMBR, V33, P279, DOI 10.1023/A:1010603206190
   Gredilla R, 2010, EXP GERONTOL, V45, P478, DOI 10.1016/j.exger.2010.01.017
   Grösch S, 1999, BIOCHEM BIOPH RES CO, V261, P859, DOI 10.1006/bbrc.1999.1125
   Grösch S, 1998, CANCER RES, V58, P4410
   Hagen T., 1997, P NATL ACAD SCI US, V94
   Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468
   HSIEH RH, 1994, BIOCHEM MOL BIOL INT, V32, P1009
   Humphreys V, 2007, AGE AGEING, V36, P521, DOI 10.1093/ageing/afm107
   IKEDA H, 1985, MECH AGEING DEV, V33, P77, DOI 10.1016/0047-6374(85)90110-1
   Kumaran S, 2005, EXP AGING RES, V31, P55, DOI 10.1080/03610730590882846
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Lesnefsky EJ, 2006, AGEING RES REV, V5, P402, DOI 10.1016/j.arr.2006.04.001
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   lzumi T., 2005, PNAS, V102
   Mandavilli BS, 2000, BRAIN RES, V885, P45, DOI 10.1016/S0006-8993(00)02926-7
   Martin R, 2002, EXP GERONTOL, V37, P1481, DOI 10.1016/S0531-5565(02)00168-7
   MASORO EJ, 1993, J AM GERIATR SOC, V41, P994, DOI 10.1111/j.1532-5415.1993.tb06767.x
   Modi HR, 2008, J MEMBRANE BIOL, V221, P51, DOI 10.1007/s00232-007-9086-0
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   MullerHocker J, 1996, MECH AGEING DEV, V86, P197, DOI 10.1016/0047-6374(95)01692-9
   Muradian KK, 2002, ARCH GERONTOL GERIAT, V35, P205, DOI 10.1016/S0167-4943(02)00025-0
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ojaimi J, 1999, MECH AGEING DEV, V111, P39, DOI 10.1016/S0047-6374(99)00071-8
   Pessayre D, 2002, AM J PHYSIOL-GASTR L, V282, pG193, DOI 10.1152/ajpgi.00426.2001
   Pines A, 2005, FREE RADICAL RES, V39, P269, DOI 10.1080/10715760400028423
   Ramana CV, 1998, P NATL ACAD SCI USA, V95, P5061, DOI 10.1073/pnas.95.9.5061
   Roth GS, 2004, SCIENCE, V305, P1423, DOI 10.1126/science.1102541
   Sabaretnam T, 2010, TOXICOL IN VITRO, V24, P123, DOI 10.1016/j.tiv.2009.08.018
   Santos Janine H, 2006, Methods Mol Biol, V314, P183
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Serviddio G, 2007, REDOX REP, V12, P91, DOI 10.1179/135100007X162112
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Short K., 2005, P NATL ACAD SCI US, V102
   STIO M, 1994, BIOCHEM CELL BIOL, V72, P58, DOI 10.1139/o94-010
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Vogel K., 2011, MOL REPROD DEV, V9999, P1
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
NR 59
TC 64
Z9 79
U1 1
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2012
VL 47
IS 1
BP 29
EP 37
DI 10.1016/j.exger.2011.10.002
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 890CS
UT WOS:000300123300005
PM 22027539
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Yin, Y
   Xie, YS
   Wu, ZL
   Qian, QF
   Yang, H
   Li, SL
   Li, XL
AF Yin, Yan
   Xie, Yisha
   Wu, Zhengli
   Qian, Qingfan
   Yang, Hao
   Li, Shilan
   Li, Xinli
TI Preventive Effects of Apple Polyphenol Extract on High-Fat-Diet-Induced
   Hepatic Steatosis Are Related to the Regulation of Hepatic Lipid
   Metabolism, Autophagy, and Gut Microbiota in Aged Mice
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE polyphenols; hepatic steatosis; aged; SIRT1; autophagy; microbiota
ID AKKERMANSIA-MUCINIPHILA; OBESITY; ACCUMULATION; INHIBITION; IMPAIRMENT;
   DISEASE
AB Our previous study confirmed that the ameliorated effects of an intervention with an apple polyphenol extract (APE) on hepatic steatosis induced by a high-fat diet (HFD) are dependent on SIRT1. Since SIRT1 expression decreases with age, it remains unclear whether APE intervention is effective against hepatic steatosis in aged mice. Thus, 12-month-old C57BL/6 male mice were fed with an HFD to establish an aging model of hepatic steatosis and treated with 500 mg/(kg center dot bw center dot d) APE for 12 weeks. Young mice (two months old) and baseline mice were used as controls to examine the effects of natural aging on hepatic steatosis. Compared with baseline mice, no obvious difference in hepatic histopathological assessment was observed for both young and aged mice on normal diets. Meanwhile, HFD induced much higher nonalcoholic fatty liver disease (NAFLD) activity scores in aged mice than in young mice. APE intervention ameliorated lipid and glucose metabolic disorders and liver injury in HFD-fed aged mice, improved hepatic steatosis, and reduced NAFLD activity scores. The upregulated expressions of SIRT1, HSL, ATG5, Ulk1, and Becn1 and downregulated expressions of HMGCR and FOXO1 suggested improved lipid metabolism and activated autophagy. APE intervention decreased the ratio of Firmicutes/Bacteroidetes and elevated the Akkermansia probiotics abundance. In summary, HFD showed a more significant effect on hepatic steatosis compared to the natural aging process in aged mice, and APE might be a promising dietary ingredient for alleviating hepatic steatosis.
C1 [Yin, Yan; Xie, Yisha; Wu, Zhengli; Qian, Qingfan; Yang, Hao; Li, Shilan; Li, Xinli] Soochow Univ, Sch Publ Hlth, Suzhou Med Coll, Suzhou 215123, Jiangsu, Peoples R China.
   [Li, Xinli] Soochow Univ, Med Coll, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Dis, Suzhou 215123, Jiangsu, Peoples R China.
C3 Soochow University - China; Soochow University - China
RP Li, XL (corresponding author), Soochow Univ, Sch Publ Hlth, Suzhou Med Coll, Suzhou 215123, Jiangsu, Peoples R China.; Li, XL (corresponding author), Soochow Univ, Med Coll, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Dis, Suzhou 215123, Jiangsu, Peoples R China.
EM lixinli@suda.edu.cn
FU Priority Academic Program Development of Jiangsu Higher Education
   Institutions [81973023, 81673150]; National Natural Science Foundation
   of China; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD)
FX This work was supported by grants from the National Natural Science
   Foundation of China (Nos. 81973023 and 81673150) and a project funded by
   the Priority Academic Program Development of Jiangsu Higher Education
   Institutions (PAPD). We also thank Doctor Khemayanto Hidayat for
   revising the manuscript.
CR Balbuena E, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.987103
   Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651
   Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886
   Cani PD, 2022, NAT REV GASTRO HEPAT, V19, P682, DOI 10.1038/s41575-022-00650-6
   Cao QH, 2016, AM J TRANSL RES, V8, P3831
   Catana CS, 2018, BIOTECHNOL ADV, V36, P1649, DOI 10.1016/j.biotechadv.2018.03.012
   Chen C, 2020, MECH AGEING DEV, V187, DOI 10.1016/j.mad.2020.111215
   Chen GJ, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700485
   Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370
   Chow JDY, 2014, MOL METAB, V3, P419, DOI 10.1016/j.molmet.2014.02.004
   Clarke SF, 2012, GUT MICROBES, V3, P186, DOI 10.4161/gmic.20168
   Condello M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030725
   Dusabimana T, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115528
   Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036
   Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110
   Fazmiya MJA, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/9354555
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Gu L, 2019, J AGR FOOD CHEM, V67, P13929, DOI 10.1021/acs.jafc.9b05632
   He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001
   Higarza SG, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1880240
   Huang JB, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700696
   Jennison E, 2021, CLIN MOL HEPATOL, V27, P22
   Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119
   Kim S, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.03004-19
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kociszewska D, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23137348
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Konikoff T, 2016, TRENDS MICROBIOL, V24, P523, DOI 10.1016/j.tim.2016.02.015
   Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Li DM, 2021, J AGR FOOD CHEM, V69, P6829, DOI 10.1021/acs.jafc.1c02532
   Li DM, 2021, PHYTOTHER RES, V35, P1416, DOI 10.1002/ptr.6902
   Li DM, 2019, J AGR FOOD CHEM, V67, P12208, DOI 10.1021/acs.jafc.9b05495
   Li QY, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4524-1
   Liu F, 2022, NUTRIENTS, V14, DOI 10.3390/nu14194180
   Loomba R, 2021, CELL, V184, P2537, DOI 10.1016/j.cell.2021.04.015
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu HM, 2023, ENVIRON TOXICOL, V38, P78, DOI 10.1002/tox.23663
   Lu HJ, 2020, COMPR REV FOOD SCI F, V19, P3130, DOI 10.1111/1541-4337.12620
   Lukovac S, 2014, MBIO, V5, DOI 10.1128/mBio.01438-14
   Ma RY, 2022, BIOMED PHARMACOTHER, V153, DOI 10.1016/j.biopha.2022.113424
   Miao H, 2022, J NUTR BIOCHEM, V106, DOI 10.1016/j.jnutbio.2022.109020
   Morissette A, 2020, AM J PHYSIOL-ENDOC M, V318, pE965, DOI 10.1152/ajpendo.00560.2019
   Nandagopal N, 2015, TRANSLATION, V3, DOI 10.4161/21690731.2014.983402
   O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Park MY, 2015, J SCI FOOD AGR, V95, P828, DOI 10.1002/jsfa.6973
   Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236
   Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978
   Reyes-Becerril M, 2022, FISH SHELLFISH IMMUN, V131, P408, DOI 10.1016/j.fsi.2022.10.028
   Salomone F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010085
   Seo E, 2019, AGING CELL, V18, DOI 10.1111/acel.12895
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shi AM, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.693048
   Siedentopf H G, 1988, Fortschr Med, V106, P161
   Sochocka M, 2019, MOL NEUROBIOL, V56, P1841, DOI 10.1007/s12035-018-1188-4
   Su HM, 2018, FREE RADICAL BIO MED, V126, P269, DOI 10.1016/j.freeradbiomed.2018.08.024
   Takakuwa A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112817
   THOMAS R, 1987, NATURE, V330, P110, DOI 10.1038/330110a0
   Moreira GV, 2022, BIOMED PHARMACOTHER, V155, DOI 10.1016/j.biopha.2022.113660
   Volk JK, 2019, J EXP MED, V216, P2602, DOI 10.1084/jem.20190679
   Wang XF, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11061212
   Wei W, 2021, CLIN NUTR, V40, P4234, DOI 10.1016/j.clnu.2021.01.031
   Wu ZH, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01115-9
   Xiao YC, 2022, J AGR FOOD CHEM, DOI 10.1021/acs.jafc.2c03574
   Xu J, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.993879
   Yin Y, 2022, J AGR FOOD CHEM, V70, P5579, DOI 10.1021/acs.jafc.2c01461
   Yuan GF, 2021, FOOD FUNCT, V12, P7897, DOI [10.1039/d1fo01152a, 10.1039/D1FO01152A]
   Zechner R, 2017, NAT REV MOL CELL BIO, V18, P671, DOI 10.1038/nrm.2017.76
   Zhang X, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.957829
   Zhao WP, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.934819
   Zhao XT, 2023, PHYTOTHER RES, V37, P62, DOI 10.1002/ptr.7593
   Zhou WL, 2022, PHYTOMEDICINE, V103, DOI 10.1016/j.phymed.2022.154235
NR 74
TC 0
Z9 0
U1 19
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD DEC 6
PY 2023
VL 71
IS 50
BP 20011
EP 20033
DI 10.1021/acs.jafc.3c00596
PG 23
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA CW6R3
UT WOS:001128315500001
PM 38055797
DA 2024-02-19
ER

PT J
AU Perichon, R
   Bourre, JM
AF Perichon, R
   Bourre, JM
TI Liver peroxisomal fatty acid oxidizing system during aging in control
   and clofibrate-treated mice.
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
LA English
DT Article
ID RAT-LIVER; DESATURATION; MICROSOMES; OXIDATION; DELTA-6; MOUSE
AB We have previously described an aging-related decrease in the peroxisomal polyunsaturated fatty acid oxidizing system in mouse liver. In order to determine whether peroxisome synthesis is involved in this phenomenon, we focused our work on different peroxisomal enzyme activities during aging in the liver of mice fed for 5 days with either a control or a clofibrate supplemented diet which enhanced peroxisome biogenesis. Liver peroxisomal acyl-CoA oxidase (AOX), catalase (CAT) and urate oxidase (UOX) activities per gram of liver were determined.
   In control mice, UOX activity was not affected by aging whereas CAT and AOX activities were significantly decreased. At day 300 the clofibrate treatment increased all activities although UOX was not significantly increased. Thereafter, enzyme activities after clofibrate treatment were severely depressed at day 680. CAT and UOX were not induced in very old clofibrate-treated animals, whereas AOX was induced 7 fold in such mice compared to an 11 fold induction in day 300 animals.
   The present results suggest that: 1- Aging decreased the peroxisomal polyunsaturated fatty acid oxidizing system. 2- This took place via a specific decrease in AOX activity. 3- Since clofibrate treatment triggers the peroxisomal proliferation, the aging-related decrease in peroxisomal activities might be due to an alteration in peroxisome synthesis.
RP Perichon, R (corresponding author), HOP FERNAND WIDAL,INSERM U26,200 RUE FAUBOURG ST DENIS,F-75475 PARIS 10,FRANCE.
CR AEBI H, 1974, METHOD ENZYMAT AN, V2, P680
   BEIER K, 1993, VIRCHOWS ARCH B, V63, P139, DOI 10.1007/BF02899254
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   BOURRE JM, 1992, NEUROSCI LETT, V141, P65, DOI 10.1016/0304-3940(92)90335-5
   BRENNER RR, 1984, PROG LIPID RES, V23, P69, DOI 10.1016/0163-7827(84)90008-0
   BROWN FR, 1982, JOHNS HOPKINS MED J, V151, P344
   FAHIMI HD, 1993, BIOCHIMIE, V75, P201, DOI 10.1016/0300-9084(93)90078-7
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HOLLOWAY CT, 1975, ARCH BIOCHEM BIOPHYS, V167, P496, DOI 10.1016/0003-9861(75)90492-0
   JAKOBS BS, 1991, BIOCHEM BIOPH RES CO, V178, P842, DOI 10.1016/0006-291X(91)90967-C
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043
   MAHLER HR, 1974, METHOD ENZYMAT AN, V1, P518
   MANIONGUI C, 1993, LIPIDS, V28, P291, DOI 10.1007/BF02536313
   MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585
   MANNAERTS GP, 1981, SHORT TERM REGULATIO, P273
   MARTINEZ M, 1990, NEUROLOGY, V40, P1292, DOI 10.1212/WNL.40.8.1292
   NEMALI MR, 1989, TOXICOL APPL PHARM, V97, P72, DOI 10.1016/0041-008X(89)90056-2
   PERICHON R, 1995, BIOCHIMIE, V77, P288, DOI 10.1016/0300-9084(96)88138-7
   POULOS A, 1995, LIPIDS, V30, P1, DOI 10.1007/BF02537036
   STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4
   WANDERS RJA, 1993, PEROXISOMES BIOL IMP, P63
NR 23
TC 9
Z9 9
U1 0
U2 0
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE NSW 2204, AUSTRALIA
SN 1039-9712
J9 BIOCHEM MOL BIOL INT
JI Biochem. Mol. Biol. Int.
PD OCT
PY 1995
VL 37
IS 3
BP 475
EP 480
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA VG874
UT WOS:A1995VG87400009
PM 8595387
DA 2024-02-19
ER

PT J
AU Lomas-Soria, C
   Rodríguez-González, GL
   Ibáñez, CA
   Reyes-Castro, LA
   Nathanielsz, PW
   Zambrano, E
AF Lomas-Soria, Consuelo
   Rodriguez-Gonzalez, Guadalupe L.
   Ibanez, Carlos A.
   Reyes-Castro, Luis A.
   Nathanielsz, Peter W.
   Zambrano, Elena
TI Maternal Obesity Programs the Premature Aging of Rat Offspring Liver
   Mitochondrial Electron Transport Chain Genes in a Sex-Dependent Manner
SO BIOLOGY-BASEL
LA English
DT Article
DE maternal obesity; aging; RNA-seq; liver; mitochondria; oxidative
   phosphorylation
ID FATTY LIVER; DISEASE; EXPRESSION; NAFLD; DYSFUNCTION; PREGNANCY;
   HALLMARKS; SIRT3; RISK; DIET
AB Simple Summary Developmental programming is now an area of considerable interest throughout the biomedical research community as it is now well accepted that challenges during fetal and early neonatal life program the trajectory of the development and function of multiple systems across the life span. There is now also compelling evidence that developmental programming alters the trajectory of aging, beginning early in life. The present study links mitochondrial function to molecular signaling pathways that regulate life span and to the aging process; it demonstrates the role and importance of mitochondria in the predisposition to developing a fatty liver. The overall message we wish to emphasize is that hepatic aging in offspring caused by maternal obesity in rats involves changes in the mitochondrial function pathways that result in fatty livers. These processes show sexual dimorphism as they occur in males and females at different ages. These findings throw new light on the mechanisms that underlie the well-established sexual dimorphism in aging. We hope this paper will be a stimulus to similar studies on other tissues.Abstract We investigated whether maternal obesity affects the hepatic mitochondrial electron transport chain (ETC), sirtuins, and antioxidant enzymes in young (110 postnatal days (PND)) and old (650PND) male and female offspring in a sex- and age-related manner. Female Wistar rats ate a control (C) or high-fat (MO) diet from weaning, through pregnancy and lactation. After weaning, the offspring ate the C diet and were euthanized at 110 and 650PND. The livers were collected for RNA-seq and immunohistochemistry. Male offspring livers had more differentially expressed genes (DEGs) down-regulated by both MO and natural aging than females. C-650PND vs. C-110PND and MO-110PND vs. C-110PND comparisons revealed 1477 DEGs in common for males (premature aging by MO) and 35 DEGs for females. Analysis to identify KEGG pathways enriched from genes in common showed changes in 511 and 3 KEGG pathways in the male and female livers, respectively. Mitochondrial function pathways showed ETC-related gene down-regulation. All ETC complexes, sirtuin2, sirtuin3, sod-1, and catalase, exhibited gene down-regulation and decreased protein expression at young and old ages in MO males vs. C males; meanwhile, MO females down-regulated only at 650PND. Conclusions: MO accelerates the age-associated down-regulation of ETC pathway gene expression in male offspring livers, thereby causing sex-dependent oxidative stress, premature aging, and metabolic dysfunction.
C1 [Lomas-Soria, Consuelo; Rodriguez-Gonzalez, Guadalupe L.; Ibanez, Carlos A.; Reyes-Castro, Luis A.; Zambrano, Elena] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Biol Reprod, Mexico City 14080, Mexico.
   [Lomas-Soria, Consuelo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Biol Reprod, CONAHCyT Catedras, Investigador Mexico, Mexico City 14080, Mexico.
   [Nathanielsz, Peter W.] Univ Wyoming, Wyoming Ctr Pregnancy & Life Course Hlth Res, Dept Anim Sci, Laramie, WY 82071 USA.
   [Nathanielsz, Peter W.] Texas Biomed Res Inst, Dept Genet, San Antonio, TX 78227 USA.
   [Zambrano, Elena] Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, Mexico.
C3 Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran -
   Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador
   Zubiran - Mexico; University of Wyoming; Texas Biomedical Research
   Institute; Universidad Nacional Autonoma de Mexico
RP Zambrano, E (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Biol Reprod, Mexico City 14080, Mexico.; Zambrano, E (corresponding author), Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, Mexico.
EM mconsuelo@conahcyt.mx; guadalupe.rodriguezg@incmnsz.mx;
   carlos_albertoibc@hotmail.com; luis.reyesc@incmnsz.mx;
   peter.nathanielsz@uwyo.edu; elena.zambranog@incmnsz.mx
RI Ibáñez Chávez, Carlos Alberto/AAG-2398-2020; Rodríguez-González,
   Guadalupe Leticia/AAB-1291-2021
OI Ibáñez Chávez, Carlos Alberto/0000-0002-3435-497X; Nathanielsz,
   Peter/0000-0001-8410-6280; Lomas, Consuelo/0000-0003-0390-7305;
   Zambrano, Elena/0000-0002-0362-9117
FU Laura A. Cox for the acquisition and analysis of RNA-seq data.
FX Laura A. Cox for the acquisition and analysis of RNA-seq data.
CR Aiken CE, 2019, FASEB J, V33, P7758, DOI 10.1096/fj.201802772R
   Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, V307, pR26, DOI 10.1152/ajpregu.00049.2014
   Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140908
   Arnold PK, 2023, J BIOL CHEM, V299, DOI 10.1016/j.jbc.2022.102838
   Bacalini MG, 2019, J GERONTOL A-BIOL, V74, P1, DOI 10.1093/gerona/gly048
   Baker DJ, 2017, TRENDS BIOCHEM SCI, V42, P702, DOI 10.1016/j.tibs.2017.06.005
   Baker PR, 2018, J CLIN INVEST, V128, P3692, DOI 10.1172/JCI120846
   Bayol SA, 2010, ENDOCRINOLOGY, V151, P1451, DOI 10.1210/en.2009-1192
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205
   Brumbaugh DE, 2014, PEDIATR RES, V75, P140, DOI 10.1038/pr.2013.193
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Capel F, 2011, J NUTRIGENET NUTRIGE, V4, P154, DOI 10.1159/000328190
   Chavira-Suárez E, 2022, FRONT CELL DEV BIOL, V10, DOI 10.3389/fcell.2022.892315
   Cheng CJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12905
   Chishti MA, 2013, AGE, V35, P719, DOI 10.1007/s11357-012-9404-z
   Chistiakov DA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/238463
   Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2
   Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Dabravolski SA, 2021, BIOMED PHARMACOTHER, V142, DOI 10.1016/j.biopha.2021.112041
   Dornas W, 2020, AM J PHYSIOL-GASTR L, V319, pG400, DOI 10.1152/ajpgi.00121.2020
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Fromenty B, 2023, J HEPATOL, V78, P415, DOI 10.1016/j.jhep.2022.09.020
   Goedeke L, 2022, AGING CELL, V21, DOI 10.1111/acel.13539
   Gomes P, 2015, TRENDS PHARMACOL SCI, V36, P756, DOI 10.1016/j.tips.2015.08.001
   Grundy D, 2015, J PHYSIOL-LONDON, V593, P2547, DOI 10.1113/JP270818
   Guo J, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-022-01251-0
   Hagström H, 2021, J HEPATOL, V75, P1042, DOI 10.1016/j.jhep.2021.06.045
   Han SG, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10148
   He F, 2021, J EXP MED, V218, DOI 10.1084/jem.20201416
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Ibañez CA, 2023, NUTRIENTS, V15, DOI 10.3390/nu15102245
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010
   Lemos V, 2017, HUM MOL GENET, V26, P4105, DOI 10.1093/hmg/ddx298
   Lin YS, 2022, DIABETOL METAB SYNDR, V14, DOI 10.1186/s13098-022-00930-w
   Lomas-Soria C, 2021, J PHYSIOL-LONDON, V599, P4309, DOI 10.1113/JP281822
   Lomas-Soria C, 2018, J PHYSIOL-LONDON, V596, P4611, DOI 10.1113/JP276372
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lozada-Delgado J.G., 2020, Aging, P37, DOI [10.1016/B978-0-12-818698-5.00004-3, DOI 10.1016/B978-0-12-818698-5.00004-3]
   Mennitti LV, 2022, INT J OBESITY, V46, P269, DOI 10.1038/s41366-021-00985-1
   Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067
   Nathanielsz P.W., 2022, Life before Birth: The Challenges of Fetal Development, V1st ed., P351
   Nathanielsz PW, 2020, NUTR REV, V78, P48, DOI 10.1093/nutrit/nuaa018
   Newton KP, 2017, J PEDIATR-US, V187, P141, DOI 10.1016/j.jpeds.2017.03.007
   Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011
   Odhiambo JF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186926
   Pérez LM, 2016, J PHYSIOL-LONDON, V594, P3187, DOI 10.1113/JP271691
   Puppala S, 2018, J PHYSIOL-LONDON, V596, P5823, DOI 10.1113/JP275422
   Reichetzeder C, 2021, EUR J CLIN NUTR, V75, P1710, DOI 10.1038/s41430-021-00905-6
   Ren HH, 2021, HEPATOLOGY, V74, P723, DOI [10.1002/htp.31773, 10.1002/hep.31773]
   Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539
   Riazi K, 2022, LANCET GASTROENTEROL, V7, P851, DOI 10.1016/S2468-1253(22)00165-0
   Rodríguez-González GL, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11101871
   Rodríguez-González GL, 2019, J PHYSIOL-LONDON, V597, P5549, DOI 10.1113/JP278232
   Rodríguez-González GL, 2023, BRIT J NUTR, V130, P783, DOI 10.1017/S0007114522003737
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Schmauck-Medina T, 2022, AGING-US, V14, P6829, DOI 10.18632/aging.204248
   Serafim TL, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13375
   Snelgrove-Clarke E, 2021, JBI EVID SYNTH, V19, P3183, DOI 10.11124/JBIES-20-00442
   Sultanova RF, 2020, AM J PHYSIOL-RENAL, V319, pF1117, DOI 10.1152/ajprenal.00320.2020
   Thompson MD, 2020, HEPATOL COMMUN, V4, P1392, DOI 10.1002/hep4.1578
   Thorn SR, 2014, DIABETES, V63, P2702, DOI 10.2337/db14-0276
   Tiwari A, 2023, Public Health Considerations Regarding Obesity
   Valentini F, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11030562
   Vega CC, 2015, INT J OBESITY, V39, P712, DOI 10.1038/ijo.2013.150
   Von Schulze A, 2018, J PHYSIOL-LONDON, V596, P6157, DOI 10.1113/JP276539
   Vos MB, 2017, J PEDIATR GASTR NUTR, V64, P319, DOI 10.1097/MPG.0000000000001482
   Wang Y, 2015, SCIENCE, V350, P1204, DOI 10.1126/science.aac4357
   Wankhade UD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175675
   Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Yamada T, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2022.103996
   Zambrano E, 2021, NUTRIENTS, V13, DOI 10.3390/nu13124243
   Zambrano E, 2020, J GERONTOL A-BIOL, V75, P2304, DOI 10.1093/gerona/glaa067
   Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475
   Zhang YQ, 2016, MECH AGEING DEV, V154, P1, DOI 10.1016/j.mad.2016.01.005
   Zhao YL, 2022, FRONT MED-LAUSANNE, V9, DOI 10.3389/fmed.2022.842024
   Ziolkowska S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222011128
NR 82
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD SEP
PY 2023
VL 12
IS 9
AR 1166
DI 10.3390/biology12091166
PG 22
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA S9QN4
UT WOS:001074439700001
PM 37759566
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Hakimizadeh, E
   Zamanian, MY
   Damankhorshid, M
   Giménez-Llort, L
   Sciorati, C
   Nikbakhtzadeh, M
   Moradbeygi, K
   Kujawska, M
   Kaeidi, A
   Taghipour, Z
   Fatemi, I
AF Hakimizadeh, Elham
   Zamanian, Mohammad Yassin
   Damankhorshid, Morteza
   Gimenez-Llort, Lydia
   Sciorati, Clara
   Nikbakhtzadeh, Marjan
   Moradbeygi, Khadijeh
   Kujawska, Malgorzata
   Kaeidi, Ayat
   Taghipour, Zahra
   Fatemi, Iman
TI Calcium dobesilate protects against d-galactose-induced hepatic and
   renal dysfunction, oxidative stress, and pathological damage
SO FUNDAMENTAL & CLINICAL PHARMACOLOGY
LA English
DT Article; Early Access
DE aging; calcium dobesilate; kidney; liver; mice; oxidative stress
ID GENTAMICIN-INDUCED NEPHROTOXICITY; INDUCED AGING MODEL; INDUCED LIVER;
   INJURY; BLOOD; ACID; ATORVASTATIN; PHYSIOLOGY; TOXICITY
AB Calcium dobesilate (CaD) is used for the treatment of diabetic retinopathy and nephropathy. This agent exerts antioxidant effects. In the present study, we evaluated the protective effects of oral administration of CaD against hepatorenal damages in a mice model of aging induced by d-galactose (d-gal). We used 28 male albino mice, which equally and randomly were divided into four groups as follows: intact, aging (d-gal at the dose of 500 mg/kg, p.o.), aging + CaD 50 (d-gal plus CaD at the dose of 50 mg/kg), and aging + CaD 100 (d-gal plus CaD at the dose of 100 mg/kg, p.o.). All drugs were administered orally once a day for 42 days. The liver and kidney damages were evaluated by measuring mass indices, levels of serum creatinine and blood urea nitrogen, and activities of serum alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase and by histopathological evaluation. Moreover, hepatic and renal tissue oxidant/antioxidant markers (malondialdehyde, superoxide dismutase, catalase, and glutathione peroxidase) were measured. The results showed that d-gal treatment induced significant oxidative stress in the kidney and liver that was paralleled by dysfunctions and histological alterations of these organs. CaD significantly improved the liver and kidney indices, implemented functional capacity of the liver and kidney, as well as decreased oxidative stress enhancing antioxidative enzyme activities. CaD treatment also inhibited the development of histological alterations of both kidney and liver. CaD might represent a promising therapeutic agent for the attenuation of hepatorenal injuries induced by aging.
C1 [Hakimizadeh, Elham; Damankhorshid, Morteza; Kaeidi, Ayat] Rafsanjan Univ Med Sci, Physiol Pharmacol Res Ctr, Res Inst Basic Med Sci, Rafsanjan, Iran.
   [Zamanian, Mohammad Yassin] Hamadan Univ Med Sci, Sch Med, Dept Physiol, Hamadan, Iran.
   [Zamanian, Mohammad Yassin] Hamadan Univ Med Sci, Sch Med, Dept Toxicol & Pharmacol, Hamadan, Iran.
   [Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Inst Neurosci, Barcelona, Spain.
   [Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Dept Psychiat & Forens Med, Barcelona, Spain.
   [Sciorati, Clara] IRCCS Osped San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Milan, Italy.
   [Nikbakhtzadeh, Marjan; Moradbeygi, Khadijeh] Univ Tehran Med Sci, Sch Med, Dept Physiol, Tehran, Iran.
   [Moradbeygi, Khadijeh] Abadan Fac Med Sci, Dept Nursing, Abadan, Iran.
   [Kujawska, Malgorzata] Poznan Univ Med Sci, Dept Toxicol, Poznan, Poland.
   [Kaeidi, Ayat] Rafsanjan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Rafsanjan, Iran.
   [Taghipour, Zahra] Rafsanjan Univ Med Sci, Sch Med, Dept Anat, Rafsanjan, Iran.
   [Fatemi, Iman] Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran.
C3 Hamadan University of Medical Sciences; Hamadan University of Medical
   Sciences; Autonomous University of Barcelona; Autonomous University of
   Barcelona; Tehran University of Medical Sciences; Poznan University of
   Medical Sciences; Kerman University of Medical Sciences
RP Fatemi, I (corresponding author), Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran.
EM imanfatemi@gmail.com
RI Fatemi Rabori, Seyediman/I-3054-2017; Kujawska, Małgorzata/I-6936-2015;
   Zamanian, Mohammad Yassin/AFM-9347-2022; Taghipour, Zahra/H-2197-2017;
   Hakimizadeh, Elham/N-5810-2018; Kaeidi, Ayat/O-3477-2017
OI Fatemi Rabori, Seyediman/0000-0002-9666-9651; Kujawska,
   Małgorzata/0000-0002-5306-9904; Taghipour, Zahra/0000-0002-6670-724X;
   Hakimizadeh, Elham/0000-0002-2811-7716; Gimenez-Llort,
   Lydia/0000-0002-4091-489X; Kaeidi, Ayat/0000-0002-3292-2603
FU Vice-Chancellor for Research and Technology, Rafsanjan University of
   Medical Sciences [98004]
FX Vice-Chancellor for Research and Technology, Rafsanjan University of
   Medical Sciences, Grant/Award Number: 98004
CR Alda O, 2011, PHLEBOLOGY, V26, P332, DOI 10.1258/phleb.2010.010052
   Bazmandegan G, 2021, N-S ARCH PHARMACOL, V394, P515, DOI 10.1007/s00210-020-01990-3
   Bazmandegan G, 2019, IRAN J BASIC MED SCI, V22, P563, DOI 10.22038/ijbms.2019.33620.8020
   Berthet P, 1999, INT J CLIN PRACT, V53, P631
   Bogdanov P, 2017, J DIABETES COMPLICAT, V31, P1481, DOI 10.1016/j.jdiacomp.2017.07.009
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brisco MA, 2013, CIRC-HEART FAIL, V6, P233, DOI 10.1161/CIRCHEARTFAILURE.112.968230
   Cerrahoglu M, 2009, J CARDIOVASC SURG, V50, P695
   Chen MX, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01065
   Ehsani V, 2017, RENAL FAILURE, V39, P519, DOI 10.1080/0886022X.2017.1326384
   EVERS BM, 1994, SURG CLIN N AM, V74, P23
   Farsa OI., 2012, DIABETIC RETINOPATHY, DOI [10.5772/32131, DOI 10.5772/32131]
   Fatemi I, 2018, FUND CLIN PHARMACOL, V32, P392, DOI 10.1111/fcp.12364
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Ghanbari S, 2012, DARU, V20, DOI 10.1186/2008-2231-20-68
   Ghaznavi H, 2018, J ASIAN NAT PROD RES, V20, P1182, DOI 10.1080/10286020.2017.1384819
   Goudarzi M, 2017, FUND CLIN PHARMACOL, V31, P625, DOI 10.1111/fcp.12303
   Graber R, 1998, APOPTOSIS, V3, P41, DOI 10.1023/A:1009659119635
   Hakimizadeh E, 2020, IRAN J BASIC MED SCI, V23, P368, DOI 10.22038/IJBMS.2019.40344.9556
   Haller H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1909258
   Hosseinzadeh A, 2020, BIOTECH HISTOCHEM, V95, P532, DOI 10.1080/10520295.2020.1730967
   Hu Q, 2017, TALANTA, V163, P146, DOI 10.1016/j.talanta.2016.10.097
   Jafarey M, 2014, IRAN J KIDNEY DIS, V8, P46
   Karimi MY, 2020, J DIET SUPPL, V17, P651, DOI 10.1080/19390211.2019.1634175
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   Li W., 1994, CHIN J PHARMACOL TOX, V9, P93
   Li W.B., 1995, CHIN J PHARM TOXICOL, V9, P93
   Losa GA., 1999, INT J ANGIOL, V8, pS11, DOI [10.1007/BF01619843, DOI 10.1007/BF01619843]
   Mehrzadi S, 2018, PHARMACOL REP, V70, P712, DOI 10.1016/j.pharep.2018.02.007
   Mehrzadi S, 2018, BIOMED PHARMACOTHER, V97, P233, DOI 10.1016/j.biopha.2017.10.113
   Mo ZZ, 2017, REJUV RES, V20, P231, DOI 10.1089/rej.2016.1870
   Pak JW, 2003, AGING CELL, V2, P1, DOI 10.1046/j.1474-9728.2003.00034.x
   Parmar AK, 2016, ANALYST, V141, P1488, DOI 10.1039/c5an02303c
   Priyamvada S, 2008, PROSTAG LEUKOTR ESS, V78, P369, DOI 10.1016/j.plefa.2008.04.008
   Qin LL, 2017, EXP THER MED, V14, P5012, DOI 10.3892/etm.2017.5115
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Schmitt R, 2017, KIDNEY INT, V92, P569, DOI 10.1016/j.kint.2017.02.036
   Seker A, 2016, EUR REV MED PHARMACO, V20, P2168
   Szabo ME, 2001, EUR J PHARMACOL, V428, P277, DOI 10.1016/S0014-2999(01)01196-7
   SZASZ G, 1969, CLIN CHEM, V15, P124
   Taghipour Z, 2019, PHYSIOL PHARMACOL, V23, P36
   Tajiri K., 2017, LIVER PATHOPHYSIOLOG, P331, DOI [10.1016/B978-0-12-804274-8.00026-6, DOI 10.1016/B978]
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Tan BL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01162
   Tejerina T, 1998, GEN PHARMACOL-VASC S, V31, P357, DOI 10.1016/S0306-3623(98)00040-8
   Unal Y, 2019, J INVEST SURG, V32, P238, DOI 10.1080/08941939.2018.1451936
   Ünal Y, 2018, ULUS TRAVMA ACIL CER, V24, P391, DOI 10.5505/tjtes.2018.33238
   Wong CW, 2020, HONG KONG MED J, V26, P510, DOI 10.12809/hkmj208534
   Xu Y, 2009, BIOGERONTOLOGY, V10, P153, DOI 10.1007/s10522-008-9158-2
   Zakeri M, 2019, CLIN EXP PHARMACOL P, V46, P1133, DOI 10.1111/1440-1681.13149
   Zamanian M, 2017, CAN J PHYSIOL PHARM, V95, P708, DOI 10.1139/cjpp-2016-0653
   Zhou YJ, 2018, CELL PHYSIOL BIOCHEM, V51, P1119, DOI 10.1159/000495491
NR 54
TC 2
Z9 2
U1 3
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0767-3981
EI 1472-8206
J9 FUND CLIN PHARMACOL
JI Fundam. Clin. Pharmacol.
PD 2022 AUG
PY 2022
VL 36
IS 4
BP 721
EP 730
DI 10.1111/fcp.12766
EA MAR 2022
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 2W7AU
UT WOS:000768759900001
PM 35112398
DA 2024-02-19
ER

PT J
AU Bagheri, Y
   Sadigh-Eteghad, S
   Fathi, E
   Mahmoudi, J
   Abdollahpour, A
   Namini, NJ
   Malekinejad, Z
   Mokhtari, K
   Barati, A
   Montazersaheb, S
AF Bagheri, Yasin
   Sadigh-Eteghad, Saeed
   Fathi, Ezzatollah
   Mahmoudi, Javad
   Abdollahpour, Abdollah
   Namini, Nasim Jalili
   Malekinejad, Zahra
   Mokhtari, Kiarash
   Barati, Alireza
   Montazersaheb, Soheila
TI Hepatoprotective effects of sericin on aging-induced liver damage in
   mice
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Article; Early Access
DE Sericin; Aging; Pro-inflammatory; Mice; Apoptosis; Liver
ID MESENCHYMAL STEM-CELLS; OXIDATIVE STRESS; PROTEIN; APOPTOSIS;
   INFLAMMATION; MODULATION; MECHANISMS; TYROSINASE; PATHWAYS; KINASES
AB Aging is a physiological process in which there is a progressive decline of function in multiple organs such as the liver. The development of natural therapies, such as sericin, for delaying age-associated diseases is of major interest in this regard. Twenty-seven mice were divided into three groups of nine, including young control group (8 weeks, received normal saline), aged control group (24 months, received normal saline), and sericin-treated aged mice (24 months, received sericin at dose 100 mg/kg/day) via oral administration for 14 days. The liver enzymes in serum and oxidative stress markers in liver tissue were evaluated using spectrophotometric/ELISA methods. Apoptotic proteins, pro-inflammatory cytokines, COX2, JNK, and P-38 levels were assessed by western blot analysis. beta-galactosidase expression was determined by a qRT-PCR method. The findings showed that 100 mg/kg of sericin reduced liver enzymes in aged mice. Antioxidant capacity in treated aged mice showed an improvement in all indexes in the liver tissue. Also, sericin administration declined pro-inflammatory markers to varying degrees in aged-treated mice. Sericin also increased the expression level of Bcl-2 and decreased the expression level of Bax and cleaved caspase-3.In addition, treatment with sericin suppressed protein expression of p-JNK and p-JNK/JNK. Collectively, these findings would infer that sericin administration may have a hepatoprotective effect in aging-induced liver damage in mice.
C1 [Bagheri, Yasin; Sadigh-Eteghad, Saeed; Mahmoudi, Javad] Tabriz Univ Med Sci, Neurosci Res Ctr, Tabriz, Iran.
   [Fathi, Ezzatollah] Univ Tabriz, Fac Vet Med, Dept Clin Sci, Tabriz, Iran.
   [Abdollahpour, Abdollah; Namini, Nasim Jalili; Malekinejad, Zahra; Mokhtari, Kiarash; Barati, Alireza] Islamic Azad Univ, Fac Vet Med, Tabriz Branch, Tabriz, Iran.
   [Montazersaheb, Soheila] Tabriz Univ Med Sci, Mol Med Res Ctr, Tabriz, Iran.
C3 Tabriz University of Medical Science; University of Tabriz; Islamic Azad
   University; Tabriz University of Medical Science
RP Montazersaheb, S (corresponding author), Tabriz Univ Med Sci, Mol Med Res Ctr, Tabriz, Iran.
EM smontazersaheb@gmail.com
RI Sadigh-Eteghad, Saeed/J-3918-2013; Abdollahpour, Abdollah/AAO-2439-2021;
   Fathi, Ezzatollah/H-1923-2017
OI Sadigh-Eteghad, Saeed/0000-0003-2872-1072; Abdollahpour,
   Abdollah/0000-0002-9013-9035; Montazersaheb, Soheila/0000-0001-5010-7293
FU Molecular Medicine Research Center, Tabriz University of Medical
   Sciences, Tabriz, Iran [65705, IR.TBZMED.VCR.REC.1399.334]
FX The financial sponsorship of this work was provided by the Molecular
   Medicine Research Center, Tabriz University of Medical Sciences, Tabriz,
   Iran (Pazhoohan ID., 65705; ethical code No.,
   IR.TBZMED.VCR.REC.1399.334).
CR Aramwit P, 2009, J BIOSCI BIOENG, V107, P556, DOI 10.1016/j.jbiosc.2008.12.012
   ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43
   Bagheri Y, 2021, IRAN J BASIC MED SCI, V24, P175, DOI [10.22038/ijbms.2020.51276.11642, 10.22038/IJBMS.2020.51276.11642]
   Bagheri Y, 2021, HUM EXP TOXICOL, V40, P1022, DOI 10.1177/0960327120979014
   Barajas-Gamboa JA, 2016, ING COMPET, V18, P193, DOI 10.25100/iyc.v18i2.2167
   Basso A, 1998, J GERONTOL A-BIOL, V53, pB111, DOI 10.1093/gerona/53A.2.B111
   Bejma J, 2000, ACTA PHYSIOL SCAND, V169, P343
   Carmona-Gutierrez D, 2016, AGEING RES REV, V32, P2, DOI 10.1016/j.arr.2016.04.009
   Chlapanidas T, 2013, INT J BIOL MACROMOL, V58, P47, DOI 10.1016/j.ijbiomac.2013.03.054
   Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z
   Deori M, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00319
   Di Iorio A, 2003, CYTOKINE, V22, P198, DOI 10.1016/S1043-4666(03)00152-2
   Ding AJ, 2017, NAT PRODUCT BIOPROSP, V7, P335, DOI 10.1007/s13659-017-0135-9
   Ebrahimi V, 2020, GENE, V742, DOI 10.1016/j.gene.2020.144577
   Farahzadi R, 2020, ACS CHEM NEUROSCI, V11, P1424, DOI 10.1021/acschemneuro.0c00052
   Farahzadi R, 2016, INT J STEM CELLS, V9, P107, DOI 10.15283/ijsc.2016.9.1.107
   Fathi E, 2021, INT J BIOL MACROMOL, V177, P317, DOI 10.1016/j.ijbiomac.2021.02.131
   Fathi E, 2020, TISSUE CELL, V67, DOI 10.1016/j.tice.2020.101429
   Fathi E, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-020-00063-0
   Fathi E, 2019, BLOOD RES, V54, P165, DOI 10.5045/br.2019.54.3.165
   Fathi Ezzatollah, 2019, Stem Cell Investig, V6, P7, DOI 10.21037/sci.2019.02.04
   Fathi E, 2016, BRAZ ARCH BIOL TECHN, V59, DOI 10.1590/1678-4324-2016150383
   Feizy N, 2016, NEUROCHEM RES, V41, P1410, DOI 10.1007/s11064-016-1847-7
   Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940
   Jang JY, 2018, J CLIN INVEST, V128, P3662, DOI 10.1172/JCI120842
   Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008
   Kaeberlein Matt, 2013, F1000Prime Rep, V5, P5, DOI 10.12703/P5-5
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Kunz, 2016, SILKWORM SERICIN PRO
   Kunz Regina Ines, 2016, Biomed Res Int, V2016, P8175701
   Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807
   Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mehdizadeh A, 2017, ARTIF CELL NANOMED B, V45, P1612, DOI 10.1080/21691401.2016.1269117
   Mobarak H, 2017, VET RES COMMUN, V41, P41, DOI 10.1007/s11259-016-9670-9
   Montazersaheb S, 2019, CURR PHARM BIOTECHNO, V20, P168, DOI 10.2174/1389201020666190206202650
   Morgunova G., 2015, Vestnik Moskovskogo Universiteta Seriya 16 Biologiya, P15
   Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153
   Prasong S., 2011, Journal of Biological Sciences, V11, P336, DOI 10.3923/jbs.2011.336.339
   Qin H, 2020, SAFETY ASSESSMENT WA
   Rahimi MM, 2021, HUM EXP TOXICOL, V40, P1263, DOI 10.1177/0960327121993224
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Rezabakhsh A, 2017, BIOIMPACTS, V7, P219, DOI 10.15171/bi.2017.26
   Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Sadler KC, 2004, MOL REPROD DEV, V67, P366, DOI 10.1002/mrd.20023
   Saliani N, 2017, ADV PHARM BULL, V7, P547, DOI 10.15171/apb.2017.066
   SASAKI, 2000, RESISTANT PROTEIN SE, V6, P280
   Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005
   Seyedaghamiri F, 2021, MOL BIOL REP, V48, P1371, DOI 10.1007/s11033-021-06195-2
   Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035
   Tarhriz V, 2019, J CELL BIOCHEM, V120, P18854, DOI 10.1002/jcb.29204
   Tarhriz V, 2018, J CELL BIOCHEM, V119, P547, DOI 10.1002/jcb.26213
   Tarín JJ, 2001, BIOL REPROD, V65, P141, DOI 10.1095/biolreprod65.1.141
   Walter MF, 2004, J AM COLL CARDIOL, V44, P1996, DOI 10.1016/j.jacc.2004.08.029
   Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011
   Wu, 2014, AGING CLIN EXP RES, P3, DOI [10.1016/B978-0-12-405933-7.00001-9, DOI 10.1016/B978-0-12-405933-7.00001-9]
   Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011
   Yagi K, 1998, Methods Mol Biol, V108, P101
NR 62
TC 4
Z9 4
U1 1
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD 2021 DEC
PY 2021
VL 394
IS 12
BP 2441
EP 2450
DI 10.1007/s00210-021-02160-9
EA OCT 2021
PG 10
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA WX8VK
UT WOS:000704180000001
PM 34605941
DA 2024-02-19
ER

PT J
AU Krupczak-Hollis, K
   Wang, XH
   Dennewitz, MB
   Costa, RH
AF Krupczak-Hollis, K
   Wang, XH
   Dennewitz, MB
   Costa, RH
TI Growth hormone stimulates proliferation of old-aged regenerating liver
   through Forkhead Box m1b
SO HEPATOLOGY
LA English
DT Article
ID TRANSCRIPTION FACTOR HFH-11B; CELL-CYCLE; CDC25B PHOSPHATASE; HUMAN
   FIBROBLASTS; HEPATOCYTE ENTRY; DNA-REPLICATION; S-PHASE; EXPRESSION;
   PROTEIN; DOMAIN
AB The Forkhead Box (Fox) proteins are an extensive family of transcription factors that shares homology in the winged helix DNA-binding domain and the members of which play essential roles in cellular proliferation, differentiation, and longevity. Reduced cellular proliferation during aging is associated with a progressive decline in both growth hormone (GH) secretion and Foxm1b expression. Liver regeneration studies with 12-month-old (old-aged) transgenic mice indicated that increased hepatocyte expression of Foxm1b alone is sufficient to restore hepatocyte proliferation to levels found in 2-month-old (young) regenerating liver. GH therapy in older people has been shown to cause an increase in cellular proliferation, but the transcription factors that mediated this stimulation in proliferation remain uncharacterized. In this study, we showed that human GH administration to old-aged Balb/c mice dramatically increased both expression of Foxm1b and regenerating hepatocyte proliferation. This increase in old-aged regenerating hepatocyte proliferation was associated with elevated protein expression of Cdc25A, Cdc25B, and cyclin B I, with reduced protein levels of cyclin-dependent kinase inhibitor p27(Kip1) (p27). GH treatment also was found to stimulate hepatocyte proliferation and expression of Foxm1b protein without partial hepatectomy (PHx). Furthermore, GH treatment of young Foxm1b-/- mice failed to restore regenerating hepatocyte DNA replication and mitosis caused by Foxm1b deficiency. These genetic studies provided strong evidence that the presence of Foxm1b is essential for GH to stimulate regenerating hepatocyte proliferation. In conclusion, our old-aged liver regeneration studies show that increased Foxm1b levels are essential for GH to stimulate hepatocyte proliferation, thus providing a mechanism for GH action in the elderly.
C1 Univ Illinois, Coll Med, Dept Mol Genet, Chicago, IL 60607 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Costa, RH (corresponding author), Univ Illinois, Coll Med, Dept Mol Genet MC 669, 900 S Ashland Ave,Rm 2220 MBRB, Chicago, IL 60607 USA.
FU NIA NIH HHS [R01 AG21842-01] Funding Source: Medline; NIDDK NIH HHS [R01
   DK 54687-05, T32 DK007739] Funding Source: Medline
CR Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   ASAKAWA K, 1989, J ENDOCRINOL INVEST, V12, P343, DOI 10.1007/BF03350004
   Borgne A, 1996, J BIOL CHEM, V271, P27847, DOI 10.1074/jbc.271.44.27847
   Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8
   Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780
   Cartee GD, 1996, J GERONTOL A-BIOL, V51, pB214, DOI 10.1093/gerona/51A.3.B214
   Chen MS, 2001, MOL CELL BIOL, V21, P3853, DOI 10.1128/MCB.21.12.3853-3861.2001
   CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0
   Costa RH, 2001, AM J PHYSIOL-LUNG C, V280, pL823, DOI 10.1152/ajplung.2001.280.5.L823
   Diehl AM, 2000, IMMUNOL REV, V174, P160, DOI 10.1034/j.1600-0528.2002.017411.x
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200
   Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526
   HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x
   Ishida S, 2001, MOL CELL BIOL, V21, P4684, DOI 10.1128/MCB.21.14.4684-4699.2001
   IZUMI T, 1993, MOL BIOL CELL, V4, P1337, DOI 10.1091/mbc.4.12.1337
   Kaestner KH, 2000, GENE DEV, V14, P142
   Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573
   Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065
   Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715
   Lammer C, 1998, J CELL SCI, V111, P2445
   Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4
   Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856
   Lüscher-Firzlaff JM, 1999, ONCOGENE, V18, P5620, DOI 10.1038/sj.onc.1202967
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Ma Y, 2000, ONCOGENE, V19, P4815, DOI 10.1038/sj.onc.1203834
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504
   Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890
   Nilsson I, 2000, Prog Cell Cycle Res, V4, P107
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Rausa FM, 2000, MOL CELL BIOL, V20, P8264, DOI 10.1128/MCB.20.21.8264-8282.2000
   RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101
   SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Taub R, 1999, SEMIN LIVER DIS, V19, P117, DOI 10.1055/s-2007-1007104
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903
   Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Wang XH, 2001, HEPATOLOGY, V33, P1404, DOI 10.1053/jhep.2001.24666
   Wells NJ, 1999, J CELL SCI, V112, P3361
   Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827
   Ye HG, 1999, MOL CELL BIOL, V19, P8570
   Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626
   Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039
   ZHU L, 1995, GENE DEV, V9, P1740, DOI 10.1101/gad.9.14.1740
NR 49
TC 83
Z9 104
U1 0
U2 8
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD DEC
PY 2003
VL 38
IS 6
BP 1552
EP 1562
DI 10.1016/j.hep.2003.08.052
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 751BC
UT WOS:000187032100026
PM 14647066
OA Bronze
DA 2024-02-19
ER

PT J
AU Gokarn, R
   Solon-Biet, S
   Youngson, NA
   Wahl, D
   Cogger, VC
   McMahon, AC
   Cooney, GJ
   Ballard, JWO
   Raubenheimer, D
   Morris, MJ
   Simpson, SJ
   Le Couteur, DG
AF Gokarn, Rahul
   Solon-Biet, Samantha
   Youngson, Neil A.
   Wahl, Devin
   Cogger, Victoria C.
   McMahon, Aisling C.
   Cooney, Gregory J.
   Ballard, J. William O.
   Raubenheimer, David
   Morris, Margaret J.
   Simpson, Stephen J.
   Le Couteur, David G.
TI The Relationship Between Dietary Macronutrients and Hepatic Telomere
   Length in Aging Mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Diet; Nutrition; Telomeres; Geometric Framework; Macronutrients
ID CALORIC RESTRICTION; LONGEVITY; MORTALITY; EXERCISE; PATTERNS; DISEASE;
   CANCER; HEALTH; MEN; PCR
AB Macronutrients and dietary energy influence aging, age-related health, and life span. Reduction in telomere length has been proposed as one mechanism for aging. Therefore, this study investigated the effects of varying ratios of dietary macronutrients and energy on telomere length in older adult mice. C57Bl/6 mice were fed ad libitum their entire life on one of 25 diets varying in protein, carbohydrates, fat, and energy. Average telomere length ratio (ATLR) was measured by polymerase chain reaction in livers of a subset of 161 mice aged 15 months. There was a significant positive relationship between ATLR and carbohydrate intake and a negative relationship with protein intake, but no relationships with fat or energy intake. Analysis using the Geometric Framework and Generalized Additive Models confirmed that carbohydrate intake was positively associated with ATLR, while the longest ATLR was achieved by mice restricted to low protein, high carbohydrate diets. ATLR distribution across the diets was parallel to median life-span results previously published. ATLR was associated with blood levels of some amino acids (asparagine, glutamate, taurine) but not with blood levels of fatty acids, hepatic mitochondrial function, or nutrient sensing pathways. In conclusion, mice on low protein, high carbohydrate diets have the longest hepatic telomeres and longest life span.
C1 [Gokarn, Rahul; Solon-Biet, Samantha; Wahl, Devin; Cogger, Victoria C.; Cooney, Gregory J.; Raubenheimer, David; Simpson, Stephen J.; Le Couteur, David G.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.
   [Gokarn, Rahul; Solon-Biet, Samantha; Wahl, Devin; Cogger, Victoria C.; McMahon, Aisling C.; Le Couteur, David G.] Concord Hosp, CERA, Aging & Alzheimers Inst AAAI, Concord, NSW 2139, Australia.
   [Gokarn, Rahul; Solon-Biet, Samantha; Wahl, Devin; Cogger, Victoria C.; McMahon, Aisling C.; Le Couteur, David G.] Concord Hosp, ANZAC Res Inst, Concord, NSW 2139, Australia.
   [Youngson, Neil A.; Morris, Margaret J.] Univ New South Wales, Sch Med Sci, Kensington, NSW, Australia.
   [Ballard, J. William O.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.
C3 University of Sydney; Concord Repatriation General Hospital; University
   of Sydney; ANZAC Research Institute; Concord Repatriation General
   Hospital; University of New South Wales Sydney; University of New South
   Wales Sydney
RP Le Couteur, DG (corresponding author), Concord Hosp, CERA, Aging & Alzheimers Inst AAAI, Concord, NSW 2139, Australia.; Le Couteur, DG (corresponding author), Concord Hosp, ANZAC Res Inst, Concord, NSW 2139, Australia.
EM david.lecouteur@sydney.edu.au
RI Ekanayake, Kanchana/P-8817-2016; Wahl, Devin/R-9621-2018; Youngson,
   Neil/AAB-7389-2019; Research Institute, ANZAC/CAE-9030-2022; Ballard,
   John William O./ABB-2743-2020; Solon-Biet, Samantha/R-6551-2017
OI Wahl, Devin/0000-0003-2794-0185; Ballard, John William
   O./0000-0002-2358-6003; Raubenheimer, David/0000-0001-9050-1447; Morris,
   Margaret/0000-0003-2285-5117; Youngson, Neil/0000-0003-0690-4580;
   Solon-Biet, Samantha/0000-0003-0608-958X
FU Australian National Health and Medical Research Council [571328]; Ageing
   and Alzheimers Institute; Sydney Medical School Foundation; American
   Australian Association Education Fund
FX Funding was from the Australian National Health and Medical Research
   Council (Project grant 571328, post-doctoral fellowship to S.S.-B.), the
   Ageing and Alzheimers Institute and the Sydney Medical School Foundation
   (post-graduate scholarship to R.G.). D.W. is partly supported by the
   American Australian Association Education Fund.
CR [Anonymous], 2017, AM J EPIDEMIOL, DOI DOI 10.1093/aje/kww210
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Callicott RJ, 2006, COMPARATIVE MED, V56, P17
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   Eriksson JG, 2017, AM J CLIN NUTR, V105, P144, DOI 10.3945/ajcn.116.130468
   Freitas-Simoes TM, 2016, METABOLISM, V65, P406, DOI 10.1016/j.metabol.2015.11.004
   Kark JD, 2012, AM J CLIN NUTR, V95, P479, DOI 10.3945/ajcn.111.024521
   Le Couteur DG, 2016, CELL MOL LIFE SCI, V73, P1237, DOI 10.1007/s00018-015-2120-y
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ludlow AT, 2012, J GERONTOL A-BIOL, V67, P911, DOI 10.1093/gerona/gls002
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Ozsarlak-Sozer G, 2011, J PHYSIOL BIOCHEM, V67, P35, DOI 10.1007/s13105-010-0046-2
   Rafie N, 2017, EUR J CLIN NUTR, V71, P151, DOI 10.1038/ejcn.2016.149
   Simpson S.J., 2012, NATURE NUTR UNIFYING
   Simpson SJ, 2007, J GERONTOL A-BIOL, V62, P707, DOI 10.1093/gerona/62.7.707
   Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033
   Solon-Biet SM, 2016, CELL METAB, V24, P555, DOI 10.1016/j.cmet.2016.09.001
   Solon-Biet SM, 2015, J ENDOCRINOL, V226, pR17, DOI 10.1530/JOE-15-0173
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Takubo K, 2000, J GERONTOL A-BIOL, V55, pB533, DOI 10.1093/gerona/55.11.B533
   Tanrikulu-Kucuk S, 2012, LIFE SCI, V90, P924, DOI 10.1016/j.lfs.2012.04.024
   Team RC, 2013, R LANG ENV STAT COMP
   Vera E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053760
   Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023
   Vidacek NS, 2018, J GERONTOL A-BIOL, V73, P39, DOI 10.1093/gerona/glx082
NR 27
TC 12
Z9 12
U1 3
U2 14
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD APR
PY 2018
VL 73
IS 4
BP 446
EP 449
DI 10.1093/gerona/glx186
PG 4
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA FZ8VC
UT WOS:000427887600004
PM 30052781
OA Bronze
DA 2024-02-19
ER

PT J
AU Yuneva, MO
   Aleksandrova, EM
   Kurella, EG
   Boldyrev, AA
AF Yuneva, MO
   Aleksandrova, EM
   Kurella, EG
   Boldyrev, AA
TI Characteristics of the liver microsomal membranes in mice with
   genetically determined accelerated aging
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE age-specific changes; SAM mice; lipid peroxidation; pyrene eximerization
AB The liver membranes of SAMP mice with accelerated aging display increased inducibility of peroxide processes at early stages of life (2 months) and an initially higher level of MDA at later stages (8 months). In comparison with the liver membranes of the control SAMR strain, liver membranes of rapidly aging animals are characterized by more dense packing (higher microviscosity), increasing with age, judging from the eximerization of the membrane-binding fluorescent probe pyrene. Therefore, the differences in LPO and membranous bilayer packing occur in SAMP mice at early stages of development (earlier than the neurological parameters) and contribute to specific functioning of membrane-associated enzymes.
C1 Moscow MV Lomonosov State Univ, Int Biotechnol Ctr, Moscow 117234, Russia.
   Russian Acad Med Sci, Neurol Inst, Lab Clin Neurochem, Moscow, Russia.
C3 Lomonosov Moscow State University; Research Center of Neurology; Russian
   Academy of Medical Sciences
RI Boldyrev, Alexander A/B-4267-2012
CR BOLDYREV AA, 1984, BIOCHEM INT, V8, P851
   Boldyrev AA, 1990, INTRO BIOMEMBRANOLOG
   FUMIAKI I, 1988, ARCH BIOCHEM BIOPHYS, V264, P184
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1604
   MALTSEVA EA, 1992, BIOL MEMBRANY, P830
   TAKEDA T, 1994, INT CONGR SER, V1062, P15
   YU BP, 1995, MCBU, P331
NR 7
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0007-4888
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD JAN
PY 1999
VL 127
IS 1
BP 66
EP 68
DI 10.1007/BF02432804
PG 3
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 236AF
UT WOS:000082575500019
DA 2024-02-19
ER

PT J
AU Qiu, LH
   Ma, ZX
   Sun, JX
   Wu, Z
   Wang, MT
   Wang, ST
   Zhao, YH
   Liang, S
   Hu, M
   Li, YJ
AF Qiu, Lihua
   Ma, Zhaoxia
   Sun, Jianxiu
   Wu, Zhen
   Wang, Mengting
   Wang, Sitao
   Zhao, Yunhui
   Liang, Shu
   Hu, Min
   Li, Yanjiao
TI Establishment of a Spontaneous Liver Fibrosis Model in NOD/SCID Mice
   Induced by Natural Aging
SO BIOLOGY-BASEL
LA English
DT Article
DE liver fibrosis; aging; spontaneous model; NOD/SCID mice
ID APOPTOSIS; HEPATITIS
AB Simple Summary Liver fibrosis is a chronic disease that can lead to serious health problems, including liver cancer. However, the pathogenesis of liver fibrosis caused by natural aging is not fully understood. For researchers studying liver fibrosis, an important tool for conducting mechanism research and testing anti-liver fibrosis therapies is an in vivo model that can reflect the pathological causes of liver fibrosis. This study aimed to establish a model of spontaneous liver fibrosis in NOD/SCID mice induced by natural aging. This model's validity was confirmed using cutting-edge fibrosis-related measurements. This study provides a useful tool for further research into the causes and potential treatments for liver fibrosis. The findings may help to develop new therapies for chronic liver diseases which affect millions of people worldwide.Abstract Liver fibrosis, a critical pathological feature of chronic liver diseases, arises from a multitude of pathogenic factors. Consequently, establishing an appropriate animal model to simulate liver fibrosis holds immense significance for comprehending its underlying pathogenesis. Despite the numerous methodologies available for generating liver fibrosis models, they often deviate substantially from the spontaneous age-related liver fibrosis process. In this study, compared with young (12 weeks) and middle-aged NOD/SCID mice (32 weeks), there were a large number of fibrous septum and collagen in the liver tissue of old NOD/SCID mice (43 weeks, 43 W). Immunohistochemical analysis unequivocally indicated heightened alpha-SMA content within the liver tissue of the 43 W mice, thereby underscoring aging's role in triggering the epithelial-to-mesenchymal transition. In addition, SA-beta-gal staining as well as P21 expression were increased, and SIRT1 and SIRT3 expression were decreased in 43 W mice. A comprehensive evaluation encompassing transmission electron microscopy and fluorescence quantitative analysis elucidated compromised mitochondrial function and reduced antioxidant capacity in hepatocytes of the 43 W mice. Furthermore, the aging process activated the pro-fibrotic TGF-beta-SMAD pathway, concurrently inducing hepatocellular inflammation. The results of the present study not only validate the successful construction of a spontaneous liver fibrosis mouse model through natural aging induction but also provide initial insights into the mechanisms underpinning age-induced liver fibrosis.
C1 [Hu, Min; Li, Yanjiao] Kunming Univ, Yunnan Key Lab Basic Res Bone & Joint Dis, Kunming 650214, Peoples R China.
   Kunming Univ, Yunnan Stem Cell Translat Res Ctr, Kunming 650214, Peoples R China.
C3 Kunming University; Kunming University
RP Hu, M; Li, YJ (corresponding author), Kunming Univ, Yunnan Key Lab Basic Res Bone & Joint Dis, Kunming 650214, Peoples R China.
EM lihuaqiu666@126.com; zxma@kmu.edu.cn; ts15288530428@163.com;
   wuzhenup@163.com; wmt1920228750@163.com; 18287353315@163.com;
   18314305871@163.com; 18288215906@163.com; humin@kmu.edu.cn;
   yanjiaoli@kmu.edu.cn
FU Joint Project of Colleges in Yunnan Province
FX No Statement Available
CR Bao YL, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.666138
   Chinese Medical Association Infectious and Parasitic Branch Liver Disease Branch, 2001, Chin. J. Infect. Dis, V19, P56
   Ding K, 2014, EXP TOXICOL PATHOL, V66, P257, DOI 10.1016/j.etp.2014.03.003
   El-Baz FK, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7028314
   Fallowfield JA, 2004, SCOT MED J, V49, P3, DOI 10.1177/003693300404900101
   Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781
   Höhn A, 2013, REDOX BIOL, V1, P140, DOI 10.1016/j.redox.2013.01.006
   Iwaisako K, 2012, J GASTROEN HEPATOL, V27, P65, DOI 10.1111/j.1440-1746.2011.07002.x
   Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim YO, 2017, METHODS MOL BIOL, V1559, P279, DOI 10.1007/978-1-4939-6786-5_19
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Lalitha S., 2000, BIOTECH SOFTWARE INT, V1, P270, DOI DOI 10.1089/152791600459894
   Li Guo-wen, 2016, Chinese Medical Sciences Journal, V31, P121
   Li L, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/560345
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Mamuya FA, 2014, J CELL MOL MED, V18, P656, DOI 10.1111/jcmm.12213
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sojoodi M, 2020, CANCER PREV RES, V13, P497, DOI 10.1158/1940-6207.CAPR-19-0383
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Urate S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222212432
   Wang R, 2018, DRUG DES DEV THER, V12, P1281, DOI 10.2147/DDDT.S159546
   Wang YQ, 2020, J CELL MOL MED, V24, P941, DOI 10.1111/jcmm.14805
   Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387
   Wu YT, 2015, TOXICOL APPL PHARM, V289, P163, DOI 10.1016/j.taap.2015.09.028
   Yang Kun-Lin, 2007, Comp Hepatol, V6, P9, DOI 10.1186/1476-5926-6-9
   Yang N, 2017, WORLD J GASTROENTERO, V23, P1203, DOI 10.3748/wjg.v23.i7.1203
   Zhang Y, 2014, WORLD J GASTROENTERO, V20, P6523, DOI 10.3748/wjg.v20.i21.6523
NR 30
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD DEC
PY 2023
VL 12
IS 12
AR 1493
DI 10.3390/biology12121493
PG 11
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA DF2W7
UT WOS:001130560000001
PM 38132319
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhang, YM
   Chen, XM
   Wu, D
   Zhang, XG
   Lü, Y
   Shi, SZ
   Yin, Z
AF Zhang, YM
   Chen, XM
   Wu, D
   Zhang, XG
   Lü, Y
   Shi, SZ
   Yin, Z
TI Expression of tissue inhibitor of matrix metalloproteinase-1 in aging of
   transgenic mouse liver
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE aging; tissue inhbitor of matrix metallporoteinase-1; transgenic mice;
   liver; oxidative
ID FIBROSIS; PEROXIDE
AB Background Tissue inhibitor of matrix metalloproteinase-1 (TRAP-1) is related to the aging of many organs, but few data are available on the change of TIMP-1 in liver aging. The purpose of this study was to investigate the expression and role of TRAP-1, matrix metalloproteinase-2 (MW-2) and MMP-9 in the process of natural aging in the livers of normal and transgenic mice, and to detect the effects of TIMP-1 on oxidative level and anti-oxidative ability of the livers of transgenic young mice.
   Methods Normal and transgenic mice were divided into 3 groups according to their age: 3-month-old group (n=5), 12-month-old group (n=5) and 24-month-old group (n=5). Histopathological changes of the liver were observed after HE and Masson staining. The messenger RNA (mRNA) levels of TIMP-1, MMP-2 and MMP-9 were determined by semi-quantitative reverse transcriptional polymerase chain reaction; protein expression was measured by Western blot in the livers of normal and transgenic mice of various ages. Changes in levels of superoxide dismutase (SOD), monoamine oxidase (MAO), malondialdehyde (MDA) as well as oxidative and anti-oxidative ability were measured.
   Results Histologically, more fatty degeneration and collagen deposition were found in the aging livers of transgenic mice than in those of the normal mice as their age of months increased. The mRNA and protein expressions of TIMP-1 were significantly high in the oldest animals. The histopathological changes, mRNA and protein expressions of TIMP-1 increased significantly in the liver of transgenic mice as compared with normal mice. The expression of MMP-2 and MMP-9 showed a minor change in the process of aging. Liver change and collagen deposition were not observed in young mice, but the activity of SOD decreased (P < 0.05), and the activity of MAO (P < 0.01) and the content of MDA increased in the liver of transgenic mice (P < 0.01).
   Conclusions The expression of TIMP-l is significantly high in the liver of transgenic mouse in the process of aging, indicating that the oxidative level increases and the anti-oxidative ability decreases in the liver of transgenic mouse. TIMP-1 plays an important role in the process of liver aging.
C1 PLA, Gen Hosp, Dept Nephrol, Beijing 100853, Peoples R China.
   Beijing Mil Command Gen Hosp, Dept Nephrol, Beijing 100700, Peoples R China.
RP Chen, XM (corresponding author), PLA, Gen Hosp, Dept Nephrol, Beijing 100853, Peoples R China.
EM xmchen@public.bta.net.cn
RI SHI, SZ/IXN-9432-2023
CR Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7
   Arthur MJP, 1999, ALCOHOL CLIN EXP RES, V23, P940, DOI 10.1097/00000374-199905000-00027
   Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063
   Bayne ACV, 2005, BIOCHEM J, V391, P277, DOI 10.1042/BJ20041872
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003
   Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4
   Chen Rong-Quan, 2004, Zhonghua Yi Xue Za Zhi, V84, P937
   Gagliano N, 2000, J GERONTOL A-BIOL, V55, pB365, DOI 10.1093/gerona/55.8.B365
   Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0
   Jiang W, 2005, CHINESE MED J-PEKING, V118, P192
   Jiang YF, 2002, ONCOGENE, V21, P2245, DOI 10.1038/sj.onc.1205291
   Kumar MJ, 2004, MOL NEUROBIOL, V30, P77, DOI 10.1385/MN:30:1:077
   Mannello F, 2001, APOPTOSIS, V6, P479, DOI 10.1023/A:1012493808790
   McCarroll JA, 2004, BIOCHEM PHARMACOL, V67, P1215, DOI 10.1016/j.bcp.2003.11.013
   SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X
   TIAN Y, 2003, CHIN J BIOCH MOL, V5, P558
   Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521
   Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625
   Zhang YM, 2005, WORLD J GASTROENTERO, V11, P3696, DOI 10.3748/wjg.v11.i24.3696
   任宏伟, 2002, [中华老年医学杂志, Chinese Journal of Geriatrics], V21, P278
NR 21
TC 6
Z9 7
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0366-6999
EI 2542-5641
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD MAR 20
PY 2006
VL 119
IS 6
BP 504
EP 509
DI 10.1097/00029330-200603020-00013
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 026KM
UT WOS:000236337800011
PM 16584649
OA gold
DA 2024-02-19
ER

PT J
AU Lionetti, L
   Crescenzo, R
   Mollica, MP
   Tasso, R
   Barletta, A
   Liverini, G
   Iossa, S
AF Lionetti, L
   Crescenzo, R
   Mollica, MP
   Tasso, R
   Barletta, A
   Liverini, G
   Iossa, S
TI Modulation of hepatic mitochondrial energy efficiency with age
SO CELLULAR AND MOLECULAR LIFE SCIENCES
LA English
DT Article
DE mitochondrial efficiency; basal proton leak; palmitate-induced leak;
   reactive oxygen species; youth-adulthood transition
ID CHAIN FATTY-ACIDS; OXIDATIVE-PHOSPHORYLATION; PROTON LEAK; RAT-LIVER;
   PROTEIN; RESPIRATION; INVOLVEMENT; ANTIPORTER; MECHANISM; TRANSPORT
AB This study was designed to examine the effect of youth-adulthood transition on hepatic mitochondrial energy efficiency. The changes in basal and palmitate-induced proton leak, which contribute to mitochondrial efficiency, were evaluated in mitochondria isolated from the liver of young and adult rats. Alterations in mitochondrial cytochrome oxidase and aconitase specific activities, and in adenine nucleotide translocator content were also assessed. There was no difference in basal proton leak or thermodynamic coupling and efficiency of oxidative phosphorylation in liver mitochondria between the two rat groups. On the other hand, palmitate-induced proton leak increased significantly in adult rats. The function of this uncoupling could be avoidance of elevated formation of reactive oxygen species, which are known to accelerate ageing.
C1 Univ Naples Federico II, Dept Gen & Environm Physiol, I-80134 Naples, Italy.
C3 University of Naples Federico II
RP Liverini, G (corresponding author), Univ Naples Federico II, Dept Gen & Environm Physiol, Via Mezzocannone 8, I-80134 Naples, Italy.
EM liverini@unina.it
RI Lionetti, Lilla/AAM-1756-2021; iossa, susanna/O-1625-2016
OI Lionetti, Lilla/0000-0002-4059-8030; iossa, susanna/0000-0001-6103-718X;
   Mollica, Maria Pina/0000-0003-2726-7779
CR AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x
   BARRE H, 1987, COMP BIOCHEM PHYS B, V88, P519, DOI 10.1016/0305-0491(87)90337-3
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Brand MD, 1999, INT J OBESITY, V23, pS4, DOI 10.1038/sj.ijo.0800936
   BROWN GC, 1992, FASEB J, V6, P2961, DOI 10.1096/fasebj.6.11.1644259
   Cairns CB, 1998, AM J PHYSIOL-REG I, V274, pR1376, DOI 10.1152/ajpregu.1998.274.5.R1376
   Estabrook R.W., 1967, METHOD ENZYMOL, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4
   Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2
   Glatz JFC, 2003, ACTA PHYSIOL SCAND, V178, P367, DOI 10.1046/j.1365-201X.2003.01166.x
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   Iossa S, 1999, J NUTR, V129, P1593, DOI 10.1093/jn/129.8.1593
   Iossa S, 2001, FEBS LETT, V505, P53, DOI 10.1016/S0014-5793(01)02772-7
   Iossa S, 1998, CELL BIOCHEM FUNCT, V16, P261, DOI 10.1002/(SICI)1099-0844(1998120)16:4<261::AID-CBF796>3.0.CO;2-1
   Iossa S, 2001, HORM METAB RES, V33, P343, DOI 10.1055/s-2001-15413
   Jaburek M, 2001, J BIOL CHEM, V276, P31897, DOI 10.1074/jbc.M103507200
   Korshunov SS, 1998, FEBS LETT, V435, P215, DOI 10.1016/S0014-5793(98)01073-4
   Liverini G, 1996, CELL BIOCHEM FUNCT, V14, P283
   LIVERINI G, 1991, COMP BIOCHEM PHYS B, V98, P583, DOI 10.1016/0305-0491(91)90258-F
   Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.0.CO;2-N
   NEDERGAARD J, 1983, EUR J BIOCHEM, V133, P185, DOI 10.1111/j.1432-1033.1983.tb07446.x
   RICHIERI GV, 1993, BIOCHEMISTRY-US, V32, P7574, DOI 10.1021/bi00080a032
   Rolfe DFS, 1996, AM J PHYSIOL-CELL PH, V271, pC1380, DOI 10.1152/ajpcell.1996.271.4.C1380
   Rossignol R, 2000, BIOCHEM J, V347, P45, DOI 10.1042/0264-6021:3470045
   Samartsev VN, 1997, BBA-BIOENERGETICS, V1319, P251, DOI 10.1016/S0005-2728(96)00166-1
   SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P
   Skulachev VP, 1999, J BIOENERG BIOMEMBR, V31, P431, DOI 10.1023/A:1005492205984
   VIGNAIS PV, 1976, BIOCHIM BIOPHYS ACTA, V456, P1, DOI 10.1016/0304-4173(76)90007-0
   Wieckowski MR, 1997, BIOCHEM BIOPH RES CO, V232, P414
   Wojtczak L, 1999, J BIOENERG BIOMEMBR, V31, P447, DOI 10.1023/A:1005444322823
   WONG LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16
NR 31
TC 10
Z9 11
U1 0
U2 0
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1420-682X
EI 1420-9071
J9 CELL MOL LIFE SCI
JI Cell. Mol. Life Sci.
PD MAY
PY 2004
VL 61
IS 11
BP 1366
EP 1371
DI 10.1007/s00018-004-4073-4
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 825BZ
UT WOS:000221732300010
PM 15170514
DA 2024-02-19
ER

PT J
AU JI, LL
   DILLON, D
   WU, E
AF JI, LL
   DILLON, D
   WU, E
TI ALTERATION OF ANTIOXIDANT ENZYMES WITH AGING IN RAT SKELETAL-MUSCLE AND
   LIVER
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
C1 UNIV ILLINOIS, DIV NUTR SCI, URBANA, IL 61801 USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign
RP JI, LL (corresponding author), UNIV ILLINOIS, DEPT KINESIOL, 81 FREER HALL, 906 S GOODWIN AVE, URBANA, IL 61801 USA.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   [Anonymous], 2012, FREE RADICALS BIOL
   BRADY PS, 1979, J NUTR, V109, P1103, DOI 10.1093/jn/109.6.1103
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chiu D., 1982, Free Radical Biology, V5, P115
   COHEN G, 1963, BIOCHEMISTRY-US, V2, P1420, DOI 10.1021/bi00906a038
   Cohen P, 1975, Methods Enzymol, V41, P208
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   DEVASAGAYAM TPA, 1986, FEBS LETT, V205, P246, DOI 10.1016/0014-5793(86)80906-1
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HALLIWELL B, 1985, FREE RADICAL BIO MED, P73
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harman D., 1986, FREE RADICALS AGING, P3
   HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281
   JENKINS RR, 1984, INT J SPORTS MED, V5, P11, DOI 10.1055/s-2008-1025872
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6
   JI LL, 1986, J CLIN INVEST, V78, P771, DOI 10.1172/JCI112639
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P137, DOI 10.1016/0003-9861(88)90622-4
   Johnson N.P., 1986, BIOCH MECHANISMS PLA, P1
   LAMMIKEEFE CJ, 1984, GERONTOLOGY, V30, P153, DOI 10.1159/000212623
   MACHLIN LJ, 1987, FASEB J, V1, P441, DOI 10.1096/fasebj.1.6.3315807
   MALIS CD, 1986, J BIOL CHEM, V261, P14201
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   OHRLOFF C, 1984, CURR EYE RES, V3, P109, DOI 10.3109/02713688408997191
   PACKER L, 1986, BIOCH ASPECTS PHYSIC, P73
   PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109
   REED DJ, 1986, BIOCHEM PHARMACOL, V35, P7, DOI 10.1016/0006-2952(86)90545-9
   SALMINEN A, 1983, EXP MOL PATHOL, V38, P380, DOI 10.1016/0014-4800(83)90077-1
   SLATER TF, 1987, P NUTR SOC, V46, P1, DOI 10.1079/PNS19870003
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   VANELLA A, 1982, GERONTOLOGY, V28, P108, DOI 10.1159/000212519
NR 35
TC 197
Z9 212
U1 0
U2 4
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD APR
PY 1990
VL 258
IS 4
BP R918
EP R923
DI 10.1152/ajpregu.1990.258.4.R918
PN 2
PG 6
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA DB093
UT WOS:A1990DB09300061
PM 2331035
DA 2024-02-19
ER

PT J
AU Yang, D
   Li, L
   Liu, H
   Wu, L
   Luo, Z
   Li, H
   Zheng, S
   Gao, H
   Chu, Y
   Sun, Y
   Liu, J
   Jia, L
AF Yang, D.
   Li, L.
   Liu, H.
   Wu, L.
   Luo, Z.
   Li, H.
   Zheng, S.
   Gao, H.
   Chu, Y.
   Sun, Y.
   Liu, J.
   Jia, L.
TI Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin
   ligase to suppress the growth of liver cancer cells
SO CELL DEATH AND DIFFERENTIATION
LA English
DT Article
DE ROC1; Cullin-RING ligase; autophagy; senescence; Deptor
ID HUMAN HEPATOCELLULAR-CARCINOMA; BETA-TRCP; NEDD8-ACTIVATING ENZYME; MTOR
   INHIBITOR; APOPTOSIS; ACTIVATION; MLN4924; DEPTOR; GENE; P53
AB Regulator of Cullins-1 (ROC1) or RING box protein-1 (RBX1) is an essential RING component of Cullin-RING ligase (CRL). Our previous studies showed that ROC1 is required for the growth of several cancer cell lines while ROC1 siRNA silencing inactivates CRL, leading to cell cycle arrest, cell senescence and/or apoptosis. However, it is completely unknown whether ROC1 knockdown triggers autophagic response by inactivating CRL. Moreover, the role of ROC1 in liver cancer remains elusive. In this study, we reported that ROC1 knockdown significantly inhibited the growth of liver cancer cells by sequentially and independently inducing autophagy and p21-dependent cell senescence. Mechanism analysis revealed that ROC1 silencing triggered autophagy by inhibition of mammalian target of rapamycin (mTOR) activity due to accumulation of mTOR-inhibitory protein Deptor, a substrate of CRL. Consistently, Deptor knockdown significantly blocked autophagy response upon ROC1 silencing. Biologically, autophagy response upon ROC1 silencing was a survival signal, and blockage of autophagy pathway sensitized cancer cells to apoptosis. Finally, we demonstrated that ROC1 was overexpressed in hepatocellular carcinomas, which is associated with poor prognosis of liver cancer patients. These findings suggest that ROC1 is an appealing drug target for liver cancer and provide a proof-of-concept evidence for a novel drug combination of ROC1 inhibitor and an autophagy inhibitor for effective treatment of liver cancer by enhancing apoptosis. Cell Death and Differentiation (2013) 20, 235-247; doi:10.1038/cdd.2012.113; published online 31 August 2012
C1 [Yang, D.; Li, L.; Luo, Z.; Gao, H.; Chu, Y.; Liu, J.; Jia, L.] Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200032, Peoples R China.
   [Yang, D.; Wu, L.; Luo, Z.; Li, H.; Liu, J.] Fudan Univ, Dept Digest Dis, Huashan Hosp, Shanghai 200032, Peoples R China.
   [Li, L.; Zheng, S.] NE Agr Univ, Coll Vet Med, Harbin 150030, Peoples R China.
   [Liu, H.] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai 200438, Peoples R China.
   [Chu, Y.; Jia, L.] Fudan Univ, Biotherapy Res Ctr, Shanghai 200032, Peoples R China.
   [Sun, Y.] Univ Michigan, Dept Radiat Oncol, Div Radiat & Canc Biol, Ann Arbor, MI 48109 USA.
C3 Fudan University; Fudan University; Northeast Agricultural University -
   China; Naval Medical University; Fudan University; University of
   Michigan System; University of Michigan
RP Jia, L (corresponding author), Fudan Univ, Dept Immunol, Shanghai Med Coll, Shanghai 200032, Peoples R China.
EM jialijun2002@yahoo.com.cn
RI Wang, Guang/JFS-8374-2023; SUN, YI/JBS-2950-2023; Luo,
   Zhongguang/HKM-5966-2023; Sun, Yi/K-1025-2014
OI Luo, Zhongguang/0000-0002-7620-307X; Sun, Yi/0000-0002-5841-4287
FU National Natural Science Foundation Grant of China [31071204, 81101811,
   91129702, 81125001]; National Basic Research Program of China (973
   program) [2012CB910302]; Key Project of Shanghai Municipal Health Bureau
   [2010012]; Postdoctoral Science Foundation of China [KLF101054]
FX This work is supported by the National Natural Science Foundation Grant
   of China (31071204), the National Basic Research Program of China (973
   program, 2012CB910302) and Key Project of Shanghai Municipal Health
   Bureau (2010012) to Lijun Jia, the National Natural Science Foundation
   Grant of China to Dongqin Yang (81101811) and Jie Liu
   (91129702,81125001), as well as Postdoctoral Science Foundation of China
   to Dongqin Yang (KLF101054).
CR Böck BC, 2010, J BIOL CHEM, V285, P21644, DOI 10.1074/jbc.M109.096628
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199
   Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005
   Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577
   Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030
   HUANG LR, 1995, CANCER RES, V55, P4717
   Itahana K., 2007, METHOD MOL BIOL, V371, P21
   Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734
   Jia LJ, 2011, NEOPLASIA, V13, P561, DOI 10.1593/neo.11420
   Jia LJ, 2011, J BIOL CHEM, V286, P3379, DOI 10.1074/jbc.M110.188425
   Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671
   Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367
   Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845
   Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678
   Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529
   Li T, 2010, NAT STRUCT MOL BIOL, V17, P105, DOI 10.1038/nsmb.1719
   Li Y, 2004, J CANCER RES CLIN, V130, P460, DOI 10.1007/s00432-004-0564-9
   Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062
   Luo ZG, 2012, CANCER RES, V72, P3360, DOI 10.1158/0008-5472.CAN-12-0388
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056
   Narita M, 2009, AUTOPHAGY, V5, P1046, DOI 10.4161/auto.5.7.9444
   Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8
   Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046
   Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Soucy Teresa A, 2010, Genes Cancer, V1, P708, DOI 10.1177/1947601910382898
   Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343
   Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884
   Sun Y, 2001, ANTIOXID REDOX SIGN, V3, P635, DOI 10.1089/15230860152542989
   Tan M, 2009, P NATL ACAD SCI USA, V106, P6203, DOI 10.1073/pnas.0812425106
   Ullén A, 2010, INT J ONCOL, V37, P15, DOI 10.3892/ijo_00000648
   Vollmer CM, 1999, CANCER RES, V59, P4369
   Wang CM, 2012, MOL CELL BIOCHEM, V359, P125, DOI 10.1007/s11010-011-1006-z
   Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Zhao Y, 2012, CELL DEATH IN PRESS, DOI [10.1038/cddis.2012 125, DOI 10.1038/CDDIS.2012125]
   Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029
   Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a
NR 41
TC 73
Z9 78
U1 4
U2 71
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1350-9047
EI 1476-5403
J9 CELL DEATH DIFFER
JI Cell Death Differ.
PD FEB
PY 2013
VL 20
IS 2
BP 235
EP 247
DI 10.1038/cdd.2012.113
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 079AE
UT WOS:000314141800007
PM 22935614
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU RIKANS, LE
   SNOWDEN, CD
   MOORE, DR
AF RIKANS, LE
   SNOWDEN, CD
   MOORE, DR
TI INFLUENCE OF AGING ON ETHANOL AND ACETALDEHYDE OXIDATION IN FEMALE
   RAT-LIVER
SO GERONTOLOGY
LA English
DT Article
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR,COLL MED,HLTH SCI CTR,DEPT PHARMACOL, BMSB 753, POB 26901, OKLAHOMA CITY, OK 73190 USA.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   ALDERMAN J, 1987, J BIOL CHEM, V262, P7497
   Bergmeyer H.U., 1974, Methods of Enzymatic Analysis, P752
   Bernt E, 1974, METHOD ENZYMAT AN, V3, P1499
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   BRUNT P, 1988, J HEPATOL, V7, P377, DOI 10.1016/S0168-8278(88)80011-4
   CRABB DW, 1983, ARCH BIOCHEM BIOPHYS, V224, P299, DOI 10.1016/0003-9861(83)90213-8
   DIEHL AM, 1989, MED CLIN N AM, V73, P815, DOI 10.1016/S0025-7125(16)30640-X
   FRENCH SW, 1989, CLIN BIOCHEM, V22, P41, DOI 10.1016/S0009-9120(89)80067-0
   GERLACH U, 1974, METHOD ENZYMAT AN, P569
   GUPTA NK, 1966, BIOCHIM BIOPHYS ACTA, V118, P431, DOI 10.1016/S0926-6593(66)80056-5
   HAHN HKJ, 1983, ALCOHOL CLIN EXP RES, V7, P299, DOI 10.1111/j.1530-0277.1983.tb05464.x
   LAUTERBURG BH, 1988, J HEPATOL, V7, P384, DOI 10.1016/S0168-8278(88)80012-6
   LIEBER CS, 1988, NEW ENGL J MED, V319, P1639
   LINDAHL R, 1984, BIOCHEM PHARMACOL, V33, P3383, DOI 10.1016/0006-2952(84)90109-6
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MARQUETTE BW, 1984, EXP AGING RES, V10, P7, DOI 10.1080/03610738408258534
   NORSTEN C, 1989, J BIOL CHEM, V264, P5593
   OTT JF, 1985, ALCOHOL CLIN EXP RES, V9, P59, DOI 10.1111/j.1530-0277.1985.tb05051.x
   RIKANS LE, 1981, EXP GERONTOL, V16, P253, DOI 10.1016/0531-5565(81)90021-8
   RIKANS LE, 1990, MECH AGEING DEV, V51, P139, DOI 10.1016/0047-6374(90)90096-X
   RIKANS LE, 1989, LIFE SCI, V45, P1373, DOI 10.1016/0024-3205(89)90024-6
   RIKANS LE, 1987, J PHARMACOL EXP THER, V243, P20
   RIKANS LE, 1987, DRUG METAB DISPOS, V15, P356
   RIKANS LE, 1987, ALCOHOL CLIN EXP RES, V11, P562, DOI 10.1111/j.1530-0277.1987.tb00175.x
   Schmidt E, 1974, Methods of Enzymatic Analysis, P650, DOI DOI 10.1016/B978-0-12-091302-2.50028-1
   SEITZ HK, 1989, GASTROENTEROLOGY, V97, P446, DOI 10.1016/0016-5085(89)90082-6
   TOTTMAR SOC, 1973, BIOCHEM J, V135, P577, DOI 10.1042/bj1350577a
   VERMILION JL, 1978, J BIOL CHEM, V253, P2694
   WIBERG GS, 1970, TOXICOL APPL PHARM, V16, P718, DOI 10.1016/0041-008X(70)90077-3
   YORK JL, 1982, DEV PHARMACOL THERAP, V4, P106, DOI 10.1159/000457395
NR 31
TC 7
Z9 7
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PD JUL-AUG
PY 1990
VL 36
IS 4
BP 185
EP 192
DI 10.1159/000213198
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA EM623
UT WOS:A1990EM62300001
PM 2272522
DA 2024-02-19
ER

PT J
AU LEVITSKII, EL
   GUBSKII, YI
   GOLDSHTEIN, NB
   LITOSHENKO, AY
AF LEVITSKII, EL
   GUBSKII, YI
   GOLDSHTEIN, NB
   LITOSHENKO, AY
TI LIPID-PEROXIDATION AND POLYMERASE ACTIVITIES OF LIVER CHROMATIN
   FRACTIONS OF AGING RATS
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
C1 ACAD MED SCI UKSSR,INST GERONTOL,KIEV,UKRAINE,USSR.
C3 National Academy of Medical Sciences of Ukraine; D. F. Chebotarev
   Institute of Gerontology of the National Academy of Medical Sciences of
   Ukraine
RP LEVITSKII, EL (corresponding author), MINIST HLTH UKSSR,INST PHARMACOL & TOXICOL,KIEV,UKRAINE,USSR.
CR ALESENKO AV, 1981, BIOKHIMIYA LIPIDOV I, P3
   ALESENKO AV, 1987, STRUCTURE FUNCTIONS, P188
   ASHMARIN IP, 1979, RAPID METHODS STATIS
   FICHOT O, 1979, BIOCHIM BIOPHYS ACTA, V561, P29, DOI 10.1016/0005-2787(79)90487-8
   KHILOBOK IY, 1986, VESTN AKAD MED NAUK+, P20
   KOSTYUCHENKO D A, 1982, Biokhimiya, V47, P1540
   LEVITSKII E L, 1980, Byulleten' Eksperimental'noi Biologii i Meditsiny, V89, P733
   LEVITSKII EL, 1986, B EKSP BIOL MED, V51, P309
   LEVITSKY EL, 1984, UKR BIOKHIM ZH+, V56, P460
   LEVITSKY EL, 1980, GERONTOLOGY, V26, P321, DOI 10.1159/000212435
   VLADIMIROV YA, 1972, LIPID PEROXIDATION B, P241
   VOSKRESENSKII ON, 1986, PROGR SCI TECHNO GPB, V5, P163
NR 12
TC 0
Z9 0
U1 0
U2 0
PU PLENUM PUBL CORP
PI NEW YORK
PA CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 0007-4888
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD JUN
PY 1989
VL 107
IS 6
BP 807
EP 809
DI 10.1007/BF00840745
PG 3
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA CH903
UT WOS:A1989CH90300021
DA 2024-02-19
ER

PT J
AU MOMCHILOVA, AB
   PETKOVA, DH
   KOUMANOV, KS
AF MOMCHILOVA, AB
   PETKOVA, DH
   KOUMANOV, KS
TI INFLUENCE OF AGING ON THE PHYSICOCHEMICAL PROPERTIES OF RAT-LIVER
   MICROSOMAL-MEMBRANES
SO DOKLADI NA BOLGARSKATA AKADEMIYA NA NAUKITE
LA English
DT Article
RP MOMCHILOVA, AB (corresponding author), BULGARIAN ACAD SCI,CENT LAB BIOPHYS,BU-1113 SOFIA,BULGARIA.
CR AMBRECHT HJ, 1982, EXP GERONTOL, V17, P41
   COLEMAN R, 1973, BIOCHIM BIOPHYS ACTA, V300, P1, DOI 10.1016/0304-4157(73)90010-5
   DAVE JR, 1983, MECH AGEING DEV, V23, P235, DOI 10.1016/0047-6374(83)90023-4
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   HANGER D, 1980, MECH AGEING DEV, V14, P101
   KAHOVCOVA J, 1969, J CHROMATOGR, V40, P90, DOI 10.1016/S0021-9673(01)96622-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   SCHINITZKY M, 1974, J MOL BIOL, V85, P605
   SHINITZKY M, 1974, J BIOL CHEM, V249, P2652
   SPERRY WH, 1980, J BIOL CHEM, V187, P97
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ACAD BULGARE DES SCIENCES
PI SOFIA
PA BIBLIOTHEQUE 1 RUE 15 NOEMVRI, 1040 SOFIA, BULGARIA
SN 0861-1459
J9 DOKL BOLG AKAD NAUK
PY 1987
VL 40
IS 2
BP 111
EP 112
PG 2
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA K7096
UT WOS:A1987K709600030
DA 2024-02-19
ER

PT J
AU LAGANIERE, S
   YU, BP
AF LAGANIERE, S
   YU, BP
TI EFFECT OF CHRONIC FOOD RESTRICTION IN AGING RATS .1. LIVER SUBCELLULAR
   MEMBRANES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 UNIV TEXAS,HLTH SCI CTR,DEPT PHYSIOL,7703 FLOYD CURL DR,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
FU NIA NIH HHS [AG0 1188] Funding Source: Medline
CR Adelman RC, 1972, ADV GERONTOLOGICAL R, V4, P1
   Ames BN, 1966, METHOD ENZYMOL, V8, P115, DOI DOI 10.1016/0076-6879(66)08014-5
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   FERNANDES G, 1976, P NATL ACAD SCI USA, V73, P1279, DOI 10.1073/pnas.73.4.1279
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GRINNA LS, 1977, MECH AGEING DEV, V6, P297
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   Hirai S., 1982, LIPID PEROXIDES BIOL, P305, DOI [10.1016/B978-0-12-768050-7.50026-3, DOI 10.1016/B978-0-12-768050-7.50026-3]
   JEFFCOAT R, 1984, NEW COMPREHENSIVE BI, V7, P85
   KAMATH SA, 1972, ANAL BIOCHEM, V48, P53, DOI 10.1016/0003-2697(72)90169-8
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KRISHNAMURTHY S, 1963, J LIPID RES, V4, P330
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P221, DOI 10.1016/0047-6374(89)90084-5
   LEWIN MB, 1984, MECH AGEING DEV, V24, P343, DOI 10.1016/0047-6374(84)90119-2
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASORO EJ, 1985, J NUTR, V115, P842, DOI 10.1093/jn/115.7.842
   MELLORS A, 1966, BRIT J NUTR, V20, P69, DOI 10.1079/BJN19660009
   PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652
   RICKETTS WG, 1985, J CELL PHYSIOL, V125, P492, DOI 10.1002/jcp.1041250319
   SACHER GA, 1977, HDB BIOL AGING, P582
   SCHMUCKER DL, 1984, MECH AGEING DEV, V27, P207, DOI 10.1016/0047-6374(84)90046-0
   Snedecor G.W. Cochran., 1968, STAT METHODS, V7th
   Sprecher H., 1979, GEOMETRICAL POSITION, P303
   TAYLOR SL, 1976, LIPIDS, V11, P530, DOI 10.1007/BF02532898
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
   YU BP, 1985, REV BIOL RES AGING 2, V2, P435
NR 31
TC 70
Z9 72
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUN
PY 1989
VL 48
IS 3
BP 207
EP 219
DI 10.1016/0047-6374(89)90083-3
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AB181
UT WOS:A1989AB18100001
PM 2733461
DA 2024-02-19
ER

PT J
AU Li, L
   Ng, TB
   Gao, W
   Li, W
   Fu, M
   Niu, SM
   Zhao, L
   Chen, RR
   Liu, F
AF Li, L
   Ng, TB
   Gao, W
   Li, W
   Fu, M
   Niu, SM
   Zhao, L
   Chen, RR
   Liu, F
TI Antioxidant activity of gallic acid from rose flowers in senescence
   accelerated mice
SO LIFE SCIENCES
LA English
DT Article
DE animal models; CAT; GPx
ID SUPEROXIDE-DISMUTASE; EXPRESSION; AGE; COMPONENTS; SEQUENCE; EXTRACTS;
   CATALASE; HERB
AB The activities of the antioxidant enzymes catalase (CAT) and glutathione peroxidase (GPx) in the blood and liver of the aging model induced by injection of different doses of D-gal into normal mice, and in senescence accelerated mice (SAM) of different ages, were determined. The results showed that the enzyme activities in the D-gal treated mice did not alter appreciably but the enzyme activities in blood of the SAM declined significantly with the increase in age, especially in the 9-month-old SAM. When gallic acid purified from rose flowers was used to treat the 9-month-old male SAM, it not only reinstated the activities of CAT and GPx but also significantly reduced the amount of malondialdehyde (MDA) in the liver, brain and kidney. The results demonstrated that 9-month-old male SAM represent an appropriate animal model to evaluate the antioxidant activities of natural products. (c) 2005 Elsevier Inc. All rights reserved.
C1 Chinese Univ Hong Kong, Fac Med, Dept Biochem, Shatin, Hong Kong, Peoples R China.
   Nankai Univ, Coll Life Sci, Dept Microbiol, Tianjin 300071, Peoples R China.
   Hosp Tianjin, Tianjin, Peoples R China.
C3 Chinese University of Hong Kong; Nankai University
RP Ng, TB (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Biochem, Shatin, Hong Kong, Peoples R China.
EM biochemistry@cuhk.edu.hk
OI gao, wei/0000-0002-7426-1874
CR [Anonymous], 1990, CHINESE J PHARM TOXI
   Bradley A, 2002, NATURE, V420, P512, DOI 10.1038/420512a
   CAI X, 1997, ZHONGGUO YING YONG S, V13, P131
   Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Gong G.Q., 1991, J CHINA PHARM U, V22, P101
   Gu LW, 2001, FOOD CHEM, V73, P299, DOI 10.1016/S0308-8146(00)00300-9
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6
   KEIICHI H, 1997, EXPT GERONTOLOGY, V32, P129
   KIM SY, 1994, J AM OIL CHEM SOC, V71, P633, DOI 10.1007/BF02540592
   Lei H, 2003, ACTA PHARMACOL SIN, V24, P230
   Li W.B., 1995, CHIN J PHARM TOXICOL, V9, P93
   Liu F, 2000, LIFE SCI, V66, P725, DOI 10.1016/S0024-3205(99)00643-8
   Naik GH, 2003, PHYTOCHEMISTRY, V63, P97, DOI 10.1016/S0031-9422(02)00754-9
   NIE W, 1999, CHINESE PHARMACOL B, V16, P132
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599
   SCHAFER L, 1990, SCAND J CLIN LAB INV, V50, P69, DOI 10.3109/00365519009091567
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SIMIC MG, 1988, MUTAT RES, V202, P377, DOI 10.1016/0027-5107(88)90199-6
   Sun Renyu, 2002, Zhonghua Jiehe He Huxi Zazhi, V25, P352
   TAKEDA T, 1994, INT CONGR SER, V1062, P15
   THOMAS VG, 2003, AGEING RES REV, V2, P211
   Wang Hui, 2004, Wei Sheng Yan Jiu, V33, P222
   Wang YP, 1996, J SOC GYNECOL INVEST, V3, P179, DOI 10.1016/1071-5576(96)00015-9
   XU FB, 1985, P 2 NAT C AG RES HER
NR 26
TC 106
Z9 115
U1 2
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD MAY 27
PY 2005
VL 77
IS 2
BP 230
EP 240
DI 10.1016/j.lfs.2004.12.024
PG 11
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 925IR
UT WOS:000229047300011
PM 15862607
DA 2024-02-19
ER

PT J
AU Liu, AD
   Yang, JK
   Hu, Q
   Dirsch, O
   Dahmen, U
   Zhang, CT
   Gewirtz, DA
   Fang, HS
   Sun, J
AF Liu, Anding
   Yang, Jiankun
   Hu, Qi
   Dirsch, Olaf
   Dahmen, Uta
   Zhang, Cuntai
   Gewirtz, David A.
   Fang, Haoshu
   Sun, Jian
TI Young plasma attenuates age-dependent liver ischemia reperfusion injury
SO FASEB JOURNAL
LA English
DT Article
DE autophagy; hepatocyte; AMPK; ULK1; rats
ID ISCHEMIA/REPERFUSION INJURY; AUTOPHAGY; AMPK; PHOSPHORYLATION;
   REJUVENATION; ACTIVATION; PROTECTS; DECLINE; GROWTH; CELLS
AB Aging is often associated with a decreased autophagic activity that contributes to the high sensitivity of aged livers to ischemia reperfusion injury (IRI). Blood from young animals can positively affect aged animals. This study was designed to evaluate the effect of young plasma in a model of liver IRI in aged rats. Aged rats were treated with pooled plasma collected from young rats before ischemia. Administration of young plasma restored aging-induced suppression in hepatic autophagic activity and reduced liver IRI. Inhibition of the young-plasma-restored autophagic activity abrogated the beneficial effect of young plasma against liver IRI. Similarly, young serum restored autophagic activity and reduced cellular injury after hypoxia/reoxygenation (H/R) in primary old rat hepatocytes. Mechanistic studies showed thatadministration of young plasma increased AMPK phosphorylation and led to unc-51-like autophagy activating kinase (ULK)1 activation. Furthermore, AMPK-inhibition abrogated the young serum-induced ULK1 activation and autophagic activity and diminished the protective action of young serum against H/R injury in primary old rat hepatocytes, whereas AMPK-activation potentiated the effects of young serum. Young plasma could restore age-impaired autophagy, at least in part, via AMPK/ULK1 signaling. Restoration of age-impaired autophagic activity may be a critical contributing mechanism to young-plasma-afforded protection against liver IRI in aged rats.Liu, A., Yang, J., Hu, Q., Dirsch, O., Dahmen, U., Zhang, C., Gewirtz, D. A., Fang, H., Sun, J. Young plasma attenuates age-dependent liver ischemia reperfusion injury.
C1 [Liu, Anding; Yang, Jiankun] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Expt Med Ctr, Wuhan, Hubei, Peoples R China.
   [Hu, Qi; Zhang, Cuntai] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Hubei, Peoples R China.
   [Dirsch, Olaf] Klinikum Chemnitz, Inst Pathol, Chemnitz, Germany.
   [Dahmen, Uta] Friedrich Schiller Univ Jena, Dept Gen Visceral & Vasc Surg, Expt Transplantat Surg, Jena, Germany.
   [Gewirtz, David A.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Massey Canc Ctr, Richmond, VA USA.
   [Fang, Haoshu] Anhui Med Univ, Dept Pathophysiol, Hefei, Anhui, Peoples R China.
   [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yan Jiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.
   [Sun, Jian] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Chemnitz Clinic; Friedrich Schiller University of
   Jena; Virginia Commonwealth University; Anhui Medical University; Sun
   Yat Sen University; Sun Yat Sen University
RP Sun, J (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliopancreat Surg, 107 Yan Jiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.
EM sjmed02@outlook.com
RI Liu, Anding/AAU-2477-2020; Yang, Yifan/JTV-1487-2023
OI Zhang, Cuntai/0000-0002-9044-5032
FU National Natural Science Fund of China (NSFC) [81300343]
FX This project was supported by National Natural Science Fund of China
   (NSFC) Grant 81300343 (to A.L.). The authors declare no conflicts of
   interest.
CR Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090
   Chang JT, 2017, ELIFE, V6, DOI 10.7554/eLife.18459
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Cursio R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/417590
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Iwamoto T, 2008, TRANSPLANTATION, V85, P1240, DOI 10.1097/TP.0b013e31816c7e90
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kireev RA, 2012, J SURG RES, V178, P922, DOI 10.1016/j.jss.2012.04.060
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Lai Q, 2011, J GASTROINTEST LIVER, V20, P383
   Liu AD, 2018, AGING CELL, V17, DOI 10.1111/acel.12708
   Liu AD, 2016, ONCOTARGET, V7, P78372, DOI 10.18632/oncotarget.13281
   Liu AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25042
   Liu AD, 2014, CRIT CARE MED, V42, pE762, DOI 10.1097/CCM.0000000000000659
   Liu AD, 2013, LIVER TRANSPLANT, V19, P762, DOI 10.1002/lt.23666
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Longo VD, 2015, AGING CELL, V14, P497, DOI 10.1111/acel.12338
   Martinez-Lopez N, 2015, ADV EXP MED BIOL, V847, P73, DOI 10.1007/978-1-4939-2404-2_3
   Middeldorp J, 2016, JAMA NEUROL, V73, P1325, DOI 10.1001/jamaneurol.2016.3185
   Okaya T, 2005, SHOCK, V24, P421, DOI 10.1097/01.shk.0000181282.14050.11
   Rajawat YS, 2009, AGEING RES REV, V8, P199, DOI 10.1016/j.arr.2009.05.001
   Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006
   Reznick RM, 2007, CELL METAB, V5, P151, DOI 10.1016/j.cmet.2007.01.008
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019
   Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003
   Salpeter SJ, 2013, DIABETES, V62, P3300, DOI 10.2337/db13-er09
   Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211
   Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108
   Stenesen D, 2013, CELL METAB, V17, P101, DOI 10.1016/j.cmet.2012.12.006
   Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9
   Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006
   Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
   Wang JH, 2011, GASTROENTEROLOGY, V141, P2188, DOI 10.1053/j.gastro.2011.08.005
   Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323
   Yun N, 2014, FREE RADICAL BIO MED, V68, P168, DOI 10.1016/j.freeradbiomed.2013.12.014
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang DY, 2016, AUTOPHAGY, V12, P1447, DOI 10.1080/15548627.2016.1185576
NR 48
TC 15
Z9 15
U1 0
U2 11
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD FEB
PY 2019
VL 33
IS 2
BP 3063
EP 3073
DI 10.1096/fj.201801234R
PG 11
WC Biochemistry & Molecular Biology; Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA HJ6KJ
UT WOS:000457296600121
PM 30383439
OA Bronze
DA 2024-02-19
ER

PT J
AU WOOD, WG
   WILLIAMSON, LS
   ROCCO, D
   STRONG, R
AF WOOD, WG
   WILLIAMSON, LS
   ROCCO, D
   STRONG, R
TI CHRONIC ETHANOL-CONSUMPTION AND AGING - CHANGES IN LIPID-COMPOSITION OF
   LIVER-MICROSOMES
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
C1 ST LOUIS UNIV,SCH MED,DEPT INTERNAL MED,ST LOUIS,MO 63125.
C3 Saint Louis University
RP WOOD, WG (corresponding author), VET ADM MED CTR,GERIAT RES EDUC & CLIN CTR,111G-JB,ST LOUIS,MO 63125, USA.
FU NIAAA NIH HHS [AA-02054] Funding Source: Medline
CR ARMBRECHT HJ, 1983, J PHARMACOL EXP THER, V226, P387
   BARTLETT GR, 1959, J BIOL CHEM, V193, P265
   BOWMAN RE, 1962, CLIN CHEM, V8, P302
   CUNNINGHAM CC, 1982, BIOCHIM BIOPHYS ACTA, V712, P225, DOI 10.1016/0005-2760(82)90338-1
   DIXON WJ, 1969, INTRO STATISTICAL AN
   DUTTERA SM, 1968, J BIOL CHEM, V243, P2216
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   HARRIS RA, 1984, MOL PHARMACOL, V25, P401
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HIRAYAMA C, 1979, RES COMMUN CHEM PATH, V26, P563
   HORROCKS LA, 1972, RESEARCH METHODS NEU, V1, P223
   Kirk R.E., 2012, EXPT DESIGN PROCEDUR, P302
   KOIVUSAARI U, 1981, TOXICOLOGY, V20, P173, DOI 10.1016/0300-483X(81)90049-4
   KRITCHEVSKY D, 1980, P SOC EXP BIOL MED, V165, P193, DOI 10.3181/00379727-165-40957
   LIEBER CS, 1976, SCI AM, V234, P25, DOI 10.1038/scientificamerican0376-25
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MICELI JN, 1973, LIPIDS, V8, P722, DOI 10.1007/BF02531839
   PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V779, P217, DOI 10.1016/0304-4157(84)90010-8
   SIEKEWITZ P, 1963, ANNU REV PHYSIOL, V25, P15, DOI 10.1146/annurev.ph.25.030163.000311
   SKURDAL DN, 1972, P SOC EXP BIOL MED, V140, P528, DOI 10.3181/00379727-140-36496
   SMITH TL, 1982, LIFE SCI, V31, P1419, DOI 10.1016/0024-3205(82)90002-9
   STORY JA, 1981, LIPIDS, V16, P87, DOI 10.1007/BF02535679
   STRONG R, 1984, J PHARMACOL EXP THER, V229, P726
   SUTTER MA, 1985, BIOCHEM PHARMACOL, V34, P2983, DOI 10.1016/0006-2952(85)90025-5
   TROTTA EE, 1975, BIOCHIM BIOPHYS ACTA, V394, P239, DOI 10.1016/0005-2736(75)90262-X
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VESTAL RE, 1977, CLIN PHARMACOL THER, V21, P343
   WARING AJ, 1981, P NATL ACAD SCI-BIOL, V78, P2582, DOI 10.1073/pnas.78.4.2582
   WOOD WG, 1982, PHARMACOL BIOCHEM BE, V17, P1037
   WOOD WG, 1984, LIFE SCI, V35, P1947, DOI 10.1016/0024-3205(84)90475-2
NR 30
TC 3
Z9 4
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PY 1986
VL 21
IS 3
BP 195
EP 201
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA E9246
UT WOS:A1986E924600007
PM 3803471
DA 2024-02-19
ER

PT J
AU Mann, CD
   Neal, CP
   Pattenden, CJ
   Metcalfe, MS
   Garcea, G
   Dennison, AR
   Berry, DP
AF Mann, C. D.
   Neal, C. P.
   Pattenden, C. J.
   Metcalfe, M. S.
   Garcea, G.
   Dennison, A. R.
   Berry, D. P.
TI Major resection of hepatic colorectal liver metastases in elderly
   patients - An aggressive approach is justified
SO EJSO
LA English
DT Article
DE colorectal; metastases; resection; elderly
ID HEPATOCELLULAR-CARCINOMA; CIRRHOTIC-PATIENTS; ADVANCED AGE; RECURRENCE;
   SURVIVAL; CANCER; IMPACT; HEPATECTOMY; VOLUME; SCORE
AB Aims: With a progressively ageing population, increasing numbers of elderly patients will present with colorectal metastases and be referred for surgical resection. The aim of this study was to assess the safety of hepatic resection in patients over 70 years of age by comparing outcomes with those of a younger cohort of patients.
   Methods: Forty-nine patients over 70 years of age who underwent hepatic resection of colorectal liver metastases were compared to 142 patients less than 70 years of age in terms of pre-, peri- and post-operative results, as well as long-term survival.
   Results: Major resections were performed in 61% of the elderly group and 68% of the younger group. The two groups were comparable in terms of operative duration, transfusion rate, length of HDU stay and post-operative hospital stay. The elderly group had a non-significant increase in post-operative morbidity. The 30-day and 60-day/inpatient mortality rates were similar between the two groups (elderly 0% and 4%; younger 2% and 3%). Long-term disease-free survival was similar between elderly and younger patients.
   Conclusion: This study confirms that an aggressive surgical policy towards colorectal metastases in elderly patients is associated with low peri-operative morbidity and mortality, as well as good long-term outcomes. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Mann, C. D.; Neal, C. P.; Pattenden, C. J.; Metcalfe, M. S.; Garcea, G.; Dennison, A. R.; Berry, D. P.] Univ Hosp Leicester, Leicester Gen Hosp, Dept Hepatobiliary & Pancreat Surg, Leicester LE5 4PW, Leics, England.
C3 University Hospitals of Leicester NHS Trust; Leicester General Hospital;
   University of Leicester
RP Mann, CD (corresponding author), Univ Hosp Leicester, Leicester Gen Hosp, Dept Hepatobiliary & Pancreat Surg, Gwendolen Rd, Leicester LE5 4PW, Leics, England.
EM chris.mann@doctors.org.uk
RI Berry, Donagh/J-7616-2012
OI Berry, Donagh/0000-0003-4349-1447; Dennison, Ashley/0000-0003-0090-503X
CR Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
   Aldrighetti L, 2003, WORLD J SURG, V27, P1149, DOI 10.1007/s00268-003-7072-y
   Brand MI, 2000, AM SURGEON, V66, P412
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   Chiappa A, 2002, Ann Ital Chir, V73, P397
   DICE JF, 1985, HEPATOLOGY, V5, P508, DOI 10.1002/hep.1840050328
   Ercolani G, 2002, ARCH SURG-CHICAGO, V137, P1187, DOI 10.1001/archsurg.137.10.1187
   Fernandez FG, 2004, ANN SURG, V240, P438, DOI 10.1097/01.sla.0000138076.72547.b1
   Ferrero A, 2005, WORLD J SURG, V29, P1101, DOI 10.1007/s00268-005-7768-2
   Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004
   FONG Y, 1995, ANN SURG, V222, P426
   Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X
   Imamura H, 2004, SURGERY, V135, P508, DOI 10.1016/j.surg.2003.10.009
   Imamura Hiroshi, 2001, American Journal of Gastroenterology, V96, P3178
   JAMES OFW, 1983, CLIN GASTROENTEROL, V12, P671
   Mala T, 2002, WORLD J SURG, V26, P1348, DOI 10.1007/s00268-002-6231-x
   Mann CD, 2004, ARCH SURG-CHICAGO, V139, P1168, DOI 10.1001/archsurg.139.11.1168
   Mercantini P, 2002, ANTICANCER RES, V22, P3709
   MOONEY H, 1985, CLIN GASTROENTEROL, V14, P757
   MullerHocker J, 1997, HEPATOLOGY, V26, P709
   Nagano Y, 2005, J AM COLL SURGEONS, V201, P511, DOI 10.1016/j.jamcollsurg.2005.05.010
   Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SCHEELE J, 1995, WORLD J SURG, V19, P59, DOI 10.1007/BF00316981
   Wu Ying-Sheng, 2003, Hepatobiliary Pancreat Dis Int, V2, P59
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Yeh CN, 2004, HEPATO-GASTROENTEROL, V51, P219
   Zacharias T, 2004, ANN SURG, V240, P858, DOI 10.1097/01.sla.0000143272.52505.d6
   ZIEREN HU, 1993, INT SURG, V78, P288
   ZIEREN HU, 1994, HEPATO-GASTROENTEROL, V41, P34
NR 30
TC 58
Z9 58
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0748-7983
EI 1532-2157
J9 EJSO-EUR J SURG ONC
JI EJSO
PD APR
PY 2008
VL 34
IS 4
BP 428
EP 432
DI 10.1016/j.ejso.2007.03.013
PG 5
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Surgery
GA 293VO
UT WOS:000255363700012
PM 17466484
DA 2024-02-19
ER

PT J
AU Tee, JK
   Peng, F
   Tan, YL
   Yu, B
   Ho, HK
AF Tee, Jie Kai
   Peng, Fei
   Tan, Yeong Lan
   Yu, Bo
   Ho, Han Kiat
TI Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts
   TGF-β-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE magnesium isoglycyrrhizinate; transforming growth factor beta; Smad;
   hepatic stellate cells; hepatocytes; liver fibrosis
ID LIVER FIBROSIS; MECHANISMS; SENESCENCE; DISEASE; APOPTOSIS; PROMOTES;
   STRESS; INJURY
AB Liver fibrosis is a histological change often attributed to the activation of hepatic stellate cells (HSCs) and the excessive formation of scar tissues in the liver. Advanced stages of the disease frequently lead to cirrhosis. Magnesium isoglycyrrhizinate (MgIG) has been accepted as a hepatoprotective drug with the potential of alleviating inflammatory conditions and thus promote liver recovery from viral- or drug-induced injury. While MgIG has been empirically integrated into the clinics to treat some liver diseases, its anti-fibrotic effect and the associated mechanisms remain poorly characterized. Herein, we demonstrated that 1 mg/ml MgIG attenuated the production of alpha SMA and collagen-1 in activated HSCs using TGF-beta 1-induced human HSCs LX2 as the fibrotic cell model. We found that MgIG exerts an inhibitory effect on the TGF-beta-SMAD signaling pathway by arresting the binding of downstream transcription factors SMAD2/3 and SMAD4. Furthermore, MgIG was shown to suppress proliferation and induce senescence of activated LX2 cells. Protein expression of p27 and enzymatic activity of senescence-associated beta-galactosidase were elevated upon exposure to MgIG. In addition, we observed that exposure of activated LX2 cells to MgIG reduces TGF-beta-induced apoptosis. Interestingly, a lower toxicity profile was observed when human fetal hepatocytes LO2 were exposed to the same concentration and duration of the drug, suggesting the specificity of MgIG effect toward activated HSCs. Overall, hepatoprotective concentrations of MgIG is shown to exert a direct effect on liver fibrosis through inhibiting TGF-beta-signaling, in which SMAD2/3 pathway could be one of the mechanisms responsible for the fibrotic response, thereby restoring the surviving cells toward a more quiescent phenotype. This provides critical mechanistic insights to support an otherwise empirical therapy.
C1 [Tee, Jie Kai; Tan, Yeong Lan; Ho, Han Kiat] Natl Univ Singapore, Ctr Life Sci, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.
   [Tee, Jie Kai; Peng, Fei; Tan, Yeong Lan; Ho, Han Kiat] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore, Singapore.
   [Yu, Bo] Fudan Univ, Shanghai Canc Ctr, Dept Pharm, Shanghai, Peoples R China.
C3 National University of Singapore; National University of Singapore;
   Fudan University
RP Ho, HK (corresponding author), Natl Univ Singapore, Ctr Life Sci, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.; Ho, HK (corresponding author), Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore, Singapore.
EM phahohk@nus.edu.sg
RI Peng, Fei/AAO-1118-2020
OI Tee, Jie Kai/0000-0002-2232-3279
FU NUS Graduate School for Integrative Sciences; NUS Academic Research Fund
   [R-148-000-217-112]
FX We acknowledge NUS Graduate School for Integrative Sciences and NUS
   Academic Research Fund (R-148-000-217-112 to HH) for funding support.
CR Althubiti M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.489
   Bian ML, 2017, BIOFACTORS, V43, P836, DOI 10.1002/biof.1390
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Cheng Y, 2009, PHARMACOLOGY, V84, P183, DOI 10.1159/000235873
   Dechene A, 2010, HEPATOLOGY, V52, P1008, DOI 10.1002/hep.23754
   Del Ben M, 2017, BRIT J CLIN PHARMACO, V83, P88, DOI 10.1111/bcp.12899
   Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8
   Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y
   Durand F, 2017, LIVER INT, V37, P130, DOI 10.1111/liv.13310
   Fridlyanskaya I, 2015, EXP GERONTOL, V72, P124, DOI 10.1016/j.exger.2015.09.021
   Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055
   Friedman SL, 2012, P NATL ACAD SCI USA, V109, P9230, DOI 10.1073/pnas.1206645109
   Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974
   Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247
   Fujita T, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0005-6
   Gaarenstroom T, 2014, SEMIN CELL DEV BIOL, V32, P107, DOI 10.1016/j.semcdb.2014.01.009
   Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540
   Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007
   Hnit SST, 2015, INT J BIOCHEM CELL B, V68, P9, DOI 10.1016/j.biocel.2015.08.005
   Hough C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042513
   Huang XL, 2014, INT J CLIN EXP PATHO, V7, P4755
   Huang Y, 2017, EXP CELL RES, V352, P420, DOI 10.1016/j.yexcr.2017.02.038
   Jiang WJ, 2017, ONCOTARGET, V8, P33252, DOI [10.18632/oncotarget.1662, 10.18632/oncotarget.16629]
   Khimji AK, 2008, AM J PATHOL, V173, P716, DOI 10.2353/ajpath.2008.071121
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1
   Lewindon PJ, 2002, AM J PATHOL, V160, P1705, DOI 10.1016/S0002-9440(10)61117-0
   Li JK, 2017, PROCEEDINGS OF 2017 IEEE INTERNATIONAL CONFERENCE ON UNMANNED SYSTEMS (ICUS), P12, DOI 10.1109/ICUS.2017.8278309
   Lim R, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00633
   Lu CF, 2017, IUBMB LIFE, V69, P540, DOI 10.1002/iub.1639
   Ma JJ, 2009, LIVER INT, V29, P567, DOI 10.1111/j.1478-3231.2009.01981.x
   Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988
   Nishizawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep34605
   NUSSE M, 1990, CYTOMETRY, V11, P813, DOI 10.1002/cyto.990110707
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Principe DR, 2017, ONCOGENE, V36, P4336, DOI 10.1038/onc.2016.500
   Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035
   Shang LS, 2018, J GASTROENTEROL, V53, P6, DOI 10.1007/s00535-017-1404-4
   Sui M, 2018, BIOMED PHARMACOTHER, V106, P125, DOI 10.1016/j.biopha.2018.06.060
   Tang GH, 2015, WORLD J GASTROENTERO, V21, P12370, DOI 10.3748/wjg.v21.i43.12370
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499
   Wang P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00047
   Wang Y, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3526903
   Weiskirchen Ralf, 2014, Hepatobiliary Surg Nutr, V3, P344, DOI 10.3978/j.issn.2304-3881.2014.11.03
   Wilson CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083391
   Wu ZL, 2018, EXP THER MED, V15, P1005, DOI 10.3892/etm.2017.5470
   Xie CF, 2015, INFLAMMATION, V38, P1639, DOI 10.1007/s10753-015-0140-2
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
   Xu Q, 2016, INT J MOL MED, V38, P275, DOI 10.3892/ijmm.2016.2603
   Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328
   Zhao XJ, 2017, EUR J PHARMACOL, V809, P141, DOI 10.1016/j.ejphar.2017.05.032
   Zheng J, 2015, GENET MOL RES, V14, P15453, DOI 10.4238/2015.November.30.23
NR 57
TC 18
Z9 19
U1 0
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD SEP 25
PY 2018
VL 9
AR 1018
DI 10.3389/fphar.2018.01018
PG 14
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA GU8KN
UT WOS:000445588100001
PM 30319402
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ichinohe, N
   Kon, J
   Sasaki, K
   Nakamura, Y
   Ooe, H
   Tanimizu, N
   Mitaka, T
AF Ichinohe, Norihisa
   Kon, Junko
   Sasaki, Kazunori
   Nakamura, Yukio
   Ooe, Hidekazu
   Tanimizu, Naoki
   Mitaka, Toshihiro
TI Growth Ability and Repopulation Efficiency of Transplanted Hepatic Stem
   Cells, Progenitor Cells, and Mature Hepatocytes in Retrorsine-Treated
   Rat Livers
SO CELL TRANSPLANTATION
LA English
DT Article
DE CD44; Thy1; Small hepatocytes; Maturation; Sinusoidal endothelial cells;
   Cellular senescence
ID DISEASED MOUSE-LIVER; IN-VIVO; OVAL CELLS; LONG-TERM; REGENERATION;
   CD44; CULTURE; DIFFERENTIATION; PROLIFERATION; EXPRESSION
AB Cell-based therapies as an alternative to liver transplantation have been anticipated for the treatment of potentially fatal liver diseases. Not only mature hepatocytes (MHs) but also hepatic stem/progenitor cells are considered as candidate cell sources. However, whether the stem/progenitor cells have an advantage to engraft and repopulate the recipient liver compared with MHs has not been comprehensively assessed. Therefore, we used Thy1(+) (oval) and CD44(+) (small hepatocytes) cells isolated from GalN-treated rat livers as hepatic stem and progenitor cells, respectively. Cells from dipeptidylpeptidase IV (DPPIV)(+) rat livers were transplanted into DPPIV- livers treated with retrorsine following partial hepatectomy. Both stem and progenitor cells could differentiate into hepatocytes in host livers. In addition, the growth of the progenitor cells was faster than that of MHs until days 14. However, their repopulation efficiency in the long term was very low, since the survival period of the progenitor cells was much shorter than that of MHs. Most foci derived from Thy1(+) cells disappeared within 2 months. Many cells expressed senescence-associated beta-galactosidase in 33% of CD44-derived foci at day 60, whereas the expression was observed in 13% of MH-derived ones. The short life of the cells may be due to their cellular senescence. On the other hand, the incorporation of sinusoidal endothelial cells into foci and sinusoid formation, which might be correlated to hepatic maturation, was completed faster in MH-derived foci than in CD44-derived ones. The survival of donor cells may have a close relation to not only early integration into hepatic plates but also the differentiated state of the cells at the time of transplantation.
C1 [Mitaka, Toshihiro] Sapporo Med Univ, Dept Tissue Dev & Regenerat, Res Inst Frontier Med, Sch Med,Chuo Ku, Sapporo, Hokkaido 0608556, Japan.
C3 Sapporo Medical University
RP Mitaka, T (corresponding author), Sapporo Med Univ, Dept Tissue Dev & Regenerat, Res Inst Frontier Med, Sch Med,Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.
EM tmitaka@sapmed.ac.jp
RI Mitaka, Toshihiro/K-9424-2013; Nakamura, Yukio/A-5263-2016
OI Mitaka, Toshihiro/0000-0001-9467-4871; Nakamura,
   Yukio/0000-0001-8056-4946; Ichinohe, Norihisa/0000-0003-3723-7418
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [19790294, 22790385, 17390353/21390365]; Japan Science and Technology
   Agency, Japan; Science and Technology Incubation Program in Advanced
   Regions; Ministry of Health, Labour and Welfare, Japan; Health and
   Labour Sciences Research Grants; Suhara Memorial Foundation;
   Grants-in-Aid for Scientific Research [21390365, 22790386, 19790294,
   22790385] Funding Source: KAKEN
FX We thank Dr. Tomoko Sonoda (Department of Public Health, Sapporo Medical
   University School of Medicine, Sapporo, Japan) for help with the
   statistical analysis. We also thank Ms. Minako Kuwano and Ms. Yumiko
   Tsukamoto for technical assistance and Mr. Kim Barrymore for help with
   the manuscript. This study was supported by a grant from the Ministry of
   Education, Culture, Sports, Science and Technology, Japan, Grants-in-Aid
   for Young Scientists (B) for J. Kon (19790294) and N. Ichinohe
   (22790385), and Grant-in-Aid for Scientific Research (B) for T. Mitaka
   (17390353/21390365); the Japan Science and Technology Agency, Japan, the
   Science and Technology Incubation Program in Advanced Regions for T.
   Mitaka; Program for developing the supporting system for upgrading the
   education and research for T. Mitaka; Ministry of Health, Labour and
   Welfare, Japan, Health and Labour Sciences Research Grants, Research on
   Advanced Medical Technology for T. Mitaka; Program for developing the
   supporting system for upgrading the education and research for T.
   Mitaka; the Suhara Memorial Foundation for T. Mitaka. The authors
   declare not conflicts of interest.
CR Avital I, 2002, SURGERY, V132, P384, DOI 10.1067/msy.2002.125785
   Bae SH, 2008, HEPATOL INT, V2, P63, DOI 10.1007/s12072-007-9031-4
   Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047
   Cantz T, 2003, AM J PATHOL, V162, P37, DOI 10.1016/S0002-9440(10)63796-0
   Cantz T, 2008, CELL TISSUE RES, V331, P271, DOI 10.1007/s00441-007-0483-6
   Chen Q, 2007, NAT PROTOC, V2, P1197, DOI 10.1038/nprot.2007.118
   Della Fazia MA, 2001, J HEPATOL, V34, P555, DOI 10.1016/S0168-8278(00)00065-9
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6
   Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac
   Forbes S, 2002, J PATHOL, V197, P510, DOI 10.1002/path.1163
   Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004
   Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189
   Gordon GJ, 2000, AM J PATHOL, V157, P771, DOI 10.1016/S0002-9440(10)64591-9
   Grompe M, 2006, J INHERIT METAB DIS, V29, P421, DOI 10.1007/s10545-006-0311-2
   Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213
   Haridass D, 2009, AM J PATHOL, V175, P1483, DOI 10.2353/ajpath.2009.090117
   He Y, 2008, AM J PHYSIOL-GASTR L, V295, pG305, DOI 10.1152/ajpgi.90229.2008
   Heo J, 2006, HEPATOLOGY, V44, P1478, DOI 10.1002/hep.21441
   Katayama S, 2001, AM J PATHOL, V158, P97, DOI 10.1016/S0002-9440(10)63948-X
   Kon J, 2006, J HEPATOL, V45, P90, DOI 10.1016/j.jhep.2006.01.029
   Kon J, 2009, AM J PATHOL, V175, P2362, DOI 10.2353/ajpath.2009.080338
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   Malhi H, 2002, P NATL ACAD SCI USA, V99, P13114, DOI 10.1073/pnas.192365499
   Mignon A, 1998, NAT MED, V4, P1185, DOI 10.1038/2681
   Mitaka T, 1999, HEPATOLOGY, V29, P111, DOI 10.1002/hep.510290103
   MITAKA T, 1995, BIOCHEM BIOPH RES CO, V214, P310, DOI 10.1006/bbrc.1995.2289
   MITAKA T, 1993, CANCER RES, V53, P3145
   MITAKA T, 1992, HEPATOLOGY, V16, P440, DOI 10.1002/hep.1840160224
   Ochiya T, 2010, DIFFERENTIATION, V79, P65, DOI 10.1016/j.diff.2009.10.002
   Oertel M, 2008, BBA-MOL BASIS DIS, V1782, P61, DOI 10.1016/j.bbadis.2007.12.004
   Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9
   Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266
   Petersen BE, 1998, HEPATOLOGY, V27, P433, DOI 10.1002/hep.510270218
   RHIM JA, 1994, SCIENCE, V263, P1149, DOI 10.1126/science.8108734
   Sasaki K, 2008, CELL TRANSPLANT, V17, P1221, DOI 10.3727/096368908787236666
   Satoh T, 2000, J GASTROEN HEPATOL, V15, P402, DOI 10.1046/j.1440-1746.2000.02164.x
   Schneider A, 2006, TRANSPLANTATION, V82, P1115, DOI 10.1097/01.tp.0000232451.93703.ab
   Sell S, 2001, WOUND REPAIR REGEN, V9, P467, DOI 10.1046/j.1524-475x.2001.00467.x
   Shafritz DA, 2006, HEPATOLOGY, V43, pS89, DOI 10.1002/hep.21047
   Shibata C, 2006, LIVER TRANSPLANT, V12, P78, DOI 10.1002/lt.20558
   Strick-Marchand H, 2004, P NATL ACAD SCI USA, V101, P8360, DOI 10.1073/pnas.0401092101
   Sugimoto S, 2002, J CELL BIOCHEM, V87, P16, DOI 10.1002/jcb.10274
   Tateno C, 1996, AM J PATHOL, V149, P1593
   Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506
   Weber A, 2006, J INHERIT METAB DIS, V29, P436, DOI 10.1007/s10545-006-0253-8
   Weglarz TC, 2000, AM J PATHOL, V157, P1963, DOI 10.1016/S0002-9440(10)64835-3
   Yu CH, 2009, CELL TRANSPLANT, V18, P1081, DOI 10.3727/096368909X12483162196647
NR 49
TC 17
Z9 21
U1 1
U2 10
PU COGNIZANT COMMUNICATION CORP
PI ELMSFORD
PA 3 HARTSDALE ROAD, ELMSFORD, NY 10523-3701 USA
SN 0963-6897
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2012
VL 21
IS 1
BP 11
EP 22
DI 10.3727/096368911X580626
PG 12
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 932KS
UT WOS:000303290600002
PM 21669046
DA 2024-02-19
ER

PT J
AU STUPINA, AS
   BEREZHKOV, NV
AF STUPINA, AS
   BEREZHKOV, NV
TI MORPHOLOGICAL MANIFESTATIONS OF COMPENSATORY AND ADAPTIVE PROCESSES IN
   THE LIVER DURING AGING
SO BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
RP STUPINA, AS (corresponding author), ACAD MED SCI UKSSR,INST GERONTOL,MORPHOL & CYTOL LAB,KIEV,UKRAINE,USSR.
CR BRODSKII VY, 1981, CELLULAR POLYPLOIDY
   FROLKIS VV, 1982, TXB PHYSL BIOL AGING, P213
   KANEDA K, 1983, CELL TISSUE RES, V233
   NOVIKOVA SN, 1978, THESIS KIEV
   PARAMONOVA GI, 1983, THESIS KIEV
   RYABININA ZA, 1973, POLYPOLIDY HYPERTROP
   SARKISOV DS, 1977, ESSAYS STRUCTURAL BA
   SEROV VV, 1986, ARKH PAT, P20
   STUPINA AS, 1986, VESTN AKAD MED NAUK+, P25
   STUPINA AS, 1986, VESTN AKAD MED NAUK+, P58
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
NR 11
TC 1
Z9 1
U1 0
U2 0
PU PLENUM PUBL CORP
PI NEW YORK
PA CONSULTANTS BUREAU 233 SPRING ST, NEW YORK, NY 10013
SN 0007-4888
J9 B EXP BIOL MED+
JI Bull. Exp. Biol. Med.
PD MAR
PY 1988
VL 105
IS 3
BP 451
EP 455
DI 10.1007/BF00835777
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA P8867
UT WOS:A1988P886700046
DA 2024-02-19
ER

PT J
AU Wang, LH
   Han, XJ
   Qu, GJ
   Su, L
   Zhao, BX
   Miao, JY
AF Wang, Lihong
   Han, Xianjing
   Qu, Guojing
   Su, Le
   Zhao, Baoxiang
   Miao, Junying
TI A pH probe inhibits senescence in mesenchymal stem cells
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Autophagy; Bafilomycin-A1 antagonist; Senescence; Bone marrow-derived
   mesenchymal stem cells
ID CHAPERONE-MEDIATED AUTOPHAGY; LYSOSOMAL MEMBRANE-PROTEINS; V-ATPASE;
   CELLULAR SENESCENCE; LIFE-SPAN; IN-VITRO; ACIDIFICATION; CHROMATIN;
   LIVER; ACCUMULATION
AB BackgroundBone marrow-derived mesenchymal stem cells (BMSCs) are gradually getting attention because of its multi-directional differentiation potential, hematopoietic support, and promotion of stem cell implantation. However, cultured BMSCs in vitro possess a very limited proliferation potential, and the presence of stem cell aging has substantially restricted the effect together with the efficiency in clinical treatment. Recently, increasing attention has been paid to the connection between cellular aging and lysosomal acidification as new reports indicated that vacuolar H+-ATPase (v-ATPase) activity was altered and lysosomal pH was dysregulated in the process of cellular aging. Therefore, promoting lysosomal acidification might contribute to inhibition of cell senescence. Our previous studies showed that a novel small molecule, 3-butyl-1-chloro imidazo [1, 5-a] pyridine-7-carboxylic acid (SGJ), could selectively and sensitively respond to acidic pH with fast response (within 3min), but whether SGJ can promote lysosomal acidification and inhibit senescence in BMSCs is unknown.MethodsRat BMSCs were cultured based on our system that had been already documented. BMSCs were treated with SGJ and/or Bafilomycin-A1 (Baf-A1). The co-localization between SGJ and lysosomes was assessed by a confocal microscope. Acridine orange (AO) staining and the Lysosensor Green DND-189 reagents were used for indicating changes in lysosomal concentration of H+. Changes of senescence were detected by immunoblotting of p21 and senescence-associated beta-galactosidase (SA--gal) staining as well as immunofluorescence assay of senescence-associated heterochromatin foci (SAHF). Changes of autophagy were detected by immunoblotting of MAP1LC3 (LC3B) and SQSTM1 (p62). Cell proliferation was determined by flow cytometry. Cell viability was calculated by sulforhodamine B assay (SRB). The V0 proton channel of v-ATPase was knocked down by transfecting with its small interfering RNA (si-ATP6V0C).ResultsOur work showed that SGJ can promote lysosomal acidification and inhibit senescence in BMSCs. Firstly, SGJ and lysosomes were well co-located in senescent BMSCs with the co-localization coefficient of 0.94. Secondly, SGJ increased the concentration of H+ and the protein expression of lysosome-associated membrane protein 1 (LAMP1) and lysosome-associated membrane protein 2 (LAMP2). Thirdly, SGJ suppressed the expression of p21 in the senescent BMSCs and reduced SA--gal positive cells. Fourthly, SGJ promoted senescent BMSCs' proliferation and protein level of LC3B but reduced the p62/SQSTM1 protein level. Furthermore, experimental group pretreated with 20M SGJ showed a stronger red fluorescent intensity, thinner cell morphology, less SA--gal positive cell, and less p21 protein level as well as higher cell viability in the presence of Baf-A1. Notably, ATP6V0C knockdown decreased the activity of v-ATPase and SGJ increased the concentration of H+.ConclusionOur work showed that SGJ could inhibit senescence in BMSCs and protect lysosomes by promoting expression of LAMP1 and LAMP2. Meanwhile, SGJ could promote autophagy. Furthermore, our study also suggested that SGJ was a new Baf-A1 antagonist because SGJ could target and occupy the V0 proton channel of v-ATPase.
C1 [Wang, Lihong; Han, Xianjing; Qu, Guojing; Su, Le; Miao, Junying] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China.
   [Zhao, Baoxiang] Shandong Univ, Sch Chem & Chem Engn, Inst Organ Chem, Jinan 250100, Shandong, Peoples R China.
   [Miao, Junying] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shandong, Peoples R China.
   [Miao, Junying] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250012, Shandong, Peoples R China.
C3 Shandong University; Shandong University; Shandong University; Shandong
   University
RP Miao, JY (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Jinan 250100, Shandong, Peoples R China.; Zhao, BX (corresponding author), Shandong Univ, Sch Chem & Chem Engn, Inst Organ Chem, Jinan 250100, Shandong, Peoples R China.
EM bxzhao@sdu.edu.cn; miaojy@sdu.edu.cn
OI Han, XianJing/0009-0003-2051-448X
FU National Key Research and Development Program of China [2017YFA0104604];
   National Natural Science Foundation of China [31570834, 91539105,
   91313303]; Natural Science Foundation of Shandong Province [ZR2016CM01]
FX This study was supported by the National Key Research and Development
   Program of China (2017YFA0104604), the National Natural Science
   Foundation of China (No. 31570834, 91539105, 91313303), and the Natural
   Science Foundation of Shandong Province (ZR2016CM01).
CR Aird Katherine M, 2013, Methods Mol Biol, V965, P185, DOI 10.1007/978-1-62703-239-1_12
   Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022
   Baker N, 2015, BONE, V70, P37, DOI 10.1016/j.bone.2014.10.014
   Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x
   Benderdour Mohamed, 2015, Curr Aging Sci, V8, P147
   Blasiak J, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5293258
   Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200
   Chen J, 2012, AM J PATHOL, V180, P973, DOI 10.1016/j.ajpath.2011.11.033
   Chondrogianni N, 2002, BIOGERONTOLOGY, V3, P121, DOI 10.1023/A:1015236203379
   Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004
   CRIDER BP, 1994, J BIOL CHEM, V269, P17379
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   De Kimpe L, 2013, AGE, V35, P673, DOI 10.1007/s11357-012-9403-0
   Fang H, 2018, J SPINAL CORD MED, V41, P10, DOI 10.1080/10790268.2017.1314880
   Fehrer C, 2006, ANN NY ACAD SCI, V1067, P235, DOI 10.1196/annals.1354.030
   Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7
   Ghavidel A, 2018, G3-GENES GENOM GENET, V8, P1579, DOI 10.1534/g3.118.200161
   Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654
   Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110
   Kallis YN, 2007, GUT, V56, P716, DOI 10.1136/gut.2006.098442
   Kiffin R, 2007, J CELL SCI, V120, P782, DOI 10.1242/jcs.001073
   Ko Il-Kwon, 2008, Int J Stem Cells, V1, P49
   Kwon YY, 2017, MOL CELLS, V40, P307, DOI 10.14348/molcells.2017.2279
   Liu J, 2016, PLANT PHYSIOL, V170, P1714, DOI 10.1104/pp.15.00744
   McGuire C, 2017, FRONT BIOSCI-LANDMRK, V22, P609, DOI 10.2741/4506
   Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317
   Molin Mikael, 2014, Int J Cell Biol, V2014, P913071, DOI 10.1155/2014/913071
   Nelson MP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-20
   Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0
   Patschan S, 2008, AM J PHYSIOL-RENAL, V294, pF100, DOI 10.1152/ajprenal.00261.2007
   Pollock K, 2016, MOL THER, V24, P965, DOI 10.1038/mt.2016.12
   Ruckenstuhl C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004347
   Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745
   Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056
   Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108
   Shamsi M, 2017, MAT SCI ENG C-MATER, V78, P114, DOI 10.1016/j.msec.2017.02.165
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Sykova Eva, 2013, Laser Ther, V22, P87, DOI 10.3136/islsm.22.87
   Vayas R, 2017, BIOMED MATER, V12, DOI 10.1088/1748-605X/aa6f1c
   Wang FW, 2014, RSC ADV, V4, P56722, DOI 10.1039/c4ra10404h
   Wang ZQ, 2014, J BIOL CHEM, V289, P31950, DOI 10.1074/jbc.M114.600015
   Wohlgemuth SE, 2007, REJUV RES, V10, P281, DOI 10.1089/rej.2006.0535
   Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang X, 2015, RSC ADV, V5, P89827, DOI 10.1039/c5ra14174e
   Zhou YX, 2017, ANN NY ACAD SCI, V1409, P3, DOI 10.1111/nyas.13451
NR 46
TC 24
Z9 24
U1 3
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD DEC 7
PY 2018
VL 9
AR 343
DI 10.1186/s13287-018-1081-0
PG 11
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA HD7VB
UT WOS:000452760600008
PM 30526663
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Yu, A
   Zheng, Y
   Zhang, RR
   Huang, JF
   Zhu, ZJ
   Zhou, RH
   Jin, D
   Yang, ZQ
AF Yu, An
   Zheng, Yu
   Zhang, Rongrong
   Huang, Jianfeng
   Zhu, Zhoujie
   Zhou, Ronghua
   Jin, Dan
   Yang, Zaiqing
TI Resistin impairs SIRT1 function and induces senescence-associated
   phenotype in hepatocytes
SO MOLECULAR AND CELLULAR ENDOCRINOLOGY
LA English
DT Article
DE Resistin; SIRT1; Hepatocytes; PPAR alpha; PGC-1 alpha;
   Senescence-associated beta-galactosidase activity
ID FATTY-ACID OXIDATION; CELLULAR SENESCENCE; INSULIN-RESISTANCE;
   EXPRESSION; METABOLISM; OBESITY; GLUCOSE
AB Resistin is a cysteine-rich secreted protein which significantly inhibits phosphorylation of AMP-activated protein kinase in both human and mouse hepatocytes. It has been demonstrated that resistin plays an important role in inducing hepatic insulin resistance. However, whether resistin has other unknown influences on hepatocytes still remains poorly studied. Here, we show that recombinant resistin protein significantly reduces expression of SIRT1, attenuates the interaction between SIRT1 and PPAR alpha as well as PGC-1 alpha, and increases PGC-1 alpha acetyl-lysine levels in HepG2 cells. In line with this, resistin treatment weakens the association between SIRT1 and major satellite repeats and alters the transcription level of SIRT1 target genes in mouse primary hepatocytes. Resistin treatment also significantly increases senescence-associated beta-galactosidase activity in mouse primary hepatocytes and this effect can be eliminated by co-treatment with the SIRT1 agonists resveratrol and nicotinamide mononucleotide. Our findings suggest that resistin is a negative regulator of SIRT1 in both human hepatoma cell line HepG2 and mouse hepatocytes and that it might also play an important role in the development of senescence-associated liver diseases. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
C1 [Yu, An; Zheng, Yu; Zhu, Zhoujie; Zhou, Ronghua; Jin, Dan; Yang, Zaiqing] Huazhong Agr Univ, Coll Life Sci & Technol, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan 430070, Hubei Province, Peoples R China.
   [Zhang, Rongrong] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA.
   [Huang, Jianfeng] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria.
C3 Huazhong Agricultural University; Tulane University; Medical University
   of Graz
RP Yang, ZQ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei Province, Peoples R China.
EM zaiqingy@yahoo.com.cn
RI zhang, rongrong/G-1775-2016; Huang, Jianfeng/AAM-4711-2021
OI Huang, Jianfeng/0000-0003-0107-3482
FU National key Basic Research Program of China [2012CB124702]; 948 Program
   [2013-S15]; Specialized Research Fund for the Doctoral Program of Higher
   Education [20110146130002]; Program of National Natural Science
   Foundation of China [31172093, 30970356]; National Science Foundation
   for Fostering Talents in Basic Research [J1103510]
FX This work was supported by grants from the National key Basic Research
   Program of China (2012CB124702), 948 Program (2013-S15), the Specialized
   Research Fund for the Doctoral Program of Higher Education
   (20110146130002), the Program of National Natural Science Foundation of
   China (31172093, 30970356) and the National Science Foundation for
   Fostering Talents in Basic Research, J1103510).
CR Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341
   Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x
   Cantó C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813
   Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107
   Chemaly ER, 2011, J MOL CELL CARDIOL, V51, P144, DOI 10.1016/j.yjmcc.2011.04.006
   Dohi E, 2012, NEUROCHEM INT, V60, P431, DOI 10.1016/j.neuint.2012.01.020
   Dzamko NL, 2009, ACTA PHYSIOL, V196, P115, DOI 10.1111/j.1748-1716.2009.01969.x
   Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017
   Filková M, 2009, CLIN IMMUNOL, V133, P157, DOI 10.1016/j.clim.2009.07.013
   Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004
   Ho C, 2009, FEBS LETT, V583, P3081, DOI 10.1016/j.febslet.2009.08.031
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710
   Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022
   Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383
   Lee JH, 2003, J CLIN ENDOCR METAB, V88, P4848, DOI 10.1210/jc.2003-030519
   Li YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017421
   Liu WP, 2010, MECH AGEING DEV, V131, P601, DOI 10.1016/j.mad.2010.08.006
   Lombard DB, 2011, NATURE, V477, P410, DOI 10.1038/477410a
   Luo ZF, 2009, ENDOCRINE, V36, P60, DOI 10.1007/s12020-009-9198-7
   Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070
   Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151
   Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025
   Patel L, 2003, BIOCHEM BIOPH RES CO, V300, P472, DOI 10.1016/S0006-291X(02)02841-3
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Rajala MW, 2004, DIABETES, V53, P1671, DOI 10.2337/diabetes.53.7.1671
   Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Vilà-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yagmur E, 2006, AM J GASTROENTEROL, V101, P1244, DOI 10.1111/j.1572-0241.2006.00543.x
   Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105
   Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093
   Youn BS, 2004, J CLIN ENDOCR METAB, V89, P150, DOI 10.1210/jc.2003-031121
   Zdanov S, 2007, EXP CELL RES, V313, P3046, DOI 10.1016/j.yexcr.2007.04.033
   Zhang J, 2010, INFLAMMATION, V33, P25, DOI 10.1007/s10753-009-9155-x
NR 39
TC 12
Z9 15
U1 1
U2 25
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0303-7207
J9 MOL CELL ENDOCRINOL
JI Mol. Cell. Endocrinol.
PD SEP 5
PY 2013
VL 377
IS 1-2
BP 23
EP 32
DI 10.1016/j.mce.2013.06.028
PG 10
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA 210VV
UT WOS:000323863800004
PM 23827175
DA 2024-02-19
ER

PT J
AU Misumi, Y
   Narita, Y
   Oshima, T
   Ueda, M
   Yamashita, T
   Tasaki, M
   Obayashi, K
   Isono, K
   Inomata, Y
   Ando, Y
AF Misumi, Yohei
   Narita, Yasuko
   Oshima, Toshinori
   Ueda, Mitsuharu
   Yamashita, Taro
   Tasaki, Masayoshi
   Obayashi, Konen
   Isono, Kaori
   Inomata, Yukihiro
   Ando, Yukio
TI Recipient aging accelerates acquired transthyretin amyloidosis after
   domino liver transplantation
SO LIVER TRANSPLANTATION
LA English
DT Article
ID FOLLOW-UP; POLYNEUROPATHY; NEUROPATHY; PATIENT; TRANSMISSION;
   DEPOSITION; RISK; AGE
AB Domino liver transplantation (DLT) with liver grafts from patients with hereditary transthyretin (TTR) amyloidosis has been performed throughout the world because of a severe liver graft shortage. Reports of acquired systemic TTR amyloidosis in domino liver recipients have been increasing; however, the precise pathogenesis and clinical course of acquired TTR amyloidosis remains unclear. We analyzed the relationship between the occurrence of acquired amyloidosis and clinical features in 22 consecutive domino liver donors with hereditary TTR amyloidosis (10 males and 12 females; mean age at DLT: 37.2 years; TTR mutations: V30M [n=19], Y114C [n=1], L55P [n=1], and S50I [n=1]) and 22 liver recipients (16 males and 6 females; mean age at DLT, 46.2 years). The mean times from DLT to amyloid first appearance and transplant recipient symptom onset were 8.2 years and 9.9 years, respectively. Kaplan-Meier analysis and quantification of the amyloid deposition revealed aging of recipients correlated with early de novo amyloid deposition. The sex of donors and recipients and the age, disease duration, and disease severity of donors had no significant effect on the latency of de novo amyloid deposition. In conclusion, our results demonstrate that recipient aging is associated with the early onset de novo amyloidosis. Because acquired amyloidosis will likely increase, careful follow-up for early amyloidosis detection and new treatments, including TTR stabilizers and gene-silencing therapies, are required. Liver Transplantation 22 656-664 2016 AASLD.
C1 [Misumi, Yohei; Oshima, Toshinori; Ueda, Mitsuharu; Yamashita, Taro; Tasaki, Masayoshi; Ando, Yukio] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, 1-1-1 Honjo, Kumamoto 8608556, Japan.
   [Narita, Yasuko; Isono, Kaori; Inomata, Yukihiro] Kumamoto Univ, Grad Sch Med Sci, Dept Transplantat & Pediat Surg, Kumamoto 8608556, Japan.
   [Tasaki, Masayoshi; Obayashi, Konen] Kumamoto Univ, Grad Sch Hlth Sci, Dept Morphol & Physiol Sci, Kumamoto 8608556, Japan.
C3 Kumamoto University; Kumamoto University; Kumamoto University
RP Misumi, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, 1-1-1 Honjo, Kumamoto 8608556, Japan.
EM misumiyohei@hotmail.co.jp
RI Ando, Yasumasa/F-3264-2015; Ueda, Mitsuharu/Q-8595-2019
OI Ueda, Mitsuharu/0000-0002-6814-0582; Ando, Yukio/0000-0001-7115-9105
FU Grants-in-Aid for Scientific Research [15K09318, 26860672] Funding
   Source: KAKEN
CR Abdelfatah MM, 2014, AMYLOID, V21, P136, DOI 10.3109/13506129.2014.885894
   Ando Y, 2005, ARCH NEUROL-CHICAGO, V62, P1057, DOI 10.1001/archneur.62.7.1057
   Ando Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-31
   [Anonymous], 2015, FAP WORLD TRANSPL RE
   Barreiros AP, 2010, LIVER TRANSPLANT, V16, P314, DOI 10.1002/lt.21996
   Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753
   Bolte FJ, 2013, TRANSPL INT, V26, P715, DOI 10.1111/tri.12110
   Buxbaum J, 2008, AMYLOID, V15, P255, DOI 10.1080/13506120802525285
   Conceiçao I, 2010, MUSCLE NERVE, V42, P836, DOI 10.1002/mus.21806
   Ericzon BG, 2008, TRANSPL P, V40, P1130, DOI 10.1016/j.transproceed.2008.03.020
   Goto T, 2006, AM J TRANSPLANT, V6, P2512, DOI 10.1111/j.1600-6143.2006.01484.x
   HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M
   Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l
   Jack CR, 2014, LANCET NEUROL, V13, P997, DOI 10.1016/S1474-4422(14)70194-2
   Koike H, 2011, J NEUROL NEUROSUR PS, V82, P1287, DOI 10.1136/jnnp.2010.218958
   Koike H, 2008, J NEUROL, V255, P1526, DOI 10.1007/s00415-008-0962-z
   Lladó L, 2010, LIVER TRANSPLANT, V16, P1386, DOI 10.1002/lt.22174
   Obayashi K, 2011, MUSCLE NERVE, V43, P449, DOI 10.1002/mus.21941
   Ohya Y, 2011, SURG TODAY, V41, P1211, DOI 10.1007/s00595-010-4488-5
   Okamoto S, 2011, AMYLOID, V18, P200, DOI 10.3109/13506129.2011.615872
   Okuda Y, 2011, AMYLOID, V18, P108, DOI 10.3109/13506129.2011.582198
   Pradotto L, 2012, MUSCLE NERVE, V45, P918, DOI 10.1002/mus.23265
   Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018
   Solomon A, 2006, ARTHRITIS RHEUM, V54, P3545, DOI 10.1002/art.22201
   Sousa MM, 2004, LAB INVEST, V84, P865, DOI 10.1038/labinvest.3700107
   Stangou AJ, 2005, NEW ENGL J MED, V352, P2356, DOI 10.1056/NEJM200506023522219
   Stangou AJ, 1998, TRANSPLANTATION, V65, P1496, DOI 10.1097/00007890-199806150-00016
   Su Y, 2012, PANCREAS, V41, P971, DOI 10.1097/MPA.0b013e318249926a
   Sueyoshi T, 2011, HUM PATHOL, V42, P1259, DOI 10.1016/j.humpath.2010.11.017
   Takahashi R, 2014, J NEUROL SCI, V345, P231, DOI 10.1016/j.jns.2014.07.017
   Takei Y, 2007, LIVER TRANSPLANT, V13, P215, DOI 10.1002/lt.20954
   Tashima K, 1999, J NEUROL SCI, V171, P19, DOI 10.1016/S0022-510X(99)00231-2
   Yamashita T, 2012, NEUROLOGY, V78, P637, DOI 10.1212/WNL.0b013e318248df18
   Yanagisawa A, 2015, MODERN PATHOL, V28, P201, DOI 10.1038/modpathol.2014.102
NR 34
TC 23
Z9 24
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1527-6465
EI 1527-6473
J9 LIVER TRANSPLANT
JI Liver Transplant.
PD MAY
PY 2016
VL 22
IS 5
BP 656
EP 664
DI 10.1002/lt.24371
PG 9
WC Gastroenterology & Hepatology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Surgery; Transplantation
GA DK8CV
UT WOS:000375155700011
PM 26600212
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Kitani, K
AF Kitani, K
TI Lateral mobility of proteins and lipids of cell surface membranes during
   aging: Do the data support 'The Membrane Hypothesis of Aging'?
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article; Proceedings Paper
CT 2nd International NILS Workshop on Longevity Sciences - Roles of Protein
   in Aging and Age-Associated Disorders
CY NOV 29-30, 1997
CL OBU, JAPAN
SP NILS
DE lateral mobilities of proteins; hepatocyte surface membranes; FRAP;
   intracellular enzyme activities; aging
ID HEPATOCYTE PLASMA-MEMBRANE; AGE-DEPENDENT DECREASE;
   GLUTATHIONE-S-TRANSFERASE; FLUORESCENCE RECOVERY; DIETARY RESTRICTION;
   DIFFUSION CONSTANT; BILIARY-EXCRETION; RAT-LIVER; ETHINYL-ESTRADIOL;
   ENZYME-ACTIVITIES
AB Many previous studies regarding the change with age in surface membrane fluidity of different cell types, including hepatocytes, as determined by the fluorescence anisotropy method, are in conflict, demonstrating decreased, unchanged or even; increased fluidity with age. In contrast, the results of our series of works using the fluorescence recovery after photobleaching (FRAP) technique, which measures protein lateral diffusion coefficients of hepatocyte surface membranes (Dp), have demonstrated that Dp generally declines in a linear fashion with age in hepatocytes of all animal strains and species examined. The major coworker (I. Zs.-Nagy) of these studies insists that our observations support his original hypothesis, 'The Membrane Hypothesis of Aging' (MHA), the primary assumption of which is that changes in cell surface membranes with age cause a general decline in intracellular enzyme activities. However, while it seems clear that cell surface membrane changes do occur with age, a number of past observations including those from the laboratory of this author, provide strong evidence that intracellular enzyme activities do not generally decline with age. This paper presents the data in detail, along with the author's view that the results do not support the main assumption of the MHA, but are more likely related to alterations in membrane functions with age. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Natl Inst Longev Sci, Obu, Aichi 4748522, Japan.
RP Kitani, K (corresponding author), Natl Inst Longev Sci, Gengo 36-3,Morioka Cho, Obu, Aichi 4748522, Japan.
EM kitani@nils.go.jp
CR ARMBRECHT HJ, 1982, EXP GERONTOL, V17, P41, DOI 10.1016/0531-5565(82)90007-9
   AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   CARRILLO MC, 1990, MECH AGEING DEV, V56, P237, DOI 10.1016/0047-6374(90)90085-T
   CARRILLO MC, 1991, BIOCHIM BIOPHYS ACTA, V1077, P325, DOI 10.1016/0167-4838(91)90547-D
   CARRILLO MC, 1989, MECH AGEING DEV, V44, P749
   CIMINO M, 1984, LIFE SCI, V34, P2029, DOI 10.1016/0024-3205(84)90367-9
   DEPONT JJH, 1977, MAMMALIAN CELL MEMBR, V4, P116
   EATON DL, 1978, J PHARMACOL EXP THER, V205, P480
   EATON DL, 1979, J PHARMACOL EXP THER, V208, P208
   FUJITA S, 1986, LIVER AGING 1986, P103
   GUMUCIO JJ, 1971, GASTROENTEROLOGY, V61, P339
   HEGNER D, 1975, MECH AGEING DEV, V4, P191, DOI 10.1016/0047-6374(75)90021-4
   KIMELBERG HK, 1977, CELL SURF REV, V3, P205
   Kitani K, 1996, INT HEPATOL COMMUN, V5, P236, DOI 10.1016/0928-4346(96)00303-9
   KITANI K, 1988, HEPATOLOGY, V8, P125, DOI 10.1002/hep.1840080124
   KITANI K, 1991, ARCH GERONTOL GERIAT, V12, P133, DOI 10.1016/0167-4943(91)90024-K
   Kitani K, 1998, HEPATOL RES, V12, P131, DOI 10.1016/S1386-6346(98)00043-6
   Kitani K, 1998, ARCH GERONTOL GERIAT, V26, P257, DOI 10.1016/S0167-4943(98)00008-9
   KITANI K, 1988, LIFE CHEM REPORTS, V6, P143
   KLAASSEN CD, 1974, J PHARMACOL EXP THER, V191, P201
   LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x
   MINER PB, 1983, HEPATOLOGY, V3, P481
   Nagy K, 1983, Arch Gerontol Geriatr, V2, P23, DOI 10.1016/0167-4943(83)90014-6
   NAGY VZ, 1988, TISSUE CELL, V20, P229, DOI 10.1016/0040-8166(88)90044-4
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   NOKUBO M, 1988, BIOCHIM BIOPHYS ACTA, V939, P441, DOI 10.1016/0005-2736(88)90090-9
   NOKUBO M, 1989, BIOCHIM BIOPHYS ACTA, V981, P303, DOI 10.1016/0005-2736(89)90041-2
   OHTA M, 1990, BIOCHEM PHARMACOL, V39, P1223, DOI 10.1016/0006-2952(90)90266-N
   OHTA M, 1988, BIOCHEM PHARMACOL, V37, P935
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   ROGIERS V, 1991, BIOCHEM PHARMACOL, V42, P491, DOI 10.1016/0006-2952(91)90310-2
   ROSARIO EJ, 1978, BIOCHEMISTRY-US, V27, P3939
   ROWE JW, 1976, J GERONTOL, V31, P155, DOI 10.1093/geronj/31.2.155
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SMITH DJ, 1988, J LAB CLIN MED, V112, P679
   STACEY NH, 1986, BIOCHEM PHARMACOL, V35, P2495, DOI 10.1016/0006-2952(86)90045-6
   WILLIAMS LR, 1995, ADV BEHAV BIOL, V44, P641
   WYNNE HA, 1990, AGE AGEING, V19, P419, DOI 10.1093/ageing/19.6.419
   YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
   Zs-Nagy I, 1998, MECH AGEING DEV, V101, P257, DOI 10.1016/S0047-6374(97)00179-6
   Zs-Nagy I., 1994, MEMBRANE HYPOTHESIS
   ZSNAGY I, 1991, ARCH GERONTOL GERIAT, V12, P329, DOI 10.1016/0167-4943(91)90038-R
   ZSNAGY I, 1993, J GERONTOL, V48, pB86, DOI 10.1093/geronj/48.3.B86
   ZSNAGY I, 1986, EXP GERONTOL, V21, P555, DOI 10.1016/0531-5565(86)90007-0
   ZSNAGY I, 1986, ARCH GERONTOL GERIAT, V5, P131, DOI 10.1016/0167-4943(86)90016-6
   ZSNAGY I, 1984, MIKROSKOPIE, V41, P12
   ZsNagy I, 1996, ARCH GERONTOL GERIAT, V23, P81, DOI 10.1016/0167-4943(96)00710-8
   ZSNAGY I, 1989, J GERONTOL BIOL SCI, V4, pB83
   ZSNAGY I, 1998, EXP BRAIN RES, V124, P233
   ZSNAGY I, 1993, MECH AGEING DEV, V71, P85
NR 52
TC 12
Z9 12
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR 15
PY 1999
VL 107
IS 3
BP 299
EP 322
DI 10.1016/S0047-6374(98)00139-0
PG 24
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Cell Biology; Geriatrics & Gerontology
GA 192VC
UT WOS:000080099400008
PM 10360684
DA 2024-02-19
ER

PT J
AU YEN, TC
   SU, JH
   KING, KL
   WEI, YH
AF YEN, TC
   SU, JH
   KING, KL
   WEI, YH
TI AGING-ASSOCIATED 5 KB DELETION IN HUMAN LIVER MITOCHONDRIAL-DNA
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID HEREDITARY OPTIC NEUROPATHY; DEGENERATIVE DISEASES; OXYGEN RADICALS;
   CANCER; HETEROGENEITY; RAT; HETEROPLASMY; MUTATIONS; SEQUENCE; INCREASE
C1 NATL YANG MING MED COLL,DEPT BIOCHEM,TAIPEI 11221,TAIWAN.
   NATL YANG MING MED COLL,DEPT GEN SURG,TAIPEI 11221,TAIWAN.
C3 National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University
RI Wei, Yau-Huei/ABA-6841-2021
OI Wei, Yau-Huei/0000-0002-6429-2546
CR AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E
   BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967
   CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433
   COOTE JL, 1979, FEBS LETT, V99, P255, DOI 10.1016/0014-5793(79)80967-9
   CORBISIER P, 1990, MECH AGEING DEV, V51, P249, DOI 10.1016/0047-6374(90)90075-Q
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6972
   DELACRUZ J, 1990, INT J BIOCHEM, V51, P249
   FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504
   HADLER HI, 1989, FEBS LETT, V256, P230, DOI 10.1016/0014-5793(89)81754-5
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739
   HOWELL N, 1983, SOMAT CELL GENET, V9, P1, DOI 10.1007/BF01544045
   IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LOTT MT, 1990, AM J OPHTHALMOL, V109, P625, DOI 10.1016/S0002-9394(14)72429-8
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   PALVA TK, 1985, FEBS LETT, V192, P267, DOI 10.1016/0014-5793(85)80122-8
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   RICHTER C, 1988, FEBS LETT, V241, P1, DOI 10.1016/0014-5793(88)81018-4
   SHIH KD, 1991, BIOCHEM BIOPH RES CO, V174, P1109, DOI 10.1016/0006-291X(91)91535-K
   SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   WEI YH, 1984, ARCH BIOCHEM BIOPHYS, V230, P400, DOI 10.1016/0003-9861(84)90420-X
   WHITTAM TS, 1986, P NATL ACAD SCI USA, V83, P9611, DOI 10.1073/pnas.83.24.9611
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 32
TC 227
Z9 239
U1 0
U2 3
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 15
PY 1991
VL 178
IS 1
BP 124
EP 131
DI 10.1016/0006-291X(91)91788-E
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA FW340
UT WOS:A1991FW34000018
PM 2069552
DA 2024-02-19
ER

PT J
AU Lee, TY
   Chang, HH
   Lo, WC
   Lin, HC
AF Lee, Tzung-Yan
   Chang, Hen-Hong
   Lo, Wen-Chai
   Lin, Han-Chieh
TI Alleviation of hepatic oxidative stress by Chinese herbal medicine
   Yin-Chen-Hao-Tang in obese mice with steatosis
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE oxidative stress; herbal medicine; steatosis
ID FATTY-ACID OXIDATION; INCHIN-KO-TO; INSULIN-RESISTANCE; LIVER-DISEASE;
   METABOLIC SYNDROME; ADIPOSE-TISSUE; RATS; APOPTOSIS; FIBROSIS; PROTEIN
AB Obesity is associated with a complex systemic inflammatory state that has been implicated in the development of hepatic steatosis. This study was to test the efficacy of Yin-Chen-Hao-Tang (YCHT), an agent that improves hepatic triglyceride metabolism in its ability to modulate pathways implicated in hepatic steatosis. Mice were fed with high-fat diet for fifteen weeks. The therapeutic mechanism of YCHT likely enhanced adiponectin and endothelial progenitor cells, and up-regulation of peroxisome proliferator-activated receptor gamma might be responsible for fatty liver diseases. In addition, YCHT anti-oxidative stress effect might be associated with inhibition of hepatic free fatty acid concentrations and elevation of the glutathione levels in hepatic tissues. Furthermore, YCHT action mechanisms might promote senescence marker protein-30 metabolism that increase resistance to hepatic oxidative stress. These findings suggest a novel therapeutic approach for fatty liver progression in obesity mice.
C1 [Lee, Tzung-Yan; Chang, Hen-Hong; Lo, Wen-Chai] Chang Gung Univ, Grad Inst Tradit Chinese Med, Tao Yuan 333, Taiwan.
   [Chang, Hen-Hong] Chang Gung Mem Hosp, Ctr Tradit Chinese Med, Tao Yuan, Taiwan.
   [Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan.
C3 Chang Gung University; Chang Gung Memorial Hospital; Taipei Veterans
   General Hospital
RP Lee, TY (corresponding author), Chang Gung Univ, Grad Inst Tradit Chinese Med, 259 Wen Hwa 1st Rd, Tao Yuan 333, Taiwan.
EM joyamen@mail.cgu.edu.tw
RI Hen Hong, Chang/ITT-2813-2023
FU National Science Council, Taipei, Taiwan [NSC96-2320-B-182-021]; Chang
   Gung Memorial Hospital [CMRPD180241]
FX This work was supported by the National Science Council, Taipei, Taiwan,
   NSC96-2320-B-182-021 and CMRPD180241 supported by a Research Grant from
   the Chang Gung Memorial Hospital.
CR Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Bergheim I, 2003, EUR J CLIN NUTR, V57, P431, DOI 10.1038/sj.ejcn.1601557
   Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Grundy SM, 2002, CIRCULATION, V105, P2696, DOI 10.1161/01.CIR.0000020650.86137.84
   Inao M, 2004, J HEPATOL, V41, P584, DOI 10.1016/j.jhep.2004.06.033
   Lee TY, 2007, J PHARM PHARMACOL, V59, P583, DOI 10.1211/jpp.59.4.0014
   Lee TY, 2007, J ETHNOPHARMACOL, V109, P318, DOI 10.1016/j.jep.2006.07.042
   Lee TY, 2009, MOL CELL BIOCHEM, V325, P53, DOI 10.1007/s11010-008-0019-8
   Lee TY, 2009, INT J MOL MED, V23, P477
   Lovås K, 2009, DIABETES OBES METAB, V11, P304, DOI 10.1111/j.1463-1326.2008.00958.x
   Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797
   Mohanty P, 2002, AM J CLIN NUTR, V75, P767, DOI 10.1093/ajcn/75.4.767
   Nollen EAA, 2002, J CELL SCI, V115, P2809
   Oakes ND, 2001, DIABETES, V50, P1158, DOI 10.2337/diabetes.50.5.1158
   REED DJ, 1980, ANAL BIOCHEM, V106, P55, DOI 10.1016/0003-2697(80)90118-9
   Solomon SS, 1997, HORM METAB RES, V29, P379, DOI 10.1055/s-2007-979059
   Takahashi Y, 2008, J NUTR BIOCHEM, V19, P682, DOI 10.1016/j.jnutbio.2007.09.003
   Tiikkainen M, 2004, DIABETES, V53, P2169, DOI 10.2337/diabetes.53.8.2169
   Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335
   Wu SY, 2009, ACTA PHARMACOL SIN, V30, P202, DOI 10.1038/aps.2008.17
   Yamamoto M, 1996, HEPATOLOGY, V23, P552
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yang CS, 2007, J EXP MED, V204, P583, DOI 10.1084/jem.20061849
   Zhao XY, 2009, CLIN EXP PHARMACOL P, V36, P29, DOI 10.1111/j.1440-1681.2008.05051.x
NR 28
TC 37
Z9 38
U1 0
U2 18
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD JUN
PY 2010
VL 25
IS 6
BP 837
EP 844
DI 10.3892/ijmm_00000412
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 594QB
UT WOS:000277551200002
PM 20428786
OA Bronze
DA 2024-02-19
ER

PT J
AU Kennedy, L
   Hargrove, L
   Demieville, J
   Bailey, JM
   Dar, W
   Polireddy, K
   Chen, QZ
   Rubin, MIN
   Sybenga, A
   DeMorrow, S
   Meng, FY
   Stockton, L
   Alpini, G
   Francis, H
AF Kennedy, Lindsey
   Hargrove, Laura
   Demieville, Jennifer
   Bailey, Jennifer M.
   Dar, Wasim
   Polireddy, Kishore
   Chen, Qingzheng
   Rubin, Moises I. Nevah
   Sybenga, Amelia
   DeMorrow, Sharon
   Meng, Fanyin
   Stockton, Lindsey
   Alpini, Gianfranco
   Francis, Heather
TI Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and
   Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via
   Disrupted Histamine/Leptin Signaling
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID BILE-DUCT LIGATION; LIVER DISEASE/NONALCOHOLIC STEATOHEPATITIS;
   HYPOTHALAMIC NEURONAL HISTAMINE; PRIMARY SCLEROSING CHOLANGITIS; INDUCED
   BILIARY HYPERPLASIA; NONALCOHOLIC-STEATOHEPATITIS; TARGETED DISRUPTION;
   CELLULAR SENESCENCE; DOWN-REGULATION; INDUCED OBESITY
AB Feeding a high-fat diet (HFD) coupled with sugar, mimicking a Western diet, causes fatty liver disease in mice. Histamine induces biliary proliferation and fibrosis and regulates leptin signaling. Wild-type (WT) and L-histidine decarboxylase (Hdc(-/-)) mice were fed a control diet or an HFD coupled with a high fructose corn syrup equivalent. Hematoxylin and eosin and Oil Red 0 staining were performed to determine steatosis. Biliary mass and cholangiocyte proliferation were evaluated by immunohistochemistry. Senescence and fibrosis were measured by quantitative PCR and immunohisto-chemistry. Hepatic stellate cell activation was detected by immunofluorescence. Histamine and leptin levels were measured by enzyme immunoassay. Leptin receptor (Ob-R) was evaluated by quantitative PCR. The HDC/histamine/histamine receptor axis, ductular reaction, and biliary senescence were evaluated in patients with nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, or end-stage Liver disease. Hdc(-/-) HFD mice had increased steatosis compared with WT HFD mice. WT HFD mice had increased biliary mass, biliary proliferation, senescence, fibrosis, and hepatic stellate cell activation, which were reduced in HdC(-/-) HFD mice. In Hdc(-/-) HFD mice, serum leptin levels increased, whereas biliary Ob-R expression decreased. Nonalcoholic steatohepatitis patients had increased HDC/histamine/histamine receptor signaling. Hdc(-/-) HFD mice are susceptible to obesity via dysregulated Leptin/Ob-R signaling, whereas the lack of HDC protects from HFD-induced fibrosis and cholangiocyte damage. HDC/histamine/leptin signaling may be important in managing obesity-induced biliary damage.
C1 [Kennedy, Lindsey; Demieville, Jennifer; DeMorrow, Sharon; Meng, Fanyin; Alpini, Gianfranco; Francis, Heather] Texas A&M Hlth Sci Ctr, Coll Med, Dept Res, Bryan, TX USA.
   [Kennedy, Lindsey; Hargrove, Laura; DeMorrow, Sharon; Alpini, Gianfranco; Francis, Heather] Texas A&M Hlth Sci Ctr, Coll Med, Cent Texas Vet Hlth Care Syst, Bryan, TX USA.
   [Kennedy, Lindsey; Hargrove, Laura; DeMorrow, Sharon; Alpini, Gianfranco; Francis, Heather] Texas A&M Hlth Sci Ctr, Coll Med, Dept Med Physiol, Bryan, TX USA.
   [Bailey, Jennifer M.; Polireddy, Kishore; Chen, Qingzheng; Rubin, Moises I. Nevah] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Div Gastroenterol, Houston, TX 77030 USA.
   [Dar, Wasim] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Dept Internal Med, Houston, TX 77030 USA.
   [Dar, Wasim] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Div Immunol & Organ Transplantat, Houston, TX 77030 USA.
   [Sybenga, Amelia] Baylor Scott & White Hlth, Dept Anat & Clin Pathol, Temple, TX USA.
   [DeMorrow, Sharon; Meng, Fanyin; Stockton, Lindsey; Alpini, Gianfranco; Francis, Heather] Baylor Scott & White Hlth Digest Dis Res Ctr, Dept Res, Temple, TX USA.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M Health Science Center; Texas A&M University System; Texas A&M
   University College Station; Texas A&M Health Science Center; Texas A&M
   University System; Texas A&M University College Station; Texas A&M
   Health Science Center; University of Texas System; University of Texas
   Health Science Center Houston; University of Texas System; University of
   Texas Health Science Center Houston; University of Texas System;
   University of Texas Health Science Center Houston; Baylor Health Care
   System; Baylor Health Care System
RP Francis, H (corresponding author), Texas A&M Univ, Cent Texas Vet Hlth Care Syst, Baylor Scott & White Hlth, Coll Med,Dept Med Physiol, 1901 S 1st St, Temple, TX 76504 USA.
EM hfrancis@medicine.tamhsc.edu
OI Sybenga, Amelia/0000-0001-9231-6800; Dar, Wasim/0000-0001-8095-248X
FU US Department of Veteran's Affairs VA Merit award [1I01BX003031];
   Biomedical Laboratory Research and Development Service VA Research
   Career Scientist Award; NIH National Institute of Diabetes and Digestive
   and Kidney Diseases Biomedical Laboratory Research and Development
   Service; PSC Partners Seeking a Cure; VA Merit award [5I01BX000574]; 
   [RO1 DK108959];  [RO1 DK082435]
FX Supported in part by the US Department of Veteran's Affairs VA Merit
   award 1I01BX003031 (H.F.), Biomedical Laboratory Research and
   Development Service VA Research Career Scientist Award (G.A.), VA Merit
   award 5I01BX000574 (G.A.), NIH National Institute of Diabetes and
   Digestive and Kidney Diseases Biomedical Laboratory Research and
   Development Service and RO1 DK108959 (H.F.) and RO1 DK082435 (S.D.M.),
   the PSC Partners Seeking a Cure (H.F. and S.D.M.), and the Dr. Nicholas
   C. Hightower Centennial Chair of Gastroenterology from Baylor Scott &
   White Health (G.A.). This material is the result of work supported with
   resources and the use of facilities at the Central Texas Veterans Health
   Care System (Temple, TX).
CR Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767
   Aravinthan A, 2014, CELL CYCLE, V13, P1489, DOI 10.4161/cc.28471
   Aravinthan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072904
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Brunt EM, 2005, HEPATOL RES, V33, P68, DOI 10.1016/j.hepres.2005.09.006
   Bugianesi Elisabetta, 2016, Recenti Progressi in Medicina, V107, P360, DOI 10.1701/2318.24928
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dattaroy D, 2015, AM J PHYSIOL-GASTR L, V308, pG298, DOI 10.1152/ajpgi.00346.2014
   Duvnjak M, 2007, WORLD J GASTROENTERO, V13, P4539, DOI 10.3748/wjg.v13.i34.4539
   Fitzgerald KR, 2013, J VASC NURS, V31, P131, DOI 10.1016/j.jvn.2013.06.004
   Francis H, 2008, AM J PHYSIOL-CELL PH, V295, pC499, DOI 10.1152/ajpcell.00369.2007
   Francis H, 2007, LAB INVEST, V87, P473, DOI 10.1038/labinvest.3700533
   Francis H, 2012, GUT, V61, P753, DOI 10.1136/gutjnl-2011-300007
   Francis HL, 2012, LAB INVEST, V92, P282, DOI 10.1038/labinvest.2011.158
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013
   Fülöp AK, 2003, ENDOCRINOLOGY, V144, P4306, DOI 10.1210/en.2003-0222
   Ganz M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0552-7
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6
   Graf A, 2014, AM J PHYSIOL-GASTR L, V307, pG813, DOI 10.1152/ajpgi.00188.2014
   Gutierrez-Reyes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010231
   Hargrove L, 2017, HEPATOLOGY, V65, P1991, DOI 10.1002/hep.29079
   Ishizuka T, 2008, BEHAV BRAIN RES, V188, P250, DOI 10.1016/j.bbr.2007.11.001
   Itateyama E, 2003, EXP BIOL MED, V228, P1132
   Johnson C, 2015, DIGEST LIVER DIS, V47, P211, DOI 10.1016/j.dld.2014.12.006
   Jones H, 2016, HEPATOLOGY, V64, P1202, DOI 10.1002/hep.28704
   Jorgensen EA, 2007, NEUROENDOCRINOLOGY, V86, P210, DOI 10.1159/000108341
   Jorgensen EA, 2006, NEUROENDOCRINOLOGY, V83, P289, DOI 10.1159/000095339
   Kennedy LL, 2014, LAB INVEST, V94, P1406, DOI 10.1038/labinvest.2014.129
   Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250
   Masaki T, 2001, DIABETES, V50, P385, DOI 10.2337/diabetes.50.2.385
   McDaniel K, 2017, HEPATOLOGY, V65, P544, DOI 10.1002/hep.28831
   Mells JE, 2015, J NUTR BIOCHEM, V26, P285, DOI 10.1016/j.jnutbio.2014.11.002
   Muff MA, 2006, LAB INVEST, V86, P940, DOI 10.1038/labinvest.3700448
   O'Hara SP, 2011, J BIOL CHEM, V286, P30352, DOI 10.1074/jbc.M111.269464
   Polyzos SA, 2009, CURR MOL MED, V9, P299, DOI 10.2174/156652409787847191
   Ray D, 2015, AM J PATHOL, V185, P1061, DOI 10.1016/j.ajpath.2014.12.004
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Smagris E, 2016, J BIOL CHEM, V291, P10659, DOI 10.1074/jbc.M116.719955
   Sorrentino P, 2005, DIGEST DIS SCI, V50, P1130, DOI 10.1007/s10620-005-2719-1
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Takahashi Y, 2014, WORLD J GASTROENTERO, V20, P15539, DOI 10.3748/wjg.v20.i42.15539
   Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300
   Toftegaard CL, 2003, REGUL PEPTIDES, V111, P83, DOI 10.1016/S0167-0115(02)00260-4
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wang KY, 2010, AM J PATHOL, V177, P713, DOI 10.2353/ajpath.2010.091198
   Wood JD, 2006, GUT, V55, P445, DOI 10.1136/gut.2005.079046
   Yoshimatsu H, 2008, NUTRITION, V24, P827, DOI 10.1016/j.nut.2008.06.014
   Yoshimatsu K, 1999, DIABETES, V48, P2286, DOI 10.2337/diabetes.48.12.2286
NR 51
TC 28
Z9 32
U1 2
U2 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD MAR
PY 2018
VL 188
IS 3
BP 600
EP 615
DI 10.1016/j.ajpath.2017.11.016
PG 16
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA FY4OT
UT WOS:000426805100006
PM 29248461
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Macias, RIR
   Hierro, C
   de Juan, SC
   Jimenez, F
   Gonzalez-San Martin, F
   Marin, JJG
AF Macias, Rocio I. R.
   Hierro, Carlos
   Cuesta de Juan, Susana
   Jimenez, Felipe
   Gonzalez-San Martin, Francisco
   Marin, Jose J. G.
TI Hepatic expression of sodium-dependent vitamin C transporters: ontogeny,
   subtissular distribution and effect of chronic liver diseases
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Ascorbic acid; Bile acids; Biliary cirrhosis; Non-alcoholic
   steatohepatitis; Ontogeny; Oxidative stress; Steatosis; Sodium-dependent
   vitamin C transporter
ID MATERNAL CHOLESTASIS; DEHYDROASCORBIC ACID; ASCORBIC-ACID; OXIDATIVE
   STRESS; EPITHELIAL-CELLS; SVCT1; RAT; LOCALIZATION; INFLAMMATION;
   APOPTOSIS
AB Ascorbic acid uptake is a key step in determining the overall bioactivity of this vitamin. Expression of Na-dependent vitamin C transporters (SVCT; SLC23A1 and SLC23A2) during long-term oxidative stress occurring in several chronic liver diseases may determine the antioxidant defence in this organ. In patients with hepatocellular cholestasis, primary biliary cirrhosis, haemochromatosis and non-alcoholic steatohepatitis, using real-time RT-PCR, an enhanced hepatic expression of both SLC23A1 and SLC23A2, but not other organic anions transporters, such as OATP1A2, OATP1B1 and OATP1B3, was found. To further investigate these findings, we used secondary biliary cirrhosis induced in rats by long-term biliary obstruction as a model of chronic liver disease accompanied by oxidative stress because of bile acid accumulation. In control rat liver, expression of Slc23a1 was low at birth, increased progressively up to adulthood and decreased in senescence, whereas expression of Slc23a2 did not change significantly after birth. In 8-week-old rats, immunohistochemistry and confocal microscopy studies revealed the expression in hepatocytes and bile duct cells of mainly Slc23a1, whereas both Slc23a1 and Slc23a2 were expressed in endothelial, stellate and Kupffer cells. In adult rats, when obstructive cholestasis was maintained for 8 weeks, a significant up-regulation of Slc23a2 accompanied by a down-regulation of Slc23a1 was found. In sum, there is a selective cell-type distribution of SVCT in the liver tissue, which, in addition to differential control in the expression of both isoforms, may play a role in the ability of different liver cell types to take up vitamin C under physiological and pathological conditions.
C1 [Macias, Rocio I. R.; Jimenez, Felipe; Gonzalez-San Martin, Francisco; Marin, Jose J. G.] Univ Salamanca, Natl Inst Study Liver & Gastrointestinal Dis CIBE, Lab Expt Hepatol & Drug Targeting HEVEFARM, E-37008 Salamanca, Spain.
   [Macias, Rocio I. R.; Marin, Jose J. G.] Dept Physiol & Pharmacol, Salamanca 37007, Spain.
   [Hierro, Carlos; Cuesta de Juan, Susana; Jimenez, Felipe; Gonzalez-San Martin, Francisco] Univ Hosp, Salamanca, Spain.
C3 University of Salamanca
RP Marin, JJG (corresponding author), Univ Salamanca, Natl Inst Study Liver & Gastrointestinal Dis CIBE, Lab Expt Hepatol & Drug Targeting HEVEFARM, E-37008 Salamanca, Spain.
EM jjgmarin@usal.es
RI Macias, Rocio IR/A-9617-2017; Marin, Jose J. G./D-5017-2011
OI Macias, Rocio IR/0000-0002-4748-0326; Marin, Jose J.
   G./0000-0003-1186-6849
FU Instituto de Salud Carlos III, FIS [PI051547]; Junta de Castilla y Leon,
   Spain [SA021B06, SA033A08, SAN673SA07/08, BIO39/SA27/10, GR75-2008];
   Ministerio de Ciencia y Tecnologia, Desarrollo e Innovacion Tecnologica,
   Spain [SAF2009-08493, SAF2010-15517]; Fundacion Investigacion Medica,
   Mutua Madrilena, Spain; Ministerio de Educacion y Ciencia, Spain;
   European Regional Development Fund (ERDF) [BFU2007-30688-E/BFI]
FX The authors thank Dr L. Munoz, J. F. Martin and J. Villoria for care of
   the animals. Technical help by E. Keck and revision of the English
   spelling, grammar and style of the manuscript by N. Skinner are also
   gratefully acknowledged. This study was supported in part by the
   Instituto de Salud Carlos III, FIS (grant no. PI051547); the Junta de
   Castilla y Leon (grant nos. SA021B06, SA033A08, SAN673SA07/08,
   BIO39/SA27/10 and GR75-2008), Spain; the Ministerio de Ciencia y
   Tecnologia, Plan Nacional de Investigacion Cientifica, Desarrollo e
   Innovacion Tecnologica (grant nos. SAF2009-08493 and SAF2010-15517),
   Spain and the Fundacion Investigacion Medica, Mutua Madrilena
   (Convocatoria VI, 2009), Spain. The group is member of the Network for
   Cooperative Research on Membrane Transport Proteins (REIT), co-funded by
   the Ministerio de Educacion y Ciencia, Spain and the European Regional
   Development Fund (ERDF) (grant no. BFU2007-30688-E/BFI) and belongs to
   the CIBERehd (Centro de Investigacion Biomedica en Red de Enfermedades
   Hepaticas y Digestivas) Instituto de Salud Carlos III, Spain. R. I. R.
   M. and J. J. G. M. designed the study; R. I. R. M., J. J. G. M., C. H.
   and S. C. D. J. carried out experimental work; R. I. R. M., F. J. and F.
   G. S. M. performed study on human samples. All the authors were involved
   in discussion of the results. R. I. R. M. and J. J. G. M. prepared the
   manuscript. All the authors revised the manuscript. The authors confirm
   that there are no conflicts of interest.
CR Aguirre R, 2008, PHARMACOL THERAPEUT, V119, P96, DOI 10.1016/j.pharmthera.2008.05.002
   BEATTIE AD, 1976, GUT, V17, P571, DOI 10.1136/gut.17.8.571
   Boyer JC, 2005, BIOCHEM BIOPH RES CO, V334, P150, DOI 10.1016/j.bbrc.2005.06.069
   Daruwala R, 1999, FEBS LETT, V460, P480, DOI 10.1016/S0014-5793(99)01393-9
   Donner MG, 2007, AM J PHYSIOL-GASTR L, V293, pG1134, DOI 10.1152/ajpgi.00079.2007
   Eck P, 2004, HUM GENET, V115, P285, DOI 10.1007/s00439-004-1167-x
   GARCIAMARIN JJ, 1988, HEPATOLOGY, V8, P332, DOI 10.1002/hep.1840080224
   Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014
   Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005
   Kuo SM, 2004, J NUTR, V134, P2216
   MacDonald L, 2002, BRIT J NUTR, V87, P97, DOI 10.1079/BJN2001492
   Marin JJ, 2009, VITAMIN C DAILY REQU
   MASHIGE F, 1976, CLIN CHIM ACTA, V70, P79, DOI 10.1016/0009-8981(76)90007-3
   Monte MJ, 1996, HEPATOLOGY, V23, P1208
   Pastore P, 2001, RAPID COMMUN MASS SP, V15, P2051, DOI 10.1002/rcm.476
   Perez MJ, 2008, TOXICOL APPL PHARM, V232, P327, DOI 10.1016/j.taap.2008.07.013
   Perez MJ, 2007, J PINEAL RES, V43, P130, DOI 10.1111/j.1600-079X.2007.00453.x
   Perez MJ, 2009, WORLD J GASTROENTERO, V15, P1677, DOI 10.3748/wjg.15.1677
   Perez MJ, 2005, J HEPATOL, V43, P324, DOI 10.1016/j.jhep.2005.02.028
   Rivas CI, 2008, J PHYSIOL BIOCHEM, V64, P357, DOI 10.1007/BF03174092
   ROSE RC, 1987, BIOCHIM BIOPHYS ACTA, V924, P254, DOI 10.1016/0304-4165(87)90094-8
   Rumsey SC, 1997, J BIOL CHEM, V272, P18982, DOI 10.1074/jbc.272.30.18982
   Rumsey SC, 2000, J BIOL CHEM, V275, P28246
   Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7
   Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986
   Varma S, 2009, BIOCHEMISTRY-US, V48, P2969, DOI 10.1021/bi802294v
   Wilson JX, 2005, ANNU REV NUTR, V25, P105, DOI 10.1146/annurev.nutr.25.050304.092647
NR 27
TC 25
Z9 27
U1 0
U2 6
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
J9 BRIT J NUTR
JI Br. J. Nutr.
PD DEC
PY 2011
VL 106
IS 12
BP 1814
EP 1825
DI 10.1017/S0007114511002273
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 862RJ
UT WOS:000298111400006
PM 21733302
OA Bronze
DA 2024-02-19
ER

PT J
AU Graupera, I
   Isus, L
   Coll, M
   Pose, E
   Díaz, A
   Vallverdú, J
   Rubio-Tomás, T
   Martínez-Sánchez, C
   Huelin, P
   Llopis, M
   Solé, C
   Solà, E
   Fondevila, C
   Lozano, JJ
   Sancho-Bru, P
   Ginès, P
   Aloy, P
AF Graupera, Isabel
   Isus, Laura
   Coll, Mar
   Pose, Elisa
   Diaz, Alba
   Vallverdu, Julia
   Rubio-Tomas, Teresa
   Martinez-Sanchez, Celia
   Huelin, Patricia
   Llopis, Marta
   Sole, Cristina
   Sola, Elsa
   Fondevila, Constantino
   Lozano, Juan Jose
   Sancho-Bru, Pau
   Gines, Pere
   Aloy, Patrick
TI Molecular characterization of chronic liver disease dynamics: From liver
   fibrosis to acute-on-chronic liver failure
SO JHEP REPORTS
LA English
DT Article; Early Access
DE chronic liver disease; ACLF; network biology; temporal gene expression
   profile; biomarker
ID DECOMPENSATED CIRRHOSIS; MEDIATORS; PROGNOSIS; KERATINS; GENES
AB Background & Aims: The molecular mechanisms driving the progression from early-chronic liver disease (CLD) to cirrhosis and, finally, acute-on-chronic liver failure (ACLF) are largely unknown. Our aim was to develop a protein network-based approach to investigate molecular pathways driving progression from early-CLD to ACLF. Methods: Transcriptome analysis was performed on liver biopsies from patients at different liver disease stages, including fibrosis, compensated cirrhosis, decompensated cirrhosis and ACLF, and control healthy livers. We created 9 liver-specific disease-related protein-protein interaction networks capturing key pathophysiological processes potentially related to CLD. We used these networks as a framework and performed gene set-enrichment analysis (GSEA) to identify dynamic gene profiles of disease progression. Results: Principal component analyses revealed that samples clustered according to the disease stage. GSEA of the defined processes showed an upregulation of inflammation, fibrosis and apoptosis networks throughout disease progression. Interestingly, we did not find significant gene expression differences between compensated and decompensated cirrhosis, while ACLF showed acute expression changes in all the defined liver disease-related networks. The analyses of disease progression patterns identified ascending and descending expression profiles associated with ACLF onset. Functional analyses showed that ascending profiles were associated with inflammation, fibrosis, apoptosis, senescence and carcinogenesis networks, while descending profiles were mainly related to oxidative stress and genetic factors. We confirmed by qPCR the upregulation of genes of the ascending profile and validated our findings in an independent patient cohort. Conclusion: ACLF is characterized by a specific hepatic gene expression pattern related to inflammation, fibrosis, apoptosis, senescence and carcinogenesis. Moreover, the observed profile is significantly different from that of compensated and decompensated cirrhosis, supporting the hypothesis that ACLF should be considered a distinct entity. Lay summary: By using transjugular biopsies obtained from patients at different stages of chronic liver disease, we unveil the molecular pathogenic mechanisms implicated in the progression of chronic liver disease to cirrhosis and acute-on-chronic liver failure. The most relevant finding in this study is that patients with acute-on-chronic liver failure present a specific hepatic gene expression pattern distinct from that of patients at earlier disease stages. This gene expression pattern is mostly related to inflammation, fibrosis, angiogenesis, and senescence and apoptosis pathways in the liver. (c) 2022 Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Graupera, Isabel; Pose, Elisa; Huelin, Patricia; Sole, Cristina; Sola, Elsa; Gines, Pere] Hosp Clin Barcelona, Liver Unit, Barcelona, Catalonia, Spain.
   [Graupera, Isabel; Coll, Mar; Pose, Elisa; Vallverdu, Julia; Rubio-Tomas, Teresa; Martinez-Sanchez, Celia; Llopis, Marta; Sancho-Bru, Pau; Gines, Pere] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Rossello 149-153, Barcelona 08036, Catalonia, Spain.
   [Graupera, Isabel; Coll, Mar; Sancho-Bru, Pau; Gines, Pere] Univ Barcelona, Fac Med, Med Dept, Barcelona, Catalonia, Spain.
   [Graupera, Isabel; Coll, Mar; Pose, Elisa; Lozano, Juan Jose; Sancho-Bru, Pau; Gines, Pere] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Catalonia, Spain.
   [Isus, Laura; Aloy, Patrick] Inst Res Biomed IRB Barcelona, Barcelona, Catalonia, Spain.
   [Isus, Laura; Aloy, Patrick] Barcelona Inst Sci & Technol, Barcelona, Catalonia, Spain.
   [Diaz, Alba] Hosp Clin IDIBAPS, Pathol Serv, Barcelona, Spain.
   [Diaz, Alba] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.
   [Fondevila, Constantino] Hosp Univ La Paz, IdiPAZ, CIBERehd, Dept Gen & Digest Surg, Madrid, Spain.
   [Aloy, Patrick] Inst Catalana Recerca & Estudis Avancats ICREA, Barcelona, Catalonia, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; University of
   Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of
   Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD;
   Barcelona Institute of Science & Technology; Institute for Research in
   Biomedicine - IRB Barcelona; Barcelona Institute of Science &
   Technology; University of Barcelona; Hospital Clinic de Barcelona;
   IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS;
   Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica
   en Red; CIBEREHD; ICREA
RP Graupera, I; Coll, M (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Rossello 149-153, Barcelona 08036, Catalonia, Spain.; Graupera, I (corresponding author), Hosp Clin Barcelona, Liver Unit, Villarroel 170, Barcelona 08036, Spain.
EM igraupe@clinic.cat; mdcoll@clinic.cat
RI Sancho-Bru, Pau/D-4900-2014; Díaz, Alba/HSH-9155-2023; Gines,
   Pere/B-6646-2009
OI Sancho-Bru, Pau/0000-0001-5569-9259; Gines, Pere/0000-0003-4657-4504;
   Diaz, Alba/0000-0002-0456-7085; POSE MENDEZ, ELISA/0000-0002-0224-7686;
   Martinez Sanchez, Celia/0000-0002-9837-7361
FU Instituto de Salud Carlos III [PI 16/00043, PI20/00579]; European
   Regional Development Fund (FEDER) [AGAUR SGR-01281]; EU [H20/20
   SC1-2016-RTD, 731875]; Insti-tuto de Salud Carlos III [FIS PI18/00862];
   Spanish Ministerio de Econom?a y Competitividad [BIO2016-77038-R];
   European Research Council [614944]; Ramon y Cajal programme from the
   Ministerio de Ciencia e Innovaci?n [RYC2019-026662-I]; European Research
   Council (ERC) [614944] Funding Source: European Research Council (ERC)
FX Some of the work mentioned has been sponsored to PG by the Instituto de
   Salud Carlos III through the Plan Estatal de Investigaci?n Cient?fica y
   T?cnica y de Innovaci?n PI 16/00043 and PI20/00579. This grant was
   cofunded by the European Regional Development Fund (FEDER) . Some of the
   investigators involved have been supported by the AGAUR SGR-01281 Grant.
   Part of this study was supported by a grant from the EU Horizon 20/20
   European programme (H20/20 SC1-2016-RTD; LIVERHOPE grant number 731875)
   related to new therapies on chronic diseases (pro-gramme SC1-PM-09-2016)
   . MC and IG are funded by a grant from Insti-tuto de Salud Carlos III
   (FIS PI18/00862) ; PA acknowledges the support of the Spanish Ministerio
   de Econom?a y Competitividad (BIO2016-77038-R) and the European Research
   Council (SysPharmAD: 614944) . L.I. is sup-ported by a ?la Caixa? Ph.D.
   fellowship. M.C is funded by Ramon y Cajal programme from the Ministerio
   de Ciencia e Innovaci?n RYC2019-026662-I.
CR Affò S, 2014, GUT, V63, P1782, DOI 10.1136/gutjnl-2013-306098
   Ariza X, 2016, J HEPATOL, V65, P57, DOI 10.1016/j.jhep.2016.03.002
   Barabási AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918
   Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201
   Casas C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09185
   Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180
   Clària J, 2016, HEPATOLOGY, V64, P1249, DOI 10.1002/hep.28740
   Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191
   European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024
   Fischer J, 2017, CYTOKINE, V91, P162, DOI 10.1016/j.cyto.2016.12.017
   Govaere O, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba4448
   Guldiken N, 2015, LIVER INT, V35, P1203, DOI 10.1111/liv.12608
   Halu A, 2019, NPJ SYST BIOL APPL, V5, DOI 10.1038/s41540-019-0092-5
   Hernaez R, 2017, GUT, V66, P541, DOI 10.1136/gutjnl-2016-312670
   Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976
   López-Vicario C, 2020, J HEPATOL, V73, P817, DOI 10.1016/j.jhep.2020.03.046
   Macdonald S, 2018, HEPATOLOGY, V67, P989, DOI 10.1002/hep.29581
   Malehmir M, 2019, NAT MED, V25, P641, DOI 10.1038/s41591-019-0379-5
   Mehrad B, 2007, THROMB HAEMOSTASIS, V97, P755, DOI 10.1160/TH07-01-0040
   Mezzano G, 2022, GUT, V71, P148, DOI 10.1136/gutjnl-2020-322161
   Morales-Ibanez O, 2013, HEPATOLOGY, V58, P1742, DOI 10.1002/hep.26521
   Moreau R, 2020, J HEPATOL, V72, P688, DOI 10.1016/j.jhep.2019.11.009
   Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042
   Nibbe RK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000639
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Pose E, 2022, HEPATOL COMMUN, V6, P1100, DOI 10.1002/hep4.1881
   Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2
   Sharma S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07161-4
   Shek FH, 2017, CELL ONCOL, V40, P443, DOI 10.1007/s13402-017-0332-x
   Solé C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32341
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun YV, 2016, ADV GENET, V93, P147, DOI 10.1016/bs.adgen.2015.11.004
   Sundaram SS, 2008, NAT CLIN PRACT GASTR, V5, P456, DOI 10.1038/ncpgasthep1179
   Tian H, 2014, CELL PHYSIOL BIOCHEM, V34, P1536, DOI 10.1159/000366357
   Trebicka J, 2020, J HEPATOL, V73, P842, DOI 10.1016/j.jhep.2020.06.013
   Tripathi DM, 2018, GASTROENTEROLOGY, V155, P1564, DOI 10.1053/j.gastro.2018.07.022
   Wang JC, 2018, MOL MED REP, V17, P8153, DOI 10.3892/mmr.2018.8871
   Zaccherini G, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2020.100176
NR 38
TC 9
Z9 10
U1 0
U2 15
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2589-5559
J9 JHEP REP
JI JHEP Rep.
PD 2022 JUN
PY 2022
VL 4
IS 6
AR 100482
DI 10.1016/j.jhepr.2022.100482
EA MAY 2022
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 1X0DD
UT WOS:000807134200003
PM 35540106
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Salmón, P
   Millet, C
   Selman, C
   Monaghan, P
   Dawson, NJ
AF Salmon, Pablo
   Millet, Caroline
   Selman, Colin
   Monaghan, Pat
   Dawson, Neal J.
TI Tissue-specific reductions in mitochondrial efficiency and increased ROS
   release rates during ageing in zebra finches, <i>Taeniopygia guttata</i>
SO GEROSCIENCE
LA English
DT Article; Early Access
DE Proton leak; Senescence; Birds; Mitochondrial physiology; Reactive
   oxygen species; Ageing
ID HYDROGEN-PEROXIDE PRODUCTION; AGE-RELATED-CHANGES; OXIDATIVE DAMAGE;
   SKELETAL-MUSCLE; LIFE-SPAN; SUPEROXIDE-DISMUTASE; HEART-MITOCHONDRIA;
   STRESS; MECHANISMS; GENERATION
AB Mitochondrial dysfunction and oxidative damage have long been suggested as critically important mechanisms underlying the ageing process in animals. However, conflicting data exist on whether this involves increased production of mitochondrial reactive oxygen species (ROS) during ageing. We employed high-resolution respirometry and fluorometry on flight muscle (pectoralis major) and liver mitochondria to simultaneously examine mitochondrial function and ROS (H2O2) release rates in young (3 months) and old (4 years) zebra finches (Taeniopygia guttata). Respiratory capacities for oxidative phosphorylation did not differ between the two age groups in either tissue. Respiratory control ratios (RCR) of liver mitochondria also did not differ between the age classes. However, RCR in muscle mitochondria was 55% lower in old relative to young birds, suggesting that muscle mitochondria in older individuals are less efficient. Interestingly, this observed reduction in muscle RCR was driven almost entirely by higher mitochondrial LEAK-state respiration. Maximum mitochondrial ROS release rates were found to be greater in both flight muscle (1.3-fold) and the liver (1.9-fold) of old birds. However, while maximum ROS (H2O2) release rates from mitochondria increased with age across both liver and muscle tissues, the liver demonstrated a proportionally greater age-related increase in ROS release than muscle. This difference in age-related increases in ROS release rates between muscle and liver tissues may be due to increased mitochondrial leakiness in the muscle, but not the liver, of older birds. This suggests that age-related changes in cellular function seem to occur in a tissue-specific manner in zebra finches, with flight muscle exhibiting signs of minimising age-related increase in ROS release, potentially to reduce damage to this crucial tissue in older individuals.
C1 [Salmon, Pablo; Millet, Caroline; Selman, Colin; Monaghan, Pat; Dawson, Neal J.] Univ Glasgow, Sch Biodivers One Hlth & Vet Med, Graham Kerr Bldg, Glasgow G12 8QQ, Lanark, Scotland.
C3 University of Glasgow
RP Salmón, P; Dawson, NJ (corresponding author), Univ Glasgow, Sch Biodivers One Hlth & Vet Med, Graham Kerr Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM pablo.salmon@glasgow.ac.uk; neal.dawson@glasgow.ac.uk
RI Salmón, Pablo/M-5033-2018
OI Salmón, Pablo/0000-0001-9718-6611; Dawson, Neal/0000-0001-5389-8692
FU Leverhulme Trust [RPG-2017-061]; European Research Council (ERC) under
   the European Union [101020037]; BBSRC [BB/P009174/1, NE/R001510/1]; ERC
   [834653]; ISSF ECR Catalyst Grant [310331-01]; Basque Government
   Postdoctoral Fellowship [POS-2020-1-0007]; NSERC [PDF-488166]; European
   Research Council (ERC) [101020037, 834653] Funding Source: European
   Research Council (ERC)
FX The work was funded by a Leverhulme Trust Research Project awarded to PM
   and CS (RPG-2017-061); funding from the European Research Council (ERC)
   to PM under the European Union's Horizon 2020 research and innovation
   programme (grant agreement No. 101020037) and BBSRC BB/P009174/1 to PM;
   NE/R001510/1 to Neil B. Metcalfe, Richard C. Hartley, CS and PM; ERC
   Advanced Grant (No. 834653) to Neil B. Metcalfe; NSERC PDF-488166 to
   NJD; ISSF ECR Catalyst Grant (#310331-01) to NJD; a Basque Government
   Postdoctoral Fellowship (POS-2020-1-0007) to PS.
CR Alway SE, 2017, EXERC SPORT SCI REV, V45, P58, DOI 10.1249/JES.0000000000000101
   Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7
   Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   Arking, 2019, BIOL LONGEVITY AGING
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bauchinger U, 2009, PHYSIOL BIOCHEM ZOOL, V82, P787, DOI 10.1086/605548
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Brandt T, 2017, ELIFE, V6, DOI 10.7554/eLife.24662
   Briga M, 2019, EXP GERONTOL, V119, P111, DOI 10.1016/j.exger.2019.01.030
   Brown K, 2019, J MORPHOL, V280, P1061, DOI 10.1002/jmor.21001
   CARRILLO MC, 1992, MECH AGEING DEV, V65, P187, DOI 10.1016/0047-6374(92)90035-C
   Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x
   Cieslak KP, 2016, HPB, V18, P691, DOI 10.1016/j.hpb.2016.05.011
   Crane JD, 2010, J GERONTOL A-BIOL, V65, P119, DOI 10.1093/gerona/glp179
   Criscuolo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013104
   Dawson NJ, 2020, EXP GERONTOL, V133, DOI 10.1016/j.exger.2020.110883
   Dawson NJ, 2020, ELIFE, V9, DOI 10.7554/eLife.56259
   Dawson NJ, 2015, BBA-GEN SUBJECTS, V1850, P97, DOI 10.1016/j.bbagen.2014.10.003
   Dick MF, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.187708
   Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525
   Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750
   Guerville F, 2020, JPAD-J PREV ALZHEIM, V7, P56, DOI 10.14283/jpad.2019.50
   Halliwell B., 2015, Free Radicals in Biology and Medicine, V5th, DOI [DOI 10.1093/ACPROF:OSO/9780198717478.001.0001, 10.1093/ACPROF:OSO/9780198717478.001.0001]
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109
   Herrero A, 1997, MECH AGEING DEV, V98, P95, DOI 10.1016/S0047-6374(97)00076-6
   Hickey AJR, 2012, AGEING RES REV, V11, P242, DOI 10.1016/j.arr.2011.12.002
   Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Jimenez AG, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.211185
   Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017
   KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B
   Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003
   Lambert AJ, 2007, AGING CELL, V6, P607, DOI 10.1111/j.1474-9726.2007.00312.x
   Lanza IR, 2009, AM J CLIN NUTR, V89, p467S, DOI 10.3945/ajcn.2008.26717D
   Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185
   LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marasco V, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2442
   Marasco V, 2017, MECH AGEING DEV, V164, P100, DOI 10.1016/j.mad.2017.04.012
   Monaghan P, 2012, P ROY SOC B-BIOL SCI, V279, P709, DOI 10.1098/rspb.2011.1291
   Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x
   Montgomery MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024138
   Munro D, 2019, AGING CELL, V18, DOI 10.1111/acel.13009
   Munro D, 2013, AGING CELL, V12, P584, DOI 10.1111/acel.12082
   Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x
   Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222
   Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x
   Powers SK, 2020, J SPORT HEALTH SCI, V9, P415, DOI 10.1016/j.jshs.2020.04.001
   Ronning B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108675
   Sakellariou GK, 2016, SCI REP-UK, V6, DOI 10.1038/srep33944
   Salin K, 2016, J EXP BIOL, V219, P1356, DOI 10.1242/jeb.133025
   Sasaki T, 2008, AGING CELL, V7, P459, DOI 10.1111/j.1474-9726.2008.00394.x
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006
   Siu PM, 2005, AM J PHYSIOL-CELL PH, V289, pC1105, DOI 10.1152/ajpcell.00154.2005
   Speakman JR, 2015, ECOL EVOL, V5, pS745, DOI 10.1002/ece3.1790
   Speakman JR, 2011, BIOESSAYS, V33, P255, DOI 10.1002/bies.201000132
   St-Jean-Pelletier F, 2017, J CACHEXIA SARCOPENI, V8, P213, DOI 10.1002/jcsm.12139
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008
   Team RC, 2020, R: A Language and Environment for Statistical
   Trenell MI, 2017, J HEPATOL, V66, P8, DOI 10.1016/j.jhep.2016.10.018
   Tsay HJ, 2000, J BIOMED SCI, V7, P466
   Van Remmen H, 2009, J GERONTOL A-BIOL, V64, P171, DOI 10.1093/gerona/gln058
   Vasilaki A, 2006, AGING CELL, V5, P109, DOI 10.1111/j.1474-9726.2006.00198.x
   Vézina F, 2021, J AVIAN BIOL, V52, DOI 10.1111/jav.02668
   WEISIGER RA, 1973, J BIOL CHEM, V248, P3582
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788
   Zann RA, 1996, ZEBRA FINCH SYNTHESI
   Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132
   Zhang YF, 2021, J EXP BIOL, V224, DOI 10.1242/jeb.221606
NR 76
TC 3
Z9 3
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2023 FEB
PY 2023
VL 45
IS 1
SI SI
BP 265
EP 276
DI 10.1007/s11357-022-00624-1
EA AUG 2022
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 8R9OV
UT WOS:000843244300001
PM 35986126
OA hybrid, Green Published, Green Accepted
DA 2024-02-19
ER

PT J
AU Wong, HK
   Riondel, J
   Ducros, V
   Ballester, B
   Mathieu, J
   Favier, A
AF Wong, HK
   Riondel, J
   Ducros, V
   Ballester, B
   Mathieu, J
   Favier, A
TI Effects of selenium supplementation on malignant lymphoproliferative
   pathologies associated with OF1 mouse ageing
SO ANTICANCER RESEARCH
LA English
DT Article
DE sodium selenite; mice; ageing; lymphoid cell neoplasma; tree radicals;
   antioxidant enzymes; lipid peroxidation
ID GLUTATHIONE-PEROXIDASE; SENESCENCE; ENZYMES; CANCER; RATS
AB Low plasma selenium (Se) levels have been shown to correlate with increased cancer incidence in humans and in mice. This study was undertaken to investigate the ability of Se to decrease mortality rate and tumor production in ageing mice. Se (2.5 ppm) given as sodium selenite in drinking water to 8 months old OF1 mice, for 4 consecutive months, reduced significantly the mortality of mice with 6% and 50% mortality rate for Se and control groups, respectively. In addition 80% of control deaths resulted from a lymphoid cell neoplasma, while no one of Se supplemented mice produced tumor. Evaluation of parameters of free radical a metabolism showed highly significant reduction of the antioxidant defence system in the liver of cancer mice, with a 78% decrease in GSH-Px activity, a 65% decrease in superoxide dismutase (SOD) activity, a 75% decrease in the GSH/GSSG ratio and a 62% decrease of plasma Se level as compared to healthy old mice. Nevertheless in the conditions of our experiment, Se didn't really improve the endogenous antioxidant status of ageing mice.
C1 Univ Grenoble, Lab Biol Stress Oxydant, Fac Pharm, F-38706 La Tronche, France.
   Ctr Rech Serv Sante Armees, Unite Radiobiochem, F-38700 La Tronche, France.
C3 Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)
RP Riondel, J (corresponding author), Univ Grenoble, Lab Biol Stress Oxydant, Fac Pharm, Domaine Merci, F-38706 La Tronche, France.
EM Jacqueline.Riondel@ujf-grenoble.fr
CR Akerboom T P, 1981, Methods Enzymol, V77, P373
   CHANDRA RK, 1990, AGE AGEING, V19, pS25, DOI 10.1093/ageing/19.suppl_1.S25
   Chidambaram N, 1996, MOL CELL BIOCHEM, V156, P101, DOI 10.1007/BF00426331
   CUTLER RG, 1991, ANN NY ACAD SCI, V621, P1
   FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525
   GUNZLER WA, 1974, Z KLIN CHEM KLIN BIO, V12, P444
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   LIN Y, 1993, BIOCHEM PHARMACOL, V45, P429, DOI 10.1016/0006-2952(93)90080-G
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKLUND S, 1974, EUR J BIOCHEM, V27, P269
   Masoro EJ, 1990, HDB BIOL AGING
   MERA SL, 1992, MED LAB SCI, V49, P271
   NEVE J, 1989, ANN BIOL CLIN-PARIS, V47, P138
   PATTENGALE PK, 1983, AM J PATHOL, V113, P235
   Patterson BH, 1997, CANCER EPIDEM BIOMAR, V6, P63
   Powers Douglas C., 1995, Aging Immunology and Infectious Disease, V6, P43
   RICHARD MJ, 1992, J CHROMATOGR-BIOMED, V577, P9, DOI 10.1016/0378-4347(92)80593-F
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   SOHAL RS, 1992, ANN NY ACAD SCI, V663, P74, DOI 10.1111/j.1749-6632.1992.tb38651.x
   SPALLHOLZ JE, 1994, FREE RADICAL BIO MED, V17, P45, DOI 10.1016/0891-5849(94)90007-8
   Stewart MS, 1999, FREE RADICAL BIO MED, V26, P42, DOI 10.1016/S0891-5849(98)00147-6
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   TURTURRO A, 1992, EXP GERONTOL, V27, P583, DOI 10.1016/0531-5565(92)90013-P
   UMEZAWA M, 1990, J NUTR, V120, P1393, DOI 10.1093/jn/120.11.1393
   YAN L, 1991, BIOL TRACE ELEM RES, V30, P145, DOI 10.1007/BF02990350
NR 25
TC 9
Z9 9
U1 0
U2 0
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0250-7005
EI 1791-7530
J9 ANTICANCER RES
JI Anticancer Res.
PD JAN-FEB
PY 2001
VL 21
IS 1A
BP 393
EP 402
PG 10
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 418DP
UT WOS:000167875900057
PM 11299768
DA 2024-02-19
ER

PT J
AU Takubo, K
   Nakamura, KI
   Izumiyama, N
   Furugori, E
   Sawabe, M
   Arai, T
   Esaki, Y
   Mafune, KI
   Kammori, M
   Fujiwara, M
   Kato, M
   Oshimura, M
   Sasajima, K
AF Takubo, K
   Nakamura, KI
   Izumiyama, N
   Furugori, E
   Sawabe, M
   Arai, T
   Esaki, Y
   Mafune, KI
   Kammori, M
   Fujiwara, M
   Kato, M
   Oshimura, M
   Sasajima, K
TI Telomere shortening with aging in human liver
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID HUMAN FIBROBLASTS; LENGTH; CARCINOMA; LEUKOCYTES; SEQUENCE; TISSUES;
   CANCER; CELLS; AGE; DNA
AB Progressive telomere shortening with aging was studied in the normal liver tissue of 94 human subjects aged between 0 and 101 years old to determine the rate of telomere loss in 1 year. Telomere length demonstrated age-related shortening with reduction of 55 base pairs (bp) per year. The mean telomere length in five neonates was 12.9 +/- 2.6 kilobase pairs (kbp), and that in one centenarian was 8.3 kbp, Mean telomere lengths by age group were 13.2 +/- 2.0 kbp (less than or equal to8 years; 10 subjects), 7.8 +/- 1.9 kbp (40-79 years; 29 subjects), and 7.5 +/- 2.0 kbp (greater than or equal to 80 years; 53 subjects), with reduction thus appearing to show slowing on the attainment of middle age. The difference of mean telomere lengths for two groups with or without advanced malignancies of other than liver origin was not significant in the older two groups. Despite the slow turnover of liver tissue, the overall reduction rate of telomere length decrease in 1 gear was almost the same as that of digestive tract mucosa, with its very rapid renewal.
C1 Tokyo Metropolitan Inst Gerontol, Dept Clin Pathol, Itabashi Ku, Tokyo 1730015, Japan.
   Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan.
   Nippon Med Sch, Dept Surg 1, Tokyo, Japan.
   Univ Tokyo, Fac Med, Dept Surg 2, Tokyo 113, Japan.
   Univ Tokyo, Fac Med, Dept Surg 3, Tokyo 113, Japan.
   Japanese Red Cross Med Ctr, Dept Pathol, Tokyo, Japan.
   Sch Life Sci, Dept Mol & Cell Genet, Tottori, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan
   Institute of Gerontology; Nippon Medical School; University of Tokyo;
   University of Tokyo; University of Tokyo; Japanese Red Cross Medical
   Center
RP Takubo, K (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Clin Pathol, Itabashi Ku, Sakaecho, Tokyo 1730015, Japan.
CR ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0
   BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441
   CAMERON I L, 1970, Texas Reports on Biology and Medicine, V28, P203
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315
   EASTWOOD GL, 1977, GASTROENTEROLOGY, V72, P962
   Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607
   Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hiyama E, 1996, INT J ONCOL, V9, P453
   HIYAMA E, 1995, CANCER RES, V55, P3258
   Hsiao RS, 1997, ANTICANCER RES, V17, P827
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303
   LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3
   LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7
   MARQUESPEREIRA JP, 1965, AM J ANAT, V117, P73, DOI 10.1002/aja.1001170106
   Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9
   Morales CP, 1998, CANCER, V83, P652, DOI 10.1002/(SICI)1097-0142(19980815)83:4<652::AID-CNCR4>3.0.CO;2-M
   MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622
   NAKAMURA K, 1999, TUMOR MARKERS, V14, P33
   OGAWA K, 1973, TOHOKU J EXP MED, V111, P253, DOI 10.1620/tjem.111.253
   Ohashi K, 1996, JPN J CANCER RES, V87, P419, DOI 10.1111/j.1349-7006.1996.tb00239.x
   Rohr H P, 1976, Prog Liver Dis, V5, P24
   SENOO H, 1993, CONNECT TISSUE, V25, P129
   Takubo K, 1997, J SURG ONCOL, V66, P88, DOI 10.1002/(SICI)1096-9098(199710)66:2<88::AID-JSO3>3.0.CO;2-H
   Takubo K, 1999, AGE, V22, P95, DOI 10.1007/s11357-999-0011-6
   Urabe Y, 1996, LIVER, V16, P293
   VAZIRI H, 1993, AM J HUM GENET, V52, P661
   Yasumoto S, 1996, ONCOGENE, V13, P433
NR 34
TC 85
Z9 93
U1 0
U2 6
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD NOV
PY 2000
VL 55
IS 11
BP B533
EP B536
DI 10.1093/gerona/55.11.B533
PG 4
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 373WH
UT WOS:000165312700004
PM 11078086
OA Bronze
DA 2024-02-19
ER

PT J
AU Jung, KJ
   Ishigami, A
   Maruyama, N
   Takahashi, R
   Goto, S
   Yu, BP
   Chung, HY
AF Jung, KJ
   Ishigami, A
   Maruyama, N
   Takahashi, R
   Goto, S
   Yu, BP
   Chung, HY
TI Modulation of gene expression of SMP-30 by LPS and calorie restriction
   during aging process
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE senescence marker protein-30; oxidative stress; aging; calorie
   restriction; lipopolysacchrides; Ca2+ hemeostasis
ID SENESCENCE MARKER PROTEIN-30; LIVER PLASMA-MEMBRANES; OXIDATIVE STRESS;
   CALCIUM HOMEOSTASIS; CELL-DEATH; SMP30; AGE; REGUCALCIN; ACTIVATION;
   ALPHA
AB Senescence marker protem-30 (SMP-30) has been proposed as an important aging marker and is now functionally identified as a Ca2+ binding protein. SMP-30 has been shown to blunt cell death caused by intracellular Ca2+ accumulation by enhancing plasma membrane Ca2+-pumping activity. Although SMP-30 is reported decrease during aging, at present, neither has the mechanism underlying this decrease been fully defined, nor have the mechanisms related to the modulation of SMP-30 been extensively explored. In the current study, we used the well-known anti-aging action of the calorie restriction (CR) paradigm to explore age-related changes in SMP-30 gene expression. The thrust of our investigation was based on CR's ability to defend against age-related oxidative stress and the inflammatory process. The kidney and liver from Fischer 344 rats at 6, 12, 18 and 24 months of age were utilized for this study. The rats were divided into two groups, ad libitum (AL)-fed and 40% restricted CR. Results showed that SMP-30 expression declined with age and that this decline was clearly blunted by CR. To correlate changes between SMP-30 gene expression and the oxidative status, SMP-30 expression and the production of reactive oxygen species (ROS) during aging and free-radical generating lipopolysaccharide (LPS) were monitored. Our data showed that the down-regulation of SMP-30 was accompanied by increased ROS generation and LPS-induced ROS. The potent anti-aging and anti-oxidative action of CR effectively suppressed the age-related down-regulation of SMP-30 by ROS reduction. (C) 2004 Elsevier Inc. All rights reserved.
C1 Pusan Natl Univ, Dept Pharm, Aging Tissue Bank, Pusan 609735, South Korea.
   Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Tokyo 1730015, Japan.
   Toho Univ, Sch Pharmaceut Sci, Dept Biochem, Chiba 2748510, Japan.
   Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA.
C3 Pusan National University; Tokyo Metropolitan Institute of Gerontology;
   Toho University; University of Texas System; University of Texas Health
   Science Center at San Antonio
RP Chung, HY (corresponding author), Pusan Natl Univ, Dept Pharm, Aging Tissue Bank, Pusan 609735, South Korea.
EM hyjung@pusan.ac.kr
OI Ishigami, Akihito/0000-0001-7875-7482
CR Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094
   Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239
   Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999
   Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x
   Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0
   FELICETTA JV, 1989, POSTGRAD MED, V85, P85
   Fu WM, 1998, NEUROBIOL DIS, V5, P229, DOI 10.1006/nbdi.1998.0192
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   FUJITA T, 1990, ADV SEC MESS PHOSPH, V24, P542
   Fujita T, 1998, Nihon Ronen Igakkai Zasshi, V35, P654
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Fujita T, 1998, J GASTROEN HEPATOL, V13, pS124
   Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x
   Kim HJ, 2002, J AM AGING ASSOC, V25, P123, DOI 10.1007/s11357-002-0011-2
   Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7
   Kim HJ, 2000, FREE RADICAL BIO MED, V28, P683, DOI 10.1016/S0891-5849(99)00274-9
   Lander HM, 1997, FASEB J, V11, P118, DOI 10.1096/fasebj.11.2.9039953
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   PERSOONROTHERT M, 1994, MOL CELL BIOCHEM, V136, P1, DOI 10.1007/BF00931598
   Prolla TA, 2001, TRENDS NEUROSCI, V24, pS21, DOI 10.1016/S0166-2236(00)01957-3
   PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Squier TC, 2000, FRONT BIOSCI-LANDMRK, V5, pD504, DOI 10.2741/Squier
   Supakar PC, 2000, BIOCHEM BIOPH RES CO, V272, P436, DOI 10.1006/bbrc.2000.2799
   TAKAHASHI H, 1994, MOL CELL BIOCHEM, V136, P71, DOI 10.1007/BF00931607
   TAKAHASHI H, 1993, MOL CELL BIOCHEM, V124, P169, DOI 10.1007/BF00929209
   THOMAS P, 1992, FREE RADIC BIOL MED, V13, P289
   Toborek M, 1997, J LIPID RES, V38, P2155
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   Yamaguchi M, 2000, LIFE SCI, V66, P1769, DOI 10.1016/S0024-3205(99)00602-5
   Yu BP, 1996, FREE RADICAL BIO MED, V21, P651, DOI 10.1016/0891-5849(96)00162-1
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 40
TC 47
Z9 51
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 2004
VL 39
IS 8
BP 1169
EP 1177
DI 10.1016/j.exger.2004.04.005
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 848VZ
UT WOS:000223497500006
PM 15288691
DA 2024-02-19
ER

PT J
AU Finlay, LA
   Michels, AJ
   Butler, JA
   Smith, EJ
   Monette, JS
   Moreau, RF
   Shay, KP
   Frei, B
   Hagen, TM
AF Finlay, Liam A.
   Michels, Alex J.
   Butler, Judy A.
   Smith, Eric J.
   Monette, Jeffrey S.
   Moreau, Regis F.
   Shay, Kate Petersen
   Frei, Balz
   Hagen, Tory M.
TI R-α-lipoic acid does not reverse hepatic inflammation of aging, but
   lowers lipid anabolism, while accentuating circadian rhythm transcript
   profiles
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE microarray; lipid metabolism; circadian rhythm
ID GENE-EXPRESSION PROFILE; NF-KAPPA-B; AGE-RELATED LOSS; CALORIC
   RESTRICTION; (R)-ALPHA-LIPOIC ACID; DIABETIC POLYNEUROPATHY;
   ENDOTHELIAL-CELLS; OXIDATIVE STRESS; NRF2 ACTIVATION; THIOCTIC ACID
AB Finlay LA, Michels AJ, Butler JA, Smith EJ, Monette JS, Moreau RF, Petersen Shay K, Frei B, Hagen TM. R-alpha-lipoic acid does not reverse hepatic inflammation of aging, but lowers lipid anabolism, while accentuating circadian rhythm transcript profiles. Am J Physiol Regul Integr Comp Physiol 302: R587-R597, 2012. First published November 2, 2011; doi:10.1152/ajpregu.00393.2011.-To determine the effects of age and lipoic acid supplementation on hepatic gene expression, we fed young (3 mo) and old (24 mo) male Fischer 344 rats a diet with or without 0.2% (wt/wt) R-alpha-lipoic acid (LA) for 2 wk. Total RNA isolated from liver tissue was analyzed by Affymetrix microarray to examine changes in transcriptional profiles. Results showed elevated proinflammatory gene expression in the aging liver and evidence for increased immune cell activation and tissue remodeling, together representing 45% of the age-related transcriptome changes. In addition, age-related increases in transcripts of genes related to fatty acid, triglyceride, and cholesterol synthesis, including acetyl-CoA carboxylase-beta (Acacb) and fatty acid synthase (Fasn), were observed. Supplementation of old animals with LA did not reverse the necroinflammatory phenotype but, intriguingly, altered the expression of genes governing circadian rhythm. Most notably, Arntl, Npas2, and Per changed in a coordinated manner with respect to rhythmic transcription. LA further caused a decrease in transcripts of several bile acid and lipid synthesis genes, including Acacb and Fasn, which are regulated by first-order clock transcription factors. Similar effects of LA supplementation on bile acid and lipid synthesis genes were observed in young animals. Transcript changes of lipid metabolism genes were corroborated by a decrease in FASN and ACC protein levels. We conclude that advanced age is associated with a necroinflammatory phenotype and increased lipid synthesis, while chronic LA supplementation influences hepatic genes associated with lipid and energy metabolism and circadian rhythm, regardless of age.
C1 [Hagen, Tory M.] Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA.
   [Smith, Eric J.; Monette, Jeffrey S.; Moreau, Regis F.; Frei, Balz; Hagen, Tory M.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.
C3 Oregon State University; Oregon State University
RP Hagen, TM (corresponding author), Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA.
EM tory.hagen@oregonstate.edu
RI Michels, Alexander J/ABG-5602-2020
OI Michels, Alexander J/0000-0003-4528-7976; Moreau,
   Regis/0000-0003-0532-9887
FU National Institute on Aging [RO1-AG-17141A]; National Center for
   Complementary and Alternative Medicine [PO1-AT-002034]; National
   Institute of Environmental Health Sciences; Environmental Health Science
   Center at Oregon State University [P30-ES-00210]
FX This study was supported by National Institute on Aging Grant
   RO1-AG-17141A and National Center for Complementary and Alternative
   Medicine Grant PO1-AT-002034, and by the National Institute of
   Environmental Health Sciences-funded Grant P30-ES-00210 from the
   Environmental Health Science Center at Oregon State University.
CR Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Butler JA, 2009, ARCH BIOCHEM BIOPHYS, V485, P63, DOI 10.1016/j.abb.2009.01.024
   Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052
   Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005
   Elangovan S, 2008, INT J ONCOL, V33, P833, DOI 10.3892/ijo_00000071
   Esteve E, 2005, CLIN NUTR, V24, P16, DOI 10.1016/j.clnu.2004.08.004
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400
   Hagen TM, 2000, ANTIOXID REDOX SIGN, V2, P473, DOI 10.1089/15230860050192251
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442
   Huong DTT, 2008, BRIT J NUTR, V100, P79, DOI 10.1017/S0007114507876227
   Ishihara A, 2007, J BIOL RHYTHM, V22, P324, DOI 10.1177/0748730407302107
   Jones W, 2002, FREE RADICAL BIO MED, V33, P83, DOI 10.1016/S0891-5849(02)00862-6
   Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503
   Kim HS, 2007, EXP MOL MED, V39, P106, DOI 10.1038/emm.2007.12
   Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207
   Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005
   Kovac J, 2009, MOL CELLS, V28, P75, DOI 10.1007/s10059-009-0113-0
   Kunt T, 1999, CLIN SCI, V96, P75, DOI 10.1042/CS19980224
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lee CK, 2004, FREE RADICAL BIO MED, V36, P1043, DOI 10.1016/j.freeradbiomed.2004.01.015
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   Li LX, 2010, ANN NY ACAD SCI, V1203, P151, DOI 10.1111/j.1749-6632.2010.05555.x
   Lii CK, 2010, J NUTR, V140, P885, DOI 10.3945/jn.110.121418
   Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767
   MacKenzie GG, 2006, FREE RADICAL RES, V40, P75, DOI 10.1080/10715760500312305
   McMackin Craig J, 2007, J Clin Hypertens (Greenwich), V9, P249
   Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104
   Min AK, 2010, BIOCHEM BIOPH RES CO, V393, P536, DOI 10.1016/j.bbrc.2010.02.050
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461
   PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R
   Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5
   Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x
   Park SK, 2005, AGEING RES REV, V4, P55, DOI 10.1016/j.arr.2004.09.003
   Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905
   Ramakrishnan Sathiya N, 2006, Nucl Recept Signal, V4, pe009
   Reljanovic M, 1999, FREE RADICAL RES, V31, P171, DOI 10.1080/10715769900300721
   Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026
   Sola S, 2005, CIRCULATION, V111, P343, DOI 10.1161/01.CIR.0000153272.48711.B9
   Straub RH, 2010, J INTERN MED, V267, P543, DOI 10.1111/j.1365-2796.2010.02218.x
   Suh JH, 2004, ARCH BIOCHEM BIOPHYS, V423, P126, DOI 10.1016/j.abb.2003.12.020
   Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101
   Suh JH, 2001, FASEB J, V15, P700, DOI 10.1096/fj.00-0176com
   SUZUKI YJ, 1991, FREE RADICAL RES COM, V15, P255, DOI 10.3109/10715769109105221
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Takahashi S, 2010, J ATHEROSCLER THROMB, V17, P73, DOI 10.5551/jat.2410
   Targher G, 2008, DIABETOLOGIA, V51, P1947, DOI 10.1007/s00125-008-1135-4
   Wu T, 2010, CHRONOBIOL INT, V27, P1, DOI 10.3109/07420520903398625
   Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683
   Xie ZQ, 2010, METABOLISM, V59, P554, DOI 10.1016/j.metabol.2009.08.022
   Zhang WJ, 2008, CIRCULATION, V117, P421, DOI 10.1161/CIRCULATIONAHA.107.725275
   Zhang WJ, 2007, P NATL ACAD SCI USA, V104, P4077, DOI 10.1073/pnas.0700305104
   Zhang WJ, 2001, FASEB J, V15, P2423, DOI 10.1096/fj.01-0260com
   Ziegler D, 2004, DIABETIC MED, V21, P114, DOI 10.1111/j.1464-5491.2004.01109.x
NR 62
TC 21
Z9 22
U1 0
U2 9
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD MAR
PY 2012
VL 302
IS 5
BP R587
EP R597
DI 10.1152/ajpregu.00393.2011
PG 11
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 905NM
UT WOS:000301279100013
PM 22049228
OA Green Published
DA 2024-02-19
ER

PT J
AU Mossanen, JC
   Kohlhepp, M
   Wehr, A
   Krenkel, O
   Liepelt, A
   Roeth, AA
   Möckel, D
   Heymann, F
   Lammers, T
   Gassler, N
   Hermann, J
   Jankowski, J
   Neumann, UP
   Luedde, T
   Trautwein, C
   Tacke, F
AF Mossanen, Jana C.
   Kohlhepp, Marlene
   Wehr, Alexander
   Krenkel, Oliver
   Liepelt, Anke
   Roeth, Anjali A.
   Moeckel, Diana
   Heymann, Felix
   Lammers, Twan
   Gassler, Nikolaus
   Hermann, Juliane
   Jankowski, Joachim
   Neumann, Ulf P.
   Luedde, Tom
   Trautwein, Christian
   Tacke, Frank
TI CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and
   CD4<SUP>+</SUP> T-Cell-Dependent Control of Senescence
SO GASTROENTEROLOGY
LA English
DT Article
DE Liver Cancer; Chemokine; Senescence; NKT Cells
ID HEPATOCELLULAR-CARCINOMA; TUMOR MICROENVIRONMENT; LIVER; SURVEILLANCE;
   CANCER; IMMUNOTHERAPY; INFLAMMATION; HEPATOCYTES; HOMEOSTASIS;
   PROGRESSION
AB BACKGROUND & AIMS: Inflammation in the liver provokes fibrosis, but inflammation is also important for tumor surveillance. Inhibitors of chemokine pathways, such as CXCL16 and CXCR6 regulation of lymphocyte trafficking, are being tested as antifibrotic agents, but their effects on the development of hepatocellular carcinoma (HCC) are unclear. We assessed the roles of CXCR6-dependent immune mechanisms in hepatocarcinogenesis. METHODS: C57BL/6J wild-type (WT) mice and CXCR6-deficient mice (Cxcr6(eGfp/eGfp)) were given injections of diethylnitrosamine (DEN) to induce liver cancer and alpha-galactosylceramide to activate natural killer T (NKT) cells. We also performed studies in mice with conditional, hepatocyte-specific deletion of NEMO, which develop inflammation-associated liver tumors (Nemo(LPC-KO) and Nemo(LPC-KO)Cxcr6(eGfp/eGfp) mice). We collected liver tissues from patients with cirrhosis (n = 43), HCC (n = 35), and neither of these diseases (control individuals, n = 25). Human and mouse liver tissues were analyzed by histology, immunohistochemistry, flow cytometry, RNA expression arrays (from sorted hepatic lymphocytes), and matrix-assisted laser desorption/ionization imaging. Bone marrow was transferred from Cxcr6(eGfp/eGfp) or WT mice to irradiated C57BL/6J mice, and spleen and liver cells were analyzed by flow cytometry. CD4(+) T cells or NKT cells were isolated from the spleen and liver of CD45.1(+) WT mice and transferred into CXCR6-deficient mice after DEN injection. RESULTS: After DEN injection, CXCR6-deficient mice had a significantly higher tumor burden than WT mice and increased tumor progression, characterized by reduced intrahepatic numbers of invariant NKT and CD4(+) T cells that express tumor necrosis factor and interferon gamma. Livers of Nemo(LPC-KO) Cxcr6(eGfp/eGfp) mice had significantly more senescent hepato-cytes than livers of NemoLPC-KO mice. In studies of bone-marrow chimeras, adoptive cell transfer experiments, and analyses of Nemo(LPC-KO) mice, we found that NKT and CD4 T cells promote the removal of senescent hepatocytes to prevent hepatocarcinogenesis, and that this process required CXCR6. Injection of WT with alpha-galactosylceramide increased removal of senescent hepatocytes by NKT cells. We observed peritumoral accumulation of CXCR6-associated lymphocytes in human HCC, which appeared reduced compared with cirrhosis tissues. CONCLUSIONS: In studies of mice with liver tumors, we found that CXCR6 mediated NKT-cell and CD4(+) T-cell removal of senescent hepatocytes. Antifibrotic strategies to reduce CXCR6 activity in liver, or to reduce inflammation or modulate the immune response, should be tested for their effects on hepatocarcinogenesis.
C1 [Mossanen, Jana C.; Kohlhepp, Marlene; Wehr, Alexander; Krenkel, Oliver; Liepelt, Anke; Heymann, Felix; Luedde, Tom; Trautwein, Christian; Tacke, Frank] RWTH Univ Hosp Aachen, Dept Med 3, Aachen, Germany.
   [Mossanen, Jana C.] RWTH Univ Hosp Aachen, Dept Intens Care, Aachen, Germany.
   [Wehr, Alexander; Heymann, Felix; Tacke, Frank] Charite Univ Med Ctr, Dept Hepatol Gastroenterol, Berlin, Germany.
   [Roeth, Anjali A.; Neumann, Ulf P.] RWTH Univ Hosp Aachen, Dept Gen Visceral & Transplantat Surg, Aachen, Germany.
   [Moeckel, Diana; Lammers, Twan] RWTH Univ Hosp Aachen, Inst Expt Mol Imaging, Dept Nanomed & Theranost, Aachen, Germany.
   [Gassler, Nikolaus] Clin Ctr Braunschweig, Inst Pathol, Braunschweig, Germany.
   [Hermann, Juliane; Jankowski, Joachim] Univ Hosp Aachen, Inst Mol Cardiovasc Res, Aachen, Germany.
C3 RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen
   University; RWTH Aachen University Hospital; Free University of Berlin;
   Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH
   Aachen University; RWTH Aachen University Hospital; RWTH Aachen
   University; RWTH Aachen University Hospital; RWTH Aachen University;
   RWTH Aachen University Hospital
RP Tacke, F (corresponding author), Charite Univ Med Ctr Berlin, Dept Gastroenterol Hepatol, Augustenburger Pl 1, D-13353 Berlin, Germany.
EM frank.tacke@gmx.net
RI Tacke, Frank/ABF-2212-2020; Wehr, Alexander/L-5524-2013; Lammers,
   Twan/U-2794-2018; Luedde, Tom/AAE-9135-2022
OI Wehr, Alexander/0000-0001-7117-441X; Lammers, Twan/0000-0002-1090-6805;
   Luedde, Tom/0000-0002-6288-8821; Heymann, Felix/0000-0003-3344-8621;
   Mossanen, Jana/0000-0003-3480-4448
FU German Research Foundation [Ta434/3-1, SFB/TRR57, SFB/TRR219];
   Interdisciplinary Center for Clinical Research Aachen
FX This work was supported by the German Research Foundation (Ta434/3-1,
   SFB/TRR57, SFB/TRR219) and the Interdisciplinary Center for Clinical
   Research Aachen. The CD1d MR1 tetramer was kindly provided by the
   National Institutes of Health Tetramer Core Facility.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937
   Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021
   Braumüller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824
   Chew V, 2010, J HEPATOL, V52, P370, DOI 10.1016/j.jhep.2009.07.013
   Cubero FJ, 2013, CELL DEATH DIFFER, V20, P1580, DOI 10.1038/cdd.2013.112
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2
   El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683
   Gao Q, 2012, CANCER RES, V72, P3546, DOI 10.1158/0008-5472.CAN-11-4032
   Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113
   Germanov E, 2008, J IMMUNOL, V181, P81, DOI 10.4049/jimmunol.181.1.81
   Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002
   Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055
   Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200
   Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783
   Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Koch A, 2014, LIVER INT, V34, P1330, DOI 10.1111/liv.12512
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610
   Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001
   Lee JH, 2015, GASTROENTEROLOGY, V148, P1383, DOI 10.1053/j.gastro.2015.02.055
   Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481
   Liepelt A, 2019, BBA-MOL BASIS DIS, V1865, P391, DOI 10.1016/j.bbadis.2018.11.020
   Liew PX, 2017, IMMUNITY, V47, P752, DOI 10.1016/j.immuni.2017.09.016
   Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]
   Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016
   Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205
   Margalit M, 2005, INT J CANCER, V115, P443, DOI 10.1002/ijc.20889
   Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043
   Mossanen JC, 2016, HEPATOLOGY, V64, P1667, DOI 10.1002/hep.28682
   Mossanen JC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26468
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Prieto J, 2015, NAT REV GASTRO HEPAT, V12, P681, DOI 10.1038/nrgastro.2015.173
   Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918
   Rotman Y, 2017, GUT, V66, P180, DOI 10.1136/gutjnl-2016-312431
   Schneider AT, 2017, CANCER CELL, V31, P94, DOI 10.1016/j.ccell.2016.11.009
   Schneider C, 2012, GUT, V61, P1733, DOI 10.1136/gutjnl-2011-301116
   Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284
   Wehr A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112327
   Wehr A, 2013, J IMMUNOL, V190, P5226, DOI 10.4049/jimmunol.1202909
   Xiao YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070345
NR 43
TC 74
Z9 84
U1 0
U2 41
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD MAY
PY 2019
VL 156
IS 6
BP 1877
EP +
DI 10.1053/j.gastro.2019.01.247
PG 17
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA HT6FI
UT WOS:000464659200045
PM 30710528
DA 2024-02-19
ER

PT J
AU Yasuda, S
   Nomi, T
   Hokuto, D
   Yoshikawa, T
   Matsuo, Y
   Sho, M
AF Yasuda, Satoshi
   Nomi, Takeo
   Hokuto, Daisuke
   Yoshikawa, Takahiro
   Matsuo, Yasuko
   Sho, Masayuki
TI Liver Regeneration After Major Liver Resection for Hepatocellular
   Carcinoma in the Elderly
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Article
DE liver regeneration; liver resection; elderly patients; hepatocellular
   carcinoma; major hepatectomy
ID HEPATIC RESECTION; HEPATECTOMY; LOBECTOMY; FAILURE; DONORS; SAFETY
AB Background: With an aging population, more elderly patients are being considered for hepatic resection for hepatocellular carcinoma (HCC). This study aimed to evaluate postoperative outcomes including liver regeneration after major hepatectomy for HCC in the elderly. Methods: We assessed 41 patients who underwent major hepatectomy (>= 3 segments) at our institute between 2000 and 2013. Patients were divided into two age groups, elderly group (age >= 70 years, n = 23) and younger group (age <70 years, n = 18). Clinicopathological data and outcomes were retrospectively compared. To evaluate the effect of aging on liver regeneration, we measured liver volumes preoperatively and at 1 and 6 months after liver resection using a 3D simulation imaging system. Results: Overall and major complications after hepatectomy were not different between elderly and younger groups, and no case of mortality was recorded. Moreover, recurrence-free and overall survivals were similar in both groups. With regard to liver regeneration, no differences were observed between elderly and younger groups at 1 and 6 months after liver resection. Baseline liver functions were comparable between the groups. Furthermore, the only factor associated with liver regeneration was resected liver volume (R-2 = 0.631, p < 0.001). Age was not correlated with liver regeneration rate (R-2 = 0.00537, p = 0.695). Conclusions: Liver regeneration after major hepatectomy for HCC was not affected by age and that resected liver volume is an important factor for liver regeneration. Short- and long-term outcomes after major hepatectomy were similar in elderly and younger patients.
C1 [Yasuda, Satoshi; Nomi, Takeo; Hokuto, Daisuke; Yoshikawa, Takahiro; Matsuo, Yasuko; Sho, Masayuki] Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.
C3 Nara Medical University
RP Nomi, T (corresponding author), Nara Med Univ, Dept Surg, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.
EM t.nomi45@gmail.com
RI Yasuda, Satoshi/AAD-2497-2022
OI Yasuda, Satoshi/0000-0003-4323-7422
CR Balzan S, 2005, ANN SURG, V242, P824, DOI 10.1097/01.sla.0000189131.90876.9e
   Cannon RM, 2011, J SURG ONCOL, V104, P804, DOI 10.1002/jso.22042
   Cho SW, 2011, ANN SURG ONCOL, V18, P1088, DOI 10.1245/s10434-010-1404-6
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Fukushima K, 2014, J GASTROINTEST SURG, V18, P729, DOI 10.1007/s11605-013-2423-y
   Haga J, 2008, LIVER TRANSPLANT, V14, P1718, DOI 10.1002/lt.21622
   Hanazaki K, 2001, J AM COLL SURGEONS, V192, P38, DOI 10.1016/S1072-7515(00)00778-X
   Ishizawa T, 2009, ARCH SURG-CHICAGO, V144, P46, DOI 10.1001/archsurg.2008.511
   Jaeck Daniel, 2004, Liver Transpl, V10, pS58, DOI 10.1002/lt.20041
   Kamat A, 2008, J GERONTOL A-BIOL, V63, P683, DOI 10.1093/gerona/63.7.683
   Katsuta E, 2014, AM J SURG, V208, P450, DOI 10.1016/j.amjsurg.2014.01.015
   Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002
   LIN TY, 1979, ANN SURG, V190, P48, DOI 10.1097/00000658-197907000-00011
   NAGASUE N, 1987, ANN SURG, V206, P30, DOI 10.1097/00000658-198707000-00005
   Nakajima Y, 2001, HEPATO-GASTROENTEROL, V48, P1680
   Nakajima Y, 2001, J AM COLL SURGEONS, V192, P339, DOI 10.1016/S1072-7515(00)00789-4
   Palmer HJ, 1999, J BIOL CHEM, V274, P11424, DOI 10.1074/jbc.274.16.11424
   Pomfret EA, 2003, TRANSPLANTATION, V76, P5, DOI 10.1097/01.TP.0000079064.08263.8E
   Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001
   Schiergens TS, 2014, J GASTROINTEST SURG, V18, P1161, DOI 10.1007/s11605-014-2516-2
   SHIMADA M, 1994, SURG TODAY, V24, P44, DOI 10.1007/BF01676884
   Shirabe K, 2013, SCAND J SURG, V102, P101, DOI 10.1177/1457496913482250
   Wang XH, 2002, J BIOL CHEM, V277, P44310, DOI 10.1074/jbc.M207510200
   Yamamoto K, 1997, HEPATO-GASTROENTEROL, V44, P514
   Yamamoto T, 2005, J HEPATOL, V42, P707, DOI 10.1016/j.jhep.2004.12.033
   YAMANAKA N, 1993, HEPATOLOGY, V18, P79, DOI 10.1016/0270-9139(93)90510-T
   Zhou YM, 2013, WORLD J SURG, V37, P2899, DOI 10.1007/s00268-013-2184-5
   Zhu CZ, 2014, J GASTROEN HEPATOL, V29, P1102, DOI 10.1111/jgh.12468
NR 29
TC 9
Z9 9
U1 0
U2 12
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0894-1939
EI 1521-0553
J9 J INVEST SURG
JI J. Invest. Surg.
PD APR 20
PY 2020
VL 33
IS 4
BP 332
EP 338
DI 10.1080/08941939.2018.1517839
PG 7
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA KL2BE
UT WOS:000513233500006
PM 30388925
DA 2024-02-19
ER

PT J
AU Kong, J
   Sun, SM
   Min, F
   Hu, XL
   Zhang, Y
   Cheng, Y
   Li, HY
   Wang, XJ
   Liu, X
AF Kong, Jie
   Sun, Siming
   Min, Fei
   Hu, Xingli
   Zhang, Yuan
   Cheng, Yan
   Li, Haiyan
   Wang, Xiaojie
   Liu, Xin
TI Integrating Network Pharmacology and Transcriptomic Strategies to
   Explore the Pharmacological Mechanism of Hydroxysafflor Yellow A in
   Delaying Liver Aging
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE hydroxysafflor yellow A; liver aging; network pharmacology;
   transcriptomics
ID OXIDATIVE STRESS; CELLULAR SENESCENCE; SIGNALING PATHWAY; INJURY;
   INFLAMMATION; MICE; IDENTIFICATION; METHODOLOGY; PROTECTS; MOUSE
AB Aging affects the structure and function of the liver. Hydroxysafflor yellow A (HSYA) effectively improves liver aging (LA) in mice, but the potential mechanisms require further exploration. In this study, an integrated approach combining network pharmacology and transcriptomics was used to elucidate the potential mechanisms of HSYA delay of LA. The targets of HSYA were predicted using the PharmMapper, SwissTargetPrediction, and CTD databases, and the targets of LA were collected from the GeneCards database. An ontology (GO) analysis and a Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway annotation of genes related to HSYA delay of LA were performed using the DAVID database, and Cytoscape software was used to construct an HSYA target pathway network. The BMKCloud platform was used to sequence mRNA from mouse liver tissue, screen differentially expressed genes (DEGs) that were altered by HSYA, and enrich their biological functions and signaling pathways through the OmicShare database. The results of the network pharmacology and transcriptomic analyses were combined. Then, quantitative real-time PCR (qRT-PCR) and Western blot experiments were used to further verify the prediction results. Finally, the interactions between HSYA and key targets were assessed by molecular docking. The results showed that 199 potentially targeted genes according to network pharmacology and 480 DEGs according to transcriptomics were involved in the effects of HSYA against LA. An integrated analysis revealed that four key targets, including HSP90AA1, ATP2A1, NOS1 and CRAT, as well as their three related pathways (the calcium signaling pathway, estrogen signaling pathway and cGMP-PKG signaling pathway), were closely related to the therapeutic effects of HSYA. A gene and protein expression analysis revealed that HSYA significantly inhibited the expressions of HSP90AA1, ATP2A1 and NOS1 in the liver tissue of aging mice. The molecular docking results showed that HSYA had high affinities with the HSP90AA1, ATP2A1 and NOS1 targets. Our data demonstrate that HSYA may delay LA in mice by inhibiting the expressions of HSP90AA1, ATP2A1 and NOS1 and regulating the calcium signaling pathway, the estrogen signaling pathway, and the cGMP-PKG signaling pathway.
C1 [Kong, Jie; Sun, Siming; Min, Fei; Hu, Xingli; Zhang, Yuan; Cheng, Yan; Li, Haiyan; Liu, Xin] Jilin Agr Univ, Chinese Minist Educ Bioreactor & Pharmaceut Dev, Engn Res Ctr, Coll Life Sci, Changchun 130118, Peoples R China.
   [Li, Haiyan] Hainan Univ, Coll Trop Crops, Haikou 580228, Hainan, Peoples R China.
   [Wang, Xiaojie] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Peoples R China.
C3 Jilin Agricultural University; Hainan University; Wenzhou Medical
   University
RP Liu, X (corresponding author), Jilin Agr Univ, Chinese Minist Educ Bioreactor & Pharmaceut Dev, Engn Res Ctr, Coll Life Sci, Changchun 130118, Peoples R China.; Wang, XJ (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325035, Peoples R China.
EM susanwang1214@wmu.edu.cn; xinl@jlau.edu.cn
RI li, yansong/JXL-5023-2024; Li, Kun/JLL-6505-2023; Yang,
   Mei/JNS-2225-2023; zhou, han/JUV-0193-2023; peng, jy/JMB-2297-2023;
   Cheng, Yan/U-8483-2018; Li, Jiawei/JOJ-9277-2023; Wang,
   Chao/JHT-6081-2023; Wang, Xintong/JJE-1189-2023; yang,
   kun/JGM-4169-2023; jiang, lei/IWE-1124-2023; li, bai/JNE-1502-2023;
   Ding, Yang/JUV-4842-2023; xuan, li/JNI-7432-2023
OI Li, Kun/0000-0002-3638-2974; peng, jy/0000-0001-9665-1059; Cheng,
   Yan/0000-0002-2471-2219; 
FU Special Project of Industrial Technology Research and Development in
   Jilin Province [2020C036-1]; Science and Technology Research Planning
   Project of Education Department in Jilin Province [JJKH20210327KJ]
FX This research was supported by the Special Project of Industrial
   Technology Research and Development in Jilin Province (2020C036-1) and
   the Science and Technology Research Planning Project of Education
   Department in Jilin Province (JJKH20210327KJ).
CR Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60
   Arvanitis DA, 2011, J MOL CELL CARDIOL, V50, P43, DOI 10.1016/j.yjmcc.2010.08.021
   Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016
   Beyzaei Z, 2022, ORPHANET J RARE DIS, V17, DOI 10.1186/s13023-022-02284-y
   Cai CZ, 2020, CANCER BIOMARK, V29, P69, DOI 10.3233/CBM-190169
   Cai FF, 2019, BIOMED PHARMACOTHER, V114, DOI 10.1016/j.biopha.2019.108863
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen Jun-Ren, 2022, Zhongguo Zhong Yao Za Zhi, V47, P4574, DOI 10.19540/j.cnki.cjcmm.20220217.701
   Izquierdo MC, 2012, NEFROLOGIA, V32, P715, DOI 10.3265/Nefrologia.pre2012.Aug.11667
   Costa SSF, 2020, BRIEF FUNCT GENOMICS, V19, P343, DOI 10.1093/bfgp/elaa014
   Cui Q, 2021, EUR J PHARMACOL, V908, DOI 10.1016/j.ejphar.2021.174360
   Davis AP, 2021, NUCLEIC ACIDS RES, V49, pD1138, DOI 10.1093/nar/gkaa891
   Delshad Elahe, 2018, Electron Physician, V10, P6672, DOI 10.19082/6672
   Eurostat, 2019, Ageing Europe: Looking at the lives of older people in the EU
   Francis SH, 2010, PHARMACOL REV, V62, P525, DOI 10.1124/pr.110.002907
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   García-Villafranca J, 2003, BIOCHEM PHARMACOL, V65, P807, DOI 10.1016/S0006-2952(02)01623-4
   Gokarn R, 2018, J GERONTOL A-BIOL, V73, P446, DOI 10.1093/gerona/glx186
   Gong P, 2021, PHYTOMEDICINE, V84, DOI 10.1016/j.phymed.2021.153509
   He D, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.755421
   He YH, 2015, J PHYSIOL BIOCHEM, V71, P69, DOI 10.1007/s13105-015-0382-3
   Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118
   Hou XM, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.966759
   Hsin KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083922
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002
   Kakhlon O, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99694
   Kao E, 2012, HEPATOLOGY, V56, P594, DOI 10.1002/hep.25702
   Kelly SP, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.199364
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kishnani PS, 2019, GENET MED, V21, P772, DOI 10.1038/s41436-018-0364-2
   Kong SZ, 2013, REJUV RES, V16, P404, DOI 10.1089/rej.2013.1433
   Kuo KK, 2013, INT J IMMUNOPATH PH, V26, P93, DOI 10.1177/039463201302600109
   Lan SY, 2021, MEDICINE, V100, DOI 10.1097/MD.0000000000025660
   Lee S, 2015, J PHARMACOPUNCT, V18, P11
   Li F, 2015, ACTA PHARMACOL SIN, V36, P1337, DOI 10.1038/aps.2015.70
   Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]
   Li T., 2007, THESIS DUKE U DURHAM
   Li WL, 2013, NEUROSCI LETT, V549, P146, DOI 10.1016/j.neulet.2013.06.007
   Li XY, 2020, LIVER INT, V40, P1378, DOI 10.1111/liv.14428
   Li YN, 2017, MOL MED REP, V15, P47, DOI 10.3892/mmr.2016.5965
   Lin LF, 2020, LIVER CANCER, V9, P563, DOI 10.1159/000508568
   Liu F, 2020, TOXICOL LETT, V333, P49, DOI 10.1016/j.toxlet.2020.07.024
   Luo Q, 2021, Nan Fang Yi Ke Da Xue Xue Bao, V41, P319, DOI 10.12122/j.issn.1673-4254.2021.03.02
   Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34
   Mao SA, 2014, TRANSL RES, V163, P352, DOI 10.1016/j.trsl.2014.01.005
   Maslov AY, 2013, AGING CELL, V12, P467, DOI 10.1111/acel.12071
   Min F, 2020, EUR J PHARMACOL, V881, DOI 10.1016/j.ejphar.2020.173214
   Negash AA, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007593
   Pan Y, 2003, J BIOL CHEM, V278, P13367, DOI 10.1074/jbc.M213228200
   Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378
   Razandi M, 2003, J BIOL CHEM, V278, P2701, DOI 10.1074/jbc.M205692200
   de França MER, 2020, INT IMMUNOPHARMACOL, V79, DOI 10.1016/j.intimp.2019.106082
   Selli C, 2015, BIOMED PHARMACOTHER, V71, P194, DOI 10.1016/j.biopha.2015.02.024
   Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442
   [宋浩然 Song Haoran], 2018, [肿瘤, Tumor], V38, P830
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   van der Staay FJ, 2008, NEUROPHARMACOLOGY, V55, P908, DOI 10.1016/j.neuropharm.2008.07.005
   Velasco A, 2013, FOOD CHEM, V141, P2006, DOI 10.1016/j.foodchem.2013.05.077
   Wang DX, 2022, MOLECULES, V27, DOI 10.3390/molecules27144502
   Wang TX, 2018, MOLECULES, V23, DOI 10.3390/molecules23061312
   Wu B, 2019, J ETHNOPHARMACOL, V229, P73, DOI 10.1016/j.jep.2018.09.039
   Wu LP, 2020, FREE RADICAL BIO MED, V153, P140, DOI 10.1016/j.freeradbiomed.2020.04.009
   Xie YF, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/8214128
   Yang Fangfang, 2015, Eur J Pharmacol, V754, P105, DOI 10.1016/j.ejphar.2015.02.015
   Yang JF, 2020, J ETHNOPHARMACOL, V256, DOI 10.1016/j.jep.2020.112790
   Yang LQ, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.813772
   Yu L, 2020, CELL MOL NEUROBIOL, V40, P1271, DOI 10.1007/s10571-020-00812-7
   Yuan HD, 2017, MOLECULES, V22, DOI 10.3390/molecules22071135
   Zhang LL, 2016, AM J CHINESE MED, V44, P197, DOI 10.1142/S0192415X16500130
   Zhang YB, 2011, EUR J PHARMACOL, V660, P438, DOI 10.1016/j.ejphar.2011.04.015
   Zhang ZH, 2014, BRAIN RES, V1563, P72, DOI 10.1016/j.brainres.2014.03.036
   Zhao FL, 2015, J ETHNOPHARMACOL, V168, P1, DOI 10.1016/j.jep.2015.03.035
   Zheng XB, 2017, HEPATOLOGY, V66, P809, DOI 10.1002/hep.29238
   Zhu Y, 2022, J HAZARD MATER, V434, DOI 10.1016/j.jhazmat.2022.128820
NR 75
TC 4
Z9 4
U1 13
U2 28
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD NOV
PY 2022
VL 23
IS 22
AR 14281
DI 10.3390/ijms232214281
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 6K2RF
UT WOS:000887355400001
PM 36430769
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Lehtinen, SK
   Rahkila, P
   Helenius, M
   Salminen, A
AF Lehtinen, SK
   Rahkila, P
   Helenius, M
   Salminen, A
TI Down-regulation of nuclear binding activities of OXBOX-REBOX
   transcription factors during cellular senescence
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID MITOCHONDRIAL GENE; MUSCLE; EXPRESSION; CELLS
AB Functional capacity of mitochondria declines during aging and this impairment may have a major role in aging process. Several observations indicate that transcriptional efficiency is reduced during aging. Our purpose was to find out whether aging and cellular senescence affect the nuclear binding activities of transcription factors which bind to OXBOX-REBOX sequence present in promoter regions of numerous nuclear genes encoding mitochondrial proteins. These factors regulate and coordinate the expression of mitochondrial proteins. We observed a strong down-regulation in the nuclear binding activities of OXBOX-REBOX factors in replicatively senesced human WI-38 and IMR-90 fibroblasts. On the contrary, SV-40 immortalization highly increased the nuclear binding activities. A considerable down-regulation of OXBOX-REBOX factors was also observed in UVB-irradiated WI-38 fibroblasts. Irradiation induced photoaging in fibroblasts which involved cell cycle arrest and senescent morphology. Interestingly, the nuclear binding activities of OXBOX-REBOX factors were also prominently decreased in the liver of Wistar rats at the age of 30 months but not yet at the age of 18 months. Our results suggest that the down-regulation of OXBOX-REBOX factors could affect the expression level of mitochondrial proteins encoded in nucleus and hence induce disturbances in mitochondrial function and promote the cellular aging process. (C) 1996 Academic Press, Inc.
C1 UNIV KUOPIO,DEPT NEUROSCI & NEUROL,FIN-70211 KUOPIO,FINLAND.
   UNIV JYVASKYLA,DEPT CELL BIOL,FIN-40351 JYVASKYLA,FINLAND.
   PEURUNKA MED REHABIL & PHYS EXERCISE CTR,FIN-41350 LAUKAA,FINLAND.
C3 University of Eastern Finland; University of Jyvaskyla
CR AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541
   CALLEJA M, 1993, J BIOL CHEM, V268, P18891
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   CHUNG AB, 1992, J BIOL CHEM, V267, P21154
   Curtsinger JW, 1995, ANNU REV GENET, V29, P553
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023
   GOLDSTEIN S, 1981, J CELL BIOL, V91, P392, DOI 10.1083/jcb.91.2.392
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   HELENIUS M, 1996, IN PRESS BIOCH
   KAGAWA Y, 1990, INT J BIOCHEM, V22, P219
   NAGLEY P, 1991, TRENDS GENET, V7, P1, DOI 10.1016/0168-9525(91)90002-8
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   SUZUKI H, 1991, J BIOL CHEM, V266, P2333
   TORRONI A, 1990, J BIOL CHEM, V265, P20589
   TOUSSAINT O, 1995, EXP GERONTOL, V30, P1, DOI 10.1016/0531-5565(94)00038-5
   TYRRELL RM, 1994, MOL ASPECTS MED, V15, P3
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
NR 21
TC 6
Z9 6
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 13
PY 1996
VL 226
IS 2
BP 403
EP 406
DI 10.1006/bbrc.1996.1368
PG 4
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA VJ525
UT WOS:A1996VJ52500018
PM 8806647
DA 2024-02-19
ER

PT J
AU Bertolotti, M
   Lonardo, A
   Mussi, C
   Baldelli, E
   Pellegrini, E
   Ballestri, S
   Romagnoli, D
   Loria, P
AF Bertolotti, Marco
   Lonardo, Amedeo
   Mussi, Chiara
   Baldelli, Enrica
   Pellegrini, Elisa
   Ballestri, Stefano
   Romagnoli, Dante
   Loria, Paola
TI Nonalcoholic fatty liver disease and aging: Epidemiology to management
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Adipose tissue; Atherosclerosis; Aortic valve sclerosis; Autonomic
   dysfunction; Arrhythmia; Cirrhosis; Dementia; Falls; Frailty;
   Hepatocellular carcinoma; Microbiota; Nuclear receptors; Pathogenesis;
   Sarcopenia; Treatment
ID MAGNETIC-RESONANCE SPECTROSCOPY; MUSCLE MASS SARCOPENIA; VITAMIN-D
   DEFICIENCY; DIET-INDUCED OBESITY; RISK-FACTORS; INSULIN-RESISTANCE;
   HEPATOCELLULAR-CARCINOMA; INTESTINAL MICROBIOTA; METABOLIC SYNDROME;
   NATURAL-HISTORY
AB Nonalcoholic fatty liver disease (NAFLD) is common in the elderly, in whom it carries a more substantial burden of hepatic (nonalcoholic steatohepatitis, cirrhosis and hepatocellular carcinoma) and extra-hepatic manifestations and complications (cardiovascular disease, extrahepatic neoplasms) than in younger age groups. Therefore, proper identification and management of this condition is a major task for clinical geriatricians and geriatric hepatologists. In this paper, the epidemiology and pathophysiology of this condition are reviewed, and a full discussion of the link between NAFLD and the aspects that are peculiar to elderly individuals is provided; these aspects include frailty, multimorbidity, polypharmacy and dementia. The proper treatment strategy will have to consider the peculiarities of geriatric patients, so a multidisciplinary approach is mandatory. Non-pharmacological treatment (diet and physical exercise) has to be tailored individually considering the physical limitations of most elderly people and the need for an adequate caloric supply. Similarly, the choice of drug treatment must carefully balance the benefits and risks in terms of adverse events and pharmacological interactions in the common context of both multiple health conditions and polypharmacy. In conclusion, further epidemiological and pathophysiological insight is warranted. More accurate understanding of the molecular mechanisms of geriatric NAFLD will help in identifying the most appropriate diagnostic and therapeutic approach for individual elderly patients. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
C1 [Bertolotti, Marco; Lonardo, Amedeo; Mussi, Chiara; Baldelli, Enrica; Pellegrini, Elisa; Ballestri, Stefano; Romagnoli, Dante; Loria, Paola] Univ Modena & Reggio Emilia, Nuovo Osped Civile Modena, Dept Biomed Metab & Neural Sci, I-41126 Modena, Italy.
   [Bertolotti, Marco; Lonardo, Amedeo; Mussi, Chiara; Baldelli, Enrica; Pellegrini, Elisa; Ballestri, Stefano; Romagnoli, Dante; Loria, Paola] Azienda USL Modena, I-41126 Modena, Italy.
   [Ballestri, Stefano] Pavullo Hosp, Div Internal Med, I-41026 Pavullo nel Frignano, MO, Italy.
C3 Universita di Modena e Reggio Emilia
RP Bertolotti, M (corresponding author), Univ Modena & Reggio Emilia, Nuovo Osped Civile Modena, Dept Biomed Metab & Neural Sci, Via Giardini 1355, I-41126 Modena, Italy.
EM marco.bertolotti@unimore.it
RI Bertolotti, Marco/P-6040-2015; Romagnoli, Dante/AAA-4381-2019; LONARDO,
   AMEDEO/I-5911-2019; Ballestri, Stefano/AAQ-1541-2021; Mussi,
   Chiara/G-3955-2016
OI Bertolotti, Marco/0000-0001-6908-1820; LONARDO,
   AMEDEO/0000-0001-9886-0698; Mussi, Chiara/0000-0001-5598-9969;
   Romagnoli, Dante/0000-0001-6960-1267; ballestri,
   stefano/0000-0002-1424-7894; BALDELLI, Enrica/0000-0003-2602-8944
CR Abbatecola AM, 2011, J NUTR HEALTH AGING, V15, P890, DOI 10.1007/s12603-011-0366-0
   Abbatecola AM, 2007, ARCH INTERN MED, V167, P2145, DOI 10.1001/archinte.167.19.2145-b
   Abraldes JG, 2009, GASTROENTEROLOGY, V136, P1651, DOI 10.1053/j.gastro.2009.01.043
   Akahoshi M, 2001, HYPERTENS RES, V24, P337, DOI 10.1291/hypres.24.337
   Al-hamoudi W, 2012, ANN SAUDI MED, V32, P288, DOI 10.5144/0256-4947.2012.288
   Alexander J, 2013, J GASTROEN HEPATOL, V28, P848, DOI 10.1111/jgh.12116
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x
   [Anonymous], 2009, 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases: prevent and control cardiovascular diseases, cancers, chronic respiratory diseases and diabetes
   Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Argo CK, 2008, HEPATOLOGY, V48, P662, DOI 10.1002/hep.22402
   Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227
   Athyros VG, 2010, LANCET, V376, P1916, DOI 10.1016/S0140-6736(10)61272-X
   Attili AF, 1997, HEPATOLOGY, V26, P809, DOI 10.1002/hep.510260401
   Ballestri S, 2014, WORLD J GASTROENTERO, V20, P1724, DOI 10.3748/wjg.v20.i7.1724
   Bambace C, 2014, HEART VESSELS, V29, P42, DOI 10.1007/s00380-012-0315-9
   Bambha K, 2012, HEPATOLOGY, V55, P769, DOI 10.1002/hep.24726
   Barchetta I, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-85
   Barzilai N, 2012, J GERONTOL A-BIOL, V67, P1329, DOI 10.1093/gerona/gls145
   Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35
   Bays Harold E, 2008, Expert Rev Cardiovasc Ther, V6, P343, DOI 10.1586/14779072.6.3.343
   Bedogni G, 2007, HEPATOLOGY, V46, P1387, DOI 10.1002/hep.21827
   Bertolotti M, 2007, EUR J CLIN INVEST, V37, P501, DOI 10.1111/j.1365-2362.2007.01808.x
   BERTOLOTTI M, 1993, J LIPID RES, V34, P1001
   Bertolotti M, 2014, CLIN INTERV AGING, V9, P425, DOI 10.2147/CIA.S57714
   BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827
   Beyer I, 2012, CURR OPIN CLIN NUTR, V15, P12, DOI 10.1097/MCO.0b013e32834dd297
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005
   Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5
   Boyce JM, 2006, POSTGRAD MED J, V82, P239, DOI 10.1136/pgmj.2005.039453
   Brea A, 2005, ARTERIOSCL THROM VAS, V25, P1045, DOI 10.1161/01.ATV.0000160613.57985.18
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168
   Caballería L, 2010, EUR J GASTROEN HEPAT, V22, P24, DOI 10.1097/MEG.0b013e32832fcdf0
   Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347
   Caldwell SH, 2004, J HEPATOL, V40, P578, DOI 10.1016/j.jhep.2004.02.013
   Camm AJ, 1996, CIRCULATION, V93, P1043
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Cartwright MJ, 2010, J GERONTOL A-BIOL, V65, P242, DOI 10.1093/gerona/glp213
   Carulli L, 2006, HEPATOLOGY, V44, P278, DOI 10.1002/hep.21218
   Ceda GP, 1998, J CLIN ENDOCR METAB, V83, P499, DOI 10.1210/jc.83.2.499
   Chalasani N, 2005, HEPATOLOGY, V41, P690, DOI 10.1002/hep.20671
   Chen CH, 2006, J CLIN GASTROENTEROL, V40, P745, DOI 10.1097/00004836-200609000-00016
   Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708
   Cheng J, 2013, CURR TOP MICROBIOL, V358, P323, DOI 10.1007/82_2011_189
   Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Collins SM, 2009, GASTROENTEROLOGY, V136, P2003, DOI 10.1053/j.gastro.2009.01.075
   Corey KE, 2014, CLIN GASTROENTEROL H, V12, P1077, DOI 10.1016/j.cgh.2013.08.014
   Cuervo AM, 2011, SCIENCE, V332, P1392, DOI 10.1126/science.1208607
   Cummings JH, 1997, JPEN-PARENTER ENTER, V21, P357, DOI 10.1177/0148607197021006357
   D'Aversa Francesca, 2013, Intern Emerg Med, V8 Suppl 1, pS11, DOI 10.1007/s11739-013-0916-z
   Dali-Youcef N, 2009, QJM-INT J MED, V102, P17, DOI 10.1093/qjmed/hcn138
   de Groot LCPMG, 2004, J GERONTOL A-BIOL, V59, P1277, DOI 10.1093/gerona/59.12.1277
   de Vos WM, 2013, NATURE, V498, P48, DOI 10.1038/nature12251
   DEGUCHI Y, 1985, AGR BIOL CHEM TOKYO, V49, P13, DOI 10.1080/00021369.1985.10866683
   Della Corte C, 2012, J ADOLESCENT HEALTH, V51, P305, DOI 10.1016/j.jadohealth.2012.01.010
   Dunn W, 2008, AM J GASTROENTEROL, V103, P2263, DOI 10.1111/j.1572-0241.2008.02034.x
   Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   Elphick HL, 2006, GERIATRICS, V61, P21
   ERICSSON S, 1991, J CLIN INVEST, V87, P591, DOI 10.1172/JCI115034
   Estep JM, 2010, CURR MOL MED, V10, P166, DOI 10.2174/156652410790963321
   Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042
   Fedirko V, 2013, ANN ONCOL, V24, P2166, DOI 10.1093/annonc/mdt168
   Finelli C, 2013, AGEING RES REV, V12, P996, DOI 10.1016/j.arr.2013.05.007
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014
   Fontana L, 2013, HEPATOLOGY, V57, P995, DOI 10.1002/hep.26099
   Forton DM, 2002, HEPATOLOGY, V35, P433, DOI 10.1053/jhep.2002.30688
   Foster T, 2013, DIGEST DIS SCI, V58, P2392, DOI 10.1007/s10620-013-2652-7
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Frith J, 2009, LIVER INT, V29, P483, DOI 10.1111/j.1478-3231.2009.01985.x
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   García-Monzón C, 2011, J HEPATOL, V54, P142, DOI 10.1016/j.jhep.2010.06.021
   Genser D, 2008, ANN NUTR METAB, V52, P29, DOI 10.1159/000115345
   Gerin I, 2005, J BIOL CHEM, V280, P23024, DOI 10.1074/jbc.M412564200
   Giannini EG, 2009, CLIN GASTROENTEROL H, V7, P580, DOI 10.1016/j.cgh.2009.01.001
   Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001
   Guerrerio AL, 2012, AM J CLIN NUTR, V95, P892, DOI 10.3945/ajcn.111.020156
   Guo W, 2007, AM J PHYSIOL-ENDOC M, V292, pE1041, DOI 10.1152/ajpendo.00557.2006
   Gupta A, 2006, J CAN DENT ASSOC, V72, P841
   Guzzetti S, 2005, CIRCULATION, V112, P465, DOI 10.1161/CIRCULATIONAHA.104.518449
   Hamaguchi M, 2012, WORLD J GASTROENTERO, V18, P237, DOI 10.3748/wjg.v18.i3.237
   Hamer HM, 2012, AM J PHYSIOL-GASTR L, V302, pG1, DOI 10.1152/ajpgi.00048.2011
   Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033
   Henry HL, 2010, J STEROID BIOCHEM, V121, P4, DOI 10.1016/j.jsbmb.2010.05.008
   Hong HC, 2014, HEPATOLOGY, V59, P1772, DOI 10.1002/hep.26716
   Hu XN, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-123
   Jakovljevic DG, 2013, CLIN SCI, V125, P143, DOI 10.1042/CS20120684
   Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x
   Jin JL, 2009, AGING-US, V1, P582, DOI 10.18632/aging.100060
   Jones K, 2012, AGEING RES REV, V11, P442, DOI 10.1016/j.arr.2012.02.007
   Kagansky N, 2004, LIVER INT, V24, P588, DOI 10.1111/j.1478-3231.2004.0969.x
   Karlström O, 1998, CLIN INFECT DIS, V26, P141, DOI 10.1086/516277
   Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005
   Kellow NJ, 2014, BRIT J NUTR, V111, P1147, DOI 10.1017/S0007114513003607
   Kenney WL, 2001, MED SCI SPORT EXER, V33, P1524, DOI 10.1097/00005768-200109000-00016
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   Kitajima Y, 2010, J GASTROENTEROL, V45, P218, DOI 10.1007/s00535-009-0147-2
   Kodama K, 2013, ALCOHOL CLIN EXP RES, V37, pE247, DOI 10.1111/j.1530-0277.2012.01900.x
   Koehler EM, 2012, J HEPATOL, V57, P1305, DOI 10.1016/j.jhep.2012.07.028
   Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8
   Koplay M, 2011, J INVEST MED, V59, P1137, DOI 10.2310/JIM.0b013e31822a29f5
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Lahtinen SJ, 2009, AGE, V31, P59, DOI 10.1007/s11357-008-9081-0
   Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049
   Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007
   Laurin D, 1994, J Can Dent Assoc, V60, P443
   Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007
   Li LH, 2013, DIGEST DIS SCI, V58, P2376, DOI 10.1007/s10620-013-2658-1
   Li M, 2012, J CLIN ENDOCR METAB, V97, P2033, DOI 10.1210/jc.2011-3010
   Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6
   Liu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061803
   Lonardo A, 2006, WORLD J GASTROENTERO, V12, P5826, DOI 10.3748/wjg.v12.i36.5826
   Lonardo A, 2006, J HEPATOL, V44, P1196, DOI 10.1016/j.jhep.2006.03.005
   Lonardo A, 2013, CURR PHARM DESIGN, V19, P5177, DOI 10.2174/1381612811319290003
   Lonardo A, 2012, J GASTROEN HEPATOL, V27, P1654, DOI 10.1111/j.1440-1746.2012.07232.x
   Lonardo A, 2012, DIGEST LIVER DIS, V44, P451, DOI 10.1016/j.dld.2012.02.020
   Lonardo A, 2010, EXPERT REV ENDOCRINO, V5, P403, DOI 10.1586/EEM.10.5
   Loria P, 2007, NUTR METAB CARDIOVAS, V17, P684, DOI 10.1016/j.numecd.2007.01.007
   Loria P, 2010, DIGEST LIVER DIS, V42, P272, DOI 10.1016/j.dld.2010.01.021
   Loria P, 2008, CLIN SCI, V115, P1, DOI 10.1042/CS20070311
   Loria P, 2013, HEPATOL RES, V43, P51, DOI 10.1111/j.1872-034X.2012.01031.x
   Loria P, 2009, NAT REV GASTRO HEPAT, V6, P236, DOI 10.1038/nrgastro.2009.33
   LUDWIG J, 1980, MAYO CLIN PROC, V55, P434
   Lutchman G, 2007, HEPATOLOGY, V46, P424, DOI 10.1002/hep.21661
   MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442
   Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021
   Maggio M, 2006, J AM GERIATR SOC, V54, P1832, DOI 10.1111/j.1532-5415.2006.00963.x
   Mak KM, 2012, ANAT REC, V295, P1159, DOI 10.1002/ar.22504
   Mäkivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553
   Mallikarjuna K, 2010, ALCOHOL, V44, P523, DOI 10.1016/j.alcohol.2010.07.004
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Masetti M, 2014, AGING CLIN EXP RES, V26, P241, DOI 10.1007/s40520-013-0156-0
   Maurantonio M, 2011, ARCH MED RES, V42, P337, DOI 10.1016/j.arcmed.2011.08.004
   Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012
   Mazzella N, 2014, CLIN LIVER DIS, V18, P73, DOI 10.1016/j.cld.2013.09.005
   Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110
   Miyaaki H, 2008, LIVER INT, V28, P519, DOI 10.1111/j.1478-3231.2007.01614.x
   MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974
   Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006
   Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4
   Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623
   Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x
   Nakajima T., 2012, J GASTROEN HEPATOL, V1, P315
   Nakamura Y, 2009, OBESITY, V17, P1269, DOI 10.1038/oby.2009.3
   Nascimbeni F, 2013, J HEPATOL, V59, P859, DOI 10.1016/j.jhep.2013.05.044
   Newton JL, 2008, HEPATOLOGY, V48, P541, DOI 10.1002/hep.22371
   Newton JL, 2010, DIGEST DIS, V28, P214, DOI 10.1159/000282089
   Newton JL, 2009, CLIN AUTON RES, V19, P319, DOI 10.1007/s10286-009-0031-4
   Ng ACT, 2010, CIRCULATION, V122, P2538, DOI 10.1161/CIRCULATIONAHA.110.955542
   NOMURA H, 1988, JPN J MED, V27, P142, DOI 10.2169/internalmedicine1962.27.142
   North KE, 2012, EUR J GASTROEN HEPAT, V24, P9, DOI 10.1097/MEG.0b013e32834a94fb
   Noureddin M, 2013, HEPATOLOGY, V58, P1644, DOI 10.1002/hep.26465
   O'Leary F, 2012, BRIT J NUTR, V108, P1948, DOI 10.1017/S0007114512004175
   O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010
   Oni ET, 2013, ATHEROSCLEROSIS, V230, P258, DOI 10.1016/j.atherosclerosis.2013.07.052
   Oudshoom C, 2009, BRIT J NUTR, V101, P1597, DOI 10.1017/S0007114509338842
   Ovchinsky N, 2012, SEMIN LIVER DIS, V32, P317, DOI 10.1055/s-0032-1329905
   PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178
   Panasiuk A, 2006, WORLD J GASTROENTERO, V12, P6198, DOI 10.3748/wjg.v12.i38.6198
   Paolisso G, 1999, EUR J CLIN INVEST, V29, P758
   Pappagallo M, 2001, AM J SURG, V182, p11S, DOI 10.1016/S0002-9610(01)00782-6
   Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Pérez-López FR, 2011, MATURITAS, V69, P27, DOI 10.1016/j.maturitas.2011.02.014
   Perry RJ, 2013, AGING-US, V5, P791, DOI 10.18632/aging.100617
   POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114
   Pradelli D, 2013, EUR J CANCER PREV, V22, P229, DOI 10.1097/CEJ.0b013e328358761a
   Premoli A, 2009, Minerva Gastroenterol Dietol, V55, P71
   Rakoski MO, 2010, ALIMENT PHARM THER, V32, P1211, DOI 10.1111/j.1365-2036.2010.04467.x
   Ramírez G, 2012, CURR VASC PHARMACOL, V10, P767, DOI 10.2174/157016112803520918
   de Carvalho SCR, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-37
   Ratziu V, 2010, HEPATOLOGY, V52, P2206, DOI 10.1002/hep.24042
   Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]
   Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x
   Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062
   Ritze Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080169
   Rolfe RD, 1997, GASTROINTESTINAL MIC, P501
   Roth CL, 2012, HEPATOLOGY, V55, P1103, DOI 10.1002/hep.24737
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675
   Sanada K, 2012, EUR J CLIN NUTR, V66, P1093, DOI 10.1038/ejcn.2012.43
   Sanguino E, 2005, BRIT J PHARMACOL, V145, P853, DOI 10.1038/sj.bjp.0706260
   Savastano S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-136
   Sawada N, 2012, GASTROENTEROLOGY, V142, P1468, DOI 10.1053/j.gastro.2012.02.018
   Scaglioni F, 2013, CLIN RES HEPATOL GAS, V37, P353, DOI 10.1016/j.clinre.2012.10.009
   Sepe A, 2011, GERONTOLOGY, V57, P66, DOI 10.1159/000279755
   Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613
   Shah BM, 2012, CLIN GERIATR MED, V28, P173, DOI 10.1016/j.cger.2012.01.002
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shen L, 2003, WORLD J GASTROENTERO, V9, P1106
   Siersbæk R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010
   Singh P, 2011, J GERONTOL A-BIOL, V66, P944, DOI 10.1093/gerona/glr094
   Singh S, 2013, AM J GASTROENTEROL, V108, P881, DOI 10.1038/ajg.2013.5
   Singh S, 2013, GASTROENTEROLOGY, V144, P323, DOI 10.1053/j.gastro.2012.10.005
   Sinha R, 2002, DIABETES, V51, P1022, DOI 10.2337/diabetes.51.4.1022
   Soresi M, 2013, ACTA DIABETOL, V50, P241, DOI 10.1007/s00592-012-0406-1
   Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Stine Jonathan G, 2013, Curr Gastroenterol Rep, V15, P299, DOI 10.1007/s11894-012-0299-8
   Stramaglia G, 2010, J NUTR HEALTH AGING, V14, P6, DOI 10.1007/s12603-010-0002-4
   Stroffolini T, 2011, DIGEST LIVER DIS, V43, P875, DOI 10.1016/j.dld.2011.05.002
   Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a
   Suzuki A, 2005, NAT CLIN PRACT GASTR, V2, P208, DOI 10.1038/ncpgasthep0172
   Tajiri K, 2013, WORLD J GASTROENTERO, V19, P8459, DOI 10.3748/wjg.v19.i46.8459
   Tamaki Y, 2013, J GASTROENTEROL, V48, P491, DOI 10.1007/s00535-012-0651-7
   Tang QQ, 2004, BIOCHEM BIOPH RES CO, V319, P235, DOI 10.1016/j.bbrc.2004.04.176
   Tarantino G, 2007, HEPATOL RES, V37, P410, DOI 10.1111/j.1872-034X.2007.00072.x
   Tarantino G, 2013, WORLD J GASTROENTERO, V19, P6735, DOI 10.3748/wjg.v19.i40.6735
   Tarantino G, 2011, WORLD J GASTROENTERO, V17, P5280, DOI 10.3748/wjg.v17.i48.5280
   Tarantino G, 2011, WORLD J GASTROENTERO, V17, P3785, DOI 10.3748/wjg.v17.i33.3785
   Tarantino G, 2010, WORLD J GASTROENTERO, V16, P4773, DOI 10.3748/wjg.v16.i38.4773
   Targher G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057183
   Targher G, 2009, SEMIN THROMB HEMOST, V35, P277, DOI 10.1055/s-0029-1222606
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010
   Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Trevisani F, 2004, AM J GASTROENTEROL, V99, P1470, DOI 10.1111/j.1572-0241.2004.30137.x
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587
   van der Poorten D, 2013, HEPATOLOGY, V57, P2180, DOI 10.1002/hep.26072
   van Tongeren SP, 2005, APPL ENVIRON MICROB, V71, P6438, DOI 10.1128/AEM.71.10.6438-6442.2005
   Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x
   Vigna GB, 2011, CLIN LIPIDOL, V6, P339, DOI 10.2217/CLP.11.20
   Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604
   Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
   Wang CY, 2012, GERIATR GERONTOL INT, V12, P388, DOI 10.1111/j.1447-0594.2012.00851.x
   Wang ZL, 2013, EXP GERONTOL, V48, P705, DOI 10.1016/j.exger.2013.05.059
   WILSON PWF, 1994, J GERONTOL, V49, pM252, DOI 10.1093/geronj/49.6.M252
   Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342
   Wong VWS, 2011, GUT, V60, P829, DOI 10.1136/gut.2011.237974
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Xu CF, 2013, AM J GASTROENTEROL, V108, P1299, DOI 10.1038/ajg.2013.104
   Yan J, 2013, J GASTROEN HEPATOL, V28, P1654, DOI 10.1111/jgh.12290
   Yilmaz Y, 2009, HEPATOLOGY, V49, P698, DOI 10.1002/hep.22752
   Younossi ZM, 2014, ALIMENT PHARM THER, V39, P3, DOI 10.1111/apt.12543
   Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49
   Zelber-Sagi S, 2006, LIVER INT, V26, P856, DOI 10.1111/j.1478-3231.2006.01311.x
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang H, 2013, SCAND J GASTROENTERO, V48, P78, DOI 10.3109/00365521.2012.719926
   Zhou YJ, 2007, WORLD J GASTROENTERO, V13, P6419, DOI 10.3748/wjg.13.6419
NR 251
TC 198
Z9 209
U1 3
U2 59
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD OCT 21
PY 2014
VL 20
IS 39
BP 14185
EP 14204
DI 10.3748/wjg.v20.i39.14185
PG 20
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AR9GQ
UT WOS:000343881500010
PM 25339806
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Sengupta, S
   Peterson, TR
   Laplante, M
   Oh, S
   Sabatini, DM
AF Sengupta, Shomit
   Peterson, Timothy R.
   Laplante, Mathieu
   Oh, Stephanie
   Sabatini, David M.
TI mTORC1 controls fasting-induced ketogenesis and its modulation by ageing
SO NATURE
LA English
DT Article
ID PROLIFERATOR-ACTIVATED RECEPTOR; FATTY-ACID OXIDATION; RAT-LIVER; MICE;
   IDENTIFICATION; GENES
AB The multi-component mechanistic target of rapamycin complex 1 (mTORC1) kinase is the central node of a mammalian pathway that coordinates cell growth with the availability of nutrients, energy and growth factors(1). Progress has been made in the identification of mTORC1 pathway components and in understanding their functions in cells, but there is relatively little known about the role of the pathway in vivo. Specifically, we have little knowledge regarding the role mTOCR1 has in liver physiology. In fasted animals, the liver performs numerous functions that maintain whole-body homeostasis, including the production of ketone bodies for peripheral tissues to use as energy sources. Here we show that mTORC1 controls ketogenesis in mice in response to fasting. We find that liver-specific loss of TSC1 (tuberous sclerosis 1), an mTORC1 inhibitor(1), leads to a fasting-resistant increase in liver size, and to a pronounced defect in ketone body production and ketogenic gene expression on fasting. The loss of raptor (regulatory associated protein of mTOR, complex 1) an essential mTORC1 component(1), has the opposite effects. In addition, we find that the inhibition of mTORC1 is required for the fasting-induced activation of PPAR alpha (peroxisome proliferator activated receptor alpha), the master transcriptional activator of ketogenic genes(2), and that suppression of NCoR1 (nuclear receptor co-repressor 1), a co-repressor of PPAR alpha(3), reactivates ketogenesis in cells and livers with hyperactive mTORC1 signalling. Like livers with activated mTORC1, livers from aged mice have a defect in ketogenesis(4,5), which correlates with an increase in mTORC1 signalling. Moreover, we show that the suppressive effects of mTORC1 activation and ageing on PPAR alpha activity and ketone production are not additive, and that mTORC1 inhibition is sufficient to prevent the ageing-induced defect in ketogenesis. Thus, our findings reveal that mTORC1 is a key regulator of PPAR alpha function and hepatic ketogenesis and suggest a role for mTORC1 activity in promoting the ageing of the liver.
C1 [Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.
   [Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA.
   [Sengupta, Shomit; Peterson, Timothy R.; Laplante, Mathieu; Oh, Stephanie; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
C3 Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard
   Hughes Medical Institute; Massachusetts Institute of Technology (MIT);
   Massachusetts Institute of Technology (MIT)
RP Sabatini, DM (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.
EM sabatini@wi.mit.edu
RI sabatini, david/JJC-2011-2023
OI Oh, Stephanie/0000-0002-6287-9116; Sabatini, David
   M./0000-0002-1446-7256
FU American Diabetes Association; Ludwig Cancer Fund; Canadian Institutes
   of Health Research; NIH [CA103866, CA129105]
FX We thank S. Biddinger and C. R. Kahn for providing the
   Ir<SUP>loxP/loxP</SUP> and Li-Ir<SUP>KO</SUP> mice; D. Kwiatkowski for
   the Tsc1<SUP>loxP/loxP</SUP> mice; R. Zoncu for assistance with imaging
   experiments and image analysis; F. Reinhardt for assistance in animal
   virus injections; and T. Jacks, L. Guarente, V. Mootha and members of
   the Sabatini laboratory for support and discussions. This research was
   supported by fellowships from the American Diabetes Association and
   Ludwig Cancer Fund to T. R. P.; a fellowship from the Canadian
   Institutes of Health Research to M. L.; and NIH grants CA103866 and
   CA129105 to D. M. S. D. M. S. is an investigator of the Howard Hughes
   Medical Institute.
CR Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Dowell P, 1999, J BIOL CHEM, V274, P15901, DOI 10.1074/jbc.274.22.15901
   Faraj M, 2004, AM J PHYSIOL-ENDOC M, V287, pE150, DOI 10.1152/ajpendo.00398.2003
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623
   Glass CK, 2000, GENE DEV, V14, P121
   Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199
   Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242
   Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200
   Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217
   Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   MCGARRY JD, 1973, J BIOL CHEM, V248, P270
   MCGARRY JD, 1971, J BIOL CHEM, V246, P1149
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040
   NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424
   Osoegawa K, 2000, GENOME RES, V10, P116
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Rodríguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034
   Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007
   Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283
NR 30
TC 473
Z9 543
U1 2
U2 57
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD DEC 23
PY 2010
VL 468
IS 7327
BP 1100
EP U502
DI 10.1038/nature09584
PG 7
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 697XT
UT WOS:000285553800058
PM 21179166
DA 2024-02-19
ER

PT J
AU Kronfol, MM
   Abudahab, S
   Dozmorov, MG
   Jahr, FM
   Halquist, MS
   McRae, M
   Wijesinghe, DS
   Price, ET
   Slattum, PW
   McClay, JL
AF Kronfol, Mohamad M.
   Abudahab, Sara
   Dozmorov, Mikhail G.
   Jahr, Fay M.
   Halquist, Matthew S.
   McRae, MaryPeace
   Wijesinghe, Dayanjan S.
   Price, Elvin T.
   Slattum, Patricia W.
   McClay, Joseph L.
TI Histone acetylation at the sulfotransferase 1a1 gene is associated with
   its hepatic expression in normal aging
SO PHARMACOGENETICS AND GENOMICS
LA English
DT Article
DE acetylation; aging; biomarkers; DNA methylation; epigenome; gene
   expression; histones; liver; posttranslational; protein processing
ID DRUG-METABOLIZING-ENZYMES; DNA METHYLATION; EPIGENETIC REGULATION;
   PHARMACOEPIGENETICS; PROFILES; ESTROGEN; WIDE
AB Objectives Phase II drug metabolism is poorly studied in advanced age and older adults may exhibit significant variability in their expression of phase II enzymes. We hypothesized that age-related changes to epigenetic regulation of genes involved in phase II drug metabolism may contribute to these effects. Methods We examined published epigenome-wide studies of human blood and identified the SULT1A1 and UGT1A6 genes as the top loci showing epigenetic changes with age. To assess possible functional alterations with age in the liver, we assayed DNA methylation (5mC) and histone acetylation changes around the mouse homologs Sult1a1 and Ugt1a6 in liver tissue from mice aged 4-32 months. Results Our sample shows a significant loss of 5mC at Sult1a1 (beta = -1.08, 95% CI [-1.8, -0.2], SE = 0.38, P = 0.011), mirroring the loss of 5mC with age observed in human blood DNA at the same locus. We also detected increased histone 3 lysine 9 acetylation (H3K9ac) with age at Sult1a1 (beta = 0.11, 95% CI [0.002, 0.22], SE = 0.05, P = 0.04), but no change to histone 3 lysine 27 acetylation (H3K27ac). Sult1a1 gene expression is significantly positively associated with H3K9ac levels, accounting for 23% of the variation in expression. We did not detect any significant effects at Ugt1a6. Conclusions Sult1a1 expression is under epigenetic influence in normal aging and this influence is more pronounced for H3K9ac than DNA methylation or H3K27ac in this study. More generally, our findings support the relevance of epigenetics in regulating key drug-metabolizing pathways. In the future, epigenetic biomarkers could prove useful to inform dosing in older adults.
C1 [Kronfol, Mohamad M.; Abudahab, Sara; Jahr, Fay M.; McRae, MaryPeace; Wijesinghe, Dayanjan S.; Price, Elvin T.; Slattum, Patricia W.; McClay, Joseph L.] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23298 USA.
   [Dozmorov, Mikhail G.] Virginia Commonwealth Univ, Dept Biostat, Sch Med, Richmond, VA 23298 USA.
   [Halquist, Matthew S.] Virginia Commonwealth Univ, Dept Pharmaceut, Richmond, VA 23298 USA.
   [Price, Elvin T.; Slattum, Patricia W.] Virginia Commonwealth Univ, Geriatr Pharmacotherapy Program, Sch Pharm, Richmond, VA 23298 USA.
   [Price, Elvin T.; Slattum, Patricia W.] Virginia Commonwealth Univ, Inst Inclus Inquiry & Innovat Hlth & Wellness Agi, Richmond, VA 23298 USA.
C3 Virginia Commonwealth University; Virginia Commonwealth University;
   Virginia Commonwealth University; Virginia Commonwealth University;
   Virginia Commonwealth University
RP McClay, JL (corresponding author), Virginia Commonwealth Univ, Smith Bldg,410 North 12th St, Richmond, VA 23298 USA.
EM jilmcclay@vcu.edu
RI McClay, Joseph/C-9931-2009; Kronfol, Mohamad/Y-7953-2019
OI McClay, Joseph/0000-0002-3628-2447; Kronfol, Mohamad/0000-0002-0283-2420
FU US National Institute on Aging, National Institutes of Health
   [R15AG061649]; Virginia Commonwealth University School of Pharmacy
FX We are grateful to the staff at the NIA Rodent Tissue Bank for providing
   us with the samples to carry out this study. We are grateful for support
   from the US National Institute on Aging, National Institutes of Health
   grant R15AG061649 to J.L.M. and for a graduate studentship from Virginia
   Commonwealth University School of Pharmacy to M.M. K. M. M.K. completed
   this study in partial fulfillment of the doctoral requirements in
   Pharmaceutical Sciences at Virginia Commonwealth University. An earlier
   version of this report was released as a preprint on bioRxiv: doi.
   org/10.1101/2020.09.17.300657.
CR [Anonymous], 2001, RISING LIFE EXPECTAN, DOI DOI 10.1017/CBO9781316036495
   [Anonymous], 2006, PATT MED US US REP S
   Bell CG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1824-y
   Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048
   Brauch H, 2009, CLIN CHEM, V55, P1770, DOI 10.1373/clinchem.2008.121756
   Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858
   Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053
   Chang AY, 2019, LANCET PUBLIC HEALTH, V4, pE159, DOI 10.1016/S2468-2667(19)30019-2
   Coughtrie MWH, 1999, BIOCHEM J, V337, P45, DOI 10.1042/0264-6021:3370045
   Duanmu ZB, 2006, J PHARMACOL EXP THER, V316, P1310, DOI 10.1124/jpet.105.093633
   ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d
   Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906
   Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919
   Fenley AT, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0181-5
   Fisel P, 2016, CLIN PHARMACOL THER, V99, P512, DOI 10.1002/cpt.343
   Fu ZD, 2012, DRUG METAB DISPOS, V40, P1216, DOI 10.1124/dmd.111.044461
   Glatt H, 2001, MUTAT RES-FUND MOL M, V482, P27, DOI 10.1016/S0027-5107(01)00207-X
   Gomez A, 2009, CLIN PHARMACOL THER, V85, P426, DOI 10.1038/clpt.2009.2
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109
   Hildebrandt M, 2009, PHARMACOGENET GENOM, V19, P404, DOI 10.1097/FPC.0b013e32832e042e
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230
   Kinirons MT, 2004, BRIT J CLIN PHARMACO, V57, P540, DOI 10.1111/j.1365-2125.2004.02096.x
   Kronfol MM, 2020, GEROSCIENCE, V42, P819, DOI 10.1007/s11357-020-00181-5
   Kronfol MM, 2017, EXPERT REV PRECIS ME, V2, P33, DOI 10.1080/23808993.2017.1284557
   Lauschke VM, 2018, ANNU REV PHARMACOL, V58, P161, DOI 10.1146/annurev-pharmtox-010617-053021
   Marto N, 2017, DRUG METAB REV, V49, P357, DOI 10.1080/03602532.2017.1335749
   Marttila S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1381-z
   McClay JL, 2014, HUM MOL GENET, V23, P1175, DOI 10.1093/hmg/ddt511
   McDaid AF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15842
   McLachlan AJ, 2012, J GERONTOL A-BIOL, V67, P175, DOI 10.1093/gerona/glr118
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Meer MV, 2018, ELIFE, V7, DOI 10.7554/eLife.40675
   Mian P, 2018, DRUG AGING, V35, P603, DOI 10.1007/s40266-018-0559-x
   Newman MR, 2012, EPIGENETICS-US, V7, P92, DOI 10.4161/epi.7.1.18815
   Rebbeck TR, 2006, J NATL CANCER I, V98, P1311, DOI 10.1093/jnci/djj360
   Reynolds LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6366
   Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399
   Sakakibara Y, 2002, GENE, V285, P39, DOI 10.1016/S0378-1119(02)00431-6
   Sanchez-Spitman AB, 2018, BREAST CANCER RES TR, V172, P401, DOI 10.1007/s10549-018-4923-7
   Seripa D, 2015, EXPERT OPIN DRUG MET, V11, P1073, DOI 10.1517/17425255.2015.1041919
   Shiratani H, 2008, DRUG METAB DISPOS, V36, P1745, DOI 10.1124/dmd.108.021469
   Singh M, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01315-5
   Steegenga Wilma T, 2014, Age (Dordr), V36, P9648, DOI 10.1007/s11357-014-9648-x
   Strassburg CP, 2008, ARCH TOXICOL, V82, P415, DOI 10.1007/s00204-008-0314-x
   Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890
   U.S. Census Bureau, 2017, 2017 National Population Projections Tables: Main Series
   Wang JQ, 2020, DRUG METAB DISPOS, V48, P759, DOI 10.1124/dmd.120.000008
   Wang T, 2020, CELL SYST, V11, P176, DOI 10.1016/j.cels.2020.06.006
   Zhang WQ, 2020, NAT REV MOL CELL BIO, V21, P137, DOI 10.1038/s41580-019-0204-5
NR 53
TC 3
Z9 3
U1 2
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1744-6872
EI 1744-6880
J9 PHARMACOGENET GENOM
JI Pharmacogenet. Genomics
PD DEC
PY 2021
VL 31
IS 9
BP 207
EP 214
DI 10.1097/FPC.0000000000000443
PG 8
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
GA WB6AJ
UT WOS:000703652500004
PM 34320608
OA Green Submitted, Green Accepted
DA 2024-02-19
ER

PT J
AU Jia, Y
   Jin, HH
   Gao, LY
   Yang, X
   Wang, FX
   Ding, H
   Chen, AP
   Tan, SZ
   Zhang, F
   Shao, JJ
   Wang, SJ
   Zheng, SZ
AF Jia, Yan
   Jin, Huanhuan
   Gao, Liyuan
   Yang, Xiang
   Wang, Feixia
   Ding, Hai
   Chen, Anping
   Tan, Shanzhong
   Zhang, Feng
   Shao, Jiangjuan
   Wang, Shijun
   Zheng, Shizhong
TI A novel lncRNA PLK4 up-regulated by talazoparib represses hepatocellular
   carcinoma progression by promoting YAP-mediated cell senescence
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article; Early Access
DE cellular senescence; hepatocellular carcinoma; polo-like kinase 4
   associated lncRNA; talazoparib; Yes-associated protein
ID LONG NONCODING RNA; SELF-RENEWAL; TUMOR-GROWTH; CANCER; HIPPO;
   METASTASIS; ACTIVATION; INHIBITION
AB A growing number of studies recognize that long non-coding RNAs (lncRNAs) are essential to mediate multiple tumorigenic processes, including hepatic tumorigenesis. However, the pathological mechanism of lncRNA-regulated liver cancer cell growth remains poorly understood. In this study, we identified a novel function lncRNA, named polo-like kinase 4 associated lncRNA (lncRNA PLK4, GenBank Accession No. RP11-50D9.3), whose expression was dramatically down-regulated in hepatocellular carcinoma (HCC) tissues and cells. Interestingly, talazoparib, a novel and highly potent poly-ADP-ribose polymerase 1/2 (PARP1/2) inhibitor, could increase lncRNA PLK4 expression in HepG2 cells. Importantly, we showed that talazoparib-induced lncRNA PLK4 could function as a tumour suppressor gene by Yes-associated protein (YAP) inactivation and induction of cellular senescence to inhibit liver cancer cell viability and growth. In summary, our findings reveal the molecular mechanism of talazoparib-induced anti-tumor effect, and suggest a potential clinical use of talazoparib-targeted lncRNA PLK4/YAP-dependent cellular senescence for the treatment of HCC.
C1 [Jia, Yan; Gao, Liyuan; Yang, Xiang; Wang, Feixia; Zhang, Feng; Shao, Jiangjuan; Zheng, Shizhong] Nanjing Univ Chinese Med, Sch Pharm, Dept Pharmacol, Nanjing, Peoples R China.
   [Jin, Huanhuan] Wannan Med Coll, Sch Pharm, Dept Pharmacol, Wuhu, Peoples R China.
   [Ding, Hai] Nanjing Second Hosp, Dept Surg, Nanjing, Peoples R China.
   [Chen, Anping] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.
   [Tan, Shanzhong] Nanjing Second Hosp, Dept Hepatol Integrated Tradit Chinese & Western, Nanjing, Peoples R China.
   [Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Pharmacol & Safety Evaluat Chines, Nanjing, Peoples R China.
   [Zhang, Feng; Zheng, Shizhong] Nanjing Univ Chinese Med, Jiangsu Key Lab Therapeut Mat Chinese Med, Nanjing, Peoples R China.
   [Wang, Shijun] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Shandong Coinnovat Ctr TCM Formula, Jinan, Peoples R China.
C3 Nanjing University of Chinese Medicine; Wannan Medical College; Saint
   Louis University; Nanjing University of Chinese Medicine; Nanjing
   University of Chinese Medicine; Shandong University of Traditional
   Chinese Medicine
RP Shao, JJ; Zheng, SZ (corresponding author), Nanjing Univ Chinese Med, 138 Xianlin Ave, Nanjing 210023, Jiangsu, Peoples R China.; Wang, SJ (corresponding author), Univ Tradit Chinese Med, 4655 Daxue Rd, Jinan 250035, Shandong, Peoples R China.
EM jjshao1976@163.com; wsj@sdutcm.edu.cn; nytws@163.com
RI Wang, Peiyun/JVE-1196-2024
OI Zheng, Shizhong/0000-0002-7092-7843; Shao, Jiangjuan/0000-0001-7658-9884
FU Open Project Program of Jiangsu Key Laboratory for Pharmacology and
   Safety Evaluation of Chinese Materia Medica [JKLPSE 201502]; University
   Science Research Project of Jiangsu Province [16KJB310010]; National
   Natural Science Foundation of China [31401210, 31571455, 31600653,
   81270514, 81600483]; Postgraduate Research & Practice Innovation Program
   of Jiangsu Province [KYCX181577]; Project of the Priority Academic
   Program Development of Jiangsu Higher Education Institutions
FX the Open Project Program of Jiangsu Key Laboratory for Pharmacology and
   Safety Evaluation of Chinese Materia Medica, Grant/Award Number: JKLPSE
   201502; University Science Research Project of Jiangsu Province,
   Grant/Award Number: 16KJB310010; National Natural Science Foundation of
   China, Grant/Award Number: 31401210, 31571455, 31600653, 81270514 and
   81600483; Postgraduate Research & Practice Innovation Program of Jiangsu
   Province, Grant/Award Number: KYCX181577; the Project of the Priority
   Academic Program Development of Jiangsu Higher Education Institutions
CR Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012
   Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634
   Chen RC, 2018, HEPATOLOGY, V67, P1823, DOI 10.1002/hep.29663
   Cho YS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04090-2
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Di Cecilia S, 2016, CANCER RES, V76, P5615, DOI 10.1158/0008-5472.CAN-15-1824
   Ding ZY, 2014, HEPATOLOGY, V60, P1620, DOI 10.1002/hep.27273
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Furth N, 2018, CELL DEATH DIFFER, V25, P81, DOI 10.1038/cdd.2017.163
   Guo J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03072-8
   He CB, 2019, EMBO REP, V20, DOI 10.15252/embr.201744948
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Holden JK, 2018, CANCERS, V10, DOI 10.3390/cancers10030081
   Huang YQ, 2018, CANCER LETT, V437, P56, DOI 10.1016/j.canlet.2018.08.024
   Iwagami Y, 2016, HEPATOLOGY, V63, P1213, DOI 10.1002/hep.28411
   Jeong SH, 2018, J CLIN INVEST, V128, P1010, DOI 10.1172/JCI95802
   Jin HH, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12431
   Jin HH, 2017, EUR J PHARM SCI, V96, P323, DOI 10.1016/j.ejps.2016.10.002
   Kanwal F, 2019, GASTROENTEROLOGY, V157, P54, DOI 10.1053/j.gastro.2019.02.049
   Keshavarz M, 2019, FEBS J, V286, P2611, DOI 10.1111/febs.14825
   Laird JH, 2018, CLIN CANCER RES, V24, P5143, DOI 10.1158/1078-0432.CCR-18-0401
   Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218
   Litton JK, 2018, NEW ENGL J MED, V379, P753, DOI 10.1056/NEJMoa1802905
   Liu RP, 2019, HEPATOLOGY, V70, P1317, DOI 10.1002/hep.30662
   Lok BH, 2017, CLIN CANCER RES, V23, P523, DOI 10.1158/1078-0432.CCR-16-1040
   Lu S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0676-x
   Lu WJ, 2014, CARCINOGENESIS, V35, P915, DOI 10.1093/carcin/bgt401
   Ma ML, 2019, HEPATOLOGY, V70, P215, DOI 10.1002/hep.30602
   Malakar P, 2019, CANCER RES, V79, P2480, DOI 10.1158/0008-5472.CAN-18-1432
   Martinez-Zamudio Ricardo Ivan, 2017, Cell, V170, P816, DOI 10.1016/j.cell.2017.07.049
   Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y
   Ni W, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0449-4
   Perra A, 2014, J HEPATOL, V61, P1088, DOI 10.1016/j.jhep.2014.06.033
   Qu K, 2013, CANCER LETT, V331, P105, DOI 10.1016/j.canlet.2012.12.008
   Rognoni E, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050411
   Seehawer M, 2018, NATURE, V562, P69, DOI 10.1038/s41586-018-0519-y
   Shi C, 2018, REDOX BIOL, V14, P59, DOI 10.1016/j.redox.2017.08.013
   Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013
   Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048
   Sun XH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08334-7
   Turner NC, 2019, CLIN CANCER RES, V25, P2717, DOI 10.1158/1078-0432.CCR-18-1891
   Wang JC, 2019, J CELL PHYSIOL, V234, P8709, DOI 10.1002/jcp.27530
   Wang JY, 2014, CELL SIGNAL, V26, P1048, DOI 10.1016/j.cellsig.2014.01.022
   Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819
   Wang Y, 2017, CANCER LETT, V385, P234, DOI 10.1016/j.canlet.2016.10.018
   Wang YL, 2019, HEPATOLOGY, V70, P259, DOI 10.1002/hep.30613
   Wei CH, 2018, CELL PHYSIOL BIOCHEM, V49, P447, DOI 10.1159/000492979
   White SM, 2019, ONCOGENE, V38, P2899, DOI 10.1038/s41388-018-0649-6
   Wong CM, 2018, NAT REV GASTRO HEPAT, V15, P137, DOI 10.1038/nrgastro.2017.169
   Xie Q, 2013, CANCER RES, V73, P3615, DOI 10.1158/0008-5472.CAN-12-3793
   Xu FY, 2019, CANCER RES, V79, P1305, DOI 10.1158/0008-5472.CAN-18-1659
   Yang LX, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.464
   Yang XM, 2018, GASTROENTEROLOGY, V155, P1233, DOI 10.1053/j.gastro.2018.07.010
   Zhang H, 2019, HEPATOLOGY, V69, P1046, DOI 10.1002/hep.30300
   Zheng X, 2017, EMBO J, V36, P3325, DOI 10.15252/embj.201797609
   Zhu PP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13608
   Zhuo W, 2017, NAT CELL BIOL, V19, P81, DOI 10.1038/ncb3467
NR 57
TC 14
Z9 15
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-1838
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD 2020 MAY
PY 2020
VL 24
IS 9
BP 5304
EP 5316
DI 10.1111/jcmm.15186
EA APR 2020
PG 13
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA LK3ZD
UT WOS:000523222800001
PM 32243714
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Li, YC
   Lua, I
   French, SW
   Asahina, K
AF Li, Yuchang
   Lua, Ingrid
   French, Samuel W.
   Asahina, Kinji
TI Role of TGF-β signaling in differentiation of mesothelial cells to
   vitamin A-poor hepatic stellate cells in liver fibrosis
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE capsular fibrosis; fibrosis regression; Glisson's capsule;
   myofibroblasts; vitamin A
ID TISSUE GROWTH-FACTOR; MESENCHYMAL TRANSITION; MYOFIBROBLASTS; MOUSE;
   RECEPTOR; MICE; IDENTIFICATION; REGENERATION; SENESCENCE; REGRESSION
AB Mesothelial cells (MCs) form a single layer of the mesothelium and cover the liver surface. A previous study demonstrated that, upon liver injury, MCs migrate inward from the liver surface and give rise to hepatic stellate cells (HSCs) in biliary fibrosis induced by bile duct ligation (BDL) or myofibroblasts in CCl4-induced fibrosis. The present study analyzed the role of transforming growth factor-beta (TGF-beta) signaling in mesothelial-mesenchymal transition (MMT) and the fate of MCs during liver fibrosis and its regression. Deletion of TGF-beta type II receptor (Tgfbr2) gene in cultured MCs suppressed TGF-beta beta-mediated myofibroblastic conversion. Conditional deletion of Tgfbr2 gene in MCs reduced the differentiation of MCs to HSCs and myofibroblasts in the BDL and CCl4 models, respectively, indicating that the direct TGF-beta signaling in MCs is responsible to MMT. After BDL and CCl4 treatment, MC-derived HSCs and myofibroblasts were distributed near the liver surface and the thickness of collagen was increased in Glisson's capsule beneath the liver surface. Fluorescence-activated cell sorting analysis revealed that MC-derived HSCs and myofibroblasts store little vitamin A lipids and have fibrogenic phenotype in the fibrotic livers. MCs contributed to 1.4 and 2.0% of activated HSCs in the BDL and CCl4 models, respectively. During regression of CCl4-induced fibrosis, 20% of MC-derived myofibroblasts survived in the liver and deactivated to vitamin A-poor HSCs. Our data indicate that MCs participate in capsular fibrosis by supplying vitamin A-poor HSCs during a process of liver fibrosis and regression.
C1 [Li, Yuchang; Lua, Ingrid; Asahina, Kinji] Univ So Calif, Keck Sch Med, Dept Pathol, Southern Calif Res Ctr ALPD & Cirrhosis, 1333 San Pablo St,MMR 301, Los Angeles, CA 90033 USA.
   [French, Samuel W.] Harbor UCLA Med Ctr, Dept Pathol, Torrance, CA 90509 USA.
C3 University of Southern California; University of California System;
   University of California Los Angeles; University of California Los
   Angeles Medical Center
RP Asahina, K (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Southern Calif Res Ctr ALPD & Cirrhosis, 1333 San Pablo St,MMR 301, Los Angeles, CA 90033 USA.
EM asahina@usc.edu
RI Asahina, Kinji/X-8794-2019
OI Asahina, Kinji/0000-0003-0398-8395
FU NIH [R01AA020753]; Robert E. and May R. Wright foundation award; 
   [P50AA011999];  [P30DK048522];  [T32HD060549]
FX This work was supported by NIH grant R01AA020753 (to K. Asahina), pilot
   project funding (to K. Asahina) from P50AA011999, pilot project funding
   (to K. Asahina) from P30DK048522, training program (to I. Lua) from
   T32HD060549, and the Robert E. and May R. Wright foundation award (to K.
   Asahina).
CR Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826
   Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119
   Asahina K, 2009, HEPATOLOGY, V49, P998, DOI 10.1002/hep.22721
   Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023
   Chapman GB, 2007, TISSUE CELL, V39, P343, DOI 10.1016/j.tice.2007.06.005
   Chen L, 2011, J HEPATOL, V55, P399, DOI 10.1016/j.jhep.2010.11.025
   Dixit R, 2013, DEVELOPMENT, V140, P4398, DOI 10.1242/dev.098079
   Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758
   Levéen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560
   Li YC, 2013, P NATL ACAD SCI USA, V110, P2324, DOI 10.1073/pnas.1214136110
   Lua I, 2015, AM J PATHOL, V185, P3258, DOI 10.1016/j.ajpath.2015.08.009
   Lua I, 2014, HEPATOLOGY, V60, P311, DOI 10.1002/hep.27035
   Mutsaers SE, 2004, INT J BIOCHEM CELL B, V36, P9, DOI 10.1016/S1357-2725(03)00242-5
   Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335
   Ogawa T, 2007, HISTOCHEM CELL BIOL, V127, P161, DOI 10.1007/s00418-006-0237-7
   Onitsuka I, 2010, GASTROENTEROLOGY, V138, P1525, DOI 10.1053/j.gastro.2009.12.059
   Pellicoro A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S26
   Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   RAMM GA, 1995, AM J PHYSIOL-GASTR L, V269, pG532, DOI 10.1152/ajpgi.1995.269.4.G532
   Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378
   Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028
   Testerink N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034945
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Winters NI, 2012, DEVELOPMENT, V139, P2926, DOI 10.1242/dev.082396
   Yang MD, 2012, HEPATOLOGY, V55, P1271, DOI 10.1002/hep.24792
   Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067
   Yata Y, 2002, HEPATOLOGY, V35, P1022, DOI 10.1053/jhep.2002.32673
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060
NR 35
TC 24
Z9 28
U1 0
U2 11
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD FEB 15
PY 2016
VL 310
IS 4
BP G262
EP G272
DI 10.1152/ajpgi.00257.2015
PG 11
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA DD7TL
UT WOS:000370127000006
PM 26702136
OA Green Published
DA 2024-02-19
ER

PT J
AU Wei, PF
   Li, LX
   Ran, CQ
   Jin, MY
   Zhao, HJ
   Yang, KLE
   Wang, Y
   He, HQ
   Jia, MY
   Pan, HY
   Li, Q
   Guo, J
AF Wei, Pengfei
   Li, Lixuan
   Ran, Chenqiu
   Jin, Mingyue
   Zhao, Huijuan
   Yang, Kelaier
   Wang, Yu
   He, Huaqiu
   Jia, Mengyang
   Pan, Hongyan
   Li, Qiang
   Guo, Jing
TI High fat diet-induced downregulation of TRPV2 mediates hepatic steatosis
   via <i>p21</i> signalling
SO JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article; Early Access
DE Fatty liver; Hepatic steatosis; Lipid accumulation; TRPV2; p21
ID PROGRESSIVE FIBROSIS; SERIES LIPOTOXICITY; CELL-DEATH; ER STRESS;
   CHANNELS; MOUSE; HEPATOCYTES; ACTIVATION; THERMOGENESIS; REGENERATION
AB The global prevalence and incidence of non-alcoholic fatty liver disease (NAFLD) are exhibiting an increasing trend. NAFLD is characterized by a significant accumulation of lipids, though its underlying mechanism is still unknown. Here we report that high-fat diet (HFD) feeding induced hepatic steatosis in mice, which was accompanied by a reduction in the expression and function of hepatic TRPV2. Moreover, conditional knockout of TRPV2 in hepatocytes exacerbated HFD-induced hepatic steatosis. In an in vitro model of NAFLD, TRPV2 regulated lipid accumulation in HepG2 cells, and TRPV2 activation inhibited the expression of the cellular senescence markers p21 and p16, all of which were mediated by AMPK phosphorylation. Finally, we found that administration of probenecid, a TRPV2 agonist, impaired HFD-induced hepatic steatosis and suppressed HFD-induced elevation in p21 and p16. Collectively, our findings imply that hepatic TRPV2 protects against the accumulation of lipids by modulating p21 signalling.
C1 [Wei, Pengfei; Jin, Mingyue; Zhao, Huijuan; Yang, Kelaier; Wang, Yu; He, Huaqiu; Jia, Mengyang; Pan, Hongyan; Li, Qiang; Guo, Jing] Shenzhen Univ, Shenzhen Univ Gen Hosp, Dept Endocrinol & Metab, Shenzhen 518052, Guangdong, Peoples R China.
   [Wei, Pengfei; Jin, Mingyue; Zhao, Huijuan; Yang, Kelaier; Wang, Yu; He, Huaqiu; Jia, Mengyang; Pan, Hongyan; Li, Qiang; Guo, Jing] Shenzhen Univ, Acad Clin Med Sci, Shenzhen 518052, Guangdong, Peoples R China.
   [Li, Lixuan] Guangdong Med Univ, Zhanjiang 524023, Guangdong, Peoples R China.
   [Ran, Chenqiu] Shenzhen Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Shenzhen, Peoples R China.
C3 Shenzhen University; Shenzhen University; Guangdong Medical University;
   Shenzhen University
RP Li, Q; Guo, J (corresponding author), Shenzhen Univ, Shenzhen Univ Gen Hosp, Dept Endocrinol & Metab, Shenzhen 518052, Guangdong, Peoples R China.; Li, Q; Guo, J (corresponding author), Shenzhen Univ, Acad Clin Med Sci, Shenzhen 518052, Guangdong, Peoples R China.
EM qiangli@szu.edu.cn; guojing@szu.edu.cn
OI Huaqiu, He/0000-0003-2246-5362; WANG, YU/0000-0001-7873-4002; Jin,
   Mingyue/0000-0003-0552-8608; JIA, Mengyang Jia/0000-0003-3914-8304
FU National Natural Science Foundation of China [81900517]; Shenzhen
   Science and Technology Program [JCYJ20190808151805516]; Natural Science
   Foundation of Shenzhen University General Hospital [SUGH2019QD015,
   SUGH2018QD008]
FX This work was supported by the National Natural Science Foundation of
   China (Grant: 81900517), Shenzhen Science and Technology Program (Grant:
   JCYJ20190808151805516), and Natural Science Foundation of Shenzhen
   University General Hospital (Grants: SUGH2019QD015 and SUGH2018QD008).
CR Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Bort A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071660
   CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2
   Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011
   Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6
   Eynaudi A, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.775382
   Feng Q, 2019, DIABETES METAB SYNDR, V12, P2755, DOI 10.2147/DMSO.S210764
   Ferreira-Gonzalez S, 2021, SEMIN LIVER DIS, V41, P50, DOI 10.1055/s-0040-1722262
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Guo J, 2019, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00661
   Guy CD, 2012, HEPATOLOGY, V55, P1711, DOI 10.1002/hep.25559
   Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hilton JK, 2015, BIOCHEMISTRY-US, V54, P2401, DOI 10.1021/acs.biochem.5b00071
   Hirsova P, 2016, J LIPID RES, V57, P1758, DOI 10.1194/jlr.R066357
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Hsu WL, 2020, AGING CELL, V19, DOI 10.1111/acel.13075
   Hydbring P, 2010, AGING-US, V2, P244, DOI 10.18632/aging.100140
   Kreis NN, 2019, CANCERS, V11, DOI 10.3390/cancers11091220
   LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350
   Li L, 2012, PFLUG ARCH EUR J PHY, V463, P727, DOI 10.1007/s00424-012-1078-y
   Meijnikman AS, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100301
   Moustakas II, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073446
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Rychkov GY, 2011, ADV EXP MED BIOL, V704, P667, DOI 10.1007/978-94-007-0265-3_35
   Sacks D, 2018, INT J STROKE, V13, P612, DOI [10.1016/j.jvir.2017.11.026, 10.1177/1747493018778713]
   Severgnini M, 2012, CYTOTECHNOLOGY, V64, P187, DOI 10.1007/s10616-011-9407-0
   Sun WP, 2017, CHANNELS, V11, P94, DOI 10.1080/19336950.2016.1228401
   Sun WP, 2016, PFLUG ARCH EUR J PHY, V468, P1527, DOI 10.1007/s00424-016-1846-1
   Sun WP, 2016, EMBO REP, V17, P383, DOI 10.15252/embr.201540819
   Tomita K, 2012, J HEPATOL, V57, P837, DOI 10.1016/j.jhep.2012.05.013
   Torbenson M, 2002, AM J PATHOL, V161, P155, DOI 10.1016/S0002-9440(10)64167-3
   Vriens J, 2004, CELL CALCIUM, V36, P19, DOI 10.1016/j.ceca.2003.11.006
   Yue ZC, 2015, AM J PHYSIOL-HEART C, V308, pH157, DOI 10.1152/ajpheart.00457.2014
   Zeng X, 2020, NUTR METAB, V17, DOI 10.1186/s12986-020-0434-8
NR 39
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1138-7548
EI 1877-8755
J9 J PHYSIOL BIOCHEM
JI J. Physiol. Biochem.
PD 2024 FEB
PY 2024
VL 80
IS 1
BP 113
EP 126
DI 10.1007/s13105-023-00988-8
EA OCT 2023
PG 14
WC Biochemistry & Molecular Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Physiology
GA FS1R1
UT WOS:001096151200001
PM 37882938
DA 2024-02-19
ER

PT J
AU Wilkinson, AL
   Hulme, S
   Kennedy, JI
   Mann, ER
   Horn, P
   Shepherd, EL
   Yin, KL
   Zaki, MYW
   Hardisty, G
   Lu, WY
   Rantakari, P
   Adams, DH
   Salmi, M
   Hoare, M
   Patten, DA
   Shetty, S
AF Wilkinson, Alex L.
   Hulme, Samuel
   Kennedy, James I.
   Mann, Emily R.
   Horn, Paul
   Shepherd, Emma L.
   Yin, Kelvin
   Zaki, Marco Y. W.
   Hardisty, Gareth
   Lu, Wei-Yu
   Rantakari, Pia
   Adams, David H.
   Salmi, Marko
   Hoare, Matthew
   Patten, Daniel A.
   Shetty, Shishir
TI The senescent secretome drives PLVAP expression in cultured human
   hepatic endothelial cells to promote monocyte transmigration
SO ISCIENCE
LA English
DT Article; Early Access
ID CYCLIN-DEPENDENT KINASE; GROWTH-FACTOR; PAL-E; PROTEIN PLVAP; RAT-LIVER;
   LYMPHOCYTES; INCREASES; FETAL; SURVEILLANCE; PERMEABILITY
AB Liver sinusoidal endothelial cells (LSEC) undergo significant phenotypic change in chronic liver disease (CLD), and yet the factors that drive this process and the impact on their function as a vascular barrier and gatekeeper for immune cell recruitment are poorly understood. Plasmalemma-vesicle-associated protein (PLVAP) has been characterized as a marker of LSEC in CLD; notably we found that PLVAP upregulation strongly correlated with markers of tissue senescence. Furthermore, exposure of human LSEC to the senescence-associated secretory phenotype (SASP) led to a significant upregulation of PLVAP. Flow based assays demonstrated that SASP-driven leukocyte recruitment was characterized by paracellular transmigration of monocytes while the majority of lymphocytes migrated transcellularly. Knockdown studies confirmed that PLVAP selectively supported monocyte transmigration mediated through PLVAP's impact on LSEC permeability by regulating phospho-VE-cadherin expression and endothelial gap formation. PLVAP may therefore represent an endothelial target that selectively shapes the senescence-mediated immune microenvironment in liver disease.
C1 [Wilkinson, Alex L.; Hulme, Samuel; Kennedy, James I.; Mann, Emily R.; Horn, Paul; Adams, David H.; Patten, Daniel A.; Shetty, Shishir] Univ Birmingham, Ctr Liver & Gastrointestinal Res, Inst Immunol & Immunotherapy, Birmingham B15 2TT, England.
   [Yin, Kelvin; Hoare, Matthew] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.
   [Zaki, Marco Y. W.] Minia Univ, Fac Pharm, Dept Biochem, Al Minya, Egypt.
   [Zaki, Marco Y. W.; Hardisty, Gareth] Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH8 9YL, Scotland.
   [Hardisty, Gareth; Lu, Wei-Yu] Univ Turku, Inst Biomed, Turku, Finland.
   [Rantakari, Pia; Salmi, Marko] Univ Turku, MediCity Res Lab, Turku, Finland.
   [Hoare, Matthew] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England.
   [Patten, Daniel A.; Shetty, Shishir] Univ Hosp Birmingham NHS Fdn Trust, Natl Inst Hlth Res, Birmingham Biomed Res Ctr, Birmingham, England.
   [Shepherd, Emma L.] Aston Univ, Coll Hlth & Life Sci, Birmingham B4 7ET, England.
C3 University of Birmingham; Cancer Research UK; University of Cambridge;
   CRUK Cambridge Institute; Egyptian Knowledge Bank (EKB); Minia
   University; University of Edinburgh; University of Turku; University of
   Turku; Cambridge University Hospitals NHS Foundation Trust;
   Addenbrooke's Hospital; University of Cambridge; University of
   Birmingham; Aston University
RP Shetty, S (corresponding author), Univ Birmingham, Ctr Liver & Gastrointestinal Res, Inst Immunol & Immunotherapy, Birmingham B15 2TT, England.; Shetty, S (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Natl Inst Hlth Res, Birmingham Biomed Res Ctr, Birmingham, England.
EM s.shetty@bham.ac.uk
RI Shetty, Shishir/AAU-4047-2021; Horn, Paul/O-6885-2015; Lu,
   Wei-Yu/Q-8130-2018
OI Shetty, Shishir/0000-0002-4729-2173; Horn, Paul/0000-0002-8755-7703;
   Rantakari, Pia/0000-0003-1638-5075; Lu, Wei-Yu/0000-0002-0419-0257;
   Shepherd, Emma/0000-0002-1345-1746
FU Wellcome Trust Ph.D studentship in Mechanisms of Inflammatory Disease;
   Medical Research Council [MR/R010013/1]; Cancer Research UK Advanced
   Clinician Scientist Fellowship [C53575/A29959]; Engineering and Physical
   Sciences Research Council LifETIME CDT Ph.D studentship - Newton Prize;
   CRUK Advanced Clinician Scientist Fellowship [C52489/A19924,
   C52489/A29681]; CRUK Accelerator Award [C18873/A26813]; Cancer Research
   United Kingdom; Fondazione AIRC; NIHR Birmingham Biomedical Research
   Center at the University Hospitals Birmingham NHS Trust; University of
   Birmingham
FX ALW was funded by a Wellcome Trust Ph.D studentship in Mechanisms of
   Inflammatory Disease and a follow-on fund awarded by the University of
   Birmingham. DAP and SS are funded by a Medical Research Council Project
   Grant (MR/R010013/1) and a Cancer Research UK Advanced Clinician
   Scientist Fellowship (C53575/A29959) awarded to SS. JIK is funded by an
   Engineering and Physical Sciences Research Council LifETIME CDT Ph.D
   studentship. MYWZ and SS are funded by the Newton Prize 2020 as a part
   of the UK's Official Development Assis-tance "ODA"and the Newton fund.
   MH is supported by a CRUK Advanced Clinician Scientist Fellowship
   (C52489/A19924) ; CRUK-OHSU Project Award (C52489/A29681) ; and CRUK
   Accelerator Award to the HUNTER consortium (C18873/A26813) funded
   through a partnership be-tween Cancer Research United Kingdom,
   Fondazione AIRC, and Fundacion Cientifica de la Asociacion Espanola
   Contra el Cancer. This paper represents independent research supported
   by the NIHR Birmingham Biomedical Research Center at the University
   Hospitals Birmingham NHS Trust. The views expressed are those of the
   authors and not necessarily those of the NHS, the NIHR, or the
   Department of Health and Social Care. We thank the patients and clinical
   staff from the Queen Elizabeth Hospital, Birmingham for donation and
   collection of tissue and blood. We also thank Dr Gary Reynolds, Subin
   Modit, and Janine Fear for their technical assistance.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Archambault AJ, 2001, LIVER TRANSPLANT, V7, P988, DOI 10.1053/jlts.2001.28444
   ARTHUR MJP, 1989, J CLIN INVEST, V84, P1076, DOI 10.1172/JCI114270
   Arts JJG, 2021, ELIFE, V10, DOI 10.7554/eLife.66074
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   BARDADIN KA, 1991, J PATHOL, V164, P253, DOI 10.1002/path.1711640311
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Bocca C, 2015, CELL MOL GASTROENTER, V1, P477, DOI 10.1016/j.jcmgh.2015.06.011
   Bodor C, 2012, AM J PHYSIOL-CELL PH, V302, pC267, DOI 10.1152/ajpcell.00138.2011
   Carson-Walter EB, 2005, CLIN CANCER RES, V11, P7643, DOI 10.1158/1078-0432.CCR-05-1099
   Crary GS, 1998, HEPATOLOGY, V28, P738, DOI 10.1002/hep.510280320
   Desroches-Castan A, 2019, HEPATOLOGY, V70, P1392, DOI 10.1002/hep.30655
   Donahower B, 2006, AM J PHYSIOL-GASTR L, V291, pG102, DOI 10.1152/ajpgi.00575.2005
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Escribano J, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006395
   Ferreira-Gonzalez S, 2021, SEMIN LIVER DIS, V41, P50, DOI 10.1055/s-0040-1722262
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Geneva World Health Organisation, 2020, About us
   Hamilton BJ, 2019, J CELL MOL MED, V23, P920, DOI 10.1111/jcmm.13993
   Heemskerk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10493
   Herrnberger L, 2012, HISTOCHEM CELL BIOL, V138, P709, DOI 10.1007/s00418-012-0987-3
   Hoare M, 2018, ANNU REV CANC BIOL, V2, P175, DOI 10.1146/annurev-cancerbio-030617-050352
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Holt AP, 2008, CLIN LIVER DIS, V12, P861, DOI 10.1016/j.cld.2008.07.002
   Holt AP, 2009, GASTROENTEROLOGY, V136, P705, DOI 10.1053/j.gastro.2008.10.020
   International Agency for Research on Cancer, 2018, US
   Ishikawa K, 1999, BIOCHEM BIOPH RES CO, V254, P587, DOI 10.1006/bbrc.1998.9984
   Iwakiri Y, 2014, J HEPATOL, V61, P912, DOI 10.1016/j.jhep.2014.05.047
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Keuschnigg J, 2009, BLOOD, V114, P478, DOI 10.1182/blood-2008-11-188763
   Kim SA, 2020, BIOCHEM BIOPH RES CO, V522, P240, DOI 10.1016/j.bbrc.2019.11.085
   Lalor PF, 2002, J IMMUNOL, V169, P983, DOI 10.4049/jimmunol.169.2.983
   Liu P, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.589908
   Love M. I., 2017, Bioconductor, V2, P1, DOI DOI 10.1186/S13059-014-0550-8
   Lunz JG, 2005, HEPATOLOGY, V41, P1262, DOI 10.1002/hep.20709
   McGuinness PH, 2000, GUT, V46, P260, DOI 10.1136/gut.46.2.260
   Morse MA, 2019, CLIN CANCER RES, V25, P912, DOI 10.1158/1078-0432.CCR-18-1254
   Muradashvili N, 2014, CELL BIOCHEM BIOPHYS, V69, P283, DOI 10.1007/s12013-013-9797-z
   Nakagami Y, 2019, EUR J PHARMACOL, V854, P240, DOI 10.1016/j.ejphar.2019.04.035
   Niemelä H, 2005, BLOOD, V106, P3405, DOI 10.1182/blood-2005-01-0254
   O'Rourke JM, 2018, WORLD J GASTROENTERO, V24, P4436, DOI 10.3748/wjg.v24.i39.4436
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Patten DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17928-4
   Patten DA, 2017, HEPATOLOGY, V65, P294, DOI 10.1002/hep.28879
   Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3
   Rantakari P, 2016, NATURE, V538, P392, DOI 10.1038/nature19814
   Rantakari P, 2015, NAT IMMUNOL, V16, P386, DOI 10.1038/ni.3101
   SCHLINGEMANN RO, 1985, LAB INVEST, V52, P71
   Sharma A, 2020, CELL, V183, P377, DOI 10.1016/j.cell.2020.08.040
   Shetty S, 2018, NAT REV GASTRO HEPAT, V15, P555, DOI 10.1038/s41575-018-0020-y
   Shetty S, 2014, JOVE-J VIS EXP, DOI 10.3791/51330
   Shetty S, 2012, HEPATOLOGY, V56, P1521, DOI 10.1002/hep.25790
   Shetty S, 2011, J IMMUNOL, V186, P4147, DOI 10.4049/jimmunol.1002961
   Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1
   Soulas C, 2011, AM J PATHOL, V178, P2121, DOI 10.1016/j.ajpath.2011.01.023
   Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003
   Stan RV, 2004, MOL BIOL CELL, V15, P3615, DOI 10.1091/mbc.E03-08-0593
   Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203
   Strickland LA, 2005, J PATHOL, V206, P466, DOI 10.1002/path.1805
   Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025
   Wan Y, 2017, AM J PATHOL, V187, P2788, DOI 10.1016/j.ajpath.2017.08.027
   Wasserman SM, 2002, PHYSIOL GENOMICS, V12, P13, DOI 10.1152/physiolgenomics.00102.2002
   Wilkinson AL, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00990
   Yin KL, 2022, GENE DEV, V36, P533, DOI 10.1101/gad.349585.122
   Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895
NR 66
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2589-0042
J9 ISCIENCE
JI iScience
PD 2023 OCT 20
PY 2023
VL 26
IS 10
AR 107966
DI 10.1016/j.isci.2023.107966
EA SEP 2023
PG 23
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA W0YF9
UT WOS:001088965000001
PM 37810232
OA Green Published, Green Accepted, gold
DA 2024-02-19
ER

PT J
AU Dolfi, C
   Bergamini, E
   Carresi, C
   Cavallini, G
   Donati, A
   Maccheroni, M
   Parentini, I
   Marino, M
   Gori, Z
AF Dolfi, C
   Bergamini, E
   Carresi, C
   Cavallini, G
   Donati, A
   Maccheroni, M
   Parentini, I
   Marino, M
   Gori, Z
TI The age-related accumulation of dolichol in rat liver may correlate with
   expectation of life
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; dolichol accumulation; food restriction; rat liver
ID FOOD RESTRICTION; HUMAN-TISSUES; CHOLESTEROL; LONGEVITY; DECLINE;
   PROTEIN; GROWTH
AB In order to test the hypothesis that the ageing-related alteration in membrane lipids might reflect the biological age of rodents, the levels of liver dolichol were assayed by the HPLC procedure in male ad-libitum fed (AL) Sprague-Dawley rats aged 2, 6, 12 and 24 months, and in 24-month-old rats on anti-aging food-restrictions (FR) differing in duration and in their effects on longevity. Results showed that the effects on liver dolichol of FR initiated at 2, 6 and 12 months of age, or initiated at 2 and interrupted at 18 months of age were significantly different, and reflected the differences in the effects of FR on expectation of life (the longer the expected residual lifespan the lower the content in liver dolichol). The conclusion is that assay of the quantity of dolichol in the liver tissue may be used as a marker of the biological age of the animal and therefore as an important biomarker of ageing.
C1 Univ Pisa, Dipartimento Patol Sperimentale Biotecnol Med Inf, Pisa, Italy.
   Azienda Osped Pisana, Pisa, Italy.
   Univ Roma Tre, Dipartimento Biol, Rome, Italy.
C3 University of Pisa; University of Pisa; Azienda Ospedaliero
   Universitaria Pisana; Roma Tre University
RP Bergamini, E (corresponding author), Univ Pisa, Dipartimento Patol Sperimentale Biotecnol Med Inf, Pisa, Italy.
CR BEAUCHENE RE, 1986, J GERONTOL, V41, P13, DOI 10.1093/geronj/41.1.13
   CARROLL KK, 1992, BIOCHEM CELL BIOL, V70, P382, DOI 10.1139/o92-059
   Cavallini G, 2002, AGING CLIN EXP RES, V14, P152
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   CHOINACKI T, 1988, BIOCHEM J, V251, P1
   CONCONI M, 1996, ARCH BIOCHEM BIOPHYS, V309, P24
   CRICK DC, 1987, BIOCHEM CELL BIOL, V65, P317, DOI 10.1139/o87-041
   Dini B, 2001, EXP GERONTOL, V37, P99, DOI 10.1016/S0531-5565(01)00156-5
   GOODRICK CL, 1982, GERONTOLOGY, V28, P233, DOI 10.1159/000212538
   ISHINAGA M, 1993, P SOC EXP BIOL MED, V203, P74, DOI 10.3181/00379727-203-43575
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   KELLER RK, 1986, LIPIDS, V21, P353, DOI 10.1007/BF02535700
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Marino M, 1998, J GERONTOL A-BIOL, V53, pB87, DOI 10.1093/gerona/53A.2.B87
   Marino M, 2002, MECH AGEING DEV, V123, P1183, DOI 10.1016/S0047-6374(02)00009-X
   Nanni G, 2000, LIFE SCI, V67, P2293, DOI 10.1016/S0024-3205(00)00819-5
   PULLARKAT RK, 1984, BIOCHIM BIOPHYS ACTA, V793, P494, DOI 10.1016/0005-2760(84)90269-8
   Sell DR, 1996, P NATL ACAD SCI USA, V93, P485, DOI 10.1073/pnas.93.1.485
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   THELIN A, 1994, MECH AGEING DEV, V76, P165, DOI 10.1016/0047-6374(94)91591-1
   Vittorini S, 1999, J GERONTOL A-BIOL, V54, pB318, DOI 10.1093/gerona/54.8.B318
NR 21
TC 13
Z9 14
U1 0
U2 0
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-5729
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2003
VL 4
IS 2
BP 113
EP 118
DI 10.1023/A:1023304021679
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 668CK
UT WOS:000182272600006
PM 12766536
DA 2024-02-19
ER

PT J
AU DEVASAGAYAM, TPA
   PUSHPENDRAN, CK
AF DEVASAGAYAM, TPA
   PUSHPENDRAN, CK
TI CHANGES IN ASCORBATE-INDUCED LIPID-PEROXIDATION OF HEPATIC ROUGH AND
   SMOOTH MICROSOMES DURING POSTNATAL-DEVELOPMENT AND AGING OF RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
RP DEVASAGAYAM, TPA (corresponding author), BHABHA ATOM RES CTR,DIV BIOCHEM,BOMBAY 400085,INDIA.
CR [Anonymous], [No title captured]
   Bus J. S., 1979, REV BIOCH TOXICOLOGY, P125
   DEPIERRE JW, 1975, BIOCHIM BIOPHYS ACTA, V415, P411, DOI 10.1016/0304-4157(75)90006-4
   DEVASAGAYAM TPA, 1983, BIOCHIM BIOPHYS ACTA, V750, P91, DOI 10.1016/0005-2760(83)90207-2
   DEVASAGAYAM TPA, 1983, MECH AGEING DEV, V21, P365, DOI 10.1016/0047-6374(83)90053-2
   DEVASAGAYAM TPA, 1979, BIOCHEM PHARMACOL, V28, P1731, DOI 10.1016/0006-2952(79)90533-1
   DHAMI MSI, 1981, RES COMMUN CHEM PATH, V32, P99
   Fleischer S, 1974, Methods Enzymol, V31, P6
   GILLETTE JR, 1979, FED PROC, V38, P1900
   GRINNA LS, 1977, MECH AGEING DEV, V6, P197, DOI 10.1016/0047-6374(77)90021-5
   GRINNA LS, 1973, BIOCHEM BIOPH RES CO, V55, P773, DOI 10.1016/0006-291X(73)91211-4
   HAGIHARA M, 1984, J GERONTOL, V39, P269, DOI 10.1093/geronj/39.3.269
   Hirai S., 1982, LIPID PEROXIDES BIOL, P305, DOI [10.1016/B978-0-12-768050-7.50026-3, DOI 10.1016/B978-0-12-768050-7.50026-3]
   OTTOLENGHI A, 1959, ARCH BIOCHEM BIOPHYS, V79, P355, DOI 10.1016/0003-9861(59)90414-X
   PLAYER TJ, 1977, BIOCHEM BIOPH RES CO, V78, P1397, DOI 10.1016/0006-291X(77)91447-4
   PUSHPENDRAN CK, 1980, INDIAN J EXP BIOL, V18, P1016
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   SAGAI M, 1980, LIFE SCI, V27, P731, DOI 10.1016/0024-3205(80)90326-4
   SCHMUCKER DL, 1981, MECH AGEING DEV, V15, P189, DOI 10.1016/0047-6374(81)90074-9
   SCHMUCKER DL, 1977, SCIENCE, V197, P1005, DOI 10.1126/science.887935
   SIKIC BI, 1977, ARCH BIOCHEM BIOPHYS, V179, P663, DOI 10.1016/0003-9861(77)90155-2
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   TAPPEL AL, 1973, FED PROC, V32, P1870
   TAYLOR SL, 1976, LIPIDS, V11, P530, DOI 10.1007/BF02532898
   WILLS ED, 1969, BIOCHEM J, V113, P315, DOI 10.1042/bj1130315
NR 25
TC 18
Z9 18
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAR
PY 1986
VL 34
IS 1
BP 13
EP 21
DI 10.1016/0047-6374(86)90101-6
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA C3676
UT WOS:A1986C367600002
PM 3713268
DA 2024-02-19
ER

PT J
AU Ju, LL
   Sun, Y
   Xue, H
   Chen, L
   Gu, CY
   Shao, JG
   Lu, RJ
   Luo, X
   Wei, J
   Ma, X
   Bian, ZL
AF Ju, Linling
   Sun, Yan
   Xue, Hong
   Chen, Lin
   Gu, Chunyan
   Shao, Jianguo
   Lu, Rujian
   Luo, Xi
   Wei, Jue
   Ma, Xiong
   Bian, Zhaolian
TI CCN1 promotes hepatic steatosis and inflammation in non-alcoholic
   steatohepatitis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LIVER FIBROSIS; PROTEINS; SENESCENCE; CYR61/CCN1
AB Non-alcoholic fatty liver disease (NAFLD) is characterized by increased uptake and accumulation of lipids in hepatocytes. Simple steatosis may progress to non-alcoholic steatohepatitis (NASH) with inflammation, hepatocellular injury and fibrosis. CCN1 is an important matrix protein that regulates cell death and promotes immune cell adhesion and may potentially control this process. The role of CCN1 in NASH remains unclear. We investigated the role of CCN1 in the pathogenesis of steatohepatitis. CCN1 upregulation was found to be closely related with steatosis in patients with NASH, obese mice and a FFA-treated hepatocyte model. Controlling the expression of CCN1 in murine NASH models demonstrated that CCN1 increased the severity of steatosis and inflammation. From the sequence results, we found that fatty acid metabolism genes were primarily involved in the MCD mice overexpressing CCN1 compared to the control. Then, the expression of fatty acid metabolism genes was determined using a custom-designed pathway-focused qPCR-based gene expression array. Expression analysis showed that CCN1 overexpression significantly upregulated the expression of fatty acid metabolism-associated genes. In vitro analysis revealed that CCN1 increased the intracellular TG content, the pro-inflammatory cytokines and the expression level of apoptosis-associated proteins in a steatosis model using murine primary hepatocytes. We identified CCN1 as an important positive regulator in NASH.
C1 [Ju, Linling; Chen, Lin; Shao, Jianguo; Luo, Xi; Bian, Zhaolian] Nantong Univ, Nantong Inst Liver Dis, Dept Gastroenterol & Hepatol, Nantong Peoples Hosp 3, Nantong, Jiangsu, Peoples R China.
   [Sun, Yan] Nantong Univ, Dept Neurol, Affiliated Hosp, Nantong, Jiangsu, Peoples R China.
   [Xue, Hong] Nantong Univ, Nantong Peoples Hosp 3, Liver Dis Infect Dis, Nantong, Jiangsu, Peoples R China.
   [Gu, Chunyan] Nantong Univ, Nantong Peoples Hosp 3, Dept Pathol, Nantong, Jiangsu, Peoples R China.
   [Lu, Rujian] Nantong Univ, Nantong Peoples Hosp 3, Dept Cardiothorac Surg, Nantong, Jiangsu, Peoples R China.
   [Wei, Jue] Shanghai Jiao Tong Univ, Tongren Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China.
   [Ma, Xiong] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes,Key Lab G, Div Gastroenterol & Hepatol,Ren Ji Hosp,Sch Med, Shanghai Inst Digest Dis,Shanghai Canc Inst,Minis, Shanghai, Peoples R China.
C3 Nantong University; Nantong University; Nantong University; Nantong
   University; Nantong University; Shanghai Jiao Tong University; Shanghai
   Jiao Tong University
RP Bian, ZL (corresponding author), Nantong Univ, Nantong Inst Liver Dis, Dept Gastroenterol & Hepatol, Nantong Peoples Hosp 3, Nantong, Jiangsu, Peoples R China.
EM bianzhaolian1998@163.com
OI Ma, Xiong/0000-0001-9616-4672
FU National Natural Science Foundation of China [81600449, 81400611,
   81601842]; Natural Science Foundation of Jiangsu Province [BK20160420];
   Nantong Science and Technology Bureau [MS22018007, JCZ18057, JCZ18036,
   MSZ18008, MS22018010]; Six Peak Talents in Jiangsu Province [YY-177];
   Project of Jiangsu Province Youth Medical Talent Development
   [QNRC2016400]; Project of Nantong Youth Medical Talent Development [05]
FX The present study was supported by the National Natural Science
   Foundation of China (Grant Nos. 81600449, 81400611, and 81601842), the
   Natural Science Foundation of Jiangsu Province (Grant No. BK20160420),
   the Nantong Science and Technology Bureau (MS22018007, JCZ18057,
   JCZ18036, MSZ18008, and MS22018010), Six Peak Talents in Jiangsu
   Province (YY-177), the Project of Jiangsu Province Youth Medical Talent
   Development (QNRC2016400) and the Project of Nantong Youth Medical
   Talent Development (No. 05).
CR Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792
   Barreto SC, 2016, J BUON, V21, P1359
   Bessone F, 2019, CELL MOL LIFE SCI, V76, P99, DOI 10.1007/s00018-018-2947-0
   Bian ZL, 2013, J LIPID RES, V54, P44, DOI 10.1194/jlr.M026013
   Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596
   Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025
   CHEN PC, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/437096
   Chen XM, 2018, LIFE SCI, V203, P291, DOI 10.1016/j.lfs.2018.04.022
   Dumitrascu Dan L, 2018, Clujul Med, V91, P147, DOI 10.15386/cjmed-993
   Feng P, 2008, INT J BIOCHEM CELL B, V40, P98, DOI 10.1016/j.biocel.2007.06.020
   Huang W, 2016, ONCOTARGET, V7, P25180, DOI 10.18632/oncotarget.7734
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kitade H, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040387
   Li J, 2015, INT J MOL MED, V36, P1451, DOI 10.3892/ijmm.2015.2390
   Lin JP, 2012, J IMMUNOL, V188, P5776, DOI 10.4049/jimmunol.1103201
   Lin SL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010021
   Liu WS, 2016, CELL MOL LIFE SCI, V73, P1969, DOI 10.1007/s00018-016-2161-x
   Malik AR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00237
   Pakradouni J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066788
   Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0
   Perbal B, 2018, J CELL COMMUN SIGNAL, V12, P3, DOI 10.1007/s12079-018-0455-5
   Quan TH, 2012, J CELL BIOCHEM, V113, P3011, DOI 10.1002/jcb.24179
   Schmitz P, 2013, INT J CLIN PHARM TH, V51, P47, DOI 10.5414/CPP51047
   Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102
   Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077
   Widjaja AA, 2019, GASTROENTEROLOGY, V157, P777, DOI 10.1053/j.gastro.2019.05.002
   Xie F, 2015, J CELL MOL MED, V19, P155, DOI 10.1111/jcmm.12364
   Yang JCZ, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040872
   Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093
NR 30
TC 15
Z9 15
U1 1
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 21
PY 2020
VL 10
IS 1
AR 3201
DI 10.1038/s41598-020-60138-8
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA NF4DK
UT WOS:000563247700015
PM 32081971
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Scheers, I
   Maerckx, C
   Khuu, DN
   Marcelle, S
   Decottignies, A
   Najimi, M
   Sokal, E
AF Scheers, Isabelle
   Maerckx, Cedric
   Dung Ngoc Khuu
   Marcelle, Sabrina
   Decottignies, Anabelle
   Najimi, Mustapha
   Sokal, Etienne
TI Adult-Derived Human Liver Progenitor Cells in Long-Term Culture Maintain
   Appropriate Gatekeeper Mechanisms Against Transformation
SO CELL TRANSPLANTATION
LA English
DT Article
DE Liver cell therapy; Progenitor cells; Cytogenetic instability; Cell
   senescence
ID MESENCHYMAL STEM-CELLS; SPONTANEOUS MALIGNANT-TRANSFORMATION; MARROW
   STROMAL CELLS; IN-VITRO; CROSS-CONTAMINATION; CELLULAR SENESCENCE;
   DIFFERENTIATION; DAMAGE; PROLIFERATION; BLOOD
AB The use of human liver progenitor cells in the development of clinical cell therapy depends on their constant availability and unaltered properties during culture. The present study investigates the effects of long-term in vitro culture on the specific characteristics of these cells and on their genetic stability. Adult-derived human liver progenitor cells (ADHLPCs) were isolated from 12 donors and cultured until senescence and cell death. Cells were analyzed at different time points for their phenotype stability and differentiation potential. In addition, growth characteristics, chromosomal karyotype, telomere maintenance mechanisms, and activity of cell cycle-related genes were studied. Finally, their in vivo tumorigenicity was investigated in a xenograft assay. The long-term culture of ADHLPCs revealed a variable proliferation capacity. Cells maintained their original phenotype and acquired hepatocyte-like metabolic functions after differentiation. Eight of the 12 cell populations grew fast (doubling time of 6.3 days) during a limited time period (mean, 116.2 days), and mainly presented normal cytogenetic features. The four other cell cultures presented an early decline in growth potential (doubling time of 28.6 days) and premature senescence. Chromosomal alterations were detected in three of four cultures at passage 6. Cytogenetic anomalies were not correlated with tumorigenic potential in vitro or in vivo, and expression of cell cycle-related genes was appropriately upregulated, inducing senescence. Although chromosomal anomalies may occur in long-term cell cultures, neither transformation nor alteration of their characteristics was noted during in vitro expansion. All ADHLPCs reached senescence and growth arrest. Presenescent ADHLPCs might therefore be considered as a suitable source for liver-based cell therapy.
C1 [Sokal, Etienne] Catholic Univ Louvain, Clin Univ St Luc, Lab Pediat Hepatol & Cell Therapy, Inst Rech Clin & Expt IREC, B-1200 Brussels, Belgium.
   [Marcelle, Sabrina] Catholic Univ Louvain, Ctr Human Genet, B-1200 Brussels, Belgium.
   [Decottignies, Anabelle] Catholic Univ Louvain, de Duve Inst, Genet & Epigenet Alterat Genomes Unit, B-1200 Brussels, Belgium.
C3 Universite Catholique Louvain; Cliniques Universitaires Saint-Luc;
   Universite Catholique Louvain; Cliniques Universitaires Saint-Luc;
   Universite Catholique Louvain
RP Sokal, E (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Lab Pediat Hepatol & Cell Therapy, Inst Rech Clin & Expt IREC, 52nd Ave Mounier Tour Vesale 3, B-1200 Brussels, Belgium.
EM etienne.sokal@uclouvain.be
OI Sokal, Etienne/0000-0001-5597-4708
FU Region Wallone [7.4592.07]; Fondation Saint Luc
FX The authors are grateful to Christine Sempoux and Amandine Van Beneden
   for their excellent technical assistance with fluorescent microscopy and
   TRF assay respectively, to Floriane Andre and Nawal Jazouli for
   excellent technical coaching. Thibault Helleputte for performing
   statistical analysis. This work was supported by Grant Waleo (Hepatera)
   from the Region Wallone, grant FNRS No. 7.4592.07 and by the Fondation
   Saint Luc. The authors declare no conflicts of interest.
CR Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0
   Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675
   Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690
   Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14
   Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218
   Campard D, 2008, GASTROENTEROLOGY, V134, P833, DOI 10.1053/j.gastro.2007.12.024
   Campisi J, 2001, EXP GERONTOL, V36, P607, DOI 10.1016/S0531-5565(00)00230-8
   de la Fuente R, 2010, CANCER RES, V70, P6682, DOI 10.1158/0008-5472.CAN-10-2451
   Khuu DN, 2011, CELL TRANSPLANT, V20, P287, DOI 10.3727/096368910X516655
   Fenech M, 1998, ANN NY ACAD SCI, V854, P23, DOI 10.1111/j.1749-6632.1998.tb09889.x
   Fitzpatrick E, 2009, J INTERN MED, V266, P339, DOI 10.1111/j.1365-2796.2009.02152.x
   FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963
   Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004
   Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Itahana K., 2007, METHOD MOL BIOL, V371, P21
   Kögler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440
   Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469
   Lysy PA, 2008, CELL PROLIFERAT, V41, P36, DOI 10.1111/j.1365-2184.2007.00507.x
   Lysy PA, 2007, HEPATOLOGY, V46, P1574, DOI 10.1002/hep.21839
   Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025
   Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681
   Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x
   Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403
   Najimi M, 2007, CELL TRANSPLANT, V16, P717, DOI 10.3727/000000007783465154
   Passos JF, 2007, NUCLEIC ACIDS RES, V35, P7505, DOI 10.1093/nar/gkm893
   RAMSEY MJ, 1995, MUTAT RES-DNAGING G, V338, P95, DOI 10.1016/0921-8734(95)00015-X
   Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005
   Rodriguez R, 2009, NEOPLASIA, V11, P397, DOI 10.1593/neo.81620
   Rooney D. E., 2001, CONSTITUTIONAL ANAL, VI
   Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630
   Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194
   Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158
   Shaffer LG, 2009, INT SYSTEM HUMAN CYT
   Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Stéphenne X, 2007, CELL TRANSPLANT, V16, P409, DOI 10.3727/000000007783464821
   Studer L, 2000, J NEUROSCI, V20, P7377
   Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907
   Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216
   Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812
NR 43
TC 20
Z9 22
U1 0
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2012
VL 21
IS 10
BP 2241
EP 2255
DI 10.3727/096368912X639026
PG 15
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA 066NK
UT WOS:000313227300012
PM 22525602
DA 2024-02-19
ER

PT J
AU Toyama, T
   Sasaki, Y
   Horimoto, M
   Iyoda, K
   Yakushijin, T
   Ohkawa, K
   Takehara, T
   Kasahara, A
   Araki, T
   Hori, M
   Hayashi, N
AF Toyama, T
   Sasaki, Y
   Horimoto, M
   Iyoda, K
   Yakushijin, T
   Ohkawa, K
   Takehara, T
   Kasahara, A
   Araki, T
   Hori, M
   Hayashi, N
TI Ninjurin1 increases p21 expression and induces cellular senescence in
   human hepatoma cells
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE ninjurin1; cellular senescence; p21; G1 arrest; carcinogenesis;
   hepatocellular carcinoma
ID ADHESION MOLECULE; HEPATITIS-B; P53; GENE; CANCER; LIVER; INHIBITORS;
   CARCINOMA; LINES
AB Background/Aims: Ninjurin1 is a novel adhesion molecule that has a role in promoting nerve regeneration. Although ninjurin1 is ubiquitously expressed in various human tissues, including the liver, the biologic functions of ninjurin1 in tissues other than the nervous system remain unknown. The aim of this study was to investigate the function of ninjurin1 in hepatocytes.
   Methods: The effect of ninjurin1 overexpression was examined in Huh-7 hepatoma cells. Ninjurin1 expression was examined by Western blot in human hepatocellular carcinoma tissues as well as their adjacent liver tissues.
   Results: Ninjurin1-overexpressing clones exhibited strong growth inhibition due to G1 cell cycle arrest, which is associated with a posttranscriptional increase in p21(WAF1/Cip1), a decrease of cyclin-dependent kinase 2 activity and the hypophosphorylation of Rb. The ninjurin1-overexpressing clones had increased senescence-associated beta-galactosidase activity and autofluorescent pigment, characteristic features of cellular senescence. The levels of ninjurin1 expression were higher in hepatocellular carcinoma tissues than those in adjacent liver tissues.
   Conclusions: The present study provides the first evidence that ninjurin1 is able to induce the senescence program. Ninjurin1 may be involved in the regulation of cellular senescence in the liver during carcinogenesis. (C) 2004 European Association for the Study of the Liver. Published by Elsevier B.V. All rights, reserved.
C1 Osaka Univ, Grad Sch Med, Dept Mol Therapeut, Suita, Osaka 5650871, Japan.
   Osaka Univ, Grad Sch Med, Dept Internal Med & Therapeut, Suita, Osaka 5650871, Japan.
   Osaka Univ, Grad Sch Med, Dept Gen Med, Suita, Osaka 5650871, Japan.
   Washington Univ, Sch Med, Dept Pathol & Immunol & Internal Med, St Louis, MO 63110 USA.
C3 Osaka University; Osaka University; Osaka University; Washington
   University (WUSTL)
RP Toyama, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Therapeut, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM toyamat@moltx.med.osaka-u.ac.jp
RI Araki, Toshiyuki/H-4289-2019
OI Araki, Toshiyuki/0000-0003-3625-2042
CR Araki T, 1997, J BIOL CHEM, V272, P21373, DOI 10.1074/jbc.272.34.21373
   Araki T, 1996, NEURON, V17, P353, DOI 10.1016/S0896-6273(00)80166-X
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Burkhart BA, 1999, EXP CELL RES, V247, P168, DOI 10.1006/excr.1998.4345
   Campisi J, 2000, IN VIVO, V14, P183
   Campomenosi P, 2001, ONCOGENE, V20, P3573, DOI 10.1038/sj.onc.1204468
   Chadwick BP, 1998, GENOMICS, V47, P58, DOI 10.1006/geno.1997.5084
   Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P10978, DOI 10.1073/pnas.97.20.10978
   Hara E, 1996, MOL CELL BIOL, V16, P859
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987
   Jia LQ, 1997, MOL CARCINOGEN, V19, P243, DOI 10.1002/(SICI)1098-2744(199708)19:4<243::AID-MC5>3.0.CO;2-D
   MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0
   NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501
   SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1002/hep.1840220403
   Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1
   Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648
   VANZGLINICKI T, 1995, GERONTOLOGY, V41, P95
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wynford-Thomas D, 1999, J PATHOL, V187, P100
NR 24
TC 16
Z9 24
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
J9 J HEPATOL
JI J. Hepatol.
PD OCT
PY 2004
VL 41
IS 4
BP 637
EP 643
DI 10.1016/j.jhep.2004.06.027
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 864YQ
UT WOS:000224669700017
PM 15464245
DA 2024-02-19
ER

PT J
AU Xie, JZ
   Wang, X
   Pan, D
   Liu, JY
   Li, JH
   Gu, J
AF Xie, Jinzhao
   Wang, Xu
   Pan, Deng
   Liu, Jiaye
   Li, Jinghua
   Gu, Jing
TI Ageing and non-liver comorbidities in population with chronic hepatitis
   B infection in the western pacific region from 1990 to 2019
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE hepatitis B virus; ageing; noncommunicable diseases; western pacific
   region; comorbidity
ID INCREASING COMORBIDITIES; PREVENTION; COHORT; LIVER; PROGRESS; RISK
AB Objectives: This study examined the age structure and burden of non-liver noncommunicable diseases in population with chronic hepatitis B virus (HBV) infection in the Western Pacific Region (WPR) from 1990 to 2019.Methods: We estimated ageing trends and the prevalence of non-liver NCDs among the HBV-infected population and the general population in 31 countries/areas in the Western Pacific Region from 1990 to 2019 based on the Global Burden of Disease 2019 dataset.Results: The proportion of individuals aged 60 or older among the HBV-infected population has increased at a faster rate compared to the general population, whereas the proportion of individuals younger than 19 years has decreased rapidly over the past three decades. Among the HBV-infected population, the prevalence of most (29/31) NCDs increased from 1990 to 2019, with the top three most significant increases found for non-Hodgkin's lymphoma (789.94% increase), prostate cancer (512.40% increase), and kidney cancer (411.34% increase). The prevalence of NCDs among the HBV-infected population increased faster than in the general population over the past three decades, especially in countries with rapid population ageing.Conclusion: This study highlights the increasing burden of non-liver comorbidities among the HBV-infected population. The integrated management of non-liver NCDs among this population should be implemented.
C1 [Xie, Jinzhao; Wang, Xu; Pan, Deng; Li, Jinghua; Gu, Jing] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat, Guangzhou, Peoples R China.
   [Liu, Jiaye] Shenzhen Univ, Sch Publ Hlth, Med Sch, Shenzhen, Peoples R China.
   [Li, Jinghua; Gu, Jing] Sun Yat Sen Univ, Sun Yat Sen Global Hlth Inst, Sch Publ Hlth, Guangzhou, Peoples R China.
   [Li, Jinghua; Gu, Jing] Sun Yat Sen Univ, Inst State Governance, Guangzhou, Peoples R China.
   [Li, Jinghua; Gu, Jing] Sun Yat Sen Univ, Key Lab Hlth Informat Guangdong Prov, Guangzhou, Peoples R China.
C3 Sun Yat Sen University; Shenzhen University; Sun Yat Sen University; Sun
   Yat Sen University; Sun Yat Sen University
RP Li, JH; Gu, J (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat, Guangzhou, Peoples R China.; Li, JH; Gu, J (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Global Hlth Inst, Sch Publ Hlth, Guangzhou, Peoples R China.; Li, JH; Gu, J (corresponding author), Sun Yat Sen Univ, Inst State Governance, Guangzhou, Peoples R China.; Li, JH; Gu, J (corresponding author), Sun Yat Sen Univ, Key Lab Hlth Informat Guangdong Prov, Guangzhou, Peoples R China.
EM lijinghua3@mail.sysu.edu.cn; gujing5@mail.sysu.edu.cn
FU National Natural Science Foundation of China [71774178]; Science and
   Technology Planning Project of Guangdong [2017A020212006]; National
   Science and Technology Major Project of the Ministry of Science and
   Technology of China [2018ZX10715004]
FX This work was funded by the National Natural Science Foundation of China
   (Grant No. 71774178), the Science and Technology Planning Project of
   Guangdong (Grant No. 2017A020212006), the National Science and
   Technology Major Project of the Ministry of Science and Technology of
   China (Grant No. 2018ZX10715004).
CR Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9
   [Anonymous], 2013, Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach
   Arena R, 2015, EUR HEART J, V36, P2097, DOI 10.1093/eurheartj/ehv207
   Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5
   Cai CX, 2015, EXP THER MED, V10, P693, DOI 10.3892/etm.2015.2537
   Cox N, 2011, EXPERT OPIN EMERG DR, V16, P713, DOI 10.1517/14728214.2011.646260
   European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021
   Fabrizi F, 2019, EXPERT REV CLIN PHAR, V12, P867, DOI 10.1080/17512433.2019.1657828
   Feigin VL, 2011, STROKE, V42, P3655, DOI 10.1161/STROKEAHA.110.596858
   Huang YW, 2013, CLIN INFECT DIS, V57, P1695, DOI 10.1093/cid/cit603
   Jiang YY, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19159761
   Kasai Dr Takeshi, 2021, Lancet Reg Health West Pac, V6, P100069, DOI 10.1016/j.lanwpc.2020.100069
   Kemp L, 2019, AGE AGEING, V48, P32, DOI 10.1093/ageing/afy170
   Kim SS, 2011, GUT LIVER, V5, P278, DOI 10.5009/gnl.2011.5.3.278
   Le LV, 2022, LIVER INT, V42, P1930, DOI 10.1111/liv.15131
   Nayagam S, 2016, LANCET INFECT DIS, V16, P1399, DOI 10.1016/S1473-3099(16)30204-3
   Nguyen MH, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00046-19
   Nguyen MH, 2019, HEPATOLOGY, V69, P959, DOI 10.1002/hep.30246
   Oh H, 2020, ALIMENT PHARM THER, V52, P371, DOI 10.1111/apt.15867
   Raddatz D, 2007, Z GASTROENTEROL, V45, P51, DOI 10.1055/s-2006-927394
   Razavi H, 2021, J VIRAL HEPATITIS, V28, P12, DOI 10.1111/jvh.13412
   Schmit N, 2021, INT J EPIDEMIOL, V50, P560, DOI 10.1093/ije/dyaa253
   Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X
   Sheena BS, 2022, LANCET GASTROENTEROL, V7, P796, DOI 10.1016/S2468-1253(22)00124-8
   Smith-Palmer J, 2020, PATIENT-RELAT OUTCOM, V11, P95, DOI 10.2147/PROM.S226936
   Song C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5718
   Tang LSY, 2018, JAMA-J AM MED ASSOC, V319, P1802, DOI 10.1001/jama.2018.3795
   Tappy L, 2001, CURR OPIN CLIN NUTR, V4, P273, DOI 10.1097/00075197-200107000-00005
   Tian T, 2020, INT J CANCER, V147, P3075, DOI 10.1002/ijc.33130
   Wiesen E, 2016, VACCINE, V34, P2855, DOI 10.1016/j.vaccine.2016.03.060
   Wong GLH, 2014, ALIMENT PHARM THER, V39, P883, DOI 10.1111/apt.12658
   Wong GLH, 2020, HEPATOLOGY, V71, P444, DOI 10.1002/hep.30833
   Wong GLH, 2015, HEPATOLOGY, V62, P684, DOI 10.1002/hep.27894
   Woodring Joseph, 2019, MMWR Morb Mortal Wkly Rep, V68, P195, DOI 10.15585/mmwr.mm6808a2
   World Health Organization, 2022, Hepatitis B
   World Health Organization, 2021, HEP DAT STAT W PAC
   World Health Organization. Regional Office for the Western, 2018, Regional framework for the triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis in Asia and the Pacific, 2018-2030
   Xiao NZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S2-S2
NR 38
TC 1
Z9 1
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD MAY 18
PY 2023
VL 14
AR 1176113
DI 10.3389/fphys.2023.1176113
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA K5EE8
UT WOS:001016661900001
PM 37275222
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Nam, YH
   Jeong, SY
   Kim, YH
   Rodriguez, I
   Nuankaew, W
   Bhawal, UK
   Hong, B
   Kang, TH
AF Nam, Youn Hee
   Jeong, Seo Yule
   Kim, Yun Hee
   Rodriguez, Isabel
   Nuankaew, Wanlapa
   Bhawal, Ujjal K.
   Hong, Bin Na
   Kang, Tong Ho
TI Anti-aging effects of Korean Red Ginseng (KRG) in differentiated embryo
   chondrocyte (DEC) knockout mice
SO JOURNAL OF GINSENG RESEARCH
LA English
DT Article
DE Korean Red Ginseng; Differentiated embryo chondrocyte; Aging; Circadian
ID AGE-RELATED HEARING; CIRCADIAN-RHYTHMS; METALLOTHIONEIN; DYSFUNCTION;
   EXPRESSION; MUTATIONS; CISPLATIN; PROTEIN; LACKING
AB Background: The circadian rhythm is the internal clock that controls sleep-wake cycles, metabolism, cognition, and several processes in the body, and its disruption has been associated with aging. The differentiated embryo chondrocyte (Dec) gene is related to circadian rhythm. To our knowledge, there are no reports of the relationship between dec gene expression and KRG effect. Therefore, we treated Dec gene knockout (KO) aging mice with KRG to study anti-aging related effects and possible mechanisms.
   Methods: We evaluated KRG and expression of Dec genes in an ototoxicity model. Dec genes expression in livers of aging mice was further analyzed. Then, we assessed the effects of DEC KO on hearing function in mice by ABR. Finally, we performed DNA microarray to identify KRG-related gene expression changes in mouse liver and assessed the results using KEGG analysis.
   Results: KRG decreased the expression of Dec genes in ototoxicity model, which may contribute to its anti-aging efficacy. Moreover, KRG suppressed Dec genes expression in liver of wild type indicating inhibition of senescence. ABR test indicated that KRG improved auditory function in aging mouse, demonstrating KRG efficacy on aging related diseases.
   Conclusion: Finally, in KEGG analysis of 238 genes that were activated and 158 that were inhibited by KRG in DEC KO mice, activated genes were involved in proliferation signaling, mineral absorption, and PPAR signalingwhereas the inhibited genes were involved in arachidonic acid metabolism and peroxisomes. Our data indicate that inhibition of senescence-related Dec genes may explain the anti-aging efficacy of KRG. (C) 2020 The Korean Society of Ginseng. Publishing services by Elsevier B.V.
C1 [Nam, Youn Hee; Jeong, Seo Yule; Kim, Yun Hee; Rodriguez, Isabel; Nuankaew, Wanlapa; Hong, Bin Na; Kang, Tong Ho] Kyung Hee Univ, Coll Life Sci, Dept Oriental Med Biotechnol, Gyeonggi 17104, South Korea.
   [Nam, Youn Hee; Jeong, Seo Yule; Kim, Yun Hee; Rodriguez, Isabel; Nuankaew, Wanlapa; Hong, Bin Na; Kang, Tong Ho] Kyung Hee Univ, Grad Sch Biotechnol, Gyeonggi 17104, South Korea.
   [Bhawal, Ujjal K.] Nihon Univ, Dept Biochem & Mol Biol, Sch Dent, Matsudo, Chiba, Japan.
C3 Kyung Hee University; Kyung Hee University; Nihon University
RP Kang, TH (corresponding author), Kyung Hee Univ, Coll Life Sci, Dept Oriental Med Biotechnol, Gyeonggi 17104, South Korea.; Kang, TH (corresponding author), Kyung Hee Univ, Grad Sch Biotechnol, Gyeonggi 17104, South Korea.
EM panjae@khu.ac.kr
OI Nuankaew, Wanlapa/0000-0001-5267-6203; Rodriguez,
   Isabel/0000-0003-3121-782X
FU Korean Society of Ginseng; Kyung Hee University [KHU-20190672]
FX This work was supported by a 2018 grant from the Korean Society of
   Ginseng.; This work was supported by a grant from the Kyung Hee
   University in 2019 (KHU-20190672).
CR Adler P, 2020, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00368
   Bailey SM, 2014, J ENDOCRINOL, V222, pR75, DOI 10.1530/JOE-14-0200
   Briot A, 2018, ARTERIOSCL THROM VAS, V38, P1134, DOI 10.1161/ATVBAHA.118.310797
   Cai AH, 1997, AM J PHYSIOL-REG I, V273, pR1764, DOI 10.1152/ajpregu.1997.273.5.R1764
   Castañeda R, 2019, J ETHNOPHARMACOL, V231, P409, DOI 10.1016/j.jep.2018.11.016
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013
   Ebadi M, 1996, NEUROCHEM INT, V29, P159, DOI 10.1016/0197-0186(95)00116-6
   Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011
   Fujita Y, 2016, BIOCHEM BIOPH RES CO, V469, P477, DOI 10.1016/j.bbrc.2015.12.045
   Ho YS, 2010, AGEING RES REV, V9, P354, DOI 10.1016/j.arr.2009.10.001
   Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517
   Hood S, 2017, J CLIN INVEST, V127, P437, DOI 10.1172/JCI90328
   Hou W, 2020, J CELL MOL MED, V24, P3751, DOI 10.1111/jcmm.15029
   Hullmann M, 2017, PART FIBRE TOXICOL, DOI 10.1186/s12989-017-0213-5
   Jain M, 2007, CANCER EPIDEM BIOMAR, V16, P178, DOI 10.1158/1055-9965.EPI-06-0542
   Kalinec GM, 2016, JOVE-J VIS EXP, DOI 10.3791/54425
   Kang YJ, 2006, EXP BIOL MED, V231, P1459, DOI 10.1177/153537020623100903
   Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099
   Kurimoto H, 2004, PHYSIOL BEHAV, V82, P345, DOI 10.1016/j.physbeh.2004.04.001
   Laborde E, 2010, CELL DEATH DIFFER, V17, P1373, DOI 10.1038/cdd.2010.80
   Lee Y, 2015, J GINSENG RES, V39, P250, DOI 10.1016/j.jgr.2015.01.003
   Liu QX, 2018, J GINSENG RES, V42, P343, DOI 10.1016/j.jgr.2017.04.006
   Mc Auley MT, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160177
   Ohkubo R, 2017, NAT STRUCT MOL BIOL, V24, P687, DOI 10.1038/nsmb.3461
   Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044
   Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731
   Sato F, 2016, J CANCER, V7, P153, DOI 10.7150/jca.13748
   Sato H, 2017, MOL MED REP, V16, P43, DOI 10.3892/mmr.2017.6571
   Schacht J, 2012, ANAT REC, V295, P1837, DOI 10.1002/ar.22578
   Seo JY, 2016, J AGR FOOD CHEM, V64, P2855, DOI 10.1021/acs.jafc.5b05789
   Seo YM, 2018, FOOD SCI BIOTECHNOL, V27, P1193, DOI 10.1007/s10068-018-0362-9
   Shahmoradi A, 2015, P NATL ACAD SCI USA, V112, pE3582, DOI 10.1073/pnas.1423989112
   Tan BL, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01162
   Tian C, 2014, EXP GERONTOL, V57, P224, DOI 10.1016/j.exger.2014.06.013
   Ulgherait M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15617-x
   Ulrich-Lai YM, 2013, EXP GERONTOL, V48, P671, DOI 10.1016/j.exger.2012.08.011
   United Nations, 2019, STESASERA430 UN
   Weinert BT, 2003, J APPL PHYSIOL, V95, P1706, DOI 10.1152/japplphysiol.00288.2003
   Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919
   Yamasoba T, 2007, HEARING RES, V226, P185, DOI 10.1016/j.heares.2006.06.004
NR 41
TC 4
Z9 5
U1 0
U2 6
PU KOREAN SOC GINSENG
PI SEOCHO-GU
PA 1807 SEOCHO WORLD OFFICETEL, 1355-3 SEOCHO-DONG, SEOCHO-GU, SEOUL
   137-862, SOUTH KOREA
SN 1226-8453
EI 2093-4947
J9 J GINSENG RES
JI J. Ginseng Res.
PD JAN
PY 2021
VL 45
IS 1
BP 183
EP 190
DI 10.1016/j.jgr.2020.09.003
PG 8
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA PO2BW
UT WOS:000604975800010
PM 33437170
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Russolillo, N
   Ratti, F
   Viganò, L
   Langella, S
   Cipriani, F
   Aldrighetti, L
   Ferrero, A
AF Russolillo, Nadia
   Ratti, Francesca
   Vigano, Luca
   Langella, Serena
   Cipriani, Federica
   Aldrighetti, Luca
   Ferrero, Alessandro
TI The Influence of Aging on Hepatic Regeneration and Early Outcome after
   Portal Vein Occlusion: A Case-Control Study
SO ANNALS OF SURGICAL ONCOLOGY
LA English
DT Article
ID DONOR LIVER-TRANSPLANTATION; MAJOR HEPATECTOMY; GRAFT FUNCTION; AGE;
   EMBOLIZATION; DYSFUNCTION; IMPACT; RESECTION; VOLUME; CHEMOTHERAPY
AB Portal vein occlusion (PVO) is used to increase inadequate future liver remnant volume (FLRV). Impaired liver regeneration has been reported in aged animals. This study was designed to evaluate the impact of patient age on hepatic regeneration.
   Sixty patients aged a parts per thousand yen70 years were matched 1:1 with 60 patients aged < 70 years. Matching criteria were sex, diabetes, cirrhosis, pre-PVO chemotherapy and bevacizumab administration, and jaundice.
   The median ages in the older and younger groups were 76 (range 70-83) years and 59 (range 20-69) years, respectively (p < 0.001). Median FLRV following PVO (33.1 +/- A 6.8 vs. 31.9 +/- A 6.0 %) and volumetric increase (0.52 +/- A 0.35 vs. 0.49 +/- A 0.34) were similar in the two groups. Of the older and younger patients, 10 % and 1.7 %, respectively, did not undergo liver surgery after PVO (p = 0.051). Mortality (5.5 vs. 6.7 %) and major morbidity (25.9.8 vs. 22 %) rates were similar. Liver failure rate was higher in older patients (35.1 vs. 16.9 %, p < 0.026), mainly due to Grade A liver failure (20.3 vs. 8.4 %, p < 0.001). Multivariate analysis showed that age a parts per thousand yen 70 years [odds ratio (OR) 3.03; 95 % confidence interval (CI) 1.18-7.78; p = 0.020] and biliary cancer diagnosis (OR 4.69; 95 % CI 1.81-12.09; p = 0.001) were independent risk factors for postoperative liver failure.
   Liver regeneration after PVO is not impaired by age. Nevertheless, liver resection in elderly patients is performed less often after PVO and carries a higher risk of liver failure.
C1 [Russolillo, Nadia; Langella, Serena; Ferrero, Alessandro] Osped Mauriziano Umberto 1, Dept Gen & Oncol Surg, Turin, Italy.
   [Ratti, Francesca; Cipriani, Federica; Aldrighetti, Luca] Hosp San Raffaele, Dept Hepatobiliary Surg, Liver Unit, I-20132 Milan, Italy.
   [Vigano, Luca] Humanitas Clin & Res Ctr, Dept Surg, Liver Surg Unit, Milan, Italy.
C3 Mauritian Umberto I Hospital; A.O.U. Citta della Salute e della Scienza
   di Torino; AOU San Giovanni Battista-Molinette; Vita-Salute San Raffaele
   University; IRCCS Ospedale San Raffaele
RP Russolillo, N (corresponding author), Osped Mauriziano Umberto 1, Dept Gen & Oncol Surg, Turin, Italy.
EM nrussolillo@mauriziano.it
RI Ratti, Francesca/AAB-2116-2019; Ferrero, Alessandro/AAJ-7492-2020;
   Cipriani, Federica/AAL-9706-2020; Vigano, Luca/E-9195-2018; Russolillo,
   Nadia/AAJ-7477-2020
OI Vigano, Luca/0000-0002-4108-4832; Ratti, Francesca/0000-0002-8108-9064;
   Aldrighetti, Luca Antonio/0000-0001-7729-2468; Cipriani,
   Federica/0000-0002-8651-5982; Russolillo, Nadia/0000-0002-0627-186X
CR Abdalla EK, 2010, J SURG ONCOL, V102, P960, DOI 10.1002/jso.21654
   Akamatsu N, 2007, TRANSPL P, V39, P3189, DOI 10.1016/j.transproceed.2007.03.116
   Aldrighetti L, 2006, J SURG ONCOL, V93, P186, DOI 10.1002/jso.20342
   Aldrighetti L, 2004, AM SURGEON, V70, P453
   [Anonymous], 1975, SEER Cancer Statistics Review
   Aussilhou B, 2009, ANN SURG ONCOL, V16, P1553, DOI 10.1245/s10434-009-0447-z
   Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224
   Balducci L, 2000, HEMATOL ONCOL CLIN N, V14, P193, DOI 10.1016/S0889-8588(05)70284-7
   Cameron AM, 2006, ANN SURG, V243, P748, DOI 10.1097/01.sla.0000219669.84192.b3
   Capussotti L, 2005, ARCH SURG-CHICAGO, V140, P1100, DOI 10.1001/archsurg.140.11.1100
   Capussotti L, 2009, BRIT J SURG, V96, P88, DOI 10.1002/bjs.6429
   Capussotti L, 2008, ARCH SURG-CHICAGO, V143, P978, DOI 10.1001/archsurg.143.10.978
   Collins BH, 2000, TRANSPLANTATION, V70, P780, DOI 10.1097/00007890-200009150-00012
   Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260
   Cuende N, 2005, TRANSPLANTATION, V79, P1445, DOI 10.1097/01.TP.0000158877.74629.AA
   Dello SAWG, 2014, WORLD J SURG, V38, P497, DOI 10.1007/s00268-013-2278-0
   Dindo D, 2008, WORLD J SURG, V32, P939, DOI 10.1007/s00268-008-9584-y
   EAGON PK, 1985, SEMIN LIVER DIS, V5, P59, DOI 10.1055/s-2008-1041758
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Ferrero A, 2005, WORLD J SURG, V29, P1101, DOI 10.1007/s00268-005-7768-2
   Ferrero A, 2007, WORLD J SURG, V31, P1643, DOI 10.1007/s00268-007-9123-2
   Garcia C E, 2004, Exp Clin Transplant, V2, P183
   Grazi GL, 2001, AM J TRANSPLANT, V1, P61, DOI 10.1034/j.1600-6143.2001.010112.x
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Iida T, 2009, CLIN TRANSPLANT, V23, P271, DOI 10.1111/j.1399-0012.2008.00933.x
   Imamura H, 1999, HEPATOLOGY, V29, P1099, DOI 10.1002/hep.510290415
   Iwamoto T, 2008, TRANSPLANTATION, V85, P1240, DOI 10.1097/TP.0b013e31816c7e90
   Kubota K, 1997, HEPATOLOGY, V26, P1176
   Matsumoto T, 2003, J SURG RES, V110, P228, DOI 10.1016/S0022-4804(03)00023-4
   Nardo B, 2004, AM J TRANSPLANT, V4, P1139, DOI 10.1111/j.1600-6143.2004.00472.x
   Ono Y, 2011, SURGERY, V150, P154, DOI 10.1016/j.surg.2011.05.004
   Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001
   Schindl MJ, 2005, GUT, V54, P289, DOI 10.1136/gut.2004.046524
   Selzner N, 2002, HEPATOLOGY, V36, P812, DOI 10.1053/jhep.2002.35535
   Shan YS, 2005, LIVER INT, V25, P96, DOI 10.1111/j.1478-3231.2005.01037.x
   Strasberg SM, 2000, HPB, V2, P333, DOI DOI 10.1016/S1365-182X(17)30755-4
   Suda K, 2009, AM J SURG, V197, P752, DOI 10.1016/j.amjsurg.2008.05.007
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Yokoyama Y, 2007, WORLD J SURG, V31, P367, DOI 10.1007/s00268-006-0526-2
   Yoshizumi T, 2008, LIVER TRANSPLANT, V14, P1007, DOI 10.1002/lt.21462
   Yoshizumi T, 2008, TRANSPL INT, V21, P81, DOI 10.1111/j.1432-2277.2007.00561.x
NR 41
TC 11
Z9 11
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1068-9265
EI 1534-4681
J9 ANN SURG ONCOL
JI Ann. Surg. Oncol.
PD NOV
PY 2015
VL 22
IS 12
BP 4046
EP 4051
DI 10.1245/s10434-015-4478-3
PG 6
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Surgery
GA CT0UP
UT WOS:000362513100044
PM 25758189
DA 2024-02-19
ER

PT J
AU SUN, JQ
   LAU, PP
   STROBEL, HW
AF SUN, JQ
   LAU, PP
   STROBEL, HW
TI AGING MODIFIES THE EXPRESSION OF HEPATIC-MICROSOMAL CYTOCHROMES-P-450
   AFTER PRETREATMENT OF RATS WITH BETA-NAPHTHOFLAVONE OR PHENOBARBITAL
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
C1 UNIV TEXAS,SCH MED,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77225.
C3 University of Texas System
FU NCI NIH HHS [KO4 CA00311] Funding Source: Medline; NIA NIH HHS [AG02081]
   Funding Source: Medline
CR BRODIE BB, 1958, ANNU REV BIOCHEM, V27, P427, DOI 10.1146/annurev.bi.27.070158.002235
   CHIANG JYL, 1982, MOL PHARMACOL, V23, P244
   GILLETTE JR, 1979, FED PROC, V38, P1900
   GUM J R, 1979, Journal of Biological Chemistry, V254, P4177
   HAUGEN DA, 1976, J BIOL CHEM, V251, P7929
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO R, 1968, J BIOCHEM-TOKYO, V63, P406
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAU PP, 1982, J BIOL CHEM, V257, P5257
   LAU PP, 1982, ARCH BIOCHEM BIOPHYS, V218, P472, DOI 10.1016/0003-9861(82)90369-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MORGAN ET, 1985, MOL PHARMACOL, V27, P471
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   PICKETT CB, 1981, J BIOL CHEM, V256, P8815
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   RIKANS LE, 1982, BIOCHEM PHARMACOL, V31, P2339, DOI 10.1016/0006-2952(82)90527-5
   RYAN D, 1975, J BIOL CHEM, V250, P2157
   RYAN DE, 1979, J BIOL CHEM, V254, P1365
   SAITO T, 1981, J BIOL CHEM, V256, P984
   Schmucker D. L., 1979, PHARMACOL REV, V30, P445
   STOHS SJ, 1980, AGE, V3, P11, DOI 10.1007/BF02435000
   STROBEL HW, 1982, CYTOCHROME P450 BIOC, P321
   THOMAS PE, 1979, ARCH BIOCH BIOPHYS, V192, P282
NR 24
TC 6
Z9 7
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PY 1986
VL 21
IS 2
BP 65
EP 73
DI 10.1016/0531-5565(86)90054-9
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA D8088
UT WOS:A1986D808800002
PM 3758228
DA 2024-02-19
ER

PT J
AU Freije, WA
   Thamotharan, S
   Lee, R
   Shin, BC
   Devaskar, SU
AF Freije, William A.
   Thamotharan, Shanthie
   Lee, Regina
   Shin, Bo-Chul
   Devaskar, Sherin U.
TI The Hepatic Transcriptome of Young Suckling and Aging Intrauterine
   Growth Restricted Male Rats
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE INTRAUTERINE GROWTH RESTRICTION (IUGR); LIVER; MICROARRAY;
   TRANSCRIPTOME; DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE; OBESITY;
   CIRCADIAN
ID POSTNATAL CALORIE RESTRICTION; CHOLESTEROL HOMEOSTASIS; DEVELOPMENTAL
   ORIGINS; GENE-EXPRESSION; ANIMAL-MODELS; ADULT DISEASE; FETAL-GROWTH;
   NOCTURNIN; OBESITY; ADIPOGENESIS
AB Intrauterine growth restriction leads to the development of adult onset obesity/metabolic syndrome, diabetes mellitus, cardiovascular disease, hypertension, stroke, dyslipidemia, and non-alcoholic fatty liver disease/steatohepatitis. Continued postnatal growth restriction has been shown to ameliorate many of these sequelae. To further our understanding of the mechanism of how intrauterine and early postnatal growth affects adult health we have employed Affymetrix microarray-based expression profiling to characterize hepatic gene expression of male offspring in a rat model of maternal nutrient restriction in early and late life. At day 21 of life (p21) combined intrauterine and postnatal calorie restriction treatment led to expression changes in circadian, metabolic, and insulin-like growth factor genes as part of a larger transcriptional response that encompasses 144 genes. Independent and controlled experiments at p21 confirm the early life circadian, metabolic, and growth factor perturbations. In contrast to the p21 transcriptional response, at day 450 of life (d450) only seven genes, largely uncharacterized, were differentially expressed. This lack of a transcriptional response identifies non-transcriptional mechanisms mediating the adult sequelae of intrauterine growth restriction. Independent experiments at d450 identify a circadian defect as well as validate expression changes to four of the genes identified by the microarray screen which have a novel association with growth restriction. Emerging from this rich dataset is a portrait of how the liver responds to growth restriction through circadian dysregulation, energy/substrate management, and growth factor modulation. J. Cell. Biochem. 9999: 1-15, 2015. (c) 2014 Wiley Periodicals, Inc. J. Cell. Biochem. 116: 566-579, 2015. (c) 2014 Wiley Periodicals, Inc.
C1 [Freije, William A.; Lee, Regina] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.
   [Thamotharan, Shanthie; Shin, Bo-Chul; Devaskar, Sherin U.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA
RP Devaskar, SU (corresponding author), Dept Pediat, 10833 Le Conte Ave,MDCC 22-412, Los Angeles, CA 90095 USA.
EM sdevaskar@mednet.ucla.edu
OI Shin, Bo-Chul/0000-0002-7569-5121
FU National Institutes of Health [HD41230 HD25024]
FX Grant sponsor: National Institutes of Health; Grant number: HD41230
   HD25024.
CR Alisi A, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/269853
   BARKER DJP, 1988, ARCH DIS CHILD, V63, P867, DOI 10.1136/adc.63.7.867
   Barker DJP, 2004, J EPIDEMIOL COMMUN H, V58, P114, DOI 10.1136/jech.58.2.114
   BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259
   Costa MJ, 2011, J BIOL CHEM, V286, P9063, DOI 10.1074/jbc.M110.164558
   Dai Y, 2012, ENDOCRINOLOGY, V153, P4216, DOI 10.1210/en.2012-1206
   Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166
   Davies BSJ, 2012, CURR OPIN LIPIDOL, V23, P35, DOI 10.1097/MOL.0b013e32834d0b33
   DERCOLE AJ, 1980, DEV BIOL, V75, P315, DOI 10.1016/0012-1606(80)90166-9
   Endo M, 2005, MOL ENDOCRINOL, V19, P1181, DOI 10.1210/me.2004-0063
   Eriksson JG, 2006, DIABETOLOGIA, V49, P2853, DOI 10.1007/s00125-006-0459-1
   Garg M, 2013, ENDOCRINOLOGY, V154, P102, DOI 10.1210/en.2012-1640
   Garg M, 2012, DIABETES, V61, P1391, DOI 10.2337/db11-1347
   Ge XM, 2011, J LIPID RES, V52, P1561, DOI 10.1194/jlr.M015859
   Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S
   Gluckman PD, 2005, BIOL NEONATE, V87, P127, DOI 10.1159/000082311
   Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104
   Hoeflich A, 2001, ENDOCRINOLOGY, V142, P1889, DOI 10.1210/en.142.5.1889
   Horrevoets AJG, 1999, BLOOD, V93, P3418, DOI 10.1182/blood.V93.10.3418.410k23_3418_3431
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   JELINEK DF, 1990, J BIOL CHEM, V265, P8190
   Jimenez-Chillaron Josep C, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P23, DOI 10.1097/MED.0b013e328013da8e
   Jugessur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011493
   Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048
   KAMATAKI T, 1983, ARCH BIOCHEM BIOPHYS, V225, P758, DOI 10.1016/0003-9861(83)90087-5
   Kawai M, 2010, P NATL ACAD SCI USA, V107, P10508, DOI 10.1073/pnas.1000788107
   Kawai M, 2010, ANN NY ACAD SCI, V1192, P131, DOI 10.1111/j.1749-6632.2009.05221.x
   Kho Y, 2008, ANIM BIOTECHNOL, V19, P89, DOI 10.1080/10495390801887361
   Kiss AM, 2004, MOL CELL BIOL, V24, P5797, DOI 10.1128/MCB.24.13.5797-5807.2004
   Knutsson A, 1989, Scand J Soc Med Suppl, V44, P1
   Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207
   Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martyn CN, 1998, LANCET, V352, P173, DOI 10.1016/S0140-6736(97)10404-4
   Nobili Valerio, 2008, Pediatr Endocrinol Rev, V6, P241
   Oak SA, 2006, AM J PHYSIOL-ENDOC M, V290, pE1321, DOI 10.1152/ajpendo.00437.2005
   OGAWA H, 1989, J BIOL CHEM, V264, P15818
   Ooi GT, 1998, MOL ENDOCRINOL, V12, P675, DOI 10.1210/me.12.5.675
   Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534
   Pendergast JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030254
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Schmidt DR, 2011, J BIOL CHEM, V286, P2425, DOI 10.1074/jbc.M110.181230
   Seki Y, 2012, ENDOCRINOLOGY, V153, P1031, DOI 10.1210/en.2011-1805
   Shin BC, 2012, J NEUROSCI RES, V90, P1169, DOI 10.1002/jnr.23013
   Sohi G, 2011, SEMIN REPROD MED, V29, P246, DOI 10.1055/s-0031-1275523
   Sohi G, 2011, MOL ENDOCRINOL, V25, P785, DOI 10.1210/me.2010-0395
   Vaiman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021222
   Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545
   Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9
NR 49
TC 11
Z9 12
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD APR
PY 2015
VL 116
IS 4
BP 566
EP 579
DI 10.1002/jcb.25008
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA CA8IU
UT WOS:000349163000010
PM 25371150
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Péré-Védrenne, C
   Prochazkova-Carlotti, M
   Rousseau, B
   He, W
   Chambonnier, L
   Sifré, E
   Buissonnière, A
   Dubus, P
   Mégraud, F
   Varon, C
   Ménard, A
AF Pere-Vedrenne, Christelle
   Prochazkova-Carlotti, Martina
   Rousseau, Benoit
   He, Wencan
   Chambonnier, Lucie
   Sifre, Elodie
   Buissonniere, Alice
   Dubus, Pierre
   Megraud, Francis
   Varon, Christine
   Menard, Armelle
TI The Cytolethal Distending Toxin Subunit CdtB of <i>Helicobacter</i>
   <i>hepaticus</i> Promotes Senescence and Endoreplication in Xenograft
   Mouse Models of Hepatic and Intestinal Cell Lines
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Helicobacter hepaticus; cytolethal distending toxin; endoreplication;
   apoptosis; senescence; mitosis
ID DNA-DAMAGE RESPONSE; HUMAN HEPATOCELLULAR-CARCINOMA; EPITHELIAL-CELLS;
   CANCER-THERAPY; HELA-CELLS; POLYPLOIDY; EXPRESSION; PATHWAY; PROTEIN;
   PHOSPHORYLATION
AB Cytolethal distending toxins (CDTs) are common among pathogenic bacteria of the human and animal microbiota. CDTs exert cytopathic effets, via their active CdtB subunit. No clear description of those cytopathic effects has been reported at the cellular level in the target organs in vivo. In the present study, xenograft mouse models of colon and liver cell lines were set up to study the effects of the CdtB subunit of Helicobacter hepaticus. Conditional transgenic cell lines were established, validated in vitro and then engrafted into immunodeficient mice. After successful engraftment, mice were treated with doxycyclin to induce the expression of transgenes (red fluorescent protein, CdtB, and mutated CdtB). For both engrafted cell lines, results revealed a delayed tumor growth and a reduced tumor weight in CdtB-expressing tumors compared to controls. CdtB-derived tumors showed gamma-H2AX foci formation, an increase in apoptosis, senescence, p21 and Ki-67 nuclear antigen expression. No difference in proliferating cells undergoing mitosis (phospho-histone H3) was observed. CdtB intoxication was also associated with an overexpression of cytokeratins in cells at the invasive front of the tumor as well as an increase in ploidy. All these features are hallmarks of endoreplication, as well as aggressiveness in cancer. These effects were dependent on the histidine residue at position 265 of the CdtB, underlying the importance of this residue in CdtB catalytic activity. Taken together, these data indicate that the CdtB triggers senescence and cell endoreplication leading to giant polyploid cells in these xenograft mouse models.
C1 [Pere-Vedrenne, Christelle; Prochazkova-Carlotti, Martina; He, Wencan; Chambonnier, Lucie; Sifre, Elodie; Buissonniere, Alice; Dubus, Pierre; Megraud, Francis; Varon, Christine; Menard, Armelle] INSERM, Bordeaux Res Translat Oncol UMR1053, BaRITOn, Bordeaux, France.
   [Pere-Vedrenne, Christelle; Prochazkova-Carlotti, Martina; He, Wencan; Chambonnier, Lucie; Sifre, Elodie; Buissonniere, Alice; Dubus, Pierre; Megraud, Francis; Varon, Christine; Menard, Armelle] Univ Bordeaux, BaRITOn, Bordeaux Res Translat Oncol UMR1053, Bordeaux, France.
   [Rousseau, Benoit] Univ Bordeaux, Serv Commun Anim, Bordeaux, France.
   [Dubus, Pierre] CHU Hop Bordeaux, Pole Biol & Pathol, Serv Biol Tumeurs, Bordeaux, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite de Bordeaux; Universite de Bordeaux; Universite de Bordeaux;
   CHU Bordeaux
RP Ménard, A (corresponding author), INSERM, Bordeaux Res Translat Oncol UMR1053, BaRITOn, Bordeaux, France.; Ménard, A (corresponding author), Univ Bordeaux, BaRITOn, Bordeaux Res Translat Oncol UMR1053, Bordeaux, France.
EM armelle.menard@u-bordeaux.fr
OI menard, armelle/0000-0002-6130-736X; Megraud,
   Francis/0000-0002-2481-1612; He, Wencan/0000-0002-3421-4598;
   Prochazkova-Carlotti, Martina/0000-0002-7719-7679; Dubus,
   Pierre/0000-0003-1803-4711; Pere-Vedrenne,
   Christelle/0000-0002-6040-1442; Varon, Christine/0000-0003-4026-2016
FU INSERM; University of Bordeaux; Federative Research Structure at the
   University of Bordeaux; Ligue Nationale Contre le Cancer
FX This work was supported in part by INSERM, the University of Bordeaux
   and the Federative Research Structure "Biology: from basics to Medicine"
   ("TransBioMed") at the University of Bordeaux (2013). CPV is the
   recipient of a predoctoral fellowship from the Ligue Nationale Contre le
   Cancer.
CR Avenaud P, 2004, BIOCHEM BIOPH RES CO, V318, P739, DOI 10.1016/j.bbrc.2004.04.089
   Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104
   Berman B, 2007, DRUG TODAY, V43, P27, DOI 10.1358/dot.2007.43.1.1025697
   Bezine E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36022
   Bezine E, 2014, CELLS-BASEL, V3, P592, DOI 10.3390/cells3020592
   Blazkova H, 2010, J CELL MOL MED, V14, P357, DOI 10.1111/j.1582-4934.2009.00862.x
   BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973
   Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234
   De Rycke J, 2000, EUR J CELL BIOL, V79, P192, DOI 10.1078/S0171-9335(04)70022-9
   Devaud C, 2009, CANCER RES, V69, P3971, DOI 10.1158/0008-5472.CAN-08-3037
   Faïs T, 2016, TOXINS, V8, DOI 10.3390/toxins8070220
   Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802
   Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531
   Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x
   Ge ZM, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12728
   Grasso F, 2015, BIOMOLECULES, V5, P1762, DOI 10.3390/biom5031762
   Guerra L, 2011, TOXINS, V3, P172, DOI 10.3390/toxins3030172
   Guidi R, 2013, CELL MICROBIOL, V15, P98, DOI 10.1111/cmi.12034
   Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707
   Lai CH, 2014, ONCOTARGET, V5, P5523, DOI 10.18632/oncotarget.2133
   Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209
   Li YP, 2011, VET MICROBIOL, V148, P75, DOI 10.1016/j.vetmic.2010.08.009
   Liu Q, 2014, NEURO-ONCOLOGY, V16, P1313, DOI 10.1093/neuonc/nou058
   Liyanage NPM, 2010, HELICOBACTER, V15, P98, DOI 10.1111/j.1523-5378.2010.00749.x
   LUNDBLAD D, 1991, ANTICANCER RES, V11, P2131
   Ménard L, 2010, J HEPATOL, V52, P681, DOI 10.1016/j.jhep.2009.12.029
   Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062
   Nougayrède JP, 2001, INFECT IMMUN, V69, P6785, DOI 10.1128/IAI.69.11.6785-6795.2001
   Ohara M, 2008, INFECT IMMUN, V76, P4783, DOI 10.1128/IAI.01612-07
   Orr-Weaver TL, 2015, TRENDS GENET, V31, P307, DOI 10.1016/j.tig.2015.03.011
   Péré-Védrenne C, 2016, J INFECT DIS, V213, P1979, DOI 10.1093/infdis/jiw042
   Peres SY, 1997, MOL MICROBIOL, V24, P1095, DOI 10.1046/j.1365-2958.1997.4181785.x
   Pham-Ledard A, 2014, MODERN PATHOL, V27, P402, DOI 10.1038/modpathol.2013.156
   Nguyen PH, 2017, CLIN CANCER RES, V23, P1586, DOI 10.1158/1078-0432.CCR-15-2157
   RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555
   Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098
   Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003
   Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489
   Scuron MD, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2015.00168
   Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518
   Shenker BJ, 2014, CELL MICROBIOL, V16, P1391, DOI 10.1111/cmi.12299
   Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557
   Sun CK, 2014, ONCOTARGET, V5, P3375, DOI 10.18632/oncotarget.1952
   van Oijen MGCT, 1998, AM J CLIN PATHOL, V110, P24
   Varon C, 2014, J INFECT DIS, V209, P588, DOI 10.1093/infdis/jit539
   Wising C, 2005, TOXICON, V45, P767, DOI 10.1016/j.toxicon.2005.01.016
   Young VB, 2000, INFECT IMMUN, V68, P184, DOI 10.1128/IAI.68.1.184-191.2000
   Zheng L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1825
NR 48
TC 33
Z9 33
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD JUN 30
PY 2017
VL 7
AR 268
DI 10.3389/fcimb.2017.00268
PG 14
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA EZ3CH
UT WOS:000404586900001
PM 28713773
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Guan, LL
   Feng, HY
   Gong, DZ
   Zhao, X
   Cai, L
   Wu, Q
   Yuan, B
   Yang, M
   Zhao, J
   Zou, Y
AF Guan, Lili
   Feng, Haiyan
   Gong, Dezheng
   Zhao, Xu
   Cai, Li
   Wu, Qiong
   Yuan, Bo
   Yang, Mei
   Zhao, Jie
   Zou, Yuan
TI Genipin ameliorates age-related insulin resistance through inhibiting
   hepatic oxidative stress and mitochondrial dysfunction
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Genipin; Oxidative stress; Insulin resistance; Mitochondria; Aging
ID SKELETAL-MUSCLE; TARGETED EXPRESSION; DIABETIC MICE; LIVER; HEPATOCYTES;
   GENIPOSIDE; PALMITATE; RATS; SENSITIVITY; MEMBRANE
AB Insulin resistance (IR) increases with age and plays a key role in the pathogenesis of type 2 diabetes mellitus. Oxidative stress and mitochondrial dysfunction are supposed to be major factors leading to age-related IR. Genipin, an extract from Gardenia jasminoides Ellis fruit, has been reported to stimulate insulin secretion in pancreatic islet cells by regulating mitochondrial function. In this study, we first investigated the effects of genipin on insulin sensitivity and the potential mitochondrial mechanisms in the liver of aging rats. The rats were randomly assigned to receive intraperitoneal injections of either 25 mg/kg genipin or vehicle once daily for 12 days. The aging rats showed hyperinsulinemia and hyperlipidemia, and insulin resistance as examined by the decreased glucose decay constant rate during insulin tolerance test (kITT). The hepatic tissues showed steatosis and reduced glycogen content. Hepatic malondialdehyde level and mitochondrial reactive oxygen species (ROS) were higher, and levels of mitochondrial membrane potential (MMP) and ATP were lower as compared with the normal control rats. Administration of genipin ameliorated systemic and hepatic insulin resistance, alleviated hyperinsulinemia, hyperglyceridemia and hepatic steatosis, relieved hepatic oxidative stress and mitochondrial dysfunction in aging rats. Furthermore, genipin not only improved insulin sensitivity by promoting insulin-stimulated glucose consumption and glycogen synthesis, inhibited cellular ROS overproduction and alleviated the reduction of levels of MMP and ATP, but also reversed oxidative stress-associated JNK hyperactivation and reduced Akt phosphorylation in palmitate-treated L02 hepatocytes. In conclusion, genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Guan, Lili; Feng, Haiyan; Gong, Dezheng; Cai, Li; Wu, Qiong; Yuan, Bo; Zhao, Jie; Zou, Yuan] Dalian Med Univ, Dept Physiol, Dalian 116044, Peoples R China.
   [Zhao, Xu; Yang, Mei] Liaoning Normal Univ, Dept Analyt Chem, Dalian 116023, Peoples R China.
C3 Dalian Medical University; Liaoning Normal University
RP Zhao, J (corresponding author), Dalian Med Univ, Dept Physiol, Dalian 116044, Peoples R China.
EM zhaoj@dlmedu.edu.cn; zouyuan@hotmail.com
FU Natural Science of Liaoning Province, China [201102051]
FX This study was supported by grants from the Natural Science of Liaoning
   Province, China (No. 201102051).
CR AKINMOKUN A, 1992, DIABETIC MED, V9, P432, DOI 10.1111/j.1464-5491.1992.tb01813.x
   Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Capozza F, 2005, AM J PHYSIOL-CELL PH, V288, pC1317, DOI 10.1152/ajpcell.00489.2004
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619
   EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X
   Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574
   Figueiredo PA, 2009, J GERONTOL A-BIOL, V64, P21, DOI 10.1093/gerona/gln048
   Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Kim SJ, 2010, EUR J PHARMACOL, V635, P188, DOI 10.1016/j.ejphar.2010.03.007
   KIMURA Y, 1982, CHEM PHARM BULL, V30, P4444
   Kojima K, 2011, BIOL PHARM BULL, V34, P1613, DOI 10.1248/bpb.34.1613
   Koo HJ, 2004, EUR J PHARMACOL, V495, P201, DOI 10.1016/j.ejphar.2004.05.031
   Krentz AJ, 2013, DIABETIC MED, V30, P535, DOI 10.1111/dme.12063
   Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004
   Lehnen AM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-67
   Ma TT, 2011, J PHARM PHARMACOL, V63, P587, DOI 10.1111/j.2042-7158.2011.01256.x
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MIYASITA S, 1976, American Journal of Chinese Medicine, V4, P239, DOI 10.1142/S0192415X76000317
   Muller DC, 1996, SEMIN NEPHROL, V16, P289
   Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200
   Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200
   Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871
   Okada K, 2007, AM J PHYSIOL-GASTR L, V292, pG1450, DOI 10.1152/ajpgi.00302.2006
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Phielix E, 2011, GERONTOLOGY, V57, P387, DOI 10.1159/000317691
   Rains JL, 2011, FREE RADICAL BIO MED, V50, P567, DOI 10.1016/j.freeradbiomed.2010.12.006
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Shang YL, 2009, HEPATOLOGY, V50, P1204, DOI 10.1002/hep.23121
   Takamura T, 2012, ENDOCR J, V59, P745, DOI 10.1507/endocrj.EJ12-0228
   TSENG TH, 1995, CANCER LETT, V97, P61, DOI 10.1016/0304-3835(95)03964-X
   Viljoen A, 2011, MED CLIN N AM, V95, P615, DOI 10.1016/j.mcna.2011.02.003
   Wan XD, 2009, J ENDOCRINOL INVEST, V32, P454, DOI 10.1007/BF03346485
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wu Q, 2009, DIGEST DIS SCI, V54, P1918, DOI 10.1007/s10620-008-0650-y
   Wu SY, 2009, ACTA PHARMACOL SIN, V30, P202, DOI 10.1038/aps.2008.17
   Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010
   Zanquetta MM, 2003, J PINEAL RES, V35, P141, DOI 10.1034/j.1600-079X.2003.00067.x
   Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010
NR 44
TC 55
Z9 67
U1 3
U2 65
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD DEC
PY 2013
VL 48
IS 12
BP 1387
EP 1394
DI 10.1016/j.exger.2013.09.001
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 258WQ
UT WOS:000327489800002
PM 24041487
DA 2024-02-19
ER

PT J
AU Alison, MR
AF Alison, Malcolm R.
TI Liver stem cells - Implications for hepatocarcinogenesis
SO STEM CELL REVIEWS
LA English
DT Article
DE stem cells; cholangiocytes; hepatic progenitor cells; small cell
   dysplasia; oval cells; bone marrow; cell senescence; chronic
   inflammation fibrosis
ID B-VIRUS-DNA; HUMAN HEPATOCELLULAR CARCINOMAS; HEPATIC PROGENITOR CELLS;
   HEPATOCYTE GROWTH-FACTOR; CHRONIC VIRAL-HEPATITIS; TUMOR-SUPPRESSOR
   GENE; MATURE HEPATOCYTES; CELLULAR-ORIGIN; CLONAL ORIGIN; OVAL CELLS
AB Numerous studies point to the fact that liver tumours are derived from single cells (mono-clonal), but the important question is, which cell? Stem cell biology and cancer are inextricably linked. In continually renewing tissues such as the intestinal mucosa and epidermis, in which a steady flux of cells occurs from the stem cell zone to the terminally differentiated cells that are imminently to be lost, it is widely accepted that cancer is a disease of stem cells, as these are the only cells that persist in the tissue for a sufficient length of time to acquire the requisite number of genetic changes for neo-plastic development. In the liver the identity of the founder cells for the two major primary tumours, hepatocellular carinoma (HCC) and cholangiocarinoma (CC), is more problematic. the reason for this is that no such obvious undirectional flux occurs in the liver, though it is held that the centrilobular hepatocytes may be more differentiated (polyploid) and closer to cell senescence than those cells closest to the portal areas. Moreover the existence of bipotential hepatic progenitor cells (HPCs), along with hepatocytes endowed with longevity and long-term repopulating potential suggests there may be more than one type of carcinogen target cell. Irrespective of which target cell is involved, cell proliferation at the time of carinogen exposure is pivotal for "fixation" of the genotoxic injury into a heritable form. Taking this view, any proliferative cell in the liver can be suspectible to neoplastic transformation. Thus, hepatocytes are implicated in many instances of liver damage irrespective of etiology, making such cells very likely carinogen targets. Of course, we must qualify this assertion by stating that many carcinogens are both cytotoxic and cytostatic, and that HPC proliferation may be merely a bystander effect of this toxicity. An indepth discussion of causes of cancer in the liver are beyond the scope of this review, but infectious agents (e.g., hepatitis B and C viruses) play a major role, not just in transactivating or otherwise disrupting cellular proto-oncogenes (hepatitus B virus [HBV]), but in also causing chronic inflammation (hepatitus C virus [HCV] and HBV). Sustained epithelial proliferation in a milieu rich in inflammatory cells, growth factors, and DNA-damaging agents (reactive oxygen and nitrogen species produced to fight infection), will lead to permanent genetic changes in proliferating cells. The upregulation of the transcription factor nuclear factor kappa B (NF-kappa B) in transformed hepatocytes, through the paracrine action of tumour necrosis factor-alpha from neighboring endothelia and inflammatory cells, may be critical for tumour progression given the mitogenic and anti-apoptopic properties of proteins encoded by many of NF kappa B's target genes.
C1 Univ London Queen Mary & Westfield Coll, London E1 4NS, England.
C3 University of London; Queen Mary University London
RP Alison, MR (corresponding author), Inst Cell & Mol Sci, Ctr Diabet & Metab Med, 4 Newark St,Whitechapel, London E1 2AT, England.
EM m.alison@qmul.ac.uk
RI Alison, Malcolm/H-6961-2019
CR Alison M, 1998, PHILOS T R SOC B, V353, P877, DOI 10.1098/rstb.1998.0252
   Alison MR, 1996, GASTROENTEROLOGY, V110, P1182, DOI 10.1053/gast.1996.v110.pm8613008
   Alison MR, 2003, SEMIN LIVER DIS, V23, P325
   Alison MR, 2004, CELL PROLIFERAT, V37, P1, DOI 10.1111/j.1365-2184.2004.00297.x
   Avril A, 2004, J HEPATOL, V41, P737, DOI 10.1016/j.jhep.2004.07.029
   Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012
   Bonura C, 1999, HEPATOLOGY, V30, P677, DOI 10.1002/hep.510300325
   Bralet MP, 2002, HEPATOLOGY, V36, P623, DOI 10.1053/jhep.2002.35540
   Bréchot C, 2004, GASTROENTEROLOGY, V127, pS56, DOI 10.1053/j.gastro.2004.09.016
   CRADDOCK VM, 1975, CHEM-BIOL INTERACT, V10, P313, DOI 10.1016/0009-2797(75)90052-6
   DIREKZE NC, 2004, CANCER RES, V64, P8942
   Donato MF, 2002, DIGEST LIVER DIS, V34, P197, DOI 10.1016/S1590-8658(02)80193-1
   Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435
   ESUMI M, 1986, CANCER RES, V46, P5767
   Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X
   Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214
   Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025
   Freeman A, 2003, J VIRAL HEPATITIS, V10, P345, DOI 10.1046/j.1365-2893.2003.00454.x
   Gordon GJ, 2002, TRANSPLANTATION, V73, P1236, DOI 10.1097/00007890-200204270-00008
   Gordon GJ, 2000, AM J PATHOL, V156, P607, DOI 10.1016/S0002-9440(10)64765-7
   Górnicka B, 2001, J HEPATOL, V34, P955, DOI 10.1016/S0168-8278(01)00011-3
   Gournay J, 2002, LAB INVEST, V82, P781, DOI 10.1097/01.LAB.0000017363.11489.AD
   GOVINDARAJAN S, 1988, HUM PATHOL, V19, P403, DOI 10.1016/S0046-8177(88)80488-X
   Gupta S, 2000, SEMIN CANCER BIOL, V10, P161
   Hixson DC, 2000, EXP MOL PATHOL, V68, P152, DOI 10.1006/exmp.2000.2302
   Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513
   HSIA CC, 1994, J MED VIROL, V43, P216, DOI 10.1002/jmv.1890430304
   Isfort RJ, 1997, ONCOGENE, V15, P1797, DOI 10.1038/sj.onc.1201535
   Ishikawa H, 2004, GUT, V53, P884, DOI 10.1136/gut.2003.026047
   Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132
   Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5
   Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326
   Libbrecht L, 2005, LIVER INT, V25, P16, DOI 10.1111/j.1478-3231.2005.01016.x
   Libbrecht L, 2003, HISTOPATHOLOGY, V42, P618, DOI 10.1046/j.1365-2559.2003.01615.x
   Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084952102001258
   Libbrecht L, 2000, J HEPATOL, V33, P76, DOI 10.1016/S0168-8278(00)80162-2
   Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6
   Marshall A, 2005, GASTROENTEROLOGY, V128, P33, DOI 10.1053/j.gastro.2004.09.076
   Michalopoulos GK, 2005, HEPATOLOGY, V41, P535, DOI 10.1002/hep.20600
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Neaud V, 1997, HEPATOLOGY, V26, P1458, DOI 10.1002/hep.510260612
   Ng IOL, 2003, J PATHOL, V199, P345, DOI 10.1002/path.1287
   Novikoff PM, 1998, J HISTOCHEM CYTOCHEM, V46, P613, DOI 10.1177/002215549804600507
   Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398
   Overturf K, 1997, AM J PATHOL, V151, P1273
   Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924
   Roskams TA, 2003, SEMIN LIVER DIS, V23, P385
   SELL S, 1993, INT J DEV BIOL, V37, P189
   SELL S, 1994, LAB INVEST, V70, P6
   Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007
   Sell S, 2003, CANCER RES, V63, P7553
   Sell S, 2002, SEMIN CELL DEV BIOL, V13, P419, DOI 10.1016/S1084952102001295
   SELL S, 1993, ENVIRON HEALTH PERSP, V101, P15, DOI 10.2307/3431838
   Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043
   SHAFRITZ DA, 1981, HEPATOLOGY, V1, P1, DOI 10.1002/hep.1840010102
   SHAFRITZ DA, 1981, NEW ENGL J MED, V305, P1067, DOI 10.1056/NEJM198110293051807
   Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537
   Taat F, 2004, PEDIATR BLOOD CANCER, V43, P603, DOI 10.1002/pbc.20115
   Theise ND, 2003, HISTOPATHOLOGY, V43, P263, DOI 10.1046/j.1365-2559.2003.01707.x
   Theise ND, 1999, HEPATOLOGY, V30, P1425, DOI 10.1002/hep.510300614
   Toyoda H, 2005, GUT, V54, P297, DOI 10.1136/gut.2004.043893
   Tsuneyama K, 2003, PATHOL INT, V53, P90, DOI 10.1046/j.1440-1827.2003.01443.x
   von Schweinitz D, 2000, INT J CANCER, V85, P151, DOI 10.1002/(SICI)1097-0215(20000115)85:2<151::AID-IJC1>3.0.CO;2-6
   Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531
   Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062
   Xiao JC, 2003, HISTOPATHOLOGY, V42, P141, DOI 10.1046/j.1365-2559.2003.01544.x
   Yamamoto T, 1999, HEPATOLOGY, V29, P1446, DOI 10.1002/hep.510290523
   Yang SQ, 2004, HEPATOLOGY, V39, P403, DOI 10.1002/hep.20082
   Zhang SH, 2004, J CLIN PATHOL, V57, P556, DOI 10.1136/jcp.2003.012823
NR 69
TC 123
Z9 145
U1 0
U2 12
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1550-8943
J9 STEM CELL REV
JI Stem Cell Rev.
PY 2005
VL 1
IS 3
BP 253
EP 260
DI 10.1385/SCR:1:3:253
PG 8
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 083OU
UT WOS:000240468900010
PM 17142862
DA 2024-02-19
ER

PT J
AU Lee, DH
   Park, JO
   Kim, TS
   Kim, SK
   Kim, TH
   Kim, MC
   Park, GS
   Kim, JH
   Kuninaka, S
   Olson, EN
   Saya, H
   Kim, SY
   Lee, H
   Lim, DS
AF Lee, Da-Hye
   Park, Jae Oh
   Kim, Tae-Shin
   Kim, Sang-Kyum
   Kim, Tack-hoon
   Kim, Min-chul
   Park, Gun Soo
   Kim, Jeong-Hwan
   Kuninaka, Shinji
   Olson, Eric N.
   Saya, Hideyuki
   Kim, Seon-Young
   Lee, Ho
   Lim, Dae-Sik
TI LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling
   and <i>Hnf4</i>α expression during liver development
SO NATURE COMMUNICATIONS
LA English
DT Article
ID YES-ASSOCIATED PROTEIN; INTRAHEPATIC BILE-DUCTS; ORGAN SIZE CONTROL;
   HIPPO PATHWAY ACTIVITY; CELL FATE; HEPATOCYTE DIFFERENTIATION;
   HEPATOCELLULAR-CARCINOMA; PROGENITOR CELLS; MAMMALIAN LIVER; STEM-CELLS
AB The Hippo pathway regulates the self-renewal and differentiation of various adult stem cells, but its role in cell fate determination and differentiation during liver development remains unclear. Here we report that the Hippo pathway controls liver cell lineage specification and proliferation separately from Notch signalling, using mice and primary hepatoblasts with liver-specific knockout of Lats1 and Lats2 kinase, the direct upstream regulators of YAP and TAZ. During and after liver development, the activation of YAP/TAZ induced by loss of Lats1/2 forces hepatoblasts or hepatocytes to commit to the biliary epithelial cell (BEC) lineage. It increases BEC and fibroblast proliferation by up-regulating TGF beta signalling, but suppresses hepatoblast to hepatocyte differentiation by repressing Hnf4 alpha expression. Notably, oncogenic YAP/TAZ activation in hepatocytes induces massive p53-dependent cell senescence/death. Together, our results reveal that YAP/TAZ activity levels govern liver cell differentiation and proliferation in a context-dependent manner.
C1 [Lee, Da-Hye; Park, Jae Oh; Kim, Tae-Shin; Kim, Tack-hoon; Kim, Min-chul; Park, Gun Soo; Lim, Dae-Sik] Korea Adv Inst Sci & Technol, Dept Biol Sci, Natl Creat Res Initiat Ctr Cell Div & Differentia, Daejeon 34141, South Korea.
   [Kim, Sang-Kyum] Yonsei Univ, Coll Med, Dept Pathol, Seoul 03722, South Korea.
   [Kim, Jeong-Hwan; Kim, Seon-Young] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea.
   [Kuninaka, Shinji; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo 1608582, Japan.
   [Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
   [Lee, Ho] Natl Canc Ctr, Res Inst, Grad Sch Canc Sci & Policy, Goyang 10408, South Korea.
C3 Korea Advanced Institute of Science & Technology (KAIST); Yonsei
   University; Yonsei University Health System; Korea Research Institute of
   Bioscience & Biotechnology (KRIBB); Keio University; University of Texas
   System; University of Texas Southwestern Medical Center Dallas; National
   Cancer Center - Korea (NCC)
RP Lim, DS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Natl Creat Res Initiat Ctr Cell Div & Differentia, Daejeon 34141, South Korea.
EM daesiklim@kaist.ac.kr
RI Olson, Eric N./B-4391-2013; Lim, Dae-Sik/C-1599-2011; Kim,
   Minchul/AAF-9852-2021; Saya, Hideyuki/J-4325-2013
OI Olson, Eric N./0000-0003-1151-8262; Lim, Dae-Sik/0000-0003-2356-7555;
   Kim, Minchul/0000-0002-6863-841X; Kim, Tae-Shin/0000-0003-4736-0727;
   Saya, Hideyuki/0000-0001-6610-1902; Kim, Sang Kyum/0000-0003-0768-9923
FU National Creative Research Initiatives Center Program
   [NRF-2010-0018277]; Korea Mouse Phenotyping Project [NRF-2014
   M3A9D5A01073556, NRF-2014M3A9D5A01075128]; Korea Foundation for Cancer
   Research [KFCR-2013-003]
FX We thank Dr. Won-Il Jeong, who conducts the Korea Mouse Phenotyping
   Project (NRF-2014 M3A9D5A01073556), for providing technical support in
   the phenotypic analysis of the mouse livers. This study was supported by
   a grant from the National Creative Research Initiatives Center Program
   (NRF-2010-0018277, to D.S.L), Korea Mouse Phenotyping Project
   (NRF-2014M3A9D5A01075128, to H.L.) and by a grant from Korea Foundation
   for Cancer Research (KFCR-2013-003, to D.H.L.).
CR Alder O, 2014, CELL REP, V9, P261, DOI 10.1016/j.celrep.2014.08.046
   Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051
   Aylon Y, 2010, GENE DEV, V24, P2420, DOI 10.1101/gad.1954410
   Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769
   Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710
   Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021
   Boulter L, 2013, J CLIN INVEST, V123, P1867, DOI 10.1172/JCI66026
   Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039
   Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049
   Cebola I, 2015, NAT CELL BIOL, V17, P615, DOI 10.1038/ncb3160
   Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123
   Chiyoda T, 2012, J CELL BIOL, V197, P625, DOI 10.1083/jcb.201110110
   Chung C, 2013, P NATL ACAD SCI USA, V110, P7732, DOI 10.1073/pnas.1220603110
   Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305
   Crestani M, 1998, J LIPID RES, V39, P2192
   Das A, 2013, NAT CELL BIOL, V15, P1035, DOI 10.1038/ncb2828
   Diehl AM, 2013, J CLIN INVEST, V123, P1858, DOI 10.1172/JCI69966
   Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019
   Ehmer U, 2014, CELL REP, V8, P370, DOI 10.1016/j.celrep.2014.06.025
   Fiorotto R, 2013, J HEPATOL, V59, P124, DOI 10.1016/j.jhep.2013.02.025
   Fitamant J, 2015, CELL REP, V10, P1692, DOI 10.1016/j.celrep.2015.02.027
   Gao T, 2013, GASTROENTEROLOGY, V144, P1543, DOI 10.1053/j.gastro.2013.02.037
   Giovannini M, 2000, GENE DEV, V14, P1617
   Gressner OA, 2014, CLIN CHIM ACTA, V433, P111, DOI 10.1016/j.cca.2014.02.021
   Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002
   Harada N, 2004, CANCER RES, V64, P48, DOI 10.1158/0008-5472.CAN-03-2123
   Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118
   Irvine KD, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019224
   Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161
   Kim M, 2013, HIPPO SIGNALING PATH, P225
   Kim M, 2015, CELL REP, V11, P270, DOI 10.1016/j.celrep.2015.03.015
   Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102
   Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004
   Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906
   Lee JH, 2008, EMBO J, V27, P1231, DOI 10.1038/emboj.2008.63
   Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107
   Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107
   Matallanas D, 2011, MOL CELL, V44, P893, DOI 10.1016/j.molcel.2011.10.016
   Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638
   Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876
   Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033
   Oh S, 2009, MOL CELL BIOL, V29, P6309, DOI 10.1128/MCB.00551-09
   Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007
   Park YN, 2006, J HEPATOL, V45, P734, DOI 10.1016/j.jhep.2006.08.002
   Nguyen Q, 2015, DIGEST LIVER DIS, V47, P826, DOI 10.1016/j.dld.2015.05.011
   Roskams T, 2008, ANAT REC, V291, P628, DOI 10.1002/ar.20710
   Seth A, 2014, DEVELOPMENT, V141, P538, DOI 10.1242/dev.099481
   Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011
   Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107
   Stanger BZ, 2015, ANNU REV PHYSIOL, V77, P179, DOI 10.1146/annurev-physiol-021113-170255
   Su T, 2015, ELIFE, V4, DOI 10.7554/eLife.02948
   Takayama K, 2014, DEVELOPMENT, V141, P91, DOI 10.1242/dev.103168
   Tchorz JS, 2009, HEPATOLOGY, V50, P871, DOI 10.1002/hep.23048
   Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009
   Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376
   Vigneron AM, 2010, GENE DEV, V24, P2430, DOI 10.1101/gad.1954310
   Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034
   Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110
   Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278
   Yamashita T, 2013, J CLIN INVEST, V123, P1911, DOI 10.1172/JCI66024
   Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060
   Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060
   Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015
   Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691
   Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108
   Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026
   Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033
   Zhu Y, 2015, CELL SIGNAL, V27, P606, DOI 10.1016/j.cellsig.2014.12.002
NR 68
TC 139
Z9 164
U1 0
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN
PY 2016
VL 7
AR 11961
DI 10.1038/ncomms11961
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DQ3NH
UT WOS:000379108500001
PM 27358050
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Donati, A
   Recchia, G
   Cavallini, G
   Bergamini, E
AF Donati, Alessio
   Recchia, Gianluca
   Cavallini, Gabriella
   Bergamini, Ettore
TI Effect of aging and anti-aging caloric restriction on the endocrine
   regulation of rat liver autophagy
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE autophagy; caloric restriction; aging; insulin; glucagon
ID BODY PROTEIN BREAKDOWN; INSULIN-RECEPTOR; DIETARY RESTRICTION;
   PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; FOOD RESTRICTION;
   GENE-EXPRESSION; PLASMA-GLUCOSE; AMINO-ACID; AGE
AB Autophagy is a process that sequesters and degrades altered organelles and macromolecular cytoplasmic constituents for cellular restructuring and repair, and as a source of nutrients for metabolic use in early starvation it may be involved in anti-aging mechanisms of caloric restriction. The effects of 40% daily dietary restriction (DR) and intermittent feeding (EOD) on the age-related changes in the endocrine regulation of autophagic proteolysis were studied by monitoring the rate of valine release from isolated rat liver cells. Results show that in ad libitum-fed rats sensitivity of autophagy to glucagon and insulin declines by one order of magnitude in older rats. Both DR and EOD maintain the sensitivity to glucagon at juvenile levels, whereas only EOD can fully maintain response to insulin. It is concluded that changes in the sensitivity to glucagon may have a role in the aging process.
C1 [Donati, Alessio; Recchia, Gianluca; Cavallini, Gabriella; Bergamini, Ettore] Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, I-56126 Pisa, Italy.
C3 University of Pisa
RP Donati, A (corresponding author), Univ Pisa, Ctr Ric Biol & Patol Invecchiamento, Roma 55, I-56126 Pisa, Italy.
EM a.donati@med.unipi.it
CR Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374
   BERGAMINI E, 1990, PROTEIN METABOLISM A, P295
   Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020
   Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930
   BERTRAND HA, 1999, METHODS AGING RES, P271
   Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x
   Carvalho CRO, 1996, ENDOCRINOLOGY, V137, P151, DOI 10.1210/en.137.1.151
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   Chu CA, 2004, AM J PHYSIOL-GASTR L, V286, pG627, DOI 10.1152/ajpgi.00218.2003
   Del Roso A, 2003, EXP GERONTOL, V38, P519, DOI 10.1016/S0531-5565(03)00002-0
   DETATA V, 1993, J GERONTOL, V48, pB191
   Donati A, 2001, J GERONTOL A-BIOL, V56, pB375, DOI 10.1093/gerona/56.9.B375
   Donati A, 2006, REJUV RES, V9, P408, DOI 10.1089/rej.2006.9.408
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FRAEYMAN N, 1993, MECH AGEING DEV, V70, P115, DOI 10.1016/0047-6374(93)90063-W
   FUKAGAWA NK, 1985, J CLIN INVEST, V76, P2306, DOI 10.1172/JCI112240
   Fulop T, 2003, PATHOL BIOL, V51, P574, DOI 10.1016/j.patbio.2003.09.007
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   Guillet C, 2004, J CLIN ENDOCR METAB, V89, P6017, DOI 10.1210/jc.2003-031323
   Kissler HJ, 1999, RES EXP MED, V199, P73, DOI 10.1007/s004330050134
   KMIEC Z, 1983, EXP GERONTOL, V18, P173, DOI 10.1016/0531-5565(83)90030-X
   Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016
   Latour MG, 1999, AM J PHYSIOL-REG I, V276, pR1258, DOI 10.1152/ajpregu.1999.276.5.R1258
   MASORO EJ, 1993, J AM GERIATR SOC, V41, P994, DOI 10.1111/j.1532-5415.1993.tb06767.x
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   MASORO EJ, 2002, RES PROFILE AGING, V1
   Masternak MM, 2005, EXP GERONTOL, V40, P491, DOI 10.1016/j.exger.2005.04.002
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Mortimore G E, 1996, Subcell Biochem, V27, P93
   MORTIMORE GE, 1989, DIABETES METAB REV, V5, P49, DOI 10.1002/dmr.5610050105
   NAIR KS, 1987, AM J PHYSIOL, V253, pE208, DOI 10.1152/ajpendo.1987.253.2.E208
   Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837
   Podolin DA, 1996, AM J PHYSIOL-REG I, V270, pR365, DOI 10.1152/ajpregu.1996.270.2.R365
   Podolin DA, 2001, AM J PHYSIOL-ENDOC M, V281, pE516, DOI 10.1152/ajpendo.2001.281.3.E516
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   Ruiter M, 2003, DIABETES, V52, P1709, DOI 10.2337/diabetes.52.7.1709
   Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023
   SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169
   Seglen P O, 1990, Semin Cell Biol, V1, P441
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509
   TAPUHI Y, 1981, ANAL BIOCHEM, V115, P123, DOI 10.1016/0003-2697(81)90534-0
   Teillet L, 2002, MECH AGEING DEV, V123, P427, DOI 10.1016/S0047-6374(01)00400-6
   Teillet L, 2001, MECH AGEING DEV, V122, P385, DOI 10.1016/S0047-6374(00)00251-7
   TESSARI P, 1986, AM J PHYSIOL, V251, pE334, DOI 10.1152/ajpendo.1986.251.3.E334
   Tom A, 2006, J NUTR, V136, p324S, DOI 10.1093/jn/136.1.324S
   TSUJIMOTO A, 1986, MECH AGEING DEV, V33, P167, DOI 10.1016/0047-6374(86)90025-4
   VENERANDO R, 1994, AM J PHYSIOL, V266, pC455, DOI 10.1152/ajpcell.1994.266.2.C455
   WARD WF, 1988, J GERONTOL, V43, pB121, DOI 10.1093/geronj/43.5.B121
   WATANABE M, 1988, CELL TISSUE RES, V253, P337
   WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854
   Youngren JF, 2007, CELL MOL LIFE SCI, V64, P873, DOI 10.1007/s00018-007-6359-9
   YU BP, 1995, HDB PHYSL, V11, P613
   Zhu M, 2005, NUTRITION, V21, P378, DOI 10.1016/j.nut.2004.06.030
NR 55
TC 45
Z9 47
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUN
PY 2008
VL 63
IS 6
BP 550
EP 555
DI 10.1093/gerona/63.6.550
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 318IH
UT WOS:000257084300002
PM 18559627
OA Bronze, Green Submitted
DA 2024-02-19
ER

PT S
AU Riga, D
   Riga, S
   Schneider, F
AF Riga, D
   Riga, S
   Schneider, F
BE DeGrey, ADN
TI Regenerative medicine:: Antagonic-Stress® therapy in distress and aging
   -: I.: Predinical synthesis -: 2003
SO STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF
   AGING MAY BE FORESEEABLE
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 10th Congress of the International-Association-of-Biomedical-Gerontology
CY SEP 19-23, 2003
CL Cambridge, ENGLAND
SP Int Assoc Biomed Gerontol
DE regenerative medicine; preclinical studies; synthesis; antistress and
   antiaging therapy
AB Repetitive and cumulative distress (acute and/or chronic, psychic and/or biologic) and aging processes (impairment phenomena, agglomerated, and accumulated with the passing of life and senescence periods), as well as distress double left right arrow aging reciprocal amplification-accelerating-aggravation relationships require strong and rational (etiopathogenic) therapeutic interventions. Therefore, the drug, Antagonic-Stress(R) (AS)-a new integrative therapy, with specific synergistic formula, being patented worldwide becomes an important solution in distress, senescence, and their related pathologies. In acute (contention) stress, AS treatment significantly decreased rat mortality, number and surface of stomach ulcerations, nonesterified fatty acids (NEFAs), and increased superoxide dismutase (SOD) from blood. In chronic psychic stress, live nerve cells selectively isolated from rat cerebral cortex were highly protected by the administration of AS. In addition, antistress and antiaging homeostatic actions of AS were demonstrated in accelerated senescence (aging + distress) at multiple brain levels: on functional anabolism [increase in total ribonucleic acids (RNA), total proteins (TP), and water-soluble proteins (WSP)]; on functional catabolism [decrease in water-insoluble proteins (WIP)]; on structural anabolism (increased regeneration of free ribosomes, rough endoplasmic reticulum, mitochondria, and Nissl bodies); on structural catabolism (lipofuscinolysis and ceroidolysis, neurono-glial transfer of lipopigment continuously processed and dissoluted, and finally capillary elimination). Preclinical research with AS demonstrated important regenerative processes in the key organs (liver, heart, and brain), which mostly suffer due to both distress and senescence.
C1 Al Obregia Clin Hosp Psychiat, Dept Stress Res & Prophylaxis, RO-041914 Bucharest 8, Romania.
   Vasile Goldis Western Univ, Ctr Appl Physiol & Mol Biol, RO-310396 Arad, Romania.
C3 Vasile Goldis Western University of Arad
RP Riga, D (corresponding author), Al Obregia Clin Hosp Psychiat, Dept Stress Res & Prophylaxis, 10 Berceni Rd,Sector 4, RO-041914 Bucharest 8, Romania.
EM d_s_riga@yahoo.com
RI Riga, Sorin/C-2136-2011; Riga, Dan/AAL-5762-2021
CR de Grey ADNJ, 2002, TRENDS BIOTECHNOL, V20, P452, DOI 10.1016/S0167-7799(02)02062-0
   Riga D, 1998, ANN NY ACAD SCI, V854, P495, DOI 10.1111/j.1749-6632.1998.tb09943.x
   Riga D, 1994, Arch Gerontol Geriatr, V19 Suppl 1, P227, DOI 10.1016/S0167-4943(05)80068-8
   RIGA D, 2000, TXB MENTAL HLTH, V1, P211
   RIGA D, 1995, LIPOFUSCIN CEROID PI, P271
   RIGA D, 1998, 2 WORLD C STRESS MEL
   Riga S, 1995, ANN NY ACAD SCI, V771, P535, DOI 10.1111/j.1749-6632.1995.tb44708.x
   Riga S, 1994, Arch Gerontol Geriatr, V19 Suppl 1, P217, DOI 10.1016/S0167-4943(05)80067-6
   RIGA S, 2003, BIOGERONTOLOGY S1, V4, P82
NR 9
TC 2
Z9 2
U1 0
U2 3
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-496-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1019
BP 396
EP 400
DI 10.1196/annals.1297.071
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Science & Technology - Other Topics
GA BAN77
UT WOS:000223002700071
PM 15247053
DA 2024-02-19
ER

PT J
AU Chen, TS
   Richie, JP
   Nagasawa, HT
   Lang, CA
AF Chen, TS
   Richie, JP
   Nagasawa, HT
   Lang, CA
TI Glutathione monoethyl ester protects against glutathione deficiencies
   due to aging and acetaminophen in mice
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE glutathione; acetaminophen; glutathione monoethyl ester; liver; kidney;
   aging
ID INDUCED HEPATIC NECROSIS; COVALENT BINDING; RENAL-FAILURE; L-CYSTEINE;
   RATS; HEPATOTOXICITY; MOUSE; METABOLISM; TRANSPORT; DEPLETION
AB Our previous results indicated that glutathione (GSH) and/or cysteine (Cys) deficiency occurs in many aging tissues and also after acetaminophen (APAP) administration. The aim of this study was to investigate whether GSH monoethyl ester (GSH-OEt) can correct these deficiencies. Mice of different ages (3-31 months) through the life span were sacrificed 2 h after i.p. injection of GSH-OEt (10 mmol/kg). In separate experiments, old mice (30-31 months) received the same dose of ester 30 min before the administration of APAP (375 mg/kg) or buthionine sulfoximine (BSO, 4 mmol/kg), an inhibitor of GSH biosynthesis. Liver and kidney samples were analyzed for GSH and Cys by HPLC. The hepatic GSH and renal cortical GSH and Cys concentrations were about 30% lower in old mice (30-31 months) compared to mature mice (12 months). GSH-OEt corrected these aging-related decreases. APAP decreased both hepatic and renal cortical GSH and Cys concentrations in old mice, but GSH-OEt prevented these decreases. GSH-OEt also prevented the BSO-induced decreases in hepatic and renal GSH concentrations. The results demonstrated that GSH-OEt protected against GSH deficiency due to biological aging as well as APAP-induced decreases in old mice. (C) 2000 Published by Elsevier Science Ireland Ltd.
C1 Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.
   Amer Hlth Fdn, Valhalla, NY 10595 USA.
   Univ Minnesota, VA Med Ctr, Minneapolis, MN USA.
   Univ Minnesota, Dept Med Chem, Minneapolis, MN USA.
   Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.
C3 University of Louisville; American Health Foundation; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA
   Health Care System; University of Minnesota System; University of
   Minnesota Twin Cities; University of Minnesota System; University of
   Minnesota Twin Cities; University of Louisville
RP Chen, TS (corresponding author), Univ Louisville, Sch Med, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.
OI Richie, John/0000-0001-8239-2850; Nagasawa, Herbert/0000-0002-9106-1823
CR ANDERSON ME, 1985, ARCH BIOCHEM BIOPHYS, V239, P538, DOI 10.1016/0003-9861(85)90723-4
   BEIERSCHMITT WP, 1986, AGE, V9, P7, DOI 10.1007/BF02431894
   BOYER TD, 1971, J AMER MED ASSOC, V218, P440, DOI 10.1001/jama.218.3.440
   CAMPBELL EB, 1989, ANAL BIOCHEM, V183, P21, DOI 10.1016/0003-2697(89)90165-6
   CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399
   CHEN TS, 1990, DRUG METAB DISPOS, V18, P882
   DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327
   GOLDMAN R, 1973, BIOCHIM BIOPHYS ACTA, V318, P205, DOI 10.1016/0005-2736(73)90114-4
   GOLDMAN R, 1974, BIOCHIM BIOPHYS ACTA, V338, P224, DOI 10.1016/0304-4165(74)90351-1
   GOLDMAN R, 1976, LYSOSOM BIOL PATHOL, V5, P309
   GRATTAGLIANO I, 1995, J PHARMACOL EXP THER, V272, P484
   GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P5606, DOI 10.1073/pnas.76.11.5606
   GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P6319, DOI 10.1073/pnas.76.12.6319
   Harding JJ, 1996, BIOCHEM SOC T, V24, P881, DOI 10.1042/bst0240881
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   KLEINMAN JG, 1980, CLIN NEPHROL, V14, P201
   MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431
   MINERS JO, 1988, EUR J CLIN PHARMACOL, V35, P157, DOI 10.1007/BF00609245
   MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211
   MUDGE GH, 1978, J PHARMACOL EXP THER, V206, P218
   MURRAY DL, 1990, CURR EYE RES, V9, P55, DOI 10.3109/02713689009000055
   NAGASAWA HT, 1984, J MED CHEM, V27, P591, DOI 10.1021/jm00371a006
   Nakata K, 1996, MECH AGEING DEV, V90, P195, DOI 10.1016/0047-6374(96)01771-X
   POTTER DW, 1993, TOXICOL APPL PHARM, V120, P186, DOI 10.1006/taap.1993.1102
   PURI RN, 1983, P NATL ACAD SCI-BIOL, V80, P5258, DOI 10.1073/pnas.80.17.5258
   RICHIE JP, 1985, DRUG METAB DISPOS, V13, P14
   RICHIE JP, 1987, P SOC EXP BIOL MED, V184, P113
   RICHIE JP, 1988, P SOC EXP BIOL MED, V187, P235
   RICHIE JP, 1992, BIOCHEM PHARMACOL, V44, P129, DOI 10.1016/0006-2952(92)90046-L
   RICHIE JP, 1987, ANAL BIOCHEM, V163, P9, DOI 10.1016/0003-2697(87)90085-6
   RIKANS LE, 1988, DRUG CHEM TOXICOL, V11, P237, DOI 10.3109/01480548809017880
   ROBERTS JC, 1987, J MED CHEM, V30, P1891, DOI 10.1021/jm00393a034
   STANDEVEN AM, 1991, TOXICOL APPL PHARM, V107, P269, DOI 10.1016/0041-008X(91)90208-V
   Tarloff JB, 1996, FUND APPL TOXICOL, V30, P13, DOI 10.1006/faat.1996.0038
   WELLNER VP, 1984, P NATL ACAD SCI-BIOL, V81, P4732, DOI 10.1073/pnas.81.15.4732
   WILLIAMSON JM, 1982, P NATL ACAD SCI-BIOL, V79, P6246, DOI 10.1073/pnas.79.20.6246
NR 36
TC 35
Z9 37
U1 0
U2 6
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD DEC 1
PY 2000
VL 120
IS 1-3
BP 127
EP 139
DI 10.1016/S0047-6374(00)00214-1
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 379PA
UT WOS:000165650600011
PM 11087910
DA 2024-02-19
ER

PT J
AU Navarro, A
   Boveris, A
AF Navarro, A
   Boveris, A
TI Rat brain and liver mitochondria develop oxidative stress and lose
   enzymatic activities on aging
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE mitochondrial nitric oxide synthase; manganese-superoxide dismutase;
   NADH-cytochrome c reductase; cytochrome oxidase; mitochondrial
   fragility; oxidative stress
ID SUPEROXIDE-DISMUTASE ACTIVITY; NITRIC-OXIDE SYNTHASE;
   GLUTATHIONE-PEROXIDASE; LIPID-PEROXIDATION; ANTIOXIDANT ENZYMES; DAMAGE;
   DYSFUNCTION; GENERATION; CATALASE; SURVIVAL
AB The mitochondrial mass of rat brain and liver remained unchanged on aging in young adults, old adults, and senescent animals (28, 60, and 92 wk of age); the values were 15 - 17 and 29 - 31 mg protein/g for brain and liver, respectively. The whole aging process was associated with an increased content of the oxidation products, thiobarbituric acid-reactive substances and protein carbonyls, by 61 - 69% in brain and 36 - 45% in liver, respectively. The activities of critical enzymes for mitochondrial function, mitochondrial nitric oxide synthase, Mn-superoxide dismutase, complex I, and complex IV, decreased progressively during aging with activity losses of 73, 37, 29, and 28%, respectively, in the brain and 47, 46, 30, and 24% in the liver of senescent rats compared with young adults. Brain mitochondria isolated from aged rats showed increased mitochondrial fragility, as assayed by mitochondrial marker enzyme activities in the postmitochondrial supernatant, and increased volume and water permeability, as assayed by light scattering. Liver mitochondria isolated from young and old rats did not show differences in fragility and water permeability. A subpopulation of brain mitochondria with increased size and fragility was differentiated in aging rats, whereas liver showed a homogeneous mitochondrial population.
C1 Univ Cadiz, Fac Med, Dept Biochem & Mol Biol, Cadiz 11003, Spain.
   Univ Buenos Aires, Sch Pharm & Biochem, Buenos Aires, DF, Argentina.
C3 Universidad de Cadiz; University of Buenos Aires
RP Navarro, A (corresponding author), Univ Cadiz, Fac Med, Dept Biochem & Mol Biol, Plaza Fragela 9, Cadiz 11003, Spain.
EM ana.navarro@uca.es
CR Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8
   Boveris A, 2003, ANTIOXID REDOX SIGN, V5, P265, DOI 10.1089/152308603322110841
   Boveris A, 2002, METHOD ENZYMOL, V359, P328
   BOVERIS A, 1999, OXIDAT STRESS DIS, V2, P1
   BRACCO F, 1991, P SOC EXP BIOL MED, V196, P36
   Brown GC, 2003, SCIENCE, V299, P838, DOI 10.1126/science.1082028
   CADENAS E, 1980, BIOCHEM J, V188, P31, DOI 10.1042/bj1880031
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CRISTIANO F, 1995, MECH AGEING DEV, V80, P93, DOI 10.1016/0047-6374(94)01561-Y
   DEHAAN JB, 1995, BIOCHEM MOL BIOL INT, V35, P1281
   Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200
   Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765
   FRAGA CG, 1988, FREE RADICAL BIO MED, V4, P155, DOI 10.1016/0891-5849(88)90023-8
   Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5
   Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038
   GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223
   Gould E, 1993, Curr Opin Neurobiol, V3, P676, DOI 10.1016/0959-4388(93)90138-O
   Hagen TM, 1998, ANN NY ACAD SCI, V854, P214, DOI 10.1111/j.1749-6632.1998.tb09904.x
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4
   LAMMIKEEFE CJ, 1984, GERONTOLOGY, V30, P153, DOI 10.1159/000212623
   Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8
   Leutner S, 2001, J NEURAL TRANSM, V108, P955, DOI 10.1007/s007020170015
   LOPEZTORRES M, 1993, FREE RADICAL BIO MED, V15, P133, DOI 10.1016/0891-5849(93)90052-V
   MARIA CS, 1995, FEBS LETT, V374, P85
   McCarter Roger J. M., 1995, P95
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   MO JQ, 1995, MECH AGEING DEV, V81, P73, DOI 10.1016/0047-6374(95)01586-O
   Nakahara H, 1998, FREE RADICAL BIO MED, V24, P85, DOI 10.1016/S0891-5849(97)00164-0
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001
   Navarro Ana, 2004, Molecular Aspects of Medicine, V25, P37, DOI 10.1016/j.mam.2004.02.007
   NOHL H, 1979, MECH AGEING DEV, V11, P145, DOI 10.1016/0047-6374(79)90050-2
   Okabe T, 1996, J NEUROL SCI, V141, P100, DOI 10.1016/0022-510X(96)00160-8
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   Sandhu SK, 2002, BIOGERONTOLOGY, V3, P161, DOI 10.1023/A:1015643107449
   Sastre J, 1998, FREE RADICAL BIO MED, V24, P298, DOI 10.1016/S0891-5849(97)00228-1
   SCARPA A, 1973, J GEN PHYSIOL, V62, P756, DOI 10.1085/jgp.62.6.756
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0
   Stadtman ER, 2002, FREE RADICAL BIO MED, V33, P597, DOI 10.1016/S0891-5849(02)00904-8
   Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Viña J, 2003, ANTIOXID REDOX SIGN, V5, P549, DOI 10.1089/152308603770310194
NR 49
TC 240
Z9 263
U1 1
U2 9
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD NOV
PY 2004
VL 287
IS 5
BP R1244
EP R1249
DI 10.1152/ajpregu.00226.2004
PG 6
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 860YW
UT WOS:000224382700034
PM 15271654
DA 2024-02-19
ER

PT J
AU Koh, YC
   Kuo, LH
   Chang, YY
   Tung, YC
   Lo, YC
   Pan, MH
AF Koh, Yen-Chun
   Kuo, Lee-Han
   Chang, Ya-Yun
   Tung, Yen-Chen
   Lo, Yi-Chen
   Pan, Min-Hsiung
TI Modulatory Effect of Fermented Black Soybean and Adlay on Gut Microbiota
   Contributes to Healthy Aging
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article; Early Access
DE adlay; Bacillus subtilis natto; black soybean; fermentation; gut
   microbiota; natural aging
ID JAPANESE DIET; LIFE-SPAN; SENESCENCE; GENDER
AB ScopeAging is a natural process characterized by a multifactorial, physical decline, and functional disability. Nevertheless, healthy aging can be achieved by following a multidirectional strategy. The current study aims to investigate the anti-aging potential of fermented black soybean and adlay (FBA). Methods and resultsFBA supplements are incorporated into a natural aging mouse model that is designed to evaluate anti-aging effects. Results show that FBA supplementation prevents muscle loss and visceral adipose tissue accumulation. FBA can also reduce aging biomarkers (including the expression of hepatic p16(INK4A) and galactosidase beta-1 (GLB1). Hepatic 8-hydoxy-2'-deoxyguanosine (8-oxodG) and pro-inflammatory cytokines have been significantly reduced. Lastly, FBA supplementation improves aging-related gut microbial dysbiosis by reshaping gut microbial composition and promoting the growth of beneficial microbes such as Alistipes, Anaeroplasma, Coriobacteriaceae UCG002, and Parvibacter members in both genders of aged mice. In the functional prediction of gut microbiota, correlations to metabolic, neurodegenerative, infectious, and immune system diseases have been reduced in supplemented mice compared to aged mice. Moreover, FBA supplementation can reverse the reduced ability of microbiota in aged mice for lipid metabolism and xenobiotics biodegradation. ConclusionsThe results suggest that FBA exhibits noteworthy anti-aging effects and that it can potentially be developed into a functional food for healthy aging.
C1 [Koh, Yen-Chun; Kuo, Lee-Han; Chang, Ya-Yun; Lo, Yi-Chen; Pan, Min-Hsiung] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei City 106216, Taiwan.
   [Tung, Yen-Chen] Natl Ilan Univ, Dept Food Sci, Yilan 26047, Taiwan.
   [Pan, Min-Hsiung] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 404327, Taiwan.
   [Pan, Min-Hsiung] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
C3 National Ilan University; China Medical University Taiwan; China Medical
   University Hospital - Taiwan; Asia University Taiwan
RP Pan, MH (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, Taipei City 106216, Taiwan.; Pan, MH (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung 404327, Taiwan.; Pan, MH (corresponding author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
EM mhpan@ntu.edu.tw
RI Pan, Min-Hsiung/AAT-8865-2021; Tung, Yen-Chen/K-4460-2019
OI Pan, Min-Hsiung/0000-0002-5188-7030; Tung, Yen-Chen/0000-0001-9055-5509;
   KOH, YEN CHUN/0000-0001-7683-873X
FU Ministry of Science and Technology, Taiwan [108-2321-B-002-020]
FX Acknowledgements This work was supported by the Ministry of Science and
   Technology, Taiwan [108-2321-B-002-020].
CR Amamoto R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91917-6
   Beller A, 2019, ANN RHEUM DIS, V78, pA45, DOI 10.1136/annrheumdis-2018-EWRR2019.92
   Beller A, 2020, EUR J IMMUNOL, V50, P783, DOI 10.1002/eji.201948474
   Boccardi V, 2021, MECH AGEING DEV, V197, DOI 10.1016/j.mad.2021.111526
   Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305
   Bosco N, 2021, GENES IMMUN, V22, P289, DOI 10.1038/s41435-021-00126-8
   Cao J, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103643
   Choromanska B, 2021, FREE RADICAL BIO MED, V175, P108, DOI 10.1016/j.freeradbiomed.2021.08.009
   Chou HY, 2021, FOOD CHEM TOXICOL, V150, DOI 10.1016/j.fct.2021.112020
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Das G, 2020, FOOD RES INT, V134, DOI 10.1016/j.foodres.2020.109269
   DeJong EN, 2020, CELL HOST MICROBE, V28, P180, DOI 10.1016/j.chom.2020.07.013
   Dohrmann DD, 2019, FOOD RES INT, V120, P464, DOI 10.1016/j.foodres.2018.10.090
   Duncan SH, 2016, ENVIRON MICROBIOL, V18, P2214, DOI 10.1111/1462-2920.13158
   Durack J, 2019, J EXP MED, V216, P20, DOI 10.1084/jem.20180448
   Grimble RF, 2003, CURR OPIN CLIN NUTR, V6, P21, DOI 10.1097/00075197-200301000-00005
   Gurau F, 2018, AGEING RES REV, V46, P14, DOI 10.1016/j.arr.2018.05.001
   He RH, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.642948
   Hu CC, 2004, J AGR FOOD CHEM, V52, P5735, DOI 10.1021/jf035075b
   Huang HW, 2021, J AGR FOOD CHEM, V69, P7353, DOI 10.1021/acs.jafc.1c01547
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Ibe S, 2013, BIOSCI BIOTECH BIOCH, V77, P392, DOI 10.1271/bbb.120726
   Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787
   Kang K, 2021, EXP THER MED, V21, DOI 10.3892/etm.2021.9862
   Kim HJ, 2021, ARCH GERONTOL GERIAT, V94, DOI 10.1016/j.archger.2020.104333
   Kim S, 2018, GERONTOLOGY, V64, P513, DOI 10.1159/000490615
   Kirkland JL, 2017, J AM GERIATR SOC, V65, P2297, DOI 10.1111/jgs.14969
   Koh YC, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202100434
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Kushida M, 2019, J NUTR BIOCHEM, V64, P121, DOI 10.1016/j.jnutbio.2018.10.011
   Leeming ER, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122862
   Li XA, 2021, PHARMACOL RES, V168, DOI 10.1016/j.phrs.2021.105587
   Li YY, 2022, INT J BIOL MACROMOL, V213, P234, DOI 10.1016/j.ijbiomac.2022.05.130
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liu HJ, 2018, SURG OBES RELAT DIS, V14, P584, DOI 10.1016/j.soard.2018.01.012
   Lozada-Delgado J. G., 2020, AGING
   Luo DS, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109550
   Maffei VJ, 2017, J GERONTOL A-BIOL, V72, P1474, DOI 10.1093/gerona/glx042
   Mancabelli L, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix153
   Milan-Mattos JC, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431X20198392, 10.1590/1414-431x20198392]
   Moraes TB, 2013, CELL MOL NEUROBIOL, V33, P253, DOI 10.1007/s10571-012-9892-5
   Mu HN, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.585066
   Mukherjee A, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1802866
   Parker P. A., 2020, DROPPED, P11
   Pinchuk I, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101204
   Ragonnaud E, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-020-00213-w
   Rhayat L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00564
   Tang WJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7261619
   Thomas-Ahner JM, 2007, CANCER RES, V67, P3468, DOI 10.1158/0008-5472.CAN-06-3798
   Thompson CL, 2013, MUCOSAL IMMUNOL, V6, P200, DOI 10.1038/mi.2012.91
   Toma VA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153627
   Tsang MSM, 2018, MOLECULES, V23, DOI 10.3390/molecules23112776
   Wang X., 2022, FOOD SCI TECH-BRAZIL, V43, P378
   Wei Z.-Y., 2021, GENOMICS, P1672
   Wilmanski T, 2021, NAT METAB, V3, P274, DOI 10.1038/s42255-021-00348-0
   Wolfe AE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236595
   Wu GJ, 2021, NUTRIENTS, V13, DOI 10.3390/nu13093155
   Yamamoto K, 2016, NUTRITION, V32, P122, DOI 10.1016/j.nut.2015.07.002
   Yin Ran, 2019, Curr Pharmacol Rep, V5, P332, DOI 10.1007/s40495-019-00196-3
   Zhang X., 2022, FRONT NUTR, V9
   Zhong Y., 2021, FRONT MICROBIOL, V12
NR 61
TC 3
Z9 3
U1 9
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD 2023 MAR
PY 2023
VL 67
IS 5
DI 10.1002/mnfr.202200700
EA FEB 2023
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA Q5OR7
UT WOS:000922164900001
PM 36655510
DA 2024-02-19
ER

PT J
AU Li, C
   Tan, F
   Yang, JJ
   Yang, Y
   Gou, YT
   Li, ST
   Zhao, X
AF Li, Chong
   Tan, Fang
   Yang, Jianjun
   Yang, Yue
   Gou, Yuting
   Li, Shuting
   Zhao, Xin
TI Antioxidant Effects of <i>Apocynum venetum</i> Tea Extracts on
   d-Galactose-Induced Aging Model in Mice
SO ANTIOXIDANTS
LA English
DT Article
DE Apocynum venetum tea extracts; d-galactose; mice; oxidative damage;
   biological components
ID OXIDATIVE STRESS; HEALTH; ACID; PROLIFERATION; SENESCENCE; APOPTOSIS;
   ENZYMES; CELLS; LIVER
AB As a traditional Chinese medicinal drink, Apocynum venetum, a local tea from Xinjiang, China, is favored for its rich flavor and biological functionality. This study looked at aging mice induced by d-galactose to determine the in vivo anti-aging effect of Apocynum venetum tea extracts (AVTEs) and its bioactive components. We evaluated the weight of major organs (via organ index) and pathological changes in the liver. We also detailed the effects of AVTE (250 mg/kg in the low dose group, 500 mg/kg in the high dose group) on biochemical parameters (malondialdehyde, superoxide dismutase, glutathione, glutathione peroxidase, catalase, total antioxidant capacity, and nitric oxide) and cytokines (IL-6, IL-12, TNF-alpha and IL-1 beta) in the serum of aging mice. We investigated the anti-aging effects of AVTE in d-galactose-induced aging mice via quantitative real-time reverse transcription-polymerase chain reaction (RT-qPCR) assay. In addition, we analyzed the biological components of AVTEs by high performance liquid chromatography (HPLC). The results were remarkable, suggesting that AVTE significantly improved d-galactose-induced aging mice, with the high dose group showing the best results among other groups. ATVE can effectively alleviate hepatocyte edema, as well as inflammatory cell infiltration and injury in mice, induce a protective effect via up-regulation of glutathione (GSH), glutathione peroxidase (GSH-Px), superoxide dismutase (SOD), and catalase (CAT) antioxidant related factors, and play an important role in the up-regulation of anti-inflammatory factors (IL-10) and the down-regulation of pro-inflammatory factors (IL-6, TNF-alpha and IL-1 beta). At the same time, HPLC analysis showed that AVTEs contain neochlorogenic acid, chlorogenic acid, cryptochlorogenic acid, rutin, isoquercitrin, isochlorogenic acid B, isochlorogenic acid A, astragalin, isochlorogenic acid C, rosmarinic acid, and trans-cinnamic acid. Thus, AVTE appears to be an effectively functional drink due to its rich functional components and anti-aging activities.
C1 [Li, Chong; Yang, Jianjun; Yang, Yue; Gou, Yuting; Li, Shuting; Zhao, Xin] Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Li, Chong; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing 400067, Peoples R China.
   [Li, Chong; Zhao, Xin] Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.
   [Tan, Fang] Our Lady Fatima Univ, Dept Publ Hlth, Valenzuela 838, Philippines.
   [Yang, Jianjun; Yang, Yue; Gou, Yuting; Li, Shuting] Chongqing Univ Educ, Coll Biol & Chem Engn, Chongqing 400067, Peoples R China.
C3 Chongqing University of Education; Chongqing University of Education;
   Chongqing University of Education; Our Lady of Fatima University;
   Chongqing University of Education
RP Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Collaborat Innovat Ctr Funct Food, Chongqing 400067, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Res Ctr Funct Food, Chongqing 400067, Peoples R China.; Zhao, X (corresponding author), Chongqing Univ Educ, Chongqing Engn Lab Res & Dev Funct Food, Chongqing 400067, Peoples R China.
EM zhaoxin@cque.edu.cn
OI Tan, Fang/0000-0003-2406-129X
FU Program for Innovation Team Building at Institutions of Higher Education
   in Chongqing [CXTDX201601040]; Research Project of Chongqing University
   of Education [KY201921C]
FX This research was funded by the Program for Innovation Team Building at
   Institutions of Higher Education in Chongqing [CXTDX201601040], and the
   Research Project of Chongqing University of Education [KY201921C],
   China.
CR Amoah SKS, 2016, PLANTA MED, V82, P388, DOI 10.1055/s-0035-1568274
   Aydin AF, 2016, METAB BRAIN DIS, V31, P337, DOI 10.1007/s11011-015-9755-0
   BOLWELL GP, 1988, PHYTOCHEMISTRY, V27, P2109, DOI 10.1016/0031-9422(88)80106-7
   Case AJ, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6040082
   Chandrasekaran A, 2017, REDOX BIOL, V11, P91, DOI 10.1016/j.redox.2016.11.005
   Chung SS, 2017, MEDIAT INFLAMM, V2017, P1, DOI DOI 10.1155/2017/5958429
   Cömert ED, 2018, FOOD RES INT, V105, P76, DOI 10.1016/j.foodres.2017.10.056
   Crawford A, 2012, GENE, V501, P89, DOI 10.1016/j.gene.2012.04.011
   Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385
   Dong FX, 2017, BIOCHEM BIOPH RES CO, V491, P636, DOI 10.1016/j.bbrc.2017.07.151
   DRAPER HH, 1990, METHOD ENZYMOL, V186, P421
   Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5
   Ghasemi H, 2018, OCUL IMMUNOL INFLAMM, V26, P37, DOI 10.1080/09273948.2016.1277247
   Glorieux C, 2017, BIOL CHEM, V398, P1095, DOI 10.1515/hsz-2017-0131
   Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853
   Gullón B, 2017, TRENDS FOOD SCI TECH, V67, P220, DOI 10.1016/j.tifs.2017.07.008
   Gupta S, 2019, BASIC CLIN PHARMACOL, V124, P351, DOI 10.1111/bcpt.13032
   Han R, 2018, CHEMOSPHERE, V200, P283, DOI 10.1016/j.chemosphere.2018.02.137
   Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709
   Huang SP, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090948
   Irie K, 2009, J NAT MED, V63, P111, DOI 10.1007/s11418-008-0296-2
   Jia YN, 2018, INT IMMUNOPHARMACOL, V56, P105, DOI 10.1016/j.intimp.2018.01.014
   Junzhen W., 2014, BIOMED RES INT, V2014
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Keles MS, 2001, CAN J NEUROL SCI, V28, P141, DOI 10.1017/S0317167100052823
   Kobayashi S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0250-9
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Li C, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9071325
   Li W, 2017, J AGR FOOD CHEM, V65, P5961, DOI 10.1021/acs.jafc.7b02120
   Liang N, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010016
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liu HY, 2018, FOOD AGR IMMUNOL, V29, P316, DOI 10.1080/09540105.2017.1376037
   Long P, 2014, ACTA PHARM SIN B, V4, P227, DOI 10.1016/j.apsb.2014.02.006
   Matés JM, 1999, CLIN BIOCHEM, V32, P595, DOI 10.1016/S0009-9120(99)00075-2
   Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007
   McKay DL, 2002, J AM COLL NUTR, V21, P1
   McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64
   Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   SOOS E, 1949, Sci Pharm, V17, P121
   Tamareille S, 2011, BASIC RES CARDIOL, V106, P1329, DOI 10.1007/s00395-011-0210-z
   Villarreal-Soto SA, 2018, J FOOD SCI, V83, P580, DOI 10.1111/1750-3841.14068
   [王海明 Wang Haiming], 2007, [食品科学, Food Science], V28, P326
   WILKE BC, 1992, CLIN CHIM ACTA, V207, P137, DOI 10.1016/0009-8981(92)90157-L
   Wu P, 2017, FOOD FUNCT, V8, P3707, DOI 10.1039/c7fo00778g
   Xie WY, 2012, J ETHNOPHARMACOL, V141, P1, DOI 10.1016/j.jep.2012.02.003
   Xiong QB, 2000, PLANTA MED, V66, P127, DOI 10.1055/s-2000-11135
   Zhang W, 2018, J PHYSIOL BIOCHEM, V74, P301, DOI 10.1007/s13105-018-0618-0
   Zhang XL, 2013, FOOD CHEM TOXICOL, V58, P50, DOI 10.1016/j.fct.2013.04.006
NR 54
TC 32
Z9 35
U1 3
U2 37
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD SEP
PY 2019
VL 8
IS 9
AR 381
DI 10.3390/antiox8090381
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA JA6MU
UT WOS:000487957300045
PM 31500342
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Lossow, K
   Kopp, JF
   Schwarz, M
   Finke, H
   Winkelbeiner, N
   Renko, K
   Meçi, X
   Ott, C
   Alker, W
   Hackler, J
   Grune, T
   Schomburg, L
   Haase, H
   Schwerdtle, T
   Kipp, AP
AF Lossow, Kristina
   Kopp, Johannes F.
   Schwarz, Maria
   Finke, Hannah
   Winkelbeiner, Nicola
   Renko, Kostja
   Meci, Xheni
   Ott, Christiane
   Alker, Wiebke
   Hackler, Julian
   Grune, Tilman
   Schomburg, Lutz
   Haase, Hajo
   Schwerdtle, Tanja
   Kipp, Anna P.
TI Aging affects sex- and organ-specific trace element profiles in mice
SO AGING-US
LA English
DT Article
DE aging; trace elements; biomarkers; homeostasis; epigenetic markers
ID OXIDATIVE STRESS; SERUM ZINC; INFLAMMATORY RESPONSE;
   MOLECULAR-MECHANISMS; IRON REGULATION; IMMUNE-SYSTEM; IN-VIVO; SELENIUM;
   AGE; DEFICIENCY
AB A decline of immune responses and dynamic modulation of the redox status are observed during aging and are influenced by trace elements such as copper, iodine, iron, manganese, selenium, and zinc. So far, analytical studies have focused mainly on single trace elements. Therefore, we aimed to characterize age-specific profiles of several trace elements simultaneously in serum and organs of adult and old mice. This allows for correlating multiple trace element levels and to identify potential patterns of age-dependent alterations. In serum, copper and iodine concentrations were increased and zinc concentration was decreased in old as compared to adult mice. In parallel, decreased copper and elevated iron concentrations were observed in liver. The age-related reduction of hepatic copper levels was associated with reduced expression of copper transporters, whereas the increased hepatic iron concentrations correlated positively with proinflammatory mediators and Nrf2-induced ferritin H levels. Interestingly, the age-dependent inverse regulation of copper and iron was unique for the liver and not observed in any other organ. The physiological importance of alterations in the iron/copper ratio for liver function and the aging process needs to be addressed in further studies.
C1 [Lossow, Kristina; Schwarz, Maria; Kipp, Anna P.] Friedrich Schiller Univ Jena, Inst Nutr Sci, Dept Mol Nutr Physiol, Jena, Germany.
   [Lossow, Kristina; Kopp, Johannes F.; Finke, Hannah; Winkelbeiner, Nicola; Schwerdtle, Tanja] Univ Potsdam, Inst Nutr Sci, Dept Food Chem, Nuthetal, Germany.
   [Lossow, Kristina; Ott, Christiane; Grune, Tilman] German Inst Human Nutr, Nuthetal, Germany.
   [Lossow, Kristina; Kopp, Johannes F.; Schwarz, Maria; Winkelbeiner, Nicola; Alker, Wiebke; Hackler, Julian; Schomburg, Lutz; Haase, Hajo; Schwerdtle, Tanja; Kipp, Anna P.] TraceAge DFG Res Unit Interact Essential Trace El, Potsdam, Germany.
   [Renko, Kostja; Meci, Xheni; Hackler, Julian; Schomburg, Lutz] Charite, Inst Expt Endocrinol, Med Sch Berlin, Berlin, Germany.
   [Renko, Kostja; Schwerdtle, Tanja] German Fed Inst Risk Assessment BfR, Berlin, Germany.
   [Ott, Christiane] German Ctr Cardiovasc Res, DZHK, Berlin, Germany.
   [Alker, Wiebke; Haase, Hajo] Tech Univ Berlin, Dept Food Chem & Toxicol, Berlin, Germany.
C3 Friedrich Schiller University of Jena; University of Potsdam; Deutsches
   Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free
   University of Berlin; Humboldt University of Berlin; Charite
   Universitatsmedizin Berlin; Federal Institute for Risk Assessment;
   German Centre for Cardiovascular Research; Technical University of
   Berlin
RP Kipp, AP (corresponding author), Friedrich Schiller Univ Jena, Inst Nutr Sci, Dept Mol Nutr Physiol, Jena, Germany.; Kipp, AP (corresponding author), TraceAge DFG Res Unit Interact Essential Trace El, Potsdam, Germany.
EM anna.kipp@uni-jena.de
RI Kopp, Johannes Florian/G-9269-2016; Haase, Hajo/B-9280-2009; Schomburg,
   Lutz/D-8096-2013; Schwarz, Maria/KBA-4119-2024
OI Kopp, Johannes Florian/0000-0001-9929-6937; Haase,
   Hajo/0000-0002-1622-8718; Schomburg, Lutz/0000-0001-9445-1555; Kipp,
   Anna Patricia/0000-0002-3307-1038; Winkelbeiner,
   Nicola/0000-0003-3455-7774; Ott, Christiane/0000-0002-3199-0655
FU DFG research unit FOR 2558
FX DFG research unit FOR 2558.
CR Akçil E, 2003, BIOL TRACE ELEM RES, V93, P95, DOI 10.1385/BTER:93:1-3:95
   Alker W, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164006
   Ames BN, 2006, P NATL ACAD SCI USA, V103, P17589, DOI 10.1073/pnas.0608757103
   Armstrong VL, 2014, J GERONTOL A-BIOL, V69, P923, DOI 10.1093/gerona/glt133
   Arnaud J, 2007, J TRACE ELEM MED BIO, V21, P66, DOI 10.1016/j.jtemb.2007.09.025
   Arnaud J, 2007, J NUTR BIOCHEM, V18, P482, DOI 10.1016/j.jnutbio.2006.09.004
   Avanesov AS, 2014, ELIFE, V3, DOI 10.7554/eLife.02077
   BAUDRY J, 2019, EUR J NUTR, DOI DOI /10.1007/S00394-019-02143-W
   BEISEL WR, 1976, MED CLIN N AM, V60, P831, DOI 10.1016/S0025-7125(16)31864-8
   Bruns DR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/732596
   Bryl E, 2001, J IMMUNOL, V167, P3231, DOI 10.4049/jimmunol.167.6.3231
   Caballero B, 2009, J PINEAL RES, V46, P106, DOI 10.1111/j.1600-079X.2008.00637.x
   Cao L, 2017, J NUTR, V147, P1858, DOI 10.3945/jn.117.247775
   Castelo-Branco C, 2014, GYNECOL ENDOCRINOL, V30, P16, DOI 10.3109/09513590.2013.852531
   Chakravarti Bulbul, 2017, Curr Aging Sci, V10, P246, DOI 10.2174/1874609810666170315112634
   Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409
   Clark NA, 2007, CHEMOSPHERE, V70, P155, DOI 10.1016/j.chemosphere.2007.06.038
   COUSINS RJ, 1988, FASEB J, V2, P2884, DOI 10.1096/fasebj.2.13.2458983
   Crisp MJ, 2015, J CLIN INVEST, V125, P2772, DOI 10.1172/JCI80705
   Fasolino M, 2017, EPIGENOMICS-UK, V9, P21, DOI 10.2217/epi-2016-0084
   Feridaooni HA, 2015, J MOL CELL CARDIOL, V83, P62, DOI 10.1016/j.yjmcc.2014.12.004
   Feridooni HA, 2017, J PHYSIOL-LONDON, V595, P3721, DOI 10.1113/JP274134
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   FISCHER PWF, 1990, NUTR RES, V10, P1081
   Florian S, 2010, FREE RADICAL BIO MED, V49, P1694, DOI 10.1016/j.freeradbiomed.2010.08.029
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Frasca D, 2013, VACCINE, V31, P3603, DOI 10.1016/j.vaccine.2013.05.003
   Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002
   Gouya L, 2007, GASTROENTEROLOGY, V132, P679, DOI 10.1053/j.gastro.2006.11.024
   GREAVES MW, 1970, LANCET, V2, P889
   Grimm SA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08067-z
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Hadad N, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0080-6
   Hahn P, 2009, EXP GERONTOL, V44, P594, DOI 10.1016/j.exger.2009.06.006
   Harada N, 2011, ARCH BIOCHEM BIOPHYS, V508, P101, DOI 10.1016/j.abb.2011.02.001
   Hasan R, 2016, BIOL TRACE ELEM RES, V171, P79, DOI 10.1007/s12011-015-0515-0
   HAWKER FH, 1990, CRIT CARE MED, V18, P442, DOI 10.1097/00003246-199004000-00020
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Hedrich HJ, 2012, LABORATORY MOUSE, P1
   Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406
   Hoeger J, 2015, BIOMETALS, V28, P693, DOI 10.1007/s10534-015-9858-4
   Hoffmann FW, 2010, J NUTR, V140, P1155, DOI 10.3945/jn.109.120725
   Hotz C, 2003, AM J CLIN NUTR, V78, P756, DOI 10.1093/ajcn/78.4.756
   Huang Z, 2012, ANTIOXID REDOX SIGN, V16, P705, DOI 10.1089/ars.2011.4145
   Hughes DJ, 2015, INT J CANCER, V136, P1149, DOI 10.1002/ijc.29071
   Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Jayarama-Naidu R, 2015, ENDOCRINOLOGY, V156, P2739, DOI 10.1210/en.2015-1016
   JOHNSON PE, 1992, AM J CLIN NUTR, V56, P917, DOI 10.1093/ajcn/56.5.917
   Keller KM, 2016, CAN J CARDIOL, V32, P1065, DOI 10.1016/j.cjca.2016.03.017
   Kerins MJ, 2018, ANTIOXID REDOX SIGN, V29, P1756, DOI 10.1089/ars.2017.7176
   Knyushko TV, 2005, BIOCHEMISTRY-US, V44, P13071, DOI 10.1021/bi051226n
   Kopp JF, 2019, J TRACE ELEM MED BIO, V54, P221, DOI 10.1016/j.jtemb.2019.04.015
   KUSHNER I, 1993, PERSPECT BIOL MED, V36, P611
   Lardenoije R, 2015, NEUROBIOL AGING, V36, P3079, DOI 10.1016/j.neurobiolaging.2015.08.001
   Lessard-Beaudoin M, 2015, EXP GERONTOL, V63, P27, DOI 10.1016/j.exger.2015.01.003
   Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma SM, 2015, CELL REP, V13, P1319, DOI 10.1016/j.celrep.2015.10.014
   Marschall TA, 2017, METALLOMICS, V9, P268, DOI 10.1039/c6mt00300a
   MASON KE, 1979, J NUTR, V109, P1979, DOI 10.1093/jn/109.11.1979
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   Mayer LS, 2014, METALLOMICS, V6, P1288, DOI 10.1039/c4mt00051j
   Minelli A, 2009, BBA-REV CANCER, V1795, P83, DOI 10.1016/j.bbcan.2008.11.001
   Mocchegiani E, 2014, MECH AGEING DEV, V136, P29, DOI 10.1016/j.mad.2013.12.007
   Mocchegiani E, 2013, AGE, V35, P839, DOI 10.1007/s11357-011-9377-3
   Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X
   Müller M, 2010, GENES NUTR, V5, P297, DOI 10.1007/s12263-010-0168-8
   Müller SM, 2018, ARCH TOXICOL, V92, P1751, DOI 10.1007/s00204-018-2194-z
   Mullick S, 2006, INDIAN J MED RES, V124, P647
   O'Connell MA, 2015, BIOCHEM SOC T, V43, P687, DOI 10.1042/BST20150069
   Prasad AS, 2009, J AM COLL NUTR, V28, P257, DOI 10.1080/07315724.2009.10719780
   Provinciali M, 2010, BIOGERONTOLOGY, V11, P615, DOI 10.1007/s10522-010-9280-9
   Quinn Joseph F, 2011, Int J Alzheimers Dis, V2011, P150916, DOI 10.4061/2011/150916
   Ravaglia G, 2000, J CLIN ENDOCR METAB, V85, P2260, DOI 10.1210/jc.85.6.2260
   Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9
   Reeg S, 2015, ANTIOXID REDOX SIGN, V23, P239, DOI 10.1089/ars.2014.6062
   Renko K, 2012, ENDOCRINOLOGY, V153, P2506, DOI 10.1210/en.2011-1863
   Schwarz M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092112
   Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795
   Sfar S, 2009, EXP GERONTOL, V44, P812, DOI 10.1016/j.exger.2009.10.008
   SHENKIN A, 1995, NUTRITION, V11, P100
   Squitti R, 2014, NEUROBIOL AGING, V35, pS40, DOI 10.1016/j.neurobiolaging.2014.02.031
   Swamy SM, 2016, AM J PATHOL, V186, P1712, DOI 10.1016/j.ajpath.2016.02.022
   Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3
   TAGGART DP, 1990, EUR J CARDIO-THORAC, V4, P587, DOI 10.1016/1010-7940(90)90017-T
   Tammen Stephanie A, 2014, J Cancer Prev, V19, P301, DOI [10.15430/JCP.2014.19.4.301, 10.15430/JCP.2014.19.2.301]
   TENGRUP I, 1977, ACTA CHIR SCAND, V143, P195
   Unger EL, 2007, NUTR NEUROSCI, V10, P89, DOI 10.1080/10284150701350653
   Valiathan R, 2016, SCAND J IMMUNOL, V83, P255, DOI 10.1111/sji.12413
   van den Briel T, 2001, J NUTR, V131, P2701, DOI 10.1093/jn/131.10.2701
   Wang B, 2011, BIOCHEM BIOPH RES CO, V410, P289, DOI 10.1016/j.bbrc.2011.05.134
   Weiss G, 2019, BLOOD, V133, P40, DOI 10.1182/blood-2018-06-856500
   Wong CP, 2013, J NUTR BIOCHEM, V24, P353, DOI 10.1016/j.jnutbio.2012.07.005
   WOOD RJ, 1995, AM J CLIN NUTR, V62, P493, DOI 10.1093/ajcn/62.3.493
   WOODWARD WD, 1984, J GERONTOL, V39, P521, DOI 10.1093/geronj/39.5.521
   World Health Organization, 2007, ASS IOD DEF DIS MON
   Wu KC, 2011, TOXICOL SCI, V123, P590, DOI 10.1093/toxsci/kfr183
   Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005
   Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225
NR 101
TC 13
Z9 13
U1 1
U2 7
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUL 15
PY 2020
VL 12
IS 13
BP 13762
EP 13790
DI 10.18632/aging.103572
PG 29
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA MM0XQ
UT WOS:000549883400023
PM 32620712
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU González-Puertos, VY
   Hernández-Pérez, E
   Nuño-Lámbarri, N
   Ventura-Gallegos, JL
   López-Diázguerrero, NE
   Robles-Díaz, G
   Gutiérrez-Ruiz, MC
   Konigsberg, M
AF Gonzalez-Puertos, Viridiana Y.
   Hernandez-Perez, Elizabeth
   Nuno-Lambarri, Natalia
   Ventura-Gallegos, Jose L.
   Lopez-Diazguerrero, Norma E.
   Robles-Diaz, Guillermo
   Gutierrez-Ruiz, Maria C.
   Konigsberg, Mina
TI Bcl-2 overexpression in hepatic stellate cell line CFSC-2G, induces a
   pro-fibrotic state
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article
DE acetaldehyde; Bcl-2; extracellular matrix; H2O2; liver fibrosis;
   oxidative stress
ID OXIDATIVE STRESS; LIVER FIBROSIS; EXPRESSION; PROTEINS; FAMILY; DEATH;
   TRANSGLUTAMINASE; PROLIFERATION; MECHANISM; ETHANOL
AB Background and Aim:
   Development of hepatic fibrosis is a complex process that involves oxidative stress (OS) and an altered balance between pro- and anti-apoptotic molecules. Since Bcl-2 overexpression preserves viability against OS, our objective was to address the effect of Bcl-2 overexpression in the hepatic stellate cells (HSC) cell-line CFSC-2G under acetaldehyde and H2O2 challenge, and explore if it protects these cells against OS, induces replicative senescence and/or modify extracellular matrix (ECM) remodeling potential.
   Methods:
   To induce Bcl-2 overexpression, HSC cell line CFSC-2G was transfected by lipofection technique. Green fluorescent protein-only CFSC-2G cells were used as a control. Cell survival after H2O2 treatment and total protein oxidation were assessed. To determine cell cycle arrest, proliferation-rate, DNA synthesis and senescence were assessed. Matrix metalloproteinases (MMP), tissue-inhibitor of MMP (TIMP), transglutaminases (TG) and smooth muscle a-actin (alpha-SMA) were evaluated by western blot in response to acetaldehyde treatment as markers of ECM remodeling capacity in addition to transforming growth factor-beta (TGF-beta) mRNA.
   Results:
   Cells overexpressing Bcl-2 survived approximate to 20% more than control cells when exposed to H2O2 and approximate to 35% proteins were protected from oxidation, but Bcl-2 did not slow proliferation or induced senescence. Bcl-2 overexpression did not change alpha-SMA levels, but it increased TIMP-1 (55%), tissue transglutaminases (tTG) (25%) and TGF-beta mRNA (49%), when exposed to acetaldehyde, while MMP-13 content decreased (47%).
   Conclusions:
   Bcl-2 overexpression protected HSC against oxidative stress but it did not induce replicative senescence. It increased TIMP-1, tTG and TGF-beta mRNA levels and decreased MMP-13 content, suggesting that Bcl-2 overexpression may play a key role in the progression of fibrosis in chronic liver diseases.
C1 [Gonzalez-Puertos, Viridiana Y.; Hernandez-Perez, Elizabeth; Nuno-Lambarri, Natalia; Lopez-Diazguerrero, Norma E.; Gutierrez-Ruiz, Maria C.; Konigsberg, Mina] Metropolitan Independent Univ, Biol & Hlth Sci Div, Hlth & Sci Dept, Mexico City, DF, Mexico.
   [Gonzalez-Puertos, Viridiana Y.] Metropolitan Independent Univ, Grad Program Expt Biol, Mexico City, DF, Mexico.
   [Robles-Diaz, Guillermo] Independent Natl Univ Mexico, Fac Med, Expt Med Unit, Mexico City, DF, Mexico.
   [Ventura-Gallegos, Jose L.] Independent Natl Univ Mexico, Dept Biochem, Natl Inst Med Sci & Rescuing Nutr Salvador Zubira, Mexico City, DF, Mexico.
   [Ventura-Gallegos, Jose L.] Independent Natl Univ Mexico, Genom Med Dept, Mexico City, DF, Mexico.
C3 Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma
   de Mexico; Universidad Nacional Autonoma de Mexico
RP Konigsberg, M (corresponding author), Univ Autonoma Metropolitana Iztapalapa, Dept Ciencias Salud, Div Ciencias Biol & Salud, AP 55-535, Mexico City 09340, DF, Mexico.
EM mcgr@xanum.uam.mx; mkf@xanum.uam.mx
OI LOPEZ DIAZ GUERRERO, NORMA EDITH/0000-0001-7470-9360; Nuno Lambarri,
   Natalia/0000-0001-7616-2661; Gutierrez-Ruiz, Maria
   Concepcion/0000-0003-0501-7226
FU CONACYT [45921-M, CB-2006-1-59659]; Secretaria de Educacion Publica
   [PIFI2006-35-129-346/CA 142006-35-40]
FX Financial support for this research was provided by CONACYT grants no.
   45921-M and CB-2006-1-59659, as well as Secretaria de Educacion Publica,
   PIFI2006-35-129-346/CA 142006-35-40. V.Y. Gonzalez Puertos and N.
   Nuno-Lambarri are CONACYT scholarship holders. The authors thank Dr A.
   Hernandez from CINVESTAV for generously providing us with the actin
   antibody and Dr Ramon Coral from Centro Medico Nacional Siglo XXI for
   kindly donating us the alpha-SMA antibody.
CR Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220
   Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004
   Baroni GS, 1998, HEPATOLOGY, V27, P720
   Borner C, 1996, J BIOL CHEM, V271, P12695, DOI 10.1074/jbc.271.22.12695
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cárdenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735
   Chen CS, 2008, TOXICOLOGY, V246, P148, DOI 10.1016/j.tox.2008.01.009
   CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
   Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67
   De Vivo Giulia, 2008, Inflammation & Allergy Drug Targets, V7, P24
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4
   Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683
   Garcia-Ruiz C, 2007, J GASTROEN HEPATOL, V22, pS38, DOI 10.1111/j.1440-1746.2006.04644.x
   Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x
   Gutiérrez-Ruiz MC, 2007, LIVER INT, V27, P434, DOI 10.1111/j.1478-3231.2007.01469.x
   HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N
   Iimuro Y, 2008, PHARM RES-DORDR, V25, P249, DOI 10.1007/s11095-007-9311-7
   Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1053/jhep.1996.v24.pm0008707259
   Jang JH, 2003, BIOCHEM PHARMACOL, V66, P1371, DOI 10.1016/S0006-2952(03)00487-8
   Kim J, 2005, ENVIRON TOXICOL CHEM, V24, P3069, DOI 10.1897/04-503R3.1
   Kowaltowski AJ, 2004, FREE RADICAL BIO MED, V37, P1845, DOI 10.1016/j.freeradbiomed.2004.09.005
   Lee M, 2001, FREE RADICAL BIO MED, V31, P1550, DOI 10.1016/S0891-5849(01)00633-5
   Lieber CS, 2008, ALCOHOL CLIN EXP RES, V32, P1031, DOI 10.1111/j.1530-0277.2008.00664.x
   López-Diazguerrero NE, 2006, FREE RADICAL BIO MED, V40, P1161, DOI 10.1016/j.freeradbiomed.2005.11.002
   Meredith MJ, 1998, BIOCHEM BIOPH RES CO, V248, P458, DOI 10.1006/bbrc.1998.8998
   Mitchell C, 2009, AM J PATHOL, V175, P1929, DOI 10.2353/ajpath.2009.090332
   Novo E, 2006, GUT, V55, P1174, DOI 10.1136/gut.2005.082701
   Osman H G, 2007, Indian J Med Microbiol, V25, P323
   Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8
   Parola M, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-4
   Piekarska A, 2007, HISTOPATHOLOGY, V50, P928, DOI 10.1111/j.1365-2559.2007.02697.x
   Quiroz SC, 2001, J GASTROEN HEPATOL, V16, P1267, DOI 10.1046/j.1440-1746.2001.02619.x
   Schinzel A, 2004, BBA-MOL CELL RES, V1644, P95, DOI 10.1016/j.bbamcr.2003.09.006
   Seyfried J, 2003, FREE RADICAL BIO MED, V34, P1517, DOI 10.1016/S0891-5849(03)00103-5
   Théret N, 1998, AM J PATHOL, V153, P945, DOI 10.1016/S0002-9440(10)65636-2
   Tombor B, 2003, BIOCHEM BIOPH RES CO, V303, P800, DOI 10.1016/S0006-291X(03)00402-9
   TSUJIMOTO Y, 1987, ONCOGENE, V2, P3
   Urtasun R, 2008, CLIN LIVER DIS, V12, P769, DOI 10.1016/j.cld.2008.07.005
   Vairo G, 2000, MOL CELL BIOL, V20, P4745, DOI 10.1128/MCB.20.13.4745-4753.2000
   Vairo G, 1996, ONCOGENE, V13, P1511
   WANG E, 1995, CANCER RES, V55, P2284
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
NR 43
TC 6
Z9 8
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD JUL
PY 2010
VL 25
IS 7
BP 1306
EP 1314
DI 10.1111/j.1440-1746.2009.06175.x
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 615GV
UT WOS:000279123700021
PM 20594261
DA 2024-02-19
ER

PT J
AU Haduch, A
   Puklo, R
   Alenina, N
   Nikiforuk, A
   Popik, P
   Bader, M
   Daniel, WA
AF Haduch, Anna
   Puklo, Renata
   Alenina, Natalia
   Nikiforuk, Agnieszka
   Popik, Piotr
   Bader, Michael
   Daniel, Wladyslawa A.
TI The effect of ageing and cerebral serotonin deficit on the activity of
   cytochrome P450 2D (CYP2D) in the brain and liver of male rats
SO NEUROCHEMISTRY INTERNATIONAL
LA English
DT Article
DE Cytochrome P450; CYP2D; Ageing; Brain; Liver; TPH2-Deficit
ID DRUG-METABOLISM; 5-METHOXYTRYPTAMINE
AB Brain cytochrome P450 (CYP) contributes to the local metabolism of endogenous substrates and drugs. The aim of present study was to ascertain whether the cytochrome P450 2D (CYP2D) activity changes with ageing and in cerebral serotonin deficit. Kinetics of 5-methoxytryptamine O-demethylation to serotonin was studied and the CYP2D activity was measured in brain and liver microsomes of Dark Agouti wild type (WT) rats (mature 3.5-month-old and senescent 21-month-old rats) and in tryptophan hydroxylase 2 (TPH2)-deficient senescent rats. The CYP2D activity and protein level decreased in the frontal cortex of senescent WT rats, but increased in senescent TPH2-deficient rats (compared to senescent WT). In contrast, in the hippocampus, hypothalamus and striatum the CYP2D activity/protein level increased with ageing, but did not change in senescent TPH2-deficient animals (compared to senescent WT). The activity and protein level of liver CYP2D was lower in senescent WT rats than in the mature animals and further decreased in senescent TPH2-deficient rats. In conclusion, ageing and TPH2-deficit affect the CYP2D activity and protein level, which may have a positive impact on neurotransmitter synthesis in brain structures involved in cognitive, emotional or motor functions, but a negative effect on drug metabolism in the liver.
C1 [Haduch, Anna; Puklo, Renata; Daniel, Wladyslawa A.] Polish Acad Sci, Maj Inst Pharmacol, Dept Pharmacokinet & Drug Metab, Krakow, Poland.
   [Alenina, Natalia; Bader, Michael] Max Delbruck Ctr Mol Med, Berlin, Germany.
   [Alenina, Natalia; Bader, Michael] German Ctr Cardiovasc Res DZHK, Partner Site Berlin, Berlin, Germany.
   [Nikiforuk, Agnieszka; Popik, Piotr] Polish Acad Sci, Maj Inst Pharmacol, Dept Behav Neurosci & Drug Dev, Krakow, Poland.
   [Bader, Michael] Univ Lubeck, Inst Biol, Lubeck, Germany.
   [Bader, Michael] Charite, Berlin, Germany.
C3 Polish Academy of Sciences; Maj Institute of Pharmacology of the Polish
   Academy of Sciences; Helmholtz Association; Max Delbruck Center for
   Molecular Medicine; German Centre for Cardiovascular Research; Polish
   Academy of Sciences; Maj Institute of Pharmacology of the Polish Academy
   of Sciences; University of Lubeck; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin
RP Daniel, WA (corresponding author), Polish Acad Sci, Maj Inst Pharmacol, Dept Pharmacokinet & Drug Metab, Krakow, Poland.
EM nfdaniel@cyf-kr.edu.pl
RI Popik, Piotr/R-5383-2016; Bader, Michael/K-2124-2013
OI Popik, Piotr/0000-0003-0722-1263; Nikiforuk,
   Agnieszka/0000-0002-2424-8348; Haduch, Anna/0000-0002-3925-3828; Bader,
   Michael/0000-0003-4780-4164; Daniel, Wladyslawa
   Anna/0000-0002-1226-1721; Puklo, Renata/0000-0003-4820-9084
FU Grant ERA-NET Neuron II JTC 2015 Respond; Maj Institute of Pharmacology,
   Polish Academy of Sciences, Krak 'ow, Poland
FX This study was financially supported by the Grant ERA-NET Neuron II JTC
   2015 Respond and statutory funds from the Maj Institute of Pharmacology,
   Polish Academy of Sciences, Krak ' ow, Poland.
CR Arivazhagan P, 2002, EXP GERONTOL, V37, P1489, DOI 10.1016/S0531-5565(02)00122-5
   Bromek E, 2010, EUR J PHARMACOL, V626, P171, DOI 10.1016/j.ejphar.2009.09.062
   Haduch A, 2018, BIOCHEM PHARMACOL, V156, P398, DOI 10.1016/j.bcp.2018.09.005
   Haduch A, 2015, J NEUROCHEM, V133, P83, DOI 10.1111/jnc.13031
   Haduch A, 2013, PHARMACOL RES, V67, P53, DOI 10.1016/j.phrs.2012.10.009
   Haduch A, 2011, EUR J PHARMACOL, V651, P51, DOI 10.1016/j.ejphar.2010.10.077
   Kaplan K, 2016, J APPL PHYSIOL, V120, P1070, DOI 10.1152/japplphysiol.01015.2015
   Li J, 2015, BRIT J PHARMACOL, V172, P4639, DOI 10.1111/bph.13206
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Malikovic J, 2019, BEHAV BRAIN FUNCT, V15, DOI 10.1186/s12993-019-0161-3
   Mann A, 2012, NEUROBIOL AGING, V33, P2160, DOI 10.1016/j.neurobiolaging.2011.08.014
   Miksys S, 2013, J PSYCHIATR NEUROSCI, V38, P152, DOI 10.1503/jpn.120133
   Renton KW, 2000, J PHARMACOL EXP THER, V294, P524
   Satoh A, 2017, NAT REV NEUROSCI, V18, P362, DOI 10.1038/nrn.2017.42
   Schulz-Utermoehl T, 1999, PHARMACOGENETICS, V9, P357, DOI 10.1097/00008571-199906000-00011
   Siegle I, 2001, PHARMACOGENETICS, V11, P237, DOI 10.1097/00008571-200104000-00007
   WYSS A, 1995, MOL PHARMACOL, V47, P1148
   Yu AM, 2003, PHARMACOGENETICS, V13, P173, DOI 10.1097/00008571-200303000-00007
   Zhang FR, 2018, NEUROSCIENCE, V379, P115, DOI 10.1016/j.neuroscience.2018.03.009
NR 19
TC 10
Z9 11
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0197-0186
EI 1872-9754
J9 NEUROCHEM INT
JI Neurochem. Int.
PD DEC
PY 2020
VL 141
AR 104884
DI 10.1016/j.neuint.2020.104884
PG 7
WC Biochemistry & Molecular Biology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA OZ2XY
UT WOS:000594796400003
PM 33091481
DA 2024-02-19
ER

PT J
AU Khafaga, AF
   Noreldin, AE
   Taha, AE
AF Khafaga, Asmaa F.
   Noreldin, Ahmed E.
   Taha, Ayman E.
TI The adaptogenic anti-ageing potential of resveratrol against heat
   stress-mediated liver injury in aged rats: Role of HSP70 and NF-kB
   signalling
SO JOURNAL OF THERMAL BIOLOGY
LA English
DT Article
DE Resveratrol; NF-kB; HSP70; Ageing; Heat stress
ID INDUCED OXIDATIVE STRESS; GINKGO-BILOBA EXTRACT; KAPPA-B; INDUCED
   HEPATOTOXICITY; CALORIC RESTRICTION; REPEATED INJECTION; SHOCK PROTEINS;
   EXPRESSION; ANTIOXIDANT; PROTECTS
AB Heat stress (HS) is a major international problem which has attracted a considerable attention due to its oxidative tissue effects and high morbidity and mortality rates, especially among elderly people. Discovering an effective antioxidant is pivotal for overcoming HS-induced injury. Therefore, the aim of this study was to estimate the hepatic protective effects of orally supplemented resveratrol (RES) against HS-mediated liver injury in young and old male Wistar albino rats. Compared to control rats, RES administered orally at a dose of 20 mg/kg BW for 21 successive days efficiently ameliorated HS-induced oxidative damage by significantly increasing (P <= 0.05) the level of reduced glutathione and glutathione peroxidase, and decreasing the levels of malondialdehyde and TNF-alpha in hepatic tissue of both young and aged rats. However, level of NF-kappa B was down regulated significantly in aged rats rather than young rats. Moreover, RES significantly decreased (P <= 0.05) the serum levels of aspartate transaminase and alkaline phosphatase in both ages of rats compared to their corresponding HS-stressed rats. Furthermore, RES upregulated the immunohistochemical expression of caspase 3 and heat shock protein 70 in young and aged rats, however it was more pronounced in young one. In addition, RES administration moderately normalized (P <= 0.0001) the harmful effects of HS on the hepatic architecture of both young and aged rats. In conclusion, this study reveals for the first time that RES exerts promising hepatoameliorative effects against HS-induced oxidative stress in the young and aged rats via its antioxidant, anti-inflammatory, and anti-apoptotic effect, as well as via its inhibitory effect against the NE-kappa B signalling in a cellular system.
C1 [Khafaga, Asmaa F.] Alexandria Univ, Fac Vet Med, Dept Pathol, Edfina 22758, Egypt.
   [Noreldin, Ahmed E.] Damanhour Univ, Dept Histol & Cytol, Fac Vet Med, Damanhour 22516, Egypt.
   [Taha, Ayman E.] Alexandria Univ, Fac Vet Med, Dept Anim Husb & Anim Wealth Dev, Edfina 22758, Egypt.
C3 Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge
   Bank (EKB); Damanhour University; Egyptian Knowledge Bank (EKB);
   Alexandria University
RP Khafaga, AF (corresponding author), Alexandria Univ, POB 22758, Edfina, Egypt.
EM soma_path2008@yahoo.com; nourislam2010@yahoo.com;
   ayman.taha@alexu.edu.eg
RI Taha, Ayman/GQZ-7528-2022; Noreldin, Ahmed E./S-1130-2017; Taha,
   Ayman/X-9472-2019; Khafaga, Asmaa F./AAG-5325-2021; Khafaga,
   Asmaa/AAG-8992-2019
OI Noreldin, Ahmed E./0000-0002-8344-0807; Taha, Ayman/0000-0002-0429-2587;
   Khafaga, Asmaa F./0000-0003-4235-669X; Khafaga,
   Asmaa/0000-0003-4235-669X
CR Abdelnour SA, 2019, J THERM BIOL, V79, P120, DOI 10.1016/j.jtherbio.2018.12.013
   ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749
   Avenatti RC, 2018, COMP EXERC PHYSIOL, V14, P27, DOI 10.3920/CEP170020
   Bancroft J.D., 2013, THEORY PRACTICE HIST, V7th, P179
   Bettermann K, 2017, MECH MOL CARCINOGENE, V1, P87
   Bloomer SA, 2014, BLOOD CELL MOL DIS, V52, P19, DOI 10.1016/j.bcmd.2013.07.002
   Bunker A, 2016, EBIOMEDICINE, V6, P258, DOI 10.1016/j.ebiom.2016.02.034
   Butt H, 2017, LIFE SCI, V184, P1, DOI 10.1016/j.lfs.2017.07.002
   Colaco CA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/461230
   Das A, 2011, TOXICOL MECH METHOD, V21, P393, DOI 10.3109/15376516.2010.550016
   de Toda IM, 2015, BIOGERONTOLOGY, V16, P709, DOI 10.1007/s10522-015-9607-7
   DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478
   Duthie GG, 2000, NUTR RES REV, V13, P79, DOI 10.1079/095442200108729016
   El Okle OS, 2018, ENVIRON SCI POLLUT R, V25, P4678, DOI 10.1007/s11356-017-0850-0
   Fillebeen C, 2014, JOVE-J VIS EXP, DOI 10.3791/52230
   Gu ZT, 2014, SCI REP-UK, V4, DOI 10.1038/srep04469
   Hafez HM, 2015, EUR J PHARMACOL, V768, P1, DOI 10.1016/j.ejphar.2015.08.047
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   Hall DM, 2000, J APPL PHYSIOL, V89, P749, DOI 10.1152/jappl.2000.89.2.749
   Juan ME, 2002, J NUTR, V132, P257, DOI 10.1093/jn/132.2.257
   Kanitkar M, 2008, LIFE SCI, V82, P182, DOI 10.1016/j.lfs.2007.10.026
   Khafaga A.F., 2016, ASIAN J ANIM SCI, DOI [10.3923/ajas.2016.235.246, DOI 10.3923/ajas.2016.235.246]
   Khafaga AF, 2018, LIFE SCI, V196, P9, DOI 10.1016/j.lfs.2018.01.010
   Khafaga AF, 2016, INT J PHARMACOL, V12, P340, DOI 10.3923/ijp.2016.340.350
   Kregel KC, 2002, J APPL PHYSIOL, V92, P2177, DOI 10.1152/japplphysiol.01267.2001
   Lanneau D, 2010, THESCIENTIFICWORLDJO, V10, P1543, DOI 10.1100/tsw.2010.152
   Lebda M. A, 2018, OXID MED CELL LONGEV, V2018, P14
   LIU L, 2013, POULTRY SCI, V95, P54, DOI DOI 10.1016/J.CES.2013.03.023
   Liu LL, 2016, FOOD FUNCT, V7, P1329, DOI [10.1039/c5fo01338k, 10.1039/C5FO01338K]
   Liu Y, 2011, EUR J PHARMACOL, V650, P130, DOI 10.1016/j.ejphar.2010.10.009
   Mahmoud KZ, 2004, COMP BIOCHEM PHYS C, V137, P11, DOI 10.1016/j.cca.2003.10.013
   Margolis HG, 2014, RESPIR MED SER, V7, P85, DOI 10.1007/978-1-4614-8417-2_6
   Meyer T. N, 1998, ACTA CIR BRAS, V13, P217
   Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788
   Mujahid Ahmad, 2007, Journal of Poultry Science, V44, P439, DOI 10.2141/jpsa.44.439
   Mujahid A, 2007, FEBS LETT, V581, P3461, DOI 10.1016/j.febslet.2007.06.051
   Mukherjee S, 2013, J NUTR BIOCHEM, V24, P2040, DOI 10.1016/j.jnutbio.2013.07.005
   Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962
   Noreldin AE, 2018, ACTA HISTOCHEM, V120, P323, DOI 10.1016/j.acthis.2018.03.001
   Noreldin AE, 2016, ACTA HISTOCHEM, V118, P109, DOI 10.1016/j.acthis.2015.12.001
   Orhan C, 2012, BRIT POULTRY SCI, V53, P828, DOI 10.1080/00071668.2012.747084
   Pachauri R.K., 2014, Fifth Assessment Report on Climate Change
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Panda AK, 2008, BRIT POULTRY SCI, V49, P592, DOI 10.1080/00071660802337233
   Perkins SE, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053361
   Putics A, 2008, ANTIOXID REDOX SIGN, V10, P65, DOI 10.1089/ars.2007.1866
   Ramis MR, 2015, MECH AGEING DEV, V146, P28, DOI 10.1016/j.mad.2015.03.008
   Ramnath V, 2008, EVID-BASED COMPL ALT, V5, P77, DOI 10.1093/ecam/nel116
   Sahin K, 2012, J ANIM PHYSIOL AN N, V96, P66, DOI 10.1111/j.1439-0396.2010.01123.x
   Sahin K, 2010, POULTRY SCI, V89, P1190, DOI 10.3382/ps.2010-00635
   Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004
   Schmatz R, 2012, BIOCHIMIE, V94, P374, DOI 10.1016/j.biochi.2011.08.005
   Schmeltz MT, 2016, CLIMATIC CHANGE, V138, P567, DOI 10.1007/s10584-016-1747-5
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schwabe RF, 2001, J IMMUNOL, V166, P6812, DOI 10.4049/jimmunol.166.11.6812
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   Sener G, 2006, HEPATOL RES, V35, P62, DOI 10.1016/j.hepres.2006.02.005
   Sgambato A, 2001, MUTAT RES-GEN TOX EN, V496, P171, DOI 10.1016/S1383-5718(01)00232-7
   Shen H, 2014, HEPATOLOGY, V60, P2065, DOI 10.1002/hep.27348
   Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0
   Slimen IB, 2014, INT J HYPERTHER, V30, P513, DOI 10.3109/02656736.2014.971446
   SUN Y, 1988, CLIN CHEM, V34, P497
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   Yang J, 2009, FOOD CHEM, V116, P332, DOI 10.1016/j.foodchem.2009.02.021
   Yu JM, 2008, CELL STRESS CHAPERON, V13, P327, DOI 10.1007/s12192-008-0031-7
NR 65
TC 38
Z9 39
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4565
J9 J THERM BIOL
JI J. Therm. Biol.
PD JUL
PY 2019
VL 83
BP 8
EP 21
DI 10.1016/j.jtherbio.2019.04.012
PG 14
WC Biology; Zoology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Zoology
GA IN5GU
UT WOS:000478704700003
PM 31331528
DA 2024-02-19
ER

PT J
AU Ramanujan, VK
   Herman, BA
AF Ramanujan, V. Krishnan
   Herman, Brian A.
TI Aging process modulates nonlinear dynamics in liver cell metabolism
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FRACTAL DYNAMICS; CANCER; MITOCHONDRIA; COMPLEXITY; DISEASE; DAMAGE
AB Regulatory dynamics of energy metabolism in living cells entails a coordinated response of multiple enzyme networks that operate under non-equilibrium conditions. Here we show that mitochondrial dysfunctions associated with the aging process significantly modify nonlinear dynamical signatures in free radical generation/removal, thereby altering energy metabolism in liver cells. We support our data with a plausible biochemical mechanism for modified bioenergetics that involves uncoupling protein-2 that is up-regulated in aged cells as an adaptive response to mitigate increased oxidative stress. Combining high spatial and temporal resolution imaging and bio-energetic measurements, our work provides experimental support to the hypothesis that mitochondria manifest nonlinear dynamical behavior for efficiently regulating energy metabolism in intact cells, and any partial or complete reduction in this behavior would contribute to organ dysfunctions including the aging process and other disease processes.
C1 Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP Herman, BA (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.
EM hermanb@uthscsa.edu
RI Ramanujan, V Krishnan/A-6395-2011; Ramanujan, V Krishnan/O-2831-2014
FU NIA NIH HHS [R01-AG007218-18A1] Funding Source: Medline
CR Acharya UR, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-24
   Ashkenazy Y, 2001, PHYS REV LETT, V86, P1900, DOI 10.1103/PhysRevLett.86.1900
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Beckman KB, 1998, ANN NY ACAD SCI, V854, P118, DOI 10.1111/j.1749-6632.1998.tb09897.x
   BEZERIANOS A, 1995, CHAOS, V5, P95, DOI 10.1063/1.166104
   Brennan M, 2002, AM J PHYSIOL-HEART C, V283, pH1873, DOI 10.1152/ajpheart.00405.2000
   Cadenas Enrique, 2004, Molecular Aspects of Medicine, V25, P17, DOI 10.1016/j.mam.2004.02.005
   Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024
   Echtay KS, 2005, BIOFACTORS, V24, P119, DOI 10.1002/biof.5520240114
   Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a
   Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201
   English BP, 2006, NAT CHEM BIOL, V2, P87, DOI 10.1038/nchembio759
   Fosslien E, 2001, ANN CLIN LAB SCI, V31, P25
   Gavrilov Leonid A, 2002, ScientificWorldJournal, V2, P339
   Genova ML, 1997, FEBS LETT, V410, P467
   Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499
   Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262
   HAVLIN S, 1995, CHAOS SOLITON FRACT, V6, P171, DOI 10.1016/0960-0779(95)80025-C
   Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861
   KNOOK D, 1986, HDB CELL BIOL AGING, P229
   Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592
   Mangel M, 2001, J THEOR BIOL, V213, P559, DOI 10.1006/jtbi.2001.2431
   PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141
   Ramanujan VK, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2098753
   Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501
   SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P
   Skulachev VP, 2006, APOPTOSIS, V11, P473, DOI 10.1007/s10495-006-5881-9
   Stam CJ, 2004, HUM BRAIN MAPP, V22, P97, DOI 10.1002/hbm.20016
   Stanley HE, 2002, P NATL ACAD SCI USA, V99, P2561, DOI 10.1073/pnas.022582899
   Starkov AA, 1997, BIOSCIENCE REP, V17, P273, DOI 10.1023/A:1027380527769
   Vaillancourt DE, 2004, J APPL PHYSIOL, V97, P454, DOI 10.1152/japplphysiol.00244.2004
   Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Yang NC, 2002, ANAL BIOCHEM, V306, P323, DOI 10.1006/abio.2002.5698
   Zhang YP, 2002, EXP GERONTOL, V37, P777, DOI 10.1016/S0531-5565(02)00013-X
NR 35
TC 15
Z9 15
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 29
PY 2007
VL 282
IS 26
BP 19217
EP 19226
DI 10.1074/jbc.M700572200
PG 10
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 181ZQ
UT WOS:000247475300062
PM 17446172
OA hybrid
DA 2024-02-19
ER

PT J
AU Rountree, CB
   Senadheera, S
   Mato, JM
   Crooks, GM
   Lu, SC
AF Rountree, C. Bart
   Senadheera, Shantha
   Mato, Jose M.
   Crooks, Gay M.
   Lu, Shelly C.
TI Expansion of liver cancer stem cells during aging in methionine
   adenosyltransferase 1A-deficient mice
SO HEPATOLOGY
LA English
DT Article
ID HEPATIC PROGENITOR CELLS; ADENOSYL-L-METHIONINE; S-ADENOSYLMETHIONINE;
   OVAL CELLS; EPITHELIAL-CELLS; BONE-MARROW; EXPRESSION; RAT;
   DIFFERENTIATE; REGENERATION
AB Methionine adenosyltransferase (MAT) is an essential enzyme that catalyzes the biosynthesis of S-adenosylmethionine. Hepatic MAT activity falls in chronic liver diseases, and mice lacking Mat1a are predisposed to liver injury and develop hepatocellular carcinoma (HCC) spontaneously by 18 months. The current work examined the hypothesis that liver cancer stem cells contribute to HCC in this model. Livers from 6- and 18-month-old Mat1a-knockout (KO) mice and their wild-type (WT) littermates were fractionated and isolated by flow cytometry. CD45-nonparenchymal (NP) cells were cultured using liver stem cell conditions. Cells were analyzed by real-time PCR and fluorescent immunohistochemistry (FIHC). Tumor formation was assessed by injecting 1 x 106 CD 133+CD49f+ cells intraperitoneally into immune-deficient mice. The proportion of CD49f+ and CD133+ cells in the CD45-NP fraction increased 4.5- to 5.5-fold from 6 to 18 months in KO mice but not in their WT littermates. Compared to CD49f- cells from old KO mice, CD49f+ cells from the same animals had a markedly increased expression of several oncogenes. CD133+ cells with CD49f coexpression were selected in vitro and exhibited rapid growth, with the expression of biliary cytokeratins, a-fetoprotein, and c-Met by FIHC. Clonal expansion of single CD133+CD49f+ cells revealed maintenance of bipotency. After CD133+CD49f+ cells were injected into immune-deficient mice, 3 of the 8 mice developed tumors of liver epithelial cells after 6-8 weeks. Conclusion: Mat1a(-/-) mice have expansion of liver stem cells as they age. These cells have increased expression of several oncogenes and are tumorigenic in vivo. This is the first demonstration of adult liver stem cells possessing tumorigenic potential without the use of a carcinogen or manipulation of tumor-suppressor or oncogene expression.
C1 [Rountree, C. Bart] Penn State Childrens Hosp, Div Pediat Gastroenterol, Hershey, PA 17033 USA.
   [Rountree, C. Bart] Childrens Hosp, Div Gastroenterol, Los Angeles, CA 90027 USA.
   [Rountree, C. Bart; Senadheera, Shantha; Crooks, Gay M.] Childrens Hosp, Gene Immunol & Stem Cell Program, Los Angeles, CA 90027 USA.
   [Mato, Jose M.] Technol Pk Bizkaia, CIBERehd, CIC BioGUNE, Bizkaia, Spain.
   [Lu, Shelly C.] USC, Keck Sch Med, UCLA Res Ctr Alcohol Liver & Pancreat Dis, USC Res Ctr Liver Dis,Div Gastrointestinal & Live, Los Angeles, CA USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Penn State Health; Children's Hospital
   Los Angeles; Children's Hospital Los Angeles; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEREHD; CIC bioGUNE; University of
   Southern California; University of Southern California Keck Hospital
RP Rountree, CB (corresponding author), Penn State Childrens Hosp, Div Pediat Gastroenterol, H0850,500 Univ Dr,POB 850, Hershey, PA 17033 USA.
EM CRountree@hmc.psu.edu
RI Lu, Shelly/AAH-5937-2021; MATO, JOSE/A-5187-2011
OI Lu, Shelly/0000-0003-2128-5407; MATO, JOSE/0000-0003-1264-3153
FU NCCIH NIH HHS [AT1576, R01 AT001576-05, R01 AT001576] Funding Source:
   Medline; NIAAA NIH HHS [AA12677, R01 AA012677-05, AA13847, R01
   AA013847-05, R01 AA012677, R01 AA013847] Funding Source: Medline; NICHD
   NIH HHS [K12 HD000850, K12-HD00850] Funding Source: Medline; NIDDK NIH
   HHS [R01 DK051719, P30 DK048522, DK48522, DK51719, R01 DK051719-11]
   Funding Source: Medline
CR Akhurst B, 2001, HEPATOLOGY, V34, P519, DOI 10.1053/jhep.2001.26751
   CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251
   Chen LX, 2004, FASEB J, V18, P914, DOI 10.1096/fj.03-1204fje
   Cimica V, 2005, GENOMICS, V86, P352, DOI 10.1016/j.ygeno.2005.05.001
   Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512
   Crosby HA, 2001, GASTROENTEROLOGY, V120, P534, DOI 10.1053/gast.2001.21175
   Dumble ML, 2002, CARCINOGENESIS, V23, P435, DOI 10.1093/carcin/23.3.435
   Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281
   HUANG Z, 1998, AM J PHYSIOL, V614, pG14
   Jelnes P, 2007, HEPATOLOGY, V45, P1462, DOI 10.1002/hep.21569
   Kanno N, 2001, AM J PHYSIOL-GASTR L, V281, pG612, DOI 10.1152/ajpgi.2001.281.3.G612
   Kofman AV, 2005, HEPATOLOGY, V41, P1252, DOI 10.1002/hep.20696
   Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377
   Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398
   Martínez-Chantar ML, 2006, GASTROENTEROLOGY, V131, P223, DOI 10.1053/j.gastro.2006.04.019
   Mato JM, 1999, J HEPATOL, V30, P1081, DOI 10.1016/S0168-8278(99)80263-3
   Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev
   Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650
   NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223
   RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0
   Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558
   Rountree CB, 2007, STEM CELLS, V25, P2419, DOI 10.1634/stemcells.2007-0176
   Rountree CB, 2007, HEPATOLOGY, V45, P1250, DOI 10.1002/hep.21600
   Sell S, 2002, SEMIN CELL DEV BIOL, V13, P419, DOI 10.1016/S1084952102001295
   Shimano K, 2003, AM J PATHOL, V163, P3, DOI 10.1016/S0002-9440(10)63624-3
   SHIVAPURKAR N, 1983, CARCINOGENESIS, V4, P1051, DOI 10.1093/carcin/4.8.1051
   Shmelkov SV, 2005, INT J BIOCHEM CELL B, V37, P715, DOI 10.1016/j.biocel.2004.08.010
   Suzuki A, 2000, HEPATOLOGY, V32, P1230, DOI 10.1053/jhep.2000.20349
   Suzuki A, 2002, J CELL BIOL, V156, P173, DOI 10.1083/jcb.200108066
   THEISE ND, 2006, AM J PHYSIOL-GASTR L, V290, pG193
   Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   VENDEMIALE G, 1989, SCAND J GASTROENTERO, V24, P407, DOI 10.3109/00365528909093067
   Walkup MH, 2006, STEM CELLS, V24, P1833, DOI 10.1634/stemcells.2006-0063
   Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100
   Wang XL, 2006, STEM CELLS, V24, P307, DOI 10.1634/stemcells.2005-0052
   Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425
   Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476
   Yovchev MI, 2007, HEPATOLOGY, V45, P139, DOI 10.1002/hep.21448
NR 39
TC 79
Z9 82
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD APR
PY 2008
VL 47
IS 4
BP 1288
EP 1297
DI 10.1002/hep.22141
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 283LG
UT WOS:000254637100021
PM 18167064
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Jin, JL
   Iakova, P
   Breaux, M
   Sullivan, E
   Jawanmardi, N
   Chen, DH
   Jiang, YJ
   Medrano, EM
   Timchenko, NA
AF Jin, Jingling
   Iakova, Polina
   Breaux, Meghan
   Sullivan, Emily
   Jawanmardi, Nicole
   Chen, Dahu
   Jiang, Yanjun
   Medrano, Estela M.
   Timchenko, Nikolai A.
TI Increased Expression of Enzymes of Triglyceride Synthesis Is Essential
   for the Development of Hepatic Steatosis
SO CELL REPORTS
LA English
DT Article
ID BINDING-PROTEIN-ALPHA; GROWTH-INHIBITORY ACTIVITY; C/EBP-ALPHA;
   CELL-PROLIFERATION; LIVER PROLIFERATION; INSULIN-RESISTANCE; FATTY
   LIVER; OLD MICE; TRANSCRIPTION; DISEASE
AB Molecular mechanisms underpinning nonalcoholic fatty liver disease (NAFLD) are not well understood. The earliest step of NAFLD is hepatic steatosis, which is one of the main characteristics of aging liver. Here, we present a molecular scenario of age-related liver steatosis. We show that C/EBP alpha-S193D knockin mice have age-associated epigenetic changes and develop hepatic steatosis at 2 months of age. The underlying mechanism of the hepatic steatosis in old wild-type (WT) mice and in young S193D mice includes increased amounts of tripartite p300-C/EBP alpha/beta complexes that activate promoters of five genes that drive triglyceride synthesis. Knockdown of p300 in old WT mice inhibits hepatic steatosis. Indeed, transgenic mice expressing dominant-negative p300 have fewer C/EBP alpha/beta-p300 complexes and do not develop age-dependent hepatic steatosis. Notably, the p300-C/EBP alpha/beta pathway is activated in the livers of patients with NAFLD. Thus, our results show that p300 and C/EBP proteins are essential participants in hepatic steatosis.
C1 [Jin, Jingling; Iakova, Polina; Breaux, Meghan; Sullivan, Emily; Jawanmardi, Nicole; Chen, Dahu; Jiang, Yanjun; Medrano, Estela M.; Timchenko, Nikolai A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
   [Jin, Jingling; Iakova, Polina; Breaux, Meghan; Sullivan, Emily; Jawanmardi, Nicole; Chen, Dahu; Jiang, Yanjun; Medrano, Estela M.; Timchenko, Nikolai A.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.
   [Jin, Jingling; Iakova, Polina; Breaux, Meghan; Sullivan, Emily; Jawanmardi, Nicole; Chen, Dahu; Jiang, Yanjun; Medrano, Estela M.; Timchenko, Nikolai A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine
RP Timchenko, NA (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.
EM nikolait@bcm.tmc.edu
RI Chen, Dahu/AAX-6349-2021
OI Jin, Jingling/0000-0002-4365-1837
FU NIH [GM551888, CA100070, AG039885, AG032135, AG028865, CA159942]
FX This work was supported by NIH grants GM551888, CA100070, AG039885,
   AG032135, AG028865, and CA159942 (NAT). We thank Adam Antebi for
   discussion of the results and Sharra Hammond for help with genotyping of
   dnp300 mice.
CR Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Dansen TB, 2009, NAT CHEM BIOL, V5, P664, DOI 10.1038/nchembio.194
   Erickson RL, 2001, J BIOL CHEM, V276, P16348, DOI 10.1074/jbc.M100128200
   Flodby P, 1996, J BIOL CHEM, V271, P24753, DOI 10.1074/jbc.271.40.24753
   Floreani A, 2007, DIGEST DIS, V25, P138, DOI 10.1159/000099478
   Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142
   Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3
   Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022
   Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191
   Jin JL, 2010, AGING CELL, V9, P895, DOI 10.1111/j.1474-9726.2010.00617.x
   Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09
   Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459
   Kantartzis K, 2009, CLIN SCI, V116, P531, DOI 10.1042/CS20080306
   Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x
   Li N, 2011, FEBS LETT, V585, P3106, DOI 10.1016/j.febslet.2011.08.044
   Lindemann RK, 2004, CELL CYCLE, V3, P779
   Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005
   Prieur A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1473
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651
   Soriano HE, 1998, HEPATOLOGY, V27, P392, DOI 10.1002/hep.510270212
   Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200
   Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200
   Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Tsai J, 2007, ARTERIOSCL THROM VAS, V27, P211, DOI 10.1161/01.ATV.0000249861.80471.96
   Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006
   Wang GL, 2005, MOL CELL BIOL, V25, P1325, DOI 10.1128/MCB.25.4.1325-1338.2005
   Wang GL, 2004, GENE DEV, V18, P912, DOI 10.1101/gad.1183304
   Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200
   Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200
   Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200
   Wang GL, 2010, J CLIN INVEST, V120, P2549, DOI 10.1172/JCI41933
   Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930
   Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5
   Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200
   Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783
   Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1
NR 39
TC 59
Z9 63
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD MAR
PY 2013
VL 3
IS 3
BP 831
EP 843
DI 10.1016/j.celrep.2013.02.009
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 184MZ
UT WOS:000321896000026
PM 23499441
OA Green Accepted, gold
DA 2024-02-19
ER

PT J
AU Gomez, CR
   Acuna-Castillo, C
   Perez, C
   Leiva-Salcedo, E
   Riquelme, DM
   Ordenes, G
   Oshima, K
   Aravena, M
   Perez, VI
   Nishimura, S
   Sabaj, V
   Walter, R
   Sierra, F
AF Gomez, Christian R.
   Acuna-Castillo, Claudio
   Perez, Claudio
   Leiva-Salcedo, Elias
   Riquelme, Denise M.
   Ordenes, Gamaliel
   Oshima, Kiyoko
   Aravena, Mauricio
   Perez, Viviana I.
   Nishimura, Sumiyo
   Sabaj, Valeria
   Walter, Robin
   Sierra, Felipe
TI Diminished Acute Phase Response and Increased Hepatic Inflammation of
   Aged Rats in Response to Intraperitoneal Injection of Lipopolysaccharide
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Liver; Inflammation; Injury; Acute phase response; Aging
ID GENE-EXPRESSION; IMMUNE-SYSTEM; MICE; INTERLEUKIN-6; PATHWAYS; INJURY;
   LIVER; ENDOTOXEMIA; MODULATION; MECHANISMS
AB Aging is associated with a deterioration of the acute phase response to inflammatory challenges. However, the nature of these defects remains poorly defined. We analyzed the hepatic inflammatory response after intraperitoneal administration of lipopolysaccharide (LPS) given to Fisher 344 rats aged 6, 15, and 22-23 months. Induction of the acute phase proteins (APPs), haptoglobin, a-I-acid glycoprotein, and T-kininogen was reduced and/or retarded with aging. Initial induction of interleukin-6 in aged rats was normal, but the later response was increased relative to younger counterparts. An exacerbated hepatic injury was observed in aged rats receiving LPS, as evidenced by the presence of multiple microabscesses in portal tracts, confluent necrosis, higher nentrophil accumulation, and elevated serum levels of alanine aminotransferase, relative to younger animals. Our results suggest that aged rats displayed a reduced expression of APPS and increased hepatic injury in response to the inflammatory insult.
C1 [Gomez, Christian R.; Acuna-Castillo, Claudio; Perez, Claudio; Leiva-Salcedo, Elias; Riquelme, Denise M.; Aravena, Mauricio; Perez, Viviana I.; Nishimura, Sumiyo; Sabaj, Valeria; Walter, Robin; Sierra, Felipe] Univ Chile, Fac Med, Ctr FONDAP Estudios Mol Celula, Inst Ciencias Biomed, Santiago 7, Chile.
   [Acuna-Castillo, Claudio] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, USACH, Santiago, Chile.
   [Gomez, Christian R.] Univ Diego Portales, Fac Ciencies Salud, Santiago, Chile.
   [Ordenes, Gamaliel] Univ Chile, Fac Med, Escuela Tecnol Med, Santiago, Chile.
   [Oshima, Kiyoko] Loyola Univ, Med Ctr, Dept Pathol, Maywood, IL 60153 USA.
   [Walter, Robin; Sierra, Felipe] Lankenau Inst Med Res, Philadelphia, PA USA.
C3 Universidad de Chile; Universidad de Santiago de Chile; University Diego
   Portales; Universidad de Chile; Loyola University Chicago; Lankenau
   Medical Center; Lankenau Institute for Medical Research
RP Sierra, F (corresponding author), NIA, NIH, 7201 Wisconsin Ave,Suite 2C231, Bethesda, MD 20892 USA.
EM sierraf@nia.nih.gov
RI Oshima, Kiyoko/CAF-1543-2022; Acuña-Castillo, Claudio/AAI-7090-2021
OI Acuña-Castillo, Claudio/0000-0003-3607-6077
FU Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)
   [101061, 2000038, 2010071]; Fondo de Financiamiento de Centros de
   Excelencia en Investigacion (FONDAP) [15010006]; National Institutes of
   Health/National Institute on Aging [AG13902]
FX This work was supported by Fondo Nacional de Desarrollo Cientifico y
   Tecnologico (FONDECYT; grants 101061 [F.S.], 2000038 [V.P.], 2010071
   [C.A.C.]), Fondo de Financiamiento de Centros de Excelencia en
   Investigacion (FONDAP; 15010006 [F.S.]), and the National Institutes of
   Health/National Institute on Aging (AG13902 [F.S.]).; We thank Drs.
   Elizabeth J. Kovacs, Pamela Witte, and Patrick Greiffenstein for
   thoughtful discussions and critical review of this manuscript.
CR Amacher DE, 1998, REGUL TOXICOL PHARM, V27, P119, DOI 10.1006/rtph.1998.1201
   BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6
   Bruunsgaard H, 1999, J INFECT DIS, V180, P551, DOI 10.1086/314873
   Bruunsgaard H, 2003, CLIN EXP IMMUNOL, V132, P24, DOI 10.1046/j.1365-2249.2003.02137.x
   Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001
   CARTER KC, 1991, BIOCHIM BIOPHYS ACTA, V1089, P197, DOI 10.1016/0167-4781(91)90008-A
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159
   Deutschman CS, 2006, CRIT CARE MED, V34, P2613, DOI 10.1097/01.CCM.0000240229.98275.07
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Gomez CR, 2006, SHOCK, V25, P581, DOI 10.1097/01.shk.000029553.39081.ec
   Gomez CR, 2007, EXP GERONTOL, V42, P451, DOI 10.1016/j.exger.2006.11.013
   Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013
   GOMEZ CR, 2008, SHOCK           0716
   Heinonen J, 1998, TOPOLOGY, V37, P1, DOI 10.1016/S0040-9383(97)00015-3
   HEWETT JA, 1992, LAB INVEST, V66, P347
   Hsieh CC, 1998, MOL BIOL CELL, V9, P1479, DOI 10.1091/mbc.9.6.1479
   Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009
   Krabbe KS, 2001, CLIN DIAGN LAB IMMUN, V8, P333, DOI 10.1128/CDLI.8.2.333-338.2001
   Liu YS, 1996, J BIOL CHEM, V271, P3604
   Luedde T, 2006, LIVER INT, V26, P1163, DOI 10.1111/j.1478-3231.2006.01366.x
   MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835
   Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x
   MORRONE G, 1989, EMBO J, V8, P3767, DOI 10.1002/j.1460-2075.1989.tb08553.x
   Munford RS, 2001, J ENDOTOXIN RES, V7, P327, DOI 10.1177/09680519010070040501
   NAPOLI J, 1994, GASTROENTEROLOGY, V107, P789, DOI 10.1016/0016-5085(94)90128-7
   PAPACONSTANTINOU J, 1994, ANN NY ACAD SCI, V719, P195, DOI 10.1111/j.1749-6632.1994.tb56829.x
   POST DJ, 1991, ANN NY ACAD SCI, V621, P66
   PUISSANT C, 1990, BIOTECHNIQUES, V8, P148
   Rabek JP, 1998, BBA-GENE STRUCT EXPR, V1398, P137, DOI 10.1016/S0167-4781(98)00038-4
   Rose R, 2007, J APPL TOXICOL, V27, P602, DOI 10.1002/jat.1243
   Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002
   Samols D., 2002, CYTOKINE REFERENCE O
   Sierra F, 1995, MECH AGEING DEV, V84, P127, DOI 10.1016/0047-6374(95)01639-2
   SIERRA F, 1989, MOL CELL BIOL, V9, P5610, DOI 10.1128/MCB.9.12.5610
   Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268
   Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996
   Walter R, 1998, J GERONTOL A-BIOL, V53, pB102, DOI 10.1093/gerona/53A.2.B102
   Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001
   Xu XW, 1996, AM J PHYSIOL-ENDOC M, V271, pE903, DOI 10.1152/ajpendo.1996.271.5.E903
   Yee SB, 2002, J TOXICOL ENV HEAL A, V65, P961, DOI 10.1080/00984100290071261
NR 41
TC 10
Z9 11
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD DEC
PY 2008
VL 63
IS 12
BP 1299
EP 1306
DI 10.1093/gerona/63.12.1299
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 395PG
UT WOS:000262535400004
PM 19126842
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Huang, LG
   Chin, LC
   Kimura, K
   Nakahata, Y
AF Huang, Liguo
   Chin, Lit-Chein
   Kimura, Koichi
   Nakahata, Yasukazu
TI Human Placental Extract Delays In Vitro Cellular Senescence through the
   Activation of NRF2-Mediated Antioxidant Pathway
SO ANTIOXIDANTS
LA English
DT Article
DE cellular senescence; human placental extract; oxidative stress; dermal
   fibroblasts
ID NRF2; DEGRADATION; MECHANISMS; EFFICACY
AB Senescent cells accumulate in the organs of aged animals and exacerbate organ dysfunction, resulting in age-related diseases. Oxidative stress accelerates cellular senescence. Placental extract, used in the alleviation of menopausal symptoms and promotion of wound healing and liver regeneration, reportedly protects against oxidative stress. In this study, we investigated the effects of human placental extract (HPE) on cellular senescence in normal human dermal fibroblasts (NHDFs) under oxidative stress conditions. We demonstrated that HPE delays the onset of cellular senescence. Next-generation sequencing analysis revealed that under oxidative stress conditions, HPE treatment enhanced the expression of the antioxidant genes CYGB, APOE, NQO1, and PTGS1. Further, HPE treatment under oxidative stress conditions increased the protein level of nuclear factor-erythroid factor 2-related factor 2 (NRF2)-a vital molecule in the antioxidant pathway-via post-transcriptional and/or post-translational regulations. These findings indicate that HPE treatment in NHDFs, under chronic oxidative stress, delays cellular senescence by mitigating oxidative stress via upregulation of the NRF2-mediated antioxidant pathway, and HPE treatment could potentially ameliorate skin-aging-associated damage, in vivo.
C1 [Huang, Liguo; Chin, Lit-Chein; Kimura, Koichi] Melsmon Pharmaceut Co Ltd, Res Dev Dept, Tokyo 1710014, Japan.
   [Nakahata, Yasukazu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurobiol & Behav, Nagasaki 8528523, Japan.
C3 Nagasaki University
RP Nakahata, Y (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Neurobiol & Behav, Nagasaki 8528523, Japan.
EM yasu-nakahata@nagasaki-u.ac.jp
OI Nakahata, Yasukazu/0000-0003-3814-5822
CR Ayers D, 2015, J NUCLEIC ACIDS, V2015, DOI 10.1155/2015/143636
   Bak DH, 2018, INT J MOL MED, V42, P2569, DOI 10.3892/ijmm.2018.3830
   Bak DH, 2019, J CELL PHYSIOL, V234, P1643, DOI 10.1002/jcp.27034
   Bataille AM, 2012, CLIN PHARMACOL THER, V92, P340, DOI 10.1038/clpt.2012.110
   Bocheva G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112798
   Campagna R, 2021, CANCERS, V13, DOI 10.3390/cancers13194943
   Mesa-Arango AC, 2017, IATREIA, V30, P160, DOI 10.17533/udea.iatreia.v30n2a05
   Chang PY, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-15270-y
   Choi JY, 2014, BIOL PHARM BULL, V37, P1853, DOI 10.1248/bpb.b13-00979
   Emanuelli M, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11040612
   Farage MA, 2013, ADV WOUND CARE, V2, P5, DOI 10.1089/wound.2011.0356
   Ghoneum M, 2021, CANCER CHEMOTH PHARM, V88, P961, DOI 10.1007/s00280-021-04349-4
   Hashimoto K, 2017, CELL SIGNAL, V33, P69, DOI 10.1016/j.cellsig.2017.02.012
   Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x
   Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001
   Karasawa Y., 1981, MED TREAT, V9, P1
   Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004
   Kong MH, 2008, MENOPAUSE, V15, P296, DOI 10.1097/gme.0b013e3181405b74
   Kong M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/732915
   Melzer D, 2020, NAT REV GENET, V21, P88, DOI 10.1038/s41576-019-0183-6
   Murakami S, 2015, FREE RADICAL BIO MED, V88, P168, DOI 10.1016/j.freeradbiomed.2015.06.030
   Nagae M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061671
   Park SY, 2010, PLACENTA, V31, P873, DOI 10.1016/j.placenta.2010.07.010
   Samiei F, 2016, IRAN J PHARM RES, V15, P75
   Tiwary S K, 2006, J Wound Care, V15, P325
   Togashi SI, 2002, PLACENTA, V23, P497, DOI 10.1053/plac.2002.0833
   Tossetta G, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11040663
   Watanabe S, 2002, J NUTR SCI VITAMINOL, V48, P36
   Yagi M., 2018, Glycative Stress Res., V5, P50, DOI DOI 10.3793/JAAM.8.23
   Yoshikawa C, 2014, CLIMACTERIC, V17, P370, DOI 10.3109/13697137.2013.871695
NR 30
TC 2
Z9 3
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD AUG
PY 2022
VL 11
IS 8
AR 1545
DI 10.3390/antiox11081545
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA 4C1RC
UT WOS:000846238900001
PM 36009264
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Fujihira, H
   Masahara-Negishi, Y
   Akimoto, Y
   Hirayama, H
   Lee, HC
   Story, BA
   Mueller, WF
   Jakob, P
   Clauder-Münster, S
   Steinmetz, LM
   Radhakrishnan, SK
   Kawakami, H
   Kamada, Y
   Miyoshi, E
   Yokomizo, T
   Suzuki, T
AF Fujihira, Haruhiko
   Masahara-Negishi, Yuki
   Akimoto, Yoshihiro
   Hirayama, Hiroto
   Lee, Hyeon-Cheol
   Story, Benjamin A.
   Mueller, William F.
   Jakob, Petra
   Clauder-Muenster, Sandra
   Steinmetz, Lars M.
   Radhakrishnan, Senthil K.
   Kawakami, Hayato
   Kamada, Yoshihiro
   Miyoshi, Eiji
   Yokomizo, Takehiko
   Suzuki, Tadashi
TI Liver-specific deletion of <i>Ngly1</i> causes abnormal nuclear
   morphology and lipid metabolism under food stress
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE NGLY1-deficiency; Ngly1; Nfe2l1; Hepatocyte nuclear morphology; Liver
   function
ID TRANSCRIPTION FACTOR NRF1; PROTEASOMAL DEGRADATION; DROSOPHILA MODEL;
   GENE; ACTIVATION; PACKAGE; HOMEOSTASIS; DEFICIENCY; MECHANISMS;
   INHIBITION
AB The cytoplasmic peptide:N-glycanase (Ngly1) is a de-N-glycosylating enzyme that cleaves N-glycans from misfolded glycoproteins and is involved in endoplasmic reticulum-associated degradation. The recent discovery of NGLY1-deficiency, which causes severe systemic symptoms, drew attention to the physiological function of Ngly1 in mammals. While several studies have been carried out to reveal the physiological necessity of Ngly1, the semi-lethal nature of Ngly1-deficient animals made it difficult to analyze its function in adults. In this study, we focus on the physiological function of Ngly1 in liver (hepatocyte)-specific Ngly1 -deficient mice generated using the cre-loxP system. We found that hepatocyte-specific Ngly1-deficient mice showed abnormal hepatocyte nuclear size/morphology with aging but did not show other notable defects in unstressed conditions. This nuclear phenotype did not appear to be related to the function of the only gene currently reported to rescue Ngly1-deficient murine lethality so far, endo-O-N-acetylglucosaminidase. We also found that under a high fructose diet induced stress, the hepatocyte-specific Ngly1-deletion resulted in liver transaminases elevation and increased lipid droplet accumulation. We showed that the processing and localization of the transcription factor, nuclear factor erythroid 2-like 1 (Nfe2l1), was impaired in the Ngly1-deficient hepatocytes. Therefore, Nfe2l1, at least partially, contributes to the phenotypes observed in hepatocyte-specific Ngly1-deficient mice. Our results indicate that Ngly1 plays important roles in the adult liver impacting nuclear morphology and lipid metabolism. Hepatocyte-specific Ngly1-deficient mice could thus serve as a valuable animal model for assessing in vivo efficacy of drugs and/or treatment for NGLY1-deficiency.
C1 [Fujihira, Haruhiko; Masahara-Negishi, Yuki; Hirayama, Hiroto; Suzuki, Tadashi] RIKEN, Glycometab Biochem Lab, Cluster Pioneering Res, Saitama 3510198, Japan.
   [Fujihira, Haruhiko] Juntendo Univ, Grad Sch Med, Intractable Dis Res Ctr, Div Glycobiol, Tokyo 1138421, Japan.
   [Akimoto, Yoshihiro; Kawakami, Hayato] Kyorin Univ, Dept Anat, Sch Med, Tokyo 1818611, Japan.
   [Story, Benjamin A.; Mueller, William F.; Jakob, Petra; Clauder-Muenster, Sandra; Steinmetz, Lars M.] EMBL, Genome Biol Unit, D-69117 Heidelberg, Germany.
   [Steinmetz, Lars M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.
   [Clauder-Muenster, Sandra; Radhakrishnan, Senthil K.] Virginia Commonwealth Univ, Dept Pathol, Med Coll Virginia Campus, Richmond, VA 23298 USA.
   [Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Osaka 5650871, Japan.
   [Hirayama, Hiroto; Suzuki, Tadashi] T CiRA Joint Program, Suzuki Project, Fujisawa, Kanagawa 2518555, Japan.
   [Lee, Hyeon-Cheol; Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Grad Sch Med, Tokyo 1138421, Japan.
C3 RIKEN; Juntendo University; Kyorin University; European Molecular
   Biology Laboratory (EMBL); Stanford University; Virginia Commonwealth
   University; Osaka University; Juntendo University
RP Suzuki, T (corresponding author), RIKEN, Glycometab Biochem Lab, Cluster Pioneering Res, Saitama 3510198, Japan.
EM tsuzuki_gm@riken.jp
RI Kamada, Yoshihiro/GQA-8854-2022; Yokomizo, Takehiko/P-5673-2016; Suzuki,
   Tadashi/AAX-5707-2021; Suzuki, Tadashi/I-4536-2014; Kamada,
   Yoshihiro/AHC-1613-2022; Lee-Okada, Hyeon-Cheol/AAQ-4520-2021; hirayama,
   hiroto/HCH-9202-2022
OI Kamada, Yoshihiro/0000-0001-5485-902X; Yokomizo,
   Takehiko/0000-0002-5219-1553; Suzuki, Tadashi/0000-0003-1030-7631;
   Lee-Okada, Hyeon-Cheol/0000-0002-5493-8112; Hirayama,
   Hiroto/0000-0003-1909-9488; Steinmetz, Lars/0000-0002-3962-2865; Story,
   Benjamin/0000-0001-7212-7842
FU Toray Science Foundation; RIKEN pioneering project "glyco-lipidologue
   initiative"; Grace Science Foundation; Rakuten Inc.; Tokyo, Japan; 
   [16K18520];  [18K14655];  [18K16246];  [15H05904];  [18H02627]
FX This work was supported in part by Grants-in-Aid for Scientific Research
   (grant no. 16K18520, 18K14655 to HF, 18K16246 to HL, 15H05904, 18H02627
   to TY), Toray Science Foundation (to TS), RIKEN pioneering project
   "glyco-lipidologue initiative" (to TS) and by Grace Science Foundation
   (to TS, LMS and SKR). We also would like to express sincere gratitude to
   Mr. Hiroshi Mikitani (Rakuten Inc.; Tokyo, Japan) for his financial
   support for Nglyl research.
CR BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bosch DGM, 2016, EUR J HUM GENET, V24, P660, DOI 10.1038/ejhg.2015.186
   Bugno M, 2015, BBA-GENE REGUL MECH, V1849, P1260, DOI 10.1016/j.bbagrm.2015.08.001
   Caglayan AO, 2015, EUR J MED GENET, V58, P39, DOI 10.1016/j.ejmg.2014.08.008
   Chow MD, 2017, MOL ASPECTS MED, V56, P34, DOI 10.1016/j.mam.2017.04.004
   Coluzzi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110963
   DeBosch BJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac5472
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Enns GM, 2014, GENET MED, V16, P751, DOI 10.1038/gim.2014.22
   Fujihira H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006696
   Funakoshi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010545
   Galeone A, 2017, ELIFE, V6, DOI 10.7554/eLife.27612
   Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752
   Gu XS, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002110
   Guijas C, 2012, J LIPID RES, V53, P2343, DOI 10.1194/jlr.M028423
   Heeley J, 2015, AM J MED GENET A, V167, P816, DOI 10.1002/ajmg.a.36889
   Hirotsu Y, 2012, MOL CELL BIOL, V32, P2760, DOI 10.1128/MCB.06706-11
   Holowka D, 2017, MOL BIOL CELL, V28
   Hoopes SL, 2015, PROSTAG OTH LIPID M, V120, P9, DOI 10.1016/j.prostaglandins.2015.03.002
   Hoshikawa Y, 2011, CANCER SCI, V102, P934, DOI 10.1111/j.1349-7006.2011.01889.x
   Huang CC, 2015, P NATL ACAD SCI USA, V112, P1398, DOI 10.1073/pnas.1414593112
   Kawanishi N, 2018, AM J PHYSIOL-REG I, V314, pR892, DOI 10.1152/ajpregu.00371.2017
   Kobayashi A, 2011, GENES CELLS, V16, P692, DOI 10.1111/j.1365-2443.2011.01522.x
   Kong JP, 2018, MITOCHONDRION, V38, P6, DOI 10.1016/j.mito.2017.07.008
   Lam C, 2017, GENET MED, V19, P160, DOI 10.1038/gim.2016.75
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Lehrbach NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.17721
   Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819
   Oh DH, 2012, FEBS J, V279, P4121, DOI 10.1111/febs.12005
   Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132
   Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200
   Owings KG, 2018, HUM MOL GENET, V27, P1055, DOI 10.1093/hmg/ddy026
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Qu W, 2001, J BIOL CHEM, V276, P25467, DOI 10.1074/jbc.M100545200
   Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rodriguez TP, 2018, G3-GENES GENOM GENET, V8, P2193, DOI 10.1534/g3.118.300578
   Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012
   Suzuki T, 2016, MOL ASPECTS MED, V51, P89, DOI 10.1016/j.mam.2016.05.004
   Tomlin FM, 2017, ACS CENTRAL SCI, V3, P1143, DOI 10.1021/acscentsci.7b00224
   Tsujita T, 2014, MOL CELL BIOL, V34, P3800, DOI 10.1128/MCB.00110-14
   van Keulen BJ, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.13979
   Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568
   Xu JL, 2012, DRUG METAB DISPOS, V40, P259, DOI 10.1124/dmd.111.039925
   Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102
   Yang K, 2018, J EXP MED, V215, P2600, DOI 10.1084/jem.20180783
   Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zhang YG, 2016, BIOCHEM J, V473, P961, DOI 10.1042/BJ20151182
NR 51
TC 17
Z9 17
U1 0
U2 13
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD MAR 1
PY 2020
VL 1866
IS 3
AR 165588
DI 10.1016/j.bbadis.2019.165588
PG 14
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA KH2UY
UT WOS:000510504400014
PM 31733337
DA 2024-02-19
ER

PT J
AU HUNT, CM
   WESTERKAM, WR
   STAVE, GM
AF HUNT, CM
   WESTERKAM, WR
   STAVE, GM
TI EFFECT OF AGE AND GENDER ON THE ACTIVITY OF HUMAN HEPATIC-CYP3A
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
ID CYTOCHROME-P-450 NIFEDIPINE OXIDASE; HUMAN-LIVER CYTOCHROME-P-450;
   HUMAN-FETAL LIVERS; DRUG-METABOLISM; RAT-LIVER; DISPOSITION; SEX;
   SEQUENCE; THERAPY; CDNA
AB Many pharmacokinetic investigations in the elderly population reveal decreased clearance of lipophilic drugs metabolized by the cytochrome P450 enzymes; however, few studies have evaluated aging-dependent or gender-related changes in specific cytochrome P450 enzymes. The clearance of quinidine, midazolam, triazolam, erythromycin, and lidocaine declines with age: these drugs are metabolized by the isoform, CYP3A. To determine whether these metabolic effects are due to changes in CYP3A, the effects of age and gender on CYP3A activity were examined. The activity of the human hepatic cytochrome P450, CYP3A, was quantified in vitro as erythromycin N-demethylation in microsomes prepared from forty-three resected human liver specimens obtained from patients, age 27 to 83, with normal liver function. Erythromycin N-demethylation varied 5-fold in human liver microsomes. CYP3A activity was 24% higher in females than males (P = 0.027). CYP3A activity did not correlate with age, smoking status, ethanol consumption or percent ideal body weight. Large interindividual differences and a small female-specific increase in CYP3A activity were obtained. However, CYP3A activity was unaffected by age over the range of 27-83 years. suggesting that the aging-related alteration in the clearance of CYP3A substrates is secondary to changes in liver blood flow, size, or drug binding and distribution with aging.
C1 DUKE UNIV,MED CTR,DEPT COMMUNITY & FAMILY MED,DURHAM,NC 27710.
C3 Duke University
RP HUNT, CM (corresponding author), DUKE UNIV,MED CTR,DEPT MED,BOX 3064,DURHAM,NC 27710, USA.
CR ABERNETHY DR, 1986, ANN INTERN MED, V105, P329, DOI 10.7326/0003-4819-105-3-329
   ALPERS DH, 1985, MANUAL NUTRITIONAL G, P150
   ANDERSON MS, 1990, ARCH INTERN MED, V150, P2459
   AOYAMA T, 1989, J BIOL CHEM, V264, P10388
   AUSTIN KL, 1980, BRIT J CLIN PHARMACO, V10, P273, DOI 10.1111/j.1365-2125.1980.tb01755.x
   BACH B, 1981, CLIN PHARMACOKINET, V6, P389, DOI 10.2165/00003088-198106050-00005
   BARGETZI MJ, 1989, CLIN PHARMACOL THER, V46, P521, DOI 10.1038/clpt.1989.180
   BEAUNE PH, 1986, P NATL ACAD SCI USA, V83, P8064, DOI 10.1073/pnas.83.21.8064
   BORK RW, 1989, J BIOL CHEM, V264, P910
   CROWLEY JJ, 1988, J PHARMACOL EXP THER, V245, P513
   DUNDEE JW, 1985, ANAESTHESIA, V40, P441
   DURNAS C, 1990, CLIN PHARMACOKINET, V19, P359, DOI 10.2165/00003088-199019050-00002
   EBERHART DC, 1991, MOL PHARMACOL, V40, P859
   GONZALEZ FJ, 1988, DNA-J MOLEC CELL BIO, V7, P79, DOI 10.1089/dna.1988.7.79
   GONZALEZ FJ, 1990, PHARMACOL THERAPEUT, V45, P1, DOI 10.1016/0163-7258(90)90006-N
   GREENBLATT DJ, 1980, CLIN PHARMACOL THER, V27, P301, DOI 10.1038/clpt.1980.40
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   GREENBLATT DJ, 1986, THER DRUG MONIT, V8, P249, DOI 10.1097/00007691-198609000-00001
   GREENBLATT DJ, 1991, NEW ENGL J MED, V324, P1691, DOI 10.1056/NEJM199106133242403
   GREENBLATT DJ, 1982, J PHARMACOL EXP THER, V220, P120
   GREENBLATT DJ, 1985, CLIN PHARMACOL THER, V38, P697, DOI 10.1038/clpt.1985.248
   GREENBLATT DJ, 1980, J PHARMACOL EXP THER, V215, P86
   GUENGERICH FP, 1989, ANNU REV PHARMACOL, V29, P241
   GUENGERICH FP, 1986, MOL PHARMACOL, V30, P287
   HUNT CM, 1992, CLIN PHARMACOL THER, V51, P18, DOI 10.1038/clpt.1992.3
   HUNT CM, 1990, BIOCHEM PHARMACOL, V40, P1666, DOI 10.1016/0006-2952(90)90470-6
   HUNT CM, IN PRESS MECH AGEING
   KAHAN BD, 1988, TRANSPLANTATION, V46, P631, DOI 10.1097/00007890-198811000-00002
   KITADA M, 1988, ARCH BIOCHEM BIOPHYS, V264, P61, DOI 10.1016/0003-9861(88)90570-X
   KITADA M, 1985, ARCH BIOCHEM BIOPHYS, V241, P275, DOI 10.1016/0003-9861(85)90383-2
   KNODELL RG, 1982, GASTROENTEROLOGY, V82, P84
   KOBLIAKOV V, 1991, EUR J BIOCHEM, V195, P585, DOI 10.1111/j.1432-1033.1991.tb15741.x
   KRONBACH T, 1988, CLIN PHARMACOL THER, V43, P630, DOI 10.1038/clpt.1988.87
   KRONBACH T, 1989, MOL PHARMACOL, V36, P89
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MIGNOLI A, 1990, EUR J CLIN PHARMACOL, V39, P161
   MOLOWA D T, 1988, Journal of Cell Biology, V107, p195A
   MOLOWA DT, 1986, P NATL ACAD SCI USA, V83, P5311, DOI 10.1073/pnas.83.14.5311
   MONTAMAT SC, 1989, NEW ENGL J MED, V321, P303
   NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416
   NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1
   OCHS HR, 1982, PHARMACOLOGY, V14, P341
   OMALLEY K, 1971, BMJ-BRIT MED J, V3, P607, DOI 10.1136/bmj.3.5775.607
   RICHEY DP, 1977, ANNU REV PHARMACOL, V17, P49, DOI 10.1146/annurev.pa.17.040177.000405
   SALAZAR DE, 1988, BIOCHEM BIOPH RES CO, V157, P315, DOI 10.1016/S0006-291X(88)80049-4
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P364
   SCHUETZ JD, 1989, ARCH BIOCHEM BIOPHYS, V274, P355, DOI 10.1016/0003-9861(89)90449-9
   VESTAL RF, 1982, J AM GERIATR SOC, V30, P191, DOI 10.1111/j.1532-5415.1982.tb01303.x
   WATKINS PB, 1990, SEMIN LIVER DIS, V10, P235, DOI 10.1055/s-2008-1040480
   WATKINS PB, 1987, J CLIN INVEST, V80, P1029, DOI 10.1172/JCI113156
   WATKINS PB, 1985, P NATL ACAD SCI USA, V82, P6310, DOI 10.1073/pnas.82.18.6310
   WATKINS PB, 1989, J CLIN INVEST, V83, P688, DOI 10.1172/JCI113933
   WILSON K, 1984, CLIN PHARMACOKINET, V9, P189, DOI 10.2165/00003088-198409030-00001
   WRIGHTON SA, 1989, MOL PHARMACOL, V36, P97
   WRIGHTON SA, 1990, MOL PHARMACOL, V38, P207
   1979, DRUGS, V22, P279
NR 56
TC 331
Z9 354
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD JUL 22
PY 1992
VL 44
IS 2
BP 275
EP 283
DI 10.1016/0006-2952(92)90010-G
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA JG230
UT WOS:A1992JG23000010
PM 1642641
DA 2024-02-19
ER

PT J
AU PARKHOUSE, WS
   WILLIS, PE
   ZHANG, J
AF PARKHOUSE, WS
   WILLIS, PE
   ZHANG, J
TI HEPATIC LIPID-PEROXIDATION AND ANTIOXIDANT ENZYME RESPONSES TO LONG-TERM
   VOLUNTARY PHYSICAL-ACTIVITY AND AGING
SO AGE
LA English
DT Article
ID SUPEROXIDE-DISMUTASE; SKELETAL-MUSCLE; SELENIUM DEFICIENCY; ADAPTIVE
   RESPONSE; MEMBRANE FLUIDITY; RAT-LIVER; VITAMIN-E; EXERCISE; AGE;
   PHOSPHOLIPASE-A2
AB Hepatic lipid perioxidation and antioxidant capacities as a function of aging and long-term voluntary physical activity were investigated in C57BI/6 mice. Female mice ages 1, 5 and 15 months were divided into control (C) or voluntary wheel trained (WT) groups (n=6 animals/grp). Voluntary wheel training consisted of unlimited access to a 16 cm wheel. Animals were sacrificed following training at 4, 8 and 24 months of age. The total distance run per day was 2.5 times greater in the 4 month old animals as compared the 8 or 24 month old animals (1.9 and 2.1 km/day, respectively). Malondialdehyde (MDA) levels were assessed as a marker of lipid perioxidation. MDA levels increased 2.5 fold from 4 to 24 months of age and were significantly lower in all age groups following chronic physical activity. Glutathione perioxidase (GSH-px), catalase (CAT), and mitochondrial (MnSOD), cytosolic (CuZnSOD) and total superoxide dismutase (SOD) levels were all significantly decreased with increasing age. Chronic physical activity significantly increased GSH-px and CAT levels at all ages and to a lesser extent CuZnSOD and total SOD in the 8 and 24 month old animals. MnSOD was unaffected by chronic physical activity at all ages. These findings suggest chronic physical activity provides a protective effect in this tissue against active O2 mediated cellular damage accompanying aging and this protective effect is partly related to elevations in GSH-px and CAT and to a lesser extent cytosolic SOD.
RP PARKHOUSE, WS (corresponding author), SIMON FRASER UNIV,SCH KINESIOL,METAB BIOCHEM LAB,BURNABY,BC V5A 1S6,CANADA.
CR ALESSIO HM, 1993, MED SCI SPORT EXER, V25, P218, DOI 10.1249/00005768-199302000-00010
   ALESSIO HM, 1988, J APPL PHYSIOL, V64, P1333, DOI 10.1152/jappl.1988.64.4.1333
   [Anonymous], 1974, METHODS ENZYMATIC AN
   [Anonymous], METHOD ENZYMOL
   BAGBY GJ, 1978, J APPL PHYSIOL, V56, P425
   BROWN M, 1992, MECH AGEING DEV, V63, P69, DOI 10.1016/0047-6374(92)90017-8
   CHEN JJ, 1994, FREE RADICAL BIO MED, V17, P411, DOI 10.1016/0891-5849(94)90167-8
   CHIA LS, 1983, BIOCHEM BIOPH RES CO, V117, P141, DOI 10.1016/0006-291X(83)91552-8
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   DE AK, 1991, MECH AGEING DEV, V59, P123, DOI 10.1016/0047-6374(91)90078-E
   DEGROOT H, 1985, BIOCHIM BIOPHYS ACTA, V815, P91, DOI 10.1016/0005-2736(85)90478-X
   DEVASAGAYAM TPA, 1986, FEBS LETT, V205, P246, DOI 10.1016/0014-5793(86)80906-1
   GOODRICK CL, 1980, GERONTOLOGY, V26, P22, DOI 10.1159/000212390
   HALLIWELL B, 1985, FREE RADICAL BIO MED, P73
   HARMAN D, 1986, BIOL AGING, P3
   HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281
   IMRE S, 1984, MECH AGEING DEV, V28, P297, DOI 10.1016/0047-6374(84)90030-7
   JENKINS RR, 1984, INT J SPORTS MED, V95, P11
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1992, J AM COLL NUTR, V11, P79
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   KANTER MM, 1985, J APPL PHYSIOL, V59, P1298, DOI 10.1152/jappl.1985.59.4.1298
   LANGANIERE S, 1989, MECH AGEING DEV, V48, P221
   MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   PINTO RE, 1969, BIOCHEM J, V112, P109, DOI 10.1042/bj1120109
   POOT M, 1991, MUTAT RES, V256, P177, DOI 10.1016/0921-8734(91)90010-9
   QUINTANILHA AT, 1984, BIOCHEM SOC T, V12, P403, DOI 10.1042/bst0120403
   SESTINI EA, 1991, EXP GERONTOL, V26, P385, DOI 10.1016/0531-5565(91)90050-V
   SLATER TF, 1987, P NUTR SOC, V46, P1, DOI 10.1079/PNS19870003
   WAHNON R, 1989, MECH AGEING DEV, V50, P249, DOI 10.1016/0047-6374(89)90103-6
   WERNIG A, 1990, J PHYSIOL-LONDON, V428, P639, DOI 10.1113/jphysiol.1990.sp018232
   WITT EH, 1992, J NUTR, V122, P766, DOI 10.1093/jn/122.suppl_3.766
   YU BP, 1992, MECH AGEING DEV, V65, P17, DOI 10.1016/0047-6374(92)90123-U
NR 35
TC 9
Z9 9
U1 0
U2 0
PU AMER AGING ASSOC
PI CHESTER
PA 2129 PROVIDENCE AVENUE, CHESTER, PA 19013
SN 0161-9152
J9 AGE
JI Age
PD JAN
PY 1995
VL 18
IS 1
BP 11
EP 17
DI 10.1007/BF02434077
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA RF425
UT WOS:A1995RF42500004
DA 2024-02-19
ER

PT J
AU BEYER, HS
   ELLEFSON, M
   SHERMAN, R
   ZIEVE, L
AF BEYER, HS
   ELLEFSON, M
   SHERMAN, R
   ZIEVE, L
TI AGING ALTERS ORNITHINE DECARBOXYLASE AND DECREASES POLYAMINES IN
   REGENERATING RAT-LIVER BUT PUTRESCINE REPLACEMENT HAS NO EFFECT
SO JOURNAL OF LABORATORY AND CLINICAL MEDICINE
LA English
DT Article
ID MESSENGER-RNA; ALPHA-DIFLUOROMETHYLORNITHINE; GENE; EXPRESSION; ACID;
   CHROMATOGRAPHY; ACCUMULATION; HEPATECTOMY; INHIBITION; SEQUENCE
AB Aging decreases rat liver regeneration. We (1) compared the expression of ornithine decarboxylase (ODC), a critical enzyme for liver regeneration, and polyamine levels in regenerating liver of 6-week-old and 1-year-old rats and (2) evaluated the effect of exogenous putrescine supplementation on liver regeneration in 1-year-old rats. ODC messenger ribonucleic acid (mRNA) transcript sizes were the same in rats of both ages. ODC mRNA content and enzyme activity were higher in the younger rats; however, magnitudes of increase after partial hepatectomy were greater in the older rats. From peak levels, the rate of decline of the mRNA was slower in the older rats, but enzyme activity declined at the same rate in both ages. ODC apoenzyme content was significantly less in normal liver tissue from 1-year-old rats, but there was little change after partial hepatectomy in rats of either age. No change in ODC transcriptional activity was found. Hepatic putrescine levels were lower in 48 hour regenerating liver tissue from 1-year-old rats. To determine whether supplemental putrescine would increase liver regeneration in 1-year-old rats, putrescine (600-mu-mol/kg IP every 4 hours) was administered beginning 4 days before or at the time of partial hepatectomy. This raised polyamine levels and decreased ODC activity significantly, but there was no change in regenerating liver weight, total DNA and RNA content, and tritiated thymidine incorporation at 48 hours. These results indicate that ODC expression is different and polyamine levels are lower in 1-year-old rats than in 6-week-old rats. However, putrescine supplementation that is sufficient to decrease ODC activity has no apparent effect on regeneration.
C1 VET ADM MED CTR,DEPT MED,MINNEAPOLIS,MN 55417.
   UNIV MINNESOTA,SCH MED,DEPT MED,MINNEAPOLIS,MN 55455.
   MINNEAPOLIS MED RES FDN INC,MINNEAPOLIS,MN.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Minneapolis VA Health Care System; University of Minnesota System;
   University of Minnesota Twin Cities; Minneapolis Medical Research
   Foundation
RP BEYER, HS (corresponding author), HENNEPIN CTY MED CTR,DEPT MED,701 PK AVE S,MINNEAPOLIS,MN 55415, USA.
CR ALISON MR, 1986, PHYSIOL REV, V66, P499, DOI 10.1152/physrev.1986.66.3.499
   AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   BEYER HS, 1991, J LAB CLIN MED, V117, P101
   BEYER HS, 1990, BIOCHEM INT, V20, P761
   BROWN ND, 1979, J CHROMATOGR, V164, P35, DOI 10.1016/S0378-4347(00)81569-8
   BUCHER NLR, 1964, CANCER RES, V24, P509
   CAVIA E, 1972, BIOCHIM BIOPHYS ACTA, V262, P546, DOI 10.1016/0005-2787(72)90498-4
   CHANG ZF, 1988, J BIOL CHEM, V263, P11431
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CLARK JL, 1975, BIOCHEMISTRY-US, V14, P4403, DOI 10.1021/bi00691a010
   COLLINS ML, 1985, ANAL BIOCHEM, V151, P211, DOI 10.1016/0003-2697(85)90168-X
   DIEHL AM, 1990, J CLIN INVEST, V85, P385, DOI 10.1172/JCI114450
   DIEHL AM, 1990, HEPATOLOGY, V12, P663
   FERIOLI ME, 1976, EXP GERONTOL, V11, P153, DOI 10.1016/0531-5565(76)90026-7
   FLECK A, 1962, BIOCHIM BIOPHYS ACTA, V55, P571
   GILES KW, 1965, NATURE, V206, P93, DOI 10.1038/206093a0
   GINTY D, 1989, AM J PHYSIOL, V19, pG342
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HIRVONEN A, 1989, BIOCHIM BIOPHYS ACTA, V1007, P120, DOI 10.1016/0167-4781(89)90140-1
   HSIEH JT, 1990, CANCER RES, V50, P2239
   JANNE J, 1978, BIOCHIM BIOPHYS ACTA, V473, P241, DOI 10.1016/0304-419X(78)90015-X
   JUMP DB, 1988, J BIOL CHEM, V263, P7254
   KANAMOTO R, 1986, EUR J BIOCHEM, V154, P539, DOI 10.1111/j.1432-1033.1986.tb09432.x
   Maniatis T., 1982, MOL CLONING
   MARIASH CN, 1982, ANAL BIOCHEM, V121, P388, DOI 10.1016/0003-2697(82)90498-5
   MCCONLOGUE L, 1984, P NATL ACAD SCI-BIOL, V81, P540, DOI 10.1073/pnas.81.2.540
   MOSHIER JA, 1990, J BIOL CHEM, V265, P4884
   NAHON JL, 1987, J BIOL CHEM, V262, P12479
   PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249
   POSO H, 1982, BIOCHIM BIOPHYS ACTA, V696, P179, DOI 10.1016/0167-4781(82)90026-4
   POSO H, 1976, BIOCHEM J, V158, P485, DOI 10.1042/bj1580485
   SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3
   SEELY JE, 1982, BIOCHEM J, V206, P311, DOI 10.1042/bj2060311
   SEELY JE, 1982, J BIOL CHEM, V257, P7549
   SERTICH GJ, 1987, AM J PHYSIOL, V253, pC687
   VANKRANEN HJ, 1987, GENE, V60, P145, DOI 10.1016/0378-1119(87)90222-8
   WARNER HR, 1989, J GERONTOL, V44, pB23, DOI 10.1093/geronj/44.1.B23
   WHITE MW, 1987, MOL CELL BIOL, V7, P3004, DOI 10.1128/MCB.7.8.3004
   WONG NCW, 1989, MOL ENDOCRINOL, V3, P645, DOI 10.1210/mend-3-4-645
   ZIEVE L, 1985, J LAB CLIN MED, V105, P331
NR 40
TC 19
Z9 20
U1 0
U2 0
PU MOSBY-YEAR BOOK INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318
SN 0022-2143
J9 J LAB CLIN MED
JI J. Lab. Clin. Med.
PD JAN
PY 1992
VL 119
IS 1
BP 38
EP 47
PG 10
WC Medical Laboratory Technology; Medicine, General & Internal; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Laboratory Technology; General & Internal Medicine; Research &
   Experimental Medicine
GA GX831
UT WOS:A1992GX83100005
PM 1727906
DA 2024-02-19
ER

PT J
AU Smiljanic, K
   Vanmierlo, T
   Djordjevic, AM
   Perovic, M
   Loncarevic-Vasiljkovic, N
   Tesic, V
   Rakic, L
   Ruzdijic, S
   Lutjohann, D
   Kanazir, S
AF Smiljanic, Kosara
   Vanmierlo, Tim
   Djordjevic, Aleksandra Mladenovic
   Perovic, Milka
   Loncarevic-Vasiljkovic, Natasa
   Tesic, Vesna
   Rakic, Ljubisav
   Ruzdijic, Sabera
   Lutjohann, Dieter
   Kanazir, Selma
TI Aging Induces Tissue-Specific Changes in Cholesterol Metabolism in Rat
   Brain and Liver
SO LIPIDS
LA English
DT Article
DE Cholesterol metabolism; Hippocampus; Liver; Cholesterol precursors;
   24S-hydroxycholesterol; Aging
ID AGE-RELATED-CHANGES; PLANT STEROLS; NEURODEGENERATIVE DISEASES; CEREBRAL
   ACCUMULATION; NEURONAL SURVIVAL; LIPID-COMPOSITION; IN-VITRO; MYELIN;
   HIPPOCAMPUS; MECHANISM
AB Disturbance of cholesterol homeostasis in the brain is coupled to age-related brain dysfunction. In the present work, we studied the relationship between aging and cholesterol metabolism in two brain regions, the cortex and hippocampus, as well as in the sera and liver of 6-, 12-, 18- and 24-month-old male Wistar rats. Using gas chromatography-mass spectrometry, we undertook a comparative analysis of the concentrations of cholesterol, its precursors and metabolites, as well as dietary-derived phytosterols. During aging, the concentrations of the three cholesterol precursors examined (lanosterol, lathosterol and desmosterol) were unchanged in the cortex, except for desmosterol which decreased (44 %) in 18-month-old rats. In the hippocampus, aging was associated with a significant reduction in lanosterol and lathosterol concentrations at 24 months (28 and 25 %, respectively), as well as by a significant decrease of desmosterol concentration at 18 and 24 months (36 and 51 %, respectively). In contrast, in the liver we detected age-induced increases in lanosterol and lathosterol concentrations, and no change in desmosterol concentration. The amounts of these sterols were lower than in the brain regions. In the cortex and hippocampus, desmosterol was the predominant cholesterol precursor. In the liver, lathosterol was the most abundant precursor. This ratio remained stable during aging. The most striking effect of aging observed in our study was a significant decrease in desmosterol concentration in the hippocampus which could reflect age-related reduced synaptic plasticity, thus representing one of the detrimental effects of advanced age.
C1 [Smiljanic, Kosara; Djordjevic, Aleksandra Mladenovic; Perovic, Milka; Loncarevic-Vasiljkovic, Natasa; Tesic, Vesna; Ruzdijic, Sabera; Kanazir, Selma] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Mol Neurobiol Lab, Dept Neurobiol, Belgrade 11060, Serbia.
   [Vanmierlo, Tim; Lutjohann, Dieter] Univ Clin Bonn, Inst Clin Chem & Clin Pharmacol, Lab Special Lipid Diagnost Ctr Internal Med UG 68, Bonn, Germany.
   [Rakic, Ljubisav] Serbian Acad Arts & Sci, Belgrade, Serbia.
C3 University of Belgrade; University of Bonn; Serbian Academy of Sciences
   & Arts
RP Kanazir, S (corresponding author), Univ Belgrade, Inst Biol Res Sinisa Stankovic, Mol Neurobiol Lab, Dept Neurobiol, Bulevar Despota Stefana 142, Belgrade 11060, Serbia.
EM selkan@ibiss.bg.ac.rs
RI Mladenovic, Aleksandra/IQR-9118-2023; Loncarevic-Vasiljkovic,
   Natasa/AFK-0840-2022; Tesic, Vesna/AHB-1184-2022; Perović,
   Milka/HKV-2237-2023; Vanmierlo, Tim/C-7773-2013; Loncarevic-Vasiljkovic,
   Natasa/AAF-7800-2022; Kanazir, Selma/E-5495-2015
OI Mladenovic, Aleksandra/0000-0001-9011-5634; Loncarevic-Vasiljkovic,
   Natasa/0000-0002-8350-1390; Perović, Milka/0000-0003-0941-6988;
   Vanmierlo, Tim/0000-0003-2912-0578; Loncarevic-Vasiljkovic,
   Natasa/0000-0002-8350-1390; Kanazir, Selma/0000-0002-7229-5296;
   Smiljanic, Kosara/0000-0002-6790-5491; Tesic, Vesna/0000-0002-7247-1034
FU Ministry of Education, Science and Technological Development of the
   Republic of Serbia [ON173056]; FWO Pegasus Marie Curie Fellowship
FX This work was supported by the Ministry of Education, Science and
   Technological Development of the Republic of Serbia, Grant ON173056.,
   and by FWO Pegasus Marie Curie Fellowship to T. Vanmierlo.
CR Ando S, 2003, NEUROCHEM RES, V28, P5, DOI 10.1023/A:1021635826032
   Aureli T, 2000, NEUROCHEM RES, V25, P395, DOI 10.1023/A:1007501306623
   Båvner A, 2010, J LIPID RES, V51, P2722, DOI 10.1194/jlr.M008326
   Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178
   Couillard-Despres S, 2011, GERONTOLOGY, V57, P559, DOI 10.1159/000323481
   Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003
   Djordjevic AM, 2010, NEUROCHEM INT, V56, P250, DOI 10.1016/j.neuint.2009.10.008
   Ledesma MD, 2012, PROG LIPID RES, V51, P23, DOI 10.1016/j.plipres.2011.11.004
   Futter M, 2009, J MED GENET, V46, P438, DOI 10.1136/jmg.2009.066399
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0
   Hac-Wydro K, 2009, J COLLOID INTERF SCI, V329, P265, DOI 10.1016/j.jcis.2008.09.057
   Hooff GP, 2012, MOL NEUROBIOL, V46, P179, DOI 10.1007/s12035-012-8285-6
   Jansen PJ, 2006, BBA-MOL CELL BIOL L, V1761, P445, DOI 10.1016/j.bbalip.2006.03.015
   JAVITT NB, 1994, FASEB J, V8, P1308, DOI 10.1096/fasebj.8.15.8001744
   Jinno S, 2011, J COMP NEUROL, V519, P451, DOI 10.1002/cne.22527
   JUREVICS H, 1995, J NEUROCHEM, V64, P895
   Koudinov AR, 2001, FASEB J, V15, P1858, DOI 10.1096/fj.00-0815fje
   Lütjohann D, 2002, J LIPID RES, V43, P1078, DOI 10.1194/jlr.M200071-JLR200
   Martin MG, 2008, MOL BIOL CELL, V19, P2101, DOI 10.1091/mbc.E07-09-0897
   Meaney S, 2007, J LIPID RES, V48, P944, DOI 10.1194/jlr.M600529-JLR200
   Mulas MF, 2005, MECH AGEING DEV, V126, P648, DOI 10.1016/j.mad.2004.11.010
   Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x
   Panzenboeck U, 2007, J LIPID RES, V48, P1167, DOI 10.1194/jlr.M700027-JLR200
   Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832
   Popescu BO, 2009, J NEUROL SCI, V283, P99, DOI 10.1016/j.jns.2009.02.321
   Sebastiao AM, 2013, NEUROPHARMACOLOGY, V64, P97, DOI 10.1016/j.neuropharm.2012.06.053
   SMITH ME, 1968, BIOCHIM BIOPHYS ACTA, V164, P285, DOI 10.1016/0005-2760(68)90154-9
   Snipes G J, 1997, Subcell Biochem, V28, P173
   SODERBERG M, 1990, J NEUROCHEM, V54, P415, DOI 10.1111/j.1471-4159.1990.tb01889.x
   Sodero AO, 2011, J NEUROCHEM, V116, P747, DOI 10.1111/j.1471-4159.2010.07079.x
   SPADY DK, 1983, J LIPID RES, V24, P303
   SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802
   Tacer KF, 2010, J STEROID BIOCHEM, V121, P619, DOI 10.1016/j.jsbmb.2010.02.026
   Thelen KM, 2006, NEUROSCI LETT, V403, P15, DOI 10.1016/j.neulet.2006.04.034
   Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124
   Vanmierlo T, 2012, J LIPID RES, V53, P726, DOI 10.1194/jlr.M017244
   Vanmierlo T, 2011, PLANT FOOD HUM NUTR, V66, P149, DOI 10.1007/s11130-011-0219-3
   Vanmierlo T, 2010, J ALZHEIMERS DIS, V19, P117, DOI 10.3233/JAD-2010-1209
   Yamaguchi M, 2007, INT J MOL MED, V20, P323
NR 39
TC 30
Z9 30
U1 2
U2 9
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0024-4201
EI 1558-9307
J9 LIPIDS
JI Lipids
PD NOV
PY 2013
VL 48
IS 11
BP 1069
EP 1077
DI 10.1007/s11745-013-3836-9
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 239TD
UT WOS:000326047500002
PM 24057446
DA 2024-02-19
ER

PT J
AU Alison, MR
   Lin, WR
AF Alison, Malcolm R.
   Lin, Wey-Ran
TI Diverse routes to liver regeneration
SO JOURNAL OF PATHOLOGY
LA English
DT Article
DE liver regeneration; stem cell niche; Axin2; lineage tracing; diploid
   hepatocytes; hybrid hepatocytes; p53; Mdm2; hepatic progenitor cells
ID FLOW-CYTOMETRIC ANALYSIS; STEM-CELL NICHE; PROGENITOR CELLS; DNA-PLOIDY;
   HEPATOCELLULAR-CARCINOMA; PERIPORTAL HEPATOCYTES; MATURE HEPATOCYTES;
   MOUSE-LIVER; CIRRHOSIS; POPULATION
AB The liver's ability to regenerate is indisputable; for example, after a two-thirds partial hepatectomy in rats all residual hepatocytes can divide, questioning the need for a specific stem cell population. On the other hand, there is a potential stem cell compartment in the canals of Hering, giving rise to ductular reactions composed of hepatic progenitor cells (HPCs) when the liver's ability to regenerate is hindered by replicative senescence, but the functional relevance of this response has been questioned. Several papers have now clarified regenerative mechanisms operative in the mouse liver, suggesting that the liver is possibly unrivalled in its versatility to replace lost tissue. Under homeostatic conditions a perivenous population of clonogenic hepatocytes operates, whereas during chronic damage a minor population of periportal clonogenic hepatocytes come to the fore, while the ability of HPCs to completely replace the liver parenchyma has now been shown. Copyright (c) 2015 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
C1 [Alison, Malcolm R.] Barts & London Queen Marys Sch Med & Dent, Ctr Tumour Biol, Charterhouse Sq, London EC1M 6BQ, England.
   [Lin, Wey-Ran] Chang Gung Univ, Dept Med, Linkou Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Taoyuan, Taiwan.
C3 University of London; Queen Mary University London; Chang Gung Memorial
   Hospital; Chang Gung University
RP Alison, MR (corresponding author), Barts & London Queen Marys Sch Med & Dent, Ctr Tumour Biol, Charterhouse Sq, London EC1M 6BQ, England.
EM m.alison@qmul.ac.uk
RI Alison, Malcolm/H-6961-2019
CR Alison M, 1998, PHILOS T R SOC B, V353, P877, DOI 10.1098/rstb.1998.0252
   Alison MR, 2009, J PATHOL, V217, P282, DOI 10.1002/path.2453
   ANTI M, 1994, CANCER, V73, P281, DOI 10.1002/1097-0142(19940115)73:2<281::AID-CNCR2820730208>3.0.CO;2-6
   Attallah AM, 1999, CANCER LETT, V142, P65, DOI 10.1016/S0304-3835(99)00165-2
   Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015
   Brunt EM, 2015, HEPAT ONCOL, V2, P255, DOI [10.2217/hep.15.8, 10.2217/HEP.15.8]
   Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791
   Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026
   Forbes SJ, 2015, J HEPATOL, V62, pS157, DOI 10.1016/j.jhep.2015.02.040
   Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722
   Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035
   Grompe M, 2014, CELL STEM CELL, V15, P257, DOI 10.1016/j.stem.2014.08.004
   Haas JE, 2001, CANCER-AM CANCER SOC, V92, P3130, DOI 10.1002/1097-0142(20011215)92:12<3130::AID-CNCR10115>3.0.CO;2-#
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   Kuwahara R, 2008, HEPATOLOGY, V47, P1994, DOI 10.1002/hep.22218
   Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547
   Lin WR, 2010, HEPATOLOGY, V51, P1017, DOI 10.1002/hep.23483
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261
   NG IOL, 1994, AM J CLIN PATHOL, V102, P80, DOI 10.1093/ajcp/102.1.80
   Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003
   SCHWARZE PE, 1984, CARCINOGENESIS, V5, P1267, DOI 10.1093/carcin/5.10.1267
   Stueck AE, 2015, HEPATOLOGY, V61, P1696, DOI 10.1002/hep.27706
   Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591
   Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408
   Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157
   Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104
   Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863
   Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003
   ZAJICEK G, 1985, LIVER, V5, P293
NR 33
TC 15
Z9 16
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD FEB
PY 2016
VL 238
IS 3
BP 371
EP 374
DI 10.1002/path.4667
PG 4
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA DC1QA
UT WOS:000368990000001
PM 26510495
OA Bronze
DA 2024-02-19
ER

PT J
AU Das, SK
   DesAulniers, J
   Dyck, JRB
   Kassiri, Z
   Oudit, GY
AF Das, Subhash K.
   DesAulniers, Jessica
   Dyck, Jason R. B.
   Kassiri, Zamaneh
   Oudit, Gavin Y.
TI Resveratrol mediates therapeutic hepatic effects in acquired and genetic
   murine models of iron-overload
SO LIVER INTERNATIONAL
LA English
DT Article
DE hepatic fibrosis; inflammation; iron-overload; lipid peroxidation;
   oxidative stress; resveratrol
ID HEREDITARY HEMOCHROMATOSIS; LIVER FIBROSIS; MOUSE MODEL; JUVENILE
   HEMOCHROMATOSIS; OXIDATIVE-METABOLISM; MEDICAL PROGRESS; DISEASE; SIRT1;
   MICE; CARDIOMYOPATHY
AB Background & Aims: Abnormal iron metabolism and hepatic iron-overload is a major cause of liver injury and in the development of chronic liver diseases. Iron-overload-mediated liver disease leads to end-stage cirrhosis and/or hepatocellular carcinoma. Methods: Using a genetic hemochromatosis (hemojuvelin knockout mice) and non-genetic (secondary ironoverload) murine models of hepatic iron-overload, we elucidated the mechanism of hepatic iron injury and the therapeutic effects of resveratrol. Results: Hepatic iron-overload was associated with hepatosplenomegaly, increased oxidative stress, hepatic fibrosis, and inflammation, and a pro-apoptotic state which was markedly corrected by resveratrol therapy. Importantly our aging studies with the hemojuvelin knockout mice showed advanced liver disease in association with steatosis in the absence of a diabetic state which recapitulates the essential pathological features seen in clinical iron-overload. Chronic hepatic iron-overload showed increased nuclear localization of acetylated Forkhead fox-O-1 (FoxO1) transcription factor whereas resveratrol dietary intervention reversed the acetylation of FoxO1 in association with increased SIRT1 levels which together with its pleotropic antioxidant properties are likely key mechanisms of its therapeutic action. Importantly, resveratrol treatment did not affect the degree of hepatic iron-overload but rather direct protects the liver from iron-mediated injury. Conclusions: Our findings illustrate a novel and definitive therapeutic action of resveratrol and represent an economically feasible therapeutic intervention to treat hepatic iron-overload and liver disease.
C1 [Das, Subhash K.; DesAulniers, Jessica; Oudit, Gavin Y.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada.
   [Dyck, Jason R. B.] Univ Alberta, Dept Pediat & Pharmacol, Edmonton, AB T6G 2S2, Canada.
   [Kassiri, Zamaneh; Oudit, Gavin Y.] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada.
C3 University of Alberta; University of Alberta; University of Alberta
RP Oudit, GY (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB T6G 2S2, Canada.
EM gavin.oudit@ualberta.ca
OI Dyck, Jason/0000-0002-7045-2884
FU Alberta Innovates-Health Solutions (AI-HS); Heart and Stroke Foundation;
   Alberta Innovates [201200927] Funding Source: researchfish
FX We acknowledge funding support from Alberta Innovates-Health Solutions
   (AI-HS) and the Heart and Stroke Foundation.
CR Abu Rajab M, 2014, HISTOPATHOLOGY, V65, P561, DOI 10.1111/his.12417
   Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534
   Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286
   Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083
   Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607
   ANGELUCCI E, 1995, BRIT J HAEMATOL, V89, P757
   BACON BR, 1990, HEPATOLOGY, V11, P127, DOI 10.1002/hep.1840110122
   BACON BR, 1985, HEPATOLOGY, V5, P789, DOI 10.1002/hep.1840050514
   BACON BR, 1989, HEPATOLOGY, V9, P398, DOI 10.1002/hep.1840090309
   Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200
   Brown KE, 2003, LIVER INT, V23, P232, DOI 10.1034/j.1600-0676.2003.00832.x
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   CARTHEW P, 1991, HEPATOLOGY, V13, P534, DOI 10.1002/hep.1840130322
   Fleming RE, 2001, P NATL ACAD SCI USA, V98, P2707, DOI 10.1073/pnas.051630898
   Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049
   Kawada N, 1998, HEPATOLOGY, V27, P1265, DOI 10.1002/hep.510270512
   Ko C, 2007, LIVER INT, V27, P1394, DOI 10.1111/j.1478-3231.2007.01596.x
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018
   Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006
   Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055
   Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261
   Mori J, 2014, CIRC-HEART FAIL, V7, P327, DOI 10.1161/CIRCHEARTFAILURE.113.000672
   Nagai H, 2002, HEPATOLOGY, V36, P55, DOI 10.1053/jhep.2002.33995
   Niederau C, 1996, GASTROENTEROLOGY, V110, P1107, DOI 10.1053/gast.1996.v110.pm8613000
   NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004
   Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683
   Oudit GY, 2004, CIRCULATION, V109, P1877, DOI 10.1161/01.CIR.0000124229.40424.80
   Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920
   Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274
   Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510
   Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573
   Pietrangelo A, 2004, HEPATOLOGY, V39, P21, DOI 10.1002/hep.20007
   PIETRANGELO A, 1995, J CLIN INVEST, V95, P1824, DOI 10.1172/JCI117861
   Pietrangelo A, 2007, HEPATOLOGY, V46, P1291, DOI 10.1002/hep.21886
   Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123
   Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378
   Sale S, 2004, BRIT J CANCER, V90, P736, DOI 10.1038/sj.bjc.6601568
   Sebastiani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025138
   Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332
   Telfer PT, 2000, BRIT J HAEMATOL, V110, P971, DOI 10.1046/j.1365-2141.2000.02298.x
   Trombini P, 2011, LIVER INT, V31, P994, DOI 10.1111/j.1478-3231.2011.02520.x
   Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18
   Wang W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000249
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521
NR 52
TC 35
Z9 36
U1 1
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD FEB
PY 2016
VL 36
IS 2
BP 246
EP 257
DI 10.1111/liv.12893
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA DE2HY
UT WOS:000370449600013
PM 26077449
DA 2024-02-19
ER

PT J
AU Fontana, L
   Zhao, EP
   Amir, M
   Dong, HQ
   Tanaka, K
   Czaja, MJ
AF Fontana, Luis
   Zhao, Enpeng
   Amir, Muhammad
   Dong, Hanqing
   Tanaka, Kathryn
   Czaja, Mark J.
TI Aging promotes the development of diet-induced murine steatohepatitis
   but not steatosis
SO HEPATOLOGY
LA English
DT Article
ID FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE;
   METABOLIC SYNDROME; HEPATIC STEATOSIS; LIPID-METABOLISM; RISK-FACTORS;
   PREVALENCE; AUTOPHAGY; MICE
AB The prevalence of the metabolic syndrome and nonalcoholic fatty liver disease (NAFLD) in humans increases with age. It is unknown whether this association is secondary to the increased incidence of risk factors for NAFLD that occurs with aging, reflects the culmination of years of exposure to lifestyle factors such as a high-fat diet (HFD), or results from physiological changes that characterize aging. To examine this question, the development of NAFLD in response to a fixed period of HFD feeding was examined in mice of different ages. Mice aged 2, 8, and 18 months were fed 16 weeks of a low-fat diet or HFD. Increased body mass and insulin insensitivity occurred in response to HFD feeding irrespective of the age of the mice. The amount of HFD-induced hepatic steatosis as determined biochemically and histologically was also equivalent among the three ages. Liver injury occurred exclusively in the two older ages as reflected by increased serum alanine aminotransferase levels, positive terminal deoxynucleotide transferasemediated deoxyuridine triphosphate nick end-labeling, and caspase activation. Older mice also had an elevated innate immune response with a more pronounced polarization of liver and adipose tissue macrophages into an M1 phenotype. Studies of cultured hepatocytes from young and old mice revealed that aged cells were selectively sensitized to the Fas death pathway. Conclusion: Aging does not promote the development of hepatic steatosis but leads to increased hepatocellular injury and inflammation that may be due in part to sensitization to the Fas death pathway and increased M1 macrophage polarization. (HEPATOLOGY 2013)
C1 [Fontana, Luis; Zhao, Enpeng; Amir, Muhammad; Dong, Hanqing; Czaja, Mark J.] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Med, Diabet Res Ctr, Bronx, NY 10461 USA.
   [Fontana, Luis; Zhao, Enpeng; Amir, Muhammad; Dong, Hanqing; Czaja, Mark J.] Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA.
   [Fontana, Luis] Univ Granada, Dept Biochem & Mol Biol 2, Sch Pharm, Ctr Biomed Res, Granada, Spain.
   [Fontana, Luis] Univ Granada, Ctr Biomed Res, Inst Nutr & Food Technol, Granada, Spain.
   [Tanaka, Kathryn] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; University of Granada;
   University of Granada; Yeshiva University; Albert Einstein College of
   Medicine
RP Czaja, MJ (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
EM mark.czaja@einstein.yu.edu
RI Fontana, Luis/K-5528-2015
OI Fontana, Luis/0000-0001-8395-8393
FU National Institutes of Health [DK061498, AG031782, DK041296, DK020541];
   Spanish Ministry of Education [PR2010-0002]
FX Supported in part by National Institutes of Health Grants DK061498 and
   AG031782 (to M.J.C.), National Institutes of Health Grants DK041296 and
   DK020541, and Spanish Ministry of Education (Estancias de Movilidad de
   Profesores e Investigadores Seniores en Centros Extranjeros de Ensenanza
   Superior e Investigacion) Grant PR2010-0002 (to L.F.).
CR Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
   Amarapurkar D, 2007, ANN HEPATOL, V6, P161, DOI 10.1016/S1665-2681(19)31922-2
   Amir M, 2011, EXPERT REV GASTROENT, V5, P159, DOI [10.1586/EGH.11.4, 10.1586/egh.11.4]
   Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019
   Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205
   Chalasani N, 2004, AM J GASTROENTEROL, V99, P1497, DOI 10.1111/j.1572-0241.2004.30159.x
   Chen CH, 2007, J GASTROEN HEPATOL, V22, P1482, DOI 10.1111/j.1440-1746.2006.04615.x
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009
   DAMBRA R, 1990, ENDOCRINOLOGY, V126, P2815, DOI 10.1210/endo-126-6-2815
   Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498
   Kichian K, 2003, CAN J GASTROENTEROL, V17, P38, DOI 10.1155/2003/268528
   Lee JY, 2007, J HEPATOL, V47, P239, DOI 10.1016/j.jhep.2007.02.007
   Li ZP, 2003, HEPATOLOGY, V37, P343, DOI 10.1053/jhep.2003.50048
   Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399
   Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980
   Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Siebler J, 2007, DIGEST DIS SCI, V52, P2396, DOI 10.1007/s10620-006-9148-7
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001
   Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132
   Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x
   Xu J, 1996, AM J PHYSIOL-GASTR L, V270, pG60, DOI 10.1152/ajpgi.1996.270.1.G60
   Xu Y, 1998, GASTROENTEROLOGY, V115, P1229, DOI 10.1016/S0016-5085(98)70095-2
   Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058
NR 36
TC 87
Z9 93
U1 0
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD MAR
PY 2013
VL 57
IS 3
BP 995
EP 1004
DI 10.1002/hep.26099
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 099TG
UT WOS:000315644200020
PM 23081825
OA Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Klein, AD
   de la Vega, JG
   Zanlungo, S
AF Klein, Andres D.
   Gonzalez de la Vega, Javier
   Zanlungo, Silvana
TI Complement Component C3 Participates in Early Stages of Niemann-Pick C
   Mouse Liver Damage
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Niemann-Pick type C disease; complement cascade; liver damage; lysosomal
   storage diseases; foam cells; cholesterol
ID DISEASE TYPE-C; ANAPHYLATOXIN C5A; FATTY LIVER; ACTIVATION; SYSTEM;
   INFLAMMATION; ACCUMULATION; PROGRESSION; ECULIZUMAB; DEFICIENCY
AB Niemann-Pick type C (NPC), a lysosomal storage disorder, is mainly caused by mutations in the NPC1 gene. Niemann-Pick type C patients and mice show intracellular cholesterol accumulation leading to hepatic failure with increased inflammatory response. The complement cascade, which belongs to the innate immunity response, recognizes danger signals from injured tissues. We aimed to determine whether there is activation of the complement system in the liver of the NPC mouse and to assess the relationship between C3 activation, a final component of the pathway, and NPC liver pathology. Niemann-Pick type C mice showed high levels of C3 staining in the liver which unexpectedly decreased with aging. Using an inducible NPC1 hepatocyte rescue mouse model, we restored NPC1 expression for a short time in young mice. We found C3 positive cells only in non-rescued cells, suggesting that C3 activation in NPC cells is reversible. Then, we studied the effect of C3 ablation on NPC liver damage at two postnatal time points, P56 and P72. Deletion of C3 reduced the presence of hepatic CD68-positive cells at postnatal day 56 and prevented the increase of transaminase levels in the blood of NPC mice. These positive effects were abrogated at P72, indicating that the complement cascade participates only during the early stages of liver damage in NPC mice, and that its inhibition may serve as a new potential therapeutic strategy for the disease.
C1 [Klein, Andres D.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Genet & Genom, Santiago 7590943, Chile.
   [Gonzalez de la Vega, Javier; Zanlungo, Silvana] Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago 8331150, Chile.
C3 Universidad del Desarrollo; Pontificia Universidad Catolica de Chile
RP Klein, AD (corresponding author), Clin Alemana Univ Desarrollo, Fac Med, Ctr Genet & Genom, Santiago 7590943, Chile.; Zanlungo, S (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Dept Gastroenterol, Santiago 8331150, Chile.
EM andresklein@udd.cl; jigonzalezdelavega@uc.cl; szanlungo@uc.cl
OI Zanlungo, Silvana/0000-0001-8383-9829; KLEIN, ANDRES/0000-0002-9951-2174
FU Fondecyt [1180337, 1190334]; European Union's Horizon 2020 Research and
   Innovation Programme (RISE) under the Marie Sklodowska-Curie grant
   [734825]; Marie Curie Actions (MSCA) [734825] Funding Source: Marie
   Curie Actions (MSCA)
FX This work was funded by Fondecyt (grant 1180337 to A.D.K. and 1190334 to
   S.Z.) and by the European Union's Horizon 2020 Research and Innovation
   Programme (RISE) under the Marie Sklodowska-Curie grant agreement No
   734825.
CR Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002
   Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5
   Beltroy EP, 2007, J LIPID RES, V48, P869, DOI 10.1194/jlr.M600488-JLR200
   Brink TC, 2009, BIOGERONTOLOGY, V10, P721, DOI 10.1007/s10522-009-9219-1
   Cai CC, 2010, AM J PHYSIOL-REG I, V299, pR1175, DOI 10.1152/ajpregu.00282.2010
   Calderón JF, 2018, MOL GENET METAB REP, V15, P135, DOI 10.1016/j.ymgmr.2018.05.001
   Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4
   Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228
   da Costa MG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02664
   Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951
   Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011
   Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648
   KELLY DA, 1993, J PEDIATR-US, V123, P242, DOI 10.1016/S0022-3476(05)81695-6
   Klein AD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113599
   Klein AD, 2014, PEDIATR ENDOCR REV P, V12, P166
   Klein AD, 2013, PEDIATR ENDOCR REV P, V11, P59
   Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106
   Lopez ME, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-216
   Lopez ME, 2012, HUM MOL GENET, V21, P2946, DOI 10.1093/hmg/dds126
   Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011
   Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262
   Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298
   Ory DS, 2017, LANCET, V390, P1758, DOI 10.1016/S0140-6736(17)31465-4
   Pandey MK, 2017, NATURE, V543, P108, DOI 10.1038/nature21368
   Parra J, 2011, BIOCHEM BIOPH RES CO, V413, P400, DOI 10.1016/j.bbrc.2011.08.096
   Platt FM, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0025-4
   Pritchard MT, 2007, GASTROENTEROLOGY, V132, P1117, DOI 10.1053/j.gastro.2007.01.053
   Qin XB, 2006, CELL MOL IMMUNOL, V3, P333
   Rensen SS, 2009, HEPATOLOGY, V50, P1809, DOI 10.1002/hep.23228
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Rimkunas VM, 2009, J LIPID RES, V50, P327, DOI 10.1194/jlr.M800415-JLR200
   Schieferdecker HL, 2001, INT IMMUNOPHARMACOL, V1, P469, DOI 10.1016/S1567-5769(00)00038-2
   Schieferdecker HL, 2000, J IMMUNOL, V164, P5453, DOI 10.4049/jimmunol.164.10.5453
   Schlaf G, 2004, EUR J IMMUNOL, V34, P3257, DOI 10.1002/eji.200324806
   Stapp JM, 2005, CYTOKINE, V30, P78, DOI 10.1016/j.cyto.2004.12.007
   Suzuki M, 2007, J NEUROSCI, V27, P1879, DOI 10.1523/JNEUROSCI.5282-06.2007
   Vincent M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012941
   Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101
   Wehling C, 2017, CLIN EXP IMMUNOL, V187, P304, DOI 10.1111/cei.12890
   Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969
   Yerushalmi B, 2002, J PEDIATR GASTR NUTR, V35, P44, DOI 10.1097/00005176-200207000-00011
NR 42
TC 9
Z9 9
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2020
VL 21
IS 6
AR 2127
DI 10.3390/ijms21062127
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA LJ0UU
UT WOS:000529890200223
PM 32244854
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Kim, KS
   Kim, MS
   Seu, YB
   Chung, HY
   Kim, JH
   Kim, JR
AF Kim, Kwang Seok
   Kim, Min-Sun
   Seu, Young Bae
   Chung, Hae Young
   Kim, Jung Hye
   Kim, Jae-Ryong
TI Regulation of replicative senescence by insulin-like growth
   factor-binding protein 3 in human umbilical vein endothelial cells
SO AGING CELL
LA English
DT Article
DE calorie restriction; FOXO3a; HUVEC; IGFBP3; senescence
ID FORKHEAD TRANSCRIPTION FACTOR; CDNA MICROARRAY TECHNOLOGY; HUMAN DERMAL
   FIBROBLASTS; CELLULAR SENESCENCE; LIFE-SPAN; IN-VITRO; TUMOR
   SUPPRESSION; IGF-I; P53; APOPTOSIS
AB Insulin/insulin-like growth factor (IGF) signaling pathways are among the most conserved processes in aging in organisms ranging from yeast to mammals. Previously, using cDNA microarray technology, we reported that expression of IGF-binding protein 3 (IGFBP3), one of the IGF-binding proteins, was increased with age in human dermal fibroblasts. In this study, the role of IGFBP3 on cellular senescence was studied in human umbilical vein endothelial cells (HUVEC). The expression levels of IGFBP3 mRNA and protein were increased in HUVECs with age. Knockdown of IGFBP3 in old cells with IGFBP3 short hairpin RNA (shRNA) retrovirus resulted in the partial reduction of a variety of senescent phenotypes, such as changes in cell morphology, and decreases in population doubling times and senescence-associated beta-galactosidase (SA-beta-gal) staining. Down-regulation of IGFBP3 rescued the growth arrest induced by p53 overexpression in young HUVECs. In contrast, up-regulation of IGFBP3 in young cells and prolonged IGFBP3 treatment accelerated cellular senescence, confirmed by cell proliferation and SA-beta-gal staining. The FOXO3a (forkhead box O3a) protein level was increased in old IGFBP3 shRNA cells. The treatment of young HUVECs with IGFBP3 repressed the levels of FOXO3a protein. Furthermore, calorie restriction reduced IGFBP3 protein levels, which were found to be increased with age in the rat liver and serum. These results suggest that IGFBP3 might play an important role in the cellular senescence of HUVECs as well as in vivo aging.
C1 Yeungnam Univ, Coll Med, Aging Associated Vasc Dis Res Ctr, Dept Biochem & Mol Biol, Taegu 705717, South Korea.
   Kyungpook Natl Univ, Coll Nat Sci, Dept Microbiol, Taegu 702701, South Korea.
   Pusan Natl Univ, Coll Pharm, Dept Pharm, Pusan 609735, South Korea.
C3 Yeungnam University; Kyungpook National University; Pusan National
   University
RP Kim, JR (corresponding author), Yeungnam Univ, Coll Med, Aging Associated Vasc Dis Res Ctr, Dept Biochem & Mol Biol, 317-1 Daemyung-Dong, Taegu 705717, South Korea.
EM kimjr@med.yu.ac.kr
CR Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0
   Baege AC, 2004, J VIROL, V78, P5720, DOI 10.1128/JVI.78.11.5720-5727.2004
   Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Browner WS, 2004, AM J MED, V117, P851, DOI 10.1016/j.amjmed.2004.06.033
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0
   Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Chakravarthy MV, 2000, J BIOL CHEM, V275, P35942, DOI 10.1074/jbc.M005832200
   Clemmons David R., 1997, Cytokine and Growth Factor Reviews, V8, P45, DOI 10.1016/S1359-6101(96)00053-6
   Cristofalo VJ, 2004, MECH AGEING DEV, V125, P827, DOI 10.1016/j.mad.2004.07.010
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200
   Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002
   Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033
   Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/er.17.5.481
   Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169
   GARFINKEL S, 1994, P NATL ACAD SCI USA, V91, P1559, DOI 10.1073/pnas.91.4.1559
   GOLDSTEIN S, 1991, P NATL ACAD SCI USA, V88, P9680, DOI 10.1073/pnas.88.21.9680
   GRIGORIEV VG, 1995, EXP CELL RES, V219, P315, DOI 10.1006/excr.1995.1234
   Grimberg A, 2005, J CLIN ENDOCR METAB, V90, P3568, DOI 10.1210/jc.2004-1213
   Hampel B, 2005, AGING CELL, V4, P325, DOI 10.1111/j.1474-9726.2005.00180.x
   Hampel B, 2004, EXP GERONTOL, V39, P1713, DOI 10.1016/j.exger.2004.05.010
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hekimi S, 1998, TRENDS GENET, V14, P14, DOI 10.1016/S0168-9525(97)01299-7
   Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298
   Hong J, 2002, J BIOL CHEM, V277, P10489, DOI 10.1074/jbc.M109604200
   Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100
   Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x
   Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x
   Katic M, 2005, CELL MOL LIFE SCI, V62, P320, DOI 10.1007/s00018-004-4297-y
   Kelley KM, 1996, INT J BIOCHEM CELL B, V28, P619, DOI 10.1016/1357-2725(96)00005-2
   Kim HK, 2005, J GERONTOL A-BIOL, V60, P4, DOI 10.1093/gerona/60.1.4
   Kim JR, 2003, EXP MOL MED, V35, P403, DOI 10.1038/emm.2003.53
   Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383
   Li WL, 1997, ENDOCRINOLOGY, V138, P1763, DOI 10.1210/en.138.4.1763
   Liu BR, 2000, J BIOL CHEM, V275, P33607, DOI 10.1074/jbc.M002547200
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Lu XF, 2005, J BIOL CHEM, V280, P22606, DOI 10.1074/jbc.M412073200
   Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045
   PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392
   Rajah R, 1997, J BIOL CHEM, V272, P12181, DOI 10.1074/jbc.272.18.12181
   Rosenzweig SA, 2004, GROWTH HORM IGF RES, V14, P329, DOI 10.1016/j.ghir.2004.02.003
   Schedlich LJ, 2000, J BIOL CHEM, V275, P23462, DOI 10.1074/jbc.M002208200
   Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200
   Smith JR, 1996, SCIENCE, V273, P63, DOI 10.1126/science.273.5271.63
   Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796
   Wagner M, 2001, EXP GERONTOL, V36, P1327, DOI 10.1016/S0531-5565(01)00105-X
   Wahl GM, 2001, NAT CELL BIOL, V3, pE277, DOI 10.1038/ncb1201-e277
   Yoon IK, 2004, EXP GERONTOL, V39, P1369, DOI 10.1016/j.exger.2004.07.002
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 53
TC 63
Z9 70
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD AUG
PY 2007
VL 6
IS 4
BP 535
EP 545
DI 10.1111/j.1474-9726.2007.00315.x
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 190VF
UT WOS:000248088000014
PM 17635417
OA hybrid
DA 2024-02-19
ER

PT J
AU Wang, L
   Li, S
   Wang, HY
   Zeng, J
   Zhang, ZZ
   Lv, DY
   Kuang, WH
AF Wang, Lu
   Li, Shu
   Wang, Han-Yu
   Zeng, Juan
   Zhang, Zheng-Zheng
   Lv, Dong-Yong
   Kuang, Wei-Hong
TI In a Rat Model of Acute Liver Failure, Icaritin Improved the Therapeutic
   Effect of Mesenchymal Stem Cells by Activation of the Hepatocyte Growth
   Factor/c-Met Pathway
SO EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE
LA English
DT Article
ID DELAYS SENESCENCE; STROMAL CELLS; SELF-RENEWAL; APOPTOSIS; HGF;
   REGENERATION; DIFFERENTIATION; PROLIFERATION
AB Acute liver failure (ALF) is a serious life-threatening condition. Mesenchymal stem cells (MSCs) may be an effective treatment for this condition and a good alternative to liver transplantation. Icaritin (ICT) is an active ingredient of the genus Epimedium, a traditional Chinese medicine, with the potential to enhance the proliferation of MSCs. The purpose of this study was to explore whether ICT increased the therapeutic effects of MSCs and explore its underlying mechanisms. For in vivo experiments, a rat ALF model was established by intraperitoneal injection of D(+)-galactosamine/lipopolysaccharide. MSCs cocultured with ICT were used to treat ALF rats and the protective effects assessed as survival rate, levels of serum AST and ALT, and histological changes in liver tissue. For in vitro experiments, MSCs were treated in serum-free culture for 72 h to simulate the disruption of intrahepatic microcirculation. MSCs apoptosis was examined to determine whether ICT rescued impaired MSCs. The role of the hepatocyte growth factor (HGF)/c-Met pathway in MSCs was assessed by constructing genetically modified MSCs overexpressing c-Met and by using the c-Met receptor inhibitor (crizotinib). The results showed that MSCs increased the survival rate of ALF rats and reduced liver damage. MSCs cocultured with ICT exerted a greater therapeutic effect than MSCs alone. Further, the HGF/c-Met pathway played a key role in the antiapoptotic activity of MSCs, which was associated with the optimized efficacy of ICT. In conclusion, this study demonstrated that ICT enhances the therapeutic effect of MSCs in a model of ALF, improving the antiapoptotic potential of MSCs by upregulation of the HGF/c-Met pathway. The combination of stem cell therapy with traditional herbal extracts may improve MSC-based clinical applications.
C1 [Wang, Lu; Li, Shu; Wang, Han-Yu; Zeng, Juan; Zhang, Zheng-Zheng; Kuang, Wei-Hong] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510405, Guangdong, Peoples R China.
   [Wang, Lu; Li, Shu; Wang, Han-Yu; Zeng, Juan; Lv, Dong-Yong] Guangzhou Univ Chinese Med, Guangzhou 510405, Guangdong, Peoples R China.
   [Wang, Lu; Zeng, Juan] Guangzhou Univ Chinese Med, Res Ctr Basic Integrat Med, Guangzhou 510006, Guangdong, Peoples R China.
   [Li, Shu; Wang, Han-Yu] Guangzhou Univ Chinese Med, Lingnan Med Res Ctr, Guangzhou 510405, Guangdong, Peoples R China.
C3 Guangzhou University of Chinese Medicine; Guangzhou University of
   Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou
   University of Chinese Medicine
RP Zhang, ZZ; Kuang, WH (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510405, Guangdong, Peoples R China.; Lv, DY (corresponding author), Guangzhou Univ Chinese Med, Guangzhou 510405, Guangdong, Peoples R China.
EM mousezzz48@126.com; lvdongyong2006@gzucm.edu.cn; kwh@gzucm.edu.cn
OI Zhang, Zheng-Zheng/0000-0002-8999-1570; wang, lu/0000-0001-8579-0387
FU High Level University Construction Project of Guangzhou University of
   Chinese Medicine [A1-AFD018161Z1508, A1-AFD018171Z11035,
   A1-AFD018171Z0721]
FX The authors would like to thank Professor Dongfeng Chen for his
   extraordinary support and encouragement throughout this project, as well
   as Dr. Zhenxing Ren for expert advice and guidance in the process. This
   study was supported by a grant from the High Level University
   Construction Project of Guangzhou University of Chinese Medicine [grant
   numbers: A1-AFD018161Z1508, A1-AFD018171Z11035, and A1-AFD018171Z0721].
CR Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912
   Bradshaw A, 2018, CURR PATHOBIOL REP, V6, P109, DOI 10.1007/s40139-018-0167-9
   Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886
   Chen MW, 2009, J ETHNOPHARMACOL, V125, P75, DOI 10.1016/j.jep.2009.06.013
   Choi JH, 2012, CELL PROLIFERAT, V45, P420, DOI 10.1111/j.1365-2184.2012.00839.x
   Deng LS, 2014, SCI WORLD J, DOI 10.1155/2014/103643
   El-Ansary M, 2012, STEM CELL REV REP, V8, P972, DOI 10.1007/s12015-011-9322-y
   Fang Ling, 2018, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V26, P1531, DOI 10.7534/j.issn.1009-2137.2018.05.045
   Friedman R, 2007, BIOL BLOOD MARROW TR, V13, P1477, DOI 10.1016/j.bbmt.2007.08.048
   Gershon H., 2002, BIOCHEMISTRY-US, V32, P7143
   Go MJ, 2008, EXP CELL RES, V314, P1147, DOI 10.1016/j.yexcr.2007.11.021
   Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101
   Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003
   Li CF, 2016, ONCOL LETT, V12, P3537, DOI 10.3892/ol.2016.5089
   Li F, 2015, CELL BIOL INT, V39, P1131, DOI 10.1002/cbin.10486
   Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395
   Liang HX, 2018, ACS NANO, V12, P6536, DOI 10.1021/acsnano.8b00553
   Lim RZL, 2018, BBA-GEN SUBJECTS, V1862, P1680, DOI 10.1016/j.bbagen.2018.04.016
   Lin BL, 2017, HEPATOLOGY, V66, P209, DOI 10.1002/hep.29189
   Liu JP, 2014, INT J MED SCI, V11, P626, DOI 10.7150/ijms.8228
   Liu T, 2015, ANDROLOGIA, V47, P1020, DOI 10.1111/and.12372
   Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335
   Ma HC, 2014, WORLD J GASTROENTERO, V20, P14884, DOI 10.3748/wjg.v20.i40.14884
   Nakamura T, 2010, P JPN ACAD B-PHYS, V86, P588, DOI 10.2183/pjab.86.588
   Sanap A, 2017, BIOMED PHARMACOTHER, V93, P772, DOI 10.1016/j.biopha.2017.06.107
   Seo KW, 2009, BIOCHEM BIOPH RES CO, V384, P120, DOI 10.1016/j.bbrc.2009.04.094
   Shi M, 2012, STEM CELL TRANSL MED, V1, P725, DOI 10.5966/sctm.2012-0034
   Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230
   Sun L, 2015, MOL MED REP, V11, P3094, DOI 10.3892/mmr.2014.3007
   Sun L, 2013, MOL MED REP, V8, P1883, DOI 10.3892/mmr.2013.1742
   Suzuki H, 2009, LIVER INT, V29, P1562, DOI 10.1111/j.1478-3231.2009.02102.x
   Tsang WP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40894
   Udalamaththa VL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0366-4
   van Poll D, 2008, HEPATOLOGY, V47, P1634, DOI 10.1002/hep.22236
   Volarevic V, 2014, STEM CELLS, V32, P2818, DOI 10.1002/stem.1818
   Wang HY, 2014, CYTOTHERAPY, V16, P309, DOI 10.1016/j.jcyt.2013.07.011
   Wang HY, 2012, CYTOTHERAPY, V14, P423, DOI 10.3109/14653249.2011.652735
   Wang J, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0576-4
   Warrier SR, 2013, CELL PROLIFERAT, V46, P283, DOI 10.1111/cpr.12026
   Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898
   Xiao Jiang-Qiang, 2013, Zhonghua Gan Zang Bing Za Zhi, V21, P308, DOI 10.3760/cma.j.issn.1007-3418.2013.04.016
   Xu LJ, 2017, ACS APPL MATER INTER, V9, P14716, DOI 10.1021/acsami.7b02805
   XU Z, 2017, TRADITIONAL CHINESE, V28, P159, DOI DOI 10.1016/J.CCLET.2016.07.032
   Xue HL, 2015, TRANSPL P, V47, P412, DOI 10.1016/j.transproceed.2014.10.048
   Yo Y, 1998, KIDNEY INT, V54, P1128, DOI 10.1046/j.1523-1755.1998.00092.x
   Yuan SF, 2014, EXP THER MED, V8, P1150, DOI 10.3892/etm.2014.1848
   Zomerman WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141381
NR 47
TC 10
Z9 11
U1 0
U2 6
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1741-427X
EI 1741-4288
J9 EVID-BASED COMPL ALT
JI Evid.-based Complement Altern. Med.
PD NOV 7
PY 2019
VL 2019
AR 4253846
DI 10.1155/2019/4253846
PG 13
WC Integrative & Complementary Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine
GA JV3PH
UT WOS:000502277700001
PM 31915446
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Aoi, T
   Tanaka, A
   Furuhashi, K
   Ikeya, M
   Shimizu, A
   Arioka, Y
   Kushima, I
   Ozaki, N
   Maruyama, S
AF Aoi, Tomonori
   Tanaka, Akihito
   Furuhashi, Kazuhiro
   Ikeya, Makoto
   Shimizu, Asuka
   Arioka, Yuko
   Kushima, Itaru
   Ozaki, Norio
   Maruyama, Shoichi
TI Mesenchymal stem/stromal cells generated from induced pluripotent stem
   cells are highly resistant to senescence
SO NAGOYA JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE induced pluripotent stem cell-derived mesenchymal stem/stromal cells;
   mesenchymal stem/ stromal cells; induced pluripotent stem cells;
   cellular senescence; fluorescein di-b-D-galactopyranoside
ID STROMAL CELLS; ADIPOSE-TISSUE; SYNOVIUM; MARROW
AB The use of mesenchymal stem/stromal cells (MSCs) has attracted attention in the field of regenerative medicine based on their anti-inflammatory and tissue repair-promoting effects. Bone marrow is widely used as a source of MSCs; however, the performance of bone marrow (BM)-MSCs deteriorates as the cells age along with cell passaging. Recently, it has been reported that MSCs can be generated from induced pluripotent stem cells (iPSCs), which is expected to represent a new source of MSCs. However, few studies have investigated aging in iPSC-derived MSCs (iMSCs) and their functions. In this study, we investigated whether iMSCs overcome cellular senescence compared to that in BM-MSCs. Cellular senescence was quantitatively evaluated by staining iMSCs and BM-MSCs with fluorescein di-b-D-galactopyranoside (FDG) and following flow cytometer analysis. The hepatocyte growth factor (HGF) concentration in the culture supernatant was also measured as a factor in the therapeutic efficacy of nephritis. The iMSCs did not reach their proliferation limit and their morphology did not change even after 10 passages. The FDG positivity of BM-MSCs increased with passaging, whereas that in iMSCs did not increase. The HGF concentration increased with passaging in iMSCs. In conclusion, our results suggest that iMSCs may be less susceptible to senescence than BM-MSCs and may be used in clinical applications.
C1 [Aoi, Tomonori; Shimizu, Asuka; Maruyama, Shoichi] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Japan.
   [Tanaka, Akihito; Furuhashi, Kazuhiro] Nagoya Univ Hosp, Dept Nephrol, Nagoya, Japan.
   [Furuhashi, Kazuhiro] Nagoya Univ, Inst Adv Res, Nagoya, Japan.
   [Ikeya, Makoto] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Clin Applicat, Kyoto, Japan.
   [Arioka, Yuko; Kushima, Itaru; Ozaki, Norio] Nagoya Univ, Dept Psychiat, Grad Sch Med, Nagoya, Japan.
   [Tanaka, Akihito; Furuhashi, Kazuhiro] Nagoya Univ Hosp, Dept Nephrol, 65 Tsurumai Cho,Showa Ku, Nagoya 4668560, Japan.
C3 Nagoya University; Nagoya University; Nagoya University; Kyoto
   University; Nagoya University; Nagoya University
RP Tanaka, A; Furuhashi, K (corresponding author), Nagoya Univ Hosp, Dept Nephrol, 65 Tsurumai Cho,Showa Ku, Nagoya 4668560, Japan.
EM tanaka17@med.nagoya-u.ac.jp; furu13@med.nagoya-u.ac.jp
CR Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816
   Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Frobel J, 2014, STEM CELL REP, V3, P414, DOI 10.1016/j.stemcr.2014.07.003
   Furuhashi K, 2013, J AM SOC NEPHROL, V24, P587, DOI 10.1681/ASN.2012030264
   Iwashima S, 2009, STEM CELLS DEV, V18, P533, DOI 10.1089/scd.2008.0358
   Kamiya D, 2022, NPJ REGEN MED, V7, DOI 10.1038/s41536-022-00241-8
   Katsuno T, 2013, CELL TRANSPLANT, V22, P287, DOI 10.3727/096368912X655019
   Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033225
   Mushahary D, 2018, CYTOM PART A, V93A, P19, DOI 10.1002/cyto.a.23242
   Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212
   Shimamura Y, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03712-2
   Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084
   Yang NC, 2004, ANAL BIOCHEM, V325, P337, DOI 10.1016/j.ab.2003.11.012
   Yang YHK, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0876-3
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
NR 17
TC 0
Z9 0
U1 0
U2 0
PU NAGOYA UNIV, SCH MED
PI NAGOYA
PA EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU,
   NAGOYA, 466-8550, JAPAN
SN 2186-3326
EI 0027-7622
J9 NAGOYA J MED SCI
JI Nagoya J. Med. Sci.
PD NOV
PY 2023
VL 85
IS 4
BP 682
EP 690
DI 10.18999/nagjms.85.4.682
PG 9
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA Z3UQ7
UT WOS:001111364000003
PM 38155616
DA 2024-02-19
ER

PT J
AU Iwama, M
   Amano, A
   Shimokado, K
   Maruyama, N
   Ishigami, A
AF Iwama, Mizuki
   Amano, Akiko
   Shimokado, Kentaro
   Maruyama, Naoki
   Ishigami, Akihito
TI Ascorbic Acid Levels in Various Tissues, Plasma and Urine of Mice during
   Aging
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE aging; ascorbic acid; vitamin C; urine; mouse
ID SENESCENCE MARKER PROTEIN-30; VITAMIN-C; RAT HEPATOCYTES; AGE;
   BIOSYNTHESIS; TRANSPORT; DECLINE; CELLS; SVCT2; RISK
AB Here we quantified ascorbic acid (AA) levels in 14 tissues, plasma and urine of C57BL/6 male mice to track its turnover during 3 to 30 mo of aging. The AA content of adrenal glands and testes decreased somewhat with age, and eventually rose, but increased in the spleen, lungs, eyes and heart. AA levels rose in the liver, skin and skeletal muscles from 6 to 12 mo of age, but declined from 12 to 24 mo. In the cerebellum, cerebrum, small intestine, kidney and plasma, amounts of AA remained almost constant as the animals aged. Most notably, urinary AA decreased markedly until becoming almost undetectable at 24 and 30 mo of age. Collectively, these results, which compare changes in AA levels in specific physiologic targets throughout the aging process, strongly suggest that the AA synthesizing capacity declines over time to become a major factor in senescence-related diseases.
C1 [Iwama, Mizuki; Amano, Akiko; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo 1730015, Japan.
   [Iwama, Mizuki; Shimokado, Kentaro] Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Tokyo 1138510, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Medical & Dental
   University (TMDU)
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
EM ishigami@tmig.or.jp
OI Ishigami, Akihito/0000-0001-7875-7482; Amano, Akiko/0000-0003-4324-2758
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
FX This study is supported by a Grant-in-Aid for Scientific Research from
   the Ministry of Education, Culture, Sports, Science and Technology of
   Japan (to A.I. and N.M.). We thank Ms. P. Minick for the excellent
   English editorial assistance.
CR Aguirre R, 2008, PHARMACOL THERAPEUT, V119, P96, DOI 10.1016/j.pharmthera.2008.05.002
   Best KA, 2005, MOL CELL BIOCHEM, V271, P43, DOI 10.1007/s11010-005-3442-0
   Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493
   Harrison FE, 2009, FREE RADICAL BIO MED, V46, P719, DOI 10.1016/j.freeradbiomed.2008.12.018
   Hornig B, 1998, CIRCULATION, V97, P363
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Liang WJ, 2001, MOL MEMBR BIOL, V18, P87, DOI 10.1080/09687680120706
   Lykkesfeldt J, 1998, FASEB J, V12, P1183, DOI 10.1096/fasebj.12.12.1183
   Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   Masaki KH, 2000, NEUROLOGY, V54, P1265, DOI 10.1212/WNL.54.6.1265
   Massip L, 2010, FASEB J, V24, P158, DOI 10.1096/fj.09-137133
   Michels AJ, 2003, ARCH BIOCHEM BIOPHYS, V410, P112, DOI 10.1016/S0003-9861(02)00678-1
   Parker CR, 1997, J CLIN ENDOCR METAB, V82, P3898, DOI 10.1210/jc.82.11.3898
   Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7
   SASAKI R, 1983, TOHOKU J EXP MED, V140, P97, DOI 10.1620/tjem.140.97
   Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364
   Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Tokumaru S, 1996, J AGR FOOD CHEM, V44, P2748, DOI 10.1021/jf960184u
   Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986
   Tzaphlidou M, 2004, MICRON, V35, P173, DOI 10.1016/j.micron.2003.11.003
   Yamamoto Y, 2003, ANAT REC PART A, V272A, P538, DOI 10.1002/ar.a.10172
   Yoshida M, 2007, EUR J NUTR, V46, P118, DOI 10.1007/s00394-006-0641-8
NR 26
TC 27
Z9 29
U1 0
U2 6
PU CENTER ACADEMIC PUBL JAPAN
PI TOKYO
PA 2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN
SN 0301-4800
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD JUN
PY 2012
VL 58
IS 3
BP 169
EP 174
DI 10.3177/jnsv.58.169
PG 6
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 968ZK
UT WOS:000306025300003
PM 22878386
OA gold
DA 2024-02-19
ER

PT J
AU Liu, Q
   Song, SL
   Song, L
   Bi, YK
   Zhu, KQ
   Qiao, XL
   Wang, HW
   Gao, C
   Cai, H
   Ji, GJ
AF Liu, Qun
   Song, Shaole
   Song, Lei
   Bi, Youkun
   Zhu, Keqi
   Qiao, Xinlong
   Wang, Huiwen
   Gao, Chao
   Cai, Hong
   Ji, Guangju
TI Mesenchymal stem cells alleviate aging<i> in</i><i> vitro</i> and<i>
   in</i><i> vivo</i>
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Article; Early Access
DE Mesenchymal stem cells (MSCs); IMR-90; cell senescence; aging; bladder
   hyperactivity
ID UMBILICAL-CORD BLOOD; ADIPOSE-TISSUE; BONE-MARROW; AGE; MAINTENANCE;
   SENESCENCE; DISEASE; BLADDER
AB Background: Aging is a natural and multi-factorial phenomenon associated with multiple human pathologies. Mesenchymal stem cells (MSCs) hold great promise in clinical fields of medicine including tissue repair, cardiovascular disease, and brain ischemic injury. The purpose of this study was to explore the roles of MSCs in improving the condition of aging cells, repairing aging tissues and organs, and extending the life span of elderly mice.Methods: This study was carried out both in vitro and in vivo. We used MSCs to intervene with IMR-90 senescent cells induced by D-galactose and aged C57BL/6 mice.Results: After 48 hours of co-culturing the aged cells with MSCs, the up-regulated expression of inflammatory factor, interleukin 6 (IL6), and the down-regulated expression of several growth factors, such as transforming growth factor (TGF beta 1) and growth differentiation factor (GDF11), in D-galactose induced senescent cells were reversed. Moreover, compared with aged cells, the number of mitochondria and the telomere length were increased with MSC treatment. Similarly, in aged mice, the symptoms related to aging were improved after MSC treatment: the mouse hair became shiny and dense, and the symptoms of bladder overactivity were relieved. Hematoxylin and eosin (H&E) and Masson's trichrome staining showed that the histopathological changes in skin, bladder, liver, and lung were apparently improved.Conclusions: Treatment with MSCs effectively improves aging-related phenotypes and plays a beneficial role in improving aging and aging-related diseases.
C1 [Liu, Qun; Song, Shaole; Bi, Youkun; Zhu, Keqi; Wang, Huiwen; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Beijing, Peoples R China.
   [Liu, Qun; Song, Shaole; Song, Lei; Bi, Youkun; Zhu, Keqi; Qiao, Xinlong; Ji, Guangju] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Gao, Chao; Cai, Hong] PLA, Air Force Med Ctr, Dept Dermatol, Beijing, Peoples R China.
   [Ji, Guangju] Chinese Acad Sci, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.
   [Cai, Hong] PLA, Air Force Med Ctr, Dept Dermatol, 30 Fucheng Rd, Beijing 100142, Peoples R China.
C3 Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese
   Academy of Sciences; University of Chinese Academy of Sciences, CAS;
   Chinese Academy of Sciences; Institute of Biophysics, CAS
RP Ji, GJ (corresponding author), Chinese Acad Sci, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.; Cai, H (corresponding author), PLA, Air Force Med Ctr, Dept Dermatol, 30 Fucheng Rd, Beijing 100142, Peoples R China.
EM ch1031@163.com; gj28@ibp.ac.cn
RI Wang, Huiwen/JED-3206-2023
FU National Key Research and Development Project; National Foundation of
   Sciences and Technology;  [2019YFA0110400];  [31971051];  [31771562]
FX Acknowledgments Funding: This work was supported by grants from the
   National Key Research and Development Project (No. 2019YFA0110400 to GJ)
   and the National Foundation of Sciences and Technology (Nos. 31971051,
   31771562 to GJ) .
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816
   Borup MT, 2008, J THEOR BIOL, V250, P66, DOI 10.1016/j.jtbi.2007.09.016
   Camoes J, 2015, UROL INT, V95, P373, DOI 10.1159/000437336
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chung S, 2016, INT J MOL MED, V37, P1170, DOI 10.3892/ijmm.2016.2532
   Daly DM, 2014, J PHYSIOL-LONDON, V592, P537, DOI 10.1113/jphysiol.2013.262634
   De Domenico E, 2017, ONCOTARGET, V8, P57991, DOI 10.18632/oncotarget.19854
   Deng P, 2021, CELL STEM CELL, V28, P1057, DOI 10.1016/j.stem.2021.01.010
   Du WJ, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0418-9
   Evans MA, 2020, ANNU REV PATHOL-MECH, V15, P419, DOI 10.1146/annurev-pathmechdis-012419-032544
   Fibbe WE, 2013, NAT MED, V19, P812, DOI 10.1038/nm.3222
   Franzke B, 2015, MUTAT RES-REV MUTAT, V766, P48, DOI 10.1016/j.mrrev.2015.08.001
   FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267
   Gregorini F, 2015, BJU INT, V115, P18, DOI 10.1111/bju.13066
   Halim M, 2019, DIABETES METAB SYND, V13, P1165, DOI 10.1016/j.dsx.2019.01.040
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Higgins-Chen AT, 2021, SEMIN CELL DEV BIOL, V116, P180, DOI 10.1016/j.semcdb.2021.01.003
   Infante A, 2021, J PERS MED, V11, DOI 10.3390/jpm11101043
   Jeon YJ, 2016, J CELL BIOCHEM, V117, P1112, DOI 10.1002/jcb.25395
   Jia HY, 2018, MOL MED REP, V17, P3439, DOI 10.3892/mmr.2017.8311
   Jin HJ, 2013, INT J MOL SCI, V14, P17986, DOI 10.3390/ijms140917986
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015
   Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027
   Levy O, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba6884
   Li X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43559
   Li Z, 2021, BIOGERONTOLOGY, V22, P165, DOI 10.1007/s10522-021-09910-5
   Lin YS, 2009, DIS MARKERS, V27, P23, DOI [10.3233/DMA-2009-0643, 10.1155/2009/529253]
   Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003
   Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427
   Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3
   Ni K, 2018, AM J RESP CELL MOL, V58, P684, DOI 10.1165/rcmb.2017-0326OC
   Ogrodnik M, 2021, AGING CELL, V20, DOI 10.1111/acel.13338
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Pignolo RJ, 2021, JBMR PLUS, V5, DOI 10.1002/jbm4.10488
   Ren XQ, 2019, CELL REP, V26, P3643, DOI 10.1016/j.celrep.2019.02.088
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Slijepcevic P, 2008, MECH AGEING DEV, V129, P11, DOI 10.1016/j.mad.2007.10.012
   Spees JL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0363-7
   Wagner KH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060338
   Wang HF, 2018, MOL MED REP, V17, P3769, DOI 10.3892/mmr.2017.8326
   Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105
   Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411
   Yin YJ, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12154
   Zarei F, 2019, CURR STEM CELL RES T, V14, P244, DOI 10.2174/1574888X13666181113113415
   Zhang WQ, 2018, CIRC RES, V123, P773, DOI 10.1161/CIRCRESAHA.118.312497
   Zhang YH, 2016, ONCOTARGET, V7, P12063, DOI 10.18632/oncotarget.7642
   Zheng HF, 2021, J NANOBIOTECHNOL, V19, DOI 10.1186/s12951-021-01077-y
   Zimmers TA, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0639-9
NR 51
TC 6
Z9 6
U1 1
U2 11
PU AME PUBLISHING COMPANY
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD 2022 OCT
PY 2022
VL 10
IS 20
DI 10.21037/atm-22-1206
EA JUL 2022
PG 14
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA 6G6OQ
UT WOS:000862710200001
PM 36388801
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhang, KX
   Chen, CS
   Liu, YY
   Chen, H
   Liu, JP
AF Zhang, Kexiong
   Chen, Chengshu
   Liu, Yingying
   Chen, Hao
   Liu, Jun-Ping
TI Cellular senescence occurred widespread to multiple selective sites in
   the fetal tissues and organs of mice
SO CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
LA English
DT Article
DE bone; cell senescence; embryonic development; ossification; placenta;
   skeletal development
ID ONCOGENE-INDUCED SENESCENCE; BETA-GALACTOSIDASE; IN-VIVO;
   MOLECULAR-MECHANISMS; LIVER-CANCER; HUMAN-CELLS; TELOMERASE; APOPTOSIS;
   PROTEIN; RESISTANCE
AB Cellular senescence protects multicellular organisms from tissue overgrowth including cancer, and contributes to tissue ageing. With stable cell cycle arrests, cellular senescence has been mostly studied in the adult tissues of mammals. In the present study, we report widespread cellular senescence within certain time windows of late-phase normal development of mouse embryos. Using in situ senescence-associated beta-galactosidase (SA-beta-gal) staining, we showed SA-beta-gal activity in selected cell populations of the brain, stomach, interdigital webs, tail, ear, limbs and nasal mouth area on gestation day 14.5 of the mouse embryos. On day 18.5 of gestation, selected cells in the intestines and bone developmental areas showed SA-beta-gal activity. The chondrocytes in ossification zones were significantly marked by the activities of SA-beta-gal, p21, p15 and Hp1Y, suggesting activation of the cell cycle checkpoint by the p53 and Rb pathways, and development of senescence-associated heterochromatic foci. Throughout gestation days 14.5-18.5, the trophoblast cells in the labyrinth layer of the placentas also showed strong activities of SA-beta-gal, p53 and p21. Increased expressions of p19, p16 and Rb of the p16/Rb pathway, and reduced expressions of Ki67 were also observed in the placentas. Taken together, the present findings suggest that cellular senescence represents an essential mechanism at multiple sites including the fetal bone forming zones and placenta during mammalian embryonic development, playing potential roles in the full embryonic development of tissue growth and organ formation.
C1 [Zhang, Kexiong; Chen, Chengshu; Liu, Yingying; Chen, Hao; Liu, Jun-Ping] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou 311121, Zhejiang, Peoples R China.
   [Liu, Jun-Ping] Monash Univ, Cent Eastern Clin Sch, Dept Immunol, Melbourne, Vic 3004, Australia.
   [Liu, Jun-Ping] Monash Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia.
C3 Hangzhou Normal University; Monash University; Monash University
RP Zhang, KX (corresponding author), Hangzhou Normal Univ, Sch Med, Inst Aging Res, 1378 Wen Yi West Rd, Hangzhou 311121, Zhejiang, Peoples R China.
EM kxzhang@fudan.edu.cn; jun-ping.liu@monash.edu
RI LIU, YING/GZL-7252-2022; liu, ying/GXF-4294-2022
OI Liu, Jun-Ping/0000-0001-7442-2116; Zhang, Kexiong/0000-0001-9517-8386
FU National Basic Research Program of China [2012CB911204]; National
   Natural Science Foundation of China [81170313, 81272889]; Hangzhou
   Normal University; National Health and Medical Research Council of
   Australia
FX This work was supported by grants from the National Basic Research
   Program of China (2012CB911204), National Natural Science Foundation of
   China (81170313, 81272889), Hangzhou Normal University, and National
   Health and Medical Research Council of Australia.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773
   Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Bayne S, 2008, CELL RES, V18, P1141, DOI 10.1038/cr.2008.291
   Braumüller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824
   Burton DGA, 2014, CELL MOL LIFE SCI, V71, P4373, DOI 10.1007/s00018-014-1691-3
   Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004
   Chen L, 2005, FRONT BIOSCI-LANDMRK, V10, P1961, DOI 10.2741/1671
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dörr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437
   Dong F, 2013, PLACENTA, V34, P1243, DOI 10.1016/j.placenta.2013.09.009
   EDNEY EB, 1968, NATURE, V220, P281, DOI 10.1038/220281a0
   Fitzner B, 2012, J CELL MOL MED, V16, P2620, DOI 10.1111/j.1582-4934.2012.01573.x
   GIBSON GE, 1981, SCIENCE, V213, P674, DOI 10.1126/science.7256270
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011
   Harbo M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3687
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   HOLLIDAY R, 1973, NATURE, V242, P332, DOI 10.1038/242332a0
   HUGHES KA, 1994, NATURE, V367, P64, DOI 10.1038/367064a0
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0
   Kim KM, 2012, INT J MOL MED, V29, P619, DOI 10.3892/ijmm.2012.892
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kurz DJ, 2000, J CELL SCI, V113, P3613
   Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Li H, 2002, BIOGERONTOLOGY, V3, P107, DOI 10.1023/A:1015232102470
   Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815
   Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167
   Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091
   Liu JP, 2014, CLIN EXP PHARMACOL P, V41, P445, DOI 10.1111/1440-1681.12247
   Liu JP, 2010, CLIN EXP PHARMACOL P, V37, P88, DOI 10.1111/j.1440-1681.2009.05251.x
   MUELLER SN, 1980, SCIENCE, V207, P889, DOI 10.1126/science.7355268
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Nelson DM, 1996, PLACENTA, V17, P387, DOI 10.1016/S0143-4004(96)90019-3
   Ohtani N, 2007, P NATL ACAD SCI USA, V104, P15034, DOI 10.1073/pnas.0706949104
   Ohtani N, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-1
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007
   Ryu SJ, 2009, EXPERT OPIN THER TAR, V13, P479, DOI [10.1517/14728220902832705 , 10.1517/14728220902832705]
   Sagiv A, 2013, ONCOGENE, V32, P1971, DOI 10.1038/onc.2012.206
   Sanders YY, 2013, REDOX BIOL, V1, P8, DOI 10.1016/j.redox.2012.11.004
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   SHAPIRO BL, 1979, SCIENCE, V203, P1251, DOI 10.1126/science.424752
   Sharp AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087621
   Smith SC, 2000, AM J OBSTET GYNECOL, V183, P697, DOI 10.1067/mob.2000.106555
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Stewart S, 2000, ANAT EMBRYOL, V201, P483, DOI 10.1007/s004290050335
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Su N, 2008, FRONT BIOSCI-LANDMRK, V13, P2842, DOI 10.2741/2890
   Waaijer MEC, 2012, AGING CELL, V11, P722, DOI 10.1111/j.1474-9726.2012.00837.x
   Wang Y, 2006, MOL HUM REPROD, V12, P451, DOI 10.1093/molehr/gal054
   Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005
   Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417
   Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0
   Zhang KX, 2013, MOL CANCER THER, V12, P787, DOI 10.1158/1535-7163.MCT-12-1240
   Zhang R, 2006, P NATL ACAD SCI USA, V103, P365, DOI 10.1073/pnas.0507979103
NR 72
TC 11
Z9 12
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0305-1870
EI 1440-1681
J9 CLIN EXP PHARMACOL P
JI Clin. Exp. Pharmacol. Physiol.
PD DEC
PY 2014
VL 41
IS 12
BP 965
EP 975
DI 10.1111/1440-1681.12328
PG 11
WC Pharmacology & Pharmacy; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Physiology
GA AX1SR
UT WOS:000346726900004
PM 25345622
DA 2024-02-19
ER

PT J
AU KATZ, MS
AF KATZ, MS
TI FOOD RESTRICTION MODULATES BETA-ADRENERGIC-SENSITIVE ADENYLATE-CYCLASE
   IN RAT-LIVER DURING AGING
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
C1 AUDIE L MURPHY MEM VET HOSP,SAN ANTONIO,TX 78284.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   Audie L. Murphy Memorial Veterans Hospital
RP KATZ, MS (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT MED,DIV ENDOCRINOL,SAN ANTONIO,TX 78284, USA.
FU NIA NIH HHS [R01-AG-03168] Funding Source: Medline
CR ABRAMOWITZ J, 1984, ENDOCRINOLOGY, V114, P1955, DOI 10.1210/endo-114-6-1955
   BERTRAND HA, 1980, ENDOCRINOLOGY, V107, P591, DOI 10.1210/endo-107-2-591
   BITENSKY MW, 1968, BIOCHEM BIOPH RES CO, V31, P706, DOI 10.1016/0006-291X(68)90619-0
   COOPER B, 1976, J CLIN INVEST, V57, P161, DOI 10.1172/JCI108256
   COOPER B, 1977, J CLIN INVEST, V59, P467, DOI 10.1172/JCI108661
   DARFLER FJ, 1982, J BIOL CHEM, V257, P1901
   DAX EM, 1986, J RECEPTOR RES, V6, P165, DOI 10.3109/10799898609073931
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   GILMAN AG, 1984, J CLIN INVEST, V73, P1, DOI 10.1172/JCI111179
   GREGERMAN RI, 1981, TXB ENDOCRINOLOGY, P1192
   HOFFMAN BB, 1984, J CLIN INVEST, V74, P1750, DOI 10.1172/JCI111593
   KALISH MI, 1977, BIOCHIM BIOPHYS ACTA, V483, P452, DOI 10.1016/0005-2744(77)90073-0
   KATZ MS, 1985, AM J PHYSIOL, V248, pE712, DOI 10.1152/ajpendo.1985.248.6.E712
   KATZ MS, 1987, FASEB J, V46, P567
   KATZ MS, 1983, 65TH ANN M END SOC S, P250
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MASORO EJ, 1985, J NUTR, V115, P842, DOI 10.1093/jn/115.7.842
   McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63
   MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1
   NARAYANAN N, 1986, MECH AGEING DEV, V34, P249, DOI 10.1016/0047-6374(86)90077-1
   POBINER BF, 1985, J BIOL CHEM, V260, P6200
   REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175
   SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X
   SCARPACE PJ, 1986, FASEB J, V45, P51
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   SEAMON K, 1981, J BIOL CHEM, V256, P9799
   STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888
   VOSS KH, 1982, MECH AGEING DEV, V18, P135, DOI 10.1016/0047-6374(82)90083-5
   WEILAND GA, 1980, MOL PHARMACOL, V18, P341
   YU BP, 1984, MECH AGEING DEV, V24, P67
   YU BP, 1980, METABOLISM, V29, P438, DOI 10.1016/0026-0495(80)90169-9
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 33
TC 30
Z9 30
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD JAN
PY 1988
VL 254
IS 1
BP E54
EP E62
DI 10.1152/ajpendo.1988.254.1.E54
PN 1
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA L8255
UT WOS:A1988L825500031
PM 2827512
DA 2024-02-19
ER

PT J
AU KONO, S
   KUZUYA, H
   OKAMOTO, M
   NISHIMURA, H
   KOSAKI, A
   KAKEHI, T
   OKAMOTO, M
   INOUE, G
   MAEDA, I
   IMURA, H
AF KONO, S
   KUZUYA, H
   OKAMOTO, M
   NISHIMURA, H
   KOSAKI, A
   KAKEHI, T
   OKAMOTO, M
   INOUE, G
   MAEDA, I
   IMURA, H
TI CHANGES IN INSULIN-RECEPTOR KINASE WITH AGING IN RAT SKELETAL-MUSCLE AND
   LIVER
SO AMERICAN JOURNAL OF PHYSIOLOGY
LA English
DT Article
RP KONO, S (corresponding author), KYOTO UNIV,SCH MED,DEPT MED,DIV 2,SHOGOIN KAWAHARACHO 54,SAKYO KU,KYOTO 606,JAPAN.
CR ALEXANDRIDES T, 1989, ENDOCRINOLOGY, V124, P1064, DOI 10.1210/endo-124-2-1064
   BURANT CF, 1986, J CLIN INVEST, V77, P260, DOI 10.1172/JCI112285
   BURANT CF, 1984, DIABETES, V33, P704, DOI 10.2337/diabetes.33.7.704
   BURANT CF, 1986, J BIOL CHEM, V261, P8985
   CARO JF, 1987, J CLIN INVEST, V79, P1330, DOI 10.1172/JCI112958
   CECCHIN F, 1988, AM J PHYSIOL, V254, pE394, DOI 10.1152/ajpendo.1988.254.4.E394
   CHEN M, 1985, J CLIN ENDOCR METAB, V60, P13, DOI 10.1210/jcem-60-1-13
   COMI RJ, 1987, J CLIN INVEST, V79, P453, DOI 10.1172/JCI112833
   CZECH MP, 1988, J BIOL CHEM, V263, P11017
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   DEFRONZO RA, 1979, DIABETES, V28, P1095, DOI 10.2337/diab.28.12.1095
   FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908
   FREIDENBERG GR, 1985, J BIOL CHEM, V260, P2444
   FREIDENBERG GR, 1987, J CLIN INVEST, V79, P240, DOI 10.1172/JCI112789
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   GRUNBERGER G, 1983, BIOCHEM BIOPH RES CO, V115, P560, DOI 10.1016/S0006-291X(83)80181-8
   HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311
   KAHN CR, 1988, J CLIN INVEST, V82, P1151, DOI 10.1172/JCI113711
   KAKEHI T, 1988, J GERONTOL, V43, pM40, DOI 10.1093/geronj/43.2.M40
   KASUGA M, 1982, SCIENCE, V215, P185, DOI 10.1126/science.7031900
   MORRISON DF, 1976, MULTIVARIATE STATIST
   NISHIMURA H, 1988, AM J PHYSIOL, V254, pE92, DOI 10.1152/ajpendo.1988.254.1.E92
   OKAMOTO M, 1986, AM J PHYSIOL, V251, pE542, DOI 10.1152/ajpendo.1986.251.5.E542
   PILCH PF, 1979, J BIOL CHEM, V254, P3375
   PILCH PF, 1980, J BIOL CHEM, V255, P1722
   REDDY SSK, 1988, J CLIN INVEST, V82, P1359, DOI 10.1172/JCI113739
   ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440
   TRUGLIA JA, 1988, DIABETES, V37, P147, DOI 10.2337/diabetes.37.2.147
NR 30
TC 33
Z9 33
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0002-9513
J9 AM J PHYSIOL
JI Am. J. Physiol.
PD JUL
PY 1990
VL 259
IS 1
BP E27
EP E35
DI 10.1152/ajpendo.1990.259.1.E27
PN 1
PG 9
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA DQ456
UT WOS:A1990DQ45600025
PM 2164787
DA 2024-02-19
ER

PT J
AU Li, L
   Li, YM
   Luo, J
   Jiang, YQ
   Zhao, Z
   Chen, YY
   Huang, QH
   Zhang, LQ
   Wu, T
   Pang, JX
AF Li, Lu
   Li, Yongmei
   Luo, Jian
   Jiang, Yanqing
   Zhao, Zean
   Chen, Yanyu
   Huang, Qinghua
   Zhang, Leqi
   Wu, Ting
   Pang, Jianxin
TI Resveratrol, a novel inhibitor of GLUT9, ameliorates liver and kidney
   injuries in a d-galactose-induced ageing mouse model <i>via</i> the
   regulation of uric acid metabolism
SO FOOD & FUNCTION
LA English
DT Article; Early Access
ID INDUCED OXIDATIVE STRESS; D-GAL; MICE; PROTECTS; CELLS; OLIGOSACCHARIDE;
   DYSFUNCTION; ACTIVATION; EPITHELIUM; EXCRETION
AB Accumulating evidence has shown that chronic injection of d-galactose (d-gal) can mimic natural ageing and induce liver and kidney injury. Previous studies showed that d-gal increased uric acid (UA) levels in mice. The increase in UA levels caused inflammation, accelerated oxidative stress, and aggravated liver and kidney injury. Oxidative stress and inflammation play vital roles in the ageing process. Therefore, reducing the levels of UA in ageing mice improved liver and kidney injury. Glucose transporter 9 (GLUT9) is responsible for the reabsorption of UA in the body, and its inhibition helps downregulate UA levels. The present study investigated the UA-lowering activity of the GLUT9 inhibitor resveratrol (RSV) using the patch clamping technique established in our laboratory in vitro. This research is the first study to demonstrate that RSV effectively inhibits UA uptake via GLUT9 (IC50 = 68.77 mu M) in vitro. An in vivo study was also performed to investigate the possible protective effect of RSV on d-gal-induced liver and kidney injury. RSV significantly reduced serum UA levels via the downregulation of GLUT9 mRNA and protein expression and promoted the excretion of excess UA through urine. Biochemical analysis showed that RSV significantly downregulated abnormal increases in serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and creatinine (CRE) caused by long-term d-gal treatment, which effectively improved pathological damage, increased superoxide dismutase (SOD) activity and decreased the content of malondialdehyde (MDA) in the liver and kidneys. RSV also downregulated the expression of the inflammatory cytokines, interleukin IL-6, IL-1 beta and tumor necrosis factor (TNF)-alpha in the liver and kidneys of ageing mice. Our findings provide new insights into the treatment strategies for ageing-induced liver and kidney injury and reveal a new mechanism of RSV-induced reduction in UA levels in ageing individuals.
C1 [Li, Lu; Li, Yongmei; Luo, Jian; Jiang, Yanqing; Zhao, Zean; Chen, Yanyu; Huang, Qinghua; Zhang, Leqi; Wu, Ting; Pang, Jianxin] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Drug Screening, Guangzhou 510515, Guangdong, Peoples R China.
C3 Southern Medical University - China
RP Wu, T; Pang, JX (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Drug Screening, Guangzhou 510515, Guangdong, Peoples R China.
EM pjx@smu.edu.cn
RI li, yong/HDN-3885-2022
OI li, lu/0000-0003-3082-4265
FU National Science Foundation of China [81773794, 81974507, 82003819]
FX This work was supported by the National Science Foundation of China
   (Grant No. 81773794, 81974507 and 82003819).
CR Atmon G, 2005, MECH AGEING DEV, V126, P341, DOI 10.1016/j.mad.2004.08.026
   Chen P, 2019, NEUROTHERAPEUTICS, V16, P1269, DOI 10.1007/s13311-019-00753-0
   Chen YY, 2021, PHYTOMEDICINE, V80, DOI 10.1016/j.phymed.2020.153374
   Cui DL, 2020, PHYTOMEDICINE, V66, DOI 10.1016/j.phymed.2019.153111
   De Pergola G, 2018, ENDOCR METAB IMMUNE, V18, P251, DOI 10.2174/1871530318666180212101548
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Gao L, 2015, PHYTOTHER RES, V29, P1131, DOI 10.1002/ptr.5357
   Hampel H, 2019, PROG NEUROBIOL, V181, DOI 10.1016/j.pneurobio.2019.101662
   He M, 2009, BIOL PHARM BULL, V32, P55, DOI 10.1248/bpb.32.55
   Holthoff JH, 2012, KIDNEY INT, V81, P370, DOI 10.1038/ki.2011.347
   Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007
   Khosla S, 2020, NAT REV ENDOCRINOL, V16, P263, DOI 10.1038/s41574-020-0335-y
   Kim DH, 2011, AM J PHYSIOL-RENAL, V301, pF427, DOI 10.1152/ajprenal.00258.2010
   Kimura Y, 2020, ARTERIOSCL THROM VAS, V40, P570, DOI 10.1161/ATVBAHA.119.313224
   Kitada M, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/568093
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Lai JYC, 2012, J AM GERIATR SOC, V60, P745, DOI 10.1111/j.1532-5415.2012.03902.x
   Lee CT, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601030
   Li BL, 2019, FOOD FUNCT, V10, P1707, DOI 10.1039/c8fo01920g
   Li L, 2018, AM J TRANSL RES, V10, P957
   Li X, 2020, CLIN INTERV AGING, V15, P97, DOI 10.2147/CIA.S237601
   Liang GY, 2019, PHYTOMEDICINE, V59, DOI 10.1016/j.phymed.2018.11.032
   Liu YJ, 2021, FOOD FUNCT, V12, P2148, DOI [10.1039/D0FO02707C, 10.1039/d0fo02707c]
   Lu XL, 2014, FOOD FUNCT, V5, P2892, DOI 10.1039/c4fo00391h
   Luo J, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.100982
   Maarman GJ, 2017, J APPL PHYSIOL, V122, P1003, DOI 10.1152/japplphysiol.00873.2016
   Mandal AK, 2015, ANNU REV PHYSIOL, V77, P323, DOI 10.1146/annurev-physiol-021113-170343
   Nakanishi T, 2013, NEPHROL DIAL TRANSPL, V28, P603, DOI 10.1093/ndt/gfs574
   Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013
   Pan H, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6623328
   Pang J, 2020, SLAS DISCOV, V60, P1536
   Perez-Ruiz F, 2002, ARTHRIT RHEUM-ARTHR, V47, P610, DOI 10.1002/art.10792
   Preitner F, 2009, P NATL ACAD SCI USA, V106, P15501, DOI 10.1073/pnas.0904411106
   Rauf A, 2017, FOOD FUNCT, V8, P4284, DOI [10.1039/C7FO01300K, 10.1039/c7fo01300k]
   Shi YW, 2012, MOL NUTR FOOD RES, V56, P1433, DOI 10.1002/mnfr.201100828
   Song P, 2020, AGEING RES REV, V60, DOI 10.1016/j.arr.2020.101072
   Tasaki E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179426
   van Dam E, 2020, CELL METAB, V31, P710, DOI 10.1016/j.cmet.2020.02.016
   Walker J, 2014, FOOD FUNCT, V5, P74, DOI 10.1039/c3fo60236b
   Wang LP, 2020, J ETHNOPHARMACOL, V254, DOI 10.1016/j.jep.2020.112670
   Wang Y, 2017, NUTR METAB, V14, DOI 10.1186/s12986-017-0190-6
   Wang YQ, 2020, J AGR FOOD CHEM, V68, P12271, DOI 10.1021/acs.jafc.0c04358
   Wu LN, 2012, MOL BIOL REP, V39, P9085, DOI 10.1007/s11033-012-1780-z
   Xu LQ, 2016, FOOD FUNCT, V7, P4545, DOI 10.1039/c6fo01057a
   Yan JK, 2013, FOOD CHEM, V141, P3766, DOI 10.1016/j.foodchem.2013.06.092
   Yang Y, 2019, EUR REV MED PHARMACO, V23, P378, DOI 10.26355/eurrev_201901_16786
   Yu SL, 2010, ACTA PHARMACOL SIN, V31, P1532, DOI 10.1038/aps.2010.152
   Zhang HL, 2020, J CELL MOL MED, V24, P8849, DOI 10.1111/jcmm.15523
   Zhang Y, 2018, FOOD FUNCT, V9, P371, DOI [10.1039/c7fo01511a, 10.1039/C7FO01511A]
   Zhao ZA, 2020, ACS OMEGA, V5, P33421, DOI 10.1021/acsomega.0c05360
NR 50
TC 11
Z9 14
U1 7
U2 42
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD 2021 SEP 21
PY 2021
VL 12
IS 18
BP 8274
EP 8287
DI 10.1039/d1fo00538c
EA MAY 2021
PG 14
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA US9CL
UT WOS:000667343300001
PM 34180933
DA 2024-02-19
ER

PT J
AU Amor, C
   Feucht, J
   Leibold, J
   Ho, YJ
   Zhu, CY
   Alonso-Curbelo, D
   Mansilla-Soto, J
   Boyer, JA
   Li, X
   Giavridis, T
   Kulick, A
   Houlihan, S
   Peerschke, E
   Friedman, SL
   Ponomarev, V
   Piersigilli, A
   Sadelain, M
   Lowe, SW
AF Amor, Corina
   Feucht, Judith
   Leibold, Josef
   Ho, Yu-Jui
   Zhu, Changyu
   Alonso-Curbelo, Direna
   Mansilla-Soto, Jorge
   Boyer, Jacob A.
   Li, Xiang
   Giavridis, Theodoros
   Kulick, Amanda
   Houlihan, Shauna
   Peerschke, Ellinor
   Friedman, Scott L.
   Ponomarev, Vladimir
   Piersigilli, Alessandra
   Sadelain, Michel
   Lowe, Scott W.
TI Senolytic CAR T cells reverse senescence-associated pathologies
SO NATURE
LA English
DT Article; Early Access
ID CELLULAR SENESCENCE; UROKINASE RECEPTOR; STELLATE CELLS; LYMPHOCYTES;
   CANCER; CYTOTOXICITY; THERAPY; TUMORS
AB Cellular senescence is characterized by stable cell-cycle arrest and a secretory program that modulates the tissue microenvironment(1,2). Physiologically, senescence serves as a tumour-suppressive mechanism that prevents the expansion of premalignant cells(3,4)and has a beneficial role in wound-healing responses(5,6). Pathologically, the aberrant accumulation of senescent cells generates an inflammatory milieu that leads to chronic tissue damage and contributes to diseases such as liver and lung fibrosis, atherosclerosis, diabetes and osteoarthritis(1,7). Accordingly, eliminating senescent cells from damaged tissues in mice ameliorates the symptoms of these pathologies and even promotes longevity(1,2,8-10). Here we test the therapeutic concept that chimeric antigen receptor (CAR) T cells that target senescent cells can be effective senolytic agents. We identify the urokinase-type plasminogen activator receptor (uPAR)(11)as a cell-surface protein that is broadly induced during senescence and show that uPAR-specific CAR T cells efficiently ablate senescent cells in vitro and in vivo. CAR T cells that target uPAR extend the survival of mice with lung adenocarcinoma that are treated with a senescence-inducing combination of drugs, and restore tissue homeostasis in mice in which liver fibrosis is induced chemically or by diet. These results establish the therapeutic potential of senolytic CAR T cells for senescence-associated diseases.
   Chimeric antigen receptor (CAR) T cells targeting uPAR, a cell-surface protein that is upregulated on senescent cells, eliminate senescent cells in vitro and in vivo and reduce liver fibrosis in mice.
C1 [Amor, Corina; Boyer, Jacob A.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA.
   [Amor, Corina; Leibold, Josef; Ho, Yu-Jui; Zhu, Changyu; Alonso-Curbelo, Direna; Li, Xiang; Houlihan, Shauna; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.
   [Feucht, Judith; Mansilla-Soto, Jorge; Giavridis, Theodoros; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA.
   [Feucht, Judith; Mansilla-Soto, Jorge; Giavridis, Theodoros; Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA.
   [Boyer, Jacob A.; Kulick, Amanda] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.
   [Li, Xiang] Weill Cornell Grad Sch Med Sci, New York, NY USA.
   [Peerschke, Ellinor] Mem Sloan Kettering Canc Ctr, Dept Lab Med, 1275 York Ave, New York, NY 10021 USA.
   [Friedman, Scott L.] Icahn Sch Med Mt Sinai, Div Liver Dis, New York, NY 10029 USA.
   [Ponomarev, Vladimir] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA.
   [Piersigilli, Alessandra] Rockefeller Univ, Lab Comparat Pathol, Weill Cornell Med, 1230 York Ave, New York, NY 10021 USA.
   [Piersigilli, Alessandra] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.
   [Lowe, Scott W.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
C3 Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer
   Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering
   Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell
   University; Memorial Sloan Kettering Cancer Center; Icahn School of
   Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center;
   Rockefeller University; Cornell University; Weill Cornell Medicine;
   Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute
RP Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.; Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, 1275 York Ave, New York, NY 10021 USA.; Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Lowe, SW (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.
EM m-sadelain@ski.mskcc.org; lowes@mskcc.org
RI Ho, Yu-Jui/HNS-9777-2023; Li, Xiang/HKE-2548-2023; Amor,
   Corina/AAZ-1904-2020; Alonso Curbelo, Direna/AFT-1035-2022
OI Alonso Curbelo, Direna/0000-0001-6674-3059; Zhu,
   Changyu/0000-0003-3583-3638; Leibold, Josef/0000-0003-2336-1987; Ho,
   Yu-jui/0000-0002-7540-024X; Amor, Corina/0000-0002-7654-6216; Giavridis,
   Theodoros/0000-0002-8716-781X
FU National Institute of Aging [AG065396]; Pasteur-Weizmann/Servier award;
   Memorial Sloan Kettering Cancer Center support grant [P30 CA008748];
   National Institute of Diabetes and Digestive and Kidney Diseases
   [R01DK56621]; Department of Defense [CA150272]; P30 grant [CA165979]; La
   Caixa foundation; Harold E. Varmus graduate student fellowship from the
   Gerstner Sloan Kettering graduate school; Care-for-Rare Foundation;
   German Research Foundation (DFG); DFG; Shulamit Katzman Endowed
   Postdoctoral Research Fellowship; Fundacion Ramon Areces; Grayer
   postgraduate fellowship from the Gerstner Sloan Kettering graduate
   school; Geoffrey Been graduate student fellowship from the Gerstner
   Sloan Kettering graduate school; National Cancer Institute [U54
   0D020355-01]
FX We thank A. Lujambio and R. Brody and the Biorepository and Pathology
   Core at Icahn School of Medicine at Mount Sinai, and G. Askan and O.
   Basturk at the Department of Pathology at MSKCC, for tissue samples; L.
   Zender and H. Chen for sharing plasmids; N. Salgado, H. Chen, T. Baslan,
   S. Tian, A. Wuest, W. Luan and G. Gunset for technical assistance; and
   C. J. Sherr, E. de Stanchina, N. Kuhn, A. Dobrin, M. L. Sjostrand and
   other members of the Lowe and Sadelain laboratories for insightful
   discussions. This work was supported by a grant from the National
   Institute of Aging (AG065396) to S.W.L., the Pasteur-Weizmann/Servier
   award to M.S. and a Memorial Sloan Kettering Cancer Center support grant
   (P30 CA008748) to both S.W.L. and M.S. laboratories. S.L.F. was
   supported by a grant from the National Institute of Diabetes and
   Digestive and Kidney Diseases (R01DK56621), a grant from the Department
   of Defense (CA150272) and the P30 grant (CA165979); C.A. was supported
   by a postgraduate fellowship from La Caixa foundation and is the
   recipient of the Harold E. Varmus graduate student fellowship from the
   Gerstner Sloan Kettering graduate school; J.F. was supported by the
   Care-for-Rare Foundation and the German Research Foundation (DFG); J.L.
   was supported by a fellowship from the DFG and a Shulamit Katzman
   Endowed Postdoctoral Research Fellowship; J.F. and J.L. are part of the
   Experimental Medicine Program at the University of Tuebingen; D.A.-C.
   was supported by a postdoctoral fellowship from Fundacion Ramon Areces;
   J.A.B. was supported by the Grayer postgraduate fellowship and the
   Geoffrey Been graduate student fellowship from the Gerstner Sloan
   Kettering graduate school; and A.K. was supported by a grant from the
   National Cancer Institute (U54 0D020355-01). S.W.L. is the Geoffrey Been
   Chair of Cancer Biology and a Howard Hughes Medical Institute
   Investigator. We thank the following MSKCC core facilities for support:
   SKI flow cytometry core facility, animal facility, antitumor assessment
   core, laboratory for comparative biology, bioinformatics core and
   integrated genomics operation core.
CR Aghajanian H, 2019, NATURE
   Anderson KG, 2017, CANCER CELL, V31, P311, DOI 10.1016/j.ccell.2017.02.008
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Belcher C, 1996, ANN RHEUM DIS, V55, P230, DOI 10.1136/ard.55.4.230
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674
   Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827
   Brunt EM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.80
   BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Davila ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061338
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dobrenkov K, 2008, J NUCL MED, V49, P1162, DOI 10.2967/jnumed.107.047324
   Du HW, 2019, CANCER CELL, V35, P221, DOI 10.1016/j.ccell.2019.01.002
   Feucht J, 2019, NAT MED, V25, P82, DOI 10.1038/s41591-018-0290-5
   Fujii M, 2013, MED MOL MORPHOL, V46, P141, DOI 10.1007/s00795-013-0016-1
   Gargett T, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00235
   Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7
   Guthoff M, 2017, SCI REP, V7
   Hagani AB, 1999, J GENE MED, V1, P341
   Hayek SS, 2015, NEW ENGL J MED, V373, P1916, DOI 10.1056/NEJMoa1506362
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuhn NF, 2019, CANCER CELL, V35, P473, DOI 10.1016/j.ccell.2019.02.006
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Livshits G, 2018, ELIFE, V7, DOI 10.7554/eLife.35216
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70
   Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4
   Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919
   Paszkiewicz PJ, 2016, J CLIN INVEST, V126, P4262, DOI 10.1172/JCI84813
   Pellegatta S, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat6463
   Perna F, 2017, CANCER CELL, V32, P506, DOI 10.1016/j.ccell.2017.09.004
   Puche JE, 2013, HEPATOLOGY, V57, P340, DOI 10.1002/hep.26053
   Ruscetti M, 2018, SCIENCE, V362, P1416, DOI 10.1126/science.aas9090
   Sadelain M, 2017, NATURE, V545, P423, DOI 10.1038/nature22395
   Santos EB, 2009, NAT MED, V15, P338, DOI 10.1038/nm.1930
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Schuliga M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41770
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Simon DI, 1996, BLOOD, V88, P3185, DOI 10.1182/blood.V88.8.3185.bloodjournal8883185
   Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821
   Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217
   Van der Schueren B, 2015, INT J OBESITY, V39, P1254, DOI 10.1038/ijo.2015.58
   Wang C, 2019, NATURE, V574, P268, DOI 10.1038/s41586-019-1607-3
   Wang L, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109173
   Wang XB, 2016, CELL METAB, V24, P848, DOI 10.1016/j.cmet.2016.09.016
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Zhu CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0344
NR 58
TC 509
Z9 548
U1 33
U2 318
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD 2020 JUL 2
PY 2020
VL 583
IS 7814
BP 127
EP +
DI 10.1038/s41586-020-2403-9
EA JUN 2020
PG 32
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA ME6OV
UT WOS:000541024900011
PM 32555459
OA Green Accepted
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Vogt, BL
   Richie, JP
AF Vogt, Barbara L.
   Richie, John P., Jr.
TI Glutathione depletion and recovery after acute ethanol administration in
   the aging mouse
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
DE ethanol; aging; glutathione; mouse
ID HEPATIC GLUTATHIONE; RAT-LIVER; LIPID-PEROXIDATION; MEDIATED
   HEPATOTOXICITY; SULFHYDRYL COMPOUNDS; CYSTEINE LEVELS; ADVANCING AGE;
   FREE-RADICALS; LIFE-SPAN; IN-VITRO
AB Glutathione (GSH) plays an important role in the detoxification of ethanol (EtOH) and acute EtOH administration leads to GSH depletion in the liver and other tissues. Aging is also associated with a progressive decline in GSH levels and impairment in GSH biosynthesis in many tissues. Thus, the present study was designed to examine the effects of aging on EtOH-induced depletion and recovery of GSH in different tissues of the C57Bl/6NNIA mouse. EtOH (25 g/kg) or saline was administered i.p. to mice of ages 6 months (young), 12 months (mature), and 24 months (old); and GSH and cyst(e)ine concentrations were measured 0-24 h thereafter. EtOH administration (5 g/kg) depleted hepatic GSH levels >50% by 6 h in all animals. By 24 h, levels remained low in both young and old mice, but recovered to baseline levels in mature mice. At 6 h, the decrease in hepatic GSH was dose-dependent up to 3 g/kg EtOH, but not at higher doses. The extent of depletion at the 3 g/kg dose was dependent upon age, with old mice demonstrating significantly lower GSH levels than mature mice (P < 0.001). Altogether these results indicate that aging was associated with a greater degree of EtOH and fasting-induced GSH depletion and subsequent impaired recovery in liver. An impaired ability to recover was also observed in young animals. Further studies are required to determine if an inability to recover from GSH depletion by EtOH is associated with enhanced toxicity. (c) 2007 Elsevier Inc. All rights reserved.
C1 Penn State Univ Hosp, Milton S Hershey Med Ctr, Penn State Canc Inst, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA.
   Penn State Univ Hosp, Milton S Hershey Med Ctr, Penn State Canc Inst, Dept Pharmacol, Hershey, PA 17033 USA.
   Former Inst Canc Prevent, Valhalla, NY USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE);
   Pennsylvania State University; Penn State Health; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Pennsylvania State
   University; Penn State Health
RP Richie, JP (corresponding author), Penn State Univ Hosp, Milton S Hershey Med Ctr, Penn State Canc Inst, Dept Hlth Evaluat Sci, Hershey, PA 17033 USA.
EM jrichie@psu.edu
OI Richie, John/0000-0001-8239-2850
FU NIA NIH HHS [R01 AG014102-03] Funding Source: Medline
CR ADAMS WL, 1993, JAMA-J AM MED ASSOC, V270, P1222, DOI 10.1001/jama.270.10.1222
   AEBI S, 1992, AM J PHYSIOL, V263, pR348, DOI 10.1152/ajpregu.1992.263.2.R348
   BLAKE MJ, 1991, P NATL ACAD SCI USA, V88, P9873, DOI 10.1073/pnas.88.21.9873
   BOYER CS, 1990, ALCOHOL CLIN EXP RES, V14, P28, DOI 10.1111/j.1530-0277.1990.tb00441.x
   Bresci G, 1991, Minerva Med, V82, P753
   BUMP EA, 1992, RADIOTHER ONCOL, V23, P21, DOI 10.1016/0167-8140(92)90301-A
   Calabrese V, 2000, BIOCHEM BIOPH RES CO, V269, P397, DOI 10.1006/bbrc.2000.2311
   CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399
   CHEN TS, 1990, DRUG METAB DISPOS, V18, P882
   Choi DW, 2000, J TOXICOL ENV HEAL A, V60, P459, DOI 10.1080/00984100050079520
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627
   GUERRI C, 1980, PHARMACOL BIOCHEM BE, V13, P53, DOI 10.1016/S0091-3057(80)80009-8
   GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q
   HAHN HKJ, 1983, ALCOHOL CLIN EXP RES, V7, P299, DOI 10.1111/j.1530-0277.1983.tb05464.x
   HAZELTON GA, 1984, P SOC EXP BIOL MED, V176, P249
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   HEMMINKI K, 1982, TOXICOL LETT, V11, P1, DOI 10.1016/0378-4274(82)90096-0
   HIDALGO J, 1990, J PHARMACOL EXP THER, V255, P554
   Higashi T, 1983, Prog Clin Biol Res, V125, P419
   Kallama S, 1983, J APPL TOXICOL, V3, P313, DOI 10.1002/jat.2550030608
   KERA Y, 1985, AGENTS ACTIONS, V17, P48, DOI 10.1007/BF01966681
   KERSHAW WC, 1990, TOXICOL APPL PHARM, V106, P448, DOI 10.1016/0041-008X(90)90339-V
   KERSHAW WC, 1990, TOXICOL APPL PHARM, V104, P267, DOI 10.1016/0041-008X(90)90301-A
   Kim YC, 2003, LIFE SCI, V74, P509, DOI 10.1016/j.lfs.2003.07.009
   Kleinman WA, 2000, BIOCHEM PHARMACOL, V60, P19, DOI 10.1016/S0006-2952(00)00293-8
   KNECHT KT, 1990, MOL PHARMACOL, V38, P26
   LANG CA, 1992, J LAB CLIN MED, V120, P720
   LAUTERBURG BH, 1984, J PHARMACOL EXP THER, V230, P7
   LAUTERBURG BH, 1981, J CLIN INVEST, V67, P1415, DOI 10.1172/JCI110170
   LAUTERBURG BH, 1984, HEPATOLOGY, V4, P586, DOI 10.1002/hep.1840040402
   LESLIE SW, 1992, MOL PHARMACOL, V41, P308
   LI GC, 1983, J CELL PHYSIOL, V115, P116, DOI 10.1002/jcp.1041150203
   LIU AYC, 1989, J BIOL CHEM, V264, P12037
   LOGUERCIO C, 1993, GUT, V34, P161, DOI 10.1136/gut.34.2.161
   Loguercio C, 1997, ITAL J GASTROENTEROL, V29, P168
   Lucey MR, 1999, J STUD ALCOHOL, V60, P103, DOI 10.15288/jsa.1999.60.103
   Luczaj W, 2004, J TOXICOL ENV HEAL A, V67, P595, DOI 10.1080/15287390490425579
   MACDONALD CM, 1977, BIOCHEM PHARMACOL, V26, P1529, DOI 10.1016/0006-2952(77)90428-2
   MALLIKARJUNA K, 2006, PATHOPHYSIOLOGY
   MARTIN J, 1982, TREATMENT PSYCHOPATH
   MARUYAMA E, 1968, J BIOCHEM-TOKYO, V63, P398
   MCINTYRE TM, 1980, INT J BIOCHEM, V12, P545, DOI 10.1016/0020-711X(80)90005-1
   MENDENHALL CL, 1989, ALCOHOL ALCOHOLISM, V24, P11, DOI 10.1093/oxfordjournals.alcalc.a044862
   Moos RH, 2004, AM J PUBLIC HEALTH, V94, P1985, DOI 10.2105/AJPH.94.11.1985
   NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K
   Oscar-Berman M, 1990, NIDA Res Monogr, V101, P136
   PESSAYRE D, 1979, GASTROENTEROLOGY, V77, P264
   PIERSON JL, 1986, BIOCHEM PHARMACOL, V35, P1533, DOI 10.1016/0006-2952(86)90121-8
   Pistelli A, 1992, Clin Ter, V140, P461
   PLESSET J, 1982, BIOCHEM BIOPH RES CO, V108, P1340, DOI 10.1016/0006-291X(82)92147-7
   PONSODA X, 1991, TOXICOLOGY, V70, P293, DOI 10.1016/0300-483X(91)90004-K
   RATHBUN WB, 1991, EXP EYE RES, V53, P205, DOI 10.1016/0014-4835(91)90075-P
   REINKE LA, 1991, FREE RADICAL BIO MED, V11, P31, DOI 10.1016/0891-5849(91)90185-6
   RICHIE JP, 1988, P SOC EXP BIOL MED, V187, P235
   Richie JP, 1996, CLIN CHEM, V42, P64
   RICHIE JP, 1987, ANAL BIOCHEM, V163, P9, DOI 10.1016/0003-2697(87)90085-6
   RICHIE JP, 1992, EXP GERONTOL, V27, P615, DOI 10.1016/0531-5565(92)90015-R
   Rigler SK, 2000, AM FAM PHYSICIAN, V61, P1710
   RIKANS LE, 1989, LIFE SCI, V45, P1373, DOI 10.1016/0024-3205(89)90024-6
   RITZMANN RF, 1980, AGE, V3, P15, DOI 10.1007/BF02435001
   RYAN C, 1982, ALCOHOL CLIN EXP RES, V6, P22, DOI 10.1111/j.1530-0277.1982.tb05378.x
   Ryle P R, 1987, Alcohol Alcohol Suppl, V1, P289
   SEITZ HK, 1989, GASTROENTEROLOGY, V97, P446, DOI 10.1016/0016-5085(89)90082-6
   SHAW S, 1989, FREE RADICAL BIO MED, V7, P541, DOI 10.1016/0891-5849(89)90030-0
   SLUSSER SO, 1990, AM J PHYSIOL, V258, pF1547, DOI 10.1152/ajprenal.1990.258.6.F1547
   SPEISKY H, 1988, ALCOHOL CLIN EXP RES, V12, P224, DOI 10.1111/j.1530-0277.1988.tb00184.x
   SPEISKY H, 1985, BIOCHEM J, V225, P565, DOI 10.1042/bj2250565
   SPRINCE H, 1974, AGENTS ACTIONS, V4, P125, DOI 10.1007/BF01966822
   STRUBELT O, 1987, TOXICOLOGY, V45, P213, DOI 10.1016/0300-483X(87)90107-7
   *US BUR CENS, 1989, PROJ POP US AG SEX R
   UYSAL M, 1985, IRCS MED SCI, V11, P879
   VESTAL RE, 1977, CLIN PHARMACOL THER, V21, P343
   VIDELA L, 1990, GLUTATHIONE ALCOHOL
   VIDELA LA, 1987, CELL BIOCHEM FUNCT, V5, P273, DOI 10.1002/cbf.290050406
   VINA J, 1980, BIOCHEM J, V188, P549, DOI 10.1042/bj1880549
   VINA J, 1989, CRC HDB FREE RADICAL
   VOGT BL, 1993, BIOCHEM PHARMACOL, V46, P257, DOI 10.1016/0006-2952(93)90412-P
   WANG CJ, 1990, BIOCHEM PHARMACOL, V40, P715, DOI 10.1016/0006-2952(90)90306-6
   WEAVER MS, 1993, ALCOHOL CLIN EXP RES, V17, P643, DOI 10.1111/j.1530-0277.1993.tb00812.x
   YANG CM, 1991, BIOCHEM PHARMACOL, V41, P923, DOI 10.1016/0006-2952(91)90197-D
   YORK JL, 1983, PHARMACOL BIOCHEM BE, V19, P687
NR 83
TC 45
Z9 50
U1 1
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD MAY 15
PY 2007
VL 73
IS 10
BP 1613
EP 1621
DI 10.1016/j.bcp.2007.01.033
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 162MH
UT WOS:000246091200011
PM 17343832
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Lorenzini, A
   Hrelia, S
   Bordoni, A
   Biagi, P
   Frisoni, L
   Marinucci, T
   Cristofalo, VJ
AF Lorenzini, A
   Hrelia, S
   Bordoni, A
   Biagi, P
   Frisoni, L
   Marinucci, T
   Cristofalo, VJ
TI Is increased arachidonic acid release a cause or a consequence of
   replicative senescence?
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE arachidonic acid; human fibroblasts; cell proliferation; replicative
   senescence; fatty acids; ceramide; prostaglandins
ID EPIDERMAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; AGE-RELATED-CHANGES;
   HUMAN-FIBROBLASTS; CYTOSOLIC PHOSPHOLIPASE-A(2); CELLULAR SENESCENCE;
   EXTRACELLULAR ATP; RAT-LIVER; PROLIFERATION; CELLS
AB Arachidonic acid (AA) has been related to both stimulation and inhibition of cellular proliferation. During replicative senescence of human fibroblasts, increased levels of AA have been thought to play a causal role in the limited proliferative capacity of the cells. To clarify the role of AA in the proliferation of normal fibroblasts and in cellular senescence, we examined uptake from and release of AA into the culture media and its effects on DNA synthesis. Our results indicate that some aspects of AA metabolism in normal human fibroblasts aged in culture an significantly different in comparison to early passage cells. Particularly, AA release following different mitogenic stimulation is higher in senescent than in young cells. Notwithstanding this significant difference, AA, at the concentration used, has no inhibitory effect on fibroblast DNA synthesis. Moreover AA and prostaglandins are responsible for the proliferative block in neither senescent cells nor mediate ceramide inhibition of DNA synthesis. So our results suggest that the increasing AA release is not causal, but rather the result of in vitro aging. (C) 2001 Elsevier Science Inc. All rights reserved.
C1 Lankenau Inst Med Res, Wynnewood, PA 19096 USA.
   Univ Bologna, Dept Biochem, I-40126 Bologna, Italy.
   Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.
C3 Lankenau Medical Center; Lankenau Institute for Medical Research;
   University of Bologna; Jefferson University
RP Cristofalo, VJ (corresponding author), Lankenau Inst Med Res, 100 Lankenau Ave, Wynnewood, PA 19096 USA.
RI Hrelia, Silvana/P-2864-2015; Lorenzini, Antonello/G-4463-2012; Bordoni,
   Alessandra/J-3047-2012; LORENZINI, ANTONELLO/E-6582-2016
OI Hrelia, Silvana/0000-0001-7857-4512; LORENZINI,
   ANTONELLO/0000-0001-9615-9697; Bordoni, Alessandra/0000-0003-4579-1662
FU NIA NIH HHS [AG00378, AG13282] Funding Source: Medline
CR BIAGI PL, 1993, J NUTR BIOCHEM, V4, P690, DOI 10.1016/0955-2863(93)90108-9
   CRISTOFALO VJ, 1989, J GERONTOL, V44, P55, DOI 10.1093/geronj/44.6.55
   CRISTOFALO VJ, 1973, EXP CELL RES, V76, P419, DOI 10.1016/0014-4827(73)90394-7
   Cristofalo VJ, 1996, EXP GERONTOL, V31, P111, DOI 10.1016/0531-5565(95)02018-7
   CRISTOFALO VJ, 1970, RESEARCH PROGRESS OR, V2, P95
   Cristofalo VJ, 1980, J TISSUE CULT METHOD, V6, P117, DOI DOI 10.1007/BF02082862
   FAYARD JM, 1994, EUR J PHARMACOL, V251, P281, DOI 10.1016/0014-2999(94)90410-3
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Hayakawa M, 1996, BIOCHEM BIOPH RES CO, V220, P681, DOI 10.1006/bbrc.1996.0464
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HORI T, 1991, BIOCHEM BIOPH RES CO, V174, P758, DOI 10.1016/0006-291X(91)91482-R
   HORI T, 1989, J CELL PHYSIOL, V141, P275, DOI 10.1002/jcp.1041410207
   HOWARD BV, 1969, LIPIDS, V5, P49
   HRELIA S, 1989, BIOCHEM BIOPH RES CO, V163, P348, DOI 10.1016/0006-291X(89)92142-6
   HRELIA S, 1994, BIOCHEM MOL BIOL INT, V34, P449
   HUANG NN, 1993, J BIOL CHEM, V268, P10789
   HUANG NN, 1991, J CELL PHYSIOL, V146, P483, DOI 10.1002/jcp.1041460320
   Irons CE, 1996, AM J PHYSIOL-CELL PH, V270, pC1642, DOI 10.1152/ajpcell.1996.270.6.C1642
   KAN M, 1982, J CELL PHYSIOL, V111, P155, DOI 10.1002/jcp.1041110206
   Krischer SM, 1998, BIOCHEMISTRY-US, V37, P12884, DOI 10.1021/bi980696x
   Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709
   LIN LL, 1992, J BIOL CHEM, V267, P23451
   Loftin CD, 1996, ARCH BIOCHEM BIOPHYS, V330, P419, DOI 10.1006/abbi.1996.0271
   Lorenzini A, 1997, PROSTAG LEUKOTR ESS, V57, P143, DOI 10.1016/S0952-3278(97)90004-1
   MACIEIRACOELHO A, 1966, EXPERIENTIA, V22, P390, DOI 10.1007/BF01901156
   Martinez J, 1997, AM J PHYSIOL-CELL PH, V273, pC1466, DOI 10.1152/ajpcell.1997.273.5.C1466
   Moreno JJ, 1997, PFLUG ARCH EUR J PHY, V433, P351
   MUROTA SI, 1979, BIOCHIM BIOPHYS ACTA, V574, P351
   NARROD SA, 1964, J BIOL CHEM, V239, P2189
   PELUFFO R O, 1970, American Journal of Physiology, V218, P669
   Petr MJ, 1998, EXP CELL RES, V244, P310, DOI 10.1006/excr.1998.4181
   PHILLIPS PD, 1981, EXP CELL RES, V134, P297, DOI 10.1016/0014-4827(81)90429-8
   POLGAR P, 1980, MECH AGEING DEV, V12, P305, DOI 10.1016/0047-6374(80)90063-9
   RAEDERSTORFF D, 1995, INT J VITAM NUTR RES, V65, P51
   SPECTOR AA, 1979, J LIPID RES, V20, P536
   STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047
   Tripathi SC, 1996, BBA-MOL BASIS DIS, V1316, P5, DOI 10.1016/0925-4439(96)00012-9
   Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701
NR 38
TC 8
Z9 9
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2001
VL 36
IS 1
BP 65
EP 78
DI 10.1016/S0531-5565(00)00192-3
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 392VB
UT WOS:000166432300006
PM 11162912
DA 2024-02-19
ER

PT J
AU BIRCHENALLSPARKS, MC
   ROBERTS, MS
   RUTHERFORD, MS
   RICHARDSON, A
AF BIRCHENALLSPARKS, MC
   ROBERTS, MS
   RUTHERFORD, MS
   RICHARDSON, A
TI THE EFFECT OF AGING ON THE STRUCTURE AND FUNCTION OF LIVER MESSENGER-RNA
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 ILLINOIS STATE UNIV,DEPT CHEM,NORMAL,IL 61761.
C3 Illinois State University
FU NIA NIH HHS [AG 00344, AG 04091] Funding Source: Medline
CR ARENDES J, 1980, ANAL BIOCHEM, V101, P488, DOI 10.1016/0003-2697(80)90218-3
   ASSELBERGS FAM, 1978, BIOCHIM BIOPHYS ACTA, V520, P577, DOI 10.1016/0005-2787(78)90143-0
   ATRYZEK V, 1979, BIOCHEMISTRY-US, V18, P1281, DOI 10.1021/bi00574a025
   BERMAN AE, 1978, BIOCHEMISTRY-MOSCOW+, V43, P1443
   BERND A, 1982, MECH AGEING DEV, V19, P361, DOI 10.1016/0047-6374(82)90019-7
   CASTLE T, 1979, ARCH BIOCHEM BIOPHYS, V195, P423, DOI 10.1016/0003-9861(79)90369-2
   CASTLE T, 1978, MECH AGEING DEV, V8, P383, DOI 10.1016/0047-6374(78)90037-4
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   Cox R.A., 1968, METHODS ENZYMOL, V12, P120, DOI [10.1016/0076-6879, DOI 10.1016/0076-6879]
   ENGLEMANN GL, 1981, MECH AGEING DEV, V16, P385
   FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P1904, DOI 10.1073/pnas.72.5.1904
   JELINEK W, 1978, CELL, V15, P205, DOI 10.1016/0092-8674(78)90095-8
   Karpetsky T P, 1979, Subcell Biochem, V6, P1
   KEMPER B, 1977, BIOCHEMISTRY-US, V16, P5676, DOI 10.1021/bi00645a004
   KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9
   LAYMAN DK, 1976, ARCH BIOCHEM BIOPHYS, V173, P246, DOI 10.1016/0003-9861(76)90256-3
   MOORE RE, 1980, CANCER RES, V40, P1449
   MOUDGIL PG, 1979, GERONTOLOGY, V25, P322, DOI 10.1159/000212360
   MUTHUKRISHNAN S, 1978, J BIOL CHEM, V253, P1710
   NIYOGI SK, 1969, J BIOL CHEM, V244, P1576
   NOKIN P, 1976, EUR J BIOCHEM, V68, P431, DOI 10.1111/j.1432-1033.1976.tb10830.x
   PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x
   RICCA GA, 1981, J BIOL CHEM, V256, P362
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   RICHARDSON A, 1982, J GERONTOL, V37, P666, DOI 10.1093/geronj/37.6.666
   Richardson A., 1983, REV BIOL RES AGING, V1, P275
   Richardson A, 1983, REV BIOL RES AGING, V1, P255
   RICHARDSON A, 1981, HDB BIOCH AGING, P79
   ROBERTS BE, 1973, P NATL ACAD SCI USA, V70, P2330, DOI 10.1073/pnas.70.8.2330
   ROMAN R, 1976, NATURE, V260, P359, DOI 10.1038/260359a0
   SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8
   SHEINESS D, 1973, NATURE-NEW BIOL, V241, P265, DOI 10.1038/newbio241265a0
   SHEINESS D, 1975, P NATL ACAD SCI USA, V72, P1077, DOI 10.1073/pnas.72.3.1077
   SHIMOTOHNO K, 1977, P NATL ACAD SCI USA, V74, P2734, DOI 10.1073/pnas.74.7.2734
   SUZUKI H, 1978, J BIOCHEM-TOKYO, V84, P1125, DOI 10.1093/oxfordjournals.jbchem.a132227
NR 36
TC 12
Z9 12
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PY 1985
VL 32
IS 1
BP 99
EP 111
DI 10.1016/0047-6374(85)90039-9
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AUH16
UT WOS:A1985AUH1600010
PM 2423817
DA 2024-02-19
ER

PT J
AU NOKUBO, M
AF NOKUBO, M
TI PHYSICAL-CHEMICAL AND BIOCHEMICAL DIFFERENCES IN LIVER PLASMA-MEMBRANES
   IN AGING F344 RATS
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
RP NOKUBO, M (corresponding author), TOKYO METROPOLITAN INST GERONTOL,CLIN PHYSIOL LAB 1,35-2 SAKAECHO,ITABASHI KU,TOKYO 173,JAPAN.
CR AGNISOLA C, 1980, MECH AGEING DEV, V13, P227, DOI 10.1016/0047-6374(80)90035-4
   ARONSON NN, 1974, METHODS ENZYMOLOGY, V13
   BLITZER BL, 1978, J CLIN INVEST, V62, P1104, DOI 10.1172/JCI109216
   BOYER JL, 1975, BIOCHIM BIOPHYS ACTA, V401, P59, DOI 10.1016/0005-2736(75)90341-7
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   FUJITA S, 1982, LIVER AGING 1982
   HEGNER D, 1975, MECH AGEING DEV, V4, P191, DOI 10.1016/0047-6374(75)90021-4
   INOUE T, 1982, BIOMED GERONTOL, V6, P4
   KANISAWA M, 1980, BIOMEDICAL GERONTOLO, V4, P22
   KIMELBERG HK, 1977, CELL SURFACE REV, V3
   KING TE, 1967, METHODS ENZYMOLOGY, V10
   KITANI K, 1981, MECH AGEING DEV, V17, P381, DOI 10.1016/0047-6374(81)90055-5
   LINDNER J, 1977, LIVER AGEING
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Nagy K, 1983, Arch Gerontol Geriatr, V2, P23, DOI 10.1016/0167-4943(83)90014-6
   NAITO Y, 1981, BIOCHEMISTRY-US, V20, P5188, DOI 10.1021/bi00521a014
   NAKAMURA S, 1978, BIOMEDICAL GERONTOLO, V2, P38
   REICHEN J, 1977, J CLIN INVEST, V60, P429, DOI 10.1172/JCI108792
   RIVNAY B, 1979, MECH AGEING DEV, V10, P71, DOI 10.1016/0047-6374(79)90071-X
   SCHMUCKER DL, 1976, J GERONTOL, V31, P135, DOI 10.1093/geronj/31.2.135
   SHINITZKY M, 1976, BIOCHIM BIOPHYS ACTA, V433, P133, DOI 10.1016/0005-2736(76)90183-8
   STORCH J, 1983, BIOCHIM BIOPHYS ACTA, V727, P209, DOI 10.1016/0005-2736(83)90386-3
   WHETTON AD, 1983, BIOCHEM J, V214, P851, DOI 10.1042/bj2140851
NR 23
TC 57
Z9 57
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PY 1985
VL 40
IS 4
BP 409
EP 414
DI 10.1093/geronj/40.4.409
PG 6
WC Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA ALY61
UT WOS:A1985ALY6100002
PM 2989354
DA 2024-02-19
ER

PT J
AU SPEARMAN, ME
   LEIBMAN, KC
AF SPEARMAN, ME
   LEIBMAN, KC
TI AGING SELECTIVELY ALTERS GLUTATHIONE S-TRANSFERASE ISOZYME
   CONCENTRATIONS IN LIVER AND LUNG CYTOSOL
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
C1 UNIV FLORIDA, DEPT PHARMACOL & THERAPEUT, GAINESVILLE, FL 32610 USA.
C3 State University System of Florida; University of Florida
FU NCRR NIH HHS [RR05362] Funding Source: Medline; NIEHS NIH HHS [ES02895]
   Funding Source: Medline; NIOSH CDC HHS [OH00316] Funding Source: Medline
CR BAIRD MB, 1979, CANCER RES, V39, P4752
   BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158
   CLIFTON G, 1978, BIOCHEM PHARMACOL, V27, P1284, DOI 10.1016/0006-2952(78)90465-3
   COBB D, 1983, BIOCHEMISTRY-US, V22, P805, DOI 10.1021/bi00273a015
   FJELLSTEDT TA, 1973, J BIOL CHEM, V248, P3702
   GUTHENBERG C, 1980, BIOCHIM BIOPHYS ACTA, V631, P1, DOI 10.1016/0304-4165(80)90047-1
   GUTHENBERG C, 1979, BIOCHEM BIOPH RES CO, V86, P1304, DOI 10.1016/0006-291X(79)90258-4
   HABIG WH, 1976, ARCH BIOCHEM BIOPHYS, V175, P710, DOI 10.1016/0003-9861(76)90563-4
   HABIG WH, 1975, BIOCHEM BIOPH RES CO, V64, P501, DOI 10.1016/0006-291X(75)90349-6
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HALES BF, 1978, BIOCHEM J, V175, P937, DOI 10.1042/bj1750937
   HALES BF, 1977, BIOCHEM PHARMACOL, V26, P555, DOI 10.1016/0006-2952(77)90337-9
   HALES BF, 1976, BIOCHEM J, V160, P231, DOI 10.1042/bj1600231
   HALES BF, 1982, BIOCHEM PHARMACOL, V31, P2389, DOI 10.1016/0006-2952(82)90534-2
   HALES BF, 1976, BIOCHEM J, V160, P223, DOI 10.1042/bj1600223
   HAYES JD, 1982, BIOCHEM J, V207, P459, DOI 10.1042/bj2070459
   HESSE S, 1980, BIOCHEM BIOPH RES CO, V94, P612, DOI 10.1016/0006-291X(80)91276-0
   HESSE S, 1982, CARCINOGENESIS, V3, P757, DOI 10.1093/carcin/3.7.757
   JAMES MO, 1977, DRUG METAB DISPOS, V5, P19
   KAPLOWITZ N, 1975, BIOCHEM J, V146, P351, DOI 10.1042/bj1460351
   KEEN JH, 1976, J BIOL CHEM, V251, P6183
   KITAHARA A, 1982, LIVER AGING 1982, P135
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANNERVIK B, 1982, J BIOL CHEM, V257, P9909
   MORGENSTERN R, 1982, CANCER RES, V42, P4215
   MUKHTAR H, 1976, BIOCHEM PHARMACOL, V25, P1081, DOI 10.1016/0006-2952(76)90501-3
   MUKHTAR H, 1978, CHEM-BIOL INTERACT, V22, P153, DOI 10.1016/0009-2797(78)90122-9
   MUNOZ J, 1971, METHODS IMMUNOLOGY I, V3, P146
   PABST MJ, 1974, J BIOL CHEM, V249, P7140
   PATEL JM, 1980, DRUG METAB DISPOS, V8, P305
   PICKETT CB, 1982, BIOCHEM BIOPH RES CO, V104, P611, DOI 10.1016/0006-291X(82)90681-7
   PICKETT CB, 1983, ARCH BIOCHEM BIOPHYS, V221, P89, DOI 10.1016/0003-9861(83)90124-8
   PICKETT CB, 1982, ARCH BIOCHEM BIOPHYS, V215, P539, DOI 10.1016/0003-9861(82)90113-8
   ROBAIRE B, 1982, BIOL REPROD, V26, P559, DOI 10.1095/biolreprod26.4.559
   SPARNINS VL, 1982, J NATL CANCER I, V68, P493
   SPARNINS VL, 1982, CANCER RES, V42, P1205
   SPEARMAN ME, 1983, LIFE SCI, V33, P2615, DOI 10.1016/0024-3205(83)90345-4
   SPEARMAN ME, 1984, BIOCHEM PHARMACOL, V33, P1309, DOI 10.1016/0006-2952(84)90185-0
   STOHS SJ, 1982, BIOCHEM PHARMACOL, V31, P2113, DOI 10.1016/0006-2952(82)90429-4
   STOHS SJ, 1982, GEN PHARMACOL, V13, P519, DOI 10.1016/0306-3623(82)90028-3
   WEBER K, 1969, J BIOL CHEM, V244, P4406
NR 41
TC 30
Z9 30
U1 0
U2 0
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
EI 1521-009X
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PY 1984
VL 12
IS 5
BP 661
EP 671
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TL062
UT WOS:A1984TL06200022
PM 6149920
DA 2024-02-19
ER

PT J
AU Bruni, E
   Cazzetta, V
   Donadon, M
   Cimino, M
   Torzilli, G
   Spata, G
   Leonardi, G
   Dieli, F
   Mikulak, J
   Mavilio, D
AF Bruni, Elena
   Cazzetta, Valentina
   Donadon, Matteo
   Cimino, Matteo
   Torzilli, Guido
   Spata, Gianmarco
   Leonardi, Gloria
   Dieli, Francesco
   Mikulak, Joanna
   Mavilio, Domenico
TI Chemotherapy accelerates immune-senescence and functional impairments of
   Vδ2<SUP>pos</SUP> T cells in elderly patients affected by liver
   metastatic colorectal cancer
SO JOURNAL FOR IMMUNOTHERAPY OF CANCER
LA English
DT Article
DE gamma d T cells; Immune-senescence/Aging; Cancer; Chemotherapy
ID NATURAL-KILLER; MARKERS; NAIVE
AB Human (gamma delta)gamma d T cells are unconventional innate-like lymphocytes displaying a broad array of anti-tumor activities with promising perspectives in cancer immunotherapy. In this context, V delta 2(pos) T cells represent the preferential target of several immunotherapy protocols against solid tumors. However, the impact of both aging and chemotherapy (CHT) on V delta 2(pos) T cells is still unknown. The present study evaluates with multi-parametric flow cytometry the frequencies, terminal differentiation, senescence and effector-functions of peripheral blood and tumor infiltrating V delta 2(pos) T cells purified from liver metastases (CLM) of patients affected by colorectal cancer (CRC) compared to those of sex- and age-matched healthy donors. The peripheral blood of CLM patients underwent CHT is characterized by decreased amounts of V delta 2(pos) T cells showing a relative increase of terminally-differentiated CD27(neg)/CD45RA(pos) (T-EMRA) cells. The enrichment of this latter subset is associated with an increased expression of the senescent marker CD57. The acquisition of CD57 on T-EMRA V delta 2(pos) T cells is also coupled with impairments in cytotoxicity and production of TNF-alpha and IFN-gamma. These features resemble the acquisition of an immune-senescent profile by V delta 2(pos) T cells from CLM patients that received CHT, a phenomenon that is also associated with the loss of the co-stimulatory marker CD28 and with the induced expression of CD16. The group of CLM patients underwent CHT and older than 60 years old showed higher frequencies of CD57(pos) and T-EMRA V delta 2(pos) T cells. Similar results were found for tumor infiltrating V delta 2(pos) T cell subset purified from CLM specimens of patients treated with CHT. The toxicity of CHT regimens also affects the homeostasis of V delta 2(pos) T cells by inducing higher frequencies of circulating CD57(pos) T-EMRA subset in CLM underwent CHT and younger than 60 years old. Taken together, our data demonstrate that the enrichment of senescent V delta 2(pos) T cells in CLM patients is not only induced by patients' aging but also by the toxicity of CHT that further accelerates the accumulation of CD57(pos) T-EMRA cells highly dysfunctional in their anti-tumor activities. These results are important to both predict the clinical outcome of CLM and to optimize those protocols of cell cancer immunotherapy employing unconventional V delta 2(pos) T cells.
C1 [Bruni, Elena; Cazzetta, Valentina; Spata, Gianmarco; Leonardi, Gloria; Mikulak, Joanna; Mavilio, Domenico] IRCCS, Unit Clin & Expt Immunol, Humanitas Clin & Res Ctr, Via Alessandro Manzoni 56, Milan, Italy.
   [Bruni, Elena; Cazzetta, Valentina; Spata, Gianmarco; Leonardi, Gloria; Mikulak, Joanna; Mavilio, Domenico] Univ Milan, Dept Med Biotechnol & Translat Med BioMeTra, Milan, Italy.
   [Donadon, Matteo; Cimino, Matteo; Torzilli, Guido] Humanitas Univ, Dept Hepatobiliary & Gen Surg, Humanitas Clin & Res Ctr, IRCCS, Milan, Italy.
   [Dieli, Francesco] Cent Lab Adv Diag & Biomed Res, Palermo, Italy.
   [Dieli, Francesco] Univ Palermo, Dept Biomed Neurosci & Adv Diagnost BiND, Palermo, Italy.
C3 University of Milan; Humanitas University; University of Palermo
RP Mikulak, J; Mavilio, D (corresponding author), IRCCS, Unit Clin & Expt Immunol, Humanitas Clin & Res Ctr, Via Alessandro Manzoni 56, Milan, Italy.
EM joanna.mikulak@humanitasresearch.it; domenico.mavilio@unimi.it
RI mikulak, joanna/AAB-3070-2022; Leonardi, Gloria/CAF-9037-2022; Bruni,
   Elena/AAU-4777-2020; Cimino, Matteo/C-6305-2018; Cazzetta,
   Valentina/ABI-1142-2020; Cimino, Matteo/AAY-9558-2021; Dieli,
   Francesco/IAR-6877-2023; Leonardi, Gloria/CAI-5690-2022
OI mikulak, joanna/0000-0001-8310-9543; Bruni, Elena/0000-0003-4714-8275;
   Cimino, Matteo/0000-0003-0838-964X; Cazzetta,
   Valentina/0000-0001-7183-2793; Cimino, Matteo/0000-0003-0838-964X;
   Spata, Gianmarco/0000-0002-6410-8833
FU Associazione Italiana per la Ricerca sul Cancro [IG-14687, IG 21567];
   Italian Ministry of Health (Bando Ricerca Finalizzata)
   [PE-2016-02363915]; Intramural Research Funding of Istituto Clinico
   Humanitas
FX This work was supported by Associazione Italiana per la Ricerca sul
   Cancro (IG-14687 and IG 21567 to D.M.), Italian Ministry of Health
   (Bando Ricerca Finalizzata PE-2016-02363915 to D.M.) and Intramural
   Research Funding of Istituto Clinico Humanitas (to D.M.).
CR Akagi J, 2008, INT J CLIN ONCOL, V13, P528, DOI 10.1007/s10147-008-0789-8
   Angelini DF, 2004, BLOOD, V104, P1801, DOI 10.1182/blood-2004-01-0331
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   Caccamo N, 2005, EUR J IMMUNOL, V35, P1764, DOI 10.1002/eji.200525983
   Chou JP, 2013, CURR PHARM DESIGN, V19, P1680
   Donadon M, 2017, J GASTROINTEST SURG, V21, P1226, DOI 10.1007/s11605-017-3446-6
   Godfrey DI, 2018, IMMUNITY, V48, P453, DOI 10.1016/j.immuni.2018.03.009
   Henderson Tara O, 2014, Am Soc Clin Oncol Educ Book, pe423, DOI 10.14694/EdBook_AM.2014.34.e423
   Hurria Arti, 2016, Am Soc Clin Oncol Educ Book, V35, pe516, DOI 10.14694/EDBK_156160
   Kolligs FT, 2016, VISC MED, V32, P158, DOI 10.1159/000446488
   Konopke R, 2012, J GASTROINTEST LIVER, V21, P83
   Lanna A, 2014, NAT IMMUNOL, V15, P965, DOI 10.1038/ni.2981
   Larbi A, 2014, CYTOM PART A, V85A, P25, DOI 10.1002/cyto.a.22351
   Mou D, 2014, AM J TRANSPLANT, V14, P2460, DOI 10.1111/ajt.12937
   Onyema OO, 2015, ANTICANCER RES, V35, P1481
   Pancione M, 2017, CURR MED CHEM, V24, P1383, DOI 10.2174/0929867324666170227114356
   Roberto A, 2018, HAEMATOLOGICA, V103, P1390, DOI 10.3324/haematol.2017.186619
   Rubbia-Brandt L, 2007, ANN ONCOL, V18, P299, DOI 10.1093/annonc/mdl386
   Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904
   Smetana K, 2016, ANTICANCER RES, V36, P5009, DOI 10.21873/anticanres.11069
   Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384
   Willcox BE, 2019, NAT IMMUNOL, V20, P121, DOI 10.1038/s41590-018-0304-y
   Xu WL, 2019, EBIOMEDICINE, V39, P44, DOI 10.1016/j.ebiom.2018.11.053
   Xu WL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081742
   Zou C, 2017, ONCOTARGET, V8, P8900, DOI 10.18632/oncotarget.13051
NR 25
TC 31
Z9 32
U1 1
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2051-1426
J9 J IMMUNOTHER CANCER
JI J. Immunother. Cancer
PD DEC 11
PY 2019
VL 7
IS 1
AR 347
DI 10.1186/s40425-019-0825-4
PG 8
WC Oncology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Immunology
GA KI1QU
UT WOS:000511123600003
PM 31829255
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU SILBER, JR
   FRY, M
   MARTIN, GM
   LOEB, LA
AF SILBER, JR
   FRY, M
   MARTIN, GM
   LOEB, LA
TI FIDELITY OF DNA-POLYMERASES ISOLATED FROM REGENERATING LIVER CHROMATIN
   OF AGING MUS-MUSCULUS
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
C1 UNIV WASHINGTON, DEPT PATHOL SM30, JOSEPH GOTTSTEIN MEM CANC RES LAB, SEATTLE, WA 98195 USA.
   NATL CTR TOXICOL RES, JEFFERSON, AR 72079 USA.
   TECHNION ISRAEL INST TECHNOL, FAC MED, BIOCHEM UNIT, IL-31096 HAIFA, ISRAEL.
   UNIV WASHINGTON, DIV GENET PATHOL, SEATTLE, WA 98195 USA.
C3 University of Washington; University of Washington Seattle; US Food &
   Drug Administration (FDA); Technion Israel Institute of Technology;
   Rappaport Faculty of Medicine; University of Washington; University of
   Washington Seattle
FU NCI NIH HHS [CA-24845] Funding Source: Medline; NIA NIH HHS [AG-00057,
   AG-01451] Funding Source: Medline
CR AGARWAL SS, 1978, J CELL PHYSIOL, V96, P235, DOI 10.1002/jcp.1040960212
   BATTULA N, 1974, J BIOL CHEM, V249, P4086
   FRY M, 1981, J CELL PHYSIOL, V106, P435, DOI 10.1002/jcp.1041060313
   FRY M, 1976, BIOCHEMISTRY-US, V15, P4319, DOI 10.1021/bi00664a028
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   FRY M, 1983, ENZYMES NUCLEIC ACID, V1, P39
   GERSHON H, 1970, NATURE, V227, P1214, DOI 10.1038/2271214a0
   GOLDSTEIN S, 1975, NATURE, V255, P159, DOI 10.1038/255159a0
   GOLDSTEIN S, 1974, NATURE, V251, P719, DOI 10.1038/251719b0
   GOODMAN MF, 1983, J BIOL CHEM, V258, P3469
   HANAWALT PC, 1979, ANNU REV BIOCHEM, V48, P783, DOI 10.1146/annurev.bi.48.070179.004031
   HOLLIDAY R, 1972, NATURE, V238, P26, DOI 10.1038/238026a0
   JOVIN TM, 1969, J BIOL CHEM, V244, P2996
   KNOPF KW, 1977, BIOCHEMISTRY-US, V16, P3190, DOI 10.1021/bi00633a023
   Korn D, 1981, Prog Nucleic Acid Res Mol Biol, V26, P63, DOI 10.1016/S0079-6603(08)60395-5
   KRAUSS SW, 1982, BIOCHEMISTRY-US, V21, P1002, DOI 10.1021/bi00534a027
   KUNKEL TA, 1980, J BIOL CHEM, V255, P9961
   KUNKEL TA, 1979, J BIOL CHEM, V254, P5718
   KUNKEL TA, 1981, SCIENCE, V213, P765, DOI 10.1126/science.6454965
   LEWIS CM, 1970, NATURE, V228, P877, DOI 10.1038/228877a0
   LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018
   LINN S, 1976, P NATL ACAD SCI USA, V73, P2818, DOI 10.1073/pnas.73.8.2818
   LOEB LA, 1969, J BIOL CHEM, V244, P1672
   LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241
   LYNCH WE, 1975, J BIOL CHEM, V250, P8179
   Maniatis T., 1982, MOL CLONING
   MURRAY V, 1981, J MOL BIOL, V146, P55, DOI 10.1016/0022-2836(81)90366-1
   ORGEL LE, 1973, NATURE, V244, P441, DOI 10.1038/243441a0
   PENDERGRASS WR, 1976, J CELL PHYSIOL, V87, P3, DOI 10.1002/jcp.1040870103
   SCHENDEL PF, 1981, CRC CR REV TOXICOL, V8, P311, DOI 10.3109/10408448109089902
   STALKER DM, 1976, BIOCHEMISTRY-US, V15, P3114, DOI 10.1021/bi00659a027
   WEYMOUTH LA, 1978, P NATL ACAD SCI USA, V75, P1924, DOI 10.1073/pnas.75.4.1924
   WULF JH, 1975, EXP GERONTOL, V10, P101, DOI 10.1016/0531-5565(75)90040-6
NR 33
TC 29
Z9 29
U1 0
U2 0
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PY 1985
VL 260
IS 2
BP 1304
EP 1310
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AAL98
UT WOS:A1985AAL9800096
PM 3968062
DA 2024-02-19
ER

PT J
AU Gadi, S
   Niture, S
   Hoang, H
   Qi, Q
   Hatcher, C
   Huang, XY
   Haider, J
   Norford, DC
   Leung, T
   Levine, KE
   Kumar, D
AF Gadi, Sashi
   Niture, Suryakant
   Hoang, Hieu
   Qi, Qi
   Hatcher, Charles
   Huang, Xiaoyan
   Haider, Jamil
   Norford, Derek C.
   Leung, Tinchung
   Levine, Keith E.
   Kumar, Deepak
TI Deficiency of <i>spns1</i> exacerbates per- and polyfluoroalkyl
   substances mediated hepatic toxicity and steatosis in zebrafish
   <i>(Danio rerio)</i>
SO TOXICOLOGY
LA English
DT Article
DE Zebrafish (Danio rerio ); Perfluorooctanoic acid (PFOA); Unfolded
   protein response (UPR); Senescence; Hepatic steatosis; Nonalcoholic
   fatty liver disease
ID UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; PERFLUOROOCTANE
   SULFONATE; PERFLUOROALKYL ACIDS; AUTOPHAGY; PFOA; EXPOSURE; CELL;
   ASSOCIATION; MECHANISMS
AB Per- and polyfluoroalkyl substances (PFAS) are man-made long-lasting chemical compounds that are found in everyday household items. Today they occur in the environment as a major group of pollutants. These compounds are broadly used in commercial product preparation such as, for food packaging, nonstick coatings, and firefighting foam. In humans, PFAS can cause immune disorders, impaired fetal development, abnormal skeletal tissue development, osteoarthritis, thyroid dysfunctions, cholesterol changes, affect insulin regulation and lipid metabolism, and are also involved in the development of fatty liver disease. In the current study, we investigated the effect of low, but physiologically relevant, concentrations of perfluorooctanoic acid (PFOA), heptafluorobutyric acid (HFBA), and perfluorotetradecanoic acid (PFTA) on gene expression markers of an inflammatory response (tnfa, il-1b, il-6, rplp0, edem1, and dnajc3a), unfolded protein response (UPR) (bip, atf4a, atf6, xbp1, and ddit3), senescence (p21, pai1, smp30, mdm2, and baxa), lipogenesis (scd1, acc, srebp1, ppar gamma, and fasn) and autophagy (p62, atg3, atg7, rab7, lc3b, and becn1) in AB wild-type (+/+), spns1-wt sibling (+/+), (+/-) and spns1 homozygous mutant (-/-) zebrafish embryos. Exposure to PFOA and HFBA (50 and 100 nM) specifically modulated inflammatory, UPR, senescence, lipogenic, and autophagy signaling in spns1-wt (+/+), (+/-), and spns1-mutant (-/-) zebrafish embryos. Furthermore, PFOA, but not HFBA, upregulated lipogenic-related gene expression and enhanced hepatic steatosis in spns1-wt (+/+), (+/-) zebrafish embryos. Combined exposure to PFOA, HFBA, and PFTA differentially expressed inflammatory, senescence, lipogenic, and autophagy-associated gene expression in spns1-mutant (-/-) zebrafish embryos compared with spns1-wt (+/+), (+/-) and AB-wt (+/+) zebrafish embryos. In addition, chronic exposure (similar to 2 months) to PFOA (120-600 nM) upregulated the expression of hepatic lipogenic and steatosis biomarkers in AB-wt (+/+) zebrafish. Collectively, our data suggest that acute/chronic physiologically relevant concentrations of PFOA upregulate inflammatory, UPR, senescence, and lipogenic signaling in spns1-wt (+/+), (+/-) and spns1-mutant (-/-) zebrafish embryos as well as in two-month-old AB-wt zebrafish, by targeting autophagy and hence induces toxicity that could promote nonalcoholic fatty liver disease.
C1 [Gadi, Sashi; Niture, Suryakant; Hoang, Hieu; Qi, Qi; Hatcher, Charles; Norford, Derek C.; Kumar, Deepak] North Carolina Cent Univ NCCU, Julius L Chambers Biomed Biotechnol Res Inst JLC B, Durham, NC USA.
   [Huang, Xiaoyan; Haider, Jamil; Leung, Tinchung] NCCU, JLC BBRI North Carolina Res Campus, Kannapolis, NC USA.
   [Niture, Suryakant; Levine, Keith E.; Kumar, Deepak] NCCU, RTI Ctr Appl Res Environm Sci CARES, RTI Int, Res Triangle Pk, Durham, NC USA.
   [Niture, Suryakant; Kumar, Deepak] North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst BBRI, 1801 Fayetteville St, Durham, NC 27707 USA.
C3 Research Triangle Institute; University of North Carolina; North
   Carolina Central University
RP Niture, S; Kumar, D (corresponding author), North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst BBRI, 1801 Fayetteville St, Durham, NC 27707 USA.
EM sniture@nccu.edu; dkumar@nccu.edu
OI Niture, Suryakant/0000-0003-0613-9399; Levine, Keith/0000-0001-7976-916X
FU North Carolina PFAS Testing Network through North Carolina
   Collaboratory; National Institute on Minority Health and Health
   Disparities/National Institutes of Health (NIMHD/NIH) [U54MD012392,
   R01MD012767]; Center for Human Health; Environment of NC State
   University & National Institute of Environmental Health Sciences
   [P30ES025128]
FX This study was supported by North Carolina PFAS Testing Network through
   The North Carolina Collaboratory and grants U54MD012392 and R01MD012767
   from National Institute on Minority Health and Health
   Disparities/National Institutes of Health (NIMHD/NIH) to D.K; Pilot
   project funding from Center for Human Health and the Environment of NC
   State University & National Institute of Environmental Health Sciences
   (P30ES025128) to TL, DN, DK. We are also thankful to CARES laboratory
   members for providing valuable suggestions, and thankful to Ms. Chunyu
   Xi for zebrafish care.
CR Abbadie C, 2020, TRENDS BIOCHEM SCI, V45, P371, DOI 10.1016/j.tibs.2020.02.005
   Adedara IA, 2022, ECOTOX ENVIRON SAFE, V239, DOI 10.1016/j.ecoenv.2022.113635
   Behr AC, 2020, TOXICOL IN VITRO, V62, DOI 10.1016/j.tiv.2019.104700
   Brennan NM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182010900
   Buhrke T, 2015, TOXICOLOGY, V333, P53, DOI 10.1016/j.tox.2015.04.004
   Cave MC, 2016, BBA-GENE REGUL MECH, V1859, P1083, DOI 10.1016/j.bbagrm.2016.03.002
   Chang ET, 2016, CRIT REV TOXICOL, V46, P279, DOI 10.3109/10408444.2015.1122573
   Cheng JF, 2016, AQUAT TOXICOL, V176, P45, DOI 10.1016/j.aquatox.2016.04.013
   Coffey EC, 2021, J DEV BIOL, V9, DOI 10.3390/jdb9040052
   Costello E, 2022, ENVIRON HEALTH PERSP, V130, DOI 10.1289/EHP10092
   Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129
   Czaja MJ, 2016, DIGEST DIS SCI, V61, P1304, DOI 10.1007/s10620-015-4025-x
   Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063
   Das KP, 2017, TOXICOLOGY, V378, P37, DOI 10.1016/j.tox.2016.12.007
   Eldakhakhny BM, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.641888
   Forsthuber M, 2020, ENVIRON INT, V137, DOI 10.1016/j.envint.2019.105324
   Fraher D, 2016, CELL REP, V14, P1317, DOI 10.1016/j.celrep.2016.01.016
   Frisbee SJ, 2010, ARCH PEDIAT ADOL MED, V164, P860, DOI 10.1001/archpediatrics.2010.163
   Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0
   Geiger SD, 2014, CHEMOSPHERE, V98, P78, DOI 10.1016/j.chemosphere.2013.10.005
   Glüge J, 2020, ENVIRON SCI-PROC IMP, V22, P2345, DOI 10.1039/d0em00291g
   Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62
   Gupta T., 2010, J Vis Exp
   He ML, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2210353119
   Huang J, 2022, SCI TOTAL ENVIRON, V839, DOI 10.1016/j.scitotenv.2022.156388
   Huang QY, 2013, TOXICOL LETT, V223, P211, DOI 10.1016/j.toxlet.2013.09.002
   Jackson TW, 2021, ENVIRON SCI TECHNOL, V55, P12291, DOI 10.1021/acs.est.1c01200
   Jin R, 2020, ENVIRON INT, V134, DOI 10.1016/j.envint.2019.105220
   Kanungo J, 2014, CURR PHARM DESIGN, V20, P5416, DOI 10.2174/1381612820666140205145658
   Khan A, 2021, J CELL MOL MED, V25, P1048, DOI 10.1111/jcmm.16171
   Khandia R, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070674
   Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152
   Kwon J, 2023, ANIM CELLS SYST, V27, P29, DOI 10.1080/19768354.2023.2181217
   Li Y, 2018, OCCUP ENVIRON MED, V75, P46, DOI 10.1136/oemed-2017-104651
   Liu YX, 2023, ENVIRON INT, V176, DOI 10.1016/j.envint.2023.107977
   Luebker DJ, 2002, TOXICOLOGY, V176, P175, DOI 10.1016/S0300-483X(02)00081-1
   Marion MJ, 2010, METHODS MOL BIOL, V640, P261, DOI 10.1007/978-1-60761-688-7_13
   Melzer D, 2010, ENVIRON HEALTH PERSP, V118, P686, DOI 10.1289/ehp.0901584
   Chahardehi AM, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9101345
   Namkoong S, 2018, MOL CELLS, V41, P3, DOI 10.14348/molcells.2018.2213
   Nelson JW, 2010, ENVIRON HEALTH PERSP, V118, P197, DOI 10.1289/ehp.0901165
   Nicole W, 2013, ENVIRON HEALTH PERSP, V121, pA340, DOI 10.1289/ehp.121-A340
   Niture S, 2023, TOXINS, V15, DOI 10.3390/toxins15070411
   Niture S, 2021, INT J HEPATOL, V2021, DOI 10.1155/2021/6675762
   Panieri E, 2022, TOXICS, V10, DOI 10.3390/toxics10020044
   Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014
   Qi Q, 2023, ENVIRON TOXICOL, V38, P225, DOI 10.1002/tox.23680
   Roth K, 2021, ENVIRON INT, V157, DOI 10.1016/j.envint.2021.106843
   Rubinstein AL, 2006, EXPERT OPIN DRUG MET, V2, P231, DOI 10.1517/17425255.2.2.231
   Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138
   Sasaki T, 2017, AUTOPHAGY, V13, P386, DOI 10.1080/15548627.2016.1256934
   Sasaki T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004409
   Satbhai K, 2022, CHEMOSPHERE, V308, DOI 10.1016/j.chemosphere.2022.136131
   Scharenberg SG, 2023, SCI ADV, V9, DOI 10.1126/sciadv.adf8966
   Schlezinger JJ, 2020, TOXICOL APPL PHARM, V405, DOI 10.1016/j.taap.2020.115204
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sen P, 2022, J HEPATOL, V76, P283, DOI 10.1016/j.jhep.2021.09.039
   Sheng N, 2016, ARCH TOXICOL, V90, P217, DOI 10.1007/s00204-014-1391-7
   Shin DW, 2020, MOL CELLS, V43, P686, DOI 10.14348/molcells.2020.0046
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sunderland EM, 2019, J EXPO SCI ENV EPID, V29, P131, DOI 10.1038/s41370-018-0094-1
   Uhl SA, 2013, ENVIRON HEALTH PERSP, V121, P447, DOI 10.1289/ehp.1205673
   Ulhaq ZS, 2023, J HAZARD MATER, V457, DOI 10.1016/j.jhazmat.2023.131722
   Wan C, 2016, TOXICOL APPL PHARM, V295, P85, DOI 10.1016/j.taap.2016.01.023
   Wan HT, 2012, BBA-GEN SUBJECTS, V1820, P1092, DOI 10.1016/j.bbagen.2012.03.010
   Wang PW, 2022, TOXICS, V10, DOI 10.3390/toxics10050265
   Xie YC, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00431
   Xu JW, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10071632
   Xu YY, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP6785
   Yanagisawa H, 2003, CELL DEATH DIFFER, V10, P798, DOI 10.1038/sj.cdd.4401246
   Yang ZY, 2023, SCI TOTAL ENVIRON, V861, DOI 10.1016/j.scitotenv.2022.160691
   Yazdani HO, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020091
   Young RM, 2002, DEV DYNAM, V223, P298, DOI 10.1002/dvdy.10060
   Zhang LM, 2016, TOXICOL SCI, V153, P186, DOI 10.1093/toxsci/kfw120
NR 74
TC 0
Z9 0
U1 10
U2 10
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
EI 1879-3185
J9 TOXICOLOGY
JI Toxicology
PD NOV
PY 2023
VL 499
AR 153641
DI 10.1016/j.tox.2023.153641
EA OCT 2023
PG 16
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA Y4EW1
UT WOS:001104821100001
PM 37806615
DA 2024-02-19
ER

PT J
AU Zhang, ZY
   Fang, C
   Zhang, Y
   Su, S
   Li, B
   Liu, G
   Hu, ZH
   Tian, J
AF Zhang, Zeyu
   Fang, Cheng
   Zhang, Yang
   Su, Song
   Li, Bo
   Liu, Gang
   Hu, Zhenhua
   Tian, Jie
TI NIR-II nano fluorescence image guided hepatic carcinoma resection on
   cirrhotic patient
SO PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY
LA English
DT Article
DE NIR-II fluorescence imaging; Hepatic carcinoma (HCC); Cirrhosis;
   Image-guided surgery; Nano probe
AB Precise resection of hepatic carcinoma (HCC) remains challenging for cirrhotic patients. Cirrhosis not only effects intraoperative palpation, but can also cause severe false-positive problems to indocyanine green (ICG) fluores-cence imaging. Herein, we report the application of a nano-scale probe IgG-IRDye800CW to achieve precise HCC resection from cirrhotic liver. A 66-year-old male patient with liver cancer received intravenous injection of IgG-IRDye800CW (10 mg) 6 days prior to surgery, and none adverse effects were observed. During the operation, the HCC lesion in the right liver lobe was specifically detected on the near-infrared window II (NIR-II) fluorescence images. The high-contrast NIR-II fluorescence delineated a clear margin to improve surgical precision. These clinical observations showed high safety and feasibility of applying IgG-IRDye800CW NIR-II fluorescence im-aging to guide hepatic surgery and minimize hepatic function damage.
C1 [Zhang, Zeyu; Tian, Jie] Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Sch Engn Med, Beijing, Peoples R China.
   [Zhang, Zeyu; Hu, Zhenhua; Tian, Jie] Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing Key Lab Mol Imaging, Beijing, Peoples R China.
   [Fang, Cheng; Su, Song; Li, Bo] Southwest Med Univ, Dept Gen Surg Hepatobiliary Surg, Affiliated Hosp, Luzhou, Peoples R China.
   [Zhang, Yang; Liu, Gang] Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diag, Xiamen, Peoples R China.
   [Hu, Zhenhua] Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing, Peoples R China.
C3 Beihang University; Chinese Academy of Sciences; Institute of
   Automation, CAS; Southwest Medical University; Xiamen University;
   Chinese Academy of Sciences; University of Chinese Academy of Sciences,
   CAS
RP Hu, ZH; Tian, J (corresponding author), Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing Key Lab Mol Imaging, Beijing, Peoples R China.; Liu, G (corresponding author), Xiamen Univ, Ctr Mol Imaging & Translat Med, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diag, Xiamen, Peoples R China.
EM gangliu.cmitm@xmu.edu; zhenhua.hu@ia.ac; tian@ieee.org
RI Zhang, Zeyu/HTO-6741-2023; Tian, Jie/H-1190-2011; Liu,
   Gang/AAC-4177-2020; li, xiang/JCN-9316-2023
OI Tian, Jie/0000-0003-0498-0432; Liu, Gang/0000-0003-2613-7286; Zhang,
   Yang/0000-0002-3476-8937
FU National Key Research and Development Program of China [2017YFA0205200];
   National Natural Science Foundation of China (NSFC) [62027901, 92059207,
   81930048, 81930053, 81227901, 81801864, 82102236]; Chinese Academy of
   Sciences [QYZDJ-SSW-JSC005]; CAS Youth Interdisciplinary Team
   [JCTD-2021-08]; Beijing Natural Science Foundation [JQ19027]; China
   Postdoctoral Science Foundation [2022T150037, 2021M690007]; Zhuhai
   High-level Health Personnel Team Project (Zhuhai) [HLHPTP201703];
   innovative research team of high-level local universities in Shanghai
FX This study was funded by the National Key Research and Development
   Program of China (2017YFA0205200) , National Natural Science Foundation
   of China (NSFC) (62027901, 92059207, 81930048, 81930053, 81227901,
   81801864, 82102236, 81801864) , the Chinese Academy of Sciences
   (QYZDJ-SSW-JSC005) , CAS Youth Interdisciplinary Team (JCTD-2021-08) ,
   Beijing Natural Science Foundation (JQ19027) , China Postdoctoral
   Science Foundation (2022T150037, 2021M690007) , the innovative research
   team of high-level local universities in Shanghai, and the Zhuhai
   High-level Health Personnel Team Project (Zhuhai HLHPTP201703) .
CR An Y, 2018, VIS COMPUT IND BIOME, V1, DOI 10.1186/s42492-018-0001-6
   Antaris AL, 2016, NAT MATER, V15, P235, DOI [10.1038/NMAT4476, 10.1038/nmat4476]
   Cao CG, 2022, IEEE T BIO-MED ENG, V69, P2404, DOI 10.1109/TBME.2022.3143859
   Cao CG, 2021, CLIN TRANSL MED, V11, DOI 10.1002/ctm2.604
   Chang BS, 2022, NAT BIOMED ENG, V6, P629, DOI 10.1038/s41551-021-00773-2
   Garrido A, 2021, TRENDS CANCER, V7, P29, DOI 10.1016/j.trecan.2020.08.005
   Hu ZH, 2020, NAT BIOMED ENG, V4, P259, DOI 10.1038/s41551-019-0494-0
   Kanwal F, 2019, GASTROENTEROLOGY, V157, P54, DOI 10.1053/j.gastro.2019.02.049
   Mieog JSD, 2022, NAT REV CLIN ONCOL, V19, P9, DOI 10.1038/s41571-021-00548-3
   Qu QJ, 2022, EUR J NUCL MED MOL I, V49, P4752, DOI 10.1007/s00259-022-05895-6
   Shi XJ, 2022, IEEE T BIO-MED ENG, V69, P1889, DOI 10.1109/TBME.2021.3130195
   Wang XY, 2021, ANN SURG, V274, P97, DOI 10.1097/SLA.0000000000004718
   Yang JY, 2021, NANO TODAY, V38, DOI 10.1016/j.nantod.2021.101120
   Zhang ZY, 2022, EUR J NUCL MED MOL I, V49, P2531, DOI 10.1007/s00259-022-05730-y
NR 14
TC 6
Z9 6
U1 10
U2 42
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1572-1000
EI 1873-1597
J9 PHOTODIAGN PHOTODYN
JI Photodiagnosis Photodyn. Ther.
PD DEC
PY 2022
VL 40
AR 103098
DI 10.1016/j.pdpdt.2022.103098
PG 3
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 4W9KW
UT WOS:000860474600007
PM 36055624
DA 2024-02-19
ER

PT J
AU LECOUTEUR, DG
   RIVORY, LP
   POND, SM
AF LECOUTEUR, DG
   RIVORY, LP
   POND, SM
TI THE EFFECTS OF AGING AND NUTRITIONAL STATE ON HYPOXIA-REOXYGENATION
   INJURY IN THE PERFUSED-RAT-LIVER
SO TRANSPLANTATION
LA English
DT Article
ID REPERFUSION INJURY; PH; TRANSPLANTATION; PARADOX
AB During liver transplantation, donor livers are subject to hypoxia and reoxygenation. Recently, because of a shortage of suitable donors, the livers of older donors have been used for transplantation. In this study, we examined the influence of aging and nutritional state on hepatic intracellular pH (pH(i)) and the susceptibility of the rat liver to hypoxia-reoxygenation injury. Perfused livers from fasted and fed, young (23 months) and aged (24-28 months) male Wistar rats were compared during 30 min of nitrogen hypoxia followed by 20 min of reoxygenation. Under control conditions, pH(i) was significantly lower and glucose release higher in livers from fed young rats (7.24+/-0.04, 3.4+/-1.8 mu mol/min/g) than in those from fasted young (7.33+/-0.04, 0.0+/-1.3), fasted aged (7.32+/-0.03, -0.1+/-0.5), and fed aged rats (7.29+/-0.06, 0.9+/- 1.0). In all groups, pH(i) fell by similar to 0.15 U during hypoxia. Lactate dehydrogenase (LDH) release from the livers of fed young livers was unaffected by hypoxia-reoxygenation as was that from the livers of fed aged rats, despite features that would be expected to predispose to injury (reduced glucose output and more alkaline pH(i)). In contrast, livers from fasted young and aged rats had substantially increased LDH release and reduced bile flow during hypoxia. There were no age-related differences in these parameters, but, during reoxygenation, LDH release was significantly less in the aged livers. These results indicate that the livers of fed rats are resistant to hypoxia-reoxygenation injury and that aging does not increase the susceptibility of the liver to injury in the fasted state.
RP LECOUTEUR, DG (corresponding author), UNIV QUEENSLAND,PRINCESS ALEXANDRA HOSP,DEPT MED,WOOLLOONGABBA,QLD 4102,AUSTRALIA.
OI Le Couteur, David/0000-0002-4227-5817; Rivory,
   Laurent/0000-0002-1734-7882
CR ADAM R, 1991, TRANSPLANT P, V23, P2602
   ANDERSSON BS, 1987, AM J PHYSIOL, V252, pC349, DOI 10.1152/ajpcell.1987.252.4.C349
   AOKI T, 1965, JNCI-J NATL CANCER I, V34, P255, DOI 10.1093/jnci/34.2.255
   ASTARCIOGLU I, 1991, TRANSPLANT P, V23, P2465
   BOWERS JL, 1992, AM J PHYSIOL, V262, pG636, DOI 10.1152/ajpgi.1992.262.4.G636
   BRADFORD BU, 1986, J PHARMACOL EXP THER, V236, P263
   BRASS CA, 1992, AM J PHYSIOL, V263, pG293, DOI 10.1152/ajpgi.1992.263.3.G293
   BRONK SF, 1993, AM J PHYSIOL, V264, pG744, DOI 10.1152/ajpgi.1993.264.4.G744
   BROUWER A, 1991, LIVER AGING 1990, P267
   CURRIN RT, 1991, FASEB J, V5, P207, DOI 10.1096/fasebj.5.2.2004664
   GORESKY CA, 1963, AM J PHYSIOL, V204, P626
   HEMS DA, 1980, PHYSIOL REV, V60, P1
   JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355
   KONNO H, 1992, TRANSPLANTATION, V52, P1211
   LECOUTEUR D, 1992, BIOCHEM PHARMACOL, V43, P913, DOI 10.1016/0006-2952(92)90264-J
   LECOUTEUR DG, 1993, AM J PHYSIOL, V264, pG767, DOI 10.1152/ajpgi.1993.264.4.G767
   LEMASTERS JJ, 1983, J CELL BIOL, V97, P778, DOI 10.1083/jcb.97.3.778
   LINDERT KA, 1992, AM J PHYSIOL, V262, pG345, DOI 10.1152/ajpgi.1992.262.2.G345
   PRUIM J, 1989, TRANSPLANT P, V21, P2383
   SAKAI Y, 1993, TRANSPLANTATION, V55, P18, DOI 10.1097/00007890-199301000-00005
   SHIMAZU T, 1978, LIVER AGING 1978, P263
   SINGH SN, 1968, J BIOL CHEM, V243, P4526
   STITH RD, 1985, MECH AGEING DEV, V30, P73, DOI 10.1016/0047-6374(85)90060-0
   THURMAN RG, 1988, TRANSPLANTATION, V46, P502, DOI 10.1097/00007890-198810000-00006
   VITORICA J, 1981, ENZYME, V26, P144
   WALL WJ, 1990, TRANSPLANTATION, V49, P377, DOI 10.1097/00007890-199002000-00030
   WYNNE HA, 1990, AGE AGEING, V19, P1, DOI 10.1093/ageing/19.1.1
NR 27
TC 25
Z9 25
U1 0
U2 0
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD SEP 15
PY 1994
VL 58
IS 5
BP 531
EP 536
DI 10.1097/00007890-199409150-00001
PG 6
WC Immunology; Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Surgery; Transplantation
GA PG202
UT WOS:A1994PG20200001
PM 8091478
OA Bronze
DA 2024-02-19
ER

PT J
AU Tokumaru, S
   Iguchi, H
   Kojo, S
AF Tokumaru, S
   Iguchi, H
   Kojo, S
TI Change of the lipid hydroperoxide level in mouse organs on ageing
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE ageing; hydroperoxide; lipid peroxidation; radical reaction (Mouse)
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; ACID-REACTIVE SUBSTANCES;
   PHOSPHATIDYLCHOLINE HYDROPEROXIDE; OXYGEN-CONSUMPTION; MALONDIALDEHYDE;
   RAT
AB Change in the total level of tissue lipid hydroperoxides during ageing in the mouse was determined by our newly developed specific and sensitive method. The hepatic level of lipid hydroperoxides of 5-week-old mice was 239 +/- 31 pmol/mg protein. Hydroperoxide levels in the liver of 20-, 30-, 40-, 60- and 85-week-old groups were 487 +/- 115, 348 +/- 87, 395 +/- 65, 498 +/- 98 and 431 +/- 81 pmol/mg protein, respectively, and these values were significantly higher than the content of the 5-week-old animals. In the heart and kidney, the level of lipid hydroperoxides increased also significantly at 20 weeks of age compared with that of the 5 week-old mouse. The hydroperoxide level did not increase significantly thereafter until 85 weeks of age. The hydroperoxide level in the brain did not change during 5-85 weeks of age.
C1 NARA WOMENS UNIV,DEPT FOOD SCI & NUTR,NARA 630,JAPAN.
   KYOTO UNIV,FAC MED,DEPT PUBL HLTH,KYOTO 606,JAPAN.
C3 Nara Womens University; Kyoto University
RI Kojo, Shosuke/GNP-0971-2022
CR AKASAKA K, 1987, ANAL LETT, V20, P731
   BECKMAN JK, 1991, FREE RADICAL BIO MED, V11, P335, DOI 10.1016/0891-5849(91)90148-V
   CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433
   COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908
   Cutler R., 1984, Free Radicals in Biology, V6, P371
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   Halliwell B., 1989, FREE RADICAL BIO MED, P1
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   KISHIDA E, 1990, BIOCHIM BIOPHYS ACTA, V1045, P187, DOI 10.1016/0005-2760(90)90149-R
   KISHIDA E, 1993, J AGR FOOD CHEM, V41, P1598, DOI 10.1021/jf00034a013
   KISHIDA E, 1993, J AGR FOOD CHEM, V41, P1, DOI 10.1021/jf00025a001
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MIYAZAWA T, 1988, J BIOCHEM-TOKYO, V103, P744, DOI 10.1093/oxfordjournals.jbchem.a122339
   MIYAZAWA T, 1993, LIPIDS, V28, P789, DOI 10.1007/BF02536232
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   TOKUMARU S, 1995, ANAL CHIM ACTA, V307, P97, DOI 10.1016/0003-2670(95)00045-2
   YAMAMOTO Y, 1990, METHOD ENZYMOL, V186, P371
   YAMAMOTO Y, 1987, ANAL BIOCHEM, V160, P7, DOI 10.1016/0003-2697(87)90606-3
   ZHANG JR, 1994, BRAIN RES, V639, P275, DOI 10.1016/0006-8993(94)91741-8
NR 21
TC 22
Z9 23
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JAN 5
PY 1996
VL 86
IS 1
BP 67
EP 74
DI 10.1016/0047-6374(95)01674-0
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TX129
UT WOS:A1996TX12900006
PM 8866737
DA 2024-02-19
ER

PT J
AU Yao, Q
   Yang, GB
   Wang, H
   Liu, JZ
   Zheng, JP
   Lv, B
   Yang, MY
   Yang, Y
   Gao, CS
   Guo, YX
AF Yao, Qing
   Yang, Guobao
   Wang, Hao
   Liu, Jingzhou
   Zheng, Jinpeng
   Lv, Bai
   Yang, Meiyan
   Yang, Yang
   Gao, Chunsheng
   Guo, Yongxue
TI Aging erythrocyte membranes as biomimetic nanometer carriers of
   liver-targeting chromium poisoning treatment
SO DRUG DELIVERY
LA English
DT Article
DE Aging erythrocyte membranes; bionic nanocarrier; chromium poisoning;
   dimercaptosuccinic acid; liver-targeted
ID CELLS
AB Chromium poisoning has become one of the most common heavy metal poisoning occupational diseases with high morbidity and mortality. However, most antidotes detoxify the whole body and are highly toxic. To achieve hepato-targeted chromium poisoning detoxification, a novel hepato-targeted strategy was developed using aging erythrocyte membranes (AEMs) as biomimetic material coated with a dimercaptosuccinic acid (DMSA) nanostructured lipid carrier to construct a biomimetic nano-drug delivery system. The particle size, potential, drug loading, encapsulation rate, in vitro release, and stability of the nanoparticles (NPs) were characterized. Confocal microscopy and flow cytometry showed that the prepared NPs could be phagocytized by RAW264.7 macrophage cells. The efficacy of AEM-DMSA-NPs for targeted liver detoxification was evaluated by in vitro MTT analysis and an in vivo model of chromium poisoning. The results showed that the NPs could safely and efficiently achieve targeted liver chromium poisoning detoxification. All the results indicated that the biomimetic nano-drug delivery system mediated by aging erythrocyte membranes and containing DMSA nanoparticles could be used as a novel therapeutic drug delivery system potentially targeting liver detoxification.
C1 [Yao, Qing; Guo, Yongxue] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang, Peoples R China.
   [Yao, Qing; Yang, Guobao; Wang, Hao; Liu, Jingzhou; Zheng, Jinpeng; Yang, Meiyan; Yang, Yang; Gao, Chunsheng] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China.
   [Wang, Hao] Jiamusi Univ, Sch Pharm, Jiamusi, Peoples R China.
   [Lv, Bai] Qiqihar Med Univ, Sch Pharm, Qiqihar, Peoples R China.
C3 Shenyang Pharmaceutical University; Academy of Military Medical Sciences
   - China; Jiamusi University; Qiqihar Medical University
RP Guo, YX (corresponding author), Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang, Peoples R China.; Yang, Y (corresponding author), Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China.
EM jiamusi101@126.com; yongxueguo@163.com
CR Amin KA, 2017, BIOL TRACE ELEM RES, V175, P136, DOI 10.1007/s12011-016-0748-6
   Chen F., 2008, CHIN J NEW DRUGS, V6, P21
   Chen L., 2014, STRAITS J PREVENTIVE, V3, P82
   [陈瑶 Chen Yao], 2014, [中国药科大学学报, Journal of China Pharmaceutical University], V45, P544
   CHISOLM JJ, 1992, J TOXICOL-CLIN TOXIC, V30, P493, DOI 10.3109/15563659209017937
   Chu J, 2020, NEURAL REGEN RES, V15, P528, DOI 10.4103/1673-5374.266060
   Fan YF, 2002, WORLD J GASTROENTERO, V8, P853, DOI 10.3748/wjg.v8.i5.853
   Fang RH, 2018, ADV MATER, V30, DOI 10.1002/adma.201706759
   GRAZIANO JH, 1986, MED TOXICOL ADV DRUG, V1, P155, DOI 10.1007/BF03259834
   [何婉瑛 He Wanying], 2014, [华东理工大学学报. 自然科学版, Journal of East China University of Science and Technoloy. Natural Sciences Edition], V40, P444
   Hu Yu-ping, 2016, Yaoxue Xuebao, V51, P1340, DOI 10.16438/j.0513-4870.2015-1072
   [黄波 Huang Bo], 2018, [中国新药与临床杂志, Chinese Journal of New Drugs and Clinical Remedies], V37, P707
   [李德涛 Li Detao], 2014, [中国细胞生物学学报, Chinese Journal of Cell Biology], V36, P1491
   [李淑芳 Li Shufang], 2018, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V34, P34
   Li SY., 2018, ELECT J METAB NUTR C, V32, P192
   Liu R., 2019, J HARBIN U COMMER, V35, P129
   [刘世军 Liu Shijun], 2011, [中国药房, China Pharmacy], V22, P413
   Ma LL, 2015, HENAN TRADIT CHIN ME, V35, P2769
   Shi BH., 2013, INT J LAB MED, V34, P2540
   Wang Erjin, 2019, Asian Journal of Ecotoxicology, V14, P63, DOI 10.7524/AJE.1673-5897.20180925002
   Wang Nan, 2010, Yaoxue Xuebao, V45, P934
   Wang XK, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.655557
   Wang ZC., 2013, MODERN ONCOL, V21, P1707
   Xia Y, 2021, BIOACT MATER, V6, P1330, DOI 10.1016/j.bioactmat.2020.10.019
   [颜世能 Yan Shineng], 2013, [中国现代医学杂志, China Journal of Modern Medicine], V23, P39
   Yang DK, 2020, LIVER INT, V40, P2064, DOI 10.1111/liv.14579
   [于秀艳 Yu Xiuyan], 2016, [中国免疫学杂志, Chinese Journal of Immunology], V32, P1467
   Yu XL., 2018, INT J STOMATOL, V45, P391
   Yuan L., 2013, CHIN TRADIT MED, V9, P2023
   [庄婕 Zhuang Jie], 2010, [中国药科大学学报, Journal of China Pharmaceutical University], V41, P353
   王霄腾, 2017, [中华消化杂志, Chinese Journal of Digestion], V37, P468
   马俊杰(编译), 2014, [中国药物化学杂志, Chinese Journal of Medicinal Chemistry], V24, P419
NR 32
TC 12
Z9 13
U1 4
U2 50
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-7544
EI 1521-0464
J9 DRUG DELIV
JI Drug Deliv.
PD JAN 1
PY 2021
VL 28
IS 1
BP 1455
EP 1465
DI 10.1080/10717544.2021.1949075
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA TF5TX
UT WOS:000670784800001
PM 34236248
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhang, HB
   Zheng, H
   Mu, WJ
   He, ZY
   Yang, B
   Ji, Y
   Hui, LJ
AF Zhang, Haibin
   Zheng, Hai
   Mu, Wenjing
   He, Zhiying
   Yang, Bo
   Ji, Yuan
   Hui, Lijian
TI DUSP16 ablation arrests the cell cycle and induces cellular senescence
SO FEBS JOURNAL
LA English
DT Article
DE DUSP16; liver cancer; p53; senescence; Rb
ID TUMOR-SUPPRESSOR; IN-VIVO; PHOSPHATASE; CANCER; P53; PROTEIN; KINASE;
   PATHWAY; TUMORIGENESIS; RESTORATION
AB Dual-specificity phosphatases (DUSPs) are a family of protein phosphatases that dephosphorylate both phosphotyrosine and phosphoserine/phosphothreonine residues. DUSPs are de-regulated in many human diseases, including cancers. However, the function of DUSPs in tumorigenesis remains largely unknown. Here, using short hairpin RNA-based gene knockdown, we found that several members of the DUSP family play critical roles in regulating cell proliferation. In particular, we showed that DUSP16 ablation leads to a G(1)/S transition arrest, reduced incorporation of 5-bromodeoxyuridine, enhanced senescence-associated beta-galactosidase activity, and formation of senescence-associated heterochromatic foci. Mechanistically, DUSP16 silencing causes cellular senescence by activating the tumor suppressors p53 and Rb. The phosphatase activity of DUSP16 is necessary for antagonizing cellular senescence. Importantly, the expression levels of DUSP16 are up-regulated in human liver cancers, and are positively correlated with tumor cell proliferation. Taken together, our findings indicate that DUSP16 plays a role in tumorigenesis by protecting cancer cells from senescence.
C1 [Zhang, Haibin] Second Mil Med Univ, Eastern Hepatobilliary Surg Hosp, Shanghai, Peoples R China.
   [Zheng, Hai; Mu, Wenjing; Hui, Lijian] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Cell Biol, Beijing 100864, Peoples R China.
   [Zheng, Hai] Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Synthet Biol Engn Res, Beijing 100864, Peoples R China.
   [He, Zhiying] Second Mil Med Univ, Dept Cell Biol, Shanghai, Peoples R China.
   [Yang, Bo] Tianjin Med Univ Canc Inst & Hosp, Dept Pathol, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.
   [Ji, Yuan] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China.
C3 Naval Medical University; Chinese Academy of Sciences; Chinese Academy
   of Sciences; Shenzhen Institute of Advanced Technology, CAS; Naval
   Medical University; Tianjin Medical University; Fudan University
RP Ji, Y (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China.
EM newera_ji@yahoo.com; ljhui@sibcb.ac.cn
RI Zhang, Yunxuan/IXD-9283-2023
OI he, zhiying/0000-0002-0087-2277
FU National Key Basic Research and Development Program of China
   [2014CB910601]; Shanghai Municipal Commission for Science and Technology
   [14XD1404200, 14411964000]; National Natural Science Foundation of China
   [31225016]; Postdoctoral Research Program of Shanghai Institutes for
   Biological Sciences, Chinese Academy of Sciences [2014KIP302]
FX This was funded by the National Key Basic Research and Development
   Program of China (2014CB910601), the Shanghai Municipal Commission for
   Science and Technology (14XD1404200 and 14411964000), the National
   Natural Science Foundation of China (31225016), and the Postdoctoral
   Research Program of Shanghai Institutes for Biological Sciences, Chinese
   Academy of Sciences (2014KIP302).
CR Chan HM, 2005, GENE DEV, V19, P196, DOI 10.1101/gad.1280205
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Cho KA, 2004, J BIOL CHEM, V279, P42270, DOI 10.1074/jbc.M402352200
   Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Hoornaert I, 2003, ONCOGENE, V22, P7728, DOI 10.1038/sj.onc.1207089
   Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116
   Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289
   Kee SH, 2002, J INVEST DERMATOL, V119, P440, DOI 10.1046/j.1523-1747.2002.01826.x
   Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1
   Koh JLY, 2012, NUCLEIC ACIDS RES, V40, pD957, DOI 10.1093/nar/gkr959
   Lee S, 2010, BRIT J CANCER, V103, P265, DOI 10.1038/sj.bjc.6605711
   Masuda K, 2001, J BIOL CHEM, V276, P39002, DOI 10.1074/jbc.M104600200
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Michalopoulos GK, 2014, EXPERT REV GASTROENT, V8, P897, DOI 10.1586/17474124.2014.934358
   Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398
   Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shang X, 2010, ONCOGENE, V29, P4938, DOI 10.1038/onc.2010.244
   Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
NR 32
TC 18
Z9 19
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD DEC
PY 2015
VL 282
IS 23
BP 4580
EP 4594
DI 10.1111/febs.13518
PG 15
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA DA4AR
UT WOS:000367743000010
PM 26381291
OA Bronze
DA 2024-02-19
ER

PT J
AU SHARMA, R
   PATNAIK, SK
AF SHARMA, R
   PATNAIK, SK
TI REGULATION OF ASPARTATE-AMINOTRANSFERASE ISOENZYMES BY HYDROCORTISONE IN
   THE LIVER OF AGING RATS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
C1 BANARAS HINDU UNIV, INST TECHNOL, DEPT PHARMACEUT, DIV BIOCHEM, VARANASI 221005, UTTAR PRADESH, INDIA.
C3 Banaras Hindu University (BHU); Indian Institute of Technology System
   (IIT System); Indian Institute of Technology BHU Varanasi (IIT BHU
   Varanasi)
RP SHARMA, R (corresponding author), MANIPUR UNIV, DEPT LIFE SCI, IMPHAL 795003, INDIA.
CR BOYD JW, 1961, BIOCHEM J, V81, P434, DOI 10.1042/bj0810434
   BRAUNSTEIN AE, 1973, ENZYMES, V9, P397
   FLEISHER GA, 1960, P SOC EXP BIOL MED, V103, P229, DOI 10.3181/00379727-103-25469
   GARRETT HE, 1966, STATISTICS PSYCHOL E
   HERZFELD A, 1971, BIOCHIM BIOPHYS ACTA, V237, P88, DOI 10.1016/0304-4165(71)90033-X
   JOHANNESSEN E., 1940, Nordisk Medicin, V8, P2231
   Kanungo M. S., 1980, BIOCH AGING
   KARMEN A, 1955, J CLIN INVEST, V34, P126, DOI 10.1172/JCI103055
   LARDY HA, 1965, P NATL ACAD SCI USA, V53, P1410, DOI 10.1073/pnas.53.6.1410
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NAKATA Y, 1964, J BIOCHEM, V55, P199
   Porter E, 1926, LANCET, V2, P947
   ROTH GS, 1975, EXP GERONTOL, V10, P1, DOI 10.1016/0531-5565(75)90009-1
   SHARMA R, 1985, MOL PHYSIOL, V7, P195
   SHARMA R, 1982, DEV GROWTH DIFFER, V24, P501, DOI 10.1111/j.1440-169X.1982.00501.x
   SHARMA R, 1982, BIOCHEM INT, V5, P561
   SHARMA R, 1984, ARCH GERONTOL GERIAT, V3, P167, DOI 10.1016/0167-4943(84)90008-6
   SINGER S, 1973, INT J BIOCHEM, V4, P569, DOI 10.1016/0020-711X(73)90035-9
NR 18
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-4943
EI 1872-6976
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD APR
PY 1987
VL 6
IS 1
BP 27
EP 32
DI 10.1016/0167-4943(87)90036-7
PG 6
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA H1341
UT WOS:A1987H134100005
PM 3592848
DA 2024-02-19
ER

PT J
AU Kawase, A
   Ito, A
   Yamada, A
   Iwaki, M
AF Kawase, Atsushi
   Ito, Ayami
   Yamada, Ayano
   Iwaki, Masahiro
TI Age-related changes in mRNA levels of hepatic transporters, cytochrome
   P450 and UDP-glucuronosyltransferase in female rats
SO EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
LA English
DT Article
DE Cytochrome P450; Transporter; Aging; Liver
ID PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; METABOLIZING
   ENZYME GENE; ACTIVATED RECEPTOR; HORMONAL-REGULATION;
   GENDER-DIFFERENCES; ENHANCER MODULE; P-GLYCOPROTEIN; EXPRESSION; LIVER
AB Hepatic transporters and metabolic enzymes affect drug pharmacokinetics. Limited information exists on the alteration in mRNA levels of hepatic transporters and metabolic enzymes with aging. We examined the effects of aging on the mRNA levels of representative hepatic drug transporters and metabolic enzymes by analyzing their levels in 10-, 30- and 50-week-old male and female rats. Levels of mRNA of drug transporters including multidrug resistance protein (Mdr)1a, multidrug resistance-associated protein (Mrp)2, breast cancer resistance protein (Bcrp) and organic anion-transporting polypeptide (Oatp)1a1, and the metabolic enzymes cytochrome P450 (CYP)3A1, CYP3A2 and UDP-glucuronosyltransferase (UGT)1A1 were analyzed using real-time reverse transcriptase polymerase chain reaction. The mRNA levels of transporters in male rats did not decrease with age, while the mRNA levels of Bcrp and Oatp1a1 in female rats decreased with age. The mRNA levels of CYP3A1 and CYP3A2 in male rats were higher than those in female rats. The mRNA levels of metabolic enzymes decreased with age in female but not male rats. In particular, the mRNA levels of UGT1A1 in 10-week-old female rats were higher than those in male rats. mRNA expression of hepatic transporters and metabolic enzymes are more susceptible to aging in female than male rats. The age-related decreases in the mRNA levels of Bcrp, Oatp1a1, CYP3A1 and CYP3A2 in female rats may affect the metabolism and transport of substrates. This study showed that aging affected the mRNA expression of hepatic transporters and metabolic enzymes in rats.
C1 [Kawase, Atsushi; Ito, Ayami; Yamada, Ayano; Iwaki, Masahiro] Kinki Univ, Sch Pharm, Dept Pharm, Higashi Osaka 5778502, Japan.
C3 Kindai University (Kinki University)
RP Iwaki, M (corresponding author), Kinki Univ, Sch Pharm, Dept Pharm, 3-4-1 Kowakae, Higashi Osaka 5778502, Japan.
EM kawase@phar.kindai.ac.jp; iwaki@phar.kindai.ac.jp
CR Buckley DB, 2009, DRUG METAB DISPOS, V37, P834, DOI 10.1124/dmd.108.024224
   BURCHELL B, 1994, HEPATOLOGY, V20, P1622, DOI 10.1002/hep.1840200636
   BURCHELL B, 1989, PHARMACOL THERAPEUT, V43, P261, DOI 10.1016/0163-7258(89)90122-8
   Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019
   Chen GF, 1997, J PHARMACOL EXP THER, V283, P1486
   Cheng XG, 2005, DRUG METAB DISPOS, V33, P1276, DOI 10.1124/dmd.105.003988
   DUTTON GJ, 1978, ANNU REV PHARMACOL, V18, P17, DOI 10.1146/annurev.pa.18.040178.000313
   Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI 10.2165/00003088-200948030-00001
   Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200
   Imai Y, 2005, CANCER RES, V65, P596
   Jiang ZW, 2006, PHARMACOGENET GENOM, V16, P359, DOI 10.1097/01.fpc.0000204994.99429.46
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   Kawase A, 2007, DRUG METAB DISPOS, V35, P256, DOI 10.1124/dmd.106.011536
   Kawase A, 2008, DRUG METAB PHARMACOK, V23, P196, DOI 10.2133/dmpk.23.196
   Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Komura H, 2005, J PHARM SCI-US, V94, P397, DOI 10.1002/jps.20255
   Le Marchand L, 2002, CANCER EPIDEM BIOMAR, V11, P1019
   Lee C, 2006, DRUG METAB DISPOS, V34, P1530, DOI 10.1124/dmd.106.009936
   Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144
   LEGRAVEREND C, 1992, FASEB J, V6, P711, DOI 10.1096/fasebj.6.2.1537461
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638
   MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T
   MORGAN ET, 1985, J BIOL CHEM, V260, P1895
   Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286
   MORSELLI PL, 1980, CLIN PHARMACOKINET, V5, P485, DOI 10.2165/00003088-198005060-00001
   Osabe M, 2008, DRUG METAB DISPOS, V36, P294, DOI 10.1124/dmd.107.017731
   Pampori NA, 1999, ENDOCRINOLOGY, V140, P1245, DOI 10.1210/en.140.3.1245
   Rost D, 2005, EUR J CLIN INVEST, V35, P635, DOI 10.1111/j.1365-2362.2005.01556.x
   Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226
   SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5
   SHIMADA M, 1995, J PHARMACOL EXP THER, V275, P972
   STEWART CF, 1987, CLIN PHARMACY, V6, P548
   Sugatani J, 2004, BIOCHEM PHARMACOL, V67, P989, DOI 10.1016/j.bcp.2003.11.002
   Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172
   Suzuki T, 2006, LIFE SCI, V79, P455, DOI 10.1016/j.lfs.2006.01.024
   Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200
   Takeuchi T, 2004, BIOCHEM BIOPH RES CO, V325, P549, DOI 10.1016/j.bbrc.2004.10.073
   Tanaka Y, 2005, BIOCHEM BIOPH RES CO, V326, P181, DOI 10.1016/j.bbrc.2004.11.012
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Timsit YE, 2000, TOXICOL APPL PHARM, V163, P105, DOI 10.1006/taap.1999.8862
   Uno S, 2008, XENOBIOTICA, V38, P482, DOI [10.1080/00498250801935982, 10.1080/00498250801935982 ]
   Uno S, 2007, DRUG METAB PHARMACOK, V22, P313, DOI 10.2133/dmpk.22.313
   Yueh MF, 2003, J BIOL CHEM, V278, P15001, DOI 10.1074/jbc.M300645200
   Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1
NR 46
TC 12
Z9 12
U1 0
U2 5
PU SPRINGER FRANCE
PI PARIS
PA 22 RUE DE PALESTRO, PARIS, 75002, FRANCE
SN 0378-7966
EI 2107-0180
J9 EUR J DRUG METAB PH
JI Eur. J. Drug Metabol. Pharmacokinet.
PD JUN
PY 2015
VL 40
IS 2
BP 239
EP 244
DI 10.1007/s13318-014-0208-7
PG 6
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA CH7KN
UT WOS:000354215200012
PM 24899460
DA 2024-02-19
ER

PT J
AU Shimoyoshi, S
   Takemoto, D
   Ono, Y
   Kitagawa, Y
   Shibata, H
   Tomono, S
   Unno, K
   Wakabayashi, K
AF Shimoyoshi, Satomi
   Takemoto, Daisuke
   Ono, Yoshiko
   Kitagawa, Yoshinori
   Shibata, Hiroshi
   Tomono, Susumu
   Unno, Keiko
   Wakabayashi, Keiji
TI Sesame Lignans Suppress Age-Related Cognitive Decline in
   Senescence-Accelerated Mice
SO NUTRIENTS
LA English
DT Article
DE sesame lignans; sesamin; episesamin; cognitive decline; depression;
   SAMP10; senescence-accelerated mouse; reactive carbonyl
ID LIPID-PEROXIDATION; OXIDATIVE STRESS; ALZHEIMER-DISEASE; ANIMAL-MODEL;
   MOUSE MODEL; BRAIN; DAMAGE; DYSFUNCTION; LIVER; IMPAIRMENT
AB Sesame lignans, which are biologically active compounds present in sesame seeds and oil, are known to have neuroprotective effects in several models of brain dysfunction. However, the effects of sesame lignans on age-related brain dysfunction are not clear and were thus investigated in the present study using a senescence-accelerated mouse (SAMP10). Two-month-old male SAMP10 mice were administrated a basal diet with 0% or 0.05% sesame lignans for two months, or with 0%, 0.02%, or 0.05% sesame lignans for 10 months and subjected to step-through passive avoidance tasks and forced swim tests. Reactive carbonyl species (RCs) were evaluated as markers of oxidative stress using a recently developed comprehensive analytical method. Both learning time in passive avoidance tasks and immobile time in forced swim tests became longer with aging (p < 0.05). However, the administration of sesame lignans significantly ameliorated age-related effects in both tests (p < 0.05). Age-related increases in RCs such as 4-hydroxy-2-nonenal in the cerebral cortex and liver were reduced in mice fed sesame lignans. These results suggest that sesame lignans can prevent age-related brain dysfunction via anti-oxidative activity.
C1 [Shimoyoshi, Satomi; Takemoto, Daisuke; Ono, Yoshiko; Kitagawa, Yoshinori; Shibata, Hiroshi] Suntory Wellness Ltd, Inst Hlth Care Sci, Kyoto 6190284, Japan.
   [Tomono, Susumu; Wakabayashi, Keiji] Univ Shizuoka, Grad Div Nutr & Environm Sci, Shizuoka 4228526, Japan.
   [Tomono, Susumu] Aichi Med Univ, Dept Microbiol & Immunol, Nagakute, Aichi 4801195, Japan.
   [Unno, Keiko] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan.
C3 Suntory Holdings Ltd; University of Shizuoka; Aichi Medical University;
   University of Shizuoka
RP Ono, Y (corresponding author), Suntory Wellness Ltd, Inst Hlth Care Sci, Kyoto 6190284, Japan.
EM Yoshiko_Toyoda@suntory.co.jp
FU Suntory Wellness Limited; Joint Research Program of University of
   Shizuoka
FX This research received no external funding. S.T., K.U. and K.W. received
   research grants from Suntory Wellness Limited and Joint Research Program
   of University of Shizuoka.
CR Ahmad S, 2014, NEUROTOXICOLOGY, V45, P100, DOI 10.1016/j.neuro.2014.10.002
   AKIMOTO K, 1993, ANN NUTR METAB, V37, P218, DOI 10.1159/000177771
   Barnes LL, 2014, HEALTH AFFAIR, V33, P580, DOI 10.1377/hlthaff.2013.1353
   BOWLING AC, 1995, LIFE SCI, V56, P1151, DOI 10.1016/0024-3205(95)00055-B
   Bradley MA, 2012, NEUROBIOL AGING, V33, P1034, DOI 10.1016/j.neurobiolaging.2010.08.016
   D'Mello C, 2011, AM J PHYSIOL-GASTR L, V301, pG749, DOI 10.1152/ajpgi.00184.2011
   Di Domenico F, 2017, FREE RADICAL BIO MED, V111, P253, DOI 10.1016/j.freeradbiomed.2016.10.490
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   Fujikawa T, 2005, BIOL PHARM BULL, V28, P169, DOI 10.1248/bpb.28.169
   GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8
   Hamada N, 2011, BIOORGAN MED CHEM, V19, P1959, DOI 10.1016/j.bmc.2011.01.059
   Hamoya T, 2017, J CLIN BIOCHEM NUTR, V60, P199, DOI 10.3164/jcbn.16-107
   Hasegawa-Ishii S, 2016, BRAIN STRUCT FUNCT, V221, P1513, DOI 10.1007/s00429-014-0987-2
   Hasegawa-Ishii S, 2011, NEUROPATHOLOGY, V31, P20, DOI 10.1111/j.1440-1789.2010.01126.x
   Head E, 2002, J NEUROCHEM, V82, P375, DOI 10.1046/j.1471-4159.2002.00969.x
   Hirata F, 1996, ATHEROSCLEROSIS, V122, P135, DOI 10.1016/0021-9150(95)05769-2
   Ikeda M, 2004, J NEUROL NEUROSUR PS, V75, P146
   Ikeda T, 2003, INT J SPORTS MED, V24, P530
   Ito N, 2018, J ALZHEIMERS DIS, V62, P1767, DOI 10.3233/JAD-170969
   Keller JN, 1999, J NEUROSCI RES, V58, P823, DOI 10.1002/(SICI)1097-4547(19991215)58:6<823::AID-JNR9>3.0.CO;2-T
   Keller JN, 1998, REV NEUROSCIENCE, V9, P105
   Keller JN, 1997, J NEUROCHEM, V69, P273
   Kishido T, 2007, BIOGERONTOLOGY, V8, P423, DOI 10.1007/s10522-007-9085-7
   Le TD, 2019, EUR REV MED PHARMACO, V23, P1826, DOI 10.26355/eurrev_201902_17146
   Lei H, 2013, J SCI FOOD AGR, V93, P1833, DOI 10.1002/jsfa.5974
   Liu SL, 2011, J GASTROEN HEPATOL, V26, P1010, DOI 10.1111/j.1440-1746.2011.06672.x
   Long EK, 2008, J NEUROCHEM, V105, P714, DOI 10.1111/j.1471-4159.2007.05175.x
   LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g
   Mark RJ, 1997, J NEUROCHEM, V68, P255
   Miyamoto M, 1997, EXP GERONTOL, V32, P139, DOI 10.1016/S0531-5565(96)00061-7
   Miyamoto Masaomi, 1998, CNS Drug Reviews, V4, P361, DOI 10.1111/j.1527-3458.1998.tb00076.x
   Nair U, 2007, FREE RADICAL BIO MED, V43, P1109, DOI 10.1016/j.freeradbiomed.2007.07.012
   Nakai M, 2003, J AGR FOOD CHEM, V51, P1666, DOI 10.1021/jf0258961
   Nakai M, 2006, BIOSCI BIOTECH BIOCH, V70, P1273, DOI 10.1271/bbb.70.1273
   Nakano D, 2006, J PHARMACOL EXP THER, V318, P328, DOI 10.1124/jpet.105.100149
   Onuma W, 2016, ONCOTARGET, V7, P8640, DOI 10.18632/oncotarget.7082
   Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530
   Pohanka M, 2018, BRATISL MED J, V119, P535, DOI 10.4149/BLL_2018_097
   PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0
   Rapp MA, 2011, AM J GERIAT PSYCHIAT, V19, P357, DOI 10.1097/JGP.0b013e3181e898d0
   Sakul A, 2013, EXP GERONTOL, V48, P476, DOI 10.1016/j.exger.2013.02.028
   Savva GM, 2009, BRIT J PSYCHIAT, V194, P212, DOI 10.1192/bjp.bp.108.049619
   Seo JS, 2012, J NEUROSCI, V32, P9690, DOI 10.1523/JNEUROSCI.0794-12.2012
   Shibata N, 2004, BRAIN RES, V1019, P170, DOI 10.1016/j.brainres.2004.05.110
   Shimada A, 2006, NEUROPATH APPL NEURO, V32, P1, DOI 10.1111/j.1365-2990.2006.00632.x
   SHIMADA A, 1993, BRAIN RES, V608, P266, DOI 10.1016/0006-8993(93)91467-7
   SHIMADA A, 1992, J NEUROPATH EXP NEUR, V51, P440, DOI 10.1097/00005072-199207000-00006
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tomono S, 2015, J CHROMATOGR B, V988, P149, DOI 10.1016/j.jchromb.2015.02.036
   Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4
   Unno K, 2004, EXP GERONTOL, V39, P1027, DOI 10.1016/j.exger.2004.03.033
   Unno K, 2007, BIOGERONTOLOGY, V8, P89, DOI 10.1007/s10522-006-9036-8
   Unno K, 2011, BIOL PHARM BULL, V34, P311, DOI 10.1248/bpb.34.311
   Walton JC, 2013, BEHAV BRAIN RES, V256, P320, DOI 10.1016/j.bbr.2013.08.003
   Wentworth P, 2003, SCIENCE, V302, P1053, DOI 10.1126/science.1089525
   Williams TI, 2006, NEUROBIOL AGING, V27, P1094, DOI 10.1016/j.neurobiolaging.2005.06.004
NR 56
TC 22
Z9 23
U1 2
U2 24
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUL
PY 2019
VL 11
IS 7
AR 1582
DI 10.3390/nu11071582
PG 14
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IN7TT
UT WOS:000478885400019
PM 31336975
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Frohlich, J
   Kovacovicova, K
   Mazza, T
   Emma, MR
   Cabibi, D
   Foti, M
   Sobolewski, C
   Oben, JA
   Peyrou, M
   Villarroya, F
   Soresi, M
   Rezzani, R
   Ello, MC
   Bonomini, F
   Alisi, A
   Vinciguerra, M
AF Frohlich, Jan
   Kovacovicova, Kristina
   Mazza, Tommaso
   Emma, Maria R.
   Cabibi, Daniela
   Foti, Michelangelo
   Sobolewski, Cyril
   Oben, Jude A.
   Peyrou, Marion
   Villarroya, Francesc
   Soresi, Maurizio
   Rezzani, Rita
   Ello, Meichiorre Cery
   Bonomini, Francesca
   Alisi, Anna
   Vinciguerra, Manlio
TI GDF11 induces mild hepatic fibrosis independent of metabolic health
SO AGING-US
LA English
DT Article
DE liver; NAFLD; NASH; fibrosis; growth differentiation factor 11
ID DIFFERENTIATION FACTOR 11; LIVER; GROWTH; AGE; MUSCLE
AB Background & aims: Growth Differentiation Factor 11 (GDF11) is an anti-aging factor, yet its role in liver diseases is not established. We evaluated the role of GDF11 in healthy conditions and in the transition from non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH).
   Results: GDF11 mRNA levels positively correlated with NAFLD activity score and with CPT1, SREBP, PPAR gamma and Col1A1 mRNA levels, and associated to portal fibrosis, in morbidly obese patients with NAFLD/NASH. GDF11-treatedmice showed mildly exacerbated hepatic collagen deposition, accompanied by weight loss and without changes in liver steatosis or inflammation. GDF11 triggered ALK5-dependent SMAD2/3 nuclear translocation and the pro-fibrogenic activation of HSC.
   Conclusions: GDF11 supplementation promotes mild liver fibrosis. Even considering its beneficial metabolic effects, caution should be taken when considering therapeutics that regulate GDF11.
   Methods: We analyzed liver biopsies from a cohort of 33 morbidly obese adults with NAFLD/NASH. We determined the correlations in mRNA expression levels between GDF11 and genes involved in NAFLD-to-NASH progression and with pathological features. We also exposed wild type or obese mice with NAFLD to recombinant GDF11 by daily intra-peritoneal injection and monitor the hepatic pathological changes. Finally, we analyzed GDF11-activated signaling pathways in hepatic stellate cells (HSC).
C1 [Frohlich, Jan; Kovacovicova, Kristina; Vinciguerra, Manlio] St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.
   [Mazza, Tommaso] IRCCS Casa Sollievo Sofferenza, Bioinformat Unit, San Giovanni Rotondo, Italy.
   [Emma, Maria R.; Ello, Meichiorre Cery] Natl Res Council CNR, Inst Biomed Res & Innovat, Palermo, Italy.
   [Cabibi, Daniela; Soresi, Maurizio] Univ Palermo, Dept Hlth Promot Sci Maternal & Infantile Care, Internal Med & Med Specialties, Palermo, Italy.
   [Foti, Michelangelo; Sobolewski, Cyril] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, Geneva, Switzerland.
   [Oben, Jude A.; Vinciguerra, Manlio] Univ Coll London UCL, Inst Liver & Digest Hlth, Div Med, London, England.
   [Peyrou, Marion; Villarroya, Francesc] Univ Barcelona, Dept Biochem & Mol Biomed, Inst Biomed, Barcelona, Catalonia, Spain.
   [Peyrou, Marion; Villarroya, Francesc] Inst Recerca Hosp Santa Creu & St Pau, Barcelona, Catalonia, Spain.
   [Villarroya, Francesc] CIBER Fisiopatol Obesidad & Nutr, Barcelona, Catalonia, Spain.
   [Rezzani, Rita; Bonomini, Francesca] Univ Brescia, Dept Clin & Expt Sci, Anat & Physiopathol Div, Brescia, Italy.
   [Rezzani, Rita; Bonomini, Francesca] Univ Brescia, Interdept Univ Ctr Res Adapt & Regenerat Tissues, Brescia, Italy.
   [Alisi, Anna] IRCCS, Bambino Gest Childrens Hosp, Res Unit Mol Genet Complex Phenotypes, Res Area Multifactorial Dis, Rome, Italy.
C3 St Anne's University Hospital Brno (FNUSA-ICRC); IRCCS Casa Sollievo
   Della Sofferenza; Consiglio Nazionale delle Ricerche (CNR); Istituto
   Ricerca l'Innovazione Biomedica (IRIB-CNR); University of Palermo;
   University of Geneva; University of London; University College London;
   University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBER -
   Centro de Investigacion Biomedica en Red; CIBEROBN; University of
   Brescia; University of Brescia; IRCCS Bambino Gesu
RP Vinciguerra, M (corresponding author), St Annes Univ Hosp, Int Clin Res Ctr, Brno, Czech Republic.; Vinciguerra, M (corresponding author), Univ Coll London UCL, Inst Liver & Digest Hlth, Div Med, London, England.; Alisi, A (corresponding author), IRCCS, Bambino Gest Childrens Hosp, Res Unit Mol Genet Complex Phenotypes, Res Area Multifactorial Dis, Rome, Italy.
EM anna.alisi@opbg.net; manlio.vinciguerra@fnusa.cz
RI Frohlich, Jan/AAI-4184-2021; Mazza, Tommaso/I-4531-2019; cabibi,
   daniela/D-7438-2013; Alisi, Anna/A-6469-2010; Sobolewski,
   Cyril/ABA-8197-2021; Vinciguerra, Manlio/N-1309-2015; Peyrou,
   Marion/A-7190-2015
OI Frohlich, Jan/0000-0002-8312-0483; Mazza, Tommaso/0000-0003-0434-8533;
   cabibi, daniela/0000-0001-6571-6577; Alisi, Anna/0000-0001-7241-6329;
   Sobolewski, Cyril/0000-0002-9404-6290; Vinciguerra,
   Manlio/0000-0002-1768-3894; Foti, Michelangelo/0000-0001-7199-4135;
   Oben, Jude/0000-0003-3350-8356; Peyrou, Marion/0000-0002-1210-6094
FU European Social Fund; European Regional Development Fund - Project
   MAGNET [CZ.02.1.01/0.0/0.0/15_003/0000492]; Associazione Italiana per la
   Ricerca sul Cancro (AIRC) [18394]; Swiss National Science Foundation
   [310030-172862]
FX This work was supported by the European Social Fund and European
   Regional Development Fund - Project MAGNET (No.
   CZ.02.1.01/0.0/0.0/15_003/0000492, to M.V.), by the Associazione
   Italiana per la Ricerca sul Cancro (AIRC; No. 18394, to M.C.), and by
   the Swiss National Science Foundation (Grant no. 310030-172862 to M.F.).
CR Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001
   Abe N, 2019, BIOL OPEN, V8, DOI 10.1242/bio.041251
   Añón-Hidalgo J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060878
   Benegiamo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060527
   Benegiamo G, 2012, DIGEST DIS SCI, V57, P1598, DOI 10.1007/s10620-012-2160-1
   Borghesan M, 2016, CANCER RES, V76, P594, DOI 10.1158/0008-5472.CAN-15-1336
   Dai Z, 2020, GUT, V69, P1104, DOI 10.1136/gutjnl-2019-318812
   Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010
   Fabregat I, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00357
   Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014
   Frühbeck G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02848-0
   Gerardo-Ramírez M, 2019, BBA-MOL BASIS DIS, V1865, P1540, DOI 10.1016/j.bbadis.2019.03.003
   Hammers DW, 2017, EMBO MOL MED, V9, P531, DOI 10.15252/emmm.201607231
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.21492, 10.3322/caac.20107]
   Katsimpardi L, 2020, AGING CELL, V19, DOI 10.1111/acel.13038
   Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Liu AD, 2018, FASEB J, V32, P5186, DOI 10.1096/fj.201800195R
   Liu JP, 2006, DEVELOPMENT, V133, P2865, DOI 10.1242/dev.02478
   Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015
   Lu BX, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-02166-1
   Mallat A, 2013, AM J PHYSIOL-CELL PH, V305, pC789, DOI 10.1152/ajpcell.00230.2013
   Matsuda Y, 1997, HEPATOLOGY, V26, P81
   McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320
   Mei W, 2016, MOL THER, V24, P1926, DOI 10.1038/mt.2016.160
   Nagahashi M, 2016, SURG TODAY, V46, P995, DOI 10.1007/s00595-015-1270-8
   Parola M, 2019, MOL ASPECTS MED, V65, P37, DOI 10.1016/j.mam.2018.09.002
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Podrini C, 2015, FASEB J, V29, P1676, DOI 10.1096/fj.14-262717
   Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005
   Rochette L, 2015, PHARMACOL THERAPEUT, V156, P26, DOI 10.1016/j.pharmthera.2015.10.006
   Rodgers BD, 2015, ENDOCRINOLOGY, V156, P3885, DOI 10.1210/en.2015-1628
   Sanyal AJ, 2019, NAT REV GASTRO HEPAT, V16, P377, DOI 10.1038/s41575-019-0144-8
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152
   Smith SC, 2015, CIRC RES, V117, P926, DOI 10.1161/CIRCRESAHA.115.307527
   Sutter AG, 2015, ANN HEPATOL, V14, P735, DOI 10.1016/S1665-2681(19)30769-0
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010
   Walker RG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61443-y
   Wang LJ, 2018, AM J PHYSIOL-GASTR L, V315, pG909, DOI 10.1152/ajpgi.00159.2018
   Wang WH, 2019, INFLAMMATION, V42, P319, DOI 10.1007/s10753-018-0895-3
   Yan J, 2019, GASTROENTEROLOGY, V157, P793, DOI 10.1053/j.gastro.2019.05.066
   Zhang W, 2018, J ALZHEIMERS DIS, V62, P807, DOI 10.3233/JAD-170474
   Zhang YH, 2018, EXP THER MED, V15, P3495, DOI 10.3892/etm.2018.5861
   Zhang YH, 2017, ONCOTARGET, V8, P81604, DOI 10.18632/oncotarget.20258
NR 46
TC 11
Z9 13
U1 0
U2 14
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD OCT 31
PY 2020
VL 12
IS 20
BP 20024
EP 20046
DI 10.18632/aging.104182
PG 23
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA OJ3AX
UT WOS:000583838700016
PM 33126224
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU SOHAL, RS
   BRUNK, UT
AF SOHAL, RS
   BRUNK, UT
TI MITOCHONDRIAL PRODUCTION OF PRO-OXIDANTS AND CELLULAR SENESCENCE
SO MUTATION RESEARCH
LA English
DT Article
DE PRO-OXIDANTS; MITOCHONDRIAL PROOXIDANT GENERATION; FREE RADICALS;
   OXYRADICALS; AGING
AB Mitochondria are the major intracellular producers of O2- and H2O2. The level of oxidative stress in cells, as indicated by the in vivo exhalation of alkanes and the concentration of molecular products of oxy-radical reactions, increases during aging in mammals as well as insects. In this paper, we discuss the relationship between mitochondrial generation of O2- and H2O2, and the aging process. The rate of mitochondrial O2 and H2O2 generation increases with age in houseflies and the brain, heart and liver of rat. This rate has been found to correspond to the life expectancy of flies and to the maximum life span potential (MLSP) of six different mammalian species, namely, mouse, rat, guinea pig, rabbit, pig and cow. In contrast, the level of antioxidant defenses provided by activities of superoxide dismutase, catalase, glutathione peroxidase and glutathione concentration neither uniformly declines with age nor corresponds to variations in MLSP of different mammalian species. It is argued that the rate of mitochondrial O2- and H2O2 generation rather than the antioxidant level may act as a longevity determinant.
C1 LINKOPING UNIV, DEPT PATHOL 2, S-58183 LINKOPING, SWEDEN.
C3 Linkoping University
RP SOHAL, RS (corresponding author), SO METHODIST UNIV, DEPT BIOL SCI, DALLAS, TX 75275 USA.
FU NIA NIH HHS [R01 AG7657, R01 AG8459] Funding Source: Medline
CR AZZI A, 1975, BIOCHEM BIOPH RES CO, V65, P597, DOI 10.1016/S0006-291X(75)80188-4
   BALCAVAGE WX, 1982, MECH AGEING DEV, V19, P159, DOI 10.1016/0047-6374(82)90007-0
   BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435
   BOVERIS A, 1984, METHOD ENZYMOL, V105, P429
   Boveris A., 1982, SUPEROXIDE DISMUTASE, VII, P15, DOI DOI 10.1007/978-1-4615-9035-4_5
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Davis RA, 1940, J EXP BIOL, V17, P402
   DIONISI O, 1975, BIOCHIM BIOPHYS ACTA, V403, P292, DOI 10.1016/0005-2744(75)90059-5
   DONATO HJ, 1981, HDB BIOCH AGING, P221
   FARMER KJ, 1987, EXP GERONTOL, V22, P59, DOI 10.1016/0531-5565(87)90015-5
   FARMER KJ, 1989, FREE RADICAL BIO MED, V7, P23, DOI 10.1016/0891-5849(89)90096-8
   FORMAN HJ, 1982, FREE RADICAL BIO MED, V5, P65
   FREEMAN BA, 1982, ARCH BIOCHEM BIOPHYS, V216, P477, DOI 10.1016/0003-9861(82)90236-3
   GIROTTI AW, 1986, ARCH BIOCHEM BIOPHYS, V251, P639, DOI 10.1016/0003-9861(86)90374-7
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3
   HYSLOP PA, 1984, ANAL BIOCHEM, V141, P280, DOI 10.1016/0003-2697(84)90457-3
   LANDER ES, 1990, CELL, V61, P925, DOI 10.1016/0092-8674(90)90055-J
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MACKAY WJ, 1989, GENETICS, V122, P643
   MACKAY WJ, 1990, MOL BIOL AGING, P157
   McCord J M, 1983, Physiologist, V26, P156
   MIKI M, 1987, ARCH BIOCHEM BIOPHYS, V258, P373, DOI 10.1016/0003-9861(87)90358-4
   MIQUEL J, 1984, EXP GERONTOL, V19, P31, DOI 10.1016/0531-5565(84)90029-9
   MUSCARI C, 1990, BIOCHIM BIOPHYS ACTA, V1015, P200, DOI 10.1016/0005-2728(90)90021-U
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   NOY N, 1985, MECH AGEING DEV, V29, P63, DOI 10.1016/0047-6374(85)90047-8
   ORR WC, 1992, MECH AGEING DEV
   PHILLIPS JP, 1989, P NATL ACAD SCI USA, V86, P2761, DOI 10.1073/pnas.86.8.2761
   RAGLAND SS, 1973, EXP GERONTOL, V8, P135, DOI 10.1016/0531-5565(73)90003-X
   REIS RJS, 1990, REV BIOL RES AGING, V4, P293
   RICHTER C, 1988, FREE RADICAL BIO MED, V4, P365, DOI 10.1016/0891-5849(88)90088-3
   ROCKSTEIN M, 1966, BIOL BULL-US, V131, P479, DOI 10.2307/1539987
   SAGAI M, 1980, LIFE SCI, V27, P731, DOI 10.1016/0024-3205(80)90326-4
   SETO NOL, 1990, P NATL ACAD SCI USA, V87, P4270, DOI 10.1073/pnas.87.11.4270
   SOHAL RS, 1991, MECH AGEING DEV, V60, P189, DOI 10.1016/0047-6374(91)90130-R
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S
   SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M
   SOHAL RS, 1985, MECH AGEING DEV, V29, P317, DOI 10.1016/0047-6374(85)90071-5
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1987, ARCH GERONTOL GERIAT, V6, P95, DOI 10.1016/0167-4943(87)90001-X
   SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   SOHAL RS, 1986, ADV FREE RADICAL BIO, V2, P117, DOI 10.1016/S8755-9668(86)80026-6
   SOHAL RS, 1979, J GERONTOL, V34, P489, DOI 10.1093/geronj/34.4.489
   SOHAL RS, 1986, EXP GERONTOL, V21, P509, DOI 10.1016/0531-5565(86)90003-3
   STADTMAN ER, 1991, J BIOL CHEM, V266, P2005
   TOY PL, 1986, ARCH GERONTOL GERIAT, V5, P183, DOI 10.1016/0167-4943(86)90020-8
   TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5
   TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P411, DOI 10.1016/0003-9861(82)90519-7
   TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0
   TURRENS JF, 1990, FREE RADICALS LIPOPR, P203
NR 54
TC 107
Z9 115
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
JI Mutat. Res.
PD SEP
PY 1992
VL 275
IS 3-6
BP 295
EP 304
DI 10.1016/0921-8734(92)90033-L
PG 10
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA JV302
UT WOS:A1992JV30200019
PM 1383771
DA 2024-02-19
ER

PT J
AU Chan, YC
   Chang, SC
   Liu, SY
   Yang, HL
   Hseu, YC
   Liao, JW
AF Chan, Yin-Ching
   Chang, Shih-Chieh
   Liu, Sin-Yie
   Yang, Hsin-Ling
   Hseu, You-Cheng
   Liao, Jiunn-Wang
TI Beneficial effects of yam on carbon tetrachloride-induced hepatic
   fibrosis in rats
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE lyophilised yam, liver fibrosis; CCI4, rat
ID CELL-PROLIFERATION; LIPID-METABOLISM; DIOSCOREA-ALATA; LIVER FIBROSIS;
   CHINESE-YAM; FLOUR DIET; ANTIOXIDANT; SILYMARIN; CIRRHOSIS; MICE
AB BACKGROUND: In a previous study, lyophilised yam reduced brain amyloid beta-protein (A beta) accumulation and improved the antioxidative defence system in senescence-accelerated (SAMP8) mice. Therefore, the aim of this study was to investigate the hepatic protection of yam in the carbon tetrachloride-induced hepatic fibrosis of rats. Hepatic fibrosis was induced in rats via intraperitoneal injections Of CCI4 at a dose of 1 mL kg(-1) body weight (BW) twice weekly for 8 weeks. Three groups of rats were gavaged daily with yams at doses of 0.5, 1 and 2 g kg(-1) BW for 8 weeks, respectively.
   RESULTS: Yam treatments significantly decreased the ratio of liver/body weight, levels of gamma-glutaminotranspeptidase (GGT), low-density lipoprotein, and triglyceride in serum when compared with those administered CCI4 alone. Treatment with yams significantly elevated antioxidant activities of glutathione peroxidase (GSH-Px) and superoxidase dismutase (SOD) in livers. Microscopically, yam-treated groups presented with low histoscores Of CCI4-induced liver injury and fibrosis. Additionally, yam treatment reduced the area of GGT-positive foci and the index of proliferating cell nuclear antigen (PCNA) in liver.
   CONCLUSION: Daily administration of yam attenuates CCI4-induced hepatic fibrosis in rats in a dose-dependent manner; this attenuation may be related to the antioxidant properties of yams. (c) 2009 Society of Chemical Industry
C1 [Chan, Yin-Ching; Liao, Jiunn-Wang] Providence Univ, Dept Food & Nutr, Taichung, Taiwan.
   [Chang, Shih-Chieh] Natl Chung Hsing Univ, Grad Inst Vet Pathobiol, Taichung 402, Taiwan.
   [Chang, Shih-Chieh] Natl Chung Hsing Univ, Dept Vet Med, Taichung 402, Taiwan.
   [Liu, Sin-Yie] Chung Chou Inst Technol, Dept Nutr & Hlth Sci, Changhua, Taiwan.
   [Yang, Hsin-Ling; Hseu, You-Cheng] China Med Univ, Inst Nutr, Taichung, Taiwan.
   [Yang, Hsin-Ling; Hseu, You-Cheng] China Med Univ, Dept Cosmeceut, Taichung, Taiwan.
C3 Providence University - Taiwan; National Chung Hsing University;
   National Chung Hsing University; China Medical University Taiwan; China
   Medical University Taiwan
RP Liao, JW (corresponding author), Natl Chung Hsing Univ, Grad Inst Vet Pathol, 250 Kuokuang Rd, Taichung 402, Taiwan.
RI Liao, Jun/JUF-2784-2023
OI Chan, Yin Ching/0000-0001-9602-0775; Liao,
   Jiunn-Wang/0000-0001-7374-1203
FU Council of Agriculture [93AST-5.1.3-FAD-P1(3)]
FX The authors would liketothankthe Council of Agriculture [Contract No No.
   93AST-5.1.3-FAD-P1(3)] for financially supporting this research, and Mr
   C.P Liu, Ms S.G Tung, and Ms F.H Kao for technical assistance
CR *AM ASS CER CHEM, 1983, APPR METH AACC
   ARAGHINIKNAM M, 1996, PHARM LETT, V59, P149
   Cameron GR, 1936, J PATHOL BACTERIOL, V42, P1, DOI 10.1002/path.1700420104
   CAYEN MN, 1979, J LIPID RES, V20, P162
   Chan YC, 2006, J SCI FOOD AGR, V86, P1517, DOI 10.1002/jsfa.2536
   Chang SJ, 2004, J AGR FOOD CHEM, V52, P1720, DOI 10.1021/jf0345954
   Chen HL, 2003, NUTRITION, V19, P646, DOI 10.1016/S0899-9007(03)00058-3
   Choi EM, 2002, FITOTERAPIA, V73, P629, DOI 10.1016/S0367-326X(02)00238-1
   Department of Army, 1999, MILPRF49052 NPFC DEP, P1
   Farombi EO, 1997, FOOD CHEM TOXICOL, V35, P975, DOI 10.1016/S0278-6915(97)87266-3
   Farombi EO, 2000, FOOD RES INT, V33, P493, DOI 10.1016/S0963-9969(00)00074-0
   FERENCI P, 1989, J HEPATOL, V9, P105, DOI 10.1016/0168-8278(89)90083-4
   Gregus Z., 1996, CASARETT DOULLS TOXI, P35
   HANIGAN MH, 1985, CARCINOGENESIS, V6, P165, DOI 10.1093/carcin/6.2.165
   Hou WC, 2002, PLANTA MED, V68, P1072, DOI 10.1055/s-2002-36356
   ICHINOSE T, 1994, J APPL TOXICOL, V14, P453, DOI 10.1002/jat.2550140611
   KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511
   Komesaroff P A, 2001, Climacteric, V4, P144
   Lee SC, 2002, AM J CHINESE MED, V30, P609, DOI 10.1142/S0192415X02000624
   Lee SC, 2002, ACTA PHARMACOL SIN, V23, P503
   LETTERON P, 1990, BIOCHEM PHARMACOL, V39, P2027, DOI 10.1016/0006-2952(90)90625-U
   Liao J. W., 2002, Plant Protection Bulletin (Taichung), V44, P75
   Liao Jiunn-Wang, 1993, Journal of the Chinese Society of Veterinary Science, V19, P259
   LIU JS, 1996, ATLAS MANUAL HISTOPO, P48
   Liu SinYie, 1999, Journal of Agricultural Research of China, V48, P1
   Luo YJ, 2004, WORLD J GASTROENTERO, V10, P1037
   MCCAY PB, 1984, J BIOL CHEM, V259, P2135
   MEHTA R, 1995, CANCER LETT, V93, P85, DOI 10.1016/0304-3835(95)03790-4
   MEREISH KA, 1991, PHARMACEUT RES, V8, P273, DOI 10.1023/A:1015868809990
   Nzeako UC, 1996, AM J CLIN PATHOL, V105, P65
   OLUOHA U, 1995, PHYTOCHEMISTRY, V40, P677, DOI 10.1016/0031-9422(95)00309-U
   OZO ON, 1985, ADV YAM RES, P165
   RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517
   RUWART MJ, 1989, HEPATOLOGY, V10, P801, DOI 10.1002/hep.1840100509
   TRUMP BF, 1995, FASEB J, V9, P219, DOI 10.1096/fasebj.9.2.7781924
   Wang GS, 1999, J HEPATOL, V30, P689, DOI 10.1016/S0168-8278(99)80201-3
   Wang Li-Ting, 1999, Journal of the Chinese Agricultural Chemical Society, V37, P141
   Yao XX, 2005, WORLD J GASTROENTERO, V11, P2583, DOI 10.3748/wjg.v11.i17.2583
   Yen-Wenn L, 2007, FOOD CHEM TOXICOL, V45, P2312, DOI 10.1016/j.fct.2007.06.009
   Yu J.Y.L., 2004, GUIDELINE CARE USE L, P207
NR 40
TC 8
Z9 8
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JAN 15
PY 2010
VL 90
IS 1
BP 161
EP 167
DI 10.1002/jsfa.3801
PG 7
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA 530AJ
UT WOS:000272561000023
PM 20355026
OA Bronze
DA 2024-02-19
ER

PT J
AU Ruhland, MK
   Coussens, LM
   Stewart, SA
AF Ruhland, Megan K.
   Coussens, Lisa M.
   Stewart, Sheila A.
TI Senescence and cancer: An evolving inflammatory paradox
SO BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
LA English
DT Article
DE Cancer; Inflammation; Senescence; Immune cell
ID ONCOGENE-INDUCED SENESCENCE; TERMINAL PROLIFERATION ARREST; DNA-DAMAGE
   RESPONSE; CELLULAR SENESCENCE; SECRETORY PHENOTYPE; TUMOR-CELLS; HUMAN
   FIBROBLASTS; LIVER-CANCER; ASPIRIN USE; TRIGGERS SENESCENCE
AB The senescent phenotype was first described in 1961 as a phenomenon characterized by the cessation of cellular division. After years of debate as to whether it represented a tissue culture artifact or an important biological process, it is now appreciated that senescence plays an important role in tumorigenesis. Further, senescence is integral to normal biological processes such as embryogenesis and the maintenance of tissue homeostasis. Now with defined roles in development, wound healing, tumor promotion and tumor suppression, it is not surprising that attention has turned to refining our understanding of the mechanisms behind, and consequences of, the induction of senescence. One emerging role for senescence lies in the ability of senescence to orchestrate an inflammatory response: factors secreted by senescent cells have been identified in multiple contexts to modulate various aspects of the immune response. As with many of the previously described roles for senescence, the type of inflammation established by the senescence phenotype is varied and dependent on context. In this review, we discuss the current state of the field with a focus on the paradoxical outcomes of the senescence-induced inflammatory responses in the context of cancer. A more complete understanding of senescence and an appreciation for its complexities will be important for eventual development of senescence-targeted therapies. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ruhland, Megan K.; Stewart, Sheila A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.
   [Coussens, Lisa M.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA.
   [Coussens, Lisa M.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA.
   [Stewart, Sheila A.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, ICCE Inst, St Louis, MO 63110 USA.
   [Stewart, Sheila A.] Washington Univ, Sch Med, Dept Med, ICCE Inst, St Louis, MO 63110 USA.
C3 Washington University (WUSTL); Oregon Health & Science University;
   Oregon Health & Science University; Washington University (WUSTL);
   Washington University (WUSTL)
RP Coussens, LM (corresponding author), Oregon Hlth & Sci Univ, Cell Dev & Canc Biol, Knight Canc Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Stewart, SA (corresponding author), Washington Univ, BJC IH ICCE Inst, 660 S Euclid Ave,Box 8228, St Louis, MO 63110 USA.
EM coussenl@ohsu.edu; sheila.stewart@wustl.edu
RI Coussens, Lisa/ABH-9834-2020
FU NCI NIH HHS [T32 CA113275, P30 CA091842, R01 CA155331, 5 R01CA151518,
   R01 CA151518, U54 CA163123] Funding Source: Medline
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Alspach E, 2014, CANCER DISCOV, V4, P716, DOI 10.1158/2159-8290.CD-13-0743
   Alspach Elise, 2013, Critical Reviews in Oncogenesis, V18, P549
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Beaugerie L, 2015, NEW ENGL J MED, V372, P1441, DOI 10.1056/NEJMra1403718
   Bhatia B, 2008, INT J CANCER, V122, P1483, DOI 10.1002/ijc.23222
   Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059
   Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   Braig M, 2006, CANCER RES, V66, P2881, DOI 10.1158/0008-5472.CAN-05-4006
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chang BD, 1999, CANCER RES, V59, P3761
   Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppé JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Coppé JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009188
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9
   de Martel C., 2012, LANCET ONCOL, V13, P607, DOI DOI 10.1016/S1470-2045(12)70137-7
   de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782
   Deisseroth A, 2015, CLIN CANCER RES, V21, P950, DOI 10.1158/1078-0432.CCR-14-1678
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540
   Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x
   Ernst PB, 2000, ANNU REV MICROBIOL, V54, P615, DOI 10.1146/annurev.micro.54.1.615
   Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364
   Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4
   Fleischmann Roy, 2006, Expert Rev Clin Immunol, V2, P331, DOI 10.1586/1744666X.2.3.331
   Fraser DM, 2014, BRIT J CANCER, V111, P623, DOI 10.1038/bjc.2014.264
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043
   Hampel B, 2006, EXP GERONTOL, V41, P474, DOI 10.1016/j.exger.2006.03.001
   Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Iannello A, 2013, J EXP MED, V210, P2057, DOI 10.1084/jem.20130783
   Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Karsdal MA, 2012, SEMIN ARTHRITIS RHEU, V42, P131, DOI 10.1016/j.semarthrit.2012.01.004
   Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009
   Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   MARTINSGREEN M, 1994, CANCER RES, V54, P4334
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318
   Ogryzko VV, 1996, MOL CELL BIOL, V16, P5210
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143
   Paolisso G, 1998, AM J PHYSIOL-ENDOC M, V275, pE294, DOI 10.1152/ajpendo.1998.275.2.E294
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Pazolli E, 2008, CURR OPIN GENET DEV, V18, P42, DOI 10.1016/j.gde.2007.12.002
   Pazolli E, 2012, CANCER RES, V72, P2251, DOI 10.1158/0008-5472.CAN-11-3386
   Pazolli E, 2009, CANCER RES, V69, P1230, DOI 10.1158/0008-5472.CAN-08-2970
   Pérez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Perry VH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009373
   Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013
   Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005
   Qi M, 2013, J PHARMACOL SCI, V121, P200, DOI 10.1254/jphs.12269FP
   Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1
   Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122
   Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Streicher SA, 2014, CANCER EPIDEM BIOMAR, V23, P1254, DOI 10.1158/1055-9965.EPI-13-1284
   THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301
   Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044
   Tsai KKC, 2005, CANCER RES, V65, P6734, DOI 10.1158/0008-5472.CAN-05-0703
   Tuxhorn JA, 2001, J UROLOGY, V166, P2472, DOI 10.1016/S0022-5347(05)65620-0
   Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9
   Verschoor CP, 2013, J LEUKOCYTE BIOL, V93, P633, DOI 10.1189/jlb.0912461
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   WEI J, 1992, LIFE SCI, V51, P1953, DOI 10.1016/0024-3205(92)90112-3
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
NR 102
TC 39
Z9 44
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-419X
EI 0006-3002
J9 BBA-REV CANCER
JI Biochim. Biophys. Acta-Rev. Cancer
PD JAN
PY 2016
VL 1865
IS 1
SI SI
BP 14
EP 22
DI 10.1016/j.bbcan.2015.10.001
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Oncology
GA DF4YT
UT WOS:000371359200003
PM 26453912
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Lao, YX
   Li, YY
   Zhang, P
   Shao, QQ
   Lin, WR
   Qiu, BT
   Lv, YZ
   Tang, LC
   Su, SS
   Zhang, HY
   Tian, CY
   Sun, AH
   Wei, HD
   Zhang, PM
   Wu, Y
   Jiang, Y
   He, FC
AF Lao, Yuanxiang
   Li, Yanyan
   Zhang, Ping
   Shao, Qianqian
   Lin, Weiran
   Qiu, Bintao
   Lv, Yongzhuang
   Tang, Lichun
   Su, Shishuai
   Zhang, Hongyu
   Tian, Chunyan
   Sun, Aihua
   Wei, Handong
   Zhang, Pumin
   Wu, Yan
   Jiang, Ying
   He, Fuchu
TI Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to
   Bypass Fibrosis during Chronic Liver Injury in Mice
SO MOLECULAR THERAPY
LA English
DT Article
ID HEPATIC STELLATE CELLS; GROWTH-FACTOR; RESOLUTION; ACTIVATION;
   SENESCENCE; VEGF; CAPILLARIZATION; DEACTIVATION; ANGIOGENESIS;
   REGRESSION
AB Liver sinusoidal endothelial cells (LSECs) have great capacity for liver regeneration, and this capacity can easily switch to profibrotic phenotype, which is still poorly understood. In this study, we elucidated a potential target in LSECs for regenerative treatment that can bypass fibrosis during chronic liver injury. Proregenerative LSECs can be transformed to profibrotic phenotype after 4 weeks of carbon tetrachloride administration or 10 days of bile duct ligation. This phenotypic alternation of LSECs was mediated by extracellular regulated protein kinases 1 and 2 (Erk1/2)-Akt axis switch in LSECs during chronic liver injury; Erk1/2 was normally associated with maintenance of the LSEC proregenerative phenotype, inhibiting hepatic stellate cell (HSC) activation and promoting tissue repair by enhancing nitric oxide (NO)/reactive oxygen species (ROS) ratio and increasing expression of hepatic growth factor (HGF) and Wingless-type MMTV integration site family member 2 (Wnt2). Alternatively, Akt induced LSEC profibrotic phenotype, which mainly stimulated HSC activation and concomitant senescence by reducing NO/ROS ratio and decreasing HGF/Wnt2 expression. LSEC-targeted adenovirus or drug particle to promote Erk1/2 activity can alleviate liver fibrosis, accelerate fibrosis resolution, and enhance liver regeneration. This study demonstrated that the Erk1/2-Akt axis acted as a switch to regulate the proregenerative and profibrotic phenotypes of LSECs, and targeted therapy promoted liver regeneration while bypassing fibrosis, providing clues for a more effective treatment of liver diseases.
C1 [Lao, Yuanxiang; He, Fuchu] Chinese Acad Med Sci, Sch Basic Med, Peking Union Med Coll, Inst Basic Med Sci, Beijing 100730, Peoples R China.
   [Li, Yanyan] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Lao, Yuanxiang; Li, Yanyan; Zhang, Ping; Shao, Qianqian; Lin, Weiran; Qiu, Bintao; Lv, Yongzhuang; Tang, Lichun; Zhang, Hongyu; Tian, Chunyan; Sun, Aihua; Wei, Handong; Zhang, Pumin; Jiang, Ying; He, Fuchu] Beijing Inst Lifeom, Beijing Proteome Res Ctr, Natl Ctr Prot Sci Beijing, State Key Lab Prote, 38 Life Sci Pk Rd, Beijing 102206, Peoples R China.
   [Su, Shishuai; Wu, Yan] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China.
   [Jiang, Ying] Anhui Med Univ, Hefei 230032, Anhui, Peoples R China.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Peking Union Medical College; Institute of Basic Medical Sciences -
   CAMS; Tsinghua University; Chinese Academy of Sciences; National Center
   for Nanoscience & Technology, CAS; Anhui Medical University
RP Jiang, Y; He, FC (corresponding author), Beijing Inst Lifeom, Beijing Proteome Res Ctr, Natl Ctr Prot Sci Beijing, State Key Lab Prote, 38 Life Sci Pk Rd, Beijing 102206, Peoples R China.
EM jiangying304@hotmail.com; hefc@bmi.ac.cn
RI Yan, Jun/IXD-7801-2023; feng, chen/JLM-8296-2023; Wei,
   Han/JVN-4916-2024; huang, shan/JVN-1240-2024
OI Tang, Lichun/0000-0002-1636-9705
FU National Key R&D Program of China [2018YFA0507502, 2016YFC0902400,
   2017YFC0906603]; Chinese State Key Projects for Basic Research ("973
   Program") [2014CBA02001]; National Natural Science Foundation of China
   [81770581, 81570526, 81123001]; Beijing Science and Technology Project
   [Z161100002616036]; Open Project Program of the State Key Laboratory of
   Proteomics (Academy of Military Medical Sciences) [SKLP-O201509];
   Innovation project [16CXZ027]
FX This work was partially supported by the National Key R&D Program of
   China (grants 2018YFA0507502, 2016YFC0902400, and 2017YFC0906603),
   Chinese State Key Projects for Basic Research ("973 Program") (grant
   2014CBA02001), National Natural Science Foundation of China (grants
   81770581, 81570526, and 81123001), Innovation project (grant 16CXZ027),
   Beijing Science and Technology Project (grant Z161100002616036), and
   Open Project Program of the State Key Laboratory of Proteomics (Academy
   of Military Medical Sciences grant SKLP-O201509). The authors thank
   Shanshan Du and Yanfei Hu (Tsinghua University), and Juanjuan Shang and
   Ping Wu (National Center for Protein Sciences, Beijing) for their
   invaluable assistance with scanning electron microscopy; Prof. Pumin
   Zhang, Dr. Lichun Tang, and Dr. Chen Qiu (National Center for Protein
   Sciences, Beijing) for kindly providing RGD-ROBO4-modified adenovirus;
   and Prof. Yan Wu and Dr. Shishuai Su (National Center of Nanoscience and
   Technology) for kindly providing RGD-labeled honokiol coated with PEG
   nanoparticles.
CR Ankoma-Sey V, 1998, ONCOGENE, V17, P115, DOI 10.1038/sj.onc.1201912
   Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304
   Bellien J, 2012, CIRCULATION, V125, P1266, DOI 10.1161/CIRCULATIONAHA.111.070680
   Brouwers B, 2016, ONCOTARGET, V7, P29977, DOI 10.18632/oncotarget.8796
   Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026
   Chan LLY, 2012, AUTOPHAGY, V8, P1371, DOI 10.4161/auto.21028
   Chiang CK, 2006, KIDNEY INT, V70, P682, DOI 10.1038/sj.ki.5001617
   Connolly MK, 2010, J IMMUNOL, V185, P2200, DOI 10.4049/jimmunol.1000332
   Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524
   Dai JX, 2014, GLIA, V62, P2096, DOI 10.1002/glia.22729
   Danhier F, 2009, J CONTROL RELEASE, V140, P166, DOI 10.1016/j.jconrel.2009.08.011
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351
   Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681
   Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493
   Ding C, 2016, MOL CELL PROTEOMICS, V15, P3190, DOI 10.1074/mcp.M116.060145
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   Guixé-Muntet S, 2017, J HEPATOL, V66, P86, DOI 10.1016/j.jhep.2016.07.051
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Kantari-Mimoun C, 2017, ONCOTARGET, V8, P15085, DOI 10.18632/oncotarget.14749
   Kantari-Mimoun C, 2015, HEPATOLOGY, V61, P2042, DOI 10.1002/hep.27635
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Kordes C, 2008, BIOCHEM BIOPH RES CO, V367, P116, DOI 10.1016/j.bbrc.2007.12.085
   Kornek M, 2006, J HEPATOL, V45, P370, DOI 10.1016/j.jhep.2006.03.017
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lu ZH, 2017, ONCOTARGET, V8, P12272, DOI 10.18632/oncotarget.14699
   Lu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083933
   Marrone G, 2013, J HEPATOL, V58, P98, DOI 10.1016/j.jhep.2012.08.026
   Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049
   Moles A, 2014, J HEPATOL, V60, P782, DOI 10.1016/j.jhep.2013.12.005
   Negoescu A, 1996, J HISTOCHEM CYTOCHEM, V44, P959, DOI 10.1177/44.9.8773561
   Nieto N, 2002, HEPATOLOGY, V35, P62, DOI 10.1053/jhep.2002.30362
   Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc
   Rahimi RS, 2011, CURR OPIN GASTROEN, V27, P204, DOI 10.1097/MOG.0b013e3283460c7d
   Sahin H, 2012, HEPATOLOGY, V55, P1610, DOI 10.1002/hep.25545
   Sanburn N, 1999, GENE THER, V6, P1340, DOI 10.1038/sj.gt.3300948
   Schuppan D, 2013, J CLIN INVEST, V123, P1887, DOI 10.1172/JCI66028
   Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444
   Straub AC, 2007, HEPATOLOGY, V45, P205, DOI 10.1002/hep.21444
   Straub AC, 2008, J CLIN INVEST, V118, P3980, DOI 10.1172/JCI35092
   Suh W, 2002, MOL THER, V6, P664, DOI 10.1006/mthe.2002.0721
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Wang J, 2015, ONCOTARGET, V6, P7325, DOI 10.18632/oncotarget.2621
   Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774
   Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747
   Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017
   Yang L, 2014, GASTROENTEROLOGY, V146, P1339, DOI 10.1053/j.gastro.2014.01.061
   Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369
   Yoshiji H, 2003, GUT, V52, P1347, DOI 10.1136/gut.52.9.1347
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yu Y, 2010, STEM CELLS DEV, V19, P903, DOI 10.1089/scd.2009.0254
   Zhai H, 2005, EUR J PHARMACOL, V516, P112, DOI 10.1016/j.ejphar.2005.04.035
NR 54
TC 17
Z9 20
U1 6
U2 29
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD DEC 5
PY 2018
VL 26
IS 12
BP 2779
EP 2797
DI 10.1016/j.ymthe.2018.08.016
PG 19
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA HF1FG
UT WOS:000453910900008
PM 30266653
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU James, EL
   Michalek, RD
   Pitiyage, GN
   de Castro, AM
   Vignola, KS
   Jones, J
   Mohney, RP
   Karoly, ED
   Prime, SS
   Parkinson, EK
AF James, Emma L.
   Michalek, Ryan D.
   Pitiyage, Gayani N.
   de Castro, Alice M.
   Vignola, Katie S.
   Jones, Janice
   Mohney, Robert P.
   Karoly, Edward D.
   Prime, Stephen S.
   Parkinson, Eric Kenneth
TI Senescent Human Fibroblasts Show Increased Glycolysis and Redox
   Homeostasis with Extracellular Metabolomes That Overlap with Those of
   Irreparable DNA Damage, Aging, and Disease
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE extracellular; senescence; aging metabolome; DNA damage; energy; redox
   homeostasis; citrate
ID ONCOGENE-INDUCED SENESCENCE; CANCER-ASSOCIATED FIBROBLASTS; CELLULAR
   SENESCENCE; REPLICATIVE SENESCENCE; OXIDATIVE STRESS; UP-REGULATION;
   LIVER; CELLS; P53; SIGNATURE
AB Cellular senescence can modulate various pathologies and is associated with irreparable DNA double-strand breaks (IrrDSBs). Extracellular senescence metabolomes (ESMs) were generated from fibroblasts rendered senescent by proliferative exhaustion (PEsen) or 20 Gy of gamma rays (IrrDSBsen) and compared with those of young proliferating cells, confluent cells, quiescent cells, and cells exposed to repairable levels of DNA damage to identify novel noninvasive markers of senescent cells. ESMs of PEsen and IrrDSBsen overlapped and showed increased levels of citrate, molecules involved in oxidative stress, a sterol, monohydroxylipids, tryptophan metabolism, phospholipid, and nucleotide catabolism, as well as reduced levels of dipeptides containing branched chain amino acids. The ESM overlaps with the aging and disease body fluid metabolomes, supporting their utility in the noninvasive detection of human senescent cells in vivo and by implication the detection of a variety of human pathologies. Intracellular metabolites of senescent cells showed a relative increase in glycolysis, gluconeogenesis, the pentose-phosphate pathway, and, consistent with this, pyruvate dehydrogenase kinase transcripts. In contrast, tricarboxylic acid cycle enzyme transcript levels were unchanged and their metabolites were depleted. These results are surprising because glycolysis antagonizes senescence entry but are consistent with established senescent cells entering a state of low oxidative stress.
C1 [James, Emma L.; Pitiyage, Gayani N.; de Castro, Alice M.; Prime, Stephen S.; Parkinson, Eric Kenneth] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London E1 2AD, England.
   [Michalek, Ryan D.; Vignola, Katie S.; Jones, Janice; Mohney, Robert P.; Karoly, Edward D.] Metabolon Inc, Durham, NC 27713 USA.
C3 University of London; Queen Mary University London; Metabolon
RP Parkinson, EK (corresponding author), Blizard Inst, Ctr Clin & Diagnost Oral Sci, 4 Newark St, London E1 2AT, England.
EM e.k.parkinson@qmul.ac.uk
OI James, Emma/0000-0002-4031-4210
FU Blizard Institute Molecular and Cellular Biology of Medicine Theme;
   James Paget Ph.D. studentship; Research into Ageing (Age U.K.)
FX We thank Cleo Bishop, James Koh, and Chris Paraskeva for their generous
   gifts of the p16<SUP>INK4A</SUP> antibody (C.B. and J.K.) and colon
   fibroblasts (C.P.). We are grateful to Kenny Linton and the Blizard
   Institute Molecular and Cellular Biology of Medicine Theme for financial
   support. E.J. is in receipt of the James Paget Ph.D. studentship, and
   A.D.C. was supported by a Research into Ageing (Age U.K.) Ph.D.
   studentship.
CR Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Aird KM, 2013, CELL REP, V3, P1252, DOI 10.1016/j.celrep.2013.03.004
   Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   AXELSON M, 1989, J LIPID RES, V30, P1877
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Capparelli C, 2012, CELL CYCLE, V11, P2285, DOI 10.4161/cc.20718
   Castro P, 2003, PROSTATE, V55, P30, DOI 10.1002/pros.10204
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140
   DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081
   Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h
   Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121
   Fuchs S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-14
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Funayama R, 2007, CHROMOSOMA, V116, P431, DOI 10.1007/s00412-007-0115-7
   Ghneim HK, 2010, CELL BIOCHEM FUNCT, V28, P283, DOI 10.1002/cbf.1653
   Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Hassona Y, 2013, CARCINOGENESIS, V34, P1286, DOI 10.1093/carcin/bgt035
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107
   Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520
   Itahana Y, 2015, ONCOGENE, V34, P1799, DOI 10.1038/onc.2014.119
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105
   Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Kim YM, 2010, J BIOL CHEM, V285, P29069, DOI 10.1074/jbc.M110.120386
   Kondoh H, 2005, CANCER RES, V65, P177
   Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Leong WF, 2009, MOL CANCER RES, V7, P354, DOI 10.1158/1541-7786.MCR-08-0373
   Lushchak OV, 2014, REDOX REP, V19, P8, DOI 10.1179/1351000213Y.0000000073
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   Martien S, 2013, BBA-MOL CELL BIOL L, V1831, P1217, DOI 10.1016/j.bbalip.2013.04.005
   Martin FPJ, 2011, J PROTEOME RES, V10, P990, DOI 10.1021/pr100703a
   Mazurek MP, 2010, EMBO REP, V11, P431, DOI 10.1038/embor.2010.51
   Mendez MV, 1998, J VASC SURG, V28, P876, DOI 10.1016/S0741-5214(98)70064-3
   Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094
   Munro J, 2001, ONCOGENE, V20, P3541, DOI 10.1038/sj.onc.1204460
   Mycielska ME, 2006, INT J BIOCHEM CELL B, V38, P1766, DOI 10.1016/j.biocel.2006.04.008
   Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Pezze PD, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003728
   Pitiyage GN, 2012, J ORAL PATHOL MED, V41, P454, DOI 10.1111/j.1600-0714.2012.01129.x
   Pitiyage GN, 2011, J PATHOL, V223, P604, DOI 10.1002/path.2839
   Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800
   Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108
   Rizza S, 2014, ATHEROSCLEROSIS, V232, P260, DOI 10.1016/j.atherosclerosis.2013.10.029
   Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Schwarz MJ, 2013, EUR ARCH PSY CLIN N, V263, P345, DOI 10.1007/s00406-012-0384-x
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031
   Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y
   TAKAHASHI S, 1978, BIOCHIM BIOPHYS ACTA, V522, P63, DOI 10.1016/0005-2744(78)90322-4
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   Tan L, 2012, J NEUROL SCI, V323, P1, DOI 10.1016/j.jns.2012.08.005
   Tomás-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034
   Tomás-Loba A, 2013, AGING CELL, V12, P93, DOI 10.1111/acel.12025
   Wei JE, 2011, INT J CANCER, V129, P2207, DOI 10.1002/ijc.25881
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wijeyesekera A, 2012, J PROTEOME RES, V11, P2224, DOI 10.1021/pr2010154
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
   Yang G, 2006, P NATL ACAD SCI USA, V103, P16472, DOI 10.1073/pnas.0605752103
   Zahavi M., 1965, Journal of Insect Physiology, V11, P811, DOI 10.1016/0022-1910(65)90160-5
   Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020
NR 80
TC 153
Z9 165
U1 2
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD APR
PY 2015
VL 14
IS 4
BP 1854
EP 1871
DI 10.1021/pr501221g
PG 18
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA CF3QJ
UT WOS:000352463300019
PM 25690941
OA hybrid
DA 2024-02-19
ER

PT J
AU Michael, MD
   Kulkarni, RN
   Postic, C
   Previs, SF
   Shulman, GI
   Magnuson, MA
   Kahn, CR
AF Michael, MD
   Kulkarni, RN
   Postic, C
   Previs, SF
   Shulman, GI
   Magnuson, MA
   Kahn, CR
TI Loss of insulin signaling in hepatocytes leads to severe insulin
   resistance and progressive hepatic dysfunction
SO MOLECULAR CELL
LA English
DT Article
ID DEPENDENT DIABETES-MELLITUS; MESSENGER-RNA STABILITY; PANCREATIC
   BETA-CELLS; GENE-EXPRESSION; FATTY-ACID; GLUCOSE OUTPUT; RECEPTOR
   SUBSTRATE-1; GLYCOGEN-SYNTHASE; RENAL METABOLISM; PRIMARY CULTURES
AB The liver plays a central role in the control of glucose homeostasis and is subject to complex regulation by substrates, insulin, and other hormones. To investigate the effect of the loss of direct insulin action in liver, we have used the Cre-loxP system to inactivate the insulin receptor gene in hepatocytes. Liver-specific insulin receptor knockout (LIRKO) mice exhibit dramatic insulin resistance, severe glucose intolerance, and a failure of insulin to suppress hepatic glucose production and to regulate hepatic gene expression. These alterations are paralleled by marked hyperinsulinemia due to a combination of increased insulin secretion and decreased insulin clearance. With aging, the LIRKO liver exhibits morphological and functional changes, and the metabolic phenotype becomes less severe, Thus, insulin signaling in liver is critical in regulating glucose homeostasis and maintaining normal hepatic function.
C1 Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA.
   Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA.
   Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.
   Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA.
C3 Harvard University; Joslin Diabetes Center, Inc.; Harvard Medical
   School; Harvard University; Harvard Medical School; Vanderbilt
   University; Yale University
RP Kahn, CR (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA.
RI Postic, Catherine/P-2271-2017; Magnuson, Mark/AAY-7172-2021; Kahn,
   Ronald/AAY-2435-2021; Magnuson, Mark A/B-1335-2009; Shulman, Gerald
   I./P-7176-2019; Previs, Stephen/JNE-8752-2023
OI Postic, Catherine/0000-0002-1875-6960; Magnuson,
   Mark/0000-0002-8824-6499; Kahn, Ronald/0000-0002-7583-9228; Magnuson,
   Mark A/0000-0002-8824-6499; Shulman, Gerald I./0000-0003-1529-5668;
   Michael, Mervyn/0000-0002-0224-1065
FU NIDDK NIH HHS [R01 DK040936, P01 DK42502, R01 DK31036, F32 DK09825]
   Funding Source: Medline
CR ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0
   ASSIMACOPOULOSJEANNET F, 1977, BIOCHIM BIOPHYS ACTA, V498, P91, DOI 10.1016/0304-4165(77)90090-3
   BEYLOT M, 1993, ANAL BIOCHEM, V212, P526, DOI 10.1006/abio.1993.1363
   BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49
   Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0
   Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6
   BRUNT EM, 1991, HEPATOLOGY, V13, P1017, DOI 10.1002/hep.1840130602
   CHAN WC, 1975, PATHOLOGY, V7, P299, DOI 10.3109/00313027509081686
   CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117
   Cherrington A D, 1978, Biochem Soc Symp, P31
   COHEN P, 1978, BIOCH SOC S, V43, P69
   DAVIDSON MB, 1981, METABOLISM, V30, P279, DOI 10.1016/0026-0495(81)90152-9
   DeFronzo RA, 1997, DIABETES REV, V5, P177
   DENTON RM, 1983, PHILOS T R SOC B, V302, P33, DOI 10.1098/rstb.1983.0036
   DRAKE RL, 1985, BIOCHEM BIOPH RES CO, V130, P317
   Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608
   EATON RP, 1984, J CLIN ENDOCR METAB, V58, P555, DOI 10.1210/jcem-58-3-555
   Exton J H, 1970, Recent Prog Horm Res, V26, P411
   FERNYHOUGH P, 1989, MOL BRAIN RES, V6, P109, DOI 10.1016/0169-328X(89)90044-2
   FERRANNINI E, 1983, AM J PHYSIOL, V244, pE517
   FLAIM KE, 1985, AM J PHYSIOL, V249, pE447, DOI 10.1152/ajpendo.1985.249.5.E447
   Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737
   Foretz M, 1999, MOL CELL BIOL, V19, P3760
   Goalstone ML, 1999, BIOCHEM BIOPH RES CO, V254, P243, DOI 10.1006/bbrc.1998.9922
   Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184
   HOFMANN C, 1980, DIABETES, V29, P865, DOI 10.2337/diabetes.29.11.865
   KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066
   Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872
   Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096
   Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411
   Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2
   Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339
   LEVINE R, 1956, DIABETES, V5, P209, DOI 10.2337/diab.5.3.209
   Lewis GF, 1997, DIABETES, V46, P1111, DOI 10.2337/diabetes.46.7.1111
   LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703
   LLOYD CE, 1987, AM J PHYSIOL, V252, pC205, DOI 10.1152/ajpcell.1987.252.2.C205
   MADISON LL, 1969, ARCH INTERN MED, V123, P284, DOI 10.1001/archinte.123.3.284
   MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V
   MCCRAW EF, 1967, P SOC EXP BIOL MED, V126, P232
   MORTIMORE GE, 1963, AM J PHYSIOL, V204, P699, DOI 10.1152/ajplegacy.1963.204.4.699
   MULLER MJ, 1988, METABOLISM, V37, P55, DOI 10.1016/0026-0495(88)90029-7
   Nickenig G, 1998, CIRCULATION, V98, P2453, DOI 10.1161/01.CIR.98.22.2453
   Niswender KD, 1997, J BIOL CHEM, V272, P22564, DOI 10.1074/jbc.272.36.22564
   Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570
   OBrien RM, 1996, PHYSIOL REV, V76, P1109, DOI 10.1152/physrev.1996.76.4.1109
   OKUBO M, 1991, ARCH BIOCHEM BIOPHYS, V288, P126, DOI 10.1016/0003-9861(91)90173-G
   Pagliassotti M, 1994, ROLE LIVER MAINTAINI, P45
   Peng HM, 1998, MOL PHARMACOL, V54, P740
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Proud CG, 1997, BIOCHEM J, V328, P329
   REBRIN K, 1995, DIABETES, V44, P1038, DOI 10.2337/diabetes.44.9.1038
   Rebrin K, 1996, J CLIN INVEST, V98, P741, DOI 10.1172/JCI118846
   RUDERMAN NB, 1968, AM J PHYSIOL, V214, P1346, DOI 10.1152/ajplegacy.1968.214.6.1346
   RUVALCABA RH, 1966, AM J DIS CHILD, V112, P558, DOI 10.1001/archpedi.1966.02090150102009
   Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656
   SHULMAN GI, 1978, J CLIN INVEST, V62, P487, DOI 10.1172/JCI109150
   Soskin S, 1938, AM J PHYSIOL, V124, P558, DOI 10.1152/ajplegacy.1938.124.2.558
   SPARKS JD, 1994, BBA-LIPID LIPID MET, V1215, P9, DOI 10.1016/0005-2760(94)90088-4
   STARZL TE, 1976, LANCET, V1, P821
   Terauchi Y, 1997, J CLIN INVEST, V99, P861, DOI 10.1172/JCI119250
   TERRIS S, 1979, CAN J BIOCHEM CELL B, V57, P459, DOI 10.1139/o79-059
   TOMITA T, 1992, PANCREAS, V7, P367, DOI 10.1097/00006676-199205000-00015
   TOPPING DL, 1972, BIOCHEM J, V126, P295, DOI 10.1042/bj1260295
   WAHREN J, 1972, J CLIN INVEST, V51, P1870, DOI 10.1172/JCI106989
   WARRAM JH, 1995, JOSLINS DIABETES MEL
   WEIBEL ER, 1979, PRACTICAL METHODS BI, V1
   WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625
   WITTERS LA, 1992, J BIOL CHEM, V267, P2864
   YEUNG RTT, 1973, CANCER, V32, P1482, DOI 10.1002/1097-0142(197312)32:6<1482::AID-CNCR2820320627>3.0.CO;2-4
   YOKOO H, 1978, ARCH PATHOL LAB MED, V102, P213
   Zammit VA, 2000, BIOCHEM SOC T, V28, P103, DOI 10.1042/bst0280103
   ZAVARONI I, 1987, J CLIN ENDOCR METAB, V65, P494, DOI 10.1210/jcem-65-3-494
NR 73
TC 971
Z9 1161
U1 1
U2 57
PU CELL PRESS
PI CAMBRIDGE
PA 1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA
SN 1097-2765
J9 MOL CELL
JI Mol. Cell.
PD JUL
PY 2000
VL 6
IS 1
BP 87
EP 97
DI 10.1016/S1097-2765(00)00010-1
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 345DD
UT WOS:000088799400009
PM 10949030
OA hybrid
DA 2024-02-19
ER

PT J
AU Lu, XR
   Li, JX
   Ma, YC
   Khan, I
   Yang, Y
   Li, YX
   Wang, YF
   Liu, GL
   Zhang, ZM
   Yang, PR
   Zhang, CJ
AF Lu, Xuerui
   Li, Junxiang
   Ma, Yingchun
   Khan, Israr
   Yang, Yun
   Li, Yuxi
   Wang, YaFei
   Liu, GuanLan
   Zhang, Zhiming
   Yang, Pingrong
   Zhang, Chunjiang
TI Fermented <i>Angelica sinensis</i> activates Nrf2 signaling and
   modulates the gut microbiota composition and metabolism to attenuate
   d-gal induced liver aging
SO FOOD & FUNCTION
LA English
DT Article; Early Access
ID LACTOBACILLUS-PLANTARUM; ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS;
   EXPRESSION; PROBIOTICS; HEALTH
AB Aging is an inevitable physiological process associated with an imbalance in the oxidative defense system. Angelica sinensis, a kind of traditional Chinese medicine (TCM), has anti-oxidant effects and has been considered as a potential supplement in anti-aging treatment. Nevertheless, it has the disadvantages of slow efficacy and long duration of treatment. Fermentation, as an efficient biotechnological approach, is beneficial for improving the nutritional capacity of the material. Fermented TCMs are considered to be more effective. In this study, fermented Angelica sinensis (FAS) and non-fermented Angelica sinensis (NFAS) were used to investigate changes in the chemical constituents. Furthermore, the improvement effect of FAS on d-galactose-induced aging in mice and the potential mechanisms were explored. The results revealed that FAS and NFAS had different constituents under the influence of fermentation, such as 3-phenyllactic acid, l-5-hydroxytryptophan, taxifolin and methyl gallate. These elevated constituents of FAS might help increase the ability of FAS to improve aging. The aging model was established by intraperitoneal injection of d-galactose (2.5 g kg(-1) day(-1)) for 44 days, and FAS (3 g kg(-1) day(-1)) was administered daily by oral gavage after 2 weeks of induction with d-galactose. FAS was observed to significantly ameliorate changes associated with liver aging, such as reduction of MDA, AGEs and 8-OHdG. The contents of pro-inflammatory cytokines containing TNF-alpha, IL-1 beta and IL-6 were significantly suppressed in the FAS group. In addition, FAS activated Nrf2 signaling better than NFAS, improved the expression of Nrf2, HO-1, NQO1, GCLC, GCLM and GSS, and further increased the activities of SOD, CAT and other antioxidant enzymes in the liver. Simultaneously, it had a certain repair effect on the liver tissues of mice. The intestinal microbiota analysis showed that FAS could regulate the microbiota imbalance caused by aging, increase the ratio of Firmicutes/Bacteroidetes by 95% and improve the relative abundance of beneficial bacteria related to Nrf2 signaling, such as Lactobacillus. Besides, fecal metabolite analysis identified uric acid as an evidential metabolite, suggesting that FAS participates in purine metabolism to improve aging. Therefore, the regulation of intestinal microbiota and metabolism may be one of the important mechanisms of FAS in alleviating hepatic oxidative stress via the gut-liver axis. The results of this study could provide information for the future development of postbiotic products that may have beneficial effects on the prevention or treatment of aging.
C1 [Lu, Xuerui; Li, Junxiang; Yang, Yun; Wang, YaFei; Yang, Pingrong] Lanzhou Univ, Sch Pharm, Lanzhou 730020, Peoples R China.
   [Ma, Yingchun; Yang, Pingrong] Gansu Inst Drug Control, Lanzhou 730000, Peoples R China.
   [Khan, Israr; Li, Yuxi; Liu, GuanLan; Zhang, Chunjiang] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.
   [Khan, Israr; Li, Yuxi; Liu, GuanLan; Zhang, Chunjiang] Lanzhou Univ, Key Lab Cell Act & Stress Adaptat, Minist Educ, Lanzhou 730000, Peoples R China.
   [Khan, Israr; Li, Yuxi; Liu, GuanLan; Zhang, Chunjiang] Lanzhou Univ, Gansu Key Lab Biomonitoring & Bioremediat Environm, Lanzhou 730000, Peoples R China.
   [Zhang, Zhiming] Gansu Prov Hosp TCM, Lanzhou 730000, Peoples R China.
C3 Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou
   University
RP Yang, PR (corresponding author), Lanzhou Univ, Sch Pharm, Lanzhou 730020, Peoples R China.; Yang, PR (corresponding author), Gansu Inst Drug Control, Lanzhou 730000, Peoples R China.; Zhang, CJ (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.; Zhang, CJ (corresponding author), Lanzhou Univ, Key Lab Cell Act & Stress Adaptat, Minist Educ, Lanzhou 730000, Peoples R China.; Zhang, CJ (corresponding author), Lanzhou Univ, Gansu Key Lab Biomonitoring & Bioremediat Environm, Lanzhou 730000, Peoples R China.
EM lijunxiang20@lzu.edu.cn; 1425264975@qq.com; chunjiangz122@sina.com
RI zhang, chunjiang/AAQ-5398-2021; 王, 亚飞/HJG-9433-2022
OI 王, 亚飞/0000-0001-6984-6918; Li, Junxiang/0000-0002-1138-6039
FU Gansu Province Key RD Plan; Science and Technology Major Project of
   Gansu Province; Guangzhou Science and Technology Planning Project;
   "Innovation Star" Project of the Excellent Postgraduate in Gansu
   Province;  [21YF5FA105];  [22ZD1FA001];  [202206010165];  [2022CXZX-139]
FX This work was supported by the Gansu Province Key R&D Plan (No.
   21YF5FA105), the Science and Technology Major Project of Gansu Province
   (No. 22ZD1FA001), the Guangzhou Science and Technology Planning Project
   (No. 202206010165), and the "Innovation Star" Project of the Excellent
   Postgraduate in Gansu Province (No. 2022CXZX-139).
CR Ahmed Tanvir, 2021, Heliyon, V7, pe08133, DOI 10.1016/j.heliyon.2021.e08133
   Babaeenezhad E, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e07465
   Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4
   Dey TB, 2016, TRENDS FOOD SCI TECH, V53, P60, DOI 10.1016/j.tifs.2016.04.007
   Dong WP, 2017, J ENDOCRINOL, V232, P71, DOI 10.1530/JOE-16-0322
   Fan QS, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-02054-5
   Froldi G, 2008, PHARMACOLOGY, V81, P70, DOI 10.1159/000109297
   Gao DW, 2013, FOOD FUNCT, V4, P982, DOI 10.1039/c3fo30316k
   Gao Y, 2021, AGING-US, V13, P15320, DOI 10.18632/aging.203090
   Guo R, 2020, CHIN MED-UK, V15, DOI 10.1186/s13020-020-00379-x
   Han MJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040634
   Hong SM, 2021, FOOD FUNCT, V12, P3611, DOI [10.1039/D0FO02966A, 10.1039/d0fo02966a]
   Honma Y, 2021, MED MOL MORPHOL, V54, P41, DOI 10.1007/s00795-020-00258-2
   Huang ZR, 2020, FOOD RES INT, V136, DOI 10.1016/j.foodres.2020.109511
   Hussain A, 2016, FOOD RES INT, V81, P1, DOI 10.1016/j.foodres.2015.12.026
   Jacouton E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01553
   Kuo YW, 2021, PEERJ, V9, DOI 10.7717/peerj.11209
   Li BL, 2019, FOOD FUNCT, V10, P1707, DOI 10.1039/c8fo01920g
   Li BL, 2018, FOOD FUNCT, V9, P6587, DOI 10.1039/c8fo01768a
   Li MH, 2019, CURR MICROBIOL, V76, P706, DOI 10.1007/s00284-019-01681-0
   Li X, 2016, EXP GERONTOL, V83, P89, DOI 10.1016/j.exger.2016.07.012
   Lin TL, 2021, PROTEIN CELL, V12, P394, DOI 10.1007/s13238-020-00784-w
   Liu LH, 2021, FOODS, V10, DOI 10.3390/foods10061343
   Liu XL, 2021, FOOD FUNCT, V12, P12142, DOI [10.1039/d1fo01349a, 10.1039/D1FO01349A]
   Mirzaei S, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10030349
   Mitchell ES, 2009, J NEUROSCI RES, V87, P2803, DOI 10.1002/jnr.22100
   Ning KT, 2020, ACS OMEGA, V5, P20800, DOI 10.1021/acsomega.0c01689
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Park DJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197068
   Park J, 2015, NEUROSCI LETT, V584, P191, DOI 10.1016/j.neulet.2014.10.016
   Park YA, 2018, J MICROBIOL BIOTECHN, V28, P1391, DOI 10.4014/jmb.1805.05065
   Radhakrishnan R, 2018, J NUCL MED, V59, P1445, DOI 10.2967/jnumed.117.206516
   Reyes-Gonzales MC, 2009, J MEMBRANE BIOL, V231, P93, DOI 10.1007/s00232-009-9208-y
   Royce GH, 2019, GEROSCIENCE, V41, P795, DOI 10.1007/s11357-019-00131-w
   Ryu BI, 2022, FOOD SCI BIOTECHNOL, V31, P1063, DOI 10.1007/s10068-022-01120-0
   Shaw P, 2020, J CELL PHYSIOL, V235, P3119, DOI 10.1002/jcp.29219
   Shen CY, 2017, BRIT J PHARMACOL, V174, P1395, DOI 10.1111/bph.13631
   Shi HT, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-020-01092-6
   Singh VP, 2013, J PAK MED ASSOC, V63, P253
   Socha R, 2009, FOOD CHEM, V113, P568, DOI 10.1016/j.foodchem.2008.08.029
   Sochocka M, 2019, MOL NEUROBIOL, V56, P1841, DOI 10.1007/s12035-018-1188-4
   Stanton C, 2005, CURR OPIN BIOTECH, V16, P198, DOI 10.1016/j.copbio.2005.02.008
   Sun LY, 2020, BIOCHEM BIOPH RES CO, V521, P113, DOI 10.1016/j.bbrc.2019.10.088
   Sun MF, 2018, AGEING RES REV, V45, P53, DOI 10.1016/j.arr.2018.04.004
   Sunil C, 2019, PHYTOCHEMISTRY, V166, DOI 10.1016/j.phytochem.2019.112066
   Tanaka M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21061992
   Todd CD, 2006, J EXP BOT, V57, P5, DOI 10.1093/jxb/erj013
   Tu WJ, 2019, AGING DIS, V10, P637, DOI 10.14336/AD.2018.0513
   Wang Hai-ying, 2016, Zhong Yao Cai, V39, P2091
   Wang L, 2011, J BIOTECHNOL, V156, P125, DOI 10.1016/j.jbiotec.2011.07.024
   Wen JJ, 2021, FOOD FUNCT, V12, P2617, DOI [10.1039/D0FO02600J, 10.1039/d0fo02600j]
   Wu T, 2021, FOOD FUNCT, V12, P11760, DOI [10.1039/D1FO02588K, 10.1039/d1fo02588k]
   Wu Y, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1897211
   Xing Y, 2016, J ZHEJIANG UNIV-SC B, V17, P391, DOI 10.1631/jzus.B1500264
   Yamanaka H, 2019, MOD RHEUMATOL, V29, P146, DOI 10.1080/14397595.2018.1442183
   Yan S, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/6236904
   Yang LC, 2020, J BIOSCI BIOENG, V129, P514, DOI [10.1016/j.jbiosc.2019.10.003, 10.1016/j.jbi0sc.2019.10.003]
   Yuan QX, 2020, CARBOHYD POLYM, V236, DOI 10.1016/j.carbpol.2020.116047
   Yuan S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76249-1
   Zhang DD, 2020, NAT PROD REP, V37, P797, DOI 10.1039/c9np00061e
   Zhang F, 2020, MICROBIOL MOL BIOL R, V84, DOI 10.1128/MMBR.00072-19
   Zhang HY, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00187
   Zhang J, 2017, J DAIRY SCI, V100, P6025, DOI 10.3168/jds.2016-12480
   Zhang KX, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7187946
   Zhang L, 2019, MOLECULES, V24, DOI 10.3390/molecules24193461
   Zhang LY, 2021, NAT PROD RES, V35, P4084, DOI 10.1080/14786419.2020.1716349
   Zhao D, 2021, REJUV RES, V24, P86, DOI 10.1089/rej.2020.2352
   Zhao JC, 2018, FOOD FUNCT, V9, P917, DOI [10.1039/c7fo01574g, 10.1039/C7FO01574G]
   Zhou QQ, 2021, FOOD FUNCT, V12, P5591, DOI [10.1039/d1fo00166c, 10.1039/D1FO00166C]
   Zhuang C, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/3240820
   Zhuang C, 2018, INT J BIOL MACROMOL, V115, P281, DOI 10.1016/j.ijbiomac.2018.04.083
NR 71
TC 4
Z9 4
U1 16
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD 2023 JAN 3
PY 2023
VL 14
IS 1
BP 215
EP 230
DI 10.1039/d2fo01637k
EA NOV 2022
PG 16
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 7I4QL
UT WOS:000893754000001
PM 36477974
DA 2024-02-19
ER

PT J
AU Kemeleva, EA
   Sinitsyna, OI
   Conlon, KA
   Berrios, M
   Kolosova, NG
   Zharkov, DO
   Vasyunina, EA
   Nevinsky, GA
AF Kemeleva, E. A.
   Sinitsyna, O. I.
   Conlon, K. A.
   Berrios, M.
   Kolosova, N. G.
   Zharkov, D. O.
   Vasyunina, E. A.
   Nevinsky, G. A.
TI Oxidation of guanine in liver and lung DNA of prematurely aging OXYS
   rats
SO BIOCHEMISTRY-MOSCOW
LA English
DT Article
DE oxidative stress; 8-oxoguanine; premature aging; OXYS rats
ID FREE-RADICAL THEORY; 8-OXOGUANINE; 8-HYDROXYGUANINE; DAMAGE;
   MITOCHONDRIA; ANTIOXIDANTS; GLYCOSYLASE; MUTAGENESIS; CATARACT; STRESS
AB Immunofluorescence assay was applied for determination of 8-oxoguanine (8-oxoG) in DNA. The 8-oxoG content in liver and lung DNA of 2- and 18-month-old Wistar rats was compared with that of prematurely aging OXYS rats. It was shown that for rats of both strains, 8-oxoG content in lung DNA compared with liver DNA was 1.7-2.0-fold and 1.3-1.7-fold higher for 2- and 18-month-old rats, respectively. However, the degree of oxidative damage in liver DNA of OXYS rats was 2.4- (p < 0.01) and 1.5-fold (p < 0.05) higher for 2- and 18-month-old animals, respectively, than that in liver DNA of Wistar rats. Oxidation of guanine in lung DNA of OXYS rats was 2- (p < 0.01) and 1.7-fold (p < 0.05) higher for 2- and 18-month-old animals, respectively, than that in lung DNA of Wistar rats. The data indicate that elevated DNA oxidative damage in various organs of OXYS rats may be an important factor of accelerated aging and progression of age-related diseases-cataract, macular dystrophy, hypertension, osteoporosis, cognitive and behavioral dysfunctions, and also lung and liver pathologies.
C1 Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia.
   Russian Acad Sci, Novosibirsk Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia.
   SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.
   SUNY Stony Brook, Univ Microscopy Ctr, Stony Brook, NY 11794 USA.
C3 Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB
   RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian
   Branch of the RAS; Russian Academy of Sciences; State University of New
   York (SUNY) System; State University of New York (SUNY) Stony Brook;
   State University of New York (SUNY) System; State University of New York
   (SUNY) Stony Brook
RP Nevinsky, GA (corresponding author), Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Pr Lavrenteva 10, Novosibirsk 630090, Russia.
EM nevinsky@niboch.nse.ru
RI Kolosova, Nataliya G/AAR-7409-2020; Kolosova, Nataliya G/P-3178-2015;
   Zharkov, Dmitry/K-2158-2012; Nevinsky, Georgy/E-6053-2012; Sinitsyna,
   Olga/U-3682-2019
OI Kolosova, Nataliya G/0000-0003-2398-8544; Kolosova, Nataliya
   G/0000-0003-2398-8544; Zharkov, Dmitry/0000-0001-5013-0194; 
FU NCI NIH HHS [CA8403301] Funding Source: Medline
CR Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547
   Bobko AA, 2005, BIOCHEM BIOPH RES CO, V330, P367, DOI 10.1016/j.bbrc.2005.02.166
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Collins A, 2002, CARCINOGENESIS, V23, P2129, DOI 10.1093/carcin/23.12.2129
   Conlon KA, 2000, J HISTOTECHNOL, V23, P37
   DEGAN P, 1991, CARCINOGENESIS, V12, P865, DOI 10.1093/carcin/12.5.865
   DIZDAROGLU M, 1985, BIOCHEMISTRY-US, V24, P4476, DOI 10.1021/bi00337a032
   EPE B, 1993, MUTAT RES, V299, P135, DOI 10.1016/0165-1218(93)90091-Q
   Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1
   GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z
   Gutteridge J. M. C., 1989, FREE RADICALS BIOL M
   HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Hosokawa M, 2000, MECH AGEING DEV, V118, P61, DOI 10.1016/S0047-6374(00)00158-5
   ISCHENKO A, 2003, MET SCI MONIT, V9, P16
   Ishchenko AA, 1998, MOL BIOL+, V32, P454
   KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2137, DOI 10.1093/nar/12.4.2137
   Kolosova NG, 2001, B EXP BIOL MED+, V132, P814, DOI 10.1023/A:1013014919721
   Kolosova NG, 2004, B EXP BIOL MED+, V137, P249, DOI 10.1023/B:BEBM.0000031561.71977.85
   KOLOSOVA NG, 2003, USPEKHI GERONTOL, V12, P143
   LOSKUTOVA LV, 2000, B EKSP BIOL MED, V130, P155
   Marsili S, 2004, EXP EYE RES, V79, P595, DOI 10.1016/j.exer.2004.06.008
   Mori M, 2001, FREE RADICAL BIO MED, V30, P1130, DOI 10.1016/S0891-5849(01)00511-1
   MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y
   PARK EM, 1992, P NATL ACAD SCI USA, V89, P3375, DOI 10.1073/pnas.89.8.3375
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V199, P726, DOI 10.1006/bbrc.1994.1289
   SALGANIK RI, 1994, BIOCHEM BIOPH RES CO, V205, P180, DOI 10.1006/bbrc.1994.2647
   Shabalina I G, 2001, Eksp Klin Farmakol, V64, P34
   SHIGENAGA MK, 1989, P NATL ACAD SCI USA, V86, P9697, DOI 10.1073/pnas.86.24.9697
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Sinitsyna O, 2006, J CELL MOL MED, V10, P206, DOI 10.1111/j.1582-4934.2006.tb00301.x
   SOLOVEVA NA, 1975, GENETIKA+, V11, P63
   Takeda T, 1999, NEUROBIOL AGING, V20, P105, DOI 10.1016/S0197-4580(99)00008-1
   TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690
   von Sonntag C., 1987, CHEM BASIS RAD BIOL
   Yelinova V, 1996, BIOCHEM BIOPH RES CO, V221, P300, DOI 10.1006/bbrc.1996.0590
   1996, INBRED STRAINS RATS, P52
NR 37
TC 11
Z9 11
U1 0
U2 3
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0006-2979
EI 1608-3040
J9 BIOCHEMISTRY-MOSCOW+
JI Biochem.-Moscow
PD JUN
PY 2006
VL 71
IS 6
BP 612
EP 618
DI 10.1134/S0006297906060046
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 059XN
UT WOS:000238765600004
PM 16827652
DA 2024-02-19
ER

PT J
AU Yang, GY
   Liu, RX
   Rezaei, S
   Liu, X
   Wan, YJY
AF Yang, Guiyan
   Liu, Rex
   Rezaei, Shahbaz
   Liu, Xin
   Wan, Yu-Jui Yvonne
TI Uncovering the Gut-Liver Axis Biomarkers for Predicting Metabolic Burden
   in Mice
SO NUTRIENTS
LA English
DT Article
DE diet; aging; bile acid; FXR; gut-liver axis; cognitive dysfunction;
   chronic inflammation; machine learning
ID FARNESOID-X RECEPTOR; FATTY LIVER; HEPATIC INFLAMMATION;
   DOWN-REGULATION; BILE-ACID; DISEASE; FXR; HEPATOCARCINOGENESIS; PLASMA;
   HEALTH
AB Western diet (WD) intake, aging, and inactivation of farnesoid X receptor (FXR) are risk factors for metabolic and chronic inflammation-related health issues ranging from metabolic dysfunction-associated steatotic liver disease (MASLD) to dementia. The progression of MASLD can be escalated when those risks are combined. Inactivation of FXR, the receptor for bile acid (BA), is cancer prone in both humans and mice. The current study used multi-omics including hepatic transcripts, liver, serum, and urine metabolites, hepatic BAs, as well as gut microbiota from mouse models to classify those risks using machine learning. A linear support vector machine with K-fold cross-validation was used for classification and feature selection. We have identified that increased urine sucrose alone achieved 91% accuracy in predicting WD intake. Hepatic lithocholic acid and serum pyruvate had 100% and 95% accuracy, respectively, to classify age. Urine metabolites (decreased creatinine and taurine as well as increased succinate) or increased gut bacteria (Dorea, Dehalobacterium, and Oscillospira) could predict FXR deactivation with greater than 90% accuracy. Human disease relevance is partly revealed using the metabolite-disease interaction network. Transcriptomics data were also compared with the human liver disease datasets. WD-reduced hepatic Cyp39a1 (cytochrome P450 family 39 subfamily a member 1) and increased Gramd1b (GRAM domain containing 1B) were also changed in human liver cancer and metabolic liver disease, respectively. Together, our data contribute to the identification of noninvasive biomarkers within the gut-liver axis to predict metabolic status.
C1 [Yang, Guiyan; Wan, Yu-Jui Yvonne] Univ Calif Davis, Dept Med Pathol, Lab Med Sacramento, Davis, CA 95817 USA.
   [Liu, Rex; Rezaei, Shahbaz; Liu, Xin] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA.
C3 University of California System; University of California Davis;
   University of California System; University of California Davis
RP Wan, YJY (corresponding author), Univ Calif Davis, Dept Med Pathol, Lab Med Sacramento, Davis, CA 95817 USA.
EM yangguiyan1990@hotmail.com; rexliu@ucdavis.edu; srezaei@ucdavis.edu;
   xinliu@ucdavis.edu; yjywan@ucdavis.edu
RI Yang, Guiyan/HTS-4476-2023
OI , Guiyan/0000-0001-8885-6396; Wan, Yu-Jui Yvonne/0000-0003-2243-7759
CR Ahmed MY, 2015, NEUROLOGY, V84, P1745, DOI 10.1212/WNL.0000000000001523
   Albillos A, 2020, J HEPATOL, V72, P558, DOI 10.1016/j.jhep.2019.10.003
   Allison SJ, 2019, NAT REV NEPHROL, V15, P1, DOI 10.1038/s41581-018-0086-3
   Bendlová B, 2017, PHYSIOL RES, V66, pS425, DOI 10.33549/physiolres.933731
   Bjune MS, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158887
   Carter CE, 2012, CLIN J AM SOC NEPHRO, V7, P595, DOI 10.2215/CJN.09300911
   Chauhan VK, 2019, ARTIF INTELL REV, V52, P803, DOI 10.1007/s10462-018-9614-6
   Chen SY, 2014, MOL ENDOCRINOL, V28, P1987, DOI 10.1210/me.2014-1164
   Chiba T, 2016, J PHARM PHARMACOL, V68, P1567, DOI 10.1111/jphp.12646
   Chung M, 2014, AM J CLIN NUTR, V100, P833, DOI 10.3945/ajcn.114.086314
   Ciou SC, 2015, INT J CANCER, V137, P104, DOI 10.1002/ijc.29361
   de Souza CO, 2017, J CELL PHYSIOL, V232, P2168, DOI 10.1002/jcp.25715
   Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572
   Ding L, 2020, EUR J LIPID SCI TECH, V122, DOI 10.1002/ejlt.202000179
   DiNicolantonio JJ, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2017-000676
   dos Santos ALS, 2021, EXPERT REV GASTROENT, V15, P181, DOI 10.1080/17474124.2021.1829470
   Ferrarini A, 2019, J PROTEOME RES, V18, P3067, DOI 10.1021/acs.jproteome.9b00185
   Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807
   Gilbert MC, 2023, LIVER RES-PRC, V7, P296, DOI 10.1016/j.livres.2022.11.005
   Goldberg AA, 2010, AGING-US, V2, P393, DOI 10.18632/aging.100168
   Han J, 2021, CLIN EXP MED, V21, P479, DOI 10.1007/s10238-021-00698-9
   Harber KJ, 2020, METABOLITES, V10, DOI 10.3390/metabo10090372
   Hasegawa Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71592-9
   Hassan HM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.039
   Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428
   Hirvonen OP, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11122319
   Jakaria M, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101223
   Jena PK, 2017, AM J PATHOL, V187, P1800, DOI 10.1016/j.ajpath.2017.04.019
   Jena PK, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11030504
   Jena PK, 2020, BIOMARK RES, V8, DOI 10.1186/s40364-020-00239-8
   Jena PK, 2019, J DERMATOL SCI, V95, P13, DOI 10.1016/j.jdermsci.2019.05.007
   Jena PK, 2018, FASEB J, V32, P2866, DOI 10.1096/fj.201700984RR
   Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425
   Ji FB, 2022, GUT, V71, P2313, DOI 10.1136/gutjnl-2021-326050
   Jian HF, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/4704771
   Jiang CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10166
   Jiao Y, 2015, ACTA PHARMACOL SIN, V36, P44, DOI 10.1038/aps.2014.116
   Ju HK, 2013, BIOANALYSIS, V5, P41, DOI [10.4155/BIO.12.296, 10.4155/bio.12.296]
   Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6
   Kawaguchi T, 2018, MOL MED REP, V18, P2033, DOI 10.3892/mmr.2018.9223
   Ketu S, 2021, COMPLEX INTELL SYST, V7, P2597, DOI 10.1007/s40747-021-00435-5
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249
   Kim MH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051051
   Koga M, 2011, ANN CLIN BIOCHEM, V48, P121, DOI 10.1258/acb.2010.010053
   Kong FY, 2020, CANCER MED-US, V9, P2462, DOI 10.1002/cam4.2903
   Küry S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913
   Lee H, 2019, INT J OBESITY, V43, P1620, DOI 10.1038/s41366-018-0212-0
   Lee KS, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10061216
   Leung H, 2022, SCI TRANSL MED, V14, DOI 10.1126/scitranslmed.abk0855
   Li D, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5175581
   Li D, 2018, AGING CELL, V17, DOI 10.1111/acel.12768
   Li L, 2020, MOLECULES, V25, DOI 10.3390/molecules25061274
   Li RF, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab460
   Li WW, 2015, J BREATH RES, V9, DOI 10.1088/1752-7155/9/1/016005
   Li Y, 2017, KNOWL INF SYST, V53, P551, DOI 10.1007/s10115-017-1059-8
   Liu NA, 2012, MOL ENDOCRINOL, V26, P775, DOI 10.1210/me.2011-1383
   Lou-Bonafonte JM, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800136
   Luceri C, 1996, CANCER EPIDEM BIOMAR, V5, P167
   Masuda K, 2017, HEPATOL RES, V47, P983, DOI 10.1111/hepr.12832
   Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008
   Mills EL, 2021, NAT METAB, V3, P604, DOI 10.1038/s42255-021-00389-5
   Mladenic D., 2004, Proceedings of Sheffield SIGIR 2004. The Twenty-Seventh Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P234, DOI 10.1145/1008992.1009034
   Laparra JM, 2015, BRIT J NUTR, V114, P1395, DOI 10.1017/S0007114515003153
   Monacelli F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070670
   Nagamani SCS, 2021, MOL GENET METAB, V133, P148, DOI 10.1016/j.ymgme.2021.04.001
   Nagao K, 2005, J NUTR, V135, P9, DOI 10.1093/jn/135.1.9
   Nakano A, 2003, J INVEST DERMATOL, V120, P963, DOI 10.1046/j.1523-1747.2003.12243.x
   Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200
   Palomer E, 2016, CELL REP, V16, P2889, DOI 10.1016/j.celrep.2016.08.028
   Rao Y, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1927633
   Razzaghi T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155119
   Sato Y, 2021, NATURE, V599, P458, DOI 10.1038/s41586-021-03832-5
   Schlingmann KP, 2021, J AM SOC NEPHROL, V32, P1498, DOI 10.1681/ASN.2020111587
   Shao JW, 2022, INFLAMM RES, V71, P1389, DOI 10.1007/s00011-022-01629-4
   Sheng LL, 2021, HEPATOBIL SURG NUTR, V10, P31, DOI 10.21037/hbsn-20-671
   Sheng LL, 2018, FASEB J, V32, P6371, DOI 10.1096/fj.201800370R
   Sheng LL, 2017, J PATHOL, V243, P431, DOI 10.1002/path.4983
   Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9
   Sim WC, 2020, METABOLISM, V102, DOI 10.1016/j.metabol.2019.154000
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Sindhwani V., 2001, P 2001 SIAM INT C DA, P1
   Song Q, 2021, J FUNCT FOODS, V77, DOI 10.1016/j.jff.2020.104351
   Souza CO, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158776
   Su HY, 2012, AM J PHYSIOL-GASTR L, V303, pG1245, DOI 10.1152/ajpgi.00439.2011
   Sun LL, 2021, NAT REV GASTRO HEPAT, V18, P335, DOI 10.1038/s41575-020-00404-2
   Sun Y, 2022, SCAND J GASTROENTERO, V57, P1227, DOI 10.1080/00365521.2022.2069476
   Takahashi S, 2018, HEPATOL COMMUN, V2, P1567, DOI 10.1002/hep4.1263
   Tan HY, 2021, HEPATOLOGY, V73, P2326, DOI 10.1002/hep.31600
   Tan RR, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms232415931
   Tan XY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900257
   Tang J, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202001025
   Trupp M, 2014, J PARKINSON DIS, V4, P549, DOI 10.3233/JPD-140389
   Velazquez-Villegas LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02068-0
   Venkatesan C, 2018, IEEE ACCESS, V6, P9767, DOI 10.1109/ACCESS.2018.2794346
   Veskovic M, 2019, EUR J PHARMACOL, V848, P39, DOI 10.1016/j.ejphar.2019.01.043
   Wan YJY, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.05881
   Wan YJY, 2019, NAT REV GASTRO HEPAT, V16, P204, DOI 10.1038/s41575-019-0108-z
   Wang G, 2014, J PROTEOME RES, V13, P2649, DOI 10.1021/pr5000895
   Wang HY, 2022, BIOCHEM PHARMACOL, V200, DOI 10.1016/j.bcp.2022.115033
   Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125
   Wang SQ, 2021, PHARMACOLOGY, V106, P606, DOI 10.1159/000518492
   Wang XB, 2020, CELL METAB, V31, P969, DOI 10.1016/j.cmet.2020.03.010
   Wang XXX, 2017, J BIOL CHEM, V292, P12018, DOI 10.1074/jbc.C117.794982
   Weaver Benjamin P, 2010, PLoS One, V5, DOI 10.1371/journal.pone.0013158
   Xing S, 2019, AGING-US, V11, P8474, DOI 10.18632/aging.102333
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Yamagishi S, 1998, ACTA DIABETOL, V35, P65, DOI 10.1007/s005920050104
   Yang C, 2020, FOOD RES INT, V131, DOI 10.1016/j.foodres.2020.108994
   Yang GY, 2023, BIOMARK RES, V11, DOI 10.1186/s40364-023-00458-9
   Zhang LJ, 2022, J CLIN TRANSL HEPATO, V10, P651, DOI 10.14218/JCTH.2021.00347
   Zheng WV, 2022, J CELL MOL MED, V26, P840, DOI 10.1111/jcmm.17131
   Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895
   Zhu MN, 2022, DATA BRIEF, V40, DOI 10.1016/j.dib.2021.107773
NR 114
TC 1
Z9 1
U1 9
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2023
VL 15
IS 15
AR 3406
DI 10.3390/nu15153406
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA O7NL0
UT WOS:001045632200001
PM 37571345
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Gan, W
   Nie, B
   Shi, F
   Xu, XM
   Qian, JC
   Takagi, Y
   Hayakawa, H
   Sekiguchi, M
   Cai, JP
AF Gan, Wei
   Nie, Ben
   Shi, Fei
   Xu, Xin-Min
   Qian, Jian-Chang
   Takagi, Yasumitsu
   Hayakawa, Hiroshi
   Sekiguchi, Mutsuo
   Cai, Jian-Ping
TI Age-dependent increases in the oxidative damage of DNA, RNA, and their
   metabolites in normal and senescence-accelerated mice analyzed by
   LC-MS/MS: Urinary 8-oxoguanosine as a novel biomarker of aging
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Senescence-accelerated mouse; Mass spectrometry; 8-Oxoguanosine;
   Oxidative damage; Free radicals
ID MESSENGER-RNA; MUTT PROTEIN; MOUSE; GENE; MTH2; QUANTIFICATION;
   EXPRESSION; REPAIR; MODEL
AB A sensitive and accurate isotope-diluted LC-MS/MS method was developed for determination of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dGsn), derived from DNA, and 8-oxo-7,8-dihydroguanosine (8-oxo-Gsn), derived from RNA, in various tissue specimens obtained from normal SAMR1 and senescence-accelerated SAMP8 mice. An age-dependent accumulation of oxidative DNA and RNA damage was observed in all the organs examined, namely, the brain, liver, lungs, heart, kidneys, and testes. Among these, the brain samples exhibited the highest values for DNA damage. These age-related increases in the 8-oxoguanine content in DNA and RNA occurred more rapidly in SAMP8 than in SAMR1 mice. Age-related increases in the contents of 8-oxo-dGsn and 8-oxo-Gsn were also observed in the plasma and urine; however, the ratios of 8-oxo-Gsn to 8-oxo-dGsn in these samples were considerably higher (6 to 13) compared with the values for the samples derived from other tissues (roughly 1), indicating that measurement of 8-oxo-Gsn in urine could be a novel means of evaluating the aging process. (c) 2012 Elsevier Inc. All rights reserved.
C1 [Gan, Wei; Nie, Ben; Shi, Fei; Xu, Xin-Min; Qian, Jian-Chang; Cai, Jian-Ping] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China.
   [Gan, Wei; Nie, Ben; Shi, Fei; Xu, Xin-Min; Qian, Jian-Chang; Cai, Jian-Ping] Minist Hlth, Beijing Inst Geriatr, Beijing 100730, Peoples R China.
   [Gan, Wei; Shi, Fei; Xu, Xin-Min] Chinese Acad Med Sci, Grad Sch, Beijing 100730, Peoples R China.
   [Gan, Wei; Shi, Fei; Xu, Xin-Min] Peking Union Med Coll, Beijing 100730, Peoples R China.
   [Gan, Wei; Xu, Xin-Min] Natl Ctr Clin Labs, Beijing 100730, Peoples R China.
   [Nie, Ben; Qian, Jian-Chang] Wenzhou Med Coll, Dept Pharm, Wenzhou 325035, Zhejiang, Peoples R China.
   [Takagi, Yasumitsu; Hayakawa, Hiroshi; Sekiguchi, Mutsuo] Fukuoka Dent Coll, Frontier Res Ctr, Fukuoka 8140193, Japan.
C3 Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union
   Medical College; Chinese Academy of Medical Sciences - Peking Union
   Medical College; Peking Union Medical College; Wenzhou Medical
   University; Fukuoka Dental College (FDC)
RP Cai, JP (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China.
EM caijp61@vip.sina.com
FU Key International Science and Technology Cooperation Projects of China
   [2006DFB31410]; National Natural Science Foundation of China [81171028]
FX This work was supported by the Key International Science and Technology
   Cooperation Projects of China with Code No. 2006DFB31410 and the
   National Natural Science Foundation of China with Code No. 81171028. We
   are grateful to the members of the Institute of Geriatrics of the
   Ministry of Health for advice and assistance.
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Barciszewski J, 1999, MOL BIOL REP, V26, P231, DOI 10.1023/A:1007058602594
   BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7
   Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773
   Brégeon D, 2005, MUTAT RES-FUND MOL M, V577, P293, DOI 10.1016/j.mrfmmm.2005.04.002
   Cai JP, 2003, BIOCHEM BIOPH RES CO, V305, P1073, DOI 10.1016/S0006-291X(03)00864-7
   Chao MR, 2008, FREE RADICAL BIO MED, V44, P464, DOI 10.1016/j.freeradbiomed.2007.10.003
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Collins A, 2003, FREE RADICAL BIO MED, V34, P1089, DOI 10.1016/s0891-5849(03)00041-8
   Cooke MS, 2000, FREE RADICAL RES, V32, P381, DOI 10.1080/10715760000300391
   Dani S.U., 1997, PRINCIPLES NEURAL AG
   David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978
   FIALA ES, 1989, CANCER RES, V49, P5518
   Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hayakawa H, 2002, BIOCHEMISTRY-US, V41, P12739, DOI 10.1021/bi0201872
   Hayakawa H, 2006, BIOCHEMISTRY-US, V45, P6749, DOI 10.1021/bi052585l
   Hayakawa H, 2010, BIOCHEM BIOPH RES CO, V403, P220, DOI 10.1016/j.bbrc.2010.11.011
   Helbock HJ, 1998, P NATL ACAD SCI USA, V95, P288, DOI 10.1073/pnas.95.1.288
   Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014
   Hofer T, 2005, BIOL CHEM, V386, P333, DOI 10.1515/bc.2005.040
   Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007
   Hori M, 2010, FREE RADICAL BIO MED, V48, P1197, DOI 10.1016/j.freeradbiomed.2010.02.002
   Ishibashi T, 2005, NUCLEIC ACIDS RES, V33, P3779, DOI 10.1093/nar/gki682
   Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k
   Kasai H., 2008, Genes Environ, V30, DOI DOI 10.3123/JEMSGE.30.33
   Korstanje R, 2008, AGING STUDY URINE AL
   MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510
   Nunomura A, 1999, J NEUROSCI, V19, P1959
   Nunomura A, 2009, ACTA NEUROPATHOL, V118, P151, DOI 10.1007/s00401-009-0508-1
   Pallas M, 2008, J ALZHEIMERS DIS, V15, P615
   Sekiguchi M, 2006, P JPN ACAD B-PHYS, V82, P278, DOI 10.2183/pjab.82.278
   Shan X, 2006, NEUROBIOL AGING, V27, P657, DOI 10.1016/j.neurobiolaging.2005.03.022
   Shen ZZ, 2000, BIOCHEMISTRY-US, V39, P5474, DOI 10.1021/bi992809y
   Simm A, 2008, BIOL CHEM, V389, P257, DOI 10.1515/BC.2008.034
   Slupska MM, 1996, J BACTERIOL, V178, P3885, DOI 10.1128/jb.178.13.3885-3892.1996
   Song XN, 2011, NEUROCHEM RES, V36, P1558, DOI 10.1007/s11064-011-0484-4
   Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104
   Weimann A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e7
   Zheng JD, 2009, J NEUROL SCI, V287, P188, DOI 10.1016/j.jns.2009.07.027
NR 42
TC 75
Z9 85
U1 0
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAY 1
PY 2012
VL 52
IS 9
BP 1700
EP 1707
DI 10.1016/j.freeradbiomed.2012.02.016
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 944DB
UT WOS:000304177500021
PM 22348977
DA 2024-02-19
ER

PT J
AU NISHIYAMA, N
   ZHOU, YP
   SAITO, H
AF NISHIYAMA, N
   ZHOU, YP
   SAITO, H
TI AMELIORATIVE EFFECTS OF CHRONIC TREATMENT USING DX-9386, A TRADITIONAL
   CHINESE PRESCRIPTION, ON LEARNING-PERFORMANCE AND LIPID PEROXIDE CONTENT
   IN SENESCENCE-ACCELERATED MOUSE
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE AGING; STEP-DOWN TEST; MORRIS WATER MAZE TEST
ID AGE-RELATED-CHANGES; AVOIDANCE PERFORMANCE; GRANULAR STRUCTURES;
   MEDICINAL-PLANTS; MURINE MODEL; BRAIN-SLICES; SAM; ACID; MICE; TANNINS
AB DX-9386 is a traditional Chinese prescription consisting of ginseng, polygala, acorus and hoelen. The effect of chronic oral treatment with this preparation on learning behaviors and lipid peroxide concentration was studied in senescence accelerated mouse (SPM). SAM P8, a senescence prone of SAM, and SAM R1, a senescence resistant substrain of SAM, were started on a diet containing 1% of DX-9386 from the age of 2 months. All the experiments sere performed at the age of 10 months. The prescription ameliorated the memory disorders of SAM P8, as evaluated in a step down test as well as a spatial memory test. The preparation, however, did not affect the learning behaviors in SAM R1. DX-9386 reduced the elevated levers of lipid peroxide in the serum and liver of SAM P8, while it did not alter that in SAM R1. These results suggested that DX-9386 slowed the aging process of SAM P8 in terms of learning behaviors and lipid peroxidation.
RP NISHIYAMA, N (corresponding author), UNIV TOKYO, FAC PHARMACEUT SCI, DEPT CHEM PHARMACOL, BUNKYO KU, 7-3-1 HONGO, TOKYO 113, JAPAN.
CR ABE H, 1981, N-S ARCH PHARMACOL, V316, P262, DOI 10.1007/BF00505660
   AKIYAMA H, 1986, ACTA NEUROPATHOL, V72, P124, DOI 10.1007/BF00685973
   ANDO S, 1990, NEUROSCI LETT, V113, P199, DOI 10.1016/0304-3940(90)90303-Q
   BARJA QG, 1990, J NEUROSCI RES, V26, P370
   CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K
   FLOOD JF, 1993, NEUROBIOL AGING, V14, P159, DOI 10.1016/0197-4580(93)90092-P
   HARMAN D, 1956, J GERONTOL, V11, P293
   HARN DR, 1978, 2ND P INT GINS S KOR, P135
   HATANO T, 1989, CHEM PHARM BULL, V37, P2083
   HIGUCHI K, 1983, LAB INVEST, V48, P231
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   HUSAIN SR, 1987, PHYTOCHEMISTRY, V26, P2489, DOI 10.1016/s0031-9422(00)83860-1
   KIMURA Y, 1985, CHEM PHARM BULL, V33, P2028
   KISO Y, 1985, PLANTA MED, V51, P331, DOI 10.1055/s-2007-969504
   KITAMURA Y, 1989, NEUROSCI LETT, V106, P334, DOI 10.1016/0304-3940(89)90186-9
   KITAMURA Y, 1992, NEUROSCI LETT, V137, P169, DOI 10.1016/0304-3940(92)90396-O
   MATSUURA T, 1970, TETRAHEDRON, V26, P435, DOI 10.1016/S0040-4020(01)97840-8
   NAIKI H, 1993, LAB INVEST, V68, P332
   NISHIZAWA K, 1990, JPN J PHARMACOL, V54, P375, DOI 10.1254/jjp.54.375
   NOMURA Y, 1989, EXP GERONTOL, V24, P49, DOI 10.1016/0531-5565(89)90034-X
   OKUDA T, 1983, CHEM PHARM BULL, V31, P1625
   ROBAK J, 1988, BIOCHEM PHARMACOL, V37, P837, DOI 10.1016/0006-2952(88)90169-4
   SEGAWA M, 1990, BIOGENIC AMINES, V7, P191
   SUGIYAMA H, 1987, CLIN NEUROL, V27, P841
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKEMURA M, 1993, AM J PATHOL, V142, P1887
   TAKESHITA S, 1982, MECH AGEING DEV, V20, P13, DOI 10.1016/0047-6374(82)90070-7
   TAKEUCHI N, 1976, EXP GERONTOL, V11, P179, DOI 10.1016/0531-5565(76)90031-0
   UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1
   YAGI H, 1989, J NEUROPATH EXP NEUR, V48, P577, DOI 10.1097/00005072-198909000-00008
   YOSHIKAWA M, 1967, J GERONTOL, V22, P162, DOI 10.1093/geronj/22.2.162
   ZHANG YX, 1994, BIOL PHARM BULL, V17, P1199, DOI 10.1248/bpb.17.1199
   ZHANG YX, 1994, BIOL PHARM BULL, V17, P1337, DOI 10.1248/bpb.17.1337
   ZHAO XH, 1992, INT J DEV NEUROSCI, V10, P121, DOI 10.1016/0736-5748(92)90040-7
   ZHAO XH, 1990, INT J DEV NEUROSCI, V8, P267, DOI 10.1016/0736-5748(90)90032-W
   1977, DICT TRADITIONAL CHI, V1, P612
NR 37
TC 44
Z9 48
U1 0
U2 0
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD NOV
PY 1994
VL 17
IS 11
BP 1481
EP 1484
PG 4
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA PV057
UT WOS:A1994PV05700011
PM 7703968
OA Bronze
DA 2024-02-19
ER

PT J
AU TAWA, R
   UENO, S
   YAMAMOTO, K
   YAMAMOTO, Y
   SAGISAKA, K
   KATAKURA, R
   KAYAMA, T
   YOSHIMOTO, T
   SAKURAI, H
   ONO, T
AF TAWA, R
   UENO, S
   YAMAMOTO, K
   YAMAMOTO, Y
   SAGISAKA, K
   KATAKURA, R
   KAYAMA, T
   YOSHIMOTO, T
   SAKURAI, H
   ONO, T
TI METHYLATED CYTOSINE LEVEL IN HUMAN LIVER DNA DOES NOT DECLINE IN AGING
   PROCESS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; DNA METHYLATION; HUMAN; LIVER; SPLEEN
ID AGE-RELATED-CHANGES; MICE; MOUSE; CELLS; GENE; TISSUE; 5-METHYLCYTOSINE;
   RADIATION; EMBRYOS; MYELOMA
AB In order to ascertain a generality of the age-dependent decrease in DNA methylation level among different mammalian species, methylated cytosine contents in human liver and spleen DNA at different ages have been determined using high performance liquid chromatography (HPLC). Unexpectedly, the liver DNA revealed no appreciable decline with age while the spleen DNA showed a slight reduction. It indicates that a decrease of methylation level in genomic DNA is not a common denominator of age-related changes in mammals.
C1 TOHOKU UNIV, SCH MED,DEPT RADIAT RES,SEIRYO MACHI 2-1,AOBA KU, SENDAI, MIYAGI 980, JAPAN.
   KYOTO PHARMACEUT UNIV, DEPT ANALYT CHEM, YAMASHINA KU, KYOTO 607, JAPAN.
   TOHOKU UNIV, SCH MED, DEPT FORENS MED, AOBA KU, SENDAI, MIYAGI 980, JAPAN.
   KYOTO UNIV, FAC MED, DEPT LEGAL MED, SAKYO KU, KYOTO 606, JAPAN.
   TOHOKU UNIV, SCH MED, DEPT RADIAT RES, AOBA KU, SENDAI, MIYAGI 980, JAPAN.
C3 Tohoku University; Kyoto Pharmaceutical University; Tohoku University;
   Kyoto University; Tohoku University
CR ADAMS RLP, 1985, MOL BIOL DNA METHYLA, P115
   BOEHM TLJ, 1983, CANCER RES, V43, P6066
   DRINKWATER RD, 1989, MUTAT RES, V219, P29, DOI 10.1016/0921-8734(89)90038-6
   GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9
   GOLBUS J, 1990, EUR J IMMUNOL, V20, P1869, DOI 10.1002/eji.1830200836
   GRUNWALD S, 1989, PROG CLIN BIOCH MED, V9, P61, DOI DOI 10.1007/978-3-642-74734-2_3
   HOALVANHELDEN EG, 1989, MUTAT RES, V219, P263, DOI 10.1016/0921-8734(89)90027-1
   KALINICH JF, 1989, RADIAT RES, V117, P185, DOI 10.2307/3577319
   KASTAN MB, 1982, CELL, V30, P509, DOI 10.1016/0092-8674(82)90248-3
   KROGER H, 1983, INT J BIOCHEM, V15, P627, DOI 10.1016/0020-711X(83)90186-6
   LIEBERMAN MW, 1983, CELL, V35, P207, DOI 10.1016/0092-8674(83)90223-4
   LOW M, 1976, INT J RADIAT ONCOL, V1, P289, DOI 10.1016/0360-3016(76)90053-5
   MAKINODAN T, 1977, HDB BIOL AGING, P379
   MAYSHOOPES L, 1986, DEV GENET, V7, P65, DOI 10.1002/dvg.1020070202
   MAYSHOOPES LL, 1983, MOL CELL BIOL, V3, P1371, DOI 10.1128/MCB.3.8.1371
   MAYSHOOPES LL, 1989, INT REV CYTOL, V114, P181
   MONK M, 1987, DEVELOPMENT, V99, P371
   NYCE J, 1986, NUCLEIC ACIDS RES, V14, P4353, DOI 10.1093/nar/14.10.4353
   NYCE J, 1989, CANCER RES, V49, P5829
   ONO T, 1990, MUTAT RES, V237, P239, DOI 10.1016/0921-8734(90)90005-C
   ONO T, 1985, MECH AGEING DEV, V32, P227, DOI 10.1016/0047-6374(85)90082-X
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   SINGER J, 1979, NUCLEIC ACIDS RES, V7, P2369, DOI 10.1093/nar/7.8.2369
   SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6
   SWISSHELM K, 1990, MUTAT RES, V237, P131, DOI 10.1016/0921-8734(90)90019-N
   TAWA R, 1990, DIFFERENTIATION, V45, P44, DOI 10.1111/j.1432-0436.1990.tb00455.x
   UEHARA Y, 1989, ONCOGENE, V4, P1023
   UTSUYAMA M, 1987, MECH AGEING DEV, V40, P89, DOI 10.1016/0047-6374(87)90037-6
   VANYUSHI.BF, 1973, GERONTOLOGY, V19, P138, DOI 10.1159/000211967
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7
NR 31
TC 18
Z9 18
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAR 1
PY 1992
VL 62
IS 3
BP 255
EP 261
DI 10.1016/0047-6374(92)90111-P
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HH668
UT WOS:A1992HH66800004
PM 1583911
DA 2024-02-19
ER

PT J
AU Wang, B
   Lee, WYW
   Huang, B
   Zhang, JF
   Wu, TY
   Jiang, XH
   Wang, CC
   Li, G
AF Wang, Bin
   Lee, Wayne Yuk-Wai
   Huang, Biao
   Zhang, Jin-Fang
   Wu, TianYi
   Jiang, Xiaohua
   Wang, Chi Chiu
   Li, Gang
TI Secretome of Human Fetal Mesenchymal Stem Cell Ameliorates Replicative
   Senescence
SO STEM CELLS AND DEVELOPMENT
LA English
DT Article
DE fetal mesenchymal stem cells; secrotome; aging; osteogenesis
ID BONE-MARROW; GROWTH-FACTOR; GENE-EXPRESSION; DIFFERENTIATION;
   FIBROBLASTS; LIVER; P21
AB Autologous mesenchymal stem cells (MSC) are widely used cell source for cell-based tissue repair and regeneration, but replicative senescence and the associated loss of cellular activity during in vitro expansion limit their therapeutic potential. How to preserve or even enhance the proliferation and differentiation ability of MSC from aged donors without genetic modification remains a challenge to meet clinical need. MSC isolated from human fetal tissues (hFMSC) exhibit higher proliferation and differentiation activities even in prolonged in vitro culture, which might be modulated by autocrine/paracrine action. In the present study, we hypothesized that the bioactive factors secreted by hFMSC, collectively named as hFMSC secretome (HFS), could possess beneficial effect on human adult MSC (hAMSC) undergoing replicative senescence, thus promoting their capability of proliferation and differentiation. HFS was prepared by centrifugation of hFMSC conditioned medium, followed by column-based concentration, and the total protein content of the HFS was quantified to standardize treatment concentration. When compared with hAMSC secretome (HAS), HFS treatment significantly reduced senescence associated-beta-galactosidase expression and activity (senescence marker) and enhanced cell proliferation and osteogenic differentiation potential of hAMSC in prolonged in vitro culture. Cellular studies revealed concomitant activation of sirt1 and foxo3a in hAMSC after HFS treatment, which was associated with upregulation of p21 and downregulation of bax and p53. The changes of these senescence associated markers suggested that HFS, but not HAS, could ameliorate replicative senescence of hAMSC in vitro. In nude mice, HFS pretreatment restored the osteogenic ability of senescent hAMSC. Tumor xenograft model revealed that HFS did not promote tumor growth. In conclusion, this study suggests that HFS could be an effective and safe method to overcome replicative senescence and facilitate the therapeutic potential of hAMSC.
C1 [Wang, Bin; Lee, Wayne Yuk-Wai; Zhang, Jin-Fang; Wu, TianYi; Li, Gang] Chinese Univ Hong Kong, Stem Cells & Regenerat Med Lab, Dept Orthopaed & Traumatol, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
   [Wang, Bin; Lee, Wayne Yuk-Wai; Zhang, Jin-Fang; Wu, TianYi; Li, Gang] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.
   [Huang, Biao; Jiang, Xiaohua] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Fac Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.
   [Huang, Biao; Jiang, Xiaohua; Li, Gang] Chinese Univ Hong Kong, Minist Educ, Key Lab Regenerat Med, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.
   [Wang, Chi Chiu] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Fac Med, Hong Kong, Hong Kong, Peoples R China.
   [Wang, Chi Chiu] Chinese Univ Hong Kong, Reprod & Dev, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
   [Wang, Chi Chiu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.
C3 Chinese University of Hong Kong; CUHK Shenzhen Research Institute; The
   Chinese University of Hong Kong, Shenzhen; Chinese University of Hong
   Kong; Chinese University of Hong Kong; Chinese University of Hong Kong;
   Chinese University of Hong Kong; Chinese University of Hong Kong
RP Li, G (corresponding author), Chinese Univ Hong Kong, Stem Cells & Regenerat Med Lab, Prince Wales Hosp, Dept Orthopaed & Traumatol,Li Ka Shing Inst Hlth, Room 904,9-F, Shatin, Hong Kong, Peoples R China.
EM gangli@cuhk.edu.hk
RI Lee, Wayne YW/H-8298-2013; jiang, cynthia xiaohua/F-7580-2017; Wang,
   Ronald/C-6541-2014; Li, Gang/J-7830-2018; WANG, BIN/O-2346-2019; Huang,
   Biao/AAV-7021-2021
OI Lee, Wayne YW/0000-0002-0486-360X; jiang, cynthia
   xiaohua/0000-0002-7372-4961; Wang, Ronald/0000-0002-3928-7278; Li,
   Gang/0000-0002-3981-2239; WANG, BIN/0000-0002-1348-1494; 
FU National Natural Science Foundation of China (NSFC) [81371946, 81272548,
   81374568, 31400834]; Hong Kong Government Research Grant Council,
   General Research Fund [CUHK470813, 14119115]; China Shenzhen City
   Science and Technology Bureau [JGJHZ20140419120051680]; SMART program,
   Lui Che Woo Institute of Innovative Medicine, The Chinese University of
   Hong Kong
FX The authors thank Li Ka Shing Institute of Health Science, The Chinese
   University of Hong Kong, for providing the use of clean room human cell
   culture facilities and Dr. Nina Chu for help in specimen collection. The
   work was partially supported by grants from National Natural Science
   Foundation of China (NSFC no. 81371946, 81272548, 81374568, 31400834) to
   Gang Li, Xiao-hua Jiang, and Liangliang Xu, respectively. Hong Kong
   Government Research Grant Council, General Research Fund (CUHK470813 and
   14119115), and a project grant from China Shenzhen City Science and
   Technology Bureau (JGJHZ20140419120051680) to Gang Li are gratefully
   acknowledged. This study was also partly supported by SMART program, Lui
   Che Woo Institute of Innovative Medicine, The Chinese University of Hong
   Kong.
CR Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535
   Bäckesjö CM, 2009, CELLS TISSUES ORGANS, V189, P93, DOI 10.1159/000151744
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Baldock PA, 2006, J BONE MINER RES, V21, P1618, DOI 10.1359/JBMR.060714
   Bhandari DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010493
   Bin Noh H, 2010, GENES GENOM, V32, P87, DOI 10.1007/s13258-010-0868-x
   Bollini S, 2013, J CLIN MED, V2, P302, DOI 10.3390/jcm2040302
   Bonab MM, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-14
   Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562
   Chen HQ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00103
   Cho HH, 2005, J CELL BIOCHEM, V96, P533, DOI 10.1002/jcb.20544
   Coppé JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Di GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113572
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   Donovan J, 2013, FRONT BIOSCI-LANDMRK, V18, P106, DOI 10.2741/4090
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   Gabay O, 2013, JOINT BONE SPINE, V80, P613, DOI 10.1016/j.jbspin.2013.01.001
   Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2
   Götherström C, 2005, HAEMATOLOGICA, V90, P1017
   Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573
   Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107
   Hu JB, 2012, ONCOL REP, V28, P1385, DOI 10.3892/or.2012.1909
   Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894
   Kang MK, 2003, EXP CELL RES, V287, P272, DOI 10.1016/S0014-4827(03)00061-2
   Kim M, 2012, MECH AGEING DEV, V133, P215, DOI 10.1016/j.mad.2012.03.014
   Konala VBR, 2016, CYTOTHERAPY, V18, P13, DOI 10.1016/j.jcyt.2015.10.008
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee WY, 2016, MOL CELL ENDOCRINOL, V430, P97, DOI 10.1016/j.mce.2016.04.014
   Lee WYW, 2013, CYTOTHERAPY, V15, P1484, DOI 10.1016/j.jcyt.2013.06.010
   Lee WYW, 2012, TISSUE ENG PT A, V18, P484, DOI [10.1089/ten.TEA.2011.0130, 10.1089/ten.tea.2011.0130]
   Li AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113785
   Liu XB, 2014, J HEART LUNG TRANSPL, V33, P1083, DOI 10.1016/j.healun.2014.05.008
   MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935
   Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Nasef A, 2008, CELL IMMUNOL, V253, P16, DOI 10.1016/j.cellimm.2008.06.002
   Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880
   Qin L, 2014, J ORTHOP TRANSL, V2, P43, DOI 10.1016/j.jot.2013.12.001
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269
   Severino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.445
   Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359
   STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157
   Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261
   Sun Y, 2011, FASEB J, V25, P1474, DOI 10.1096/fj.10-161497
   Sze SK, 2007, MOL CELL PROTEOMICS, V6, P1680, DOI 10.1074/mcp.M600393-MCP200
   Tang BL, 2011, TRANSL RES, V157, P276, DOI 10.1016/j.trsl.2010.11.006
   Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468
   Tögel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136
   Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846
   Xu LL, 2014, J ORTHOP TRANSL, V2, P1, DOI 10.1016/j.jot.2013.11.002
   Yuan HF, 2012, J MOL MED, V90, P389, DOI 10.1007/s00109-011-0825-4
   Zhang T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt221
   Zhang X, 2011, EURASIP J WIREL COMM, DOI 10.1155/2011/765143
NR 63
TC 32
Z9 37
U1 1
U2 33
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1547-3287
EI 1557-8534
J9 STEM CELLS DEV
JI Stem Cells Dev.
PD NOV 15
PY 2016
VL 25
IS 22
BP 1755
EP 1766
DI 10.1089/scd.2016.0079
PG 12
WC Cell & Tissue Engineering; Hematology; Medicine, Research &
   Experimental; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Hematology; Research & Experimental Medicine;
   Transplantation
GA EB2VM
UT WOS:000387220700007
PM 27539404
DA 2024-02-19
ER

PT J
AU Moon, IJ
   Yoo, H
   Paik, SH
   Kim, HT
   Kim, SY
   Song, Y
   Chang, SE
AF Moon, Ik Jun
   Yoo, Hanju
   Paik, Seung Hwan
   Kim, Hak Tae
   Kim, Su Yeon
   Song, Youngsup
   Chang, Sung Eun
TI Ursodeoxycholic Acid May Inhibit Environmental Aging-Associated
   Hyperpigmentation
SO ANTIOXIDANTS
LA English
DT Article
DE ursodeoxycholic acid; antioxidant; photoaging; environmental aging;
   particulate matter; hyperpigmentation; fibroblasts; ultraviolet light
AB Extrinsic aging of the skin caused by ultraviolet (UV) light or particulate matter is often manifested by hyperpigmentation due to increased melanogenesis in senescent skin. Ursodeoxycholic acid (UDCA), which has been commonly used as a health remedy for liver diseases, is known to possess antioxidant properties. This study was done to investigate whether UDCA inhibits cellular aging processes in the cells constituting human skin and it reduces melanin synthesis. ROS, intracellular signals, IL-1 alpha, IL-8, TNF-alpha, cyclooxygenase (COX)-2, type I collagen, and matrix metalloproteinases (MMPs) levels were measured in human dermal fibroblasts treated with or without UDCA after UV exposure. Melanin levels and mechanistic pathways for melanogenesis were investigated. UDCA decreased ROS, senescence-associated secretory phenotype (SASP), and proinflammatory cytokines induced by UV treatment. UDCA reduced melanogenesis in normal human melanocytes cocultured with skin constituent cells. Our results suggest that UDCA could be a comprehensive agent for the treatment of environmental aging-associated hyperpigmentation disorders.
C1 [Moon, Ik Jun; Yoo, Hanju; Kim, Hak Tae; Kim, Su Yeon; Chang, Sung Eun] Univ Ulsan, Dept Dermatol, Asan Med Ctr, Coll Med, Seoul 05505, South Korea.
   [Yoo, Hanju; Kim, Su Yeon; Chang, Sung Eun] Univ Ulsan, Coll Med, Biomed Inst Technol BMIT, Seoul 05505, South Korea.
   [Paik, Seung Hwan] Seoul ONE Dermatol Clin, Seoul 05505, South Korea.
   [Song, Youngsup] Univ Ulsan, Dept Biomed Sci, Asan Med Ctr, Coll Med, Seoul 05505, South Korea.
C3 University of Ulsan; University of Ulsan; University of Ulsan
RP Chang, SE (corresponding author), Univ Ulsan, Dept Dermatol, Asan Med Ctr, Coll Med, Seoul 05505, South Korea.; Chang, SE (corresponding author), Univ Ulsan, Coll Med, Biomed Inst Technol BMIT, Seoul 05505, South Korea.; Song, Y (corresponding author), Univ Ulsan, Dept Biomed Sci, Asan Med Ctr, Coll Med, Seoul 05505, South Korea.
EM ikjun.moon@gmail.com; yoo@hanmail.net; 2kilo1mine@hanmail.net;
   httkmd@gmail.com; u2u2star@naver.com; ysong@amc.seoul.kr;
   changse2016@gmail.com
OI Song, Youngsup/0000-0002-6268-5223; Yoo, Hanju/0000-0002-0332-6423;
   Moon, Ik Jun/0000-0002-1123-4166
FU Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea
   [2021-415]; National Research Foundation of Korea (NRF) - Korean
   government [2020R1A4A4079708]
FX This work was supported by a grant (2021-415) from the Asan Institute
   for Life Sciences, Asan Medical Center, Seoul, Korea and the National
   Research Foundation of Korea (NRF) grant funded by the Korean government
   (grant number: 2020R1A4A4079708).
CR Burke KE, 2010, GIORN ITAL DERMAT V, V145, P445
   Byun JW, 2016, CLIN EXP DERMATOL, V41, P601, DOI 10.1111/ced.12874
   Cavinato M, 2017, BIOGERONTOLOGY, V18, P499, DOI 10.1007/s10522-017-9715-7
   Chen YS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030253
   Chung JH, 2003, PHOTODERMATOL PHOTO, V19, P109, DOI 10.1034/j.1600-0781.2003.00027.x
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222
   Debacq-Chainlaux F, 2005, J CELL SCI, V118, P743, DOI 10.1242/jcs.01651
   Dijkhoff IM, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00366-y
   Dobrzynska I, 2016, J MEMBRANE BIOL, V249, P319, DOI 10.1007/s00232-016-9870-9
   Duval C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114182
   Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462
   Fisher GJ, 1996, NATURE, V379, P335, DOI 10.1038/379335a0
   GILCHREST BA, 1989, J AM ACAD DERMATOL, V21, P610, DOI 10.1016/S0190-9622(89)70227-9
   Hirobe T, 2013, J DERMATOL SCI, V71, P45, DOI 10.1016/j.jdermsci.2013.03.012
   Ho SGY, 2009, AM J CLIN DERMATOL, V10, P153, DOI 10.2165/00128071-200910030-00002
   Hüls A, 2019, J INVEST DERMATOL, V139, P974, DOI 10.1016/j.jid.2018.09.034
   Itoh S, 2007, CLIN EXP DERMATOL, V32, P398, DOI 10.1111/j.1365-2230.2007.02401.x
   Jin SP, 2018, J DERMATOL SCI, V91, P175, DOI 10.1016/j.jdermsci.2018.04.015
   Jo K, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090844
   Kammeyer A, 2015, AGEING RES REV, V21, P16, DOI 10.1016/j.arr.2015.01.001
   Karapetsas A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9070566
   Kohl E, 2011, J EUR ACAD DERMATOL, V25, P873, DOI 10.1111/j.1468-3083.2010.03963.x
   Kovacs D, 2010, BRIT J DERMATOL, V163, P1020, DOI 10.1111/j.1365-2133.2010.09946.x
   Lapenna D, 2002, BIOCHEM PHARMACOL, V64, P1661, DOI 10.1016/S0006-2952(02)01391-6
   Lei L, 2017, MOL MED REP, V15, P3977, DOI 10.3892/mmr.2017.6532
   Magnani ND, 2016, TOXICOL SCI, V149, P227, DOI 10.1093/toxsci/kfv230
   McDaniel D, 2018, J COSMET DERMATOL-US, V17, P124, DOI 10.1111/jocd.12518
   Moon HR, 2020, J DERMATOL SCI, V99, P100, DOI 10.1016/j.jdermsci.2020.06.007
   Nakamura M, 2015, EXP DERMATOL, V24, P407, DOI 10.1111/exd.12690
   Nobile V, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.31871
   Oh AR, 2016, BMB REP, V49, P105, DOI 10.5483/BMBRep.2016.49.2.173
   Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010
   Rodrigues CMP, 2001, EXPERT OPIN INV DRUG, V10, P1243, DOI 10.1517/13543784.10.7.1243
   Roma MG, 2011, CLIN SCI, V121, P523, DOI 10.1042/CS20110184
   Ryu YS, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0305-4
   Salducci M, 2014, PIGM CELL MELANOMA R, V27, P502, DOI 10.1111/pcmr.12234
   Toutfaire M, 2017, BIOCHEM PHARMACOL, V142, P1, DOI 10.1016/j.bcp.2017.04.011
   Wang YJ, 2017, J DERMATOL SCI, V88, P159, DOI 10.1016/j.jdermsci.2017.06.018
   Won KH, 2016, J COSMET LASER THER, V18, P381, DOI 10.1080/14764172.2016.1191645
   Yamaguchi Y, 2004, J CELL BIOL, V165, P275, DOI 10.1083/jcb.200311122
   Yang YF, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/619560
   Yoon JE, 2018, THERANOSTICS, V8, P4620, DOI 10.7150/thno.26975
NR 43
TC 2
Z9 2
U1 0
U2 11
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD FEB
PY 2021
VL 10
IS 2
AR 267
DI 10.3390/antiox10020267
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA QM9DU
UT WOS:000622074800001
PM 33572325
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kim, YM
   Shin, HT
   Seo, YH
   Byun, HO
   Yoon, SH
   Lee, IK
   Hyun, DH
   Chung, HY
   Yoon, G
AF Kim, You-Mie
   Shin, Hyun-Taek
   Seo, Yong-Hak
   Byun, Hae-Ok
   Yoon, Soo-Han
   Lee, In-Kyu
   Hyun, Dong-Hoon
   Chung, Hae-Young
   Yoon, Gyesoon
TI Sterol Regulatory Element-binding Protein (SREBP)-1-mediated Lipogenesis
   Is Involved in Cell Senescence
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FATTY-ACID SYNTHESIS; ATP CITRATE LYASE; TRANSCRIPTION FACTOR; HUMAN
   FIBROBLASTS; OXIDATIVE STRESS; MITOCHONDRIAL MASS; LIPID-SYNTHESIS;
   GROWTH; DNA; INHIBITORS
AB Increased cell mass is one of the characteristics of senescent cells, but this event has not been clearly defined. When subcellular organellar mass was estimated with organelle-specific fluorescence dyes, we observed that most membranous organelles progressively increase in mass during cell senescence. This increase was accompanied by an increase in membrane lipids and augmented expression of lipogenic enzymes, such as fatty acid synthase (FAS), ATP citrate lyase, and acetyl-CoA carboxylase. The mature form of sterol regulatory element-binding protein (SREBP)-1 was also elevated. Increased expression of these lipogenic effectors was further observed in the liver tissues of aging Fischer 344 rats. Ectopic expression of mature form of SREBP-1 in both Chang cells and primary young human diploid fibroblasts was enough to induce senescence. Blocking lipogenesis with FAS inhibitors (cerulenin and C75) and via siRNA-mediated silencing of SREBP-1 and ATP citrate lyase significantly attenuated H2O2-induced senescence. Finally, old human diploid fibroblasts were effectively reversed to young-like cells by challenging with FAS inhibitors. Our results suggest that enhanced lipogenesis is not only a common event, but also critically involved in senescence via SREBP-1 induction, thereby contributing to the increase in organelle mass (as a part of cell mass), a novel indicator of senescence.
C1 [Yoon, Gyesoon] Ajou Univ, Dept Biochem & Mol Biol, Sch Med, Suwon 443721, South Korea.
   [Yoon, Soo-Han] Ajou Univ, Dept Neurosurg, Sch Med, Suwon 443721, South Korea.
   [Kim, You-Mie; Shin, Hyun-Taek; Seo, Yong-Hak; Byun, Hae-Ok; Yoon, Soo-Han; Yoon, Gyesoon] Ajou Univ, Dept Mol Sci & Technol, Grad Sch, Suwon 443721, South Korea.
   [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu 700721, South Korea.
   [Hyun, Dong-Hoon] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea.
   [Chung, Hae-Young] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea.
C3 Ajou University; Ajou University; Ajou University; Kyungpook National
   University; Ewha Womans University; Pusan National University
RP Yoon, G (corresponding author), Ajou Univ, Dept Biochem & Mol Biol, Sch Med, Suwon 443721, South Korea.
EM ypeace@ajou.ac.kr
RI Lee, In-Kyu/AAR-6374-2021
FU Korean government [R13-2003-019-01007-0]
FX This work was supported by Korean Science and Engineering Foundation
   Grant R13-2003-019-01007-0 funded by the Korean government.
CR Assmus B, 2003, CIRC RES, V92, P1049, DOI 10.1161/01.RES.0000070067.64040.7C
   Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773
   BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2
   Chondrogianni N, 2004, BIOGERONTOLOGY, V5, P55, DOI 10.1023/B:BGEN.0000017687.55667.42
   Chondrogianni N, 2002, BIOGERONTOLOGY, V3, P121, DOI 10.1023/A:1015236203379
   CRISTOFA.VJ, 1969, MED EXP, V19, P313
   Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005
   GREENBERG SB, 1977, IN VITRO CELL DEV B, V13, P297
   Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961
   Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100
   Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2
   Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005
   Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200
   Kim KH, 2004, J BIOL CHEM, V279, P51999, DOI 10.1074/jbc.M405522200
   KUPKE IR, 1978, J CHROMATOGR, V146, P261, DOI 10.1016/S0378-4347(00)81892-7
   Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009
   Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058
   Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1159/000064724
   Lee HC, 1998, FEBS LETT, V441, P292, DOI 10.1016/S0014-5793(98)01564-6
   LIPETZ J, 1972, J ULTRA MOL STRUCT R, V39, P43, DOI 10.1016/S0022-5320(72)80005-4
   Maeda M, 2009, LIFE SCI, V84, P119, DOI 10.1016/j.lfs.2008.11.009
   Nakakuki M, 2007, FEBS J, V274, P4440, DOI 10.1111/j.1742-4658.2007.05973.x
   OMURA S, 1976, BACTERIOL REV, V40, P681, DOI 10.1128/MMBR.40.3.681-697.1976
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Pizer ES, 1998, CANCER RES, V58, P4611
   Porstmann T, 2009, BIOCHEM SOC T, V37, P278, DOI 10.1042/BST0370278
   Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200
   Schmucker DL, 2002, ARCH GERONTOL GERIAT, V34, P249, DOI 10.1016/S0167-4943(01)00218-7
   Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x
   Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8
   Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Tahara S, 2001, MECH AGEING DEV, V122, P415, DOI 10.1016/S0047-6374(00)00257-8
   Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598
   Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011
   Wei YH, 2001, ANN NY ACAD SCI, V928, P97
   Yoon G, 2002, BIOCHEM J, V366, P613, DOI 10.1042/BJ20011445
   Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753
NR 43
TC 70
Z9 72
U1 0
U2 12
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 17
PY 2010
VL 285
IS 38
BP 29069
EP 29077
DI 10.1074/jbc.M110.120386
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 649BC
UT WOS:000281740100008
PM 20615871
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Burraco, P
   Hernandez-Gonzalez, M
   Metcalfe, NB
   Monaghan, P
AF Burraco, Pablo
   Hernandez-Gonzalez, Miguel
   Metcalfe, Neil B.
   Monaghan, Pat
TI Ageing across the great divide: tissue transformation, organismal growth
   and temperature shape telomere dynamics through the metamorphic
   transition
SO PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
LA English
DT Article
DE climate warming; ectotherms; frogs; growth rate; senescence; Xenopus
ID CELL-DIVISION; XENOPUS; LENGTH; SIZE; ECTOTHERMS; STRESS;
   SUSCEPTIBILITY; CONSEQUENCES; SENESCENCE; FITNESS
AB Telomere attrition is considered a useful indicator of cellular and whole-organism ageing rate. While approximately 80% of animal species undergo metamorphosis that includes extensive tissue transformations (involving cell division, apoptosis, de-differentiation and de novo formation of stem cells), the effect on telomere dynamics is unknown. We measured telomeres in Xenopus laevis developing from larvae to adults under contrasting environmental temperatures. Telomere dynamics were linked to the degree of tissue transformation during development. Average telomere length in gut tissue increased dramatically during metamorphosis, when the gut shortens by 75% and epithelial cells de-differentiate into stem cells. In the liver (retained from larva) and hindlimb muscle (newly formed before metamorphosis), telomeres gradually shortened until adulthood, likely due to extensive cell division. Tail muscle telomere lengths were constant until tail resorption, and those in heart (retained from larva) showed no change over time. Telomere lengths negatively correlated with larval growth, but for a given growth rate, telomeres were shorter in cooler conditions, suggesting that growing in the cold is more costly. Telomere lengths were not related to post-metamorphic growth rate. Further research is now needed to understand whether telomere dynamics are a good indicator of ageing rate in species undergoing metamorphosis.
C1 [Burraco, Pablo; Hernandez-Gonzalez, Miguel; Metcalfe, Neil B.; Monaghan, Pat] Univ Glasgow, Sch Biodivers One Hlth & Vet Med, Glasgow G12 8QQ, Scotland.
   [Burraco, Pablo] Donana Biol Stn CSIC, Ecol Evolut & Dev Grp, Seville 41092, Spain.
C3 University of Glasgow; Consejo Superior de Investigaciones Cientificas
   (CSIC); CSIC - Estacion Biologica de Donana (EBD)
RP Burraco, P (corresponding author), Univ Glasgow, Sch Biodivers One Hlth & Vet Med, Glasgow G12 8QQ, Scotland.; Burraco, P (corresponding author), Donana Biol Stn CSIC, Ecol Evolut & Dev Grp, Seville 41092, Spain.
EM burraco@ebd.csic.es
RI Monaghan, Pat/E-6810-2015; Metcalfe, Neil B./C-5997-2009
OI Monaghan, Pat/0000-0003-2430-0326; Metcalfe, Neil
   B./0000-0002-1970-9349; Burraco, Pablo/0000-0002-9007-2643;
   Hernandez-Gonzalez, Miguel/0000-0002-4059-0223
CR ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306
   Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x
   Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498
   Barneche DR, 2019, FUNCT ECOL, V33, P1256, DOI 10.1111/1365-2435.13348
   Bednarek D, 2015, CELL REP, V12, P1691, DOI 10.1016/j.celrep.2015.07.064
   Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389
   Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38
   Boonekamp J, 2022, MOL ECOL, V31, P6128, DOI 10.1111/mec.15888
   Bousman S, 2003, J EXP ZOOL PART B, V295B, P82, DOI 10.1002/jez.b.00007
   Brown DD, 2007, DEV BIOL, V306, P20, DOI 10.1016/j.ydbio.2007.03.021
   Burraco P., 2023, FIGSHARE, DOI [10.6084/m9.figshare.21688343, DOI 10.6084/M9.FIGSHARE.21688343]
   Burraco P., 2023, FIGSHARE, DOI [10.6084/m9.figshare.c.6403972, DOI 10.6084/M9.FIGSHARE.C.6403972]
   Burraco P, 2022, ECOGRAPHY, V2022, DOI 10.1111/ecog.05565
   Burraco P, 2020, GLOBAL CHANGE BIOL, V26, P5371, DOI 10.1111/gcb.15305
   Burraco P, 2020, J ANIM ECOL, V89, P855, DOI 10.1111/1365-2656.13138
   Burraco P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07201-z
   Cabrera-Guzmán E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070121
   Chanoine C, 2003, DEV DYNAM, V226, P12, DOI 10.1002/dvdy.10206
   Chatelain M, 2020, ECOL LETT, V23, P381, DOI 10.1111/ele.13426
   Criscuolo F, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1877
   Crockett EL, 2008, J COMP PHYSIOL B, V178, P795, DOI 10.1007/s00360-008-0275-7
   Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602
   Debes PV, 2016, MOL ECOL, V25, P5412, DOI 10.1111/mec.13856
   Denver RJ, 2021, NEUROBIOL STRESS, V14, DOI 10.1016/j.ynstr.2021.100301
   Denver RJ, 2009, ANN NY ACAD SCI, V1163, P1, DOI 10.1111/j.1749-6632.2009.04433.x
   Earl JE, 2015, COPEIA, V103, P297, DOI 10.1643/CH-14-128
   Eimanifar A, 2019, PEERJ, V7, DOI 10.7717/peerj.6886
   Fabre AC, 2020, NAT ECOL EVOL, V4, P1129, DOI 10.1038/s41559-020-1225-3
   Friesen CR, 2022, MOL ECOL, V31, P6069, DOI 10.1111/mec.16154
   Gilbert S.F., 2020, Developmental Biology, V12th ed.
   Hector KL, 2012, J ZOOL, V286, P93, DOI 10.1111/j.1469-7998.2011.00850.x
   Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178
   Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671
   Ishizuya-Oka A, 2011, DEV GROWTH DIFFER, V53, P202, DOI 10.1111/j.1440-169X.2010.01222.x
   Kärkkäinen T, 2020, J AVIAN BIOL, V51, DOI 10.1111/jav.02300
   Lowe WH, 2021, TRENDS ECOL EVOL, V36, P360, DOI 10.1016/j.tree.2020.11.012
   Mai ME., 2022, BIORXIV, DOI [10.1101/2022.01.10.475664, DOI 10.1101/2022.01.10.475664]
   Marshall LN, 2019, P NATL ACAD SCI USA, V116, P3614, DOI 10.1073/pnas.1803794116
   Mclennan D, 2016, MOL ECOL, V25, P5425, DOI 10.1111/mec.13857
   McLennan D, 2017, FUNCT ECOL, V31, P2070, DOI 10.1111/1365-2435.12939
   MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283
   Mohun TJ, 2000, DEV BIOL, V218, P74, DOI 10.1006/dbio.1999.9559
   Monaghan P, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0446
   Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x
   Mukhi S, 2010, DEV BIOL, V338, P117, DOI 10.1016/j.ydbio.2009.10.041
   Nanda I, 2008, CYTOGENET GENOME RES, V122, P396, DOI 10.1159/000167828
   Nieuwkoop P.D., 1967, Normal Table of Xenopus laevis
   Nussey DH, 2014, METHODS ECOL EVOL, V5, P299, DOI 10.1111/2041-210X.12161
   O'Brien KM, 2011, J EXP BIOL, V214, P275, DOI 10.1242/jeb.046854
   Olsson M, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0449
   Peckarsky BL, 2001, ECOLOGY, V82, P740, DOI 10.2307/2680193
   Rainford JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109085
   Reichert S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081496
   Rödder D, 2017, ECOL EVOL, V7, P4044, DOI 10.1002/ece3.3010
   Rollings N, 2019, ECOL EVOL, V9, P6211, DOI 10.1002/ece3.5164
   Salmón P, 2022, MOL ECOL, V31, P6018, DOI 10.1111/mec.16370
   Sánchez-Montes G, 2020, BIOL LETTERS, V16, DOI 10.1098/rsbl.2020.0168
   Schreiber AM, 2005, P NATL ACAD SCI USA, V102, P3720, DOI 10.1073/pnas.0409868102
   Schulte PM, 2015, J EXP BIOL, V218, P1856, DOI 10.1242/jeb.118851
   Seebacher F, 2015, NAT CLIM CHANGE, V5, P61, DOI 10.1038/NCLIMATE2457
   SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173
   Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296
   Shi YB., 2013, ANIMAL METAMORPHOSIS
   Shibata Y, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00411-5
   Shibota Y, 2000, DIFFERENTIATION, V66, P227, DOI 10.1111/j.1432-0436.2000.660409.x
   Sinai N, 2022, J THERM BIOL, V106, DOI 10.1016/j.jtherbio.2022.103233
   Smith SM, 2016, ECOL EVOL, V6, P2833, DOI 10.1002/ece3.2080
   Weng NP, 1997, P NATL ACAD SCI USA, V94, P10827, DOI 10.1073/pnas.94.20.10827
   Wolf SE, 2022, J EXP ZOOL PART A, V337, P346, DOI 10.1002/jez.2571
   Yamane H, 2013, IN VITRO CELL DEV-AN, V49, P524, DOI 10.1007/s11626-013-9635-z
   Yaoita Y, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00143
   Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105
   Young AJ, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2016.0452
   Zimmermann S, 2008, CELL TISSUE RES, V331, P79, DOI 10.1007/s00441-007-0469-4
NR 74
TC 0
Z9 0
U1 1
U2 6
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 0962-8452
EI 1471-2954
J9 P ROY SOC B-BIOL SCI
JI Proc. R. Soc. B-Biol. Sci.
PD FEB 8
PY 2023
VL 290
IS 1992
AR 20222448
DI 10.1098/rspb.2022.2448
PG 10
WC Biology; Ecology; Evolutionary Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA 8Y0IV
UT WOS:000932389100007
PM 36750187
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Innes, AJ
   Sun, B
   Wagner, V
   Brookes, S
   McHugh, D
   Pombo, J
   Porreca, RM
   Dharmalingam, G
   Vernia, S
   Zuber, J
   Vannier, JB
   Garcia-Escudero, R
   Gil, J
AF Innes, Andrew J.
   Sun, Bin
   Wagner, Verena
   Brookes, Sharon
   McHugh, Domhnall
   Pombo, Joaquim
   Porreca, Rosa Maria
   Dharmalingam, Gopuraja
   Vernia, Santiago
   Zuber, Johannes
   Vannier, Jean-Baptiste
   Garcia-Escudero, Ramon
   Gil, Jesus
TI XPO7 is a tumor suppressor regulating p21<SUP>CIP1</SUP>-dependent
   senescence
SO GENES & DEVELOPMENT
LA English
DT Article
DE XPO7; functional screen; senescence; tumor suppressor; TCF3; p21(CIP1)
ID ONCOGENE-INDUCED SENESCENCE; DNA-DAMAGE; CELLULAR SENESCENCE; CANCER;
   TELOMERES; PROGRAM; IDENTIFICATION; SECRETOME; SURVIVAL; COMPLEX
AB Senescence is a key barrier to neoplastic transformation. To identify senescence regulators relevant to cancer, we screened a genome-wide shRNA library. Here, we describe exportin 7 (XPO7) as a novel regulator of senescence and validate its function in telomere-induced, replicative, and oncogene-induced senescence (OIS). XPO7 is a bidirectional transporter that regulates the nuclear-cytoplasmic shuttling of a broad range of substrates. Depletion of XPO7 results in reduced levels of TCF3 and an impaired induction of the cyclin-dependent kinase inhibitor p21CIP1 during OIS. Deletion of XPO7 correlates with poorer overall survival in several cancer types. Moreover, depletion of XPO7 alleviated OIS and increased tumor formation in a mouse model of liver cancer. Our results suggest that XPO7 is a novel tumor suppressor that regulates p21CIP1 expression to control senescence and tumorigenesis.
C1 [Innes, Andrew J.; Sun, Bin; Wagner, Verena; Brookes, Sharon; McHugh, Domhnall; Pombo, Joaquim; Porreca, Rosa Maria; Dharmalingam, Gopuraja; Vernia, Santiago; Vannier, Jean-Baptiste; Gil, Jesus] MRC London Inst Med Sci LMS, London W12 0NN, England.
   [Innes, Andrew J.; Sun, Bin; Wagner, Verena; Brookes, Sharon; McHugh, Domhnall; Pombo, Joaquim; Porreca, Rosa Maria; Dharmalingam, Gopuraja; Vernia, Santiago; Vannier, Jean-Baptiste; Gil, Jesus] Imperial Coll London, Inst Clin Sci ICS, Fac Med, London W12 0NN, England.
   [Innes, Andrew J.] Imperial Coll London, Dept Immunol & Inflammat, Ctr Haematol, London W12 0NN, England.
   [Zuber, Johannes] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.
   [Garcia-Escudero, Ramon] Ctr Invest Energet Medioambientales & Tecnol CIEM, Mol Oncol Unit, Madrid 28040, Spain.
   [Garcia-Escudero, Ramon] Res Inst 12 Octubre i 12, Madrid 28041, Spain.
   [Garcia-Escudero, Ramon] Ctr Invest Biomed Red Canc CIBERONC, Madrid 28029, Spain.
C3 Imperial College London; Imperial College London; Vienna Biocenter
   (VBC); Research Institute of Molecular Pathology (IMP); Centro de
   Investigaciones Energeticas, Medioambientales Tecnologicas; CIBER -
   Centro de Investigacion Biomedica en Red; CIBERONC
RP Gil, J (corresponding author), MRC London Inst Med Sci LMS, London W12 0NN, England.; Gil, J (corresponding author), Imperial Coll London, Inst Clin Sci ICS, Fac Med, London W12 0NN, England.
EM jesus.gil@imperial.ac.uk
RI Garcia-Escudero, Ramon/A-2735-2012; Zuber, Johannes/E-7517-2011; Vernia,
   Santiago/Q-7038-2017
OI Garcia-Escudero, Ramon/0000-0001-5640-6542; Zuber,
   Johannes/0000-0001-8810-6835; Wagner, Verena/0000-0003-2604-0759;
   Vernia, Santiago/0000-0001-6728-5555; Innes, Andrew/0000-0003-0918-8882
FU Medical Research Council (MRC) [MC_U120085810]; Worldwide Cancer
   Research (WCR) [18-0215]; Cancer Research UK (CRUK) [C15075/A28647];
   Chain-Florey Clinical Fellowship; National Institute for Health Research
   (NIHR) Clinical Lectureship; NIHR Imperial Biomedical Research Centre
   (BRC); German Cancer Aid Mildred-Scheel-Postdoc Program; ERC Starter
   Grant (MetDNASecStr) [637798]; NIHR; MRC; MRC [MC_UP_1102/18,
   MC_U120085810, MC_UP_1102/14] Funding Source: UKRI; European Research
   Council (ERC) [637798] Funding Source: European Research Council (ERC)
FX We are grateful to D. Gorlich (Max Planck Institute for Biophysical
   Chemistry, Gottingen, Germany) for helpful feedback, comments, and
   reagents. We thank R. Benezra (Memorial Sloan Kettering Cancer Center,
   New York) for the pcDNA3 hE47 plasmid (obtained via Addgene). We thank
   members of J.G.'s laboratory for reagents, comments, and other
   contributions to this project. We thank members of the Genomics LMS
   facility (L. Game, K. Rekopoulou, and A. Ivan) and the Bioinformatics
   LMS facility (M. Karimi and H. Pallikonda) for help with RNAseq and data
   processing. J.G. was supported by the Medical Research Council (MRC;
   MC_U120085810) and by grants from Worldwide Cancer Research (WCR;
   18-0215) and from Cancer Research UK (CRUK; C15075/A28647). A.J.I. was
   supported by a Chain-Florey Clinical Fellowship and a National Institute
   for Health Research (NIHR) Clinical Lectureship and acknowledges the
   support of the NIHR, the NIHR Imperial Biomedical Research Centre (BRC),
   and the MRC. V.W. was funded by the German Cancer Aid
   Mildred-Scheel-Postdoc Program. J.-B.V. and R.M.P. are funded by an ERC
   Starter Grant (637798; MetDNASecStr).
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Aksu M, 2018, J CELL BIOL, V217, P2329, DOI 10.1083/jcb.201712013
   Andrysik Z, 2013, CELL REP, V3, P1346, DOI 10.1016/j.celrep.2013.04.014
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005
   Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Georgilis A, 2018, CANCER CELL, V34, P85, DOI 10.1016/j.ccell.2018.06.007
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hattangadi SM, 2014, BLOOD, V124, P1931, DOI 10.1182/blood-2013-11-537761
   Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148
   Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583
   Jacobs JJL, 2004, CURR BIOL, V14, P2302, DOI 10.1016/j.cub.2004.12.025
   JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Kutay U, 2000, J BIOL CHEM, V275, P40163, DOI 10.1074/jbc.M006242200
   Lee JH, 2010, J CELL BIOCHEM, V111, P195, DOI 10.1002/jcb.22689
   Liang PZ, 2013, TRAFFIC, V14, P1132, DOI 10.1111/tra.12097
   Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052
   Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411
   Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984
   Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314
   Suram A, 2012, EMBO J, V31, P2839, DOI 10.1038/emboj.2012.132
   Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491
   Tordella L, 2016, GENE DEV, V30, P2187, DOI 10.1101/gad.286112.116
   Victorelli S, 2017, EBIOMEDICINE, V21, P14, DOI 10.1016/j.ebiom.2017.03.027
   Wang YF, 2016, GENE DEV, V30, P293, DOI 10.1101/gad.271445.115
   Yamauchi T, 2018, CANCER CELL, V33, P386, DOI 10.1016/j.ccell.2018.01.012
NR 39
TC 4
Z9 5
U1 0
U2 1
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD AUG 1
PY 2020
VL 34
IS 15-16
BP 379
EP 391
DI 10.1101/gad.343269.120
PG 13
WC Cell Biology; Developmental Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA QR8JF
UT WOS:000625458800002
PM 33602872
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Sugimura, T
   Jounai, K
   Ohshio, K
   Suzuki, H
   Kirisako, T
   Sugihara, Y
   Fujiwara, D
AF Sugimura, Tetsu
   Jounai, Kenta
   Ohshio, Konomi
   Suzuki, Hiroaki
   Kirisako, Takayoshi
   Sugihara, Yoshihiko
   Fujiwara, Daisuke
TI Long-term administration of pDC-Stimulative <i>Lactococcus</i>
   <i>lactis</i> strain decelerates senescence and prolongs the lifespan of
   mice
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article
DE Lactic acid bacteria; Plasmacytoid dendritic cells; Senescence; Skin
ID PLASMACYTOID DENDRITIC CELLS; ACCELERATED MOUSE SAM; CD8(+) T-CELLS; I
   INTERFERON; IMMUNITY; DISEASE; INNATE; VIRUS; DIFFERENTIATION;
   INFLAMMATION
AB The decline in immune function caused by aging increases the risk of infectious diseases, tumorigeneses and chronic inflammation, resulting in accelerating senescence. We previously reported a lactic acid bacteria, Lactococcus lactis strain Plasma (synonym of Lactococcus laths subsp. lactis JCM 5805, Lc-Plasma), that stimulates plasmacytoid dendritic cells (pDCs), which play a crucial role in phylaxis from viral infection. In this study, we investigated the anti-aging effects of long-term oral administration of Lc-Plasma in a senescence-accelerated mouse strain, SAMP6. Mice given Lc-Plasma showed a significant improvement in survival rate at 82 weeks and a decreased senescence score as compared with control mice throughout this study. Anatomic analysis at 82 weeks revealed that the frequency of altered hepatocellular foci was significantly lower, and the incidence of other pathological findings in the liver and lungs tended to be lower in Lc-Plasma mice than in control mice. Transcription level of the IL-1 beta gene in lungs also tended to be lower in Lc-Plasma mice. Furthermore, the thinning of skin and age-related decrease in muscle mass were also significantly suppressed in the Lc-Plasma group as compared with the control group. Consistent with these phenotypic features, pDCs activity was significantly higher in Lc-Plasma mice than in control mice. In conclusion, long-term administration of Lc-Plasma can decelerate senescence and prolong lifespan via maintenance of the immune system due to activation of pDCs.
C1 [Sugimura, Tetsu; Jounai, Kenta; Ohshio, Konomi; Suzuki, Hiroaki; Kirisako, Takayoshi; Sugihara, Yoshihiko; Fujiwara, Daisuke] Kirin Co Ltd, Cent Labs Key Technol, Yokohama, Kanagawa, Japan.
   [Jounai, Kenta] Koiwai Dairy Prod Co Ltd, Tech Deveropment Ctr, Sayama, Osaka, Japan.
RP Sugimura, T (corresponding author), Kirin Co Ltd, Cent Labs Key Technol, Yokohama, Kanagawa, Japan.
EM Tetsu_Sugimura@kirin.co.jp
CR Bhattacharyya Tapan K, 2004, Arch Facial Plast Surg, V6, P21, DOI 10.1001/archfaci.6.1.21
   Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101
   Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985
   Frasca D, 2004, CRIT REV IMMUNOL, V24, P297, DOI 10.1615/CritRevImmunol.v24.i5.10
   Frasca D, 2011, J CLIN IMMUNOL, V31, P430, DOI 10.1007/s10875-010-9501-7
   Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010
   Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1
   Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727
   Gigley JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020838
   Goronzy JJ, 2015, J IMMUNOL, V194, P4073, DOI 10.4049/jimmunol.1500046
   Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102
   Grolleau-Julius A, 2008, CANCER RES, V68, P6341, DOI 10.1158/0008-5472.CAN-07-5769
   Gupta S, 2014, EXP GERONTOL, V54, P47, DOI 10.1016/j.exger.2013.12.009
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5
   Jounai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119055
   Jounai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032588
   Kawase M, 2012, FEMS MICROBIOL LETT, V326, P125, DOI 10.1111/j.1574-6968.2011.02440.x
   Kimoto-Nira H, 2007, BRIT J NUTR, V98, P1178, DOI 10.1017/S0007114507787469
   Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012
   Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978
   Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0
   Matsumoto S, 2001, DIGESTION, V64, P92, DOI 10.1159/000048846
   Maue AC, 2009, TRENDS IMMUNOL, V30, P301, DOI 10.1016/j.it.2009.04.007
   Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x
   Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326
   Pawelec G, 2014, CURR OPIN IMMUNOL, V29, P23, DOI 10.1016/j.coi.2014.03.007
   Poeck H, 2004, BLOOD, V103, P3058, DOI 10.1182/blood-2003-08-2972
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879
   Shaw AC, 2010, CURR OPIN IMMUNOL, V22, P507, DOI 10.1016/j.coi.2010.05.003
   Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835
   Stout-Delgado HW, 2008, J IMMUNOL, V181, P6747, DOI 10.4049/jimmunol.181.10.6747
   Sugimura T, 2015, BRIT J NUTR, V114, P727, DOI 10.1017/S0007114515002408
   Sugimura T, 2013, CLIN IMMUNOL, V149, P509, DOI 10.1016/j.clim.2013.10.007
   Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TRINCHIERI G, 1978, J EXP MED, V147, P1314, DOI 10.1084/jem.147.5.1314
   Wulf HC, 2004, MICRON, V35, P185, DOI 10.1016/j.micron.2003.11.005
   Zhang N, 2005, J IMMUNOL, V174, P8125, DOI 10.4049/jimmunol.174.12.8125
NR 41
TC 10
Z9 12
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD MAY
PY 2018
VL 58
BP 166
EP 172
DI 10.1016/j.intimp.2018.03.024
PG 7
WC Immunology; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Pharmacology & Pharmacy
GA GG3UI
UT WOS:000432618300022
PM 29605632
DA 2024-02-19
ER

PT J
AU MASUDA, M
   NUKUZUMA, C
   KAZUSAKA, A
   FUJITA, S
AF MASUDA, M
   NUKUZUMA, C
   KAZUSAKA, A
   FUJITA, S
TI ALTERATIONS IN ACTIVATION AND DEACTIVATION OF MUTAGENS IN AGING
   RAT-LIVER
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID LIDOCAINE METABOLISM; MICROSOMES; AGE; CYTOCHROME-P-450; CARCINOGENS
AB Age-associated alterations in activation and deactivation of benzo[a]pyrene (BP), furylfuramide (AF2), and 2-nitrofluorene (NF) in rat liver were investigated. A modified Ames mutagenicity test system used liver 9000 g supernatant (S-9) from male Fischer 344 rats aged 3, 6, 12, and 24 months fortified with NADPH generating system alone or together with cofactors of conjugating enzymes. The numbers of revertant colonies due to mutagenic activation of BP during preincubation were markedly high in young rats and decreased with aging. They were decreased by the addition of UDP-glucuronic acid (15 mM) or glutathione (30 mM), the cofactors for UDP-glucuronyl transferase and glutathione S-transferase, respectively, in the preincubation mixture. The difference in the BP activation by liver S-9 from different age groups almost disappeared by the addition of reduced glutathione. A direct mutagen, AF2, was not metabolized during preincubation in the absence of cofactors of conjugating enzymes, but detoxified up to about 50% by the addition of glutathione to the preincubation mixture containing liver S-9 from rats of any age group. Another direct mutagen, NF, was partly detoxified during preincubation by liver S-9 from 3-month-old rats more than by that from 24-month-old rats. It is suggested that incidence of chemical carcinogenesis may increase along with aging due to the altered xenobiotics metabolism.
C1 HOKKAIDO UNIV,FAC VET MED,DEPT TOXICOL,SAPPORO,HOKKAIDO 060,JAPAN.
C3 Hokkaido University
CR AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1
   BAIRD MB, 1979, CANCER RES, V39, P4752
   FUJITA S, 1985, BIOCHEM BIOPH RES CO, V126, P117, DOI 10.1016/0006-291X(85)90579-0
   FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369
   FUJITA S, 1988, CANCER RES, V48, P254
   IMAOKA S, 1990, J PHARMACOL EXP THER, V255, P1385
   IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1907, P187
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Masuda Makihiko, 1994, Journal of Toxicological Sciences, V19, P235
   MCCACHREN SS, 1991, AGING ENV TOXICOLOGY, P56
   MOLLER L, 1987, CARCINOGENESIS, V8, P637, DOI 10.1093/carcin/8.5.637
   OHGIYA N, 1989, J BIOCHEM-TOKYO, V105, P234, DOI 10.1093/oxfordjournals.jbchem.a122645
NR 13
TC 2
Z9 2
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD SEP
PY 1995
VL 50
IS 5
BP B303
EP B306
DI 10.1093/gerona/50A.5.B303
PG 4
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA RY605
UT WOS:A1995RY60500009
PM 7671022
DA 2024-02-19
ER

PT J
AU MYSLIWSKI, A
   KMIEC, Z
AF MYSLIWSKI, A
   KMIEC, Z
TI EFFECT OF AGING ON GLYCOGEN-SYNTHESIS IN LIVER OF STARVED-REFED RATS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
DE STARVATION; REFEEDING; GLYCOGEN SYNTHESIS; LIVER; AGING
ID AGE; GLUCOSE; HEPATOCYTES; ABSORPTION; INSULIN; YOUNG; OLD
AB Glycogen content in the livers of young, adult and old rats starved for 40 h and refed with a standard diet for 1, 2 or 4 h was determined. In the fed animals the amount of liver glycogen was similar in all the age groups. Fasting depleted liver glycogen almost completely. Chow refeeding led to glycogen synthesis in the livers of young and adult rats; however, glycogen deposition in the livers of old animals was delayed by 1 h. The amount of liver glycogen replenished in the rats refed for 4 h was similar in all the age groups. Plasma glucose concentrations were similar in all the age groups of the fed, starved and refed rats. The mechanisms of age-dependent delay of glycogen synthesis in the liver of starved-refed rats are discussed.
RP MYSLIWSKI, A (corresponding author), UNIV GDANSK SCH MED,DEPT HISTOL,PL-80210 GDANSK,POLAND.
CR ADELMAN RC, 1970, J BIOL CHEM, V245, P1032
   BABCOCK MB, 1974, AM J ANAT, V143, P299
   COLOSIA AD, 1988, J BIOL CHEM, V263, P18669
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   ESPOSITO G, 1985, AM J PHYSIOL, V249, pG328, DOI 10.1152/ajpgi.1985.249.3.G328
   FREMINET A, 1980, COMP BIOCHEM PHYS B, V65, P363, DOI 10.1016/0305-0491(80)90027-9
   GOMMERS A, 1975, ACTA DIABETOL LAT, V12, P303, DOI 10.1007/BF02581103
   HOLNESS M, 1988, BIOCHEM J, V247, P627
   KATZ J, 1976, P NATL ACAD SCI USA, V73, P3433, DOI 10.1073/pnas.73.10.3433
   KHANDENWAL RL, 1984, MECH AGEING DEV, V20, P13
   KMIEC Z, 1990, ARCH GERONTOL GERIAT, V10, P9, DOI 10.1016/0167-4943(90)90039-9
   KMIEC Z, 1985, EXP GERONTOL, V20, P271, DOI 10.1016/0531-5565(85)90052-X
   KMIEC Z, 1983, EXP GERONTOL, V18, P173, DOI 10.1016/0531-5565(83)90030-X
   KUWAJIMA M, 1986, J BIOL CHEM, V261, P2632
   LUST WD, 1975, ANAL BIOCHEM, V68, P328, DOI 10.1016/0003-2697(75)90712-5
   MINDEROP RH, 1987, EUR J BIOCHEM, V164, P181, DOI 10.1111/j.1432-1033.1987.tb11009.x
   NUTTALL FQ, 1988, AM J MED, V85, P77, DOI 10.1016/0002-9343(88)90400-7
   POLAND JL, 1982, GERONTOLOGY, V28, P99, DOI 10.1159/000212517
   VINARDELL MP, 1990, MECH AGEING DEV, V51, P243, DOI 10.1016/0047-6374(90)90074-P
   VINARDELL MP, 1987, COMP BIOCHEM PHYS A, V86, P617, DOI 10.1016/0300-9629(87)90611-6
   WERNER W, 1970, FRESEN Z ANAL CHEM, V252, P224
   YOUN JH, 1989, J BIOL CHEM, V264, P168
   YU BP, 1984, MECH AGEING DEV, V24, P67
NR 23
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PD JAN-FEB
PY 1992
VL 14
IS 1
BP 85
EP 92
DI 10.1016/0167-4943(92)90009-S
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA HK365
UT WOS:A1992HK36500008
PM 15374412
DA 2024-02-19
ER

PT J
AU Frampton, G
   Reddy, P
   Jefferson, B
   Ali, M
   Khan, D
   McMillin, M
AF Frampton, Gabriel
   Reddy, Priyanka
   Jefferson, Brandi
   Ali, Malaika
   Khan, Durreshahwar
   McMillin, Matthew
TI Inhibition of thrombospondin-1 reduces glutathione activity and worsens
   acute liver injury during acetaminophen hepatotoxicity in mice
SO TOXICOLOGY AND APPLIED PHARMACOLOGY
LA English
DT Article
DE Transforming growth factor beta 1; Hepatotoxicity; Acute liver failure;
   Nrf2
ID TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; CHOLANGIOCARCINOMA GROWTH;
   ACTIVATION; LATENT; EXPRESSION; RECEPTOR; SMAD7; CELLS; MECHANISMS
AB Acetaminophen (N-Acetyl-p-Aminophenol or APAP)-induced hepatotoxicity is the most common cause of acute liver failure in the United States and Western Europe. Previous studies have shown that TGF beta 1 is elevated during APAP-induced hepatotoxicity and promotes liver injury by reducing liver regeneration while inducing hepatocyte senescence. At this time, little is known about the role of proteins that activate latent TGF beta 1 and their effects during APAP-induced hepatotoxicity. Thrombospondin-1 (TSP1) is a homotrimeric protein that can not only activate latent TGF beta 1 but can also interact with other proteins including Nrf2 to induce antioxidant signaling. The aim of the current study was to assess the role of thrombospondin-1 (TSP1) in both TGF beta 1 activation and its contribution to APAP-induced liver injury. C57B1/6 mice or TSP1 null mice (TSP1(-/-)) were administered 300 mg/kg or 600 mg/kg of APAP. TGF beta 1 signaling, TSP1 expression, measures of hepatic injury, Nrf2 expression, measures of oxidative/nitrosative stress and GSH metabolism were assessed. The expression of TGF beta 1, TSP1 and phosphorylation of SMAD proteins increased in APAP-treated mice compared to controls. TSP1(-/-) mice had reduced TGF beta 1 expression and phosphorylation of SMAD proteins but increased liver injury. Hepatocyte cell death was increased in TSP1(-/-) mice and this was associated with decreased Nrf2 activity, decreased GSH levels and increased oxidative stress in comparison to wild-type C57B1/6 mice. Together, these data demonstrate that elimination of TSP1 protein in APAP-treated mice reduces TGF beta 1 signaling but leads to increased liver injury by reducing Nrf2 expression and GSH activity, ultimately resulting in increased cell death.
C1 [Frampton, Gabriel; Reddy, Priyanka; Jefferson, Brandi; Ali, Malaika; Khan, Durreshahwar; McMillin, Matthew] Cent Texas Vet Hlth Care Syst, Austin, TX USA.
   [Frampton, Gabriel; McMillin, Matthew] Univ Texas Austin, Dept Internal Med, Dell Med Sch, Austin, TX 78701 USA.
C3 University of Texas System; University of Texas Austin
RP McMillin, M (corresponding author), Univ Texas Austin, Dell Med Sch, 1601 Trinity St,Bldg B, Austin, TX 78701 USA.
EM matthew.mcmillin@austin.utexas.edu
FU Department of Veterans Affairs Biomedical Laboratory Research &
   Development Service [BX003486]
FX This work was supported by the Department of Veterans Affairs Biomedical
   Laboratory Research & Development Service [grant number BX003486].
CR Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678
   Akino N, 2018, MOL CELL ENDOCRINOL, V470, P96, DOI 10.1016/j.mce.2017.10.002
   Bachhawat AK, 2018, IUBMB LIFE, V70, P585, DOI 10.1002/iub.1756
   BAENZIGER NL, 1972, J BIOL CHEM, V247, P2723
   Bernal W, 2015, J HEPATOL, V62, pS112, DOI 10.1016/j.jhep.2014.12.016
   Bird TG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1230
   Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4
   Chen P, 2016, ONCOTARGET, V7, P6105, DOI 10.18632/oncotarget.6835
   Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9
   Cunha DA, 2016, CELL DEATH DIFFER, V23, P1995, DOI 10.1038/cdd.2016.89
   Daubon T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08480-y
   DeMorrow S, 2008, AM J PHYSIOL-GASTR L, V295, pG1150, DOI 10.1152/ajpgi.90455.2008
   Ebisawa T, 2001, J BIOL CHEM, V276, P12477, DOI 10.1074/jbc.C100008200
   El-Youssef M, 1999, J PEDIATR GASTR NUTR, V28, P386, DOI 10.1097/00005176-199904000-00008
   Fan XY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01334
   Frampton G, 2012, GUT, V61, P268, DOI 10.1136/gutjnl-2011-300643
   Grant Stephanie, 2018, Gene Expression, V18, P171, DOI 10.3727/105221618X15287315176503
   Jefferson B, 2020, AM J PATHOL, V190, P347, DOI 10.1016/j.ajpath.2019.10.003
   Jin Y, 2019, ACTA PHARMACOL SIN, V40, P75, DOI 10.1038/s41401-018-0024-8
   Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9
   Khalil N, 1999, MICROBES INFECT, V1, P1255, DOI 10.1016/S1286-4579(99)00259-2
   Kim CW, 2017, CIRCULATION, V136, P1217, DOI 10.1161/CIRCULATIONAHA.116.026361
   Kumar R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15494
   Kuo LJ, 2008, IN VIVO, V22, P305
   Liu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21602
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lopez-Dee Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/296069
   Lv HM, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-018-0314-2
   Matkowskyj KA, 1999, AM J PHYSIOL-GASTR L, V277, pG455, DOI 10.1152/ajpgi.1999.277.2.G455
   McMillin M, 2019, TOXICOL SCI, V170, P549, DOI 10.1093/toxsci/kfz122
   Mirochnik Y, 2008, CURR DRUG TARGETS, V9, P851, DOI 10.2174/138945008785909347
   MOSHER DF, 1982, J CELL BIOL, V93, P343, DOI 10.1083/jcb.93.2.343
   Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0
   Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188
   Neuschwander-Tetri BA, 2006, INT J BIOCHEM CELL B, V38, P102, DOI 10.1016/j.biocel.2005.08.008
   Qu YY, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.96914
   RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6
   Resovi A, 2014, MATRIX BIOL, V37, P83, DOI 10.1016/j.matbio.2014.01.012
   Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586
   SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923
   Seif K, 2018, THROMB HAEMOSTASIS, V118, P2074, DOI 10.1055/s-0038-1675229
   Shi WB, 2004, J CELL BIOL, V164, P291, DOI 10.1083/jcb.200307151
   Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.3233/DMA-2011-0798, 10.1155/2011/535109]
   Suzuki T, 2015, J RHEUMATOL, V42, P943, DOI 10.3899/jrheum.141292
   Wang YQ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124050
   Warren J, 2018, MOL HUM REPROD, V24, P602, DOI 10.1093/molehr/gay044
   Yu Q, 2000, GENE DEV, V14, P163
   Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0
NR 48
TC 5
Z9 5
U1 1
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0041-008X
EI 1096-0333
J9 TOXICOL APPL PHARM
JI Toxicol. Appl. Pharmacol.
PD DEC 15
PY 2020
VL 409
AR 115323
DI 10.1016/j.taap.2020.115323
PG 12
WC Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy; Toxicology
GA PG1MH
UT WOS:000599506200006
PM 33176120
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Hoffmeister, KM
   Falet, H
AF Hoffmeister, Karin M.
   Falet, Herve
TI Platelet clearance by the hepatic Ashwell-Morrell receptor: mechanisms
   and biological significance
SO THROMBOSIS RESEARCH
LA English
DT Article
DE platelet clearance; glycans; Ashwell Morell Receptor; thrombopoietin;
   JAK2; STAT3
ID THROMBOPOIETIN MESSENGER-RNA; C-MPL; APLASTIC-ANEMIA; SERUM-LEVELS;
   BONE-MARROW; LIVER; EXPRESSION; JAK2; THROMBOCYTOPENIA; MEGAKARYOCYTES
AB The daily production of billions of platelets must be regulated to avoid spontaneous bleeding or arterial occlusion and organ damage. Complex mechanisms control platelet production and clearance in physiological and pathological conditions. This review will focus on the mechanisms of platelet senescence with specific emphasis on the role of post-translational modifications in platelet life-span and thrombopoietin production downstream of the hepatic Ashwell-Morrell receptor. (C) 2016 Elsevier Ltd. All rights reserved.
C1 Brigham & Womens Hosp, Dept Med, Div Hematol, One Blackfan Circle,Karp 6, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Boston, MA 02115 USA.
C3 Harvard University; Brigham & Women's Hospital; Harvard University;
   Harvard Medical School
RP Hoffmeister, KM (corresponding author), Brigham & Womens Hosp, Div Hematol, One Blackfan Circle,Karp 6, Boston, MA 02115 USA.
EM khoffmeister@bwh.harvard.edu
OI Falet, Herve/0000-0003-0788-9204
CR Alioglu B, 2009, PATHOPHYSIOL HAEMO T, V37, P55, DOI 10.1159/000321379
   Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001
   [Anonymous], P NATL ACAD SCI US
   Ballmaier M, 2001, BLOOD, V97, P139, DOI 10.1182/blood.V97.1.139
   Ballmaier M, 1997, BLOOD, V90, P612, DOI 10.1182/blood.V90.2.612.612_612_619
   Bender M, 2015, BLOOD, V125, P1014, DOI 10.1182/blood-2014-07-587857
   Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476
   Burmester H, 2005, J INTERF CYTOK RES, V25, P407, DOI 10.1089/jir.2005.25.407
   Cerutti A, 1997, BRIT J HAEMATOL, V99, P281, DOI 10.1046/j.1365-2141.1997.3823196.x
   CohenSolal K, 1996, BLOOD, V88, P2578, DOI 10.1182/blood.V88.7.2578.bloodjournal8872578
   Crook M, 1990, Platelets, V1, P167, DOI 10.3109/09537109009005484
   Crook M, 1991, Platelets, V2, P1, DOI 10.3109/09537109109005496
   Dalton SR, 2009, BIOCHEM PHARMACOL, V77, P1283, DOI 10.1016/j.bcp.2008.12.023
   Engel C, 1999, BRIT J HAEMATOL, V105, P832, DOI 10.1046/j.1365-2141.1999.01459.x
   Eulenfeld R, 2012, EUR J CELL BIOL, V91, P486, DOI 10.1016/j.ejcb.2011.09.010
   Fielder PJ, 1996, BLOOD, V87, P2154, DOI 10.1182/blood.V87.6.2154.bloodjournal8762154
   Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760
   Grewal PK, 2010, METHOD ENZYMOL, V479, P223, DOI 10.1016/S0076-6879(10)79013-3
   Griesshammer M, 1998, ANN HEMATOL, V77, P211, DOI 10.1007/s002770050445
   Grisouard J, 2014, HAEMATOLOGICA, V99, pE52, DOI 10.3324/haematol.2013.100016
   Grozovsky R, 2015, NAT MED, V21, P47, DOI 10.1038/nm.3770
   Gu J, 2002, CHINESE MED J-PEKING, V115, P983
   Hitchcock IS, 2008, BLOOD, V112, P2222, DOI 10.1182/blood-2008-01-134049
   Hoffmeister KM, 2011, J THROMB HAEMOST, V9, P35, DOI 10.1111/j.1538-7836.2011.04276.x
   Ichikawa N, 1996, THROMB HAEMOSTASIS, V76, P156
   Ihara K, 1999, P NATL ACAD SCI USA, V96, P3132, DOI 10.1073/pnas.96.6.3132
   Jansen AJG, 2012, BLOOD, V119, P1263, DOI 10.1182/blood-2011-05-355628
   Jansen AJG, 2015, AM J HEMATOL, V90, pE94, DOI 10.1002/ajh.23953
   Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720
   Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674
   Kaushansky K, 2015, SEMIN HEMATOL, V52, P4, DOI 10.1053/j.seminhematol.2014.10.003
   Kaushansky Kenneth, 2009, Hematology Am Soc Hematol Educ Program, P147, DOI 10.1182/asheducation-2009.1.147
   Kosugi S, 1996, BRIT J HAEMATOL, V93, P704, DOI 10.1046/j.1365-2141.1996.d01-1702.x
   Kuter DJ, 2009, ANNU REV MED, V60, P193, DOI 10.1146/annurev.med.60.042307.181154
   KUTER DJ, 1995, BLOOD, V85, P2720, DOI 10.1182/blood.V85.10.2720.bloodjournal85102720
   LaFave LM, 2012, TRENDS PHARMACOL SCI, V33, P574, DOI 10.1016/j.tips.2012.08.005
   Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842
   Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966
   Machlus KR, 2014, BRIT J HAEMATOL, V165, P227, DOI 10.1111/bjh.12758
   MCCARTY JM, 1995, BLOOD, V86, P3668, DOI 10.1182/blood.V86.10.3668.bloodjournal86103668
   McIntosh B, 2008, EXP HEMATOL, V36, P799, DOI 10.1016/j.exphem.2008.02.012
   Meyer SC, 2014, BLOOD, V124, P2280, DOI 10.1182/blood-2014-03-560441
   Mouthon MA, 1999, RADIAT RES, V152, P390, DOI 10.2307/3580223
   Ng AP, 2014, P NATL ACAD SCI USA, V111, P5884, DOI 10.1073/pnas.1404354111
   Park SO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059675
   Pecquet C, 2012, BLOOD, V119, P4625, DOI 10.1182/blood-2011-08-372524
   Qian SG, 1998, BLOOD, V92, P2189, DOI 10.1182/blood.V92.6.2189
   Reimers H J, 1977, Adv Exp Med Biol, V82, P231
   Rumjantseva V, 2010, TRANSFUS APHER SCI, V42, P63, DOI 10.1016/j.transci.2009.10.008
   Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030
   Schrezenmeier H, 1998, BRIT J HAEMATOL, V100, P571, DOI 10.1046/j.1365-2141.1998.00590.x
   Shao L, 2014, PLATELETS, P1
   Shinjo K, 1998, LEUKEMIA, V12, P295, DOI 10.1038/sj.leu.2400946
   Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414
   Stone RL, 2012, NEW ENGL J MED, V366, P610, DOI 10.1056/NEJMoa1110352
   Sungaran R, 1997, BLOOD, V89, P101, DOI 10.1182/blood.V89.1.101
   Sungaran R, 2000, BLOOD, V95, P3094, DOI 10.1182/blood.V95.10.3094.009k05_3094_3101
   Wang JC, 1998, AM J MED, V104, P451, DOI 10.1016/S0002-9343(98)00090-4
   Wolber EM, 1999, HEPATOLOGY, V29, P1739, DOI 10.1002/hep.510290627
   Wolber EM, 2000, J INTERF CYTOK RES, V20, P499, DOI 10.1089/10799900050023915
   Wolber EM, 2001, THROMB HAEMOSTASIS, V86, P1421
   Zhang L, 2012, J EXP MED, V209, P2165, DOI 10.1084/jem.20121090
NR 62
TC 46
Z9 62
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
EI 1879-2472
J9 THROMB RES
JI Thromb. Res.
PD MAY
PY 2016
VL 141
SU 2
BP S68
EP S72
PG 5
WC Hematology; Peripheral Vascular Disease
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Hematology; Cardiovascular System & Cardiology
GA DM2TR
UT WOS:000376201100019
PM 27207430
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Shin, HK
   Park, JH
   Yu, JH
   Jin, YJ
   Suh, YJ
   Lee, JW
   Kim, W
AF Shin, Hee Kyung
   Park, Jeong Hwan
   Yu, Jung Hwan
   Jin, Young-Joo
   Suh, Young Ju
   Lee, Jin-Woo
   Kim, Won
CA Korean Nonalcoholic Fatty Liver St
TI Association between telomere length and hepatic fibrosis in
   non-alcoholic fatty liver disease
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HEPATOCELLULAR-CARCINOMA; SENESCENCE; STEATOHEPATITIS; SYSTEM
AB Telomere length has been linked to the prevalence and progression of metabolic disease. However, clinical implications of telomere length in biopsy-proven non-alcoholic fatty liver disease (NAFLD) patients remain unclear. Therefore, this study aimed to investigate the association of telomere length with the histological severity of NAFLD. The cross-sectional data derived from the prospectively enrolled Boramae NAFLD registry (n = 91) were analyzed. The liver tissues and clinical information were obtained from both NAFLD patients and non-NAFLD subjects. Binary logistic regression was performed to identify the independent association between telomere length and the histological severity of NAFLD. A total of 83 subjects with or without biopsy-proven NAFLD were included for analysis: non-NAFLD in 23 (27.7%), non-alcoholic fatty liver in 15 (18.1%), and non-alcoholic steatohepatitis (NASH) in 45 (54.2%). Telomere length measured from liver tissues showed a strong negative correlation (p < 0.001) with age, regardless of NAFLD status. Therefore, telomere length was corrected for age. Age-adjusted telomere length than decreased gradually with an increasing severity of fibrosis in patients with NAFLD (p < 0.028). In multivariate analysis, age-adjusted telomere length (odds ratio [OR] 0.59; 95% CI 0.37-0.92; p = 0.019) and high-density lipoprotein cholesterol (OR 0.94; 95% CI 0.80-0.99; p = 0.039) were independently associated with significant fibrosis. The age-adjusted telomere length tends to decrease along with the fibrosis stage of NAFLD. In particular, among the histological components of NAFLD, fibrosis severity seems to be related to telomere length in the liver.
C1 [Shin, Hee Kyung; Yu, Jung Hwan; Lee, Jin-Woo] Inha Univ, Inha Univ Hosp, Dept Internal Med, Sch Med, Inchon, South Korea.
   [Park, Jeong Hwan] Seoul Natl Univ, Dept Pathol, Seoul Metropolitan Govt Boramae Med Ctr, Coll Med, Seoul, South Korea.
   [Suh, Young Ju] Inha Univ, Dept Biomed Sci, Coll Med, Inchon, South Korea.
   [Kim, Won] Seoul Natl Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Seoul Metropolitan Govt Boramae Med Ctr,Coll Med, Seoul, South Korea.
C3 Inha University; Inha University Hospital; Seoul National University
   (SNU); Inha University; Seoul National University (SNU)
RP Yu, JH (corresponding author), Inha Univ, Inha Univ Hosp, Dept Internal Med, Sch Med, Inchon, South Korea.; Kim, W (corresponding author), Seoul Natl Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Seoul Metropolitan Govt Boramae Med Ctr,Coll Med, Seoul, South Korea.
EM junghwan0081@naver.com; drwon1@snu.ac.kr
RI Kim, Won/H-6940-2019; lee, wj/JNR-4926-2023; Lee, JIn/HTL-6278-2023
OI Kim, Won/0000-0002-2926-1007; Park, Jeong Hwan/0000-0003-4522-9928
FU National Research Foundation of Korea (NRF) - Korea Government (MEST)
   [2019R1G1A1100419, 2021R1A2C2005820, 2021M3A9E4021818]; Korea Health
   Technology R&D Project through the Korea Health Industry Development
   Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea
   [HI21C0538]; Research Supporting Program of the Korean Association for
   the Study of the Liver [KASL2018-05]; Inha University
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grant funded by the Korea Government (MEST) (2019R1G1A1100419,
   2021R1A2C2005820, and 2021M3A9E4021818), the Korea Health Technology R&D
   Project through the Korea Health Industry Development Institute (KHIDI)
   funded by the Ministry of Health & Welfare, Republic of Korea
   (HI21C0538), the Research Supporting Program of the Korean Association
   for the Study of the Liver (Grant no. KASL2018-05), and an Inha
   University Research Grant.
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Brunt EM, 2003, MODERN PATHOL, V16, P49, DOI 10.1097/01.MP.0000042420.21088.C7
   Hanson Amanda, 2018, Non-Coding RNA, V4, P18, DOI 10.3390/ncrna4030018
   Ikejima K, 2020, CLIN MOL HEPATOL, V26, P728, DOI 10.3350/cmh.2020.0202
   Kang SH, 2021, CLIN MOL HEPATOL, V27, P257, DOI 10.3350/cmh.2021.0067
   Kim D, 2018, LIVER INT, V38, P1839, DOI 10.1111/liv.13886
   Kim H, 2013, J HEPATOL, V59, P746, DOI 10.1016/j.jhep.2013.05.011
   Kim SU, 2012, J HEPATOL, V57, P556, DOI 10.1016/j.jhep.2012.04.029
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Ko E, 2018, HEPATOLOGY, V67, P1378, DOI 10.1002/hep.29604
   Laish I, 2016, CYTOGENET GENOME RES, V150, P93, DOI 10.1159/000454654
   Lee MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188321
   Ma LJ, 2017, J PATHOL, V243, P407, DOI 10.1002/path.4961
   Mangge H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63916-6
   Marcuccilli M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040562
   Marjot T, 2020, ENDOCR REV, V41, P66, DOI 10.1210/endrev/bnz009
   Nakashio R, 1997, INT J ONCOL, V11, P139
   Nault JC, 2019, NAT REV GASTRO HEPAT, V16, P544, DOI 10.1038/s41575-019-0165-3
   O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Saini N, 2009, LIVER INT, V29, P1162, DOI 10.1111/j.1478-3231.2009.02082.x
   Sakaguchi S, 2011, DRUG METAB PHARMACOK, V26, P30, DOI 10.2133/dmpk.DMPK-10-RV-087
   Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376
   Shetty Akshay, 2019, Fed Pract, V36, P14
   Soon G, 2021, CLIN MOL HEPATOL, V27, P44, DOI 10.3350/cmh.2020.0181
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yoo JJ, 2019, CLIN MOL HEPATOL, V25, P1, DOI 10.3350/cmh.2018.0037
   Zhang J, 2017, INT J CLIN EXP MED, V10, P11204
   Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388
NR 33
TC 10
Z9 11
U1 1
U2 4
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 9
PY 2021
VL 11
IS 1
AR 18004
DI 10.1038/s41598-021-97385-2
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA UP3GW
UT WOS:000695272000108
PM 34504179
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Son, TG
   Park, HR
   Kim, SJ
   Kim, K
   Kim, MS
   Ishigami, A
   Handa, S
   Maruyama, N
   Chung, HY
   Lee, J
AF Son, Tae Gen
   Park, Hee Ra
   Kim, So Jung
   Kim, Keunho
   Kim, Min-Sun
   Ishigami, Akihito
   Handa, Setsuko
   Maruyama, Naoki
   Chung, Hae Young
   Lee, Jaewon
TI Senescence Marker Protein 30 Is Up-Regulated in Kainate-Induced
   Hippocampal Damage Through ERK-Mediated Astrocytosis
SO JOURNAL OF NEUROSCIENCE RESEARCH
LA English
DT Article
DE aging; astrocytosis; kainate; microglia; neurodegenerative diseases
ID OXIDATIVE STRESS; KAINIC ACID; INDUCED SEIZURES; GENE-REGULATION;
   KNOCKOUT MICE; CELL-DEATH; SMP30; RAT; BRAIN; EXPRESSION
AB Senescence maker protein 30 (SMP30) is decreased in an androgen-independent manner in kidney and liver with age. However, regulation of SMP30 expression in the brain has not been examined in aging and neurodegenerative diseases. To investigate SMP30 expression in the brain, we utilized aging and kainate (KA)-induced neurodegenerative disease models. Interestingly, expression of SMP30 was unlikely to decrease in the aged brain, but total levels of SMP30 protein were increased at 4 weeks after KA injury. Increased glial fibrillary acidic protein (GFAP) with elevated SMP30 expression was observed at the same time post-KA, indicating that regulation of SMP30 expression in the brain may be associated with astrocytosis. We confirmed that KA induced GFAP expression with increased SMP30 in rat astrocyte cells. Moreover, we found that ERK1/2 activation was involved in the up-regulation of SMP30 in astrocytes. Our results suggest that elevated SMP30 in activated astrocytes plays an important supportive role after brain damage. (C) 2009 Wiley-Liss, Inc.
C1 [Son, Tae Gen; Park, Hee Ra; Kim, So Jung; Kim, Keunho; Kim, Min-Sun; Chung, Hae Young; Lee, Jaewon] Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea.
   [Son, Tae Gen; Park, Hee Ra; Kim, So Jung; Kim, Keunho; Kim, Min-Sun; Chung, Hae Young; Lee, Jaewon] Pusan Natl Univ, Res Inst Drug Dev, Longev Life Sci Inst, Pusan 609735, South Korea.
   [Son, Tae Gen; Park, Hee Ra; Kim, So Jung; Kim, Keunho; Kim, Min-Sun; Chung, Hae Young; Lee, Jaewon] Pusan Natl Univ, Inst Technol, Pusan 609735, South Korea.
   [Ishigami, Akihito] Toho Univ, Fac Pharmaceut Sci, Dept Biochem, Chiba 2748510, Japan.
   [Ishigami, Akihito; Handa, Setsuko; Maruyama, Naoki] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
C3 Pusan National University; Pusan National University; Pusan National
   University; Toho University; Tokyo Metropolitan Institute of Gerontology
RP Lee, J (corresponding author), Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea.
EM neuron@pusan.ac.kr
RI Lee, Jaewon/N-9064-2013; Lee, Jaewon/IQR-8432-2023
OI Lee, Jaewon/0000-0003-3203-2130; Ishigami, Akihito/0000-0001-7875-7482
FU Korea Research Foundation Grant Funded by the Korean Government
   [KRF-2007-331-C00233]; Korea Science & engineering Foundation Through
   the Joint Research Program [F01-2008-000-10049-0]; Grants-in-Aid for
   Scientific Research [21590974, 21590392] Funding Source: KAKEN
FX Korea Resarch Foundation Grant funded by the Korean Government (MOEHRI).
   Basic Research Promotion Fund; Korea Science & Engineering Foundation
   through the Joint Research Program; 2008 Specializaiton Project Research
   Grant funded by the Psan National University
CR Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Che YZ, 2001, MOL BRAIN RES, V94, P157, DOI 10.1016/S0169-328X(01)00233-9
   Crespo-Biel N, 2007, NEUROCHEM INT, V50, P435, DOI 10.1016/j.neuint.2006.10.002
   Feng DY, 2004, ANN NY ACAD SCI, V1019, P360, DOI 10.1196/annals.1297.062
   Ferraguti F, 2001, EXP BRAIN RES, V137, P1, DOI 10.1007/s002210000633
   Ferrer I, 2002, ACTA NEUROPATHOL, V103, P391, DOI 10.1007/s00401-001-0481-9
   FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5
   Furuichi Y, 2004, BRAIN RES, V1014, P120, DOI 10.1016/j.brainres.2004.04.031
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Kondo Y, 2008, BIOCHEM BIOPH RES CO, V377, P291, DOI 10.1016/j.bbrc.2008.09.132
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023
   Ogita K, 2001, NEUROPHARMACOLOGY, V41, P285, DOI 10.1016/S0028-3908(01)00081-8
   Otani N, 2003, ACTA NEUROCHIR SUPPL, V86, P571
   Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387
   RADANY EH, 1992, P NATL ACAD SCI USA, V89, P6467, DOI 10.1073/pnas.89.14.6467
   Ronaldson PT, 2004, J NEUROCHEM, V89, P788, DOI 10.1111/j.1471-4159.2004.02417.x
   Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002
   Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   SON TG, 2006, KOR J GERONTOL, V16, P1
   Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003
   Wu GS, 2005, J NEUROSCI, V25, P11014, DOI 10.1523/JNEUROSCI.3635-05.2005
NR 31
TC 16
Z9 23
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0360-4012
EI 1097-4547
J9 J NEUROSCI RES
JI J. Neurosci. Res.
PD OCT
PY 2009
VL 87
IS 13
BP 2890
EP 2897
DI 10.1002/jnr.22122
PG 8
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA 492SB
UT WOS:000269678600008
PM 19437547
DA 2024-02-19
ER

PT J
AU Dose, J
   Nebel, A
   Piegholdt, S
   Rimbach, G
   Huebbe, P
AF Dose, Janina
   Nebel, Almut
   Piegholdt, Stefanie
   Rimbach, Gerald
   Huebbe, Patricia
TI Influence of the <i>APOE</i> genotype on hepatic stress response:
   Studies in APOE targeted replacement mice and human liver cells
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Apolipoprotein E isoform; Hepatocytes; Endoplasmic reticulum stress;
   Mitochondrial function; Proteasome activity; Apoptosis; Autophagy; ATP
ID HUMAN APOLIPOPROTEIN-E; MITOCHONDRIAL DYSFUNCTION; ALZHEIMERS-DISEASE;
   ANTIOXIDANT ACTIVITY; CEREBROSPINAL-FLUID; DOMAIN INTERACTION; PROTEIN
   OXIDATION; HUMAN LONGEVITY; CONFIRMS APOE; LIFE-SPAN
AB Apolipoprotein E (APOE) is a multifunctional plasma protein mainly acting in lipid metabolism. Human APOE is polymorphic with three major isoforms (APOE2, APOE3 and APOE4). Up to 75% of the body's APOE is produced by the liver. There is increasing evidence from studies in brain-derived cells that APOE4 affects mitochondrial function and biogenesis as well as stress and inflammatory responses processes, whose disturbances are considered hallmarks of the ageing process. However, although the liver is the main production site of APOE, knowledge about the impact of the APOE genotype on hepatic stress response-related processes is rather limited. Therefore, we studied biomarkers of oxidative status (glutathione levels, 3-nitrotyrosine adducts, protein carbonyl concentration), ER stress (XBP1(S), BiP, DDIT3), proteasome activity, mitochondrial function (respiratory complexes, ATP levels and mitochondria) membrane potential as well as biomarkers of mitochondrial biogenesis, fission and fusion), autophagy (LC3, LAMP2A), apoptosis (BCL2, BAX, CYCS) and DNA damage in the liver of APOE targeted replacement (TR) mice and in Huh7 hepatocytes overexpressing the APOE3 and the APOE4 isoform, respectively. APOE4 mice exhibited a lower chymotrypsin-like and a higher trypsin-like proteasome activity. Levels of protein carbonyls were moderately higher in liver tissue of APOE4 vs. APOE3 mice. Other biomarkers of oxidative stress were similar between the two genotypes. Under basal conditions, the stress-response pathways investigated appeared largely unaffected by the APOE genotype. However, upon stress induction, APOE4 expressing cells showed lower levels of adenosine triphosphate (ATP) and lower mRNA levels of the ATP-generating complex V of the mitochondrial respiratory chain. Overall, our findings provide evidence for a rather low influence of the APOE genotype on the hepatic stress response processes investigated in this study. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Dose, Janina; Piegholdt, Stefanie; Rimbach, Gerald; Huebbe, Patricia] Univ Kiel, Inst Human Nutr & Food Sci, Hermann Rodewald Str 6, D-24118 Kiel, Germany.
   [Nebel, Almut] Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, Schittenhelmstr 12, D-24105 Kiel, Germany.
C3 University of Kiel; University of Kiel; Schleswig Holstein University
   Hospital
RP Huebbe, P (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Hermann Rodewald Str 6, D-24118 Kiel, Germany.
EM dose@foodsci.uni-kiel.de; a.nebel@mucosa.de;
   piegholdt@foodsci.uni-kiel.de; rimbach@foodsci.uni-kiel.de;
   huebbe@foodsci.uni-kiel.de
RI Rimbach, Gerald/A-7178-2011; Nebel, Almut/E-4196-2010
OI Rimbach, Gerald/0000-0001-7888-4684
FU Deutsche Forschungsgemeinschaft [RTG 1743/1]
FX This study was conducted within the scope of the research training
   program "Genes, Environment and Inflammation" (RTG 1743/1), supported by
   the Deutsche Forschungsgemeinschaft.
CR Badía MC, 2013, FREE RADICAL BIO MED, V63, P274, DOI 10.1016/j.freeradbiomed.2013.05.003
   Beaver JP, 1996, CELL DEATH DIFFER, V3, P415
   Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380
   Broer L, 2015, J GERONTOL A-BIOL, V70, P110, DOI 10.1093/gerona/glu166
   Brown CM, 2002, FREE RADICAL BIO MED, V32, P1071, DOI 10.1016/S0891-5849(02)00803-1
   Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739
   Cash JG, 2012, J BIOL CHEM, V287, P27876, DOI 10.1074/jbc.M112.377549
   Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102
   Chen HK, 2012, J BIOL CHEM, V287, P5253, DOI 10.1074/jbc.M111.276162
   Chen HK, 2011, J BIOL CHEM, V286, P5215, DOI 10.1074/jbc.M110.151084
   Chin D, 2014, GENES NUTR, V9, DOI 10.1007/s12263-014-0397-3
   Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   De Feo E, 2012, MOL BIOL REP, V39, P7381, DOI 10.1007/s11033-012-1570-7
   de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167
   DeKroon RM, 2011, J PROTEOME RES, V10, P1632, DOI 10.1021/pr1009788
   Demirag MD, 2007, DIGEST DIS SCI, V52, P3399, DOI 10.1007/s10620-007-9740-5
   DONG LM, 1994, J BIOL CHEM, V269, P22358
   Dong LM, 1996, J BIOL CHEM, V271, P19053, DOI 10.1074/jbc.271.32.19053
   Esatbeyoglu T, 2014, FOOD CHEM TOXICOL, V73, P119, DOI 10.1016/j.fct.2014.08.007
   Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031
   Finch CE, 2010, P NATL ACAD SCI USA, V107, P1718, DOI 10.1073/pnas.0909606106
   Fitzenberger E, 2013, BBA-MOL BASIS DIS, V1832, P565, DOI 10.1016/j.bbadis.2013.01.012
   Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106
   Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245
   Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200
   Gibson GE, 2000, ANN NEUROL, V48, P297, DOI 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z
   Graeser AC, 2011, J MOL MED, V89, P1027, DOI 10.1007/s00109-011-0771-1
   Hagl S, 2015, J ALZHEIMERS DIS, V43, P927, DOI 10.3233/JAD-132084
   HALLMAN DM, 1991, AM J HUM GENET, V49, P338
   Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100
   Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008
   Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005
   Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051
   Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698
   Huebbe P, 2015, MOL NUTR FOOD RES, V59, P334, DOI 10.1002/mnfr.201400636
   James R, 2012, J CEREBR BLOOD F MET, V32, P164, DOI 10.1038/jcbfm.2011.120
   Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322
   Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x
   KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6
   Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1
   Korolainen MA, 2009, ACTA NEUROL SCAND, V119, P32, DOI 10.1111/j.1600-0404.2008.01057.x
   Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253
   Lee Dong-Min, 2002, Taehan Kan Hakhoe Chi, V8, P355
   Liu M, 2012, AM J PHYSIOL-REG I, V303, pR903, DOI 10.1152/ajpregu.00219.2012
   Mahley RW, 2012, J MED CHEM, V55, P8997, DOI 10.1021/jm3008618
   MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935
   Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602
   McKay GJ, 2011, AM J EPIDEMIOL, V173, P1357, DOI 10.1093/aje/kwr015
   McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8
   Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55
   Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m
   Nakamura T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-35
   Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008
   Nguyen D, 2014, BIOCHEMISTRY-US, V53, P4025, DOI 10.1021/bi500340z
   Pickering AM, 2015, J CLIN INVEST, V125, P2059, DOI 10.1172/JCI80514
   Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7
   Piegholdt S, 2014, FREE RADICAL BIO MED, V70, P255, DOI 10.1016/j.freeradbiomed.2014.02.025
   Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107
   Ramaswamy G, 2005, J NEUROSCI, V25, P10658, DOI 10.1523/JNEUROSCI.1922-05.2005
   Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637
   Renaud HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088584
   Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008
   Rocha-Martins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043028
   Sazci A, 2008, DIGEST DIS SCI, V53, P3218, DOI 10.1007/s10620-008-0271-5
   SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29
   Schloesser A, 2015, REJUV RES, V18, P30, DOI 10.1089/rej.2014.1630
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Singh PP, 2006, ANN HUM BIOL, V33, P279, DOI 10.1080/03014460600594513
   Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com
   Srivastava RAK, 1996, BIOCHEM MOL BIOL INT, V38, P91
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08
   Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129
   VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791
   Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607
   WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518
   WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077
   WILLIAMS DL, 1985, J BIOL CHEM, V260, P2444
   Yang MH, 2005, HEPATO-GASTROENTEROL, V52, P1832
   Yang ZH, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-32
   Zhang YM, 2011, FREE RADICAL BIO MED, V51, P2172, DOI 10.1016/j.freeradbiomed.2011.09.005
   Zhong N, 2009, J BIOL CHEM, V284, P27273, DOI 10.1074/jbc.M109.014464
NR 83
TC 6
Z9 8
U1 0
U2 11
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JUL
PY 2016
VL 96
BP 264
EP 272
DI 10.1016/j.freeradbiomed.2016.04.031
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA DO2OO
UT WOS:000377619600024
PM 27130033
DA 2024-02-19
ER

PT J
AU Lee, N
   Ryu, HG
   Kwon, JH
   Kim, DK
   Kim, SR
   Wang, HJ
   Kim, KT
   Choi, KY
AF Lee, Namgyu
   Ryu, Hye Guk
   Kwon, Jung-Hee
   Kim, Dae-Kyum
   Kim, Sae Rom
   Wang, Hee Jung
   Kim, Kyong-Tai
   Choi, Kwan Yong
TI SIRT6 Depletion Suppresses Tumor Growth by Promoting Cellular Senescence
   Induced by DNA Damage in HCC
SO PLOS ONE
LA English
DT Article
ID HISTONE DEACETYLASE SIRT6; HEPATOCELLULAR-CARCINOMA; TELOMERE
   DYSFUNCTION; CANCER-CELLS; REPAIR; EXPRESSION; METABOLISM; RESISTANCE;
   MUTATIONS; APOPTOSIS
AB The role of Sirtuin 6 (SIRT6) as a tumor suppressor or oncogene in liver cancer remains controversial. Thus, we identified the specific role of SIRT6 in the progression of hepatocellular carcinoma (HCC). SIRT6 expression was significantly higher in HCC cell lines and HCC tissues from 138 patients than in an immortalized hepatocyte cell line, THLE-2 and non-tumor tissues, respectively. SIRT6 knockdown by shRNA suppressed the growth of HCC cells and inhibited HCC tumor growth in vivo. In addition, SIRT6 silencing significantly prevented the growth of HCC cell lines by inducing cellular senescence in the p16/Rb- and p53/p21-pathway independent manners. Microarray analysis revealed that the expression of genes involved in nucleosome assembly was apparently altered in SIRT6-depleted Hep3B cells. SIRT6 knockdown promoted G2/M phase arrest and downregulation of genes encoding histone variants associated with nucleosome assembly, which could be attributed to DNA damage. Taken together, our findings suggest that SIRT6 acts as a tumor promoter by preventing DNA damage and cellular senescence, indicating that SIRT6 represents a potential therapeutic target for the treatment of HCC.
C1 [Lee, Namgyu; Ryu, Hye Guk; Kim, Sae Rom; Kim, Kyong-Tai; Choi, Kwan Yong] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Gyeongbuk, South Korea.
   [Kwon, Jung-Hee] Cbs Biosci Inc, Daejeon, South Korea.
   [Kim, Dae-Kyum] Univ Toronto, Donnelly Ctr, Dept Mol Genet, Toronto, ON, Canada.
   [Kim, Dae-Kyum] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.
   [Kim, Dae-Kyum] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.
   [Wang, Hee Jung] Ajou Univ, Sch Med, Dept Surg, Suwon, South Korea.
   [Kim, Kyong-Tai; Choi, Kwan Yong] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea.
   [Lee, Namgyu] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.
C3 Pohang University of Science & Technology (POSTECH); University of
   Toronto; University of Toronto; University of Toronto; Sinai Health
   System Toronto; Lunenfeld Tanenbaum Research Institute; Ajou University;
   Pohang University of Science & Technology (POSTECH); University of
   Massachusetts System; University of Massachusetts Worcester
RP Choi, KY (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Gyeongbuk, South Korea.; Choi, KY (corresponding author), Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea.
EM kchoi@postech.ac.kr
RI Kwon, Jung Shick/JEO-9886-2023
OI KIM, KYONG-TAI/0000-0001-7292-2627; Lee, Namgyu/0000-0002-2980-2758;
   Kim, Dae-Kyum/0000-0003-4568-8278
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MEST) [2014R1A2A2A01002931]; Next Generation BioGreen 21 Program, Rural
   Development Administration, Republic of Korea [PJ011216012016];
   CbsBioscience
FX This study was supported by a grant from the National Research
   Foundation of Korea (NRF) grant funded by the Korea government (MEST)
   (2014R1A2A2A01002931) and the Next Generation BioGreen 21 Program, Rural
   Development Administration, Republic of Korea (PJ011216012016). The
   funders provided support in the form of salaries for authors [NL, KYC],
   but did not have any additional role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. JHK is employees of CbsBioscience, whose company provided
   support in the form of salary for her, but did not have any additional
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Ahn SM, 2014, HEPATOLOGY, V60, P1972, DOI 10.1002/hep.27198
   Bauer I, 2012, J BIOL CHEM, V287, P40924, DOI 10.1074/jbc.M112.405837
   de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cardus A, 2013, CARDIOVASC RES, V97, P571, DOI 10.1093/cvr/cvs352
   Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   DiPaola RS, 2002, CLIN CANCER RES, V8, P3311
   El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061
   Feng XX, 2015, CANCER SCI, V106, P559, DOI 10.1111/cas.12632
   Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016
   Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015
   Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291
   Hengstschläger M, 1999, MUTAT RES-REV MUTAT, V436, P1, DOI 10.1016/S1383-5742(98)00022-2
   Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   Jia GX, 2012, MOL CELL BIOCHEM, V364, P345, DOI 10.1007/s11010-012-1236-8
   Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049
   Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052
   Khongkow M, 2013, CARCINOGENESIS, V34, P1476, DOI 10.1093/carcin/bgt098
   Kugel S, 2015, CELL REP, V13, P479, DOI 10.1016/j.celrep.2015.09.022
   Kwon JH, 2010, CLIN CANCER RES, V16, P5511, DOI 10.1158/1078-0432.CCR-10-0825
   Lee N, 2015, ONCOTARGET, V6, P30130, DOI 10.18632/oncotarget.4967
   Lee N, 2014, PROTEOMICS, V14, P1610, DOI 10.1002/pmic.201400001
   Liu R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470393
   Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x
   Lombard DB, 2009, AGING-US, V1, P12, DOI 10.18632/aging.100014
   Lopez MF, 2012, AGING-US, V4, P823, DOI 10.18632/aging.100507
   Mao ZY, 2012, P NATL ACAD SCI USA, V109, P11800, DOI 10.1073/pnas.1200583109
   Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723
   Marquardt JU, 2013, HEPATOLOGY, V58, P1054, DOI 10.1002/hep.26413
   McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011
   Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590
   Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010
   Nagai K, 2015, OSTEOARTHR CARTILAGE, V23, P1412, DOI 10.1016/j.joca.2015.03.024
   Oberdoerffer P, 2010, NAT CELL BIOL, V12, P1029, DOI 10.1038/ncb1110-1029
   Ran LK, 2016, CLIN CANCER RES, V22, P3372, DOI 10.1158/1078-0432.CCR-15-1638
   Sebastián C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047
   Sociali G, 2015, EUR J MED CHEM, V102, P530, DOI 10.1016/j.ejmech.2015.08.024
   Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341
   Thirumurthi U, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005076
   Wang D, 2014, DNA CELL BIOL, V33, P581, DOI 10.1089/dna.2013.2257
NR 42
TC 35
Z9 40
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 8
PY 2016
VL 11
IS 11
AR e0165835
DI 10.1371/journal.pone.0165835
PG 19
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EB8BE
UT WOS:000387615200036
PM 27824900
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Martin, H
   Uring-Lambert, B
   Adrian, M
   Lahlou, A
   Bonet, A
   Demougeot, C
   Devaux, S
   Laurant, P
   Richert, L
   Berthelot, A
AF Martin, Helene
   Uring-Lambert, Beatrice
   Adrian, Markus
   Lahlou, Abdeslam
   Bonet, Alexandre
   Demougeot, Celine
   Devaux, Sylvie
   Laurant, Pascal
   Richert, Lysiane
   Berthelot, Alain
TI Effects of long-term dietary intake of magnesium on oxidative stress,
   apoptosis and ageing in rat liver
SO MAGNESIUM RESEARCH
LA English
DT Article; Proceedings Paper
CT European Meeting on Magnesium (EuroMag)
CY MAY 15-17, 2008
CL Paris, FRANCE
DE magnesium; long-term; chronic; rat liver; oxidative stress; apoptosis;
   telomere; ageing
ID ENDOTHELIAL-CELLS; CULTURED-HEPATOCYTES; ANTIOXIDANT STATUS; METABOLIC
   SYNDROME; OXIDANT STRESS; BLOOD-PRESSURE; CDNA ARRAY; DEFICIENCY;
   POPULATION; HYPOMAGNESEMIA
AB In the present study, we investigated the effect of long-term dietary Mg intake on the rate of oxidative stress, apoptosis and ageing in rat livers. To address this issue, rats were fed diets containing either a moderately deficient (0.15 g Mg/kg diet), a standard (0.8 g Mg/kg diet) or a high (3.2 g Mg/kg diet) Mg dose for two years. It is noteworthy that a higher percentage of animal mortality was observed in the lowest Mg diet, as compared to the other groups. Oxidative stress and antioxidant status were evaluated by measuring different enzyme activities, among which glutathione peroxidase activity was significantly reduced when Mg content was decreased in the diet. Moreover, we obtained an activation of caspase-3 and a higher lipid peroxidation in the Mg-deficient group, as compared to the Mg standard group, while no changes in Mg-supplemented group were observed, in accordance with our previously published data in primary cultures of rat hepatocytes (Martin et al., J Nutr 2003). Telomere shortening was measured in rat livers, as a marker of ageing. We found that telomere length was decreased in old animals, as compared to young animals confirming that telomere shortening correlated well with ageing events. Moreover, in old animals, we obtained a decrease of telomere length in the Mg-deficient group, as compared to the other groups. Taken together, our results show that a long-term chronic Mg deficiency led to oxidative stress, apoptosis and an acceleration of ageing in rat livers.
C1 [Martin, Helene; Bonet, Alexandre; Richert, Lysiane] UFR Sci Med & Pharmaceut, EA 2SBP, Lab Toxicol Cellulaire, F-25030 Besancon, France.
   [Uring-Lambert, Beatrice; Lahlou, Abdeslam] Hop Univ, Immunol Lab, Strasbourg, France.
   [Adrian, Markus; Demougeot, Celine; Devaux, Sylvie; Laurant, Pascal; Berthelot, Alain] UFR Sci Med & Pharmaceut, EA 2SBP, Physiol Lab, F-25030 Besancon, France.
C3 CHU Strasbourg
RP Martin, H (corresponding author), UFR Sci Med & Pharmaceut, EA 2SBP, Lab Toxicol Cellulaire, Pl St Jacques, F-25030 Besancon, France.
EM helene.martin@univ-fcomte.fr
OI Demougeot, Celine/0000-0003-0639-9756; DEVAUX,
   Sylvie/0000-0003-4206-7580; MARTIN, helene/0000-0001-8318-3858; Bonet,
   Alexandre/0000-0003-2226-793X
CR Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007
   Belin RJ, 2007, MAGNESIUM RES, V20, P107
   Binda D, 2001, MOL CELL BIOCHEM, V218, P139, DOI 10.1023/A:1007268825721
   Blache D, 2006, FREE RADICAL BIO MED, V41, P277, DOI 10.1016/j.freeradbiomed.2006.04.008
   Bussiere FI, 2002, MAGNESIUM RES, V15, P37
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   DiPietrantonio AM, 1999, BIOCHEM BIOPH RES CO, V255, P477, DOI 10.1006/bbrc.1999.0208
   Durlach J, 1998, MAGNESIUM RES, V11, P25
   Ferrè S, 2007, MAGNESIUM RES, V20, P66
   Galan P, 1997, MAGNESIUM RES, V10, P321
   Gündüz F, 2004, PHYSIOL RES, V53, P171, DOI 10.33549/physiolres.930384
   GUNTHER T, 1995, MOL CELL BIOCHEM, V144, P141, DOI 10.1007/BF00944393
   Hultdin M, 1998, NUCLEIC ACIDS RES, V26, P3651, DOI 10.1093/nar/26.16.3651
   Ji LL, 1998, ANN NY ACAD SCI, V854, P102, DOI 10.1111/j.1749-6632.1998.tb09896.x
   Karbowski M, 1999, FREE RADICAL BIO MED, V26, P396, DOI 10.1016/S0891-5849(98)00209-3
   Killilea DW, 2008, P NATL ACAD SCI USA, V105, P5768, DOI 10.1073/pnas.0712401105
   King DE, 2007, MAGNESIUM RES, V20, P32
   Kuzniar A, 2003, BIOMETALS, V16, P349, DOI 10.1023/A:1020632505289
   Larsson I, 1979, Dev Biol Stand, V42, P193
   MARK IT, 1994, AM J PHYSIOL, V267, pC1366
   Martin H, 2003, J NUTR, V133, P2505, DOI 10.1093/jn/133.8.2505
   Martin H, 2007, MAGNESIUM RES, V20, P259
   Martin H, 2006, J AM COLL NUTR, V25, P363, DOI 10.1080/07315724.2006.10719547
   Mazur A, 2007, ARCH BIOCHEM BIOPHYS, V458, P48, DOI 10.1016/j.abb.2006.03.031
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1
   Nicod L, 2000, MOL CELL BIOCHEM, V213, P65, DOI 10.1023/A:1007112130769
   Petrault I, 2002, BBA-MOL BASIS DIS, V1586, P92, DOI 10.1016/S0925-4439(01)00089-8
   Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155
   RAYSSIGUIER Y, 1993, J AM COLL NUTR, V12, P133
   Rayssiguier Y, 2006, MAGNESIUM RES, V19, P237
   Rimbach G, 1999, FOOD CHEM TOXICOL, V37, P37, DOI 10.1016/S0278-6915(98)00103-3
   Roos G, 2001, CYTOMETRY, V45, P79, DOI 10.1002/1097-0320(20010901)45:1<79::AID-CYTO1147>3.0.CO;2-Q
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Schimatschek HF, 2001, MAGNESIUM RES, V14, P283
   Singh RB, 1996, MAGNESIUM RES, V9, P299
   Tejero-Taldo MI, 2007, MAGNESIUM RES, V20, P208
   Weglicki WB, 1996, CARDIOVASC RES, V31, P677, DOI 10.1016/0008-6363(95)00196-4
   Zhou Q, 1999, MAGNESIUM RES, V12, P19
   ZHU ZJ, 1993, BIOL TRACE ELEM RES, V37, P209, DOI 10.1007/BF02783796
NR 40
TC 40
Z9 44
U1 0
U2 4
PU JOHN LIBBEY EUROTEXT LTD
PI MONTROUGE
PA 127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE
SN 0953-1424
J9 MAGNESIUM RES
JI Magnes. Res.
PD JUN
PY 2008
VL 21
IS 2
BP 124
EP 130
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 326NH
UT WOS:000257665700008
PM 18705541
DA 2024-02-19
ER

PT J
AU Peixoto, AS
   Moreno, MF
   Castro, E
   Perandini, LA
   Belchior, T
   Oliveira, TE
   Vieira, TS
   Gilio, GR
   Tomazelli, CA
   Leonardi, BF
   Ortiz-Silva, M
   Silva, L Jr
   Moretti, EH
   Steiner, AA
   Festuccia, WT
AF Peixoto, Albert S.
   Moreno, Mayara F.
   Castro, Erique
   Perandini, Luiz A.
   Belchior, Thiago
   Oliveira, Tiago E.
   Vieira, Thayna S.
   Gilio, Gustavo R.
   Tomazelli, Caroline A.
   Leonardi, Bianca F.
   Ortiz-Silva, Milene
   Silva Junior, Luciano P.
   Moretti, Eduardo H.
   Steiner, Alexandre A.
   Festuccia, William T.
TI Hepatocellular carcinoma induced by hepatocyte Pten deletion reduces BAT
   UCP-1 and thermogenic capacity in mice, despite increasing serum FGF-21
   and iWAT browning
SO JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article; Early Access
DE Nonalcoholic fatty liver disease; Energy expenditure; UCP-1; Thermogenic
   capacity; Brown adipose tissue; White adipose tissue browning
ID GROWTH-FACTOR 21; TUMOR-SUPPRESSOR GENE; FATTY LIVER-DISEASE;
   ADIPOSE-TISSUE; ENERGY-EXPENDITURE; INSULIN SENSITIVITY; VISCERAL
   ADIPOSITY; HEPATIC STEATOSIS; PPAR-ALPHA; FGF21
AB Hepatocellular carcinoma (HCC) markedly enhances liver secretion of fibroblast growth factor 21 (FGF-21), a hepatokine that increases brown and subcutaneous inguinal white adipose tissues (BAT and iWAT, respectively) uncoupling protein 1 (UCP-1) content, thermogenesis and energy expenditure. Herein, we tested the hypothesis that an enhanced BAT and iWAT UCP-1-mediated thermogenesis induced by high levels of FGF-21 is involved in HCC-associated catabolic state and fat mass reduction. For this, we evaluated body weight and composition, liver mass and morphology, serum and tissue levels of FGF-21, BAT and iWAT UCP-1 content, and thermogenic capacity in mice with Pten deletion in hepatocytes that display a well-defined progression from steatosis to steatohepatitis (NASH) and HCC upon aging. Hepatocyte Pten deficiency promoted a progressive increase in liver lipid deposition, mass, and inflammation, culminating with NASH at 24 weeks and hepatomegaly and HCC at 48 weeks of age. NASH and HCC were associated with elevated liver and serum FGF-21 content and iWAT UCP-1 expression (browning), but reduced serum insulin, leptin, and adiponectin levels and BAT UCP-1 content and expression of sympathetically regulated gene glycerol kinase (GyK), lipoprotein lipase (LPL), and fatty acid transporter protein 1 (FATP-1), which altogether resulted in an impaired whole-body thermogenic capacity in response to CL-316,243. In conclusion, FGF-21 pro-thermogenic actions in BAT are context-dependent, not occurring in NASH and HCC, and UCP-1-mediated thermogenesis is not a major energy-expending process involved in the catabolic state associated with HCC induced by Pten deletion in hepatocytes.
C1 [Peixoto, Albert S.; Moreno, Mayara F.; Castro, Erique; Perandini, Luiz A.; Belchior, Thiago; Oliveira, Tiago E.; Vieira, Thayna S.; Gilio, Gustavo R.; Tomazelli, Caroline A.; Leonardi, Bianca F.; Ortiz-Silva, Milene; Silva Junior, Luciano P.; Festuccia, William T.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Ave Prof Lineu Prestes, 1524, BR-05508000 Sao Paulo, Brazil.
   [Moretti, Eduardo H.; Steiner, Alexandre A.] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, SP, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo
RP Festuccia, WT (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Ave Prof Lineu Prestes, 1524, BR-05508000 Sao Paulo, Brazil.
EM william.festuccia@usp.br
RI da Silva, Tiago Eugênio Oliveira/HZI-2882-2023; Festuccia,
   William/C-7618-2012; Gilio, Gustavo Renan/E-5897-2019; Souza Peixoto,
   Albert/E-4532-2018; Moreno, Mayara Franzoi/N-4433-2017; Perandini,
   Luiz/B-8818-2012
OI da Silva, Tiago Eugênio Oliveira/0000-0002-2801-4637; Festuccia,
   William/0000-0003-4769-0806; Gilio, Gustavo Renan/0000-0002-9850-6389;
   Souza Peixoto, Albert/0000-0002-7234-7252; Franco Leonardi,
   Bianca/0000-0002-9777-9975; Moreno, Mayara Franzoi/0000-0001-9078-2795;
   Perandini, Luiz/0000-0001-8767-251X; dos Santos Vieira,
   Thayna/0000-0001-8357-8251
FU Sao Paulo Research Foundation (FAPESP) [15/19530-5, 19/01763-4,
   20/04159-8, 2022/02123-1, 2017/17582-3, 2020/166566, 2019/17660-0,
   2015/22983-1, 2019/04271-5, 2020/10215-8, 2021/14419-0, 2017/12260-8,
   2020/09399-7, 301756/2019-8, 303784/2022-9]; Brazilian National Council
   for Scientific and Technological Development (CNPq) [2018/03418-0,
   2017/23040-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES)
FX & nbsp;This work was supported by grants from the Sao Paulo Research
   Foundation (FAPESP #15/19530-5, 19/01763-4, and 20/04159-8) and the
   Brazilian National Council for Scientific and Technological Development
   (CNPq #301756/2019-8 and #303784/2022-9) to W.F. and FAPESP to A.A.S.
   (#2018/03418-0). A.S.P. (#2017/23040-9 and 2022/02123-1), M.F.M.
   (#2017/17582-3), E.C. (#2020/166566), L.A.P. (#2019/17660-0), T.B.
   (#2015/22983-1), T.E.O. (#2019/04271-5), T.S.V. (#2020/10215-8), B.F.L.
   (#2021/14419-0), M. O-S. (#2017/12260-8), and E.H.M (#2020/09399-7) were
   recipients of a Ph.D. studentship from FAPESP. G.R.G. and C.A.T. were
   recipients of Ph.D. fellowship from CNPq and & nbsp;Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), respectively.
CR Albhaisi S, 2019, JHEP REP, V1, P329, DOI 10.1016/j.jhepr.2019.08.002
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Bae JJ, 2007, ONCOL REP, V18, P1007
   Becker AS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239990
   Berthou F, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23073959
   Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003
   Castro É, 2021, AM J PHYSIOL-ENDOC M, V321, pE592, DOI 10.1152/ajpendo.00587.2020
   Castro E, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2017-0042
   Chimin P, 2017, J LIPID RES, V58, P1797, DOI 10.1194/jlr.M074518
   Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943
   Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816
   de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015
   Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054
   Eljalby M, 2023, AM J PHYSIOL-ENDOC M, V324, pE144, DOI 10.1152/ajpendo.00187.2022
   Festuccia WTL, 2003, AM J PHYSIOL-REG I, V284, pR1536, DOI 10.1152/ajpregu.00764.2002
   Fisher FM, 2017, MOL METAB, V6, P14, DOI 10.1016/j.molmet.2016.11.008
   Govaere O, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba4448
   Han J, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0657-0
   Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019
   Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513
   Hotta Y, 2009, ENDOCRINOLOGY, V150, P4625, DOI 10.1210/en.2009-0119
   Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Jensen-Cody SO, 2021, MOL METAB, V44, DOI 10.1016/j.molmet.2020.101138
   Kaiyala KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103301
   Kaiyala KJ, 2010, DIABETES, V59, P1657, DOI 10.2337/db09-1582
   Kawashita NH, 2002, AM J PHYSIOL-REG I, V282, pR1185, DOI 10.1152/ajpregu.00419.2001
   Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528
   Labbé SM, 2018, AM J PHYSIOL-ENDOC M, V315, pE815, DOI 10.1152/ajpendo.00210.2018
   Labbé SM, 2016, AM J PHYSIOL-ENDOC M, V311, pE260, DOI 10.1152/ajpendo.00545.2015
   Liang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085686
   Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005
   Magdalon J, 2016, BBA-MOL CELL BIOL L, V1861, P430, DOI 10.1016/j.bbalip.2016.02.023
   Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266
   McCullough AJ, 1999, AM J CLIN NUTR, V69, P1066
   Mouchiroud M, 2019, MOL METAB, V30, P184, DOI 10.1016/j.molmet.2019.09.014
   Mouchiroud M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129492
   Müller MJ, 1999, AM J CLIN NUTR, V69, P1194
   Oliveira TE, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800813
   Oost LJ, 2019, J CACHEXIA SARCOPENI, V10, P630, DOI 10.1002/jcsm.12409
   Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001
   Rahmouni K, 2004, J CLIN INVEST, V114, P652, DOI 10.1172/JCI200421737
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   de Urturi DS, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28749-z
   Sanders FWB, 2016, BIOL REV, V91, P452, DOI 10.1111/brv.12178
   Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252
   Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044
   She QY, 2022, METABOLISM, V130, DOI 10.1016/j.metabol.2022.155166
   SHELLOCK FG, 1986, J CANCER RES CLIN, V111, P82, DOI 10.1007/BF00402783
   Steiner AA, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13100
   Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100
   Sullivan AI, 2022, MOL METAB, V64, DOI 10.1016/j.molmet.2022.101564
   Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010
   Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846
   Wang QY, 2019, NAT METAB, V1, P251, DOI 10.1038/s42255-018-0020-9
   Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392
   Yang CF, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-67
   Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x
   Zouhar P, 2021, MOL METAB, V53, DOI 10.1016/j.molmet.2021.101324
NR 59
TC 0
Z9 0
U1 1
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1138-7548
EI 1877-8755
J9 J PHYSIOL BIOCHEM
JI J. Physiol. Biochem.
PD 2023 NOV
PY 2023
VL 79
IS 4
BP 731
EP 743
DI 10.1007/s13105-023-00970-4
EA JUL 2023
PG 13
WC Biochemistry & Molecular Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Physiology
GA X9XV2
UT WOS:001022573100001
PM 37405670
DA 2024-02-19
ER

PT J
AU Lechel, A
   Satyanarayana, A
   Ju, ZY
   Plentz, RR
   Schaetzlein, S
   Rudolph, C
   Wilkens, L
   Wiemann, SU
   Saretzki, G
   Malek, NP
   Manns, MP
   Buer, J
   Rudolph, KL
AF Lechel, A
   Satyanarayana, A
   Ju, ZY
   Plentz, RR
   Schaetzlein, S
   Rudolph, C
   Wilkens, L
   Wiemann, SU
   Saretzki, G
   Malek, NP
   Manns, MP
   Buer, J
   Rudolph, KL
TI The cellular level of telomere dysfunction determines induction of
   senescence or apoptosis <i>in vivo</i>
SO EMBO REPORTS
LA English
DT Article
DE telomere; TRF2; Terc; p53; senescence
ID REGENERATION; BIOMARKER; P53
AB Telomere dysfunction induces two types of cellular response: cellular senescence and apoptosis. We analysed the extent to which the cellular level of telomere dysfunction and p53 gene status affect these cellular responses in mouse liver using the experimental system of TRF2 inhibition by a dominant-negative version of the protein (TRF2(DeltaBDeltaM)). We show that the level of telomere dysfunction correlates with the level of TRF2(DeltaBDeltaM) protein expression resulting in chromosomal fusions, aberrant mitotic figures and aneuploidy of liver cells. These alterations provoked p53-independent apoptosis, but a strictly p53-dependent senescence response in distinct populations of mouse liver cells depending on the cellular level of TRF2(DeltaBDeltaM) expression. Apoptosis was associated with higher expression of TRF2(DeltaBDeltaM), whereas cellular senescence was associated with low levels of TRF2(DeltaBDeltaM) expression. Our data provide experimental evidence that induction of senescence or apoptosis in vivo depends on the cellular level of telomere dysfunction and differentially on p53 gene function.
C1 Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.
   Hannover Med Sch, Inst Cell & Mol Pathol, D-30625 Hannover, Germany.
   Hannover Med Sch, Inst Med Microbiol, D-30625 Hannover, Germany.
   Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.
   Gesell Biotechnol Forsch mbH, Dept Cell Biol, D-3300 Braunschweig, Germany.
C3 Hannover Medical School; Hannover Medical School; Hannover Medical
   School; Newcastle University - UK; Gesellschaft fur Biotechnologische
   Forschung mbH
RP Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM rudolph.lenhard@mh-hannover.de
RI Lechel, André/AAQ-2041-2021; Saretzki, Gabriele Christine/I-7175-2019
OI Lechel, André/0000-0003-0221-6959; Saretzki, Gabriele
   Christine/0000-0003-2100-8223; Buer, Jan/0000-0002-7602-1698; Rudolph,
   Karl Lenhard/0000-0002-4839-2862
CR Blackburn EH, 2000, COLD SPRING HARB SYM, V65, P253, DOI 10.1101/sqb.2000.65.253
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   Cimino-Reale G, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e35
   de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Djojosubroto MW, 2003, MOL CELLS, V15, P164
   Gorbunova V, 2003, J BIOL CHEM, V278, P7692, DOI 10.1074/jbc.M212944200
   Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321
   Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523
   Keys B, 2004, AGING CELL, V3, P103, DOI 10.1111/j.1474-9728.2004.00094.x
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Martin-Ruiz C, 2004, J BIOL CHEM, V279, P17826, DOI 10.1074/jbc.M311980200
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Satyanarayana A, 2004, HEPATOLOGY, V40, P276, DOI 10.1002/hep.20308
   Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   SHAY JW, 1991, EXP CELL RES, V96, P1
   Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433
   van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0
NR 23
TC 69
Z9 93
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD MAR
PY 2005
VL 6
IS 3
BP 275
EP 281
DI 10.1038/sj.embor.7400352
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 901QM
UT WOS:000227297000018
PM 15723042
OA Green Published
DA 2024-02-19
ER

PT J
AU Heck, SO
   Fulco, BCW
   Quines, CB
   Oliveira, CES
   Leite, MR
   Cechella, JL
   Nogueira, CW
AF Heck, Suelen O.
   Fulco, Bruna C. W.
   Quines, Caroline B.
   Oliveira, Carla E. S.
   Leite, Marlon R.
   Cechella, Jose L.
   Nogueira, Cristina W.
TI Combined Therapy With Swimming Exercise and a Diet Supplemented With
   Diphenyl Diselenide Is Effective Against Age-Related Changes in the
   Hepatic Metabolism of Rats
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE AGING; LIVER METABOLISM; DIPHENYL DISELENIDE; ORGANOSELENIUM; SWIMMING
   EXERCISE
ID PHYSICAL-EXERCISE; OXIDATIVE STRESS; GLUCOSE-METABOLISM; ADIPOSE-TISSUE;
   LIVER-DISEASE; SERUM-LEVELS; STEM-CELL; SYSTEM; ASSAY; FAT
AB Aging is characterized by a widespread loss of homeostasis in biological systems and is accompanied by pathophysiological changes including the liver injury. The aim of the present study was to investigate the effects of the combined therapy with swimming exercise (20min session, 5 days/week during 4 weeks) and a diet supplemented with 1ppm of (PhSe)(2) on the hepatic metabolic alterations caused by aging in rats. In this study, male old Wistar rats had an increase in the epididymal fat relative weight, disturbances in the activities of hepatic enzymes associated to the glucose homeostasis, higher hepatic triglyceride content and higher activity of the plasma alanine aminotransferase (ALT), and aspartate aminotransferase (AST). The combined therapy normalized the activities of glucose-6-Pase and tyrosine aminotransferase, gluconeogenic enzymes, increased the hepatic glycogen content and was effective against the increase in the hepatic triglycerides content, without altering the activities of hexoquinase, and citrate synthase. Moreover, the combined therapy normalized the activities of AST and ALT, indicating a hepatoprotective effect. The combined therapy with swimming exercise and a diet supplemented with 1ppm of (PhSe)(2) contributed to the hepatic glucose homeostasis in old rats. Nevertheless, more studies are needed to investigate the possible mechanisms of action behind these effects. (c) 2016 Wiley Periodicals, Inc.
C1 [Heck, Suelen O.; Fulco, Bruna C. W.; Quines, Caroline B.; Oliveira, Carla E. S.; Leite, Marlon R.; Cechella, Jose L.; Nogueira, Cristina W.] Univ Fed Santa Maria, Lab Sintese Reatividade & Avaliacao Farmacol & To, Ctr Ciencias Nat & Exatas, BR-97105900 Santa Maria, RS, Brazil.
C3 Universidade Federal de Santa Maria (UFSM)
RP Nogueira, CW (corresponding author), Univ Fed Santa Maria, Lab Sintese Reatividade & Avaliacao Farmacol & To, Ctr Ciencias Nat & Exatas, Dept Bioquim & Biol Mol, BR-97105900 Santa Maria, RS, Brazil.
EM criswn@ufsm.br
RI DA CRUZ WEBER FULCO, BRUNA/GZM-9370-2022; Nogueira, Cristina
   W/H-1581-2012; Da Cruz Weber Fulco, Bruna/AAE-8376-2022
OI Nogueira, Cristina W/0000-0003-2950-3632; Da Cruz Weber Fulco,
   Bruna/0000-0002-7079-6214
FU UFSM; FAPERGS [2239-2551/14]; CNPq [441405/2014-2]
FX Grant sponsor: UFSM; Grant sponsor: FAPERGS; Grant number: 2239-2551/14;
   Grant sponsor: CNPq; Grant number: 441405/2014-2.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Akasaki Y, 2014, AGING CELL, V13, P80, DOI 10.1111/acel.12153
   Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005
   Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brady CW, 2015, WORLD J GASTROENTERO, V21, P7613, DOI 10.3748/wjg.v21.i25.7613
   BRANDSTRUP N, 1957, J GERONTOL, V12, P166, DOI 10.1093/geronj/12.2.166
   Carvalho NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081961
   Castro MD, 2012, EXP GERONTOL, V47, P29, DOI 10.1016/j.exger.2011.10.002
   Cechella JL, 2014, AGE, V36, DOI 10.1007/s11357-014-9666-8
   Conn VS, 2014, J PRIM CARE COMMUNIT, V5, P211, DOI 10.1177/2150131913520328
   de Bem AF, 2009, BASIC CLIN PHARMACOL, V105, P17, DOI 10.1111/j.1742-7843.2009.00414.x
   DIAMONDSTONE TI, 1966, ANAL BIOCHEM, V16, P395, DOI 10.1016/0003-2697(66)90220-X
   DOBROSIELSKIVERGONA K, 1982, ENDOCRINOLOGY, V111, P953, DOI 10.1210/endo-111-3-953
   Dunderski JS, 2003, ARCH BIOL SCI BELGRA, V55, P3
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406
   Harman D, 2001, ANN NY ACAD SCI, V928, P1, DOI 10.1111/j.1749-6632.2001.tb05631.x
   Johnson NA, 2012, SEMIN LIVER DIS, V32, P65, DOI 10.1055/s-0032-1306427
   Kiran TR, 2004, COMP BIOCHEM PHYS B, V137, P187, DOI 10.1016/j.cbpc.2003.11.002
   KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3
   Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516
   Leite MR, 2015, CYTOKINE, V71, P119, DOI 10.1016/j.cyto.2014.09.006
   Leite MR, 2014, EXP GERONTOL, V53, P67, DOI 10.1016/j.exger.2014.03.008
   Meng R, 2011, ANN CLIN LAB SCI, V41, P236
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Dias GRM, 2014, PHYSIOL BEHAV, V124, P116, DOI 10.1016/j.physbeh.2013.10.036
   Murphy T, 2015, AGEING RES REV, V19, P53, DOI 10.1016/j.arr.2014.11.004
   Nam SM, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0116-4
   Niu YC, 2013, AGING CELL, V12, P1041, DOI 10.1111/acel.12133
   Nogueiras R, 2009, J NEUROSCI, V29, P5916, DOI 10.1523/JNEUROSCI.5977-08.2009
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ordoñez R, 2015, CURR MOL MED, V15, P3, DOI 10.2174/1566524015666150114110551
   Paulmier C., 1986, Selenium Reagents and Intermediates in Organic Synthesis, V1st ed., P25, DOI DOI 10.1002/ange.19881000236
   Porteiro B, 2013, ENDOCRINOLOGY, V154, P3671, DOI 10.1210/en.2013-1176
   Quines CB, 2016, AMINO ACIDS, V48, P137, DOI 10.1007/s00726-015-2073-3
   Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540
   Reijne AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149419
   RICKETTS TR, 1963, CLIN CHIM ACTA, V8, P160, DOI 10.1016/0009-8981(63)90218-3
   Rincon M, 2005, EXP GERONTOL, V40, P873, DOI 10.1016/j.exger.2005.06.014
   Rocha JBT, 2012, TOXICOL RES-UK, V1, P85, DOI 10.1039/c2tx20014g
   Roden M, 2003, BEST PRACT RES CL EN, V17, P365, DOI 10.1016/S1521-690X(03)00031-9
   Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g
   SASSA S, 1982, ENZYME, V28, P133, DOI 10.1159/000459097
   Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310
   Shephard RJ, 2015, EUR J APPL PHYSIOL, V115, P1, DOI 10.1007/s00421-014-3031-6
   SRERE PA, 1963, FED PROC, V22, P240
   Stanford KI, 2015, DIABETES, V64, P2361, DOI 10.2337/db15-0227
   Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308
   Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528
   Vatner SF, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/250310
   Vina J, 2012, BRIT J PHARMACOL, V167, P1, DOI 10.1111/j.1476-5381.2012.01970.x
   Vincent HK, 2012, AGEING RES REV, V11, P361, DOI 10.1016/j.arr.2012.03.002
   Wendel A, 1981, Methods Enzymol, V77, P325
   Zampieri S, 2015, EUR J TRANSL MYOL, V25, P237, DOI 10.4081/ejtm.2015.5374
NR 56
TC 8
Z9 8
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD JUN
PY 2017
VL 118
IS 6
BP 1574
EP 1582
DI 10.1002/jcb.25819
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA ER1EM
UT WOS:000398532500029
PM 27918086
DA 2024-02-19
ER

PT J
AU Hiramoto, K
   Goto, K
   Tanaka, S
   Horikawa, T
   Ooi, K
AF Hiramoto, Keiichi
   Goto, Kenji
   Tanaka, Shota
   Horikawa, Tsuneki
   Ooi, Kazuya
TI Skin, Liver, and Kidney Interactions Contribute to Skin Dryness in Aging
   KK-Ay/Tajcl Mice
SO BIOMEDICINES
LA English
DT Article
DE type 2 diabetes; collagen; mast cell; tumor necrosis factor-alpha;
   interleukin-6; reactive oxygen species
ID BARRIER FUNCTION; TYPE-2; PRURITUS; OBESITY; CELLS; MODEL; AGE
AB Type 2 diabetes is a lifestyle-related disease that affects people worldwide and is especially prevalent in the elderly. Many elderly people with diabetes also complain of dry skin; however, the relationship between aging and dry skin in type 2 diabetes is unknown. The purpose of this study was to examine the interaction between aging and dry skin using the specific pathogen-free KK-Ay/TaJcl type 2 diabetes mouse model. Skin dryness in this model increases with age and was evaluated at 10, 27, 40, and 50 weeks. We observed increased mast cell expression, increased histamine and matrix metalloproteinase-1 levels, and decreased collagen expression in the skin of aging KK-Ay/TaJcl mice. In addition, the increased expression of angiopoietin 2, interleukin-6, tumor necrosis factor-alpha, and endostatin in the blood indicated kidney damage in this model. Aging KK-Ay/TaJcl mice also showed fatty liver pathology, which led to increased reactive oxygen species in the blood and liver, as well as the increased expression of M1 macrophages in the liver. These results showed that dry skin is associated with skin, kidney, and liver interactions in an aging type 2 diabetes mouse model.
C1 [Hiramoto, Keiichi; Tanaka, Shota; Horikawa, Tsuneki; Ooi, Kazuya] Suzuka Univ Med Sci, Dept Pharmaceut Sci, Suzuka 5138670, Japan.
   [Goto, Kenji] Nichinichi Pharmaceut Co Ltd, Res Labs, Iga 5181417, Japan.
RP Ooi, K (corresponding author), Suzuka Univ Med Sci, Dept Pharmaceut Sci, Suzuka 5138670, Japan.
EM zooi@suzuka-u.ac.jp
FU JSPS KAKENHI Grant [18K11085]
FX This study was supported by the JSPS KAKENHI Grant (Number 18K11085).
CR BAREL AO, 1995, SKIN PHARMACOL, V8, P186
   Barnett KN, 2006, AGE AGEING, V35, P463, DOI 10.1093/ageing/afl019
   Bekeredjian R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011693
   Donate-Correa J, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/948417
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   Duque MI, 2006, CLIN NEPHROL, V66, P184
   FURUTA T, 1993, AM J KIDNEY DIS, V21, P480, DOI 10.1016/S0272-6386(12)80393-3
   Goto K, 2019, BIOL PHARM BULL, V42, P468, DOI 10.1248/bpb.b18-00803
   Hofmann B, 2013, EXP GERONTOL, V48, P38, DOI 10.1016/j.exger.2012.04.011
   Horikawa T, 2021, INT J MED SCI, V18, P474, DOI 10.7150/ijms.50764
   Horio F., 2018, Journal of Japanese Society of Nutrition and Food Science, V71, P267, DOI 10.4327/jsnfs.71.267
   Jabbour SA, 2003, AM J CLIN DERMATOL, V4, P315, DOI 10.2165/00128071-200304050-00003
   Janghorbani M, 2014, ACTA DIABETOL, V51, P519, DOI 10.1007/s00592-014-0579-x
   Karkucinska-Wieckowska A, 2022, EUR J CLIN INVEST, V52, DOI 10.1111/eci.13622
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Murota H, 2016, CURR PROBL DERMATOL, V51, P57, DOI 10.1159/000446760
   Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019
   Nakae S, 2013, ALLERGOL INT, V62, P13, DOI 10.2332/allergolint.13-RAI-0538
   Nanayakkara N, 2021, DIABETOLOGIA, V64, P275, DOI 10.1007/s00125-020-05319-w
   NEILLY JB, 1986, DIABETES CARE, V9, P273, DOI 10.2337/diacare.9.3.273
   Tsai YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173906
   Tsai YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep39400
   Ueki K, 2011, NAT MED, V17, P246, DOI 10.1038/nm0311-246
   Wahid Z, 1998, J Pak Med Assoc, V48, P304
   Wang C, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.803037
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Williams KH, 2013, ENDOCR REV, V34, P84, DOI 10.1210/er.2012-1009
   Xu LY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.708978
   Yokoyama S, 2015, BIOL PHARM BULL, V38, P947, DOI 10.1248/bpb.b15-00208
NR 29
TC 4
Z9 4
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD OCT
PY 2022
VL 10
IS 10
AR 2648
DI 10.3390/biomedicines10102648
PG 14
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA 5R1HO
UT WOS:000874269300001
PM 36289909
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ferreira-Gonzalez, S
   Man, TY
   Esser, H
   Aird, R
   Kilpatrick, AM
   Rodrigo-Torres, D
   Younger, N
   Campana, L
   Gadd, VL
   Dwyer, B
   Aleksieva, N
   Boulter, L
   Macmillan, MT
   Wang, YM
   Mylonas, KJ
   Ferenbach, DA
   Kendall, TJ
   Lu, WY
   Acosta, JC
   Kurian, D
   O'Neill, S
   Oniscu, GC
   Banales, JM
   Krimpenfort, PJ
   Forbes, SJ
AF Ferreira-Gonzalez, Sofia
   Man, Tak Yung
   Esser, Hannah
   Aird, Rhona
   Kilpatrick, Alastair M.
   Rodrigo-Torres, Daniel
   Younger, Nicholas
   Campana, Lara
   Gadd, Victoria L.
   Dwyer, Benjamin
   Aleksieva, Niya
   Boulter, Luke
   Macmillan, Mark T.
   Wang, Yinmiao
   Mylonas, Katie J.
   Ferenbach, David A.
   Kendall, Timothy J.
   Lu, Wei-Yu
   Acosta, Juan Carlos
   Kurian, Dominic
   O'Neill, Stephen
   Oniscu, Gabriel C.
   Banales, Jesus M.
   Krimpenfort, Paul J.
   Forbes, Stuart J.
TI Senolytic treatment preserves biliary regenerative capacity lost through
   cellular senescence during cold storage
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID MIGRATION INHIBITORY FACTOR; MESENCHYMAL STEM-CELLS; NF-KAPPA-B;
   LIVER-TRANSPLANTATION; INDUCED APOPTOSIS; OXIDATIVE STRESS; CARDIAC
   DEATH; RISK-FACTORS; BILE-DUCTS; CHOLANGIOCYTES
AB Liver transplantation is the only curative option for patients with end-stage liver disease. Despite improvements in surgical techniques, nonanastomotic strictures (characterized by the progressive loss of biliary tract architecture) continue to occur after liver transplantation, negatively affecting liver function and frequently leading to graft loss and retransplantation. To study the biological effects of organ preservation before liver transplantation, we generated murine models that recapitulate liver procurement and static cold storage. In these models, we explored the response of cholangiocytes and hepatocytes to cold storage, focusing on responses that affect liver regeneration, including DNA damage, apoptosis, and cellular senescence. We show that biliary senescence was induced during organ retrieval and exacerbated during static cold storage, resulting in impaired biliary regeneration. We identified decoy receptor 2 (DCR2)-dependent responses in cholangiocytes and hepatocytes, which differentially affected the outcome of those populations during cold storage. Moreover, CRISPR-mediated DCR2 knockdown in vitro increased cholangiocyte proliferation and decreased cellular senescence but had the opposite effect in hepatocytes. Using the p21KO model to inhibit senescence onset, we showed that biliary tract architecture was better preserved during cold storage. Similar results were achieved by administering senolytic ABT737 to mice before procurement. Last, we perfused senolytics into discarded human donor livers and showed that biliary architecture and regenerative capacities were better preserved. Our results indicate that cholangiocytes are susceptible to senescence and identify the use of senolytics and the combination of senotherapies and machine-perfusion preservation to prevent this phenotype and reduce the incidence of biliary injury after transplantation.
C1 [Ferreira-Gonzalez, Sofia; Man, Tak Yung; Esser, Hannah; Aird, Rhona; Kilpatrick, Alastair M.; Rodrigo-Torres, Daniel; Campana, Lara; Gadd, Victoria L.; Dwyer, Benjamin; Aleksieva, Niya; Macmillan, Mark T.; Wang, Yinmiao; Banales, Jesus M.; Forbes, Stuart J.] Univ Edinburgh, MRC Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Scotland.
   [Esser, Hannah] Innsbruck Med Univ, Ctr Operat Med, Dept Visceral Transplant & Thorac Surg, Anichstr 35, A-6020 Innsbruck, Austria.
   [Younger, Nicholas; Boulter, Luke] Univ Edinburgh, Inst Genet & Canc, MRC Human Genet Unit, Edinburgh EH4 2XU, Scotland.
   [Mylonas, Katie J.; Ferenbach, David A.; Kendall, Timothy J.; Lu, Wei-Yu] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res CIR, 47 Little France Crescent, Edinburgh EH16 4TJ, Scotland.
   [Acosta, Juan Carlos] Univ Edinburgh, MRC Inst Genet & Canc, Canc Res UK Edinburgh Ctr, Crewe Rd, Edinburgh EH4 2XR, Scotland.
   [Acosta, Juan Carlos] Univ Cantabria, Inst Biomed & Biotecnol Cantabria IBBTEC, CSIC, SODERCAN, C Albert Einstein 22, Santander 39011, Spain.
   [Kurian, Dominic] Univ Edinburgh, Roslin Inst, Prote & Metabol Unit, Easter Bush Campus, Midlothian EH25 9RG, Scotland.
   [O'Neill, Stephen] Belfast City Hosp, Dept Transplant Surg, 51 Lisburn Rd, Belfast BT9 7AB, North Ireland.
   [O'Neill, Stephen] Queens Univ Belfast, Royal Victoria Hosp, Inst Clin Sci, Ctr Publ Hlth, Belfast BT12 6BA, North Ireland.
   [Oniscu, Gabriel C.] Royal Infirm Edinburgh NHS Trust, Edinburgh Transplant Ctr, 51 Little France Crescent, Edinburgh EH16 4SA, Scotland.
   [Oniscu, Gabriel C.] Univ Edinburgh, Dept Clin Surg, 51 Little France Crescent, Edinburgh EH16 4SA, Scotland.
   [Banales, Jesus M.] Univ Basque Country UPV EHU, Donostia Univ Hosp, Biodonostia Hlth Res Inst, Dept Liver & Gastrointestinal Dis,CIBERehd,Ikerbas, San Sebastian 20014, Spain.
   [Banales, Jesus M.] Univ Navarra, Sch Sci, Dept Biochem & Genet, Pamplona 31009, Spain.
   [Krimpenfort, Paul J.] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands.
C3 University of Edinburgh; Medical University of Innsbruck; University of
   Edinburgh; University of Edinburgh; University of Edinburgh; Consejo
   Superior de Investigaciones Cientificas (CSIC); Universidad de
   Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria
   (IBBTEC); University of Edinburgh; UK Research & Innovation (UKRI);
   Biotechnology and Biological Sciences Research Council (BBSRC); Roslin
   Institute; Belfast City Hospital; Queens University Belfast; Royal
   Infirmary of Edinburgh; University of Edinburgh; University of
   Edinburgh; Instituto de Investigacion Sanitaria Biodonostia; University
   Hospital Donostia; University of Basque Country; CIBER - Centro de
   Investigacion Biomedica en Red; CIBEREHD; University of Navarra;
   Netherlands Cancer Institute
RP Forbes, SJ (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, 5 Little France Dr, Edinburgh EH16 4UU, Scotland.
EM stuart.forbes@ed.ac.uk
RI Acosta, Juan/O-8420-2019; gonzalez, Sofia/JVZ-0275-2024; Kendall,
   Tim/H-2698-2019; Esser, Hannah/HPE-4082-2023
OI Kendall, Tim/0000-0002-4174-2786; Banales, Jesus M./0000-0002-5224-2373;
   Esser, Hannah/0000-0003-3980-7381; Aleksieva, Niya/0000-0002-7887-5494;
   Boulter, Luke/0000-0002-7954-6705; Rodrigo-Torres,
   Daniel/0000-0001-7840-1523; Younger, Nicholas/0000-0001-7601-9283;
   Ferreira-Gonzalez, Sofia/0000-0001-7776-287X; Kilpatrick,
   Alastair/0000-0002-4795-8799; Gadd, Victoria/0000-0003-1819-8660
FU UK Medical Research MRC [MR/L012766/1]; Computational and Chemical
   Biology of Stem Cell Niche [MR/K026666/1]; UK Regenerative Medicine
   Platform [MR/K026666/1, PI15/01132]; Wellcome Trust Institutional
   Translational Partnership Award (WT iTPA); Spanish Carlos III Health
   Institute (ISCIII) - " Fondo Europeo de Desarrollo Regional" (FEDER)
   [PI15/01132, PI18/01075, CON14/ 00129, CPII19/00008]; Instituto de Salud
   Carlos III" (CIBERehd), Spain; Euskadi RIS3 [2019222054, 2020333010];
   Department of Industry of the Basque Country [KK-2020/00008]; Wellcome
   Trust [209710/Z/17/Z]; Wellcome Trust [209710/Z/17/Z] Funding Source:
   Wellcome Trust
FX This work was supported by the UK Medical Research MRC (MR/K017047/1)
   (to S.J.F.), the Computational and Chemical Biology of Stem Cell Niche
   (MR/L012766/1) (to S.J.F.), the UK Regenerative Medicine Platform
   (MR/K026666/1) (to S.J.F.), and the Wellcome Trust Institutional
   Translational Partnership Award (WT iTPA) (to S.F.-G.). J.M.B. was
   supported by the Spanish Carlos III Health Institute (ISCIII)
   (PI15/01132, PI18/01075, and Miguel Servet Program CON14/ 00129 and
   CPII19/00008) cofinanced by " Fondo Europeo de Desarrollo Regional"
   (FEDER); " Instituto de Salud Carlos III" (CIBERehd), Spain; " Euskadi
   RIS3" (2019222054 and 2020333010); and the Department of Industry of the
   Basque Country (Elkartek: KK-2020/00008). This research was funded in
   whole or in part by The Wellcome Trust (grant number 209710/Z/17/Z), a
   cOAlition S organization.
CR Abe Y, 2009, FREE RADICAL BIO MED, V46, P1, DOI 10.1016/j.freeradbiomed.2008.09.029
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Adam R, 2018, TRANSPL INT, V31, P1293, DOI 10.1111/tri.13358
   Andersen KJ, 2013, INT J SURG, V11, P903, DOI 10.1016/j.ijsu.2013.07.009
   [Anonymous], 2 NHS BLOOD TRANSPLA
   Azzaroli F, 2002, HEPATOLOGY, V36, P49, DOI 10.1053/jhep.2002.34511
   Banales JM, 2012, HEPATOLOGY, V56, P687, DOI 10.1002/hep.25691
   Bartel K, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0399-2
   Brain JG, 2013, AM J TRANSPLANT, V13, P1688, DOI 10.1111/ajt.12271
   Braschi B, 2019, NUCLEIC ACIDS RES, V47, pD786, DOI 10.1093/nar/gky930
   Braun H, 2012, J AM SOC NEPHROL, V23, P1467, DOI 10.1681/ASN.2011100967
   Brunner SM, 2013, J HEPATOL, V58, P1133, DOI 10.1016/j.jhep.2012.12.022
   Buis CI, 2007, LIVER TRANSPLANT, V13, P708, DOI 10.1002/lt.21166
   Castanedo S, 2020, WORLD J GASTRO SURG, V12, P336, DOI 10.4240/wjgs.v12.i8.336
   Chen J, 2017, AM J PHYSIOL-RENAL, V313, pF273, DOI 10.1152/ajprenal.00689.2016
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI [10.1093/nar/gkt1102, 10.1093/nar/gkz1031]
   Cui D, 2014, ONCOGENE, V33, P2225, DOI 10.1038/onc.2013.170
   Cursio R, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/164329
   de Vries Y, 2018, BBA-MOL BASIS DIS, V1864, P1507, DOI 10.1016/j.bbadis.2017.06.013
   Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Dutkowski P, 2014, J HEPATOL, V60, P765, DOI 10.1016/j.jhep.2013.11.023
   Dutkowski P, 2019, GASTROENTEROLOGY, V156, P1542, DOI 10.1053/j.gastro.2018.12.037
   Elias-Miró M, 2013, FREE RADICAL RES, V47, P555, DOI 10.3109/10715762.2013.811721
   Faber W, 2011, TRANSPL P, V43, P3789, DOI 10.1016/j.transproceed.2011.10.048
   Farr L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01273
   Feng PF, 2020, J CELL MOL MED, V24, P4368, DOI 10.1111/jcmm.15141
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Foley DP, 2011, ANN SURG, V253, P817, DOI 10.1097/SLA.0b013e3182104784
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005
   Haase M, 2016, GENE, V575, P171, DOI 10.1016/j.gene.2015.08.063
   Hansen T, 2012, VIRCHOWS ARCH, V461, P41, DOI 10.1007/s00428-012-1245-8
   Heinrichs D, 2014, FASEB J, V28, P5136, DOI 10.1096/fj.14-256776
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826
   Im CN, 2016, CELL STRESS CHAPERON, V21, P553, DOI 10.1007/s12192-016-0687-3
   Iske J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18039-x
   Jay CL, 2012, LIVER TRANSPLANT, V18, P630, DOI 10.1002/lt.23418
   Jimenez-Castro M. B., 2013, INTECHOPEN
   Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X
   Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Linxweiler M, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.2
   Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939
   Lu SN, 2020, NUCLEIC ACIDS RES, V48, pD265, DOI 10.1093/nar/gkz991
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2
   Martín-Caballero J, 2001, CANCER RES, V61, P6234
   Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092
   Mourad MM, 2014, WORLD J GASTROENTERO, V20, P6159, DOI 10.3748/wjg.v20.i20.6159
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Nasralla D, 2018, NATURE, V557, P50, DOI 10.1038/s41586-018-0047-9
   Nosrati N, 2015, GENE, V559, P44, DOI 10.1016/j.gene.2015.01.014
   O'Neill S, 2014, TRANSPL INT, V27, P1159, DOI 10.1111/tri.12403
   Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294
   Okamura S, 2021, BMC CANCER, V21, DOI 10.1186/s12885-020-07717-0
   Op den Dries S, 2014, J HEPATOL, V60, P1172, DOI 10.1016/j.jhep.2014.02.010
   Oughtred R, 2021, PROTEIN SCI, V30, P187, DOI 10.1002/pro.3978
   Ovadya Y, 2018, J CLIN INVEST, V128, P1247, DOI 10.1172/JCI95149
   Pereira P, 2018, GE PORT J GASTROENT, V25, P1, DOI 10.1159/000480489
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Sagiv A, 2013, ONCOGENE, V32, P1971, DOI 10.1038/onc.2012.206
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Sampaziotis F, 2021, SCIENCE, V371, P839, DOI 10.1126/science.aaz6964
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Santos J, 2014, IMMUNOL LETT, V162, P281, DOI 10.1016/j.imlet.2014.08.011
   Screaton RA, 2003, P NATL ACAD SCI USA, V100, P5211, DOI 10.1073/pnas.0431215100
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Soto-Gamez A, 2019, J MOL BIOL, V431, P2629, DOI 10.1016/j.jmb.2019.05.036
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Urribarri AD, 2014, GUT, V63, P1658, DOI 10.1136/gutjnl-2013-305281
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   van Noesel MM, 2002, CANCER RES, V62, P2157
   Vinken M, 2015, METHODS MOL BIOL, V1250, P95, DOI 10.1007/978-1-4939-2074-7_6
   Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106
   Williams R, 2020, LANCET, V395, P226, DOI 10.1016/S0140-6736(19)32908-3
   Xia WZ, 2018, INT J MOL MED, V41, P1127, DOI 10.3892/ijmm.2017.3282
   Xie KF, 2019, BIOCHEM BIOPH RES CO, V511, P323, DOI 10.1016/j.bbrc.2019.02.043
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019
   Zhang X, 2008, APOPTOSIS, V13, P983, DOI 10.1007/s10495-008-0228-3
   Zhang YL, 2019, AGING-US, V11, P12641, DOI 10.18632/aging.102592
   Zhou BR, 2020, J CELL MOL MED, V24, P2087, DOI 10.1111/jcmm.14952
   Zhu WS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24498
NR 91
TC 6
Z9 6
U1 4
U2 7
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD DEC 7
PY 2022
VL 14
IS 674
AR eabj4375
DI 10.1126/scitranslmed.abj4375
PG 16
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 7K2BH
UT WOS:000905089700007
PM 36475903
OA Green Submitted, Green Accepted
DA 2024-02-19
ER

PT J
AU Sabaretnam, T
   Kritharides, L
   O'Reilly, JN
   Le Couteur, DG
AF Sabaretnam, Tharani
   Kritharides, Leonard
   O'Reilly, Jennifer N.
   Le Couteur, David G.
TI The effect of aging on the response of isolated hepatocytes to hydrogen
   peroxide and tert-butyl hydroperoxide
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Hepatocyte; Liver; Oxidative stress; Superoxide dismutase; Catalase;
   Glutathione peroxidase; Apolipoprotein E; Mitochondria
ID OXIDATIVE STRESS; APOLIPOPROTEIN-E; RAT-LIVER; AGE; ENZYMES; EXPRESSION;
   DISEASE; MECHANISMS; TRANSPORT; INJURY
AB Aging is associated with increased susceptibility to oxidative stress. To study this in the liver and to elucidate underlying mechanisms, hepatocytes from young (4-6 months) and old (24-26 months) rats were exposed to two oxidants, hydrogen peroxide and tert-butyl hydroperoxide. ATP content and mitochondrial activity were lower in old hepatocytes and decreased further with oxidative stress. Expression of Cu/Zn superoxide dismutase, Mn superoxide dismutase and catalase was not substantially influenced by oxidative stress in young and old hepatocytes, whereas glutathione peroxidase 1 expression was markedly increased only in young hepatocytes. Oxidative stress in young hepatocytes led to increased expression of apoE and movement of apoE to the early endosomes. In old hepatocytes, oxidative stress did not increase apoE expression and apoE was co-localized with early endosomes under control conditions. The results show that old age is associated with impaired hepatocyte responses of mitochondria, ATP, glutathione peroxidase 1 and apoE to oxidative stress. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.
C1 [Sabaretnam, Tharani; O'Reilly, Jennifer N.; Le Couteur, David G.] Concord RG Hosp, Ctr Educ & Res Ageing, Concord, NSW 2139, Australia.
   [Sabaretnam, Tharani; Kritharides, Leonard; O'Reilly, Jennifer N.; Le Couteur, David G.] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2006, Australia.
   [Sabaretnam, Tharani; Kritharides, Leonard] Concord Hosp, Dept Cardiol, Sydney, NSW, Australia.
   [Kritharides, Leonard] Univ New S Wales, Sch Med Sci, Ctr Vasc Res, Sydney, NSW 2052, Australia.
C3 Concord Repatriation General Hospital; University of Sydney; ANZAC
   Research Institute; Concord Repatriation General Hospital; University of
   New South Wales Sydney
RP Le Couteur, DG (corresponding author), Concord RG Hosp, Ctr Educ & Res Ageing, Hosp Rd, Concord, NSW 2139, Australia.
EM dlecouteur@med.usyd.edu.au
RI Ekanayake, Kanchana/P-8817-2016; Research Institute,
   ANZAC/CAE-9030-2022; Kritharides, Leonard/AAQ-2720-2020
OI Kritharides, Leonard/0000-0001-5818-8024; Le Couteur,
   David/0000-0002-4227-5817; Sabaretnam, Tharani/0000-0003-3655-8578
FU Australian National Health and Medical Research Council; Australian
   Research Council; Ageing and Alzheimers Research Foundation; University
   of Sydney; Department of Cardiology
FX Supported by grants from the Australian National Health and Medical
   Research Council, Australian Research Council and the Ageing and
   Alzheimers Research Foundation. T. Sabaretnam is funded by a University
   of Sydney and Department of Cardiology postgraduate scholarship.
CR Alía M, 2005, J BIOCHEM MOL TOXIC, V19, P119, DOI 10.1002/jbt.20061
   Amicarelli F, 1997, MECH AGEING DEV, V97, P215, DOI 10.1016/S0047-6374(97)00061-4
   Ang LS, 2008, EXP GERONTOL, V43, P615, DOI 10.1016/j.exger.2008.03.010
   Chen J, 2006, J GERONTOL A-BIOL, V61, P20, DOI 10.1093/gerona/61.1.20
   Cogger VC, 2004, J HEPATOL, V41, P370, DOI 10.1016/j.jhep.2004.04.034
   Cogger VC, 2001, PHARMACOL TOXICOL, V89, P306, DOI 10.1034/j.1600-0773.2001.d01-165.x
   Dekroon RM, 2002, CELL BIOL INT, V26, P407, DOI 10.1006/cbir.2002.0868
   Drahota Z, 2005, PHYSIOL RES, V54, P67, DOI 10.33549/physiolres.930578
   Espiritu DJ, 2008, DIABETES, V57, P2992, DOI 10.2337/db08-0592
   Farkas MH, 2004, J LIPID RES, V45, P1546, DOI 10.1194/jlr.M400104-JLR200
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Hagen TM, 2000, ANTIOXID REDOX SIGN, V2, P473, DOI 10.1089/15230860050192251
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Heeren J, 2001, J BIOL CHEM, V276, P42333, DOI 10.1074/jbc.M107461200
   Hilmer SN, 2004, EXP GERONTOL, V39, P53, DOI 10.1016/j.exger.2003.09.016
   Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068
   Le Couteur DG, 1999, PHARMACOL TOXICOL, V85, P230
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LECOUTEUR D, 1995, INT HEPATOL COMMUN, V3, P244, DOI 10.1016/0928-4346(94)00186-9
   Li J, 2003, FREE RADICAL BIO MED, V35, P292, DOI 10.1016/S0891-5849(03)00308-3
   López-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014
   Martin R, 2002, EXP GERONTOL, V37, P1481, DOI 10.1016/S0531-5565(02)00168-7
   Matés JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1
   Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034
   Muradian KK, 2002, ARCH GERONTOL GERIAT, V35, P205, DOI 10.1016/S0167-4943(02)00025-0
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Smith JD, 2002, AGEING RES REV, V1, P345, DOI 10.1016/S1568-1637(02)00005-3
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859
   Zhu MY, 2005, METABOLISM, V54, P1309, DOI 10.1016/j.metabol.2005.04.019
NR 36
TC 4
Z9 6
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD FEB
PY 2010
VL 24
IS 1
BP 123
EP 128
DI 10.1016/j.tiv.2009.08.018
PG 6
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 548AA
UT WOS:000273930000016
PM 19720132
DA 2024-02-19
ER

PT J
AU Musicco, C
   Capelli, V
   Pesce, V
   Timperio, AM
   Calvani, M
   Mosconi, L
   Cantatore, P
   Gadaleta, MN
AF Musicco, Clara
   Capelli, Valentina
   Pesce, Vito
   Timperio, Anna Maria
   Calvani, Menotti
   Mosconi, Luigi
   Cantatore, Palmiro
   Gadaleta, Maria Nicola
TI Rat liver mitochondrial proteome: Changes associated with aging and
   acetyl-L-carnitine treatment
SO JOURNAL OF PROTEOMICS
LA English
DT Article
DE Rat liver mitochondria proteome; Aging; Acetyl-L-carnitine;
   Two-dimensional gel electrophoresis; Mass spectrometry
ID DNA COPY NUMBER; AGED RAT; CALORIC RESTRICTION; SKELETAL-MUSCLE;
   10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE; PEROXIREDOXIN-III; PHOSPHATE
   CARRIER; LIPID-COMPOSITION; OXIDATIVE DAMAGE; GENE-EXPRESSION
AB Oxidative stress has a central role in aging and in several age-linked diseases such as neurodegenerative diseases, diabetes and cancer. Mitochondria, as the main cellular source and target of reactive oxygen species (ROS) in aging, are recognized as very important players in the above reported diseases. Impaired mitochondrial oxidative phosphorylation has been reported in several aging tissues. Defective mitochondria are not only responsible of bioenergetically less efficient cells but also increase ROS production further contributing to tissues oxidative stress. Acetyl-L-carnitine (ALCAR) is a biomolecule able to limit age-linked mitochondrial decay in brain, liver, heart and skeletal muscles by increasing mitochondrial efficiency.
   Here the global changes induced by aging and by ALCAR supplementation to old rat on the mitochondrial proteome of rat liver has been analyzed by means of the two-dimensional polyacrylamide gel electrophoresis. Mass spectrometry has been used to identify the differentially expressed proteins. A significant age-related change occurred in 31 proteins involved in several metabolisms. ALCAR supplementation altered the levels of 26 proteins. In particular, ALCAR reversed the age-related alterations of 10 mitochondrial proteins relative to mitochondrial cristae morphology, to the oxidative phosphorylation and antioxidant systems, to urea cycle, to purine biosynthesis. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Musicco, Clara; Cantatore, Palmiro; Gadaleta, Maria Nicola] CNR Natl Res Council Italy Inst Biomembranes & Bi, I-70126 Bari, Italy.
   [Capelli, Valentina; Pesce, Vito; Cantatore, Palmiro; Gadaleta, Maria Nicola] Univ Bari, Dept Biochem & Mol Biol Ernesto Quagliariello, Bari, Italy.
   [Pesce, Vito; Gadaleta, Maria Nicola] Univ Bari, Ctr Eccellenza Genom Campo Biomed Agr, Bari, Italy.
   [Timperio, Anna Maria] Univ Tuscia, Dept Environm Sci, Viterbo, Italy.
   [Calvani, Menotti; Mosconi, Luigi] Sigma Tau Ind Farmaceut Riunite SpA, Rome, Italy.
C3 Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari
   Aldo Moro; Tuscia University
RP Musicco, C (corresponding author), CNR Natl Res Council Italy Inst Biomembranes & Bi, Via Amendola 165-A, I-70126 Bari, Italy.
EM c.musicco@ibbe.cnr.it
RI Timperio, Anna Maria/AAN-4248-2020; Musicco, Clara/B-9480-2015
OI Timperio, Anna Maria/0000-0001-8457-042X; Musicco,
   Clara/0000-0003-4359-4403; PESCE, VITO/0000-0002-9148-3129
FU University of Bari, Fondi Ateneo; fiRSt srl; FIRB-MERIT [RBNE08HWLZ_012,
   MIUR-CNR N.157 - WP1]
FX We are very grateful to Flavio Fracasso for technical assistance. This
   work was supported by the University of Bari, Fondi Ateneo 2008 and 2009
   (to MNG and VP), fiRSt srl 2009 (to MNG), FIRB-MERIT 2008 No.
   RBNE08HWLZ_012 and MIUR-CNR N.157 - WP1.
CR Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   BONOMI F, 1977, EUR J BIOCHEM, V72, P17, DOI 10.1111/j.1432-1033.1977.tb11219.x
   Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4
   Breusing N, 2009, MECH AGEING DEV, V130, P748, DOI 10.1016/j.mad.2009.09.004
   Bu SY, 2010, J LIPID RES, V51, P3270, DOI 10.1194/jlr.M009407
   Cassano P, 2006, BBA-BIOENERGETICS, V1757, P1421, DOI 10.1016/j.bbabio.2006.05.019
   Cassano P, 2004, ANN NY ACAD SCI, V1019, P269, DOI 10.1196/annals.1297.045
   CHAMPION KM, 1994, P NATL ACAD SCI USA, V91, P11338, DOI 10.1073/pnas.91.24.11338
   Chang J, 2007, J GERONTOL A-BIOL, V62, P223, DOI 10.1093/gerona/62.3.223
   Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200
   Chumanevich AA, 2004, J BIOL CHEM, V279, P14355, DOI 10.1074/jbc.M313934200
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   Dhitavat S, 2002, NEUROCHEM RES, V27, P501, DOI 10.1023/A:1019800703683
   Donoghue P, 2010, J PROTEOMICS, V73, P1441, DOI 10.1016/j.jprot.2010.01.014
   Douette P, 2005, J PROTEOME RES, V4, P2024, DOI 10.1021/pr050187z
   Fernández-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028
   Fountoulakis M, 2002, ELECTROPHORESIS, V23, P311, DOI 10.1002/1522-2683(200202)23:2<311::AID-ELPS311>3.0.CO;2-0
   Friguet Bertrand, 2008, Biotechnology Journal, V3, P757, DOI 10.1002/biot.200800041
   Fugere NA, 2006, J GERONTOL A-BIOL, V61, P806, DOI 10.1093/gerona/61.8.806
   Gadaleta MN, 1995, PROG CELL R, V5, P231
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   GADALETA MN, 1994, ANN NY ACAD SCI, V717, P150, DOI 10.1111/j.1749-6632.1994.tb12082.x
   Greenawalt J W, 1974, Methods Enzymol, V31, P310
   Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562
   Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004
   Huang SB, 2003, BIOCHEM BIOPH RES CO, V309, P344, DOI 10.1016/j.bbrc.2003.08.010
   Jiang XS, 2005, MOL CELL PROTEOMICS, V4, P12, DOI 10.1074/mcp.M400079-MCP200
   John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.E04-08-0697
   Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718
   Kamzalov S, 2004, EXP GERONTOL, V39, P1199, DOI 10.1016/j.exger.2004.04.007
   KOJ A, 1975, FEBS LETT, V57, P42, DOI 10.1016/0014-5793(75)80148-7
   KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711
   KRAHENBUHL S, 1990, J CLIN INVEST, V86, P2054, DOI 10.1172/JCI114942
   Lash LH, 2006, CHEM-BIOL INTERACT, V163, P54, DOI 10.1016/j.cbi.2006.03.001
   Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Lindner AB, 2009, BBA-GEN SUBJECTS, V1790, P980, DOI 10.1016/j.bbagen.2009.06.005
   Liu JK, 2005, NUTR NEUROSCI, V8, P67, DOI 10.1080/10284150500047161
   Madiraju P, 2009, EPIGENETICS-US, V4, P296
   Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Mollica MP, 2001, CELL MOL LIFE SCI, V58, P477, DOI 10.1007/PL00000871
   Musicco C, 2009, BBA-BIOENERGETICS, V1787, P890, DOI 10.1016/j.bbabio.2009.03.002
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   Navarro A, 2007, AM J PHYSIOL-CELL PH, V292, pC670, DOI 10.1152/ajpcell.00213.2006
   NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603
   O'Connell K, 2009, PROTEOMICS, V9, P5509, DOI 10.1002/pmic.200900472
   OGATA K, 1990, J BIOL CHEM, V265, P8087
   PAGANI S, 1983, BIOCHIM BIOPHYS ACTA, V742, P278, DOI 10.1016/0167-4838(83)90312-6
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   Paradies G, 1999, FEBS LETT, V454, P207, DOI 10.1016/S0014-5793(99)00809-1
   PARADIES G, 1992, BIOCHIM BIOPHYS ACTA, V1103, P324, DOI 10.1016/0005-2736(92)90103-S
   Paradies G, 1995, MECH AGEING DEV, V84, P103, DOI 10.1016/0047-6374(95)01636-8
   Park SK, 2009, AGING CELL, V8, P484, DOI 10.1111/j.1474-9726.2009.00496.x
   Pesce V, 2001, FREE RADICAL BIO MED, V30, P1223, DOI 10.1016/S0891-5849(01)00517-2
   Pesce V, 2004, ANN NY ACAD SCI, V1019, P430, DOI 10.1196/annals.1297.077
   Pesce V, 2010, REJUV RES, V13, P148, DOI 10.1089/rej.2009.0955
   PETRUZZELLA V, 1992, ARCH GERONTOL GERIAT, V14, P131, DOI 10.1016/0167-4943(92)90048-9
   Phang JM, 2008, J NUTR, V138, p2008S, DOI 10.1093/jn/138.10.2008S
   Poon HF, 2006, ANTIOXID REDOX SIGN, V8, P381, DOI 10.1089/ars.2006.8.381
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   Rosca MG, 2009, ADV DRUG DELIVER REV, V61, P1332, DOI 10.1016/j.addr.2009.06.009
   Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882
   Sabelli R, 2008, FEBS J, V275, P3884, DOI 10.1111/j.1742-4658.2008.06535.x
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.0.CO;2-2
   Soskic V, 2008, EXP GERONTOL, V43, P247, DOI 10.1016/j.exger.2007.12.001
   Traina G, 2009, MOL NEUROBIOL, V39, P101, DOI 10.1007/s12035-009-8056-1
   Wei Yau-Huei, 2009, Chang Gung Med J, V32, P113
NR 76
TC 23
Z9 25
U1 0
U2 22
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD OCT 19
PY 2011
VL 74
IS 11
SI SI
BP 2536
EP 2547
DI 10.1016/j.jprot.2011.05.041
PG 12
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 847TH
UT WOS:000296994900025
PM 21672642
DA 2024-02-19
ER

PT J
AU Kim, H
   You, S
   Foster, LK
   Farris, J
   Choi, YJ
   Foster, DN
AF Kim, H
   You, S
   Foster, LK
   Farris, J
   Choi, YJ
   Foster, DN
TI Differential expression of chicken dimerization cofactor of hepatocyte
   nuclear factor-1 (DcoH) and its novel counterpart, DcoHα
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE chicken embryo fibroblast; DF-1; hepatocyte nuclear factor-1;
   immortalization; senescence
ID PHENYLALANINE-HYDROXYLASE STIMULATOR; 4A-CARBINOLAMINE DEHYDRATASE;
   MESSENGER-RNA; CELL-LINE; PROTEIN; GENE; TRANSCRIPTION; HNF1; REGION;
   RAT
AB We have used differential display PCR to study altered gene expression in immortalized chicken embryo fibroblasts (CEFs) that have been established in our laboratory. This technique resulted in the cloning of a novel counterpart of the previously cloned chicken dimerization cofactor of hepatocyte nuclear factor (HNF)-1 (cDcoH), which was identified as cDcoH alpha. The steady-state mRNA levels of cDcoH alpha were up-regulated in all immortal CEFs tested compared with primary CEF cells, cDcoH and cDcoH alpha showed opposite patterns of mRNA expression due to differential regulation of transcription rates, but not mRNA half-lives, in primary and immortal CEFs. Expression of cDcoH alpha increased in the late G1 and early S phases of the cell cycle, while cDcoH mRNA increased in the late S and G2/M phases. In contrast with consistent expression of both genes in primary quiescent cells, cDcoH mRNA, but not cDcoH alpha mRNA, was dramatically decreased in primary senescent cells. The highest levels of cDcoH alpha mRNA were found in the kidney, liver, heart and ovarian follicles, while the major tissues expressing cDcoH were hypothalamus, kidney and liver. cDcoH and cDcoH alpha probes did not cross-hybridize to human hepatocyte mRNA. When transfected into human HepG2 cells, both cDcoH and cDcoH alpha showed similar functional activity as measured by increased expression of a reporter gene, as well as alpha-fetoprotein and albumin genes that both contain HNF-1 binding elements in their promoters. Our results suggest that the novel chicken DcoH alpha, might function as a transcriptional cofactor for HNF-1 in specific cellular-environmental states.
C1 Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.
   Seoul Natl Univ, Sch Agr Biotechnol, Suwon 441744, South Korea.
C3 University of Minnesota System; University of Minnesota Twin Cities;
   Seoul National University (SNU)
RP Foster, DN (corresponding author), Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.
RI Kim, Hyunggee/F-2673-2013; Kang, Phil Jun/F-4716-2013; Choi,
   Yunjaie/B-4697-2014; You, Seungkwon/H-3067-2015
OI Kim, Hyunggee/0000-0002-4738-0990; 
CR Anastasiadis PZ, 1996, MOL PHARMACOL, V49, P149
   BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642
   Bossow S, 1998, BIOL CHEM, V379, P1359
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   CITRON BA, 1993, AM J HUM GENET, V53, P768
   COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937
   DAVIS MD, 1991, FEBS LETT, V285, P17, DOI 10.1016/0014-5793(91)80714-E
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x
   FEUERMAN MH, 1989, MOL CELL BIOL, V9, P4204, DOI 10.1128/MCB.9.10.4204
   HANSEN LP, 1993, CURR OPIN GENET DEV, V3, P246, DOI 10.1016/0959-437X(93)90030-S
   HAUER CR, 1993, J BIOL CHEM, V268, P4828
   Himly M, 1998, VIROLOGY, V248, P295, DOI 10.1006/viro.1998.9290
   Johnen G, 1997, P NATL ACAD SCI USA, V94, P13469, DOI 10.1073/pnas.94.25.13469
   KIM JL, 1995, STRUCTURE, V3, P531, DOI 10.1016/S0969-2126(01)00186-1
   LAZARUS RA, 1983, J BIOL CHEM, V258, P960
   Lei XD, 1998, P NATL ACAD SCI USA, V95, P1500, DOI 10.1073/pnas.95.4.1500
   Lei XD, 1999, DNA CELL BIOL, V18, P243, DOI 10.1089/104454999315466
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   Madisen L, 1998, MOL CELL BIOL, V18, P6281, DOI 10.1128/MCB.18.11.6281
   MEDEL DB, 1991, GENE DEV, V5, P1042
   MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325
   NICHOL CA, 1985, ANNU REV BIOCHEM, V54, P729, DOI 10.1146/annurev.biochem.54.1.729
   POGGE V, 1995, DEVELOPMENT, V121, P1217
   Rhee KH, 1997, J MOL BIOL, V265, P20, DOI 10.1006/jmbi.1996.0708
   Rose RB, 2000, NAT STRUCT BIOL, V7, P744
   Schaefer-Klein J, 1998, VIROLOGY, V248, P305, DOI 10.1006/viro.1998.9291
   Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078
   SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1
   Sourdive DJD, 1997, NUCLEIC ACIDS RES, V25, P1476, DOI 10.1093/nar/25.8.1476
   SRIVER CR, 1989, METABOLIC BASIS INHE, P495
   STEIN GH, 1995, BIOESSAYS, V17, P537, DOI 10.1002/bies.950170610
   TRONCHE F, 1992, BIOESSAYS, V14, P579, DOI 10.1002/bies.950140902
NR 33
TC 9
Z9 14
U1 0
U2 1
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON W1N 3AJ, ENGLAND
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD MAR 15
PY 2001
VL 354
BP 645
EP 653
DI 10.1042/0264-6021:3540645
PN 3
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 416TH
UT WOS:000167795900019
PM 11237869
OA Green Published
DA 2024-02-19
ER

PT J
AU TAYLOR, LV
   JONES, AL
   SCHMUCKER, DL
AF TAYLOR, LV
   JONES, AL
   SCHMUCKER, DL
TI DOES AGING AFFECT LIVER MICROTUBULES
SO PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
ID DIMERIC IMMUNOGLOBULIN; QUANTITATIVE-ANALYSIS; RAT; TUBULIN; PROTEIN;
   AGE; STIMULATION; FIBROBLASTS; COLCHICINE; SECRETION
AB Microtubules are essential for many cell processes, e.g., ligand-receptor endocytosis and the vectorial movement of endosomes.  The cytoskeleton, particularly microtubules, may undergo age-related changes that are reflected in cell dysfunctions.  For example, the translocation of I-125-IgA-containing vesicles from the sinusoidal surface to the pericanalicular cytoplasm is reduced (> 40%) in old versus young rats.  Electron microscopic analysis demonstrated that the concentration of microtubule profiles in young animals is within 10-20% of that in old rats.  The relative concentration of polymerized tubulin declines > 70% by 12 months of age, but the total tubulin content remains unchanged until later, i.e., declining 50% by 24 months.  Concomitant increases occur in the free fractions of microtubule-associated proteins (MAP), i.e., MAP1 and heat-stable MAPS.  These fractions are not associated with polymerized tubulin.  The declines in total and polymerized tubulin, together with the increases in the MAPS' free fractions, may be indicative of fewer and/or shorter microtubules.  These data lend credence to the supposition that aging is accompanied by perturbations of microtubule functions that ultimately are expressed as biomarkers characteristic of aging.
C1 VET AFFAIRS MED CTR,CELL BIOL & AGING SECT 151E,4150 CLEMENT ST,SAN FRANCISCO,CA 94121.
   UNIV CALIF SAN FRANCISCO,DEPT ANAT,SAN FRANCISCO,CA 94143.
   UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143.
   UNIV CALIF SAN FRANCISCO,CTR LIVER,SAN FRANCISCO,CA 94143.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco;
   University of California System; University of California San Francisco
FU NIA NIH HHS [AG07226] Funding Source: Medline; NIDDK NIH HHS [DK38436,
   DK25878] Funding Source: Medline
CR BLOSE SH, 1984, J CELL BIOL, V98, P847, DOI 10.1083/jcb.98.3.847
   CARON JM, 1985, J CELL BIOL, V101, P1763, DOI 10.1083/jcb.101.5.1763
   DANIELS CK, 1985, J IMMUNOL, V134, P3855
   GOLDMAN IS, 1983, GASTROENTEROLOGY, V85, P130
   HORBACH GJM, 1987, REV BIOL RES AGING, V3, P485
   JONES AL, 1980, SEMIN LIVER DIS, V5, P136
   JONES AL, 1988, AGING LIVER GASTROIN, P181
   KACICH RL, 1983, GASTROENTEROLOGY, V85, P385
   MAURICE M, 1980, BIOCHEM BIOPH RES CO, V97, P355, DOI 10.1016/0006-291X(80)90272-7
   MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x
   OLMSTED JB, 1981, J BIOL CHEM, V256, P3507
   PATZELT C, 1975, J CELL BIOL, V66, P609, DOI 10.1083/jcb.66.3.609
   RAO KMK, 1990, EXP GERONTOL, V25, P7, DOI 10.1016/0531-5565(90)90004-L
   REAVEN EP, 1977, J CELL BIOL, V75, P731, DOI 10.1083/jcb.75.3.731
   SCHMUCKER DL, 1988, IMMUNOLOGY, V64, P691
   SCHMUCKER DL, 1985, GASTROENTEROLOGY, V88, P436, DOI 10.1016/0016-5085(85)90504-9
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   SCHMUCKER DL, 1977, SCIENCE, V197, P1005, DOI 10.1126/science.887935
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   SLOBODA RD, 1976, BIOCHEMISTRY-US, V15, P4497, DOI 10.1021/bi00665a026
   STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342
NR 21
TC 12
Z9 12
U1 0
U2 4
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0037-9727
J9 P SOC EXP BIOL MED
JI Proc. Soc. Exp. Biol. Med.
PD APR
PY 1992
VL 199
IS 4
BP 441
EP 445
PG 5
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA HJ858
UT WOS:A1992HJ85800010
PM 1549622
DA 2024-02-19
ER

PT J
AU Chaker, D
   Mouawad, C
   Azar, A
   Quilliot, D
   Achkar, I
   Fajloun, Z
   Makdissy, N
AF Chaker, Diana
   Mouawad, Charbel
   Azar, Albert
   Quilliot, Didier
   Achkar, Ibrahim
   Fajloun, Ziad
   Makdissy, Nehman
TI Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte
   differentiation from human adipose-derived mesenchymal stem cells via
   the Wnt5a/PI3K/miR-122 pathway: impact of the age of the donor
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Aging; Cdc42; ML141; Adipose derived mesenchymal stem cells; Hepatocyte
   differentiation; Exosomes release; miR122; Wnt; MAPK; PI3K
ID INDUCED HEMATOPOIETIC STEM; SMALL GTPASE CDC42; HEPATIC DIFFERENTIATION;
   STROMAL CELLS; BETA-CATENIN; BONE-MARROW; IN-VITRO; RAPID GENERATION;
   LIVER-DISEASE; KEY-FACTOR
AB Background: Human adipose-derived mesenchymal stem cells (hADSCs) are promising cells that may promote hepatocyte differentiation (Hep-Dif) and improve liver function, but the involvement of Cdc42, a key small RhoGTPase which plays a crucial role in aging, is still not well established. We hypothesized that the inhibition of Cdc42 may rescue the hepatogenic potential of hADSCs derived from aged donors.
   Methods: hADSCs isolated from 61 women of different ages were cultured for evaluation of the proliferation of cells, adherence, apoptosis, immunomodulation, immunophenotyping, multipotency, gene expression, and cell function during Hep-Dif. Inhibition of Cdc42 by ML141 was realized during two phases: initiation (days -2 to 14 (D-2/14)) from undifferentiated to hepatoblast-like cells, or maturation (days 14 to 28 (D14/28)) from undifferentiated to hepatocyte-like cells. Mechanistic insights of the Wnt(s)/MAPK/PI3K/miR-122 pathways were studied.
   Results: Cdc42 activity in undifferentiated hADSCs showed an age-dependent significant increase in Cdc42-GTP correlated to a decrease in Cdc42-GAP; the low potentials of cell proliferation, doubling, adherence, and immunomodulatory ability (proinflammatory over anti-inflammatory) contrary to the apoptotic index of the aged group were significantly reversed by ML141. Aged donor cells showed a decreased potential for Hep-Dif which was rescued by ML141 treatment, giving rise to mature and functional hepatocyte-like cells as assessed by hepatic gene expression, cytochrome activity, urea and albumin production, low-density lipoprotein (LDL) uptake, and glycogen storage. ML141-induced Hep-Dif showed an improvement in mesenchymal-epithelial transition, a switch from Wtn3a/beta-catenin to Wnt5a signaling, involvement of PI3K/PKB but not the MAPK (ERK/JNK/p38) pathway, induction of miR-122 expression, reinforcing the exosomes release and the production of albumin, and epigenetic changes. Inhibition of PI3K and miR-122 abolished completely the effects of ML141 indicating that inhibition of Cdc42 promotes the Hep-Dif through a Wnt5a/PI3K/miR-122/HNF4 alpha/albumin/E-cadherin-positive action. The ML141(D-2/14) protocol had more pronounced effects when compared with ML141(D14/28); inhibition of DNA methylation in combination with ML141(D-2/14) showed more efficacy in rescuing the Hep-Dif of aged hADSCs. In addition to Hep-Dif, the multipotency of aged hADSC-treated ML141 was observed by rescuing the adipocyte and neural differentiation by inducing PPAR gamma/FABP4 and NeuN/O4 but inhibiting Pref-1 and GFAP, respectively.
   Conclusion: ML141 has the potential to reverse the age-related aberrations in aged stem cells and promotes their hepatogenic differentiation. Selective inhibition of Cdc42 could be a potential target of drug therapy for aging and may give new insights on the improvement of Hep-Dif.
C1 [Chaker, Diana; Fajloun, Ziad; Makdissy, Nehman] Lebanese Univ, Doctoral Sch Sci & Technol, Azm Ctr Res Biotechnol & Its Applicat, Lab Appl Biotechnol, Tripoli, Lebanon.
   [Chaker, Diana; Azar, Albert] Middle East Inst Hlth Hosp, Reviva Regenerat Med Ctr, Ctr Human Genet, Bsalim, Lebanon.
   [Chaker, Diana] Paris Saclay Univ, Doctoral Sch, Therapeut Innovat, Inserm UMR935, Villejuif, France.
   [Mouawad, Charbel] Kfarzeina, Zgharta, Lebanon.
   [Quilliot, Didier] Univ Henri Poincare Lorraine, CHRU Nancy, INSERM 954, Diabetol Endocrinol & Nutr,Fac Med, Nancy, France.
   [Achkar, Ibrahim] St Elie Ctr, Achkar Clin, Antelias, Lebanon.
   [Fajloun, Ziad; Makdissy, Nehman] Lebanese Univ, Fac Sci 3, Dept Biol, Kobbe, Lebanon.
C3 Lebanese University; Universite Paris Saclay; CHU de Nancy; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Universite de
   Lorraine
RP Makdissy, N (corresponding author), Lebanese Univ, Doctoral Sch Sci & Technol, Azm Ctr Res Biotechnol & Its Applicat, Lab Appl Biotechnol, Tripoli, Lebanon.; Makdissy, N (corresponding author), Lebanese Univ, Fac Sci 3, Dept Biol, Kobbe, Lebanon.
EM almakdissy@hotmail.com
RI Fajloun, Ziad/AAO-8595-2021; Quillot, Didier/ABB-5326-2021
OI Fajloun, Ziad/0000-0002-6502-3110
FU Lebanese University; CEDRE from the French MENESR [35399WH]
FX This work was supported by grants from the Lebanese University and the
   CEDRE from the French MENESR (35399WH).
CR del Barrio JLA, 2017, CORNEA, V36, P952, DOI 10.1097/ICO.0000000000001228
   Alizadeh E, 2016, CHEM BIOL DRUG DES, V87, P296, DOI 10.1111/cbdd.12664
   Apte U, 2007, AM J PHYSIOL-GASTR L, V292, pG1578, DOI 10.1152/ajpgi.00359.2006
   Azandeh S, 2016, BIOIMPACTS, V6, P9, DOI 10.15171/bi.2016.02
   Bandiera S, 2015, J HEPATOL, V62, P448, DOI 10.1016/j.jhep.2014.10.004
   Beane OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115963
   Bonora-Centelles A, 2009, CELL TRANSPLANT, V18, P1319, DOI 10.3727/096368909X12483162197321
   Brunet A, 2017, CURR OPIN CELL BIOL, V45, P1, DOI 10.1016/j.ceb.2016.12.009
   Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286
   Cammarano MS, 2005, MOL CELL BIOL, V25, P9532, DOI 10.1128/MCB.25.21.9532-9542.2005
   Chen C, 2015, INT J HEMATOL, V101, P5, DOI 10.1007/s12185-014-1690-z
   Chen F, 2017, CELL TRANSPLANT, V26, P1483, DOI 10.1177/0963689717735407
   Chen HY, 2013, EMBO MOL MED, V5, P723, DOI 10.1002/emmm.201202140
   Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790
   Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8
   Cipriano M, 2017, ARCH TOXICOL, V91, P2469, DOI 10.1007/s00204-016-1901-x
   Coulouarn C, 2009, ONCOGENE, V28, P3526, DOI 10.1038/onc.2009.211
   Decaens T, 2008, HEPATOLOGY, V47, P247, DOI 10.1002/hep.21952
   Deng XG, 2014, LIVER INT, V34, P281, DOI 10.1111/liv.12239
   Doddapaneni R, 2013, J CELL BIOCHEM, V114, P1575, DOI 10.1002/jcb.24499
   Vilaboa SDA, 2014, CYTOTHERAPY, V16, P1092, DOI 10.1016/j.jcyt.2014.02.007
   Estrada JC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.211
   Flohr TR, 2009, CURR OPIN ORGAN TRAN, V14, P64, DOI 10.1097/MOT.0b013e328320fd7b
   Florian MC, 2017, J GERONTOL A-BIOL, V72, P1196, DOI 10.1093/gerona/glx091
   Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007
   Frese L, 2016, TRANSFUS MED HEMOTH, V43, P268, DOI 10.1159/000448180
   Fu YL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0364-6
   Fujimaki S, 2015, HISTOL HISTOPATHOL, V30, P1411, DOI 10.14670/HH-11-657
   Gailhouste L, 2013, HEPATOLOGY, V58, P1153, DOI 10.1002/hep.26422
   Gao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112698
   Geiger H, 2007, CELL CYCLE, V6, P884, DOI 10.4161/cc.6.8.4131
   Geiger H, 2014, EXP CELL RES, V329, P214, DOI 10.1016/j.yexcr.2014.09.001
   Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433
   Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019
   Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388
   Guo YN, 2015, MOL CANCER THER, V14, P2215, DOI 10.1158/1535-7163.MCT-15-0419
   Han B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081781
   Higuchi M, 1998, ONCOGENE, V17, P2753, DOI 10.1038/sj.onc.1202211
   Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kesavan G, 2009, CELL, V139, P791, DOI 10.1016/j.cell.2009.08.049
   Khan H, 2018, CURR STEM CELL RES T, V13, P378, DOI 10.2174/1574888X11666160429122527
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kim YH, 2015, BIOMOL THER, V23, P486, DOI 10.4062/biomolther.2015.041
   Kokai LE, 2017, AESTHET SURG J, V37, P454, DOI 10.1093/asj/sjw197
   Kumar A, 2014, ONCOTARGET, V5, P11709, DOI 10.18632/oncotarget.2606
   Laudadio I, 2012, GASTROENTEROLOGY, V142, P119, DOI 10.1053/j.gastro.2011.09.001
   Lee CW, 2017, STEM CELL REP, V9, P247, DOI 10.1016/j.stemcr.2017.05.008
   Legzdina D, 2016, INT J STEM CELLS, V9, P124, DOI 10.15283/ijsc.2016.9.1.124
   Li B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017092
   Liang R, 2014, ANTIOXID REDOX SIGN, V20, P1902, DOI 10.1089/ars.2013.5300
   Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131
   Liu MC, 2017, CELL TRANSPLANT, V26, P1505, DOI 10.1177/0963689717721221
   Lou GH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.63
   Lu J, 2017, STEM CELLS DEV, V26, P1283, DOI 10.1089/scd.2017.0032
   Lu T, 2014, GENET MOL RES, V13, P415, DOI 10.4238/2014.January.21.9
   Magner NL, 2013, STEM CELLS, V31, P2095, DOI 10.1002/stem.1478
   Makdissy N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133181
   Maredziak M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2152435
   McGee-Lawrence ME, 2011, GENE, V474, P1, DOI 10.1016/j.gene.2010.12.003
   Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230
   Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000
   Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124
   Nejak-Bowen Kari, 2008, Organogenesis, V4, P92
   Nguyen DHT, 2017, MICROCIRCULATION, V24, DOI 10.1111/micc.12372
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   Okura H, 2010, TISSUE ENG PART C-ME, V16, P761, DOI [10.1089/ten.tec.2009.0208, 10.1089/ten.TEC.2009.0208]
   Pettinato G, 2016, SCI REP-UK, V6, DOI 10.1038/srep32888
   Puls A, 1999, J CELL SCI, V112, P2983
   Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217
   Sakamori R, 2014, CANCER RES, V74, P5480, DOI 10.1158/0008-5472.CAN-14-0267
   Salehi H, 2016, STEM CELL REV REP, V12, P26, DOI 10.1007/s12015-015-9631-7
   Seeliger C, 2013, CELL TRANSPLANT, V22, P119, DOI 10.3727/096368912X638946
   Shukla U, 2013, DRUG METAB DISPOS, V41, P1769, DOI 10.1124/dmd.113.052860
   Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011
   Snykers S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-24
   Snykers S, 2009, J HEPATOL, V51, P187, DOI 10.1016/j.jhep.2009.03.009
   Surviladze Z., 2010, POTENT SELECTIVE INH
   Talens-Visconti R, 2006, WORLD J GASTROENTERO, V12, P5834, DOI 10.3748/wjg.v12.i36.5834
   Teng NY, 2015, TISSUE ENG PT A, V21, P1444, DOI [10.1089/ten.tea.2014.0320, 10.1089/ten.TEA.2014.0320]
   Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30
   Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020
   Wang L, 2007, P NATL ACAD SCI USA, V104, P1248, DOI 10.1073/pnas.0609149104
   Wang L, 2013, STEM CELLS, V31, P1383, DOI 10.1002/stem.1388
   Wang YS, 2013, J CELL BIOCHEM, V114, P2231, DOI 10.1002/jcb.24569
   Wu N, 2016, CANCER BIOL THER, V17, P558, DOI 10.1080/15384047.2016.1177675
   Xu XP, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0617-z
   Yan XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090846
   Yin LB, 2015, MOL MED REP, V11, P1722, DOI 10.3892/mmr.2014.2935
   Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x
   Zhang Y, 2017, J REPROD DEVELOP, V63, P505, DOI 10.1262/jrd.2017-034
NR 91
TC 30
Z9 32
U1 2
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD JUN 19
PY 2018
VL 9
AR 167
DI 10.1186/s13287-018-0910-5
PG 27
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA GJ7WU
UT WOS:000435601600002
PM 29921325
OA gold, Green Published
DA 2024-02-19
ER

PT S
AU Mocchegiani, E
   Giacconi, R
   Muti, E
   Rogo, C
   Bracci, M
   Muzzioli, M
   Cipriano, C
   Malavolta, M
AF Mocchegiani, E
   Giacconi, R
   Muti, E
   Rogo, C
   Bracci, M
   Muzzioli, M
   Cipriano, C
   Malavolta, M
BE DeGrey, ADN
TI Zinc, immune plasticity, aging, and successful aging - Role of
   metallothionein
SO STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF
   AGING MAY BE FORESEEABLE
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 10th Congress of the International-Association-of-Biomedical-Gerontology
CY SEP 19-23, 2003
CL Cambridge, ENGLAND
SP Int Assoc Biomed Gerontol
DE NKT cells; NKT alpha beta and gamma delta cells; zinc; metallothionein;
   IL-6; gp130; PARP-1; immune plasticity; liver extrathymic T cell
   pathway; circadian cycle; partial hepatectomy; liver regeneration;
   aging; successful aging
ID OLD MICE; NK CELLS; IMMUNOSENESCENCE; EXPRESSION
AB The capacity of the remodeling immune responses during stress (immune plasticity) is fundamental to reach successful aging. We herein report two pivotal models to demonstrate the relevance of the immune plasticity in aging and successful aging. One model is represented by the circadian rhythms of immune responses; the other one is the immune responses during partial hepatectomy/liver regeneration (pHx). The latter is suggestive because it mimics the immunosenescence and chronic inflammation 48 hours after partial hepatectomy in the young through the continuous production of IL-6, which is the main cause of immune plasticity lack in aging. The constant production of IL-6 leads to abnormal increments of zinc-bound metallothionein (NIT), which is, in turn, unable in zinc release in aging. As a consequence, low zinc ion bioavailability appears for thymic and extrathymic immune efficiency, in particular, of liver NKT cells bearing TCR gd. The remodeling during the circadian cycle and during pHx of zinc-bound NIT confers the immune plasticity of liver NKT gammadelta cells and NK cells in young and very old age, not in old age. Therefore, zinc-bound MT homeostasis is crucial in conferring liver immune plasticity with subsequent successful aging.
C1 INRCA Ancona, Res Dept, Sect Nutr Immun & Ageing, Immunol Ctr, I-60121 Ancona, Italy.
C3 IRCCS INRCA
RP Mocchegiani, E (corresponding author), INRCA Ancona, Res Dept, Sect Nutr Immun & Ageing, Immunol Ctr, Via Birarelli 8, I-60121 Ancona, Italy.
EM e.mocchegiani@inrca.it
RI Bracci, Massimo/K-1192-2018; Malavolta, Marco/J-8215-2012; Giacconi,
   Robertina/J-5349-2018
OI Bracci, Massimo/0000-0003-3901-5376; Malavolta,
   Marco/0000-0002-8442-1763; Giacconi, Robertina/0000-0002-1468-2140
CR Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4
   Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7
   Cipriano C, 2003, MECH AGEING DEV, V124, P877, DOI 10.1016/S0047-6374(03)00146-5
   Davis SR, 2000, J NUTR, V130, P1085
   Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7
   Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478
   Miyaji C, 2000, HUM IMMUNOL, V61, P908, DOI 10.1016/S0198-8859(00)00153-1
   Mocchegiani E, 1997, LIFE SCI, V61, P1125, DOI 10.1016/S0024-3205(97)00646-2
   Mocchegiani E, 1998, MECH AGEING DEV, V106, P183, DOI 10.1016/S0047-6374(98)00115-8
   Mocchegiani E, 2000, TRENDS PHARMACOL SCI, V21, P205, DOI 10.1016/S0165-6147(00)01476-0
   Mocchegiani E, 2003, MECH AGEING DEV, V124, P459, DOI 10.1016/S0047-6374(03)00023-X
   Mocchegiani E, 2002, EXP GERONTOL, V37, P349, DOI 10.1016/S0531-5565(01)00202-9
   Mocchegiani E, 1998, J NEUROIMMUNOL, V86, P111, DOI 10.1016/S0165-5728(97)00253-1
   Pawelec G, 1997, IMMUNOL TODAY, V18, P514, DOI 10.1016/S0167-5699(97)01145-6
   Romano GC, 2000, MECH AGEING DEV, V121, P231
   TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891
NR 16
TC 30
Z9 33
U1 0
U2 7
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-497-8; 1-57331-496-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1019
BP 127
EP 134
DI 10.1196/annals.1297.023
PG 8
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Science & Technology - Other Topics
GA BAN77
UT WOS:000223002700023
PM 15247005
DA 2024-02-19
ER

PT J
AU Mukherjee, S
   Asaithambi, A
   Thakur, MK
AF Mukherjee, S
   Asaithambi, A
   Thakur, MK
TI Androgen treatment protects mouse liver chromatin from cleavage by
   endogenous nucleases during aging - Androgen and nuclease activity
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE aging; androgen; endogenous nuclease; mice liver
ID ENDONUCLEASE; RECEPTOR
AB We have examined the endogenous nuclease activity of the liver of intact, castrated and testosterone-treated mice of different ages. Both Mg2+- and Ca2+-dependent endogenous nuclease activities decline in old age. Withdrawal of the hormone increases nuclease activity in the immature and young. However, testosterone administration prevents the digestion of nuclei to different extents in all ages. These findings suggest a possible protective role of testosterone in the cleavage of liver chromatin by endogenous nucleases during the aging of mice.
C1 BANARAS HINDU UNIV,CTR ADV STUDY ZOOL,BIOCHEM & MOL BIOL LAB,VARANASI 221005,UTTAR PRADESH,INDIA.
C3 Banaras Hindu University (BHU)
CR [Anonymous], 1989, MOL CLONING LAB MANU
   FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897
   HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7
   ISHIDA R, 1974, BIOCHEM BIOPH RES CO, V56, P703, DOI 10.1016/0006-291X(74)90662-7
   KYPRIANOU N, 1988, ENDOCRINOLOGY, V122, P552, DOI 10.1210/endo-122-2-552
   PAUL J, 1976, BIOCHEM BIOPH RES CO, V68, P97
   ROY AK, 1973, ENDOCRINOLOGY, V92, P957, DOI 10.1210/endo-92-3-957
   SHALKA M, 1976, FEBS LETT, V72, P241
   SIMPSON RT, 1976, NUCLEIC ACIDS RES, V3, P117, DOI 10.1093/nar/3.1.117
   THAKUR MK, 1995, CURR SCI INDIA, V68, P806
   WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0
   YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.ge.19.120185.001233
NR 12
TC 3
Z9 3
U1 0
U2 3
PU KLUWER ACADEMIC PUBL
PI DORDRECHT
PA SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 0301-4851
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PY 1996
VL 22
IS 1
BP 59
EP 61
DI 10.1007/BF00996306
PG 3
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA VB217
UT WOS:A1996VB21700007
DA 2024-02-19
ER

PT J
AU VINAYAK, M
AF VINAYAK, M
TI AMINOACYLATION OF RAT-LIVER TRANSFER-RNA WITH HOMOLOGOUS AND
   HETEROLOGOUS ENZYME-SYSTEMS DURING AGING
SO BIOCHEMISTRY INTERNATIONAL
LA English
DT Article
RP VINAYAK, M (corresponding author), BANARAS HINDU UNIV,DEPT ZOOL,BIOCHEM LAB,VARANASI 221005,UTTAR PRADESH,INDIA.
CR BICK MD, 1971, P NATL ACAD SCI USA, V68, P224, DOI 10.1073/pnas.68.1.224
   Bick MD, 1972, MECH AGEING DEV, V1, P33, DOI 10.1016/0047-6374(72)90050-4
   DURE LS, 1973, MOL TECHNIQUES APPRO, P199
   KANABUS J, 1971, P NATL ACAD SCI USA, V68, P873, DOI 10.1073/pnas.68.5.873
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANJULA, 1980, J BIOSCI BANGALORE, V2, P243
   MANS RJ, 1961, ARCH BIOCHEM BIOPHYS, V94, P48, DOI 10.1016/0003-9861(61)90009-1
   SCHNEIDER WC, 1957, METHOD ENZYMOL, V3, P680, DOI 10.1016/S0076-6879(57)03442-4
   STULBERG MP, 1971, CANCER RES, V31, P671
   YANG WK, 1971, METHOD ENZYMOL, V20, P45
NR 10
TC 4
Z9 4
U1 0
U2 0
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE NSW 2204, AUSTRALIA
SN 0158-5231
J9 BIOCHEM INT
PD MAR
PY 1986
VL 12
IS 3
BP 479
EP 484
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA A8098
UT WOS:A1986A809800012
PM 3635385
DA 2024-02-19
ER

PT J
AU Yang, SJ
   Lim, Y
AF Yang, Soo Jin
   Lim, Yunsook
TI Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3
   inflammasome activation
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article
DE Hepatic metaflammation; NLRP3 inflammasome; Non-alcoholic fatty liver
   disease; Resveratrol; Sirtuin
ID FATTY LIVER-DISEASE; INSULIN-RESISTANCE; IN-VITRO; PROTEIN-KINASE;
   OXIDATIVE STRESS; SKELETAL-MUSCLE; DIET; STEATOSIS; CYTOKINES; MODEL
AB Objective. Resveratrol (RSV) regulates NAD bioavailability and sirtuin-related metabolism, which relates to aging, metabolic syndrome and non-alcoholic fatty liver disease. The purpose of this study was to investigate the effects of resveratrol on hepatic metaflammation in a rodent model of high-fat (HF) diet-induced obesity (DIO).
   Materials/Methods. DIO was induced in a subset of mice given an HF diet (45% kcal fat). After 6 weeks of HF diet feeding, RSV was delivered via an osmotic pump for 4 weeks. The experimental groups were as follows: 1) lean control fed with a standard diet, 2) HF diet-induced obese control, and 3) HF_RSV (8 mg/kg/day). After 4 weeks of each treatment, blood and liver tissues were collected and the indices of glucose control, serum and liver triglyceride (TG), sirtuin pathway, inflammation, and NOD-like receptor family, pryin domain containing 3 (NLRP3) inflammasome were analyzed.
   Results. Body weight and food intake were not altered by administering resveratrol. Glucose control was impaired, and serum and liver TG levels were increased by the HF diet. Hepatic inflammation was aggravated in mice fed with the HF diet, as shown by the increased levels of the pro-inflammatory markers interleukin-1 (IL-1), IL-6 and tumor necrosis factor-alpha in the liver. However, resveratrol administration significantly improved glucose control, and serum and liver TG contents. Also, resveratrol treatment reduced the levels of the pro-inflammatory markers. These improvements were accompanied by alterations in sirtuin pathway and NLRP3 inflammasome activation.
   Conclusion. These results demonstrate that resveratrol ameliorates hepatic metaflammation, accompanied by alterations in NLRP3 inflammasome. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Yang, Soo Jin] Chonnam Natl Univ, Dept Food & Nutr, Kwangju 500757, South Korea.
   [Yang, Soo Jin] Chonnam Natl Univ, Human Ecol Res Inst, Kwangju 500757, South Korea.
   [Lim, Yunsook] Kyung Hee Univ, Dept Food & Nutr, Seoul, South Korea.
C3 Chonnam National University; Chonnam National University; Kyung Hee
   University
RP Yang, SJ (corresponding author), Chonnam Natl Univ, Dept Food & Nutr, Kwangju 500757, South Korea.
EM sjyang89@chonnam.ac.kr
RI Lim, Yunsook/AAI-8996-2020
OI Yang, Soo Jin/0000-0001-7892-7648
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF); Ministry of Education, Science and Technology
   [NRF-2012R1A1A1004861]; Chonnam National University in Korea
FX This research was supported by grants from Basic Science Research
   Program through the National Research Foundation of Korea (NRF) funded
   by the Ministry of Education, Science and Technology
   (NRF-2012R1A1A1004861) and Chonnam National University (2012) in Korea.
CR Ahn J, 2012, MOL NUTR FOOD RES, V56, P1665, DOI 10.1002/mnfr.201200182
   Asrih M, 2013, J ENDOCRINOL, V218, pR25, DOI 10.1530/JOE-13-0201
   Bertelli AAA, 2009, J CARDIOVASC PHARM, V54, P468, DOI 10.1097/FJC.0b013e3181bfaff3
   Brasnyó P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316
   Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003
   Chang CC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-47
   Chen LL, 2011, METABOLISM, V60, P1598, DOI 10.1016/j.metabol.2011.04.002
   Cho SJ, 2012, BRIT J NUTR, V108, P2166, DOI 10.1017/S0007114512000347
   Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341
   Dixon LJ, 2012, LAB INVEST, V92, P713, DOI 10.1038/labinvest.2012.45
   Dowman JK, 2011, DIABETES OBES METAB, V13, P692, DOI 10.1111/j.1463-1326.2011.01403.x
   Fuentes E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/136584
   Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250
   Hill A, 2013, INT J PHARMACEUT, V451, P57, DOI 10.1016/j.ijpharm.2013.04.060
   Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200
   Kang W, 2012, METABOLISM, V61, P424, DOI 10.1016/j.metabol.2011.08.003
   Kashi MR, 2008, SEMIN LIVER DIS, V28, P396, DOI 10.1055/s-0028-1091984
   Kern PA, DIABETES
   Kitada M, 2013, DIABETES METAB J, V37, P315
   Liu YX, 2011, J AGR FOOD CHEM, V59, P12254, DOI 10.1021/jf203136j
   McCarthy EM, 2012, J ACAD NUTR DIET, V112, P401, DOI 10.1016/j.jada.2011.10.007
   Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25
   Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822
   Poulsen MM, 2012, NUTR RES, V32, P701, DOI 10.1016/j.nutres.2012.08.004
   Ramos-Nino Maria E, 2013, ISRN Oncol, V2013, P697521, DOI 10.1155/2013/697521
   Richardson VR, 2013, IMMUNOBIOLOGY, V218, P1497, DOI 10.1016/j.imbio.2013.05.002
   Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040
   Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003
   Sharma S, 2011, PHYTOTHER RES, V25, P67, DOI 10.1002/ptr.3221
   Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017
   Sourianarayanane A, 2013, Minerva Gastroenterol Dietol, V59, P69
   Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035
   Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x
   Tarantino G, 2010, WORLD J GASTROENTERO, V16, P4773, DOI 10.3748/wjg.v16.i38.4773
   Tilg H, 2010, Minerva Gastroenterol Dietol, V56, P159
   Timmers S, 2013, ANN NY ACAD SCI, V1290, P83, DOI 10.1111/nyas.12185
   Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077
   Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279
   Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163
   Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592
   Wu JM, 2011, AM J CARDIOVASC DIS, V1, P38
   Wu JM, 2011, ANN NY ACAD SCI, V1215, P16, DOI 10.1111/j.1749-6632.2010.05854.x
   Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130
   Xiao J, 2014, EUR J NUTR, V53, P187, DOI 10.1007/s00394-013-0516-8
   Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015
   Zheng J, 2012, METABOLISM, V61, P954, DOI 10.1016/j.metabol.2011.11.005
NR 46
TC 102
Z9 111
U1 0
U2 31
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD MAY
PY 2014
VL 63
IS 5
BP 693
EP 701
DI 10.1016/j.metabol.2014.02.003
PG 9
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA AG1UC
UT WOS:000335200700012
PM 24629563
DA 2024-02-19
ER

PT J
AU Wei, Q
   Zhou, BY
   Yang, GY
   Hu, WJ
   Zhang, LL
   Liu, R
   Li, MY
   Wang, K
   Gu, HF
   Guan, YF
   Zhu, ZM
   Zheng, HT
   Peng, J
   Li, L
AF Wei, Qin
   Zhou, Baoyong
   Yang, Gangyi
   Hu, Wenjing
   Zhang, Lili
   Liu, Rui
   Li, Minyan
   Wang, Kuan
   Gu, Harvest F.
   Guan, Youfei
   Zhu, Zhiming
   Zheng, Hongting
   Peng, Jun
   Li, Ling
TI JAZF1 ameliorates age and diet-associated hepatic steatosis through
   SREBP-1c-dependent mechanism
SO CELL DEATH & DISEASE
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; FATTY LIVER-DISEASE; ELEMENT-BINDING PROTEIN;
   TRANSCRIPTION FACTOR; METABOLIC SYNDROME; SREBP-1C PROMOTER; RAT
   HEPATOCYTES; DEFICIENT MICE; IN-VITRO; EXPRESSION
AB JAZF zinc finger 1 (JAZF1) is involved in glucose and lipid metabolisms. However, its role in aging-and nutrient-related hepatic steatosis is unclear. In the current study, we demonstrated that JAZF1 expression was markedly down-regulated in obesity-associated mice and nonalcoholic fatty liver disease (NAFLD) patients. During aging, JAZF1 expression was gradually down-regulated in both C57BL/6 J and JAZF1-Tg mice. In JAZF1-Tg mice, body fat content and hepatosteatosis were protected from HFD-induced steatosis, and accompanied by decreased lipogenesis gene expression. The inhibitory effects of hepatic steatosis in JAZF1-Tg mice, however, were disappeared during aging. In hepatocytes, over-expression of JAZF1 attenuated, while knockdown of JAZF1 enhanced the expression of lipogenesis genes. The over-expressing of JAZF1 in hepatocytes displayed the increased adenosine monophosphate-activated protein kinase (AMPK) phosphorylation and decreased sterol regulatory element-binding protein 1c (SREBP-1c) expression. The roles of JAZF1 were partially attenuated by Compound C. Mechanistically, JAZF1 suppressed SREBP-1c expression through the inhibition of transcriptional activity of liver X receptor response elements (LXREs) in the SREBP-1c promoter. Data illustrate that JAZF1 may have a crucial role in the regulation of age and nutrient-associated hepatosteatosis through an AMPK/SREBP-1c-dependent mechanism.
C1 [Wei, Qin; Li, Minyan; Wang, Kuan; Li, Ling] Chongqing Med Univ, Coll Lab Med, Key Lab Diagnost Med, Minist Educ, Chongqing, Peoples R China.
   [Wei, Qin; Li, Minyan; Wang, Kuan; Li, Ling] Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Chongqing, Peoples R China.
   [Yang, Gangyi; Hu, Wenjing; Zhang, Lili; Liu, Rui] Chongqing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Chongqing, Peoples R China.
   [Zhou, Baoyong] Chongqing Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Chongqing, Peoples R China.
   [Gu, Harvest F.] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Jiangsu, Peoples R China.
   [Gu, Harvest F.] Karolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, Stockholm, Sweden.
   [Guan, Youfei; Peng, Jun] Dalian Med Univ, Adv Inst Med Sci, Dalian, Liaoning, Peoples R China.
   [Zhu, Zhiming] Third Mil Med Univ, Chongqing Inst Hypertens, Daping Hosp, Dept Hypertens & Endocrinol, Chongqing, Peoples R China.
   [Zheng, Hongting] Third Mil Med Univ, Xinqiao Hosp, Dept Endocrinol, Chongqing, Peoples R China.
C3 Chongqing Medical University; Chongqing Medical University; Chongqing
   Medical University; Chongqing Medical University; China Pharmaceutical
   University; Karolinska Institutet; Karolinska University Hospital;
   Dalian Medical University; Army Medical University; Army Medical
   University
RP Li, L (corresponding author), Chongqing Med Univ, Coll Lab Med, Key Lab Diagnost Med, Minist Educ, Chongqing, Peoples R China.; Li, L (corresponding author), Chongqing Med Univ, Coll Lab Med, Dept Clin Biochem, Chongqing, Peoples R China.
EM liling31@hotmail.com
RI zhang, yuyang/IVV-5089-2023; zhou, baoyong/GSJ-3816-2022
OI Li, Ling/0000-0002-0087-3034; guan, youfei/0000-0002-5231-0209
FU National Natural Science Foundation of China [81270913, 81300702,
   81300670, 81601214 81070640, IRT1216]; Natural Science Foundation
   Project of CQ [cstc2015jcyjA10084, cstc2013jcyjA10067]; Science and
   Technology Key Program of Health Bureau of Chongqing [2015ZDXM038]
FX This study was supported by the Grants from the National Natural Science
   Foundation of China (No. 81270913, 81300702, 81300670, 81601214 81070640
   and IRT1216), the Natural Science Foundation Project of CQ (No.
   cstc2015jcyjA10084 and cstc2013jcyjA10067) and the Science and
   Technology Key Program of Health Bureau of Chongqing (2015ZDXM038).
CR Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200
   Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723
   Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162
   Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Farrell GC, 2007, J GASTROEN HEPATOL, V22, P775, DOI 10.1111/j.1440-1746.2007.05002.x
   Foretz M, 1998, J BIOL CHEM, V273, P14767, DOI 10.1074/jbc.273.24.14767
   GIBBONS GF, 1994, J LIPID RES, V35, P1801
   Gómez-Lechón MJ, 2007, CHEM-BIOL INTERACT, V165, P106, DOI 10.1016/j.cbi.2006.11.004
   Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x
   Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821
   Jang WY, 2014, BIOCHEM BIOPH RES CO, V444, P296, DOI 10.1016/j.bbrc.2013.12.094
   Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962
   Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721
   Li L, 2011, METABOLISM, V60, P523, DOI 10.1016/j.metabol.2010.04.021
   Li XQ, 2014, INT J CARDIOL, V177, P100, DOI 10.1016/j.ijcard.2014.09.007
   Nakajima T, 2004, NUCLEIC ACIDS RES, V32, P4194, DOI 10.1093/nar/gkh741
   Nikolaou N, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12944
   Ruhl Constance E, 2004, Clin Liver Dis, V8, P501, DOI 10.1016/j.cld.2004.04.008
   Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832
   Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248
   Song CY, 2013, TOXICOL IN VITRO, V27, P1065, DOI 10.1016/j.tiv.2013.01.020
   Sulander T, 2004, AGE AGEING, V33, P632, DOI 10.1093/ageing/afh212
   Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016
   Wu J, 2013, HEPATOLOGY, V58, P617, DOI 10.1002/hep.26272
   Yang ML, 2014, FEBS J, V281, P3193, DOI 10.1111/febs.12853
   Yuan L, 2015, INT J OBESITY, V39, P949, DOI 10.1038/ijo.2015.5
   Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188
   Zhou B, 2017, ACTA PHARMACOL SIN, V38, P998, DOI 10.1038/aps.2016.175
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 32
TC 34
Z9 36
U1 0
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD AUG 28
PY 2018
VL 9
AR 859
DI 10.1038/s41419-018-0923-0
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA GR9MK
UT WOS:000443087500016
PM 30154417
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Elbialy, A
AF Elbialy, Abdalla
TI Ageing genetic signature of hypersomatotropism
SO OPEN BIOLOGY
LA English
DT Article
DE acromegaly; growth hormone; ageing signature; zebrafish
AB Acromegaly is a pathological condition that is caused by over-secretion of growth hormone (GH) and develops primarily from a pituitary adenoma. Excess GH exposure over a prolonged period of time leads to a wide range of systemic manifestations and comorbidities. Studying the effect of excess GH on the cellular level could help to understand the underlying causes of acromegaly health complications and comorbidities. In our previous publications, we have shown that excess GH reduces body side population (SP) stem cells and induces signs of premature ageing in an acromegaly zebrafish model. Here, we study acromegaly ageing in greater depth at the level of gene expression. We investigated whether acromegaly induces an ageing genetic signature in different organs. Using the GenAge database, our acromegaly model showed a significant enrichment of ageing genetic datasets in the muscle but not in other organs. Likewise, the hierarchical clustering of wild type (WT), acromegaly and aged RNA data from various organs revealed the similarity of gene expression profiles between the acromegaly and the aged muscles. We therefore identified overlapping differentially expressed genes (DEGs) in different organs between acromegaly and aged zebrafish. Importantly, about half of the muscle, liver and brain acromegaly DEGs overlapped with aged zebrafish DEGs. Interestingly, overlapping was observed in the same way; acromegaly-up DEGs overlapped with aged zebrafish up DEGs, not down DEGs, and vice versa. We then identified the biological functions of overlapping DEGs. Enrichment database analysis and gene ontology showed that most overlapping muscle genes were involved in ageing metabolism, while overlapping liver DEGs were involved in metabolic pathways, response to hypoxia and endoplasmic reticulum stress. Thus, this study provides a full ageing genetic signature of acromegaly at the gene expression level.
C1 [Elbialy, Abdalla] Damanhour Univ, Fac Vet Med, Lab Fish Dis, Damanhour 22511, Egypt.
C3 Egyptian Knowledge Bank (EKB); Damanhour University
RP Elbialy, A (corresponding author), Damanhour Univ, Fac Vet Med, Lab Fish Dis, Damanhour 22511, Egypt.
EM abdallakhiry@vetmed.dmu.edu.eg
RI Elbialy, Abdalla/AAT-2225-2021; Elbialy, Abdalla/HPG-2018-2023; Elbialy,
   Abdalla/AAI-2438-2020
OI Elbialy, Abdalla/0000-0002-6344-9425
CR Bayram F, 2014, GROWTH HORM IGF RES, V24, P29, DOI 10.1016/j.ghir.2013.12.002
   Chanson P, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-17
   Colao A, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0071-6
   de Magalhaes JP, 2004, FEBS LETT, V571, P243, DOI 10.1016/j.febslet.2004.07.006
   Elbialy A, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9060120
   Elbialy A, 2018, BIOLOGY-BASEL, V7, DOI 10.3390/biology7040047
   Hamurcu Z, 2011, METABOLISM, V60, P1620, DOI 10.1016/j.metabol.2011.03.013
   Hannah-Shmouni F, 2016, GROWTH HORM IGF RES, V30-31, P37, DOI 10.1016/j.ghir.2016.08.002
   Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091
   Nishizawa H, 2012, GROWTH HORM IGF RES, V22, P64, DOI 10.1016/j.ghir.2012.02.001
   Pauliny A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0436-8
   Petrossians P, 2017, ENDOCR-RELAT CANCER, V24, P505, DOI 10.1530/ERC-17-0253
   Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015
   Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Trivellin G, 2014, NEW ENGL J MED, V371, P2363, DOI 10.1056/NEJMoa1408028
   Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100
NR 17
TC 0
Z9 0
U1 3
U2 5
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
EI 2046-2441
J9 OPEN BIOL
JI Open Biol
PD APR 14
PY 2021
VL 11
IS 4
AR 200265
DI 10.1098/rsob.200265
PG 11
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA RN5FR
UT WOS:000640377500001
PM 33849304
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Bakala, H
   Hamelin, M
   Mary, J
   Borot-Laloi, C
   Friguet, B
AF Bakala, Hilaire
   Hamelin, Maud
   Mary, Jean
   Borot-Laloi, Caroline
   Friguet, Bertrand
TI Catalase, a target of glycation damage in rat liver mitochondria with
   aging
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Aging; Glycation; Catalase; Mitochondrion; Liver; Antioxidant enzyme
ID HYDROGEN-PEROXIDE RELEASE; AGE-RELATED-CHANGES; OXIDATIVE DAMAGE;
   GLUTATHIONE-PEROXIDASE; ANTIOXIDANT ENZYMES; CHAPERONE FUNCTION; PROTEIN
   OXIDATION; FREE-RADICALS; LIFE-SPAN; OVEREXPRESSION
AB Aging is characterized by progressive decline of major cell functions, associated with accumulation of altered macromolecules, particularly proteins. This deterioration parallels age-related dysfunction of mitochondria, thought to be a major determinant of this decline in cell function, since these organelles are both the main sources of reactive oxygen species and targets for their damaging effects. To investigate the link between glycation damages that accumulate with aging and the status of mitochondrial antioxidant enzymes, we identified, by mass spectrometry after two dimensional-gel electrophoresis and western blotting, advanced glycation endproduct-modified matrix proteins in rat liver mitochondria. Catalase appeared to be the only antioxidant enzyme markedly glycated in old rats. Immunogold labeling performed on isolated mitochondria confirmed the mitochondrial matrix location of this enzyme. The content of catalase protein in mitochondrial extract increased with aging whereas the catalase activity was not significantly modified, in spite of a significant increase rate of glycation. Treatment of catalase with the glycating agent fructose led to significant time-dependent inactivation of the enzyme, while methylglyoxal had no noticeable effect. Catalase was co-identified with unglycated glutathione peroxidase-1 in the mitochondrial extracts. Taken together, these results indicate that both anti-oxidant enzymes catalase and glutathione peroxidase-1 housed in liver mitochondria, exhibited a differential sensitivity to glycation; moreover, they lend support to the hypothesis that glycation damages targeting catalase with aging may severely affect its activity, suggesting a link between glycation stress and the age-related decline in antioxidant defense in the mitochondria. (C) 2012 Elsevier B.V. All rights reserved.
C1 [Bakala, Hilaire; Hamelin, Maud; Mary, Jean; Borot-Laloi, Caroline; Friguet, Bertrand] Univ Paris 06, UR4 UPMC, IFR 83, Lab Biol Cellulaire Vieillissement, F-75252 Paris 05, France.
   [Bakala, Hilaire; Friguet, Bertrand] Univ Paris 07, Lab Biol & Biochim Cellulaire Vieillissement, F-75221 Paris 05, France.
C3 Sorbonne Universite; Universite Paris Cite
RP Bakala, H (corresponding author), Univ Paris 06, UR4 UPMC, IFR 83, Lab Biol Cellulaire Vieillissement, F-75252 Paris 05, France.
EM bakala@univ-paris-diderot.fr
RI Mary, Jean/H-2344-2011
OI Mary, Jean/0000-0002-2438-8383; Friguet, Bertrand/0000-0001-8085-1961
FU French Ministry of Research; EC/FP6 Proteomage grant [IP 518230]
FX The financial support of the French Ministry of Research and the EC/FP6
   Proteomage grant (IP 518230) is gratefully acknowledged.
CR AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   Arita Y, 2006, AM J PHYSIOL-LUNG C, V290, pL978, DOI 10.1152/ajplung.00296.2005
   Bai JX, 2001, BIOL SIGNAL RECEPT, V10, P189
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Biswas A, 2006, BIOCHEMISTRY-US, V45, P4569, DOI 10.1021/bi052574s
   BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200
   CORMAN B, 1987, AM J PHYSIOL, V253, pR555, DOI 10.1152/ajpregu.1987.253.4.R555
   CUTLER RG, 1991, ANN NY ACAD SCI, V621, P1
   Delaval E, 2004, EUR J BIOCHEM, V271, P4559, DOI 10.1111/j.1432-1033.2004.04422.x
   Esworthy RS, 1997, ARCH BIOCHEM BIOPHYS, V340, P59, DOI 10.1006/abbi.1997.9901
   Fountoulakis M, 2002, ELECTROPHORESIS, V23, P311, DOI 10.1002/1522-2683(200202)23:2<311::AID-ELPS311>3.0.CO;2-0
   GHOSH MK, 1986, ANAL BIOCHEM, V159, P169, DOI 10.1016/0003-2697(86)90323-4
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hamelin M, 2007, FEBS J, V274, P5949, DOI 10.1111/j.1742-4658.2007.06118.x
   Handy DE, 2009, J BIOL CHEM, V284, P11913, DOI 10.1074/jbc.M900392200
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200
   Hook DWA, 1997, EUR J BIOCHEM, V247, P380, DOI 10.1111/j.1432-1033.1997.00380.x
   Jiang XS, 2005, MOL CELL PROTEOMICS, V4, P12, DOI 10.1074/mcp.M400079-MCP200
   JONES DP, 1978, J BIOL CHEM, V253, P6031
   Kang YB, 1996, LEUKEMIA RES, V20, P397, DOI 10.1016/0145-2126(95)00162-X
   KEHRER JP, 1993, CRIT REV TOXICOL, V23, P21, DOI 10.3109/10408449309104073
   Kim JR, 2000, ANAL BIOCHEM, V283, P214, DOI 10.1006/abio.2000.4623
   KINNULA VL, 1992, AM J RESP CELL MOL, V7, P95, DOI 10.1165/ajrcmb/7.1.95
   Koito W, 2004, J BIOCHEM, V136, P831, DOI 10.1093/jb/mvh193
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   LOPEZTORRES M, 1993, FREE RADICAL BIO MED, V15, P133, DOI 10.1016/0891-5849(93)90052-V
   MAKINO N, 1994, J BIOL CHEM, V269, P1020
   Meng QY, 2007, MECH AGEING DEV, V128, P286, DOI 10.1016/j.mad.2006.12.008
   Münch G, 1999, NAT BIOTECHNOL, V17, P1006, DOI 10.1038/13704
   MUSCARI C, 1990, BIOCHIM BIOPHYS ACTA, V1015, P200, DOI 10.1016/0005-2728(90)90021-U
   Nagaraj RH, 2003, BIOCHEMISTRY-US, V42, P10746, DOI 10.1021/bi034541n
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Ottaviano FG, 2009, MOL CELL BIOCHEM, V327, P111, DOI 10.1007/s11010-009-0049-x
   Pamplona R, 1998, EUR J BIOCHEM, V255, P685, DOI 10.1046/j.1432-1327.1998.2550685.x
   Prakash K, 2002, PROTEIN SCI, V11, P46, DOI 10.1110/ps.ps.20102
   Putnam CD, 2000, J MOL BIOL, V296, P295, DOI 10.1006/jmbi.1999.3458
   RADI R, 1991, J BIOL CHEM, V266, P22028
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E
   Rhee SG, 1999, EXP MOL MED, V31, P53, DOI 10.1038/emm.1999.9
   Rosca MG, 2002, AM J PHYSIOL-RENAL, V283, pF52, DOI 10.1152/ajprenal.00302.2001
   Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191
   Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296
   TEPHLY TR, 1961, J PHARMACOL EXP THER, V134, P77
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699
   Vetrano AM, 2005, J BIOL CHEM, V280, P35372, DOI 10.1074/jbc.M503991200
   Wu S, 2007, CLIN EXP PHARMACOL P, V34, P81, DOI 10.1111/j.1440-1681.2007.04540.x
   Yan H, 1997, BIOCHEM J, V328, P599, DOI 10.1042/bj3280599
   Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168
NR 67
TC 41
Z9 44
U1 0
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD OCT
PY 2012
VL 1822
IS 10
BP 1527
EP 1534
DI 10.1016/j.bbadis.2012.05.016
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 996AM
UT WOS:000308056400003
PM 22683338
OA hybrid
DA 2024-02-19
ER

PT J
AU NISITANI, S
   HOSOKAWA, M
   SASAKI, MS
   YASUOKA, K
   NAIKI, H
   MATSUSHITA, T
   TAKEDA, T
AF NISITANI, S
   HOSOKAWA, M
   SASAKI, MS
   YASUOKA, K
   NAIKI, H
   MATSUSHITA, T
   TAKEDA, T
TI ACCELERATION OF CHROMOSOME-ABERRATIONS IN SENESCENCE-ACCELERATED STRAINS
   OF MICE
SO MUTATION RESEARCH
LA English
DT Article
DE CHROMOSOME ABERRATIONS; SENESCENCE-ACCELERATED MOUSE; ACCELERATED
   SENESCENCE
ID AGE-RELATED-CHANGES; MURINE MODEL; MOUSE SAM; ALTERED ENZYME; CELLS;
   LIVER; DNA
AB Age-related changes in the frequency of chromosome aberrations were examined using bone marrow cells of senescence-accelerated strains of mice (SAM). An accelerated senescence-prone strain, SAM-P/1, showed a striking increase in the frequency of chromosome aberrations, from age 3 to 8 months, whereas an accelerated senescence-resistant strain, SAM-R/1, at the same ages showed only a slight increase. Both these strains were derived from the same ancestral strain (AKR/J). The rate of increase of chromosome aberration frequency paralleled the advancement of senescence in both strains. These observations suggest that there are genetic factors which closely relate to chromosomal instability and acceleration of the senescence processes.
C1 KYOTO UNIV, CHEST DIS RES INST, DEPT SENESCENCE BIOL, SAKYO KU, KYOTO 606, JAPAN.
   KYOTO UNIV, CTR RADIAT BIOL, KYOTO 606, JAPAN.
   KYOTO UNIV, CHEST DIS RES INST, DEPT LAB ANIM, KYOTO 606, JAPAN.
C3 Kyoto University; Kyoto University; Kyoto University
RI Naiki, Hironobu/G-5599-2014
CR BERGTOLD DS, 1985, MOL BIOL AGING
   BROOKS AL, 1973, J GERONTOL, V28, P452, DOI 10.1093/geronj/28.4.452
   CHEN WH, 1989, AM J PATHOL, V135, P379
   CHETSANGA CJ, 1975, NATURE, V253, P130, DOI 10.1038/253130a0
   CROWLEY C, 1963, P NATL ACAD SCI USA, V49, P626, DOI 10.1073/pnas.49.5.626
   CURTIS HJ, 1971, J GERONTOL, V26, P292, DOI 10.1093/geronj/26.3.292
   CURTIS HJ, 1971, J GERONTOL, V26, P1
   CURTIS HJ, 1966, J GERONTOL, V21, P268, DOI 10.1093/geronj/21.2.268
   CUTLER RG, 1976, AGEING CARCINOGENESI
   DAMJANOVICH S, 1989, ARCH GERONTOL GERIAT, V8, P37, DOI 10.1016/0167-4943(89)90068-X
   GERSHON H, 1988, BLOOD CELLS, V14, P93
   HOLLIDAY R, 1974, NATURE, V248, P762, DOI 10.1038/248762a0
   HOLLIDAY R, 1972, HUMANGENETIK, V16, P83, DOI 10.1007/BF00393991
   LAMSON SH, 1980, AM J HUM GENET, V32, P743
   MARTIN GM, 1985, ISRAEL J MED SCI, V21, P296
   MATSUSHITA M, 1986, AM J PATHOL, V125, P276
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   NAIKI H, 1988, AM J PATHOL, V130, P579
   NAKANISHI Y, 1979, CYTOGENET CELL GENET, V24, P61, DOI 10.1159/000131357
   PETES TD, 1974, NATURE, V251, P434, DOI 10.1038/251434a0
   REIS RJS, 1980, CELL, V21, P739, DOI 10.1016/0092-8674(80)90437-7
   RUSSEL E, 1966, BIOL LABORATORY MOUS
   Shmookler Reis R J, 1985, Nature, V316, P167
   STADTMAN ER, 1988, EXP GERONTOL, V23, P327, DOI 10.1016/0531-5565(88)90036-8
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKESHITA S, 1982, MECH AGEING DEV, V20, P13, DOI 10.1016/0047-6374(82)90070-7
   YAMAGISHI H, 1985, MECH AGEING DEV, V29, P101, DOI 10.1016/0047-6374(85)90051-X
   1970, CYTOGENET CELL GENET, V21, P309
NR 28
TC 43
Z9 44
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0921-8262
J9 MUTAT RES
JI Mutat. Res.
PD SEP-NOV
PY 1990
VL 237
IS 5-6
BP 221
EP 228
DI 10.1016/0921-8734(90)90003-A
PG 8
WC Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity; Toxicology
GA FF366
UT WOS:A1990FF36600003
PM 2079961
DA 2024-02-19
ER

PT J
AU Iwabayashi, M
   Taniyama, Y
   Sanada, F
   Azuma, J
   Iekushi, K
   Okayama, K
   Chatterjee, A
   Rakugi, H
   Morishita, R
AF Iwabayashi, Masaaki
   Taniyama, Yoshiaki
   Sanada, Fumihiro
   Azuma, Junya
   Iekushi, Kazuma
   Okayama, Keita
   Chatterjee, Amarnath
   Rakugi, Hiromi
   Morishita, Ryuichi
TI Inhibition of Lp(a)-induced functional impairment of endothelial cells
   and endothelial progenitor cells by hepatocyte growth factor
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Lp(a); HGF; PAD; Senescence; EPC
ID LOW-DENSITY-LIPOPROTEIN; FACTOR GENE; CELLULAR DYSFUNCTION; LIMB
   ISCHEMIA; IN-VITRO; APOLIPOPROTEIN(A); ANGIOGENESIS; SENESCENCE;
   DISEASE; NEOVASCULARIZATION
AB Background: Lipoprotein (a) (Lp(a)) is one of the risk factors for peripheral artery disease (PAD). Our previous report demonstrated that hepatocyte growth factor (HGF) gene therapy attenuated the impairment of collateral formation in Lp(a) transgenic mice. Since risk factors for atherosclerosis accelerate endothelial senescence and impair angiogenesis, we examined the role of Lp(a) in dysfunction and senescence of endothelial progenitor cells (EPC) and endothelial cells.
   Methods: In vitro and in vivo incorporation assays were performed using ex-vivo expanded DiI-labeled human EPC. Senescence of cultured endothelial cells, production of oxidative stress and angiogenesis function were evaluated by SA-beta-galactosidase staining, dihydroethidium (DHE) staining and Matrigel assay, respectively.
   Results: EPC transplantation significantly stimulated recovery of ischemic limb perfusion, while EPC pretreated with Lp(a) did not increase ischemic limb perfusion. Impairment of angiogenesis by EPC with Lp(a) was associated with a significant decrease in CD31-positive capillaries and DiI-labeled EPC. Importantly, Lp(a) significantly accelerated the onset of senescence and production of reactive oxygen species (ROS) in human aortic endothelial cells, accompanied by a significant increase in the protein expression of p53 and p21. On the other hand, HGF significantly attenuated EPC dysfunction, senescence, ROS production, and p53 and p21 expression induced by Lp(a).
   Conclusion: Lp(a) might affect atherosclerosis via acceleration of senescence, ROS production, and functional impairment of the endothelial cell lineage. HGF might have inhibitory effects on these atherogenic actions of Lp(a). (C) 2012 Elsevier Inc. All rights reserved.
C1 [Iwabayashi, Masaaki; Taniyama, Yoshiaki; Sanada, Fumihiro; Azuma, Junya; Iekushi, Kazuma; Okayama, Keita; Chatterjee, Amarnath; Morishita, Ryuichi] Osaka Univ, Dept Clin Gene Therapy, Grad Sch Med, Suita, Osaka 5650871, Japan.
   [Taniyama, Yoshiaki; Azuma, Junya; Iekushi, Kazuma; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan.
C3 Osaka University; Osaka University
RP Taniyama, Y (corresponding author), Osaka Univ, Dept Clin Gene Therapy, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.
EM taniyama@cgt.med.osaka-u.ac.jp; morishit@cgt.med.osaka-u.ac.jp
OI Rakugi, Hiromi/0000-0001-6508-4338
FU Organization for Pharmaceutical Safety and Research; Ministry of Public
   Health and Welfare; Japan Promotion of Science; Ministry of Education,
   Culture, Sports, Science and Technology, of the Japanese Government
FX This work was partially supported by a Grant-in-Aid from the
   Organization for Pharmaceutical Safety and Research, a Grant-in-Aid from
   the Ministry of Public Health and Welfare, a Grant-in-Aid from Japan
   Promotion of Science, and through special coordination funds of the
   Ministry of Education, Culture, Sports, Science and Technology, of the
   Japanese Government.
CR Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745
   Biemond BJ, 1997, CIRCULATION, V96, P1612, DOI 10.1161/01.CIR.96.5.1612
   Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544
   Dieplinger B, 2007, CLIN CHEM, V53, P1298, DOI 10.1373/clinchem.2007.088013
   Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152
   EATON DL, 1987, P NATL ACAD SCI USA, V84, P3224, DOI 10.1073/pnas.84.10.3224
   Fan YF, 2008, J CEREBR BLOOD F MET, V28, P90, DOI 10.1038/sj.jcbfm.9600509
   Galle J, 1999, KIDNEY INT, V55, P1450, DOI 10.1046/j.1523-1755.1999.00351.x
   Greiber S, 1997, NEPHROL DIAL TRANSPL, V12, P1330, DOI 10.1093/ndt/12.7.1330
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E
   Imanishi T, 2004, CLIN EXP PHARMACOL P, V31, P407, DOI 10.1111/j.1440-1681.2004.04022.x
   Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673
   JURGENS G, 1995, STROKE, V26, P1841, DOI 10.1161/01.STR.26.10.1841
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Liu L, 2009, ATHEROSCLEROSIS, V202, P405, DOI 10.1016/j.atherosclerosis.2008.05.024
   Maier JAM, 1996, ATHEROSCLEROSIS, V123, P115, DOI 10.1016/0021-9150(95)05793-5
   MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0
   Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a
   Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045
   Morishita R, 2002, CIRCULATION, V105, P1491, DOI 10.1161/01.CIR.0000012146.07240.FD
   Morishita R, 2011, ARTERIOSCL THROM VAS, V31, P713, DOI 10.1161/ATVBAHA.110.219550
   Nakagami F, 2010, ATHEROSCLEROSIS, V211, P41, DOI 10.1016/j.atherosclerosis.2010.01.016
   Sanada F, 2009, CIRC RES, V105, P667, DOI 10.1161/CIRCRESAHA.109.202713
   Sanada F, 2009, HYPERTENSION, V53, P77, DOI 10.1161/HYPERTENSIONAHA.108.120725
   Shigematsu H, 2010, GENE THER, V17, P1152, DOI 10.1038/gt.2010.51
   Szöcs K, 2002, ARTERIOSCL THROM VAS, V22, P21, DOI 10.1161/hq0102.102189
   Taniyama Y, 2001, CIRCULATION, V104, P2344, DOI 10.1161/hc4401.098470
   Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93
   Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003
   Wu YJ, 2006, CIRC RES, V99, P315, DOI 10.1161/01.RES.0000235986.35957.a3
   Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607
NR 33
TC 13
Z9 15
U1 1
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUN 22
PY 2012
VL 423
IS 1
BP 79
EP 84
DI 10.1016/j.bbrc.2012.05.086
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 983AE
UT WOS:000307087700014
PM 22634007
DA 2024-02-19
ER

PT J
AU Jalan-Sakrikar, N
   Anwar, A
   Yaqoob, U
   Gan, C
   Lagnado, AB
   Wixom, AQ
   Jurk, D
   Huebert, RC
AF Jalan-Sakrikar, Nidhi
   Anwar, Abid
   Yaqoob, Usman
   Gan, Can
   Lagnado, Anthony B.
   Wixom, Alexander Q.
   Jurk, Diana
   Huebert, Robert C.
TI Telomere dysfunction promotes cholangiocyte senescence and biliary
   fibrosis in primary sclerosing cholangitis
SO JCI INSIGHT
LA English
DT Article
ID CELLULAR SENESCENCE; CIRRHOSIS; INHIBITION; EXPRESSION; DISEASE; DNA
AB Cellular senescence and biliary fibrosis are prototypical features of obliterative cholangiopathies, such as primary sclerosing cholangitis (PSC). Telomere dysfunction can lead to senescence either through telomere erosion or damaged telomeres. Our goal was to investigate a mechanistic relationship between telomere damage and biliary fibrosis in PSC. Telomere attrition was observed in the bile ducts of patients with PSC along with a reduction in telomerase reverse transcriptase (TERT) expression, compared with that in normal livers. Similarly, liver tissue from mouse models of biliary fibrosis showed telomere attrition with increased damage at telomeres measured as telomere-associated foci (TAF). Cellular models of senescence induction increased the TAF in cholangiocytes. This coincided with decreased TERT expression and increased senescence, which was rescued by modulating TERT levels. Epigenetic analysis revealed increased acquisition of repressive histone methylation at the TERT promoter, which correlated with decreased TERT transcription. Cholangiocyte-selective deletion of TERT in mice exacerbated fibrosis, whereas androgen therapy toward telomerase rescued liver fibrosis and liver function in a genetic mouse model of PSC. Our results demonstrate a mechanistic role for telomere dysfunction in cellular senescence and fibrosis that characterize PSC. This suggests that PSC may be, in part, a telomere biology disorder, and identifies TERT as a potential therapeutic target.
C1 [Jalan-Sakrikar, Nidhi; Anwar, Abid; Yaqoob, Usman; Gan, Can; Wixom, Alexander Q.; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN USA.
   [Jalan-Sakrikar, Nidhi; Anwar, Abid; Yaqoob, Usman; Gan, Can; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Gastroenterol Res Unit, Rochester, MN USA.
   [Jalan-Sakrikar, Nidhi; Jurk, Diana; Huebert, Robert C.] Mayo Clin & Mayo Fdn, Ctr Cell Signaling Gastroenterol, Rochester, MN USA.
   [Lagnado, Anthony B.; Jurk, Diana] Mayo Clin & Mayo Fdn, Physiol & Biomed Engn, Rochester, MN USA.
   [Jalan-Sakrikar, Nidhi; Huebert, Robert C.] Mayo Clin, Gastroenterol Res Unit, 200 First St SW, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic
RP Jalan-Sakrikar, N; Huebert, RC (corresponding author), Mayo Clin, Gastroenterol Res Unit, 200 First St SW, Rochester, MN 55905 USA.
EM sakrikar.nidhi@mayo.edu; huebert.robert@mayo.edu
OI Wixom, Alexander/0000-0003-2982-7303; Anwar, Abid/0009-0006-8722-7145;
   Jurk, Diana/0000-0003-4486-0857; Huebert, Robert/0000-0002-9812-7573
FU National Institute of Diabetes and Digestive and Kidney Diseases of the
   NIH [DK117861]; Mayo Clinic Center for Cell Signaling in
   Gastroenterology [P30DK084567]; National Center for Advancing
   Translational Science [KL2 TR002379]
FX Research reported in this publication work was supported by grants from
   the National Institute of Diabetes and Digestive and Kidney Diseases of
   the NIH under award DK117861 (to RCH), the Mayo Clinic Center for Cell
   Signaling in Gastroenterology (grant P30DK084567 to NJS), and by the
   National Center for Advancing Translational Science under award KL2
   TR002379 (to NJS). The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   NIH. The authors thank the Epigenomics Development Laboratory and Genome
   Analysis Core at Mayo Clinic, Rochester, MN, for the ChIP-Seq
   experimentation.
CR Aini W, 2014, TRANSPL IMMUNOL, V31, P55, DOI 10.1016/j.trim.2014.06.008
   Aseem SO, 2021, GASTROENTEROLOGY, V160, P889, DOI 10.1053/j.gastro.2020.10.008
   Bar C, 2016, F1000Res, V5
   Bernadotte A, 2016, AGING-US, V8, P3, DOI 10.18632/aging.100871
   de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007
   de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245
   Bogert PS, 2022, CURR OPIN GASTROEN, V38, P121, DOI 10.1097/MOG.0000000000000805
   Bryan C, 2015, STRUCTURE, V23, P1934, DOI 10.1016/j.str.2015.08.006
   Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173
   Carulli L, 2015, WORLD J GASTROENTERO, V21, P379, DOI 10.3748/wjg.v21.i2.379
   Cazzagon N, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2021.100286
   Chakravarti D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18420-w
   Chung BK, 2018, BBA-MOL BASIS DIS, V1864, P1390, DOI 10.1016/j.bbadis.2017.08.020
   Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Ding DQ, 2013, FASEB J, V27, P4375, DOI 10.1096/fj.13-230904
   Donati B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030383
   Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133
   Gal C, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109835
   Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931
   Gild P, 2018, J UROLOGY, V200, P573, DOI 10.1016/j.juro.2018.03.135
   Gordon A., 2010, FASTX TOOLKIT FASTQ
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Greider CW, 1998, CURR BIOL, V8, pR178, DOI 10.1016/S0960-9822(98)70105-8
   Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546
   Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Huda N, 2022, J INVEST MED, V70, P1438, DOI 10.1136/jim-2021-002213
   Jalan-Sakrikar N, 2022, HEPATOL COMMUN, V6, P345, DOI 10.1002/hep4.1809
   Jalan-Sakrikar N, 2019, HEPATOLOGY, V70, P1674, DOI 10.1002/hep.30706
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Kanehisa M, 2020, PROTEIN SCI, V29, P28, DOI 10.1002/pro.3711
   Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Kocarnik JM, 2022, JAMA ONCOL, V8, P420, DOI 10.1001/jamaoncol.2021.6987
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Laish I, 2016, CYTOGENET GENOME RES, V150, P93, DOI 10.1159/000454654
   Laish I, 2015, DIGEST LIVER DIS, V47, P790, DOI 10.1016/j.dld.2015.05.002
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lazaridis KN, 2016, NEW ENGL J MED, V375, P1161, DOI 10.1056/NEJMra1506330
   Lin SD, 2018, NATURE, V556, P244, DOI 10.1038/s41586-018-0004-7
   Liu TJ, 2019, J BIOL CHEM, V294, P8861, DOI 10.1074/jbc.RA118.006615
   Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285
   Meadows V, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.803098
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Penrice DD, 2023, Hepatology
   Ponnala S, 2011, CELL SIGNAL, V23, P2065, DOI 10.1016/j.cellsig.2011.08.001
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Ramírez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257
   Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Shim HS, 2021, NATURE AGING, V1, P1162, DOI 10.1038/s43587-021-00146-z
   Shin HK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97385-2
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319
   Vega-Benedetti Ana F, 2018, Oncotarget, V9, P32775, DOI 10.18632/oncotarget.25996
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
NR 62
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD OCT 23
PY 2023
VL 8
IS 20
AR e170320
DI 10.1172/jci.insight.170320
PG 19
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA W1OZ9
UT WOS:001089407700001
PM 37707950
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Gratte, FD
   Pasic, S
   Abu Bakar, NDB
   Gogoi-Tiwari, J
   Liu, X
   Carlessi, R
   Kisseleva, T
   Brenner, DA
   Ramm, GA
   Olynyk, JK
   Tirnitz-Parker, JEE
AF Gratte, Francis D.
   Pasic, Sara
   Abu Bakar, N. Dianah B.
   Gogoi-Tiwari, Jully
   Liu, Xiao
   Carlessi, Rodrigo
   Kisseleva, Tatiana
   Brenner, David A.
   Ramm, Grant A.
   Olynyk, John K.
   Tirnitz-Parker, Janina E. E.
TI Previous liver regeneration induces fibro-protective mechanisms during
   thioacetamide-induced chronic liver injury
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article; Early Access
DE Chronic liver disease; Liver progenitor cells; Hepatic stellate cells;
   Fibrosis; Thioacetamide
ID HEPATIC STELLATE CELLS; PROGENITOR-CELL; DUCTULAR REACTION; MURINE
   MODEL; SENESCENCE; REGRESSION; YIELD
AB Chronic liver injury is characterised by continuous or repeated epithelial cell loss and inflammation. Hepatic wound healing involves matrix deposition through activated hepatic stellate cells (HSCs) and the expansion of closely associated Ductular Reactions and liver progenitor cells (LPCs), which are thought to give rise to new epithelial cells. In this study, we used the murine thioacetamide (TAA) model to reliably mimic these injury and regeneration dynamics and assess the impact of a recovery phase on subsequent liver injury and fibrosis. Agematched na?ve or 6-week TAA-treated/4-week recovered mice (C57BL/6 J, n = 5?9) were administered TAA for six weeks (C57BL/6 J, n = 5?9). Sera and liver tissues were harvested at key time points to assess liver injury biochemically, by real-time PCR for fibrotic mediators, Sirius Red staining and hydroxyproline assessment for collagen deposition as well as immunofluorescence for inflammatory, HSC and LPC markers. In addition, primary HSCs and the HSC cell line LX-2 were co-cultured with the well-characterised LPC line BMOL and analysed for potential changes in expression of fibrogenic mediators. Our data demonstrate that recovery from a previous TAA insult, with LPCs still present on day 0 of the second treatment, led to a reduced TAA-induced disease progression with less severe fibrosis than in na?ve TAA-treated animals. Importantly, primary activated HSCs significantly reduced pro-fibrogenic gene expression when co-cultured with LPCs. Taken together, previous TAA injury established a fibro-protective molecular and cellular microenvironment. Our proof-of principle HSC/LPC coculture data demonstrate that LPCs communicate with HSCs to regulate fibrogenesis, highlighting a key role for LPCs as regulatory cells during chronic liver disease.
C1 [Gratte, Francis D.; Gogoi-Tiwari, Jully] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.
   [Gratte, Francis D.; Pasic, Sara; Abu Bakar, N. Dianah B.; Gogoi-Tiwari, Jully; Carlessi, Rodrigo; Tirnitz-Parker, Janina E. E.] Curtin Univ, Curtin Med Sch, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.
   [Liu, Xiao; Kisseleva, Tatiana] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA.
   [Brenner, David A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.
   [Ramm, Grant A.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.
   [Ramm, Grant A.] Univ Queensland, Brisbane, Qld, Australia.
   [Olynyk, John K.] Fiona Stanley & Fremantle Hosp Grp, Perth, WA, Australia.
   [Olynyk, John K.] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia.
C3 Murdoch University; Curtin University; University of California System;
   University of California San Diego; University of California System;
   University of California San Diego; QIMR Berghofer Medical Research
   Institute; University of Queensland; Edith Cowan University
RP Tirnitz-Parker, JEE (corresponding author), Curtin Univ, Curtin Med Sch, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.
EM 32707216@student.murdoch.edu.au; sara.pasic@postgrad.curtin.edu.au;
   nurdianah.abubakar@postgrad.curtin.edu.au;
   jully.gogoitiwari@murdoch.edu.au; xil094@ucsd.edu;
   Rodrigo.Carlessi@curtin.edu.au; tkisseleva@health.ucsd.edu;
   dbrenner@health.ucsd.edu; Grant.Ramm@qimrberghofer.edu.au;
   John.Olynyk@health.wa.gov.au; n.tirnitz-parker@curtin.edu.au
RI Ramm, Grant A/G-2669-2013
OI Ramm, Grant A/0000-0001-7058-6201; Tirnitz-Parker,
   Janina/0000-0002-3558-5892; Carlessi, Rodrigo/0000-0003-0038-7391; Gogoi
   Tiwari, Jully/0000-0001-7648-5858; Olynyk, John/0000-0003-0417-3411
FU National Health and Medical Research Council [APP1087125, APP1160323];
   Spinnaker-Health Research Foundation; Murdoch University; Curtin
   University
FX This research was supported by the National Health and Medical Research
   Council provided Project Grant funding (APP1087125 and APP1160323). The
   Spinnaker-Health Research Foundation and Murdoch University co-funded a
   Belberry Medical Research PhD scholarship, while Curtin University
   provided Australian Government-funded Research Training Program PhD
   scholarships.
CR Breitkopf-Heinlein K, 2020, GUT, V69, P975, DOI 10.1136/gutjnl-2019-320203
   Cai XY, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104720
   Chen JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130310
   Chen L, 2019, HEPATOL COMMUN, V3, P180, DOI 10.1002/hep4.1290
   Dai Z, 2020, GUT, V69, P1104, DOI 10.1136/gutjnl-2019-318812
   Dwyer BJ, 2021, J HEPATOL, V74, P860, DOI 10.1016/j.jhep.2020.11.018
   Dwyer BJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00039
   Español-Suñer R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024
   Grzelak CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171480
   Grzelak CA, 2014, J HEPATOL, V60, P143, DOI 10.1016/j.jhep.2013.08.012
   Hicks DF, 2017, SCI REP-UK, V7, DOI 10.1038/srep42563
   Kallis YN, 2011, GUT, V60, P525, DOI 10.1136/gut.2010.224436
   Kisseleva T, 2021, NAT REV GASTRO HEPAT, V18, P151, DOI 10.1038/s41575-020-00372-7
   Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109
   Köhn-Gaone J, 2016, AM J PHYSIOL-GASTR L, V310, pG143, DOI 10.1152/ajpgi.00215.2015
   Köhn-Gaone J, 2016, AM J PATHOL, V186, P1762, DOI 10.1016/j.ajpath.2016.03.005
   Koyama Y, 2016, DIGEST DIS, V34, P589, DOI 10.1159/000445269
   Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1
   Lemoinne S, 2019, CURR OPIN PHARMACOL, V49, P60, DOI 10.1016/j.coph.2019.09.006
   Liedtke C, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-19
   Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Müller M, 2016, ONCOTARGET, V7, P17431, DOI 10.18632/oncotarget.7836
   Prakoso E, 2014, LIVER TRANSPLANT, V20, P1508, DOI 10.1002/lt.24007
   Raven A, 2017, NATURE, V547, P350, DOI 10.1038/nature23015
   Ruddell RG, 2009, HEPATOLOGY, V49, P227, DOI 10.1002/hep.22597
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9
   Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008
   Tirnitz-Parker JEE, 2019, HEPATOLOGY, V69, P2286, DOI 10.1002/hep.30340
   Tirnitz-Parker JEE, 2014, HEPATOLOGY, V59, P1198, DOI 10.1002/hep.26701
   Tirnitz-Parker JEE, 2010, HEPATOLOGY, V52, P291, DOI 10.1002/hep.23663
   Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039
   Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820
   Wood MJ, 2014, HEPATOLOGY, V59, P848, DOI 10.1002/hep.26706
   Zhou JY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14138-6
NR 38
TC 1
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD 2021 MAY
PY 2021
VL 134
AR 105933
DI 10.1016/j.biocel.2021.105933
EA MAR 2021
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA RZ2MZ
UT WOS:000648433900005
PM 33540107
DA 2024-02-19
ER

PT J
AU VINAYAK, M
AF VINAYAK, M
TI A COMPARISON OF TRANSFER-RNA POPULATIONS OF RAT-LIVER AND
   SKELETAL-MUSCLE DURING AGING
SO BIOCHEMISTRY INTERNATIONAL
LA English
DT Article
RP VINAYAK, M (corresponding author), BANARAS HINDU UNIV, DEPT ZOOL, BIOCHEM LAB, VARANASI 221005, UTTAR PRADESH, INDIA.
CR Bick MD, 1972, MECH AGEING DEV, V1, P33, DOI 10.1016/0047-6374(72)90050-4
   CHUANG RY, 1972, J BIOL CHEM, V247, P3476
   DAIKEE L, 1976, BIOL NEONATE, V28, P27
   DURE LS, 1973, MOL TECHNIQUES APPRO, P199
   HATFIELD D, 1970, P NATL ACAD SCI USA, V67, P1200, DOI 10.1073/pnas.67.3.1200
   HEYMAN T, 1973, BIOCHIMIE, V55, P127, DOI 10.1016/S0300-9084(73)80384-0
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANS RJ, 1961, ARCH BIOCHEM BIOPHYS, V94, P48, DOI 10.1016/0003-9861(61)90009-1
   MCMILLIAN RA, 1975, J BACTERIOL, V122, P526, DOI 10.1128/JB.122.2.526-531.1975
   Medvedev ZA, 1986, DRUGS AGING, P1
   MUSCHINSKI JF, 1971, BIOCHEMISTRY-US, V10, P4190
   NEUMEISTER JA, 1981, MECH AGEING DEV, V16, P319, DOI 10.1016/0047-6374(81)90016-6
   ORTWERTH BJ, 1971, BIOCHEMISTRY-US, V10, P4190, DOI 10.1021/bi00799a006
   OSTERMAN LA, 1979, BIOCHIMIE, V61, P323, DOI 10.1016/S0300-9084(79)80126-1
   PILLAY DTN, 1981, GERONTOLOGY, V27, P194, DOI 10.1159/000212473
   ROGG H, 1977, P NATL ACAD SCI USA, V74, P4243, DOI 10.1073/pnas.74.10.4243
   ROTHSTEIN M, 1982, BIOCH APPROACHES AGI, pCH7
   SCHNEIDER WC, 1957, METHOD ENZYMOL, V3, P680, DOI 10.1016/S0076-6879(57)03442-4
   STREHLER BL, 1967, P NATL ACAD SCI USA, V57, P1751, DOI 10.1073/pnas.57.6.1751
   SUEOKA N, 1964, P NATL ACAD SCI USA, V52, P1535, DOI 10.1073/pnas.52.6.1535
   TAYLOR WW, 1968, J MOL BIOL, V33, P809, DOI 10.1016/0022-2836(68)90321-5
   VINAYAK M, 1986, BIOCHEM INT, V12, P479
   VOLD B, 1975, SPORES, V6, P282
   Yang W. K., 1971, METHOD ENZYMOL, V20, P44
NR 24
TC 6
Z9 6
U1 0
U2 0
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE, NSW 2204, AUSTRALIA
SN 0158-5231
J9 BIOCHEM INT
PD AUG
PY 1987
VL 15
IS 2
BP 279
EP 285
PG 7
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA K2396
UT WOS:A1987K239600003
PM 3435524
DA 2024-02-19
ER

PT J
AU Zhang, N
   Zhang, ZT
   Xu, W
   Jing, P
AF Zhang, Nan
   Zhang, Zhentao
   Xu, Wei
   Jing, Pu
TI TMT-based quantitative proteomic analysis of hepatic tissue reveals the
   effects of dietary cyanidin-3-diglucoside-5-glucoside-rich extract on
   alleviating D-galactose-induced aging in mice
SO JOURNAL OF PROTEOMICS
LA English
DT Article; Early Access
DE Cyanidin-3-diglucoside-5-glucoside; Hepatic proteome; Reactive oxygen
   species; Electron transport chain; Glycolysis
ID INDUCED LIVER-INJURY; OXIDATIVE STRESS; ANTHOCYANINS; ACTIVATION;
   LONGEVITY; TARGET; CANCER; ROLES; ITRAQ
AB Cyanidin-3-diglucoside-5-glucoside (CY3D5G) derivatives as major pigments in red cabbage exhibit in vitro antioxidant effects. This study evaluated the effects of CY3D5G-rich extract on oxidative stress in D-galactose-induced accelerated aging. Thirty male C57BL/6 J mice were divided into three groups: a normal control group and two D-galactose-injected groups orally administered with or without CY3D5G-rich extract (700 mu mol/kg body weight). Dietary supplementation of CY3D5G-rich extract for 6 weeks increased superoxide dismutase activity, glutathione peroxidase activity, and total antioxidant capacity while suppressed malondialdehyde content in serum (p < 0.05) and tissues. Hepatic proteome analysis revealed that 243 proteins were significantly modulated by experimental treatment (p < 0.05). CY3D5G-rich extract treatment suppressed proteins involved in electron transport chain and up-regulated proteins that play important roles in glycolysis, tricarboxylic acid cycle, and actin cytoskeleton. These changes in above metabolic pathways may contribute to reducing the production and release of ROS and attenuating oxidative damage in aged mice.
   Significance: Anthocyanins are the most abundant dietary flavonoids with potential health benefits. The proteomic analysis of mice liver in this study revealed the effect of cyanidin-3-diglucoside-5-glucoside (CY3D5G) consumption in D-galactose-induced accelerated aging. In total, 2054 protein groups were quantified in all samples without any missing value, and 243 protein groups were identified with statistical significance (p < 0.05). Bioinformatics analysis suggested that electron transport chain, glycolysis, tricarboxylic acid cycle, and actin cytoskeleton were closely correlated with CY3D5G treatment. These findings provide useful information to understand the anti-aging effect of anthocyanin, and the results of which could promote the use of anthocyanins in food and pharmaceutical industries.
C1 [Zhang, Nan; Xu, Wei; Jing, Pu] Shanghai Jiao Tong Univ, Sch Agr & Biol, Key Lab Urban Agr South, Shanghai Food Safety & Engn Technol Res Ctr,Bor S, Shanghai 200240, Peoples R China.
   [Zhang, Zhentao] Chinese Acad Sci, Tech Inst Phys & Chem, Beijing 100190, Peoples R China.
C3 Shanghai Jiao Tong University; Chinese Academy of Sciences; Technical
   Institute of Physics & Chemistry, CAS
RP Jing, P (corresponding author), Shanghai Jiao Tong Univ, 800 Dongchuan Rd, Shanghai, Peoples R China.
EM pjing@sjtu.edu.cn
RI xu, wei/HHD-2891-2022; Jing, Pu/AAG-7020-2021
FU Key-Area Research and Development Program of Guangdong Province
   [2018B020239001]; Shanghai Food Safety and Engineering Technology
   Research Center [16DZ2281400]
FX This work was supported by the Key-Area Research and Development Program
   of Guangdong Province (2018B020239001) and Shanghai Food Safety and
   Engineering Technology Research Center (16DZ2281400).
CR Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408
   Chen YH, 2019, FOOD CHEM, V270, P229, DOI 10.1016/j.foodchem.2018.07.095
   Cheong LZ, 2017, FOOD FUNCT, V8, P2038, DOI [10.1039/c6fo01848c, 10.1039/C6FO01848C]
   De la Fuente M, 2009, CURR PHARM DESIGN, V15, P3003, DOI 10.2174/138161209789058110
   Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477
   dos Santos NM, 2019, CURR OPIN FOOD SCI, V26, P71, DOI 10.1016/j.cofs.2019.03.008
   Fernández-García C, 2019, EUR J NUTR, V58, P653, DOI 10.1007/s00394-018-1657-6
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017
   Glinska S, 2007, ECOTOX ENVIRON SAFE, V68, P343, DOI 10.1016/j.ecoenv.2007.02.004
   Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148
   Guo HH, 2015, REV ENDOCR METAB DIS, V16, P1, DOI 10.1007/s11154-014-9302-z
   Hou FL, 2013, J FUNCT FOODS, V5, P1705, DOI 10.1016/j.jff.2013.07.015
   Hung CL, 2017, J PROTEOME RES, V16, P3504, DOI 10.1021/acs.jproteome.7b00148
   Igarashi K, 2000, BIOSCI BIOTECH BIOCH, V64, P1600, DOI 10.1271/bbb.64.1600
   Jing P, 2008, J AGR FOOD CHEM, V56, P9391, DOI 10.1021/jf8005917
   Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456
   Kil IS, 2004, FREE RADICAL BIO MED, V37, P1765, DOI 10.1016/j.freeradbiomed.2004.08.025
   Kolodziejczyk J, 2011, CENT EUR J BIOL, V6, P565, DOI 10.2478/s11535-011-0037-5
   LINTS FA, 1989, GERONTOLOGY, V35, P36, DOI 10.1159/000212998
   Liu CW, 2019, J PROTEOMICS, V196, P1, DOI 10.1016/j.jprot.2019.01.011
   Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905
   Lodeiro M, 2017, J GERONTOL A-BIOL, V72, P319, DOI 10.1093/gerona/glw073
   Lu XL, 2014, FOOD FUNCT, V5, P2892, DOI 10.1039/c4fo00391h
   Ma YF, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700661
   Ma Z, 2020, J BIOMOL STRUCT DYN, V38, P1858, DOI 10.1080/07391102.2019.1618735
   Munkácsy E, 2014, EXP GERONTOL, V56, P221, DOI 10.1016/j.exger.2014.03.016
   Ongkowijoyo P, 2018, FOOD CHEM, V250, P113, DOI 10.1016/j.foodchem.2018.01.055
   Plumel MI, 2016, J PROTEOMICS, V135, P181, DOI 10.1016/j.jprot.2015.09.008
   Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P67, DOI 10.1016/j.bbadis.2012.09.003
   Sankhari JM, 2012, J SCI FOOD AGR, V92, P1688, DOI 10.1002/jsfa.5532
   Song J, 2015, J PROTEOMICS, V122, P1, DOI 10.1016/j.jprot.2015.03.017
   Strauch RC, 2019, FOOD CHEM, V301, DOI 10.1016/j.foodchem.2019.125289
   Swomley AM, 2017, J NUTR BIOCHEM, V39, P169, DOI 10.1016/j.jnutbio.2016.10.006
   Toivola DM, 2015, FASEB J, V29, P5081, DOI 10.1096/fj.14-269795
   Tong T, 2017, J FUNCT FOODS, V32, P9, DOI 10.1016/j.jff.2017.01.051
   Tucker KL, 2016, ANN NY ACAD SCI, V1367, P38, DOI 10.1111/nyas.13062
   Wallace TC, 2011, ADV NUTR, V2, P1, DOI 10.3945/an.110.000042
   Wojdylo A, 2018, J FUNCT FOODS, V48, P632, DOI 10.1016/j.jff.2018.07.061
   Xu W, 2019, FOOD RES INT, V126, DOI 10.1016/j.foodres.2019.108591
   Yang HP, 2011, J AGR FOOD CHEM, V59, P2069, DOI 10.1021/jf1033619
   Yarian CS, 2006, MECH AGEING DEV, V127, P79, DOI 10.1016/j.mad.2005.09.028
   Yeh SL, 2014, EUR J NUTR, V53, P449, DOI 10.1007/s00394-013-0545-3
   Zhao C, 2019, FOOD CHEM, V271, P148, DOI 10.1016/j.foodchem.2018.07.115
   Zheng XX, 2020, J PROTEOMICS, V215, DOI 10.1016/j.jprot.2020.103653
NR 45
TC 4
Z9 4
U1 4
U2 39
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD 2021 FEB 10
PY 2021
VL 232
AR 104042
DI 10.1016/j.jprot.2020.104042
EA JAN 2021
PG 10
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA PQ6CE
UT WOS:000606630700003
PM 33161165
OA hybrid
DA 2024-02-19
ER

PT J
AU LEAKEY, JEA
   CUNNY, HC
   BAZARE, J
   WEBB, PJ
   LIPSCOMB, JC
   SLIKKER, W
   FEUERS, RJ
   DUFFY, PH
   HART, RW
AF LEAKEY, JEA
   CUNNY, HC
   BAZARE, J
   WEBB, PJ
   LIPSCOMB, JC
   SLIKKER, W
   FEUERS, RJ
   DUFFY, PH
   HART, RW
TI EFFECTS OF AGING AND CALORIC RESTRICTION ON HEPATIC DRUG-METABOLIZING
   ENZYMES IN THE FISCHER-344 RAT .2. EFFECTS ON CONJUGATING ENZYMES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 NATL CTR TOXICOL RES,DIV GENET TOXICOL,JEFFERSON,AR 72079.
   NATL CTR TOXICOL RES,OFF DIRECTOR,JEFFERSON,AR 72079.
   UNIV ARKANSAS MED SCI,DEPT PHARMACOL & INTERDISCIPLINARY TOXICOL,LITTLE ROCK,AR 72205.
C3 US Food & Drug Administration (FDA); US Food & Drug Administration
   (FDA); University of Arkansas System; University of Arkansas Medical
   Sciences
RP LEAKEY, JEA (corresponding author), NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,JEFFERSON,AR 72079, USA.
CR ARMARIO A, 1987, ANN NUTR METAB, V31, P81, DOI 10.1159/000177254
   BENSON AM, 1977, P NATL ACAD SCI USA, V74, P158, DOI 10.1073/pnas.74.1.158
   BILLON MC, 1980, MOL CELL ENDOCRINOL, V18, P99, DOI 10.1016/0303-7207(80)90085-4
   BIRNBAUM LS, 1987, J AM GERIATR SOC, V35, P51, DOI 10.1111/j.1532-5415.1987.tb01319.x
   BURCHELL B, 1980, FEBS LETT, V111, P131, DOI 10.1016/0014-5793(80)80777-0
   BURCHELL B, 1981, REV BIOCHEM TOXICOL, V3, P1
   CAMPBELL TC, 1974, PHARMACOL REV, V26, P171
   CHOWDHURY JR, 1986, BIOCHEM J, V233, P827, DOI 10.1042/bj2330827
   CONSTANTOPOULOS SA, 1976, GASTROENTEROLOGY, V75, P486
   Dutton G J, 1981, Methods Enzymol, V77, P383
   DUTTON GJ, 1978, ANNU REV PHARMACOL, V18, P17, DOI 10.1146/annurev.pa.18.040178.000313
   FALANY CN, 1983, ARCH BIOCHEM BIOPHYS, V227, P248, DOI 10.1016/0003-9861(83)90368-5
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   GUENGERICH FP, 1984, ANNU REV NUTR, V4, P207, DOI 10.1146/annurev.nu.04.070184.001231
   Guenthner T M, 1981, Methods Enzymol, V77, P344
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   JAKOBY WB, 1980, ENZYMATIC BASIS DETO, V2, P199
   KATO R, 1977, XENOBIOTICA, V7, P25, DOI 10.3109/00498257709036242
   KITANI K, 1988, GERONTOLOGY, V34, P55, DOI 10.1159/000212931
   Leakey JE, 1983, BIOL BASIS DETOXICAT, P77
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P145, DOI 10.1016/0047-6374(89)90046-8
   LEAKEY JEA, 1978, BIOCHEM J, V175, P1119, DOI 10.1042/bj1751119
   LEAKEY JEA, 1987, BIOCHEM J, V243, P859, DOI 10.1042/bj2430859
   LEAKEY JEA, 1985, ADV GLUCURONIDE CONJ, P111
   LILIENBLUM W, 1982, BIOCHEM PHARMACOL, V31, P377
   Mannervik B, 1985, Adv Enzymol Relat Areas Mol Biol, V57, P357
   MATSUI M, 1982, BIOCHEM J, V202, P171, DOI 10.1042/bj2020171
   MOUNIE J, 1986, J NUTR, V116, P2034, DOI 10.1093/jn/116.10.2034
   ORLOWSKI M, 1965, J BIOL CHEM, V240, P338
   PUIG JF, 1986, MOL PHARMACOL, V30, P558
   RAO GS, 1976, BIOCHEM J, V74, P545
   RIKANS LE, 1982, BIOCHEM PHARMACOL, V31, P2339, DOI 10.1016/0006-2952(82)90527-5
   Schmucker D. L., 1979, PHARMACOL REV, V30, P445
   Sekura R D, 1981, Methods Enzymol, V77, P197
   SINGER SS, 1984, BIOCHEM SOC T, V12, P35, DOI 10.1042/bst0120035
   SINGER SS, 1979, ANAL BIOCHEM, V96, P34, DOI 10.1016/0003-2697(79)90550-5
   TUKEY R, 1980, LIFE SCI, V27, P2471, DOI 10.1016/0024-3205(80)90524-X
   VANROY FP, 1968, BIOCHEM J, V107, P507, DOI 10.1042/bj1070507
   VONMEYERINCK L, 1985, DRUG METAB DISPOS, V13, P700
   WEATHERILL PJ, 1980, BIOCHEM J, V189, P377, DOI 10.1042/bj1890377
   Weber W W, 1981, Methods Enzymol, V77, P272
   WILLIAMS RT, 1959, DETOXICATION MECHANI, P1
   WISHART GJ, 1978, BIOCHEM J, V174, P671, DOI 10.1042/bj1740671
NR 43
TC 60
Z9 60
U1 1
U2 3
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAY
PY 1989
VL 48
IS 2
BP 157
EP 166
DI 10.1016/0047-6374(89)90047-X
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA U7806
UT WOS:A1989U780600006
PM 2500570
DA 2024-02-19
ER

PT J
AU Wang, H
   Zhang, ZS
   Guo, Y
   Sun, P
   Lv, XL
   Zuo, YB
AF Wang, Hao
   Zhang, Zesheng
   Guo, Ying
   Sun, Ping
   Lv, Xiaoling
   Zuo, Yanbo
TI Hawthorn fruit increases the antioxidant capacity and reduces lipid
   peroxidation in senescence-accelerated mice
SO EUROPEAN FOOD RESEARCH AND TECHNOLOGY
LA English
DT Article
DE Hawthorn fruit extract; Antioxidant activity; Superoxide dismutase;
   Catalase; Glutathione peroxidase; Lipid peroxidation;
   Senescence-accelerated mice
ID EXTRACTS; DAMAGE; FLAVONOIDS; CRATAEGUS; RADIATION; BRAIN; MODEL; RATS
AB Hawthorn fruit has long been used as a folk medicine with many medicinal benefits. HPLC analysis revealed that hawthorn fruit extract (HFE) contained 19.86% procyanidin B2, 15.27% epicatechin, 3.10% chlorogenic acid, 2.91% hyperoside, and 1.34% isoquercitrin. Antioxidants are essential for protection of the bodies against the damaging action of free radicals. And we hypothesized that HFE could enhance antioxidant defenses and improve antioxidant status in aged mice. To test this hypothesis, senescence-accelerated mice (SAM) used as an aging animal model were treated with HFE to evaluate the antioxidant effects of HFE in vivo. We found that the activities of antioxidant enzymes, namely, superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) in serum, liver, and brain of SAM mice increased upon HFE treatment, meanwhile the malondialdehyde (MDA) content declined. Concurrently, the gene expression levels of SOD, CAT, and GSH-Px were up-regulated in liver. Furthermore, the antioxidant potential of HFE was also investigated with different systems such as superoxide anion radical scavenging and reducing power. The results showed that HFE indicated a concentration-dependent antioxidant activity in vitro.
C1 [Wang, Hao; Zhang, Zesheng; Guo, Ying; Sun, Ping; Lv, Xiaoling; Zuo, Yanbo] Tianjin Univ Sci & Technol, Key Lab Food Nutr & Safety, Minist Educ, Tianjin 300457, Peoples R China.
C3 Tianjin University Science & Technology
RP Zhang, ZS (corresponding author), Tianjin Univ Sci & Technol, Key Lab Food Nutr & Safety, Minist Educ, Tianjin 300457, Peoples R China.
EM zhangzesheng@tust.edu.cn
RI Zhang, zs/GXN-3521-2022; Liu, Xiaoling/HGD-3566-2022; zhang,
   zhi/HPH-4905-2023
FU National Natural Science Foundation of China [30671766]
FX This work is partly supported by a grant from the National Natural
   Science Foundation of China (grant no. 30671766).
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AKIKO S, 2004, ARCH GERONTOL GERIAT, V39, P69
   AMMON HPT, 1981, PLANTA MED, V43, P209, DOI 10.1055/s-2007-971502
   ANA S, 2009, FOOD CHEM TOXICOL, V47, P547
   Anila L, 2003, FOOD CHEM, V83, P569, DOI 10.1016/S0308-8146(03)00155-9
   BAHORUN T, 1994, PLANTA MED, V60, P323, DOI 10.1055/s-2006-959493
   Bahorun T, 1996, ARZNEIMITTEL-FORSCH, V46, P1086
   BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8
   BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARLOS KBF, 2004, BIOGERONTOLOGY, V5, P275
   CHINNASAMY E, 2009, INT J DEV NEUROSCI, V27, P799
   Coto-Montes A, 1999, J PINEAL RES, V27, P154, DOI 10.1111/j.1600-079X.1999.tb00610.x
   Dorman HJD, 2003, FOOD CHEM, V83, P255, DOI 10.1016/S0308-8146(03)00088-8
   Ferrari CKB, 2001, INT MED J, V8, P175
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Juskiewicz J, 2002, FOOD RES INT, V35, P201, DOI 10.1016/S0963-9969(01)00184-3
   KONO Y, 1982, J BIOL CHEM, V257, P5751
   KRZEMINSKI T, 1993, PHARM PHARM LETT, V3, P45
   Kwok CY, 2010, J FUNCT FOODS, V2, P179, DOI 10.1016/j.jff.2010.04.006
   Lee SC, 2006, FOOD CHEM, V94, P489, DOI 10.1016/j.foodchem.2004.12.001
   Liu F, 1997, LIFE SCI, V60, P763, DOI 10.1016/S0024-3205(97)00004-0
   Liu JK, 1999, NEUROCHEM RES, V24, P1479, DOI 10.1023/A:1022597010078
   Liu XJ, 2003, MUTAT RES-GEN TOX EN, V539, P1, DOI 10.1016/S1383-5718(03)00112-8
   Luo Y, 2009, INNOV FOOD SCI EMERG, V10, P215, DOI 10.1016/j.ifset.2008.06.004
   Marcilhac Anne, 2004, Psychol Neuropsychiatr Vieil, V2, P203
   Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8
   MINOTTI G, 1988, ANN NY ACAD SCI, V551, P34, DOI 10.1111/j.1749-6632.1988.tb22318.x
   Miyamoto M, 1997, EXP GERONTOL, V32, P139, DOI 10.1016/S0531-5565(96)00061-7
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   SHANTHI S, 1994, INDIAN J BIOCHEM BIO, V31, P143
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   TAKEDA T, 1994, ARCH GERONTOL GERIAT, V19, P185, DOI 10.1016/0167-4943(94)90039-6
   Wang B, 2007, COLLOID SURFACE B, V60, P36, DOI 10.1016/j.colsurfb.2007.05.020
   Wang H, 2008, FOOD CHEM, V106, P888, DOI 10.1016/j.foodchem.2007.05.068
   Yao M, 2008, J ETHNOPHARMACOL, V118, P127, DOI 10.1016/j.jep.2008.03.020
   Zhang ZS, 2009, MOL NUTR FOOD RES, V53, P921, DOI 10.1002/mnfr.200800517
   Zhang ZS, 2002, FOOD RES INT, V35, P885, DOI 10.1016/S0963-9969(02)00099-6
   Zhang ZS, 2002, J NUTR, V132, P5, DOI 10.1093/jn/132.1.5
   Zhang ZS, 2001, J NUTR BIOCHEM, V12, P144, DOI 10.1016/S0955-2863(00)00137-6
NR 41
TC 21
Z9 41
U1 1
U2 49
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1438-2377
EI 1438-2385
J9 EUR FOOD RES TECHNOL
JI Eur. Food Res. Technol.
PD MAY
PY 2011
VL 232
IS 5
BP 743
EP 751
DI 10.1007/s00217-011-1435-7
PG 9
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 752ZA
UT WOS:000289732800001
DA 2024-02-19
ER

PT J
AU JEFFERY, S
   MERRY, BJ
   HOLEHAN, AM
   CARTER, ND
AF JEFFERY, S
   MERRY, BJ
   HOLEHAN, AM
   CARTER, ND
TI THE EFFECTS OF AGING ON CARBONIC-ANHYDRASE CONCENTRATIONS IN RAT-LIVER
   AND SKELETAL-MUSCLE
SO BIOCHEMICAL JOURNAL
LA English
DT Article
C1 UNIV HULL,WOLFSON INST,HULL HU6 7RX,N HUMBERSIDE,ENGLAND.
C3 University of Hull
RP JEFFERY, S (corresponding author), ST GEORGES HOSP,SCH MED,DEPT CHILD HLTH,CRANMER TERRACE,LONDON SW17 0RE,ENGLAND.
CR CARTER N, 1982, FEBS LETT, V139, P265, DOI 10.1016/0014-5793(82)80866-1
   CARTER N, 1985, BIOCHEM SOC T, V13, P531, DOI 10.1042/bst0130531
   DODGSON SJ, 1980, P NATL ACAD SCI-BIOL, V77, P5562, DOI 10.1073/pnas.77.9.5562
   EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555
   HOLMES RS, 1977, EUR J BIOCHEM, V78, P511, DOI 10.1111/j.1432-1033.1977.tb11764.x
   JEFFERY S, 1987, J HISTOCHEM CYTOCHEM, V35, P663, DOI 10.1177/35.6.2952707
   JEFFERY S, 1984, BIOCHEM J, V221, P927, DOI 10.1042/bj2210927
   JEFFERY S, 1986, J ENDOCRINOL, V110, P123, DOI 10.1677/joe.0.1100123
   JEFFERY S, 1986, J HISTOCHEM CYTOCHEM, V34, P513, DOI 10.1177/34.4.2936798
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MERRY BJ, 1981, EXP GERONTOL, V16, P431, DOI 10.1016/0531-5565(81)90025-5
   MODE A, 1982, ENDOCRINOLOGY, V111, P1692, DOI 10.1210/endo-111-5-1692
   NORSTEDT G, 1984, CELL, V36, P805, DOI 10.1016/0092-8674(84)90030-8
   REGISTER AM, 1978, J BIOL CHEM, V253, P4143
   SHIELS A, 1983, BIOCHIM BIOPHYS ACTA, V760, P335, DOI 10.1016/0304-4165(83)90370-7
   SONNTAG WE, 1985, J GERONTOL, V40, P689, DOI 10.1093/geronj/40.6.689
   WISTRAND PJ, 1987, COMP BIOCHEM PHYS A, V86, P177, DOI 10.1016/0300-9629(87)90298-2
   WISTRAND PJ, 1977, PFLUG ARCH EUR J PHY, V370, P121, DOI 10.1007/BF00581684
NR 18
TC 10
Z9 10
U1 0
U2 2
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD FEB 15
PY 1988
VL 250
IS 1
BP 303
EP 305
DI 10.1042/bj2500303
PG 3
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA M2058
UT WOS:A1988M205800044
PM 3128278
OA Green Published
DA 2024-02-19
ER

PT J
AU Nejak-Bowen, KN
   Zeng, G
   Tan, XP
   Cieply, B
   Monga, SP
AF Nejak-Bowen, Kari N.
   Zeng, Gang
   Tan, Xinping
   Cieply, Benjamin
   Monga, Satdarshan P.
TI β-Catenin Regulates Vitamin C Biosynthesis and Cell Survival in Murine
   Liver
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SENESCENCE MARKER PROTEIN-30; DEOXYRIBONUCLEIC-ACID SYNTHESIS;
   REGUCALCIN MESSENGER-RNA; HEPATOCYTE GROWTH-FACTOR;
   NECROSIS-FACTOR-ALPHA; BINDING PROTEIN; RAT-LIVER; ENDOGENOUS
   REGUCALCIN; MOUSE HEPATOCYTES; SIGNALING PATHWAY
AB Because the Wnt/beta-catenin pathway plays multiple roles in liver pathobiology, it is critical to identify gene targets that mediate such diverse effects. Here we report a novel role of, beta-catenin in controlling ascorbic acid biosynthesis in murine liver through regulation of expression of regucalcin or senescence marker protein 30 and L-gulonolactone oxidase. Reverse transcription-PCR, Western blotting, and immunohistochemistry demonstrate decreased regucalcin expression in beta-catenin-null livers and greater expression in beta-catenin overexpressing transgenic livers, HepG2 hepatoma cells (contain constitutively active beta-catenin), regenerating livers, and in hepatocellular cancer tissues that exhibit beta-catenin activation. Interestingly, coprecipitation and immunofluorescence studies also demonstrate an association of beta-catenin and regucalcin. Luciferase reporter and chromatin immunoprecipitation assays verified a functional TCF-4-binding site located between -163 and -157 (CTTTGCA) on the regucalcin promoter to be critical for regulation by beta-catenin. Significantly lower serum ascorbate levels were observed in beta-catenin knockout mice secondary to decreased expression of regucalcin and also Of L-gulonolactone oxidase, the penultimate and last (also rate-limiting) steps in the synthesis of ascorbic acid, respectively. These mice also show enhanced basal hepatocyte apoptosis. To test if ascorbate deficiency secondary to beta-catenin loss and regucalcin decrease was contributing to apoptosis, beta-catenin-null hepatocytes or regucalcin small interfering RNA-transfected HepG2 cells were cultured, which exhibited significant apoptosis that was alleviated by the addition of ascorbic acid. Thus, through regucalcin and L-gulonolactone oxidase expression, beta-catenin regulates vitamin C biosynthesis in murine liver, which in turn may be one of the mechanisms contributing to the role of beta-catenin in cell survival.
C1 [Monga, Satdarshan P.] Univ Pittsburgh, Dept Pathol, Div Expt Pathol, Sch Med, Pittsburgh, PA 15216 USA.
   [Monga, Satdarshan P.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15216 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh
RP Monga, SP (corresponding author), Univ Pittsburgh, Dept Pathol, Div Expt Pathol, Sch Med, 200 Lothrop St,S-421 BST, Pittsburgh, PA 15216 USA.
EM smonga@pitt.edu
RI Zeng, Gang G/J-9995-2018
OI Zeng, Gang G/0000-0002-2954-9051; Monga, Satdarshan/0000-0002-8437-3378;
   Nejak-Bowen, Kari/0000-0001-6051-5338
FU National Institutes of Health [1R01 DK62277, 1R01 CA1 24414]; Rango's
   Fund for the Enhancement of Pathology Research
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants 1R01 DK62277 and 1R01 CA1 24414 (to S. P. S. M.). This
   work was also supported by Rango's Fund for the Enhancement of Pathology
   Research.
CR Apte U, 2006, HEPATOLOGY, V44, P992, DOI 10.1002/hep.21317
   Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151
   Barroso MP, 1997, ARCH BIOCHEM BIOPHYS, V343, P243, DOI 10.1006/abbi.1997.0170
   Behari J, 2007, J HEPATOL, V46, P849, DOI 10.1016/j.jhep.2006.11.017
   Bell AW, 2006, HEPATOLOGY, V44, P186, DOI 10.1002/hep.21234
   Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015
   Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133
   Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118
   Cieply B, 2009, HEPATOLOGY, V49, P821, DOI 10.1002/hep.22695
   de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
   Devereux TR, 1999, ONCOGENE, V18, P4726, DOI 10.1038/sj.onc.1202858
   Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120
   Elchuri S, 2007, PROTEOMICS, V7, P2121, DOI 10.1002/pmic.200601011
   Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2
   Fujita T, 1999, BIOCHEM BIOPH RES CO, V254, P1, DOI 10.1006/bbrc.1998.9841
   Fujita T, 1998, J GASTROEN HEPATOL, V13, pS124
   Graveel CR, 2001, ONCOGENE, V20, P2704, DOI 10.1038/sj.onc.1204391
   Hanada S, 2008, HEPATOLOGY, V48, P943, DOI 10.1002/hep.22436
   He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509
   Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Izumi T, 2004, J CELL BIOCHEM, V92, P296, DOI 10.1002/jcb.20056
   Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200
   Koh TJ, 2000, J CLIN INVEST, V106, P533, DOI 10.1172/JCI9476
   Köhler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Lee HS, 2007, LIFE SCI, V80, P690, DOI 10.1016/j.lfs.2006.10.024
   LIDA M, 2003, CARCINOGENESIS, V24, P757
   Linster CL, 2007, FEBS J, V274, P1, DOI 10.1111/j.1742-4658.2006.05607.x
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Majer BJ, 2004, MUTAT RES-FUND MOL M, V551, P153, DOI 10.1016/j.mrfmmm.2004.02.022
   Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161
   Michalopoulos GK, 2001, AM J PATHOL, V159, P1877, DOI 10.1016/S0002-9440(10)63034-9
   Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000
   Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786
   Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P
   Murata T, 1998, BIOCHEM J, V329, P157, DOI 10.1042/bj3290157
   Murata T, 1997, MOL CELL BIOCHEM, V175, P163, DOI 10.1023/A:1006844815743
   Nejak-Bowen Kari, 2008, Organogenesis, V4, P92
   Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Ray R, 2003, CANCER RES, V63, P8085
   Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923
   Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Takahasi H, 1996, MOL CELL BIOCHEM, V162, P133
   Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225
   Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042
   Tan XP, 2005, GASTROENTEROLOGY, V129, P285, DOI 10.1053/j.gastro.2005.04.013
   Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651
   Toualbi K, 2007, ONCOGENE, V26, P3492, DOI 10.1038/sj.onc.1210133
   Tsurusaki Y, 2004, INT J MOL MED, V14, P277
   Tsurusaki Y, 2002, J CELL BIOCHEM, V85, P516, DOI 10.1002/jcb.10153
   Tsurusaki Y, 2000, INT J MOL MED, V6, P295
   vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X
   Yamaguchi M, 2005, INT J MOL MED, V15, P371
   Yamaguchi M, 2002, MOL CELL BIOCHEM, V241, P61, DOI 10.1023/A:1020822610085
   Yamaguchi M, 2000, BIOCHEM BIOPH RES CO, V276, P1, DOI 10.1006/bbrc.2000.3359
   YAMAGUCHI M, 1995, J CELL BIOCHEM, V57, P185, DOI 10.1002/jcb.240570203
   Yamaguchi M, 1996, MOL CELL BIOCHEM, V162, P121
   Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498
   Yang JW, 2001, HEPATOLOGY, V33, P848, DOI 10.1053/jhep.2001.23438
   Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469
   Zeng G, 2007, HEPATOLOGY, V45, P195, DOI 10.1002/hep.21473
   Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607
NR 65
TC 33
Z9 45
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 9
PY 2009
VL 284
IS 41
BP 28115
EP 28127
DI 10.1074/jbc.M109.047258
PG 13
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 505FP
UT WOS:000270676300038
PM 19690176
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU WARD, WF
AF WARD, WF
TI ENHANCEMENT BY FOOD RESTRICTION OF LIVER PROTEIN-SYNTHESIS IN THE AGING
   FISCHER-344 RAT
SO JOURNALS OF GERONTOLOGY
LA English
DT Article
RP WARD, WF (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT PHYSIOL,SAN ANTONIO,TX 78284, USA.
FU NIA NIH HHS [AG01188] Funding Source: Medline
CR BERTRAND HA, 1980, J GERONTOL, V35, P827, DOI 10.1093/geronj/35.6.827
   BIRCHENALLSPARKS MC, 1985, J NUTR, V115, P944, DOI 10.1093/jn/115.7.944
   BOLLA RI, 1982, AGE, V5, P72, DOI 10.1007/BF02431711
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHEN JC, 1973, BIOCHIM BIOPHYS ACTA, V312, P598, DOI 10.1016/0005-2787(73)90458-9
   CONIGLIO JJ, 1979, MECH AGEING DEV, V11, P77, DOI 10.1016/0047-6374(79)90026-5
   DRAPER NR, 1966, APPLIED REGRESSION A
   EXTON JH, 1975, METHODS ENZYMOLOGY
   FLORINI JR, 1981, NIH812194 PUBL
   GEARY S, 1972, J GERONTOL, V27, P325, DOI 10.1093/geronj/27.3.325
   GOLDSPINK DF, 1987, EXP GERONTOL, V22, P67, DOI 10.1016/0531-5565(87)90016-7
   GOLDSPINK DF, 1986, CARDIOVASC RES, V20, P672, DOI 10.1093/cvr/20.9.672
   HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5
   HERLIHY JT, 1984, AM J PHYSIOL, V246, pH369, DOI 10.1152/ajpheart.1984.246.3.H369
   HOLEHAN AM, 1986, BIOL REV, V61, P329, DOI 10.1111/j.1469-185X.1986.tb00658.x
   KHAIRALLAH EA, 1976, J BIOL CHEM, V251, P1375
   LEWIS SEM, 1985, EXP GERONTOL, V20, P253, DOI 10.1016/0531-5565(85)90050-6
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MASORO EJ, 1985, MOL BIOL AGING
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   RICHARDSON A, 1982, LIFE SCI, V31, P605, DOI 10.1016/0024-3205(82)90761-5
   RICHARDSON A, 1985, HDB NUTRITION AGED
   RICKETTS WG, 1985, J CELL PHYSIOL, V125, P492, DOI 10.1002/jcp.1041250319
   VANBEZOOIJEN CFA, 1976, BIOCHEM BIOPH RES CO, V71, P513, DOI 10.1016/0006-291X(76)90817-2
   WOODSIDE KH, 1972, J BIOL CHEM, V247, P6474
   WOODSIDE KH, 1974, J BIOL CHEM, V249, P5488
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 28
TC 41
Z9 43
U1 0
U2 0
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006
SN 0022-1422
J9 J GERONTOL
JI J. Gerontol.
PD MAR
PY 1988
VL 43
IS 2
BP B50
EP B53
DI 10.1093/geronj/43.2.B50
PG 4
WC Gerontology
WE Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA M5609
UT WOS:A1988M560900013
PM 3346519
DA 2024-02-19
ER

PT J
AU Li, SS
   Li, J
   Pan, RY
   Cheng, JB
   Cui, QH
   Chen, JX
   Yuan, ZQ
AF Li, Shuoshuo
   Li, Jun
   Pan, Ruiyuan
   Cheng, Jinbo
   Cui, Qinghua
   Chen, Jianxin
   Yuan, Zengqiang
TI Sodium rutin extends lifespan and health span in mice including positive
   impacts on liver health
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article; Early Access
DE ageing; autophagy; longevity; metabolism; metabolomics; sodium rutin
ID AUTOPHAGIC DEGRADATION; LONGEVITY; METFORMIN; DIET; RESVERATROL;
   METABOLISM; GLUCOSE; PROTEIN; ENERGY; MEMORY
AB Background and Purpose: Ageing is associated with progressive metabolic dysregulation. Rutin is a metabolic regulator with a poor solubility. Using soluble sodium rutin we investigating the effect and mechanisms of rutin in ageing process.
   Experimental Approach: Wild type male mice were treated with or without sodium rutin ( 0.2 mg.ml(-1) in drinking water from 8-month-old until end of life. Kaplan-Meier survival curve was used for lifespan assay, ageing-related histopathology analysis and metabolic analysis were performed to determine the effects of chronic sodium rutin on the longevity. Serological test, liver tissue metabolomics and transcriptomics were used for liver function assay. SiRNA knockdown Angptl8 and autophagy flux assay in HepG2 cell lines explored the mechanism through which sodium rutin might impact the function of hepatocyte.
   Key Results: Sodium rutin treatment extends the lifespan of mice by 10%. Sodium rutin supplementation alleviates ageing-related pathological changes and promotes behaviour performance in ageing mice. Sodium rutin supplementation altered the whole-body metabolism in mice, which exhibited increased energy expenditure and lower respiratory quotient. Transcriptomics analysis showed that Sodium rutin affected the expression of metabolic genes. Metabolomics analysis showed that Sodium rutin reduced liver steatosis through increased lipid beta-oxidation. Sodium rutin treatment increased the autophagy level both in vivo and in vitro. The inhibition of autophagy partially abolished the sodium rutin-mediated effect on lipolysis in HepG2 cells.
   Conclusion and Implications: Sodium rutin treatment extends the lifespan and health span of mice with beneficial effects on metabolism, which were achieved by enhancing the autophagy activity in hepatocytes.
C1 [Li, Shuoshuo; Pan, Ruiyuan; Cheng, Jinbo; Yuan, Zengqiang] Beijing Inst Basic Med Sci, Brain Sci Ctr, 27 Taiping Rd, Beijing 100850, Peoples R China.
   [Li, Jun] Capital Med Univ, Beijing Inst Brain Disorders, Beijing, Peoples R China.
   [Cheng, Jinbo; Yuan, Zengqiang] Minzu Univ China, Coll Life & Environm Sci, Ctr Translat Neurosci, Beijing, Peoples R China.
   [Cui, Qinghua] Peking Univ, Sch Basic Med Sci, Ctr Noncoding RNA Med, Dept Biomed Informat, Beijing, Peoples R China.
   [Chen, Jianxin] Beijing Univ Chinese Med, Sch Tradit Chinese Med, Beijing, Peoples R China.
C3 Academy of Military Medical Sciences - China; Capital Medical
   University; Minzu University of China; Peking University; Beijing
   University of Chinese Medicine
RP Yuan, ZQ (corresponding author), Beijing Inst Basic Med Sci, Brain Sci Ctr, 27 Taiping Rd, Beijing 100850, Peoples R China.; Chen, JX (corresponding author), Beijing Univ Chinese Med, 11 Bei San Huan Dong Lu, Beijing 100029, Peoples R China.
EM cjx@bucm.edu.cn; zqyuan@bmi.ac.cn
RI Rui-Yuan, Pan/JNS-0921-2023; li, shuoshuo/AAH-1781-2021; Yuan,
   Zengqiang/G-5245-2017
OI li, shuoshuo/0000-0003-3499-2717; Pan, Rui-Yuan/0000-0002-2057-5237;
   Yuan, Zengqiang/0000-0001-5739-2867; Cheng, Jinbo/0000-0002-3627-8544
FU Beijing Natural Science Foundation [7161009]; National Major Project of
   Support Program [2019-JCJQ-ZD-195]; National Natural Science Foundation
   of China [81630026, 81930029]
FX Beijing Natural Science Foundation, Grant/Award Number: 7161009;
   National Major Project of Support Program, Grant/Award Number:
   2019-JCJQ-ZD-195; National Natural Science Foundation of China,
   Grant/Award Numbers: 81630026, 81930029
CR Acland A, 2013, NUCLEIC ACIDS RES, V41, pD8, DOI [10.1093/nar/gks1189, 10.1093/nar/gkaa892, 10.1093/nar/gkx1095, 10.1093/nar/gkv1290]
   Alexander SPH, 2019, BRIT J PHARMACOL, V176, pS1, DOI 10.1111/bph.14747
   Alexander SPH, 2018, BRIT J PHARMACOL, V175, P407, DOI 10.1111/bph.14112
   Alonso C, 2014, FREE RADICAL BIO MED, V75, P149, DOI 10.1016/j.freeradbiomed.2014.07.014
   Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355
   Azzu V, 2017, GERONTOLOGY, V63, P327, DOI 10.1159/000454924
   Bárcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5
   Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354
   Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060
   Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4
   Brockmole JR, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00012
   Chattopadhyay D, 2017, BIOGERONTOLOGY, V18, P397, DOI 10.1007/s10522-017-9700-1
   Chen J, 2017, ELIFE, V6, DOI 10.7554/eLife.31268
   Cheng JB, 2020, AUTOPHAGY, V16, P2193, DOI 10.1080/15548627.2020.1719723
   Chua LS, 2013, J ETHNOPHARMACOL, V150, P805, DOI 10.1016/j.jep.2013.10.036
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371
   Fernandez Alvaro F, 2018, Nature, V558, P136, DOI 10.1038/s41586-018-0162-7
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0
   Harding SD, 2018, NUCLEIC ACIDS RES, V46, pD1091, DOI 10.1093/nar/gkx1121
   Hubbard BP, 2014, TRENDS PHARMACOL SCI, V35, P146, DOI 10.1016/j.tips.2013.12.004
   Jové M, 2014, AGING CELL, V13, P828, DOI 10.1111/acel.12241
   Kimira M, 1998, J Epidemiol, V8, P168
   Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451
   Kulkarni AS, 2020, CELL METAB, V32, P15, DOI 10.1016/j.cmet.2020.04.001
   Li SS, 2022, BRIT J PHARMACOL, V179, P1825, DOI 10.1111/bph.15410
   López-Otín C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031
   Mahmoud AM, 2012, EXP TOXICOL PATHOL, V64, P783, DOI 10.1016/j.etp.2011.01.016
   Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192
   Mitchell SJ, 2018, CELL METAB, V27, P667, DOI 10.1016/j.cmet.2018.02.001
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Pallauf K, 2016, CURR MED CHEM, V23, P4639, DOI 10.2174/0929867323666161024151233
   Pan RY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6328
   Papatheodoridi AM, 2020, HEPATOLOGY, V71, P363, DOI 10.1002/hep.30834
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Samsonowicz M, 2015, SPECTROCHIM ACTA A, V151, P926, DOI 10.1016/j.saa.2015.07.027
   Scheja L, 2016, J HEPATOL, V64, P1176, DOI 10.1016/j.jhep.2016.01.025
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Schneider JL, 2014, NAT REV GASTRO HEPAT, V11, P187, DOI 10.1038/nrgastro.2013.211
   Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Thomas I, 2017, PEDIATR DIABETES, V18, P10, DOI 10.1111/pedi.12473
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Uchitomi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46929-8
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Wallis LJ, 2016, AGE, V38, DOI 10.1007/s11357-015-9866-x
   Wu R, 2017, DIABETOLOGIA, V60, P900, DOI 10.1007/s00125-016-4202-2
   Wu R, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2016.54
   Xie K, 2018, P NATL ACAD SCI USA, V115, pE2348, DOI 10.1073/pnas.1707337115
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yuan XX, 2017, FASEB J, V31, P333, DOI [10.1096/fj.201600459RR, 10.1096/fj.201600459rr]
   Zhang Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02355-w
   Zhou LL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.184
NR 56
TC 14
Z9 14
U1 3
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD 2022 MAY
PY 2022
VL 179
IS 9
BP 1825
EP 1838
DI 10.1111/bph.15410
EA FEB 2021
PG 14
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 0F8WF
UT WOS:000622423300001
PM 33555034
OA Bronze
DA 2024-02-19
ER

PT J
AU Modi, HR
   Katyare, SS
   Patel, MA
AF Modi, Hiren R.
   Katyare, Surendra S.
   Patel, Minal A.
TI Ageing-induced alterations in lipid/phospholipid profiles of rat brain
   and liver mitochondria: Implications for mitochondrial energy-linked
   functions
SO JOURNAL OF MEMBRANE BIOLOGY
LA English
DT Article
DE age; brain mitochondrial lipid; liver mitochondrial lipid; brain
   mitochondrial phospholipid profile; liver mitochondrial phospholipid
   profile; mitochondrial respiration
ID AGE-RELATED-CHANGES; FATTY-ACID COMPOSITION; THYROID-HORMONE TREATMENT;
   CENTRAL-NERVOUS-SYSTEM; LIPID-COMPOSITION; DEHYDROEPIANDROSTERONE DHEA;
   PHOSPHOLIPID-COMPOSITION; CEREBRAL MITOCHONDRIA; MEMBRANE FLUIDITY;
   WISTAR RATS
AB Effects of ageing on the lipid/phospholipid profile of brain and liver mitochondria from rats were examined. In the brain mitochondria the contents of total phospholipid (TPL) and cholesterol (CHL) increased with simultaneous increase in the TPL/CHL (mole:mole) ratio. The proportion and contents of lysophospholipid (Lyso), sphingomyelin (SPM), phosphatidylinositol (PI), phosphatidylserine (PS) and diphosphatidylglycerol (DPG) components increased, with maximal increases seen for PS and PI; phosphatidylcholine (PC) and phosphatidylethanolamine (PE) components registered decrease. In the liver mitochondria contents of TPL and CHL increased. However, the TPL/CHL (mole:mole) ratio was not altered. Lyso, PI and PS increased. However, the magnitude of increase was competitively lower; PE and DPG decreased. SPM and PC did not change as a consequence of ageing. These changes altered the contents of individual phospholipids in the two membrane systems. Respiration with glutamate, pyruvate + malate, succinate and ascorbate + N,N,N',N'-tetramethyl-p-phenylenediamine was significantly impaired in brain mitochondria from old animals. For liver mitochondria the respiratory activity declined with glutamate and succinate. Correlation studies by regression analysis revealed that the lipid/phospholipid classes regulate respiratory function differently in the mitochondria from the two tissues. The respiration-related parameters in the brain mitochondria were dependent on multiple lipid/phospholipid components, and the process of regulation was complex compared to the liver mitochondrial functions.
C1 [Modi, Hiren R.; Katyare, Surendra S.; Patel, Minal A.] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Baroda 390002, Gujarat, India.
C3 Maharaja Sayajirao University Baroda
RP Modi, HR (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Baroda 390002, Gujarat, India.
EM modi_hiren@yahoo.co.in
OI Modi, Hiren/0000-0003-1731-7111
CR Ando S, 2002, J NEUROSCI RES, V70, P290, DOI 10.1002/jnr.10352
   Aureli T, 2000, NEUROCHEM RES, V25, P395, DOI 10.1023/A:1007501306623
   BANGUR CS, 1995, BIOCHEM J, V305, P29, DOI 10.1042/bj3050029
   Baranowska B, 2007, NEUROBIOL AGING, V28, P774, DOI 10.1016/j.neurobiolaging.2006.03.014
   BARTLETT GR, 1954, J BIOL CHEM, V34, P466
   Bourre J M, 2004, J Nutr Health Aging, V8, P163
   Carver JD, 2001, BRAIN RES BULL, V56, P79, DOI 10.1016/S0361-9230(01)00551-2
   DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4
   de Boschero MGI, 2000, EXP GERONTOL, V35, P653, DOI 10.1016/S0531-5565(00)00104-2
   Delion S, 1997, J LIPID RES, V38, P680
   DUGAN RE, 1977, BIOCHEM ACTION HORM, V4, P197
   Elmlinger MW, 2003, CLIN CHEM LAB MED, V41, P934, DOI 10.1515/CCLM.2003.142
   Farooqui AA, 2004, NEUROCHEM RES, V29, P1961, DOI 10.1007/s11064-004-6871-3
   Favrelière S, 2000, NEUROBIOL AGING, V21, P653, DOI 10.1016/S0197-4580(00)00170-6
   Favrelière S, 2003, NEUROBIOL AGING, V24, P233, DOI 10.1016/S0197-4580(02)00064-7
   FERREIRA J, 1984, BIOCHEM J, V218, P61, DOI 10.1042/bj2180061
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208
   GIUSTO NM, 1992, LIPIDS, V27, P835, DOI 10.1007/BF02535859
   GRINNA LS, 1977, MECH AGEING DEV, V6, P197, DOI 10.1016/0047-6374(77)90021-5
   GRINNA SL, 1977, MECH AGEING DEV, V6, P453
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HOSTETLER KY, 1991, BIOCHIM BIOPHYS ACTA, V1086, P139, DOI 10.1016/0005-2760(91)90165-E
   Katewa SD, 2004, DRUG CHEM TOXICOL, V27, P41, DOI 10.1081/DCT-120027898
   Katyare SS, 2005, EXP NEUROL, V195, P416, DOI 10.1016/j.expneurol.2005.06.004
   Katyare SS, 2003, EXP NEUROL, V183, P241, DOI 10.1016/S0014-4886(03)00176-6
   KATYARE SS, 1989, BRIT J PHARMACOL, V96, P51, DOI 10.1111/j.1476-5381.1989.tb11783.x
   KIM JH, 1988, MECH AGEING DEV, V46, P263
   KIM JH, 1988, MECH AGEING DEV, V46, P279, DOI 10.1016/0047-6374(88)90130-3
   LOPEZ GH, 1995, COMP BIOCHEM PHYS B, V112, P331, DOI 10.1016/0305-0491(95)00079-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASELLA R, 1995, COMP BIOCHEM PHYS B, V111, P319, DOI 10.1016/0305-0491(94)00217-I
   McDaniel MA, 2003, NUTRITION, V19, P957, DOI 10.1016/S0899-9007(03)00024-8
   Moreira DG, 2005, EXP GERONTOL, V40, P330, DOI 10.1016/j.exger.2005.01.006
   Mourdjeva M, 2006, AM J REPROD IMMUNOL, V56, P249, DOI 10.1111/j.1600-0897.2006.00422.x
   Murphy EJ, 2000, BRAIN RES, V867, P9, DOI 10.1016/S0006-8993(00)02205-8
   PANDYA JD, 2004, LIPIDS HLTH DIS, V22, P3
   PARMAR DV, 1995, EUR J BIOCHEM, V230, P576
   Pasquaré SJ, 2001, EXP GERONTOL, V36, P1387, DOI 10.1016/S0531-5565(01)00106-1
   PASQUINI JM, 1980, BIOCHEM J, V186, P127, DOI 10.1042/bj1860127
   Patel MA, 2007, AGE, V29, P41, DOI 10.1007/s11357-007-9029-9
   Patel MA, 2006, NEUROSCI LETT, V402, P131, DOI 10.1016/j.neulet.2006.03.057
   Patel SP, 2006, NEUROSCI LETT, V399, P129, DOI 10.1016/j.neulet.2006.01.044
   Poon HF, 2004, J GERONTOL A-BIOL, V59, P478
   RUGGIERO FM, 1984, LIPIDS, V19, P171, DOI 10.1007/BF02534794
   RUGGIERO FM, 1992, J NEUROCHEM, V59, P487, DOI 10.1111/j.1471-4159.1992.tb09396.x
   SKIPSKI VP, 1967, BIOCHEM J, V104, P340, DOI 10.1042/bj1040340
   SODERBERG M, 1990, J NEUROCHEM, V54, P415, DOI 10.1111/j.1471-4159.1990.tb01889.x
   Toescu EC, 2000, CELL CALCIUM, V28, P329, DOI 10.1054/ceca.2000.0167
   VIANI P, 1991, J NEUROCHEM, V56, P253, DOI 10.1111/j.1471-4159.1991.tb02589.x
   ZLATKIS A, 1953, J LAB CLIN MED, V41, P486
NR 51
TC 30
Z9 39
U1 1
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0022-2631
J9 J MEMBRANE BIOL
JI J. Membr. Biol.
PD JAN
PY 2008
VL 221
IS 1
BP 51
EP 60
DI 10.1007/s00232-007-9086-0
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Physiology
GA 250DB
UT WOS:000252279100006
PM 18097631
DA 2024-02-19
ER

PT J
AU Inoue, Y
   Inoue, J
   Lambert, G
   Yim, SH
   Gonzalez, FJ
AF Inoue, Y
   Inoue, J
   Lambert, G
   Yim, SH
   Gonzalez, FJ
TI Disruption of hepatic C/EBPα results in impaired glucose tolerance and
   age-dependent hepatosteatosis
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ENHANCER-BINDING-PROTEIN; TRIGLYCERIDE TRANSFER PROTEIN;
   LIPOPROTEIN-LIPASE; KNOCKOUT MICE; CHOLESTERYL ESTERS;
   DIABETES-MELLITUS; SELECTIVE UPTAKE; IN-VIVO; LIVER; GENE
AB C/EBPalpha is highly expressed in liver and regulates many genes that are preferentially expressed in liver. Because C/EBPalpha-null mice die soon after birth, it is impossible to analyze the function of C/EBPalpha in the adult with this model. To address the function of C/EBPalpha in adult hepatocytes, liver-specific C/EBPalpha-null mice were produced using a floxed C/EBPalpha allele and the albumin-Cre transgene. Unlike whole body C/EBPalpha-null mice, mice lacking hepatic C/EBPalpha expression did not exhibit hypoglycemia, nor did they show reduced hepatic glycogen in adult. Expression of liver glycogen synthase, phosphoenolpyruvate carboxykinase, and glucose-6-phosphatase remained at normal levels. However, these mice exhibited impaired glucose tolerance due in part to reduced expression of hepatic glucokinase, and hyperammonemia from reduced expression of hepatic carbamoyl phosphate synthase-I. These mice also had reduced serum cholesterol and steatotic livers that was exacerbated with aging. This phenotype could be explained by increased expression of hepatic lipoprotein lipase and reduced expression of microsomal triglyceride transfer protein, apolipoproteins B100, and A-IV. These data demonstrate that hepatic C/EBPalpha is critical for ammonia detoxification and glucose and lipid homeostasis in adult mice.
C1 NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.
   INSERM, U539, F-44035 Nantes, France.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Institut National de la Sante et de la Recherche Medicale
   (Inserm)
RP Gonzalez, FJ (corresponding author), NIH, Bldg 37,Rm 3106, Bethesda, MD 20892 USA.
EM fjgonz@helix.nih.gov
RI Inoue, Yusuke/O-6207-2018
OI Inoue, Yusuke/0000-0002-9710-7482; Gonzalez, Frank/0000-0002-7990-2140;
   Lambert, Gilles/0000-0001-5632-0685
CR Basso F, 2003, J LIPID RES, V44, P296, DOI 10.1194/jlr.M200414-JLR200
   BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146
   Boelsterli UA, 2002, BIOCHEM PHARMACOL, V63, P1, DOI 10.1016/S0006-2952(01)00817-6
   Burgess-Beusse BL, 1998, MOL CELL BIOL, V18, P7269, DOI 10.1128/MCB.18.12.7269
   Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051
   CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0
   Davies N, 1997, BRIT J HAEMATOL, V99, P578, DOI 10.1046/j.1365-2141.1997.4603263.x
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005
   GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932
   Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694
   GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7
   GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   HOWELL BW, 1989, MOL CELL BIOL, V9, P2928, DOI 10.1128/MCB.9.7.2928
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Inoue Y, 2002, J BIOL CHEM, V277, P25257, DOI 10.1074/jbc.M203126200
   JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133
   Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498
   Kim JW, 1998, BIOCHEM J, V336, P83, DOI 10.1042/bj3360083
   Kimura T, 1998, J BIOL CHEM, V273, P27505, DOI 10.1074/jbc.273.42.27505
   Lambert G, 2000, J LIPID RES, V41, P667
   LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786
   Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014
   Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545
   Lettéron P, 2003, HEPATOLOGY, V38, P133, DOI 10.1053/jhep.2003.50309
   Leung GK, 2000, J BIOL CHEM, V275, P7515, DOI 10.1074/jbc.275.11.7515
   Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898
   Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9
   Merkel M, 1998, J CLIN INVEST, V102, P893, DOI 10.1172/JCI2912
   MOORMAN AFM, 1991, FEBS LETT, V288, P133, DOI 10.1016/0014-5793(91)81019-5
   Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576
   Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508
   Rinninger F, 1998, J LIPID RES, V39, P1335
   Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x
   Shen W, 2001, J BIOL CHEM, V276, P42812, DOI 10.1074/jbc.M106344200
   TAKIGUCHI M, 1991, J BIOL CHEM, V266, P9186
   WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557
   Weinstock PH, 1997, J LIPID RES, V38, P1782
   Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751
   Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200
   WU AL, 1979, J BIOL CHEM, V254, P7316
   Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
   Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569
   Zhang Y, 2001, J BIOL CHEM, V276, P43018, DOI 10.1074/jbc.M107823200
NR 48
TC 63
Z9 70
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 22
PY 2004
VL 279
IS 43
BP 44740
EP 44748
DI 10.1074/jbc.M405177200
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 862QJ
UT WOS:000224505600062
PM 15292250
OA hybrid
DA 2024-02-19
ER

PT J
AU RIKANS, LE
   SNOWDEN, CD
AF RIKANS, LE
   SNOWDEN, CD
TI EFFECTS OF ACUTE ETHANOL ADMINISTRATION ON FEMALE RAT-LIVER AS A
   FUNCTION OF AGING
SO LIFE SCIENCES
LA English
DT Article
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA,HLTH SCI CTR,COLL MED,DEPT PHARMACOL,OKLAHOMA CITY,OK 73190, USA.
FU NIA NIH HHS [AG04984] Funding Source: Medline
CR BELLOMO G, 1985, HEPATOLOGY, V5, P876, DOI 10.1002/hep.1840050529
   BERGMEYER HU, 1974, METHOD ENZYMAT AN, P752
   Bernst E, 1974, METHOD ENZYMAT AN, P1499
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   COMPORTI M, 1973, LIPIDS, V8, P498, DOI 10.1007/BF02531984
   FRENCH SW, 1989, CLIN BIOCHEM, V22, P41, DOI 10.1016/S0009-9120(89)80067-0
   GERLACH U, 1974, METHOD ENZYMAT AN, P569
   HORMANN VA, 1989, TOXICOL APPL PHARM, V98, P375, DOI 10.1016/0041-008X(89)90167-1
   LAUTERBURG BH, 1984, J PHARMACOL EXP THER, V230, P7
   LAUTERBURG BH, 1980, J PHARMACOL EXP THER, V213, P54
   LIEBER CS, 1988, NEW ENGL J MED, V319, P1639
   MACDONALD CM, 1977, BIOCHEM PHARMACOL, V26, P1529, DOI 10.1016/0006-2952(77)90428-2
   RIKANS LE, 1986, IRCS MED SCI-BIOCHEM, V14, P467
   RIKANS LE, 1987, ALCOHOL CLIN EXP RES, V11, P562, DOI 10.1111/j.1530-0277.1987.tb00175.x
   Rolf M, 1985, ADV FREE RADICALS BI, V1, P165
   SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4
   SOHAL RS, 1987, REV BIOL RES AGING, V3, P431
   SPEISKY H, 1985, BIOCHEM J, V225, P565, DOI 10.1042/bj2250565
   STRUBELT O, 1987, TOXICOLOGY, V45, P213, DOI 10.1016/0300-483X(87)90107-7
   VIDELA LA, 1982, LIFE SCI, V31, P2395, DOI 10.1016/0024-3205(82)90743-3
   1981, MAMMALIAN MODELS RES, P93
NR 21
TC 19
Z9 19
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0024-3205
J9 LIFE SCI
JI Life Sci.
PY 1989
VL 45
IS 15
BP 1373
EP 1379
DI 10.1016/0024-3205(89)90024-6
PG 7
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA AT056
UT WOS:A1989AT05600007
PM 2796607
DA 2024-02-19
ER

PT J
AU Ito, Y
   Sorensen, KK
   Bethea, NW
   Svistounov, D
   McCuskey, MK
   Smedsrod, BH
   McCuskey, RS
AF Ito, Yoshiya
   Sorensen, Karen K.
   Bethea, Nancy W.
   Svistounov, Dmitri
   McCuskey, Margaret K.
   Smedsrod, Balrd H.
   McCuskey, Robert S.
TI Age-related changes in the hepatic microcirculation in mice
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE aging; liver; microcirculation; sinusoids; sinusoidal endothelial cells;
   Kupffer cells; AGE; scavenger receptor
ID GLYCATION END-PRODUCTS; FINE-STRUCTURE; ENDOTHELIAL-CELLS; RECEPTOR;
   LIVER; PSEUDOCAPILLARIZATION; N-EPSILON-(CARBOXYMETHYL)LYSINE;
   ACCUMULATION; ACTIVATION; MECHANISM
AB Aging of the liver is associated with impaired metabolism of drugs, adverse drug interactions, and susceptibility to toxins. Since reduced hepatic blood flow is suspected to contribute this impairment, we examined age-related alterations in hepatic microcirculation. Livers of C57B1/6 mice were examined at 0.8 (pre-pubertal), 3 (young adult), 14 (middle-aged), and 27 (senescent) months of age using in vivo and electron microscopic methods. The results demonstrated a 14% reduction in the numbers of perfused sinusoids between 0.8 and 27 month mice associated with 35% reduction in sinusoidal blood flow. This was accompanied by an inflammatory response evidenced by a fivefold increase in leukocyte adhesion in 27 month mice, up-regulated expression of ICAM-1, and increases in intrahepatic macrophages. Sinusoidal diameter decreased 6-10%. Liver sinusoidal endothelial cell (LSEC) dysfunction was seen as early as 14 months when there was a threefold increase in the numbers of swollen LSEC. The endocytotic capacity of LSEC also was found to be reduced in older animals. The sinusoidal endothelium in 27 month old mice exhibited pseudocapillarization. In conclusion, the results suggest that leukocyte accumulation in the sinusoids and narrowing of sinusoidal lumens due to pseudocapillarization and dysfunction of LSEC reduce sinusoidal blood flow in aged livers. (c) 2007 Elsevier Inc. All rights reserved.
C1 Univ Arizona, Coll Med, Dept Cell Biol & Anat, Tucson, AZ 85724 USA.
   Univ Tromso, Dept Cell Biol & Histol, N-9037 Tromso, Norway.
C3 University of Arizona; UiT The Arctic University of Tromso
RP McCuskey, RS (corresponding author), Univ Arizona, Coll Med, Dept Cell Biol & Anat, POB 245044,1501 N Campbell Ave, Tucson, AZ 85724 USA.
EM mccuskey@email.arizona.edu
OI Smedsrod, Bard/0000-0002-3308-8948
FU NIA NIH HHS [R21 AG026582, R21 AG 02582, R21 AG026582-01A1] Funding
   Source: Medline
CR BASTA M, 1989, J CLIN INVEST, V84, P1974, DOI 10.1172/JCI114387
   BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   DELEEUW AM, 1990, J ELECTRON MICR TECH, V14, P218
   DUNN JA, 1991, BIOCHEMISTRY-US, V30, P1205, DOI 10.1021/bi00219a007
   Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788
   Friedman EA, 1999, DIABETES CARE, V22, pB65
   Hammes HP, 1999, INVEST OPHTH VIS SCI, V40, P1855
   Hansen B, 2002, DIABETOLOGIA, V45, P1379, DOI 10.1007/s00125-002-0912-8
   Hilmer SN, 2005, HEPATOLOGY, V42, P1349, DOI 10.1002/hep.20937
   Hori O, 1996, NEPHROL DIAL TRANSPL, V11, P13
   Ito Y, 2003, MICROCIRCULATION, V10, P391, DOI 10.1038/sj.mn.7800204
   Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271
   Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   Licastro Federico, 2005, Immun Ageing, V2, P8
   MCCANCE DR, 1993, J CLIN INVEST, V91, P2470, DOI 10.1172/JCI116482
   MCCUSKEY RS, 1990, J ELECTRON MICR TECH, V14, P237, DOI 10.1002/jemt.1060140305
   MCCUSKEY RS, 1993, PROGR APPL MICR, V19, P76
   McCuskey RS, 1986, PHYS TECH, P247
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   MEGO JL, 1967, J CELL BIOL, V32, P699, DOI 10.1083/jcb.32.3.699
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180
   Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   Sebeková K, 1998, CELL MOL BIOL, V44, P1051
   SEMDSROD B, 2004, COMP HEPATOL S1, V3, P22
   Seternes T, 2002, P NATL ACAD SCI USA, V99, P7594, DOI 10.1073/pnas.102173299
   Simm A, 2004, ANN NY ACAD SCI, V1019, P228, DOI 10.1196/annals.1297.038
   Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591
   Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567
   Thornalley PJ, 1998, CELL MOL BIOL, V44, P1013
   Vollmar B, 2002, LIVER, V22, P330, DOI 10.1034/j.1600-0676.2001.01631.x
   WARREN A, 2005, J GERONTOL, V38, P1101
   WHEATLEY AM, 1993, MICROVASC RES, V45, P290, DOI 10.1006/mvre.1993.1025
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 41
TC 79
Z9 86
U1 2
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 2007
VL 42
IS 8
BP 789
EP 797
DI 10.1016/j.exger.2007.04.008
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 202LX
UT WOS:000248904300010
PM 17582718
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Lopez-Noriega, L
   Capilla-González, V
   Cobo-Vuilleumier, N
   Martin-Vazquez, E
   Lorenzo, PI
   Martinez-Force, E
   Soriano-Navarro, M
   García-Fernández, M
   Romero-Zerbo, SY
   Bermúdez-Silva, FJ
   Díaz-Contreras, I
   Sánchez-Cuesta, A
   Santos-Ocaña, C
   Hmadcha, A
   Soria, B
   Martín, F
   Gauthier, BR
   Martin-Montalvo, A
AF Lopez-Noriega, Livia
   Capilla-Gonzalez, Vivian
   Cobo-Vuilleumier, Nadia
   Martin-Vazquez, Eugenia
   Isabel Lorenzo, Petra
   Martinez-Force, Enrique
   Soriano-Navarro, Mario
   Garcia-Fernandez, Maria
   Yanina Romero-Zerbo, Silvana
   Javier Bermudez-Silva, Francisco
   Diaz-Contreras, Irene
   Sanchez-Cuesta, Ana
   Santos-Ocana, Carlos
   Hmadcha, Abdelkrim
   Soria, Bernat
   Martin, Franz
   Raymond Gauthier, Benoit
   Martin-Montalvo, Alejandro
TI Inadequate control of thyroid hormones sensitizes to
   hepatocarcinogenesis and unhealthy aging
SO AGING-US
LA English
DT Article
DE lifespan; healthspan; thyroid hormones; hyperthyroidism; hypothyroidism;
   glucose metabolism
ID FAMILIAL LONGEVITY; SUBCLINICAL HYPOTHYROIDISM; TRIIODOTHYRONINE LEVELS;
   CALORIC RESTRICTION; FATTY-ACIDS; LIFE-SPAN; EXPRESSION; MICE; CELLS;
   RISK
AB An inverse correlation between thyroid hormone levels and longevity has been reported in several species and reduced thyroid hormone levels have been proposed as a biomarker for healthy aging and metabolic fitness. However, hypothyroidism is a medical condition associated with compromised health and reduced life expectancy. Herein, we show, using wild-type and the Pax8 ablated model of hypothyroidism in mice, that hyperthyroidism and severe hypothyroidism are associated with an overall unhealthy status and shorter lifespan. Mild hypothyroid Pax8 +/- mice were heavier and displayed insulin resistance, hepatic steatosis and increased prevalence of liver cancer yet had normal lifespan. These pathophysiological conditions were precipitated by hepatic mitochondrial dysfunction and oxidative damage accumulation. These findings indicate that individuals carrying mutations on PAX8 may be susceptible to develop liver cancer and/or diabetes and raise concerns regarding the development of interventions aiming to modulate thyroid hormones to promote healthy aging or lifespan in mammals.
C1 [Lopez-Noriega, Livia; Capilla-Gonzalez, Vivian; Cobo-Vuilleumier, Nadia; Martin-Vazquez, Eugenia; Isabel Lorenzo, Petra; Diaz-Contreras, Irene; Hmadcha, Abdelkrim; Martin, Franz; Raymond Gauthier, Benoit; Martin-Montalvo, Alejandro] Univ Seville, CSIC, Univ Pablo de Olavide, Dept Regenerat & Cell Therapy,Andalusian Ctr Mol, Seville, Spain.
   [Martinez-Force, Enrique] Univ Pablo de Olavide, Inst Grasa CSIC, Seville, Spain.
   [Soriano-Navarro, Mario] Ctr Invest Principe Felipe, Valencia, Spain.
   [Garcia-Fernandez, Maria] Univ Malaga, Biomed Res Inst Malaga IBIMA, Dept Human Physiol, Malaga, Spain.
   [Garcia-Fernandez, Maria] Hosp Reg Univ Malaga, UGC Endocrinol & Nutr, Inst Invest Biomed Malaga IBIMA, Malaga, Spain.
   [Yanina Romero-Zerbo, Silvana; Javier Bermudez-Silva, Francisco; Soria, Bernat; Martin, Franz; Raymond Gauthier, Benoit] Inst Salud Carlos III, Biomed Res Network Diabet & Related Metab Dis CIB, Madrid, Spain.
   [Sanchez-Cuesta, Ana; Santos-Ocana, Carlos] Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain.
   [Sanchez-Cuesta, Ana; Santos-Ocana, Carlos] CIBERER, Alicante, Spain.
   [Soria, Bernat] Univ Miguel Hernandez, Sch Med Sant Joan dAlacant, Dept Physiol, Alicante, Spain.
C3 Universidad Pablo de Olavide; Consejo Superior de Investigaciones
   Cientificas (CSIC); University of Sevilla; Universidad Pablo de Olavide;
   Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de la Grasa (IG); Prince Felipe Research Center; Instituto de
   Investigacion Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA);
   Universidad de Malaga; Instituto de Investigacion Biomedica de Malaga y
   Plataforma en Nanomedicina (IBIMA); Universidad de Malaga; Instituto de
   Salud Carlos III; Consejo Superior de Investigaciones Cientificas
   (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for
   Developmental Biology (CABD); CIBER - Centro de Investigacion Biomedica
   en Red; CIBERER; Universidad Miguel Hernandez de Elche
RP Gauthier, BR; Martin-Montalvo, A (corresponding author), Univ Seville, CSIC, Univ Pablo de Olavide, Dept Regenerat & Cell Therapy,Andalusian Ctr Mol, Seville, Spain.; Gauthier, BR (corresponding author), Inst Salud Carlos III, Biomed Res Network Diabet & Related Metab Dis CIB, Madrid, Spain.
EM benoit.gauthier@cabimer.es; alejandro.martinmontalvo@cabimer.es
RI , Bernat/AAL-6470-2021; Hmadcha, Abdelkrim/T-1173-2019; Martínez-Force,
   Enrique/A-7979-2008; Ocaña, Carlos Santos/E-8115-2011; Martin,
   Franz/K-4197-2014; López Noriega, Livia/AAC-9076-2022; ,
   B/HZK-8896-2023; Gauthier, Benoit R/C-3138-2017; Bermudez-Silva,
   Francisco-Javier/Q-6920-2016; Martin-Montalvo, Alejandro/C-2031-2017;
   Garcia Fernandez, Maria Inmaculada/H-8196-2017
OI Hmadcha, Abdelkrim/0000-0002-4105-3702; Martínez-Force,
   Enrique/0000-0001-5324-9537; Ocaña, Carlos Santos/0000-0002-2379-796X;
   Martin, Franz/0000-0002-5745-8704; Gauthier, Benoit
   R/0000-0001-8146-7486; Bermudez-Silva,
   Francisco-Javier/0000-0003-3133-9691; Martin-Montalvo,
   Alejandro/0000-0002-3886-5355; Romero-Zerbo,
   Silvana-Yanina/0000-0002-6737-992X; Garcia Fernandez, Maria
   Inmaculada/0000-0002-6436-1361; Soria, Bernat/0000-0002-2356-0380;
   CAPILLA-GONZALEZ, VIVIAN/0000-0003-2020-1662; Soriano Navarro,
   Mario/0000-0002-7245-2095; Lopez Noriega, Livia/0000-0002-2905-9490
FU Ministerio de Economia y Competitividad, Instituto de Salud Carlos III;
   nonprofit foundation 'Fundacion Progreso y Salud' of the Andalusian
   Regional Ministry of Health [BFU2017-83588-P, CP14/00105, PI18/01590,
   PI15/00134, PI-0272-2017, CD16/00118, PI17/01286]; Fondos FEDER
FX This work was funded by grants from the Ministerio de Economia y
   Competitividad, Instituto de Salud Carlos III co-funded by Fondos FEDER
   and from the nonprofit foundation 'Fundacion Progreso y Salud' of the
   Andalusian Regional Ministry of Health (BFU2017-83588-P to B.R.G;
   CP14/00105, PI18/01590 and PI15/00134 to A. M-M; PI-0272-2017 and
   CD16/00118 to V.C-G; PI17/01286 to C.S-O and A.S-C).
CR Aguayo-Mazzucato C, 2015, J CLIN ENDOCR METAB, V100, P3651, DOI 10.1210/jc.2015-2632
   Aguayo-Mazzucato C, 2013, DIABETES, V62, P1569, DOI 10.2337/db12-0849
   Atzmon G, 2009, J CLIN ENDOCR METAB, V94, P4768, DOI 10.1210/jc.2009-0808
   Bano A, 2017, JAMA INTERN MED, V177, P1650, DOI 10.1001/jamainternmed.2017.4836
   Barbe P, 2001, FASEB J, V15, P13
   Bartke A, 2002, NEUROPEPTIDES, V36, P201, DOI 10.1054/npep.2002.0889
   Bello RI, 2003, J BIOENERG BIOMEMBR, V35, P169, DOI 10.1023/A:1023702321148
   Bowers J, 2013, ENDOCR REV, V34, P556, DOI 10.1210/er.2012-1056
   Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005
   Brown-Borg HM, 2009, MOL CELL ENDOCRINOL, V299, P64, DOI 10.1016/j.mce.2008.07.001
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   Buras A, 2014, HORM BEHAV, V65, P88, DOI 10.1016/j.yhbeh.2013.11.008
   Chaker L, 2015, J CLIN ENDOCR METAB, V100, P2181, DOI 10.1210/jc.2015-1438
   Chi HC, 2017, ONCOGENE, V36, P5274, DOI 10.1038/onc.2017.136
   De Andrade PBM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00254
   Elbein SC, 2009, DIABETES, V58, P268, DOI 10.2337/db08-0931
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Gao CX, 2015, HORM METAB RES, V47, P220, DOI 10.1055/s-0034-1394370
   Garasto S, 2017, MECH AGEING DEV, V165, P98, DOI 10.1016/j.mad.2017.03.002
   Gesing A, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-16
   Giuliani C, 2017, FOOD CHEM TOXICOL, V107, P237, DOI 10.1016/j.fct.2017.06.044
   Gjedde S, 2008, J CLIN ENDOCR METAB, V93, P2277, DOI 10.1210/jc.2007-2619
   Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008
   Gredilla R, 2001, FREE RADICAL RES, V35, P417, DOI 10.1080/10715760100300931
   He WW, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00335
   Heiman ML, 2003, ENDOCRINE, V20, P149, DOI 10.1385/ENDO:20:1-2:149
   Hine C, 2017, CELL METAB, V25, P1320, DOI 10.1016/j.cmet.2017.05.003
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Jansen SW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11525
   Jansen SW, 2015, J CLIN ENDOCR METAB, V100, P3806, DOI 10.1210/jc.2015-2624
   Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769
   Kim YW, 2012, BIOCHEM BIOPH RES CO, V420, P462, DOI 10.1016/j.bbrc.2012.03.020
   Kovar FM, 2015, WIEN KLIN WOCHENSCHR, V127, P924, DOI 10.1007/s00508-015-0846-z
   Lanni A, 2003, FEBS LETT, V543, P5, DOI 10.1016/S0014-5793(03)00320-X
   Lonardo A, 2019, DIGEST LIVER DIS, V51, P462, DOI 10.1016/j.dld.2018.12.014
   López-Noriega L, 2017, BRIT J PHARMACOL, V174, P3795, DOI 10.1111/bph.13975
   Ma SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173700
   Malenczyk K, 2018, MOL METAB, V14, P108, DOI 10.1016/j.molmet.2018.05.019
   Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87
   Mansouri A, 2018, GASTROENTEROLOGY, V155, P629, DOI 10.1053/j.gastro.2018.06.083
   Mantovani A, 2018, THYROID, V28, P1270, DOI 10.1089/thy.2018.0257
   Jiménez-Moreno CM, 2015, CURR GENE THER, V15, P436, DOI 10.2174/1566523215666150630121557
   Martin-Montalvo A, 2019, DIABETES, V68, P109, DOI 10.2337/db18-0285
   Müller MJ, 2015, AM J CLIN NUTR, V102, P807, DOI 10.3945/ajcn.115.109173
   Nishi M, 2018, DIABETOL INT, V9, P108, DOI 10.1007/s13340-018-0352-4
   OOKA H, 1986, MECH AGEING DEV, V33, P275, DOI 10.1016/0047-6374(86)90052-7
   Palomer X, 2018, TRENDS ENDOCRIN MET, V29, P178, DOI 10.1016/j.tem.2017.11.009
   Paradies G, 2014, WORLD J GASTROENTERO, V20, P14205, DOI 10.3748/wjg.v20.i39.14205
   Qiao AJ, 2017, J CELL BIOL, V216, P723, DOI 10.1083/jcb.201607091
   Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057
   Reddy A, 2007, CLIN GASTROENTEROL H, V5, P118, DOI 10.1016/j.cgh.2006.07.011
   Rozing MP, 2010, J CLIN ENDOCR METAB, V95, P4979, DOI 10.1210/jc.2010-0875
   Rozing MP, 2010, J GERONTOL A-BIOL, V65, P365, DOI 10.1093/gerona/glp200
   Sato Y, 1996, TISSUE CELL, V28, P637, DOI 10.1016/S0040-8166(96)80067-X
   Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299
   Simonsick EM, 2016, J GERONTOL A-BIOL, V71, P961, DOI 10.1093/gerona/glv226
   Solanes G, 2005, BIOCHEM J, V386, P505, DOI 10.1042/BJ20041073
   Soria B, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00204
   Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9
   Vinciguerra M, 2009, J HEPATOL, V50, P1132, DOI 10.1016/j.jhep.2009.01.027
   Wistuba J, 2007, J ENDOCRINOL, V192, P99, DOI 10.1677/JOE-06-0054
   Yang DY, 2012, INT J CARDIOL, V154, P43, DOI 10.1016/j.ijcard.2010.08.057
   Yao X, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-38
   Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011
NR 64
TC 8
Z9 8
U1 0
U2 6
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP 30
PY 2019
VL 11
IS 18
BP 7746
EP 7779
DI 10.18632/aging.102285
PG 34
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Geriatrics & Gerontology
GA JB0VH
UT WOS:000488275300028
PM 31518338
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Seol, MA
   Jung, U
   Eom, HS
   Kim, SH
   Park, HR
   Jo, SK
AF Seol, Min-A
   Jung, Uhee
   Eom, Hyeon Soo
   Kim, Seol-Hwa
   Park, Hae-Ran
   Jo, Sung-Kee
TI Prolonged expression of senescence markers in mice exposed to
   gamma-irradiation
SO JOURNAL OF VETERINARY SCIENCE
LA English
DT Article
DE mitochondrial DNA deletion; p21; radiation; senescence;
   senescence-associated beta-galactosidase
ID DNA-DAMAGE RESPONSE; IONIZING-RADIATION; CELLULAR SENESCENCE;
   STEM-CELLS; IN-VIVO; BETA-GALACTOSIDASE; DWARF MICE; DELETION;
   APOPTOSIS; MECHANISMS
AB Although ionizing radiation is known to induce cellular senescence in vitro and in vivo, its long-term in vivo effects are not well defined. In this study, we examined the prolonged expression of senescence markers in mice irradiated with single or fractionated doses. C57BL/6 female mice were exposed to 5 Gy of gamma-rays in single or 5, 10,25 fractions. At 2, 4, and 6 months after irradiation, senescence markers including mitochondrial DNA (mtDNA) common deletion, p21, and senescence-associated beta-galactosidase (SA beta-gal) were monitored in the lung, liver, and kidney. Increases of mtDNA deletion were detected in the lung, liver, and kidney of irradiated groups. p21 expression and SA beta-gal staining were also increased in the irradiated groups compared to the non-irradiated control group. Increases of senescence markers persisted up to 6 months after irradiation. Additionally, the extent of mtDNA deletion and the numbers of SA beta-gal positive cells were greater as the number of radiation fractions increased. In conclusion, our results showed that ionizing radiation, especially that delivered in fractions, can cause the persistent upregulation of senescence marker expression in vivo. This should be considered when dealing with chronic normal tissue injuries caused by radiation therapy or radiation accidents.
C1 [Seol, Min-A; Jung, Uhee; Eom, Hyeon Soo; Kim, Seol-Hwa; Park, Hae-Ran; Jo, Sung-Kee] Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Biotechnol Res Div, Jeongeup 580185, South Korea.
C3 Korea Atomic Energy Research Institute (KAERI)
RP Jung, U (corresponding author), Korea Atom Energy Res Inst, Adv Radiat Technol Inst, Radiat Biotechnol Res Div, Jeongeup 580185, South Korea.
EM uhjung@kaeri.re.kr
FU Ministry of Science and Technology, Korea [2007-2000091]
FX This study was supported by the Nuclear R&D Program of Ministry of
   Science and Technology, Korea (Project No. 2007-2000091).
CR Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com
   Berneburg M, 2004, J INVEST DERMATOL, V122, P1277, DOI 10.1111/j.0022-202X.2004.22502.x
   Choi J, 2000, UROLOGY, V56, P160, DOI 10.1016/S0090-4295(00)00538-0
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eriksson D, 2010, TUMOR BIOL, V31, P363, DOI 10.1007/s13277-010-0042-8
   Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160
   Han YH, 2005, FEBS LETT, V579, P4897, DOI 10.1016/j.febslet.2005.07.049
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   Jackson JG, 2011, J PATHOL, V223, P127, DOI 10.1002/path.2783
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Jo SK, 2011, INT J RADIAT BIOL, V87, P302, DOI 10.3109/09553002.2010.537429
   Le ONL, 2010, AGING CELL, V9, P398, DOI 10.1111/j.1474-9726.2010.00567.x
   Li KL, 2007, BIOCELL, V31, P213
   LING CC, 1995, CANCER RES, V55, P5207
   Little MP, 2009, J RADIOL PROT, V29, pA43, DOI 10.1088/0952-4746/29/2A/S04
   Maruyama N, 2004, ANN NY ACAD SCI, V1019, P383, DOI 10.1196/annals.1297.068
   Meng AM, 2003, CANCER RES, V63, P5414
   Mirzayans R, 2010, J CELL PHYSIOL, V223, P57, DOI 10.1002/jcp.22002
   Murakami S, 2006, EXP GERONTOL, V41, P1014, DOI 10.1016/j.exger.2006.06.061
   Muthna D, 2010, STEM CELLS DEV, V19, P1855, DOI 10.1089/scd.2009.0449
   Oh CW, 2001, RADIAT RES, V156, P232, DOI 10.1667/0033-7587(2001)156[0232:IOASLP]2.0.CO;2
   Park HR, 2011, INT J RADIAT BIOL, V87, P534, DOI 10.3109/09553002.2011.542540
   Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078
   Richardson RB, 2009, AGING-US, V1, P887, DOI 10.18632/aging.100081
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Sabin Rebecca J, 2011, Genome Integr, V2, P7, DOI 10.1186/2041-9414-2-7
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Suh Y, 2002, MECH AGEING DEV, V123, P881, DOI 10.1016/S0047-6374(02)00025-8
   Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang L, 2007, INT J RADIAT BIOL, V83, P433, DOI 10.1080/09553000701370878
   Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418
   Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138
   Zhang XX, 2002, CHINESE MED J-PEKING, V115, P1390
NR 38
TC 30
Z9 32
U1 0
U2 25
PU KOREAN SOC VETERINARY SCIENCE
PI SEOUL
PA SEOUL NATL UNIV,  COLLEGE VETERINARY MEDICINE,, SEOUL, 151-742, SOUTH
   KOREA
SN 1229-845X
EI 1976-555X
J9 J VET SCI
JI J. Vet. Sci.
PD DEC
PY 2012
VL 13
IS 4
BP 331
EP 338
DI 10.4142/jvs.2012.13.4.331
PG 8
WC Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Veterinary Sciences
GA 066LH
UT WOS:000313221800001
PM 23271173
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Xiang, DJ
   Zhu, XY
   Zhang, YQ
   Zou, J
   Li, J
   Kong, LY
   Zhang, H
AF Xiang, Dejuan
   Zhu, Xiaoyun
   Zhang, Yanqiu
   Zou, Jie
   Li, Jie
   Kong, Lingyi
   Zhang, Hao
TI Tribbles homolog 2 promotes hepatic fibrosis and hepatocarcinogenesis
   through phosphatase 1A-Mediated stabilization of yes-associated protein
SO LIVER INTERNATIONAL
LA English
DT Article; Early Access
DE hepatocarcinogenesis; liver fibrosis; PP1A; TRIB2; YAP
ID LIVER-CANCER; C/EBP-ALPHA; ACTS DOWNSTREAM; TRIB2; YAP; HIPPO; CELLS;
   SENESCENCE; EFFECTOR; CATENIN
AB Background & Aims: Hepatic stellate cells (HSCs) play critical roles in liver fibrosis and hepatocellular carcinoma (HCC). Tribbles homolog 2 (TRIB2) is an oncogene implicated in a variety of cancers, including liver cancer. However, the biological function and regulatory mechanism of TRIB2 in HSCs are poorly understood. In addition, little is known about its role in liver fibrosis progression to HCC. Here, we revealed the clinical significance of TRIB2 in liver fibrosis and HCC development.
   Methods: We investigated TRIB2 promoting liver fibrosis in vitro and in vivo. In mouse model of liver fibrosis and HCC, we measured hepatic fibrosis and HCC level through knockdown TRIB2 with shRNA. In addition, we performed western blotting, real-time quantitative PCR, immunofluorescence and co-immunoprecipitation assay to study TRIB2 function in LX-2 cells.
   Results: TRIB2 expression was strongly upregulated in human fibrotic liver tissues and HCC tissues. TRIB2 colocalized with alpha-smooth muscle actin (alpha-SMA) in fibrotic and HCC liver tissues. Knockdown of TRIB2 inhibited HSC activation and liver fibrosis in vitro and in vivo. TRIB2 promoted Yes-associated protein (YAP) stabilization, nuclear localization, and subsequent fibrotic gene expression independent of the MST-LATS phosphorylation cascade in HSCs. TRIB2 interacted with YAP to recruit phosphatase 1A (PP1A), promoting PP1A-mediated YAP dephosphorylation. TRIB2 knockdown potently attenuated the development of fibrosis-associated liver cancer.
   Conclusions: TRIB2 is an attractive target for hepatic fibrosis and fibrosis-associated liver cancer treatment.
C1 [Xiang, Dejuan; Zhu, Xiaoyun; Zhang, Yanqiu; Zou, Jie; Li, Jie; Kong, Lingyi; Zhang, Hao] China Pharmaceut Univ, State Key Lab Nat Med, Sch Tradit Chinese Pharm, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.
   [Xiang, Dejuan; Zhu, Xiaoyun; Zhang, Yanqiu; Zou, Jie; Li, Jie; Kong, Lingyi; Zhang, Hao] China Pharmaceut Univ, Jiangsu Key Lab Bioact Nat Prod Res, Sch Tradit Chinese Pharm, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.
C3 China Pharmaceutical University; China Pharmaceutical University
RP Kong, LY; Zhang, H (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Sch Tradit Chinese Pharm, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.; Kong, LY; Zhang, H (corresponding author), China Pharmaceut Univ, Jiangsu Key Lab Bioact Nat Prod Res, Sch Tradit Chinese Pharm, 24 Tong Jia Xiang, Nanjing 210009, Peoples R China.
EM cpu_lykong@126.com; hiaaron@sina.cn
RI Wang, Xiaobing/H-5927-2019; Zhu, Xiaoyun/ACE-1141-2022
OI Wang, Xiaobing/0000-0001-5044-3721; 
FU National Natural Science Foundation of China [81872889]; Natural Science
   Foundation of Jiangsu Province [BK20181332]; Drug Innovation Major
   Project [2018ZX09711-001-007, 2018ZX09735002-003]; "Double First-Class"
   University Project [CPU2018GF03]; Postgraduate Research AMP; Practice
   Innovation Program of Jiangsu Province [KYCX190652]
FX National Natural Science Foundation of China, Grant/Award Number:
   81872889; Natural Science Foundation of Jiangsu Province, Grant/Award
   Number: BK20181332; The Drug Innovation Major Project, Grant/Award
   Number: 2018ZX09711-001-007 and 2018ZX09735002-003; "Double First-Class"
   University Project, Grant/Award Number: CPU2018GF03; Postgraduate
   Research & Practice Innovation Program of Jiangsu Province, Grant/Award
   Number: KYCX190652
CR Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096
   Cai H, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-31
   Caviglia JM, 2018, HEPATOLOGY, V67, P2414, DOI 10.1002/hep.29627
   Coulouarn C, 2014, J HEPATOL, V60, P1306, DOI 10.1016/j.jhep.2014.02.003
   Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019
   Eyers PA, 2017, TRENDS CELL BIOL, V27, P284, DOI 10.1016/j.tcb.2016.11.002
   Franceschi S, 2009, CANCER LETT, V286, P5, DOI 10.1016/j.canlet.2008.10.046
   Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268
   Grandinetti KB, 2011, ONCOGENE, V30, P3328, DOI 10.1038/onc.2011.57
   Grannas K, 2015, J MOL BIOL, V427, P3407, DOI 10.1016/j.jmb.2015.04.015
   Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4
   Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022
   Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010
   Hill R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14687
   Hill R, 2015, CARCINOGENESIS, V36, P469, DOI 10.1093/carcin/bgv002
   Hou ZL, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0922-x
   Hu JKH, 2017, CELL STEM CELL, V21, P91, DOI 10.1016/j.stem.2017.03.023
   Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626
   Kawashima M, 2010, SLEEP, V33, P869, DOI 10.1093/sleep/33.7.869
   Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012
   Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361
   Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115
   Liang KL, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2015.50
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Mannaerts I, 2015, J HEPATOL, V63, P679, DOI 10.1016/j.jhep.2015.04.011
   O'Connor C, 2016, ONCOGENE, V35, P5272, DOI 10.1038/onc.2016.66
   Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047
   Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014
   Qi Q, 2015, P NATL ACAD SCI USA, V112, P7255, DOI 10.1073/pnas.1505917112
   Ray Katrina, 2014, Nat Rev Gastroenterol Hepatol, V11, P74, DOI 10.1038/nrgastro.2013.244
   Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031
   Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542
   Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176
   Tu KS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-110
   Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013
   Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060
   Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810
NR 41
TC 5
Z9 5
U1 2
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD 2021 MAY
PY 2021
VL 41
IS 5
BP 1131
EP 1147
DI 10.1111/liv.14782
EA JAN 2021
PG 17
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA RN9QU
UT WOS:000606337900001
PM 33386706
DA 2024-02-19
ER

PT J
AU Ji, LL
   Xue, RY
   Tang, WQ
   Wu, WB
   Hu, TT
   Liu, XJ
   Peng, XM
   Gu, JX
   Chen, S
   Zhang, S
AF Ji, Lingling
   Xue, Ruyi
   Tang, Wenqing
   Wu, Weibin
   Hu, Tingting
   Liu, Xijun
   Peng, Xiaomin
   Gu, Jianxin
   Chen, She
   Zhang, Si
TI Toll like receptor 2 knock-out attenuates carbon tetrachloride
   (CC1<sub>4</sub>)-induced liver fibrosis by downregulating MAPK and
   NF-κB signaling pathways
SO FEBS LETTERS
LA English
DT Article
DE Liver fibrosis; Toll like receptor 2; Carbon tetrachloride; Hepatic
   stellate cell; mitogen-activated protein kinases; NF-kappa B
ID HEPATIC STELLATE CELLS; INHIBITION; SENESCENCE; INJURY; INFLAMMATION;
   MODULATION; ACTIVATION; CONTRIBUTE; APOPTOSIS
AB Innate immune signaling associated with Toll-like receptors (TLRs) is a key pathway involved in the progression of liver fibrosis. In this study, we reported that TLR2 is required for hepatic fibrogenesis induced by carbon tetrachloride (CCl4). After CCl4 treatment, TLR2(-/-) mice had reduced liver enzyme levels, diminished collagen deposition, decreased inflammatory infiltration and impaired activation of hepatic stellate cells (HSCs) than wild type (WT) mice. Furthermore, after CCl4 treatment, TLR2(-/-) mice demonstrated downregulated expression of profibrotic and proinflammatory genes and impaired nitogen-activated protein kinases (MAPK) and nuclear factor kappa B (NF-kappa B) activation than WT mice. Collectively, our data indicate that TLR2 deficiency protects against CCl4-induced liver fibrosis. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
C1 [Ji, Lingling; Wu, Weibin; Liu, Xijun; Peng, Xiaomin; Gu, Jianxin; Chen, She; Zhang, Si] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Glycoconjugate Res,Minist Publ Hlth,Gene, Shanghai 200032, Peoples R China.
   [Xue, Ruyi; Tang, Wenqing; Hu, Tingting] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai 200032, Peoples R China.
C3 Fudan University; Fudan University
RP Chen, S (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, 130 Dong An Rd, Shanghai 200032, Peoples R China.
EM SheChen@fudan.edu.cn; Zhangsi@fudan.edu.cn
RI zhang, si/AAG-9094-2021; tingting, hu/AGX-8728-2022
OI Wu, Weibin/0000-0003-3637-754X; Liu, Xijun/0000-0002-5712-9142; Xue,
   Ruyi/0000-0002-5710-0091; zhang, Si/0000-0002-5682-4995
FU National Natural Science Foundation of China [81371268, 81100344,
   1173078, 81070235, 81000968, 81100355]
FX The authors thank Dr. Dongwei Jia for technical instruction in liver
   fibrosis induction by CCl<INF>4</INF>. This investigation was supported
   in part by the Grants of National Natural Science Foundation of China
   81371268, 81100344, 1173078, 81070235, 81000968 and 81100355.
CR Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bourbonnais E, 2012, GASTROENTEROLOGY, V142, P130, DOI 10.1053/j.gastro.2011.09.033
   Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668
   Chu PS, 2013, HEPATOLOGY, V58, P337, DOI 10.1002/hep.26351
   Coenen M, 2011, LAB INVEST, V91, P1375, DOI 10.1038/labinvest.2011.78
   Hartmann P, 2012, GASTROENTEROLOGY, V143, P1330, DOI 10.1053/j.gastro.2012.07.099
   Hasenfuss S. C., 2013, HEPATOLOGY
   Jagavelu K, 2010, HEPATOLOGY, V52, P590, DOI 10.1002/hep.23739
   Jia DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060115
   Junjie Xie, 2012, BMC Cancer, V12, P57, DOI 10.1186/1471-2407-12-57
   Kim HS, 2011, J IMMUNOL, V187, P4007, DOI 10.4049/jimmunol.1101654
   Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee IT, 2010, AM J PATHOL, V176, P1671, DOI 10.2353/ajpath.2010.090714
   Lin H, 2013, HEPATOLOGY, V57, P171, DOI 10.1002/hep.25991
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   Marra F, 1999, HEPATOLOGY, V30, P951, DOI 10.1002/hep.510300406
   Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307
   Miura K, 2013, HEPATOLOGY, V57, P577, DOI 10.1002/hep.26081
   Moles A, 2014, J HEPATOL, V60, P782, DOI 10.1016/j.jhep.2013.12.005
   Moles A, 2013, HEPATOLOGY, V57, P817, DOI 10.1002/hep.26068
   Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003
   Paik YH, 2006, LAB INVEST, V86, P676, DOI 10.1038/labinvest.3700422
   Pradere JP, 2013, HEPATOLOGY
   Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Sonoyama T, 2009, FEBS LETT, V583, P2067, DOI 10.1016/j.febslet.2009.05.025
   Tan ZM, 2013, J IMMUNOL, V191, P1835, DOI 10.4049/jimmunol.1203013
   Tolosa L, 2005, CELL SIGNAL, V17, P1333, DOI 10.1016/j.cellsig.2005.02.001
   Tu CT, 2012, FOOD CHEM TOXICOL, V50, P3343, DOI 10.1016/j.fct.2012.05.050
   Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613
   Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049
NR 33
TC 43
Z9 49
U1 1
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD JUN 5
PY 2014
VL 588
IS 12
BP 2095
EP 2100
DI 10.1016/j.febslet.2014.04.042
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA AJ5ZQ
UT WOS:000337769900010
PM 24815695
DA 2024-02-19
ER

PT J
AU BEIER, K
   VOLKL, A
   FAHIMI, HD
AF BEIER, K
   VOLKL, A
   FAHIMI, HD
TI THE IMPACT OF AGING ON ENZYME PROTEINS OF RAT-LIVER PEROXISOMES -
   QUANTITATIVE-ANALYSIS BY IMMUNOBLOTTING AND IMMUNOELECTRON MICROSCOPY
SO VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY
LA English
DT Article
DE OXIDATIVE STRESS; QUANTITATIVE IMMUNOCYTOCHEMISTRY; MORPHOMETRY
ID AUTOMATIC IMAGE-ANALYSIS; SUPEROXIDE-DISMUTASE; STEREOLOGICAL ANALYSIS;
   CRYSTALLINE CORES; BETA-OXIDATION; FINE-STRUCTURE; URATE OXIDASE; AGE;
   CATALASE; LOCALIZATION
AB The alterations of hepatic peroxisomes and their enzymes during aging were investigated in male rats. Peroxisomes in the livers of young (2 months) and old (39 months) male Wistar rats were analyzed by morphometry and quantitative immunocytochemistry, as well as by immunoblotting of highly purified peroxisomal fractions. Immunoblots showed that catalase and acyl-CoA oxidase were decreased in peroxisomes of old animals but the trifunctional enzyme, thiolase, and urate oxidase were increased. The morphometrical analysis revealed a heterogeneous distribution of peroxisomes in the liver lobule of the old animals, with a significant elevation of peroxisomal volume density in pericentral over periportal hepatocytes, in contrast to the uniform pattern in the young rats. Furthermore, age-related lobular gradients were also observed by quantitative immunocytochemistry in the peroxisomal concentrations of trifunctional enzyme (central>portal) and, inversely, for catalase (portal > central). Whereas acyl-CoA oxidase was diminished across the liver lobule, the enzyme 3-ketoacyl-CoA thiolase was elevated. These observations show that peroxisomes are significantly altered in aged animals and suggest that these alterations may contribute to the disturbance of lipid metabolism in aged animals. Moreover, the diminution in catalase and the elevation of urate oxidase could contribute to the oxidative stress which is considered to be of fundamental importance in the aging process.
RP BEIER, K (corresponding author), INST ANAT & ZELLBIOL 2,NEUENHEIMER FELD 307,W-6900 HEIDELBERG,GERMANY.
CR AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   ANGERMULLER S, 1987, EUR J CELL BIOL, V45, P137
   ANGERMULLER S, 1989, PROG HISTOCHEM CYTOC, V20, P1
   APPELKVIST EL, 1990, ARCH BIOCHEM BIOPHYS, V282, P318, DOI 10.1016/0003-9861(90)90123-G
   BAUDHUIN P, 1965, J CELL BIOL, V26, P219, DOI 10.1083/jcb.26.1.219
   BEIER K, 1992, MICROSC RES TECHNIQ, V21, P271, DOI 10.1002/jemt.1070210404
   BEIER K, 1985, HISTOCHEMISTRY, V82, P99, DOI 10.1007/BF00502096
   BEIER K, 1987, CELL TISSUE RES, V247, P179, DOI 10.1007/BF00216560
   BEIER K, 1988, EUR J CELL BIOL, V46, P383
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHANDOGA, 1984, BRATISL LEK LISTY, V81, P176
   CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169
   DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323
   DHAUNSI GS, 1992, J BIOL CHEM, V267, P6870
   FAHIMI HD, 1969, J CELL BIOL, V43, P275, DOI 10.1083/jcb.43.2.275
   FAHIMI HD, 1982, ANN NY ACAD SCI, V386, P111, DOI 10.1111/j.1749-6632.1982.tb21410.x
   Fahimi HD, 1987, PEROXISOMES BIOL MED
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   GENSLER H L, 1987, P451
   HAINING JL, 1973, EXP GERONTOL, V8, P85, DOI 10.1016/0531-5565(73)90018-1
   HAJRA AK, 1982, ANN NY ACAD SCI, V386, P170, DOI 10.1111/j.1749-6632.1982.tb21415.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HASHIMOTO T, 1987, PEROXISOMES BIOL MED, P97
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HILTUNEN JK, 1991, SCAND J CLIN LAB INV, V51, P33, DOI 10.3109/00365519109104593
   INESTROSA NC, 1979, BIOCHEM J, V182, P779, DOI 10.1042/bj1820779
   JEDLITSCHKY G, 1991, J BIOL CHEM, V266, P24763
   KELLER GA, 1991, P NATL ACAD SCI USA, V88, P7381, DOI 10.1073/pnas.88.16.7381
   KELLER GA, 1985, P NATL ACAD SCI USA, V82, P770, DOI 10.1073/pnas.82.3.770
   KESSLER AR, 1985, BIOCHEM PHARMACOL, V34, P1120, DOI 10.1016/0006-2952(85)90620-3
   LOUD AV, 1968, J CELL BIOL, V37, P27, DOI 10.1083/jcb.37.1.27
   MATSUO M, 1992, MECH AGEING DEV, V64, P273, DOI 10.1016/0047-6374(92)90084-Q
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   MIYAZAWA S, 1980, BIOCHIM BIOPHYS ACTA, V630, P367, DOI 10.1016/0304-4165(80)90285-8
   OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z
   PALOSAARI PM, 1990, J BIOL CHEM, V265, P2446
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   ROTH J, 1982, TECHNIQUES IMMUNOCYT, P108
   SCHEPERS L, 1988, J BIOL CHEM, V263, P2724
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   SCHMUCKER DL, 1978, J CELL BIOL, V78, P319, DOI 10.1083/jcb.78.2.319
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SHINITZKY M, 1987, GERONTOLOGY, V33, P149, DOI 10.1159/000212868
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   SONNTAG W E, 1987, P299
   SVOBODA D, 1969, J CELL BIOL, V40, P735
   THOMPSON SL, 1990, J BIOL CHEM, V265, P5731
   USUDA N, 1988, LAB INVEST, V58, P100
   VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105
   VOLKL A, 1988, J HISTOCHEM CYTOCHEM, V36, P329, DOI 10.1177/36.4.3346536
   VOLKL A, 1985, EUR J BIOCHEM, V149, P257, DOI 10.1111/j.1432-1033.1985.tb08920.x
   WIENER J, 1968, J CELL BIOL, V37, P47, DOI 10.1083/jcb.37.1.47
NR 56
TC 48
Z9 48
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0340-6075
J9 VIRCHOWS ARCH B
JI Virchows Arch. B-Cell Molec. Pathol.
PD MAR
PY 1993
VL 63
IS 3
BP 139
EP 146
DI 10.1007/BF02899254
PG 8
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA KQ474
UT WOS:A1993KQ47400002
PM 8097070
DA 2024-02-19
ER

PT J
AU HOMMA, H
   NAKAGOME, I
   KAMAKURA, M
   MATSUI, M
AF HOMMA, H
   NAKAGOME, I
   KAMAKURA, M
   MATSUI, M
TI IMMUNOCHEMICAL CHARACTERIZATION OF DEVELOPMENTAL-CHANGES IN RAT HEPATIC
   HYDROXYSTEROID SULFOTRANSFERASE
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
DE SULFOTRANSFERASE; ANDROSTERONE; DEVELOPMENT; ISOENZYME; ISOELECTRIC
   VARIANT; (RAT LIVER)
ID BILE-ACID SULFOTRANSFERASE; DRUG-METABOLIZING-ENZYMES; ENZYMATIC
   SULFATION; CORTISOL SULFATION; STEROIDS; SENESCENCE; SEQUENCE;
   INDUCTION; HORMONE; CLONING
AB A major isoenzyme of hepatic androsterone-sulfating sulfotransferase (AD-ST) was purified from adult female rats. The activity was purified 122-fold over that found in the cytosol and showed a single protein band with a subunit molecular mass of 30 kDa after sodium dodecyl sulfate polyacrylamide gel electrophoresis. The purified enzyme exhibited four isoelectric variants of subunits on denaturing isoelectrofocusing gels (pI=5.8, 6.1, 6.7 and 7.2). Rabbit antiserum raised against the enzyme specifically detected AD-ST polypeptide in rat liver cytosol. Immunoblot analysis of liver cytosol from female and male rats at various ages showed good correlation between the levels of AD-ST activity and AD-ST polypeptide. Significant levels of AD-ST activity and polypeptide were detected in senescent male rats, though normal adult male rats have very low levels of AD-ST activity and protein. The relative content of the isoelectric variants of AD-ST were different in liver cytosol of weanling and adult females, indicating that age- and gender-related alterations of hepatic AD-ST activity are primarily determined by the levels of AD-ST polypeptide and the relative amounts of the four isoelectric variants of the enzyme.
C1 KYORITSU COLL PHARMACEUT SCI,SHIBAKOEN,MINATO KU,TOKYO 105,JAPAN.
CR BARNES S, 1989, J LIPID RES, V30, P529
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   COLLINS RH, 1987, AM J PHYSIOL, V252, pG276, DOI 10.1152/ajpgi.1987.252.2.G276
   COLLINS RH, 1986, HEPATOLOGY, V6, P579, DOI 10.1002/hep.1840060406
   ELIASSON E, 1990, P NATL ACAD SCI USA, V87, P3225, DOI 10.1073/pnas.87.8.3225
   FALANY CN, 1991, TRENDS PHARMACOL SCI, V12, P255, DOI 10.1016/0165-6147(91)90566-B
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   HOMMA H, 1991, CHEM PHARM BULL, V39, P3307
   HOMMA H, 1991, CHEM PHARM BULL, V39, P1499
   Jakoby WB, 1984, PROGR DRUG METABOLIS, V8, P11
   KANE RE, 1988, PEDIATR RES, V24, P247, DOI 10.1203/00006450-198808000-00022
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEAKEY JEA, 1989, MECH AGEING DEV, V48, P157, DOI 10.1016/0047-6374(89)90047-X
   MATSUI M, 1982, BIOCHEM J, V204, P441, DOI 10.1042/bj2040441
   MATSUI M, 1985, J PHARMACOBIODYN, V8, P148
   MULDER GJ, 1990, CONJUGATION REACTION, P107
   NASH AR, 1990, AGE, V13, P13, DOI 10.1007/BF02432503
   OGURA K, 1990, MOL PHARMACOL, V37, P848
   OGURA K, 1989, BIOCHEM BIOPH RES CO, V165, P168, DOI 10.1016/0006-291X(89)91050-4
   OGURA K, 1990, BIOCHEM BIOPH RES CO, V166, P1494, DOI 10.1016/0006-291X(90)91036-R
   PORTER TD, 1989, MOL PHARMACOL, V36, P61
   RUNGEMORRIS M, 1991, BIOCHEM BIOPH RES CO, V175, P1051, DOI 10.1016/0006-291X(91)91671-X
   SINGER SS, 1979, ANAL BIOCHEM, V96, P34, DOI 10.1016/0003-2697(79)90550-5
   SINGER SS, 1976, ENDOCRINOLOGY, V98, P963, DOI 10.1210/endo-98-4-963
   SINGER SS, 1978, EXP GERONTOL, V13, P425, DOI 10.1016/0531-5565(78)90053-0
   SINGER SS, 1985, BIOCH PHARM TOXICOLO, V1, P95
   SONG BJ, 1989, J BIOL CHEM, V264, P3568
   SONG CS, 1990, BIOCHEMISTRY-US, V29, P542, DOI 10.1021/bi00454a031
   WATANABE HK, 1984, J PHARMACOBIO-DYNAM, V7, P641
   YAMAZOE Y, 1989, MOL PHARMACOL, V35, P707
NR 30
TC 18
Z9 18
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD MAY 22
PY 1992
VL 1121
IS 1-2
BP 69
EP 74
DI 10.1016/0167-4838(92)90338-E
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA HY699
UT WOS:A1992HY69900010
PM 1599953
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Jamhiri, I
   Zahri, S
   Mehrabani, D
   Khodabandeh, Z
   Dianatpour, M
   Yaghobi, R
   Hosseini, SY
AF Jamhiri, Iman
   Zahri, Saber
   Mehrabani, Davood
   Khodabandeh, Zahra
   Dianatpour, Mehdi
   Yaghobi, Ramin
   Hosseini, Seyed Younes
TI Enhancing the apoptotic effect of IL-24/mda-7 on the human hepatic
   stellate cell through RGD peptide modification
SO IMMUNOLOGICAL INVESTIGATIONS
LA English
DT Article
DE Apoptosis; human hepatic stellate cells; IL-24; mda-7; LX-2; RGD
   peptide; senescence
ID LIVER FIBROSIS; HEPATOCELLULAR-CARCINOMA; EXTRACELLULAR-MATRIX; MDA-7
   IL-24; MDA-7/IL-24; EXPRESSION; ACTIVATION; SENESCENCE; GENES;
   PROLIFERATION
AB Induction of apoptosis or quiescent hepatic stellate cells (HSCs) can be an attractive molecular strategy due to the importance of activation of HSCs during hepatic fibrogenesis. Interleukin-24/melanoma differentiation-associated gene-7 (IL-24/mda-7) is a cytokine that has attracted a great deal of attention in the tumor killing as well as pathophysiology of the diseases. In this study, the Pro-apoptotic and senescence inductive properties of IL-24/mda-7 were assessed in human-derived HSCs. Three plasmids expressing natural mda-7, peptide modified version, mda-7-RGD genes beside a recombinant IL-24 protein, were added or transfected into activated LX-2 cells. Cell viability and the amount of apoptosis were analyzed using MTT and Annexin V staining method, respectively. Hence, the expression levels of apoptotic genes and PPAR in different groups were also compared by real-time PCR analysis. Furthermore, the senescence effect of IL-24/mda-7 by a -galactosidase (SA--gal) senescence assay, was evaluated. The viability assessment showed that pmda-7-RGD had the most significant growth inhibitory effect when compared to the control group, pcDNA3.1 (P=0.0002). The apoptosis analysis also revealed a significant impact of different mda-7 forms in apoptosis induction. The measuring of cell senescence also indicated that IL-24/mda-7 in plasmid and protein formsexhibited a senescence inductive activity as determined by an increase in PPAR gene expression and beta-galctosidase activity. In conclusion, our findings demonstrated that both endogenous and soluble forms of IL-24/mda-7 induced apoptosis and senescence in activated LX-2 cells and more importantly, fusion of RGD peptide to this cytokine enhanced these activities. So, RGD-modified IL-24/mda-7 could be a suitable candidate for further molecular therapy of fibrosis.
C1 [Jamhiri, Iman; Zahri, Saber] Univ Mohaghegh Ardabili, Dept Biol Cell & Mol Lab, Cell & Mol Lab, Fac Sci, Ardebil, Iran.
   [Mehrabani, Davood; Khodabandeh, Zahra; Dianatpour, Mehdi] Shiraz Univ Med Sci, Stem Cell Technol Res Ctr, Shiraz, Iran.
   [Dianatpour, Mehdi] Shiraz Univ Med Sci, Sch Med, Dept Human Genet, Shiraz, Iran.
   [Yaghobi, Ramin] Shiraz Univ Med Sci, Transplant Res Ctr, Shiraz, Iran.
   [Hosseini, Seyed Younes] Shiraz Univ Med Sci, Dept Bacteriol & Virol, Shiraz 7134814336, Iran.
C3 University of Mohaghegh Ardabili; Shiraz University of Medical Science;
   Shiraz University of Medical Science; Shiraz University of Medical
   Science; Shiraz University of Medical Science
RP Hosseini, SY (corresponding author), Shiraz Univ Med Sci, Dept Bacteriol & Virol, Shiraz 7134814336, Iran.; Zahri, S (corresponding author), Univ Mohaghegh Ardabili, Dept Biol Cell & Mol Lab, Fac Sci, Ardebil 5619911367, Iran.
EM sazahri@gmail.com; hoseini.younes@gmail.com
RI Khodabandeh, Zahra/P-9130-2017; Dianatpour, Mehdi/V-3558-2017;
   Mehrabani, Davood/K-7509-2013; Zahri, Saber/AAD-3707-2022; Hosseini,
   Seyed Younes/T-9414-2019; Khodabandeh, Zahra/ITT-3394-2023; Capital
   Partners, L.P., Willow Creek/E-7792-2018; Jamhiri, Iman/O-7421-2018
OI Khodabandeh, Zahra/0000-0003-2276-2674; Mehrabani,
   Davood/0000-0002-5738-1719; Hosseini, Seyed Younes/0000-0002-5881-6796;
   Khodabandeh, Zahra/0000-0003-2276-2674; Capital Partners, L.P., Willow
   Creek/0000-0001-9902-2688; Jamhiri, Iman/0000-0002-4772-8678
FU Shiraz University of Medical Sciences [14993, 13610, 7238]; University
   of Mohaghegh Ardabili, Ardabil
FX The authors would like to thank the Laboratory staff of the Stem Cell
   Technology Research Center, Shiraz University of Medical Sciences. The
   current study was financially supported as a part of PhD thesis
   (University of Mohaghegh Ardabili, Ardabil) as well as by Shiraz
   University of Medical Sciences (Grants No. 14993, 13610 and 7238).
CR Assa-Munt N, 2001, BIOCHEMISTRY-US, V40, P2373, DOI 10.1021/bi002101f
   Bhoopathi P, 2016, CANCER RES, V76, P3572, DOI 10.1158/0008-5472.CAN-15-2959
   Craig R, 2008, MOL THER, V16, P901, DOI 10.1038/mt.2008.40
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Dent P, 2005, J CELL BIOCHEM, V95, P712, DOI 10.1002/jcb.20502
   Dent P, 2010, ANTI-CANCER DRUG, V21, P725, DOI 10.1097/CAD.0b013e32833cfbe1
   El-Lakkany NM, 2017, ASIAN PAC J TROP MED, V10, P423, DOI 10.1016/j.apjtm.2017.05.012
   Giotakis AI, 2016, CLIN BIOCHEM, V49, P890, DOI 10.1016/j.clinbiochem.2016.04.010
   He YJ, 2017, PLANTA MED, V7, P808
   Hosseini E, 2017, MOL MED REP, V15, P495, DOI 10.3892/mmr.2016.6009
   Hosseini SY, 2017, JUNDISHAPUR J NAT PH, V12, DOI 10.5812/jjnpp.40285
   Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018
   Jamhiri I, 2017, BIOMED REP, V7, P173, DOI 10.3892/br.2017.931
   Jin H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.92
   Khodadad M, 2015, IRAN J BASIC MED SCI, V18, P780
   Kisseleva T, 2007, J GASTROEN HEPATOL, V22, pS73, DOI 10.1111/j.1440-1746.2006.04658.x
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Kong XN, 2011, HEPATOLOGY, V54, p733A
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1
   Liang J, 2011, ANN PLAS SURG, V66, P660, DOI 10.1097/SAP.0b013e3181e05039
   Liu XR, 2012, J CELL MOL MED, V16, P1298, DOI 10.1111/j.1582-4934.2011.01396.x
   Menezes ME, 2014, ADV EXP MED BIOL, V818, P127, DOI 10.1007/978-1-4471-6458-6_6
   Nieberler M, 2017, CANCERS, V9, DOI 10.3390/cancers9090116
   Panebianco C, 2017, CLIN EXP MED, V17, P269, DOI 10.1007/s10238-016-0438-x
   Pap D, 2017, KIDNEY BLOOD PRESS R, V42, P16, DOI 10.1159/000464317
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   Pei DS, 2012, J INTERF CYTOK RES, V32, P66, DOI 10.1089/jir.2011.0040
   Persaud L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060869
   Pinzani M, 2004, DIGEST LIVER DIS, V36, P231, DOI 10.1016/j.dld.2004.01.003
   Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055
   Reetz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067091
   Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766
   Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199
   Sarkar D, 2002, BIOTECHNIQUES, P30
   Sauane M, 2004, CANCER RES, V64, P2988, DOI 10.1158/0008-5472.CAN-04-0200
   Sauane M, 2003, J CELL PHYSIOL, V196, P334, DOI 10.1002/jcp.10309
   Sauane M, 2008, P NATL ACAD SCI USA, V105, P9763, DOI 10.1073/pnas.0804089105
   Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641
   Tacke F, 2012, EXPERT REV GASTROENT, V6, P67, DOI [10.1586/EGH.11.92, 10.1586/egh.11.92]
   Tan HB, 2016, IMMUNOL INVEST, V45, P371, DOI 10.3109/08820139.2015.1137935
   Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38
   Tung YC, 2015, J AGR FOOD CHEM, V63, P5008, DOI 10.1021/acs.jafc.5b01779
   Weber WA, 2001, Q J NUCL MED, V45, P179
   Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188
   Xiao B, 2009, MOL BIOTECHNOL, V41, P138, DOI 10.1007/s12033-008-9115-y
   Xie YX, 2017, IMMUNOL LETT, V188, P116, DOI 10.1016/j.imlet.2017.06.009
   Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012
   Yu X, 2015, INT IMMUNOPHARMACOL, V28, P560, DOI 10.1016/j.intimp.2015.07.014
   Zheng J, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0224-8
   Zheng SZ, 2004, BIOCHEM J, V384, P149, DOI 10.1042/BJ20040928
NR 52
TC 7
Z9 8
U1 1
U2 7
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0882-0139
EI 1532-4311
J9 IMMUNOL INVEST
JI Immunol. Invest.
PY 2018
VL 47
IS 4
BP 335
EP 350
DI 10.1080/08820139.2018.1433202
PG 16
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA GD7UI
UT WOS:000430718100002
PM 29498551
DA 2024-02-19
ER

PT J
AU Takahashi, K
   Takisawa, S
   Shimokado, K
   Kono, N
   Arai, H
   Ishigami, A
AF Takahashi, Keita
   Takisawa, Shoko
   Shimokado, Kentaro
   Kono, Nozomu
   Arai, Hiroyuki
   Ishigami, Akihito
TI Age-related changes of vitamin E: α-tocopherol levels in plasma and
   various tissues of mice and hepatic α-tocopherol transfer protein
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Vitamin E; alpha-Tocopherol; alpha-Tocopherol transfer protein; Aging;
   Liver
ID COGNITIVE IMPAIRMENT; LIFE-SPAN; IN-VITRO; DEFICIENCY; DISCRIMINATION;
   DEGRADATION; PERFORMANCE; METABOLISM; VIVO
AB Purpose Despite numerous studies on the RRR-and all-rac-alpha-tocopherol isoform of vitamin E (VE) during aging, this relationship has not been examined in specific tissues. Since a-tocopherol is the most abundant of VE's eight isoforms, and VE is an important antioxidant that impacts the aging process, we analyzed alpha-tocopherol levels in plasma and tissues of mice at progressive ages. Moreover, we examined protein and mRNA expression levels of hepatic alpha-tocopherol transfer protein (alpha-TTP), which specifically binds alpha-tocopherol, during aging.
   Methods The alpha-tocopherol levels in plasma, liver, cerebrum, hippocampus, cerebellum, heart, kidney, epididymal adipose tissue, testis, pancreas, soleus muscle, plantaris muscle, and duodenum from male C57BL/6NCr mice at 3, 6, 12, 18, and 24 months of age were determined by HPLC and fluorescence detection. Also, hepatic alpha-TTP protein and mRNA expression levels were analyzed by Western blot and qPCR, respectively.
   Results Tissue-specific, age-related changes of a-tocopherol levels normalized by tissue weight were observed in the liver, cerebrum, hippocampus, cerebellum, heart, kidney, and epididymal adipose tissue. Specifically, alpha-tocopherol levels in epididymal adipose tissue increased greatly as mice aged from 6 to 24 months. Although hepatic alpha-TTP protein levels also showed age-related changes, alpha-TTP mRNA expression levels measured after overnight fasting were not altered.
   Conclusions In this study, we determined that alpha-tocopherol levels and hepatic alpha-TTP protein levels of mice undergo significant tissue-specific, age-related changes. This is the first report to investigate VE in terms of the alpha-tocopherol levels in plasma and various tissues of mice and hepatic alpha-TTP protein levels during aging.
C1 [Takahashi, Keita; Takisawa, Shoko; Ishigami, Akihito] TMIG, Mol Regulat Aging, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
   [Takahashi, Keita; Shimokado, Kentaro] Tokyo Med & Dent Univ, Dept Geriatr & Vasc Med, Tokyo 1138510, Japan.
   [Kono, Nozomu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Medical & Dental
   University (TMDU); University of Tokyo
RP Ishigami, A (corresponding author), TMIG, Mol Regulat Aging, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
EM ishigami@tmig.or.jp
RI KONO, nozomu/AAM-3178-2020
FU Japan Society for the Promotion of Science (JSPS) [24380073];
   Grants-in-Aid for Scientific Research [25460060, 15H04505, 15J02327]
   Funding Source: KAKEN
FX We are grateful to Mr. H. Tamura, Eisai Food and Chemical Co., Ltd.
   Japan, for providing dl-tocol and alpha-tocopherol standards. We also
   thank Dr. K. Fukui, Shibaura Institute of Technology for technical
   assistance and Ms. P. Minick for the excellent English editorial
   assistance. This study is supported by Japan Society for the Promotion
   of Science (JSPS) KAKENHI Grant Number 24380073 (A.I.).
CR Alzoubi KH, 2013, PHYSIOL BEHAV, V119, P72, DOI 10.1016/j.physbeh.2013.06.011
   Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008
   Bardowell SA, 2012, J LIPID RES, V53, P2667, DOI 10.1194/jlr.M030734
   Belda JI, 1999, MECH AGEING DEV, V107, P159, DOI 10.1016/S0047-6374(98)00144-4
   Cherubini A, 2005, NEUROBIOL AGING, V26, P987, DOI 10.1016/j.neurobiolaging.2004.09.002
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Christiansen-Weber TA, 2000, AM J PATHOL, V157, P1017, DOI 10.1016/S0002-9440(10)64614-7
   Donato AJ, 2014, J PHYSIOL-LONDON, V592, P4083, DOI 10.1113/jphysiol.2014.274175
   Ernst IMA, 2013, AGEING RES REV, V12, P365, DOI 10.1016/j.arr.2012.10.002
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Grebenstein N, 2014, MOL NUTR FOOD RES, V58, P1052, DOI 10.1002/mnfr.201300756
   Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7
   Kaempf-Rotzoll DE, 2003, CURR OPIN LIPIDOL, V14, P249, DOI 10.1097/00041433-200306000-00004
   Kaempf-Rotzoll DE, 2002, BIOL REPROD, V67, P599, DOI 10.1095/biolreprod67.2.599
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   Kono N, 2013, SCIENCE, V340, P1106, DOI 10.1126/science.1233508
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lennox KA, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.46
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mangialasche F, 2012, NEUROBIOL AGING, V33, P2282, DOI 10.1016/j.neurobiolaging.2011.11.019
   Morley AA, 2001, BIOGERONTOLOGY, V2, P109, DOI 10.1023/A:1011589218219
   Navarro A, 2005, AM J PHYSIOL-REG I, V289, pR1392, DOI 10.1152/ajpregu.00834.2004
   Niki E, 2014, FREE RADICAL BIO MED, V66, P3, DOI 10.1016/j.freeradbiomed.2013.03.022
   Parker RS, 2004, ANN NY ACAD SCI, V1031, P13, DOI 10.1196/annals.1331.002
   Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010
   Shichiri M, 2010, J NUTR BIOCHEM, V21, P451, DOI 10.1016/j.jnutbio.2009.02.002
   Takahashi K, 2014, BBA-GEN SUBJECTS, V1840, P2289, DOI 10.1016/j.bbagen.2014.03.019
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Tébi A, 2000, NUTR RES, V20, P1395, DOI 10.1016/S0271-5317(00)80021-4
   Thakur V, 2010, BIOCHEMISTRY-US, V49, P9339, DOI 10.1021/bi100960b
   Traber MG, 2013, J LIPID RES, V54, P2295, DOI 10.1194/jlr.R032946
   TRABER MG, 1990, J LIPID RES, V31, P675
   Ulatowski L, 2014, NEUROSCIENCE, V260, P120, DOI 10.1016/j.neuroscience.2013.12.001
   Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85
NR 34
TC 14
Z9 17
U1 3
U2 17
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD APR
PY 2017
VL 56
IS 3
BP 1317
EP 1327
DI 10.1007/s00394-016-1182-4
PG 11
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA EO6OO
UT WOS:000396812600036
PM 26893162
DA 2024-02-19
ER

PT J
AU ZAHNER, D
   MALAISSE, WJ
AF ZAHNER, D
   MALAISSE, WJ
TI ALTERED KINETIC-BEHAVIOR OF LIVER GLUCOKINASE IN STARVED RATS
SO DIABETES NUTRITION & METABOLISM
LA English
DT Article
DE LIVER GLUCOKINASE; STARVATION; N-ACETYL-D-GLUCOSAMINE
ID FRUCTOSE 1-PHOSPHATE; HEXOKINASE; PROTEIN
AB Semi-purified hepatic glucokinase from starved rats displayed an abnormal kinetic behaviour in terms of both apparent affinity for D-glucose and temperature dependency, when compared to the enzyme prepared from fed animals. These anomalies persisted in the presence of N-acetyl-D-glucosamine. The fasting-induced decrease in the apparent affinity of glucokinase for D-glucose, which could reflect an altered ratio between newly synthesized and ageing enzyme, might participate in starvation diabetes.
C1 FREE UNIV BRUSSELS,ERASMUS MED SCH,MED EXPTL LAB,CP 618,ROUTE LENNICK,B-1070 BRUSSELS,BELGIUM.
C3 Universite Libre de Bruxelles
CR ALLEN MB, 1980, BIOCHEM J, V185, P577, DOI 10.1042/bj1850577
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   REYES A, 1984, BIOCHEM J, V221, P303, DOI 10.1042/bj2210303
   SENER A, 1985, BIOCHEM J, V230, P345, DOI 10.1042/bj2300345
   VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179
   ZAHNER D, 1990, DIABETES RES CLIN EX, V14, P101
   ZAHNER D, 1990, DIABETES RES CLIN EX, V14, P117
   ZAHNER D, 1990, DIABETES RES CLIN EX, V14, P109
   ZAHNER D, 1990, BIOCHIMIE, V72, P715, DOI 10.1016/0300-9084(90)90155-A
NR 9
TC 0
Z9 0
U1 0
U2 0
PU EDITRICE KURTIS S R L
PI MILANO
PA VIA LUIGI ZOJA, 30-20153 MILANO, ITALY
SN 0394-3402
J9 DIABETES NUTR METAB
JI Diabetes Nutr. Metab.
PD SEP
PY 1992
VL 5
IS 3
BP 161
EP 166
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA JR795
UT WOS:A1992JR79500002
DA 2024-02-19
ER

PT J
AU Yumura, W
   Imasawa, T
   Suganuma, S
   Ishigami, A
   Handa, S
   Kubo, S
   Joh, K
   Maruyama, N
AF Yumura, W.
   Imasawa, T.
   Suganuma, S.
   Ishigami, A.
   Handa, S.
   Kubo, S.
   Joh, K.
   Maruyama, N.
TI Accelerated tubular cell senescence in SMP30 knockout mice
SO HISTOLOGY AND HISTOPATHOLOGY
LA English
DT Article
DE renal senescence; tubular cells; SMP30; knockout mouse; lipofuscin;
   senescence-associated; beta-galactoside
ID MARKER PROTEIN-30 SMP30; ALLOGRAFT SURVIVAL; LIFE-SPAN; IN-VIVO; AGE;
   LIVER; ACCUMULATION; EXPRESSION; KIDNEYS
AB An experimental model with accelerated but not drastic renal senescence seemed useful to recognize the mechanisms of how kidney function deteriorates with age. Senescence marker protein-30 (SMP30), whose expression decreased with age and was sex-independent, is mainly expressed in hepatocytes and proximal tubular cells. Therefore, we established a SMP30 deficient strain of mice with a C57BL/6 background by gene targeting to investigate whether this molecule is involved in renal tubular cell senescence. Male SMP30 knockout (SMP30Y/-) mice and male wild-type (SMPY/+) mice (n = 5) aged 12 months were examined histologically. Their tubular epithelia showed the deposition of lipofuscin and the presence of senescence-associated beta-galactosidase (SA-beta-GAL). However, no tubular cells were atrophic. In electron microscopy, SMP30-KO mice showed markedly enlarged lysosomes containing an electron dense substance. These are convincing hallmarks of senescence. We recognized the early manifestation of senescence hallmarks in SMP30-KO mice at 12 months old. Thus, this model represents the first report of a mouse strain that manifests accelerated ordinal senescence in a kidney after gene manipulation.
C1 Chiba E Natl Hosp, Clin Res Ctr, Dept Internal Med, Chiba 2608712, Japan.
   Chiba E Natl Hosp, Clin Res Ctr, Div Immunopathol, Chiba 2608712, Japan.
   Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo, Japan.
   Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Tokyo, Japan.
C3 Tokyo Women's Medical University; Tokyo Metropolitan Institute of
   Gerontology
RP Imasawa, T (corresponding author), Chiba E Natl Hosp, Clin Res Ctr, Dept Internal Med, 673 Nitona, Chiba 2608712, Japan.
EM timasawa@yahoo.co.jp
OI Joh, Kensuke/0000-0002-9334-3664
CR Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1999, MECH AGEING DEV, V107, P271, DOI 10.1016/S0047-6374(98)00136-5
   HARMAN D, 1989, ADV EXP MED BIOL, V266, P3
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hoang K, 2003, KIDNEY INT, V64, P1417, DOI 10.1046/j.1523-1755.2003.00207.x
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   ISHII K, 2002, OTOLAR JPN, V105, P915
   Kasiske BL, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341067
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Melk A, 2003, KIDNEY INT, V63, P2134, DOI 10.1046/j.1523-1755.2003.00032.x
   Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   Moreso F, 1999, NEPHROL DIAL TRANSPL, V14, P930, DOI 10.1093/ndt/14.4.930
   MORREAU H, 1989, J BIOL CHEM, V264, P20655
   Wright WE, 2002, NAT BIOTECHNOL, V20, P682, DOI 10.1038/nbt0702-682
   YUMURA W, 1989, EXP GERONTOL, V24, P237, DOI 10.1016/0531-5565(89)90015-6
   KIDNEY INT
NR 22
TC 34
Z9 38
U1 0
U2 2
PU F HERNANDEZ
PI MURCIA
PA PLAZA FUENSANTA 2-7 C, 30008 MURCIA, SPAIN
SN 0213-3911
J9 HISTOL HISTOPATHOL
JI Histol. Histopath.
PD NOV
PY 2006
VL 21
IS 11
BP 1151
EP 1156
PG 6
WC Cell Biology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Pathology
GA 066OR
UT WOS:000239239800002
PM 16874657
DA 2024-02-19
ER

PT J
AU Bernard, M
   Yang, B
   Migneault, F
   Turgeon, J
   Dieudé, M
   Olivier, MA
   Cardin, GB
   El-Diwany, M
   Underwood, K
   Rodier, F
   Hébert, MJ
AF Bernard, Monique
   Yang, Bing
   Migneault, Francis
   Turgeon, Julie
   Dieude, Melanie
   Olivier, Marc-Alexandre
   Cardin, Guillaume B.
   El-Diwany, Mostafa
   Underwood, Katy
   Rodier, Francis
   Hebert, Marie-Josee
TI Autophagy drives fibroblast senescence through MTORC2 regulation
SO AUTOPHAGY
LA English
DT Article; Early Access
DE Autophagy; MTORC2; myofibroblast; rapamycin; senescence
ID CELLULAR SENESCENCE; MYOFIBROBLAST DIFFERENTIATION; OXIDATIVE STRESS;
   REDOX REGULATION; LIVER FIBROSIS; STELLATE CELLS; GROWTH ARREST;
   UP-REGULATION; P53; ACTIVATION
AB Sustained macroautophagy/autophagy favors the differentiation of fibroblasts into myofibroblasts. Cellular senescence, another means of responding to long-term cellular stress, has also been linked to myofibroblast differentiation and fibrosis. Here, we evaluate the relationship between senescence and myofibroblast differentiation in the context of sustained autophagy. We analyzed markers of cell cycle arrest/senescence in fibroblasts in vitro, where autophagy was triggered by serum starvation (SS). Autophagic fibroblasts expressed the senescence biomarkers CDKN1A/p21 and CDKN2A/p16 and exhibited increased senescence-associated GLB1/beta-galactosidase activity. Inhibition of autophagy in serum-starved fibroblasts with 3-methyladenine, LY294002, or ATG7 (autophagy related 7) silencing prevented the expression of senescence-associated markers. Similarly, suppressing MTORC2 activation using rapamycin or by silencing RICTOR also prevented senescence hallmarks. Immunofluorescence microscopy showed that senescence and myofibroblast differentiation were induced in different cells, suggesting mutually exclusive activation of senescence and myofibroblast differentiation. Reactive oxygen species (ROS) are known inducers of senescence and exposing fibroblasts to ROS scavengers decreased ROS production during SS, inhibited autophagy, and significantly reduced the expression of senescence and myofibroblast differentiation markers. ROS scavengers also curbed the AKT1 phosphorylation at Ser473, an MTORC2 target, establishing the importance of ROS in fueling MTORC2 activation. Inhibition of senescence by shRNA to TP53/p53 and shRNA CDKN2A/p16 increased myofibroblast differentiation, suggesting a negative feedback loop of senescence on autophagy-induced myofibroblast differentiation. Collectively, our results identify ROS as central inducers of MTORC2 activation during chronic autophagy, which in turn fuels senescence activation and myofibroblast differentiation in distinct cellular subpopulations.
C1 [Bernard, Monique; Yang, Bing; Migneault, Francis; Turgeon, Julie; Dieude, Melanie; Olivier, Marc-Alexandre; Cardin, Guillaume B.; El-Diwany, Mostafa; Underwood, Katy; Rodier, Francis; Hebert, Marie-Josee] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada.
   [Bernard, Monique; Yang, Bing; Migneault, Francis; Turgeon, Julie; Dieude, Melanie; Olivier, Marc-Alexandre; Cardin, Guillaume B.; El-Diwany, Mostafa; Underwood, Katy; Rodier, Francis; Hebert, Marie-Josee] Univ Montreal, Montreal, PQ, Canada.
   [Yang, Bing; Migneault, Francis; Turgeon, Julie; Dieude, Melanie; Hebert, Marie-Josee] Canadian Donat & Transplantat Res Program, Edmonton, AB, Canada.
   [Olivier, Marc-Alexandre; Cardin, Guillaume B.; Rodier, Francis] Inst Canc Montreal, Montreal, PQ, Canada.
   [Rodier, Francis] Univ Montreal, Dept Radiol Radiooncol & Med Nucl, Montreal, PQ, Canada.
   [Hebert, Marie-Josee] Univ Montreal, Dept Med, Montreal, PQ, Canada.
C3 Universite de Montreal; Universite de Montreal; Universite de Montreal;
   Universite de Montreal; Universite de Montreal
RP Hébert, MJ (corresponding author), CRCHUM, 900 St Denis St,Pavilion R,Room R12-412, Montreal, PQ H2X 0A9, Canada.
EM marie-josee.hebert@umontreal.ca
RI ; Migneault, Francis/B-5442-2019
OI Dieude, Melanie/0000-0002-9300-4232; Migneault,
   Francis/0000-0001-7331-4498; Olivier, Marc-Alexandre/0000-0002-7919-448X
FU Canadian Institutes of Health Research (CIHR) [MOP-123436]; Canadian
   Donation and Transplantation Research Program (CDTRP); Fonds de la
   recherche en sante du Quebec (FRQS); FRQS junior I-II career awards
   [22624, 33070]; CIHR research grant [MOP114962]; Institut du cancer de
   Montreal Canderel fellowship; J.-L. Levesque Foundation
FX This work was supported by research grants from the Canadian Institutes
   of Health Research (CIHR, MOP-123436) to MJH, holder of the Shire Chair
   in Nephrology, Transplantation and Renal Regeneration of Universite de
   Montreal. MJH is also supported by the Canadian Donation and
   Transplantation Research Program (CDTRP). MB is the recipient of a
   fellowship from Fonds de la recherche en sante du Quebec (FRQS). FR is
   supported by a FRQS junior I-II career awards (22624, 33070) and a CIHR
   research grant (MOP114962). MAO received an Institut du cancer de
   Montreal Canderel fellowship. The authors thank the J.-L. Levesque
   Foundation for renewed support, the members of the Rodier and Hebert
   laboratories for valuable comments and discussions, and the CRCHUM
   microscopy platform. Special thanks to Sophie Poirier for her help in
   quantification of immunofluorescence staining.
CR Araya J, 2013, AM J PHYSIOL-LUNG C, V304, pL56, DOI 10.1152/ajplung.00213.2012
   Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Bernard M, 2014, AUTOPHAGY, V10, P2193, DOI 10.4161/15548627.2014.981786
   Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x
   Cailhier JF, 2008, J BIOL CHEM, V283, P27220, DOI 10.1074/jbc.M801164200
   Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529
   Cheng SF, 2015, CELL CYCLE, V14, P1613, DOI 10.1080/15384101.2015.1039359
   Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751
   Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Corcoran A, 2013, FEBS J, V280, P1944, DOI 10.1111/febs.12224
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150
   Gambino V, 2013, AGING CELL, V12, P435, DOI 10.1111/acel.12060
   Gewirtz DA, 2013, AUTOPHAGY, V9, P808, DOI 10.4161/auto.23922
   Gibson SB, 2013, METHOD ENZYMOL, V528, P217, DOI 10.1016/B978-0-12-405881-1.00013-6
   Goehe RW, 2012, J PHARMACOL EXP THER, V343, P763, DOI 10.1124/jpet.112.197590
   Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005
   Hernández-Gea V, 2012, AUTOPHAGY, V8, P849, DOI 10.4161/auto.19947
   Hernández-Gea V, 2012, GASTROENTEROLOGY, V142, P938, DOI 10.1053/j.gastro.2011.12.044
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78
   Itahana K, 2002, J BIOL CHEM, V277, P18206, DOI 10.1074/jbc.M201028200
   Kang C, 2016, AUTOPHAGY, V12, P898, DOI 10.1080/15548627.2015.1121361
   Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kim SW, 2019, INVEST OPHTH VIS SCI, V60, P82, DOI 10.1167/iovs.18-25376
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kuwano K, 2016, RESPIR INVESTIG, V54, P397, DOI 10.1016/j.resinv.2016.03.010
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017
   Laplante P, 2005, J IMMUNOL, V174, P5740, DOI 10.4049/jimmunol.174.9.5740
   Laplante P, 2010, CELL DEATH DIFFER, V17, P291, DOI 10.1038/cdd.2009.124
   Malaquin N, 2016, EXP GERONTOL, V82, P39, DOI 10.1016/j.exger.2016.05.010
   Mar FA, 2015, AUTOPHAGY, V11, P527, DOI 10.1080/15548627.2015.1017189
   Muteliefu G, 2012, AM J PHYSIOL-CELL PH, V303, pC126, DOI 10.1152/ajpcell.00329.2011
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Nayak BK, 2013, ONCOGENE, V32, P3147, DOI 10.1038/onc.2012.333
   Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002
   Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Regulski MJ, 2017, WOUNDS, V29, P168
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006
   Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019
NR 57
TC 81
Z9 87
U1 6
U2 48
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1554-8627
EI 1554-8635
J9 AUTOPHAGY
JI Autophagy
PD 2020 NOV 1
PY 2020
VL 16
IS 11
BP 2004
EP 2016
DI 10.1080/15548627.2020.1713640
EA JAN 2020
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA OI6MP
UT WOS:000506961900001
PM 31931659
OA Green Published, Green Submitted, Bronze
DA 2024-02-19
ER

PT J
AU Saafan, SM
   Mohamed, SA
   Noreldin, AE
   El Tedawy, FA
   Elewa, YHA
   Fadly, RS
   Al Jaouni, SK
   El-Far, AH
   Alsenosy, AA
AF Saafan, Shaimaa M.
   Mohamed, Shymaa A.
   Noreldin, Ahmed E.
   El Tedawy, Fayza A.
   Elewa, Yaser H. A.
   Fadly, Reda S.
   Al Jaouni, Soad Khalil
   El-Far, Ali H.
   Alsenosy, Abdelwahab A.
TI Rutin attenuates d-galactose-induced oxidative stress in rats' brain and
   liver: molecular docking and experimental approaches
SO FOOD & FUNCTION
LA English
DT Article; Early Access
ID ACIDIC PROTEIN GFAP; COGNITIVE IMPAIRMENTS; CELLULAR SENESCENCE; MEMORY
   IMPAIRMENT; AGING RATS; DAMAGE; NEUROINFLAMMATION; EXPRESSION;
   AUTOPHAGY; DEFICITS
AB Oxidative stress results from the imbalance between reactive oxygen species (ROS) production and antioxidant defence and is primarily involved in aging. The current study investigated the antioxidant activity of rutin in aging in rats induced by d-galactose (d-gal) for 42 days. Rutin was orally used at doses of 50 and 100 mg kg(-1) daily. Results showed that d-gal induced oxidative alterations in the brain and liver recognized via upregulation of aging and oxidative markers. In contrast, rutin ameliorated the oxidative stress induced by d-gal by enhancing antioxidant markers such as superoxide dismutase-1, glutathione peroxidase-1, and glutathione S-transferase-alpha. Also, rutin significantly decreased the accumulation of beta-galactosidase and reduced the expression of p53, p21, Bcl-2-associated X protein (Bax), caspase-3 (CASP3), and mammalian target of rapamycin (mTOR) in brain and hepatic tissues. Rutin potentially attenuated these aging-related oxidative alterations in a dose-dependent manner. Moreover, rutin markedly reduced the increased immunohistochemical expression of beta-galactosidase, 8-hydroxy-2 '-deoxyguanosine, calcium-binding adapter molecule 1, glial fibrillary acidic protein, Bax, and interleukin-6 and significantly increased Bcl2, synaptophysin, and Ki67. Furthermore, a molecular docking study revealed that rutin exhibited high affinity to rat and human caspases, PI3K/AKT/mTOR, and the IL-6 receptor. Finally, we can conclude that rutin supplementation can be a promising natural protective compound that could delay aging and maintain health.
C1 [Saafan, Shaimaa M.; El Tedawy, Fayza A.; Fadly, Reda S.] Agr Res Ctr ARC, Anim Hlth Res Inst AHRI, Dept Biochem, Damanhour Branch, Damanhour 22511, Egypt.
   [Mohamed, Shymaa A.] Alexandria Univ, Med Res Inst, Med Technol Ctr, Mol Biol,Molecular Biol Unit, Alexandria, Egypt.
   [Noreldin, Ahmed E.] Damanhour Univ, Fac Vet Med, Dept Histol & Cytol, Damanhour 22511, Egypt.
   [Elewa, Yaser H. A.] Zagazig Univ, Fac Vet Med, Dept Histol, Zagazig 44519, Egypt.
   [Elewa, Yaser H. A.] Hokkaido Univ, Fac Vet Med, Lab Anat, Basic Vet Sci, Sapporo 0600818, Japan.
   [Al Jaouni, Soad Khalil] King Abdulaziz Univ, Fac Med, Yousef Abdulatif Jameel Sci Chair Prophet Med Appl, Dept Hematol Pediat Oncol, Jeddah 21589, Saudi Arabia.
   [El-Far, Ali H.; Alsenosy, Abdelwahab A.] Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour 22511, Egypt.
C3 Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge
   Bank (EKB); Damanhour University; Egyptian Knowledge Bank (EKB); Zagazig
   University; Hokkaido University; King Abdulaziz University; Egyptian
   Knowledge Bank (EKB); Damanhour University
RP El-Far, AH (corresponding author), Damanhour Univ, Fac Vet Med, Dept Biochem, Damanhour 22511, Egypt.
EM shymaa.abdullah@alexu.edu.eg; ahmed.elsayed@damanhour.edu.eg;
   fayzaeltedawy@gmail.com; y-elewa@vetmed.hokudai.ac.jp;
   saljaouni@kau.edu.sa; ali.elfar@damanhour.edu.eg
RI Noreldin, Ahmed E./S-1130-2017; El-Far, Prof Dr/Ali H./L-7946-2017;
   ALSENOSY, ABDELWAHAB A./AAA-6680-2020
OI Noreldin, Ahmed E./0000-0002-8344-0807; El-Far, Prof Dr/Ali
   H./0000-0001-9721-4360; ALSENOSY, ABDELWAHAB A./0000-0002-2262-7555; Al
   Jaouni, Soad/0000-0003-0602-0224
CR Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128
   Arowoogun J, 2021, J BIOCHEM MOL TOXIC, V35, DOI 10.1002/jbt.22623
   Atayik MC, 2022, BIOGERONTOLOGY, V23, P401, DOI 10.1007/s10522-022-09973-y
   Atef MM, 2022, NEUROCHEM RES, V47, P1664, DOI 10.1007/s11064-022-03559-3
   Atta MS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050919
   Aydin S, 2012, BIOGERONTOLOGY, V13, P251, DOI 10.1007/s10522-011-9370-3
   Aydin S, 2010, BIOGERONTOLOGY, V11, P335, DOI 10.1007/s10522-009-9257-8
   Azman KF, 2021, EXP GERONTOL, V150, DOI 10.1016/j.exger.2021.111372
   Bancroft J.D., 2013, Theory and Practice of Histological Techniques, V7th, P173, DOI DOI 10.1016/B978-0-7020-4226-3.00010-X
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Bloomer SA, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23126502
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Budni J, 2017, METAB BRAIN DIS, V32, P811, DOI 10.1007/s11011-017-9972-9
   Budni J, 2016, BEHAV BRAIN RES, V302, P35, DOI 10.1016/j.bbr.2015.12.041
   Chen P, 2019, NEUROTHERAPEUTICS, V16, P1269, DOI 10.1007/s13311-019-00753-0
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899
   Dora MF, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22083829
   Du ZD, 2019, NEUROCHEM INT, V124, P31, DOI 10.1016/j.neuint.2018.12.008
   Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080
   El-Far AH, 2022, ENVIRON SCI POLLUT R, V29, P47436, DOI 10.1007/s11356-022-18984-8
   El-Far AH, 2021, INTEGR CANCER THER, V20, DOI 10.1177/15347354211035450
   El-Far AH, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9080990
   El-Far AH, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22136839
   El-Far AH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124348
   El-Far AH, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101369
   Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]
   Fang F, 2007, BASIC CLIN PHARMACOL, V101, P447, DOI 10.1111/j.1742-7843.2007.00138.x
   Garcez ML, 2021, METAB BRAIN DIS, V36, P213, DOI 10.1007/s11011-020-00647-7
   Garrido A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030769
   Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099
   Godugu K, 2020, MOLECULES, V25, DOI 10.3390/molecules25112597
   Hassan NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15571-7
   Hassan S, 2014, PAK J MED SCI, V30, P1027, DOI 10.12669/pjms.305.5534
   He C, 2021, IRAN J BASIC MED SCI, V24, P341, DOI 10.22038/ijbms.2021.49147.11256
   Hickman S, 2018, NAT NEUROSCI, V21, P1359, DOI 10.1038/s41593-018-0242-x
   Huang C.-C., 2013, J EVIDENCE BASED COM, V2013, P1
   JACQUE CM, 1978, J NEUROL SCI, V35, P147, DOI 10.1016/0022-510X(78)90107-7
   Javed H, 2012, NEUROSCIENCE, V210, P340, DOI 10.1016/j.neuroscience.2012.02.046
   Jiménez-Torres C, 2021, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.613225
   Juan CA, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094642
   Kalaz EB, 2014, J PHYSIOL BIOCHEM, V70, P15, DOI 10.1007/s13105-013-0275-2
   Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026
   Khan RA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-204
   Kumar D, 2014, AGING CLIN EXP RES, V26, P261, DOI 10.1007/s40520-013-0170-2
   Kuo HC, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0266331
   Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001
   Layton C., 2013, Bancroft's theory and practise of histological techniques, V7th edition
   Lebda MA, 2019, FISH SHELLFISH IMMUN, V88, P619, DOI 10.1016/j.fsi.2019.03.037
   Li X, 2016, EXP GERONTOL, V83, P89, DOI 10.1016/j.exger.2016.07.012
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Motevalian M, 2021, IRAN J BASIC MED SCI, V24, P1388, DOI [10.22038/ijbms.2021.58502.12996, 10.22038/IJBMS.2021.58502.12996]
   Nassiri-Asl M, 2010, EPILEPSY BEHAV, V18, P50, DOI 10.1016/j.yebeh.2010.03.005
   Nieoczym D, 2014, PROG NEURO-PSYCHOPH, V54, P50, DOI 10.1016/j.pnpbp.2014.05.007
   Nones J, 2012, CELL TISSUE RES, V350, P305, DOI 10.1007/s00441-012-1472-y
   Noreldin AE, 2018, ACTA HISTOCHEM, V120, P323, DOI 10.1016/j.acthis.2018.03.001
   Phatnani H, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020628
   Prajit R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041100
   Rathod R, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0241-8
   RATTY AK, 1988, BIOCHEM MED METAB B, V39, P69, DOI 10.1016/0885-4505(88)90060-6
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   Ren XJ, 2020, EXP THER MED, V20, P3228, DOI 10.3892/etm.2020.9080
   Richetti SK, 2011, BEHAV BRAIN RES, V217, P10, DOI 10.1016/j.bbr.2010.09.027
   Sayed AEH, 2017, ECOTOX ENVIRON SAFE, V143, P344, DOI 10.1016/j.ecoenv.2017.05.013
   Shen YX, 2002, J PINEAL RES, V32, P173, DOI 10.1034/j.1600-079x.2002.1o850.x
   Singh S, 2021, BIOGERONTOLOGY, V22, P35, DOI 10.1007/s10522-020-09900-z
   Sudha T, 2021, NUTR CANCER, V73, P1350, DOI 10.1080/01635581.2020.1800768
   Sun K., 2018, OXID MED CELL LONGEV, V2018, P1
   Ullah F, 2015, NEUROCHEM INT, V90, P114, DOI 10.1016/j.neuint.2015.07.001
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Wang LJ, 2018, BIOMED PHARMACOTHER, V98, P516, DOI 10.1016/j.biopha.2017.12.046
   Wang SW, 2012, NEUROTOXICOLOGY, V33, P482, DOI 10.1016/j.neuro.2012.03.003
   Wang T, 2015, J PHARM PHARMACOL, V67, P1284, DOI 10.1111/jphp.12413
   Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003
   Weichhart T, 2018, GERONTOLOGY, V64, P127, DOI 10.1159/000484629
   Weiss JF, 2003, TOXICOLOGY, V189, P1, DOI 10.1016/S0300-483X(03)00149-5
   Xia J Y, 2016, Zhonghua Gan Zang Bing Za Zhi, V24, P214, DOI 10.3760/cma.j.issn.1007-3418.2016.03.011
   Yang YC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/980276
   Yin ST, 2009, N-S ARCH PHARMACOL, V379, P551, DOI 10.1007/s00210-009-0401-4
   Yuan J, 2018, INT J MOL MED, V41, P2086, DOI 10.3892/ijmm.2018.3393
   Zhang B., 2021, OXID MED CELL LONGEV, V2021, P1
   Zhang X, 2019, J ETHNOPHARMACOL, V234, P44, DOI 10.1016/j.jep.2018.12.050
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
NR 84
TC 3
Z9 3
U1 16
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD 2023 JUN 19
PY 2023
VL 14
IS 12
BP 5728
EP 5751
DI 10.1039/d2fo03301a
EA MAR 2023
PG 24
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA J0RM3
UT WOS:001003101600001
PM 37282615
OA hybrid
DA 2024-02-19
ER

PT J
AU Heinze, I
   Bens, M
   Calzia, E
   Holtze, S
   Dakhovnik, O
   Sahm, A
   Kirkpatrick, JM
   Szafranski, K
   Romanov, N
   Sama, SN
   Holzer, K
   Singer, S
   Ermolaeva, M
   Platzer, M
   Hildebrandt, T
   Ori, A
AF Heinze, Ivonne
   Bens, Martin
   Calzia, Enrico
   Holtze, Susanne
   Dakhovnik, Oleksandr
   Sahm, Arne
   Kirkpatrick, Joanna M.
   Szafranski, Karol
   Romanov, Natalie
   Sama, Sai Nagender
   Holzer, Kerstin
   Singer, Stephan
   Ermolaeva, Maria
   Platzer, Matthias
   Hildebrandt, Thomas
   Ori, Alessandro
TI Species comparison of liver proteomes reveals links to naked mole-rat
   longevity and human aging
SO BMC BIOLOGY
LA English
DT Article
ID LONGEST-LIVING RODENT; LIFE-SPAN; PEPTIDE IDENTIFICATION; METABOLISM;
   RESISTANCE; INSIGHTS; STRESS; MITOCHONDRIA; NETWORK; CANCER
AB Background: Mammals display a wide range of variation in their lifespan. Investigating the molecular networks that distinguish long- from short-lived species has proven useful to identify determinants of longevity. Here, we compared the livers of young and old long-lived naked mole-rats (NMRs) and the phylogenetically closely related, shorter-lived, guinea pigs using an integrated omits approach.
   Results: We found that NMR livers display a unique expression pattern of mitochondrial proteins that results in distinct metabolic features of their mitochondria. For instance, we observed a generally reduced respiration rate associated with lower protein levels of respiratory chain components, particularly complex I, and increased capacity to utilize fatty acids. Interestingly, we show that the same molecular networks are affected during aging in both NMRs and humans, supporting a direct link to the extraordinary longevity of both species. Finally, we identified a novel detoxification pathway linked to longevity and validated it experimentally in the nematode Caenorhabditis elegans.
   Conclusions: Our work demonstrates the benefits of integrating proteomic and transcriptomic data to perform cross-species comparisons of longevity-associated networks. Using a multispecies approach, we show at the molecular level that livers of NMRs display progressive age-dependent changes that recapitulate typical signatures of aging despite the negligible senescence and extraordinary longevity of these rodents.
C1 [Heinze, Ivonne; Bens, Martin; Dakhovnik, Oleksandr; Sahm, Arne; Kirkpatrick, Joanna M.; Szafranski, Karol; Sama, Sai Nagender; Ermolaeva, Maria; Platzer, Matthias; Ori, Alessandro] FLI, Leibniz Inst Aging, Jena, Germany.
   [Calzia, Enrico] Univ Ulm, Inst Anesthesiol Pathophysiol & Proc Engn, Ulm, Germany.
   [Holtze, Susanne; Hildebrandt, Thomas] Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany.
   [Romanov, Natalie] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.
   [Holzer, Kerstin; Singer, Stephan] Univ Med Greifswald, Inst Pathol, Greifswald, Germany.
C3 Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung -
   Fritz-Lipmann-Institut (FLI); Ulm University; Leibniz Institut fur Zoo
   und Wildtierforschung; European Molecular Biology Laboratory (EMBL);
   Greifswald Medical School
RP Platzer, M; Ori, A (corresponding author), FLI, Leibniz Inst Aging, Jena, Germany.; Hildebrandt, T (corresponding author), Leibniz Inst Zoo & Wildlife Res IZW, Berlin, Germany.
EM matthias.platzer@leibniz.fli.de; HILDEBRAND@izw.berlin.de;
   alessandro.ori@leibniz-fli.de
RI Sahm, Arne/AAG-3842-2019; Ori, Alessandro/B-7067-2011; Ori,
   Alessandro/M-8586-2019
OI Sahm, Arne/0000-0002-7330-1790; Ori, Alessandro/0000-0002-3046-0871;
   Ori, Alessandro/0000-0002-3046-0871; Bens, Martin/0000-0001-7940-6668
FU Deutsche Forschungsgemeinschaft [PL 173/8-1, GRK1715, SFB/TR209];
   Leibniz-Gemeinschaft through the Senatsausschusswettbewerb Award
   [SAW-2012-FLI-2]; Federal Government of Germany; State of Thuringia
FX We thank the staff members from Stockholm Zoo Skansen for providing old
   NMRs, Veronika Geissler and other members of NCT tissue bank for their
   support, and Stefan Pietsch for the support with the bioinformatics
   analysis. We gratefully acknowledge support from the FLI proteomics,
   sequencing, and bioinformatics core facilities. MP acknowledges funding
   from Deutsche Forschungsgemeinschaft Award Number PL 173/8-1 and
   Leibniz-Gemeinschaft through the Senatsausschusswettbewerb Award Number:
   SAW-2012-FLI-2 (together with TH). ME acknowledges funding from Deutsche
   Forschungsgemeinschaft Award Number GRK1715. SS acknowledges funding
   from Deutsche Forschungsgemeinschaft Award Number SFB/TR209 (Project
   B04). The FLI is a member of the Leibniz Association and is financially
   supported by the Federal Government of Germany and the State of
   Thuringia.
CR Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x
   Baumgart M, 2016, CELL SYST, V2, P122, DOI 10.1016/j.cels.2016.01.014
   Beltrán-Sánchez H, 2018, ELIFE, V7, DOI 10.7554/eLife.34427
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bens M, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0546-z
   Bens M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2349-8
   Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159
   Brandt T, 2017, ELIFE, V6, DOI 10.7554/eLife.24662
   Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s
   Bruderer R, 2015, MOL CELL PROTEOMICS, V14, P1400, DOI 10.1074/mcp.M114.044305
   Buczak K, 2018, MOL CELL PROTEOMICS, V17, P810, DOI 10.1074/mcp.RA117.000189
   BUFFENSTEIN R, 1991, BRIT J NUTR, V65, P249, DOI 10.1079/BJN19910084
   Buffenstein R., 2002, SCI AGING KNOWLEDGE, V2002, pe7, DOI [DOI 10.1126/SAGEKE.2002.21.PE7., 10.1126/sageke.2002.21.pe7]
   Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5
   Bustos V, 2017, TRENDS BIOCHEM SCI, V42, P812, DOI 10.1016/j.tibs.2017.07.001
   Cellerino A, 2017, SEMIN CELL DEV BIOL, V70, P177, DOI 10.1016/j.semcdb.2017.06.012
   Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Dammann P, 2006, CURR BIOL, V16, pR117, DOI 10.1016/j.cub.2006.02.012
   Dammann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018757
   Davinelli S, 2012, IMMUN AGEING, V9, DOI 10.1186/1742-4933-9-9
   de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073
   Delire B, 2017, AGING-US, V9, P112, DOI 10.18632/aging.101124
   Done AJ, 2016, FREE RADICAL BIO MED, V96, P130, DOI 10.1016/j.freeradbiomed.2016.04.024
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   Erol A, 2007, PPAR RES, V2007, DOI 10.1155/2007/39654
   Fang XD, 2014, CELL REP, V8, P1354, DOI 10.1016/j.celrep.2014.07.030
   Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508
   Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998
   Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fraser HB, 2013, GENOME RES, V23, P1089, DOI 10.1101/gr.152710.112
   Fushan AA, 2015, AGING CELL, V14, P352, DOI 10.1111/acel.12283
   Gatto L, 2012, BIOINFORMATICS, V28, P288, DOI 10.1093/bioinformatics/btr645
   Hahn O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1187-1
   Hanzén S, 2016, CELL, V166, P140, DOI 10.1016/j.cell.2016.05.006
   Hattori K, 2006, J BIOCHEM, V139, P355, DOI 10.1093/jb/mvj041
   Holtze S, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1429, DOI 10.1134/S000629791612004X
   Holtze S, 2017, AFR J ECOL
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96
   Hughes CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34949
   Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625
   Keane M, 2014, BIOINFORMATICS, V30, P3558, DOI 10.1093/bioinformatics/btu579
   Keil G, 2015, BIOGERONTOLOGY, V16, P383, DOI 10.1007/s10522-015-9571-2
   Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533
   Kim HE, 2016, CELL, V166, P1539, DOI 10.1016/j.cell.2016.08.027
   Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf
   Lewis KN, 2015, P NATL ACAD SCI USA, V112, P3722, DOI 10.1073/pnas.1417566112
   Lewis KN, 2013, ANTIOXID REDOX SIGN, V19, P1388, DOI 10.1089/ars.2012.4911
   Lewis KN, 2012, GERONTOLOGY, V58, P453, DOI 10.1159/000335966
   Luis NM, 2016, CELL REP, V17, P1207, DOI 10.1016/j.celrep.2016.10.003
   Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161
   MacRae SL, 2015, AGING-US, V7, P1171, DOI 10.18632/aging.100866
   Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212
   MCNAB BK, 1966, ECOLOGY, V47, P712, DOI 10.2307/1934259
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Miwa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4837
   Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789
   Nyström T, 2012, GENE DEV, V26, P2001, DOI 10.1101/gad.200006.112
   Ori A, 2015, CELL SYST, V1, P224, DOI 10.1016/j.cels.2015.08.012
   Park TJ, 2017, SCIENCE, V356, P305, DOI 10.1126/science.aab3896
   Pérez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rodriguez KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035890
   Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010
   Sahm A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007272
   Sahm A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx179
   Sahm A, 2017, AGING CELL, V16, P488, DOI 10.1111/acel.12577
   Schmidt H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13905-z
   Schwanhäusser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584
   Sgarbi G, 2014, AGING-US, V6, P296, DOI 10.18632/aging.100654
   Skulachev VP, 2017, PHYSIOL REV, V97, P699, DOI 10.1152/physrev.00040.2015
   Solomon TPJ, 2008, METABOLISM, V57, P1141, DOI 10.1016/j.metabol.2008.03.021
   St-Onge MP, 2010, NUTRITION, V26, P152, DOI 10.1016/j.nut.2009.07.004
   Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tacutu R, 2018, NUCLEIC ACIDS RES, V46, pD1083, DOI 10.1093/nar/gkx1042
   Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234
   Toth MJ, 2000, EUR J CLIN NUTR, V54, pS121, DOI 10.1038/sj.ejcn.1601033
   Vizcaíno JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Yu CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026729
   Zhao Y, 2018, P NATL ACAD SCI USA, V115, P1801, DOI 10.1073/pnas.1721160115
NR 89
TC 42
Z9 44
U1 1
U2 50
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD AUG 2
PY 2018
VL 16
AR 82
DI 10.1186/s12915-018-0547-y
PG 18
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA GP1UH
UT WOS:000440602200001
PM 30068331
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Purhonen, J
   Banerjee, R
   Wanne, V
   Sipari, N
   Mörgelin, M
   Fellman, V
   Kallijärvi, J
AF Purhonen, Janne
   Banerjee, Rishi
   Wanne, Vilma
   Sipari, Nina
   Morgelin, Matthias
   Fellman, Vineta
   Kallijarvi, Jukka
TI Mitochondrial complex III deficiency drives c-MYC overexpression and
   illicit cell cycle entry leading to senescence and segmental progeria
SO NATURE COMMUNICATIONS
LA English
DT Article
ID FETAL-GROWTH-RETARDATION; DE-NOVO MUTATIONS; STRESS-RESPONSE;
   IRON-OVERLOAD; PROGENITOR CELLS; LACTIC-ACIDOSIS; SLC25A24 CAUSE; G(2)
   ARREST; LIVER; MICE
AB Mitochondria modulate both normal and premature aging, yet if primary oxidative phosphorylation deficiency can cause progeria has been unclear. Here, the authors show that mice with severe isolated respiratory complex III deficiency display cellular senescence and juvenile-onset segmental progeria.
   Accumulating evidence suggests mitochondria as key modulators of normal and premature aging, yet whether primary oxidative phosphorylation (OXPHOS) deficiency can cause progeroid disease remains unclear. Here, we show that mice with severe isolated respiratory complex III (CIII) deficiency display nuclear DNA damage, cell cycle arrest, aberrant mitoses, and cellular senescence in the affected organs such as liver and kidney, and a systemic phenotype resembling juvenile-onset progeroid syndromes. Mechanistically, CIII deficiency triggers presymptomatic cancer-like c-MYC upregulation followed by excessive anabolic metabolism and illicit cell proliferation against lack of energy and biosynthetic precursors. Transgenic alternative oxidase dampens mitochondrial integrated stress response and the c-MYC induction, suppresses the illicit proliferation, and prevents juvenile lethality despite that canonical OXPHOS-linked functions remain uncorrected. Inhibition of c-MYC with the dominant-negative Omomyc protein relieves the DNA damage in CIII-deficient hepatocytes in vivo. Our results connect primary OXPHOS deficiency to genomic instability and progeroid pathogenesis and suggest that targeting c-MYC and aberrant cell proliferation may be therapeutic in mitochondrial diseases.
C1 [Purhonen, Janne; Banerjee, Rishi; Wanne, Vilma; Fellman, Vineta; Kallijarvi, Jukka] Folkhalsan Res Ctr, Haartmaninkatu 8, Helsinki 00290, Finland.
   [Purhonen, Janne; Banerjee, Rishi; Wanne, Vilma; Fellman, Vineta; Kallijarvi, Jukka] Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, POB 63, Helsinki 00014, Finland.
   [Sipari, Nina] Univ Helsinki, Viikki Metabol Unit, POB 65, Helsinki, Finland.
   [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Div Infect Med, POB 117, S-22100 Lund, Sweden.
   [Morgelin, Matthias] Colzyx AB, Scheelevagen 2, S-22381 Lund, Sweden.
   [Fellman, Vineta] Lund Univ, Dept Clin Sci, Pediat, POB 117, S-22100 Lund, Sweden.
   [Fellman, Vineta] Univ Helsinki, Childrens Hosp, Clinicum, POB 22, Helsinki 00014, Finland.
C3 Folkhalsan Research Center; University of Helsinki; University of
   Helsinki; Lund University; Lund University; University of Helsinki
RP Kallijärvi, J (corresponding author), Folkhalsan Res Ctr, Haartmaninkatu 8, Helsinki 00290, Finland.; Kallijärvi, J (corresponding author), Univ Helsinki, Fac Med, Stem Cells & Metab Res Program, POB 63, Helsinki 00014, Finland.
EM jukka.kallijarvi@helsinki.fi
RI Sipari, Nina H/HKO-2436-2023
OI Sipari, Nina H/0000-0002-0786-2493; Banerjee, Rishi/0000-0002-5326-5075;
   Kallijarvi, Jukka/0000-0003-3773-7025; Fellman,
   Vineta/0000-0002-1355-5633
FU Samfundet Folkhaelsan; Jane and Aatos Erkko Foundation; Foundation for
   Pediatric Research; Finska Laekaresaellskapet; Medicinska
   Understoedsfoereningen Liv och Haelsa rf,; Magnus Ehrnrooth Foundation;
   Alfred Kordelin Foundation; Biomedicum Helsinki Foundation
FX We thank Elisa Alppila for technical assistance, Jayasimman Rajendran
   for discussions and for help with DEXA, Eduard Daura Sarroca for
   discussions on cellular senescence and for suggesting the assessment of
   histone H3 cleavage, and Leah Biggs for guidance on terminology
   regarding the skin histology. We also thank the core facilities of
   University of Helsinki, the FIMM metabolomics unit (supported by HiLIFE
   and Biocenter Finland) for the liver metabolomics analyses, the Tissue
   Preparation and Histochemistry Unit (Department of Anatomy) and the
   Finnish Centre for Laboratory Animal Pathology (Faculty of Veterinary
   Medicine) for processing of histological samples, the Laboratory Animal
   Center of the University of Helsinki for the animal husbandry, and the
   AAV Gene Transfer and Cell Therapy Core Facility for the rAAV
   production. We acknowledge funding from Samfundet Folkhaelsan, Jane and
   Aatos Erkko Foundation, the Foundation for Pediatric Research, Finska
   Laekaresaellskapet, Medicinska Understoedsfoereningen Liv och Haelsa rf,
   Magnus Ehrnrooth Foundation, Alfred Kordelin Foundation, and Biomedicum
   Helsinki Foundation. Graphical illustrations in Fig. 10a, j were created
   with BioRender (www.biorender.com).
CR Abu-Libdeh B, 2017, EUR J HUM GENET, V25, P1142, DOI 10.1038/ejhg.2017.112
   ANDREW W, 1962, AM J ANAT, V110, P1, DOI 10.1002/aja.1001100102
   Ansó E, 2017, NAT CELL BIOL, V19, P614, DOI 10.1038/ncb3529
   Bajzikova M, 2019, CELL METAB, V29, P399, DOI 10.1016/j.cmet.2018.10.014
   Barnhoorn S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004686
   Beaulieu ME, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aar5012
   Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489
   Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799
   Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016
   BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S
   Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104
   Carrero D, 2016, DIS MODEL MECH, V9, P719, DOI 10.1242/dmm.024711
   Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882
   Cortopassi G, 2006, MITOCHONDRION, V6, P161, DOI 10.1016/j.mito.2006.05.002
   Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314
   Covarrubias AJ, 2021, NAT REV MOL CELL BIO, V22, P119, DOI 10.1038/s41580-020-00313-x
   Croon M, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abn7105
   Cunningham SC, 2015, HEPATOLOGY, V62, P417, DOI 10.1002/hep.27842
   Della Marina Adela, 2020, JIMD Rep, V53, P10, DOI 10.1002/jmd2.12109
   Demma MJ, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00248-19
   Diebold LP, 2019, NAT METAB, V1, P158, DOI 10.1038/s42255-018-0011-x
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Douiev L, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23084149
   Douiev L, 2018, BBA-BIOENERGETICS, V1859, P893, DOI 10.1016/j.bbabio.2018.06.004
   Duarte LF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6210
   Ehmke N, 2017, AM J HUM GENET, V101, P833, DOI 10.1016/j.ajhg.2017.09.016
   Elouej S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18146-9
   Español-Suñer R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024
   Fellman V, 1998, LANCET, V351, P490, DOI 10.1016/S0140-6736(97)09272-6
   Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097
   FLURY F, 1976, GENETICS, V83, P645
   Garg A, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI156864
   Garratt M, 2011, J EVOLUTION BIOL, V24, P2398, DOI 10.1111/j.1420-9101.2011.02367.x
   Gleyzer N, 2016, J BIOL CHEM, V291, P25529, DOI 10.1074/jbc.M116.719682
   Gonzalez-Suarez I, 2011, EMBO J, V30, P3383, DOI 10.1038/emboj.2011.225
   GREGOIRE M, 1984, EUR J BIOCHEM, V142, P49, DOI 10.1111/j.1432-1033.1984.tb08249.x
   Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Gusic M, 2020, AM J HUM GENET, V106, P102, DOI 10.1016/j.ajhg.2019.12.005
   Haikala HM, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00038
   Hämäläinen RH, 2020, NAT METAB, V2, P676, DOI 10.1038/s42255-020-0265-y
   Hämäläinen RH, 2019, NAT METAB, V1, P958, DOI 10.1038/s42255-019-0120-1
   Harkema L, 2016, VET PATHOL, V53, P366, DOI 10.1177/0300985815625169
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hikmat O, 2021, ANN CLIN TRANSL NEUR, V8, P2155, DOI 10.1002/acn3.51470
   Hino Y, 2022, NUCLEIC ACIDS RES, V50, P9765, DOI 10.1093/nar/gkac735
   Hock DH, 2020, BIOCHEM J, V477, P4085, DOI 10.1042/BCJ20190767
   Islam MI, 2022, AGING CELL, V21, DOI 10.1111/acel.13531
   Jazwinski SM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00139
   Kavanaugh G, 2015, DNA REPAIR, V35, P55, DOI 10.1016/j.dnarep.2015.09.024
   Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007
   Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107
   Klement RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155050
   Kühl I, 2017, ELIFE, V6, DOI 10.7554/eLife.30952
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110
   Lee C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38477-y
   Levéen P, 2011, HEPATOLOGY, V53, P437, DOI 10.1002/hep.24031
   Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934
   Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450
   Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203
   Martínez-Reyes I, 2020, NATURE, V585, P288, DOI 10.1038/s41586-020-2475-6
   Massó-Vallés D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040883
   Mazat JP, 2021, BIOCHEM SOC T, V49, P1, DOI 10.1042/BST20190008
   Moeglin E, 2019, CANCERS, V11, DOI 10.3390/cancers11030355
   Munro D, 2019, AGING CELL, V18, DOI 10.1111/acel.13009
   Navarro CL, 2006, HUM MOL GENET, V15, pR151, DOI 10.1093/hmg/ddl214
   Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443
   Núñez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073
   Osorio FG, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002847
   Pai CC, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020057
   Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021
   Pelletier J, 2020, EMBO J, V39, DOI 10.15252/embj.2019103838
   Pendás AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871
   Porter JR, 2017, MOL CELL, V67, P1013, DOI 10.1016/j.molcel.2017.07.028
   Purhonen J, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkaa516
   Purhonen J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14201-2
   Purhonen J, 2018, FASEB J, V32, P5913, DOI 10.1096/fj.201800090R
   Purhonen J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01109-4
   QUELLE DE, 1995, CELL, V83, P993
   Rabinovitch RC, 2017, CELL REP, V21, P1, DOI 10.1016/j.celrep.2017.09.026
   Rajendran J, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809456
   Rapola J, 2002, PEDIATR PATHOL MOL M, V21, P183, DOI 10.1080/15227950252852087
   Rasmussen AK, 2003, NUCLEIC ACIDS RES, V31, P3909, DOI 10.1093/nar/gkg446
   Rathod R, 2020, METABOLITES, V10, DOI 10.3390/metabo10030103
   Robb EL, 2018, J BIOL CHEM, V293, P9869, DOI 10.1074/jbc.RA118.003647
   Rohban S, 2015, BBA-GENE REGUL MECH, V1849, P517, DOI 10.1016/j.bbagrm.2014.04.008
   Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Sekine S, 2007, HEPATOLOGY, V45, P361, DOI 10.1002/hep.21523
   Selfridge J, 2001, NUCLEIC ACIDS RES, V29, P4541, DOI 10.1093/nar/29.22.4541
   Sharma S, 2020, NAT METAB, V2, P673, DOI 10.1038/s42255-020-0264-z
   Shimada-Takayama Y, 2022, BIOCHEM BIOPH RES CO, V599, P43, DOI 10.1016/j.bbrc.2022.02.005
   Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408
   Sorge S, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107659
   Spinelli JB, 2021, SCIENCE, V374, P1227, DOI 10.1126/science.abi7495
   Suda M, 2021, NATURE AGING, V1, P1117, DOI 10.1038/s43587-021-00151-2
   Sulkowski PL, 2020, NATURE, V582, P586, DOI 10.1038/s41586-020-2363-0
   Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028
   Tameire F, 2019, NAT CELL BIOL, V21, P889, DOI 10.1038/s41556-019-0347-9
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Utani K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010089
   Varela I, 2005, NATURE, V437, P564, DOI 10.1038/nature04019
   Visapää I, 2002, AM J HUM GENET, V71, P863, DOI 10.1086/342773
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Wilhelm T, 2020, GENES-BASEL, V11, DOI 10.3390/genes11060642
   Wolny S, 2009, ACTA PAEDIATR, V98, P553, DOI 10.1111/j.1651-2227.2008.01148.x
   Writzl K, 2017, AM J HUM GENET, V101, P844, DOI 10.1016/j.ajhg.2017.09.017
   Yin S, 2015, J FLUORESC, V25, P1005, DOI 10.1007/s10895-015-1584-3
   Zhang R, 2019, HEPATOL COMMUN, V3, P1642, DOI 10.1002/hep4.1430
   Zhou Q, 2018, NATURE, V557, P351, DOI 10.1038/s41586-018-0088-0
NR 111
TC 3
Z9 3
U1 6
U2 10
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR 24
PY 2023
VL 14
IS 1
AR 2356
DI 10.1038/s41467-023-38027-1
PG 23
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA I3YN7
UT WOS:001002170200002
PM 37095097
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU KOZURKOVA, M
   MISUROVA, E
   KROPACOVA, K
AF KOZURKOVA, M
   MISUROVA, E
   KROPACOVA, K
TI AGING AND RADIATION-INDUCED ALTERATIONS OF HISTONES IN REGENERATING
   RAT-LIVER
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; GAMMA RADIATION; HISTONES; RAT LIVER; REGENERATION
ID ACETYLTRANSFERASE ACTIVITY; H1-DEGREES; CHROMATIN; MECHANISM; TISSUES;
   CELLS
AB We studied the age-related and radiation-induced changes in histones in regenerating liver of rats between 1 and 28 months of age. The examinations were carried out 30 h after a two-third hepatectomy, i.e. after the first wave of DNA and histone synthesis. During induced regeneration age-related changes in liver manifested themselves in decreasing the cellularity per gram wet weight, in slowing down the increase in DNA and histone contents per organ, in changing the mutual proportions of histone fractions H1, H2A + H2B, H4 and in increasing the H1-degrees variant within histone H1. Radiation-induced latent injury (a dose of 5.7 Gy gamma radiation 30 min before partial hepatectomy) was manifested during induced regeneration in similar but much more profound changes with their earlier onset. Since the changes in regenerating liver were found not to be milder than in intact liver it means, that induced proliferation did not lead to elimination of altered cells or to their rejuvenation.
RP KOZURKOVA, M (corresponding author), SAFARIK UNIV, FAC SCI, DEPT CELLULAR & MOLEC BIOL, MOYZESOVA 11, CS-04167 KOSICE, CZECH REPUBLIC.
RI Kozurkova, Maria/G-7433-2016
OI Kozurkova, Maria/0000-0002-2789-8397; Kozurkova,
   Maria/0000-0002-8344-0671
CR ALBERT MD, 1958, J NATL CANCER I, V20, P309
   BARBASON H, 1983, BRIT J CANCER, V47, P517, DOI 10.1038/bjc.1983.82
   BUCHER NLR, 1964, CANCER RES, V24, P1611
   BUTLER JG, 1983, EUR MOL BIOL ORG J, V3, P2599
   CATER DB, 1956, ACTA RADIOL, V46, P655, DOI 10.3109/00016925609171460
   CSORDAS A, 1990, BIOCHEM J, V265, P23, DOI 10.1042/bj2650023
   CURTIS H, 1963, RADIAT RES, V19, P337, DOI 10.2307/3571455
   FABIANOVA B, 1981, B EXP BIOL MED, V4, P490
   FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0
   GABRIELLI F, 1986, MOL CELL BIOCHEM, V71, P129, DOI 10.1007/BF00214771
   GRUNICKE HH, 1989, J CANCER RES CLIN, V115, P435, DOI 10.1007/BF00393332
   HARPER JF, 1984, COMPUT BIOL MED, V14, P437, DOI 10.1016/0010-4825(84)90044-1
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   KROPACHOVA K, 1988, Radiobiologiya, V28, P44
   KROPACOVA K, 1981, B EXP BIOL MED, V3, P359
   KROPACOVA K, 1985, VOJ ZDRAV LISTY, V3, P117
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MCGHEE JD, 1983, CELL, V33, P831, DOI 10.1016/0092-8674(83)90025-9
   MEDVEDEV ZA, 1989, T AGING RES, V13, P203
   MEDVEDEV ZA, 1990, EXP GERONTOL, V25, P189, DOI 10.1016/0531-5565(90)90050-C
   MISUROVA E, 1987, Radiobiologia Radiotherapia, V28, P59
   MISUROVA E, 1974, RADIOBIOL RADIOTHER, V15, P709
   NIEDZWIECKI A, 1985, J GERONTOL, V40, P695, DOI 10.1093/geronj/40.6.695
   NILSSON P, 1992, FEBS LETT, V313, P67, DOI 10.1016/0014-5793(92)81186-P
   PANYIM S, 1969, BIOCHEM BIOPH RES CO, V37, P1042, DOI 10.1016/0006-291X(69)90237-X
   PIERI C, 1975, EXP GERONTOL, V10, P341, DOI 10.1016/0531-5565(75)90024-8
   ROUSSEAU D, 1991, J MOL BIOL, V217, P85, DOI 10.1016/0022-2836(91)90613-B
   SREBREVA L, 1991, INT J BIOCHEM, V23, P189, DOI 10.1016/0020-711X(91)90188-S
   Suliova J, 1983, Bratisl Lek Listy, V80, P661
   Suliova J, 1982, Radiobiol Radiother (Berl), V23, P667
   SULIOVA J, 1983, RADIOBIOLOGIYA, V23, P513
   THOMAS JO, 1984, J CELL SCI, P1
   TSANEV R G, 1960, Biokhimiia, V25, P151
   VANBEZOOIJEN CFA, 1983, TOPICS AGING RES EUR, P115
   WAGNER AP, 1982, EXP GERONTOL, V17, P173, DOI 10.1016/0531-5565(82)90022-5
   WEISS G, 1988, FEBS LETT, V238, P205, DOI 10.1016/0014-5793(88)80257-6
   ZLATANOVA J, 1983, DIFFERENTIATION, V24, P79, DOI 10.1111/j.1432-0436.1983.tb01306.x
NR 37
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD NOV
PY 1993
VL 72
IS 1
BP 37
EP 48
DI 10.1016/0047-6374(93)90129-F
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA MK393
UT WOS:A1993MK39300004
PM 8114518
DA 2024-02-19
ER

PT J
AU Baragetti, A
   Da Dalt, L
   Moregola, A
   Svecla, M
   Terenghi, O
   Mattavelli, E
   De Gaetano, LN
   Uboldi, P
   Catapano, AL
   Norata, GD
AF Baragetti, Andrea
   Da Dalt, Lorenzo
   Moregola, Annalisa
   Svecla, Monika
   Terenghi, Ottavia
   Mattavelli, Elisa
   De Gaetano, Lucia Nicolini
   Uboldi, Patrizia
   Catapano, Alberico Luigi
   Norata, Giuseppe Danilo
TI Neutrophil aging exacerbates high fat diet induced metabolic alterations
SO METABOLISM-CLINICAL AND EXPERIMENTAL
LA English
DT Article; Early Access
DE Neutrophils; Metabolic syndrome; Adiposity; CXCR2; CXCR4
ID WESTERN DIET; GRANULOPOIESIS; ACTIVATION
AB Background: High fat diet (HFD) chronically hyper-activates the myeloid cell precursors, but whether it affects the neutrophil aging is unknown.Purpose: We characterized how HFD impacts neutrophil aging, infiltration in metabolic tissues and if this aging, in turn, modulates the development of metabolic alterations. We immunophenotyped neutrophils and characterized the metabolic responses in physiology (wild-type mice, WT) and in mice with constitutively aged neutrophils (MRP8 driven conditional deletion of CXCR4; herein CXCR4fl/flCre+) or with constitutively fresh neutrophils (MRP8 driven conditional deletion of CXCR2; CXCR2fl/ flCre+), following 20 weeks of HFD feeding (45 % kcal from fat).Findings: After 20 weeks HFD, the gluco-metabolic profile of CXCR4fl/flCre+ mice was comparable to that of WT mice, while CXCR2fl/flCre+ mice were protected from metabolic alterations. CXCR4fl/flCre+ infiltrated more, but CXCR2fl/flCre+ neutrophils infiltrated less, in liver and visceral adipose tissue (VAT). As consequence, while CXCR4fl/flCre+ resulted into hepatic "suicidal" neutrophils extracellular traps (NETs) and altered immune cell architecture in VAT, CXCR2fl/flCre+ promoted proresolutive hepatic NETs and reduced accumulation of pro-inflammatory macrophages in VAT. In humans, higher plasma levels of Cxcl12 (CXCR4 ligand) correlated with visceral adiposity while higher levels of Cxcl1 (the ligand of CXCR2) correlated with indexes of hepatic steatosis, adiposity and metabolic syndrome.Conclusions: Neutrophil aging might contribute to the development of HFD induced metabolic disorders.
C1 [Baragetti, Andrea; Da Dalt, Lorenzo; Moregola, Annalisa; Svecla, Monika; Terenghi, Ottavia; Mattavelli, Elisa; De Gaetano, Lucia Nicolini; Uboldi, Patrizia; Catapano, Alberico Luigi; Norata, Giuseppe Danilo] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.
   [Baragetti, Andrea; Mattavelli, Elisa; De Gaetano, Lucia Nicolini; Catapano, Alberico Luigi] IRCCS Multimed Hosp, Milan, Italy.
   [Norata, Giuseppe Danilo] Bassini Hosp, SISA Ctr Study Atherosclerosis, Cinisello Balsamo, Italy.
C3 University of Milan
RP Norata, GD (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.; Norata, GD (corresponding author), Bassini Hosp, SISA Ctr Study Atherosclerosis, Cinisello Balsamo, Italy.
EM danilo.norata@unimi.it
OI Svecla, Monika/0000-0002-7269-7308
FU Telethon Foundation [RF-2019-12370896]; Progetti di Rilevante Interesse
   Nazionale; Ricerca Finalizzata, Italian Ministry of Health [PRIN
   2017H5F943]; "Cibo, Microbiota, Salute" by "Vini di Batasiolo S.p.A"
   [PNRR M4C2-Investimento 1.4-CN00000041]; Peanut Institute"
   [1.4-CN00000041, ERANET ER-2017-2364981]; European Union-NextGeneration
   EU; Ministry of Health-Ricerca Corrente to IRCCS MultiMedica; Ministry
   of Health-Ricerca Corrente-IRCCS MultiMedica [1.4-CN00000041];
   Fondazione SISA; PNRR NextGenerationEU; Peanut Institute;  [GGP19146]; 
   [AL_RIC19ABARA_01];  [PRIN 2017 K55HLC]
FX & nbsp;The work was supported by: Telethon Foundation [GGP19146] ,
   Progetti di Rilevante Interesse Nazionale [PRIN 2017 K55HLC] , Ricerca
   Finalizzata, Italian Ministry of Health [RF-2019-12370896] , PNRR
   NextGenerationEU [M4C2-Investimento 1.4-CN00000041 National Center for
   Gene Therapy and Drugs based on RNA Technology] and PNRR
   NextGenerationEU [Multilayered Urban Sustainability Action - MUSA] to
   GDN. The work of A. Baragetti is supported by: "Cibo, Microbiota,
   Salute" by "Vini di Batasiolo S.p.A" AL_RIC19ABARA_01; a research award
   (2021) from "the Peanut Institute"; PRIN 2017H5F943; ERANET
   ER-2017-2364981; "PNRR M4C2-Investimento 1.4-CN00000041", European
   Union-NextGeneration EU. A. Baragetti has been supported in part by
   Ministry of Health-Ricerca Corrente to IRCCS MultiMedica. The work of
   A.L. Catapano is supported by Ministry of Health-Ricerca Corrente-IRCCS
   MultiMedica, PRIN 2017H5F943, ERANET ER-2017-2364981, and Fondazione
   SISA.
CR Adamiak M, 2020, STEM CELL REV REP, V16, P954, DOI 10.1007/s12015-020-10005-w
   Adrover JM, 2020, NAT IMMUNOL, V21, P135, DOI 10.1038/s41590-019-0571-2
   Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002
   Auer PL, 2014, NAT GENET, V46, P629, DOI 10.1038/ng.2962
   Baragetti A, 2022, STROKE, V53, pE411, DOI 10.1161/STROKEAHA.122.038887
   Baragetti Andrea, 2021, Immunometabolism, V3, pe210014, DOI 10.20900/immunometab20210014
   Bonacina F, 2019, CARDIOVASC RES, V115, P1861, DOI 10.1093/cvr/cvz068
   Boro M, 2017, J IMMUNOL, V199, P1660, DOI 10.4049/jimmunol.1700129
   Casanova-Acebes M, 2018, J EXP MED, V215, P2778, DOI 10.1084/jem.20181468
   Casanova-Acebes M, 2013, CELL, V153, P1025, DOI 10.1016/j.cell.2013.04.040
   Christ A, 2019, IMMUNITY, V51, P794, DOI 10.1016/j.immuni.2019.09.020
   Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013
   Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200
   Evrard M, 2018, IMMUNITY, V48, P364, DOI 10.1016/j.immuni.2018.02.002
   Guerra Fabiola, 2023, EJHaem, V4, P551, DOI 10.1002/jha2.649
   Hevko U, 2021, METABOLISM, V116, P22, DOI 10.1016/j.metabol.2020.154522
   Hidalgo A, 2022, CARDIOVASC RES, V118, P2737, DOI 10.1093/cvr/cvab329
   Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363
   Hoyer FF, 2020, CIRCULATION, V142, P244, DOI 10.1161/CIRCULATIONAHA.120.046038
   Huang SL, 2021, METABOLISM, V120, DOI 10.1016/j.metabol.2021.154797
   Javaid HMA, 2023, METABOLISM, V142, DOI 10.1016/j.metabol.2023.155527
   Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294
   Kalafati L, 2020, CELL, V183, P771, DOI 10.1016/j.cell.2020.09.058
   Kleinholz CL, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94425-9
   Langer MM, 2023, LIVER INT, V43, P896, DOI 10.1111/liv.15486
   Leslie J, 2022, GUT, V71, P2093, DOI 10.1136/gutjnl-2021-326259
   McDowell SAC, 2021, NAT CANCER, V2, P545, DOI 10.1038/s43018-021-00194-9
   Méndez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x
   Moorlag SJCFM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108387
   Münzer P, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.683803
   Nour J, 2022, METABOLITES, V12, DOI 10.3390/metabo12121205
   Olmastroni E, 2019, STROKE, V50, P1758, DOI 10.1161/STROKEAHA.118.024692
   Passegué E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010
   Phillips BE, 2022, CARDIOVASC DIABETOL, V21, DOI 10.1186/s12933-022-01564-y
   Piek A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55263-y
   Radbakhsh S, 2022, METABOLISM, V132, DOI 10.1016/j.metabol.2022.155211
   Rawshani A, 2018, NEW ENGL J MED, V379, P633, DOI 10.1056/NEJMoa1800256
   Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200
   Sanchez-Pino MD, 2022, EBIOMEDICINE, V77, DOI 10.1016/j.ebiom.2022.103910
   Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10
   Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011
   Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885
   Tam TH, 2020, J BIOL CHEM, V295, P4902, DOI 10.1074/jbc.RA119.010868
   Trim WV, 2022, NAT REV IMMUNOL, V22, P371, DOI 10.1038/s41577-021-00635-7
   Vázquez RD, 2004, METABOLISM, V53, P59, DOI 10.1016/j.metabol.2003.08.010
   Yan MY, 2022, METABOLISM, V134, DOI 10.1016/j.metabol.2022.155264
NR 46
TC 1
Z9 1
U1 5
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0026-0495
EI 1532-8600
J9 METABOLISM
JI Metab.-Clin. Exp.
PD 2023 JUL
PY 2023
VL 144
AR 155576
DI 10.1016/j.metabol.2023.155576
EA MAY 2023
PG 14
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA P9VX7
UT WOS:001054096800001
PM 37116643
OA hybrid
DA 2024-02-19
ER

PT J
AU Ren, RX
   He, Y
   Ding, D
   Cui, AY
   Bao, HR
   Ma, J
   Hou, X
   Li, Y
   Feng, DC
   Li, XL
   Liangpunsakul, S
   Gao, B
   Wang, H
AF Ren, Ruixue
   He, Yong
   Ding, Dong
   Cui, Aoyuan
   Bao, Huarui
   Ma, Jing
   Hou, Xin
   Li, Yu
   Feng, Dechun
   Li, Xiaoling
   Liangpunsakul, Suthat
   Gao, Bin
   Wang, Hua
TI Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice
   and humans by inhibiting neutrophilic sirtuin 1-C/EBPα-miRNA-223 axis
SO HEPATOLOGY
LA English
DT Article; Early Access
ID ATTENUATES HEPATIC STEATOSIS; INFLAMMATION; RESVERATROL; MICRORNAS;
   DELETION
AB Background and Aims Aging exacerbates liver neutrophil infiltration and alcohol-associated liver disease (ALD) in mice and humans, but the underlying mechanisms remain obscure. This study aimed to examine the effect of aging and alcohol consumption on neutrophilic Sirtuin 1 (SIRT1) and microRNA-223 (miR-223), and their contribution to ALD pathogeneses. Approach and Results Young and aged myeloid-specific Sirt1 knockout mice were subjected to chronic-plus-binge ethanol feeding. Blood samples from healthy controls and patients with chronic alcohol drinking who presented with acute intoxication were analyzed. Neutrophilic Sirt1 and miR-223 expression were down-regulated in aged mice compared with young mice. Deletion of the Sirt1 gene in myeloid cells including neutrophils exacerbated chronic-plus-binge ethanol-induced liver injury and inflammation and down-regulated neutrophilic miR-223 expression. Immunoprecipitation experiments revealed that SIRT1 promoted C/EBP alpha deacetylation by directly interacting with C/EBP alpha, a key transcription factor that controls miR-223 biogenesis, and subsequently elevated miR-223 expression in neutrophils. Importantly, down-regulation of SIRT1 and miR-223 expression was also observed in circulating neutrophils from middle-aged and elderly subjects compared with those from young individuals. Chronic alcohol users with acute intoxication had a reduction in neutrophilic SIRT1 expression in young and middle-aged patients, with a greater reduction in the latter group. The neutrophilic SIRT1 expression correlated with neutrophilic miR-223 and serum alanine transaminase levels in those patients. Conclusions Aging increases the susceptibility of alcohol-induced liver injury in mice and humans through the down-regulation of the neutrophilic SIRT1-C/EBP alpha-miR-223 axis, which could be a therapeutic target for the prevention and/or treatment of ALD.
C1 [Ren, Ruixue; Wang, Hua] Anhui Med Univ, Dept Oncol, Affiliated Hosp 1, 218 Jixi Rd, Hefei 230022, Peoples R China.
   [Ren, Ruixue; He, Yong; Ma, Jing; Hou, Xin; Feng, Dechun; Gao, Bin] NIAAA, Lab Liver Dis, NIH, Bethesda, MD USA.
   [Ren, Ruixue; Wang, Hua] Anhui Med Univ, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei, Peoples R China.
   [Ding, Dong; Cui, Aoyuan; Li, Yu] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai, Peoples R China.
   [Bao, Huarui] Anhui Med Univ, Dept Emergency, Affiliated Hosp 1, Hefei, Peoples R China.
   [Li, Xiaoling] NIEHS, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.
   [Liangpunsakul, Suthat] Indiana Univ Sch Med, Div Gastroenterol & Hepatol, Dept Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.
   [Liangpunsakul, Suthat] Richard L Roudebush Vet Adm Med Ctr, Indianapolis, IN USA.
C3 Anhui Medical University; National Institutes of Health (NIH) - USA; NIH
   National Institute on Alcohol Abuse & Alcoholism (NIAAA); Anhui Medical
   University; Chinese Academy of Sciences; University of Chinese Academy
   of Sciences, CAS; Shanghai Institute of Nutrition & Health, CAS; Anhui
   Medical University; National Institutes of Health (NIH) - USA; NIH
   National Institute of Environmental Health Sciences (NIEHS); Indiana
   University System; Indiana University Bloomington; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Richard L.
   Roudebush VA Medical Center
RP Wang, H (corresponding author), Anhui Med Univ, Dept Oncol, Affiliated Hosp 1, 218 Jixi Rd, Hefei 230022, Peoples R China.
EM wanghua@ahmu.edu.cn
RI Feng, Dechun/Q-5962-2016
OI Li, Yu/0000-0001-6910-5933; He, Yong/0009-0006-8681-5287
FU National Nature and Science Foundation [81770588]; NIAAA, NIH, USA
FX This study was supported in part by the National Nature and Science
   Foundation (81770588 to HW) and by the intramural program of the NIAAA,
   NIH, USA (BG). Dr. Hua Wang and Dr. Bin Gao are co-mentors for Ms.
   Ruixue Ren, who was a participant in the NIH Graduate Partnerships
   Program and a graduate student in the Anhui Medical University when she
   worked on this project during 2018-2020 and was affiliated with the
   Anhui Medical University and the NIH Graduate Partnerships Program (GPP)
CR Adrover JM, 2016, TRENDS IMMUNOL, V37, P334, DOI 10.1016/j.it.2016.03.005
   Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008
   Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087
   Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014
   Avila MA, 2020, GUT, V69, P764, DOI 10.1136/gutjnl-2019-319720
   Batliner J, 2012, LEUKEMIA RES, V36, P237, DOI 10.1016/j.leukres.2011.10.006
   Bertola A, 2013, HEPATOLOGY, V58, P1814, DOI 10.1002/hep.26419
   Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032
   Boule LA, 2017, J LEUKOCYTE BIOL, V102, P41, DOI 10.1189/jlb.4RU1016-450R
   Calvente CJ, 2019, J CLIN INVEST, V129, P4091, DOI 10.1172/JCI122258
   Cho Y, 2021, HEPATOLOGY, V74, P503, DOI 10.1002/hep.31680
   Crabb DW, 2020, HEPATOLOGY, V71, P306, DOI 10.1002/hep.30866
   Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986
   Fan HB, 2014, BLOOD, V124, P1320, DOI 10.1182/blood-2013-12-545012
   Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197
   Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048
   Gantier MP, 2013, J LEUKOCYTE BIOL, V94, P575, DOI 10.1189/jlb.1012539
   Gao B, 2019, J HEPATOL, V70, P249, DOI 10.1016/j.jhep.2018.10.023
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   He Y, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI141513
   He Y, 2019, HEPATOLOGY, V70, P1150, DOI 10.1002/hep.30645
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843
   Lee SH, 2019, BMB REP, V52, P24, DOI 10.5483/BMBRep.2019.52.1.290
   Li M, 2017, GUT, V66, P705, DOI 10.1136/gutjnl-2016-311861
   Li Y, 2014, GASTROENTEROLOGY, V146, P539, DOI 10.1053/j.gastro.2013.10.059
   McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223
   Andrade JMO, 2014, NUTRITION, V30, P915, DOI 10.1016/j.nut.2013.11.016
   Pawelec G, 2014, CURR OPIN IMMUNOL, V29, P23, DOI 10.1016/j.coi.2014.03.007
   Ramirez T, 2017, J HEPATOL, V66, P601, DOI 10.1016/j.jhep.2016.11.004
   Ramis MR, 2015, MECH AGEING DEV, V146, P28, DOI 10.1016/j.mad.2015.03.008
   Ren RX, 2020, INT J BIOL SCI, V16, P3174, DOI 10.7150/ijbs.49535
   Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Wang XL, 2021, GUT, V70, P784, DOI 10.1136/gutjnl-2020-322526
   Xiao J, 2019, J HEPATOL, V71, P212, DOI 10.1016/j.jhep.2019.03.004
   Xie J, 2013, PHARMACOL RES, V67, P60, DOI 10.1016/j.phrs.2012.10.010
   Xu R, 2020, J NUTR HEALTH AGING, V24, P846, DOI 10.1007/s12603-020-1392-6
   Yao HW, 2012, BIOCHEM PHARMACOL, V84, P1332, DOI 10.1016/j.bcp.2012.06.031
   Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008
   Zaini MA, 2018, CELL REP, V22, P497, DOI 10.1016/j.celrep.2017.12.061
   Zhou Z, 2020, AM J PATHOL, V190, P82, DOI 10.1016/j.ajpath.2019.09.012
NR 44
TC 26
Z9 28
U1 4
U2 39
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2022 MAR
PY 2022
VL 75
IS 3
BP 646
EP 660
DI 10.1002/hep.32152
EA DEC 2021
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA YY3YH
UT WOS:000726341700001
PM 34510484
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Misaka, T
   Suzuki, S
   Miyata, M
   Kobayashi, A
   Ishigami, A
   Shishido, T
   Saitoh, S
   Kubota, I
   Takeishi, Y
AF Misaka, Tomofumi
   Suzuki, Satoshi
   Miyata, Makiko
   Kobayashi, Atsushi
   Ishigami, Akihito
   Shishido, Tetsuro
   Saitoh, Shu-ichi
   Kubota, Isao
   Takeishi, Yasuchika
TI Senescence marker protein 30 inhibits angiotensin II-induced cardiac
   hypertrophy and diastolic dysfunction
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Cardiac remodeling; Oxidative stress; Aging; Angiotensin II; Transgenic
   mouse
ID CARDIOVASCULAR-DISEASE ENTERPRISES; OXIDATIVE STRESS; TRANSGENIC MICE;
   MAJOR SHAREHOLDERS; RAT-LIVER; SMP30; HEART; ARTERIAL
AB Background and objective: Senescence marker protein 30 (SMP30) is assumed to behave as an anti-aging factor. Recently, we have demonstrated that deficiency of SMP30 exacerbates angiotensin II-induced cardiac hypertrophy, dysfunction and remodeling, suggesting that SMP30 may have a protective role in the heart. Thus, this study aimed to test the hypothesis that up-regulation of SMP30 inhibits cardiac adverse remodeling in response to angiotensin II.
   Methods: We generated transgenic mice with cardiac-specific overexpression of SMP30 gene using alpha-myosin heavy chain promoter. Transgenic mice and wild-type littermate mice were subjected to continuous angiotensin II infusion (800 ng/kg/min).
   Results: After 14 days, heart weight and left ventricular weight were lower in transgenic mice than in wild-type mice, although blood pressure was similarly elevated during angiotensin II infusion. Cardiac hypertrophy and diastolic dysfunction in response to angiotensin II were prevented in transgenic mice compared with wild-type mice. The degree of cardiac fibrosis by angiotensin II was lower in transgenic mice than in wild-type mice. Angiotensin II-induced generation of superoxide and subsequent cellular senescence were attenuated in transgenic mouse hearts compared with wild-type mice.
   Conclusions: Cardiac-specific overexpression of SMP30 inhibited angiotensin II-induced cardiac adverse remodeling. SMP30 has a cardio-protective role with anti-oxidative and anti-aging effects and could be a novel therapeutic target to prevent cardiac hypertrophy and remodeling due to hypertension. (C) 2013 The Authors. Published by Elsevier Inc. All rights reserved.
C1 [Misaka, Tomofumi; Suzuki, Satoshi; Miyata, Makiko; Kobayashi, Atsushi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima 9601295, Japan.
   [Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
   [Shishido, Tetsuro; Kubota, Isao] Yamagata Univ, Sch Med, Dept Internal Med 1, Yamagata 99023, Japan.
C3 Fukushima Medical University; Tokyo Metropolitan Institute of
   Gerontology; Yamagata University
RP Takeishi, Y (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.
EM takeishi@fmu.ac.jp
OI Ishigami, Akihito/0000-0001-7875-7482
FU Japan Society for the Promotion of Science [24591100]; Japanese Ministry
   of Health, Labor, and Welfare, Tokyo, Japan; Grants-in-Aid for
   Scientific Research [25870584, 24591100] Funding Source: KAKEN
FX We thank Ms. Emiko Kaneda for the excellent technical assistance. This
   study was supported in part by a grant-in-aid for Scientific Research
   (No. 24591100) from the Japan Society for the Promotion of Science and
   the grants-in-aid from the Japanese Ministry of Health, Labor, and
   Welfare, Tokyo, Japan.
CR Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Ito N, 2007, AM J HYPERTENS, V20, P792, DOI 10.1016/j.amjhyper.2007.02.004
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163
   Kobayashi A, 2007, HYPERTENSION, V50, P1040, DOI 10.1161/HYPERTENSIONAHA.107.097006
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7
   Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02
   LITTLE JS, 1989, BIOCHEM PHARMACOL, V38, P23, DOI 10.1016/0006-2952(89)90144-5
   Machii H, 2010, MECH AGEING DEV, V131, P710, DOI 10.1016/j.mad.2010.09.009
   Misaka T, 2013, CARDIOVASC RES
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   TSAO CS, 1987, J NUTR, V117, P291, DOI 10.1093/jn/117.2.291
   Wang MY, 2010, J MOL CELL CARDIOL, V48, P765, DOI 10.1016/j.yjmcc.2010.01.006
   Wilson RM, 2009, HYPERTENSION, V54, P583, DOI 10.1161/HYPERTENSIONAHA.109.134932
NR 22
TC 14
Z9 14
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 13
PY 2013
VL 439
IS 1
BP 142
EP 147
DI 10.1016/j.bbrc.2013.08.002
PG 6
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 223GB
UT WOS:000324791600025
PM 23933320
OA hybrid
DA 2024-02-19
ER

PT J
AU Bozukova, M
   Nikopoulou, C
   Kleinenkuhnen, N
   Grbavac, D
   Goetsch, K
   Tessarz, P
AF Bozukova, Mihaela
   Nikopoulou, Chrysa
   Kleinenkuhnen, Niklas
   Grbavac, Dora
   Goetsch, Katrin
   Tessarz, Peter
TI Aging is associated with increased chromatin accessibility and reduced
   polymerase pausing in liver
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE aging; chromatin architecture; nascent transcription; promoter-proximal
   pausing
ID RNA-POLYMERASE; TRANSCRIPTION; PROMOTER; REVEALS; COMPLEX; DISTINCT;
   PACKAGE; NELF; DSIF; SEQ
AB Regulation of gene expression is linked to the organization of the genome. With age, chromatin alterations occur on all levels of genome organization, accompanied by changes in the gene expression profile. However, little is known about the changes in the level of transcriptional regulation. Here, we used a multi-omics approach and integrated ATAC-, RNA- and NET-seq to identify age-related changes in the chromatin landscape of murine liver and to investigate how these are linked to transcriptional regulation. We provide the first systematic inventory of the connection between aging, chromatin accessibility, and transcriptional regulation in a whole tissue. Aging in murine liver is characterized by an increase in chromatin accessibility at promoter regions, but not in an increase in transcriptional output. Instead, aging is accompanied by a decrease in promoter-proximal pausing of RNA polymerase II (Pol II), while initiation of transcription is not decreased as assessed by RNA polymerase mapping using CUT&RUN. Based on the data reported, we propose that these age-related changes in transcriptional regulation are due to a reduced stability of the pausing complex.
C1 [Bozukova, Mihaela; Nikopoulou, Chrysa; Kleinenkuhnen, Niklas; Grbavac, Dora; Goetsch, Katrin; Tessarz, Peter] Max Planck Inst Biol Ageing, Max Planck Res Grp Chromatin & Ageing, Cologne, Germany.
   [Kleinenkuhnen, Niklas] Univ Cologne, Inst Med Stat & Computat Biol, Fac Med, Cologne, Germany.
   [Tessarz, Peter] Univ Cologne, Cellular Stress Responses Aging Associated Dis CE, Cologne, Germany.
   Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.
C3 Max Planck Society; University of Cologne; University of Cologne;
   University of Lausanne
RP Tessarz, P (corresponding author), Max Planck Inst Biol Ageing, Max Planck Res Grp Chromatin & Ageing, Cologne, Germany.; Tessarz, P (corresponding author), Univ Cologne, Cellular Stress Responses Aging Associated Dis CE, Cologne, Germany.
EM ptessarz@age.mpg.de
RI Tessarz, Peter/ABB-6551-2021
OI Tessarz, Peter/0000-0002-6953-9835; Nikopoulou,
   Chrysa/0000-0001-7982-7737
FU Max Planck Society; Deutsche Forschungsgemeinschaft (DFG) [EXC
   2030-390661388]; Cologne Graduate School of Ageing Research; Projekt
   DEAL
FX We would like to thank all members of the Tessarz lab for continuous
   discussion and Swati Parekh and Theodoros Georgomonolis for support of
   bioinformatic analysis. We are grateful to A. Pouikli for critical
   reading of the manuscript. We thank the following core facilities of the
   Max Planck Institute for Biology of Ageing, Cologne, for expert
   technical assistance: Comparative Biology for mouse husbandry,
   Proteomics Core facility (particularly Xinping Li and Ilian Atanassov)
   as well as FACS and Imaging. Sequencing was performed at the Genomic
   Core Facilities of the MPI for Molecular Genetics, Berlin and Plant
   Breeding, Cologne. This work was funded by the Max Planck Society (to
   P.T.) and the Deutsche Forschungsgemeinschaft (DFG, under Germany's
   Excellence Strategy-EXC 2030-390661388) (to P.T.). M.B. received support
   by the Cologne Graduate School of Ageing Research. Models were drawn
   using Biorender. Open Access funding enabled and organized by Projekt
   DEAL.
CR Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293
   Almanzar N, 2020, NATURE, V583, P590, DOI 10.1038/s41586-020-2496-1
   [Anonymous], 2014, GENOME BIOL
   Aoi Y, 2021, MOL CELL, V81, P4413, DOI 10.1016/j.molcel.2021.08.006
   Aoi Y, 2020, MOL CELL, V78, P261, DOI 10.1016/j.molcel.2020.02.014
   Baluapuri A, 2019, MOL CELL, V74, P674, DOI 10.1016/j.molcel.2019.02.031
   Beagrie RA, 2016, BIOESSAYS, V38, P881, DOI 10.1002/bies.201600032
   Benayoun BA, 2019, GENOME RES, V29, P697, DOI 10.1101/gr.240093.118
   Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048
   Bernecky C, 2017, NAT STRUCT MOL BIOL, V24, P809, DOI 10.1038/nsmb.3465
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   Borsari B, 2021, GENOME RES, V31, P1325, DOI 10.1101/gr.270371.120
   Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458
   Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]
   Carroll T., 2017, ASSESSING CHIP SEQ S
   Chen Yilin, 2020, Transl Med Aging, V4, P22, DOI 10.1016/j.tma.2019.12.003
   Chondronasiou D., 2022, bioRxiv, DOI [10.1101/2022.01.20.477063, 10.1101/2022.01.20.477063, DOI 10.1101/2022.01.20.477063]
   Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]
   Core L, 2019, GENE DEV, V33, P960, DOI 10.1101/gad.325142.119
   Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Elrod ND, 2019, MOL CELL, V76, P738, DOI 10.1016/j.molcel.2019.10.034
   Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x
   Gaspar JM., 2018, BIORXIV, DOI DOI 10.1101/496521
   Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004
   Greten FR, 2019, IMMUNITY, V51, P27, DOI 10.1016/j.immuni.2019.06.025
   Henriques T, 2018, GENE DEV, V32, P26, DOI 10.1101/gad.309351.117
   Henriques T, 2013, MOL CELL, V52, P517, DOI 10.1016/j.molcel.2013.10.001
   Hu SB, 2021, MOL CELL, V81, P4425, DOI 10.1016/j.molcel.2021.08.029
   Kaplan CD, 2008, MOL CELL, V30, P547, DOI 10.1016/j.molcel.2008.04.023
   Koohy H, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1489-y
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li XP, 2021, METHODS MOL BIOL, V2261, P13, DOI 10.1007/978-1-0716-1186-9_2
   Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Lu RJ, 2021, NATURE AGING, V1, P715, DOI 10.1038/s43587-021-00086-8
   Lu YC, 2020, NATURE, V588, P124, DOI 10.1038/s41586-020-2975-4
   Maleszewska M., 2016, Current molecular biology reports, V2, P26, DOI [10.1007/s40610-016-0031-9, DOI 10.1007/S40610-016-0031-9]
   MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335
   Martin M., 2011, EMBnet. J., V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]
   Mayer A, 2016, NAT PROTOC, V11, P813, DOI 10.1038/nprot.2016.047
   Mayer A, 2015, CELL, V161, P541, DOI 10.1016/j.cell.2015.03.010
   Meers MP, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0287-4
   Morgan M, 2017, RSAMTOOLS BINARY ALI
   Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192
   Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21
   Mylonas C, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800085
   Nikopoulou C., 2021, BIORXIV, DOI [10.1101/2021.12.14.472593, DOI 10.1101/2021.12.14.472593]
   Nikopoulou C, 2019, BIOL CHEM, V400, P867, DOI 10.1515/hsz-2018-0449
   Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052
   Ou JH, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4559-3
   Pantano L., 2019, DEGreport: Report of DEG analysis
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106
   Petesch SJ, 2012, TRENDS GENET, V28, P285, DOI 10.1016/j.tig.2012.02.005
   Pouikli A, 2021, NATURE AGING, V1, P810, DOI 10.1038/s43587-021-00105-8
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030
   Ramírez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Scruggs BS, 2015, MOL CELL, V58, P1101, DOI 10.1016/j.molcel.2015.04.006
   Shao WQ, 2017, NAT GENET, V49, P1045, DOI 10.1038/ng.3867
   Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284
   Skaar JR, 2015, CELL RES, V25, P288, DOI 10.1038/cr.2015.19
   Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856
   Tessarz P, 2014, NATURE, V505, P564, DOI 10.1038/nature12819
   Ucar D, 2017, J EXP MED, V214, P3123, DOI 10.1084/jem.20170416
   Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941
   Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343
   Williams LH, 2015, MOL CELL, V58, P311, DOI 10.1016/j.molcel.2015.02.003
   Wong KH, 2014, MOL CELL, V54, P601, DOI 10.1016/j.molcel.2014.03.024
   Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403
   Yamamoto J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5263
   Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111
   Zhang MJ, 2021, ELIFE, V10, DOI 10.7554/eLife.62293
   Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237
NR 83
TC 6
Z9 6
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD SEP
PY 2022
VL 18
IS 9
AR e11002
DI 10.15252/msb.202211002
PG 21
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 4J6MW
UT WOS:000851379700001
PM 36082605
OA Green Published
DA 2024-02-19
ER

PT J
AU Stout-Delgado, HW
   Du, W
   Shirali, AC
   Booth, CJ
   Goldstein, DR
AF Stout-Delgado, Heather W.
   Du, Wei
   Shirali, Anushree C.
   Booth, Carmen J.
   Goldstein, Daniel R.
TI Aging Promotes Neutrophil-Induced Mortality by Augmenting IL-17
   Production during Viral Infection
SO CELL HOST & MICROBE
LA English
DT Article
ID HERPES-SIMPLEX-VIRUS; COMMUNITY-ACQUIRED PNEUMONIA; PLASMACYTOID
   DENDRITIC CELLS; EFFECTOR T-CELLS; ROR-GAMMA-T; NKT CELLS; CUTTING EDGE;
   TH17 CELLS; CYTOKINES; RECEPTOR
AB Morbidity and mortality associated with viral infections increase with age, although the underlying mechanisms are unclear. Here, we investigated whether aging alters inflammatory responses during systemic viral infection and thereby contributes to virus-induced death. We found that infection of aged mice with systemic herpes viruses led to rapid increases in serum IL-17, neutrophil activation, and mortality due to hepatocyte necrosis. In contrast, all young mice survived infection, displaying weaker IL-17 induction and neutrophil activation. Natural killer T (NKT) cells isolated from the livers of aged mice produced more IL-17 than did young cells, and adoptively transferred aged NKT cells induced liver injury in young mice impaired in viral control. Importantly, IL-17 neutralization or neutrophil depletion during viral infection reduced liver damage and prevented death of aged mice. These results demonstrate that, during systemic viral infection, aging alters the host-pathogen interaction to overproduce IL-17, contributing to liver injury and death.
C1 [Stout-Delgado, Heather W.; Du, Wei; Shirali, Anushree C.; Goldstein, Daniel R.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA.
   [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA.
C3 Yale University; Yale University
RP Goldstein, DR (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.
EM daniel.goldstein@yale.edu
RI Stout-Delgado, Heather/ABB-5628-2020
OI Goldstein, Daniel/0000-0001-6695-979X; Stout-Delgado,
   Heather/0000-0002-2387-6924
FU NIH [R01AG028082, K02AGO33049, T32AGO19134, 5T32DK 007276-30]
FX This work was supported by NIH grants R01AG028082 and K02AGO33049 to
   D.R.G. H.W.S.-D. is supported by NIH grant T32AGO19134, and A.. is
   supported by NIH grant 5T32DK 007276-30. The authors have no conflicting
   financial interests. The authors thank Marisa Alegre (University of
   Chicago) for her constructive input.
CR Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1
   Bokov A, 2004, MECH AGEING DEV, V125, P811, DOI 10.1016/j.mad.2004.07.009
   Brüünsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5
   Chu CQ, 2007, ARTHRITIS RHEUM, V56, P1145, DOI 10.1002/art.22453
   CRISPE IN, 2003, CURR PROTOC IMMUNOL, pCH3
   Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247
   Delale T, 2005, J IMMUNOL, V175, P6723, DOI 10.4049/jimmunol.175.10.6723
   Faunce DE, 2005, J IMMUNOL, V175, P3102, DOI 10.4049/jimmunol.175.5.3102
   Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593
   Gadjeva M, 2004, CLIN EXP IMMUNOL, V138, P304, DOI 10.1111/j.1365-2249.2004.02616.x
   Garcia GG, 2001, J IMMUNOL, V166, P3151, DOI 10.4049/jimmunol.166.5.3151
   Gorina Y, 2008, AGING TRENDS, V8, P1
   Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430
   Grubor-Bauk B, 2008, J VIROL, V82, P11073, DOI 10.1128/JVI.00205-08
   Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567
   Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013
   Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030
   Inui T, 2002, J IMMUNOL, V169, P6127, DOI 10.4049/jimmunol.169.11.6127
   Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035
   Kaplan V, 2003, CRIT CARE CLIN, V19, P729, DOI 10.1016/S0749-0704(03)00057-5
   Kaplan V, 2002, AM J RESP CRIT CARE, V165, P766, DOI 10.1164/ajrccm.165.6.2103038
   Kawabata T, 2008, HEPATOLOGY, V48, P1586, DOI 10.1002/hep.22489
   Kawakami Y, 2009, J EXP MED, V206, P1219, DOI 10.1084/jem.20082835
   Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007
   Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033
   Linton PJ, 1996, J EXP MED, V184, P1891, DOI 10.1084/jem.184.5.1891
   Liu Y, 2006, J IMMUNOL METHODS, V312, P34, DOI 10.1016/j.jim.2006.02.009
   Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162
   Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510
   Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551
   Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70
   Nagata T, 2008, J IMMUNOL, V181, P7473, DOI 10.4049/jimmunol.181.11.7473
   O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120
   Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167
   Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163
   Rosenstiel P, 2008, GENES IMMUN, V9, P103, DOI 10.1038/sj.gene.6364454
   Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005
   Stout-Delgado HW, 2008, J IMMUNOL, V181, P6747, DOI 10.4049/jimmunol.181.10.6747
   THOMAN ML, 1982, J IMMUNOL, V128, P2358
   Tyznik AJ, 2008, J IMMUNOL, V181, P4452, DOI 10.4049/jimmunol.181.7.4452
   Wada K, 2009, MICROBIOL IMMUNOL, V53, P22, DOI 10.1111/j.1348-0421.2008.00090.x
   Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557
   Wesley JD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000106
NR 43
TC 97
Z9 110
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD NOV 19
PY 2009
VL 6
IS 5
BP 446
EP 456
DI 10.1016/j.chom.2009.09.011
PG 11
WC Microbiology; Parasitology; Virology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology; Parasitology; Virology
GA 529TE
UT WOS:000272539700009
PM 19917499
OA hybrid, Green Accepted
DA 2024-02-19
ER

PT J
AU Nucci, RAB
   Teodoro, ACD
   Neto, WK
   Silva, WD
   de Souza, RR
   Anaruma, CA
   Gama, EF
AF Baptista Nucci, Ricardo Aparecido
   de Souza Teodoro, Ana Caroline
   Krause Neto, Walter
   Silva, Wellington de Assis
   de Souza, Romeu Rodrigues
   Anaruma, Carlos Alberto
   Gama, Eliane Florencio
TI Effects of resistance training on liver structure and function of aged
   rats
SO AGING MALE
LA English
DT Article
DE Liver; aging; resistance training; hepatic structure; exercise
ID OLDER-ADULTS; BLOOD-FLOW; EXERCISE; METAANALYSIS; INTENSITY;
   HYPERTROPHY; PREVENTION; RESPONSES; DEMENTIA; STRENGTH
AB The aging process may cause negative physiological changes. However, exercises as resistance training (RT) have been considered an important intervention to attenuate these changes. Additionally, liver plays an important role in blood glucose homeostasis in exercise.Aim: This study aimed to analyze the effects of RT on the liver components of aged animals.Methods: Male Wistar rats were divided into two groups: 24 months' group (CONTROL); and group submitted to a progressive RT protocol for 16 weeks (EXERCISE). Both groups were sacrificed at 24 months.Results: We observed a decrease in blood flow due to the practice of resistance exercises. Besides, our results showed that hepatic tissue plays an important role in glycemic homeostasis during RT. In addition, RT increased mitogen capacity of hepatocytes.Conclusions: Our study showed many implications for the knowledge about the effects of strength training on old animals' liver.
C1 [Baptista Nucci, Ricardo Aparecido; de Souza Teodoro, Ana Caroline; de Souza, Romeu Rodrigues; Gama, Eliane Florencio] Univ Sao Judas Tadeu, Dept Aging Sci, 546 Taquari St, Sao Paulo, Brazil.
   [Krause Neto, Walter; Silva, Wellington de Assis; de Souza, Romeu Rodrigues; Gama, Eliane Florencio] Univ Sao Judas Tadeu, Dept Phys Educ, Sao Paulo, Brazil.
   [Anaruma, Carlos Alberto] Julio de Mesquita Filho Sao Paulo State Univ, Dept Phys Educ, Sao Paulo, Brazil.
C3 Universidade Sao Judas Tadeu; Universidade Sao Judas Tadeu; Universidade
   Estadual Paulista
RP Nucci, RAB (corresponding author), Univ Sao Judas Tadeu, Dept Aging Sci, 546 Taquari St, Sao Paulo, Brazil.
EM r.aparecido.nucci@uol.com.br
RI Teodoro, Ana/B-5840-2011; Nucci, Ricardo Aparecido Baptista/A-4577-2017;
   Neto, Walter Krause/R-2323-2017; Gama, Eliane Florencio/G-1741-2014
OI Teodoro, Ana/0000-0002-8043-6431; Nucci, Ricardo Aparecido
   Baptista/0000-0001-5649-2145; Neto, Walter Krause/0000-0002-6881-0208;
   Gama, Eliane Florencio/0000-0002-9770-8819; de Assis Silva,
   Wellington/0000-0001-6343-5501
CR Nucci RAB, 2017, AGING MALE, V20, P134, DOI 10.1080/13685538.2017.1284779
   CAMPBELL WW, 1994, AM J CLIN NUTR, V60, P167, DOI 10.1093/ajcn/60.2.167
   Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680
   Cunha TS, 2005, LIFE SCI, V77, P1030, DOI 10.1016/j.lfs.2005.03.001
   DAVIES K J A, 1986, Journal of Free Radicals in Biology and Medicine, V2, P155, DOI 10.1016/S0748-5514(86)80066-6
   Evans WJ, 1999, MED SCI SPORT EXER, V31, P12, DOI 10.1097/00005768-199901000-00004
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Fontana K, 2008, HISTOL HISTOPATHOL, V23, P1367, DOI 10.14670/HH-23.1367
   Gil SM, 1998, SPORTS MED, V26, P365, DOI 10.2165/00007256-199826060-00001
   Goncalves L, 2014, AGING MALE, V17, P243, DOI 10.3109/13685538.2014.919252
   Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019
   Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002
   Hurley BF, 1998, EXERCISE SPORT SCI R, V26, P61
   Kawasaki T, 2011, HYPERTENS RES, V34, P1059, DOI 10.1038/hr.2011.81
   Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004
   LOVLIN R, 1987, EUR J APPL PHYSIOL, V56, P313, DOI 10.1007/BF00690898
   Mandarim-De-Lacerda CA, 2003, AN ACAD BRAS CIENC, V75, P469, DOI 10.1590/S0001-37652003000400006
   Marliss EB, 2000, J APPL PHYSIOL, V88, P457, DOI 10.1152/jappl.2000.88.2.457
   Matheson PJ, 2000, J SURG RES, V93, P182, DOI 10.1006/jsre.2000.5862
   Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008
   Mensink PBF, 2011, GUT, V60, P722, DOI 10.1136/gut.2009.199695
   Nakamoto H, 2007, EXP GERONTOL, V42, P287, DOI 10.1016/j.exger.2006.11.006
   Nucci R. A. B., 2016, Journal of Morphological Sciences, V33, P179, DOI 10.4322/jms.100616
   Otte JA, 2001, J APPL PHYSIOL, V91, P866, DOI 10.1152/jappl.2001.91.2.866
   Peterson MD, 2010, AGEING RES REV, V9, P226, DOI 10.1016/j.arr.2010.03.004
   Poulsen HE, 1996, J SPORT SCI, V14, P343, DOI 10.1080/02640419608727720
   PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.273.17.1341
   QAMAR MI, 1987, GUT, V28, P583, DOI 10.1136/gut.28.5.583
   Raue U, 2009, J APPL PHYSIOL, V106, P1611, DOI 10.1152/japplphysiol.91587.2008
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Shephard RJ, 1997, CRIT REV ONCOGENESIS, V8, P219, DOI 10.1615/CritRevOncog.v8.i2-3.40
   Singh MAF, 2002, J GERONTOL A-BIOL, V57, pM262, DOI 10.1093/gerona/57.5.M262
   van Wijck K, 2012, AM J PHYSIOL-GASTR L, V303, pG155, DOI 10.1152/ajpgi.00066.2012
   Wright H, 2011, CLIN J SPORT MED, V21, P337, DOI 10.1097/JSM.0b013e31822148b8
NR 34
TC 5
Z9 5
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1368-5538
EI 1473-0790
J9 AGING MALE
JI Aging Male
PY 2018
VL 21
IS 1
BP 60
EP 64
DI 10.1080/13685538.2017.1350157
PG 5
WC Endocrinology & Metabolism; Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Urology & Nephrology
GA GB5JB
UT WOS:000429099300009
PM 28696823
OA Green Published
DA 2024-02-19
ER

PT J
AU Navarro-Arévalo, A
   Sánchez-Del-Pino, MJ
AF Navarro-Arévalo, A
   Sánchez-Del-Pino, MJ
TI Age and exercise-related changes in lipid peroxidation and super-oxide
   dismutase activity in liver and soleus muscle tissues of rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; exercise; lipid peroxidation; superoxide dismutase
ID ANTIOXIDANT ENZYME-ACTIVITY; SKELETAL-MUSCLE; OXIDATIVE STRESS;
   FREE-RADICALS; SENESCENCE; INTENSITY; DAMAGE; BRAIN
AB Thiobarbituric acid-reactive substances (TBARS) level, as marker of lipid peroxidation, and superoxide dismutase (SOD) activity, as endogenous antioxidant enzyme, were examined in liver and soleus muscle tissue of young and old male Wistar rats. We established different types of exercise running on a treadmill both for young and old rats, investigated the effect of aging, exhaustion and training on these groups. The hepatic TBARS levels were raised in the short-training young group and in the long-training old group. On the other hand, the TBARS content decreased in soleus muscle in the short-training young group, and long-training exercise enhanced lipid peroxidation in old rats. SOD activity increased in liver in short-training group; while this activity showed the lowest values in long-training old rats. With respect to soleus muscle tissue, SOD activity was elevated after exhaustive exercise in young rats and old rats had the highest activity in the long-training old group. These findings suggest that free radicals play a role in aging and that the different type, intensity and duration of exercise modify the lipid peroxidation level and antioxidant enzyme activity. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Cadiz, Fac Med, Dept Bioquim & Biol Mol, E-11003 Cadiz, Spain.
C3 Universidad de Cadiz
RP Navarro-Arévalo, A (corresponding author), Univ Cadiz, Fac Med, Dept Bioquim & Biol Mol, Plaza Fragela S-N, E-11003 Cadiz, Spain.
OI Sanchez del Pino, Maria Jesus/0000-0001-6704-2027
CR ALESSIO HM, 1993, MED SCI SPORT EXER, V25, P218, DOI 10.1249/00005768-199302000-00010
   Buege J A, 1978, Methods Enzymol, V52, P302
   Cartee G D, 1994, Exerc Sport Sci Rev, V22, P91
   CRISWELL D, 1993, MED SCI SPORT EXER, V25, P1135
   Cutler RG, 1986, PHYSL OXYGEN RADICAL, P251
   DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1
   DEQIROGA GB, 1992, FREE RADICALS AGING, P109
   DUTHIE GG, 1990, ARCH BIOCHEM BIOPHYS, V282, P78, DOI 10.1016/0003-9861(90)90089-H
   ELSTERN EF, 1988, METHOD ENZYMAT AN, P293
   Fielding RA, 1997, AGING-CLIN EXP RES, V9, P12, DOI 10.1007/BF03340124
   GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623
   HAMMEREN J, 1992, INT J SPORTS MED, V13, P412, DOI 10.1055/s-2007-1021290
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HARMAN D, 1986, BIOL AGING, P3
   HIGUCHI M, 1985, J GERONTOL, V40, P281, DOI 10.1093/geronj/40.3.281
   JENKINS RR, 1988, SPORTS MED, V5, P156, DOI 10.2165/00007256-198805030-00003
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1993, MED SCI SPORT EXER, V25, P225
   JI LL, 1992, J APPL PHYSIOL, V72, P549, DOI 10.1152/jappl.1992.72.2.549
   KRETZSCHMAR D, 1990, INT J SPORTS MED, V12, P218
   LAUGHLIN MH, 1990, J APPL PHYSIOL, V68, P2337, DOI 10.1152/jappl.1990.68.6.2337
   LAWLER JM, 1993, AM J PHYSIOL, V265, pR1344, DOI 10.1152/ajpregu.1993.265.6.R1344
   LAWLER JM, 1994, RESP PHYSIOL, V96, P139, DOI 10.1016/0034-5687(94)90122-8
   Leaf DA, 1997, MED SCI SPORT EXER, V29, P1036, DOI 10.1097/00005768-199708000-00008
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MIQUEL J, 1989, HDB FREE RADICALS AN, P3
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   Ohishi S, 1997, CLIN EXP PHARMACOL P, V24, P326, DOI 10.1111/j.1440-1681.1997.tb01196.x
   REZNICK AZ, 1992, FREE RADICALS AGING, P423
   Rogers M A, 1993, Exerc Sport Sci Rev, V21, P65
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SJODIN B, 1990, SPORTS MED, V10, P236
   STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352
   VIANI P, 1991, J NEUROCHEM, V56, P253, DOI 10.1111/j.1471-4159.1991.tb02589.x
   WAHLEFELD AW, 1988, METHOD ENZYMAT AN, P126
   YEN TC, 1994, FREE RADICAL BIO MED, V16, P207, DOI 10.1016/0891-5849(94)90145-7
NR 37
TC 40
Z9 41
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD AUG 1
PY 1998
VL 104
IS 1
BP 91
EP 102
DI 10.1016/S0047-6374(98)00061-X
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 112AQ
UT WOS:000075471800007
PM 9751434
DA 2024-02-19
ER

PT J
AU Kong, XN
   Feng, DC
   Mathews, S
   Gao, B
AF Kong, Xiaoni
   Feng, Dechun
   Mathews, Stephanie
   Gao, Bin
TI Hepatoprotective and anti-fibrotic functions of interleukin-22:
   Therapeutic potential for the treatment of alcoholic liver disease
SO JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
LA English
DT Article; Proceedings Paper
CT 7th International Symposium on Alcoholic Liver and Pancreatic Diseases
   and Cirrhosis
CY SEP 06-07, 2012
CL Beijing, PEOPLES R CHINA
DE hepatic stellate cells; liver fibrosis; liver progenitor cells;
   senescence
ID HEPATIC STELLATE CELLS; VIRUS-INFECTION; B-VIRUS; MICE; INJURY; IL-22;
   ACTIVATION; PROTECTS; FIBROSIS; STAT3
AB Interleukin-22 (IL-22) plays a key role in promoting antimicrobial immunity and tissue repair at barrier surfaces by binding to the receptors IL-22R1, which is generally thought to be expressed exclusively in epithelial cells, and IL-10R2. Our laboratory previously demonstrated that IL-22 plays an important role in ameliorating liver injury in many rodent models by targeting hepatocytes that express high levels of IL-22R1 and IL-10R2. Recently, we have identified high expression levels of IL-22R1 and IL-10R2 in liver progenitor cells and hepatic stellate cells (HSCs). Overexpression of IL-22 in vivo or treatment with IL-22 in vitro promotes proliferation of liver progenitor cells via a signal transducer and activator of transcription 3 (STAT3)-dependent mechanism. IL-22 treatment also prevents HSC apoptosis in vitro and in vivo. Surprisingly, overexpression of IL-22, via either gene targeting or exogenous administration of adenovirus expressing IL-22, reduces liver fibrosis and accelerates the resolution of liver fibrosis during recovery. The anti-fibrotic effects of IL-22 are mediated via the activation of STAT3 in HSCs and subsequent induction of suppressor of cytokine signaling 3, which induces HSC senescence. Taken together, the hepatoprotective, mitogenic, and anti-fibrotic effects of IL-22 are beneficial in ameliorating alcoholic liver injury. Importantly, due to the restricted expression of IL-22R1, IL-22 therapy is expected to have few side effects, thus making IL-22 a potential candidate for treatment of alcoholic liver disease.
C1 [Kong, Xiaoni; Feng, Dechun; Mathews, Stephanie; Gao, Bin] NIAAA, Lab Liver Dis, NIH, Bethesda, MD USA.
   [Kong, Xiaoni] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.
   [Kong, Xiaoni] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Alcohol Abuse & Alcoholism (NIAAA); Shanghai Jiao Tong University;
   Shanghai Jiao Tong University
RP Kong, XN (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, 1954 Huashan Rd, Shanghai 200030, Peoples R China.
EM xiaonikong@sjtu.edu.cn
RI Feng, Dechun/Q-5962-2016
FU NIAAA, NIH
FX This work was supported by the Intramural Program of NIAAA, NIH.
CR Boetticher NC, 2008, GASTROENTEROLOGY, V135, P1953, DOI 10.1053/j.gastro.2008.08.057
   Brand S, 2007, AM J PHYSIOL-GASTR L, V292, pG1019, DOI 10.1152/ajpgi.00239.2006
   Chestovich PJ, 2012, TRANSPLANTATION, V93, P485, DOI 10.1097/TP.0b013e3182449136
   Dambacher J, 2008, CYTOKINE, V41, P209, DOI 10.1016/j.cyto.2007.11.016
   Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814
   Feng DC, 2012, GASTROENTEROLOGY, V143, P188, DOI 10.1053/j.gastro.2012.03.044
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Gao B, 2012, J GASTROEN HEPATOL, V27, P89, DOI 10.1111/j.1440-1746.2011.07003.x
   Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002
   Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613
   Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419
   Jiang RQ, 2011, HEPATOLOGY, V54, P900, DOI 10.1002/hep.24486
   Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837
   Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Louvet A, 2009, GASTROENTEROLOGY, V137, P541, DOI 10.1053/j.gastro.2009.04.062
   Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786
   Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599
   Mastelic B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00085
   Mathurin P, 2011, GUT, V60, P255, DOI 10.1136/gut.2010.224097
   Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049
   Michalopoulos GK, 2011, INT J BIOCHEM CELL B, V43, P173, DOI 10.1016/j.biocel.2009.09.014
   Naveau S, 2004, HEPATOLOGY, V39, P1390, DOI 10.1002/hep.20206
   Nguyen-Khac E, 2011, NEW ENGL J MED, V365, P1781, DOI 10.1056/NEJMoa1101214
   O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258
   Pan HN, 2004, CELL MOL IMMUNOL, V1, P43
   Park O, 2011, HEPATOLOGY, V54, P252, DOI 10.1002/hep.24339
   Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184
   Ren XD, 2010, AM J PHYSIOL-GASTR L, V298, pG74, DOI 10.1152/ajpgi.00075.2009
   Roskams T, 2010, CLIN LIVER DIS, V14, P705, DOI 10.1016/j.cld.2010.08.003
   Rountree CB, 2012, HEPATOLOGY, V55, P298, DOI 10.1002/hep.24762
   Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   Tanaka M, 2011, J BIOCHEM, V149, P231, DOI 10.1093/jb/mvr001
   Tilg H, 2007, NAT CLIN PRACT GASTR, V4, P24, DOI 10.1038/ncpgasthep0683
   Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157
   Wilson MS, 2010, J IMMUNOL, V184, P4378, DOI 10.4049/jimmunol.0903416
   Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x
   Xiang XG, 2012, IMMUNOL CELL BIOL, V90, P611, DOI 10.1038/icb.2011.79
   Xing WW, 2011, CYTOKINE, V56, P174, DOI 10.1016/j.cyto.2011.07.022
   Xing WW, 2011, BIOSCI BIOTECH BIOCH, V75, P1290, DOI 10.1271/bbb.110061
   Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004
   Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9
   Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023
   Zhang XY, 2010, HEPATOLOGY, V52, P2137, DOI 10.1002/hep.23909
   Zhang Y, 2011, GASTROENTEROLOGY, V141, P1897, DOI 10.1053/j.gastro.2011.06.051
NR 46
TC 73
Z9 80
U1 1
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0815-9319
EI 1440-1746
J9 J GASTROEN HEPATOL
JI J. Gastroenterol. Hepatol.
PD AUG
PY 2013
VL 28
SU 1
SI SI
BP 56
EP 60
DI 10.1111/jgh.12032
PG 5
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)
SC Gastroenterology & Hepatology
GA 286JB
UT WOS:000329463400011
PM 23855297
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Marino, M
   Dolfi, C
   Paradiso, C
   Cavallini, G
   Masini, M
   Gori, Z
   Pollera, M
   Trentalance, A
   Bergamini, E
AF Marino, M
   Dolfi, C
   Paradiso, C
   Cavallini, G
   Masini, M
   Gori, Z
   Pollera, M
   Trentalance, A
   Bergamini, E
TI Age-dependent accumulation of dolichol in rat liver: Is tissue dolichol
   a biomarker of aging?
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID MEMBRANE-PROPERTIES; LIPID COMPOSITIONS; PROTEIN OXIDATION;
   PLASMA-MEMBRANES; AMINO-ACIDS; METABOLISM; PHOSPHATE; BRAIN;
   CHOLESTEROL; RESTRICTION
AB Dolichols are long hydrophobic molecules broadly distributed in all tissues and cellular membranes of eukariotic cells. Dolichol affects membrane structure and fluidity, membrane-associated protein activities, and membrane sensitivity to oxidative stress. Reports Rave shown that dolichols exhibit a remarkable (6- to 30-fold) age-related increase in the tissues of adult and mature rats and of old flies, mice, and humans. III our longitudinal study, the age-related accumulation of dolichol Has monitored in the liver tissue of male Sprague Dawley rats fed ad libitum up to age of 27 months. In addition 24-month-old rats subjected to different regimens of anti-aging diet restriction (40% calorie restriction or every-other-day feeding ad libitum) were tested. A parallel study of the accumulation of carbonyl in liver protein (a proposed biomarker of aging) was made. In addition, the age-related decline of liver autophagy/proteolysis was studied in isolated liver cells, in view of die essential role of this function in liver membrane maintenance. Results show that an age-dependent accumulation of dolichol can be observed in the liver of the rats fed ad libitum but not in the liver of 24-month-old food-restricted rats, that accumulation of dolichol precedes the accumulation of altered liver proteins, and that dolichol accumulation is accompanied by a decline in liver autophagy. It is concluded that dolichol accumulation satisfies the proposed primary and secondary applicable criteria and die desirable features required to be qualified as a biomarker of aging.
C1 Univ Pisa, Ist Patol Gen, I-56126 Pisa, Italy.
   Univ Roma Tre, Dipartimento Biol, Rome, Italy.
C3 University of Pisa; Roma Tre University
RP Bergamini, E (corresponding author), Univ Pisa, Ist Patol Gen, Via Roma 55, I-56126 Pisa, Italy.
CR BERGAMINI E, 1992, ANN NY ACAD SCI, V663, P43, DOI 10.1111/j.1749-6632.1992.tb38647.x
   Bergamini E, 1995, AGING-CLIN EXP RES, V7, P473, DOI 10.1007/BF03324374
   BERGAMINI E, 1990, PROTEIN METABOLISM A, P295
   BOUCHARD G, 1994, P SOC EXP BIOL MED, V206, P409
   CARROLL KK, 1992, BIOCHEM CELL BIOL, V70, P382, DOI 10.1139/o92-059
   CHOEN MB, 1985, LIFE SCI, V37, P1403
   CHOINACKI T, 1988, BIOCHEM J, V251, P1
   CRICK DC, 1987, BIOCHEM CELL BIOL, V65, P317, DOI 10.1139/o87-041
   DANIELS I, 1990, LIPIDS, V25, P586, DOI 10.1007/BF02536006
   EDLUND C, 1992, BIOCHEM CELL BIOL, V70, P422, DOI 10.1139/o92-065
   EDLUND C, 1994, NEUROCHEM INT, V25, P35, DOI 10.1016/0197-0186(94)90050-7
   ELMBERGER PG, 1989, LIPIDS, V24, P919, DOI 10.1007/BF02544535
   GOODRICK CL, 1982, GERONTOLOGY, V28, P233, DOI 10.1159/000212538
   Gruenler Jacob, 1994, Biochimica et Biophysica Acta, V1212, P259
   HARTNELL JM, 1989, J GERONTOL, V44, pB125, DOI 10.1093/geronj/44.5.B125
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HEMMING FW, 1992, BIOCHEM CELL BIOL, V70, P377, DOI 10.1139/o92-058
   ISHINAGA M, 1993, P SOC EXP BIOL MED, V203, P74, DOI 10.3181/00379727-203-43575
   JACOBSSONBORIN A, 1994, BIOCHIM BIOPHYS ACTA, V1213, P159
   JANKOWSKI W, 1992, ACTA BIOCHIM POL, V39, P215
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   KALEN A, 1990, LIPIDS, V25, P93, DOI 10.1007/BF02562211
   KEENAN RW, 1977, BIOCHIM BIOPHYS ACTA, V486, P1, DOI 10.1016/0005-2760(77)90064-9
   KELLER RK, 1987, TRENDS BIOCHEM SCI, V12, P443
   KELLER RK, 1986, LIPIDS, V21, P353, DOI 10.1007/BF02535700
   KESSLER AR, 1985, BIOCHEM PHARMACOL, V34, P1120, DOI 10.1016/0006-2952(85)90620-3
   KIN NMKNY, 1983, J NEUROCHEM, V40, P1465, DOI 10.1111/j.1471-4159.1983.tb13592.x
   Leloir L F, 1977, Adv Exp Med Biol, V83, P9
   MALTESE WA, 1989, J BIOL CHEM, V264, P18168
   MARINO M, 1986, BIOSCIENCE REP, V6, P409, DOI 10.1007/BF01116429
   MARINO M, 1990, BIOCHIM BIOPHYS ACTA, V1047, P192, DOI 10.1016/0005-2760(90)90047-2
   MARINO M, 1994, METABOLISM, V43, P677, DOI 10.1016/0026-0495(94)90114-7
   MASORO EJ, 1990, PROTEIN METABOLISM A, P257
   MIOTTO G, 1994, J BIOL CHEM, V269, P25348
   MOORADIAN AD, 1990, J GERONTOL, V45, pB183, DOI 10.1093/geronj/45.6.B183
   MORRIS GN, 1991, COMP BIOCHEM PHYS B, V98, P267, DOI 10.1016/0305-0491(91)90177-F
   MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   NOVELLI M, IN PRESS J GERONTOL
   PIERI C, 1991, ANN NY ACAD SCI, V621, P353
   PULLARKAT RK, 1990, BIOCHEM J, V265, P891, DOI 10.1042/bj2650891
   PULLARKAT RK, 1982, J BIOL CHEM, V257, P5991
   PULLARKAT RK, 1984, BIOCHIM BIOPHYS ACTA, V793, P494, DOI 10.1016/0005-2760(84)90269-8
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357
   RIP JW, 1983, CAN J BIOCHEM CELL B, V61, P1025, DOI 10.1139/o83-131
   RIP JW, 1985, BIOCHEM J, V227, P705, DOI 10.1042/bj2270705
   RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6
   ROINE R, 1992, BIOCHEM CELL BIOL, V70, P404, DOI 10.1139/o92-062
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SELL DR, 1991, DIABETES METAB REV, V7, P239, DOI 10.1002/dmr.5610070404
   SODERBERG M, 1990, J NEUROCHEM, V54, P415, DOI 10.1111/j.1471-4159.1990.tb01889.x
   SPECTOR AA, 1985, J LIPID RES, V26, P1015
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   STROSZNAJDER J, 1989, MOL CHEM NEUROPATHOL, V11, P77, DOI 10.1007/BF03160042
   STRYER L, 1995, BIOCHEMISTRY-US, P696
   TAPUHI Y, 1981, ANAL BIOCHEM, V115, P123, DOI 10.1016/0003-2697(81)90534-0
   THELIN A, 1994, MECH AGEING DEV, V76, P165, DOI 10.1016/0047-6374(94)91591-1
   VALTERSSON C, 1985, J BIOL CHEM, V260, P2742
   Van Dessel G, 1990, Subcell Biochem, V16, P227
   VIGO C, 1984, BIOCHIM BIOPHYS ACTA, V774, P221, DOI 10.1016/0005-2736(84)90295-5
   Vittorini S, 1995, AGING-CLIN EXP RES, V7, P476, DOI 10.1007/BF03324376
   Vittorini S, 1995, AGING CLIN EXP RES, V7, P480, DOI 10.1007/BF03324380
   WOOD WG, 1989, CHEM PHYS LIPIDS, V51, P219, DOI 10.1016/0009-3084(89)90009-1
   WOODSIDE KH, 1972, J BIOL CHEM, V247, P6474
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 67
TC 40
Z9 41
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAR
PY 1998
VL 53
IS 2
BP B87
EP B93
DI 10.1093/gerona/53A.2.B87
PG 7
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA ZB926
UT WOS:000072522200002
PM 9520903
OA Bronze
DA 2024-02-19
ER

PT S
AU Marineo, G
   Marotta, F
   Sisti, G
AF Marineo, G
   Marotta, F
   Sisti, G
BE DeGrey, ADN
TI Cirrhosis progression as a model of accelerated senescence - Affecting
   the biological aging clock by a breakthrough biophysical methodology
SO STRATEGIES FOR ENGINEERED NEGLIGIBLE SENESCENCE: WHY GENUINE CONTROL OF
   AGING MAY BE FORESEEABLE
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 10th Congress of the International-Association-of-Biomedical-Gerontology
CY SEP 19-23, 2003
CL Cambridge, ENGLAND
SP Int Assoc Biomed Gerontol
DE entropy; cirrhosis; regeneration; aging
AB To test new treatment modalities, a pilot study with a novel noninvasive biophysical methodology (Delta-S DVD) that can artificially exert a "decrease of entropy" through the patented electromagnetic-driven delivery of,,energy clusters" was designed. This process has been modulated and integrated by the body as a "self" source to support the energy-dependent functional stores, thus modifying reparative into regenerative mechanisms of liver parenchyma. Seven long-standing hepatitis C virus-positive (Child A-B) cirrhosis patients with overt symptoms and portal hypertension and failure or side effects of antiviral drug treatment underwent 40-min sessions of Delta-S DVD daily for six months and were followed up monthly. At the end of the first month, rapid improvement of symptoms and a decrease of portal hypertension were noted. At the end of treatment, all patients showed either a complete (80%) or a partial (20%) regression of fatigue (FISK score), peripheral edema, pruritus, and palmar erythema. As observed, despite having stopped betablockers, F1 esophageal varices disappeared (60%), whereas F2 decreased to F1. The Doppler ultrasound aspect of partial (40%) or total (20%) atrophy was either reduced (60%) or reverted to normal (20%), and the respiratory dynamics of the portal vein improved (80%) or normalized (20%), whereas gross scarring nodules disappeared in 40% of cases. These promising data pave the way for an innovative physiopathological approach with extensive clinical applications.
C1 Univ Roma Tor Vergata, Res Ctr Med Bioengn, Delta Res & Dev, I-00187 Rome, Italy.
C3 University of Rome Tor Vergata
RP Marineo, G (corresponding author), Univ Roma Tor Vergata, Res Ctr Med Bioengn, Delta Res & Dev, Via Mezzocammino 85, I-00187 Rome, Italy.
EM g.marineo@mclink.it
RI Marotta, Francesco/ABI-1960-2020; Sisti, Giovanni/J-1174-2014; Marineo,
   Giuseppe/AAI-4048-2020
OI Marotta, Francesco/0000-0002-6016-1864; Sisti,
   Giovanni/0000-0003-4152-0603; Marineo, Giuseppe/0000-0002-5685-7607
CR Ciccocioppo R, 2003, ALIMENT PHARM THER, V17, P271, DOI 10.1046/j.1365-2036.2003.01413.x
   MARINEO G, 2002, 19 KUM MED BIOSC S C
   MARINEO G, 1995, 5 WORLD C INT SOC DE
   MARINEO G, 2003, 4 ANN C REG MED WASH
   MARINEO G, 2002, 1 AS PAC C ANT MED S
   MARINEO G, 2003, ANT WORLD C PAR FRAN
NR 6
TC 4
Z9 4
U1 0
U2 3
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-496-X
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2004
VL 1019
BP 572
EP 576
DI 10.1196/annals.1297.107
PG 5
WC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Multidisciplinary Sciences
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Geriatrics &
   Gerontology; Science & Technology - Other Topics
GA BAN77
UT WOS:000223002700107
PM 15247089
DA 2024-02-19
ER

PT J
AU GORDILLO, E
   MACHADO, A
AF GORDILLO, E
   MACHADO, A
TI IMPLICATION OF LYSINE RESIDUES IN THE LOSS OF 6-PHOSPHOGLUCONATE
   DEHYDROGENASE-ACTIVITY IN AGING HUMAN ERYTHROCYTES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; 6-PHOSPHOGLUCONATE DEHYDROGENASE; ERYTHROCYTE
ID HUMAN-FIBROBLASTS; RAT-LIVER; PROTEINS; AGE; PROTEOLYSIS; SEPARATION;
   TURNOVER; ENZYMES; YOUNG
AB The activity of 6-phosphogluconate dehydrogenase (6-PGDH) decreases in aged human erythrocyte populations.  The aged enzyme has 11 lysine residues less than the young enzyme, when they are measured with 2,4,6-trinitro-benzenesulfonic acid (TNBS).  Treatment of young enzyme with ascorbate for 15 min produces the loss of 8 lysine residues and the diminution of enzymatic activity.  These results suggest that there is a modification of lysine residue in human erythrocytes during senescence, probably caused by oxidation.  This modification of lysine residue could imply the loss of enzymatic activity.  This result is similar to that found in rat liver 6-PGDH during aging, described previously (Gordillo et al., J. Biol. Chem. 264 (1989) 17014-17019).
C1 UNIV SEVILLA,FAC FARM,DEPT BIOQUIM BROMATOL & TOXICOL,PROF GARCIA GONZALEZ,E-41012 SEVILLE,SPAIN.
C3 University of Sevilla
RI IBIS, ENVEJECIMIENTO/O-9381-2015
CR CORASH LM, 1974, J LAB CLIN MED, V84, P147
   DICE JF, 1982, J BIOL CHEM, V257, P4624
   Fotino M, 1971, Ann Clin Lab Sci, V1, P131
   GAFNI A, 1981, BIOCHEMISTRY-US, V20, P6035, DOI 10.1021/bi00524a018
   GERSHON H, 1970, NATURE, V227, P1214, DOI 10.1038/2271214a0
   GOLDSTEIN S, 1976, MECH AGEING DEV, V5, P221, DOI 10.1016/0047-6374(76)90020-8
   GORDILLO E, 1988, J BIOL CHEM, V263, P8053
   GORDILLO E, 1989, J BIOL CHEM, V264, P17014
   HEBBEL RP, 1982, J CLIN INVEST, V70, P1253, DOI 10.1172/JCI110724
   HOCHSTEIN P, 1981, FED PROC, V40, P183
   KELVIN JA, 1985, CELLULAR MOL ASPECTS, P15
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEVINE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2120, DOI 10.1073/pnas.78.4.2120
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACHADO A, 1983, CARDIOLOGY AGING, P65
   MCKAY MJ, 1985, CELLULAR MOL ASPECTS, P29
   MURPHY JR, 1973, J LAB CLIN MED, V82, P334
   OLIVER CN, 1987, J BIOL CHEM, V262, P5488
   OLIVER CN, 1981, EXPERIENCES BIOCH PE, P233
   REIS W, 1975, J BIOL CHEM, V250, P826
   REZNICK AZ, 1981, FEBS LETT, V128, P221, DOI 10.1016/0014-5793(81)80085-3
   ROTHSTEIN M, 1982, BIOCH APPROACHES AGI, P213
   SAPAGHAGAR M, 1973, BIOCHEM BIOPH RES CO, V50, P179, DOI 10.1016/0006-291X(73)91080-2
   SEAMAN C, 1980, AM J HEMATOL, V8, P31, DOI 10.1002/ajh.2830080105
   SOHAL RS, ADV MYOCHEMISTRY
   STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5
   TUENGLER P, 1987, BIOCHIM BIOPHYS ACTA, V448, P1
   TURNER BM, 1974, CLIN CHIM ACTA, V50, P85, DOI 10.1016/0009-8981(74)90080-1
   VITORICA J, 1981, ENZYME, V26, P144
NR 29
TC 5
Z9 7
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUN 28
PY 1991
VL 59
IS 3
BP 291
EP 297
DI 10.1016/0047-6374(91)90139-Q
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FW718
UT WOS:A1991FW71800007
PM 1921518
DA 2024-02-19
ER

PT J
AU Chevalier, S
   Blaner, WS
   Azais-Braesco, V
   Tuchweber, B
AF Chevalier, S
   Blaner, WS
   Azais-Braesco, V
   Tuchweber, B
TI Dietary restriction alters retinol and retinol-binding protein
   metabolism in aging rats
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID VITAMIN-A; MESSENGER-RNA; FOOD RESTRICTION; ESTER HYDROLASE;
   GROWTH-HORMONE; LIVER; ACID; EXPRESSION; CELLS; TRANSTHYRETIN
AB Recent studies reported that retinoid metabolism was influenced by long-term dietary restriction (DR) in rats. Because plasma retinol was decreased in rats subjected to DR, it was thought that this dietary manipulation may have an effect on retinol-binding protein (RBP) metabolism. Thus, the aim of this study was to assess retinoids, RBF: and transthyretin (TTR) levels in plasma and liver of young (3 months), adult (12 months) and old (22 months) female Sprague-Dawley rats fed ad libitum (AL) or subjected to a 40% DR, enriched (DR), or not (DR), with vitamins and minerals. Results indicate that hepatic total retinoid concentrations and content increased with age in all the groups. DR+ rats showed higher hepatic retinoid concentrations than age-matched AL and DR rats. Adult and old DR and DR+ rats exhibited significantly lower plasma RBP-retinol and higher total retinoic acid levels than corresponding controls, although these parameters were not influenced by aging. Liver RBP levels were also decreased in DR and DR+ rats when compared to respective AL controls. There was a slight age-related decline in plasma TTR levels in DR and DR+ rats which was riot associated with modifications in liver TTR levels. Hepatic gene expression of RBP and TTR, as evaluated by Northern blot hybridization, did riot change with age or diet, suggesting that the lower levels of plasma RBP-retinol and liver RBP in vitamin A-sufficient rats subjected to DR may reflect post-transcriptional alterations and/or accelerated degradation of hepatic RBI. The elevated plasma levels of retinoic acid may represent an adaptive mechanism developed by DR rats to maintain retinoid-dependent functions.
C1 Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada.
   Columbia Univ, Inst Human Nutr, New York, NY 10032 USA.
   INRA, Metab Dis & Micronutrients Res Unit, Clermont Ferrand, France.
C3 Universite de Montreal; Columbia University; INRAE
RP Tuchweber, B (corresponding author), Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada.
CR [Anonymous], 1989, MOL CLONING LAB MANU
   AzaisBraesco V, 1995, BBA-LIPID LIPID MET, V1259, P271, DOI 10.1016/0005-2760(95)00173-5
   Bellovino D, 1996, EXP CELL RES, V222, P77, DOI 10.1006/excr.1996.0010
   BHAT PV, 1983, J CHROMATOGR, V272, P269, DOI 10.1016/S0378-4347(00)86129-0
   BHAT PV, 1986, NUTR RES, V6, P429, DOI 10.1016/S0271-5317(86)80184-1
   BLANER WS, 1990, METHOD ENZYMOL, V189, P270
   BLANER WS, 1994, J BIOL CHEM, V269, P16559
   CHEVALIER S, 1995, NUTR RES, V15, P859, DOI 10.1016/0271-5317(95)00051-J
   Chevalier S, 1996, FASEB J, V10, P1085, DOI 10.1096/fasebj.10.9.8801171
   COOPER DA, 1990, METHOD ENZYMOL, V189, P490
   DORNER H, 1995, J GERONTOL A-BIOL, V50, pB218, DOI 10.1093/gerona/50A.4.B218
   FERLAND G, 1992, J GERONTOL, V47, pB3, DOI 10.1093/geronj/47.1.B3
   GROLIER P, 1992, BIOCHIM BIOPHYS ACTA, V1111, P135, DOI 10.1016/0005-2736(92)90283-R
   HEYDARI AR, 1995, J NUTR, V125, P410
   Imamine T, 1996, DIGEST DIS SCI, V41, P1038, DOI 10.1007/BF02091549
   ISHIGAMI A, 1990, ARCH BIOCHEM BIOPHYS, V283, P362, DOI 10.1016/0003-9861(90)90655-I
   KEILSON B, 1979, J NUTR, V109, P787, DOI 10.1093/jn/109.5.787
   LINLEY LK, 1995, J GERONTOL A-BIOL, V50, pB54, DOI 10.1093/gerona/50A.1.B54
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MERCIER M, 1994, BBA-LIPID LIPID MET, V1212, P176, DOI 10.1016/0005-2760(94)90251-8
   Monaco MH, 1996, J NUTR, V126, P544, DOI 10.1093/jn/126.2.544
   MOTE PL, 1991, J GERONTOL, V46, pB95, DOI 10.1093/geronj/46.3.B95
   *NAT RES COUNC, 1995, NUTR REQ LAB AN, P11
   Ong David E., 1994, P283
   RAJAN N, 1990, J LIPID RES, V31, P821
   SOPRANO DR, 1988, J BIOL CHEM, V263, P2934
   SPINDLER SR, 1991, J GERONTOL, V46, pB233, DOI 10.1093/geronj/46.6.B233
   Tillman JB, 1996, J NUTR, V126, P416, DOI 10.1093/jn/126.2.416
   TUSHINSKI RJ, 1977, P NATL ACAD SCI USA, V74, P2357, DOI 10.1073/pnas.74.6.2357
   UNDERWOOD BA, 1979, J NUTR, V109, P796, DOI 10.1093/jn/109.5.796
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
   WARD WF, 1988, J GERONTOL, V43, pB121, DOI 10.1093/geronj/43.5.B121
   WEI SH, 1995, J BIOL CHEM, V270, P866, DOI 10.1074/jbc.270.2.866
   *WHO UNICEF, 1994, IND ASS VIT A DEF TH
   YU BP, 1994, P SOC EXP BIOL MED, V205, P97, DOI 10.3181/00379727-205-43684
NR 35
TC 5
Z9 5
U1 0
U2 1
PU GERONTOLOGICAL SOCIETY AMER
PI WASHINGTON
PA 1275 K STREET NW SUITE 350, WASHINGTON, DC 20005-4006 USA
SN 1079-5006
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD SEP
PY 1999
VL 54
IS 9
BP B384
EP B392
DI 10.1093/gerona/54.9.B384
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 331XG
UT WOS:000088043500004
PM 10536643
DA 2024-02-19
ER

PT J
AU Guo, DH
   Shen, Y
   Li, W
   Li, QJ
   Zhao, Y
   Pan, CH
   Chen, B
   Zhong, Y
   Miao, Y
AF Guo, Donghao
   Shen, Yun
   Li, Wei
   Li, Qinjie
   Zhao, Yu
   Pan, Chenhao
   Chen, Bi
   Zhong, Yuan
   Miao, Ya
TI 6-Bromoindirubin-3′-Oxime (6BIO) Suppresses the mTOR Pathway, Promotes
   Autophagy, and Exerts Anti-aging Effects in Rodent Liver
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article
DE 6-bromoindirubin-3 '-oxime; aging; autophagy; mammalian target of
   rapamycin; glycogen synthase kinase-3 beta
ID GLYCOGEN-SYNTHASE KINASE-3; WNT/BETA-CATENIN; OXIDATIVE STRESS; GSK3
   INHIBITION; PROTEIN-KINASE; CELLS; AGE; REGENERATION; INFLAMMATION;
   METABOLISM
AB Liver aging is associated with age-related histopathological and functional changes that significantly enhance the risk of numerous diseases or disorders developing in elderly populations. 6-Bromoindirubin-3'-oxime (6BIO), a potent inhibitor of glycogen synthase kinase-3 (GSK-3), has been implicated in various age-related diseases and processes, such as tumorigenesis, neurodegeneration, and diabetes. Recent studies have also revealed that 6BIO increases autophagy in yeast, mammalian cell lines, and dopaminergic neurons, which is one of the classical mechanisms strongly associated with liver aging. However, the impact or the mechanism of action of 6BIO in liver remains entirely unknown. Here, we find that 6BIO reduces oxidative stress, improves lipid metabolism, enhances autophagy, and significantly retards liver aging via modulating the GSK-3 beta pathway and mTOR pathway. Our findings suggest that 6BIO could be a potential agent to protect the liver in the field of anti-aging pharmacology.
C1 [Guo, Donghao; Shen, Yun; Li, Wei; Li, Qinjie; Zhong, Yuan; Miao, Ya] Shanghai Jiao Tong Univ, Dept Geriatr, Affiliated Peoples Hosp 6, Shanghai, Peoples R China.
   [Zhao, Yu] Shanghai Jiao Tong Univ, Dept Cardiol, Affiliated Peoples Hosp 6, Shanghai, Peoples R China.
   [Pan, Chenhao; Chen, Bi] Shanghai Jiao Tong Univ, Dept Orthoped, Affiliated Peoples Hosp 6, Shanghai, Peoples R China.
C3 Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai
   Jiao Tong University
RP Zhong, Y; Miao, Y (corresponding author), Shanghai Jiao Tong Univ, Dept Geriatr, Affiliated Peoples Hosp 6, Shanghai, Peoples R China.
EM zhongyuan_zhy@163.com; nning-my@163.com
RI Guo, Donghao/AAB-5671-2020
OI Guo, Donghao/0000-0002-8300-8176; Zhong, Yuan/0000-0002-3241-4924
FU National Natural Science Foundation of China [81300933]; Shanghai
   Natural Science Foundation
FX This work was funded by grants from the National Natural Science
   Foundation of China (No. 81300933) and the Shanghai Natural Science
   Foundation.
CR Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250
   Baar EL, 2016, AGING CELL, V15, P155, DOI 10.1111/acel.12425
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   da Cunha MDB, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111243
   Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016
   Braig S, 2013, CANCER RES, V73, P6004, DOI 10.1158/0008-5472.CAN-12-4358
   Chen ZJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23010196
   Czaja MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC973, DOI 10.1152/ajpcell.00527.2009
   Ehninger D, 2014, CELL MOL LIFE SCI, V71, P4325, DOI 10.1007/s00018-014-1677-1
   EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x
   Haga S, 2009, HEPATOLOGY, V49, P204, DOI 10.1002/hep.22583
   He J, 2018, POULTRY SCI, V97, P2005, DOI 10.3382/ps/pey077
   Jimenez AG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195832
   Kennedy BK, 2014, TRANSL RES, V163, P456, DOI 10.1016/j.trsl.2013.11.007
   Kim IH, 2016, AGE, V38, P291, DOI 10.1007/s11357-016-9938-6
   Kim S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182566
   Klamer G, 2013, EXP HEMATOL, V41, P39, DOI 10.1016/j.exphem.2012.09.005
   Ko GA, 2018, NUTR RES PRACT, V12, P3, DOI 10.4162/nrp.2018.12.1.3
   Lashinger LM, 2011, CANCER PREV RES, V4, P1041, DOI 10.1158/1940-6207.CAPR-11-0023
   Li J, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00772
   Liu J, 2018, STEM CELL RES, V31, P5, DOI 10.1016/j.scr.2018.06.001
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Marchand B, 2015, J BIOL CHEM, V290, P5592, DOI 10.1074/jbc.M114.616714
   Orellana AMM, 2015, AGING-US, V7, P1094, DOI 10.18632/aging.100853
   Martínez-Cisuelo V, 2016, EXP GERONTOL, V83, P130, DOI 10.1016/j.exger.2016.08.002
   Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427
   McCubrey JA, 2016, BBA-MOL CELL RES, V1863, P2942, DOI 10.1016/j.bbamcr.2016.09.004
   Nakamura S, 2018, MOL CELLS, V41, P65, DOI 10.14348/molcells.2018.2333
   Nicolaou KA, 2012, BIOCHEM BIOPH RES CO, V425, P76, DOI 10.1016/j.bbrc.2012.07.053
   Niedernhofer LJ, 2017, AGEING RES REV, V35, P241, DOI 10.1016/j.arr.2016.09.012
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Qian Yingjuan, 2013, Methods Mol Biol, V965, P37, DOI 10.1007/978-1-62703-239-1_3
   Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458
   Shen S, 2015, STEM CELLS DEV, V24, P724, DOI 10.1089/scd.2014.0230
   Siegmund SE, 2017, HUM MOL GENET, V26, P4588, DOI 10.1093/hmg/ddx341
   Sklirou AD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11662-7
   Sun AJ, 2016, PROSTATE, V76, P172, DOI 10.1002/pros.23106
   Suresh SN, 2017, AUTOPHAGY, V13, P1221, DOI 10.1080/15548627.2017.1302045
   Tsakiri EN, 2017, ANTIOXID REDOX SIGN, V27, P1027, DOI 10.1089/ars.2016.6910
   Vaiserman AM, 2016, AGEING RES REV, V31, P9, DOI 10.1016/j.arr.2016.08.004
   Wang TN, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1186-2
   Wong VKW, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00351
   Wu Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00877
   Yew WW, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02637-17
   Yi G, 2013, INT J ONCOL, V43, P1503, DOI 10.3892/ijo.2013.2077
   Yuan J, 2018, INT J MOL MED, V41, P2086, DOI 10.3892/ijmm.2018.3393
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhang XW, 2017, MOL THER, V25, P79, DOI 10.1016/j.ymthe.2016.10.017
   Zhao YY, 2017, CELL TRANSPLANT, V26, P395, DOI 10.3727/096368916X694364
   Zhou L, 2018, REDOX BIOL, V14, P35, DOI 10.1016/j.redox.2017.08.014
   Zhou W, 2018, CELL BIOL INT, V42, P1282, DOI 10.1002/cbin.11015
NR 51
TC 10
Z9 14
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD APR 10
PY 2019
VL 10
AR 320
DI 10.3389/fphar.2019.00320
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA HT2JD
UT WOS:000464388100001
PM 31057395
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU SHIMADA, M
   MATSUMATA, T
   MAEDA, T
   ITASAKA, H
   SUEHIRO, T
   SUGIMACHI, K
AF SHIMADA, M
   MATSUMATA, T
   MAEDA, T
   ITASAKA, H
   SUEHIRO, T
   SUGIMACHI, K
TI HEPATIC REGENERATION FOLLOWING RIGHT LOBECTOMY - ESTIMATION OF
   REGENERATIVE CAPACITY
SO SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
LA English
DT Article
DE MAJOR HEPATECTOMY; MULTIPLE REGRESSION ANALYSIS; PORTAL PRESSURE; AGING;
   LIVER CIRRHOSIS; CHRONIC HEPATITIS
AB The regenerative capacity of the liver was assessed using a volumetric method on computed tomography in 21 adults: 16 underwent a standard right hepatic lobectomy for hepatocellular carcinoma, there were hepatic metastases in 3 others, and 2 suffered from other diseases. The patients' ages ranged from 33 to 68 years with a mean age of 57.0 years. The regeneration rate was expressed as the rate of the volume increase of the remnant left lobe compared with the preoperative volume of the left lobe. A univariate regression analysis showed that the portal pressure had a highly inverse correlation with the regeneration rate of the liver (r = -0.4753, P = 0.0397), while a multiple regression analysis demonstrated the correlation between the portal pressure, age, and the regeneration rate (multiple r = 0.5640). The regeneration rate of the normal liver (97.6 +/- 53.5%) was significantly higher than that of the chronic hepatitic (43.0 +/- 40.7%), and also tended to be higher than that of the cirrhotic liver (51.5 +/- 13.2%). However, there were no differences between chronic hepatitic and cirrhotic livers. The portal pressure before hepatectomy of the normal liver (149 +/- 19 mmH2O) was significantly lower than those of chronic hepatitic (188 +/- 38 mmH2O) and cirrhotic (245 +/- 78 mmH2O) livers. We thus conclude that the regenerative capacity of the liver following a right hepatic lobectomy could be estimated on the basis of both portal pressure and age. The regenerative capacity was also influenced by underlying liver diseases.
RP SHIMADA, M (corresponding author), KYUSHU UNIV,FAC MED,DEPT SURG 2,3-1-1 MAIDASHI,HIGASHI KU,FUKUOKA 812,JAPAN.
NR 0
TC 32
Z9 32
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0941-1291
J9 SURG TODAY
JI Surg. Today-Jpn. J. Surg.
PY 1994
VL 24
IS 1
BP 44
EP 48
DI 10.1007/BF01676884
PG 5
WC Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery
GA MQ050
UT WOS:A1994MQ05000009
PM 8054774
DA 2024-02-19
ER

PT J
AU Rius-Pérez, S
   Tormos, AM
   Pérez, S
   Finamor, I
   Rada, P
   Valverde, AM
   Nebreda, AR
   Sastre, J
   Taléns-Visconti, R
AF Rius-Perez, Sergio
   Tormos, Ana M.
   Perez, Salvador
   Finamor, Isabela
   Rada, Patricia
   Valverde, Angela M.
   Nebreda, Angel R.
   Sastre, Juan
   Talens-Visconti, Raquel
TI p38α deficiency restrains liver regeneration after partial hepatectomy
   triggering oxidative stress and liver injury
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; P38 MAPK; CELL-PROLIFERATION; GROWTH;
   HEPATOCYTES; POLYPLOIDY; BINUCLEATION; REPLICATION; DROSOPHILA; JNK
AB p38 alpha MAPK negatively regulates the G(1)/S and G(2)/M cell cycle transitions. However, liver-specific p38 alpha deficiency impairs cytokinesis and reduces hepatocyte proliferation during cirrhosis and aging in mice. In this work, we have studied how p38 alpha down-regulation affects hepatocyte proliferation after partial hepatectomy, focusing on mitotic progression, cytokinesis and oxidative stress. We found that p38 alpha deficiency triggered up-regulation of cyclins A1, B1, B2, and D1 under basal conditions and after hepatectomy. Moreover, p38 alpha-deficient hepatocytes showed enhanced binucleation and increased levels of phospho-histone H3 but impaired phosphorylation of MNK1 after hepatectomy. The recovery of liver mass was transiently delayed in mice with p38 alpha-deficient hepatocytes vs wild type mice. We also found that p38 alpha deficiency caused glutathione oxidation in the liver, increased plasma aminotransferases and lactate dehydrogenase activities, and decreased plasma protein levels after hepatectomy. Interestingly, p38 alpha silencing in isolated hepatocytes markedly decreased phospho-MNK1 levels, and silencing of either p38 alpha or Mnk1 enhanced binucleation of hepatocytes in culture. In conclusion, p38 alpha deficiency impairs mitotic progression in hepatocytes and restrains the recovery of liver mass after partial hepatectomy. Our results also indicate that p38 alpha regulates cytokinesis by activating MNK1 and redox modulation.
C1 [Rius-Perez, Sergio; Tormos, Ana M.; Perez, Salvador; Finamor, Isabela; Sastre, Juan] Univ Valencia Burjassot, Dept Physiol, Valencia 46100, Spain.
   [Rada, Patricia; Valverde, Angela M.] CSIC UAM, Ctr Mixto, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.
   [Rada, Patricia; Valverde, Angela M.] ISCIII, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid 28029, Spain.
   [Nebreda, Angel R.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.
   [Nebreda, Angel R.] ICREA, Pg Luis Co 23, Barcelona 08010, Spain.
   [Talens-Visconti, Raquel] Univ Valencia, Dept Pharm & Pharmaceut Technol & Parasitol, E-46100 Valencia, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Investigaciones Biomedicas Alberto Sols (IIBM); Instituto de Salud
   Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM;
   Barcelona Institute of Science & Technology; Institute for Research in
   Biomedicine - IRB Barcelona; ICREA; University of Valencia
RP Taléns-Visconti, R (corresponding author), Univ Valencia, Dept Pharm & Pharmaceut Technol & Parasitol, E-46100 Valencia, Spain.
EM raquel.talens@uv.es
RI Rada, Patricia/G-7300-2015; Pérez, Salvador/N-5943-2014;
   Taléns-Visconti, Raquel/P-6621-2019; Nebreda, Angel
   Rodriguez/R-9594-2019; PEREZ, SERGIO RIUS/T-7766-2017
OI Rada, Patricia/0000-0002-6731-2098; Pérez, Salvador/0000-0003-0766-1744;
   Taléns-Visconti, Raquel/0000-0002-9816-9693; Martinez Valverde,
   Angela/0000-0003-1192-9045
FU Ministry of Economy and Competitiveness; FEDER funds [SAF 2015-71208-R];
   Spanish Ministry of Economy and Competitiveness (MINECO, Spain) [SAF
   2015-71208-R, CSD-2007-00020]; Generalitat Valenciana [GV PROMETEO II
   2014-056]; MINECO/FEDER [SAF 2015-65267-R]; Centro de Investigacion
   Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
   (CIBERdem, ISCIII, Spain)
FX A.M.T. was recipient of a fellowship from the Ministry of Economy and
   Competitiveness. This work was supported by Grants SAF 2015-71208-R with
   FEDER funds and CSD-2007-00020 from the Spanish Ministry of Economy and
   Competitiveness (MINECO, Spain,
   http://www.mineco.gob.es/portal/site/mineco/) and GV PROMETEO II
   2014-056 from Generalitat Valenciana to J.S. and R.T.V., and by Grant
   SAF 2015-65267-R (MINECO/FEDER) and by Centro de Investigacion Biomedica
   en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERdem,
   ISCIII, Spain) to A.M.V.
CR Awad MM, 2000, J BIOL CHEM, V275, P38716, DOI 10.1074/jbc.M008040200
   BENVENISTE R, 1988, CELL BIOCHEM FUNCT, V6, P231, DOI 10.1002/cbf.290060403
   Campbell JS, 2011, INT J BIOCHEM CELL B, V43, P180, DOI 10.1016/j.biocel.2010.08.002
   Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200
   Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650
   Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323
   Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010
   Dash BC, 2005, MOL CELL BIOL, V25, P3364, DOI 10.1128/MCB.25.8.3364-3387.2005
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   FABRIKANT JI, 1968, J CELL BIOL, V36, P551, DOI 10.1083/jcb.36.3.551
   Gentric G, 2012, CLIN RES HEPATOL GAS, V36, P29, DOI 10.1016/j.clinre.2011.05.011
   Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430
   Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035
   GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x
   Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0304s04, 10.1002/0471143030.cb0303s04]
   Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027
   Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774
   Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033
   Kidd D, 1997, J CELL SCI, V110, P209
   Lee K, 2010, MOL BIOL CELL, V21, P2150, DOI 10.1091/mbc.E10-02-0125
   Li HG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034566
   Lu P, 2007, MAMM GENOME, V18, P617, DOI 10.1007/s00335-007-9048-y
   Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016
   MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293
   Rannou Y, 2012, J CELL SCI, V125, P2844, DOI 10.1242/jcs.058081
   Reiling JH, 2005, CURR BIOL, V15, P24, DOI 10.1016/j.cub.2004.12.034
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44
   Tormos AM, 2013, FREE RADICAL RES, V47, P905, DOI 10.3109/10715762.2013.821200
   Tormos AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171738
   Tormos AM, 2013, HEPATOLOGY, V57, P1950, DOI 10.1002/hep.26174
   Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037
   Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694
NR 37
TC 7
Z9 9
U1 0
U2 2
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 7
PY 2019
VL 9
AR 3775
DI 10.1038/s41598-019-39428-3
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA HN9GT
UT WOS:000460508600005
PM 30846722
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Butscheid, M
   Hauptvogel, P
   Fritz, P
   Klotz, U
   Alscher, DM
AF Butscheid, M.
   Hauptvogel, P.
   Fritz, P.
   Klotz, U.
   Alscher, D. M.
TI Hepatic expression of galectin-3 and receptor for advanced glycation end
   products in patients with liver disease
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
ID MAILLARD REACTION; PROTEINS; AGE; N-EPSILON-(CARBOXYMETHYL)LYSINE;
   COMPLICATIONS; METHYLGLYOXAL; ENDOCYTOSIS; COMPLEX; BINDING; MEMBER
AB Background: Advanced glycation end products ( AGEs) are a heterogeneous group of glycosylated proteins ( of which carboxymethyl- lysine ( CML) is the most common) which accumulate during ageing processes and play an important role in the pathogenesis of a variety of chronic diseases. Impaired hepatic function might result in elevated levels of AGEs, as the liver represents the major site of AGE metabolism. The actions of AGEs are mediated by various receptors, among which the AGE- receptor complex ( including galectin- 3 as an essential part) is thought to have a cytoprotective effect, and receptor for advanced glycation end product ( RAGE) a cytotoxic effect.
   Aim: To assess the relationship between CML and expression of galectin- 3 and RAGE in different histological structures in biopsy specimens from patients with varying degrees of liver impairment.
   Method: Immunohistochemical staining of 164 biopsies from patients with varying degrees of liver impairment was performed to determine the levels of CML, galectin- 3 and RAGE in hepatocytes, Kupffer cells and bile ducts by a semiquantative score.
   Results: Independent of diagnosis, CML and RAGEs were detected in hepatocytes, whereas galectin- 3 was present only in hepatocytes of cirrhotics. By contrast, CML and galectin- 3 were highly expressed in Kupffer cells ( well correlating levels, highest scores in cholestasis) whereas expression of RAGEs was not significant. All three assessed biochemical markers showed their highest levels of expression/ detection in bile ducts.
   Conclusion: These findings indicate an increased susceptibility of hepatocytes to the detrimental effects of AGEs and underline the protective function of Kupffer cells. Furthermore, the biliary system seems to play an important role in the disposition of AGEs.
C1 Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany.
   Robert Bosch Krankenhaus, Dept Diagnost Med, Div Pathol, Stuttgart, Germany.
   Robert Bosch Krankenhaus, Div Gen Internal Med & Nephrol, Stuttgart, Germany.
C3 Eberhard Karls University of Tubingen; Eberhard Karls University
   Hospital; Bosch; Robert Bosch Krankenhaus; Bosch; Robert Bosch
   Krankenhaus
RP Butscheid, M (corresponding author), Paumgartnerstr 15, D-90429 Nurnberg, Germany.
EM dr.m.butscheid@email.de
OI Alscher, Mark Dominik/0000-0002-9658-1211
CR Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565
   Cerami C, 1997, P NATL ACAD SCI USA, V94, P13915, DOI 10.1073/pnas.94.25.13915
   HAYASE F, 1989, J BIOL CHEM, V264, P3758
   Horiuchi S, 2002, J HEPATOL, V36, P123, DOI 10.1016/S0168-8278(01)00293-8
   HORIUCHI S, 1996, DIABETES S3, V45, P73
   Hsu DK, 1999, INT J CANCER, V81, P519, DOI 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.0.CO;2-0
   Iacobini C, 2005, AM J PHYSIOL-RENAL, V289, pF611, DOI 10.1152/ajprenal.00435.2004
   Iacobini C, 2003, J AM SOC NEPHROL, V14, pS264, DOI 10.1097/01.ASN.0000077402.95720.B4
   Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550
   Kasper M, 2001, ARCH GERONTOL GERIAT, V32, P233, DOI 10.1016/S0167-4943(01)00103-0
   Krzeslak A, 2004, CELL MOL BIOL LETT, V9, P305
   Li YM, 1996, P NATL ACAD SCI USA, V93, P11047, DOI 10.1073/pnas.93.20.11047
   LO TWC, 1994, J BIOL CHEM, V269, P32299
   Ohgami N, 2001, ANN NY ACAD SCI, V947, P350
   REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021
   Sebeková K, 2002, J HEPATOL, V36, P66, DOI 10.1016/S0168-8278(01)00232-X
   SELL DR, 1989, J BIOL CHEM, V264, P21597
   Shimonishi T, 2001, HUM PATHOL, V32, P302, DOI 10.1053/hupa.2001.22767
   Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591
   Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567
   Stern DM, 2002, AGEING RES REV, V1, P1, DOI 10.1016/S0047-6374(01)00366-9
   VLASSARA H, 1994, P NATL ACAD SCI USA, V91, P11704, DOI 10.1073/pnas.91.24.11704
   VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604
   VLASSARA H, 1992, P NATL ACAD SCI USA, V89, P12043, DOI 10.1073/pnas.89.24.12043
   Zhu WQ, 2001, BIOCHEM BIOPH RES CO, V280, P1183, DOI 10.1006/bbrc.2001.4256
NR 25
TC 32
Z9 37
U1 0
U2 7
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD APR
PY 2007
VL 60
IS 4
BP 415
EP 418
DI 10.1136/jcp.2005.032391
PG 4
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 153KZ
UT WOS:000245434600015
PM 16775125
OA Green Published
DA 2024-02-19
ER

PT J
AU Maya-Mendoza, A
   Hernández-Muñoz, R
   Gariglio, P
   Aranda-Anzaldo, A
AF Maya-Mendoza, A
   Hernández-Muñoz, R
   Gariglio, P
   Aranda-Anzaldo, A
TI Gene positional changes relative to the nuclear substructure during
   carbon tetrachloride-induced hepatic fibrosis in rats
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE DNA loops; DNA replication; DNA topology; liver fibrosis; nuclear matrix
ID REPLICATION ORIGINS; MATRIX; DNA; ASSOCIATION; CELLS; CIRRHOSIS; MOTION;
   ORGANIZATION; ARCHITECTURE; CHROMOSOMES
AB In the interphase nucleus the DNA of higher eukaryotes is organized in loops anchored to a substructure known as the nuclear matrix (NM). The topological relationship between gene sequences located in the DNA loops and the NM appears to be very important for nuclear physiology because processes such as replication, transcription, and processing of primary transcripts occur at macromolecular complexes located at discrete sites upon the NM. Mammalian hepatocytes rarely divide but preserve a proliferating capacity that is displayed in vivo after specific stimulus. We have previously shown that transient changes in the relative position of specific: genes to the NM occur during the process of liver regeneration after partial ablation of the liver, but also that such changes correlate with the replicating status of the cells. Moreover, since chronic exposure to carbon tetrachloride (CCl4) leads to bouts of hepatocyte damage and regeneration, and eventually to non-reversible liver fibrosis in the rat, we used this animal model in order to explore if genes that show differential activity in the liver change or modify their relative position to the NM during the process of liver fibrosis induction. We found that changes in the relative position of specific genes to the NM Occur during the chronic administration Of CCl4, but also that such changes correlate with the proliferating status of the hepatocytes that goes from quiescence to regeneration to replicative senescence along the course Of CCl4-induced liver fibrosis, indicating that specific configurations in the higher-order DNA structure underlie the stages of progression towards liver fibrosis. (C) 2004 Wiley-Liss, Inc.
C1 UAEMex, Fac Med, Lab Biol Mol, Toluca 50000, Mexico.
   IPN, CINVESTAV, Dept Genet & Biol Mol, Mexico City 07000, DF, Mexico.
   Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular, Mexico City 04510, DF, Mexico.
C3 Universidad Autonoma del Estado de Mexico; CINVESTAV - Centro de
   Investigacion y de Estudios Avanzados del Instituto Politecnico
   Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional
   Autonoma de Mexico
RP Aranda-Anzaldo, A (corresponding author), UAEMex, Fac Med, Lab Biol Mol, Apartado Postal 428 CP, Toluca 50000, Mexico.
EM aaa@uaemex.mx
RI Aranda-Anzaldo, Armando/A-6513-2014
OI Aranda-Anzaldo, Armando/0000-0002-5583-5465; Maya-Mendoza,
   Apolinar/0000-0001-7452-9896
CR Aranda-Anzaldo A, 1999, BBA-GENE STRUCT EXPR, V1446, P181, DOI 10.1016/S0167-4781(99)00086-X
   Aranda-Anzaldo A, 1998, RES VIROLOGY, V149, P195, DOI 10.1016/S0923-2516(98)80001-0
   Aranda-Anzaldo A, 1997, RES VIROLOGY, V148, P397, DOI 10.1016/S0923-2516(97)83629-1
   ARANDAANZALDO A, 1992, ARCH VIROL, V122, P317, DOI 10.1007/BF01317193
   BECKER F, 1974, LIVER
   BEREZNEY R, 1981, EXP CELL RES, V132, P1, DOI 10.1016/0014-4827(81)90076-8
   Berezney R, 1995, INT REV CYTOL, V162A, P1
   BLONDEL O, 1993, J BIOL CHEM, V268, P11356
   BODE J, 1992, SCIENCE, V255, P195, DOI 10.1126/science.1553545
   BUONGIORNONARDELLI M, 1982, NATURE, V298, P100, DOI 10.1038/298100a0
   Campisi J, 2001, EXP GERONTOL, V36, P607, DOI 10.1016/S0531-5565(00)00230-8
   CARRI MT, 1986, EXP CELL RES, V164, P426, DOI 10.1016/0014-4827(86)90041-8
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4
   CIEJEK EM, 1983, NATURE, V306, P607, DOI 10.1038/306607a0
   Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790
   COOK PR, 1982, EMBO J, V1, P447, DOI 10.1002/j.1460-2075.1982.tb01189.x
   COOK PR, 1976, J CELL SCI, V22, P303
   Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075
   DALTON S, 1986, NUCLEIC ACIDS RES, V14, P6507, DOI 10.1093/nar/14.16.6507
   DENHARDT DT, 1985, BIOESSAYS, V2, P148, DOI 10.1002/bies.950020403
   DIJKWEL PA, 1986, NUCLEIC ACIDS RES, V14, P3241, DOI 10.1093/nar/14.8.3241
   Djeliova V, 2001, NUCLEIC ACIDS RES, V29, P3181, DOI 10.1093/nar/29.15.3181
   Dufour JF, 1999, HEPATOLOGY, V30, P1018, DOI 10.1002/hep.510300421
   EHRINPREIS MN, 1980, BIOCHIM BIOPHYS ACTA, V629, P184, DOI 10.1016/0304-4165(80)90277-9
   FLEGG G, 1974, GEOM TOPOL, P17
   Fouad FM, 1996, J TOXICOL ENV HEALTH, V47, P601, DOI 10.1080/009841096161564
   Fountoulakis M, 2002, TOXICOL APPL PHARM, V183, P71, DOI 10.1006/taap.2002.9460
   Freshney I., 1994, CULTURE ANIMAL CELLS, P320
   GANS JH, 1984, P SOC EXP BIOL MED, V175, P237
   HernandezMunoz R, 1997, HEPATOLOGY, V26, P1100
   HERNANDEZMUNOZ R, 1990, HEPATOLOGY, V12, P242, DOI 10.1002/hep.1840120210
   HOZAK P, 1993, CELL, V73, P361, DOI 10.1016/0092-8674(93)90235-I
   Jackson DA, 1995, INT REV CYTOL, V162A, P125
   Laskowski M., 1971, ENZYMES, V4
   LAZAREVICH NL, 2000, BIOKHIMIYA, V65, P139
   Lewin B., 1980, GENE EXPRESSION, P360
   Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X
   Maya-Mendoza A, 2003, NUCLEIC ACIDS RES, V31, P6168, DOI 10.1093/nar/gkg825
   Maya-Mendoza A, 2003, ANAL BIOCHEM, V313, P196, DOI 10.1016/S0003-2697(02)00611-5
   MORELLO D, 1990, ONCOGENE, V5, P1511
   Nickerson JA, 2001, J CELL SCI, V114, P463
   PANDURO A, 1988, HEPATOLOGY, V8, P259, DOI 10.1002/hep.1840080212
   RAMANAMURTY CV, 1988, BIOCHIM BIOPHYS ACTA, V949, P27
   RAZIN SV, 1986, NUCLEIC ACIDS RES, V14, P8189, DOI 10.1093/nar/14.20.8189
   Razin SV, 1995, INT REV CYTOL, V162B, P405
   Razin SV, 2001, CELL MOL BIOL LETT, V6, P59
   ROBINSON SI, 1982, CELL, V28, P99, DOI 10.1016/0092-8674(82)90379-8
   ROTI JLR, 1993, ADV RADIAT BIOL, V17, P227
   SMALL D, 1985, NUCLEIC ACIDS RES, V13, P2413, DOI 10.1093/nar/13.7.2413
   Stein GS, 1995, INT REV CYTOL, V162A, P251
   TALJANIDISZ J, 1989, MOL CELL BIOL, V9, P2881, DOI 10.1128/MCB.9.7.2881
   Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6
   Visser AE, 1999, J CELL SCI, V112, P3353
   Zink D, 1998, HUM GENET, V102, P241, DOI 10.1007/s004390050686
NR 55
TC 14
Z9 15
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD DEC 15
PY 2004
VL 93
IS 6
BP 1084
EP 1098
DI 10.1002/jcb.20264
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 875JP
UT WOS:000225416700002
PM 15449316
DA 2024-02-19
ER

PT J
AU McMurphy, T
   Huang, W
   Queen, NJ
   Ali, S
   Widstrom, KJ
   Liu, XL
   Xiao, R
   Siu, JJ
   Cao, L
AF McMurphy, Travis
   Huang, Wei
   Queen, Nicholas J.
   Ali, Seemaab
   Widstrom, Kyle J.
   Liu, Xianglan
   Xiao, Run
   Siu, Jason J.
   Cao, Lei
TI Implementation of environmental enrichment after middle age promotes
   healthy aging
SO AGING-US
LA English
DT Article
DE environmental enrichment; aging; glucose tolerance; BDNF; steatosis;
   adipose tissue
ID HEPATIC INSULIN-RESISTANCE; ANXIETY-LIKE BEHAVIORS; CALORIE RESTRICTION;
   ADIPOSE-TISSUE; MICE LACKING; DORSOMEDIAL HYPOTHALAMUS; MOUSE MODEL;
   GENETIC ACTIVATION; ENERGY-EXPENDITURE; ANIMAL-MODELS
AB With increases in life expectancy, it is vital to understand the dynamics of aging, their interaction with lifestyle factors, and the connections to age-related disease processes. Our work on environmental enrichment (EE), a housing environment boosting mental health, has revealed a novel anticancer and anti-obesity phenotype mediated by a brain-fat axis: the hypothalamic-sympathoneural-adipocyte (HSA) axis in young animals. Here we investigated EE effects on healthspan and lifespan when initiated after middle age. Short-term EE for six weeks activated the HSA axis in 10-month-old mice. Long-term EE for twelve months reduced adiposity, improved glucose tolerance, decreased leptin levels, enhanced motor abilities, and inhibited anxiety. In addition to adipose remodeling, EE decreased age-related liver steatosis, reduced hepatic glucose production, and increased glucose uptake by liver and adipose tissue contributing to the improved glycemic control. The EE-induced liver modulation was associated with a suppression of protein kinase C epsilon. Moreover, EE down-regulated the expression of inflammatory genes in the brain, adipose, and liver. EE initiated at 18-month of age significantly improved glycemic control and showed a trend of positive impact on mean lifespan. These data suggest that EE induces metabolic and behavioral adaptations that are shared by factors known to increase healthspan and lifespan.
C1 [McMurphy, Travis; Huang, Wei; Queen, Nicholas J.; Ali, Seemaab; Widstrom, Kyle J.; Liu, Xianglan; Xiao, Run; Siu, Jason J.; Cao, Lei] Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Columbus, OH 43210 USA.
C3 University System of Ohio; Ohio State University
RP Cao, L (corresponding author), Ohio State Univ, Coll Med, Dept Canc Biol & Genet, Columbus, OH 43210 USA.
EM lei.cao@osumc.edu
RI li, Li/JPA-0218-2023; Cao, Lei/H-3185-2019
OI Queen, Nicholas/0000-0003-1864-5790; Cao, Lei/0000-0003-0322-4985; Ali,
   Seemaab/0000-0002-5337-8782
FU NIH [AG041250, CA166590, CA178227, CA163640]
FX This work was supported by NIH grants AG041250, CA166590, CA178227,
   CA163640 to L.C.
CR ALBANES D, 1987, CANCER RES, V47, P1987
   Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875
   Anderson RM, 2009, TOXICOL PATHOL, V37, P47, DOI 10.1177/0192623308329476
   Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151
   Barone FC, 2008, PHARMACOLOGY, V81, P11, DOI 10.1159/000107662
   Blüher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Blüher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5
   Boini KM, 2009, AM J PHYSIOL-REG I, V296, pR1695, DOI 10.1152/ajpregu.90839.2008
   Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2
   Cao L, 2012, ANNU REV NEUROSCI, V35, P331, DOI 10.1146/annurev-neuro-062111-150546
   Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020
   Cao L, 2010, CELL, V142, P52, DOI 10.1016/j.cell.2010.05.029
   Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933
   Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2
   Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457
   de Noronha SR, 2017, BEHAV BRAIN RES, V316, P38, DOI 10.1016/j.bbr.2016.08.042
   During MJ, 2015, ENDOCRINOLOGY, V156, P2059, DOI 10.1210/en.2014-1905
   Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0
   Enerbäck S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Freret T, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.028
   Gariepy G, 2010, INT J OBESITY, V34, P407, DOI 10.1038/ijo.2009.252
   Garofalo S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7623
   Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007
   Goldberg NRS, 2011, NEUROSCIENCE, V172, P443, DOI 10.1016/j.neuroscience.2010.09.062
   Harburger LL, 2007, BEHAV BRAIN RES, V185, P43, DOI 10.1016/j.bbr.2007.07.009
   Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539
   Heitmann BL, 2002, AM J CLIN NUTR, V75, P840, DOI 10.1093/ajcn/75.5.840
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Huang FL, 2007, LEARN MEMORY, V14, P512, DOI 10.1101/lm.636107
   Hüttenrauch M, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00062
   Huffman DM, 2010, INTERD T GERONT GERI, V37, P157, DOI 10.1159/000320000
   Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101
   JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x
   Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x
   Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005
   Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x
   Kreilaus F, 2016, J HUNTINGTONS DIS, V5, P285, DOI 10.3233/JHD-160204
   Li GH, 2015, SCI REP-UK, V5, DOI 10.1038/srep07856
   Lin EJD, 2011, BEHAV BRAIN RES, V216, P349, DOI 10.1016/j.bbr.2010.08.019
   Liu XL, 2014, MOL THER, V22, P1275, DOI 10.1038/mt.2014.45
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004
   Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526
   Mattson MP, 2004, AGEING RES REV, V3, P445, DOI 10.1016/j.arr.2004.08.001
   Mattson MP, 2001, MECH AGEING DEV, V122, P757, DOI 10.1016/S0047-6374(01)00226-3
   Mauvais-Jarvis F, 2000, DIABETES, V49, P2126, DOI 10.2337/diabetes.49.12.2126
   Mazarakis NK, 2014, J HUNTINGTONS DIS, V3, P299, DOI 10.3233/JHD-140118
   Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027
   Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]
   Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705
   Nachat-Kappes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051525
   Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970
   Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798
   Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001
   PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6
   Perry RJ, 2016, DIABETOLOGIA, V59, P933, DOI 10.1007/s00125-016-3909-4
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80
   Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013
   Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005
   Renoir T, 2013, NEUROBIOL DIS, V57, P12, DOI 10.1016/j.nbd.2012.04.003
   Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234
   Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400
   Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x
   Sansevero G, 2016, EXP NEUROL, V283, P49, DOI 10.1016/j.expneurol.2016.06.006
   Segovia G, 2009, J NEURAL TRANSM, V116, P1007, DOI 10.1007/s00702-009-0214-0
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   SHEKHAR A, 1993, BRAIN RES, V627, P17, DOI 10.1016/0006-8993(93)90743-7
   Silva MSCF, 2014, BEHAV BRAIN RES, V271, P249, DOI 10.1016/j.bbr.2014.06.018
   Smith DL, 2010, EUR J CLIN INVEST, V40, P440, DOI 10.1111/j.1365-2362.2010.02276.x
   Stanford SC, 2007, J PSYCHOPHARMACOL, V21, P134, DOI 10.1177/0269881107073199
   Stuart KE, 2017, J COMP NEUROL, V525, P1797, DOI 10.1002/cne.24156
   Tang YZ, 2015, TRENDS NEUROSCI, V38, P36, DOI 10.1016/j.tins.2014.10.002
   Tomiga Y, 2016, BIOCHEM BIOPH RES CO, V476, P635, DOI 10.1016/j.bbrc.2016.06.010
   Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128
   Varty GB, 2000, BIOL PSYCHIAT, V47, P864, DOI 10.1016/S0006-3223(99)00269-3
   Xiao R, 2016, CANCER IMMUNOL RES, V4, P488, DOI 10.1158/2326-6066.CIR-15-0297
   Zambrana C, 2007, ANN NY ACAD SCI, V1100, P543, DOI 10.1196/annals.1395.060
   Zhang R, 2017, MOL PSYCHIATR, V22, P733, DOI 10.1038/mp.2016.136
NR 87
TC 31
Z9 31
U1 0
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD JUL
PY 2018
VL 10
IS 7
BP 1698
EP 1721
DI 10.18632/aging.101502
PG 24
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA GO8VH
UT WOS:000440376500016
PM 30036185
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Lunz, JG
   Contrucci, S
   Ruppert, K
   Murase, N
   Fung, JJ
   Starzl, TE
   Demetris, AJ
AF Lunz, JG
   Contrucci, S
   Ruppert, K
   Murase, N
   Fung, JJ
   Starzl, TE
   Demetris, AJ
TI Replicative senescence of biliary epithelial cells precedes bile duct
   loss in chronic liver allograft rejection -: <i>Increased expression of
   p21<SUP>WAF1/Cip1</SUP> as a disease marker and the influence of
   immunosuppressive drugs</i>
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID HEPATOCYTE GROWTH-FACTOR; FACTOR-BETA; TGF-BETA; RANDOMIZED TRIAL;
   PRIMARY CULTURES; RESCUE THERAPY; CYCLOSPORINE-A; UP-REGULATION; FK506;
   TRANSPLANTATION
AB Early chronic liver allograft rejection (CR) is characterized by distinctive cytological changes in biliary epithelial cells (BECs) that resemble cellular senescence, in vitro, and precede bile duct loss. If patients suffering from early CR are treated aggressively, the clinical and histopathological manifestations of CR can be completely reversed and bile duct loss can be prevented. We first tested whether the senescence-related p21(WAF1/Cip1) protein is increased in BECs during early CR, and whether treatment reversed the expression, The percentage of p21+ BECs and the number of p21+ BECs per portal tract is significantly increased in early CR (26 +/- 17% and 3.6 +/- 3.1) compared to BECs in normal liver allograft biopsies or those with nonspecific changes (1 +/- 1% and 0.1 +/- 0.3; P < 0.0001 and P < 0.02), chronic hepatitis C (2 +/- 3% and 0.7 +/- 1; P < 0.0001 and P < 0.04) or obstructive cholangiopathy (7 +/- 7% and 0.7 +/- 0.6; P < 0.006 and P = 0.04), Successful treatment of early CR is associated with a decrease in the percentage of p21+ BECs and the number of p21+ BECs per portal tract, In vitro, nuclear p21(WAF1/Cip1) expression is increased in large and multinucleated BECs, and is induced by transforming growth factor (TGF)-<beta>, TGF-beta1 also increases expression of TGF-beta receptor II, causes phosphorylation of SMAD-2 and nuclear translocation of p21(WAF1/Cip1), Which inhibits BEC growth. Because conversion from cyclosporine to tacrolimus is an effective treatment for early CR,we next tested whether these two immunosuppressive drugs directly influenced BEC growth in vitro, The results show that cyclosporine, but not tacrolimus, stimulates BEC TGF-beta1 production, which in turn, causes BEC mito-inhibition and up-regulation of nuclear p21(WAF1/Cip1) In conclusion, expression of the senescence-related p21(WAF1/Cip1) protein is increased in BECs during early CR and decreases with successful recovery, Replicative senescence accounts for the characteristic BEC cytological alterations used for the diagnosis of early CR and lack of a proliferative response to injury. The ability of cyclosporine to inhibit the growth of damaged BECs likely accounts for the relative duct sparing properties of tacrolimus.
C1 Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Med Ctr, Pittsburgh, PA 15261 USA.
   Univ Pittsburgh, Dept Pathol, Med Ctr, Pittsburgh, PA 15261 USA.
   Univ Pittsburgh, Dept Surg, Med Ctr, Div Transplantat, Pittsburgh, PA 15261 USA.
   Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh
RP Demetris, AJ (corresponding author), Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Med Ctr, E1548 BMST, Pittsburgh, PA 15261 USA.
RI FUNG, John Julian/A-2679-2012; Ruppert, Kristine/C-2555-2016
OI FUNG, John Julian/0000-0002-3038-0441; Ruppert,
   Kristine/0000-0002-3008-6584
FU NIAID NIH HHS [R01AI40329-05, R01AI38899-01A2] Funding Source: Medline;
   NIDDK NIH HHS [R01 DK049615, R01DK49615-05] Funding Source: Medline
CR AFFORD SC, 1995, J PATHOL, V176, P373, DOI 10.1002/path.1711760408
   AHUJA SS, 1995, TRANSPLANTATION, V60, P718, DOI 10.1097/00007890-199510150-00018
   Blakolmer K, 2000, TRANSPLANTATION, V69, P2330, DOI 10.1097/00007890-200006150-00019
   Blakolmer K, 1999, AM J SURG PATHOL, V23, P1328, DOI 10.1097/00000478-199911000-00003
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   BURCKART GJ, 1986, TRANSPLANT P, V18, P46
   BUSUTTIL RW, 1994, NEW ENGL J MED, V331, P1110
   Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078
   Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291
   Demetris A, 2000, Hepatology, V31, P792
   DEMETRIS AJ, 1992, TRANSPLANTATION, V53, P1056, DOI 10.1097/00007890-199205000-00017
   DEMETRIS AJ, 1991, TRANSPLANT P, V23, P3005
   DEMETRIS AJ, 1988, IN VITRO CELL DEV B, V24, P464
   DEMETRIS AJ, 1997, IMMUNOPATHOLOGY HUMA, P127
   Demirci G, 1996, TRANSPLANTATION, V62, P1776, DOI 10.1097/00007890-199612270-00016
   FENNELL RH, 1985, HEPATOLOGY, V5, P1083, DOI 10.1002/hep.1840050604
   Florenes VA, 1996, ONCOGENE, V13, P2447
   FREESE DK, 1991, HEPATOLOGY, V13, P882, DOI 10.1016/0270-9139(91)90258-W
   Fung JJ, 1996, J AM COLL SURGEONS, V183, P117
   FUNG JJ, 1991, TRANSPLANT P, V23, P14
   Gold BG, 1999, DRUG METAB REV, V31, P649, DOI 10.1081/DMR-100101940
   GOLD BG, 1995, J NEUROSCI, V15, P7509
   Gotloib L, 1999, NEPHRON, V82, P164, DOI 10.1159/000045393
   Halloran PF, 1999, J AM SOC NEPHROL, V10, P167
   HUBSCHER SG, 1991, TRANSPLANTATION, V51, P1004, DOI 10.1097/00007890-199105000-00014
   JORGE AD, 1993, HEPATOLOGY, V18, P1108
   KHANNA A, 1994, TRANSPLANTATION, V57, P577
   Kleeff J, 1999, PANCREAS, V18, P364, DOI 10.1097/00006676-199905000-00006
   Lautenschlager I, 1997, HEPATOLOGY, V25, P190, DOI 10.1053/jhep.1997.v25.pm0008985289
   Liu ZJ, 1998, HEPATOLOGY, V28, P1260, DOI 10.1002/hep.510280514
   MCDIARMID SV, 1993, TRANSPLANT INT, V6, P305, DOI 10.1007/BF00335966
   Miyazaki M, 1998, BIOCHEM BIOPH RES CO, V246, P873, DOI 10.1006/bbrc.1998.8712
   Mohamed MAS, 1999, TRANSPLANT P, V31, P1173, DOI 10.1016/S0041-1345(98)01950-2
   Moustakas A, 1998, P NATL ACAD SCI USA, V95, P6733, DOI 10.1073/pnas.95.12.6733
   NAWAZ S, 1994, HISTOPATHOLOGY, V25, P137, DOI 10.1111/j.1365-2559.1994.tb01569.x
   NEUHAUS P, 1994, LANCET, V344, P423
   OGUMA S, 1989, HEPATOLOGY, V9, P204, DOI 10.1002/hep.1840090207
   OGUMA S, 1989, TRANSPL P, V21, P2203
   Popper H, 1990, Prog Liver Dis, V9, P27
   POPPER HANS, 1957, JOUR MT SINAI HOSP, V24, P551
   PRASHAR Y, 1995, FEBS LETT, V358, P109, DOI 10.1016/0014-5793(94)01382-B
   PRINTSEVA OY, 1992, AM J HYPERTENS, V5, pS118, DOI 10.1093/ajh/5.6.118S
   Saha P, 1997, MOL CELL BIOL, V17, P4338, DOI 10.1128/MCB.17.8.4338
   SCANLON L, 1986, TRANSPLANTATION, V41, P657
   Sher LS, 1997, TRANSPLANTATION, V64, P258, DOI 10.1097/00007890-199707270-00014
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   STARZL TE, 1989, LANCET, V2, P1000
   STRAIN AJ, 1995, AM J PATHOL, V146, P537
   Strom SC, 1996, METHOD ENZYMOL, V272, P388, DOI 10.1016/S0076-6879(96)72044-X
   Sugiyama A, 1997, BIOCHEM BIOPH RES CO, V238, P539, DOI 10.1006/bbrc.1997.7338
   Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021
   Taibi A, 1998, TRANSPLANT P, V30, P1411, DOI 10.1016/S0041-1345(98)00294-2
   Ueno Y, 2000, HEPATOLOGY, V31, P966, DOI 10.1053/he.2000.5764
   VENKATARAMANAN R, 1990, TRANSPLANT P, V22, P52
   VENKATARAMANAN R, 1987, TRANSPLANT P, V19, P30
   VENKATARAMANAN R, 1991, TRANSPLANT P, V23, P931
   WOLF G, 1995, TRANSPLANTATION, V60, P237, DOI 10.1097/00007890-199508000-00005
   Wolf G, 1996, EXP NEPHROL, V4, P304
   Yokomuro S, 2000, HEPATOLOGY, V32, P26, DOI 10.1053/jhep.2000.8535
   Yokomuro S, 2000, CYTOKINE, V12, P727, DOI 10.1006/cyto.1999.0612
   ZEEVI A, 1988, TRANSPLANT P, V20, P115
   Zhang J G, 1998, Transpl Int, V11 Suppl 1, pS325, DOI 10.1007/s001470050489
NR 62
TC 84
Z9 87
U1 0
U2 4
PU AMER SOC INVESTIGATIVE PATHOLOGY, INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3993 USA
SN 0002-9440
J9 AM J PATHOL
JI Am. J. Pathol.
PD APR
PY 2001
VL 158
IS 4
BP 1379
EP 1390
DI 10.1016/S0002-9440(10)64089-8
PG 12
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 422RX
UT WOS:000168134000024
PM 11290556
OA Green Published, Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Huang, EJ
   Xu, K
   Gu, XM
   Zhu, QH
AF Huang, Erjiong
   Xu, Ke
   Gu, Xuemei
   Zhu, Qihan
TI PinX1 Depletion Improves Liver Injury in a Mouse Model of Nonalcoholic
   Fatty Liver Disease via Increasing Telomerase Activity and Inhibiting
   Apoptosis
SO CYTOGENETIC AND GENOME RESEARCH
LA English
DT Article; Early Access
DE PinX1; NAFLD; Apoptosis; Lipid accumulation; Telomerase activity
ID HEPATOCELLULAR-CARCINOMA; SENESCENCE; PROGRESSION
AB PIN2/TRF1-interacting telomerase inhibitor 1 (PinX1) can inhibit tumor growth by inhibiting telomerase activity. However, only few studies investigated the expression and function of PinX1 in nonalcoholic fatty liver disease (NAFLD). Thus, here we aimed to explore the roles of PinX1 in high-fat diet (HFD)-induced NAFLD in mice and in isolated hepatocytes. The mRNA expression of PinX1 and mTERT as well as telomere length were analyzed by RT-PCR. Pathological changes were detected by HE staining and oil red O staining. Triglyceride, cholesterol, alanine aminotransferase, aspartic aminotransferase, and telomerase activity were detected by ELISA. Hepatocyte apoptosis was determined by TUNEL and flow cytometry, and protein expression was analyzed by western blotting. We found that the expression of PinX1 was upregulated in the HFD group compared with the WT group. PinX1 knockout improved HFD-induced liver injury in mice and exhibited less lipid accumulation in hepatocytes. Moreover, telomere length, telomerase activity, and mTERT expression were significantly reduced in liver tissues of HFD-induced mice and palmitic acid-induced hepatocytes, while PinX1 knockout attenuated the effect. Furthermore, HFD-induced PinX1(-/-) mice exhibited less hepatocyte apoptosis than HFD-induced WT mice. Besides, PinX1 knockout inhibited the increase of cleaved caspase-3 and cleaved PARP expression in vivo and in vitro. Moreover, inhibition of mTERT reversed the effect of PinX1 knockout in hepatocytes. Taken together, our findings indicate that PinX1 promotes hepatocyte apoptosis and lipid accumulation by decreasing telomere length and telomerase activity in the development of NAFLD. PinX1 might be a target for the treatment of NAFLD.
C1 [Huang, Erjiong] Wenzhou Med Univ, Dept Gastroenterol, Affiliated Hosp 1, Wenzhou, Peoples R China.
   [Xu, Ke; Gu, Xuemei; Zhu, Qihan] Wenzhou Med Univ, Dept Endocrinol, Affiliated Hosp 1, Wenzhou, Peoples R China.
C3 Wenzhou Medical University; Wenzhou Medical University
RP Gu, XM; Zhu, QH (corresponding author), Wenzhou Med Univ, Dept Endocrinol, Affiliated Hosp 1, Wenzhou, Peoples R China.
EM xuemeigu1990@163.com; qihanzhu1989@163.com
RI Gu, Xuemei/AAS-6926-2020
CR Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Arndt GM, 2016, NAT REV CANCER, V16, P508, DOI 10.1038/nrc.2016.55
   Bessone F, 2019, CELL MOL LIFE SCI, V76, P99, DOI 10.1007/s00018-018-2947-0
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Carulli L, 2015, WORLD J GASTROENTERO, V21, P379, DOI 10.3748/wjg.v21.i2.379
   Donati B, 2017, CANCER MED-US, V6, P1930, DOI 10.1002/cam4.1078
   Donati B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030383
   El Idrissi M, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-64
   Feng YZ, 2017, ONCOL REP, V38, P109, DOI 10.3892/or.2017.5696
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Fu X, 2017, CANCER SCI, V108, P620, DOI 10.1111/cas.13177
   Ho ST, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0306-y
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0
   Kanda T, 2018, WORLD J GASTROENTERO, V24, P2661, DOI 10.3748/wjg.v24.i25.2661
   Khan HA, 2017, HEPATOB PANCREAT DIS, V16, P245, DOI 10.1016/S1499-3872(17)60014-6
   Kim D, 2018, LIVER INT, V38, P1839, DOI 10.1111/liv.13886
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Lai XF, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-12
   Laish I, 2018, ISR MED ASSOC J, V20, P295
   Laish I, 2016, CYTOGENET GENOME RES, V150, P93, DOI 10.1159/000454654
   Lamy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053240
   Li JN, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182109
   Li LM, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7580707
   Liang H, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4621015
   Lin J, 2007, BIOCHEM BIOPH RES CO, V353, P946, DOI 10.1016/j.bbrc.2006.12.123
   Liu XX, 2016, ONCOL LETT, V11, P3911, DOI 10.3892/ol.2016.4509
   Nault JC, 2019, NAT REV GASTRO HEPAT, V16, P544, DOI 10.1038/s41575-019-0165-3
   Neuschwander-Tetri BA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0806-8
   Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062
   Shibany KA, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.268
   Sookoian S, 2019, SEMIN LIVER DIS, V39, P124, DOI 10.1055/s-0039-1679920
   Tanaka S, 2016, HEPATOLOGY, V64, P1994, DOI 10.1002/hep.28820
   Wan SG, 2012, LIVER INT, V32, P1233, DOI 10.1111/j.1478-3231.2012.02801.x
   Wang XJ, 2018, ANN INTERN MED, V169, pITC65, DOI 10.7326/AITC201811060
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Yang YY, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01689-8
   Yonekawa T, 2012, MOL CELL BIOL, V32, P1387, DOI 10.1128/MCB.05641-11
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang R, 2014, ONCOL REP, V32, P286, DOI 10.3892/or.2014.3199
   Zhang X, 2018, PROTEIN CELL, V9, P164, DOI 10.1007/s13238-017-0436-0
   Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452
   Zuo J, 2013, ONCOL REP, V30, P1823, DOI 10.3892/or.2013.2649
   Zvereva MI, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1563, DOI 10.1134/S0006297910130055
NR 44
TC 4
Z9 3
U1 0
U2 6
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1424-8581
EI 1424-859X
J9 CYTOGENET GENOME RES
JI Cytogenet. Genome Res.
PD 2021 
PY 2021
VL 161
IS 8-9
BP 449
EP 462
DI 10.1159/000518284
EA OCT 2021
PG 14
WC Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Genetics & Heredity
GA YY1RV
UT WOS:000710826400001
PM 34657040
OA hybrid
DA 2024-02-19
ER

PT J
AU Minteer, C
   Morselli, M
   Meer, M
   Cao, J
   Higgins-Chen, A
   Lang, SM
   Pellegrini, M
   Yan, Q
   Levine, ME
AF Minteer, Christopher
   Morselli, Marco
   Meer, Margarita
   Cao, Jian
   Higgins-Chen, Albert
   Lang, Sabine M.
   Pellegrini, Matteo
   Yan, Qin
   Levine, Morgan E.
TI Tick tock, tick tock: Mouse culture and tissue aging captured by an
   epigenetic clock
SO AGING CELL
LA English
DT Article; Early Access
DE aging; calorie restriction; DNA methylation; epigenome; in vitro
   techniques; longevity; oxidative stress; replicative senescence
ID DNA METHYLATION; LIFE-SPAN; CALORIC RESTRICTION; MECHANISMS
AB Aging is associated with dramatic changes to DNA methylation (DNAm), although the causes and consequences of such alterations are unknown. Our ability to experimentally uncover mechanisms of epigenetic aging will be greatly enhanced by our ability to study and manipulate these changes using in vitro models. However, it remains unclear whether the changes elicited by cells in culture can serve as a model of what is observed in aging tissues in vivo. To test this, we serially passaged mouse embryonic fibroblasts (MEFs) and assessed changes in DNAm at each time point via reduced representation bisulfite sequencing. By developing a measure that tracked cellular aging in vitro, we tested whether it tracked physiological aging in various mouse tissues and whether anti-aging interventions modulate this measure. Our measure, termed CultureAGE, was shown to strongly increase with age when examined in multiple tissues (liver, lung, kidney, blood, and adipose). As a control, we confirmed that the measure was not a marker of cellular senescence, suggesting that it reflects a distinct yet progressive cellular aging phenomena that can be induced in vitro. Furthermore, we demonstrated slower epigenetic aging in animals undergoing caloric restriction and a resetting of our measure in lung and kidney fibroblasts when re-programmed to iPSCs. Enrichment and clustering analysis implicated EED and Polycomb group (PcG) factors as potentially important chromatin regulators in translational culture aging phenotypes. Overall, this study supports the concept that physiologically relevant aging changes can be induced in vitro and used to uncover mechanistic insights into epigenetic aging.
C1 [Minteer, Christopher; Meer, Margarita; Cao, Jian; Higgins-Chen, Albert; Lang, Sabine M.; Yan, Qin; Levine, Morgan E.] Yale Sch Med, Dept Pathol, New Haven, CT 06519 USA.
   [Morselli, Marco; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA.
   [Cao, Jian] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA.
C3 Yale University; University of California System; University of
   California Los Angeles; Rutgers University System; Rutgers University
   New Brunswick; Rutgers University Biomedical & Health Sciences; Rutgers
   Cancer Institute of New Jersey
RP Minteer, C (corresponding author), Yale Sch Med, Dept Pathol, New Haven, CT 06519 USA.
EM christopher.minteer@yale.edu
RI Higgins-Chen, Albert/ITU-0273-2023; Yan, Qin/E-8893-2012; Morselli,
   Marco/AAF-3182-2019
OI Higgins-Chen, Albert/0000-0003-2904-2741; Yan, Qin/0000-0003-4077-453X;
   Morselli, Marco/0000-0003-3351-5791; Levine, Morgan/0000-0001-9890-9324
FU National Institute on Aging [R01AG065403, R01AG068285]; Glenn Foundation
   for Medical Research
FX National Institute on Aging, Grant/Award Number: R01AG065403 and
   R01AG068285; Glenn Foundation for Medical Research
CR Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21
   Basenko EY, 2015, P NATL ACAD SCI USA, V112, pE6339, DOI 10.1073/pnas.1511377112
   Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38
   Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x
   Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020
   Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997
   Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001
   Colman MS, 2000, MUTAT RES-REV MUTAT, V462, P179, DOI 10.1016/S1383-5742(00)00035-1
   Farrell C, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab033
   Ferry L, 2017, MOL CELL, V67, P550, DOI 10.1016/j.molcel.2017.07.012
   Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750
   Gonzalez J., 2019, DNA METHYLATION FING, DOI [10.1101/674580, DOI 10.1101/674580]
   Haines DC, 2001, TOXICOL PATHOL, V29, P653, DOI 10.1080/019262301753385988
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Hata K, 2002, DEVELOPMENT, V129, P1983
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Heydari AR, 2007, NUCLEIC ACIDS RES, V35, P7485, DOI 10.1093/nar/gkm860
   Higgins-Chen A.T., 2021, COMPUTATIONAL SOLUTI, DOI DOI 10.1101/2021.04.16.440205
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10
   Izzo F, 2020, NAT GENET, V52, P378, DOI 10.1038/s41588-020-0595-4
   Kari F W, 1999, J Nutr Health Aging, V3, P92
   Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Levine M, 2020, ELIFE, V9, DOI 10.7554/eLife.59201
   Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414
   LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0
   Li L, 2011, GEN COMP ENDOCR, V174, P232, DOI 10.1016/j.ygcen.2011.09.005
   Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108
   Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0
   Ma ZJ, 2018, ELIFE, V7, DOI [10.7554/elife.35368, 10.7554/eLife.35368]
   Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x
   MAYSHOOPES LL, 1989, INT REV CYTOL, V114, P181
   Oh J, 2014, NAT MED, V20, P870, DOI 10.1038/nm.3651
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392
   Petkovich DA, 2017, CELL METAB, V25, P954, DOI 10.1016/j.cmet.2017.03.016
   RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315
   Sturm G, 2019, EPIGENETICS-US, V14, P961, DOI 10.1080/15592294.2019.1626651
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Thompson MJ, 2018, AGING-US, V10, P2832, DOI 10.18632/aging.101590
NR 43
TC 11
Z9 12
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2022 FEB
PY 2022
VL 21
IS 2
AR e13553
DI 10.1111/acel.13553
EA FEB 2022
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA YY9JH
UT WOS:000749262500001
PM 35104377
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Bruce, KD
   Dobrinskikh, E
   Wang, H
   Rudenko, I
   Gao, H
   Libby, AE
   Gorkhali, S
   Yu, T
   Zsombok, A
   Eckel, RH
AF Bruce, Kimberley D.
   Dobrinskikh, Evgenia
   Wang, Hong
   Rudenko, Ivan
   Gao, Hong
   Libby, Andrew E.
   Gorkhali, Sachi
   Yu, Tian
   Zsombok, Andrea
   Eckel, Robert H.
TI Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and
   Hepatic Metabolism
SO METABOLITES
LA English
DT Article
DE lipoprotein lipase; neuronal metabolism; fatty liver; brain-liver axis;
   FLIM
ID LIVER-RELATED NEURONS; PARAVENTRICULAR NUCLEUS; INSULIN-RESISTANCE;
   GLYCOGEN-SYNTHETASE; BODY-WEIGHT; FATTY-ACIDS; FOOD-INTAKE; GLUCOSE;
   OBESITY; HYPOTHALAMUS
AB The autonomic regulation of hepatic metabolism offers a novel target for the treatment of non-alcoholic fatty liver disease (NAFLD). However, the molecular characteristics of neurons that regulate the brain-liver axis remain unclear. Since mice lacking neuronal lipoprotein lipase (LPL) develop perturbations in neuronal lipid-sensing and systemic energy balance, we reasoned that LPL might be a component of pre-autonomic neurons involved in the regulation of hepatic metabolism. Here, we show that, despite obesity, mice with reduced neuronal LPL (NEXCreLPL(flox) (LPL KD)) show improved glucose tolerance and reduced hepatic lipid accumulation with aging compared to wilt type (WT) controls (LPLflox). To determine the effect of LPL deficiency on neuronal physiology, liver-related neurons were identified in the paraventricular nucleus (PVN) of the hypothalamus using the transsynaptic retrograde tracer PRV-152. Patch-clamp studies revealed reduced inhibitory post-synaptic currents in liver-related neurons of LPL KD mice. Fluorescence lifetime imaging microscopy (FLIM) was used to visualize metabolic changes in LPL-depleted neurons. Quantification of free vs. bound nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FAD) revealed increased glucose utilization and TCA cycle flux in LPL-depleted neurons compared to controls. Global metabolomics from hypothalamic cell lines either deficient in or over-expressing LPL recapitulated these findings. Our data suggest that LPL is a novel feature of liver-related preautonomic neurons in the PVN. Moreover, LPL loss is sufficient to cause changes in neuronal substrate utilization and function, which may precede changes in hepatic metabolism.
C1 [Bruce, Kimberley D.; Wang, Hong; Rudenko, Ivan; Gorkhali, Sachi; Yu, Tian; Eckel, Robert H.] Univ Colorado, Div Endocrinol Metab & Diabet, Denver Anschutz Med Campus, Aurora, CO 80045 USA.
   [Dobrinskikh, Evgenia] Univ Colorado, Dept Med, Denver Anschutz Med Campus, Aurora, CO 80045 USA.
   [Gao, Hong; Zsombok, Andrea] Tulane Univ, Sch Med, Dept Physiol, New Orleans, LA 70112 USA.
   [Libby, Andrew E.] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Med Ctr, Washington, DC 20057 USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado System; University of Colorado Anschutz
   Medical Campus; Tulane University; Georgetown University
RP Bruce, KD (corresponding author), Univ Colorado, Div Endocrinol Metab & Diabet, Denver Anschutz Med Campus, Aurora, CO 80045 USA.
EM kimberley.bruce@cuanschutz.edu; evgenia.dobrinskikh@cuanschutz.edu;
   hong_wang01@yahoo.com; ivan.a.rudenko@gmail.com; hgao1@tulane.edu;
   andrew.libby@georgetown.edu; sachigorkhali@gmail.com;
   tian.yu@ucdenver.edu; azsombo@tulane.edu; robert.eckel@cuanschutz.edu
OI Libby, Andrew/0000-0003-3726-2170
FU NIH [5KL2TR002534-02, R01 DK089309-01A1, R01 DK099598-01A1]
FX This research was funded by the NIH, with grants awarded to K.D.B.
   (5KL2TR002534-02) R.H.E. (R01 DK089309-01A1), and A.Z. (R01
   DK099598-01A1).
CR Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686
   Bazan NG, 2003, J LIPID RES, V44, P2221, DOI 10.1194/jlr.R300013-JLR200
   Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z
   Blüher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc
   Bolaños JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006
   Bril F, 2017, DIABETES CARE, V40, P419, DOI 10.2337/dc16-1787
   Broberger C, 1999, NEUROENDOCRINOLOGY, V70, P295, DOI 10.1159/000054490
   Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205
   Bruinstroop E, 2012, DIABETES, V61, P1043, DOI 10.2337/db11-1142
   Cheng LC, 2015, J NUTR BIOCHEM, V26, P541, DOI 10.1016/j.jnutbio.2014.12.011
   Denis GV, 2013, CURR OPIN ENDOCRINOL, V20, P369, DOI 10.1097/01.med.0000433058.78485.b3
   Dienel GA, 2012, J CEREBR BLOOD F MET, V32, P1107, DOI 10.1038/jcbfm.2011.175
   Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154
   Dobrinskikh E, 2019, J SURG RES, V239, P242, DOI 10.1016/j.jss.2019.02.015
   Drozdowicz-Tomsia K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086016
   Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280
   Friedman JE, 2018, HEPATOL COMMUN, V2, P313, DOI 10.1002/hep4.1139
   Gao H, 2017, J NEUROSCI, V37, P11140, DOI 10.1523/JNEUROSCI.1706-17.2017
   Gao H, 2012, DIABETES, V61, P1381, DOI 10.2337/db11-0820
   GUNION MW, 1989, BRAIN RES, V478, P47, DOI 10.1016/0006-8993(89)91476-5
   Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881
   Hurr C, 2019, J PHYSIOL-LONDON, V597, P4565, DOI 10.1113/JP277994
   IONESCU E, 1989, American Journal of Physiology, V257, pR1370
   Jelenik T, 2017, DIABETES, V66, P2241, DOI 10.2337/db16-1147
   Jenkins AJ, 2003, DIABETES CARE, V26, P810, DOI 10.2337/diacare.26.3.810
   Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004
   Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5
   Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060
   Krashes MJ, 2014, NATURE, V507, P238, DOI 10.1038/nature12956
   Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540
   Laperrousaz E, 2017, DIABETOLOGIA, V60, P1314, DOI 10.1007/s00125-017-4282-7
   Libby AE, 2018, J LIPID RES, V59, P1482, DOI 10.1194/jlr.M086249
   Libby AE, 2016, J BIOL CHEM, V291, P24231, DOI 10.1074/jbc.M116.759795
   Libby AE, 2015, BIOCHEM BIOPH RES CO, V465, P287, DOI 10.1016/j.bbrc.2015.08.026
   Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379
   Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035
   Marwan AI, 2019, FETAL DIAGN THER, V45, P145, DOI 10.1159/000487752
   McCurdy CE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86612
   Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166
   O'Hare JD, 2016, AM J PHYSIOL-ENDOC M, V310, pE183, DOI 10.1152/ajpendo.00302.2015
   Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861
   Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873
   Orlicky DJ, 2019, J PHYSIOL-LONDON, V597, P1565, DOI 10.1113/JP277140
   PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625
   Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478
   Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439
   Ribeiro IMR, 2018, AM J PHYSIOL-GASTR L, V315, pG538, DOI 10.1152/ajpgi.00290.2017
   Ranjit S, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201900156
   Ranjit S, 2017, BIOMED OPT EXPRESS, V8, P3143, DOI 10.1364/BOE.8.003143
   Samocha-Bonet D, 2012, TRENDS ENDOCRIN MET, V23, P116, DOI 10.1016/j.tem.2011.12.005
   SHIMAZU T, 1971, BIOCHIM BIOPHYS ACTA, V252, P28, DOI 10.1016/0304-4165(71)90089-4
   SHIMAZU T, 1967, SCIENCE, V156, P1256, DOI 10.1126/science.156.3779.1256
   Sigala B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072928
   Song BJ, 2010, LIPIDS, V45, P291, DOI 10.1007/s11745-010-3398-z
   Stringari C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048014
   van den Hoek AM, 2008, DIABETES, V57, P2304, DOI 10.2337/db07-1658
   Wallrabe H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18634-x
   Wang H, 2016, METABOLISM, V65, P987, DOI 10.1016/j.metabol.2016.01.015
   Wang H, 2011, CELL METAB, V13, P105, DOI 10.1016/j.cmet.2010.12.006
   Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418
   Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329
   Yki-Järvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4
   Yu T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135113
   Yue JTY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6970
   Zsombok A, 2011, BRAIN RES, V1398, P30, DOI 10.1016/j.brainres.2011.04.048
NR 65
TC 4
Z9 4
U1 2
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-1989
J9 METABOLITES
JI Metabolites
PD OCT
PY 2020
VL 10
IS 10
AR 385
DI 10.3390/metabo10100385
PG 17
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA ON8DX
UT WOS:000586925400001
PM 32998280
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Shi, DL
   Liu, WW
   Gao, Y
   Li, XM
   Huang, YY
   Li, XK
   James, TD
   Guo, Y
   Li, J
AF Shi, Donglei
   Liu, Wenwen
   Gao, Ying
   Li, Xinming
   Huang, Yunyuan
   Li, Xiaokang
   James, Tony D.
   Guo, Yuan
   Li, Jian
TI Photoactivatable senolysis with single-cell resolution delays aging
SO NATURE AGING
LA English
DT Article; Early Access
ID SENESCENT CELLS; BETA-GALACTOSIDASE; FLUORESCENT-PROBE; PHOTOSENSITIZER;
   MITOCHONDRIA; CLEARANCE; THERAPY; FAMILY; TISSUE; DRUGS
AB Strategies that can selectively eliminate senescent cells (SnCs), namely senolytics, have been shown to promote healthy lifespan. However, it is challenging to achieve precise, broad-spectrum and tractable senolysis. Here, we integrate multiple technologies that combine the enzyme substrate of senescence-associated beta-galactosidase (SA-beta-gal) with fluorescence tag for the precise tracking of SnCs, construction of a bioorthogonal receptor triggered by SA-beta-gal to target and anchor SnCs with single-cell resolution and incorporation of a selenium atom to generate singlet oxygen and achieve precise senolysis through controllable photodynamic therapy (PDT). We generate KSL0608-Se, a photosensitive senolytic prodrug, which is selectively activated by SA-beta-gal. In naturally-aged mice, KSL0608-Se-mediated PDT prevented upregulation of age-related SnCs markers and senescence-associated secretory phenotype factors. This treatment also countered age-induced losses in liver and renal function and inhibited the age-associated physical dysfunction in mice. We therefore provide a strategy to monitor and selectively eliminate SnCs to regulate aging.
   Shi, Liu, Gao et al. present a strategy to monitor and selectively eliminate senescent cells in mice during aging through controllable photodynamic therapy, which inhibited the age-related functional decline.
C1 [Shi, Donglei; Li, Xinming; Huang, Yunyuan; Li, Xiaokang; Li, Jian] East China Univ Sci & Technol, Sch Pharm, Shanghai Frontiers Sci Ctr Optogenet Tech Cell Met, Frontiers Sci Ctr Materiobiol & Dynam Chem,State K, Shanghai, Peoples R China.
   [Shi, Donglei; Gao, Ying; Guo, Yuan] Northwest Univ, Coll Chem & Mat Sci, Key Lab Synthet & Nat Funct Mol, Minist Educ, Xian, Peoples R China.
   [Liu, Wenwen; Li, Jian] Hainan Univ, Coll Pharm, Key Lab Trop Biol Resources, Minist Educ, Haikou, Hainan, Peoples R China.
   [James, Tony D.] Univ Bath, Dept Chem, Bath, England.
   [Li, Jian] Dali Univ, Coll Pharm, Yunnan Key Lab Screening & Res Antipathogen Plant, Dali, Peoples R China.
   [Li, Jian] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Clin Med Sci & Tech Innovat Ctr, Shanghai, Peoples R China.
C3 East China University of Science & Technology; Northwest University
   Xi'an; Hainan University; University of Bath; Dali University; Tongji
   University
RP Li, J (corresponding author), East China Univ Sci & Technol, Sch Pharm, Shanghai Frontiers Sci Ctr Optogenet Tech Cell Met, Frontiers Sci Ctr Materiobiol & Dynam Chem,State K, Shanghai, Peoples R China.; Guo, Y (corresponding author), Northwest Univ, Coll Chem & Mat Sci, Key Lab Synthet & Nat Funct Mol, Minist Educ, Xian, Peoples R China.; Li, J (corresponding author), Hainan Univ, Coll Pharm, Key Lab Trop Biol Resources, Minist Educ, Haikou, Hainan, Peoples R China.; Li, J (corresponding author), Dali Univ, Coll Pharm, Yunnan Key Lab Screening & Res Antipathogen Plant, Dali, Peoples R China.; Li, J (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Clin Med Sci & Tech Innovat Ctr, Shanghai, Peoples R China.
EM guoyuan@nwu.edu.cn; jianli@ecust.edu.cn
RI James, Tony D./B-5125-2009; Guo, Yuan/T-5324-2017
OI James, Tony D./0000-0002-4095-2191; Guo, Yuan/0000-0003-2081-7264; Li,
   Jian/0000-0002-7521-8798; Shi, Donglei/0000-0002-3934-5650; Li,
   Xiaokang/0000-0001-8154-551X
FU National Natural Science Foundation of China [22037002, 32121005,
   21977082, 22007032]; Natural Science Basic Research Program of Shaanxi
   [2020JC-38]; Innovation Program of Shanghai Municipal Education
   Commission [2021-01-07-00-02-E00104]; Shanghai Frontier Science Research
   Base of Optogenetic Techniques for Cell Metabolism [2021 Sci Tech
   03-28]; Innovative Research Team of High-level Local Universities in
   Shanghai [SHSMU-ZDCX20212702]; Chinese Special Fund for State Key
   Laboratory of Bioreactor Engineering [2060204]; Royal Society; Open
   Research Fund of the School of Chemistry and Chemical Engineering, Henan
   Normal University [2020ZD01]
FX We gratefully appreciate the financial support from the National Natural
   Science Foundation of China (grants 22037002 to J.L. and Y. Guo,
   32121005 to J.L., 21977082 to Y. Guo and 22007032 to Xinming Li), the
   Natural Science Basic Research Program of Shaanxi (grant 2020JC-38 to Y.
   Guo), the Innovation Program of Shanghai Municipal Education Commission
   (grant 2021-01-07-00-02-E00104 to J.L.), the Shanghai Frontier Science
   Research Base of Optogenetic Techniques for Cell Metabolism (grant 2021
   Sci & Tech 03-28 to J.L.), the Innovative Research Team of High-level
   Local Universities in Shanghai (grant SHSMU-ZDCX20212702 to J.L.) and
   the Chinese Special Fund for State Key Laboratory of Bioreactor
   Engineering (2060204 to J.L.). T.D.J. wishes to thank the Royal Society
   for a Wolfson Research Merit Award and the Open Research Fund of the
   School of Chemistry and Chemical Engineering, Henan Normal University
   for support (Grant 2020ZD01 to T.D.J.). The funders had no role in study
   design, data collection and analysis, decision to publish or preparation
   of the manuscript.
CR Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bakkum T, 2020, ACS CENTRAL SCI, V6, P1997, DOI 10.1021/acscentsci.0c00539
   Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576
   Benson S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22578-2
   BURSUKER I, 1982, J CELL PHYSIOL, V112, P385
   Cai YS, 2020, CELL RES, V30, P574, DOI 10.1038/s41422-020-0314-9
   Chai XZ, 2020, J AM CHEM SOC, V142, P18005, DOI 10.1021/jacs.0c05379
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chang TC, 2021, ANGEW CHEM INT EDIT, V60, P12446, DOI 10.1002/anie.202100369
   Chatsirisupachai K, 2019, AGING CELL, V18, DOI 10.1111/acel.13041
   Chen YT, 2021, CELL METAB, V33, DOI 10.1016/j.cmet.2020.11.019
   Chiba M, 2017, ANGEW CHEM INT EDIT, V56, P10418, DOI 10.1002/anie.201704793
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Doura T, 2016, ANGEW CHEM INT EDIT, V55, P9620, DOI 10.1002/anie.201603328
   Farr JN, 2017, NAT MED, V23, P1072, DOI 10.1038/nm.4385
   Fuhrmann-Stroissnigg H, 2018, CELL CYCLE, V17, P1048, DOI 10.1080/15384101.2018.1475828
   Gaikwad SM, 2020, CANCERS, V12, DOI 10.3390/cancers12102952
   Gao Y, 2021, ANGEW CHEM INT EDIT, V60, P10756, DOI 10.1002/anie.202101278
   Gnaim S, 2018, ANGEW CHEM INT EDIT, V57, P9033, DOI 10.1002/anie.201804816
   GRACEFFA P, 1983, ARCH BIOCHEM BIOPHYS, V225, P802, DOI 10.1016/0003-9861(83)90092-9
   Guerrero A, 2020, AGING CELL, V19, DOI 10.1111/acel.13133
   He LZ, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109955
   He YH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15838-0
   Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069
   Jannone G, 2020, J HISTOCHEM CYTOCHEM, V68, P269, DOI 10.1369/0022155420913534
   Johmura Y, 2021, SCIENCE, V371, P265, DOI 10.1126/science.abb5916
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Kong SZ, 2018, MAR DRUGS, V16, DOI 10.3390/md16060181
   Lee JS, 2019, P NATL ACAD SCI USA, V116, P13311, DOI 10.1073/pnas.1903847116
   Li MY, 2020, ANAL CHEM, V92, P3262, DOI 10.1021/acs.analchem.9b05102
   Li M, 2021, BIOMATERIALS, V269, DOI 10.1016/j.biomaterials.2020.120532
   Lim GT, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12077
   Liu JJ, 2021, ADV MATER, V33, DOI 10.1002/adma.202007888
   Liu Y, 2016, J AM CHEM SOC, V138, P12368, DOI 10.1021/jacs.6b04048
   Lu MR, 2020, ANGEW CHEM INT EDIT, V59, P8698, DOI 10.1002/anie.202002576
   Menicacci B, 2017, J GERONTOL A-BIOL, V72, P1187, DOI 10.1093/gerona/glw336
   Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]
   Novais EJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25453-2
   Pan C, 2021, SCIENCE, V371, P234, DOI 10.1126/science.abf6368
   PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587
   Pungsrinont T, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00422-2
   Redmond RW, 1999, PHOTOCHEM PHOTOBIOL, V70, P391, DOI 10.1562/0031-8655(1999)070<0391:ACOSOY>2.3.CO;2
   Suda M, 2021, NATURE AGING, V1, P1117, DOI 10.1038/s43587-021-00151-2
   Sun J, 2021, J AM CHEM SOC, V143, P868, DOI 10.1021/jacs.0c10517
   Sun J, 2020, ANGEW CHEM INT EDIT, V59, P12122, DOI 10.1002/anie.202003895
   Takahashi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03555-8
   Wang YY, 2016, AGING-US, V8, P2915, DOI 10.18632/aging.101100
   Wang YJ, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110660
   Wendt MD, 2008, EXPERT OPIN DRUG DIS, V3, P1123, DOI 10.1517/17460441.3.9.1123
   Won M, 2021, ANGEW CHEM INT EDIT, V60, P3196, DOI 10.1002/anie.202012687
   Wu LL, 2021, CHEM SOC REV, V50, P702, DOI 10.1039/d0cs00861c
   Xiong T, 2021, CHEM SCI, V12, P2515, DOI 10.1039/d0sc05495j
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu QX, 2021, NAT METAB, V3, P1706, DOI 10.1038/s42255-021-00491-8
   Yang WZ, 2022, ANAL CHEM, V94, P7092, DOI 10.1021/acs.analchem.2c00859
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Yousefzadeh MJ, 2018, EBIOMEDICINE, V36, P18, DOI 10.1016/j.ebiom.2018.09.015
   Zhai WH, 2019, ANGEW CHEM INT EDIT, V58, P16601, DOI 10.1002/anie.201907510
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 61
TC 11
Z9 10
U1 41
U2 55
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-8465
J9 NATURE AGING
JI Nature Aging
PD 2023 FEB 2
PY 2023
DI 10.1038/s43587-023-00360-x
EA FEB 2023
PG 26
WC Cell Biology; Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology; Neurosciences & Neurology
GA C6GM8
UT WOS:000962879800002
PM 37118423
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Huang, CH
   Lee, WJ
   Huang, YL
   Tsai, TF
   Chen, LK
   Lin, CH
AF Huang, Chen-Hua
   Lee, Wei-Ju
   Huang, Yi-Long
   Tsai, Ting-Fen
   Chen, Liang-Kung
   Lin, Chao-Hsiung
TI Sebacic Acid as a Potential Age-Related Biomarker of Liver Aging:
   Evidence Linking Mice and Human
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article; Early Access
DE Human aging; Metabolomics; Metabolomic age; Plasma
ID PLASMA; RESTRICTION; GLUCOSE
AB The aging process is complicated and involves diverse organ dysfunction; furthermore, the biomarkers that are able to reflect biological aging are eagerly sought after to monitor the system-wide decline associated with the aging process. To address this, we performed a metabolomics analysis using a longitudinal cohort study from Taiwan (N = 710) and established plasma metabolomic age using a machine learning algorithm. The resulting estimation of age acceleration among the older adults was found to be correlated with HOMA-insulin resistance. In addition, a sliding window analysis was used to investigate the undulating decrease in hexanoic and heptanoic acids that occurs among the older adults at different ages. A comparison of the metabolomic alterations associated with aging between humans and mice implied that omega-oxidation of medium-chain fatty acids was commonly dysregulated in older subjects. Among these fatty acids, sebacic acid, an omega-oxidation product produced by the liver, was significantly decreased in the plasma of both older humans and aged mice. Notably, an increase in the production and consumption of sebacic acid within the liver tissue of aged mice was observed, along with an elevation of pyruvate-to-lactate conversion. Taken together, our study reveals that sebacic acid and metabolites of omega-oxidation are the common aging biomarkers in both humans and mice. The further analysis suggests that sebacic acid may play an energetic role in supporting the production of acetyl-CoA during liver aging, and thus its alteration in plasma concentration potentially reflects the aging process.
C1 [Huang, Chen-Hua; Tsai, Ting-Fen; Lin, Chao-Hsiung] Natl Yang Ming Chiao Tung Univ, Inst Genome Sci, Dept Life Sci, Hsinchu, Taiwan.
   [Huang, Chen-Hua; Huang, Yi-Long; Chen, Liang-Kung; Lin, Chao-Hsiung] Natl Yang Ming Chiao Tung Univ, Ctr Hlth Longev & Aging Sci, Hsinchu, Taiwan.
   [Lee, Wei-Ju] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Geriatr Med, Hsinchu, Taiwan.
   [Lee, Wei-Ju] Taipei Vet Gen Hosp, Dept Family Med, Yuanshan Branch, Yilan, Taiwan.
   [Tsai, Ting-Fen] Inst Mol & Genom Med, Natl Hlth Res Inst, Miaoli, Taiwan.
   [Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan.
   [Lin, Chao-Hsiung] Natl Yang Ming Chiao Tung Univ, Inst Genome Sci, Dept Life Sci, Sec 2,Li Nong St,112, Taipei 155, Taiwan.
C3 National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University; National Yang Ming Chiao Tung University; Taipei Veterans
   General Hospital; National Health Research Institutes - Taiwan; Taipei
   Veterans General Hospital; National Yang Ming Chiao Tung University
RP Lin, CH (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Genome Sci, Dept Life Sci, Sec 2,Li Nong St,112, Taipei 155, Taiwan.
EM chaohsiunglin@nycu.edu.tw
RI Chen, Liang-Kung/JBI-8802-2023
OI Chen, Liang-Kung/0000-0002-2387-8508; LIN,
   CHAO-HSIUNG/0000-0001-6344-271X
FU Ministry of Science and Technology, Taiwan [MOST 109-2311-B-010-003,
   MOST 111-2321-B-A49-008, MOST 111-2317-B-182-004]
FX This work was supported by grants from the Ministry of Science and
   Technology, Taiwan (MOST 109-2311-B-010-003, MOST 111-2321-B-A49-008,
   and MOST 111-2317-B-182-004)
CR Adav SS, 2021, AGING DIS, V12, P646, DOI 10.14336/AD.2020.0909
   Auro K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5708
   Bai J, 2021, PHARM RES-DORDR, V38, P15, DOI 10.1007/s11095-020-02975-w
   Beyene HB, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000870
   Bunning BJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13073
   Cheng ML, 2015, J AM COLL CARDIOL, V65, P1509, DOI 10.1016/j.jacc.2015.02.018
   Darst BF, 2019, AGING-US, V11, P1262, DOI 10.18632/aging.101837
   Di Cesare F, 2022, J GERONTOL A-BIOL, V77, P918, DOI 10.1093/gerona/glab335
   Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2
   Fuchs S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-14
   Geissler C, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108907
   Gleicher N, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-67
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang YL, 2021, AGING CELL, V20, DOI 10.1111/acel.13523
   Huang YL, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222010903
   Iaconelli A, 2010, DIABETES CARE, V33, P2327, DOI 10.2337/dc10-0663
   Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6
   Jylhävä J, 2017, EBIOMEDICINE, V21, P29, DOI 10.1016/j.ebiom.2017.03.046
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383
   Lehallier B, 2019, NAT MED, V25, P1843, DOI 10.1038/s41591-019-0673-2
   Liu LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136968
   Membrez M, 2010, DIABETES OBES METAB, V12, P1120, DOI 10.1111/j.1463-1326.2010.01308.x
   Meydani SN, 2016, AGING-US, V8, P1416, DOI 10.18632/aging.100994
   Mingrone G, 2013, BRIT J CLIN PHARMACO, V75, P671, DOI 10.1111/j.1365-2125.2012.04177.x
   Novelle MG, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102071
   Pass GJ, 2002, J PHARMACOL EXP THER, V302, P442, DOI 10.1124/jpet.102.033553
   Pirhaji L, 2016, NAT METHODS, V13, P770, DOI [10.1038/NMETH.3940, 10.1038/nmeth.3940]
   Ragonnaud E, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-020-00213-w
   Robinson O, 2020, AGING CELL, V19, DOI 10.1111/acel.13149
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892
   Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023
   van den Akker EB, 2020, CIRC-GENOM PRECIS ME, V13, P541, DOI 10.1161/CIRCGEN.119.002610
   van der Lugt B, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0145-z
   Walters RO, 2018, CELL REP, V25, P663, DOI 10.1016/j.celrep.2018.09.065
   Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135
   Weitkunat K, 2017, AM J CLIN NUTR, V105, P1544, DOI 10.3945/ajcn.117.152702
   Wu C, 2017, J CLIN INVEST, V127, P4118, DOI [10.1172/jci89344, 10.1172/JCI89344]
   Yang NI, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092430
   Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x
   Zierer J, 2015, AGING CELL, V14, P933, DOI 10.1111/acel.12386
NR 42
TC 0
Z9 0
U1 2
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD 2023 OCT 9
PY 2023
VL 78
IS 10
BP 1799
EP 1808
DI 10.1093/gerona/glad121
EA MAY 2023
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA X6US7
UT WOS:000998875800001
PM 37148322
DA 2024-02-19
ER

PT J
AU Melin, N
   Yarahmadov, T
   Sanchez-Taltavull, D
   Birrer, FE
   Brodie, TM
   Petit, B
   Felser, A
   Nuoffer, JM
   Montani, M
   Vozenin, MC
   Herrmann, E
   Candinas, D
   Aebersold, DM
   Stroka, D
AF Melin, Nicolas
   Yarahmadov, Tural
   Sanchez-Taltavull, Daniel
   Birrer, Fabienne E.
   Brodie, Tess M.
   Petit, Benoit
   Felser, Andrea
   Nuoffer, Jean-Marc
   Montani, Matteo
   Vozenin, Marie-Catherine
   Herrmann, Evelyn
   Candinas, Daniel
   Aebersold, Daniel M.
   Stroka, Deborah
TI A new mouse model of radiation-induced liver disease reveals
   mitochondrial dysfunction as an underlying fibrotic stimulus
SO JHEP REPORTS
LA English
DT Article; Early Access
DE radiation-induced liver disease (RILD); sinusoidal obstruction syndrome;
   mouse model; mitochondrial dysfunction; fibrosis; p53;
   mitochondrial-DNA; ROS; senescence; image guided radiation therapy
   (IGRT)
ID SINUSOIDAL OBSTRUCTION SYNDROME; DNA; IDENTIFICATION; IRRADIATION;
   TOXICITY; INJURY; DAMAGE; HEAD
AB Background & Aims: High-dose irradiation is an essential tool to help control the growth of hepatic tumors, but it can cause radiation-induced liver disease (RILD). This life-threatening complication manifests itself months following radiation therapy and is characterized by fibrosis of the pericentral sinusoids. In this study, we aimed to establish a mouse model of RILD to investigate the underlying mechanism of radiation-induced liver fibrosis. Methods: Using a small animal image-guided radiation therapy platform, an irradiation scheme delivering 50 Gy as a single dose to a focal point in mouse livers was designed. Tissues were analyzed 1 and 6 days, and 6 and 20 weeks post-irradiation. Irradiated livers were assessed by histology, immunohistochemistry, imaging mass cytometry and RNA sequencing. Mitochondrial function was assessed using high-resolution respirometry. Results: At 6 and 20 weeks post-irradiation, pericentral fibrosis was visible in highly irradiated areas together with immune cell infiltration and extravasation of red blood cells. RNA sequencing analysis showed gene signatures associated with acute DNA damage, p53 activation, senescence and its associated secretory phenotype and fibrosis. Moreover, gene profiles of mitochondrial damage and an increase in mitochondrial DNA heteroplasmy were detected. Respirometry measurements of hepatocytes in vitro confirmed irradiation-induced mitochondrial dysfunction. Finally, the highly irradiated fibrotic areas showed markers of reactive oxygen species such as decreased glutathione and increased lipid peroxides and a senescence-like phenotype. Conclusions: Based on our mouse model of RILD, we propose that irradiation-induced mitochondrial DNA instability contributes to the development of fibrosis via the generation of excessive reactive oxygen species, p53 pathway activation and a senescence-like phenotype. Lay summary: Irradiation is an efficient cancer therapy, however, its applicability to the liver is limited by life-threatening radiation-induced hepatic fibrosis. We have developed a new mouse model of radiation-induced liver fibrosis, that recapitulates the human disease. Our model highlights the role of mitochondrial DNA instability in the development of irradiation-induced liver fibrosis. This new model and subsequent findings will help increase our understanding of the hepatic reaction to irradiation and to find strategies that protect the liver, enabling the expanded use of radiotherapy to treat hepatic tumors. (c) 2022 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Melin, Nicolas; Yarahmadov, Tural; Sanchez-Taltavull, Daniel; Birrer, Fabienne E.; Brodie, Tess M.; Candinas, Daniel; Stroka, Deborah] Univ Bern, Bern Univ Hosp, Dept Visceral Surg & Med, Inselspital, Bern, Switzerland.
   [Melin, Nicolas; Yarahmadov, Tural; Sanchez-Taltavull, Daniel; Birrer, Fabienne E.; Brodie, Tess M.; Stroka, Deborah] Univ Bern, Dept Biomed Res Visceral Surg & Med, Bern, Switzerland.
   [Petit, Benoit; Vozenin, Marie-Catherine] Univ Lausanne, Lausanne Univ Hosp, Dept Oncol, Radiat Oncol Serv,CHUV,Lab Radiat Oncol, Lausanne, Switzerland.
   [Felser, Andrea; Nuoffer, Jean-Marc] Univ Bern, Inst Clin Chem, Bern, Switzerland.
   [Montani, Matteo] Univ Bern, Dept Pathol, Bern, Switzerland.
   [Herrmann, Evelyn; Aebersold, Daniel M.] Univ Bern, Bern Univ Hosp, Dept Radiat Oncol, Dept Biomed Res, Bern, Switzerland.
   [Stroka, Deborah] Univ Bern, Dept Visceral Surg & Med, Murtenstr 35, CH-3008 Bern, Switzerland.
C3 University of Bern; University Hospital of Bern; University of Bern;
   University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV);
   University of Bern; University of Bern; University of Bern; University
   Hospital of Bern; University of Bern
RP Stroka, D (corresponding author), Univ Bern, Dept Visceral Surg & Med, Murtenstr 35, CH-3008 Bern, Switzerland.
EM deborah.stroka@dbmr.unibe.ch
RI Aebersold, Daniel Matthias/C-2946-2013; Vozenin,
   Marie-Catherine/AAR-2268-2021; Nuoffer, Jean-Marc/C-8936-2009
OI Aebersold, Daniel Matthias/0000-0002-9493-3834; Vozenin,
   Marie-Catherine/0000-0002-2109-8073; Felser, Andrea/0000-0003-4806-2940;
   Nuoffer, Jean-Marc/0000-0003-3650-6153; Brodie,
   Tess/0000-0002-7934-138X; Melin, Nicolas/0000-0001-8004-1061;
   Sanchez-Taltavull, Daniel/0000-0002-4944-0360; Birrer, Fabienne
   Esther/0000-0003-4366-9946
FU Swiss National Science Foundation [310030_173157, 316030_183501];
   Scherbarth Foundation; Swiss National Science Foundation (SNF)
   [310030_173157, 316030_183501] Funding Source: Swiss National Science
   Foundation (SNF)
FX The study was supported by the Swiss National Science Foundation Nr.
   310030_173157 and 316030_183501 (DS) , and the Scherbarth Foundation
   (EH) , all of which were not involved in the study design; in the
   collection, analysis and interpretation of data; in the writing of the
   report; and in the decision to submit the article for publication.
CR Akil A, 2015, BIOL BLOOD MARROW TR, V21, P1739, DOI 10.1016/j.bbmt.2015.07.004
   Auten RL, 2009, PEDIATR RES, V66, P121, DOI 10.1203/PDR.0b013e3181a9eafb
   Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438
   Bang A, 2019, JHEP REP, V1, P131, DOI 10.1016/j.jhepr.2019.05.004
   Baselet B, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00268
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Birrer F.E., CYTOM PART A
   Bockbrader M, 2009, EXPERT REV ANTICANC, V9, P637, DOI 10.1586/ERA.09.16
   Canta A, 2015, TOXICS, V3, P198, DOI 10.3390/toxics3020198
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   DeLeve LD, 2003, HEPATOLOGY, V38, P900, DOI 10.1053/jhep.2003.50383
   Edvardsen H, 2013, INT J RADIAT ONCOL, V86, P791, DOI 10.1016/j.ijrobp.2013.02.025
   Ferreira PR, 2004, HEAD NECK-J SCI SPEC, V26, P313, DOI 10.1002/hed.10382
   GERACI JP, 1985, RADIAT RES, V101, P508, DOI 10.2307/3576510
   Gerum S, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1048-4
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   Guha C, 2011, SEMIN RADIAT ONCOL, V21, P256, DOI 10.1016/j.semradonc.2011.05.003
   Haas RH, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020048
   Kim J, 2016, CELL PHYSIOL BIOCHEM, V40, P263, DOI 10.1159/000452543
   Krasich R, 2017, FRONT BIOSCI-LANDMRK, V22, P692, DOI 10.2741/4510
   Krstic J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030921
   Kurland IJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124795
   Lawless C, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200061
   Livingston K, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00020
   Mahadevan A, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-0969-2
   Mingatto FE, 2007, TOXICON, V50, P724, DOI 10.1016/j.toxicon.2007.06.006
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Pan CC, 2010, INT J RADIAT ONCOL, V76, pS94, DOI 10.1016/j.ijrobp.2009.06.092
   Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8
   Patergnani S, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9020216
   Rangarajan S, 2017, ANN AM THORAC SOC, V14, pS383, DOI 10.1513/AnnalsATS.201705-370AW
   REED GB, 1966, AM J PATHOL, V48, P597
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Robinson MW, 2016, CELL MOL IMMUNOL, V13, P267, DOI 10.1038/cmi.2016.3
   Robinson SM, 2013, J HEPATOL, V59, P318, DOI 10.1016/j.jhep.2013.04.014
   Schapiro D, 2017, NAT METHODS, V14, P873, DOI [10.1038/NMETH.4391, 10.1038/nmeth.4391]
   Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034
   Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663
   Shibata T, 2006, J BIOL CHEM, V281, P1196, DOI 10.1074/jbc.M509065200
   Shimura T, 2017, CELL CYCLE, V16, P565, DOI 10.1080/15384101.2017.1284716
   Wang L, 2007, INT J RADIAT BIOL, V83, P433, DOI 10.1080/09553000701370878
   Wang S, 2013, HEPATOL INT, V7, P1065, DOI 10.1007/s12072-013-9461-0
   Wang YF, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00185
   Wilding CS, 2006, RADIAT RES, V165, P202, DOI 10.1667/RR3494.1
   Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037
   Yannam GR, 2014, INT J RADIAT ONCOL, V88, P404, DOI 10.1016/j.ijrobp.2013.10.037
   Zhang JG, 2001, CHEM-BIOL INTERACT, V138, P267, DOI 10.1016/S0009-2797(01)00278-2
   Zhang P, 2016, BRIEF BIOINFORM, V17, P224, DOI 10.1093/bib/bbv057
   Zhang Steven B, 2014, Int J Cell Biol, V2014, P850460, DOI 10.1155/2014/850460
   Zhao XT, 2012, BIOMED ENVIRON SCI, V25, P533, DOI 10.3967/0895-3988.2012.05.006
NR 50
TC 7
Z9 8
U1 4
U2 18
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2589-5559
J9 JHEP REP
JI JHEP Rep.
PD 2022 JUL
PY 2022
VL 4
IS 7
AR 100508
DI 10.1016/j.jhepr.2022.100508
EA JUN 2022
PG 14
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 2T7FE
UT WOS:000822635000002
PM 35712694
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Arvapalli, RK
   Paturi, S
   Laurino, JP
   Katta, A
   Kakarla, SK
   Gadde, MK
   Wu, MZ
   Rice, KM
   Walker, EM
   Wehner, P
   Blough, ER
AF Arvapalli, Ravi Kumar
   Paturi, Satyanarayana
   Laurino, Joseph P.
   Katta, Anjaiah
   Kakarla, Sunil K.
   Gadde, Murali K.
   Wu, Miaozong
   Rice, Kevin M.
   Walker, Ernest M.
   Wehner, Paulette
   Blough, Eric R.
TI Deferasirox Decreases Age-Associated Iron Accumulation in the Aging
   F344XBN Rat Heart and Liver
SO CARDIOVASCULAR TOXICOLOGY
LA English
DT Article
DE Iron; Deferasirox; Heart; Apoptosis; Bax to Bcl2 ratio; Caspase-3
ID BROWN-NORWAY/BINIA RAT; MOLECULAR-MECHANISMS; CELLULAR SENESCENCE;
   OXIDATIVE STRESS; APOPTOSIS; PROTEINS; TRANSFERRIN; CHELATORS; OVERLOAD;
   DISEASE
AB It is thought that aging in rats and humans is associated with increases in iron accumulation and cell apoptosis. Here, we examine the relationship between cardiac iron levels and apoptosis in aged F344XBN rats that had been treated with an oral iron chelator (Deferasirox; 100 mg/kg body weight) on alternate days for 6 months. Compared to adult animals (6 month), cardiac iron (+72%), liver iron (+87%), ferritin light chain (+59%), divalent metal transporter-1 (+56%) and the number of TdT-mediated dUTP nick end labeling (TUNEL) positive cells (4.3 fold increase) were higher in 33-month-old animals (P < 0.05). Deferasirox treatment decreased cardiac iron levels by 37% (P < 0.05), and this was associated with decreases in the number of TUNEL-positive cells. Age-associated increases in cell death were coupled with increases in Bax to Bcl-2 ratio, and the amount of Bad, full-length caspase-3, and cleaved caspase-3. Deferasirox treatment decreased the Bax to Bcl-2 ratio by 17% (P < 0.05) and the amount of Bad, full-length caspase-3, cleaved caspase-3 (19 kDa), and cleaved caspase-3 (17 kDa) by 41, 16, 22, and 37%, respectively (P < 0.05). Taken together, these data suggest that deferasirox may be effective in diminishing age-associated iron accumulation and cardiac apoptosis in the F344XBN rat model.
C1 [Blough, Eric R.] Marshall Univ, Lab Mol Physiol, Huntington, WV 25755 USA.
   [Arvapalli, Ravi Kumar; Paturi, Satyanarayana; Gadde, Murali K.; Wu, Miaozong; Rice, Kevin M.; Blough, Eric R.] Marshall Univ, Dept Biol Sci, Huntington, WV 25755 USA.
   [Arvapalli, Ravi Kumar; Paturi, Satyanarayana; Gadde, Murali K.; Wu, Miaozong; Rice, Kevin M.; Walker, Ernest M.; Blough, Eric R.] Marshall Univ, Cell Differentiat & Dev Ctr, Huntington, WV 25755 USA.
   [Laurino, Joseph P.] Univ Tampa, Dept Chem, Tampa, FL 33606 USA.
   [Katta, Anjaiah; Kakarla, Sunil K.; Walker, Ernest M.; Blough, Eric R.] Marshall Univ, Dept Pharmacol Physiol & Toxicol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.
   [Wehner, Paulette] Marshall Univ, Dept Cardiol, Joan C Edwards Sch Med, Huntington, WV 25755 USA.
   [Blough, Eric R.] Marshall Univ, Dept Exercise Sci Sport & Recreat, Coll Educ & Human Serv, Huntington, WV 25755 USA.
C3 Marshall University; Marshall University; Marshall University;
   University of Tampa; Marshall University; Marshall University; Marshall
   University
RP Blough, ER (corresponding author), Marshall Univ, Lab Mol Physiol, 241N Byrd Biotechnol Bldg,1 John Marshall Dr, Huntington, WV 25755 USA.
EM blough@marshall.edu
RI Wu, Miaozong/C-1344-2009
OI Wu, Miaozong/0000-0002-2903-9625; Rice, Kevin/0000-0002-5785-3405
FU Novartis Pharmaceutical
FX This study was supported by funding from Novartis Pharmaceutical to E.
   R. B.
CR Asano S, 2007, REDOX REP, V12, P167, DOI 10.1179/135100007X200254
   Atamna H, 2004, AGEING RES REV, V3, P303, DOI 10.1016/j.arr.2004.02.002
   BASKIN SI, 1981, REPROD NUTR DEV, V21, P689, DOI 10.1051/rnd:19810508
   Bernecker Oliver Y, 2003, Cardiovasc Toxicol, V3, P183, DOI 10.1385/CT:3:3:183
   Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0
   DALLMAN PR, 1986, ANNU REV NUTR, V6, P13, DOI 10.1146/annurev.nu.06.070186.000305
   Drexler ES, 2003, J RES NATL INST STAN, V108, P183, DOI 10.6028/jres.108.018
   Gupte AA, 2008, J APPL PHYSIOL, V105, P839, DOI 10.1152/japplphysiol.00148.2008
   Hacker TA, 2006, AM J PHYSIOL-HEART C, V290, pH304, DOI 10.1152/ajpheart.00290.2005
   Hahalis G, 2005, AM J MED, V118, P957, DOI 10.1016/j.amjmed.2005.02.021
   Harman D, 2003, ANTIOXID REDOX SIGN, V5, P557, DOI 10.1089/152308603770310202
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710
   Hussein MR, 2003, J PATHOL, V199, P275, DOI 10.1002/path.1300
   Jung SH, 2008, EXP PHYSIOL, V93, P407, DOI 10.1113/expphysiol.2007.039453
   KAKHLON O, 2002, FREE RADICAL BIO MED, V33, P1037
   Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2
   Kevin LG, 2005, ANESTH ANALG, V101, P1275, DOI 10.1213/01.ANE.0000180999.81013.D0
   Killilea DW, 2004, ANN NY ACAD SCI, V1019, P365, DOI 10.1196/annals.1297.063
   Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158
   Lakatta Edward, 1994, Am J Geriatr Cardiol, V3, P11
   LAURENT S, 1995, HYPERTENSION, V26, P355, DOI 10.1161/01.HYP.26.2.355
   Menon B, 2007, J MOL CELL CARDIOL, V42, P653, DOI 10.1016/j.yjmcc.2006.12.011
   Muscari C, 1996, MOL CELL BIOCHEM, V161, P159, DOI 10.1007/BF00240046
   OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O
   Phaneuf S, 2001, MED SCI SPORT EXER, V33, P393, DOI 10.1097/00005768-200103000-00010
   Ponka P, 1998, SEMIN HEMATOL, V35, P35
   Puntarulo Susana, 2005, Molecular Aspects of Medicine, V26, P299, DOI 10.1016/j.mam.2005.07.001
   Rice KM, 2006, FREE RADICAL RES, V40, P185, DOI 10.1080/10715760500464957
   Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996
   Roth JA, 2000, J NEUROSCI, V20, P7595
   SHERMAN AR, 1985, J NUTR, V115, P607, DOI 10.1093/jn/115.5.607
   SPROTT RL, 1991, NEUROBIOL AGING, V12, P635, DOI 10.1016/0197-4580(91)90113-X
   SULLIVAN JL, 1989, AM HEART J, V117, P1177, DOI 10.1016/0002-8703(89)90887-9
   Taher A, 2009, BRIT J HAEMATOL, V146, P569, DOI 10.1111/j.1365-2141.2009.07810.x
   Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Wahr PA, 2000, AM J PHYSIOL-HEART C, V279, pH559, DOI 10.1152/ajpheart.2000.279.2.H559
   Walker EM, 2006, ANN CLIN LAB SCI, V36, P427
   Walker EM, 2007, ANN CLIN LAB SCI, V37, P22
   Wheeler MT, 2002, HUM MOL GENET, V11, P2147, DOI 10.1093/hmg/11.18.2147
   Wood JC, 2006, TRANSL RES, V148, P272, DOI 10.1016/j.trsl.2006.05.005
NR 41
TC 16
Z9 17
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1530-7905
EI 1559-0259
J9 CARDIOVASC TOXICOL
JI Cardiovasc. Toxicol.
PD JUN
PY 2010
VL 10
IS 2
BP 108
EP 116
DI 10.1007/s12012-010-9068-9
PG 9
WC Cardiac & Cardiovascular Systems; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cardiovascular System & Cardiology; Toxicology
GA 596UB
UT WOS:000277709900004
PM 20229123
DA 2024-02-19
ER

PT J
AU Hoare, M
   Ito, Y
   Kang, TW
   Weekes, MP
   Matheson, NJ
   Patten, DA
   Shetty, S
   Parry, AJ
   Menon, S
   Salama, R
   Antrobus, R
   Tomimatsu, K
   Howat, W
   Lehner, PJ
   Zender, L
   Narita, M
AF Hoare, Matthew
   Ito, Yoko
   Kang, Tae-Won
   Weekes, Michael P.
   Matheson, Nicholas J.
   Patten, Daniel A.
   Shetty, Shishir
   Parry, Aled J.
   Menon, Suraj
   Salama, Rafik
   Antrobus, Robin
   Tomimatsu, Kosuke
   Howat, William
   Lehner, Paul J.
   Zender, Lars
   Narita, Masashi
TI NOTCH1 mediates a switch between two distinct secretomes during
   senescence
SO NATURE CELL BIOLOGY
LA English
DT Article
ID CELLULAR SENESCENCE; PANCREATIC-CANCER; TUMOR-SUPPRESSOR; LIVER;
   ONCOGENE; GROWTH; DIFFERENTIATION; CLEARANCE; FATE; BETA
AB Senescence, a persistent form of cell-cycle arrest, is often associated with a diverse secretome, which provides complex functionality for senescent cells within the tissue microenvironment. We show that oncogene-induced senescence is accompanied by a dynamic fluctuation of NOTCH1 activity, which drives a TGF-beta-rich secretome, while suppressing the senescence-associated pro-inflammatory secretome through inhibition of C/EBP beta. NOTCH1 and NOTCH1-driven TGF-beta contribute to 'lateral induction of senescence' through a juxtacrine NOTCH-JAG1 pathway. In addition, NOTCH1 inhibition during senescence facilitates upregulation of pro-inflammatory cytokines, promoting lymphocyte recruitment and senescence surveillance in vivo. As enforced activation of NOTCH1 signalling confers a near mutually exclusive secretory profile compared with typical senescence, our data collectively indicate that the dynamic alteration of NOTCH1 activity during senescence dictates a functional balance between these two distinct secretomes: one representing TGF-beta and the other pro-inflammatory cytokines, highlighting that NOTCH1 is a temporospatial controller of secretome composition.
C1 [Hoare, Matthew; Ito, Yoko; Parry, Aled J.; Menon, Suraj; Salama, Rafik; Tomimatsu, Kosuke; Howat, William; Narita, Masashi] Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.
   [Hoare, Matthew; Weekes, Michael P.; Matheson, Nicholas J.; Lehner, Paul J.] Univ Cambridge, Dept Med, Addenbrookes Hosp, Cambridge CB2 0QQ, England.
   [Kang, Tae-Won; Zender, Lars] Univ Hosp Tuebingen, Div Translat Gastrointestinal Oncol, Dept Internal Med 1, Otfried Mueller Str 12, D-72076 Tubingen, Germany.
   [Kang, Tae-Won; Zender, Lars] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, D-69120 Heidelberg, Germany.
   [Weekes, Michael P.; Matheson, Nicholas J.; Antrobus, Robin; Lehner, Paul J.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England.
   [Patten, Daniel A.; Shetty, Shishir] Univ Birmingham, Birmingham Liver Biomed Res Unit, Natl Inst Hlth Res, Birmingham B15 2TT, W Midlands, England.
   [Patten, Daniel A.; Shetty, Shishir] Univ Birmingham, Liver Res Ctr, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England.
C3 Cancer Research UK; University of Cambridge; CRUK Cambridge Institute;
   Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's
   Hospital; University of Cambridge; Eberhard Karls University of
   Tubingen; Eberhard Karls University Hospital; Helmholtz Association;
   German Cancer Research Center (DKFZ); University of Cambridge; Cambridge
   University Hospitals NHS Foundation Trust; Addenbrooke's Hospital;
   University of Birmingham; University of Birmingham
RP Narita, M (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.
EM masashi.narita@cruk.cam.ac.uk
RI Shetty, Shishir/AAU-4047-2021; Kang, Tae Won/S-4864-2019
OI Shetty, Shishir/0000-0002-4729-2173; Kang, Tae Won/0000-0003-1497-8926;
   Salama, Rafik/0000-0001-5549-7796; Lehner, Paul
   Joseph/0000-0001-9383-1054; Weekes, Michael/0000-0003-3196-5545;
   Matheson, Nicholas/0000-0002-3318-1851; Hoare,
   Matthew/0000-0001-5990-9604; Patten, Daniel/0000-0002-8745-0578; Narita,
   Masashi/0000-0001-7764-577X; Parry, Aled/0000-0001-5192-3727
FU University of Cambridge; Hutchison Whampoa; Cancer Research UK Cambridge
   Institute Core Grant [C14303/A17197]; CRUK Translational Medicine
   Research Fellowship; CRUK Clinician Scientist Fellowship
   [C52489/A19924]; Wellcome Trust [WT101835, 108070/Z/15/Z, 093964/Z/10/Z,
   097162/Z/11/Z]; German Research Foundation (DFG) [FOR2314, SFB685];
   Gottfried Wilhelm Leibniz Program; European Research Council (projects
   'CholangioConcepf'); German Ministry for Education and Research (BMBF)
   (eMed-Multiscale HCC); German Universities Excellence Initiative (third
   funding line: 'future concept'); German Center for Translational Cancer
   Research (DKTK); German-Israeli Cooperation in Cancer Research
   (DKFZ-MOST); Cancer Research UK [19159, 15890, 22310, 19924] Funding
   Source: researchfish; Wellcome Trust [093964/Z/10/Z, 097162/Z/11/Z]
   Funding Source: Wellcome Trust
FX We are very grateful to J. Gil (Imperial College London, UK), A. Harris
   (CRUK, Oxford, UK) and D. Peeper (NKI, Amsterdam) for reagents; J.
   Miller and L.-A. McDuffus for assistance with the immunohistochemistry;
   E. Serrao and K. Brindle (CRUK Cambridge Institute, UK) for the murine
   pancreatic tissue; G. Slater for analysis of the ILIA locus; M. Clayton
   for the tail-vein injections; and A. Young and M. Narita for technical
   support. This work was supported by the University of Cambridge, Cancer
   Research UK and Hutchison Whampoa. The M.N. laboratory is supported by
   Cancer Research UK Cambridge Institute Core Grant (C14303/A17197). M.H.
   was supported by CRUK Translational Medicine Research Fellowship and
   CRUK Clinician Scientist Fellowship (C52489/A19924). This work was also
   supported by a Wellcome Trust PRF (WT101835) to P.J.L., a Wellcome Trust
   Senior Fellowship to M.P.W. (108070/Z/15/Z), a Wellcome Trust Training
   Fellowship to N.J.M. (093964/Z/10/Z), and a Wellcome Trust Intermediate
   Fellowship (097162/Z/11/Z) to S.S. L.Z. was funded by the German
   Research Foundation (DFG; grants FOR2314 and SFB685), the Gottfried
   Wilhelm Leibniz Program, the European Research Council (projects
   'CholangioConcepf), the German Ministry for Education and Research
   (BMBF) (eMed-Multiscale HCC), the German Universities Excellence
   Initiative (third funding line: 'future concept'), the German Center for
   Translational Cancer Research (DKTK) and the German-Israeli Cooperation
   in Cancer Research (DKFZ-MOST).
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Avila JL, 2013, TRENDS MOL MED, V19, P320, DOI 10.1016/j.molmed.2013.03.003
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105
   Caldwell ME, 2012, ONCOGENE, V31, P1599, DOI 10.1038/onc.2011.350
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Cui H, 2013, CANCER RES, V73, P3451, DOI 10.1158/0008-5472.CAN-12-3902
   D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229
   Dörr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602
   Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107
   Hata A, 1997, NATURE, V388, P82, DOI 10.1038/40424
   Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X
   Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520
   Huggins CJ, 2013, MOL CELL BIOL, V33, P3242, DOI 10.1128/MCB.01674-12
   Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644
   Kagawa S, 2015, ONCOGENE, V34, P2347, DOI 10.1038/onc.2014.169
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kirschner K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005053
   Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lee WY, 2008, J HEPATOL, V48, P504, DOI 10.1016/j.jhep.2007.12.005
   Lewis J, 1998, SEMIN CELL DEV BIOL, V9, P583, DOI 10.1006/scdb.1998.0266
   Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Nakazato Y, 1998, KIDNEY INT, V54, P71, DOI 10.1046/j.1523-1755.1998.00967.x
   Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Pitt LA, 2015, CANCER CELL, V27, P755, DOI 10.1016/j.ccell.2015.05.002
   Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228
   Shetty S, 2014, JOVE-J VIS EXP, DOI 10.3791/51330
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Weekes MP, 2013, SCIENCE, V340, P199, DOI 10.1126/science.1235047
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
NR 48
TC 295
Z9 319
U1 0
U2 48
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
EI 1476-4679
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD SEP
PY 2016
VL 18
IS 9
BP 979
EP 992
DI 10.1038/ncb3397
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA DU7TF
UT WOS:000382416800008
PM 27525720
OA Green Accepted, Green Submitted
DA 2024-02-19
ER

PT J
AU Hardiany, NS
   Putra, MAR
   Penantian, RM
   Antarianto, RD
AF Hardiany, Novi Silvia
   Putra, Muhammad Alifian Remifta
   Penantian, Raya Makarim
   Antarianto, Radiana Dhewayani
TI Effects of fasting on FOXO3 expression as an anti-aging biomarker in the
   liver
SO HELIYON
LA English
DT Article
DE FOXO3; IGF-1; SIRT1; SOD; Liver; Fasting
ID DIETARY RESTRICTION; GENE-EXPRESSION; LIFE-SPAN; TRANSCRIPTION FACTORS;
   SIRTUINS; CELLS; SIRT1
AB Background: Aging is a multifactorial degenerative process that can be modulated by fasting through activation of the Fork-head transcription factor of the O class 3 (FOXO3), which plays an important role in increasing lifespans. However, the effects of different fasting durations on the expression of FOXO3 in the liver has not yet been reported. Objective: This study analyzed the effects of different fasting durations on the FOXO3 expression and its pathway by measuring sirtuin1 (SIRT1), insulin-like growth factor-1 (IGF-1), and super-oxide dismutase (SOD) activity in the liver.Methods: New Zealand white rabbits were used to mimic the effects of fasting on humans. The rabbits were divided into the control, intermittent fasting (IF), and prolonged fasting (PF) groups. Both fasting groups were interspersed with the non-fasting phase for 8 h. This treatment was conducted for 6 days. On Day 7, all the rabbits were sacrificed, and their livers were taken to measure the FOXO3 and SIRT1 mRNA expressions, the IGF-1 protein level, and the SOD activity level. ANOVA, multiple comparison, and Pearson's correlation were performed for statistical analysis.Results: The FOXO3 and SIRT1 mRNA expressions were significantly higher in the IF group than in the control group. The FOXO3 expression was also 2.5 times higher in the IF group than in the PF group. There was a positive correlation between the FOXO3 and SIRT1 mRNA expressions. The IGF-1 protein level was significantly lower in the IF and PF groups than in the control group. The SOD-specific activity level was significantly higher in the IF group than in the control and PF groups.Conclusions: Intermittent fasting significantly increased the FOXO3 and SIRT1 mRNA expressions and the SOD activity level in the livers of the rabbits and significantly decreased the circulating and hepatic IGF-1. Therefore, intermittent fasting may give a protective intervention effect to-wards aging.
C1 [Hardiany, Novi Silvia] Univ Indonesia, Fac Med, Dept Biochem & Mol Biol, Jakarta, Indonesia.
   [Putra, Muhammad Alifian Remifta; Penantian, Raya Makarim] Univ Indonesia, Fac Med, Jakarta, Indonesia.
   [Antarianto, Radiana Dhewayani] Univ Indonesia, Fac Med, Dept Histol, Jakarta, Indonesia.
C3 University of Indonesia; University of Indonesia; University of
   Indonesia
RP Hardiany, NS (corresponding author), Univ Indonesia, Fac Med, Dept Biochem & Mol Biol, Jakarta, Indonesia.
EM novi.silvia@ui.ac.id
OI Putra, Muhammad Alifian Remifta/0009-0007-4785-4774; Antarianto, Radiana
   Dhewayani/0000-0002-8578-7505; Hardiany, Novi Silvia/0000-0003-3359-5189
FU Directorate Research & Community Engagement Universitas Indonesia
   [NKB-1510/UN2.RST/HKP.05.00/2020]
FX Funding DR Novi Silvia Hardiany was supported by Directorate Research &
   Community Engagement Universitas Indonesia
   [NKB-1510/UN2.RST/HKP.05.00/2020] .
CR Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Cheng CW, 2014, CELL STEM CELL, V14, P810, DOI 10.1016/j.stem.2014.04.014
   Daitoku H, 2011, BBA-MOL CELL RES, V1813, P1954, DOI 10.1016/j.bbamcr.2011.03.001
   Descalzo DLM, 2016, STEM CELL REP, V7, P55, DOI 10.1016/j.stemcr.2016.06.006
   Faris MAIE, 2019, DIABETES RES CLIN PR, V153, P166, DOI 10.1016/j.diabres.2019.05.023
   Faris MAIE, 2020, BRIT J NUTR, V123, P1, DOI 10.1017/S000711451900254X
   Fondevila F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222111770
   Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539
   Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999
   Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213
   Geisler CE, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0122-x
   Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006
   Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x
   Hardiany NS, 2017, MED J INDONES, V26, P19, DOI 10.13181/mji.v26i1.1511
   Imae M, 2003, J MOL ENDOCRINOL, V30, P253, DOI 10.1677/jme.0.0300253
   Jiang YZ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010100
   Jongbloed F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100853
   Kang KX, 2022, OXID MED CELL LONGEV, V2022, DOI 10.1155/2022/8169981
   Kapahi P, 2017, AGEING RES REV, V39, P3, DOI 10.1016/j.arr.2016.12.005
   Kawamura S., 2020, J TOXICOL CUR RES, V4, P16, DOI [10.24966/TCR-3735/100016, DOI 10.24966/TCR-3735/100016]
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019
   Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91
   Liang C, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03233-y
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008
   Madkour MI, 2019, DIABETES RES CLIN PR, V155, DOI 10.1016/j.diabres.2019.107801
   Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427
   Mc Auley MT, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20160177
   Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x
   Morris BJ, 2015, GERONTOLOGY, V61, P515, DOI 10.1159/000375235
   Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067
   Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204
   Rojas-Morales P, 2019, FREE RADICAL BIO MED, V135, P60, DOI 10.1016/j.freeradbiomed.2019.02.018
   Sengupta P, 2020, INT J PREVENTIVE MED, V11, DOI 10.4103/ijpvm.IJPVM_530_18
   Stefanetti Renae J, 2018, F1000Res, V7, DOI 10.12688/f1000research.15258.1
   STRAUS DS, 1990, MOL ENDOCRINOL, V4, P91, DOI 10.1210/mend-4-1-91
   Tsutsumi Y., 1967, ANKARA UNIV VET FAK, V55, P111
   United Nations Department of Economic and Social Affairs P. D., 2020, World Population Ageing 2020 Highlights: Living Arrangements of Older Persons
   Wang YJ, 2019, EUR J MED CHEM, V161, P48, DOI 10.1016/j.ejmech.2018.10.028
   Xu K, 2017, ONCOL REP, V37, P2391, DOI 10.3892/or.2017.5459
   Yanni AE, 2014, LAB ANIM-UK, V48, P349, DOI 10.1177/0023677214544184
   Zhu YM, 2013, CURR OPIN ONCOL, V25, P630, DOI 10.1097/01.cco.0000432527.49984.a3
   Zullo A, 2018, NUTR METAB CARDIOVAS, V28, P418, DOI 10.1016/j.numecd.2018.02.004
NR 45
TC 1
Z9 1
U1 1
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
EI 2405-8440
J9 HELIYON
JI Heliyon
PD FEB
PY 2023
VL 9
IS 2
AR e13144
DI 10.1016/j.heliyon.2023.e13144
EA JAN 2023
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA D4NL1
UT WOS:000968513600001
PM 36718153
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Rodríguez-González, GL
   Reyes-Castro, LA
   Bautista, CJ
   Beltrán, AA
   Ibáñez, CA
   Vega, CC
   Lomas-Soria, C
   Castro-Rodríguez, DC
   Elías-López, AL
   Nathanielsz, PW
   Zambrano, E
AF Rodriguez-Gonzalez, Guadalupe L.
   Reyes-Castro, Luis A.
   Bautista, Claudia J.
   Beltran, Azucena A.
   Ibanez, Carlos A.
   Vega, Claudia C.
   Lomas-Soria, Consuelo
   Castro-Rodriguez, Diana C.
   Elias-Lopez, Ana L.
   Nathanielsz, Peter W.
   Zambrano, Elena
TI Maternal obesity accelerates rat offspring metabolic ageing in a
   sex-dependent manner
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article; Early Access
DE ageing; developmental programming; maternal obesity; liver fat;
   metabolism; oxidative stress
ID HIGH-FAT DIET; INSULIN-RESISTANCE; OXIDATIVE STRESS; PREGNANCY; GROWTH;
   WEIGHT; WISTAR; HEALTH; MODEL; LIVER
AB Key points
   Maternal obesity predisposes to metabolic dysfunction in male and female offspring Maternal high-fat diet consumption prior to and throughout pregnancy and lactation accelerates offspring metabolic ageing in a sex-dependent manner This study provides evidence for programming-ageing interactions Human epidemiological studies show that maternal obesity (MO) shortens offspring life and health span. Life course cellular mechanisms involved in this developmental programming-ageing interaction are poorly understood. In a well-established rat MO model, female Wistar rats ate chow (controls (C)) or high energy, obesogenic diet to induce MO from weaning through pregnancy and lactation. Females were bred at postnatal day (PND) 120. Offspring (F-1) of mothers on control diet (CF1) and MO diet (MOF1) delivered spontaneously at terms. Both CF1 and MOF1 ate C diet from weaning throughout the study. Offspring were killed at PND 36, 110, 450 and 650. We determined body and liver weights, liver and serum metabolite concentrations, hormones and oxidative stress biomarkers. Male and female CF1 body weight, total fat, adiposity index, serum leptin, insulin, insulin resistance, and liver weight, fat, triglycerides, malondialdehyde, reactive oxygen species and nitrotyrosine all rose with differing ageing trajectories. Female CF1 triglycerides were unchanged with age. Age-related increases were greater in MOF1 than CF1 in both sexes for all variables except glucose in males and females and cholesterol in males. Cholesterol fell in CF1 females but not MOF1. Serum corticosterone levels were higher in male and female MOF1 than CF1 and declined with age. DHEA serum levels were lower in male and female MOF1 than CF1. Liver antioxidant enzymes decreased with age (CF1 and MOF1). Conclusions: exposure to the developmental challenge of MO accelerates progeny ageing metabolic and endocrine profiles in a sex specific manner, providing evidence for programming-ageing interactions.
C1 [Rodriguez-Gonzalez, Guadalupe L.; Reyes-Castro, Luis A.; Bautista, Claudia J.; Beltran, Azucena A.; Ibanez, Carlos A.; Vega, Claudia C.; Lomas-Soria, Consuelo; Castro-Rodriguez, Diana C.; Zambrano, Elena] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Reprod Biol, Mexico City, DF, Mexico.
   [Lomas-Soria, Consuelo; Castro-Rodriguez, Diana C.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Reprod Biol, CONACyT Catedras, Mexico City, DF, Mexico.
   [Elias-Lopez, Ana L.] Inst Nacl Salud Publ, CONACyT Catedras, Mexico City, DF, Mexico.
   [Nathanielsz, Peter W.] Univ Wyoming, Dept Anim Sci, Wyoming Ctr Pregnancy & Life Course Hlth Res, Laramie, WY 82071 USA.
C3 Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran -
   Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador
   Zubiran - Mexico; Instituto Nacional de Salud Publica; University of
   Wyoming
RP Zambrano, E (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Av Vasco de Quiroga 15, Mexico City 14080, DF, Mexico.
EM zamgon@unam.mx
RI Castro-Rodríguez, Diana C/ACR-4154-2022; Ibáñez Chávez, Carlos
   Alberto/AAG-2398-2020; Rodríguez-González, Guadalupe
   Leticia/AAB-1291-2021; REYES CASTRO, LUIS ANTONIO/E-9896-2019
OI Castro-Rodríguez, Diana C/0000-0003-0608-1799; Ibáñez Chávez, Carlos
   Alberto/0000-0002-3435-497X; Lomas, Consuelo/0000-0003-0390-7305; REYES
   CASTRO, LUIS ANTONIO/0000-0003-0397-6810; Vega-Garcia, Claudia
   Cecilia/0000-0002-1265-017X; Nathanielsz, Peter/0000-0001-8410-6280;
   Rodriguez Gonzalez, Guadalupe Leticia/0000-0002-3267-4793
FU CONACyT Mexico [155 166]; Newton Fund RCUK-CONACyT (Research Councils UK
   - Consejo Nacional de Ciencia y Tecnologia) [I000/726/2016
   FONCICYT/49/2016]
FX This work was partially supported by CONACyT Mexico (155 166) and the
   Newton Fund RCUK-CONACyT (Research Councils UK - Consejo Nacional de
   Ciencia y Tecnologia). I000/726/2016 FONCICYT/49/2016.
CR Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996
   Alves-Bezerra M, 2018, COMPR PHYSIOL, V8, P1, DOI 10.1002/cphy.c170012
   Antunes LC, 2016, ARCH ENDOCRIN METAB, V60, P138
   Bautista CJ, 2016, BRIT J NUTR, V115, P538, DOI 10.1017/S0007114515004547
   Bouret S, 2015, PHYSIOL REV, V95, P47, DOI 10.1152/physrev.00007.2014
   Bril F, 2016, J CLIN ENDOCR METAB, V101, P644, DOI 10.1210/jc.2015-3111
   Roura LC, 2015, BEST PRACT RES CL OB, V29, P5, DOI 10.1016/j.bpobgyn.2014.04.018
   Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008
   Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003
   Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.2110
   Cheng CJ, 2019, AGING CELL, V18, DOI 10.1111/acel.12905
   Clegg A, 2018, LANCET DIABETES ENDO, V6, P743, DOI 10.1016/S2213-8587(18)30110-4
   Crujeiras AB, 2015, LIFE SCI, V140, P57, DOI 10.1016/j.lfs.2015.05.003
   Desai M, 2015, INT J OBESITY, V39, P633, DOI 10.1038/ijo.2015.13
   Dickinson H, 2016, J DEV ORIG HLTH DIS, V7, P449, DOI 10.1017/S2040174416000477
   Elahi MM, 2009, BRIT J NUTR, V102, P514, DOI 10.1017/S000711450820749X
   Fasshauer M, 2015, TRENDS PHARMACOL SCI, V36, P461, DOI 10.1016/j.tips.2015.04.014
   Federico A, 2017, MINERVA GASTROENTERO, V63, P337, DOI 10.23736/S1121-421X.17.02376-5
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Grundy D, 2015, J PHYSIOL-LONDON, V593, P2547, DOI 10.1113/JP270818
   Hanson MA, 2014, PHYSIOL REV, V94, P1027, DOI 10.1152/physrev.00029.2013
   Hanson MA, 2015, INT J GYNECOL OBSTET, V131, pS213, DOI 10.1016/S0020-7292(15)30034-5
   Heindel JJ, 2017, REPROD TOXICOL, V68, P3, DOI 10.1016/j.reprotox.2016.10.001
   Herrera-Pérez JJ, 2017, BEHAV BRAIN RES, V321, P137, DOI 10.1016/j.bbr.2017.01.007
   Horwitz BA, 2002, ANNU REV NUTR, V22, P417, DOI 10.1146/annurev.nutr.22.120301.071049
   Howell KR, 2017, REPRODUCTION, V153, pR97, DOI [10.1530/REP-16-0495, 10.1530/rep-16-0495]
   Ingelfinger JR, 2012, J CLIN HYPERTENS, V14, P365, DOI 10.1111/j.1751-7176.2012.00660.x
   Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755
   Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009
   Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011
   Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Kummer KK, 2019, AGING MALE, V22, P55, DOI 10.1080/13685538.2018.1477931
   la Fleur SE, 2004, ENDOCRINOLOGY, V145, P2174, DOI 10.1210/en.2003-1359
   Landi F, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020069
   Lee KK, 2015, HYPERTENSION, V66, P938, DOI 10.1161/HYPERTENSIONAHA.115.05920
   Lomas-Soria C, 2018, J PHYSIOL-LONDON, V596, P4611, DOI 10.1113/JP276372
   Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083
   MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155
   Maffeis C, 2017, OBESITY FACTS, V10, P112, DOI 10.1159/000456668
   Mandy M, 2018, INT HEALTH, V10, P66, DOI 10.1093/inthealth/ihy006
   McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661
   Mehmood A, 2016, BRIT J PHARM RES, V14, DOI 10.9734/BJPR/2016/30333
   Schulz Kenneth F, 2010, Open Med, V4, pe60, DOI [10.1016/j.jclinepi.2010.03.004, 10.1016/j.ijsu.2011.10.001, 10.1136/bmj.c869]
   Morrison JL, 2018, J PHYSIOL-LONDON, V596, P5535, DOI 10.1113/JP274948
   Papanastasiou L, 2017, MINERVA ENDOCRINOL, V42, P151, DOI 10.23736/S0391-1977.16.02583-9
   Pérez LM, 2016, J PHYSIOL-LONDON, V594, P3187, DOI 10.1113/JP271691
   Pérez-Severiano F, 2004, EUR J PHARMACOL, V489, P197, DOI 10.1016/j.ejphar.2004.03.001
   Perla FM, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4060046
   PLAGEMANN A, 1992, EXP CLIN ENDOCRINOL, V99, P154, DOI 10.1055/s-0029-1211159
   Portha B, 2011, EXP DIABETES RES, DOI [10.1155/2011/376509, 10.1155/2011/105076]
   Prescott Susan L, 2016, Nestle Nutr Inst Workshop Ser, V85, P1, DOI 10.1159/000439477
   Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539
   Rodriguez JS, 2012, INT J DEV NEUROSCI, V30, P75, DOI 10.1016/j.ijdevneu.2011.12.012
   Rodríguez-González GL, 2015, INT J OBESITY, V39, P549, DOI 10.1038/ijo.2014.209
   Rodríguez-González GL, 2014, AGE, V36, DOI 10.1007/s11357-014-9721-5
   Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z
   Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477
   Santos M, 2015, AM J PHYSIOL-REG I, V308, pR219, DOI 10.1152/ajpregu.00398.2014
   Sarr O, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/134758
   Sethi JK, 2007, J LIPID RES, V48, P1253, DOI 10.1194/jlr.R700005-JLR200
   Sinton MC, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0702-5
   Skrypnik D, 2019, POL ARCH INTERN MED, V129, P267, DOI 10.20452/pamw.4426
   Spahis S, 2017, ANTIOXID REDOX SIGN, V26, P519, DOI 10.1089/ars.2016.6776
   Stuart Jeffrey A, 2014, Longev Healthspan, V3, P4, DOI 10.1186/2046-2395-3-4
   Tarry-Adkins JL, 2019, FASEB J, V33, P239, DOI 10.1096/fj.201701350RR
   Tarry-Adkins JL, 2016, DIS MODEL MECH, V9, P1221, DOI 10.1242/dmm.026591
   Tsuneto A, 2010, HYPERTENS RES, V33, P638, DOI 10.1038/hr.2010.45
   Vaiserman AM, 2018, MECH AGEING DEV, V173, P61, DOI 10.1016/j.mad.2018.04.003
   Vega CC, 2015, INT J OBESITY, V39, P712, DOI 10.1038/ijo.2013.150
   Villamor E, 2006, LANCET, V368, P1164, DOI 10.1016/S0140-6736(06)69473-7
   Wang AD, 2019, EXP CELL RES, V381, P29, DOI 10.1016/j.yexcr.2019.05.001
   Yokomizo H, 2014, AM J PHYSIOL-ENDOC M, V306, pE1163, DOI 10.1152/ajpendo.00688.2013
   Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313
   Zambrano E, 2015, AGE, V37, DOI 10.1007/s11357-015-9774-0
   Zambrano E, 2010, J PHYSIOL-LONDON, V588, P1791, DOI 10.1113/jphysiol.2010.190033
   Zambrano E, 2016, J ENDOCRINOL, V231, P49, DOI 10.1530/JOE-16-0321
   Zambrano E, 2016, ARCH MED RES, V47, P1, DOI 10.1016/j.arcmed.2016.01.004
   Zambrano E, 2013, NUTR REV, V71, pS42, DOI 10.1111/nure.12068
NR 79
TC 36
Z9 36
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD 2019 DEC
PY 2019
VL 597
IS 23
BP 5549
EP 5563
DI 10.1113/JP278232
EA NOV 2019
PG 15
WC Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology; Physiology
GA JQ6WB
UT WOS:000495506700001
PM 31591717
OA Bronze
DA 2024-02-19
ER

PT J
AU Niemann, J
   Johne, C
   Schröder, S
   Koch, F
   Ibrahim, SM
   Schultz, J
   Tiedge, M
   Baltrusch, S
AF Niemann, Jan
   Johne, Cindy
   Schroeder, Susanne
   Koch, Franziska
   Ibrahim, Saleh M.
   Schultz, Julia
   Tiedge, Markus
   Baltrusch, Simone
TI An mtDNA mutation accelerates liver aging by interfering with the ROS
   response and mitochondrial life cycle
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE Aging; Conplastic mice; Liver; Mitochondria; Reactive oxygen species
ID CYTOCHROME-C-OXIDASE; OXIDATIVE STRESS; DNA MUTATIONS; SUBUNIT; FISSION;
   FUSION; DRP1; COMPLEXES; PROTEIN; ENZYME
AB Mitochondrial dysfunction affects liver metabolism, but it remains unclear whether this interferes with normal liver aging. We investigated several mitochondrial pathways in hepatocytes and liver tissue from a conplastic mouse strain compared with the control C57BL/6NTac strain over 18 months of life. The C57BL/6NTac-mtNODLtJ mice differed from C57BL/6NTac mice by a point mutation in mitochondrial-encoded subunit 3 of cytochrome c oxidase. Young C57BL/6NTac-mtNODLtJ mice showed reduced mitochondrial metabolism but similar reactive oxygen species (ROS) production to C57BL/6NTac mice. Whereas ROS increased almost equally up to 9 months in both strains, different mitochondrial adaptation strategies resulted in decreasing ROS in advanced age in C57BL/6NTac mice, but persistent ROS production in C57BL/6NTac-mtNODLtJ mice. Only the conplastic strain developed elongated mitochondrial networks with artificial loop structures, depressed autophagy, high mitochondrial respiration and up-regulated antioxidative response. Our results indicate that mtDNA mutations accelerate liver ballooning degeneration and carry a serious risk of premature organ aging.
C1 [Niemann, Jan; Johne, Cindy; Schroeder, Susanne; Koch, Franziska; Schultz, Julia; Tiedge, Markus; Baltrusch, Simone] Univ Rostock, Inst Med Biochem & Mol Biol, Rostock, Germany.
   [Koch, Franziska] Oskar Kellner Leibnitz Inst Farm Anim Bio, Inst Nutr Physiol Oskar Kellner Oskar, Dummerstorf, Germany.
   [Ibrahim, Saleh M.] Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany.
C3 University of Rostock; Forschungsinstitut fur Nutztierbiologie (FBN);
   University of Lubeck
RP Baltrusch, S (corresponding author), Univ Rostock, Inst Med Biochem & Mol Biol, Rostock, Germany.
EM simone.baltrusch@med.uni-rostock.de
RI Ibrahim, Saleh/AAO-9541-2020; Koch, Franziska/AAF-2159-2021
OI Ibrahim, Saleh/0000-0001-7827-2290; Koch, Franziska/0000-0002-1798-5374
FU BMBF GERONTOSYS 2 project ROSAge; DFG [ExC-306]; DDG
FX This work was supported by the BMBF GERONTOSYS 2 project ROSAge, the DFG
   ExC-306 (S.M. Ibrahim) and the DDG (S. Baltrusch). We are grateful to A.
   Kott, R. Waterstradt, S. Giers, I. Klamfuss and L. Wengler for technical
   assistance, to Dr. J. Brenmohl (Leibniz Institute for Farm Animal
   Biology, Institute for Genome Biology, Dummerstorf, Germany) for help
   with the Seahorse XF Cell Mito Stress Test and to D. Beattie (freelance
   medical writer/UK) for editorial assistance.
CR Abreu IA, 2010, BBA-PROTEINS PROTEOM, V1804, P263, DOI 10.1016/j.bbapap.2009.11.005
   Alexeyev MF, 2004, CLIN SCI, V107, P355, DOI 10.1042/CS20040148
   Arnold S, 2012, MITOCHONDRION, V12, P46, DOI 10.1016/j.mito.2011.05.003
   Asgharpour A., 2016, J HEPATOL
   Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015
   Baltrusch S, 2005, DIABETES, V54, P2829, DOI 10.2337/diabetes.54.10.2829
   Bancroft J.D., 2008, Theory and practice of histological techniques
   Brand MD, 2000, EXP GERONTOL, V35, P811, DOI 10.1016/S0531-5565(00)00135-2
   Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   Fontanesi F, 2008, IUBMB LIFE, V60, P557, DOI 10.1002/iub.86
   Girotto S, 2014, J BIOL CHEM, V289, P10887, DOI 10.1074/jbc.M113.535112
   Han B, 2011, BIOCHEM BIOPH RES CO, V408, P45, DOI 10.1016/j.bbrc.2011.03.114
   Hanna MG, 1998, AM J HUM GENET, V63, P29, DOI 10.1086/301910
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Horváth R, 2005, NEUROMUSCULAR DISORD, V15, P851, DOI 10.1016/j.nmd.2005.09.005
   Hübscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x
   Jahani-Asl A, 2007, J BIOL CHEM, V282, P23788, DOI 10.1074/jbc.M703812200
   Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034
   Kirkman HN, 2007, TRENDS BIOCHEM SCI, V32, P44, DOI 10.1016/j.tibs.2006.11.003
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300
   Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294
   Logan A, 2014, AGING CELL, V13, P765, DOI 10.1111/acel.12212
   Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246
   Mailloux RJ, 2012, TRENDS ENDOCRIN MET, V23, P451, DOI 10.1016/j.tem.2012.04.004
   MANFREDI G, 1995, NEUROMUSCULAR DISORD, V5, P391, DOI 10.1016/0960-8966(94)00079-O
   Massa V, 2008, AM J HUM GENET, V82, P1281, DOI 10.1016/j.ajhg.2008.05.002
   Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018
   Milani P, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/836760
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152
   Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303
   Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172
   Schmitt H, 2011, DIABETOLOGIA, V54, P1744, DOI 10.1007/s00125-011-2133-5
   Suga M, 2011, ACTA CRYSTALLOGR D, V67, P742, DOI 10.1107/S0907444911022803
   Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200
   Tamiya G, 2014, AM J HUM GENET, V95, P294, DOI 10.1016/j.ajhg.2014.07.013
   Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606
   Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733
   Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136
   Van Raamsdonk JM, 2010, GENETICS, V185, P559, DOI 10.1534/genetics.110.115378
   WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661
   Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955
   Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586
   WILSON KS, 1990, ARCH BIOCHEM BIOPHYS, V282, P413, DOI 10.1016/0003-9861(90)90137-N
   Wu SN, 2011, FEBS J, V278, P941, DOI 10.1111/j.1742-4658.2011.08010.x
   Yamamoto T, 2016, AUTOPHAGY, V12, P801, DOI 10.1080/15548627.2016.1159376
   Yamashita S, 2010, J NEUROCHEM, V113, P860, DOI 10.1111/j.1471-4159.2010.06658.x
   Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855
   Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108
   Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028
NR 55
TC 34
Z9 38
U1 0
U2 15
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JAN
PY 2017
VL 102
BP 174
EP 187
DI 10.1016/j.freeradbiomed.2016.11.035
PG 14
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA EI3AG
UT WOS:000392361200015
PM 27890640
DA 2024-02-19
ER

PT J
AU Ozaki, N
   Sato, E
   Kurokawa, T
   Ishibashi, S
AF Ozaki, N
   Sato, E
   Kurokawa, T
   Ishibashi, S
TI Early changes in the expression of GLUT4 protein in the heart of
   senescence-accelerated mouse
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE senescence-accelerated mouse (SAM); SAMP8; SAMR1; GLUT4; GLUT1
ID GLUCOSE TRANSPORTER GLUT4; GRANULAR STRUCTURES; INSULIN; RAT; MEMORY;
   BRAIN; STIMULATION; SAM-P/8; STRAIN; MODEL
AB The content of facilitative glucose transporter proteins in the heart, lung, liver, testis and cerebellum of SAMP8, a substrain of senescence-accelerated prone mouse, was investigated. The increase in the expression of facilitative glucose transporter proteins, estimated by the D-glucose inhibitable cytochalasin B binding assay, was observed only in the heart of 4-8 week old SAMP8 in comparison with SAMR1, a substrain of senescence-accelerated resistant mouse. The increase in cytochalasin B binding protein in SAMP8 was restricted at 4-8 weeks old, thereafter no significant difference was observed between the two substrains. Furthermore, the immunoblotting revealed that the content of the GLUT4 (glucose transporter isoform 4) protein in the crude membranes prepared from 4-8 week old SAMP8 was greater than that of SAMR1, without the difference in the content of the GLUT1 (glucose transporter isoform 1) protein. Additionally, the increased GLUT4 protein in SAMP8 was localized in the intracellular membranes. These results suggest that an accelerated ageing of SAMP8 is possibly related to the overproduction of the energy in the heart through the increase in glucose uptake after the translocation of GLUT4 from the intracellular pools to the plasma membranes.
C1 HIROSHIMA UNIV, SCH MED, DEPT PHYSIOL, MINAMI KU, HIROSHIMA 734, JAPAN.
C3 Hiroshima University
CR AKIYAMA H, 1986, ACTA NEUROPATHOL, V72, P124, DOI 10.1007/BF00685973
   AVRUCH J, 1971, BIOCHIM BIOPHYS ACTA, V233, P334, DOI 10.1016/0005-2736(71)90331-2
   AXELROD JD, 1983, BIOCHEMISTRY-US, V22, P2222, DOI 10.1021/bi00278a025
   BERGER J, 1989, NATURE, V340, P70, DOI 10.1038/340070a0
   BOUREY RE, 1990, J CLIN INVEST, V86, P542, DOI 10.1172/JCI114742
   CHAKRABARTI R, 1994, J BIOL CHEM, V269, P7926
   GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329
   HERMAN GA, 1994, P NATL ACAD SCI USA, V91, P12750, DOI 10.1073/pnas.91.26.12750
   HOLMAN GD, 1990, J BIOL CHEM, V265, P18172
   ISHII K, 1994, BIOCHEM BIOPH RES CO, V205, P857, DOI 10.1006/bbrc.1994.2743
   KAESTNER KH, 1991, P NATL ACAD SCI USA, V88, P1933, DOI 10.1073/pnas.88.5.1933
   KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017
   KOLTER T, 1992, BIOCHEM BIOPH RES CO, V189, P1207, DOI 10.1016/0006-291X(92)92333-S
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAWRENCE JC, 1992, P NATL ACAD SCI USA, V89, P3493, DOI 10.1073/pnas.89.8.3493
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   MORCOS NC, 1980, BIOCHIM BIOPHYS ACTA, V598, P27, DOI 10.1016/0005-2736(80)90263-1
   OHTA A, 1989, BRAIN RES, V498, P195, DOI 10.1016/0006-8993(89)90421-6
   PETERSEN S, 1991, FEBS LETT, V286, P1, DOI 10.1016/0014-5793(91)80927-U
   SATO E, 1994, BRAIN RES, V637, P133, DOI 10.1016/0006-8993(94)91226-2
   Sato E, 1996, MECH AGEING DEV, V86, P105, DOI 10.1016/0047-6374(95)01681-3
   SILVERMAN M, 1991, ANNU REV BIOCHEM, V60, P757, DOI 10.1146/annurev.bi.60.070191.003545
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKEDA T, 1994, INT CONGR SER, V1062, P15
   TAKEMURA M, 1993, AM J PATHOL, V142, P1887
   WANG C, 1991, BIOCHEM BIOPH RES CO, V177, P1095, DOI 10.1016/0006-291X(91)90651-M
   WHEELER TJ, 1994, BBA-BIOMEMBRANES, V1196, P191, DOI 10.1016/0005-2736(94)00211-8
   YAGI H, 1988, BRAIN RES, V474, P86, DOI 10.1016/0006-8993(88)90671-3
   YAGI H, 1989, J NEUROPATH EXP NEUR, V48, P577, DOI 10.1097/00005072-198909000-00008
   YAMAMOTO M, 1989, EUR J PHARMACOL, V166, P345, DOI 10.1016/0014-2999(89)90081-2
NR 31
TC 10
Z9 12
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUL 17
PY 1996
VL 88
IS 3
BP 149
EP 158
DI 10.1016/0047-6374(96)01733-2
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA UW312
UT WOS:A1996UW31200003
PM 8819098
DA 2024-02-19
ER

PT J
AU Ji, MS
   Su, XH
   Liu, JZ
   Zhao, Y
   Li, ZD
   Xu, X
   Li, HW
   Nashun, B
AF Ji, Musi
   Su, Xiaohua
   Liu, Jizhen
   Zhao, Yi
   Li, Zhidong
   Xu, Xun
   Li, Huawen
   Nashun, Bayaer
TI Comparison of naturally aging and D-galactose induced aging model in
   beagle dogs
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE aging; animal model; beagle dogs; induced aging
ID AGE-RELATED DISEASES; ALZHEIMERS-DISEASE; ANIMAL-MODELS; MOUSE MODELS;
   LIFE-SPAN; BRAIN; RATS; MICE; APOPTOSIS; PATHOLOGY
AB Animal models have been used to study aging for decades. In numerous aging studies, beagles are the most commonly used breed of dog. However, few studies have compared between naturally aging models and experimentally induced aging models in beagle dogs. In the present study, a D-galactose induced aging model was compared with a naturally aging model, and young adult dogs were considered as the young control group. The level of malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in serum, and brain tissue were measured. Histopathological comparisons of the liver, kidneys, heart, lungs and spleen were evaluated using hematoxylin and eosin (H&E) staining, in addition, the brain was evaluated by H&E staining, and Nissl staining. The expression levels of aging-associated factors in the hippocampus, including proliferating cell nuclear antigen (PCNA), P16 and P21 were also determined through reverse transcription quantitative-polymerase chain reaction, and western blot analysis. The results indicated that D-galactose induced aging significantly increased the MDA level, while the levels of SOD and GSH-Px were diminished when compared with the young control group, which was similar to the naturally aging group. Parallel histopathological features were observed in the D-galactose induced aging and naturally aging groups compared with the young control group. However, a reduced expression level of PCNA, and increased expression levels of P16 and P21 were observed in the naturally ageing and induced aging groups compared with the young control group. The results of the current study demonstrated that the beagle dogs in D-galactose induced aging model exhibited significant similarities with the naturally aging model, providing evidence to support that the D-galactose induced aging model may be applied to aging studies.
C1 [Ji, Musi; Su, Xiaohua; Liu, Jizhen; Zhao, Yi; Li, Zhidong; Xu, Xun; Li, Huawen; Nashun, Bayaer] Guangdong Med Univ, Lab Anim Ctr, Dongguan 523808, Guangdong, Peoples R China.
   [Ji, Musi] Guangdong Med Univ, Liaobu Hosp, Dept Internal Med, Dongguan 523400, Guangdong, Peoples R China.
C3 Guangdong Medical University; Guangdong Medical University
RP Nashun, B (corresponding author), Guangdong Med Univ, Lab Anim Ctr, Songshan Lake Hitech Ind Dev Zone, 1 Xincheng Rd, Dongguan 523808, Guangdong, Peoples R China.
EM bayaer17@yeah.net
FU Provincial Science and Technology Project of Guangdong Province
   [2015A030302076, 2016A030303056, 2016A020215224]; Natural Science
   Foundation Project of Guangdong Province [2015A030310046,
   2016A030313674]
FX This study was funded by Provincial Science and Technology Project of
   Guangdong Province (no. 2015A030302076, 2016A030303056 and
   2016A020215224) and the Natural Science Foundation Project of Guangdong
   Province (no. 2015A030310046 and 2016A030313674).).
CR Araujo JA, 2011, PHARMACOL BIOCHEM BE, V98, P203, DOI 10.1016/j.pbb.2011.01.005
   Borràs D, 1999, VET PATHOL, V36, P202, DOI 10.1354/vp.36-3-202
   Budni J, 2017, METAB BRAIN DIS, V32, P811, DOI 10.1007/s11011-017-9972-9
   CALVERT GD, 1975, ATHEROSCLEROSIS, V22, P583, DOI 10.1016/0021-9150(75)90036-2
   Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003
   Fast R, 2013, J VET INTERN MED, V27, P822, DOI 10.1111/jvim.12109
   Freeman LM, 2012, J VET INTERN MED, V26, P3, DOI 10.1111/j.1939-1676.2011.00838.x
   Gurkar AU, 2015, EXP GERONTOL, V68, P43, DOI 10.1016/j.exger.2015.01.045
   Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002
   Harkema L, 2016, VET PATHOL, V53, P366, DOI 10.1177/0300985815625169
   Head E, 2013, BBA-MOL BASIS DIS, V1832, P1384, DOI 10.1016/j.bbadis.2013.03.016
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224
   Kim SA, 2013, ARTERIOSCL THROM VAS, V33, P1306, DOI 10.1161/ATVBAHA.113.301312
   Kraus C, 2013, AM NAT, V181, P492, DOI 10.1086/669665
   Lees H, 2016, MATURITAS, V93, P18, DOI 10.1016/j.maturitas.2016.06.008
   Li MY, 2014, J VET SCI, V15, P353, DOI 10.4142/jvs.2014.15.3.353
   Liao CY, 2014, CURR TOP DEV BIOL, V109, P249, DOI 10.1016/B978-0-12-397920-9.00003-2
   Liu C, 2017, CLIN INTERV AGING, V12, P593, DOI 10.2147/CIA.S132277
   Maes C, 2017, NEUROSCI BIOBEHAV R, V75, P234, DOI 10.1016/j.neubiorev.2017.01.052
   Marchal J, 2013, ANN NY ACAD SCI, V1290, P67, DOI 10.1111/nyas.12214
   Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829
   Murata M, 2002, J DIABETES COMPLICAT, V16, P363, DOI 10.1016/S1056-8727(01)00171-4
   Bosch MN, 2012, CURR ALZHEIMER RES, V9, P298
   Niedernhofer LJ, 2017, AGEING RES REV, V35, P241, DOI 10.1016/j.arr.2016.09.012
   Parameshwaran K, 2010, REJUV RES, V13, P729, DOI 10.1089/rej.2010.1020
   SCHRIEFER JA, 1980, J PHARMACOL METHOD, V3, P297, DOI 10.1016/0160-5402(80)90071-6
   Shahroudi MJ, 2017, J PHARMACOPUNCT, V20, P29, DOI 10.3831/KPI.2017.20.006
   Soria-Valles C, 2015, NAT CELL BIOL, V17, P1004, DOI 10.1038/ncb3207
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   Vasilevko V, 2009, CNS NEUROL DISORD-DR, V8, P98, DOI 10.2174/187152709787847333
   Xing H, 2001, Hua Xi Yi Ke Da Xue Xue Bao, V32, P229
NR 32
TC 29
Z9 33
U1 0
U2 13
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD DEC
PY 2017
VL 14
IS 6
BP 5881
EP 5888
DI 10.3892/etm.2017.5327
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FP7LE
UT WOS:000417815000092
PM 29285136
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Miyata, M
   Suzuki, S
   Misaka, T
   Shishido, T
   Saitoh, S
   Ishigami, A
   Kubota, I
   Takeishi, Y
AF Miyata, Makiko
   Suzuki, Satoshi
   Misaka, Tomofumi
   Shishido, Tetsuro
   Saitoh, Shu-ichi
   Ishigami, Akihito
   Kubota, Isao
   Takeishi, Yasuchika
TI Senescence Marker Protein 30 Has a Cardio-Protective Role in
   Doxorubicin-Induced Cardiac Dysfunction
SO PLOS ONE
LA English
DT Article
ID OXIDATIVE STRESS; SMP30 DEFICIENCY; TRANSGENIC MICE; KNOCKOUT MICE;
   CARDIOTOXICITY; CARDIOMYOPATHY; MODULATION; LIVER; PATHOGENESIS;
   ANGIOTENSIN
AB Background: Senescence marker protein 30 (SMP30), which was originally identified as an aging marker protein, is assumed to act as a novel anti-aging factor in the liver, lungs and brain. We hypothesized that SMP30 has cardio-protective function due to its anti-aging and anti-oxidant effects on doxorubicin (DOX)-induced cardiac dysfunction.
   Methods and Results: SMP30 knockout (SMP30 KO) mice, SMP30 transgenic (SMP30 TG) mice with cardiac-specific overexpression of SMP30 gene and wild-type (WT) littermate mice at 12-14 weeks of age were given intra-peritoneal injection of DOX (20 mg/kg) or saline. Five days after DOX injection, echocardiography revealed that left ventricular ejection fraction was more severely reduced in the DOX-treated SMP30 KO mice than in the DOX-treated WT mice, but was preserved in the DOX-treated SMP30 TG mice. Generation of reactive oxygen species and oxidative DNA damage in the myocardium were greater in the DOX-treated SMP30 KO mice than in the DOX-treated WT mice, but much less in the SMP30 TG mice. The numbers of deoxynucleotidyltransferase-mediated dUTP nick end-labeling positive nuclei in the myocardium, apoptotic signaling pathways such as caspase-3 activity, Bax/Bcl-2 ratio and phosphorylation activity of c-Jun N-terminal kinase were increased in SMP30 KO mice and decreased in SMP30 TG mice compared with WT mice after DOX injection.
   Conclusions: SMP30 has a cardio-protective role by anti-oxidative and anti-apoptotic effects in DOX-induced cardiotoxicity, and can be a new therapeutic target to prevent DOX-induced heart failure.
C1 [Miyata, Makiko; Suzuki, Satoshi; Misaka, Tomofumi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan.
   [Shishido, Tetsuro; Kubota, Isao] Yamagata Univ, Sch Med, Dept Internal Med 1, Yamagata 99023, Japan.
   [Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo, Japan.
C3 Fukushima Medical University; Yamagata University; Tokyo Metropolitan
   Institute of Gerontology
RP Takeishi, Y (corresponding author), Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima, Japan.
EM takeishi@fmu.ac.jp
OI Ishigami, Akihito/0000-0001-7875-7482
FU Japan Society for the Promotion of Science [21590935, 24591100];
   Grants-in-Aid for Scientific Research [24591100, 25870584] Funding
   Source: KAKEN
FX This study was supported in part by grants-in-aid for Scientific
   Research (Nos. 21590935 and 24591100) from Japan Society for the
   Promotion of Science. No additional external funding was received for
   this study. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Arimoto T, 2006, CIRCULATION, V113, P60, DOI 10.1161/CIRCULATIONAHA.105.560771
   Bernhard D, 2008, GERONTOLOGY, V54, P24, DOI 10.1159/000113503
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Du JF, 2008, AM J PHYSIOL-HEART C, V294, pH2604, DOI 10.1152/ajpheart.91506.2007
   Ewer MS, 2005, J CLIN ONCOL, V23, P2900, DOI 10.1200/JCO.2005.05.827
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Hasegawa G, 2010, ENDOCRINOLOGY, V151, P529, DOI 10.1210/en.2009-1163
   Ichiseki T, 2005, RHEUMATOLOGY, V44, P456, DOI 10.1093/rheumatology/keh518
   Iliskovic N, 1998, MOL CELL BIOCHEM, V188, P161, DOI 10.1023/A:1006845120287
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Machii H, 2010, MECH AGEING DEV, V131, P710, DOI 10.1016/j.mad.2010.09.009
   Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21
   Menna P, 2007, CELL BIOL TOXICOL, V23, P49, DOI 10.1007/s10565-006-0143-8
   Misaka T, 2011, CIRCULATION, V124
   Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02
   Neilan TG, 2007, CIRCULATION, V116, P506, DOI 10.1161/CIRCULATIONAHA.106.652339
   Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27
   Pai VB, 2000, DRUG SAFETY, V22, P263, DOI 10.2165/00002018-200022040-00002
   Sato T, 2006, AM J RESP CRIT CARE, V174, P530, DOI 10.1164/rccm.200511-1816OC
   Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307
   Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337
   Son TG, 2008, ARCH PHARM RES, V31, P872, DOI 10.1007/s12272-001-1240-3
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002
   Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968
   TSAO CS, 1987, J NUTR, V117, P291, DOI 10.1093/jn/117.2.291
   VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710
   Wang MY, 2010, J MOL CELL CARDIOL, V48, P765, DOI 10.1016/j.yjmcc.2010.01.006
   Wu JA, 2010, J ULTRAS MED, V29, P1771, DOI 10.7863/jum.2010.29.12.1771
   Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9
   Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151
NR 36
TC 18
Z9 20
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 31
PY 2013
VL 8
IS 12
AR e79093
DI 10.1371/journal.pone.0079093
PG 8
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 284NF
UT WOS:000329325200002
PM 24391705
OA gold, Green Submitted, Green Published
DA 2024-02-19
ER

PT J
AU Yang, GY
   Jena, PK
   Hu, Y
   Sheng, LL
   Chen, SY
   Slupsky, CM
   Davis, R
   Tepper, CG
   Wan, YJY
AF Yang, Guiyan
   Jena, Prasant K. K.
   Hu, Ying
   Sheng, Lili
   Chen, Shin-Yu
   Slupsky, Carolyn M. M.
   Davis, Ryan
   Tepper, Clifford G. G.
   Wan, Yu-Jui Yvonne
TI The essential roles of FXR in diet and age influenced metabolic changes
   and liver disease development: a multi-omics study
SO BIOMARKER RESEARCH
LA English
DT Article
DE Liver; Metabolic disease; Nonalcoholic fatty liver disease; Nonalcoholic
   steatohepatitis; Hepatocellular carcinoma; Bile acid; Bile acid
   receptor; Gut microbiota
ID HEPATOCELLULAR-CARCINOMA; HEPATIC INFLAMMATION; DOWN-REGULATION;
   BILE-ACID; METABONOMICS; EXPRESSION; BIOMARKER
AB BackgroundAging and diet are risks for metabolic diseases. Bile acid receptor farnesoid X receptor (FXR) knockout (KO) mice develop metabolic liver diseases that progress into cancer as they age, which is accelerated by Western diet (WD) intake. The current study uncovers the molecular signatures for diet and age-linked metabolic liver disease development in an FXR-dependent manner.MethodsWild-type (WT) and FXR KO male mice, either on a healthy control diet (CD) or a WD, were euthanized at the ages of 5, 10, or 15 months. Hepatic transcriptomics, liver, serum, and urine metabolomics as well as microbiota were profiled.ResultsWD intake facilitated hepatic aging in WT mice. In an FXR-dependent manner, increased inflammation and reduced oxidative phosphorylation were the primary pathways affected by WD and aging. FXR has a role in modulating inflammation and B cell-mediated humoral immunity which was enhanced by aging. Moreover, FXR dictated neuron differentiation, muscle contraction, and cytoskeleton organization in addition to metabolism. There were 654 transcripts commonly altered by diets, ages, and FXR KO, and 76 of them were differentially expressed in human hepatocellular carcinoma (HCC) and healthy livers. Urine metabolites differentiated dietary effects in both genotypes, and serum metabolites clearly separated ages irrespective of diets. Aging and FXR KO commonly affected amino acid metabolism and TCA cycle. Moreover, FXR is essential for colonization of age-related gut microbes. Integrated analyses uncovered metabolites and bacteria linked with hepatic transcripts affected by WD intake, aging, and FXR KO as well as related to HCC patient survival.ConclusionFXR is a target to prevent diet or age-associated metabolic disease. The uncovered metabolites and microbes can be diagnostic markers for metabolic disease.
C1 [Yang, Guiyan; Jena, Prasant K. K.; Hu, Ying; Sheng, Lili; Davis, Ryan; Wan, Yu-Jui Yvonne] Univ Calif Davis Hlth, Dept Pathol & Lab Med, Room 3400B, Res Bldg 3, 4645 2nd Ave, Sacramento, CA 95817 USA.
   [Chen, Shin-Yu; Slupsky, Carolyn M. M.] Univ Calif Davis, Dept Nutr, Davis, CA USA.
   [Tepper, Clifford G. G.] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA USA.
C3 University of California System; University of California Davis;
   University of California System; University of California Davis
RP Wan, YJY (corresponding author), Univ Calif Davis Hlth, Dept Pathol & Lab Med, Room 3400B, Res Bldg 3, 4645 2nd Ave, Sacramento, CA 95817 USA.
EM yjywan@ucdavis.edu
RI Yang, Guiyan/HTS-4476-2023
OI , Guiyan/0000-0001-8885-6396
CR ASANO K, 1988, CLIN CHIM ACTA, V173, P305, DOI 10.1016/0009-8981(88)90018-6
   Bournat Juan C, 2010, Curr Opin Endocrinol Diabetes Obes, V17, P446, DOI 10.1097/MED.0b013e32833c3026
   Chhetri DR, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01172
   Croze ML, 2013, BIOCHIMIE, V95, P1811, DOI 10.1016/j.biochi.2013.05.011
   Ding L, 2020, EUR J LIPID SCI TECH, V122, DOI 10.1002/ejlt.202000179
   Dubois-Chevalier J, 2017, GENOME RES, V27, P985, DOI 10.1101/gr.217075.116
   Ferrarini A, 2019, J PROTEOME RES, V18, P3067, DOI 10.1021/acs.jproteome.9b00185
   Guasch-Ferré M, 2020, AM J CLIN NUTR, V111, P835, DOI [10.1093/ajcn/nqaa016, 10.1093/ajcn/ngaa016]
   Guo HL, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/5970085
   Hasegawa Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71592-9
   Huang XF, 2015, ACTA PHARMACOL SIN, V36, P37, DOI 10.1038/aps.2014.117
   Ioannou GN, 2021, J HEPATOL, V75, P1476, DOI 10.1016/j.jhep.2021.08.012
   Jena PK, 2017, AM J PATHOL, V187, P1800, DOI 10.1016/j.ajpath.2017.04.019
   Jena PK, 2020, BIOMARK RES, V8, DOI 10.1186/s40364-020-00239-8
   Jena PK, 2020, HEPATOBIL SURG NUTR, V9, P170, DOI 10.21037/hbsn.2019.09.07
   Juanola O, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18105227
   Khatamianfar V, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001410
   Kim DJ, 2019, METABOLOMICS, V15, DOI 10.1007/s11306-019-1494-5
   Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249
   Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472
   Le HH, 2022, CELL HOST MICROBE, V30, P798, DOI 10.1016/j.chom.2022.05.002
   Lefebvre P, 2014, J HEPATOL, V60, P689, DOI 10.1016/j.jhep.2014.01.001
   Li L, 2017, ONCOL REP, V38, P2607, DOI 10.3892/or.2017.5946
   Li MX, 2021, CELL ONCOL, V44, P541, DOI 10.1007/s13402-021-00599-9
   Lou-Bonafonte JM, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800136
   Lv Y, 2017, J CANCER, V8, P1205, DOI 10.7150/jca.18255
   Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171
   Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991
   Michels N, 2022, OBES REV, V23, DOI 10.1111/obr.13409
   Miyanishi K, 2019, FREE RADICAL BIO MED, V133, P200, DOI 10.1016/j.freeradbiomed.2018.07.006
   Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7
   Ni Y, 2014, J PROTEOME RES, V13, P3857, DOI 10.1021/pr500443c
   Parekh PJ, 2015, CLIN GERIATR MED, V31, P529, DOI 10.1016/j.cld.2015.05.002
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Qi SW, 2017, CLIN CHIM ACTA, V473, P89, DOI 10.1016/j.cca.2017.08.022
   Ribas V, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0106-5
   Sheng LL, 2021, HEPATOBIL SURG NUTR, V10, P31, DOI 10.21037/hbsn-20-671
   Sheng LL, 2017, J PATHOL, V243, P431, DOI 10.1002/path.4983
   Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1
   Sookoian S, 2012, WORLD J GASTROENTERO, V18, P3775, DOI 10.3748/wjg.v18.i29.3775
   Su HY, 2012, AM J PHYSIOL-GASTR L, V303, pG1245, DOI 10.1152/ajpgi.00439.2011
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tan XY, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201900257
   Tang YF, 2018, CELL PHYSIOL BIOCHEM, V47, P344, DOI 10.1159/000489811
   Veskovic M, 2019, EUR J PHARMACOL, V848, P39, DOI 10.1016/j.ejphar.2019.01.043
   Wang T, 2022, J CANCER, V13, P589, DOI 10.7150/jca.64017
   Winter H, 2019, CANCERS, V11, DOI 10.3390/cancers11121895
   Wu LW, 2021, BIOMED PHARMACOTHER, V133, DOI 10.1016/j.biopha.2020.111036
   Xia L, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.769196
   Xie XW, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.621373
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Xu DF, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03450-z
   Yang B, 2020, J CELL PHYSIOL, V235, P6507, DOI 10.1002/jcp.29444
   Zhang HF, 2021, FEBS OPEN BIO, V11, P2784, DOI 10.1002/2211-5463.13278
   Zhang X, 2021, GUT, V70, P761, DOI 10.1136/gutjnl-2019-319664
   Zheng NN, 2020, J PHARM ANAL, V10, P560, DOI 10.1016/j.jpha.2019.11.003
   Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895
NR 59
TC 3
Z9 3
U1 7
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2050-7771
J9 BIOMARK RES
JI Biomark. Res.
PD FEB 18
PY 2023
VL 11
IS 1
AR 20
DI 10.1186/s40364-023-00458-9
PG 19
WC Oncology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA 9B1JM
UT WOS:000934500800001
PM 36803569
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Huang, CH
   Huang, YL
   Shen, ZQ
   Lin, CH
   Tsai, TF
AF Huang, Chen-Hua
   Huang, Yi-Long
   Shen, Zhao-Qing
   Lin, Chao-Hsiung
   Tsai, Ting-Fen
TI Cisd2 Preserves the Youthful Pattern of the Liver Proteome during
   Natural Aging of Mice
SO BIOMEDICINES
LA English
DT Article
DE Cisd2; non-alcoholic fatty liver disease; aging; lipid metabolism;
   mitochondria; protein homeostasis
ID NONALCOHOLIC FATTY LIVER; MITOCHONDRIAL; DISEASE; STEATOHEPATITIS;
   DEGRADATION; PEROXISOMES; ADAPTATION; OXIDATION; PROTEINS; HUMANS
AB Cisd2 (CDGSH iron sulfur domain 2) is a pro-longevity gene that extends the lifespan and health span of mice, ameliorates age-associated structural damage and limits functional decline in multiple tissues. Non-alcoholic fatty liver disease (NAFLD), which plays an important role in age-related liver disorders, is the most common liver disease worldwide. However, no medicines that can be used to specifically and effectively treat NAFLD are currently approved for this disease. Our aim was to provide pathological and molecular evidence to show that Cisd2 protects the liver from age-related dysregulation of lipid metabolism and protein homeostasis. This study makes four major discoveries. Firstly, a persistently high level of Cisd2 protects the liver from age-related fat accumulation. Secondly, proteomics analysis revealed that Cisd2 ameliorates age-related dysregulation of lipid metabolism, including lipid biosynthesis and beta-oxidation, in mitochondria and peroxisomes. Thirdly, Cisd2 attenuates aging-associated oxidative modifications of proteins. Finally, Cisd2 regulates intracellular protein homeostasis by maintaining the functionality of molecular chaperones and protein synthesis machinery. Our proteomics findings highlight Cisd2 as a novel molecular target for the development of therapies targeting fatty liver diseases, and these new therapies are likely to help prevent subsequent malignant progression to cirrhosis and hepatocellular carcinoma.
C1 [Huang, Chen-Hua; Huang, Yi-Long; Shen, Zhao-Qing; Lin, Chao-Hsiung; Tsai, Ting-Fen] Natl Yang Ming Chiao Tung Univ, Dept Life Sci, Taipei 112, Taiwan.
   [Huang, Chen-Hua; Huang, Yi-Long; Shen, Zhao-Qing; Lin, Chao-Hsiung; Tsai, Ting-Fen] Natl Yang Ming Chiao Tung Univ, Inst Genome Sci, Taipei 112, Taiwan.
   [Huang, Yi-Long; Lin, Chao-Hsiung; Tsai, Ting-Fen] Natl Yang Ming Chiao Tung Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan.
   [Tsai, Ting-Fen] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan 350, Taiwan.
C3 National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung
   University; National Yang Ming Chiao Tung University; National Health
   Research Institutes - Taiwan
RP Lin, CH; Tsai, TF (corresponding author), Natl Yang Ming Chiao Tung Univ, Dept Life Sci, Taipei 112, Taiwan.; Lin, CH; Tsai, TF (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Genome Sci, Taipei 112, Taiwan.; Lin, CH; Tsai, TF (corresponding author), Natl Yang Ming Chiao Tung Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan.; Tsai, TF (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan 350, Taiwan.
EM denny1210.y@nycu.edu.tw; yilonghuang@nycu.edu.tw; d40008003@ym.edu.tw;
   chlin2@ym.edu.tw; tftsai@ym.edu.tw
OI Huang, Yi-Long/0000-0002-0980-4828; Shen, Zhao-Qing/0000-0001-9126-0219;
   Huang, Chen-Hua/0000-0003-4681-4256; LIN,
   CHAO-HSIUNG/0000-0001-6344-271X; TSAI, TING-FEN/0000-0003-3239-4430
FU Ministry of Science and Technology [MOST 109-2311-B-010-003, MOST
   109-2327-B-010-002, MOST 109-2320-B-010-043]; National Health Research
   Institutes (NHRI intramural grant) [MG-109-PP-19, MG-110-PP-15]
FX This work was supported by grants from the Ministry of Science and
   Technology (MOST 109-2311-B-010-003 to C.H.L.; MOST 109-2327-B-010-002,
   MOST 109-2320-B-010-043 to T.F.T.) and grants from the National Health
   Research Institutes (NHRI intramural grant MG-109-PP-19 and MG-110-PP-15
   to T.F.T.).
CR Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924
   Bell-Temin H, 2019, AGING-US, V11, P1045, DOI 10.18632/aging.101810
   Cai L, 2016, J LIPID RES, V57, P1412, DOI 10.1194/jlr.M065920
   Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x
   Chen YF, 2020, J PATHOL, V250, P299, DOI 10.1002/path.5374
   Chen YF, 2009, GENE DEV, V23, P1183, DOI 10.1101/gad.1779509
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Cook WS, 2001, EXP CELL RES, V268, P70, DOI 10.1006/excr.2001.5266
   D'Erasmo L, 2020, METABOLISM, V113, DOI 10.1016/j.metabol.2020.154395
   Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0
   Dirkx R, 2005, HEPATOLOGY, V41, P868, DOI 10.1002/hep.20628
   Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263
   Goo YH, 2014, ARTERIOSCL THROM VAS, V34, P386, DOI 10.1161/ATVBAHA.113.302448
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Huang YL, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10040559
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Knebel B, 2015, BBA-MOL CELL BIOL L, V1851, P965, DOI 10.1016/j.bbalip.2015.03.003
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062
   Lian JH, 2012, HEPATOLOGY, V56, P2154, DOI 10.1002/hep.25881
   Masarone M, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9547613
   Miele L, 2003, AM J GASTROENTEROL, V98, P2335, DOI 10.1111/j.1572-0241.2003.07725.x
   Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Shao D, 2017, ANTIOXID REDOX SIGN, V27, P313, DOI 10.1089/ars.2016.6716
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Sheka AC, 2020, JAMA-J AM MED ASSOC, V323, P1175, DOI 10.1001/jama.2020.2298
   Shen ZQ, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.118954
   Shen ZQ, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1441627
   Shen ZQ, 2017, CELL REP, V21, P2198, DOI 10.1016/j.celrep.2017.10.099
   Shum M, 2020, MOL METAB, V50, DOI 10.1016/j.molmet.2020.101134
   Simoes ICM, 2018, INT J BIOCHEM CELL B, V95, P93, DOI 10.1016/j.biocel.2017.12.019
   Sunny NE, 2017, TRENDS ENDOCRIN MET, V28, P250, DOI 10.1016/j.tem.2016.11.006
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Teng YC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239059
   Wang GH, 2012, BIOCHEM J, V446, P415, DOI 10.1042/BJ20112050
   Weisthal S, 2014, BBA-MOL CELL RES, V1843, P2270, DOI 10.1016/j.bbamcr.2014.03.021
   Wu CY, 2012, HUM MOL GENET, V21, P3956, DOI 10.1093/hmg/dds210
   Yeh CH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000508
   Yokokawa T, 2018, BIOCHEM BIOPH RES CO, V506, P571, DOI 10.1016/j.bbrc.2018.10.101
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zhang JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep05832
NR 43
TC 4
Z9 4
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2227-9059
J9 BIOMEDICINES
JI Biomedicines
PD SEP
PY 2021
VL 9
IS 9
AR 1229
DI 10.3390/biomedicines9091229
PG 19
WC Biochemistry & Molecular Biology; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA UX2SW
UT WOS:000700696300001
PM 34572415
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Castillo, C
   Salazar, V
   Ariznavarreta, C
   Fossati, M
   Tresguerres, JAF
   Vara, E
AF Castillo, C
   Salazar, V
   Ariznavarreta, C
   Fossati, M
   Tresguerres, JAF
   Vara, E
TI Effect of <i>S</i>-adenosylmethionine on age-induced hepatocyte damage
   in old Wistar rats
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; free radicals; glutathione; liver; oxidative stress;
   S-adenosylmethionine
ID ADENOSYL-L-METHIONINE; SEPSIS-RELATED CYTOKINES; OXIDATIVE DAMAGE; HEME
   OXYGENASE; INTRAHEPATIC CHOLESTASIS; LIPID-SYNTHESIS; DOUBLE-BLIND;
   LIVER; ADENOSYLTRANSFERASE; GLUTATHIONE
AB Aging is accompanied by changes in the morphology and physiology of organs and tissues, such as the liver. This process might be due to the accumulation of oxidative damage induced by reactive oxygen (ROS) and reactive nitrogen species (RNS). Hepatocytes are very rich in mitochondria and have a high respiratory rate, so they are exposed to large amounts of ROS and permanent oxidative stress. S-Adenosylmethionine (SAMe) is an endogenous metabolite that has shown to exert protective effects on different experimental pathological models in which free radicals are involved. The aim of this study was to investigate the effect of SAMe on age-induced damage in hepatocytes. For this purpose, male and female Wistar rats of 18 and 2 months of age were used. Cells were isolated and, after incubation in the presence or in the absence of SAMe, different parameters were measured. Aging induced a significant increase in nitric oxide, carbon monoxide and cGMP, and a reduction in reduced glutathione, ATP and phosphatidylcholine synthesis, as well as in methionine-adenosyl-transferase and methyl-transferase activities. Incubation of old cells with SAMe prevented all these age-related changes, reaching values in some of the parameters similar to those found in young animals. In conclusion, SAMe seems to have beneficial effects against age-induced damage in hepatocytes.
C1 Univ Complutense, Lab Exp Endocrinol, Dept Physiol, Sch Med, E-28040 Madrid, Spain.
   Univ Buenos Aires, Sch Nat & Exact Sci, Lab Cellular Biol, RA-1053 Buenos Aires, DF, Argentina.
   Univ Complutense, Dept Biochem & Mol Biol, Sch Med, E-28040 Madrid, Spain.
C3 Complutense University of Madrid; University of Buenos Aires;
   Complutense University of Madrid
RP Tresguerres, JAF (corresponding author), Univ Complutense, Lab Exp Endocrinol, Dept Physiol, Sch Med, Avda Complutense S-N, E-28040 Madrid, Spain.
EM guerres@med.ucm.es
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   ARIASDIAZ J, 1993, EUR J SURG, V159, P535
   AriasDiaz J, 1996, J SURG RES, V62, P79, DOI 10.1006/jsre.1996.0177
   Arivazhagan P, 2001, CHEM-BIOL INTERACT, V138, P189, DOI 10.1016/S0009-2797(01)00268-X
   Avila MA, 2002, ALCOHOL, V27, P163, DOI 10.1016/S0741-8329(02)00228-8
   Avila MA, 1998, BIOFACTORS, V8, P27, DOI 10.1002/biof.5520080106
   Avila MA, 1997, HEPATOLOGY, V25, P391
   Barañano DE, 2001, P NATL ACAD SCI USA, V98, P10996, DOI 10.1073/pnas.191351298
   BELLI DC, 1994, J HEPATOL, V21, P18, DOI 10.1016/S0168-8278(94)80131-2
   Boveris A, 2002, FREE RADICAL BIO MED, V33, P1186, DOI 10.1016/S0891-5849(02)01009-2
   CANTONI GL, 1990, GASTROENTEROLOGY, V99, P211
   Castells MC, 2004, ALLERGY ASTHMA PROC, V25, P33
   CHAWLA RK, 1994, BBA-GEN SUBJECTS, V1199, P45, DOI 10.1016/0304-4165(94)90094-9
   Chung HY, 2002, MICROSC RES TECHNIQ, V59, P264, DOI 10.1002/jemt.10203
   COOK SJ, 1991, CELL SIGNAL, V3, P273, DOI 10.1016/0898-6568(91)90055-Y
   CORRALES F, 1991, HEPATOLOGY, V14, P528, DOI 10.1016/0270-9139(91)90194-Z
   CORRALES F, 1992, DRUG INVEST, V4, P8, DOI 10.1007/BF03258359
   De La Cruz JP, 2002, NEUROSCI LETT, V318, P103, DOI 10.1016/S0304-3940(01)02475-2
   Dröge W, 2002, EXP GERONTOL, V37, P1333, DOI 10.1016/S0531-5565(02)00175-4
   DUCE AM, 1988, HEPATOLOGY, V8, P65, DOI 10.1002/hep.1840080113
   Evans PJ, 1997, FREE RADICAL BIO MED, V23, P1002, DOI 10.1016/S0891-5849(97)00124-X
   FREZZA M, 1990, HEPATO-GASTROENTEROL, V37, P122
   FREZZA M, 1990, GASTROENTEROLOGY, V99, P211, DOI 10.1016/0016-5085(90)91250-A
   Gasbarrini A, 1998, SCAND J GASTROENTERO, V33, P1107
   GIUDICI GA, 1992, METHIONINE METABOLIS, P67
   Guo X, 2001, LIFE SCI, V69, P3113, DOI 10.1016/S0024-3205(01)01417-5
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Henningsson R, 2001, AM J PHYSIOL-CELL PH, V280, pC1242, DOI 10.1152/ajpcell.2001.280.5.C1242
   Libby P, 2003, AM J CARDIOL, V91, p3A
   Lieber CS, 1999, J HEPATOL, V30, P1155, DOI 10.1016/S0168-8278(99)80274-8
   Lieber CS, 2002, ALCOHOL, V27, P173, DOI 10.1016/S0741-8329(02)00230-6
   Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9
   Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398
   Majano PL, 2001, J HEPATOL, V35, P692, DOI 10.1016/S0168-8278(01)00208-2
   Mato JM, 1997, PHARMACOL THERAPEUT, V73, P265, DOI 10.1016/S0163-7258(96)00197-0
   Mato JM, 1999, J HEPATOL, V30, P1081, DOI 10.1016/S0168-8278(99)80263-3
   McCann SM, 1998, EXP GERONTOL, V33, P813, DOI 10.1016/S0531-5565(98)00050-3
   MURIEL P, 1994, J HEPATOL, V21, P95, DOI 10.1016/S0168-8278(94)80143-6
   Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680
   OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   Peeters ACTM, 2001, EUR J CLIN INVEST, V31, P31, DOI 10.1046/j.1365-2362.2001.00743.x
   PELECH SL, 1984, BIOCHIM BIOPHYS ACTA, V779, P217, DOI 10.1016/0304-4157(84)90010-8
   Reiter RJ, 1998, PROG NEUROBIOL, V56, P359, DOI 10.1016/S0301-0082(98)00052-5
   Reiter RJ, 1999, BIOL SIGNAL RECEPT, V8, P56
   Ruiz F, 1998, HEPATOLOGY, V28, P1051, DOI 10.1002/hep.510280420
   Ryter SW, 2002, MOL CELL BIOCHEM, V234, P249, DOI 10.1023/A:1015957026924
   SanchezGongora E, 1997, FASEB J, V11, P1013, DOI 10.1096/fasebj.11.12.9337154
   Sastre J, 2000, IUBMB LIFE, V49, P427
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   STRAMENTINOLI G, 1986, 1 C BIOCH PHARM CLIN
   Szabó C, 2003, TOXICOL LETT, V140, P105, DOI 10.1016/S0378-4274(02)00507-6
   Troen BR, 2003, MT SINAI J MED, V70, P3
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Vara E, 1996, AM J PHYSIOL-LUNG C, V271, pL359, DOI 10.1152/ajplung.1996.271.3.L359
   VARA E, 1994, HEPATOLOGY, V20, P924, DOI 10.1002/hep.1840200422
   VARELA I, 1986, 1 C BIOCH PHARM CLIN, P25
   VENDEMIALE G, 1989, SCAND J GASTROENTERO, V24, P407, DOI 10.3109/00365528909093067
NR 60
TC 15
Z9 15
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PY 2005
VL 6
IS 5
BP 313
EP 323
DI 10.1007/s10522-005-4806-2
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 006TQ
UT WOS:000234920600003
PM 16463108
DA 2024-02-19
ER

PT J
AU Gasbarrini, A
   Simoncini, M
   Di Campli, C
   De Notariis, S
   Colantoni, A
   Pola, P
   Bernardi, M
   Gasbarrini, G
AF Gasbarrini, A
   Simoncini, M
   Di Campli, C
   De Notariis, S
   Colantoni, A
   Pola, P
   Bernardi, M
   Gasbarrini, G
TI Ageing affects anoxia/reoxygenation injury in rat hepatocytes
SO SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE ageing; hepatocytes; luminescence; oxidative stress; oxygen free radical
ID ISCHEMIA-REPERFUSION INJURY; OXYGEN-FREE RADICALS; CHEMI-LUMINESCENCE;
   OXIDATIVE STRESS; REACTIVE OXYGEN; SUPEROXIDE-DISMUTASE; REOXYGENATION
   INJURY; LIPID-PEROXIDATION; PROTEIN OXIDATION; GSH METABOLISM
AB Background: The reoxygenation phase after a period of anoxia leads to oxyradical formation, responsible for damage to cell membranes. Ageing is associated with functional and structural changes in liver cells, which modify their sensitivity to reoxygenation injury. The aim of this study was to determine the effects of ageing on the sensitivity of hepatocytes to anoxia/reoxygenation. Methods: Oxyradical formation and cell injury were evaluated in hepatocytes isolated from rats of different ages exposed to 2 h of anoxia and 1 h of reoxygenation. Anion superoxide was measured by lucigenin-enhanced chemiluminescence, hydrogen peroxide by luminol-enhanced chemiluminescence, and cell damage by lactate dehydrogenase (LDH) release. Results: During anoxia, oxyradical production dropped to background levels in both groups. LDH release was significantly greater in ageing hepatocytes. During reoxygenation, a massive generation of anion superoxide and hydrogen peroxide, followed by a sharp increase in LDH release, was observed in both groups. However, both oxyradicals and cell injury were significantly greater in liver cells obtained from ageing rats. Conclusions: The data confirm that hepatocytes produce high levels of free radicals during post-ischemic reoxygenation and suggest that ageing cells are more sensitive to reperfusion injury.
C1 Univ Cattolica Sacro Cuore, Ist Patol Med, Policlin Gemelli, Dept Internal Med, I-00168 Rome, Italy.
   Univ Bologna, Dept Internal Med, Bologna, Italy.
C3 Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli;
   University of Bologna
RP Gasbarrini, A (corresponding author), Univ Cattolica Sacro Cuore, Ist Patol Med, Policlin Gemelli, Dept Internal Med, Largo Gemelli 1, I-00168 Rome, Italy.
RI Gasbarrini, Antonio/AAB-8487-2019
OI Gasbarrini, Antonio/0000-0002-6230-1779
CR Adawi D, 1997, SCAND J GASTROENTERO, V32, P835, DOI 10.3109/00365529708996543
   ADKISON D, 1986, ACTA PHYSIOL SCAND, V126, P101
   ALLEN RC, 1986, METHOD ENZYMOL, V133, P449
   ARCHER SL, 1989, J APPL PHYSIOL, V67, P1912, DOI 10.1152/jappl.1989.67.5.1912
   BOVERIS A, 1980, P NATL ACAD SCI-BIOL, V77, P347, DOI 10.1073/pnas.77.1.347
   BUNKER VW, 1992, MED LAB SCI, V49, P299
   CADENAS E, 1981, BIOCHEM J, V198, P645, DOI 10.1042/bj1980645
   Cadenas E., 1984, Free Radicals in Biology, P211
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CARACENI P, 1994, AM J PHYSIOL, V266, pG799, DOI 10.1152/ajpgi.1994.266.5.G799
   CARACENI P, 1994, HEPATOLOGY, V20, P1247, DOI 10.1016/0270-9139(94)90765-X
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   FARGHALI H, 1992, BIOCHIM BIOPHYS ACTA, V1139, P105, DOI 10.1016/0925-4439(92)90089-6
   FAULKNER K, 1993, FREE RADICAL BIO MED, V15, P447, DOI 10.1016/0891-5849(93)90044-U
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   GASBARRINI A, 1992, J BIOL CHEM, V267, P6654
   GASBARRINI A, 1993, BIOCHIM BIOPHYS ACTA, V1177, P1, DOI 10.1016/0167-4889(93)90149-J
   Gasbarrini A, 1997, FREE RADICAL BIO MED, V23, P1067, DOI 10.1016/S0891-5849(97)00141-X
   GASBARRINI A, 1993, BIOCHIM BIOPHYS ACTA, V1178, P9, DOI 10.1016/0167-4889(93)90105-X
   GONZALEZFLECHA B, 1993, J CLIN INVEST, V91, P456, DOI 10.1172/JCI116223
   HANDLER JA, 1994, HEPATOLOGY, V19, P1496, DOI 10.1002/hep.1840190627
   IANTOMASI T, 1993, MECH AGEING DEV, V70, P65, DOI 10.1016/0047-6374(93)90060-5
   JAESCHKE H, 1989, BIOCHEM BIOPH RES CO, V160, P140, DOI 10.1016/0006-291X(89)91632-X
   JAESCHKE H, 1988, J CLIN INVEST, V81, P1240, DOI 10.1172/JCI113441
   JAESCHKE H, 1991, CHEM-BIOL INTERACT, V79, P115, DOI 10.1016/0009-2797(91)90077-K
   KANAI S, 1992, ARCH GERONTOL GERIAT, V14, P101, DOI 10.1016/0167-4943(92)90045-6
   KOO A, 1992, HEPATOLOGY, V15, P507, DOI 10.1002/hep.1840150325
   KUMAR C, 1990, FEBS LETT, V272, P121, DOI 10.1016/0014-5793(90)80463-S
   MCCORD JM, 1985, NEW ENGL J MED, V312, P159
   NUNES FA, 1995, DIGEST DIS SCI, V40, P1045, DOI 10.1007/BF02064197
   REISS U, 1976, BIOCHEM BIOPH RES CO, V73, P255, DOI 10.1016/0006-291X(76)90701-4
   REMBISH SJ, 1994, FREE RADICAL BIO MED, V17, P117, DOI 10.1016/0891-5849(94)90109-0
   SASTRE J, 1992, MECH AGEING DEV, V62, P181, DOI 10.1016/0047-6374(92)90054-H
   SCHULZ R, 1995, CARDIOVASC RES, V30, P432
   SNOWDOWNE KW, 1984, AM J PHYSIOL, V247, pC396, DOI 10.1152/ajpcell.1984.247.5.C396
   SOHAL RS, 1993, AGING-CLIN EXP RES, V5, P3, DOI 10.1007/BF03324120
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   [No title captured]
NR 40
TC 18
Z9 18
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0036-5521
EI 1502-7708
J9 SCAND J GASTROENTERO
JI Scand. J. Gastroenterol.
PD OCT
PY 1998
VL 33
IS 10
BP 1107
EP 1112
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 132JK
UT WOS:000076626400017
PM 9829368
DA 2024-02-19
ER

PT J
AU Laskowski, J
   Renner, B
   Pickering, MC
   Serkova, NJ
   Smith-Jones, PM
   Clambey, ET
   Nemenoff, RA
   Thurman, JM
AF Laskowski, Jennifer
   Renner, Brandon
   Pickering, Matthew C.
   Serkova, Natalie J.
   Smith-Jones, Peter M.
   Clambey, Eric T.
   Nemenoff, Raphael A.
   Thurman, Joshua M.
TI Complement factor H-deficient mice develop spontaneous hepatic tumors
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID HEMOLYTIC-UREMIC SYNDROME; COFACTOR PROTEIN MCP; LIVER INFLAMMATION;
   MONOCLONAL-ANTIBODIES; KAPPA-B; ACTIVATION; CANCER; EXPRESSION;
   PROTECTION; PATHWAY
AB Hepatocellular carcinoma (HCC) is difficult to detect, carries a poor prognosis, and is one of few cancers with an increasing yearly incidence. Molecular defects in complement factor H (CFH), a critical regulatory protein of the complement alternative pathway (AP), are typically associated with inflammatory diseases of the eye and kidney. Little is known regarding the role of CFH in controlling complement activation within the liver. While studying aging CFH-deficient (fH(-/-)) mice, we observed spontaneous hepatic tumor formation in more than 50 % of aged fH(-/-) males. Examination of fH(-/-) livers (3-24 months) for evidence of complement-mediated inflammation revealed widespread deposition of complement-activation fragments throughout the sinusoids, elevated transaminase levels, increased hepatic CD8(+) and F4/80(+) cells, overexpression of hepatic mRNA associated with inflammatory signaling pathways, steatosis, and increased collagen deposition. Immunostaining of human HCC biopsies revealed extensive deposition of complement fragments within the tumors. Investigating the Cancer Genome Atlas also revealed that increased CFH mRNA expression is associated with improved survival in patients with HCC, whereas mutations are associated with worse survival. These results indicate that CFH is critical for controlling complement activation in the liver, and in its absence, AP activation leads to chronic inflammation and promotes hepatic carcinogenesis.
C1 [Laskowski, Jennifer; Renner, Brandon; Nemenoff, Raphael A.; Thurman, Joshua M.] Univ Colorado, Dept Med Nephrol & Hypertens, Sch Med, Aurora, CO 80045 USA.
   [Pickering, Matthew C.] Imperial Coll London, Ctr Inflammatory Dis, Dept Med, Div Immunol & Inflammat, London, England.
   [Serkova, Natalie J.; Smith-Jones, Peter M.] Univ Colorado, Sch Med, Dept Med, Radiol, Aurora, CO 80045 USA.
   [Serkova, Natalie J.; Smith-Jones, Peter M.] Univ Colorado, Sch Med, Dept Med, Radiat Oncol, Aurora, CO 80045 USA.
   [Serkova, Natalie J.; Smith-Jones, Peter M.; Clambey, Eric T.] Univ Colorado, Sch Med, Dept Anesthesiol, Aurora, CO 80045 USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; Imperial College London; University of Colorado System;
   University of Colorado Anschutz Medical Campus; University of Colorado
   System; University of Colorado Anschutz Medical Campus; University of
   Colorado System; University of Colorado Anschutz Medical Campus
RP Laskowski, J; Thurman, JM (corresponding author), Univ Colorado, Sch Med, 1775 Aurora Court,M20-3201U JL,M20-3103 JMT, Aurora, CO 80045 USA.
EM jennifer.laskowski@cuanschutz.edu; joshua.thurman@cuanschutz.edu
OI Pickering, Matthew/0000-0002-1153-0192; Thurman, Joshua
   Michael/0000-0002-3476-9956; Nemenoff, Raphael A./0000-0002-9051-814X;
   Thurman, Joshua M./0000-0001-9062-3559
FU NIH [R01DK076690, R01DK113586, R01CA236222, 212252/Z/18/Z]
FX This work was supported by NIH grants R01DK076690 and R01DK113586 to JMT
   and R01CA236222 to JMT and RN. MCP is a Wellcome Trust Senior Fellow in
   Clinical Sciences (212252/Z/18/Z).
CR ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286
   ALPER CA, 1980, CLIN IMMUNOL IMMUNOP, V16, P84, DOI 10.1016/0090-1229(80)90169-5
   Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004
   Bresin E, 2013, J AM SOC NEPHROL, V24, P475, DOI 10.1681/ASN.2012090884
   Capurro M, 2003, GASTROENTEROLOGY, V125, P89, DOI 10.1016/S0016-5085(03)00689-9
   Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095
   CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3
   DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6
   Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214
   EDGEWORTH J, 1991, J BIOL CHEM, V266, P7706
   Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189
   Fakhouri F, 2016, AM J KIDNEY DIS, V68, P84, DOI 10.1053/j.ajkd.2015.12.034
   Ferrín G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118527
   Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088
   He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183
   He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048
   Jakus Z, 2008, J IMMUNOL, V180, P618, DOI 10.4049/jimmunol.180.1.618
   Jiang EL, 2014, ARTERIOSCL THROM VAS, V34, P34, DOI 10.1161/ATVBAHA.113.302077
   Ju C, 2016, PLOS ONE, V11
   Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108
   Källberg E, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-69
   Kanmura S, 2010, J GASTROENTEROL, V45, P459, DOI 10.1007/s00535-009-0160-5
   Kinugasa N, 1999, BRIT J CANCER, V80, P1820, DOI 10.1038/sj.bjc.6690604
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   Kurolap RNA, 2017, NEW ENGL J MED, V377, P1500
   Kwak JW, 2018, CANCER RES, V78, P143, DOI 10.1158/0008-5472.CAN-17-0240
   Kwo PY, 2017, AM J GASTROENTEROL, V112, P18, DOI 10.1038/ajg.2016.517
   Langford-Smith A, 2014, J INNATE IMMUN, V6, P407, DOI 10.1159/000356513
   Laskowski J, 2016, KIDNEY INT, V90, P109, DOI 10.1016/j.kint.2016.02.036
   Lee IN, 2006, PROTEOMICS, V6, P2865, DOI 10.1002/pmic.200500488
   Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]
   Lu ZJ, 2014, ONCOL REP, V31, P557, DOI 10.3892/or.2013.2877
   Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024
   Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655
   Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003
   MARTINEZHERNANDEZ A, 1993, VIRCHOWS ARCH A, V423, P1, DOI 10.1007/BF01606425
   Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720
   Medler TR, 2018, CANCER CELL, V34, P561, DOI 10.1016/j.ccell.2018.09.003
   Miwa T, 1998, IMMUNOGENETICS, V48, P363, DOI 10.1007/s002510050447
   Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672
   MUNOZ LE, 1982, CLIN EXP IMMUNOL, V47, P548
   Nabizadeh JA, 2016, J IMMUNOL, V196, P4783, DOI 10.4049/jimmunol.1600210
   Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Pettit SJ, 2000, BRIT J CANCER, V82, P1900
   Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912
   Reis ES, 2018, NAT REV IMMUNOL, V18, P5, DOI 10.1038/nri.2017.97
   Remuzzi G, 2005, AM J TRANSPLANT, V5, P1146, DOI 10.1111/j.1600-6143.2005.00783.x
   Satyam A, 2017, J IMMUNOL, V198, P788, DOI 10.4049/jimmunol.1502287
   Schmidt CQ, 2018, GLYCOBIOLOGY, V28, P765, DOI 10.1093/glycob/cwy061
   Schmidt CQ, 2016, IMMUNOL REV, V274, P152, DOI 10.1111/imr.12475
   Shalapour S, 2015, J CLIN INVEST, V125, P3347, DOI 10.1172/JCI80007
   Shen H, 2014, EXP MOL PATHOL, V97, P338, DOI 10.1016/j.yexmp.2014.09.004
   Smith-Jones PM, 2003, J NUCL MED, V44, P610
   Stijlemans B, 2015, Bio-Protocol, V5, pe1471, DOI DOI 10.21769/BIOPROTOC.1471
   Suzuki M, 2010, ANTICANCER RES, V30, P5055
   Thurman JM, 2016, KIDNEY INT, V90, P746, DOI 10.1016/j.kint.2016.04.018
   Thurman JM, 2013, J CLIN INVEST, V123, P2218, DOI 10.1172/JCI65861
   Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vasei M, 2008, HEPATO-GASTROENTEROL, V55, P1066
   Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406
   Wang BF, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-43
   Wang Y, 2016, CANCER DISCOV, V6, P1022, DOI 10.1158/2159-8290.CD-15-1412
   Xiao X, 2014, SEMIN THROMB HEMOST, V40, P465, DOI 10.1055/s-0034-1376334
   Xie JY, 2016, J AM SOC NEPHROL, V27, P3187, DOI 10.1681/ASN.2015111210
   Yao SZ, 2013, J HISTOCHEM CYTOCHEM, V61, P639, DOI 10.1369/0022155413492771
   Younossi ZM, 2018, HEPATOLOGY, V68, P349, DOI 10.1002/hep.29721
   Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620
   Zipfel PF, 2006, MOL IMMUNOL, V43, P97, DOI 10.1016/j.molimm.2005.06.015
NR 70
TC 37
Z9 39
U1 0
U2 1
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD AUG 3
PY 2020
VL 130
IS 8
BP 4039
EP 4054
DI 10.1172/JCI135105
PG 16
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA OC7TP
UT WOS:000579360700002
PM 32369457
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Ford, CT
   Sherratt, MJ
   Griffiths, CEM
   Watson, REB
AF Ford, Christopher T.
   Sherratt, Michael J.
   Griffiths, Christopher E. M.
   Watson, Rachel E. B.
TI Liver X receptor β: maintenance of epidermal expression in intrinsic and
   extrinsic skin aging
SO AGE
LA English
DT Article
DE Nuclear hormone receptors; Skin; Aging; Liver X receptor
ID LIFE-SPAN; RETINOIC ACID; LXR-ALPHA; C-ELEGANS; CAENORHABDITIS-ELEGANS;
   GENE-EXPRESSION; ADIPOSE-TISSUE; MESSENGER-RNA; HUMAN BRAIN; AGE
AB Aging in human skin is the composite of time-dependent intrinsic aging plus photoaging induced by chronic exposure to ultraviolet radiation. Nuclear hormone receptors coordinate diverse processes including metabolic homeostasis. Liver X receptor beta (LXR beta) is a close human homologue of daf-12, a regulator of nematode longevity. LXR beta is positively regulated by sirtuin-1 and resveratrol, while LXR beta-null mice show transcriptional profiles similar to those seen in aged human skin. In these studies, we examined LXR beta expression in aged and photoaged human skin. Volunteers were recruited to assess intrinsic aging and photoaging. Epidermal LXR beta mRNA was examined by in situ hybridization while protein was identified by immunofluorescence. No significant changes were observed in either LXR beta mRNA or protein expression between young and aged volunteers (mRNA p = 0.90; protein p = 0.26). Similarly, LXR beta protein expression was unaltered in photoaged skin (p = 0.75). Our data therefore suggest that, while not playing a major role in skin aging, robust cutaneous expression implies a fundamental role for LXR beta in epidermal biology.
C1 [Ford, Christopher T.; Sherratt, Michael J.; Griffiths, Christopher E. M.; Watson, Rachel E. B.] Univ Manchester, Manchester M13 9PT, Lancs, England.
C3 University of Manchester
RP Watson, REB (corresponding author), Univ Manchester, 1-443 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM rachel.watson@manchester.ac.uk
RI Sherratt, Michael J/A-1175-2015; Griffiths, Christopher
   E.M./P-5448-2014; Watson, Rachel E B/F-1090-2013; Griffiths,
   Charlotte/JQV-8476-2023
OI Sherratt, Michael J/0000-0003-4759-6617; Griffiths, Christopher
   E.M./0000-0001-5371-4427; Watson, Rachel E B/0000-0002-5162-7503; Ford,
   Christopher/0000-0003-0428-8649
FU MRC University of Manchester
FX CTF is supported by an MRC University of Manchester Strategic PhD
   studentship. We are grateful to June Bowden and Jean Bastrilles for
   their excellent support in volunteer recruitment.
CR [Anonymous], 1989, MOL CLONING LAB MANU
   BERTON G, 1994, J CELL BIOL, V126, P1111, DOI 10.1083/jcb.126.4.1111
   Chang KCN, 2008, MOL ENDOCRINOL, V22, P2407, DOI 10.1210/me.2008-0232
   Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314
   Enderlin V, 1997, FEBS LETT, V412, P629, DOI 10.1016/S0014-5793(97)00845-4
   FARRELL RE, 1998, RNA METHODOLOGIES
   Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200
   Gems D, 1998, GENETICS, V150, P129
   Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5
   Giacomoni PU, 2001, BIOGERONTOLOGY, V2, P219, DOI 10.1023/A:1013222629919
   Griffiths CEM, 2001, CLIN EXP DERMATOL, V26, P613, DOI 10.1046/j.1365-2230.2001.00892.x
   HARRISON PJ, 1990, PROG NEUROBIOL, V34, P271, DOI 10.1016/0301-0082(90)90007-4
   Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960
   Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694
   Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266
   Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0
   Kömüves LG, 2002, J INVEST DERMATOL, V118, P25, DOI 10.1046/j.0022-202x.2001.01628.x
   Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100
   LARSEN PL, 1995, GENETICS, V139, P1567
   Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032
   Lindeman R D, 2003, J Nutr Health Aging, V7, P172
   Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449
   Mooijaart SP, 2007, J GERONTOL A-BIOL, V62, P343, DOI 10.1093/gerona/62.4.343
   Mooijaart SP, 2005, AGEING RES REV, V4, P351, DOI 10.1016/j.arr.2005.03.006
   Pallet V, 1997, MECH AGEING DEV, V99, P123, DOI 10.1016/S0047-6374(97)00098-5
   Prüfer K, 2007, J CELL BIOCHEM, V100, P69, DOI 10.1002/jcb.21006
   Russell LE, 2007, EXP DERMATOL, V16, P844, DOI 10.1111/j.1600-0625.2007.00612.x
   Sevov M, 2006, BIOCHEM BIOPH RES CO, V348, P1047, DOI 10.1016/j.bbrc.2006.07.155
   Stulnig TM, 2002, MOL PHARMACOL, V62, P1299, DOI 10.1124/mol.62.6.1299
   TOHGI H, 1995, BRAIN RES, V700, P245, DOI 10.1016/0006-8993(95)00971-R
   TSOURELINIKITA E, 2004, BRIT J DERMATOL, V150, P801
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   Watson REB, 2004, MECH AGEING DEV, V125, P465, DOI 10.1016/j.mad.2004.03.008
   Watson REB, 2001, J INVEST DERMATOL, V116, P672, DOI 10.1046/j.1523-1747.2001.01322.x
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
NR 37
TC 1
Z9 1
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD DEC
PY 2009
VL 31
IS 4
SI SI
BP 365
EP 372
DI 10.1007/s11357-009-9111-6
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 546WM
UT WOS:000273844900011
PM 19697157
OA Green Published
DA 2024-02-19
ER

PT J
AU Ueberham, E
   Glöckner, P
   Göhler, C
   Straub, BK
   Teupser, D
   Schönig, K
   Braeuning, A
   Höhn, AK
   Jerchow, B
   Birchmeier, W
   Gaunitz, F
   Arendt, T
   Sansom, O
   Gebhardt, R
   Ueberham, U
AF Ueberham, Elke
   Gloeckner, Pia
   Goehler, Claudia
   Straub, Beate K.
   Teupser, Daniel
   Schoenig, Kai
   Braeuning, Albert
   Hoehn, Anne Kathrin
   Jerchow, Boris
   Birchmeier, Walter
   Gaunitz, Frank
   Arendt, Thomas
   Sansom, Owen
   Gebhardt, Rolf
   Ueberham, Uwe
TI Global Increase of p16<SUP>INK4a</SUP> in APC-Deficient Mouse Liver
   Drives Clonal Growth of p16<SUP>INK4a</SUP>-Negative Tumors
SO MOLECULAR CANCER RESEARCH
LA English
DT Article
ID BETA-CATENIN; HEPATOCELLULAR CARCINOMAS; GENE-EXPRESSION; MURINE LIVER;
   AXIN1; MICE; MUTATIONS; DELETION; CADHERIN; LESSONS
AB Reduction of beta-catenin (CTNNB1) destroying complex components, for example, adenomatous polyposis coli (APC), induces beta-catenin signaling and subsequently triggers activation of genes involved in proliferation and tumorigenesis. Though diminished expression of APC has organ-specific and threshold-dependent influence on the development of liver tumors in mice, the molecular basis is poorly understood. Therefore, a detailed investigation was conducted to determine the underlying mechanism in the development of liver tumors under reduced APC levels. Mouse liver at different developmental stages was analyzed in terms of beta-catenin target genes including Cyp2e1, Glul, and Ihh using real-time RT-PCR, reporter gene assays, and immunohistologic methods with consideration of liver zonation. Data from human livers with mutations in APC derived from patients with familial adenomatous polyposis (FAP) were also included. Hepatocyte senescence was investigated by determining p16(INK4a) expression level, presence of senescence-associated beta-galactosidase activity, and assessing ploidy. A beta-catenin activation of hepatocytes does not always result in beta-catenin positive but unexpectedly also in mixed and beta-catenin-negative tumors. In summary, a senescence-inducing program was found in hepatocytes with increased b-catenin levels and a positive selection of hepatocytes lacking p16(INK4a), by epigenetic silencing, drives the development of liver tumors in mice with reduced APC expression (Apc(580S) mice). The lack of p16(INK4a) was also detected in liver tumors of mice with triggers other than APC reduction. (C) 2014 AACR.
C1 [Ueberham, Elke; Goehler, Claudia; Gebhardt, Rolf] Univ Leipzig, Inst Biochem, Fac Med, D-04109 Leipzig, Germany.
   [Ueberham, Elke] Fraunhofer Inst Cell Therapyand Immunol, Dept Cell Engn GLP, Leipzig, Germany.
   [Gloeckner, Pia; Arendt, Thomas; Ueberham, Uwe] Paul Flechsig Inst Brain Res, Dept Mol & Cellular Mech Neurodegenerat, D-04109 Leipzig, Germany.
   [Straub, Beate K.] Heidelberg Univ, Univ Clin, Inst Pathol, Heidelberg, Germany.
   [Teupser, Daniel] Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04109 Leipzig, Germany.
   [Teupser, Daniel] Univ Munich, Inst Lab Med, Munich, Germany.
   [Schoenig, Kai] Heidelberg Univ, Dept Mol Biol, Cent Inst Mental Hlth, Mannheim, Germany.
   [Braeuning, Albert] Inst Expt & Clin Pharmacol & Toxicol, Dept Toxicol, Tubingen, Germany.
   [Hoehn, Anne Kathrin] Univ Leipzig, Inst Pathol, D-04109 Leipzig, Germany.
   [Jerchow, Boris; Birchmeier, Walter] Max Delbruck Ctr Mol Med, Berlin, Germany.
   [Gaunitz, Frank] Univ Leipzig, Dept Neurosurg, D-04109 Leipzig, Germany.
   [Sansom, Owen] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland.
C3 Leipzig University; Fraunhofer Gesellschaft; Ruprecht Karls University
   Heidelberg; Leipzig University; University of Munich; Central Institute
   of Mental Health; Ruprecht Karls University Heidelberg; Eberhard Karls
   University of Tubingen; Eberhard Karls University Hospital; Leipzig
   University; Helmholtz Association; Max Delbruck Center for Molecular
   Medicine; Leipzig University; Beatson Institute
RP Ueberham, U (corresponding author), Paul Flechsig Inst Brain Res, Dept Mol & Cellular Mech Neurodegenerat, D-04109 Leipzig, Germany.
EM Uwe.Ueberham@medizin.uni-leipzig.de
RI Gaunitz, Frank/A-2641-2008; Arendt, Thomas/C-8747-2012; Ueberham,
   Uwe/A-5181-2017
OI Ueberham, Uwe/0000-0003-4616-5153; Sansom, Owen J./0000-0001-9540-3010;
   Arendt, Thomas/0000-0003-4553-1625; Gaunitz, Frank/0000-0001-6628-0605;
   Jerchow, Boris-Alexander/0000-0002-7031-8730; Straub,
   Beate/0000-0002-4857-1561
FU European Union [CancerSys 223188]; BMBF [01EW0907]; AFI-Project
   [984000-150]; DFG [STR 1160/1-1]; Cancer Research UK [12481] Funding
   Source: researchfish
FX This work was supported in part financially by the European Union (grant
   CancerSys 223188), by the BMBF (01EW0907) in the frame of ERA-Net Neuron
   and the AFI-Project 984000-150 as well as the DFG (STR 1160/1-1).
CR Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015
   Brault V, 2001, DEVELOPMENT, V128, P1253
   Buchert M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000816
   Burke ZD, 2009, GASTROENTEROLOGY, V136, P2316, DOI 10.1053/j.gastro.2009.02.063
   Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022
   Cole AM, 2010, EMBO MOL MED, V2, P472, DOI 10.1002/emmm.201000101
   Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101
   Csepregi A, 2008, J CANCER RES CLIN, V134, P579, DOI 10.1007/s00432-007-0321-y
   de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
   Gebhardt R, 1998, Methods Mol Biol, V107, P319
   Gupta A, 2013, AM J SURG PATHOL, V37, P1058, DOI 10.1097/PAS.0b013e31828aeb18
   Hailfinger S, 2006, HEPATOLOGY, V43, P407, DOI 10.1002/hep.21082
   Ihara A, 1996, HEPATOLOGY, V23, P1441, DOI 10.1053/jhep.1996.v23.pm0008675162
   Ishizaki Y, 2004, INT J ONCOL, V24, P1077
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1
   Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933
   Kofman AV, 2005, HEPATOLOGY, V41, P1252, DOI 10.1002/hep.20696
   Lee JM, 2014, CANCER LETT, V343, P90, DOI 10.1016/j.canlet.2013.09.020
   Lindner I, 2010, CANCER RES, V70, P277, DOI 10.1158/0008-5472.CAN-09-1462
   Lu WJ, 2014, CARCINOGENESIS, V35, P915, DOI 10.1093/carcin/bgt401
   Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002
   Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268
   Omenetti A, 2011, J HEPATOL, V54, P366, DOI 10.1016/j.jhep.2010.10.003
   QUISTORFF B, 1985, BIOCHEM J, V226, P289, DOI 10.1042/bj2260289
   Reed KR, 2008, P NATL ACAD SCI USA, V105, P18919, DOI 10.1073/pnas.0805778105
   Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448
   Schönig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0
   Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592
   Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120
   Shim YH, 2003, MODERN PATHOL, V16, P430, DOI 10.1097/01.mp.0000066799.99032.A7
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591
   Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004
   Ueberham E, 2008, J CELL MOL MED, V12, P622, DOI 10.1111/j.1582-4934.2007.00178.x
   Ueberham E, 2007, J MOL HISTOL, V38, P359, DOI 10.1007/s10735-007-9098-1
   Ueberham Elke, 2010, Comp Hepatol, V9, P8, DOI 10.1186/1476-5926-9-8
   Wang S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0074141, 10.1371/journal.pone.0073946]
   Wassermann S, 2009, GASTROENTEROLOGY, V136, P196, DOI 10.1053/j.gastro.2008.09.019
   Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236
   Zucman-Rossi J, 2007, ONCOGENE, V26, P774, DOI 10.1038/sj.onc.1209824
NR 44
TC 6
Z9 6
U1 0
U2 5
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1541-7786
EI 1557-3125
J9 MOL CANCER RES
JI Mol. Cancer Res.
PD FEB
PY 2015
VL 13
IS 2
BP 239
EP 249
DI 10.1158/1541-7786.MCR-14-0278-T
PG 11
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA CD6SO
UT WOS:000351219800004
PM 25270420
OA Green Submitted, Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU RATTAN, SIS
   WARD, WF
   GLENTING, M
   SVENDSEN, L
   RIIS, B
   CLARK, BFC
AF RATTAN, SIS
   WARD, WF
   GLENTING, M
   SVENDSEN, L
   RIIS, B
   CLARK, BFC
TI DIETARY CALORIE RESTRICTION DOES NOT AFFECT THE LEVELS OF PROTEIN
   ELONGATION-FACTORS IN RAT LIVERS DURING AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; CALORIE RESTRICTION; PROTEIN SYNTHESIS; ELONGATION FACTORS
ID FOOD RESTRICTION; FACTOR 1-ALPHA; LONGEVITY; CELLS
AB Dietary calorie restriction of rats has been previously shown to increase protein synthetic rates in liver and kidney cells during ageing.  Here we have compared the activity and amounts of active elongation factors EF-1-alpha and EF-2 in cell-free extracts prepared from livers isolated from male Fischer 344 rats of different ages.  Although there is some age-related decline in the catalytic activity and amounts of active EF-1-alpha during ageing, no differences between freely-fed and calorie-restricted animals were observed.  In the case of EF-2, the amounts of ADP-ribosylatable EF-2 neither declined during ageing nor differed between freely-fed and calorie-restricted animals.  Thus differences in the protein synthetic rates in calorie-restricted and freely-fed rats are not reflected at the level of protein elongation factors, and may involve some other mechanisms of regulation.
C1 UNIV TEXAS,HLTH SCI CTR,DEPT PHYSIOL,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
RP RATTAN, SIS (corresponding author), AARHUS UNIV,DEPT CHEM,CELLULAR AGEING LAB,DK-8000 AARHUS,DENMARK.
OI Rattan, Suresh I.S./0000-0002-3478-1381
FU NIA NIH HHS [AGO1188] Funding Source: Medline
CR CAVALLIUS J, 1986, EXP GERONTOL, V21, P149, DOI 10.1016/0531-5565(86)90068-9
   CAVALLIUS J, 1989, T AGING RES, V13, P125
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   RATTAN SIS, 1988, BIOCHEM BIOPH RES CO, V152, P169, DOI 10.1016/S0006-291X(88)80695-8
   RATTAN SIS, 1986, TOP AGING RES EUR, V7, P132
   RATTAN SIS, 1987, AGING MULTIFACTORIAL, P125
   REFF ME, 1985, HDB BIOL AGING, P225
   RICHARDSON A, 1987, REV BIOL RES AGING, V3, P467
   RICKETTS WG, 1985, J CELL PHYSIOL, V125, P492, DOI 10.1002/jcp.1041250319
   RIIS B, 1990, FEBS LETT, V266, P45, DOI 10.1016/0014-5793(90)81502-F
   RIIS B, 1989, T AGING RES, V13, P117
   RIIS B, 1989, J BIOCHEM BIOPH METH, V19, P319, DOI 10.1016/0165-022X(89)90063-8
   RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K
   SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WEBSTER GC, 1985, MOL BIOL AGING GENE, P263
   WEINDRUCH R, 1990, BIOMEDICAL ADV AGING, P313
   YU BP, 1982, J GERONTOL, V37, P130, DOI 10.1093/geronj/37.2.130
   YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657
NR 20
TC 11
Z9 11
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD APR 1
PY 1991
VL 58
IS 1
BP 85
EP 91
DI 10.1016/0047-6374(91)90122-G
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Geriatrics & Gerontology
GA FD128
UT WOS:A1991FD12800008
PM 2038215
DA 2024-02-19
ER

PT J
AU VARGA, M
AF VARGA, M
TI HOW CAN FREE-RADICALS CAUSE DAMAGE TO HEPATIC CELLS - A
   MULTIDISCIPLINARY APPROACH
SO DRUG AND ALCOHOL DEPENDENCE
LA English
DT Article
DE LIVER INJURY; FREE RADICALS; MEMBRANE DAMAGE; HEPATOPROTECTIVES
ID ENZYME KINETIC-MODEL; LIVER; PROTEIN
AB Excessive alcohol intake is a factor in a significant percentage of all deaths.  Hepatoprotective drugs aim to prevent alcoholic liver damage.  Our experiments with antioxidant free radical scavengers also proved that such chemicals are hepatoprotectives.  Free radical reactions play a significant role in many biological phenomena such as aging and toxic liver cell damage.  Different disciplines support theories to interpret their effects.  In this paper, theories are summarized as a multidisciplinary approach which can provide further explanation and challenge further investigation on alcoholic liver damage and hepatoprotection.
RP VARGA, M (corresponding author), DEBRECEN UNIV MED,INST FORENS MED,PF 25,H-4012 DEBRECEN,HUNGARY.
CR ARMSTRONG D, 1984, FREE RADICALS MOL BI
   BARAONA E, 1975, SCIENCE, V190, P794, DOI 10.1126/science.1198096
   DAMJANOVICH S, 1983, J THEOR BIOL, V105, P25, DOI 10.1016/0022-5193(83)90422-8
   DAMJANOVICH S, 1989, ARCH GERONTOL GERIAT, V8, P37, DOI 10.1016/0167-4943(89)90068-X
   DAMJANOVICH S, 1973, J THEOR BIOL, V41, P567
   DIANZANI MU, 1987, P NUTR SOC, V46, P43, DOI 10.1079/PNS19870007
   LEWIS KO, 1982, LANCET, V2, P188
   LIEBER CS, 1990, PHARMACOL THERAPEUT, V46, P1, DOI 10.1016/0163-7258(90)90032-W
   LUSTYIK G, 1985, SCANNING ELECTRON MI, V1, P323
   PIERI C, 1975, EXP GERONTOL, V10, P291, DOI 10.1016/0531-5565(75)90006-6
   SOMOGYI B, 1971, ACTA BIOCHIMICA B A, V6, P353
   STEGE TE, 1983, FED PROC, V47, P513
   VARGA M, 1990, EXP MOL PATHOL, V52, P249, DOI 10.1016/0014-4800(90)90010-B
   VARGA M, 1978, STUD BIOPHYS, V70, P45
   VARGA M, 1989, J PHARM BIOCH BEHAV, V33, P52
   WELCH G R, 1982, Progress in Biophysics and Molecular Biology, V39, P109
   ZSNAGY I, 1980, MECH AGEING DEV, V14, P245, DOI 10.1016/0047-6374(80)90124-4
   ZSNAGY I, 1981, EXP GERONTOL, V16, P229, DOI 10.1016/0531-5565(81)90018-8
   ZSNAGY I, 1978, J THEOR BIOL, V75, P189, DOI 10.1016/0022-5193(78)90230-8
   ZSNAGY I, 1986, LIVER AGING
   [No title captured]
NR 21
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0376-8716
J9 DRUG ALCOHOL DEPEN
JI Drug Alcohol Depend.
PD MAR
PY 1991
VL 27
IS 2
BP 117
EP 119
DI 10.1016/0376-8716(91)90029-X
PG 3
WC Substance Abuse; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Substance Abuse; Psychiatry
GA FG354
UT WOS:A1991FG35400003
PM 2055159
DA 2024-02-19
ER

PT J
AU Cogger, VC
   Muller, M
   Fraser, R
   McLean, AJ
   Khan, J
   Le Couteur, DG
AF Cogger, VC
   Muller, M
   Fraser, R
   McLean, AJ
   Khan, J
   Le Couteur, DG
TI The effects of oxidative stress on the liver sieve
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE liver sieve; sinusoidal endothelium; oxidative stress; tert-butyl
   hydroperoxide
ID SINUSOIDAL ENDOTHELIAL-CELLS; PERFUSED-RAT-LIVER; KUPFFER CELLS; INDUCED
   DEFENESTRATION; HYDROGEN-PEROXIDE; HEPATIC SINUSOIDS; REACTIVE OXYGEN;
   INJURY; MITOCHONDRIA; HEPATOCYTES
AB Background/Aims: Oxidative stress is implicated in the pathogenesis of age-related and disease-associated changes in the hepatic sinusoid. We studied the effects of oxidative stress on the morphology of the liver, focusing specifically on the hepatic sinusoidal endothelium (the 'liver sieve').
   Methods: The effects of tert-butyl hydroperoxide on the intact liver and isolated sinusoidal endothelial cells were assessed by electron microscopy, immunohistochemistry and biochemical analysis.
   Results: Immunohistochemistry revealed a dose-dependent increase in peri-sinusoidal 3-nitrotyrosine staining, particularly in the regions adjacent to the porta, I triads. Electron microscopy showed dose-dependent formation of large intracellular gaps in the sinusoidal endothelium with reduction in the diameter of the remaining endothelial fenestrations. Activated Kupffer cells extending processes through the fenestrations to contact hepatocytes were noted. Biochemical analysis of total liver tissue showed no significant changes in malondialdehyde content but a decrease in the ratio of GSH to GSSG. tert-Butyl hydroperoxide administered directly onto isolated liver sinusoidal endothelial cells was associated with similar gap formation, indicating a direct effect on the endothelial cells by tert-butyl hydroperoxide.
   Conclusions: Oxidative stress selectively damages hepatic sinusoidal endothelial cells. This has implications for those processes associated with changes in the sinusoidal endothelium such as ageing, cirrhosis and exposure to hepatotoxins. (C) 2004 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
C1 Univ Sydney, Ctr Educ & Res Ageing, Concord, NSW, Australia.
   Univ Sydney, ANZAC Res Inst, Concord, NSW, Australia.
   Concord RG Hosp, Concord, NSW, Australia.
   Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand.
   Univ Melbourne, Natl Ageing Res Inst, Parkville, Vic 3052, Australia.
C3 University of Sydney; University of Sydney; ANZAC Research Institute;
   Concord Repatriation General Hospital; University of Otago; University
   of Melbourne; National Ageing Research Institute
RP Cogger, VC (corresponding author), Univ Sydney, Ctr Educ & Res Ageing, Concord, NSW, Australia.
EM victoric@physiol.usyd.edu.au
RI Research Institute, ANZAC/CAE-9030-2022; Ekanayake, Kanchana/P-8817-2016
OI Le Couteur, David/0000-0002-4227-5817
CR Agrawal A, 2001, MOL CELL BIOCHEM, V224, P9, DOI 10.1023/A:1011990704575
   Ahmed-Choudhury J, 1998, TOXICOL APPL PHARM, V152, P270, DOI 10.1006/taap.1998.8495
   Ardite E, 1999, J HEPATOL, V31, P921, DOI 10.1016/S0168-8278(99)80295-5
   Armeni T, 1997, MOL ASPECTS MED, V18, pS247
   Bautista Abraham P., 1999, Frontiers in Bioscience, V4, pd589, DOI 10.2741/Bautista
   BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441
   Braet F, 2003, HEPATOLOGY, V38, P394, DOI 10.1053/jhep.2003.50347
   BRAET F, 1994, LAB INVEST, V70, P944
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   Cogger VC, 2001, PHARMACOL TOXICOL, V89, P306, DOI 10.1034/j.1600-0773.2001.d01-165.x
   DAHLE LK, 1962, ARCH BIOCHEM BIOPHYS, V98, P253, DOI 10.1016/0003-9861(62)90181-9
   Deaciuc IV, 1999, J HEPATOL, V30, P213, DOI 10.1016/S0168-8278(99)80064-6
   DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x
   DOBBS BR, 1994, LIVER, V14, P230
   DURHAM SK, 1990, J PATHOL, V162, P341, DOI 10.1002/path.1711620412
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   FRASER R, 1980, BRIT J EXP PATHOL, V61, P222
   FRASER R, 1980, PATHOLOGY, V12, P371, DOI 10.3109/00313028009077098
   FRASER R, 1978, ATHEROSCLEROSIS, V29, P113, DOI 10.1016/0021-9150(78)90001-1
   FRASER R, 1986, CELLS HEPATIC SINUSO, V1, P317
   Frenzel H., 1977, KUPFFER OTHER LIVER, P213
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   Haidara K, 2002, BBA-MOL CELL RES, V1542, P173, DOI 10.1016/S0167-4889(01)00178-1
   Hines IN, 2003, AM J PHYSIOL-GASTR L, V284, pG536, DOI 10.1152/ajpgi.00400.2002
   HORN T, 1987, HEPATOLOGY, V7, P77, DOI 10.1002/hep.1840070117
   JAESCHKE H, 1991, CHEM-BIOL INTERACT, V79, P115, DOI 10.1016/0009-2797(91)90077-K
   Junqueira VBC, 1997, TOXICOLOGY, V117, P199, DOI 10.1016/S0300-483X(96)03580-9
   Karbowski M, 1999, FREE RADICAL BIO MED, V26, P396, DOI 10.1016/S0891-5849(98)00209-3
   Karbowski M, 1997, BBA-LIPID LIPID MET, V1349, P242, DOI 10.1016/S0005-2760(97)00140-9
   Kumamoto Y, 1999, HEPATOLOGY, V30, P1454, DOI 10.1002/hep.510300601
   Kuo PC, 1997, BIOCHEM BIOPH RES CO, V234, P289, DOI 10.1006/bbrc.1997.6562
   LAGNEAUX D, 1981, PATHOL BIOL, V29, P279
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LEBAIL B, 1990, J ELECTRON MICR TECH, V14, P257, DOI 10.1002/jemt.1060140307
   LIU P, 1995, SHOCK, V3, P56, DOI 10.1097/00024382-199503010-00010
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719
   Martín C, 2001, BIOCHEM PHARMACOL, V62, P705, DOI 10.1016/S0006-2952(01)00704-3
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   Miller RT, 1997, APPL IMMUNOHISTOCHEM, V5, P63, DOI 10.1097/00022744-199703000-00010
   MORIKAWA H, 1995, CAN J ANAESTH, V42, P231, DOI 10.1007/BF03010684
   Muller M, 2002, FREE RADICAL BIO MED, V33, P1527, DOI 10.1016/S0891-5849(02)01087-0
   Nolan J P, 1985, Prog Clin Biol Res, V189, P347
   NOPANITAYA W, 1976, BRIT J EXP PATHOL, V57, P604
   SCHAFFNER F, 1963, GASTROENTEROLOGY, V44, P239
   Tenenbein M, 2001, J TOXICOL-CLIN TOXIC, V39, P721, DOI 10.1081/CLT-100108513
   Teranishi M, 1999, J ELECTRON MICROSC, V48, P637, DOI 10.1093/oxfordjournals.jmicro.a023730
   Videla LA, 2003, BIOMETALS, V16, P103, DOI 10.1023/A:1020707811707
   Wack KE, 2001, HEPATOLOGY, V33, P363, DOI 10.1053/jhep.2001.21998
   WIESE AG, 1995, ARCH BIOCHEM BIOPHYS, V318, P231, DOI 10.1006/abbi.1995.1225
   WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4
   WISSE E, 1972, J ULTRA MOL STRUCT R, V38, P528, DOI 10.1016/0022-5320(72)90089-5
NR 53
TC 57
Z9 61
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD SEP
PY 2004
VL 41
IS 3
BP 370
EP 376
DI 10.1016/j.jhep.2004.04.034
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 855YI
UT WOS:000224010400002
PM 15336438
DA 2024-02-19
ER

PT J
AU Al-Eisa, RA
AF Al-Eisa, Rasha A.
TI Synergistic Antioxidant Capacity of Chitosan Nanoparticles and Lycopene
   Against Aging Hepatotoxicity Induced by D-galactose in Male Rats
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Chitosan nanoparticles; lycopene; antioxidant enzymes; oxidative
   biomarkers; hepatotoxicity
ID INDUCED OXIDATIVE STRESS; HISTOLOGICAL-CHANGES; MOUSE; GLUTATHIONE;
   MODEL; OLIGOSACCHARIDES; SUPPLEMENTATION; CHOLESTEROL; PROTECTION;
   QUERCETIN
AB Background and Objective: Ageing is frequently accompanied by the occurrence of several diseases, such as Alzheimer's and disturbance of vital organs like liver, the combination between some compounds with antioxidant properties are considered a new hope for treatment of aging consequences, so this paper aimed to evaluate the synergistic effect between chitosan nanoparticles and lycopene in ameliorating liver functions and alleviate hepatotoxicity and oxygen free radicals which are a reactive species that are permanently liberated in living cells and increased greatly in aging and causes health disturbances. This study aimed to synthesis chitosan nanoparticles (CHNPs),to determine their characteristics and to estimate the synergistic role of CHNPs incorporation with lycopene (Ly) against oxidative stress of aging and hepatotoxicity. Materials and Methods: Male wistar rats were divided into 9 groups (10 rats/group) as follow: Control group, D-galactose group(100 mg kg(-1)), CHNPs either (low dose) or (high dose) (140 or 280 mg kg(-1)), Ly group (20 mg kg(-1)), CHNPs either low dose or high dose with Ly and D-gal plus Ly and/or CHNPs with Low and high dose treated groups. The CHNPs were characterized by TEM, Zeta potential and size distribution of particles. At the end of the experiment, some biochemical parameters were measured as lipid profile, tumor marker TNF-alpha and IL-6, markers of inflammation and tissue damage LDH and CRP with histological, comet assay and TEM examination of liver tissues. Results: Chitosan showed size distribution (pdi) 0.370 nm. D-galactose induced hepatic biochemical alterations and cellular changes. CHNPs in two doses either low or high dose alone or combined with Ly significantly elicited remarkable amelioration in liver enzymes biomarkers, improved lipid profile, decreased tumor necrosis factor-alpha and IL-6, enhanced antioxidant enzymes as SOD, CAT and GPxwith decreasing marker of lipid peroxidation and proved by structural alterations in TEM, histological and comet assay of liver tissues. Conclusion: It could be proved that CHNPs and Ly could synergistically afforded protection against liver injury and oxidative stress as a result of aging. Consequently, CHNPs was an effective agent in the drug delivery in liver diseases medications. CHNP-s and Ly enhanced liver enzymes and improved their antioxidant capacities in liver.
C1 [Al-Eisa, Rasha A.] Taif Univ, Fac Sci, Dept Biol, At Taif 888, Saudi Arabia.
C3 Taif University
RP Al-Eisa, RA (corresponding author), Taif Univ, Fac Sci, Dept Biol, At Taif 888, Saudi Arabia.
RI Aleisa, Rasha/JZD-2038-2024
OI , Rasha/0000-0001-6373-849X
FU Deanship of scientific research of Taif University [1-438-6023]
FX I would like to express my sincere thanks and appreciation to the
   Deanship of Scientific research in Taif University as this research is
   financed by: Deanship of scientific research of Taif University, Project
   number: 1-438-6023.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Agrawal P, 2010, ADV DRUG DELIVER REV, V62, P42, DOI 10.1016/j.addr.2009.09.007
   Anraku M, 2008, INT J BIOL MACROMOL, V43, P159, DOI 10.1016/j.ijbiomac.2008.04.006
   Anraku M, 2010, BIOL PHARM BULL, V33, P1994, DOI 10.1248/bpb.33.1994
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X
   Chen CF, 2006, PSYCHONEUROENDOCRINO, V31, P805, DOI 10.1016/j.psyneuen.2006.03.004
   Chen LW, 2001, JNCI-J NATL CANCER I, V93, P1872, DOI 10.1093/jnci/93.24.1872
   Choi YD, 1999, J UROLOGY, V162, P1508, DOI 10.1016/S0022-5347(05)68349-8
   Chung MJ, 2012, INT IMMUNOPHARMACOL, V12, P453, DOI 10.1016/j.intimp.2011.12.027
   Collins Andrew R, 2002, Methods Mol Biol, V186, P147
   COURI D, 1979, J ENVIRON PATHOL TOX, V3, P451
   Datta S, 2016, EUR J PHARMACOL, V771, P229, DOI 10.1016/j.ejphar.2015.12.032
   Devaraj S, 2008, J AM COLL NUTR, V27, P267, DOI 10.1080/07315724.2008.10719699
   El-Shenawy NS, 2015, EXP TOXICOL PATHOL, V67, P65, DOI 10.1016/j.etp.2014.10.005
   ELDENSHARY ES, 2015, SOFT NANOSCI LETT, V5, P36, DOI DOI 10.4236/SNL.2015.52005
   Endoh D, 2002, J VET MED SCI, V64, P761, DOI 10.1292/jvms.64.761
   Engelmann NJ, 2011, ADV NUTR, V2, P51, DOI 10.3945/an.110.000075
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   FRIEDEWALD WT, 1972, CLIN CHEM, V0018
   Gabe M., 1968, Techniques histologiques, P1113
   Gao HY, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-30
   Gerster H, 1997, J AM COLL NUTR, V16, P109
   Ghanbari S, 2012, DARU, V20, DOI 10.1186/2008-2231-20-68
   Gu RL, 2010, BIOMATERIALS, V31, P1270, DOI 10.1016/j.biomaterials.2009.10.023
   HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580
   Hamza RZ, 2015, TOXICOL ENVIRON CHEM, V97, P1041, DOI 10.1080/02772248.2015.1077961
   Hamza Reham Z., 2015, Journal of Basic and Clinical Physiology and Pharmacology, V26, P237, DOI 10.1515/jbcpp-2014-0065
   Herlong H.F., 2012, SCHIFFS DIS LIVER, P17
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   HU ML, 1994, METHOD ENZYMOL, V233, P380
   Jeon TI, 2003, TOXICOLOGY, V187, P67, DOI 10.1016/S0300-483X(03)00003-9
   Jia L, 2005, CURR NANOSCI, V1, P237, DOI 10.2174/157341305774642939
   Jiang W, 2016, WORLD J GASTROENTERO, V22, P10180, DOI 10.3748/wjg.v22.i46.10180
   Kim, 2001, J CHITIN CHITOSAN, V6, P163
   Kumar A, 2012, PHARMACOL REP, V64, P1326, DOI 10.1016/S1734-1140(12)70930-1
   Kumar S, 2012, INT J BIOL MACROMOL, V50, P493, DOI 10.1016/j.ijbiomac.2012.01.015
   Lei M, 2008, BIOCHEM BIOPH RES CO, V369, P1082, DOI 10.1016/j.bbrc.2008.02.151
   LITWACK G, 1953, J BIOL CHEM, V200, P303
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Mohamed N. E., 2011, J AM SCI, V7, P406
   Mortensen A, 1997, FEBS LETT, V417, P261, DOI 10.1016/S0014-5793(97)01297-0
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ormrod DJ, 1998, ATHEROSCLEROSIS, V138, P329, DOI 10.1016/S0021-9150(98)00045-8
   Patel VR, 2011, J ADV PHARM TECHNOL, V2, P81, DOI 10.4103/2231-4040.82950
   Perez-Vizcaino F, 2006, BIOCHEM BIOPH RES CO, V346, P919, DOI 10.1016/j.bbrc.2006.05.198
   Ragab GMA., 2013, GLOBAL J PHARM, V7, P258, DOI DOI 10.5829/IDOSI.GJP.2013.7.3.7637
   Rao AV, 2002, NUTR RES, V22, P1125, DOI 10.1016/S0271-5317(02)00430-X
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   Santhosh S, 2006, TOXICOLOGY, V219, P53, DOI 10.1016/j.tox.2005.11.001
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Stahl W, 2007, MOL BIOTECHNOL, V37, P26, DOI 10.1007/s12033-007-0051-z
   Subhapradha N, 2014, APPL BIOCHEM BIOTECH, V172, P9, DOI 10.1007/s12010-013-0499-1
   SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2
   Tang ZX, 2007, APPL BIOCHEM BIOTECH, V136, P77, DOI 10.1007/BF02685940
   Vassault A., 1983, METHODS ENZYMATIC AN, V3, P118
   Visioli F, 2003, EUR J NUTR, V42, P201, DOI 10.1007/s00394-003-0415-5
   Vo TS, 2012, PROCESS BIOCHEM, V47, P327, DOI 10.1016/j.procbio.2011.10.036
   Vora SR, 2009, INDIAN J EXP BIOL, V47, P338
   Wang JL, 2011, COLLOID SURFACE B, V85, P241, DOI 10.1016/j.colsurfb.2011.02.035
   Warnick G.R., 1983, LIN CHEM, V10, P91
   Weakley B. S., 1981, BEGINNERS HDB BIOL T, P252
   Wen ZS, 2013, MAR DRUGS, V11, P3582, DOI 10.3390/md11103582
   Wen ZS, 2011, MAR DRUGS, V9, P1038, DOI 10.3390/md9061038
   Wener MH, 2000, J RHEUMATOL, V27, P2351
   Yen FL, 2007, J ETHNOPHARMACOL, V111, P123, DOI 10.1016/j.jep.2006.11.003
   Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005
NR 67
TC 4
Z9 4
U1 2
U2 11
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PY 2018
VL 14
IS 6
BP 811
EP 825
DI 10.3923/ijp.2018.811.825
PG 15
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA GN3LW
UT WOS:000438908200009
OA Bronze
DA 2024-02-19
ER

PT J
AU Zaidi, G
   Panda, H
   Supakar, P
AF Zaidi, G
   Panda, H
   Supakar, P
TI Increased phosphorylation and decreased level of IκBα during aging in
   rat liver
SO BIOGERONTOLOGY
LA English
DT Article
DE aging; I kappa B alpha; NF kappa B; p-I kappa B alpha; transcription
   factor
ID ANDROGEN RECEPTOR GENE; TRANSCRIPTION FACTOR; UP-REGULATION; ACTIVATION;
   AGE; DEGRADATION; UBIQUITINATION; EXPRESSION; INHIBITOR; MUSCLE
AB Nuclear factor kappa B (NF kappa B) is an evolutionary conserved transcription factor, which coordinates various metabolic processes triggered by innate and adaptive immune responses. Supakar et al. (J. Biol. Chem. 270: 837-842, 1995) had reported a 10-fold increase in DNA binding activity of NF kappa B in liver of old rats. In this study, we have analyzed the changes in the level of NF kappa B, inhibitor of NF kappa B (I kappa B alpha), phosphorylated-I kappa B alpha (p-I kappa B alpha) and I kappa B kinase (IKK) in rat liver during aging by reverse transcription polymerase chain reaction and/or western blotting. Here we demonstrate that there is an age-dependent increase in the level of p-I kappa B alpha with concomitant decrease in the level of I kappa B alpha, which may be correlated with increased inflammation, oxidative stress and higher level of activated NF kappa B in rat liver in old age.
C1 Inst Life Sci, Bhubaneswar 751023, Orissa, India.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS)
RP Supakar, P (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Orissa, India.
EM pcsupakar@hotmail.com
CR BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689
   BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380
   Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027
   Chapple ILC, 1997, J CLIN PERIODONTOL, V24, P287, DOI 10.1111/j.1600-051X.1997.tb00760.x
   CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   Helenius M, 2001, ANTIOXID REDOX SIGN, V3, P147, DOI 10.1089/152308601750100669
   HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0
   Kaufmann JA, 2002, NEUROREPORT, V13, P1917, DOI 10.1097/00001756-200210280-00017
   Kim HJ, 2000, FREE RADICAL BIO MED, V28, P683, DOI 10.1016/S0891-5849(99)00274-9
   Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0
   Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H
   MIYAMOTO S, 1994, MOL CELL BIOL, V14, P3276, DOI 10.1128/MCB.14.5.3276
   RICE NR, 1993, EMBO J, V12, P4685, DOI 10.1002/j.1460-2075.1993.tb06157.x
   SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259
   SONG CS, 1995, ANN NY ACAD SCI, P76197
   Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
NR 21
TC 4
Z9 4
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD MAR
PY 2005
VL 6
IS 2
BP 141
EP 145
DI 10.1007/s10522-005-3459-5
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 948GX
UT WOS:000230705200006
PM 16034681
DA 2024-02-19
ER

PT J
AU Godoy, RS
   Lanés, LEK
   Weber, V
   Stenert, C
   Nóblega, HG
   Oliveira, GT
   Maltchik, L
AF Godoy, Robson S.
   Lanes, Luis Esteban K.
   Weber, Vinicius
   Stenert, Cristina
   Noblega, Hector G.
   Oliveira, Guendalina T.
   Maltchik, Leonardo
TI Age-associated liver alterations in wild populations of <i>Austrolebias
   minuano</i>, a short-lived Neotropical annual killifish
SO BIOGERONTOLOGY
LA English
DT Article
DE Annual fish; Neoplasia; Steatosis; Temporary ponds; Liver diseases
ID ANNUAL CYPRINODONT FISH; AFRICAN ANNUAL FISHES; LIFE-SPAN;
   NOTHOBRANCHIUS-FURZERI; MODEL SYSTEM; SEX-RATIO; BODY-SIZE;
   ENVIRONMENTAL PREDICTORS; TEMPERATURE-TRANSFER; AGING CHANGES
AB Aging processes have become an attractive field for researchers and annual fish have been used as biological models. However, the study on the changes in age-associated markers during the normal aging in wild populations of annual fish remains open. Austrolebias is a genus of Neotropical annual killifishes, distributed mainly in ephemeral pools across grassland floodplains of temperate South America and represent an emerging biological model for aging research, but studies investigating rapid aging and senescence in this genus of annual fish are almost non-existent. This study was undertaken to examine the changes in age-associated liver markers at the different developmental stages in wild populations of Austrolebias minuano. We demonstrate that A. minuano has a number of liver alterations of different severities throughout the life cycle, suggesting that these changes tend to increase with age. Our results revealed that > 70% of the analyzed livers presented alterations. Thus, our study should instigate new approaches on aging using Neotropical annual fish, and could be useful to improve the knowledge already provided by consecrated biological aging models as e.g. Nothobranchius killifishes.
C1 [Godoy, Robson S.; Weber, Vinicius; Stenert, Cristina; Maltchik, Leonardo] UNISINOS Univ, Lab Ecol & Conservat Aquat Ecosyst, Ave Unisinos 950, BR-93022750 Sao Leopoldo, RS, Brazil.
   [Lanes, Luis Esteban K.; Noblega, Hector G.; Oliveira, Guendalina T.] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Lab Fisiol Conservacao, Ave Ipiranga, Porto Alegre, RS, Brazil.
C3 Pontificia Universidade Catolica Do Rio Grande Do Sul
RP Maltchik, L (corresponding author), UNISINOS Univ, Lab Ecol & Conservat Aquat Ecosyst, Ave Unisinos 950, BR-93022750 Sao Leopoldo, RS, Brazil.
EM maltchik@unisinos.br
RI Lanés, Luis E.K./D-8685-2014; Stenert, Cristina/AAD-6860-2020; Oliveira,
   Guendalina Turcato/K-6291-2012
OI Oliveira, Guendalina Turcato/0000-0001-7929-917X; Stenert,
   Cristina/0000-0002-9095-2018; Godoy, Robson/0000-0001-5757-9146;
   Maltchik, Leonardo/0000-0002-5321-7524
CR Ackerman HD, 2018, CONN'S HANDBOOK OF MODELS FOR HUMAN AGING, 2ND EDITION, P361, DOI 10.1016/B978-0-12-811353-0.00027-0
   [Anonymous], HDB BIOL AGING
   Baumgart M, 2015, BIOGERONTOLOGY, V16, P63, DOI 10.1007/s10522-014-9535-y
   Belote Drausio F., 2004, Boletim do Museu Nacional Rio de Janeiro Zoologia, V514, P1
   Berois N., 2014, Cell Dev Biol, V3, P136, DOI [10.4172/2168-9296.1000136, DOI 10.4172/2168-9296.1000136]
   Blazek R, 2017, EVOLUTION, V71, P386, DOI 10.1111/evo.13127
   Blazek R, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-24
   Cellerino A, 2016, BIOL REV, V91, P511, DOI 10.1111/brv.12183
   COMFORT A, 1961, GERONTOLOGY, V5, P209, DOI 10.1159/000211060
   COOPER EL, 1983, EXP GERONTOL, V18, P29, DOI 10.1016/0531-5565(83)90048-7
   Da Rocha CAM, 2018, ACTA FISH, V5, P19
   Davis T, 2005, EXP GERONTOL, V40, P17, DOI 10.1016/j.exger.2004.09.004
   Di Cicco E, 2011, EXP GERONTOL, V46, P249, DOI 10.1016/j.exger.2010.10.011
   Egami N, 1980, Adv Exp Med Biol, V129, P249
   García D, 2008, NEOTROP ICHTHYOL, V6, P243, DOI 10.1590/S1679-62252008000200012
   Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x
   Gerhard GS, 2007, AGEING RES REV, V6, P64, DOI 10.1016/j.arr.2007.02.007
   Gerhard GS, 2002, EXP GERONTOL, V37, P1055, DOI 10.1016/S0531-5565(02)00088-8
   Gonçalves CD, 2011, NEOTROP ICHTHYOL, V9, P191, DOI 10.1590/S1679-62252011000100019
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Hastings R, 2004, EXP GERONTOL, V39, P855, DOI 10.1016/j.exger.2004.02.003
   Herrera M, 2004, J GERONTOL A-BIOL, V59, P101
   Hsu CY, 2009, AGING CELL, V8, P726, DOI 10.1111/j.1474-9726.2009.00525.x
   Hsu CY, 2008, J GERONTOL A-BIOL, V63, P1267, DOI 10.1093/gerona/63.12.1267
   Hu CK, 2018, AGING CELL, V17, DOI 10.1111/acel.12757
   IBGE, 2004, Mapa da vegetacao do Brasil e Mapa de biomas do Brasil, V3
   Jellema RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073031
   Johnson TE, 2003, EXP GERONTOL, V38, P1329, DOI 10.1016/j.exger.2003.10.020
   Jones OR, 2017, BIOGERONTOLOGY, V18, P965, DOI 10.1007/s10522-017-9727-3
   Katic M, 2005, CELL MOL LIFE SCI, V62, P320, DOI 10.1007/s00018-004-4297-y
   Keppeler FW, 2013, ITAL J ZOOL, V80, P291, DOI 10.1080/11250003.2012.744107
   Keppeler FW, 2015, ECOL FRESHW FISH, V24, P77, DOI 10.1111/eff.12127
   Keppeler FW, 2016, HYDROBIOLOGIA, V773, P225, DOI 10.1007/s10750-016-2705-y
   Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682
   Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097
   Lanés LEK, 2018, ENVIRON BIOL FISH, V101, P963, DOI 10.1007/s10641-018-0751-1
   Lanés LEK, 2014, J NAT HIST, V48, P1971, DOI 10.1080/00222933.2013.862577
   Lanés LEK, 2012, ACTA ICHTHYOL PISCAT, V42, P247, DOI 10.3750/AIP2011.42.3.09
   Lanés LEK, 2016, J FISH BIOL, V89, P2345, DOI 10.1111/jfb.13122
   Lanés LEK, 2015, J APPL ICHTHYOL, V31, P321, DOI 10.1111/jai.12687
   LIU RK, 1975, GROWTH, V39, P337
   LIU RK, 1972, GERONTOLOGY, V18, P363, DOI 10.1159/000211944
   LIU RK, 1975, J GERONTOL, V30, P129, DOI 10.1093/geronj/30.2.129
   Loureiro M, 2018, NEOTROP ICHTHYOL, V16, DOI 10.1590/1982-0224-20180007
   Lucas-Sánchez A, 2014, AGING DIS, V5, P281, DOI 10.14336/AD.2014.0500281
   MARKOFSKY J, 1979, EXP GERONTOL, V14, P11, DOI 10.1016/0531-5565(79)90003-2
   Muck J, 2018, CONN'S HANDBOOK OF MODELS FOR HUMAN AGING, 2ND EDITION, P377, DOI 10.1016/B978-0-12-811353-0.00028-2
   Nasir L, 2001, NEOPLASIA, V3, P351, DOI 10.1038/sj.neo.7900173
   Passos C, 2013, BEHAV PROCESS, V96, P20, DOI 10.1016/j.beproc.2013.01.008
   PATNAIK BK, 1994, GERONTOLOGY, V40, P113, DOI 10.1159/000213582
   Podrabsky JE, 1998, HYDROBIOLOGIA, V362, P67
   Poleksic V., 1994, P339
   Reichard M, 2009, J FISH BIOL, V74, P198, DOI 10.1111/j.1095-8649.2008.02129.x
   Reichard M, 2018, BIOL J LINN SOC, V124, P56, DOI 10.1093/biolinnean/bly022
   Reichard M, 2016, ANNUAL FISHES: LIFE HISTORY STRATEGY, DIVERSITY, AND EVOLUTION, P133
   Reichard M, 2016, ECOL EVOL, V6, P2988, DOI 10.1002/ece3.2093
   Reichard M, 2014, EVOL ECOL, V28, P1105, DOI 10.1007/s10682-014-9732-9
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Silva GG, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2774
   STEGEMAN JJ, 1991, ENVIRON HEALTH PERSP, V90, P101, DOI 10.2307/3430851
   Stenert C, 2008, MAR FRESHWATER RES, V59, P540, DOI 10.1071/MF07220
   *SYST, 2007, SYST SOFTW
   Tagliani P. R. A., 1995, THESIS
   Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866
   Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038
   Volcan MV, 2019, HYDROBIOLOGIA, V827, P367, DOI 10.1007/s10750-018-3789-3
   Vrtílek M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22878-6
   Vrtílek M, 2015, ECOL FRESHW FISH, V24, P616, DOI 10.1111/eff.12175
   WALFORD RL, 1969, EXP GERONTOL, V4, P103, DOI 10.1016/0531-5565(69)90032-1
   Woodhead AD, 1998, EXP GERONTOL, V33, P39, DOI 10.1016/S0531-5565(97)00064-8
   Wootton RJ, 2015, REPRODUCTIVE BIOLOGY OF TELEOST FISHES, P1
NR 71
TC 8
Z9 9
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD OCT
PY 2019
VL 20
IS 5
BP 687
EP 698
DI 10.1007/s10522-019-09822-5
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA IW3RS
UT WOS:000484899800007
PM 31302822
OA Green Published
DA 2024-02-19
ER

PT J
AU Tormos, AM
   Rius-Pérez, S
   Jorques, M
   Rada, P
   Ramirez, L
   Valverde, AM
   Nebreda, AR
   Sastre, J
   Taléns-Visconti, R
AF Tormos, Ana M.
   Rius-Perez, Sergio
   Jorques, Maria
   Rada, Patricia
   Ramirez, Lorena
   Valverde, Angela M.
   Nebreda, Angel R.
   Sastre, Juan
   Talens-Visconti, Raquel
TI p38α regulates actin cytoskeleton and cytokinesis in hepatocytes during
   development and aging
SO PLOS ONE
LA English
DT Article
ID ACTIVATED-PROTEIN-KINASE; P38 MAPK; NUCLEAR ACTIN; CELL-PROLIFERATION;
   INDUCED ASSOCIATION; ANIMAL CYTOKINESIS; DOUBLE-BLIND; RHO-GTPASES;
   GROWTH; PHOSPHORYLATION
AB Background
   Hepatocyte poliploidization is an age-dependent process, being cytokinesis failure the main mechanism of polyploid hepatocyte formation. Our aim was to study the role of p38 alpha MAPK in the regulation of actin cytoskeleton and cytokinesis in hepatocytes during development and aging.
   Methods
   Wild type and p38 alpha liver-specific knock out mice at different ages (after weaning, adults and old) were used.
   Results
   We show that p38 alpha MAPK deficiency induces actin disassembly upon aging and also cytokinesis failure leading to enhanced binucleation. Although the steady state levels of cyclin D1 in wild type and p38 alpha knock out old livers remained unaffected, cyclin B1-alpha marker for G2/M transition-was significantly overexpressed in p38a knock out mice. Our findings suggest that hepatocytes do enter into S phase but they do not complete cell division upon p38 alpha a deficiency leading to cytokinesis failure and binucleation. Moreover, old liver-specific p38 alpha MAPK knock out mice exhibited reduced F-actin polymerization and a dramatic loss of actin cytoskeleton. This was associated with abnormal hyperactivation of RhoA and Cdc42 GTPases. Long-term p38 alpha deficiency drives to inactivation of HSP27, which seems to account for the impairment in actin cytoskeleton as Hsp27-silencing decreased the number and length of actin filaments in isolated hepatocytes.
   Conclusions
   p38 alpha MAPK is essential for actin dynamics with age in hepatocytes.
C1 [Tormos, Ana M.; Rius-Perez, Sergio; Jorques, Maria; Sastre, Juan] Univ Valencia Burjassot, Dept Physiol, Valencia, Spain.
   [Rada, Patricia; Valverde, Angela M.] Ctr Mixto CSIC UAM, Inst Invest Biomed Alberto Sols, Arturo Duperier 4, Madrid, Spain.
   [Rada, Patricia; Valverde, Angela M.] ISCIII, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain.
   [Ramirez, Lorena; Nebreda, Angel R.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain.
   [Nebreda, Angel R.] ICREA, Barcelona, Spain.
   [Talens-Visconti, Raquel] Univ Valencia Burjassot, Dept Pharm & Pharmaceut Technol & Parasitol, Valencia, Spain.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Investigaciones Biomedicas Alberto Sols (IIBM); Instituto de Salud
   Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM;
   Barcelona Institute of Science & Technology; Institute for Research in
   Biomedicine - IRB Barcelona; ICREA
RP Taléns-Visconti, R (corresponding author), Univ Valencia Burjassot, Dept Pharm & Pharmaceut Technol & Parasitol, Valencia, Spain.
EM raquel.talens@uv.es
RI Rada, Patricia/G-7300-2015; Taléns-Visconti, Raquel/P-6621-2019; PEREZ,
   SERGIO RIUS/T-7766-2017; Nebreda, Angel Rodriguez/R-9594-2019;
   Taléns-Visconti, Raquel/A-9162-2018
OI Rada, Patricia/0000-0002-6731-2098; Taléns-Visconti,
   Raquel/0000-0002-9816-9693; Taléns-Visconti, Raquel/0000-0002-9816-9693;
   Martinez Valverde, Angela/0000-0003-1192-9045
FU Ministry of Economy and Competitiveness; postdoctoral contract Juan de
   la Cierva (MINECO, Spain); FEDER [SAF 2015-71208-R]; Spanish Ministry of
   Economy and Competitiveness (MINECO, Spain) [CSD-2007-00020];
   Generalitat Valenciana [GV PROMETEO II 2014-056]; MINECO/FEDER; Centro
   de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas
   Asociadas (CIBERDEM, ISCIII, Spain); MI NECO [BFU2010-17850]; European
   Commission [ERC 294665]; ICREA Funding Source: Custom
FX AMT was recipient of a fellowship from the Ministry of Economy and
   Competitiveness. PR was recipient of a postdoctoral contract Juan de la
   Cierva (MINECO, Spain). This work was supported by Grants SAF
   2015-71208-R with FEDER funds and CSD-2007-00020 from the Spanish
   Ministry of Economy and Competitiveness (MINECO, Spain,
   http://www.mineco.gob.es/portal/site/mineco/) and GV PROMETEO II
   2014-056 from Generalitat Valenciana to JS and RTV, and by Grant SAF
   2015-65267-R (MINECO/FEDER) and by Centro de Investigacion Biomedica en
   Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM, ISCIII,
   Spain) to AMV. ARN was funded by grants from MI NECO (BFU2010-17850) and
   the European Commission (ERC 294665).
CR Ambrosino C, 2001, BIOL CELL, V93, P47, DOI 10.1016/S0248-4900(01)01124-8
   Atkins BD, 2013, J CELL BIOL, V202, P231, DOI 10.1083/jcb.201301090
   Awad MM, 2000, J BIOL CHEM, V275, P38716, DOI 10.1074/jbc.M008040200
   Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038
   Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011
   BENNDORF R, 1994, J BIOL CHEM, V269, P20780
   BENVENISTE R, 1988, CELL BIOCHEM FUNCT, V6, P231, DOI 10.1002/cbf.290060403
   Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504
   Bitar KN, 2002, J APPL PHYSIOL, V92, P41, DOI 10.1152/jappl.2002.92.1.41
   Bitar KN, 2002, AM J PHYSIOL-GASTR L, V282, pG894, DOI 10.1152/ajpgi.00141.2001
   Buttrick GJ, 2008, CELL CYCLE, V7, P2621, DOI 10.4161/cc.7.17.6514
   Campbell JS, 2011, INT J BIOCHEM CELL B, V43, P180, DOI 10.1016/j.biocel.2010.08.002
   Celton-Morizur S, 2010, ADV EXP MED BIOL, V676, P123
   Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677
   Chevalier D, 2000, BIOCHEMISTRY-US, V39, P6145, DOI 10.1021/bi9928389
   Coleman ML, 2006, ONCOGENE, V25, P2708, DOI 10.1038/sj.onc.1209322
   Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323
   Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010
   D'Avino PP, 2005, J CELL SCI, V118, P1549, DOI 10.1242/jcs.02335
   Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485
   Danese S, 2006, WORLD J GASTROENTERO, V12, P4807
   Davies T, 2012, J CELL BIOL, V198, P769, DOI 10.1083/jcb.201207197
   Dubroca C, 2005, HYPERTENSION, V45, P974, DOI 10.1161/01.HYP.0000164582.63421.2d
   Duffy JP, 2011, ACS MED CHEM LETT, V2, P758, DOI 10.1021/ml2001455
   Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003
   Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414
   Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058
   Fisk M, 2014, AM J CARDIOVASC DRUG, V14, P155, DOI 10.1007/s40256-014-0063-6
   Gaffey K, 2013, EUR RESPIR J, V42, P28, DOI 10.1183/09031936.00170711
   Genovese MC, 2011, J RHEUMATOL, V38, P846, DOI 10.3899/jrheum.100602
   Gentric G, 2012, CLIN RES HEPATOL GAS, V36, P29, DOI 10.1016/j.clinre.2011.05.011
   Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430
   Gentric G, 2014, AM J PATHOL, V184, P322, DOI 10.1016/j.ajpath.2013.06.035
   Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351
   Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0305s06, 10.1002/0471143030.cb0304s04, 10.1002/0471143030.cb0303s04]
   Guay J, 1997, J CELL SCI, V110, P357
   Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002
   Guo K, 2008, CANCER SCI, V99, P486, DOI 10.1111/j.1349-7006.2007.00702.x
   Gupta S, 2000, SEMIN CANCER BIOL, V10, P161
   Gurgis FMS, 2014, MOL PHARMACOL, V85, P345, DOI 10.1124/mol.113.090365
   Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007
   Hill RJ, 2008, J PHARMACOL EXP THER, V327, P610, DOI 10.1124/jpet.108.139006
   Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774
   Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033
   Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Kalendová A, 2014, HISTOCHEM CELL BIOL, V142, P139, DOI 10.1007/s00418-014-1243-9
   Kato K, 2010, EXP THER MED, V1, P579, DOI 10.3892/etm_00000091
   Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200
   Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080
   Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106
   Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49
   Lee SH, 2001, J BIOL CHEM, V276, P25066, DOI 10.1074/jbc.M010892200
   Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433
   Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907
   Martin ED, 2015, BRIT J PHARMACOL, V172, P2101, DOI 10.1111/bph.12901
   MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4
   MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293
   Munsie LN, 2012, J CELL SCI, V125, P3977, DOI 10.1242/jcs.097667
   Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002
   Navas TA, 2006, LEUKEMIA, V20, P1017, DOI 10.1038/sj.leu.2404200
   Newby LK, 2014, LANCET, V384, P1187, DOI 10.1016/S0140-6736(14)60417-7
   Normand G, 2010, ADV EXP MED BIOL, V676, P27
   Núñez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073
   Patil SB, 2004, AM J PHYSIOL-GASTR L, V286, pG635, DOI 10.1152/ajpgi.00261.2003
   Pederson T, 2008, J CELL BIOL, V180, P1061, DOI 10.1083/jcb.200709082
   Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006
   Pongratz G, 2006, J IMMUNOL, V177, P2926, DOI 10.4049/jimmunol.177.5.2926
   Rannou Y, 2012, J CELL SCI, V125, P2844, DOI 10.1242/jcs.058081
   Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schäfer C, 1998, J BIOL CHEM, V273, P24173, DOI 10.1074/jbc.273.37.24173
   Schiel JA, 2010, THESCIENTIFICWORLDJO, V10, P1424, DOI 10.1100/tsw.2010.129
   Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013
   Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582
   Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964
   Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519
   Svensson CI, 2005, NEUROSCI LETT, V379, P209, DOI 10.1016/j.neulet.2004.12.064
   Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065
   Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44
   Tong SE, 2012, J CLIN PHARMACOL, V52, P717, DOI 10.1177/0091270011405496
   Tormos AM, 2013, HEPATOLOGY, V57, P1950, DOI 10.1002/hep.26174
   Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037
   Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694
   Xu JT, 2007, EXP NEUROL, V204, P355, DOI 10.1016/j.expneurol.2006.11.016
   Yang F, 2010, HEPATOLOGY, V51, P1614, DOI 10.1002/hep.23566
   Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209
   Zeitlin SG, 2001, CURR BIOL, V11, pR514, DOI 10.1016/S0960-9822(01)00307-4
   ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934
   Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x
NR 90
TC 11
Z9 12
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 6
PY 2017
VL 12
IS 2
AR e0171738
DI 10.1371/journal.pone.0171738
PG 22
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA EK1QH
UT WOS:000393700100067
PM 28166285
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Laviada, ID
   GalveRoperh, I
   Malpartida, JM
   Haro, A
AF Laviada, ID
   GalveRoperh, I
   Malpartida, JM
   Haro, A
TI cAMP signalling mechanisms with aging in the Ceratitis capitata brain
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; cAMP-dependent protein kinase; nervous system
ID DEPENDENT PROTEIN-KINASE; NEURONAL FUNCTION; BINDING; PHOSPHORYLATION;
   MORTALITY; DOMAINS; LIVER; CELLS
AB Aging has been associated with alterations in protein phosphorylation, This study was undertaken to examine eventual changes in cAMP-dependent protein kinase (PKA) activity and enzyme regulatory subunit levels from the dipterous Ceratitis capitata brain with postmaturational aging and senescence. PKA activity was determined in cytosolic and membrane fractions of the C. capitata brain during the adult stage of the insect lifespan. PKA activity markedly increased at the first stages of the life of the fly both in cytosol and in membranes. A lower peak of PKA activity was evident both in particulate and cytosolic fractions in the terminal phase of the life of the fly. Thus, PKA activity was significantly higher in the brain of mature flies when compared to the brain of aged flies. It is possible that increases in cAMP-dependent protein phosphorylation levels characterize the terminal aging process in the insect nervous tissue. On the other hand, levels of regulatory (R) subunit were also measured in membranes and cytosol by immunoblotting. Cytosolic regulatory subunit levels were more elevated near the terminal phase of life, whereas in membranes, regulatory subunit levels decrease in senescence in parallel with particulate PKA activity. The increased R subunit level in citosol may reflect a cellular response mechanisms to down-regulate the kinase system in aged flies. (C) 1997 Elsevier Science Ireland Ltd.
C1 UNIV COMPLUTENSE MADRID, FAC QUIM, DEPT BIOQUIM & BIOL MOL 1, E-28040 MADRID, SPAIN.
   UNIV ALCALA DE HENARES, FAC MED, DEPT BIOQUIM, ALCALA DE HENARES 28871, MADRID, SPAIN.
C3 Complutense University of Madrid; Universidad de Alcala
RI Diaz-Laviada, Ines/I-2838-2015; Galve-Roperh, Ismael/AAG-2369-2020
OI Diaz-Laviada, Ines/0000-0001-9704-4373; 
CR BEEBE SJ, 1994, SEMIN CANCER BIOL, V5, P285
   BLUMENTHAL EJ, 1993, MECH AGEING DEV, V72, P13, DOI 10.1016/0047-6374(93)90127-D
   BLUMENTHAL EJ, 1988, MECH AGEING DEV, V46, P201, DOI 10.1016/0047-6374(88)90125-X
   CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540
   Cashman RE, 1995, MOL CHEM NEUROPATHOL, V26, P247, DOI 10.1007/BF02815141
   CHIN JH, 1990, MECH AGEING DEV, V53, P111, DOI 10.1016/0047-6374(90)90064-M
   DIAZLAVIADA I, 1990, EMBO J, V9, P3907, DOI 10.1002/j.1460-2075.1990.tb07611.x
   DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y
   DRAIN P, 1991, NEURON, V6, P71, DOI 10.1016/0896-6273(91)90123-H
   EKANGER R, 1989, J BIOL CHEM, V264, P4374
   FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321
   GalveRoperh I, 1996, MECH AGEING DEV, V92, P21, DOI 10.1016/S0047-6374(96)01799-X
   GARCIA JL, 1981, COMP BIOCHEM PHYS C, V68, P109, DOI 10.1016/0306-4492(81)90003-4
   GARCIA JL, 1983, ARCH BIOCHEM BIOPHYS, V220, P509, DOI 10.1016/0003-9861(83)90442-3
   HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115
   HIRSH AG, 1994, EXP GERONTOL, V29, P197, DOI 10.1016/0531-5565(94)90051-5
   Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461
   KUMAR R, 1984, GERONTOLOGY, V30, P37, DOI 10.1159/000212605
   LIN LW, 1995, DRUG AGING, V6, P136, DOI 10.2165/00002512-199506020-00006
   LINTS FA, 1985, HDB BIOL AGING, P146
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAGNONI MS, 1991, LIFE SCI, V48, P373, DOI 10.1016/0024-3205(91)90492-T
   Meier-Ruge W, 1980, Adv Biochem Psychopharmacol, V23, P323
   PATRIDGE L, 1993, GENETICA, V91, P89
   PEREZBAUN JC, 1994, NEUROPHARMACOLOGY, V33, P641, DOI 10.1016/0028-3908(94)90169-4
   PISANO M R, 1991, Biomedical and Environmental Sciences, V4, P173
   PRASHAD N, 1979, BIOCHEMISTRY-US, V18, P2717, DOI 10.1021/bi00580a005
   SCHMIDT MJ, 1980, J NEUROCHEM, V35, P261, DOI 10.1111/j.1471-4159.1980.tb12514.x
   SHABB JB, 1992, J BIOL CHEM, V267, P5723
   WALAAS SI, 1991, PHARMACOL REV, V43, P299
   WALTER U, 1979, P NATL ACAD SCI USA, V76, P3251, DOI 10.1073/pnas.76.7.3251
NR 31
TC 10
Z9 10
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JUL
PY 1997
VL 97
IS 1
BP 45
EP 53
DI 10.1016/S0047-6374(97)01899-X
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA XF712
UT WOS:A1997XF71200005
PM 9223125
DA 2024-02-19
ER

PT J
AU Chen, LX
   Zhou, TH
   Wu, N
   O'Brien, A
   Venter, J
   Ceci, L
   Kyritsi, K
   Onori, P
   Gaudio, E
   Sybenga, A
   Xie, LL
   Wu, CD
   Fabris, L
   Invernizzi, P
   Zawieja, D
   Liangpunsakul, S
   Meng, FY
   Francis, H
   Alpini, G
   Huang, QB
   Glaser, S
AF Chen, Lixian
   Zhou, Tianhao
   Wu, Nan
   O'Brien, April
   Venter, Julie
   Ceci, Ludovica
   Kyritsi, Konstantina
   Onori, Paolo
   Gaudio, Eugenio
   Sybenga, Amelia
   Xie, Linglin
   Wu, Chaodong
   Fabris, Luca
   Invernizzi, Pietro
   Zawieja, David
   Liangpunsakul, Suthat
   Meng, Fanyin
   Francis, Heather
   Alpini, Gianfranco
   Huang, Qiaobing
   Glaser, Shannon
TI Pinealectomy or light exposure exacerbates biliary damage and liver
   fibrosis in cholestatic rats through decreased melatonin synthesis
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE Arylalkylamine N-acetyltransferase; Clock genes; Melatonin receptors;
   Reactive oxygen species; Senescence
ID HEPATIC STELLATE CELLS; CHOLANGIOCYTE PROLIFERATION; OXIDATIVE STRESS;
   ACTIVATION; EXPRESSION; RECEPTOR; SENESCENCE; CIRRHOSIS; MODEL;
   HYPERPLASIA
AB Melatonin, a neuroendocrine hormone synthesized by the pineal gland and cholangiocytes, decreases biliary hyperplasia and liver fibrosis during cholestasis-induced biliary injury via melatonin-dependent autocrine signaling through increased biliary arylalkylamine N-acetyltransferase (AANAT) expression and melatonin secretion, downregulation of miR-200b and specific circadian clock genes. Melatonin synthesis is decreased by pinealectomy (PINX) or chronic exposure to light. We evaluated the effect of PINX or prolonged light exposure on melatonin-dependent modulation of biliary damage/ductular reaction/liver fibrosis. Studies were performed in male rats with/without BDL for 1 week with 12:12 h dark/light cycles, continuous light or after 1 week of PINX. The expression of AANAT and melatonin levels in serum and cholangiocyte supernatant were increased in BDL rats, while decreased in BDL rats following PINX or continuous light exposure. BDL-induced increase in serum chemistry, ductular reaction, liver fibrosis, inflammation, angiogenesis and ROS generation were significantly enhanced by PINX or light exposure. Concomitant with enhanced liver fibrosis, we observed increased biliary senescence and enhanced clock genes and miR-200b expression in total liver and cholangiocytes. In vitro, the expression of AANAT, clock genes and miR-200b was increased in PSC human cholangiocyte cell lines (hPSCL). The proliferation and activation of HHStecs (human hepatic stellate cell lines) were increased after stimulating with BDL cholangiocyte supematant and further enhanced when stimulated with BDL rats following PINX or continuous light exposure cholangiocyte supernatant via intracellular ROS generation. Conclusion: Melatonin plays an important role in the protection of liver against cholestasis-induced damage and ductular reaction.
C1 [Meng, Fanyin; Francis, Heather; Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Res, Temple, TX USA.
   [Chen, Lixian; Zhou, Tianhao; Wu, Nan; O'Brien, April; Venter, Julie; Ceci, Ludovica; Kyritsi, Konstantina; Zawieja, David; Meng, Fanyin; Francis, Heather; Alpini, Gianfranco; Glaser, Shannon] Texas A&M Univ, Coll Med, Dept Med Physiol, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.
   [Wu, Nan; Venter, Julie; Ceci, Ludovica; Kyritsi, Konstantina; Liangpunsakul, Suthat; Meng, Fanyin; Francis, Heather; Alpini, Gianfranco] Richard L Roudebush VA Med Ctr, Res, Indianapolis, IN USA.
   [Wu, Nan; Venter, Julie; Ceci, Ludovica; Kyritsi, Konstantina; Liangpunsakul, Suthat; Meng, Fanyin; Francis, Heather; Alpini, Gianfranco] Indiana Univ, Gastroenterol, Med, Bloomington, IN 47405 USA.
   [Onori, Paolo; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
   [Sybenga, Amelia] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.
   [Xie, Linglin; Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA.
   [Fabris, Luca] Univ Padua, Sch Med, Dept Mol Med, Padua, Italy.
   [Fabris, Luca] Yale Univ, Sch Med, Digest Dis Sect, New Haven, CT USA.
   [Invernizzi, Pietro] Humanitas Clin & Res Ctr, Milan, Italy.
   [Chen, Lixian; Huang, Qiaobing] Southern Med Univ, Dept Pathophysiol, Key Lob Shock & Microcirculat Res Guangdong Prov, Guangzhou, Guangdong, Peoples R China.
   [Invernizzi, Pietro] Univ Milano Bicocca, San Gerardo Hosp, Dept Med & Surg, Div Gastroenterol, Monza, Italy.
   [Invernizzi, Pietro] Univ Milano Bicocca, San Gerardo Hosp, Dept Med & Surg, Ctr Autoimmune Liver Dis, Monza, Italy.
C3 Texas A&M University System; US Department of Veterans Affairs; Veterans
   Health Administration (VHA); Richard L. Roudebush VA Medical Center;
   Indiana University System; Indiana University Bloomington; Sapienza
   University Rome; Vanderbilt University; Texas A&M University System;
   Texas A&M University College Station; University of Padua; Yale
   University; Southern Medical University - China; San Gerardo Hospital;
   University of Milano-Bicocca; University of Milano-Bicocca; San Gerardo
   Hospital
RP Glaser, S (corresponding author), Texas A&M Univ, Coll Med, Dept Med Physiol, 702 SW HK Dodgen Loop, Temple, TX 76504 USA.
EM sglaser@medicine.tamhsc.edu
RI Zhou, Tianhao/AAO-3542-2021; Chen, Lixian/ABH-3076-2021; Onori,
   Paolo/J-9394-2013; Invernizzi, Pietro/AAB-8367-2022; Fabris,
   Luca/J-7565-2018
OI Zhou, Tianhao/0000-0002-5722-6954; Onori, Paolo/0000-0002-7195-3760;
   Fabris, Luca/0000-0001-8538-6317
FU VA Merit Awards from the United States Department of Veteran's Affairs,
   Biomedical Laboratory Research and Development Service [1I01BX003031,
   4I01BX000574, 1I01BX001724]; NIH [DK054811, DK076898, DK107310,
   DK110035, DK062975, DK108959, DK082435]; PSC Partners Grant
   [460933-00001]; Dr. Nicholas C. Hightower Centennial Chair of
   Gastroenterology from Baylor Scott White Health; Development Service, by
   University of Rome "La Sapienza"
FX This study was supported by (i) VA Merit Awards (1I01BX003031, HF;
   4I01BX000574, GA; 1I01BX001724, FM) from the United States Department of
   Veteran's Affairs, Biomedical Laboratory Research and Development
   Service and NIH grants DK054811, DK076898, DK107310, DK110035, DK062975
   to GA, SG, FM, DK108959, HF, and DK082435 to SD; (ii) the PSC Partners
   Grant Award 460933-00001 and Dr. Nicholas C. Hightower Centennial Chair
   of Gastroenterology from Baylor Scott & White Health (GA); and (iii)
   Development Service, by University of Rome "La Sapienza" to PO. This
   material is the result of work supported with resources and the use of
   facilities at the Central Texas Veterans Health Care System, Temple,
   Texas. The content is the responsibility of the author(s) alone and does
   not necessarily reflect the views or policies of the Department of
   Veterans Affairs or the United States Government.
CR ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537
   Baydas G, 2001, CELL BIOCHEM FUNCT, V19, P37, DOI 10.1002/cbf.897
   Bubenik GA, 1997, BIOL SIGNAL, V6, P40
   Chen P, 2013, EXP TOXICOL PATHOL, V65, P427, DOI 10.1016/j.etp.2011.12.007
   Chen P, 2010, HEPATOL RES, V40, P1117, DOI 10.1111/j.1872-034X.2010.00695.x
   Coelho LA, 2015, J PINEAL RES, V58, P490, DOI 10.1111/jpi.12234
   Colares JR, 2016, WORLD J GASTROENTERO, V22, P8918, DOI 10.3748/wjg.v22.i40.8918
   Cruz A, 2005, J PINEAL RES, V39, P143, DOI 10.1111/j.1600-079X.2005.00227.x
   CUNNANE SC, 1979, MED HYPOTHESES, V5, P403, DOI 10.1016/0306-9877(79)90107-5
   Das N, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12404
   De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033
   Dumont M, 2012, CHRONOBIOL INT, V29, P203, DOI 10.3109/07420528.2011.647177
   Esrefoglu M, 2005, WORLD J GASTROENTERO, V11, P1951
   Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034
   Glaser S, 2011, AM J PHYSIOL-GASTR L, V301, pG297, DOI 10.1152/ajpgi.00418.2010
   Gu J, 2006, J PINEAL RES, V41, P275, DOI 10.1111/j.1600-079X.2006.00364.x
   Han YY, 2014, AM J PHYSIOL-GASTR L, V307, pG894, DOI 10.1152/ajpgi.00288.2014
   Hardeland R, 2013, J PINEAL RES, V55, P325, DOI 10.1111/jpi.12090
   Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246
   Hu SL, 2009, EUR J PHARMACOL, V616, P287, DOI 10.1016/j.ejphar.2009.06.044
   ISHII M, 1989, GASTROENTEROLOGY, V97, P1236, DOI 10.1016/0016-5085(89)91695-8
   Jaworek J, 2010, PHARMACOL REP, V62, P864, DOI 10.1016/S1734-1140(10)70346-7
   Klein DC, 2002, BIOCHEM SOC T, V30, P365, DOI 10.1042/bst0300365
   LEWY AJ, 1980, J CLIN ENDOCR METAB, V50, P204, DOI 10.1210/jcem-50-1-204
   Lissoni P, 2001, NEUROENDOCRINOL LETT, V22, P45
   Liu LW, 2017, NAT MATER, V16, P1252, DOI [10.1038/NMAT5024, 10.1038/nmat5024]
   McGuinness PH, 2000, GUT, V46, P260, DOI 10.1136/gut.46.2.260
   Meng LK, 2015, AM J PATHOL, V185, P602, DOI 10.1016/j.ajpath.2014.10.027
   Renzi A, 2013, HEPATOLOGY, V57, P1130, DOI 10.1002/hep.26105
   Sánchez-Hidalgo M, 2009, J PINEAL RES, V46, P29, DOI 10.1111/j.1600-079X.2008.00604.x
   Shajari S, 2015, J PINEAL RES, V59, P391, DOI 10.1111/jpi.12271
   Sohn EJ, 2015, J CANCER, V6, P19, DOI 10.7150/jca.9591
   Susko Irfan, 2017, Med Arch, V71, P385, DOI 10.5455/medarh.2017.71.385-390
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tahan V, 2004, J PINEAL RES, V37, P78, DOI 10.1111/j.1600-079X.2004.00137.x
   Trivedi AK, 2016, PHYSIOL BEHAV, V156, P156, DOI 10.1016/j.physbeh.2016.01.019
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wang H, 2005, LIFE SCI, V77, P1902, DOI 10.1016/j.lfs.2005.04.013
   Wu N, 2017, HEPATOLOGY, V66, p367A
   Wu N, 2017, FASEB J, V31, P4305, DOI 10.1096/fj.201700097R
   Wu N, 2016, HEPATOLOGY, V64, P865, DOI 10.1002/hep.28622
   Wu N, 2014, HEPATOLOGY, V60, p403A
   Yu ST, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12405
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 46
TC 16
Z9 16
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD JUN 1
PY 2019
VL 1865
IS 6
BP 1525
EP 1539
DI 10.1016/j.bbadis.2019.03.002
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA HZ2VZ
UT WOS:000468708200042
PM 30890428
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU SHARMA, R
   PATNAIK, SK
AF SHARMA, R
   PATNAIK, SK
TI REGULATION OF CITRATE SYNTHASE AND PHOSPHOENOLPYRUVATE CARBOXYKINASE BY
   HYDROCORTISONE IN THE LIVER OF AGING RATS
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
C1 MANIPUR UNIV,DEPT LIFE SCI,IMPHAL 795003,INDIA.
C3 Manipur University
CR BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866
   GARRETT HE, 1966, STATISTICS PSYCHOL E
   GUNN JM, 1975, BIOCHEMISTRY-US, V14, P2350, DOI 10.1021/bi00682a012
   HEITZMAN RJ, 1972, FEBS LETT, V20, P19, DOI 10.1016/0014-5793(72)80006-1
   HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3
   IYNEDJIAN PB, 1977, J BIOL CHEM, V252, P655
   Kanungo M.S., 1980, BIOCH AGEING
   KIRSTEN R, 1972, AM J PHYSIOL, V223, P229, DOI 10.1152/ajplegacy.1972.223.1.229
   KREBS H. A., 1966, ADVANC ENZYME REGULAT, V4, P339, DOI 10.1016/0065-2571(66)90027-6
   LARDY HA, 1965, P NATL ACAD SCI USA, V53, P1410, DOI 10.1073/pnas.53.6.1410
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MUKHERJEE A, 1976, J BIOL CHEM, V251, P2155
   NORDLIE RC, 1963, J BIOL CHEM, V238, P2259
   PATNAIK SK, 1974, BIOCHEM BIOPH RES CO, V56, P845, DOI 10.1016/S0006-291X(74)80265-2
   ROTH GS, 1975, EXP GERONTOL, V10, P1, DOI 10.1016/0531-5565(75)90009-1
   ROTH GS, 1974, EXP GERONTOL, V9, P27, DOI 10.1016/0531-5565(74)90004-7
   SERIO M, 1969, EXP GERONTOL, V4, P95, DOI 10.1016/0531-5565(69)90031-X
   SHARMA R, 1982, DEV GROWTH DIFFER, V24, P501, DOI 10.1111/j.1440-169X.1982.00501.x
   SHARMA R, 1982, BIOCHEM INT, V5, P561
   SHRAGO E, 1963, J BIOL CHEM, V238, P3188
   SINGER S, 1973, INT J BIOCHEM, V4, P569, DOI 10.1016/0020-711X(73)90035-9
   SINGH SN, 1968, J BIOL CHEM, V243, P4526
   SINGHAL RL, 1967, J GERONTOL, V22, P77
   Srere P A, 1972, Curr Top Cell Regul, V5, P229
   SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129
   SRERE PA, 1969, BIOCHEM MED METAB B, V3, P61, DOI 10.1016/0006-2944(69)90014-3
   Tilghman SM, 1976, GLUCONEOGENESIS ITS, P47
NR 27
TC 10
Z9 10
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PY 1984
VL 3
IS 2
BP 167
EP 174
DI 10.1016/0167-4943(84)90008-6
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA TG564
UT WOS:A1984TG56400008
PM 6476976
DA 2024-02-19
ER

PT J
AU Ding, CY
   Zou, QY
   Wang, FX
   Wu, HH
   Chen, RL
   Lv, JH
   Ling, MF
   Sun, J
   Wang, W
   Li, H
   Huang, BX
AF Ding, Chenyue
   Zou, Qinyan
   Wang, Fuxin
   Wu, Huihua
   Chen, Rulei
   Lv, Jinghuan
   Ling, Mingfa
   Sun, Jian
   Wang, Wei
   Li, Hong
   Huang, Boxian
TI Human amniotic mesenchymal stem cells improve ovarian function in
   natural aging through secreting hepatocyte growth factor and epidermal
   growth factor
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Natural ovarian aging; Human amniotic mesenchymal stem cells; HGF; EGF
ID GRANULOSA-CELLS; OOCYTE MATURATION; FACTOR PROTECTS; IN-VITRO; PROMOTES;
   RECEPTOR; MODEL
AB Background: Although many reports show that various kinds of stem cells have the ability to recover function in premature ovarian aging, few studies have looked at stem cell treatment of natural ovarian aging (NOA). We designed this experimental study to investigate whether human amniotic mesenchymal stem cells (hAMSCs) retain the ability to restore ovarian function, and how hAMSCs work in this process.
   Methods: To build the NOA mouse model, the mice were fed for 12-14 months normally with young fertile female mice as the normal control group (3-5 months old). Hematoxylin and eosin staining permitted follicle counting and showed the ovarian tissue structure. An enzyme-linked immunosorbent assay was used to detect the serum levels of the sex hormones estradiol (E2), anti-mullerian hormone (AMH), and follicle-stimulating hormone (FSH). The proliferation rate and marker expression level of human ovarian granule cells (hGCs) (ki67, AMH, FSH receptor, FOXL2, and CYP19A1) were measured by flow cytometry (FACS). Cytokines (growth factors) were measured by a protein antibody array methodology. After hepatocyte growth factor (HGF) and epidermal growth factor (EGF) were co-cultured with hGes, proliferation (ki67) and apoptosis (Annexin V) levels were analyzed by FACS. After HGF and EGF were injected into the ovaries of natural aging mice, the total follicle numbers and hormone levels were tested.
   Results: After the hAMSCs were transplanted into the NOA mouse model, the hAMSCs exerted a therapeutic activity on mouse ovarian function by improving the follicle numbers over four stages. In addition, our results showed that hAMSCs significantly promoted the proliferation rate and marker expression level of ovarian granular cells that were from NOA patients. Meanwhile, we found that the secretion level of EGF and HGF from hAMSCs was higher than other growth factors. A growth factor combination (HGF with EGF) improved the proliferation rate and inhibited the apoptosis rate more powerfully after a co-culture with hGCs, and total follicle numbers and hormone levels were elevated to a normal level after the growth factor combination was injected into the ovaries of the NOA mouse model.
   Conclusions: These findings provide insight into the notion that hAMSCs play an integral role in resistance to NOA. Furthermore, our present study demonstrates that a growth factor combination derived from hAMSCs plays a central role in inhibiting ovarian aging. Therefore, we suggest that hAMSCs improve ovarian function in natural aging by secreting HGF and EGF.
C1 [Ding, Chenyue; Zou, Qinyan; Wang, Fuxin; Wu, Huihua; Sun, Jian; Wang, Wei; Li, Hong; Huang, Boxian] Nanjing Med Univ, Suzhou Municipal Hosp, Affiliated Suzhou Hosp, Ctr Reprod & Genet, Suzhou 215002, Peoples R China.
   [Chen, Rulei; Lv, Jinghuan; Ling, Mingfa; Huang, Boxian] Nanjing Med Univ, Suzhou Municipal Hosp, Affiliated Suzhou Hosp, Cent Lab, Suzhou 215002, Peoples R China.
   [Huang, Boxian] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China.
C3 Nanjing Medical University; Nanjing Medical University; Nanjing Medical
   University
RP Li, H; Huang, BX (corresponding author), Nanjing Med Univ, Suzhou Municipal Hosp, Affiliated Suzhou Hosp, Ctr Reprod & Genet, Suzhou 215002, Peoples R China.; Huang, BX (corresponding author), Nanjing Med Univ, Suzhou Municipal Hosp, Affiliated Suzhou Hosp, Cent Lab, Suzhou 215002, Peoples R China.; Huang, BX (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China.
EM hongliszivf@163.com; huangboxiannj@163.com
RI Zou, Qin/GVU-2237-2022
FU Suzhou Science and Technology for People's Livelihood [SYS201771];
   Suzhou Science and Technology for People's Livelihood, Suzhou Key
   Medicine Center [SZZX201505]; Suzhou Health Bureau Fund [lczx201411];
   Maternal and Health Care Project of Jiangsu Province-Assisted
   Reproduction Medicine Center [FKX201224]; Jiangsu Provincial Medical
   innovation team [CXTDB2017013]; China Postdoctoral Science Foundation
   [2017 M611871]; Suzhou Introduce Expert Team of Clinical Medicine
   [SZYJTD201708]
FX This work was supported by grants from Suzhou Science and Technology for
   People's Livelihood (SYS201771), Suzhou Science and Technology for
   People's Livelihood, Suzhou Key Medicine Center (SZZX201505), Suzhou
   Health Bureau Fund (lczx201411), Maternal and Health Care Project of
   Jiangsu Province-Assisted Reproduction Medicine Center (FKX201224),
   Jiangsu Provincial Medical innovation team (CXTDB2017013), project
   funded by China Postdoctoral Science Foundation (2017 M611871), and
   Suzhou Introduce Expert Team of Clinical Medicine (SZYJTD201708).
CR Alexander PB, 2015, CELL RES, V25, P135, DOI 10.1038/cr.2014.141
   Ben-Meir A, 2015, FERTIL STERIL, V104, P724, DOI 10.1016/j.fertnstert.2015.05.023
   Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82
   Bu R, 2011, LAB INVEST, V91, P124, DOI 10.1038/labinvest.2010.136
   Capobianco V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25270
   Chung Soo-Ho, 2014, J Menopausal Med, V20, P69, DOI 10.6118/jmm.2014.20.2.69
   Danieli P, 2015, STEM CELL TRANSL MED, V4, P448, DOI 10.5966/sctm.2014-0253
   Ding CY, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0613-3
   Easley CA, 2013, REPROD BIOMED ONLINE, V27, P75, DOI 10.1016/j.rbmo.2013.03.003
   Eke G, 2017, BIOMATERIALS, V129, P188, DOI 10.1016/j.biomaterials.2017.03.021
   El-Hayek S, 2014, P NATL ACAD SCI USA, V111, P16778, DOI 10.1073/pnas.1414648111
   Enriquez-Cortina C, 2013, TOXICOL SCI, V135, P26, DOI 10.1093/toxsci/kft134
   Kim SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041105
   Li J, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0514-5
   Nelson SM, 2013, HUM REPROD UPDATE, V19, P67, DOI 10.1093/humupd/dms043
   Okada M, 2004, PEDIATR RES, V56, P336, DOI 10.1203/01.PDR.0000134255.58638.59
   Sirotkin AV, 2011, J CELL PHYSIOL, V226, P2222, DOI 10.1002/jcp.22588
   Su J, 2016, HUM REPROD, V31, P1075, DOI 10.1093/humrep/dew041
   Sugimura S, 2015, DEV BIOL, V403, P139, DOI 10.1016/j.ydbio.2015.05.008
   Tatone C, 2013, FERTIL STERIL, V99, P12, DOI 10.1016/j.fertnstert.2012.11.029
   Uzumcu M, 2006, REPRODUCTION, V132, P291, DOI 10.1530/rep.1.00989
   van Kasteren YM, 1999, HUM REPROD UPDATE, V5, P483, DOI 10.1093/humupd/5.5.483
   Volarevic V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/507234
   Wang TR, 2014, HUM REPROD, V29, P568, DOI 10.1093/humrep/det465
   Wu YG, 2015, J ENDOCRINOL, V226, P167, DOI 10.1530/JOE-15-0246
   Xie CF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13975
   Xie L, 2016, MOL CELL ENDOCRINOL, V419, P198, DOI 10.1016/j.mce.2015.10.018
   Zamah AM, 2010, HUM REPROD, V25, P2569, DOI 10.1093/humrep/deq212
NR 28
TC 60
Z9 64
U1 2
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD MAR 9
PY 2018
VL 9
AR 55
DI 10.1186/s13287-018-0781-9
PG 11
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA FZ0MY
UT WOS:000427265100002
PM 29523193
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU LAGANIERE, S
   YU, BP
AF LAGANIERE, S
   YU, BP
TI EFFECT OF CHRONIC FOOD RESTRICTION IN AGING RATS .2. LIVER CYTOSOLIC
   ANTIOXIDANTS AND RELATED ENZYMES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 UNIV TEXAS,HLTH SCI CTR,DEPT PHYSIOL,SAN ANTONIO,TX 78284.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio
FU NIA NIH HHS [AGO1188] Funding Source: Medline
CR BEUTLER E, 1986, J CLIN INVEST, V77, P38, DOI 10.1172/JCI112298
   BURK R, 1985, BIOCH BIOPHYS, V757, P21
   CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8
   CHOW CK, 1979, AM J CLIN NUTR, V32, P1066, DOI 10.1093/ajcn/32.5.1066
   GIBSON DD, 1985, LIPIDS, V20, P704, DOI 10.1007/BF02534391
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HARMAN D, 1985, RELATIONS NORMAL AGI, V28, P45
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HORECKER BL, 1948, J BIOL CHEM, V175, P385
   IMANISHI H, 1985, MECH AGEING DEV, V32, P57, DOI 10.1016/0047-6374(85)90035-1
   KITAHARA A, 1982, LIVER AGING 1982, P135
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   KONRAD PN, 1972, NEW ENGL J MED, V286, P557, DOI 10.1056/NEJM197203162861101
   LAGANIERE S, 1987, BIOCHEM BIOPH RES CO, V145, P1185, DOI 10.1016/0006-291X(87)91562-2
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   NOHL H, 1979, MECH AGEING DEV, V11, P145, DOI 10.1016/0047-6374(79)90050-2
   NOY N, 1985, MECH AGEING DEV, V29, P63, DOI 10.1016/0047-6374(85)90047-8
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   PROHASKA JR, 1977, BIOCHEM BIOPH RES CO, V76, P437, DOI 10.1016/0006-291X(77)90744-6
   RACKER E, 1955, J BIOL CHEM, V217, P855
   RICHARDSON A, 1987, FED PROC, V47, P568
   ROSS D, 1988, PHARMACOL THERAPEUT, V37, P231, DOI 10.1016/0163-7258(88)90027-7
   Snedecor G.W. Cochran., 1968, STAT METHODS, V7th
   STOHS SJ, 1980, AGE, V3, P11, DOI 10.1007/BF02435000
   STOHS SJ, 1983, GEN PHARMACOL, V15, P267
   TENOVUO J, 1986, BIOCHIM BIOPHYS ACTA, V870, P377, DOI 10.1016/0167-4838(86)90244-X
   VUOPIO P, 1970, Annals of Clinical Research, V2, P184
   YOUNES M, 1981, CHEM-BIOL INTERACT, V34, P257, DOI 10.1016/0009-2797(81)90098-3
   YU BP, 1988, OXY RAD BIOL MED, V49, P1067
   ZANNONI V, 1974, BIOCHEM MED METAB B, V11, P41, DOI 10.1016/0006-2944(74)90093-3
NR 33
TC 121
Z9 121
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUN
PY 1989
VL 48
IS 3
BP 221
EP 230
DI 10.1016/0047-6374(89)90084-5
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA AB181
UT WOS:A1989AB18100002
PM 2733462
DA 2024-02-19
ER

PT J
AU Lin, HY
   Yu, IC
   Wang, RS
   Chen, YT
   Liu, NC
   Altuwaijri, S
   Hsu, CL
   Ma, WL
   Jokinen, J
   Sparks, JD
   Yeh, SY
   Chang, CS
AF Lin, Hung-Yun
   Yu, I-Chen
   Wang, Ruey-Shen
   Chen, Yei-Tsung
   Liu, Ning-Chun
   Altuwaijri, Saleh
   Hsu, Cheng-Lung
   Ma, Wen-Lung
   Jokinen, Jenny
   Sparks, Janet D.
   Yeh, Shuyuan
   Chang, Chawnshang
TI Increased hepatic steatosis and insulin resistance in mice lacking
   hepatic androgen receptor
SO HEPATOLOGY
LA English
DT Article
ID TYROSINE-PHOSPHATASE 1B; ENDOGENOUS SEX-HORMONES; FATTY LIVER-DISEASE;
   LEPTIN RESISTANCE; NUCLEAR SREBP-1C; OBESITY; SENSITIVITY; EXPRESSION;
   INHIBITORS; WOMEN
AB Early studies demonstrated that whole-body androgen receptor (AR)-knockout mice with hypogonadism exhibit insulin resistance. However, details about the mechanisms underlying how androgen/AR signaling regulates insulin sensitivity in individual organs remain unclear. We therefore generated hepatic AR-knockout (H-AR(-/y)) mice and found that male H-AR(-/y) mice, but not female H-AR(-/-) mice, fed a high-fat diet developed hepatic steatosis and insulin resistance, and aging male H-AR(-/y) mice fed chow exhibited moderate hepatic steatosis. We hypothesized that increased hepatic steatosis in obese male H-AR(-/y)mice resulted from decreased fatty acid beta-oxidation, increased de novo lipid synthesis arising from decreased PPAR alpha, increased sterol regulatory element binding protein 1c, and associated changes in target gene expression. Reduced insulin sensitivity in fat-fed H-AR(-/y) mice was associated with decreased phosphoinositide-3 kinase activity and increased phosphenolpyruvate carboxykinase expression and correlated with increased protein-tyrosine phosphatase I B expression. Conclusion: Together, our results suggest that hepatic AR may play a vital role in preventing the development of insulin resistance and hepatic steatosis. AR agonists that specifically target hepatic AR might be developed to provide a better strategy for treatment of metabolic syndrome in men.
C1 [Lin, Hung-Yun; Yu, I-Chen; Wang, Ruey-Shen; Chen, Yei-Tsung; Liu, Ning-Chun; Altuwaijri, Saleh; Hsu, Cheng-Lung; Ma, Wen-Lung; Jokinen, Jenny; Sparks, Janet D.; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.
   [Lin, Hung-Yun; Yu, I-Chen; Wang, Ruey-Shen; Chen, Yei-Tsung; Liu, Ning-Chun; Altuwaijri, Saleh; Hsu, Cheng-Lung; Ma, Wen-Lung; Jokinen, Jenny; Sparks, Janet D.; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Urol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.
   [Lin, Hung-Yun; Yu, I-Chen; Wang, Ruey-Shen; Chen, Yei-Tsung; Liu, Ning-Chun; Altuwaijri, Saleh; Hsu, Cheng-Lung; Ma, Wen-Lung; Jokinen, Jenny; Sparks, Janet D.; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Ctr Canc, Rochester, NY 14642 USA.
   [Wang, Ruey-Shen] Taipei Med Univ, Dept Gynecol & Obstet, Taipei, Taiwan.
   [Hsu, Cheng-Lung] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Div Hematol Oncol,Dept Internal Med, Tao Yuan, Taiwan.
C3 University of Rochester; University of Rochester; University of
   Rochester; Taipei Medical University; Chang Gung Memorial Hospital;
   Chang Gung University
RP Chang, CS (corresponding author), 601 Elmwood Ave,Box 626, Rochester, NY 14642 USA.
EM chang@urmc.rochester.edu
RI Ma, Wen-Lung/O-2745-2015
OI Ma, Wen-Lung/0000-0002-5571-3302; Yu, I-Chen/0000-0001-5270-9888; Chang,
   Chawnshang/0000-0001-8510-3516; Chen, Yei-Tsung/0000-0002-3891-5172;
   Sparks, Janet/0000-0002-0072-766X
FU NIDDK NIH HHS [DK073414] Funding Source: Medline
CR Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80
   Brandt JM, 1998, J BIOL CHEM, V273, P23786, DOI 10.1074/jbc.273.37.23786
   Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466
   CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726
   Chen Xin, 2006, Zhonghua Yi Xue Za Zhi, V86, P1474
   Chirieac DV, 2006, AM J PHYSIOL-GASTR L, V291, pG382, DOI 10.1152/ajpgi.00472.2005
   Cohen P, 2005, J BIOL CHEM, V280, P10034, DOI 10.1074/jbc.M413684200
   Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544
   Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573
   Gambineri A, 2004, DIABETES, V53, P2353, DOI 10.2337/diabetes.53.9.2353
   Gervois P, 1999, MOL ENDOCRINOL, V13, P1535, DOI 10.1210/me.13.9.1535
   Heinlein C.A., 2002, ENDOCR REV, V23, P175, DOI [DOI 10.1210/ER.23.2.175, 10.1210/edrv.23.2.0460]
   Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895
   Kalish GM, 2003, J CLIN ENDOCR METAB, V88, P1646, DOI 10.1210/jc.2002-021375
   Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169
   Lam NT, 2004, MOL ENDOCRINOL, V18, P1333, DOI 10.1210/me.2002-0193
   Lam NT, 2006, J MOL ENDOCRINOL, V36, P163, DOI 10.1677/jme.1.01937
   Langhans W, 2001, PHYSIOL BEHAV, V73, P499, DOI 10.1016/S0031-9384(01)00479-6
   Lee Y, 2001, J BIOL CHEM, V276, P5629, DOI 10.1074/jbc.M008553200
   Lin HY, 2005, DIABETES, V54, P1717, DOI 10.2337/diabetes.54.6.1717
   Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5
   Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844
   Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x
   MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Muller M, 2005, J CLIN ENDOCR METAB, V90, P2618, DOI 10.1210/jc.2004-1158
   Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55
   Palmer CNA, 1998, MOL PHARMACOL, V53, P14, DOI 10.1124/mol.53.1.14
   Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636
   Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200
   Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300
   Seppälä-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023
   Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028
   Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182
   Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3
   Ukkola O, 2002, J INTERN MED, V251, P467, DOI 10.1046/j.1365-2796.2002.00992.x
   Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Wu CY, 2006, PROSTATE, V66, P1125, DOI 10.1002/pros.20412
   Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200
   Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399
   Zhang ZY, 2003, EXPERT OPIN INV DRUG, V12, P223, DOI 10.1517/eoid.12.2.223.21411
   Zhang ZY, 2001, CURR OPIN CHEM BIOL, V5, P416, DOI 10.1016/S1367-5931(00)00223-4
   Zitzmann M, 2003, DIABETOLOGIA, V46, P31, DOI 10.1007/s00125-002-0980-9
NR 44
TC 156
Z9 173
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUN
PY 2008
VL 47
IS 6
BP 1924
EP 1935
DI 10.1002/hep.22252
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 308LL
UT WOS:000256391500019
PM 18449947
OA Bronze
DA 2024-02-19
ER

PT J
AU Araújo, TG
   Oliveira, AG
   Tobar, N
   Moreira, LR
   Reis, ER
   Nicola, EMD
   Jorge, GD
   Tártaro, RD
   Boin, IFSF
   Saad, MJA
   Teixeira, ARF
AF Araujo, Tiago G.
   Oliveira, Alexandre G.
   Tobar, Natalia
   Moreira, Luciana R.
   Reis, Edmyr R.
   Nicola, Ester M. D.
   Jorge, Gracinda de L.
   Tartaro, Rodolfo dos R.
   Boin, Ilka F. S. F.
   Abdalla Saad, Mario J.
   Franchi Teixeira, Antonio R.
TI Low-power laser irradiation fails to improve liver regeneration in
   elderly rats at 48 h after 70 % resection
SO LASERS IN MEDICAL SCIENCE
LA English
DT Article
DE Hepatectomy; Laser; Liver regeneration; Aging; Elderly; HGF; Met;
   Proliferation
ID ISCHEMIA-REPERFUSION INJURY; HEPATIC REGENERATION; CELL-PROLIFERATION;
   REMNANT LIVER; HEPATECTOMY; ENHANCEMENT
AB The liver regeneration is an important clinical issue after major hepatectomies. Unfortunately, many organs (including the liver) exhibit age-related impairments regarding their regenerative capacity. Recent studies found that low-power laser irradiation (LPLI) has a stimulatory effect on the liver regeneration process. However, its effects in elderly remain unknown. Thus, this study aimed to investigate the main molecular mechanisms involved in liver regeneration of partially hepatectomized elderly rats exposed to LPLI. The effects of 15 min of LPLI (wavelength of 632.8 nm; fluence of 0.97 J/cm(2); total energy delivered of 3.6 J) were evaluated in hepatectomized elderly Wistar male rats. Afterwards, through immunoblotting approaches, the protein expression and phosphorylation levels of hepatocyte growth factor (HGF), Met, Akt and Erk 1/2 signaling pathways as well as the proliferating cell nuclear antigen (PCNA) were investigated. It was observed that LPLI was not able to improve liver regeneration in elderly rats as evidenced by the lack of improvement of HGF and PCNA protein expression or phosphorylation levels of Met, Akt and Erk 1/2 in the remnant livers. In sum, this study demonstrated that the main molecular pathway, i.e. HGF/Met -> aEuro parts per thousand Akt and Erk 1/2 -> aEuro parts per thousand PCNA, involved in the hepatic regeneration process was not improved by LPLI in elderly hepatectomized rats, which in turn rules out LPLI as an adjuvant therapy, as observed in this protocol of liver regeneration evaluation (i.e. at 48 h after 70 % resection), in elderly.
C1 [Araujo, Tiago G.; Oliveira, Alexandre G.; Tobar, Natalia; Abdalla Saad, Mario J.] Univ Estadual Campinas, Dept Internal Med, BR-13081970 Campinas, SP, Brazil.
   [Moreira, Luciana R.] Univ Estadual Campinas, Dept Pathol, BR-13081970 Campinas, SP, Brazil.
   [Reis, Edmyr R.; Nicola, Ester M. D.] Univ Estadual Campinas, Med & Surg Expt Ctr, Laser Lab, BR-13081970 Campinas, SP, Brazil.
   [Jorge, Gracinda de L.; Tartaro, Rodolfo dos R.; Boin, Ilka F. S. F.; Franchi Teixeira, Antonio R.] Univ Estadual Campinas, Fac Med Sci, Dept Surg, BR-13081970 Campinas, SP, Brazil.
   [Oliveira, Alexandre G.] Sao Paulo State Univ UNESP, Dept Phys Educ, Rio Claro, SP, Brazil.
C3 Universidade Estadual de Campinas; Universidade Estadual de Campinas;
   Universidade Estadual de Campinas; Universidade Estadual de Campinas;
   Universidade Estadual Paulista
RP Teixeira, ARF (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Surg, Cidade Univ Zeferino Vaz, BR-13081970 Campinas, SP, Brazil.
EM drrteixeira@gmail.com
RI Boin, Ilka/AAM-6755-2021; Boin, Ilka FSF/C-7811-2009; Saad,
   Mario/ABD-8262-2020; Tobar, Natalia/JUU-2444-2023; Araújo,
   Tiago/W-4623-2019; Oliveira, Alexandre G/D-1288-2013; Boin,
   Ilka/M-7184-2019
OI Boin, Ilka/0000-0002-1165-2149; Tobar, Natalia/0000-0002-4383-3876;
   Araújo, Tiago/0000-0003-0917-5424; Oliveira, Alexandre
   G/0000-0002-6620-5477; 
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP; Conselho
   Nacional de Pesquisa, CNPq
FX This work was supported by grants from the Fundacao de Amparo a Pesquisa
   do Estado de Sao Paulo, FAPESP, and Conselho Nacional de Pesquisa, CNPq.
   No potential conflicts of interest relevant to this article were
   reported. The authors thank L. Janeri, J. Pinheiro and P. Latuf-Filho
   (Department of Internal Medicine, UNICAMP, Campinas, Sao Paulo) for
   their technical assistance.
CR Araújo TG, 2013, LASER MED SCI, V28, P1511, DOI 10.1007/s10103-013-1264-y
   Araújo TG, 2012, ENDOCRINOLOGY, V153, P5760, DOI 10.1210/en.2012-1496
   Barbosa AJ, 2011, ACTA CIR BRAS, V26, P470, DOI 10.1590/S0102-86502011000600011
   Ben-Dov N, 1999, BBA-MOL CELL RES, V1448, P372, DOI 10.1016/S0167-4889(98)00147-5
   Castro-e-Silva O, 2003, LASER SURG MED, V32, P50, DOI 10.1002/lsm.10141
   Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156
   Court FG, 2002, BRIT J SURG, V89, P1089, DOI 10.1046/j.1365-2168.2002.02166.x
   Di Domenico S, 2011, DIGEST LIVER DIS, V43, P814, DOI 10.1016/j.dld.2011.05.018
   Teixeira ARF, 2008, ACTA CIR BRAS, V23, P378, DOI 10.1590/S0102-86502008000400013
   Teixeira ARF, 2009, ACTA CIR BRAS, V24, P52, DOI 10.1590/S0102-86502009000100011
   Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4
   Haga S, 2010, LAB INVEST, V90, P1718, DOI 10.1038/labinvest.2010.119
   Hammond JS, 2011, BRIT J SURG, V98, P1188, DOI 10.1002/bjs.7630
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675
   Oliveira Alexandre Ferreira, 2006, Acta Cir. Bras., V21, P29, DOI 10.1590/S0102-86502006000700007
   Oron U, 2010, PHOTOMED LASER SURG, V28, P675, DOI 10.1089/pho.2009.2756
   Palmer HJ, 1999, J BIOL CHEM, V274, P11424, DOI 10.1074/jbc.274.16.11424
   Regev A, 2001, GASTROENTEROL CLIN N, V30, P547, DOI 10.1016/S0889-8553(05)70195-3
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1
   Seyama Y, 2013, J GASTROENTEROL, V48, P115, DOI 10.1007/s00535-012-0613-0
   Silva ODE, 2001, LASER SURG MED, V29, P73, DOI 10.1002/lsm.1089
   van den Broek MAJ, 2008, LIVER INT, V28, P767, DOI 10.1111/j.1478-3231.2008.01777.x
   Yigitler C, 2003, LIVER TRANSPLANT, V9, pS18, DOI 10.1053/jlts.2003.50194
NR 25
TC 1
Z9 1
U1 0
U2 8
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0268-8921
EI 1435-604X
J9 LASER MED SCI
JI Lasers Med. Sci.
PD SEP
PY 2015
VL 30
IS 7
BP 2003
EP 2008
DI 10.1007/s10103-014-1598-0
PG 6
WC Engineering, Biomedical; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering; Surgery
GA CQ8NA
UT WOS:000360863300023
PM 24880927
OA Green Published
DA 2024-02-19
ER

PT J
AU Ozturk, N
   Erdal, E
   Mumcuoglu, M
   Akcali, KC
   Yalcin, O
   Senturk, S
   Arslan-Ergul, A
   Gur, B
   Yulug, I
   Cetin-Atalay, R
   Yakicier, C
   Yagci, T
   Tez, M
   Ozturk, M
AF Ozturk, N
   Erdal, E
   Mumcuoglu, M
   Akcali, KC
   Yalcin, O
   Senturk, S
   Arslan-Ergul, A
   Gur, B
   Yulug, I
   Cetin-Atalay, R
   Yakicier, C
   Yagci, T
   Tez, M
   Ozturk, M
TI Reprogramming of replicative senescence in hepatocellular
   carcinoma-derived cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE immortality; liver cancer; SIP1; telomerase; p53
ID DNA-BINDING; TELOMERASE; GENE; SIP1; EXPRESSION; PATHWAYS; GROWTH; LINES
AB Tumor cells have the capacity to proliferate indefinitely that is qualified as replicative immortality. This ability contrasts with the intrinsic control of the number of cell divisions in human somatic tissues by a mechanism called replicative senescence. Replicative immortality is acquired by inactivation of p53 and p16(INK4a) genes and reactivation of hTERT gene expression. It is unknown whether the cancer cell replicative immortality is reversible. Here, we show the spontaneous induction of replicative senescence in p53-and p16(INK4a)-deficient hepatocellular carcinoma cells. This phenomenon is characterized with hTERT repression, telomere shortening, senescence arrest, and tumor suppression. SIP1 gene (ZFHX1B) is partly responsible for replicative senescence, because short hairpin RNA-mediated SIP1 inactivation released hTERT repression and rescued clonal hepatocellular carcinoma cells from senescence arrest.
C1 Bilkent Univ, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey.
   Ankara Numune Training & Res Hosp, Dept Surg 5, TR-06100 Ankara, Turkey.
C3 Ihsan Dogramaci Bilkent University; Ankara Numune Training & Research
   Hospital
RP Ozturk, M (corresponding author), Bilkent Univ, Dept Mol Biol & Genet, TR-06800 Ankara, Turkey.
EM ozturk@fen.bilkent.edu.tr
RI Cetin-Atalay, Rengul/F-5780-2013; Senturk, Serif/A-1263-2017; Dedeoglu,
   Bala Gur/O-1604-2014; Erdal, Esra/AAE-1339-2019; ozturk,
   mehmet/G-3330-2014; Öztürk, Mehmet/JFJ-3399-2023; ERGUL, AYCA
   ARSLAN/AAH-1655-2020; Yalcin Ozuysal, Ozden/D-5528-2019; OZTURK,
   MEHMET/AAS-7241-2021; Cetin-Atalay, Rengul/O-9826-2014; Erdal,
   Esra/T-9057-2018; Dedeoglu, Bala Gur/ABC-2436-2020; ERGUL, AYCA
   ARSLAN/F-6655-2012; Ozturk, Nuri/F-4140-2011; Tez, Mesut/F-6462-2013
OI Cetin-Atalay, Rengul/0000-0003-2408-6606; Senturk,
   Serif/0000-0003-3963-2294; Dedeoglu, Bala Gur/0000-0002-4320-5685;
   Erdal, Esra/0000-0001-7264-0574; ERGUL, AYCA ARSLAN/0000-0001-7024-907X;
   Yalcin Ozuysal, Ozden/0000-0003-0552-368X; OZTURK,
   MEHMET/0000-0002-6092-9706; Cetin-Atalay, Rengul/0000-0003-2408-6606;
   Erdal, Esra/0000-0001-7264-0574; Dedeoglu, Bala Gur/0000-0002-4320-5685;
   ERGUL, AYCA ARSLAN/0000-0001-7024-907X; Ozturk,
   Nuri/0000-0001-5206-4127; Tez, Mesut/0000-0001-5282-9492; Akcali,
   Kamil/0000-0002-7816-6938; Yulug, Isik/0000-0002-7577-2502
CR Ben-Porath I, 2004, J CLIN INVEST, V113, P8, DOI 10.1172/JCI200420663
   Boehm JS, 2005, CURR OPIN GENET DEV, V15, P13, DOI 10.1016/j.gde.2004.11.003
   BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973
   Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3
   Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X
   Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Erdal E, 2005, INT J CANCER, V115, P903, DOI 10.1002/ijc.20972
   KANEKO S, 1995, CANCER RES, V55, P5283
   KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7
   Kubicka S, 1997, HEPATOLOGY, V25, P867, DOI 10.1002/hep.510250414
   LASFARGUES EY, 1978, J NATL CANCER I, V61, P967
   Lin SY, 2003, CELL, V113, P881, DOI 10.1016/S0092-8674(03)00430-6
   Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6
   NAKABAYASHI H, 1982, CANCER RES, V42, P3858
   NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840
   Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226
   Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073
   Roncalli M, 2002, HEPATOLOGY, V36, P427, DOI 10.1053/jhep.2002.34852
   Roninson IB, 2003, CANCER RES, V63, P2705
   Satyanarayana A, 2004, HEPATOLOGY, V40, P276, DOI 10.1002/hep.20308
   Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296
   Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518
   Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2
   Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2
   Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339
   Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489
   VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z
   VOLKMANN M, 1994, ONCOGENE, V9, P195
   Wang J, 1998, GENE DEV, V12, P1769, DOI 10.1101/gad.12.12.1769
   Wei WY, 1999, EXP CELL RES, V253, P519, DOI 10.1006/excr.1999.4665
   Yolcu E, 2001, ONCOGENE, V20, P1398, DOI 10.1038/sj.onc.1204240
   Young JI, 2003, J BIOL CHEM, V278, P19904, DOI 10.1074/jbc.M301685200
NR 35
TC 52
Z9 63
U1 3
U2 26
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 14
PY 2006
VL 103
IS 7
BP 2178
EP 2183
DI 10.1073/pnas.0510877103
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 013LU
UT WOS:000235411600033
PM 16461895
OA Green Published
DA 2024-02-19
ER

PT J
AU Wan, Y
   Fu, JH
AF Wan, Yang
   Fu, Jianhua
TI GDF15 as a key disease target and biomarker: linking chronic lung
   diseases and ageing
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article; Early Access
DE GDF15; Chronic lung disease; Mitochondrial dysfunction; Senescence; SASP
ID DIFFERENTIATION FACTOR 15; MACROPHAGE INHIBITORY CYTOKINE-1; BETA
   SUPERFAMILY MEMBER; INTEGRATED STRESS-RESPONSE; EPITHELIAL-CELLS;
   HEART-FAILURE; WEIGHT-LOSS; LIFE-SPAN; IN-VIVO; GROWTH
AB Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, is expressed in several human organs. In particular, it is highly expressed in the placenta, prostate, and liver. The expression of GDF15 increases under cellular stress and pathological conditions. Although numerous transcription factors directly up-regulate the expression of GDF15, the receptors and downstream mediators of GDF15 signal transduction in most tissues have not yet been determined. Glial cell-derived neurotrophic factor family receptor alpha-like protein was recently identified as a specific receptor that plays a mediating role in anorexia. However, the specific receptors of GDF15 in other tissues and organs remain unclear. As a marker of cell stress, GDF15 appears to exert different effects under different pathological conditions. Cell senescence may be an important pathogenetic process and could be used to assess the progression of various lung diseases, including COVID-19. As a key member of the senescence-associated secretory phenotype protein repertoire, GDF15 seems to be associated with mitochondrial dysfunction, although the specific molecular mechanism linking GDF15 expression with ageing remains to be elucidated. Here, we focus on research progress linking GDF15 expression with the pathogenesis of various chronic lung diseases, including neonatal bronchopulmonary dysplasia, idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, and pulmonary hypertension, suggesting that GDF15 may be a key biomarker for diagnosis and prognosis. Thus, in this review, we aimed to provide new insights into the molecular biological mechanism and emerging clinical data associated with GDF15 in lung-related diseases, while highlighting promising research and clinical prospects.
C1 [Wan, Yang; Fu, Jianhua] China Med Univ, Dept Pediat, Shengjing Hosp, Shenyang, Peoples R China.
C3 China Medical University
RP Fu, JH (corresponding author), China Med Univ, Dept Pediat, Shengjing Hosp, Shenyang, Peoples R China.
EM fujh@sj-hospital.org
RI Wan, Yang/IAO-7622-2023
OI Wan, Yang/0000-0003-2595-185X; Wu, XingJiao/0000-0001-9146-051X
FU National Natural Science Foundation of China [82071688]; Joint plan of
   Liaoning Provincial Key RD Program [2020JH2/10300152]; Key R&D Guidance
   Plan Projects of Liaoning Province [2020JH1/10300001]
FX This study was supported by grants from the National Natural Science
   Foundation of China (No. 82071688), Joint plan of Liaoning Provincial
   Key R & D Program (2020JH2/10300152), and Key R & D Guidance Plan
   Projects of Liaoning Province (2020JH1/10300001).
CR Abulizi P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00902-5
   Adela R, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/490842
   Ahmed DS, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.820350
   Al-Mudares F, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.594137
   Albertoni M, 2002, ONCOGENE, V21, P4212, DOI 10.1038/sj.onc.1205610
   Almudares F, 2023, PEDIATR PULM, V58, P271, DOI 10.1002/ppul.26197
   Alserawan L, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11111998
   Aoshiba Kazutetsu, 2009, Proc Am Thorac Soc, V6, P596, DOI 10.1513/pats.200904-017RM
   Assadi A, 2020, PFLUG ARCH EUR J PHY, V472, P1535, DOI 10.1007/s00424-020-02459-1
   Baek SJ, 2019, PHARMACOL THERAPEUT, V198, P46, DOI 10.1016/j.pharmthera.2019.02.008
   Baek SJ, 2006, PROG LIPID RES, V45, P1, DOI 10.1016/j.plipres.2005.10.001
   Baek SJ, 2005, MOL PHARMACOL, V67, P356, DOI 10.1124/mol.104.005108
   Baek SJ, 2003, J BIOL CHEM, V278, P5845, DOI 10.1074/jbc.M208394200
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Bhattacharya S, 2014, AM J PHYSIOL-LUNG C, V307, pL516, DOI 10.1152/ajplung.00200.2014
   Bloch SAA, 2015, THORAX, V70, P219, DOI 10.1136/thoraxjnl-2014-206225
   Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514
   Böttner M, 1999, GENE, V237, P105, DOI 10.1016/S0378-1119(99)00309-1
   Breit SN, 2021, ANNU REV PHYSIOL, V83, P127, DOI 10.1146/annurev-physiol-022020-045449
   Budi EH, 2016, METHODS MOL BIOL, V1344, P1, DOI 10.1007/978-1-4939-2966-5_1
   Cao MS, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.891448
   Chen L, 2020, BIOCHEM BIOPH RES CO, V526, P293, DOI 10.1016/j.bbrc.2020.03.079
   Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110
   Clark BJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12737
   Díaz M, 2020, PEDIATR RES, V87, P897, DOI 10.1038/s41390-019-0633-z
   Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393
   Fairlie WD, 2001, J BIOL CHEM, V276, P16911, DOI 10.1074/jbc.M010000200
   Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Garfield BE, 2019, THORAX, V74, P164, DOI 10.1136/thoraxjnl-2017-211440
   Hammad H, 2020, NAT IMMUNOL, V21, P1313, DOI 10.1038/s41590-020-0797-z
   Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007
   Hansmann G, 2021, PEDIATR RES, V89, P446, DOI 10.1038/s41390-020-0993-4
   Harb H, 2020, NAT IMMUNOL, V21, P1359, DOI 10.1038/s41590-020-0777-3
   He J, 2022, FRONT GENET, V12, DOI 10.3389/fgene.2021.788417
   He KM, 2015, CELL RES, V25, P738, DOI 10.1038/cr.2015.60
   Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102
   Herter JM, 2015, THROMB HAEMOSTASIS, V114, P434, DOI 10.1160/TH14-12-1060
   Hilgendorff A, 2015, FRONT MED-LAUSANNE, V2, DOI 10.3389/fmed.2015.00002
   Hirano T, 2020, J CLIN MED, V9, DOI 10.3390/jcm9092737
   Hromas R, 1997, BBA-GENE STRUCT EXPR, V1354, P40, DOI 10.1016/S0167-4781(97)00122-X
   Hsiao EC, 2000, MOL CELL BIOL, V20, P3742, DOI 10.1128/MCB.20.10.3742-3751.2000
   Hsu JY, 2017, NATURE, V550, P255, DOI 10.1038/nature24042
   Husebo GR, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01298-2016
   Jensen EA, 2019, AM J RESP CRIT CARE, V200, P751, DOI 10.1164/rccm.201812-2348OC
   Jiang G, 2018, EXP THER MED, V16, P12, DOI 10.3892/etm.2018.6145
   Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677
   Kang SG, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102181
   Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48
   Kempf T, 2007, CLIN CHEM, V53, P284, DOI 10.1373/clinchem.2006.076828
   Kim KH, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2020.129834
   Kim M, 2014, TUBERC RESPIR DIS, V77, P243, DOI 10.4046/trd.2014.77.6.243
   Kim Y, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/8278039
   Kim YI, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0530-0
   Klaus S, 2020, EXP GERONTOL, V130, DOI 10.1016/j.exger.2019.110796
   Krieg AJ, 2010, MOL CELL BIOL, V30, P344, DOI 10.1128/MCB.00444-09
   Kunzmann S, 2007, AM J PHYSIOL-LUNG C, V292, pL223, DOI 10.1152/ajplung.00159.2006
   Lai YC, 2019, THORAX, V74, P103, DOI 10.1136/thoraxjnl-2018-212680
   Lambert JR, 2015, PROSTATE, V75, P255, DOI 10.1002/pros.22911
   Lambrecht S, 2014, ARTHRITIS RHEUMATOL, V66, P418, DOI 10.1002/art.38241
   Larissi K, 2019, BLOOD CELL MOL DIS, V77, P137, DOI 10.1016/j.bcmd.2019.04.011
   Lawton LN, 1997, GENE, V203, P17, DOI 10.1016/S0378-1119(97)00485-X
   Lee EK, 2007, BIOCHEM BIOPH RES CO, V359, P385, DOI 10.1016/j.bbrc.2007.05.121
   Li A, 2021, LIFE SCI, V275, DOI 10.1016/j.lfs.2021.119356
   Li G, 2017, PEDIATR CARDIOL, V38, P1620, DOI 10.1007/s00246-017-1705-7
   Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065549
   Li M, 2018, INT J MOL MED, V42, P1756, DOI 10.3892/ijmm.2018.3747
   Li PZ, 2022, FRONT AGING NEUROSCI, V14, DOI 10.3389/fnagi.2022.869558
   Li S, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0744-0
   Liu H, 2019, J CELL BIOCHEM, V120, P10530, DOI 10.1002/jcb.28339
   Londhe VA, 2011, PEDIATR RES, V69, P371, DOI 10.1203/PDR.0b013e318211c917
   Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033
   Martinez CH, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0521-1
   Meiners Silke, 2016, Mol Cell Pediatr, V3, P24, DOI 10.1186/s40348-016-0052-8
   Meiners S, 2015, EUR RESPIR J, V45, P807, DOI 10.1183/09031936.00186914
   Melber A, 2018, CELL RES, V28, P281, DOI 10.1038/cr.2018.16
   Michel S, 2015, MITOCHONDRION, V21, P58, DOI 10.1016/j.mito.2015.01.005
   Mirna M, 2020, HEART LUNG CIRC, V29, P337, DOI 10.1016/j.hlc.2019.03.004
   Moore AG, 2000, J CLIN ENDOCR METAB, V85, P4781, DOI 10.1210/jc.85.12.4781
   Morrow RM, 2017, P NATL ACAD SCI USA, V114, P2705, DOI 10.1073/pnas.1700997114
   Mueller T, 2015, CLIN CHIM ACTA, V445, P155, DOI 10.1016/j.cca.2015.03.033
   Mullican SE, 2017, NAT MED, V23, P1150, DOI 10.1038/nm.4392
   Mutlu LC, 2015, INFLAMMATION, V38, P1805, DOI 10.1007/s10753-015-0158-5
   Nickel N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-62
   Notz Q, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.581338
   Parikh P, 2019, AM J PHYSIOL-LUNG C, V316, pL826, DOI 10.1152/ajplung.00424.2018
   Parikh P, 2019, AM J RESP CELL MOL, V61, P51, DOI 10.1165/rcmb.2018-0176OC
   Park H, 2016, ONCOTARGET, V7, P9634, DOI 10.18632/oncotarget.7457
   Pence BD, 2021, AGING MED-PRC, V4, P47, DOI 10.1002/agm2.12128
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   Rabe KF, 2017, LANCET, V389, P1931, DOI 10.1016/S0140-6736(17)31222-9
   Radwanska A, 2022, JCI INSIGHT, V7, DOI 10.1172/jci.insight.153058
   Ratnam NM, 2017, J CLIN INVEST, V127, P3796, DOI 10.1172/JCI91561
   Rochette L, 2021, TRENDS ENDOCRIN MET, V32, P875, DOI 10.1016/j.tem.2021.08.011
   Rochette L, 2020, MOLECULES, V25, DOI 10.3390/molecules25102417
   Rochette L, 2015, PHARMACOL THERAPEUT, V146, P35, DOI 10.1016/j.pharmthera.2014.09.004
   Santos I, 2020, P NATL ACAD SCI USA, V117, P12281, DOI [10.1073/pnas.1918508117/-/DCSupplemental, 10.1073/pnas.1918508117]
   Saretzki G, 1998, J GERONTOL A-BIOL, V53, pB438, DOI 10.1093/gerona/53A.6.B438
   Sasaki T, 2013, EXP GERONTOL, V48, P457, DOI 10.1016/j.exger.2013.02.015
   Scaffa AM, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14839
   Song HJ, 2012, MOL BIOL REP, V39, P4017, DOI 10.1007/s11033-011-1182-7
   Song HY, 2020, BIOCHEM BIOPH RES CO, V526, P439, DOI 10.1016/j.bbrc.2020.03.103
   Suriben R, 2020, NAT MED, V26, P1264, DOI 10.1038/s41591-020-0945-x
   Takahashi M, 2022, P JPN ACAD B-PHYS, V98, P112, DOI 10.2183/pjab.98.008
   Takenouchi Y, 2020, EXP CELL RES, V391, DOI 10.1016/j.yexcr.2020.112010
   Tanno T, 2010, CURR OPIN HEMATOL, V17, P184, DOI 10.1097/MOH.0b013e328337b52f
   Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503
   Tantawy AAG, 2015, BLOOD CELL MOL DIS, V55, P144, DOI 10.1016/j.bcmd.2015.06.001
   Tian YQ, 2019, AGING CELL, V18, DOI 10.1111/acel.12858
   Tiwari KK, 2015, TOXICOL IN VITRO, V29, P1369, DOI 10.1016/j.tiv.2015.05.008
   Townsend LK, 2021, FASEB J, V35, DOI 10.1096/fj.202000954R
   Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC
   Verhamme FM, 2017, MUCOSAL IMMUNOL, V10, P1400, DOI 10.1038/mi.2017.3
   Volonte D, 2009, AGING-US, V1, P831, DOI 10.18632/aging.100079
   Wang DD, 2021, NAT REV ENDOCRINOL, V17, P592, DOI 10.1038/s41574-021-00529-7
   Wang XY, 2014, AGING-US, V6, P690, DOI 10.18632/aging.100687
   Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025
   Wang Y, 2022, REDOX BIOL, V52, DOI 10.1016/j.redox.2022.102322
   Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x
   Wu Q, 2018, AM J PHYSIOL-LUNG C, V314, pL514, DOI 10.1152/ajplung.00324.2017
   Wu Q, 2016, AM J RESP CELL MOL, V55, P429, DOI 10.1165/rcmb.2015-0143OC
   Wu Q, 2012, INNATE IMMUN-LONDON, V18, P617, DOI 10.1177/1753425911429837
   Xiong YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8732
   Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0
   Xu XY, 2014, J BIOL CHEM, V289, P10084, DOI 10.1074/jbc.M113.516278
   Yang H, 2010, CARCINOGENESIS, V31, P703, DOI 10.1093/carcin/bgq008
   Yang H, 2009, BIOCHEM PHARMACOL, V78, P1205, DOI 10.1016/j.bcp.2009.06.012
   Yang LD, 2017, NAT MED, V23, P1158, DOI 10.1038/nm.4394
   Yao HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080007
   Yatsuga S, 2015, ANN NEUROL, V78, P814, DOI 10.1002/ana.24506
   Zhang YZ, 2019, AM J PHYSIOL-LUNG C, V317, pL510, DOI 10.1152/ajplung.00062.2019
   Zhang YX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02407
   Zhang YH, 2017, TOXICOL APPL PHARM, V332, P8, DOI 10.1016/j.taap.2017.07.016
   Zheng HT, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/5958272
   Zhou F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-78
   Zimmers TA, 2005, SHOCK, V23, P543, DOI 10.1097/01.shk.0000163393.55350.70
NR 136
TC 5
Z9 5
U1 7
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD 2023 APR 24
PY 2023
DI 10.1007/s11010-023-04743-x
EA APR 2023
PG 14
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA E4JC6
UT WOS:000975211700001
PM 37093513
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Jiang, Z
   Hao, FX
   Zhu, F
   Yuan, FW
   Ma, LW
   Li, GD
   Chen, J
   Tong, TJ
AF Jiang, Zhe
   Hao, Fengxin
   Zhu, Feng
   Yuan, Fuwen
   Ma, Liwei
   Li, Guodong
   Chen, Jun
   Tong, Tanjun
TI RSL1D1 modulates cell senescence and proliferation via regulation of
   PPAR? mRNA stability
SO LIFE SCIENCES
LA English
DT Article; Early Access
DE CSIG; PPAR ?; HuR; Cell senescence; Post transcriptional regulation
ID GAMMA; MACROPHAGES; SUPPRESSION; METABOLISM; ACTIVATION; EXPRESSION;
   PROTEIN; GENES
AB Aims: In this study, we will examine if RSL1D1 influences PPAR gamma expression and explore the underlying mechanism that RSL1D1 regulates PPAR gamma expression. Moreover, the significance of RSL1D1-PPAR gamma pathway in cell senescence and proliferation will also be determined. Main methods: Our main methods include western blotting, immunoprecipitation (IP), real-time PCR, RNA Immunoprecipitation (RIP), biotin-labeled RNA pull down assay, dual luciferase reporter gene assay, senescence -associated beta-galactosidase staining, cell proliferation assay, colony formation assay, wound healing assay, blood biochemistry test and Oil red O staining. Key findings: By analyzing gene chip results we find that the expression of RSL1D1 and PPAR gamma might be corre-lated. Then we show that RSL1D1 is a posttranscriptional regulator of PPAR gamma. RSL1D1 overexpression elevates, while RSL1D1 knockdown inhibits, PPAR gamma mRNA and protein expression levels. Mechanistically, we find that RSL1D1 directly interacts with the 3'-untranslated region of PPAR gamma mRNA, and then promotes its stability and increases PPAR gamma protein expression level. We further demonstrate that RSL1D1 modulates cellular senescence and cell proliferation partially via PPAR gamma-regulated downstream target genes such as PTEN/p27, NF-kappa B, GLUT4, and ACL. Moreover, we find that RSL1D1 regulates PPAR gamma expression and function in a HuR-dependent manner. Last, we show that RSL1D1 knockout in mouse adipose tissue shortens mouse lifespan and leads to hepatic damage which may impair liver damage repair function. Significance: Collectively, our findings unveil a novel posttranscriptional regulation of PPAR gamma by RSL1D1 and uncover a critical role of RSL1D1-PPAR gamma-PPAR gamma downstream target genes in regulating cellular senescence and cell proliferation.
C1 [Jiang, Zhe; Hao, Fengxin; Ma, Liwei; Li, Guodong; Chen, Jun; Tong, Tanjun] Peking Univ, Res Ctr Aging, Sch Basic Med Sci, Dept Biochem & Mol Biol,Hlth Sci Ctr,Beijing Key L, Beijing, Peoples R China.
   [Zhu, Feng] Sanofi Beijing Pharmaceut Co Ltd, Beijing, Peoples R China.
   [Yuan, Fuwen] Shanghai Univ Tradit Chinese Med, Acad Integrat Med, Shanghai, Peoples R China.
C3 Peking University; Shanghai University of Traditional Chinese Medicine
RP Chen, J; Tong, TJ (corresponding author), Peking Univ, Res Ctr Aging, Sch Basic Med Sci, Dept Biochem & Mol Biol,Hlth Sci Ctr,Beijing Key L, Beijing, Peoples R China.
EM jiangzhe@pku.edu.cn; cjbiochem@bjmu.edu.cn; ttj@bjmu.edu.cn
RI Yuan, Fuwen/M-4704-2019
FU National Natural Science Foundation of China [81772949]; National Basic
   Research Programs of China [2013CB530801]
FX We are grateful to Xi Chen for helpful technical support. This work was
   supported by grants from the National Natural Science Foundation of
   China (81772949) and the National Basic Research Programs of China
   (2013CB530801) .
CR Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575
   Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773
   Brunmeir R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061738
   Chang AJ, 2006, J BIOL CHEM, V281, P14700, DOI 10.1074/jbc.M602623200
   Cheng Q, 2015, ONCOTARGET, V6, P4733, DOI 10.18632/oncotarget.2900
   Cheng ST, 2019, J CELL MOL MED, V23, P3724, DOI 10.1111/jcmm.14280
   Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291
   Ding L, 2022, EXP CELL RES, V417, DOI 10.1016/j.yexcr.2022.113211
   Ding L, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-02057-8
   Feng Z., 2018, MOL CELL BIOL, V38, DOI [10.1128/MCB.00414-18, DOI 10.1128/MCB.00414-18]
   Guo SZ, 2004, EXP CELL RES, V298, P465, DOI 10.1016/j.yexcr.2004.04.044
   Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609
   Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110
   ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
   Keen HL, 2004, PHYSIOL GENOMICS, V18, P33, DOI 10.1152/physiolgenomics.00027.2004
   Li N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.22
   Li ZY, 2019, SHOCK, V52, pE163, DOI 10.1097/SHK.0000000000001310
   Liao S.Y., 2014, NEW MED, V6, P394, DOI [10.3969/g.issn.0253-9802.2014.06.011, DOI 10.3969/G.ISSN.0253-9802.2014.06.011]
   Lin MS, 2011, ONCOL LETT, V2, P1219, DOI 10.3892/ol.2011.414
   Liu LH, 2020, DIABETES, V69, P1793, DOI 10.2337/db20-0217
   Liu XH, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-021-04492-z
   Ma LW, 2008, MOL CELL BIOL, V28, P6290, DOI 10.1128/MCB.00142-08
   Ma LW, 2016, BIOCHEM BIOPH RES CO, V469, P593, DOI 10.1016/j.bbrc.2015.12.004
   Ma LW, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00069
   Meng LJ, 2006, J CELL SCI, V119, P5124, DOI 10.1242/jcs.03292
   Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200
   Nobs SP, 2018, J LEUKOCYTE BIOL, V104, P737, DOI 10.1002/JLB.3MR0118-034R
   Peng M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000061
   Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003
   Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614
   Tautenhahn A, 2003, PPARGAMMA VERMITTELT
   Uchida Y, 2019, J BIOCHEM, V166, P375, DOI 10.1093/jb/mvz067
   Wang L, 2015, NEUROCHEM RES, V40, P713, DOI 10.1007/s11064-015-1517-1
   Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097
   Wen Q, 2018, INT IMMUNOPHARMACOL, V56, P90, DOI 10.1016/j.intimp.2018.01.023
   Xie N, 2016, SCI REP-UK, V6, DOI 10.1038/srep36171
   Yao JT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68543-9
   Yuan FW, 2017, AGING CELL, V16, P726, DOI 10.1111/acel.12602
   Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06
   Zucal C, 2015, CURR DRUG TARGETS, V16, P499, DOI 10.2174/1389450116666150223163632
NR 40
TC 3
Z9 3
U1 2
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD 2022 OCT 15
PY 2022
VL 307
AR 120848
DI 10.1016/j.lfs.2022.120848
EA AUG 2022
PG 12
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 5W4PU
UT WOS:000877898800001
PM 35940221
DA 2024-02-19
ER

PT J
AU Feng, RT
   He, W
   Ochi, H
AF Feng, RT
   He, W
   Ochi, H
TI A new murine oxidative stress model associated with senescence
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; oxidative stress; model; antioxidant
ID THYMOCYTE APOPTOSIS; OXYGEN RADICALS; DNA-DAMAGE; AGE; GLUTATHIONE;
   MOUSE; RAT; ANTIOXIDANTS; BRAIN; SUSCEPTIBILITY
AB A murine oxidative stress model was established via ozone inhalation, which was identified by detection of the response of antioxidant defense system, levels of oxidative products and effects of natural antioxidants on this model. Male BALB/c mice were exposed to 1.2 mg/m(3) ozone for 10 h per day. The control group was exposed to flowing air. From inhaling ozone, mice were killed at day 5, 10. 15 and 20. respectively. Exposure to ozone made mice show the increase of malondialdehyde (MDA) contents in heart, kidney and liver, as well as 8-OHdG levels in urine, and resulted in cytological nuclear concentration in brain neurons or thymocytes. Ozone exposure also impaired antioxidative capacity such as the decrease of total antioxidation capacity (TAC) in sera, reduced glutathione (GSH) in sera or thymus and glutathione-S-transferase: (GST) activity in spleen or thymus but not in liver. Correlation analysis showed the significant inverse correlation (r = - 0.894. P<0.05) between thymus weight index and inhalation doses of ozone. Meanwhile. thymocyte in model mice proliferated more poorly than normal controls. Catechin and clove extract could reverse parts of changes above induced by ozone inhalation. These results suggest that exposure to ozone can result in an increased production of reactive oxygen species in vivo, which causes oxidative stress. The mice under oxidative stress showed senescence-related alterations in physiological parameters as well. Taken together, our data demonstrates that an oxidative stress model in mice has been successfully established by ozone inhalation, which would be helpful to probe the relationship between oxidative stress and senescence and evaluate effects of antioxidants. (C) 2001 Elsevier Science ireland Ltd. All rights reserved.
C1 Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China.
   Peking Union Med Coll, Sch Basic Med, Beijing 100005, Peoples R China.
   Japan Inst Control Aging, Shizuoka, Japan.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Peking Union Medical College
RP He, W (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China.
CR AGARWAL S, 1993, BIOCHEM BIOPH RES CO, V194, P1203, DOI 10.1006/bbrc.1993.1950
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Andersen JK, 1996, J NEUROCHEM, V67, P2164
   Avila-Costa MR, 1999, NEUROSCI LETT, V270, P107, DOI 10.1016/S0304-3940(99)00458-9
   CAO EH, 1995, BBA-LIPID LIPID MET, V1259, P187, DOI 10.1016/0005-2760(95)00162-6
   CERUTTI PA, 1985, SCIENCE, V227, P375, DOI 10.1126/science.2981433
   CHEN TS, 1989, P SOC EXP BIOL MED, V190, P399
   Desai VG, 1996, BRAIN RES, V715, P1, DOI 10.1016/0006-8993(95)01255-9
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   Feng R., 2000, CHIN J GERIATR, V19, P174
   FENG RT, IN PRESS CHIN J HIST
   Frankel E. N, 1999, ANTIOXIDANT FOOD SUP, p[385, 511]
   García-Arumí E, 1998, CLIN SCI, V94, P447, DOI 10.1042/cs0940447
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
   HIGAMI Y, 1994, MUTAT RES-DNAGING G, V316, P59, DOI 10.1016/0921-8734(94)90008-6
   HOLMES GE, 1992, MUTAT RES, V275, P305, DOI 10.1016/0921-8734(92)90034-M
   IANTOMASI T, 1993, MECH AGEING DEV, V70, P65, DOI 10.1016/0047-6374(93)90060-5
   IMRE S, 1987, MECH AGEING DEV, V38, P259, DOI 10.1016/0047-6374(87)90094-7
   Joseph JA, 1996, FREE RADICAL BIO MED, V20, P821, DOI 10.1016/0891-5849(95)02225-2
   Kadiiska MB, 2000, FREE RADICAL BIO MED, V28, P838, DOI 10.1016/S0891-5849(00)00198-2
   Laszczyca Piotr, 1996, Materia Medica Polona, V28, P155
   Li M, 2000, MECH AGEING DEV, V113, P85, DOI 10.1016/S0047-6374(99)00096-2
   Limasset B, 1999, PLANTA MED, V65, P23, DOI 10.1055/s-1999-13956
   Lin YS, 1999, MED SCI SPORT EXER, V31, P1594, DOI 10.1097/00005768-199911000-00015
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Nakano M, 1995, GERONTOLOGY, V41, P69
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SHIGENAGA MK, 1991, FREE RADICAL BIO MED, V10, P211, DOI 10.1016/0891-5849(91)90078-H
   SIES H, 1992, TOXICOL LETT, V64-5, P547, DOI 10.1016/0378-4274(92)90230-H
   SLATER AFG, 1995, BIOCHEM J, V306, P771, DOI 10.1042/bj3060771
   SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   SOHAL RS, 1995, MECH AGEING DEV, V81, P15, DOI 10.1016/0047-6374(94)01578-A
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   Weber SU, 1999, J INVEST DERMATOL, V113, P1128, DOI 10.1046/j.1523-1747.1999.00789.x
   Yin DZ, 1995, GERONTOLOGY, V41, P159
   ZHAO BL, 1989, CELL BIOPHYS, V14, P175, DOI 10.1007/BF02797132
NR 40
TC 51
Z9 54
U1 0
U2 8
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY 15
PY 2001
VL 122
IS 6
BP 547
EP 559
DI 10.1016/S0047-6374(01)00232-9
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 432KC
UT WOS:000168689900004
PM 11295171
DA 2024-02-19
ER

PT J
AU Mahrouf-Yorgov, M
   Collin de l'Hortet, A
   Cosson, C
   Slama, A
   Abdoun, E
   Guidotti, JE
   Fromenty, B
   Mitchell, C
   Gilgenkrantz, H
AF Mahrouf-Yorgov, Meriem
   Collin de l'Hortet, Alexandra
   Cosson, Claudine
   Slama, Abdelhamid
   Abdoun, Elsa
   Guidotti, Jacques-Emmanuel
   Fromenty, Bernard
   Mitchell, Claudia
   Gilgenkrantz, Helene
TI Increased Susceptibility to Liver Fibrosis with Age Is Correlated with
   an Altered Inflammatory Response
SO REJUVENATION RESEARCH
LA English
DT Article
ID CHRONIC HEPATITIS-C; PRIMARY BILIARY-CIRRHOSIS; CARBON-TETRACHLORIDE;
   FISCHER-344 RATS; OXIDATIVE DAMAGE; RISK-FACTORS; MICE; PROGRESSION;
   INJURY; DNA
AB It has been suggested that increasing age is correlated with an acceleration of the progression of liver fibrosis induced by various agents, such as hepatitis C virus or chronic alcohol consumption. However, the cellular and molecular changes underlying this predisposition are not entirely understood. In the context of an aging population, it becomes challenging to decipher the mechanisms responsible for this higher susceptibility of older individuals to this acquired liver disorder. To address this issue, we induced liver fibrosis by carbon tetrachloride (CCl4) chronic administration to 8-week- and 15-month-old mice. We confirmed that susceptibility to fibrosis development increased with age and showed that aging did not affect fibrosis resolution capacity. We then focused on the impairment of hepatocyte proliferation, oxidative stress, and inflammation as potential mechanisms accelerating the development of fibrosis in the elderly. We detected no inhibition of hepatocyte proliferation after CCl4 injury in 15-month-old mice, whereas it was inhibited after a partial hepatectomy. Finally, we observed that, in a context in which liver oxidative stress was not differentially increased in both experimental groups, there was a higher recruitment of inflammatory cells, including mostly macrophages and lymphocytes, oriented toward a T helper 2 (T(H)2) response in older mice. Our data show that in conditions of equivalent levels of oxidative stress and maintained hepatocyte proliferative capacity, an increased inflammatory reaction mainly composed of CD4(+) lymphocytes and macrophages expressing T(H)2 cytokines is the main factor involved in the higher susceptibility to fibrosis with increasing age.
C1 [Mahrouf-Yorgov, Meriem; Collin de l'Hortet, Alexandra; Abdoun, Elsa; Guidotti, Jacques-Emmanuel; Mitchell, Claudia; Gilgenkrantz, Helene] INSERM, Cochin Inst, U1016, F-75014 Paris, France.
   [Mahrouf-Yorgov, Meriem; Collin de l'Hortet, Alexandra; Abdoun, Elsa; Guidotti, Jacques-Emmanuel; Mitchell, Claudia; Gilgenkrantz, Helene] CNRS, UMR 8104, Paris, France.
   [Mahrouf-Yorgov, Meriem; Collin de l'Hortet, Alexandra; Abdoun, Elsa; Guidotti, Jacques-Emmanuel; Mitchell, Claudia; Gilgenkrantz, Helene] Univ Paris 05, Paris, France.
   [Cosson, Claudine; Slama, Abdelhamid] Hop Bicetre, AP HP, Biochim Lab, Le Kremlin Bicetre, France.
   [Fromenty, Bernard] Univ Rennes 1, INSERM, UMR991, Rennes, France.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   Universite Paris Cite; Universite Paris Cite; Centre National de la
   Recherche Scientifique (CNRS); CNRS - National Institute for Biology
   (INSB); Universite Paris Cite; Assistance Publique Hopitaux Paris
   (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire
   Paul-Brousse - APHP; Hopital Universitaire Antoine-Beclere - APHP;
   Universite Paris Saclay; Universite Paris Cite; Hopital Universitaire
   Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Universite de Rennes
RP Gilgenkrantz, H (corresponding author), INSERM, Cochin Inst, U1016, 24 Rue Faubourg St Jacques, F-75014 Paris, France.
EM helene.gilgenkrantz@inserm.fr
RI Fromenty, Bernard/Y-8621-2019; Collin de l'Hortet,
   Alexandra/D-6025-2016; Fromenty, Bernard/E-5052-2016; Guidotti,
   Jacques-Emmanuel/M-9014-2018; Gilgenkrantz, Helene/G-5534-2017
OI Collin de l'Hortet, Alexandra/0000-0002-9437-7030; Fromenty,
   Bernard/0000-0003-2994-5465; guidotti,
   jacques-emmanuel/0000-0001-9285-8167; gilgenkrantz,
   helene/0000-0001-6770-4561
FU Agence Nationale de la Recherche (ANR); Institut National du Cancer
   (INCA)
FX We thank Drs. H Strick-Marchand, C. Desdouets, and B. Chazaud for
   fruitful discussions. We also thank Dr. P. Jaffray for ALAT
   determinations. This study was supported by the Agence Nationale de la
   Recherche (ANR) and Institut National du Cancer (INCA).
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Angulo P, 1999, HEPATOLOGY, V29, P644, DOI 10.1002/hep.510290301
   Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675
   Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288
   Forrest EH, 2005, GUT, V54, P1174, DOI 10.1136/gut.2004.050781
   Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722
   Gieling RG, 2009, AM J PHYSIOL-GASTR L, V296, pG1324, DOI 10.1152/ajpgi.90564.2008
   GOUDIE BM, 1989, AM J GASTROENTEROL, V84, P713
   Haga S, 2010, LAB INVEST, V90, P1718, DOI 10.1038/labinvest.2010.119
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003
   Ikeyama S, 2003, EXP GERONTOL, V38, P431, DOI 10.1016/S0531-5565(02)00239-5
   Ledda-Columbano GM, 2004, HEPATOLOGY, V40, P981, DOI 10.1002/hep.20403
   Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618
   Louis H, 1998, HEPATOLOGY, V28, P1607, DOI 10.1002/hep.510280621
   Marra F, 2009, SEMIN IMMUNOPATHOL, V31, P345, DOI 10.1007/s00281-009-0169-0
   Mitchell C, 2009, AM J PATHOL, V175, P1929, DOI 10.2353/ajpath.2009.090332
   Mitchell C, 2009, AM J PATHOL, V174, P1766, DOI 10.2353/ajpath.2009.080632
   Moriya K, 2001, CANCER RES, V61, P4365
   Murali B, 2004, MECH AGEING DEV, V125, P421, DOI 10.1016/j.mad.2004.03.005
   Perlemuter G, 2005, LIVER INT, V25, P946, DOI 10.1111/j.1478-3231.2005.01126.x
   Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8
   Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0
   RAMALINGAM TRP, 2009, PLOS PATHOG, V5
   Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7
   Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006
   RIKANS LE, 1984, DRUG CHEM TOXICOL, V7, P595, DOI 10.3109/01480548409042822
   RIKANS LE, 1994, MECH AGEING DEV, V76, P89, DOI 10.1016/0047-6374(94)91584-9
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9
   Sinitsyna O, 2006, J CELL MOL MED, V10, P206, DOI 10.1111/j.1582-4934.2006.tb00301.x
   Stout RD, 2005, IMMUNOL REV, V205, P60, DOI 10.1111/j.0105-2896.2005.00260.x
   Strick-Marchand H, 2008, J IMMUNOL, V181, P2764, DOI 10.4049/jimmunol.181.4.2764
   Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009
   Thompson K, 1998, HEPATOLOGY, V28, P1597, DOI 10.1002/hep.510280620
   Wali M, 2002, GUT, V51, P248, DOI 10.1136/gut.51.2.248
   Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x
   Wang XH, 2001, P NATL ACAD SCI USA, V98, P11468, DOI 10.1073/pnas.201360898
   Watanabe T, 2001, J HEPATOL, V35, P465, DOI 10.1016/S0168-8278(01)00177-5
   Weng HL, 2009, HEPATOLOGY, V50, P230, DOI 10.1002/hep.22934
   Wong V, 1997, J VIRAL HEPATITIS, V4, P255, DOI 10.1046/j.1365-2893.1997.00054.x
   Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412
   Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500
   Zhou XY, 2004, LIVER INT, V24, P492, DOI 10.1111/j.1478-3231.2004.0946.x
NR 48
TC 27
Z9 29
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1549-1684
EI 1557-8577
J9 REJUV RES
JI Rejuv. Res.
PD AUG
PY 2011
VL 14
IS 4
BP 353
EP 363
DI 10.1089/rej.2010.1146
PG 11
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 809LK
UT WOS:000294057000002
PM 21548759
DA 2024-02-19
ER

PT J
AU RIKANS, LE
AF RIKANS, LE
TI INFLUENCE OF AGING ON THE ACTIVITIES OF RAT-LIVER ENZYMES USED AS
   MARKERS FOR HEPATOTOXICITY
SO IRCS MEDICAL SCIENCE-BIOCHEMISTRY
LA English
DT Article
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA,HLTH SCI CTR,COLL MED,DEPT PHARMACOL,POB 26901,OKLAHOMA CITY,OK 73190, USA.
NR 0
TC 5
Z9 5
U1 0
U2 0
PU ELSEVIER-IRCS LTD
PI LANCASTER
PA ST LEONARDS HOUSE ST LEONARDGATE, LANCASTER, LANCS, ENGLAND LA1 1PF
J9 IRCS MED SCI-BIOCHEM
PD MAY
PY 1986
VL 14
IS 5
BP 467
EP 468
PG 2
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA C4439
UT WOS:A1986C443900029
DA 2024-02-19
ER

PT J
AU Tsukahara, A
   Seki, S
   Iiai, T
   Moroda, T
   Watanabe, H
   Suzuki, S
   Tada, T
   Hiraide, H
   Hatakeyama, K
   Abo, T
AF Tsukahara, A
   Seki, S
   Iiai, T
   Moroda, T
   Watanabe, H
   Suzuki, S
   Tada, T
   Hiraide, H
   Hatakeyama, K
   Abo, T
TI Mouse liver T cells: Their change with aging and in comparison with
   peripheral T cells
SO HEPATOLOGY
LA English
DT Article
ID CLASS-I MOLECULES; BONE-MARROW TRANSPLANTATION; LYMPHOKINE SECRETION;
   LYMPHOCYTES-T; LPR MICE; INCREASE; THYMOCYTES; AGE; THYMUS; POPULATIONS
AB Mouse liver contains both IL-2R beta(-)(or low positive) high T-cell receptor (TCRhi) cells and IL-2R beta(+) intermediate TCR (TCRint) cells, TCRint cells consist of natural killer 1.1 (NK1)(+) and NK1(-) subsets. NK1(-)TCR(int) cells increase constantly with age whereas TCRhi cells decrease, NK1(+) TCRint cell proportions in the liver increase until middle age and decrease thereafter. Although NK1(+) TCRint cells in other organs are few regardless of age, NK1(-) TCRint cells gradually appear in other lymphoid organs with aging. Skewed usage of V beta 7 and V beta 8 TCR was observed in NK1(+) TCRint cells in the liver but the predominance was less obvious in NK1(-) TCRint and TCRhi cells in the liver and other organs. TCR V alpha 14 messenger RNA (mRNA) was detected in NK1(+) TCRint cells but not in the other two populations, In contrast, although NK1(+) TCRint cells contain virtually no V alpha 11(+) T cells, NK1(-) TCRint cells contain a much higher proportion (approximately 12%) of V alpha 11(+) T cells, whereas approximately 4% of TCR cells are V alpha 11(+). NK activities of liver mononuclear cells (MNC) and splenocytes decrease with aging, although the former is always greater than the latter. NK activity of liver MNC is a function of NK cells, partly NK1(+) TCRint cells but not NK1(-) TCRint cells or TCRhi cells. These results suggest that lymphocytes of liver and other organs at old age are no longer occupied solely by conventional thymus-derived T cells, and the increase of extrathymic IL-2R beta(+) NK1(-) TCRint cells in liver and periphery could be closely related to immunological changes with aging.
C1 NATL DEF MED COLL,RES INST,DIV BASIC TRAUMATOL,TOKOROZAWA,SAITAMA 359,JAPAN.
   NIIGATA UNIV,SCH MED,DEPT IMMUNOL,NIIGATA 951,JAPAN.
   NIIGATA UNIV,SCH MED,DEPT SURG 1,NIIGATA 951,JAPAN.
C3 National Defense Medical College - Japan; Niigata University; Niigata
   University
CR Abo T, 1994, Int Rev Immunol, V11, P61, DOI 10.3109/08830189409061717
   Anzai R, 1996, IMMUNOLOGY, V88, P82, DOI 10.1046/j.1365-2567.1996.d01-638.x
   ARASE H, 1993, EUR J IMMUNOL, V23, P307, DOI 10.1002/eji.1830230151
   Arase H, 1996, J EXP MED, V183, P2391, DOI 10.1084/jem.183.5.2391
   BARNABA V, 1994, J IMMUNOL, V152, P3074
   BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820
   Bendelac A, 1996, J EXP MED, V184, P1285, DOI 10.1084/jem.184.4.1285
   BIX M, 1993, J EXP MED, V178, P901, DOI 10.1084/jem.178.3.901
   CALLAHAN JE, 1993, J IMMUNOL, V151, P6657
   COLES MC, 1994, J EXP MED, V180, P395, DOI 10.1084/jem.180.1.395
   EMOTO M, 1995, INT IMMUNOL, V7, P1729, DOI 10.1093/intimm/7.11.1729
   ERNST DN, 1990, J IMMUNOL, V145, P1295
   FREGONA I, 1985, TRANSPLANTATION, V39, P25
   GABRIEL H, 1993, EUR J IMMUNOL, V23, P2704, DOI 10.1002/eji.1830231049
   GONZALEZQUINTIAL R, 1992, J IMMUNOL, V149, P230
   GOOSSENS PL, 1990, J IMMUNOL METHODS, V132, P137, DOI 10.1016/0022-1759(90)90407-M
   HASHIMOTO W, 1995, J IMMUNOL, V154, P4333
   HAYASHI Y, 1989, CLIN EXP IMMUNOL, V78, P120
   HOSONO M, 1995, MECH AGEING DEV, V78, P197, DOI 10.1016/0047-6374(94)01537-V
   Kawachi Y, 1995, EUR J IMMUNOL, V25, P3452, DOI 10.1002/eji.1830251237
   Kenai H, 1995, EUR J IMMUNOL, V25, P3365, DOI 10.1002/eji.1830251224
   KENAI H, 1993, EUR J IMMUNOL, V23, P1818, DOI 10.1002/eji.1830230813
   KIKLY K, 1992, J IMMUNOL, V149, P403
   KOH DR, 1995, EUR J IMMUNOL, V25, P2558, DOI 10.1002/eji.1830250923
   LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097
   LERNER A, 1989, EUR J IMMUNOL, V19, P977, DOI 10.1002/eji.1830190604
   LEROY E, 1986, J IMMUNOL, V137, P2180
   LIGTHART GJ, 1986, IMMUNOLOGY, V59, P353
   Makino Y, 1994, Int Rev Immunol, V11, P31, DOI 10.3109/08830189409061715
   OHTEKI T, 1995, EUR J IMMUNOL, V25, P37, DOI 10.1002/eji.1830250108
   OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7
   OHTEKI T, 1992, J IMMUNOL, V149, P1562
   OHTEKI T, 1994, J EXP MED, V180, P395
   OKADA T, 1995, CLIN EXP IMMUNOL, V102, P159
   OKUYAMA R, 1992, J EXP MED, V175, P661, DOI 10.1084/jem.175.3.661
   PHILOSOPHE B, 1990, J GERONTOL, V45, P887
   PROUST JJ, 1987, J IMMUNOL, V139, P1472
   SADATSOWTI B, 1994, EUR J IMMUNOL, V24, P2882, DOI 10.1002/eji.1830241145
   SATO K, 1995, J EXP MED, V182, P759, DOI 10.1084/jem.182.3.759
   Satoh M, 1996, J IMMUNOL, V157, P3886
   SEKI S, 1991, J IMMUNOL, V147, P1214
   SEKI S, 1994, J IMMUNOL, V153, P637
   SINGER PA, 1989, J EXP MED, V170, P1869, DOI 10.1084/jem.170.6.1869
   SYKES M, 1990, J IMMUNOL, V145, P3209
   Takahashi M, 1996, J IMMUNOL, V156, P2436
   Takeda K, 1996, J IMMUNOL, V156, P3366
   Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198
   Watanabe H, 1996, J EXP MED, V184, P687, DOI 10.1084/jem.184.2.687
   WATANABE H, 1992, J IMMUNOL METHODS, V146, P145, DOI 10.1016/0022-1759(92)90223-G
   WATANABE H, 1995, J IMMUNOL, V155, P2972
   WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0
   YANG YP, 1995, J IMMUNOL, V155, P2564
NR 52
TC 126
Z9 131
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD AUG
PY 1997
VL 26
IS 2
BP 301
EP 309
DI 10.1002/hep.510260208
PG 9
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA XQ609
UT WOS:A1997XQ60900009
PM 9252138
OA Bronze
DA 2024-02-19
ER

PT J
AU FUKUDA, H
   IRITANI, N
AF FUKUDA, H
   IRITANI, N
TI EFFECTS OF AGING ON GENE-EXPRESSION OF ACETYL-COA CARBOXYLASE AND
   FATTY-ACID SYNTHASE IN RAT-LIVER
SO JOURNAL OF BIOCHEMISTRY
LA English
DT Article
ID POSTTRANSCRIPTIONAL REGULATION; NUTRIENTS; ENZYME; INDUCTION; HORMONES
AB After refeeding a fat-free diet to fasted rats, the time courses of transcriptional rates, mRNA concentrations, and enzyme induction of hepatic acetyl-CoA carboxylase and fatty acid synthase were compared between 1.5- and 18-month-old rats. In the old rats, the levels were mostly 40-70% of those in the young animals. Moreover, the peaks of the levels tended to be delayed in the old animals. The transcriptional rates were increased within only 1 h after the refeeding in the young animals, but not until 6 h in the old. The mRNA concentrations reached maximum at 16 h in the young rats, but at 24 h in the old. In the old rats, the incorporation of [H-3]leucine into the enzyme proteins was also decreased roughly in proportion to the enzyme induction. The mRNA concentrations in the liver polysomes were roughly proportional to the total mRNAs. Thus, the translational activities did not appear to be altered by aging. It is suggested that the age-dependent decreases of acetyl-CoA carboxylase and fatty acid synthase induction can be mainly ascribed to the transcriptional steps.
C1 TEZUKAYAMA GAKUIN COLL,2-2 HARUMIDAI 4 CHO,SAKAI,OSAKA 59001,JAPAN.
CR CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CLEMENS MJ, 1984, TRANSCRIPTION TRANSL, P218
   FUKUDA H, 1982, J NUTR SCI VITAMINOL, V28, P527
   FUKUDA H, 1990, EUR J BIOCHEM, V188, P517, DOI 10.1111/j.1432-1033.1990.tb15430.x
   HAINING JL, 1971, ARCH BIOCHEM BIOPHYS, V144, P204, DOI 10.1016/0003-9861(71)90469-3
   HIZI A, 1974, EUR J BIOCHEM, V45, P211, DOI 10.1111/j.1432-1033.1974.tb03545.x
   Hsu RY, 1969, METHOD ENZYMOL, P33
   IRITANI N, 1979, ATHEROSCLEROSIS, V34, P41, DOI 10.1016/0021-9150(79)90104-7
   IRITANI N, 1981, BIOCHIM BIOPHYS ACTA, V665, P636, DOI 10.1016/0005-2760(81)90284-8
   KATSURADA A, 1982, BIOCHEM BIOPH RES CO, V109, P250, DOI 10.1016/0006-291X(82)91592-3
   KATSURADA A, 1990, EUR J BIOCHEM, V190, P427, DOI 10.1111/j.1432-1033.1990.tb15592.x
   KATSURADA A, 1990, EUR J BIOCHEM, V190, P435, DOI 10.1111/j.1432-1033.1990.tb15593.x
   KATSURADA A, 1986, BIOCHIM BIOPHYS ACTA, V877, P350, DOI 10.1016/0005-2760(86)90199-2
   LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137
   MAJERUS PW, 1969, J BIOL CHEM, V244, P6254
   NAKANISHI S, 1970, EUR J BIOCHEM, V16, P161, DOI 10.1111/j.1432-1033.1970.tb01068.x
   SCHIMKE RT, 1969, MAMMALIAN PROTEIN ME, V4, P177
NR 17
TC 3
Z9 3
U1 0
U2 0
PU JAPANESE BIOCHEMICAL SOC
PI TOKYO
PA ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO 113, JAPAN
SN 0021-924X
J9 J BIOCHEM-TOKYO
JI J. Biochem. (Tokyo)
PD AUG
PY 1992
VL 112
IS 2
BP 277
EP 280
DI 10.1093/oxfordjournals.jbchem.a123890
PG 4
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA JG854
UT WOS:A1992JG85400018
PM 1356973
DA 2024-02-19
ER

PT J
AU DEPRIESTER, W
   VANMANEN, R
   KNOOK, DL
AF DEPRIESTER, W
   VANMANEN, R
   KNOOK, DL
TI LYSOSOMAL ACTIVITY IN THE AGING RAT-LIVER .2. MORPHOMETRY OF
   ACID-PHOSPHATASE POSITIVE DENSE BODIES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 TNO,INST EXPTL GERONTOL,RIJSWIJK,NETHERLANDS.
C3 Netherlands Organization Applied Science Research
RP DEPRIESTER, W (corresponding author), LAB ZOOL,KAISERSTRAAT 63,2311 GP LEIDEN,NETHERLANDS.
CR BARKA T, 1962, J HISTOCHEM CYTOCHEM, V10, P741, DOI 10.1177/10.6.741
   BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441
   Carriere R, 1969, Int Rev Cytol, V25, P201, DOI 10.1016/S0074-7696(08)60204-1
   Dolman C. L, 1981, ADV CELL NEUROBIOL, P205
   ESSNER E, 1961, J BIOPHYS BIOCHEM CY, V9, P773, DOI 10.1083/jcb.9.4.773
   GAHAN PB, 1977, EXP GERONTOL, V12, P133, DOI 10.1016/0531-5565(77)90021-3
   GIGER H, 1970, BIOMETR Z, V12, P156
   KNOOK D L, 1975, P155
   KNOOK DL, 1976, MECH AGEING DEV, V5, P389, DOI 10.1016/0047-6374(76)90036-1
   LOUD AV, 1968, J CELL BIOL, V37, P27, DOI 10.1083/jcb.37.1.27
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   MIDDLETON J, EXP GERONTOL
   Novikoff AB, 1964, J MICROSCOPIE, V3, P187
   PFEIFER U, 1973, VIRCHOWS ARCH B, V12, P195
   SCHMUCKER DL, 1974, J GERONTOL, V29, P506, DOI 10.1093/geronj/29.5.506
   VANMANEN R, 1983, MECH AGEING DEV, V22, P159, DOI 10.1016/0047-6374(83)90109-4
   WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68
   WIENER J, 1968, J CELL BIOL, V37, P47, DOI 10.1083/jcb.37.1.47
   WILSON PD, 1973, GERONTOLOGY, V19, P79, DOI 10.1159/000211964
   WILSON PD, 1978, GERONTOLOGY, V14, P348
   WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4
NR 21
TC 25
Z9 25
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PY 1984
VL 26
IS 2-3
BP 205
EP 216
DI 10.1016/0047-6374(84)90094-0
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TG518
UT WOS:A1984TG51800006
PM 6482519
DA 2024-02-19
ER

PT J
AU BORDONI, A
   BIAGI, PL
   TURCHETTO, E
   HRELIA, S
AF BORDONI, A
   BIAGI, PL
   TURCHETTO, E
   HRELIA, S
TI AGING INFLUENCE ON DELTA-6-DESATURASE ACTIVITY AND FATTY-ACID
   COMPOSITION OF RAT-LIVER MICROSOMES
SO BIOCHEMISTRY INTERNATIONAL
LA English
DT Article
RP BORDONI, A (corresponding author), CTR RIC NUTR,DIPARTIMENTO BIOCHIM,VIA IRNERIO 48,I-40126 BOLOGNA,ITALY.
RI Hrelia, Silvana/P-2864-2015; Bordoni, Alessandra/J-3047-2012
OI Hrelia, Silvana/0000-0001-7857-4512; Bordoni,
   Alessandra/0000-0003-4579-1662
CR ALLMANN DW, 1965, J LIPID RES, V6, P63
   [Anonymous], ANN NEW YORK ACAD SC
   BENJAMIN W, 1964, J BIOL CHEM, V239, P64
   BORDONI A, 1988, DRUG EXP CLIN RES, V14, P291
   BRENNER RR, 1974, MOL CELL BIOCHEM, V3, P41, DOI 10.1007/BF01660076
   Cook HW, 1985, BIOCH LIPIDS MEMBRAN, P181
   DUMM INTD, 1984, LIPIDS, V19, P91, DOI 10.1007/BF02534497
   ELOVSON J, 1965, BIOCHIM BIOPHYS ACTA, V106, P291, DOI 10.1016/0005-2760(65)90037-8
   FAAS FH, 1982, BIOCHEM J, V207, P29, DOI 10.1042/bj2070029
   FAAS FH, 1981, BIOCHEM J, V193, P842
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GONZALEZ S, 1983, LIPIDS, V18, P7, DOI 10.1007/BF02534683
   HORROBIN DF, 1981, MED HYPOTHESES, V7, P1211, DOI 10.1016/0306-9877(81)90064-5
   HRELIA S, 1986, BIOCHEM INT, V12, P741
   HUGHES S, 1985, BIOCHEM J, V225, P307, DOI 10.1042/bj2250307
   LENTZ BR, 1976, BIOCHEMISTRY-US, V15, P4521, DOI 10.1021/bi00665a029
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NIE NH, 1975, STATISTICAL PACKAGE
   PELUFFO R O, 1970, American Journal of Physiology, V218, P669
   PURVIS JM, 1983, COMP BIOCHEM PHYS B, V75, P199, DOI 10.1016/0305-0491(83)90313-9
   SHAND JH, 1978, BIOL NEONATE, V34, P217, DOI 10.1159/000241132
   STOFFEL W, 1959, ANAL CHEM, V31, P307, DOI 10.1021/ac60146a047
   UMEKI S, 1984, BIOCHIM BIOPHYS ACTA, V793, P123
   WALFORD RL, 1980, AM J CLIN PATHOL, V74, P247
NR 24
TC 65
Z9 67
U1 0
U2 3
PU ACADEMIC PRESS AUST
PI MARRICKVILLE
PA LOCKED BAG 16, MARRICKVILLE NSW 2204, AUSTRALIA
SN 0158-5231
J9 BIOCHEM INT
PD DEC
PY 1988
VL 17
IS 6
BP 1001
EP 1009
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA R8640
UT WOS:A1988R864000002
PM 3245835
DA 2024-02-19
ER

PT J
AU Kaczynski, J
   Odén, A
AF Kaczynski, J
   Odén, A
TI Increasing incidence of primary liver cancer -: A matter of ageing?
SO GI CANCER
LA English
DT Article
DE hepatocellular carcinoma; epidemiology; Sweden
ID HEPATOCELLULAR-CARCINOMA; POPULATION
AB Background The age-standardized incidence of primary liver cancer (PLC) has apparently increased in most countries, The aim of this study was to establish the degree of the stated increased incidence of PLC with a more precise model and to determine the role of age for incidence of PLC,
   Methods Preserved biopsy specimens from all PLC cases in a well defined population (Goteborg, Sweden) from a 22-year period, when the age-standardized incidence rate of PLC was substantially increased, were reevaluated and classified histopathologically. A Poisson model was used to calculate time trends in incidence of the hepatocellular (HCC, n = 532) and cholangiocellular (CCC, n = 48) type of PLC and, to estimate the role of age for the risk of PLC, Risk coefficients for age, sex and calendar year mere estimated by data from the material,
   Results Adjusting for age there was no significant change in incidence of PLC during the study period, The age risk coefficient was for HCC 0.102 in men and 0.082 in women, and for CCC 0.090 in men and 0.113 in women, These risk coefficients differed significantly (p < 0.001) from those concerning all cancer in western Sweden with exception for CCC in men,
   Conclusions The generally accepted age-standardized incidence method is not fully accounting for the ageing effect in studies of PLC, which was found to be an extremely age-dependent cancer, Use of this method instead of the Poisson model may give an impression of a substantial increased incidence over time.
C1 Gothenburg Univ, Sahlgrens Univ Hosp, Dept Med, S-41685 Gothenburg, Sweden.
C3 Sahlgrenska University Hospital; University of Gothenburg
RP Kaczynski, J (corresponding author), Gothenburg Univ, Sahlgrens Univ Hosp, Dept Med, CKO Plan 2, S-41685 Gothenburg, Sweden.
CR ANDERSEN IB, 1991, BRIT MED J, V302, P437, DOI 10.1136/bmj.302.6774.437
   ANTHONY PP, PATHOLOGY LIVER, P574
   AXELSSON G, 1982, J CHRON DIS, V35, P459, DOI 10.1016/0021-9681(82)90060-1
   BASSENDINE MF, 1986, J HEPATOL, V2, P513, DOI 10.1016/S0168-8278(86)80063-0
   BASSENDINE MF, 1987, BAILLIERE CLIN GASTR, V1, P1, DOI 10.1016/0950-3528(87)90031-5
   BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J
   CARRIAGA MT, 1995, CANCER-AM CANCER SOC, V75, P171, DOI 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2
   COOK GG, 1985, AM J MED, V233, P705
   Day NE., 1987, STATISTICAL METHODS, VII, P131
   HAFSTROM L, 1986, ANN CHIR GYNAECOL FE, V75, P11
   HEY A, 1985, FORTSCHR MED, V103, P238
   KACZYNSKI J, 1989, ACTA ONCOL, V28, P716, DOI 10.3109/02841868909092300
   Kaczynski J, 1996, BRIT J CANCER, V73, P128, DOI 10.1038/bjc.1996.24
   Kaczynski J, 1983, Lakartidningen, V80, P4400
   *NAT BOARD HLTH WE, 1960, CANC REG CANC INC SW
   OKUDA K, 1986, DIGEST DIS SCI, V31, pS133
   RESNICK RH, 1993, ARCH INTERN MED, V153, P1672, DOI 10.1001/archinte.153.14.1672
   SARACCI R, 1980, J NATL CANCER I, V65, P241
   SOBESLAVSKY O, 1978, VIRAL HEPATITIS, P347
   VITALE GC, 1986, SURG CLIN N AM, V66, P723
   WIGHT DGD, 1982, ATLAS LIVER PATHOLOG, P167
   YU MC, 1991, JNCI-J NATL CANCER I, V83, P1820, DOI 10.1093/jnci/83.24.1820
NR 22
TC 8
Z9 8
U1 0
U2 0
PU HARWOOD ACAD PUBL GMBH, TAYLOR & FRANCIS GROUP
PI PHILADELPHIA
PA 325 CHESTNUT ST, 8TH FL, PHILADELPHIA, PA 19106 USA
SN 1064-9700
J9 GI CANCER
JI GI Cancer
PY 1999
VL 3
IS 1
BP 67
EP 71
PG 5
WC Oncology; Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Gastroenterology & Hepatology
GA 176NF
UT WOS:000079157200009
DA 2024-02-19
ER

PT J
AU Dani, D
   Shimokawa, I
   Komatsu, T
   Higami, Y
   Warnken, U
   Schokraie, E
   Schnölzer, M
   Krause, F
   Sugawa, MD
   Dencher, NA
AF Dani, Diksha
   Shimokawa, Isao
   Komatsu, Toshimitsu
   Higami, Yoshikazu
   Warnken, Uwe
   Schokraie, Elham
   Schnoelzer, Martina
   Krause, Frank
   Sugawa, Michiru D.
   Dencher, Norbert A.
TI Modulation of oxidative phosphorylation machinery signifies a prime mode
   of anti-ageing mechanism of calorie restriction in male rat liver
   mitochondria
SO BIOGERONTOLOGY
LA English
DT Article
DE Ageing; Antioxidants; Calorie restriction; DIGE; Proteomics;
   Mitochondria
ID GENE-EXPRESSION PROFILE; CYTOCHROME-C-OXIDASE; RESPIRATORY-CHAIN;
   SHORT-TERM; COMPLEX-I; PROTEIN; STRESS; BRAIN; GLUTATHIONE; DYSFUNCTION
AB Mitochondria being the major source and target of reactive oxygen species (ROS) play a crucial role during ageing. We analyzed ageing and calorie restriction (CR)-induced changes in abundance of rat liver mitochondrial proteins to understand key aspects behind the age-retarding mechanism of CR. The combination of blue-native (BN) gel system with fluorescence Difference Gel Electrophoresis (DIGE) facilitated an efficient analysis of soluble and membrane proteins, existing as monomers or multi-protein assemblies. Changes in abundance of specific key subunits of respiratory chain complexes I, IV and V, critical for activity and/or assembly of the complexes were identified. CR lowered complex I assembly and complex IV activity, which is discussed as a molecular mechanism to minimize ROS production at mitochondria. Notably, the antioxidant system was found to be least affected. The GSH:GSSG couple could be depicted as a rapid mean to handle the fluctuations in ROS levels led by reversible metabolic shifts. We evaluated the relative significance of ROS generation against quenching. We also observed parallel and unidirectional changes as effect of ageing and CR, in subunits of ATP synthase, cytochrome P450 and glutathione S-transferase. This is the first report on such 'putatively hormetic' ageing-analogous effects of CR, besides the age-retarding ones.
C1 [Dani, Diksha; Krause, Frank; Dencher, Norbert A.] Tech Univ Darmstadt, Dept Chem, D-64287 Darmstadt, Germany.
   [Shimokawa, Isao; Komatsu, Toshimitsu; Higami, Yoshikazu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Investigat Pathol, Nagasaki 8528523, Japan.
   [Warnken, Uwe; Schokraie, Elham; Schnoelzer, Martina] DKFZ, D-69120 Heidelberg, Germany.
   [Sugawa, Michiru D.] Charite, D-10117 Berlin, Germany.
C3 Technical University of Darmstadt; Nagasaki University; Helmholtz
   Association; German Cancer Research Center (DKFZ); Free University of
   Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin
RP Dani, D (corresponding author), Tech Univ Darmstadt, Dept Chem, Petersenstr 22, D-64287 Darmstadt, Germany.
EM dikshadan@gmail.com; nad@hrzpub.tu-darmstadt.de
RI Dencher, Norbert/G-6640-2014
OI Shimokawa, Isao/0000-0001-8901-1029; Higami,
   Yoshikazu/0000-0003-1381-0777
FU EC [LSHM-CT-2004-512020]; Deutsche Forschungsgemeinschaft [SFB 472]
FX This work was supported by EC FP6 contract number LSHM-CT-2004-512020,
   MiMage, to N. A. D. and Deutsche Forschungsgemeinschaft grant SFB 472 to
   N. A. D. and H. Seelert. We are grateful to Dr. Linda Ottoboni (
   Functional Genome analysis, DKFZ, Heidelberg, Germany) and Dr. Holger
   Eubel ( ARC Centre of Excellence in Plant Energy Biology, Australia) for
   fruitful discussions on DIGE, Kerstin Kammerer and Sabine Fiedler from
   Functional Proteome Analysis, DKFZ, Heidelberg, Germany, for technical
   assistance in mass spectrometry.
CR Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Beier J, 2003, RESPIRATION, V70, P523, DOI 10.1159/000074211
   Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003
   BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Chang J, 2007, J GERONTOL A-BIOL, V62, P223, DOI 10.1093/gerona/62.3.223
   Dani Diksha, 2008, Biotechnology Journal, V3, P817, DOI 10.1002/biot.200800030
   Dencher NA, 2007, ANN NY ACAD SCI, V1100, P291, DOI 10.1196/annals.1395.030
   Domenicali M, 2001, J NUTR, V131, P105, DOI 10.1093/jn/131.1.105
   Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002
   Gillardon F, 2007, PROTEOMICS, V7, P605, DOI 10.1002/pmic.200600728
   Gómez J, 2007, BIOGERONTOLOGY, V8, P555, DOI 10.1007/s10522-007-9099-1
   Groebe K, 2007, EXP GERONTOL, V42, P887, DOI 10.1016/j.exger.2007.07.001
   Higami Y, 2006, J GERONTOL A-BIOL, V61, P1099, DOI 10.1093/gerona/61.11.1099
   Hofmann I, 2002, MOL BIOL CELL, V13, P1665, DOI 10.1091/mbc.01-12-0567
   Hunzinger C, 2006, J PROTEOME RES, V5, P625, DOI 10.1021/pr050377+
   Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4
   Johnson D., 1967, Methods Enzymol, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9
   Justo R, 2005, AM J PHYSIOL-CELL PH, V289, pC372, DOI 10.1152/ajpcell.00035.2005
   KADENBACH B, 1981, FEBS LETT, V135, P1, DOI 10.1016/0014-5793(81)80932-5
   Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6
   Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X
   KRAUSE F, 2008, CURR PROTOC PROT SCI, V51
   Krause F, 2006, ELECTROPHORESIS, V27, P2759, DOI 10.1002/elps.200600049
   Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390
   Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Marques I, 2007, EUKARYOT CELL, V6, P2391, DOI 10.1128/EC.00149-07
   Masoro Edward J., 2007, V35, P1
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006
   Perales M, 2005, J MOL BIOL, V350, P263, DOI 10.1016/j.jmb.2005.04.062
   Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511
   Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010
   Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002
   Scanlan N, 2001, Altern Med Rev, V6 Suppl, pS24
   Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4
   Schägger H, 2001, J BIOL CHEM, V276, P37861
   Shimokawa I, 2003, FASEB J, V17, P1108, DOI 10.1096/fj.02-0819fje
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   Valle A, 2007, AM J PHYSIOL-CELL PH, V293, pC1302, DOI 10.1152/ajpcell.00203.2007
   Viswanathan S, 2006, NAT PROTOC, V1, P1351, DOI 10.1038/nprot.2006.234
   WATERLAND RA, 1991, J BIOL CHEM, V266, P4180
   WEISHAUPT A, 1992, BIOCHEMISTRY-US, V31, P11477, DOI 10.1021/bi00161a028
   Yoon M, 2006, TOXICOL SCI, V89, P386, DOI 10.1093/toxsci/kfj045
NR 47
TC 28
Z9 28
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD JUN
PY 2010
VL 11
IS 3
BP 321
EP 334
DI 10.1007/s10522-009-9254-y
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 588TH
UT WOS:000277096300007
PM 19894137
DA 2024-02-19
ER

PT J
AU Franchi, C
   LaPorta, C
   Comolli, R
AF Franchi, C
   LaPorta, C
   Comolli, R
TI Activity of protein kinase C in rat liver during aging and the acute
   phase response
SO AGING-CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article; Proceedings Paper
CT Gordon Conference Satellite - Intervention in Aging IV: Consequences of
   Age Changes Explored at the Cellular and Subcellular Levels on
   Organismic Function
CY MAY 05-06, 1995
CL VOLTERRA, ITALY
RP Franchi, C (corresponding author), UNIV MILAN,CNR CTR RES CELL PATHOL,DEPT GEN PHYSIOL & BIOCHEM,GEN PATHOL SECT,MILAN,ITALY.
RI La Porta, Caterina/K-7345-2013
OI La Porta, Caterina/0000-0002-3010-8966
CR BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6
   CHANG ZF, 1994, BIOCHEM BIOPH RES CO, V200, P16, DOI 10.1006/bbrc.1994.1408
   DICE JF, 1988, LIVER BIOL PATHOBIOL, P1245
   GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x
   KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6
   KITANI K, 1994, ARCH GERONTOL GERIAT, V19, P145, DOI 10.1016/0167-4943(94)90036-1
   LAPORTA CAM, 1993, MOL CARCINOGEN, V8, P255
   NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456
   SCHMUCKER DL, 1990, EXP GERONTOL, V25, P403, DOI 10.1016/0531-5565(90)90029-2
   WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121
NR 10
TC 0
Z9 0
U1 0
U2 0
PU EDITRICE KURTIS S R L
PI MILANO
PA VIA LUIGI ZOJA, 30-20153 MILANO, ITALY
SN 0394-9532
J9 AGING-CLIN EXP RES
JI Aging-Clin. Exp. Res.
PD DEC
PY 1995
VL 7
IS 6
BP 478
EP 479
DI 10.1007/BF03324378
PG 2
WC Geriatrics & Gerontology
WE Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA TN790
UT WOS:A1995TN79000025
DA 2024-02-19
ER

PT J
AU Brown, KE
   Mathahs, MM
   Broadhurst, KA
   Coleman, MC
   Ridnour, LA
   Schmidt, WN
   Spitz, DR
AF Brown, Kyle E.
   Mathahs, M. Meleah
   Broadhurst, Kimberly A.
   Coleman, Mitchell C.
   Ridnour, Lisa A.
   Schmidt, Warren N.
   Spitz, Douglas R.
TI Increased hepatic telomerase activity in a rat model of iron overload: A
   role for altered thiol redox state?
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE glutamate cysteine ligase; glutathione; hemochromatosis; oxidative
   stress; telomeres; free radicals
ID OXIDATIVE STRESS; INDUCED APOPTOSIS; DIETARY IRON; EXPRESSION; LIVER;
   CELLS; SENESCENCE; RESISTANCE; PROLIFERATION; FIBROBLASTS
AB Telomeres are repeated sequences at chromosome ends that are incompletely replicated during mitosis. Telomere shortening caused by proliferation or oxidative damage culminates in replicative arrest and senescence, which may impair regeneration during chronic liver injury. Whereas the effects of experimental liver injury on telomeres have received little attention, prior studies suggest that telomerase, the enzyme complex that catalyzes the addition of telomeric repeats, is protective in some rodent liver injury models. Thus, the aim of this study was to determine the effects of iron overload on telomere length and telomerase activity in rat liver. Mean telomere lengths were similar in iron-loaded and control livers. However, telomerase activity was increased 3-fold by iron loading, with no change in levels of TERT mRNA or protein. Because thiol redox state has been shown to modulate telomerase activity in vitro, hepatic thiols were assessed. Significant increases in GSH (1.5-fold), cysteine (15-fold), and glutamate cysteine ligase activity (1.5-fold) were observed in iron-loaded livers, whereas telomerase activity was inhibited by treatment with N-ethylmaleimide. This is the first demonstration of increased telomerase activity associated with thiol alterations in vivo. Enhanced telomerase activity may be an important factor contributing to the resistance of rodent liver to iron-induced damage. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Iowa, Roy J & Lucille A Carver Coll Med, Div Gastroenterol Hepatol, Iowa City, IA 52242 USA.
   Iowa City VA Med Ctr, Iowa City, IA USA.
   Univ Iowa, Roy J & Lucille A Carver Coll Med, Program Free Rad & Radiat Biol, Iowa City, IA 52242 USA.
   NCI, Radiat Biol Branch, Bethesda, MD 20892 USA.
C3 University of Iowa; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Iowa City VA Health Care System; University of
   Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer
   Institute (NCI)
RP Brown, KE (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Div Gastroenterol Hepatol, 4553 JCP,200 Hawkins Dr, Iowa City, IA 52242 USA.
EM kyle-brown@uiowa.edu
OI Brown, Kyle/0000-0002-8206-036X; Coleman, Mitchell/0000-0002-5116-801X;
   schmidt, Warren/0000-0003-2893-6014; Spitz, Douglas/0000-0002-1254-8765;
   Ridnour, Lisa A./0000-0001-9446-8349
FU NCI NIH HHS [P30 CA086862, P30-CA086862, R01 CA100045, R01-CA100045]
   Funding Source: Medline; NHLBI NIH HHS [R01 HL051469] Funding Source:
   Medline; NIDDK NIH HHS [R21-DK068453-01A1, R21 DK068453] Funding Source:
   Medline
CR Aikata H, 2000, EXP CELL RES, V256, P578, DOI 10.1006/excr.2000.4862
   Akiyama M, 2003, CANCER RES, V63, P18
   Akiyama M, 2002, CANCER RES, V62, P3876
   ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Ausubel F.M., 2000, CURRENT PROTOCOLS MO
   Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656
   Borrás C, 2004, J BIOL CHEM, V279, P34332, DOI 10.1074/jbc.M402425200
   Brown KE, 2003, LIVER INT, V23, P232, DOI 10.1034/j.1600-0676.2003.00832.x
   Brown KE, 1998, FREE RADICAL BIO MED, V24, P545, DOI 10.1016/S0891-5849(97)00284-0
   Brown KE, 2006, TRANSL RES, V148, P55, DOI 10.1016/j.trsl.2006.03.002
   Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200
   Golubovskaya VM, 1997, ONCOGENE, V15, P1233, DOI 10.1038/sj.onc.1201278
   Gorbunova V, 2002, J BIOL CHEM, V277, P38540, DOI 10.1074/jbc.M202671200
   Haendeler J, 2003, FEBS LETT, V536, P180, DOI 10.1016/S0014-5793(03)00058-9
   Hayakawa N, 1999, BIOCHEMISTRY-US, V38, P11501, DOI 10.1021/bi982829k
   Henle ES, 1999, J BIOL CHEM, V274, P962, DOI 10.1074/jbc.274.2.962
   Holt SE, 1999, MOL CARCINOGEN, V25, P241, DOI 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.3.CO;2-0
   Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Liu JP, 1999, FASEB J, V13, P2091, DOI 10.1096/fasebj.13.15.2091
   Liu L, 2003, J BIOL CHEM, V278, P31998, DOI 10.1074/jbc.M303553200
   Lu CB, 2001, DEV BRAIN RES, V131, P167, DOI 10.1016/S0165-3806(01)00237-1
   Luiten RM, 2003, BLOOD, V101, P4512, DOI 10.1182/blood-2002-07-2018
   Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471
   MUIRA M, 1998, BIOCHEM BIOPH RES CO, V246, P13
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Ren JG, 2001, FEBS LETT, V488, P133, DOI 10.1016/S0014-5793(00)02397-8
   Ridnour LA, 2005, FREE RADICAL BIO MED, V38, P1361, DOI 10.1016/j.freeradbiomed.2005.01.023
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sato R, 2004, GUT, V53, P1001, DOI 10.1136/gut.2003.027516
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   STAL P, 1995, HEPATOLOGY, V21, P521, DOI 10.1016/0270-9139(95)90115-9
   von Zglinicki T, 2000, LAB INVEST, V80, P1739, DOI 10.1038/labinvest.3780184
   Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   Whittaker P, 1997, TOXICOL PATHOL, V25, P556, DOI 10.1177/019262339702500604
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3
   Yamaguchi Y, 1998, EXP CELL RES, V242, P120, DOI 10.1006/excr.1998.4102
NR 41
TC 23
Z9 24
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD JAN 15
PY 2007
VL 42
IS 2
BP 228
EP 235
DI 10.1016/j.freeradbiomed.2006.10.039
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 125AH
UT WOS:000243413400008
PM 17189828
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Zhang, YQ
   Wan, LY
   He, XM
   Ni, YR
   Wang, C
   Liu, CB
   Wu, JF
AF Zhang, Yan-Qiong
   Wan, Lin-Yan
   He, Xiao-Min
   Ni, Yi-Ran
   Wang, Chang
   Liu, Chang-Bai
   Wu, Jiang-Feng
TI Gremlin1 Accelerates Hepatic Stellate Cell Activation Through
   Upregulation of TGF-Beta Expression
SO DNA AND CELL BIOLOGY
LA English
DT Article
DE hepatic fibrosis; HSCs; gremlin1; TGF-; BMP-7; collagen
ID BONE MORPHOGENETIC PROTEIN-7; GROWTH-FACTOR-BETA; LIVER FIBROSIS;
   GENE-EXPRESSION; LIMB; ANTAGONIST; TGF-BETA-1; MEDIATOR; DISEASE; KIDNEY
AB Gremlin1, the antagonist of bone morphogenetic protein-7 and one of the target genes of transforming growth factor (TGF)- signal pathway, plays an important role in embryonic development and its expression decreases along with aging. To explore the expression of gremlin1 in liver fibrosis and the causal link between gremlin1 and hepatic stellate cell (HSC) activation, we detected the expression of gremlin1 in mice with hepatic fibrosis induced by porcine serum using real time quantitative PCR (RT-qPCR) and immunohistochemical staining. The hepatic fibrosis mice were evaluated by the external feature of the liver, histology, hepatic function, collagen deposition, and the expression of fibrosis-related genes (genes COLI2 and COLIV2) in the liver. In the HSC-T6, western blotting was used to analyze the expression of -smooth muscle actin (-SMA), COL1, and TGF-1 in conditions of overexpression of gremlin1 or gremlin1 being knocked down by specific siRNA, respectively. The results showed that the mRNA expression of the gremlin1 gene was significantly increased consistent with increased expression of COLI2 and COLIV2 in the liver tissue of the hepatic fibrosis mice. Increased expression of gremlin1 coincided with the same area of the collagen deposition. Furthermore, the results also showed that the expression of -SMA, COLI1, and TGF-1 was consistent with the expression of gremlin1 not only in the HSC-T6 overexpressing gremlin1 but also in the HSC-T6 that gremlin1 is knocked down by specific siRNA. The findings suggest that gremlin1 might play an important role in the progression of hepatic fibrosis and that it modulates HSC activation.
C1 [Zhang, Yan-Qiong; Wan, Lin-Yan; He, Xiao-Min; Ni, Yi-Ran; Wang, Chang; Liu, Chang-Bai; Wu, Jiang-Feng] China Three Gorges Univ, Dept Anat, Coll Med, Yichang 443002, Peoples R China.
   [Wan, Lin-Yan; He, Xiao-Min; Wang, Chang; Liu, Chang-Bai; Wu, Jiang-Feng] China Three Gorges Univ, Hubei Key Lab Tumor Microenvironm & Immunotheraph, Yichang 443002, Peoples R China.
   [Wan, Lin-Yan] First Peoples Hosp Yichang, Digest Med, Yichang, Hubei, Peoples R China.
C3 China Three Gorges University; China Three Gorges University
RP Liu, CB; Wu, JF (corresponding author), China Three Gorges Univ, Dept Anat, Coll Med, Yichang 443002, Peoples R China.; Liu, CB; Wu, JF (corresponding author), China Three Gorges Univ, Hubei Key Lab Tumor Microenvironm & Immunotheraph, Yichang 443002, Peoples R China.
EM cbliu@ctgu.edu.cn; wujiangfeng@ctgu.edu.cn
RI Liu, Chang-Bai/A-4028-2013
OI Liu, Chang-Bai/0000-0001-7954-0736
FU National Natural Science Foundation of China [81670555, 81070348,
   81200307, 81170412]; Opening Foundation of Hubei Key Laboratory of Tumor
   Microenvironment and Immunotherapy (China Three Gorges University)
   [2016KZL05]; Science Research Innovation Foundation of Graduate Student
   of China Three Gorges University [2016PY051]; Science Research
   Innovation Foundation of Undergraduate Student of China Three Gorges
   University [2016YCX002]
FX The authors thank Shan-Bing Yin for English language editing and
   Yan-Ling Liu for the experiment. They are thankful for the financial
   support of the National Natural Science Foundation of China (Grant Nos.:
   81670555, 81070348, 81200307, and 81170412). It was also funded by the
   Opening Foundation of Hubei Key Laboratory of Tumor Microenvironment and
   Immunotherapy (China Three Gorges University) (No. 2016KZL05), the
   Science Research Innovation Foundation of Graduate Student of China
   Three Gorges University (No. 2016PY051), and the Science Research
   Innovation Foundation of Undergraduate Student of China Three Gorges
   University (No. 2016YCX002).
CR Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227
   Bauer M, 2001, FEBS LETT, V502, P1, DOI 10.1016/S0014-5793(01)02655-2
   Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200
   Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003
   Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989
   Carvajal G, 2008, TRANSPL P, V40, P734, DOI 10.1016/j.transproceed.2008.02.064
   Cheng K, 2009, MOL PHARMACEUT, V6, P772, DOI 10.1021/mp9000469
   Church RH, 2015, BIOCHEM J, V466, P55, DOI 10.1042/BJ20140771
   Droguett A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101879
   Farkas L, 2011, AM J RESP CELL MOL, V44, P870, DOI 10.1165/rcmb.2010-0070OC
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4
   Gressner Olav A, 2007, Comp Hepatol, V6, P7, DOI 10.1186/1476-5926-6-7
   Guimei Maha, 2012, BMC Res Notes, V5, P390, DOI 10.1186/1756-0500-5-390
   Kane R, 2005, BRIT J OPHTHALMOL, V89, P1638, DOI 10.1136/bjo.2005.069591
   Kinoshita K, 2007, GUT, V56, P706, DOI 10.1136/gut.2006.092460
   Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marsell R, 2009, INJURY, V40, P4
   Martinez G, 2002, INT J DEV BIOL, V46, P525
   Merino R, 1999, DEVELOPMENT, V126, P5515
   Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251
   Nicoli S, 2005, GENE EXPR PATTERNS, V5, P539, DOI 10.1016/j.modgeg.2004.11.001
   Rodrigues-Diez R, 2012, NEPHRON EXP NEPHROL, V122, P62, DOI 10.1159/000346575
   SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O
   Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014
   Siddique I, 2014, AM J PATHOL, V184, P2976, DOI 10.1016/j.ajpath.2014.07.018
   Sudo S, 2004, J BIOL CHEM, V279, P23134, DOI 10.1074/jbc.M402376200
   Tacke F, 2007, DIGEST DIS SCI, V52, P3404, DOI 10.1007/s10620-007-9758-8
   Topol LZ, 2000, CYTOGENET CELL GENET, V89, P79, DOI 10.1159/000015568
   Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801
   Wade FM, 2005, OBES RES, V13, P818, DOI 10.1038/oby.2005.93
   Walsh DW, 2010, TRENDS CELL BIOL, V20, P244, DOI 10.1016/j.tcb.2010.01.008
   Wang SN, 2004, J BIOL CHEM, V279, P23200, DOI 10.1074/jbc.M311998200
   Wordinger RJ, 2008, EXP EYE RES, V87, P78, DOI 10.1016/j.exer.2007.11.016
   Zeisberg M, 2008, PEDIATR NEPHROL, V23, P1395, DOI 10.1007/s00467-008-0818-x
   Zhao XK, 2014, WORLD J GASTROENTERO, V20, P14875, DOI 10.3748/wjg.v20.i40.14875
   Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904
NR 38
TC 10
Z9 10
U1 1
U2 15
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1044-5498
EI 1557-7430
J9 DNA CELL BIOL
JI DNA Cell Biol.
PD JUL
PY 2017
VL 36
IS 7
BP 603
EP 610
DI 10.1089/dna.2017.3707
PG 8
WC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Genetics & Heredity
GA EZ9TH
UT WOS:000405072300012
PM 28467108
DA 2024-02-19
ER

PT J
AU Lautt, WW
AF Lautt, WW
TI A new paradigm for diabetes and obesity: the hepatic insulin sensitizing
   substance (HISS) hypothesis
SO JOURNAL OF PHARMACOLOGICAL SCIENCES
LA English
DT Article
DE insulin resistance; obesity; hypertension; diabetes; feeding
ID SENSITIVITY TEST RIST; NITRIC-OXIDE; PLASMA-GLUCOSE; RESISTANCE;
   HYPERGLYCEMIA; OSCILLATIONS; DENERVATION; SECRETION; BLOCKADE; ATROPINE
AB The glucose disposal effect of insulin after a meal is accounted for in approximately equal measure by the direct action of insulin and the action of HISS (hepatic insulin sensitizing substance) released from the liver and acting on skeletal muscle to stimulate glucose storage as glycogen. The ability of insulin to cause HISS release is determined by hepatic parasympathetic nerves. Eliminating the parasympathetic signal by surgical denervation of the liver or by blockade of hepatic muscarinic receptors, hepatic nitric oxide synthase, or hepatic cyclooxygenase results in insulin resistance that can be accounted for by the absence of HISS action and is referred to as HISS-dependent insulin resistance (HDIR). Animal models in which the insulin resistance has been shown to be HDIR includes the spontaneously hypertensive rat, sucrose fed rats, animals with liver disease, adult offspring of fetal alcohol exposure, acute stress, and ageing. We suggest that HDIR accounts for the major metabolic disturbances in type 2 diabetes, including the postprandial hyperglycemia that results in the majority of pathologies related to diabetes. The observation of meal-induced insulin sensitization (MIS) and the role of HISS allows for consideration of a new paradigm relating meal processing, diabetes, obesity, and insulin resistance. New diagnostic approaches and therapeutic targets are described.
C1 Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0T6, Canada.
C3 University of Manitoba
RP Lautt, WW (corresponding author), Univ Manitoba, Fac Med, Dept Pharmacol & Therapeut, Winnipeg, MB R3E 0T6, Canada.
EM wlautt@ms.umanitoba.ca
RI Lautt, W. Wayne/AAC-6106-2021
OI Lautt, W. Wayne/0000-0002-7239-1798
CR Avignon A, 1997, DIABETES CARE, V20, P1822, DOI 10.2337/diacare.20.12.1822
   Borch-Johnsen K, 1999, LANCET, V354, P617
   Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a
   Correia NC, 2002, P W PHARMACOL SOC, V45, P57
   DALMEIDA MS, 2002, CAN J DIABETES, V2, P301
   DALMEIDA MS, 2003, CAN J DIABETES, V27, P332
   de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249
   Del Prato S, 2001, DIABETES-METAB RES, V17, P164, DOI 10.1002/dmrr.198
   Engelgau MM, 2000, DIABETES CARE, V23, P1563, DOI 10.2337/diacare.23.10.1563
   Guarino MP, 2003, AM J PHYSIOL-GASTR L, V284, pG588, DOI 10.1152/ajpgi.00423.2002
   Guarino MP, 2001, P W PHARMACOL SOC, V44, P25
   Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617
   Latour MG, 2002, DIABETES, V51, pA422
   Latour MG, 2002, CAN J PHYSIOL PHARM, V80, P8, DOI 10.1139/Y01-094
   Latour MG, 2002, AUTON NEUROSCI-BASIC, V95, P125, DOI 10.1016/S1566-0702(01)00390-3
   Lautt WW, 1998, CAN J PHYSIOL PHARM, V76, P1080, DOI 10.1139/cjpp-76-12-1080
   Lautt WW, 2003, MED RES REV, V23, P1, DOI 10.1002/med.10022
   Lautt WW, 1998, P W PHARMACOL SOC, V41, P35
   Lautt WW, 2001, AM J PHYSIOL-GASTR L, V281, pG29, DOI 10.1152/ajpgi.2001.281.1.G29
   LAUTT WW, 1998, FALK S, V103, P1
   Minuk GY, 1998, P W PHARMACOL SOC, V41, P39
   Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a
   Moore MC, 2002, AM J PHYSIOL-ENDOC M, V282, pE286, DOI 10.1152/ajpendo.00201.2001
   Porszasz R, 2002, EUR J PHARMACOL, V443, P211, DOI 10.1016/S0014-2999(02)01603-5
   Reid MAG, 2002, CAN J PHYSIOL PHARM, V80, P811, DOI 10.1139/Y02-102
   Ribeiro RT, 2001, P W PHARMACOL SOC, V44, P27
   Ribeiro RT, 2001, P W PHARMACOL SOC, V44, P31
   Ribeiro RT, 2001, P W PHARMACOL SOC, V44, P29
   Sadri P, 1999, AM J PHYSIOL-GASTR L, V277, pG101, DOI 10.1152/ajpgi.1999.277.1.G101
   Sadri P, 2000, DIABETES, V49, pA245
   Sadri P, 1997, Proc West Pharmacol Soc, V40, P19
   Sadri P., 2003, CAN J DIABETES, V27, P239
   Shaw JE, 1999, DIABETOLOGIA, V42, P1050, DOI 10.1007/s001250051269
   SIMON C, 1987, DIABETOLOGIA, V30, P769
   Simon C, 2002, DIABETES, V51, pS258, DOI 10.2337/diabetes.51.2007.S258
   Takayama S, 2000, P W PHARMACOL SOC, V43, P33
   Vaccaro O, 1999, DIABETES CARE, V22, P1490, DOI 10.2337/diacare.22.9.1490
   XIE H, 1994, P W PHARMACOL SOC, V37, P39
   Xie H, 1996, AM J PHYSIOL-ENDOC M, V271, pE587, DOI 10.1152/ajpendo.1996.271.3.E587
   XIE HS, 1995, J AUTON PHARMACOL, V15, P361, DOI 10.1111/j.1474-8673.1995.tb00402.x
   Xie HS, 1996, J PHARMACOL TOXICOL, V35, P77, DOI 10.1016/1056-8719(96)00003-2
   XIE HS, 1993, CAN J PHYSIOL PHARM, V71, P175, DOI 10.1139/y93-024
   Xie HS, 1996, AM J PHYSIOL-ENDOC M, V270, pE858, DOI 10.1152/ajpendo.1996.270.5.E858
NR 43
TC 55
Z9 70
U1 0
U2 5
PU JAPANESE PHARMACOLOGICAL SOC
PI KYOTO
PA EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604,
   JAPAN
SN 1347-8613
EI 1347-8648
J9 J PHARMACOL SCI
JI J. Pharmacol. Sci.
PD MAY
PY 2004
VL 95
IS 1
BP 9
EP 17
DI 10.1254/jphs.95.9
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 824GY
UT WOS:000221675900002
PM 15153645
OA Bronze
DA 2024-02-19
ER

PT J
AU Alshinnawy, AS
   El-Sayed, WM
   Sayed, AA
   Salem, AM
   Taha, AM
AF Alshinnawy, Ameera Saeed
   El-Sayed, Wael Mohamed
   Sayed, Ahmed AbdelAziz
   Salem, Ahmed Mohamed
   Taha, AlShaimaa Mohamed
TI Telomerase activator-65 and pomegranate peel improved the health status
   of the liver in aged rats; multi-targets involved
SO IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES
LA English
DT Article
DE Aging; Apoptosis; IGF1; Oxidative stress; Telomerase; Thioredoxin
   reductase
ID ASTRAGALUS-MEMBRANACEUS; ANTIOXIDANT; ACTIVATION; CYCLOASTRAGENOL;
   PTP1B; STEP
AB Objective(s): This study was undertaken to investigate the efficacy of telomerase activator-65 (Ta-65) and pomegranate peel against aging-induced deteriorations in the liver.
   Materials and Methods: The rats were divided into four groups: control, aged, aged rats treated with Ta-65, and pomegranate orally for two months.
   Results: Aging significantly increased the serum levels of total protein, globulins, and protein carbonyl and reduced the insulin-like growth factor 1 (IGF-1). It also elevated the hepatic malondialdehyde and decreased the hepatic glutathione S-transferase (GST) activity. Aging elevated the expression of thioredoxin reductase1, telomerase reverse transcriptase, and cytochrome 3a1 in the liver; it increased the p53 protein level and elevated the activity of caspase-3 in the liver indicating the occurrence of apoptosis. The architecture of the liver deteriorated in the aged rats, as shown by both light and electron microscopy examinations. The liver of the aged rats had many apoptotic hepatocytes with shrunken nuclei. Many hepatocytes had dilated rough endoplasmic reticulum, many lysosomes, and many fat droplets. Administration of Ta-65 and pomegranate to the aged rats normalized most of the previous biochemical parameters and improved the liver architecture.
   Conclusion: Ta-65 and pomegranate have anti-aging activity through targeting multiple cellular pathways. It is also noteworthy that Ta-65 was superior to pomegranate in its alleviative effects.
C1 [Alshinnawy, Ameera Saeed; Sayed, Ahmed AbdelAziz; Salem, Ahmed Mohamed; Taha, AlShaimaa Mohamed] Ain Shams Univ, Dept Biochem, Fac Sci, Cairo 11566, Egypt.
   [El-Sayed, Wael Mohamed] Ain Shams Univ, Dept Zool, Fac Sci, Cairo 11566, Egypt.
   [Sayed, Ahmed AbdelAziz] Childrens Canc Hosp 57357, Cairo, Egypt.
C3 Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge
   Bank (EKB); Ain Shams University; Children's Cancer Hospital 57357
RP El-Sayed, WM (corresponding author), Ain Shams Univ, Dept Zool, Fac Sci, Cairo 11566, Egypt.
EM wael_farag@sci.asu.edu.eg
RI El-Sayed, Wael/HPF-9148-2023; WM, El-Sayed/ABD-9236-2021; Taha,
   AlShaimaa Mohamed/AAA-8792-2020
OI WM, El-Sayed/0000-0002-3622-1417; Taha, AlShaimaa
   Mohamed/0000-0002-6825-466X; Sayed, Ahmed/0000-0003-4044-4709
CR Akhtar S., 2019, BIOACTIVE MOL FOOD, P1253
   Ale-Agha N, 2014, EXP GERONTOL, V56, P189, DOI 10.1016/j.exger.2014.02.011
   Alshinnawy AS, 2020, TURK J BIOL, V44, P166, DOI 10.3906/biy-2001-5
   Amaral JD, 2010, DISCOV MED, V9, P145
   BAGHERI A, 2017, SCI REP-UK, V7, P1
   de Jesus BB, 2011, AGING CELL, V10, P604, DOI 10.1111/j.1474-9726.2011.00700.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cao HY, 2020, CANCER SCI, V111, P2789, DOI 10.1111/cas.14442
   Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287
   Chen LY, 2018, REJUV RES, V21, P270, DOI 10.1089/rej.2016.1882
   Desoutter Marie-Astrid, 2020, Soins Gerontol, V25, P12, DOI 10.1016/j.sger.2020.07.003
   El-Hadary AE, 2020, FOOD SCI NUTR, V8, P1798, DOI 10.1002/fsn3.1391
   El-Sokkary GH, 2018, J HISTOL HISTOPATHOL, V5, P8, DOI 10.7243/2055-091X-5-8
   ESTERBAUER H, 1990, METHOD ENZYMOL, V186, P407
   Fornelli G, 2016, J GERONTOL GERIATR, V64, P75
   Fujiwara M, 2012, VET MED-RES REP, V3, P79, DOI 10.2147/VMRR.S32590
   García-Iglesias MJ, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02457-6
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Handayaningsih AE, 2011, ENDOCRINOLOGY, V152, P912, DOI 10.1210/en.2010-0981
   Hassanen EI, 2019, INT J NANOMED, V14, P8905, DOI 10.2147/IJN.S229461
   Ismail T, 2012, J ETHNOPHARMACOL, V143, P397, DOI 10.1016/j.jep.2012.07.004
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Jaul E, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00335
   Kamada S, 1997, ONCOGENE, V15, P285, DOI 10.1038/sj.onc.1201192
   Klotz U, 2009, DRUG METAB REV, V41, P67, DOI 10.1080/03602530902722679
   Kokubun T, 2019, INT HEART J, V60, P736, DOI 10.1536/ihj.18-564
   Kronfol MM, 2020, GEROSCIENCE, V42, P819, DOI 10.1007/s11357-020-00181-5
   Lee S, 2013, ANTIOXID REDOX SIGN, V18, P1165, DOI 10.1089/ars.2011.4322
   Li YH, 2016, P NATL ACAD SCI USA, V113, P14402, DOI 10.1073/pnas.1611106113
   Manikandan P, 2018, CURR DRUG TARGETS, V19, P38, DOI 10.2174/1389450118666170125144557
   Maurya PK, 2010, INDIAN J CLIN BIOCHE, V25, P398, DOI 10.1007/s12291-010-0047-5
   Maynard S, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025130
   Momenah M.A., 2017, ASIAN J ANIM VET ADV, V12, P218
   Muri J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04274-w
   Packer L., 1984, METHODS ENZYMOL, V105, P113
   Radakovich LB, 2017, VET CLIN PATH, V46, P34, DOI 10.1111/vcp.12459
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Shahzad M, 2016, CURR DRUG TARGETS, V17, P1331, DOI 10.2174/1389450116666150907104742
   Shehadat Saaid Al, 2018, Eur J Dent, V12, P574, DOI 10.4103/ejd.ejd_401_17
   Szabo NJ, 2014, FOOD CHEM TOXICOL, V64, P322, DOI 10.1016/j.fct.2013.11.041
   Tan LB, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9253208
   Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037
   Vrankovic J, 2016, BIOCHEMISTRY-MOSCOW+, V81, P224, DOI 10.1134/S0006297916030044
   Wan T, 2021, PROG NEUROBIOL, V199, P1
   Wang N, 2009, MOL CELL ENDOCRINOL, V307, P89, DOI 10.1016/j.mce.2009.03.001
   Wang ZH, 2020, AGING-US, V12, P11386, DOI 10.18632/aging.103186
   Weissleder C, 2019, AGING DIS, V10, P197, DOI 10.14336/AD.2018.0317
   Xu SF, 2019, PEERJ, V7, DOI 10.7717/peerj.7429
   Yehia HM, 2011, AFR J MICROBIOL RES, V5, P3664
   Yodoi J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101081
   Zahin M, 2010, MUTAT RES-GEN TOX EN, V703, P99, DOI 10.1016/j.mrgentox.2010.08.001
   Zhang YL, 2013, EUR J DRUG METAB PH, V38, P105, DOI 10.1007/s13318-012-0102-0
   Zhao M, 2012, MOLECULES, V17, P7083, DOI 10.3390/molecules17067083
   Zhao Y, 2015, J ETHNOPHARMACOL, V169, P210, DOI 10.1016/j.jep.2015.04.030
   Zheng YJ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00349
   Zhong HH, 2017, ONCOTARGET, V8, P102640, DOI 10.18632/oncotarget.21123
NR 56
TC 2
Z9 2
U1 0
U2 6
PU MASHHAD UNIV MED SCIENCES
PI MASHHAD
PA VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 -
   445, MASHHAD, 00000, IRAN
SN 2008-3866
EI 2008-3874
J9 IRAN J BASIC MED SCI
JI Iran. J. Basic Med. Sci.
PD JUN
PY 2021
VL 24
IS 6
BP 842
EP 850
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA SM2HA
UT WOS:000657429800016
PM 34630962
DA 2024-02-19
ER

PT J
AU ASANO, K
   NAKAMURA, M
   ASANO, A
   SATO, T
   TAUCHI, H
AF ASANO, K
   NAKAMURA, M
   ASANO, A
   SATO, T
   TAUCHI, H
TI QUANTITATION OF CHANGES IN MITOCHONDRIAL-DNA DURING AGING AND
   REGENERATION OF RAT-LIVER USING NONRADIOACTIVE DNA PROBES
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE MTDNA CONTENT; BIOTINYLATED MTDNA PROBE; AGING; REGENERATED LIVER
ID TRANSFER-RNA GENES; HYBRIDIZATION; CELLS
AB By using DNA probes prepared from cloned cells which contain mitochondrial DNA (mtDNA) sequences in plasmids, the specific detection of mtDNA became possible in the presence of large excess of nuclear DNA by DNA-DNA hybridization. For this purpose, we prepared mtDNA probes labeled with non-radioactive substrate, which allowed a wider possibility of application. This method revealed that the contents of mtDNA in rat liver are strikingly decreased during aging. Furthermore, it was observed that although mtDNA content increased upon partial hepatectomy even in old rats, it decreased to the pre-operation level rather rapidly within 1 week after reaching peak in regenerated liver.
C1 KYOTO UNIV,COLL MED TECHNOL,KYOTO 606,JAPAN.
   OSAKA UNIV,INST PROT RES,SUITA,OSAKA 565,JAPAN.
   AICHI MED UNIV,INST MED SCI AGING,NAGAKUTE,AICHI 48011,JAPAN.
C3 Kyoto University; Osaka University; Aichi Medical University
CR ASANO K, 1976, ENDOCRINOLOGY, V99, P977, DOI 10.1210/endo-99-4-977
   ASANO K, 1977, LIFE SCI, V21, P49, DOI 10.1016/0024-3205(77)90423-4
   ASANO K, 1965, J MOL BIOL, V14, P71, DOI 10.1016/S0022-2836(65)80231-5
   ASANO K, 1991, MECH AGEING DEV, V60, P275, DOI 10.1016/0047-6374(91)90040-7
   ASANO K, INT CELL BIOL 1984 T, P189
   ASANO K, 1991, ANN REP MED TECH KYO, V11, P27
   BALMAIN A, 1979, BIOCHIM BIOPHYS ACTA, V561, P155, DOI 10.1016/0005-2787(79)90499-4
   BORDST P, 1977, ANN REV BIOCH, V41, P333
   BORST P, 1977, TRENDS BIOCHEM SCI, V2, P31, DOI 10.1016/0968-0004(77)90252-3
   BRIGATI DJ, 1983, VIROLOGY, V126, P32, DOI 10.1016/0042-6822(83)90460-9
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   Granick S, 1967, Prog Nucleic Acid Res Mol Biol, V6, P143
   GROSSKOPF R, 1981, CURR GENET, V4, P151, DOI 10.1007/BF00365694
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   INOUE AIKO, 1958, SAPPORO MED JOUR, V14, P100
   Koike K, 1977, Tanpakushitsu Kakusan Koso, V22, P998
   LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633
   LEARY JJ, 1983, P NATL ACAD SCI-BIOL, V80, P4045, DOI 10.1073/pnas.80.13.4045
   MANIATIS T, MOL CLONING
   MASSIE H R, 1981, Age (Media), V9, P42
   MASSIE HR, 1975, GERONTOLOGY, V21, P231, DOI 10.1159/000212049
   MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   NASS S, 1965, BIOCHIM BIOPHYS ACTA, V95, P426, DOI 10.1016/0005-2787(65)90189-9
   NASS S, 1967, BIOCHIM BIOPHYS ACTA, V145, P60, DOI 10.1016/0005-2787(67)90654-5
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P24444
   ROSENBERGER RF, 1988, DIVISION SEGREGATION, P197
   SACCONE C, 1981, NUCLEIC ACIDS RES, V9, P4139, DOI 10.1093/nar/9.16.4139
   SACCONE C, 1988, NUCLEIC ACIDS RES, V16, P6233
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SZYBALSKI W, 1971, PROCEDURES NUCLEIC A, V2, P311
   Tagashira Y, 1969, Tanpakushitsu Kakusan Koso, V14, P627
   TAUCHI H, 1968, J GERONTOL, V23, P454, DOI 10.1093/geronj/23.4.454
   Tauchi H., 1978, LIVER AGING 1978, P3
NR 34
TC 7
Z9 7
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUN
PY 1992
VL 64
IS 1-2
BP 85
EP 98
DI 10.1016/0047-6374(92)90098-X
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HZ161
UT WOS:A1992HZ16100008
PM 1630161
DA 2024-02-19
ER

PT J
AU Nishio, N
   Isobe, K
AF Nishio, Naomi
   Isobe, Ken-ichi
TI GADD34-deficient mice develop obesity, nonalcoholic fatty liver disease,
   hepatic carcinoma and insulin resistance
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RECEPTOR SUBSTRATE-1; GROWTH ARREST; MACROPHAGE ACCUMULATION; SERINE
   PHOSPHORYLATION; GENE-EXPRESSION; ADIPOSE-TISSUE; MTOR PATHWAY;
   PPAR-GAMMA; GADD34; FIBROSIS
AB The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing in parallel with the prevalence of obesity. DNA damage-inducible protein 34 (GADD34/Ppp1r15a), originally isolated from UV-inducible transcripts in Chinese hamster ovary (CHO) cells, dephosphorylates several kinases that function in important signaling cascades, including dephosphorylation of eIF2 alpha. We examined the effects of GADD34 on natural life span by using GADD34-deficient mice. Here we observed for the first time that with age GADD34-deficient mice become obese, developing fatty liver followed by liver cirrhosis, hepatocellular carcinoma, and insulin resistance. We found that myofibroblasts and immune cells infiltrated the portal veins of aged GADD34-deficient mouse livers. A high-fat diet (HFD) induced a higher level of steatosis in young GADD34-deficient mice compared with WT mice. Differentiation into fat is dependent on insulin signaling. Insulin signaling in young GADD34-deficient mice was higher than that in WT mice, which explained the higher fat differentiation of mouse embryonic fibroblasts (MEFs) observed in GADD34-deficient mice. Through aging or a HFD, insulin signaling in GADD34-deficient liver converted to be down regulated compared with WT mice. We found that a HFD or palmitate treatment converted insulin signaling by up-regulating TNF-alpha and JNK.
C1 [Nishio, Naomi; Isobe, Ken-ichi] Nagoya Univ, Grad Sch Med, Dept Immunol, Showa Ku, Nagoya, Aichi 4668550, Japan.
   [Isobe, Ken-ichi] Nagoya Womans Univ, Dept Food Sci & Nutr, Mizuho Ku, Nagoya, Aichi 4670003, Japan.
C3 Nagoya University
RP Isobe, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Immunol, Showa Ku, 65 Turumai Cho, Nagoya, Aichi 4668550, Japan.
EM kisobe@med.nagoya-u.ac.jp
FU Ministry of Education, Science, Technology, Sports and Culture, Japan
   [25293166, 26870257]; Grants-in-Aid for Scientific Research [26870257,
   25293166] Funding Source: KAKEN
FX We thank Mr. Tanaka for technical assistance with flow cytometry
   experiments and Mizuguchi for confocal microscopic analysis (Laboratory
   of Division for Medical Research Engineering, Nagoya University Graduate
   School of Medicine) as well as N. Oiwa for administrative assistance.
   This research was supported by NO 25293166 and NO 26870257 of the
   Ministry of Education, Science, Technology, Sports and Culture, Japan.
CR Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200
   Angulo P, 1999, HEPATOLOGY, V30, P1356, DOI 10.1002/hep.510300604
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003
   Connor JH, 2001, MOL CELL BIOL, V21, P6841, DOI 10.1128/MCB.21.20.6841-6850.2001
   Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024
   FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800
   Gadd VL, 2014, HEPATOLOGY, V59, P1393, DOI 10.1002/hep.26937
   Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200
   Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200
   Geoffrey C., 2005, FATTY LIVER DIS NASH
   GIRARD J, 1994, FASEB J, V8, P36, DOI 10.1096/fasebj.8.1.7905448
   Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798
   Guerrero R, 2009, HEPATOLOGY, V49, P791, DOI 10.1002/hep.22726
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798
   Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498
   Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950
   Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje
   Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058
   Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600
   Louet JF, 2006, P NATL ACAD SCI USA, V103, P17868, DOI 10.1073/pnas.0608711103
   Majka SM, 2011, STEM CELLS, V29, P1034, DOI 10.1002/stem.653
   McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004
   Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512
   Nishio N, 2014, IMMUNOL CELL BIOL, V92, P170, DOI 10.1038/icb.2013.78
   Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112
   Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011
   Oliver E, 2010, P NUTR SOC, V69, P232, DOI 10.1017/S0029665110000042
   Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627
   Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011
   Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298
   Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017
   Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   SMITH PJ, 1988, J BIOL CHEM, V263, P9402
   Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132
   Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829
   Uddin MN, 2011, BIOCHEM BIOPH RES CO, V407, P692, DOI 10.1016/j.bbrc.2011.03.077
   Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335
   Watanabe R, 2007, INT J MOL MED, V19, P475
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022
   Weston SR, 2005, HEPATOLOGY, V41, P372, DOI 10.1002/hep.20554
   Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Zhang P., 2012, Bio Protoc., V2, P186, DOI [10.21769/BioProtoc.186, DOI 10.21769/BIOPROTOC.186, DOI 10.21769/BI0PR0T0C.186]
NR 50
TC 21
Z9 23
U1 1
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 28
PY 2015
VL 5
AR 13519
DI 10.1038/srep13519
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CP9UF
UT WOS:000360239500001
PM 26316333
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU López-Lluch, G
   Rios, M
   Lane, MA
   Navas, P
   de Cabo, R
AF Lopez-Lluch, G.
   Rios, M.
   Lane, M. A.
   Navas, P.
   de Cabo, R.
TI Mouse liver plasma membrane redox system activity is altered by aging
   and modulated by calorie restriction
SO AGE
LA English
DT Article
DE cytochrome b5 reductase; plasma membrane redox system; quinone
   reductase; ubiquinone
ID OXIDATIVE DNA-DAMAGE; COENZYME-Q; LIFE-SPAN; VITAMIN-E;
   ELECTRON-TRANSPORT; HL-60 CELLS; ASCORBATE; STRESS; GENERATION;
   REDUCTASE
AB Caloric restriction (CR) is known as the only non-genetic method proven to slow the rate of aging and extend lifespan in animals. Free radical production emerges from normal metabolic activity and generates the accumulation of oxidized macromolecules, one of the main characteristics of aging. Due to its central role in cell bioenergetics, a great interest has been paid to CR-induced modifications in mitochondria, where CR has been suggested to decrease reactive oxygen species production. The plasma membrane contains a trans-membrane redox system (PMRS) that provides electrons to recycle lipophilic antioxidants, such as alpha-tocopherol and coenzyme Q (CoQ), and to modulate cytosolic redox homeostasis. In the present study, we have investigated age differences in the PMRS in mouse liver and their modulation by CR. Aging induced a decrease in the ratio of CoQ(10)/CoQ(9) and alpha-tocopherol in liver PM from AL-fed mice that was attenuated by CR. CoQ-dependent NAD(P)H dehydrogenases highly increased in CR old mice liver PMs. On the other hand, the CoQ-independent NADH-FCN reductase activity increased in AL-fed animals; whereas, in mice under CR this activity did not change during aging. Our results suggest that liver PMRS activity changes during aging and that CR modulates these changes. By this mechanism CR maintains a higher antioxidant capacity in liver PM of old animals by increasing the activity of CoQ-dependent reductases. Also, the putative role of PMRS in the modulation of redox homeostasis of cytosol is implicated.
C1 NIA, Lab Expt Gerontol, NIH, Gerontol Res Ctr, Baltimore, MD 21224 USA.
   Univ Pablo Olavide, Lab Andaluz Biol, Seville 41013, Spain.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA); Universidad Pablo de Olavide
RP de Cabo, R (corresponding author), NIA, Lab Expt Gerontol, NIH, Gerontol Res Ctr, Box 10,5600 Nathan Shock Dr, Baltimore, MD 21224 USA.
EM decabora@grc.nia.nih.gov
RI Lopez-Lluch, Guillermo/N-4742-2014; NAVAS, PLACIDO/R-5943-2019; de Cabo,
   Rafael Carlos/E-7996-2010; de Cabo, Rafael/J-5230-2016
OI Lopez-Lluch, Guillermo/0000-0001-9830-8502; NAVAS,
   PLACIDO/0000-0002-4115-7966; de Cabo, Rafael Carlos/0000-0003-2830-5693;
   de Cabo, Rafael/0000-0002-3354-2442
CR ALCAIN FJ, 1991, BIOCHIM BIOPHYS ACTA, V1073, P380, DOI 10.1016/0304-4165(91)90146-8
   Armeni T, 2003, J BIOENERG BIOMEMBR, V35, P181, DOI 10.1023/A:1023754305218
   Barja G, 2002, AGEING RES REV, V1, P397, DOI 10.1016/S1568-1637(02)00008-9
   BEYER RE, 1994, J BIOENERG BIOMEMBR, V26, P349, DOI 10.1007/BF00762775
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURON MI, 1993, BIOCHEM BIOPH RES CO, V192, P439, DOI 10.1006/bbrc.1993.1434
   CRANE FL, 1991, J BIOENERG BIOMEMBR, V23, P773, DOI 10.1007/BF00786001
   CRANE FL, 1985, BIOCHIM BIOPHYS ACTA, V811, P233, DOI 10.1016/0304-4173(85)90013-8
   De Cabo R, 2004, EXP GERONTOL, V39, P297, DOI 10.1016/j.exger.2003.12.003
   de Cabo R, 2003, EXP GERONTOL, V38, P631, DOI 10.1016/S0531-5565(03)00055-X
   de Grey ADNJ, 2001, MITOCHONDRION, V1, P129, DOI 10.1016/S1567-7249(01)00008-3
   del Castillo-Olivares A, 2000, CRIT REV BIOCHEM MOL, V35, P197
   Fernández-Ayala DJM, 2000, ANTIOXID REDOX SIGN, V2, P263, DOI 10.1089/ars.2000.2.2-263
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Forster MJ, 2000, J GERONTOL A-BIOL, V55, pB522, DOI 10.1093/gerona/55.11.B522
   GomezDiaz C, 1997, BIOCHEM BIOPH RES CO, V234, P79, DOI 10.1006/bbrc.1997.6582
   GomezDiaz C, 1997, J BIOENERG BIOMEMBR, V29, P251, DOI 10.1023/A:1022410127104
   Gredilla R, 2002, MICROSC RES TECHNIQ, V59, P273, DOI 10.1002/jemt.10204
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Jeon TI, 2001, LIPIDS, V36, P589, DOI 10.1007/s11745-001-0761-1
   KAGAN VE, 1990, ARCH BIOCHEM BIOPHYS, V282, P221, DOI 10.1016/0003-9861(90)90108-B
   KAGAN VE, 1990, ARCH BIOCHEM BIOPHYS, V280, P33, DOI 10.1016/0003-9861(90)90514-Y
   Kagan VE., 1996, HDB ANTIOXIDANTS, P157
   LARM JA, 1994, J BIOL CHEM, V269, P30097
   LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905
   Lass A, 1998, FREE RADICAL BIO MED, V25, P1089, DOI 10.1016/S0891-5849(98)00144-0
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   López-Lluch G, 1998, BIOCHEM J, V331, P21, DOI 10.1042/bj3310021
   López-Torres M, 2002, FREE RADICAL BIO MED, V32, P882, DOI 10.1016/S0891-5849(02)00773-6
   Martín SF, 2003, PROTOPLASMA, V221, P109, DOI 10.1007/s00709-002-0070-3
   MARTINUS RD, 1993, BIOCHEM MOL BIOL INT, V31, P997
   Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567
   Merker MP, 1998, AM J PHYSIOL-LUNG C, V274, pL685
   Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311
   NAVAS P, 1989, CANCER RES, V49, P2147
   NAVAS P, 1986, BIOCHEM BIOPH RES CO, V135, P110, DOI 10.1016/0006-291X(86)90949-6
   Pamplona R, 2002, MECH AGEING DEV, V123, P1437, DOI 10.1016/S0047-6374(02)00076-3
   Rafique R, 2004, FREE RADICAL RES, V38, P157, DOI 10.1080/10715760310001643311
   Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1
   RODRIGUEZAGUILERA JC, 1993, J BIOL CHEM, V268, P26346
   Santos-Ocaña C, 1998, J BIOENERG BIOMEMBR, V30, P465, DOI 10.1023/A:1020542230308
   Slater AFG, 1995, TOXICOL LETT, V82-3, P149, DOI 10.1016/0378-4274(95)03474-9
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SUN IL, 1990, BIOCHEM BIOPH RES CO, V172, P979, DOI 10.1016/0006-291X(90)91542-Z
   SUN IL, 1986, J BIOENERG BIOMEMBR, V18, P471, DOI 10.1007/BF00743145
   VILLALBA JM, 1993, J BIOENERG BIOMEMBR, V25, P411, DOI 10.1007/BF00762467
   VILLALBA JM, 1995, P NATL ACAD SCI USA, V92, P4887, DOI 10.1073/pnas.92.11.4887
   YU BP, 1994, FREE RADICALS AGING
   Zainal TA, 2000, FASEB J, V14, P1825, DOI 10.1096/fj.99-0881com
NR 50
TC 27
Z9 27
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0161-9152
EI 1574-4647
J9 AGE
JI Age
PD JUN
PY 2005
VL 27
IS 2
BP 153
EP 160
DI 10.1007/s11357-005-2726-3
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 121PJ
UT WOS:000243169200008
PM 23598622
OA Green Published
DA 2024-02-19
ER

PT J
AU Fang, J
   Yan, Y
   Teng, X
   Wen, XY
   Li, N
   Peng, S
   Liu, WS
   Donadeu, FX
   Zhao, ST
   Hua, JL
AF Fang, Jia
   Yan, Yuan
   Teng, Xin
   Wen, Xinyu
   Li, Na
   Peng, Sha
   Liu, Wenshuai
   Donadeu, F. Xavier
   Zhao, Shanting
   Hua, Jinlian
TI Melatonin prevents senescence of canine adipose-derived mesenchymal stem
   cells through activating NRF2 and inhibiting ER stress
SO AGING-US
LA English
DT Article
DE canine adipose-derived mesenchymal stem cells; senescence; melatonin;
   endoplasmic reticulum stress; Nrf2; transplantation
ID ENDOPLASMIC-RETICULUM STRESS; NF-KAPPA-B; CELLULAR SENESCENCE; OXIDATIVE
   STRESS; INVOLVEMENT; ANTIOXIDANT; EXPRESSION; AUTOPHAGY; SYNTHASE
AB Transplantation of adipose-derived mesenchymal stem cells (ADMSCs) can aid in the treatment of numerous diseases in animals. However, natural aging during in vitro expansion of ADMSCs prior to their use in transplantation restricts their beneficial effects. Melatonin is reported to exert biorhythm regulation, anti-oxidation, and anti-senescence effects in various animal and cell models. Herein, by using a senescent canine ADMSCs (cADMSCs) cell model subjected to multiple passages in vitro, we investigated the effects of melatonin on ADMSCs senescence. We found that melatonin alleviates endoplasmic reticulum stress (ERS) and cell senescence. MT1/MT2 melatonin receptor inhibitor, luzindole, diminished the mRNA expression levels and rhythm expression amplitude of Bmal1 and Nrf2 genes. Nrf2 knockdown blocked the stimulatory effects of melatonin on endoplasmic reticulum-associated degradation (ERAD)-related gene expression and its inhibitory effects on ERS-related gene expression. At the same time, the inhibitory effects of melatonin on the NF-kappa B signaling pathway and senescence-associated secretory phenotype (SASP) were blocked by Nrf2 knockdown in cADMSCs. Melatonin pretreatment improved the survival of cADMSCs and enhanced the beneficial effects of cADMSCs transplantation in canine acute liver injury. These results indicate that melatonin activates Nrf2 through the MT1/MT2 receptor pathway, stimulates ERAD, inhibits NF-kappa B and ERS, alleviates cADMSCs senescence, and improves the efficacy of transplanted cADMSCs.
C1 [Fang, Jia; Yan, Yuan; Teng, Xin; Wen, Xinyu; Li, Na; Peng, Sha; Zhao, Shanting; Hua, Jinlian] Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Yangling 712100, Shaanxi, Peoples R China.
   [Liu, Wenshuai] Yangling Demonstrat Zone Hosp, Dept Pathol, Yang Ling, Shaanxi, Peoples R China.
   [Donadeu, F. Xavier] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst Reader, Div Dev Biol, Easter Bush EH25 9RG, Midlothian, Scotland.
C3 Northwest A&F University - China; University of Edinburgh
RP Zhao, ST; Hua, JL (corresponding author), Northwest A&F Univ, Coll Vet Med, Shaanxi Ctr Stem Cells Engn & Technol, Yangling 712100, Shaanxi, Peoples R China.
EM zhaoshanting@nwsuaf.edu.cn; jinlianhua@nwsuaf.edu.cn
FU Program of National Natural Science Foundation of China [31572399];
   National Key Research and Development Program of China, Stem Cell and
   Translational Research [2016YFA0100203]
FX This work was supported by grants from the Program of National Natural
   Science Foundation of China (31572399), The National Key Research and
   Development Program of China, Stem Cell and Translational Research
   (Grant No. 2016YFA0100203).
CR Abreu T, 2015, J AFFECT DISORDERS, V185, P219, DOI 10.1016/j.jad.2015.07.017
   Alfaifi M, 2018, J HEPATOL, V68, P1272, DOI 10.1016/j.jhep.2018.01.030
   An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102
   Baehr LM, 2016, AGING-US, V8, P127, DOI 10.18632/aging.100879
   Blasiak J, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6819736
   Brodskii V Ia, 2012, Ontogenez, V43, P229
   Bruns DR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/732596
   Carloni S, 2014, J PINEAL RES, V57, P192, DOI 10.1111/jpi.12156
   Chalil S, 2015, CALCIFIED TISSUE INT, V96, P123, DOI 10.1007/s00223-014-9944-6
   Choi SI, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12426
   Claustrat B, 2015, NEUROCHIRURGIE, V61, P77, DOI 10.1016/j.neuchi.2015.03.002
   Cui YH, 2017, CELL PHYSIOL BIOCHEM, V44, P2407, DOI 10.1159/000486165
   Digaleh H, 2013, CELL MOL LIFE SCI, V70, P4681, DOI 10.1007/s00018-013-1409-y
   Dörr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437
   Du ZY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0956-4
   Galano A, 2018, MOLECULES, V23, DOI 10.3390/molecules23030530
   Gazdic M, 2018, J TISSUE ENG REGEN M, V12, pE1173, DOI 10.1002/term.2452
   Ghosh AK, 2015, J GERONTOL A-BIOL, V70, P1320, DOI 10.1093/gerona/glu186
   Gu ZF, 2015, CELL TISSUE RES, V361, P497, DOI 10.1007/s00441-015-2131-x
   Hardeland R, 2013, J PINEAL RES, V55, P325, DOI 10.1111/jpi.12090
   Hiebert P, 2018, DEV CELL, V46, P145, DOI 10.1016/j.devcel.2018.06.012
   Hu CX, 2018, J CELL MOL MED, V22, P1428, DOI 10.1111/jcmm.13492
   Huang B, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0792-1
   Janjetovic Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01305-2
   Jenwitheesuk A, 2014, INT J MOL SCI, V15, P16848, DOI 10.3390/ijms150916848
   Kannan S, 2016, ONCOTARGET, V7, P13340, DOI 10.18632/oncotarget.7958
   Kapeta S, 2010, J BIOL CHEM, V285, P8171, DOI 10.1074/jbc.M109.031575
   Li B, 2018, ANTIOXID REDOX SIGN, V28, P385, DOI 10.1089/ars.2016.6792
   Liao NS, 2016, INT J MOL MED, V37, P1389, DOI 10.3892/ijmm.2016.2528
   Ling ZQ, 2009, J ALZHEIMERS DIS, V16, P287, DOI 10.3233/JAD-2009-0949
   Manchester LC, 2015, J PINEAL RES, V59, P403, DOI 10.1111/jpi.12267
   Naderi N, 2017, INT WOUND J, V14, P112, DOI 10.1111/iwj.12569
   Negi G, 2011, J PINEAL RES, V50, P124, DOI 10.1111/j.1600-079X.2010.00821.x
   Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113
   Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014
   Reiter RJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23020509
   Reiter RJ, 2016, J PINEAL RES, V61, P253, DOI 10.1111/jpi.12360
   Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006
   Schäffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Shi C, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00005
   Singh SP, 2010, J GERONTOL A-BIOL, V65, P14, DOI 10.1093/gerona/glp165
   Torres-Farfan C, 2006, ENDOCRINOLOGY, V147, P4618, DOI 10.1210/en.2006-0628
   Vriend J, 2014, LIFE SCI, V115, P8, DOI 10.1016/j.lfs.2014.08.024
   Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213
   Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.480
   Wei YD, 2016, CELL PROLIFERAT, V49, P503, DOI 10.1111/cpr.12271
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yang F, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12422
   Zaouali MA, 2013, J PINEAL RES, V55, P65, DOI 10.1111/jpi.12051
   Zhang ZL, 2016, CANCER LETT, V382, P53, DOI 10.1016/j.canlet.2016.08.023
   Zhao H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097266
   Zhou L, 2015, J PINEAL RES, V59, P190, DOI 10.1111/jpi.12250
NR 52
TC 80
Z9 84
U1 4
U2 36
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD OCT
PY 2018
VL 10
IS 10
BP 2954
EP 2972
DI 10.18632/aging.101602
PG 19
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Cell Biology; Geriatrics & Gerontology
GA HC5OF
UT WOS:000451851600038
PM 30362962
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Hamaguchi, M
   Kojima, T
   Ohbora, A
   Takeda, N
   Fukui, M
   Kato, T
AF Hamaguchi, Masahide
   Kojima, Takao
   Ohbora, Akihiro
   Takeda, Noriyuki
   Fukui, Michiaki
   Kato, Takahiro
TI Aging is a risk factor of nonalcoholic fatty liver disease in
   premenopausal women
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Nonalcoholic fatty liver disease; Cardiovascular disease; Risk factor;
   Steatohepatitis; Postmenopausal women
ID METABOLIC SYNDROME; HEPATIC STEATOSIS; PREDICTOR; PREVALENCE;
   STEATOHEPATITIS; ASSOCIATION; NUTRITION
AB AIM: To clarify the relationship between age, menopause, and nonalcoholic fatty liver disease (NAFLD) in women.
   METHODS: We conducted a follow-up study on nonalcoholic fatty liver disease by using abdominal ultrasonography, and investigated the relationship of age and menopause with the development of NAFLD in women. We followed 1829 women and 2572 men (response rate, 86%) selected in 2001 to represent the non-institutionalized adult population of Gifu, Japan. Data collected included self-reported medical history, lifestyle factors, and menopausal status. The postmenopausal state was defined as beginning 1 year after the cessation of menses. We diagnosed NAFLD with the aid of abdominal ultrasonography by using diagnostic criteria described previously.
   RESULTS: The prevalence of NAFLD in women increases with age, but does not alter with age in men. Furthermore, the prevalence of NAFLD in premenopausal women (6%) was lower than that in men (24%) and in postmenopausal women (15%). The associations of the postmenopausal state and hormone replacement therapy with NAFLD were statistically significant in a univariate logistic regression model. At the follow-up examination, 67 women (5%) were newly diagnosed with NAFLD. The incidence of NAFLD was 3.5% (28/802) in premenopausal women, 7.5% (4/53) in menopausal women, 6.1% (24/392) in postmenopausal women, and 5.3% (11/206) in women receiving hormone replacement therapy. The weight gain in premenopausal women was equal to that in postmenopausal women. Metabolic syndrome and weight gain were independent risk factors for NAFLD in pre- and postmenopausal women, but age was an independent risk factor in premenopausal women only.
   CONCLUSION: Aging is a risk factor for NAFLD in premenopausal women, independent of weight gain or influence of metabolic syndrome. (C) 2012 Baishideng. All rights reserved.
C1 [Kojima, Takao; Ohbora, Akihiro; Kato, Takahiro] Asahi Univ, Dept Gastroenterol, Murakami Mem Hosp, Gifu 5008523, Japan.
   [Hamaguchi, Masahide] Osaka Univ, Immunol Frontier Res Ctr, Osaka 5650871, Japan.
   [Takeda, Noriyuki] Asahi Univ, Dept Endocrinol & Metab, Murakami Mem Hosp, Gifu 5008523, Japan.
   [Fukui, Michiaki] Kyoto Prefectural Univ Med, Dept Endocrinol & Metab, Grad Sch Med Sci, Kyoto 6028566, Japan.
C3 Asahi University; Osaka University; Asahi University; Kyoto Prefectural
   University of Medicine
RP Kojima, T (corresponding author), Asahi Univ, Dept Gastroenterol, Murakami Mem Hosp, 3-23 Hashimoto Cho, Gifu 5008523, Japan.
EM tkojima-gi@umin.ac.jp
RI Kato, Takahiro/R-7665-2019
OI Kato, Takahiro/0000-0001-5169-2930; Fukui, Michiaki/0000-0003-0903-1797;
   Hamaguchi, Masahide/0000-0002-8651-4445
FU Japan Society for the Promotion of Science [23790791]; Grants-in-Aid for
   Scientific Research [23790791] Funding Source: KAKEN
FX Supported by Young Scientists (B) (23790791) from Japan Society for the
   Promotion of Science
CR AARON DJ, 1995, AM J EPIDEMIOL, V142, P191, DOI 10.1093/oxfordjournals.aje.a117618
   Akabame S, 2008, CIRC J, V72, P618
   American Gastroenterological Association, 2002, Gastroenterology, V123, P1702
   [Anonymous], 2000, AS PAC PERSP RED OB
   Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734
   Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004
   Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1016/S0002-9270(99)00433-5
   Clark JM, 2002, GASTROENTEROLOGY, V122, P1649, DOI 10.1053/gast.2002.33573
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Grattagliano I, 2007, CAN FAM PHYSICIAN, V53, P857
   Grobe YG, 2010, ANN HEPATOL, V9, P402, DOI 10.1016/S1665-2681(19)31616-3
   Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009
   Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x
   Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579
   Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735
   Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5
   McKenzie J, 2006, CLIN ENDOCRINOL, V65, P40, DOI 10.1111/j.1365-2265.2006.02543.x
   Meigs JB, 2002, AM J MANAG CARE, V8, pS283
   Mulhall BP, 2002, J GASTROEN HEPATOL, V17, P1136, DOI 10.1046/j.1440-1746.2002.02881.x
   Nemoto Y, 2000, J CLIN INVEST, V105, P1819, DOI 10.1172/JCI9575
   Ninomiya JK, 2004, CIRCULATION, V109, P42, DOI 10.1161/01.CIR.0000108926.04022.0C
   Oien KA, 1999, LANCET, V353, P36, DOI 10.1016/S0140-6736(05)74872-8
   Omagari K, 2002, J GASTROEN HEPATOL, V17, P1098, DOI 10.1046/j.1440-1746.2002.02846.x
   Park SH, 2006, J GASTROEN HEPATOL, V21, P138, DOI 10.1111/j.1440-1746.2005.04086.x
   Ryu S, 2007, CLIN CHEM, V53, P71, DOI 10.1373/clinchem.2006.078980
   Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94
   Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295
   VanHoof M, 1996, ANN INTERN MED, V124, P855, DOI 10.7326/0003-4819-124-9-199605010-00015
   Völzke H, 2007, GUT, V56, P594, DOI 10.1136/gut.2006.115345
   Weltman MD, 1998, HEPATOLOGY, V27, P128, DOI 10.1002/hep.510270121
   Weston SR, 2005, HEPATOLOGY, V41, P372, DOI 10.1002/hep.20554
NR 31
TC 106
Z9 117
U1 0
U2 13
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD JAN 21
PY 2012
VL 18
IS 3
BP 237
EP 243
DI 10.3748/wjg.v18.i3.237
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 887XK
UT WOS:000299965000005
PM 22294826
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Shi, JL
   Fujieda, H
   Kokubo, Y
   Wake, K
AF Shi, JL
   Fujieda, H
   Kokubo, Y
   Wake, K
TI Apoptosis of neutrophils and their elimination by Kupffer cells in rat
   liver
SO HEPATOLOGY
LA English
DT Article
ID COLONY-STIMULATING FACTOR; HEPATOCYTE GROWTH-FACTOR; INFLAMMATORY
   MACROPHAGES; VITRONECTIN RECEPTOR; AGING NEUTROPHILS; ENDOTHELIAL-CELLS;
   PIT CELLS; IN-VITRO; PHAGOCYTOSIS; DEATH
AB The fate of neutrophils in the peripheral circulation is poorly understood, In this study, the role of Kupffer cells in eliminating aged and apoptotic neutrophils was investigated, Liver, spleen, lung, and blood samples from Wistar rats were examined by light and electron microscopy, the terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) method, and immunohistochemistry after the intravenous injection of OK-432, a streptococcal preparation, Neutrophils were trapped predominantly in the periportal and midzonal regions of hepatic lobules and were in contact with endothelial cells and Kupffer cells, or were surrounded by Kupffer cells. The trapping of neutrophils peaked after 6 hours. Apoptotic neutrophils, with or without buds, were found in the lumen of hepatic sinusoids as early as 6 hours, reached maximal levels after 12 hours, and represented greater than 60% of the total number of neutrophils in the liver, The presence of apoptotic neutrophils was correlated with the degree of neutrophil phagocytosis. Double-staining showed that TUNEL-positive neutrophils were phagocytosed or encircled by ED(1)- or ED(2)-positive Kupffer cells, In contrast, apoptosis and phagocytosis of neutrophils were rare in the spleen, lung, and peripheral blood, These results suggested that the appearance of apoptotic neutrophils in the hepatic sinusoids and their rapid clearance by Kupffer cells occurs after the invasion of bacteria (i.e., bacteremia or bacteriotoxemia) or the release of inflammatory mediators into the blood stream, These findings have important implications for the regulation of neutrophil homeostasis, the limitation of inflammation and tissue injury, and provide insight into the physiological removal of circulating, senescent neutrophils.
RP Shi, JL (corresponding author), TOKYO MED & DENT UNIV, SCH MED, DEPT ANAT, BUNKYO KU, 1-5-45 YUSHIMA, TOKYO 113, JAPAN.
OI Shi, Jialan/0000-0001-5642-5436
CR ADACHI S, 1994, EUR J HAEMATOL, V53, P129
   BICKNELL S, 1994, AM J RESP CELL MOL, V10, P16, DOI 10.1165/ajrcmb.10.1.8292377
   BOUWENS L, 1988, HEPATOLOGY, V8, P46, DOI 10.1002/hep.1840080110
   BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430
   BRACH MA, 1992, BLOOD, V80, P2920
   BURSCH W, 1990, CARCINOGENESIS, V11, P847, DOI 10.1093/carcin/11.5.847
   COLOTTA F, 1992, BLOOD, V80, P2012
   DAN C, 1985, BIOMEDICAL RES, V665, P347
   DINI L, 1993, EUR J CELL BIOL, V61, P329
   FADOK VA, 1992, J IMMUNOL, V149, P4029
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   HSU SM, 1982, J HISTOCHEM CYTOCHEM, V30, P1079, DOI 10.1177/30.10.6182185
   KANEDA K, 1983, CELL TISSUE RES, V233, P485
   KANNAN Y, 1992, BIOCHEM BIOPH RES CO, V186, P1050, DOI 10.1016/0006-291X(92)90853-D
   KAWAKAMI S, 1994, HEPATOLOGY, V20, P1255, DOI 10.1016/0270-9139(94)90766-8
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   LAGASSE E, 1994, J EXP MED, V179, P1047, DOI 10.1084/jem.179.3.1047
   LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283
   MEAGHER LC, 1992, J LEUKOCYTE BIOL, V52, P269, DOI 10.1002/jlb.52.3.269
   NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430
   PAYNE CM, 1994, MICROSC RES TECHNIQ, V28, P327, DOI 10.1002/jemt.1070280408
   PHAN SH, 1992, AM J RESP CELL MOL, V6, P270, DOI 10.1165/ajrcmb/6.3.270
   SABA TM, 1970, ARCH INTERN MED, V126, P1031, DOI 10.1001/archinte.126.6.1031
   SAKAGUCHI H, 1994, HEPATOLOGY, V19, P1157, DOI 10.1016/0270-9139(94)90862-1
   SAVILL J, 1992, KIDNEY INT, V42, P924, DOI 10.1038/ki.1992.369
   SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0
   SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970
   SAVILL JS, 1989, J CLIN INVEST, V84, P1518, DOI 10.1172/JCI114328
   SLEYSTER EC, 1982, LAB INVEST, V47, P484
   SQUIER MKT, 1995, J LEUKOCYTE BIOL, V57, P2, DOI 10.1002/jlb.57.1.2
   TOTH CA, 1992, HEPATOLOGY, V16, P255, DOI 10.1002/hep.1840160137
   VARANI J, 1992, LAB INVEST, V66, P708
   VARANI J, 1990, LAB INVEST, V63, P683
   WAKE K, 1989, INT REV CYTOL, V118, P173
   WATABE S, 1984, J NATL CANCER I, V72, P1365
   WHYTE MKB, 1993, J IMMUNOL, V150, P5124
   WILLIAMS WJ, 1990, HEMATOLOGY, P760
   Wyllie A H, 1980, Int Rev Cytol, V68, P251
   YAMAMOTO C, 1993, INFECT IMMUN, V61, P1972, DOI 10.1128/IAI.61.5.1972-1979.1993
NR 39
TC 83
Z9 89
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD NOV
PY 1996
VL 24
IS 5
BP 1256
EP 1263
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA VQ934
UT WOS:A1996VQ93400045
PM 8903407
DA 2024-02-19
ER

PT J
AU Barazzoni, R
   Nair, KS
AF Barazzoni, R
   Nair, KS
TI Changes in uncoupling protein-2 and-3 expression in aging rat skeletal
   muscle, liver, and heart
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE energy metabolism; mitochondria; adenosine 5 '-triphosphate; proton leak
ID OLD RATS; GENE-EXPRESSION; FATTY-ACIDS; HEALTHY-MEN; MITOCHONDRIAL;
   ENDURANCE; AGE; OBESITY; YOUNG; WOMEN
AB Uncoupling protein (UCP)-2 and -3 mediate mitochondrial (mt) proton leak in vitro and are potential regulators of energy expenditure and ATP production. Aging is associated with alteration of tissue functions, suggesting impaired mtATP production. To determine whether age-related changes in UCP expression occur, we measured the transcript levels of UCP-2 and -3 in skeletal muscle, liver, and heart in 6- and 27-mo-old rats. UCP-2 transcripts were higher in old animals in the white (+100%) and red (+70%, both P< 0.04) gastrocnemius muscle and in the liver (+300%, P< 0.03), whereas they were comparable in the heart in both age groups. UCP-2 transcript levels correlated positively with mitochondrial-encoded cytochrome c oxidase transcripts normalized for mtDNA (P< 0.01) and negatively with mtDNA copy number (P< 0.001). UCP-3 transcripts were lower in the less oxidative white (-50%, P< 0.04) and unchanged in the more oxidative red (-15%, P = 0.41) gastrocnemius muscle in old animals. Similar changes at protein level were confirmed by UCP-2 protein in aging liver (+300%, P< 0.01) and UCP-2 (+85%, P< 0.05) and UCP-3 (-30%, P = 0.4) protein in aging mixed gastrocnemius muscle. Aging is thus associated with tissue-specific changes of UCP-2 and -3 gene expression. Increased UCP-2 expression may limit ATP production and is related to mitochondrial gene expression in aging muscles and liver. Different age-related changes may reflect differential regulation of UCP-2 and -3 in skeletal muscle. The current data suggest a potential role of uncoupling proteins to alter energy production in aging tissues.
C1 Mayo Clin & Mayo Fdn, Endocrine Res Unit, Rochester, MN 55905 USA.
C3 Mayo Clinic
RP Nair, KS (corresponding author), Mayo Clin & Mayo Fdn, Endocrine Res Unit, Joseph 5-194, Rochester, MN 55905 USA.
EM nair.sree@mayo.edu
FU NCRR NIH HHS [RR-00585] Funding Source: Medline; NIA NIH HHS [R0
   AG-09531] Funding Source: Medline
CR Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115
   ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303
   Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   Blough ER, 2000, J APPL PHYSIOL, V88, P1265, DOI 10.1152/jappl.2000.88.4.1265
   BONADONNA RC, 1994, AM J PHYSIOL, V266, pE501
   Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143
   Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0
   BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X
   BROWN GC, 1992, FASEB J, V6, P2961, DOI 10.1096/fasebj.6.11.1644259
   Brun S, 1999, FEBS LETT, V453, P205, DOI 10.1016/S0014-5793(99)00722-X
   CARLSON LA, 1968, GERONTOLOGY, V14, P65, DOI 10.1159/000211644
   CARTEE GD, 1987, J APPL PHYSIOL, V63, P257, DOI 10.1152/jappl.1987.63.1.257
   Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082
   DAVIES CTM, 1986, ACTA MED SCAND, P219
   EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5
   Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269
   Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900
   Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129
   Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   Jaburek M, 1999, J BIOL CHEM, V274, P26003, DOI 10.1074/jbc.274.37.26003
   Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997
   Krook A, 1998, DIABETES, V47, P1528, DOI 10.2337/diabetes.47.9.1528
   LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413
   Lanni A, 1997, FEBS LETT, V418, P171, DOI 10.1016/S0014-5793(97)01375-6
   Lindstrom B, 1997, J GERONTOL A-BIOL, V52, pB59, DOI 10.1093/gerona/52A.1.B59
   Matsuda J, 1997, FEBS LETT, V418, P200, DOI 10.1016/S0014-5793(97)01381-1
   MCDONAGH MJN, 1984, GERONTOLOGY, V30, P49, DOI 10.1159/000212606
   NARICI MV, 1991, J APPL PHYSIOL, V71, P1277, DOI 10.1152/jappl.1991.71.4.1277
   POEHLMAN ET, 1990, AM J PHYSIOL, V259, pE66, DOI 10.1152/ajpendo.1990.259.1.E66
   ROLFE DFS, 1994, BBA-BIOENERGETICS, V1188, P405, DOI 10.1016/0005-2728(94)90062-0
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   RUMSEY WL, 1987, EXP GERONTOL, V22, P271, DOI 10.1016/0531-5565(87)90006-4
   SANDBERG H, 1973, J AM GERIATR SOC, V21, P433, DOI 10.1111/j.1532-5415.1973.tb01204.x
   Scarpace PJ, 2000, DIABETES, V49, P431, DOI 10.2337/diabetes.49.3.431
   Schwendner KI, 1997, J GERONTOL A-BIOL, V52, pM155, DOI 10.1093/gerona/52A.3.M155
   SCOTTO AW, 1983, ARCH BIOCHEM BIOPHYS, V222, P150, DOI 10.1016/0003-9861(83)90512-X
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061
   TZANKOFF SP, 1977, J APPL PHYSIOL, V43, P1001, DOI 10.1152/jappl.1977.43.6.1001
   TZANKOFF SP, 1978, J APPL PHYSIOL, V45, P536, DOI 10.1152/jappl.1978.45.4.536
   Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199
   VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   Weigle DS, 1998, DIABETES, V47, P298, DOI 10.2337/diabetes.47.2.298
   Welle S, 1996, AM J CLIN NUTR, V63, P151, DOI 10.1093/ajcn/63.2.151
NR 50
TC 50
Z9 55
U1 0
U2 1
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD MAR
PY 2001
VL 280
IS 3
BP E413
EP E419
DI 10.1152/ajpendo.2001.280.3.E413
PG 7
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 402DE
UT WOS:000166970100005
PM 11171595
DA 2024-02-19
ER

PT J
AU Ueoka, S
   Yamaguchi, M
AF Ueoka, S
   Yamaguchi, M
TI Sexual difference of hepatic calcium-binding protein regucalcin mRNA
   expression in rats with different ages: Effect of ovarian hormone
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE regucalcin; calcium-binding protein; sexual difference; estrogen; rat
   liver; aging
ID MESSENGER-RNA; LIVER; CLONING
AB The sexual difference of calcium-binding protein regucalcin mRNA expression in the liver of rats nas investigated by Northern blot analysis. Liver regucalcin cDNA (0.9 kb of open reading frame) was used as a probe. The analysis of total RNAs extracted from various tissues of rats indicated that regucalcin mRNA was present primarily in the liver with a size of 1.8 kb. Hepatic regucalcin mRNA was expressed in male rats more than in females. This sexual difference was also seen in aged rats (50 weeks old), although the expression was decreased with increasing age. Ovariectomy did not cause a significant alteration in hepatic regucalcin mRNA levels. The subcutaneous administration of 17 beta-estradiol (0.2 mg/100 g body weight) in ovariectomized rats did not cause an appreciable increase in hepatic mRNA levels. The results demonstrate that regucalcin mRNA expression in rat liver is based on sex, and that this difference may not be related to estrogen.
C1 Univ Shizuoka, Grad Sch Nutr Sci, Lab Endocrinol & Mol Metab, Yada, Shizuoka 422, Japan.
C3 University of Shizuoka
RP Yamaguchi, M (corresponding author), Univ Shizuoka, Grad Sch Nutr Sci, Lab Endocrinol & Mol Metab, 52-1 Yada, Yada, Shizuoka 422, Japan.
CR [Anonymous], 1989, SYNTHETIC OLIGONUCLE
   Cheung W. Y., 1984, SCIENCE, V202, P19
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   KRAUSFRIEDMANN N, 1990, CELL CALCIUM, V11, P625, DOI 10.1016/0143-4160(90)90017-O
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   SHIMOKAWA N, 1995, MOL CELL BIOCHEM, V151, P157, DOI 10.1007/BF01322338
   SHIMOKAWA N, 1992, FEBS LETT, V305, P151, DOI 10.1016/0014-5793(92)80884-J
   YAMAGUCHI M, 1995, MOL CELL BIOCHEM, V143, P137, DOI 10.1007/BF01816947
   Yamaguchi M, 1996, MOL CELL BIOCHEM, V165, P145
   YAMAGUCHI M, 1993, MOL CELL BIOCHEM, V122, P65, DOI 10.1007/BF00925738
   Yamaguchi M. A., 1992, CALCIUM INHIBITION, P19
NR 11
TC 10
Z9 10
U1 0
U2 0
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD APR
PY 1998
VL 21
IS 4
BP 405
EP 407
PG 3
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA ZH605
UT WOS:000073128300020
PM 9586582
DA 2024-02-19
ER

PT J
AU Kuhla, A
   Derbenev, M
   Shih, HY
   Vollmar, B
AF Kuhla, Angela
   Derbenev, Margarita
   Shih, Hao Yu
   Vollmar, Brigitte
TI Prophylactic and abundant intake of -lipoic acid causes hepatic
   steatosis and should be reconsidered in usage as an anti-aging drug
SO BIOFACTORS
LA English
DT Article
DE alpha-lipoic acid; lipolysis; lipogenesis; fgf21; ppar; lxr alpha;
   hepatic steatosis; hypertriglyceridemia; inflammation
ID CONTROLLED-TRIAL ALADIN; ACTIVATED PROTEIN-KINASE; DIABETIC
   POLYNEUROPATHY; RATS; STIMULATION; LIPOGENESIS; TRANSPORT; LIVER
AB The majority of research has suggested that -lipoic acid (ALA) is a potential therapeutic agent for chronic diseases associated with oxidative stress, including atherosclerosis, diabetes, and neurodegeneration. Therefore, a nutritional supplementation with ALA is recommended although the effects of a short- and long-term intake of ALA on central organs in healthy individuals are not studied in detail yet. Therefore, liver tissue of 4 and 74 weeks ALA-treated healthy C57BL6/J mice with respect to lipid metabolism was analyzed. In doing so, it was shown that short-term and long-term ALA treatment caused a marked increase of -oxidation, as indicated by a significant rise of mRNA expression of fgf21, ppar, and its target genes, for example, acox1, cpt1, and cpt2, as well as of Fgf21 plasma concentration. Glycolytic activity, as assessed by pklr1 mRNA expression and pyruvate kinase activity, was also found increased. In addition, it was shown that both short- and long-term ALA treatment increased cholesterol content, induced systemic triglyceridemia, and enhanced rxr and lxr mRNA expression. Despite the fact that short-term ALA intake reduced lipogenesis, as given by significant declines of fas and srebp1c mRNA expression, and that a long-term ALA intake induced a significant rise of these lipogenic genes, both treatment regimen caused fat accumulation. This, however, was more pronounced upon long-term ALA intake, leading to hepatic steatosis and liver injury, as indicated by increased inflammation and disruption of the general hepatic architecture. In summary, the prophylactic and abundant use of ALA under healthy conditions should be considered with caution. (c) 2016 BioFactors, 42(2):179-189, 2016
C1 [Kuhla, Angela; Derbenev, Margarita; Shih, Hao Yu; Vollmar, Brigitte] Univ Rostock, Med Ctr, Inst Expt Surg, Schillingallee 69a, D-18057 Rostock, Germany.
   [Shih, Hao Yu] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan.
C3 University of Rostock; Chang Gung University
RP Kuhla, A (corresponding author), Univ Rostock, Med Ctr, Inst Expt Surg, Schillingallee 69a, D-18057 Rostock, Germany.
EM angela.kuhla@uni-rostock.de
FU Deutsche Forschungsgemeinschaft, Bonn, Germany [KU 3280/1-1]
FX The authors cordially thank Berit Blendow, Dorothea Frenz, Maren
   Nerowski and Eva Lorbeer-Rehfeld (Institute for Experimental Surgery,
   Rostock University Medical Center, Rostock, Germany) for excellent
   technical assistance. This study was supported by a grant from the
   Deutsche Forschungsgemeinschaft, Bonn, Germany (KU 3280/1-1).
CR Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32
   Arivazhagan P, 2001, CHEM-BIOL INTERACT, V138, P189, DOI 10.1016/S0009-2797(01)00268-X
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422
   Çakatay U, 2005, BIOGERONTOLOGY, V6, P87, DOI 10.1007/s10522-005-3462-x
   Carbonelli MG, 2010, CURR PHARM DESIGN, V16, P840, DOI 10.2174/138161210790883589
   Cheng LC, 2011, FREE RADICAL BIO MED, V50, P47, DOI 10.1016/j.freeradbiomed.2010.10.706
   Crescenzo R, 2013, EUR J NUTR, V52, P537, DOI 10.1007/s00394-012-0356-y
   Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061
   Koh EH, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2010.08.005
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Luz J, 2009, DIABETES METAB, V35, P137, DOI 10.1016/j.diabet.2008.08.005
   Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496
   PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001
   Prieto-Hontoria PL, 2009, J PHYSIOL BIOCHEM, V65, P43, DOI 10.1007/BF03165968
   REED LJ, 1951, SCIENCE, V114, P93, DOI 10.1126/science.114.2952.93
   Reljanovic M, 1999, FREE RADICAL RES, V31, P171, DOI 10.1080/10715769900300721
   ROCHE TE, 1976, BIOCHEM BIOPH RES CO, V72, P1375, DOI 10.1016/S0006-291X(76)80166-0
   Schaap FG, 2014, NAT REV GASTRO HEPAT, V11, P55, DOI 10.1038/nrgastro.2013.151
   Shay KP, 2009, BBA-GEN SUBJECTS, V1790, P1149, DOI 10.1016/j.bbagen.2009.07.026
   Yaworsky K, 2000, DIABETOLOGIA, V43, P294, DOI 10.1007/s001250050047
   Yi XH, 2013, BIOCHEM BIOPH RES CO, V439, P390, DOI 10.1016/j.bbrc.2013.08.063
   Zhang YY, 2011, OBESITY, V19, P1647, DOI 10.1038/oby.2011.121
   Ziegler D, 1999, DIABETES CARE, V22, P1296, DOI 10.2337/diacare.22.8.1296
   ZIEGLER D, 1995, DIABETOLOGIA, V38, P1425, DOI 10.1007/BF00400603
NR 25
TC 6
Z9 7
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-6433
EI 1872-8081
J9 BIOFACTORS
JI Biofactors
PD MAR-APR
PY 2016
VL 42
IS 2
BP 179
EP 189
DI 10.1002/biof.1262
PG 11
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA DJ8RQ
UT WOS:000374480700005
PM 26876280
DA 2024-02-19
ER

PT J
AU Frolkis, VV
   Kobzar, AL
   Sokolova, OV
AF Frolkis, VV
   Kobzar, AL
   Sokolova, OV
TI Effects of partial hepatectomy on the plasma membrane status and the
   invertor mechanism of the hepatocyte Na,K-ATPase activity regulation in
   rats of various age
SO AGING-CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
DE aging; insulin; invertors; Na,K-ATPase; partial hepatectomy; rats
AB The experiments were performed on adult (6-8 months): and old (22-24 months) Wistar rats; Insulin induced plasma membrane hyperpolarization and hepatocyte:Na,K-ATPase activation in adult but not in old sham-operated rats. Partial hepatectomy had no effect on the invertor mechanism of Na,K-ATPase-activity regulation in the liver of adult rats, while pronounced changes took place in old animals 4 weeks after partial hepatectomy; Insulin induced hyperpolarization in hepatocyte plas ma membrane and activation of Na,K-ATPase both in old and adult hepatectomized rats. inverters, intracellular regulators of the plasma membrane status, played on important role in the mechanism of this insulin-induced hyperpolarization. Four weeks after partial hepatectomy in old animals, the invertor mechanism of hepatocyte plasma membrane regulation appeared again, as well as membrane Na,K-ATPase capability to react to insulin action.
C1 Ukraine Acad Med Sci, Physiol Lab, Inst Gerontol, UA-254114 Kiev 114, Ukraine.
C3 National Academy of Medical Sciences of Ukraine; D. F. Chebotarev
   Institute of Gerontology of the National Academy of Medical Sciences of
   Ukraine
RP Frolkis, VV (corresponding author), Ukraine Acad Med Sci, Physiol Lab, Inst Gerontol, Vyshgorodskaya St 67, UA-254114 Kiev 114, Ukraine.
RI Sokolova, Olga/G-2123-2013
OI Sokolova, Olga/0000-0003-1070-504X
CR BABAEVA AG, 1987, IMMUNOLOGY ADAPTIVE, P1
   CARILLO MC, 1996, MECH AGEING DEV, V91, P55
   FROLKIS VV, 1992, MECH AGEING DEV, V66, P187, DOI 10.1016/0047-6374(92)90135-Z
   FROLKIS VV, 1992, DOKL AKAD NAUK+, V324, P229
   FROLKIS VV, 1973, EXPERIENTIA, V14, P108
   KAPLYA AA, 1990, UKR BIOKHIM ZH, V2, P40
   KOSTUK PG, 1960, MICROELECTRODE TECHN, P1
   KULCHITSKY OK, 1987, QUESTION MED CHEM, V1, P19
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MICHELL RH, 1965, BIOCHEM BIOPH RES CO, V21, P333, DOI 10.1016/0006-291X(65)90198-1
   MOZHUCHINA TG, 1990, HERALD AMN USSR, V1, P23
   MOZHUCHINA TG, 1995, PROBLEMS AGEING LONG, V5, P3
   OBOLENSKAYA MJ, 1976, CYTOLOGY, V18, P857
   PASTORANGLADA M, 1996, J PHYSL P, V493, P159
   RATHBUN WB, 1969, ANAL BIOCHEM, V28, P436, DOI 10.1016/0003-2697(69)90198-5
   ROBINSON JD, 1979, BIOCHIM BIOPHYS ACTA, V549, P142
   SHKAPENKO AL, 1991, REPORTS ACAD SCI UKR, V1, P158
   SOKOLOVA OV, 1993, PROBLEMS AGING LONGE, V3, P105
   SZEGO C, 1989, BIOCHEM ACTION HORM, V8, P407
   Tanno M, 1996, MECH AGEING DEV, V92, P53, DOI 10.1016/S0047-6374(96)01802-7
NR 20
TC 0
Z9 0
U1 0
U2 0
PU EDITRICE KURTIS S R L
PI MILAN
PA VIA LUIGI ZOJA 30, 20153 MILAN, ITALY
SN 0394-9532
J9 AGING-CLIN EXP RES
JI Aging-Clin. Exp. Res.
PD APR
PY 1999
VL 11
IS 2
BP 130
EP 134
DI 10.1007/BF03399652
PG 5
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 201NR
UT WOS:000080602100010
PM 10386174
DA 2024-02-19
ER

PT J
AU Rikans, LE
   Ardinska, V
   Hornbrook, KR
AF Rikans, LE
   Ardinska, V
   Hornbrook, KR
TI Age-associated increase in ferritin content of male rat liver:
   Implication for diquat-mediated oxidative injury
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE aging; ferritin; iron; diquat; rat liver
ID LIPID-PEROXIDATION; OLD RATS; SUPEROXIDE-DISMUTASE; PROTEIN OXIDATION;
   REDUCTIVE RELEASE; HEPATIC-NECROSIS; CYTO-TOXICITY; AGING RATS; IRON;
   MICE
AB Our previous studies in rat hepatocytes demonstrated an age-dependent increase in sensitivity to diquat-induced cytotoxicity, possibly as a result of increased iron availability. The present study was conducted to determine whether quantitative or qualitative changes in hepatic ferritin occur as a consequence of aging and whether diquat-mediated oxidation is intensified by elevated ferritin concentrations. Hepatic ferritins were isolated from male Fischer 344 rats ages 5, 15, and 25 months. Age-associated increases were observed in amounts of ferritin protein and ferritin iron per gram of liver, but there were no differences in proportions of H to L subunits or in rates of diquat-mediated iron release, The consequences of a threefold increase in ferritin content for diquat-mediated lipid peroxidation and protein carbonyl formation were examined in microsomal incubation systems. The addition of isolated rat liver ferritin augmented diquat-mediated oxidative damage in a time- and concentration-dependent manner, and the inclusion of deferoxamine completely inhibited the stimulation by ferritin. The results indicate that availability of ferritin iron is an important determinant of diquat-mediated oxidative injury and support the hypothesis that elevated hepatic ferritin content is responsible, at least in part, for the age-associated enhancement of diquat-induced toxicity. (C) 1997 Academic Press.
RP Rikans, LE (corresponding author), UNIV OKLAHOMA, HLTH SCI CTR, COLL PHARM, DEPT PHARMACOL & TOXICOL, POB 26901, OKLAHOMA CITY, OK 73190 USA.
FU NIA NIH HHS [AG04984] Funding Source: Medline
CR BLAKEMAN DP, 1995, BIOCHEM PHARMACOL, V50, P929, DOI 10.1016/0006-2952(95)00214-K
   BROCK JH, 1989, ACTA PAEDIATR SC   S, V361, P1
   Buege J A, 1978, Methods Enzymol, V52, P302
   BURK RF, 1980, J CLIN INVEST, V65, P1024, DOI 10.1172/JCI109754
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CARNEY JM, 1991, P NATL ACAD SCI USA, V88, P3633, DOI 10.1073/pnas.88.9.3633
   CHEN TS, 1990, DRUG METAB DISPOS, V18, P882
   CHOI JH, 1994, AGE, V17, P93, DOI 10.1007/BF02435012
   CHUNG MCM, 1985, ANAL BIOCHEM, V148, P498, DOI 10.1016/0003-2697(85)90258-1
   DANH HC, 1983, J NEUROCHEM, V40, P1003, DOI 10.1111/j.1471-4159.1983.tb08084.x
   Eklow-Lastbom L, 1986, Free Radic Res Commun, V2, P57, DOI 10.3109/10715768609088055
   EURICH RE, 1980, MECH AGEING DEV, V14, P317, DOI 10.1016/0047-6374(80)90005-6
   FLOYD RA, 1993, TOXICOL IND HEALTH, V9, P197, DOI 10.1177/0748233793009001-214
   GUPTA S, 1994, TOXICOL APPL PHARM, V125, P42, DOI 10.1006/taap.1994.1047
   HARRIS LR, 1994, BIOCHEM J, V301, P385, DOI 10.1042/bj3010385
   HORNBROOK KR, 1993, EXP MOL PATHOL, V59, P27, DOI 10.1006/exmp.1993.1024
   KITANI K, 1990, BASIC SCI TOXICOLOGY, P130
   KUKIELKA E, 1994, ARCH BIOCHEM BIOPHYS, V308, P70, DOI 10.1006/abbi.1994.1010
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lauffer R.B., 1992, IRON HUMAN DIS, P1
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MASSIE HR, 1983, EXP GERONTOL, V18, P277, DOI 10.1016/0531-5565(83)90038-4
   MASSIE HR, 1979, MECH AGEING DEV, V11, P219, DOI 10.1016/0047-6374(79)90001-0
   MINOTTI G, 1989, ARCH BIOCHEM BIOPHYS, V273, P137, DOI 10.1016/0003-9861(89)90171-9
   MINOTTI G, 1993, CHEM RES TOXICOL, V6, P134, DOI 10.1021/tx00032a001
   MONTGOMERY MR, 1987, BIOCHIM BIOPHYS ACTA, V890, P271, DOI 10.1016/0005-2728(87)90028-4
   MUNRO HN, 1990, J CELL BIOCHEM, V44, P107, DOI 10.1002/jcb.240440205
   Nagy K, 1996, ARCH GERONTOL GERIAT, V22, P297, DOI 10.1016/0167-4943(96)00700-5
   OVE P, 1972, BIOCHIM BIOPHYS ACTA, V277, P211, DOI 10.1016/0005-2787(72)90367-X
   PERSIGEHL M, 1977, J RADIOANAL CHEM, V37, P611, DOI 10.1007/BF02519374
   PUNTARULO S, 1994, BBA-GEN SUBJECTS, V1200, P41, DOI 10.1016/0304-4165(94)90025-6
   REIF DW, 1992, FREE RADICAL BIO MED, V12, P417, DOI 10.1016/0891-5849(92)90091-T
   REIF DW, 1988, TOXICOL APPL PHARM, V93, P506, DOI 10.1016/0041-008X(88)90054-3
   RIKANS LE, 1988, DRUG CHEM TOXICOL, V11, P237, DOI 10.3109/01480548809017880
   RIKANS LE, 1993, TOXICOL APPL PHARM, V118, P263, DOI 10.1006/taap.1993.1032
   RIKANS LE, 1992, J PHARMACOL EXP THER, V262, P271
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   Rikans LE, 1996, MECH AGEING DEV, V91, P165, DOI 10.1016/S0047-6374(96)01784-8
   ROSKAMS AJI, 1994, J NEUROCHEM, V63, P709
   SANDY MS, 1986, BIOCHEM PHARMACOL, V35, P3095, DOI 10.1016/0006-2952(86)90392-8
   SANDY MS, 1987, ARCH BIOCHEM BIOPHYS, V259, P29, DOI 10.1016/0003-9861(87)90466-8
   SHERMAN AR, 1985, J NUTR, V115, P607, DOI 10.1093/jn/115.5.607
   SMITH CV, 1985, J PHARMACOL EXP THER, V235, P172
   SMITH CV, 1987, MOL PHARMACOL, V32, P417
   SOHAL RS, 1990, MECH AGEING DEV, V53, P217, DOI 10.1016/0047-6374(90)90040-M
   STADTMAN ER, 1991, J BIOL CHEM, V266, P2005
   STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616
   THOMAS CE, 1985, J BIOL CHEM, V260, P3275
   THOMAS CE, 1986, J BIOL CHEM, V261, P3064
   VERMILION JL, 1978, J BIOL CHEM, V253, P2694
   Walker JE, 1995, METHOD ENZYMOL, V260, P14, DOI 10.1016/0076-6879(95)60127-9
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   WINTERBOURN CC, 1991, FREE RADICAL RES COM, V12-3, P107, DOI 10.3109/10715769109145774
   WOLFGANG GHI, 1991, FREE RADICAL BIO MED, V10, P403, DOI 10.1016/0891-5849(91)90049-9
   WORWOOD M, 1989, J INTERN MED, V226, P381, DOI 10.1111/j.1365-2796.1989.tb01412.x
NR 56
TC 15
Z9 15
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 1997
VL 344
IS 1
BP 85
EP 93
DI 10.1006/abbi.1997.0172
PG 9
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA XM764
UT WOS:A1997XM76400011
PM 9244385
DA 2024-02-19
ER

PT J
AU del Bas, JM
   Rodríguez, B
   Puiggròs, F
   Mariné, S
   Rodríguez, MA
   Moriña, D
   Armengol, L
   Caimari, A
   Arola, L
AF Maria del Bas, Josep
   Rodriguez, Benjamin
   Puiggros, Francesc
   Marine, Silvia
   Angel Rodriguez, Miguel
   Morina, David
   Armengol, Lluis
   Caimari, Antoni
   Arola, Lluis
TI Hepatic accumulation of S-adenosylmethionine in hamsters with
   non-alcoholic fatty liver disease associated with metabolic syndrome
   under selenium and vitamin E deficiency
SO CLINICAL SCIENCE
LA English
DT Article
ID CULTURED RAT HEPATOCYTES; METHIONINE ADENOSYLTRANSFERASE;
   HEPATOCELLULAR-CARCINOMA; N-METHYLTRANSFERASE; DIETARY SELENIUM; C-JUN;
   INCREASED EXPRESSION; DNA METHYLATION; GENE-EXPRESSION; KNOCKOUT MICE
AB Progression of non-alcoholic fatty liver disease (NAFLD) in the context of metabolic syndrome (MetS) is only partially explored due to the lack of preclinical models. In order to study the alterations in hepatic metabolism that accompany this condition, we developed a model of MetS accompanied by the onset of steatohepatitis (NASH) by challenging golden hamsters with a high-fat diet low in vitamin E and selenium (HFD), since combined deficiency results in hepatic necroinflammation in rodents. Metabolomics and transcriptomics integrated analyses of livers revealed an unexpected accumulation of hepatic S-Adenosylmethionine (SAM) when compared with healthy livers likely due to diminished methylation reactions and repression of GNMT. SAM plays a key role in the maintenance of cellular homeostasis and cell cycle control. In agreement, analysis of over-represented transcription factors revealed a central role of c-myc and c-Jun pathways accompanied by negative correlations between SAM concentration, MYC expression and AMPK phosphorylation. These findings point to a drift of cell cycle control toward senescence in livers of HFD animals, which could explain the onset of NASH in this model. In contrast, hamsters with NAFLD induced by a conventional high-fat diet did not show SAM accumulation, suggesting a key role of selenium and vitamin E in SAM homeostasis. In conclusion, our results suggest that progression of NAFLD in the context of MetS can take place even in a situation of hepatic SAM excess and that selenium and vitamin E status might be considered in current therapies against NASH based on SAM supplementation.
C1 [Maria del Bas, Josep; Puiggros, Francesc; Caimari, Antoni; Arola, Lluis] Eurecat, Ctr Tecnol Catalunya, Technol Unit Nutr & Hlth, Reus, Spain.
   [Maria del Bas, Josep; Puiggros, Francesc; Caimari, Antoni] Eurecat, Ctr Tecnol Catalunya, Nutr & Hlth Res Grp GRNS, Reus, Spain.
   [Rodriguez, Benjamin; Armengol, Lluis] qGenomics, Quantitat Genom Med Labs, R&D Dept, Barcelona, Spain.
   [Marine, Silvia; Angel Rodriguez, Miguel] Joint Unit Univ Rovira & Virgili Eurecat, Ctr Tecnol Catalunya, Unique Sci & Tech Infrastruct, Ctr Omic Sci, Reus, Spain.
   [Morina, David] UPF, CIBER Epidemiol & Salud Publ CIBERESP, Ctr Res Environm Epidemiol CREAL, Barcelona 08003, Spain.
   [Morina, David] Univ Autonoma Barcelona, Fac Med, Unitat Bioestadist, GRAAL, Cerdanyola Del Valles 08193, Spain.
   [Arola, Lluis] Univ Rovira & Virgili, Nutrigen Res Grp, Campus Sescelades', Tarragona, Spain.
   [Arola, Lluis] Dept Biochem & Biotechnol, Campus Sescelades, Tarragona, Spain.
C3 CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra
   University; Autonomous University of Barcelona; Universitat Rovira i
   Virgili
RP Caimari, A (corresponding author), Eurecat, Ctr Tecnol Catalunya, Technol Unit Nutr & Hlth, Reus, Spain.; Caimari, A (corresponding author), Eurecat, Ctr Tecnol Catalunya, Nutr & Hlth Res Grp GRNS, Reus, Spain.
EM antoni.caimari@eurecat.org
RI Moriña, David/AAX-8427-2021; Puiggros, Francesc/AAA-6359-2019; Arola,
   Lluís/C-6074-2011; del Bas, Josep Maria/K-9310-2019; Rodríguez-Gómez,
   Miguel A/L-4942-2014; del Bas, Josep M/K-2327-2014; Puiggros,
   Francesc/I-7820-2016
OI Moriña, David/0000-0001-5949-7443; Arola, Lluís/0000-0003-2767-1974; del
   Bas, Josep Maria/0000-0002-0700-2004; Rodríguez-Gómez, Miguel
   A/0000-0001-9568-9821; del Bas, Josep M/0000-0002-0700-2004; Puiggros,
   Francesc/0000-0002-8357-9956; Caimari, Antoni/0000-0001-6144-0294
FU CDTI, Convocatoria Industria de la Ciencia [IDC-20101073]
FX This study has been supported by CDTI, Convocatoria Industria de la
   Ciencia [IDC-20101073].
CR Al-Busafi Said A, 2012, Hepat Res Treat, V2012, P947575, DOI 10.1155/2012/947575
   Zulet MA, 2009, NUTR RES, V29, P41, DOI 10.1016/j.nutres.2008.11.003
   Ansorena E, 2002, HEPATOLOGY, V35, P274, DOI 10.1053/jhep.2002.30419
   Anstee QM, 2012, J HEPATOL, V57, P1097, DOI 10.1016/j.jhep.2012.04.041
   Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031
   Auerbach RK, 2013, BIOINFORMATICS, V29, P1922, DOI 10.1093/bioinformatics/btt316
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bettinger D, 2013, HEPATOLOGY, V57, P2543, DOI 10.1002/hep.26142
   BRAVO E, 1994, COMP BIOCHEM PHYS B, V107, P347, DOI 10.1016/0305-0491(94)90058-2
   Brunt EM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.80
   Cai JX, 1998, CANCER RES, V58, P1444
   Caimari A, 2013, INT J OBESITY, V37, P576, DOI 10.1038/ijo.2012.75
   Crescenti A, 2015, J NUTR BIOCHEM, V26, P912, DOI 10.1016/j.jnutbio.2015.03.003
   Davis CD, 2000, J NUTR, V130, P2903, DOI 10.1093/jn/130.12.2903
   Davis CD, 2003, J NUTR, V133, P2907, DOI 10.1093/jn/133.9.2907
   Del Bas J. M., 2015, BR J NUTR, P1
   Dillard A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-89
   Dorn C, 2014, LAB INVEST, V94, P394, DOI 10.1038/labinvest.2014.3
   Fernandez-Sanchez ME, 2009, MOL CELL BIOL, V29, P6182, DOI 10.1128/MCB.00973-09
   Fischer A, 2001, BIOCHEM BIOPH RES CO, V285, P470, DOI 10.1006/bbrc.2001.5171
   Frau M, 2013, J HEPATOL, V59, P830, DOI 10.1016/j.jhep.2013.04.031
   García-Trevijano ER, 2000, FASEB J, V14, P2511, DOI 10.1096/fj.00-0121com
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Imajo K, 2013, INT J MOL SCI, V14, P21833, DOI 10.3390/ijms141121833
   Kalhan SC, 2011, CLIN SCI, V121, P179, DOI 10.1042/CS20110060
   Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041
   Kodama Y, 2009, HEPATOLOGY, V49, P6, DOI 10.1002/hep.22710
   Laos S, 2014, BRIT J NUTR, V112, P663, DOI 10.1017/S0007114514001342
   Latasa MU, 2001, FASEB J, V15, P1248, DOI 10.1096/fj.00-0556fjev1
   Lee TD, 2004, ALCOHOL CLIN EXP RES, V28, P173, DOI 10.1097/01.ALC.0000108654.77178.03
   Lim JW, 2014, WORLD J GASTROENTERO, V20, P8325, DOI 10.3748/wjg.v20.i26.8325
   Lu SC, 2000, AM J PHYSIOL-GASTR L, V279, pG178, DOI 10.1152/ajpgi.2000.279.1.G178
   Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398
   Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011
   Luo J, 2010, INT J BIOL SCI, V6, P784
   Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200
   Martínez-Chantar ML, 2008, HEPATOLOGY, V47, P1191, DOI 10.1002/hep.22159
   Martínez-Chantar ML, 2006, GASTROENTEROLOGY, V131, P223, DOI 10.1053/j.gastro.2006.04.019
   Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438
   Mato JM, 2007, HEPATOLOGY, V45, P1306, DOI 10.1002/hep.21650
   National Research Council (US) Subcommittee on Selenium, 1983, SEL NUTR REV ED
   Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200
   Noureddin M, 2015, EXP BIOL MED, V240, P809, DOI 10.1177/1535370215579161
   Obeid R, 2009, FEBS LETT, V583, P1215, DOI 10.1016/j.febslet.2009.03.038
   Purohit V, 2007, AM J CLIN NUTR, V86, P14, DOI 10.1093/ajcn/86.1.14
   R Development Core Team R, 2011, R LANG ENV STAT COMP, P409, DOI [DOI 10.1007/978-3-540-74686-7, 10.1007/978-3-540-74686-7]
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rohr-Udilova N, 2012, HEPATOLOGY, V55, P1112, DOI 10.1002/hep.24808
   Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103
   Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Soon RK, 2010, GASTROENTEROLOGY, V139, P1730, DOI 10.1053/j.gastro.2010.07.046
   Uthus EO, 2006, BIOL TRACE ELEM RES, V109, P201, DOI 10.1385/BTER:109:3:201
   van Liempd S, 2013, ANAL BIOANAL CHEM, V405, P5301, DOI 10.1007/s00216-013-6883-4
   Varela-Rey M, 2014, NEURON, V81, P1024, DOI 10.1016/j.neuron.2014.01.037
   Varela-Rey M, 2010, HEPATOLOGY, V52, P105, DOI 10.1002/hep.23639
   Varela-Rey M, 2009, HEPATOLOGY, V50, P443, DOI 10.1002/hep.23033
   Vázquez-Chantada M, 2009, HEPATOLOGY, V49, P608, DOI 10.1002/hep.22660
   Veena J., 2014, BR J NUTR, P1
   Vinaixa M, 2010, J PROTEOME RES, V9, P2527, DOI 10.1021/pr901203w
   Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537
   Wattacheril J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057165
   Wei J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130876
   Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319
   Zeisel SH, 2013, CLIN CHEM LAB MED, V51, P467, DOI 10.1515/cclm-2012-0518
   Zeng HW, 2009, MOLECULES, V14, P1263, DOI 10.3390/molecules14031263
   Zerbino D, 2010, CURR PROTOC BIOINFOR, V11, P1
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
   Zhang ZS, 2009, MOL NUTR FOOD RES, V53, P921, DOI 10.1002/mnfr.200800517
NR 69
TC 12
Z9 13
U1 3
U2 20
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0143-5221
EI 1470-8736
J9 CLIN SCI
JI Clin. Sci.
PD FEB 14
PY 2019
VL 133
IS 3
BP 409
EP 423
DI 10.1042/CS20171039
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA HO8LS
UT WOS:000461204200003
PM 29122967
DA 2024-02-19
ER

PT J
AU Aikata, H
   Takaishi, H
   Kawakami, Y
   Takahashi, S
   Kitamoto, M
   Nakanishi, T
   Nakamura, Y
   Shimamoto, F
   Kajiyama, G
   Ide, T
AF Aikata, H
   Takaishi, H
   Kawakami, Y
   Takahashi, S
   Kitamoto, M
   Nakanishi, T
   Nakamura, Y
   Shimamoto, F
   Kajiyama, G
   Ide, T
TI Telomere reduction in human liver tissues with age and chronic
   inflammation
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article
DE hybridization protection assay (HPA); telomere reduction; human liver;
   aging; chronic inflammation
ID REPLICATIVE LIFE-SPAN; HEPATOCELLULAR-CARCINOMA; HUMAN FIBROBLASTS;
   HUMAN-CELLS; LENGTH; DONORS; SENESCENCE
AB Telomere shortening in human liver with aging and chronic inflammation was examined by hybridization protection assay using telomere and Alu probes. The reduction rate of telomere repeats in normal liver (23 samples from patients 17-81 years old) was 120 bp per year, which is in good agreement with the reported reduction rate in fibroblasts of 50-150 bp at each cell division and replacement rate of human liver cells, once a year. Mean telomere repeat length shortened to about 10 kbp in normal livers from 80-year-old individuals. The number of telomere repeats in chronic hepatitis (26 samples) and liver cirrhosis (11 samples) was significantly lower than that in normal liver of the same age (P < 0.01). Telomere length in all these chronic liver disease samples, other than two exceptions, was not reduced shorter than 5 kbp, which was assumed to give a limit of proliferation (Hayflick's limit) to untransformed cells. (C) 2000 Academic Press.
C1 Hiroshima Univ, Sch Med, Dept Cellular & Mol Biol, Minami Ku, Hiroshima 7348551, Japan.
   Hiroshima Univ, Sch Med, Dept Internal Med 1, Minami Ku, Hiroshima 7348551, Japan.
   Hiroshima Univ, Sch Med, Dept Pathol, Minami Ku, Hiroshima 7348551, Japan.
C3 Hiroshima University; Hiroshima University; Hiroshima University
RP Ide, T (corresponding author), Hiroshima Univ, Sch Med, Dept Cellular & Mol Biol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.
CR ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Busquets J, 1999, TRANSPLANT P, V31, P2480, DOI 10.1016/S0041-1345(99)00426-1
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   De Carlis L, 1999, TRANSPLANT P, V31, P397, DOI 10.1016/S0041-1345(98)01678-9
   Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555
   EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
   GOLDSTEIN S, 1978, SCIENCE, V199, P781, DOI 10.1126/science.622567
   GOLDSTEIN S, 1989, EXP GERONTOL, V24, P461, DOI 10.1016/0531-5565(89)90052-1
   Halvorsen TL, 1999, MOL CELL BIOL, V19, P1864
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Iwama H, 1998, HUM GENET, V102, P397, DOI 10.1007/s004390050711
   Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056
   KITADA T, 1995, BIOCHEM BIOPH RES CO, V211, P33, DOI 10.1006/bbrc.1995.1774
   Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303
   MARTIN GM, 1970, LAB INVEST, V23, P86
   Miura N, 1997, CANCER GENET CYTOGEN, V93, P56, DOI 10.1016/S0165-4608(96)00329-9
   Nakamura Y, 1999, CLIN CHEM, V45, P1718
   Nakashio R, 1997, INT J ONCOL, V11, P139
   Ohashi K, 1996, CANCER, V77, P1747, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1747::AID-CNCR26>3.0.CO;2-X
   SCHNEIDER EL, 1976, P NATL ACAD SCI USA, V73, P3584, DOI 10.1073/pnas.73.10.3584
   SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086
   VAZIRI H, 1993, AM J HUM GENET, V52, P661
   VONZGLINICKI T, 1995, EXP CELL RES, V220, P186, DOI 10.1006/excr.1995.1305
   Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141
NR 28
TC 134
Z9 144
U1 1
U2 11
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
J9 EXP CELL RES
JI Exp. Cell Res.
PD MAY 1
PY 2000
VL 256
IS 2
BP 578
EP 582
DI 10.1006/excr.2000.4862
PG 5
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA 311MR
UT WOS:000086888500024
PM 10772830
DA 2024-02-19
ER

PT J
AU Sanguino, E
   Roglans, N
   Alegret, M
   Sánchez, M
   Vázquez-Carrera, M
   Laguna, JC
AF Sanguino, E
   Roglans, N
   Alegret, M
   Sánchez, M
   Vázquez-Carrera, M
   Laguna, JC
TI Atorvastatin reverses age-related reduction in rat hepatic PPARα and
   HNF-4
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE statins; PPAR; HNF-4; liver; old age
ID APOLIPOPROTEIN-B; GENE-EXPRESSION; RECEPTOR; TRIGLYCERIDE; COACTIVATOR;
   SIMVASTATIN; INHIBITOR; SECRETION; EFFICACY
AB I Old rats are resistant to fibrate-induced hypolipidemia owing to a reduction in hepatic peroxisome proliferator-activated receptor alpha (PPAR alpha). We tested whether the age-related decrease in PPAR alpha is prevented by atorvastatin (ATV), a hypolipidemic statin.
   2 We determined the activity and expression of Liver X receptor alpha (LXR alpha) and PPAR alpha in the liver of 18-month-old rats treated with 10 mg kg(-1) of ATV for 21 days. We measured fatty acid oxidation (FAO), the expression of PPAR alpha-target genes, liver triglyceride (TG) and cholesteryl ester (CE) contents and plasma concentrations of TG, cholesterol, glucose, nonesterified fatty acids (NEFA), insulin and leptin. While old female rats were practically unresponsive, ATV-treated old males showed lower liver TG (-41%) and CE (-48%), and plasma TG (-35%), glucose (-18%) and NEFA (-39%). Age-related alterations in LXR alpha expression and binding activity were reverted in ATV-treated old males. These changes were related to an increase in hepatic FAO (1.2-fold), and PPAR alpha mRNA (2.2-fold), PPAR alpha protein (1.6-fold), and PPAR alpha-binding activity.
   3 Hepatic nuclear factor-4 (HNF-4) and chicken ovalbumin upstream-transcription factor-II participate in the transcriptional regulation of the PPAR alpha gene, while peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1) behaves as a PPAR coactivator. Ageing reduced the hepatic content of HNF-4 (74%) and PGC-1 (77%) exclusively in male rats. ATV administration to old males enhanced the hepatic expression and binding activity (two-fold) of HNF-4.
   4 ATV-induced changes in hepatic HNF-4 and PPAR alpha may be responsible for the improvement of the lipid metabolic phenotype produced by ATV administration to senescent male rats.
C1 Univ Barcelona, Dept Pharmecol & Therapeut Chem, Unidad Farmacol & Farmacognosia, Fac Farm, E-08028 Barcelona, Spain.
C3 University of Barcelona
RP Laguna, JC (corresponding author), Univ Barcelona, Dept Pharmecol & Therapeut Chem, Unidad Farmacol & Farmacognosia, Fac Farm, Avda Diagnal 643, E-08028 Barcelona, Spain.
EM jclagunae@ub.edu
RI Roglans, Núria/ABH-1242-2020; Vázquez-Carrera, Manuel/H-2612-2015;
   Alegret, Marta/C-5086-2017; Laguna, JCLaguna - Juan C./C-5481-2017
OI Vázquez-Carrera, Manuel/0000-0001-7138-8207; Alegret,
   Marta/0000-0002-5652-8651; Laguna, JCLaguna - Juan
   C./0000-0002-7082-0704; Roglans, Nuria/0000-0002-5018-021X
CR ALEGRET M, 1994, BRIT J PHARMACOL, V112, P551, DOI 10.1111/j.1476-5381.1994.tb13109.x
   BakkerArkema RG, 1996, JAMA-J AM MED ASSOC, V275, P128, DOI 10.1001/jama.275.2.128
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Ferrari AU, 2003, J APPL PHYSIOL, V95, P2591, DOI 10.1152/japplphysiol.00601.2003
   Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356
   Freeman WM, 1999, BIOTECHNIQUES, V26, P112, DOI 10.2144/99261rv01
   Funatsu T, 2002, EUR J PHARMACOL, V455, P161, DOI 10.1016/S0014-2999(02)02611-0
   GRABIELY I, 2002, DIABETES, V51, P1016
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   Inoue I, 2000, LIFE SCI, V67, P863, DOI 10.1016/S0024-3205(00)00680-9
   Inoue I, 2002, BIOCHEM BIOPH RES CO, V290, P131, DOI 10.1006/bbrc.2001.6141
   James RW, 2001, CURR OPIN LIPIDOL, V12, P425, DOI 10.1097/00041433-200108000-00009
   KELLER H, 1995, MOL ENDOCRINOL, V9, P794, DOI 10.1210/me.9.7.794
   Knight JA, 2001, ADV CLIN CHEM, V35, P1, DOI 10.1016/S0065-2423(01)35014-X
   KRAUSE BR, 1995, ATHEROSCLEROSIS, V117, P237, DOI 10.1016/0021-9150(95)05576-I
   Lazarow P B, 1981, Methods Enzymol, V72, P315
   Lea AP, 1997, DRUGS, V53, P828, DOI 10.2165/00003495-199753050-00011
   Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764
   Lindén D, 2001, J LIPID RES, V42, P1831
   Llaverías G, 2002, EUR J PHARMACOL, V451, P11, DOI 10.1016/S0014-2999(02)02152-0
   Louet JF, 2002, J BIOL CHEM, V277, P37991, DOI 10.1074/jbc.M205087200
   Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852
   Moghadasian M H, 2000, Expert Opin Pharmacother, V1, P683, DOI 10.1517/14656566.1.4.683
   Mohammadi A, 1998, ARTERIOSCL THROM VAS, V18, P783, DOI 10.1161/01.ATV.18.5.783
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Roglans N, 2002, LIPIDS, V37, P445, DOI 10.1007/s11745-002-0916-0
   Roglans N, 2002, J PHARMACOL EXP THER, V302, P232, DOI 10.1124/jpet.302.1.232
   Román J, 2000, J BIOL CHEM, V275, P14684, DOI 10.1074/jbc.275.19.14684
   Sanguino E, 2004, EXP GERONTOL, V39, P1295, DOI 10.1016/j.exger.2004.06.007
   Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034
   SONNENBERG JL, 1989, NEURON, V3, P359, DOI 10.1016/0896-6273(89)90260-2
   Stein EA, 1998, AM J CARDIOL, V81, p66B, DOI 10.1016/S0002-9149(98)00041-1
   Torra IP, 2002, MOL ENDOCRINOL, V16, P1013
   Verd JC, 1999, BRIT J PHARMACOL, V127, P1479, DOI 10.1038/sj.bjp.0702668
NR 35
TC 48
Z9 53
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-1188
EI 1476-5381
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD AUG
PY 2005
VL 145
IS 7
BP 853
EP 861
DI 10.1038/sj.bjp.0706260
PG 9
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 955UC
UT WOS:000231252100002
PM 15912134
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Cavazzoni, M
   Barogi, S
   Baracca, A
   Castelli, GP
   Lenaz, G
AF Cavazzoni, M
   Barogi, S
   Baracca, A
   Castelli, GP
   Lenaz, G
TI The effect of aging and an oxidative stress on peroxide levels and the
   mitochondrial membrane potential in isolated rat hepatocytes
SO FEBS LETTERS
LA English
DT Article
DE hepatocyte; oxidative stress; adriamycin; mitochondrion; membrane
   potential
ID FLOW CYTOMETRIC ANALYSIS; COENZYME-Q; FREE-RADICALS; AGED RATS; LIVER;
   DAMAGE; CELLS; DNA; ANTHRACYCLINES; MAINTENANCE
AB We have investigated the effect of ageing and of adriamycin treatment on the bioenergetics of isolated rat hepatocytes, Ageing per se, whilst being associated with a striking increase of hydrogen peroxide in the cells, induces only minor changes on the mitochondrial membrane potential. The adriamycin treatment induces a decrease of the mitochondrial membrane potential in situ and a consistent increase of the superoxide anion cellular content independently of the donor age. The hydrogen peroxide is significantly increased in both aged and adult rat hepatocytes, however, due to the high basal level in the aged cells, it is higher in aged rat cells not subjected to oxidative stress than that elicited bg 50 mu M adriamycin in young rat hepatocytes. The results suggest that a hydrogen peroxide increase in hepatocytes of aged rats is unable to induce major modifications of mitochondrial bioenergetics. This contrasts with the damaging effect of adriamycin, suggesting that the effects of the drug may be due to the concomitant high level of both superoxide and hydrogen peroxide, (C) 1999 Federation of European Biochemical Societies.
C1 Univ Bologna, Dipartimento Biochim G Moruzzi, I-40126 Bologna, Italy.
   Univ Perfezionamento S Anna, Scuolo Super Studi, I-56127 Pisa, Italy.
C3 University of Bologna; Scuola Superiore Sant'Anna
RP Lenaz, G (corresponding author), Univ Bologna, Dipartimento Biochim G Moruzzi, Via Irnerio 48, I-40126 Bologna, Italy.
OI BARACCA, ALESSANDRA/0000-0002-0490-1776
CR BASS DA, 1983, J IMMUNOL, V130, P1910
   Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2
   Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528
   BLACK KA, 1993, CYTOMETRY, V14, P334, DOI 10.1002/cyto.990140314
   BYRNE E, 1991, REV NEUROL, V147, P532
   CEBALLOSPICOT I, 1991, BRAIN RES, V552, P198, DOI 10.1016/0006-8993(91)90084-9
   CROFT S, 1992, FREE RADICAL RES COM, V17, P21, DOI 10.3109/10715769209061086
   DAVIES KJA, 1986, J BIOL CHEM, V261, P3060
   ERNSTER I, 1993, ACTIVE OXYGEN LIPID, P1
   GENOVA ML, 1995, BIOCHEM J, V311, P105, DOI 10.1042/bj3110105
   Genova ML, 1997, FEBS LETT, V410, P467
   GOODMAN J, 1977, BIOCHEM BIOPH RES CO, V77, P797, DOI 10.1016/S0006-291X(77)80048-X
   GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N
   JUAN G, 1994, CYTOMETRY, V15, P335, DOI 10.1002/cyto.990150409
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   MIQUEL J, 1984, EXP GERONTOL, V19, P31, DOI 10.1016/0531-5565(84)90029-9
   MIQUEL J, 1980, EXP GERONTOL, V15, P573
   MULLERHOECKER J, 1993, J NEUROL SCI, V106, P14
   Ozawa T, 1997, PHYSIOL REV, V77, P425, DOI 10.1152/physrev.1997.77.2.425
   RICEEVANS C, 1992, MOL ASPECTS MED, V13, P1
   ROMERO FJ, 1983, BIOCHEM EDUC, V11, P135, DOI 10.1016/0307-4412(83)90093-6
   ROTHE G, 1990, J LEUKOCYTE BIOL, V47, P440, DOI 10.1002/jlb.47.5.440
   SAKAGUCHI Y, 1994, CANCER CHEMOTH PHARM, V33, P371, DOI 10.1007/BF00686265
   SCHON EA, 1996, CELLULAR AGING CELL, P19
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   SOHAL RS, 1995, FREE RADICAL BIO MED, V19, P499, DOI 10.1016/0891-5849(95)00037-X
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   VALLS V, 1994, BIOCHEM MOL BIOL INT, V33, P633
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 38
TC 32
Z9 35
U1 1
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD APR 16
PY 1999
VL 449
IS 1
BP 53
EP 56
DI 10.1016/S0014-5793(99)00400-7
PG 4
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 189NF
UT WOS:000079910900012
PM 10225427
OA Bronze
DA 2024-02-19
ER

PT J
AU Yamamoto, K
   Kushida, M
   Tsuduki, T
AF Yamamoto, Kazushi
   Kushida, Mamoru
   Tsuduki, Tsuyoshi
TI The effect of dietary lipid on gut microbiota in a
   senescence-accelerated prone mouse model (SAMP8)
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging; Dietary lipid; Fish oil; Gut microbiota; SAMP8
ID HIGH-FAT DIET; CONJUGATED TRIENE SYSTEM; LINOLENIC ACID ISOMER;
   INTESTINAL MICROBIOTA; INDUCED OBESITY; GENE-EXPRESSION; MURINE MODEL;
   SOY MILK; FISH-OIL; MICE
AB Gut microbiota change with aging and diet. In a previous study, it was shown that a moderate-fat diet enriched with fish oil had beneficial effects for elderly patients, so we examined the effect of this diet on aging-related changes in gut microbiota in this study. We used 3-month-old male senescence-accelerated prone mice (SAMP8). The mice were fed a normal diet containing 4 g soybean oil/100 g of diet for 6 months and then divided into 4 groups: (1) the Baseline group, ended breeding at 6 months old; (2) the Control group, continued on a normal diet until 15 months old; (3) the MF group, switched to a moderate-fat diet until 15 months old; and (4) the MF + FO group, switched to a moderate-fat diet enriched with fish oil until 15 months old. When mice were 6 or 15 months old, fecal samples were collected and gut microbiota analysis was performed. Gut microbiota analysis at the genus level showed that bacteria known to increase in association with fatty liver and intestinal inflammation increased with aging. However, this alteration was largely inhibited by the moderate-fat diet enriched with fish oil. On the other hand, there was a decrease with aging in the bacteria that play a role in energy consumption, but this alteration was inhibited by the moderate-fat diet enriched with fish oil. These results suggest that a moderate-fat diet enriched with fish oil has beneficial effects on gut microbiota in aging.
C1 [Yamamoto, Kazushi; Kushida, Mamoru; Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr Sci, Lab Food & Biomol Sci, Aoba Ku, 468-1 Aoba, Sendai, Miyagi 9800845, Japan.
C3 Tohoku University
RP Tsuduki, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Lab Food & Biomol Sci, Aoba Ku, 468-1 Aoba, Sendai, Miyagi 9800845, Japan.
EM tsudukit@m.tohoku.ac.jp
RI Tsuduki, Tsuyoshi/T-2697-2019
OI Tsuduki, Tsuyoshi/0000-0001-7810-0528
FU JSPS [16J00821]; Grants-in-Aid for Scientific Research [16J00821]
   Funding Source: KAKEN
FX KY is a research fellow of the Japan Society for the Promotion of
   Science (JSPS). This work was supported by a Grant-in-Aid for Scientific
   Research to KY from JSPS (no. 16J00821).
CR Alard J, 2016, ENVIRON MICROBIOL, V18, P1484, DOI 10.1111/1462-2920.13181
   Arai Y, 2014, J GERONTOL A-BIOL, V69, P486, DOI 10.1093/gerona/glt146
   Baldwin J, 2016, J NUTR BIOCHEM, V27, P123, DOI 10.1016/j.jnutbio.2015.08.027
   Barnett MPG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-39
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Biagi E, 2013, PHARMACOL RES, V69, P11, DOI 10.1016/j.phrs.2012.10.005
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Camuesco D, 2005, J NUTR, V135, P687, DOI 10.1093/jn/135.4.687
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636
   Chen DW, 2015, J MICROBIOL BIOTECHN, V25, P687, DOI 10.4014/jmb.1409.09085
   Cheng IC, 2005, WORLD J GASTROENTERO, V11, P1225, DOI 10.3748/wjg.v11.i8.1225
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Conley MN, 2016, PEERJ, V4, DOI 10.7717/peerj.1854
   Correale C, 2013, GASTROENTEROLOGY, V144, P346, DOI [10.1053/j.gastro.2012.10.040, 10.1053/j.gastro.2012.12.016]
   Cui CX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186216
   de Gonzalo-Calvo D, 2010, FREE RADICAL BIO MED, V49, P733, DOI 10.1016/j.freeradbiomed.2010.05.019
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Diao L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0531-z
   Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303
   Gruber L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071661
   Honma T, 2013, J JPN SOC FOOD SCI, V60, P541, DOI 10.3136/nskkk.60.541
   Honma T, 2013, J CLIN BIOCHEM NUTR, V52, P234, DOI 10.3164/jcbn.12-85
   Honma T, 2012, BIOGERONTOLOGY, V13, P93, DOI 10.1007/s10522-011-9363-2
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Kau AL, 2005, INFECT IMMUN, V73, P2461, DOI 10.1128/IAI.73.4.2461-2468.2005
   Kimoto-Nira H, 2007, BRIT J NUTR, V98, P1178, DOI 10.1017/S0007114507787469
   Kong FL, 2016, CURR BIOL, V26, pR832, DOI 10.1016/j.cub.2016.08.015
   Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9
   Lee SM, 2015, FOOD FUNCT, V6, P492, DOI 10.1039/c4fo00731j
   Li MY, 2014, J VET SCI, V15, P353, DOI 10.4142/jvs.2014.15.3.353
   Li QR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020460
   Li WZ, 2012, BRIEF BIOINFORM, V13, P656, DOI 10.1093/bib/bbs035
   Liu ZB, 2016, FOOD FUNCT, V7, P4869, DOI 10.1039/c6fo01439a
   Magrone T, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-31
   Mäkivuokko H, 2010, BRIT J NUTR, V103, P227, DOI 10.1017/S0007114509991553
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054
   Monteagudo-Mera A, 2016, BENEF MICROBES, V7, P247, DOI 10.3920/BM2015.0114
   Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14
   Munyaka PM, 2016, J BASIC MICROB, V56, P986, DOI 10.1002/jobm.201500726
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Ogata T, 2016, CELL BIOL INT, V40, P100, DOI 10.1002/cbin.10556
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Pataky Z, 2016, DIGEST DIS SCI, V61, P2721, DOI 10.1007/s10620-016-4179-1
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Qiao Y, 2014, FOOD FUNCT, V5, P1241, DOI 10.1039/c3fo60630a
   Qiao Y, 2013, APPL MICROBIOL BIOT, V97, P1689, DOI 10.1007/s00253-012-4323-6
   REUBSAET FAG, 1988, BIOCHIM BIOPHYS ACTA, V958, P434, DOI 10.1016/0005-2760(88)90229-9
   Schäkel C, 2015, 8TH ACM INTERNATIONAL CONFERENCE ON PERVASIVE TECHNOLOGIES RELATED TO ASSISTIVE ENVIRONMENTS (PETRA 2015), DOI 10.1145/2769493.2769499
   Sekita A, 2016, NUTRITION, V32, P720, DOI 10.1016/j.nut.2016.01.003
   Sen T, 2017, PHYSIOL BEHAV, V173, P305, DOI 10.1016/j.physbeh.2017.02.027
   Shinohara N, 2012, BBA-MOL CELL BIOL L, V1821, P980, DOI 10.1016/j.bbalip.2012.04.001
   Si HW, 2014, EXP GERONTOL, V58, P244, DOI 10.1016/j.exger.2014.09.001
   Tachon S, 2013, FEMS MICROBIOL ECOL, V83, P299, DOI 10.1111/j.1574-6941.2012.01475.x
   Takao M, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0368-6
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   Tian Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9462571
   Tsuduki T, 2013, J OLEO SCI, V62, P825, DOI 10.5650/jos.62.825
   Tsuduki T, 2011, NUTRITION, V27, P334, DOI 10.1016/j.nut.2010.05.017
   Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109
   Tsuzuki T, 2007, BBA-MOL CELL BIOL L, V1771, P20, DOI 10.1016/j.bbalip.2006.11.006
   Van Hul M, 2018, AM J PHYSIOL-ENDOC M, V314, pE334, DOI 10.1152/ajpendo.00107.2017
   Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Watanabe Yukiko, 2011, J Med Case Rep, V5, P356, DOI 10.1186/1752-1947-5-356
   Wijnhoven HAH, 2012, CLIN NUTR, V31, P351, DOI 10.1016/j.clnu.2011.10.013
   Wong VWS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062885
   Yamamoto K, 2018, NUTRITION, V50, P26, DOI 10.1016/j.nut.2017.10.015
   Yamamoto K, 2015, J CLIN BIOCHEM NUTR, V57, P204, DOI 10.3164/jcbn.15-60
   Yamamoto K, 2014, BIOGERONTOLOGY, V15, P463, DOI 10.1007/s10522-014-9512-5
   Zhan GF, 2018, AGING-US, V10, P1257, DOI 10.18632/aging.101464
   Zhang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3163
   Zhang L, 2016, J IMMUNOL, V196, P1799, DOI 10.4049/jimmunol.1500021
   Zhang WL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18837-2
   Zhong YD, 2015, MOL NUTR FOOD RES, V59, P2066, DOI 10.1002/mnfr.201500187
NR 77
TC 10
Z9 11
U1 0
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD OCT
PY 2018
VL 19
IS 5
BP 367
EP 383
DI 10.1007/s10522-018-9764-6
PG 17
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA GR4PP
UT WOS:000442597100004
PM 30073441
DA 2024-02-19
ER

PT J
AU Ahmad, A
   Ahmad, R
AF Ahmad, Areeba
   Ahmad, Riaz
TI Proteomic approach to identify molecular signatures during experimental
   hepatic fibrosis and resveratrol supplementation
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE 2D electrophoresis; Hepatic fibrosis; Peptide Mass Fingerprinting;
   Oxidative stress; Resveratrol
ID CARBONIC-ANHYDRASE-III; SENESCENCE MARKER PROTEIN-30; INDUCED LIVER
   FIBROSIS; STELLATE CELL ACTIVATION; HEP G2 CELLS; RAT-LIVER;
   POLYACRYLAMIDE-GELS; OXIDATIVE STRESS; BINDING PROTEIN; GENE-EXPRESSION
AB We document the changes in sera and liver proteome during experimental hepatic fibrosis (HF) and its protection by resveratrol (Rsvtrl) in rats. HF was induced by N'-Nitrosodimethylamine (NDMA) administration thrice a week for 21-days. Compared to the control group, significant (P < 0.05) elevations in ALT, AST, ALP,gamma GT and bilirubin occurred during fibrosis. H&E, IHC for alpha-SMA and reticulin stainings of liver demonstrated that collagen amassing and HF were concurrent. Rsvtrl-supplementation refurbished hepatic architecture and lessened collagen deposition. 2DE proteome analyses showed similar to 398 (pH, 3-10) and similar to 129 signatures (pH, 4-7) within 5-201 kDa range in liver and sera, respectively. Nearly, 45 spots in liver and 18 in sera were differentially expressed in fibrotic and Rsvtrl-supplemented animals. MALDI-TOF-MS/MS analysis revealed at least ten signatures as the potential biomarkers for HF, because of the significant changes (>2 fold) in their expression. Out of them, two signatures have not so far been characterized and we have accomplished it in this study. Our proteomics data provides new evidence on an overall involvement of carbohydrate, lipid, Ca2+ signaling and oxidative pathways during NDMA-induced HF. More importantly, the oxidative pathway appears to be the principal mediator in the NDMA-induced HF as well as the hepato-protection by Rsvtrl. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Ahmad, Areeba; Ahmad, Riaz] Aligarh Muslim Univ, Fac Life Sci, Dept Zool, Biochem & Clin Genet Lab,Sect Genet, Aligarh 202002, UP, India.
C3 Aligarh Muslim University
RP Ahmad, R (corresponding author), Aligarh Muslim Univ, Fac Life Sci, Dept Zool, Biochem & Clin Genet Lab,Sect Genet, Aligarh 202002, UP, India.
EM rahmad.zo@amu.ac.in
FU Department of Science & Technology (DST), New Delhi
   [DST/INSPIRE/2010/121]
FX The authors sincerely thank the Chairmen, Department of Zoology and
   Department of Pathology UN Medical College) for necessary facilities.
   Authors are grateful to Dr. Absar-ul Hasnain, AMU Aligarh; Dr. Irian
   Qureishy, Jamia Millia Islamia (New Delhi, India) and Dr. Padmavathi
   Ramanujam, Alagappa University (Karaikudi, India) for useful exchange of
   views and suggestions. Facilities extended by SANDOR Proteomics,
   Hyderabad, India are gratefully acknowledged. Thanks are also due to
   Hadiya Husain and Uzma Latief for cooperation. Financial assistance [No.
   DST/INSPIRE/2010/121] to AA from Department of Science & Technology
   (DST), New Delhi is also thankfully acknowledged.
CR Ahmad A, 2014, CHEM-BIOL INTERACT, V221, P1, DOI 10.1016/j.cbi.2014.07.007
   Ahmad A, 2014, PHARM BIOL, V52, P516, DOI 10.3109/13880209.2013.864682
   Ahmad A, 2012, SAUDI J GASTROENTERO, V18, P155, DOI 10.4103/1319-3767.96445
   Ahmad R, 2009, CHEM-BIOL INTERACT, V181, P145, DOI 10.1016/j.cbi.2009.06.021
   Ara C, 2005, J SURG RES, V127, P112, DOI 10.1016/j.jss.2005.01.024
   Aziz MH, 2003, INT J ONCOL, V23, P17
   Berman AY, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0038-6
   Bruck R, 2001, HEPATOLOGY, V33, P379, DOI 10.1053/jhep.2001.21408
   CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742
   CHAI YC, 1991, ARCH BIOCHEM BIOPHYS, V284, P270, DOI 10.1016/0003-9861(91)90295-T
   Chávez E, 2008, J APPL TOXICOL, V28, P35, DOI 10.1002/jat.1249
   Clément MV, 1998, BLOOD, V92, P996
   Deaciuc IV, 2004, ALCOHOL, V33, P17, DOI 10.1016/j.alcohol.2004.04.001
   Depeint F, 2006, CHEM-BIOL INTERACT, V163, P94, DOI 10.1016/j.cbi.2006.04.014
   Eidi A, 2013, BIOL TRACE ELEM RES, V155, P267, DOI 10.1007/s12011-013-9784-7
   Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   George J, 2001, TOXICOLOGY, V156, P129, DOI 10.1016/S0300-483X(00)00352-8
   George J, 2000, CLIN BIOCHEM, V33, P563, DOI 10.1016/S0009-9120(00)00170-3
   HAGGERTY HG, 1990, TOXICOLOGY, V63, P1, DOI 10.1016/0300-483X(90)90064-N
   Henkel C, 2006, PROTEOMICS, V6, P6538, DOI 10.1002/pmic.200600580
   HOLMSKOV U, 1994, IMMUNOL TODAY, V15, P67, DOI 10.1016/0167-5699(94)90136-8
   Hong SW, 2010, ARCH PHARM RES, V33, P601, DOI 10.1007/s12272-010-0415-y
   Husain H, 2018, INT J BIOL MACROMOL, V111, P379, DOI 10.1016/j.ijbiomac.2017.12.168
   Ishigami T, 2001, PATHOL INT, V51, P491, DOI 10.1046/j.1440-1827.2001.01238.x
   Ishii Y, 2005, BIOL PHARM BULL, V28, P1087, DOI 10.1248/bpb.28.1087
   ISOGAI M, 1994, MOL CELL BIOCHEM, V136, P85, DOI 10.1007/BF00931609
   JENKINS SA, 1985, J HEPATOL, V1, P489, DOI 10.1016/S0168-8278(85)80747-9
   Juan ME, 2005, J NUTR, V135, P757, DOI 10.1093/jn/135.4.757
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   KAYANOKI Y, 1994, J BIOL CHEM, V269, P15488
   Krajka-Kuzniak V, 2012, FOOD CHEM TOXICOL, V50, P2027, DOI 10.1016/j.fct.2012.03.062
   Lee HS, 2009, DIGEST DIS SCI, V54, P782, DOI 10.1007/s10620-008-0404-x
   LII CK, 1994, ARCH BIOCHEM BIOPHYS, V308, P231, DOI 10.1006/abbi.1994.1033
   Liu XJ, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700267
   Low TY, 2004, PROTEOMICS, V4, P3960, DOI 10.1002/pmic.200400852
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Majumdar S, 2009, ENVIRON TOXICOL, V24, P377, DOI 10.1002/tox.20442
   Mallis RJ, 2002, BIOL CHEM, V383, P649, DOI 10.1515/BC.2002.067
   Matsuyama S, 2004, BIOCHEM BIOPH RES CO, V321, P386, DOI 10.1016/j.bbrc.2004.06.161
   Misawa H, 2001, NEUROSCIENCE, V105, P87, DOI 10.1016/S0306-4522(01)00147-6
   Nagata Kiyoshi, 2007, Journal of Toxicological Sciences, V32, P453, DOI 10.2131/jts.32.453
   NESTERENKO MV, 1994, J BIOCHEM BIOPH METH, V28, P239, DOI 10.1016/0165-022X(94)90020-5
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Orallo F., 2006, RESVERATROL HLTH DIS
   Räisänen SR, 1999, FASEB J, V13, P513, DOI 10.1096/fasebj.13.3.513
   Shang J, 2008, ACTA PHARMACOL SIN, V29, P698, DOI 10.1111/j.1745-7254.2008.00807.x
   Singh CK, 2015, ANN NY ACAD SCI, V1348, P150, DOI 10.1111/nyas.12798
   Son TG, 2006, MECH AGEING DEV, V127, P451, DOI 10.1016/j.mad.2006.01.005
   THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31
   TSUCHIDA S, 1992, CRIT REV BIOCHEM MOL, V27, P337, DOI 10.3109/10409239209082566
   Tsurusaki Y, 2002, J CELL BIOCHEM, V85, P516, DOI 10.1002/jcb.10153
   VANDERVIES J, 1954, BIOCHEM J, V57, P410, DOI 10.1042/bj0570410
   Vang O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019881
   Wells RG, 2005, J CLIN GASTROENTEROL, V39, pS158, DOI 10.1097/01.mcg.0000155516.02468.0f
   Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wong VS, 1998, J VIRAL HEPATITIS, V5, P187, DOI 10.1046/j.1365-2893.1998.00100.x
   Yamaguchi M, 2005, INT J MOL MED, V15, P371
NR 60
TC 12
Z9 12
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD NOV
PY 2018
VL 119
BP 1218
EP 1227
DI 10.1016/j.ijbiomac.2018.08.062
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA GX4FD
UT WOS:000447682100137
PM 30114422
DA 2024-02-19
ER

PT J
AU O'Brien, A
   Zhou, TH
   White, T
   Medford, A
   Chen, LX
   Kyritsi, K
   Wu, N
   Childs, J
   Stiles, D
   Ceci, L
   Chakraborty, S
   Ekser, B
   Baiocchi, L
   Carpino, G
   Gaudio, E
   Wu, CD
   Kennedy, L
   Francis, H
   Alpini, G
   Glaser, S
AF O'Brien, April
   Zhou, Tianhao
   White, Tori
   Medford, Abigail
   Chen, Lixian
   Kyritsi, Konstantina
   Wu, Nan
   Childs, Jonathan
   Stiles, Danaleigh
   Ceci, Ludovica
   Chakraborty, Sanjukta
   Ekser, Burcin
   Baiocchi, Leonardo
   Carpino, Guido
   Gaudio, Eugenio
   Wu, Chaodong
   Kennedy, Lindsey
   Francis, Heather
   Alpini, Gianfranco
   Glaser, Shannon
TI FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the
   Mdr2<SUP>-/-</SUP> Mouse Model of Primary Sclerosing Cholangitis
SO HEPATOLOGY COMMUNICATIONS
LA English
DT Article; Early Access
ID HEPATIC STELLATE CELL; MIR-16; EXPRESSION; CANCER; CHOLANGIOCYTES;
   DYSREGULATION; HYPERPLASIA; ACTIVATION; SENESCENCE; POTENT
AB Fibroblast growth factor 1 (FGF1) belongs to a family of growth factors involved in cellular growth and division. MicroRNA 16 (miR-16) is a regulator of gene expression, which is dysregulated during liver injury and insult. However, the role of FGF1 in the progression of biliary proliferation, senescence, fibrosis, inflammation, angiogenesis, and its potential interaction with miR-16, are unknown. In vivo studies were performed in male bile duct-ligated (BDL, 12-week-old) mice, multidrug resistance 2 knockout (Mdr2(-/-)) mice (10-week-old), and their corresponding controls, treated with recombinant human FGF1 (rhFGF1), fibroblast growth factor receptor (FGFR) antagonist (AZD4547), or anti-FGF1 monoclonal antibody (mAb). In vitro, the human cholangiocyte cell line (H69) and human hepatic stellate cells (HSCs) were used to determine the expression of proliferation, fibrosis, angiogenesis, and inflammatory genes following rhFGF1 treatment. PSC patient and control livers were used to evaluate FGF1 and miR-16 expression. Intrahepatic bile duct mass (IBDM), along with hepatic fibrosis and inflammation, increased in BDL mice treated with rhFGF1, with a corresponding decrease in miR-16, while treatment with AZD4547 or anti-FGF1 mAb decreased hepatic fibrosis, IBDM, and inflammation in BDL and Mdr2(-/-) mice. In vitro, H69 and HSCs treated with rhFGF1 had increased expression of proliferation, fibrosis, and inflammatory markers. PSC samples also showed increased FGF1 and FGFRs with corresponding decreases in miR-16 compared with healthy controls. Conclusion: Our study demonstrates that suppression of FGF1 and miR-16 signaling decreases the presence of hepatic fibrosis, biliary proliferation, inflammation, senescence, and angiogenesis. Targeting the FGF1 and miR-16 axis may provide therapeutic options in treating cholangiopathies such as PSC.
C1 [O'Brien, April; White, Tori; Medford, Abigail; Childs, Jonathan; Stiles, Danaleigh; Chakraborty, Sanjukta; Glaser, Shannon] Texas A&M Univ, Dept Med Physiol, Coll Med, MREBII Off 2342,8447 Riverside Pkwy, Bryan, TX 77807 USA.
   [Zhou, Tianhao; Chen, Lixian; Kyritsi, Konstantina; Wu, Nan; Ceci, Ludovica; Kennedy, Lindsey; Francis, Heather; Alpini, Gianfranco] Indiana Univ Sch Med, Div Gastroenterol & Hepatol, Dept Med, Indianapolis, IN 46202 USA.
   [Ekser, Burcin] Indiana Univ Sch Med, Dept Surg, Div Transplant Surg, Indianapolis, IN 46202 USA.
   [Baiocchi, Leonardo] Univ Tor Vergata Rome, Dept Med, Hepatol Unit, Rome, Italy.
   [Carpino, Guido] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Rome, Italy.
   [Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy.
   [Wu, Chaodong] Texas A&M Univ, Dept Nutr, College Stn, TX USA.
   [Kennedy, Lindsey; Francis, Heather; Alpini, Gianfranco] Richard L Roudebush VA Med Ctr, Res, Indianapolis, IN USA.
C3 Texas A&M University System; Texas A&M University College Station;
   Indiana University System; Indiana University Bloomington; Indiana
   University System; Indiana University Bloomington; University of Rome
   Tor Vergata; Foro Italico University of Rome; Sapienza University Rome;
   Texas A&M University System; Texas A&M University College Station; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   Richard L. Roudebush VA Medical Center
RP Glaser, S (corresponding author), Texas A&M Univ, Dept Med Physiol, Coll Med, MREBII Off 2342,8447 Riverside Pkwy, Bryan, TX 77807 USA.
EM sglaser@tamu.edu
RI Ekser, Burcin/I-3288-2019; Carpino, Guido/AAB-9692-2019
OI Ekser, Burcin/0000-0003-0741-8007; Childs, Jonathan/0000-0002-4633-4191;
   ceci, Ludovica/0000-0002-2131-8494; Chakraborty,
   Sanjukta/0000-0002-4869-3198; CARPINO, Guido/0000-0001-8570-2519
FU Foundation for the National Institutes of Health [DK054811, DK062975,
   DK076898, DK108959, DK110035, DK115184, DK119421]; Hickam Endowed Chair,
   Gastroenterology, Medicine, Indiana University; Indiana University
   Health --Indiana University School of Medicine Strategic Research
   Initiative; Senior Career Scientist Award; VA Merit award [1I01BX003031,
   1IK2BX005306]; United States Department of Veteran's Affairs; American
   Heart Association [17SDG33670306, CPRIT RP210213]; Biomedical Laboratory
   Research and Development Service; NIH [DK107310, AA028711]; PSC Partners
   Seeking a Cure
FX Supported by the Foundation for the National Institutes of Health
   (DK054811, DK062975, DK076898, DK108959, DK110035, DK115184, and
   DK119421). This work was supported by the Hickam Endowed Chair,
   Gastroenterology, Medicine, Indiana University, the Indiana University
   Health --Indiana University School of Medicine Strategic Research
   Initiative, the Senior Career Scientist Award and the VA Merit award
   (5I01BX000574) to GA and the Career Scientist Award and the VA Merit
   award (1I01BX003031) to HF, and Career Development Award--2 to LK
   (1IK2BX005306) from the United States Department of Veteran's Affairs,
   American Heart Association 17SDG33670306 (SC) and CPRIT RP210213 (SC),
   Biomedical Laboratory Research and Development Service and NIH grants
   DK107310, and AA028711 (GA and SG) and the PSC Partners Seeking a Cure
   (GA). Portions of these studies were supported by resources at the
   Richard L. Roudebush VA Medical Center, Indianapolis, IN, and Medical
   Physiology, Medical Research Building, Temple, TX. The views expressed
   in this article are those of the authors and do not necessarily
   represent the views of the Department of Veterans Affairs.
CR ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   An FM, 2012, APOPTOSIS, V17, P702, DOI 10.1007/s10495-012-0704-7
   Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69
   Baiocchi L, 2021, EXPERT OPIN INV DRUG, V30, P365, DOI 10.1080/13543784.2021.1854725
   Banales JM, 2019, NAT REV GASTRO HEPAT, V16, P269, DOI 10.1038/s41575-019-0125-y
   Bao LC, 2018, BRIT J PHARMACOL, V175, P3379, DOI 10.1111/bph.14383
   Dewidar B, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111419
   Ehrlich Laurent, 2018, Gene Expression, V18, P197, DOI 10.3727/105221618X15216453076707
   Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034
   Glaser S, 2010, HEPATOLOGY, V52, P204, DOI 10.1002/hep.23657
   Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025
   He QM, 2016, ONCOTARGET, V7, P3047, DOI 10.18632/oncotarget.6504
   Hirschfield GM, 2019, J HEPATOL, V70, P483, DOI 10.1016/j.jhep.2018.10.035
   Huda N, 2019, WORLD J GASTROENTERO, V25, P5069, DOI 10.3748/wjg.v25.i34.5069
   Itoh N, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00030
   Jung DJ, 2014, PFLUG ARCH EUR J PHY, V466, P1011, DOI 10.1007/s00424-013-1364-3
   Kennedy L, 2020, AM J PATHOL, V190, P1018, DOI 10.1016/j.ajpath.2020.01.013
   Kim KM, 2018, J HEPATOL, V68, P493, DOI 10.1016/j.jhep.2017.10.011
   Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037
   Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881
   Kyritsi K, 2020, GENE EXPRESSION, V20, P89, DOI 10.3727/105221620X15889714507961
   Li JT, 2008, J GASTROENTEROL, V43, P419, DOI 10.1007/s00535-008-2180-y
   Li L, 2014, HEPATOLOGY, V60, P896, DOI 10.1002/hep.27050
   Li XK, 2019, FRONT MED-PRC, V13, P511, DOI 10.1007/s11684-019-0711-y
   Li ZY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178580
   Lin H, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01515
   Lindström L, 2018, SCAND J GASTROENTERO, V53, P297, DOI 10.1080/00365521.2017.1421705
   Link A, 2013, ADV CLIN CHEM, V62, P221, DOI 10.1016/B978-0-12-800096-0.00006-8
   Nakamura I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092273
   Nallagangula KS, 2018, FUTUR SCI OA, V4, DOI 10.4155/fsoa-2017-0083
   Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229
   Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7
   Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025
   Qu YH, 2017, ONCOTARGET, V8, P72400, DOI 10.18632/oncotarget.20398
   Rizvi S, 2016, J BIOL CHEM, V291, P8031, DOI 10.1074/jbc.M115.698472
   Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262
   Schelch K, 2018, MOL ONCOL, V12, P58, DOI 10.1002/1878-0261.12150
   Schoch A, 2014, LAB ANIMAL, V43, P95, DOI 10.1038/laban.481
   Schumacher JD, 2020, HEPATOLOGY, V71, P670, DOI 10.1002/hep.30810
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Wang C, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00601
   Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190
   Wu N, 2020, HEPATOLOGY, V72, P2219, DOI 10.1002/hep.31484
   Wunsch E, 2015, SCI REP-UK, V5, DOI 10.1038/srep13462
   Xu ZP, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00052
   Yao TJ, 2015, TUMOR BIOL, V36, P5641, DOI 10.1007/s13277-015-3237-1
   Ye DW, 2016, SCI REP-UK, V6, DOI 10.1038/srep19776
   Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5
   Zhou TH, 2019, EBIOMEDICINE, V48, P130, DOI 10.1016/j.ebiom.2019.09.013
NR 49
TC 1
Z9 1
U1 1
U2 3
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
EI 2471-254X
J9 HEPATOL COMMUN
JI Hepatol. Commun.
PD 2022 JUL
PY 2022
VL 6
IS 7
BP 1574
EP 1588
DI 10.1002/hep4.1909
EA MAR 2022
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 2J8RV
UT WOS:000766774300001
PM 35271760
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Hilmer, SN
   Cogger, VC
   Fraser, R
   McLean, AJ
   Sullivan, D
   Le Couteur, DG
AF Hilmer, SN
   Cogger, VC
   Fraser, R
   McLean, AJ
   Sullivan, D
   Le Couteur, DG
TI Age-related changes in the hepatic sinusoidal endothelium impede
   lipoprotein transfer in the rat
SO HEPATOLOGY
LA English
DT Article
ID LIVER SIEVE; CIRRHOSIS; PSEUDOCAPILLARIZATION; ATHEROSCLEROSIS;
   CHOLESTEROL; METABOLISM; CLEARANCE; DISEASE
AB The mechanisms for the association of old age with post-prandial hyperlipidernia and atherosclerosis are not well understood. Post-prandial hyperlipidemia has emerged as a significant risk for atherosclerosis. The liver is the central organ for lipoprotein metabolism. The initial step in the hepatic uptake of post-prandial lipoproteins is their transfer from the hepatic sinusoidal capillary lumen across the hepatic sinusoidal endothelium into the space of Disse. Here, they access hepatocytes for receptor-mediated uptake. We proposed that fenestrations (pores) within the hepatic sinusoidal endothelium filter lipoproteins on the basis of size. Recently we discovered age-related changes in the sinusoidal endothelium (pseudocapillarization), including reduction in the porosity of the endothelium. Using the impulse response technique in perfused rat livers, we found that aging is associated with impaired hepatic transendothelial transfer of chylomicrons with diameters smaller than those of fenestrations. In conclusion, age-related pseudocapillarization of the hepatic sinusoidal endothelium provides a novel mechanism for the association of old age with impaired hepatic lipoprotein metabolism and with atherosclerosis.
C1 Univ Sydney, Ctr Educ & Res Ageing, Concord RG Hosp, Concord, NSW 2139, Australia.
   Univ Sydney, ANZAC Res Inst, Concord RG Hosp, Concord, NSW 2139, Australia.
   Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Pathol, Christchurch, New Zealand.
   Melbourne Hlth, Natl Ageing Res Inst, Parkville, Vic, Australia.
   Univ Melbourne, Parkville, Vic 3052, Australia.
   Royal Prince Alfred Hosp, Dept Biochem, Camperdown, NSW 2050, Australia.
C3 Concord Repatriation General Hospital; University of Sydney; Concord
   Repatriation General Hospital; University of Sydney; ANZAC Research
   Institute; University of Otago; National Ageing Research Institute;
   University of Melbourne; University of Sydney; NSW Health; Royal Prince
   Alfred Hospital
RP Hilmer, SN (corresponding author), Univ Sydney, Ctr Educ & Res Ageing, Concord RG Hosp, Hosp Rd, Concord, NSW 2139, Australia.
EM shilmer@med.usyd.edu.an
RI Research Institute, ANZAC/CAE-9030-2022; Ekanayake,
   Kanchana/P-8817-2016; Hilmer, Sarah/AAW-8554-2020
OI Hilmer, Sarah/0000-0002-5970-1501; Le Couteur, David/0000-0002-4227-5817
CR Borel P, 1998, J GERONTOL A-BIOL, V53, pB133, DOI 10.1093/gerona/53A.2.B133
   CLARK SA, 1988, LANCET, V2, P1225
   Cogger VC, 2004, J HEPATOL, V41, P370, DOI 10.1016/j.jhep.2004.04.034
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1
   FRASER R, 1980, BRIT J EXP PATHOL, V61, P222
   FRASER R, 1978, ATHEROSCLEROSIS, V29, P113, DOI 10.1016/0021-9150(78)90001-1
   GARIEPY L, 1993, HEPATOLOGY, V18, P823, DOI 10.1002/hep.1840180412
   GOLDSTEIN JL, 1987, CIRCULATION, V76, P504, DOI 10.1161/01.CIR.76.3.504
   GORESKY CA, 1992, HEPATOLOGY, V16, P173, DOI 10.1002/hep.1840160129
   GORESKY CA, 1963, AM J PHYSIOL, V204, P626
   Havel RJ, 2004, ARTERIOSCL THROM VAS, V24, P213, DOI 10.1161/01.ATV.0000115382.53810.24
   Hazzard W R, 1992, Clin Geriatr Med, V8, P89
   HUET PM, 1982, J CLIN INVEST, V70, P1234, DOI 10.1172/JCI110722
   Kannel William B, 2002, Am J Geriatr Cardiol, V11, P101, DOI 10.1111/j.1076-7460.2002.00995.x
   KRASINSKI SD, 1990, J CLIN INVEST, V85, P883, DOI 10.1172/JCI114515
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   Le Couteur DG, 2005, CLIN PHARMACOKINET, V44, P187, DOI 10.2165/00003088-200544020-00004
   Le Couteur DG, 1999, J PHARMACOL EXP THER, V289, P1553
   Le Couteur DG, 2002, LANCET, V359, P1612, DOI 10.1016/S0140-6736(02)08524-0
   Le Couteur DG, 2001, HEPATOLOGY, V33, P537, DOI 10.1053/jhep.2001.22754
   LECOUTEUR D, 1995, INT HEPATOL COMMUN, V3, P244, DOI 10.1016/0928-4346(94)00186-9
   MADARAME T, 1993, CELLS HEPATIC SINUSO, V4, P191
   McLean AJ, 2003, J PATHOL, V200, P112, DOI 10.1002/path.1328
   MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731
   REDGRAVE T G, 1970, Journal of Clinical Investigation, V49, P465, DOI 10.1172/JCI106255
   Reichen J, 1999, NEWS PHYSIOL SCI, V14, P117, DOI 10.1152/physiologyonline.1999.14.3.117
   ROGERS GWT, 1992, LIVER, V12, P326
   Simons LA, 2001, ATHEROSCLEROSIS, V159, P201, DOI 10.1016/S0021-9150(01)00495-6
   Steg PG, 2002, AM J CARDIOL, V90, P358, DOI 10.1016/S0002-9149(02)02489-X
   VARIN F, 1985, J CLIN INVEST, V76, P1904, DOI 10.1172/JCI112186
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427
   Yu KC, 2001, FRONT BIOSCI, V6, P332
   ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473
NR 35
TC 103
Z9 108
U1 1
U2 3
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD DEC
PY 2005
VL 42
IS 6
BP 1349
EP 1354
DI 10.1002/hep.20937
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 989TS
UT WOS:000233697400017
PM 16317689
DA 2024-02-19
ER

PT J
AU Jung, JC
   Park, GT
   Kim, KH
   Woo, JH
   An, JM
   Kim, KC
   Chung, HY
   Bae, YS
   Park, JW
   Kang, SS
   Lee, YS
AF Jung, JC
   Park, GT
   Kim, KH
   Woo, JH
   An, JM
   Kim, KC
   Chung, HY
   Bae, YS
   Park, JW
   Kang, SS
   Lee, YS
TI Differential expression of transforming growth factor-β in the
   interstitial tissue of testis during aging
SO JOURNAL OF CELLULAR BIOCHEMISTRY
LA English
DT Article
DE senescence; TGF-beta; testis
ID RECEPTORS; PROTEIN; FETAL; FACTOR-BETA-3; SENESCENCE; APOPTOSIS; CELLS;
   FAS
AB Transforming growth factor-betas (TGF-betas) have significant effects on testis development. The pattern of TGF-beta expression in aging testis has not been established to date. We examined age-related changes in the expression of TGF-beta and its receptors in the testis using Western blot analysis. TGF-beta1 expression increased continuously in aging rat testis, whereas no age-associated changes were observed for TGF-beta3. Strong expression of TGF-beta2, as well as type I and 11 receptors was observed in 12-month-old testis, but following this time, expression decreased dramatically. Interestingly, TGF-beta2 and -beta3 displayed strong and similar expression patterns in liver, regardless of age, suggesting that the down-regulation of TGF-beta2 is testis-specific. We observed significant induction of p53 and p21(WAF1) in 18-month-old testis that appeared to correspond with aging. Moreover, caloric restriction (CR) prevented age-related decrease in TGF-beta2 expression. Using immunohistochemistry, we showed that all TGF-beta1, -beta2, and -beta3 proteins are expressed primarily in interstitial cells, which are located in the space between adjoining seminiferous tubules. Our data collectively indicate that aging in the testis is regulated by differential expression of TGF-beta proteins, and decreased levels of TGF-beta2 contribute to the aging process. (C) 2004 Wiley-Liss, Inc.
C1 Kyungpook Natl Univ, Dept Biochem, Coll Nat Sci, Taegu 702701, South Korea.
   Kyungpook Natl Univ, Dept Biol, Coll Nat Sci, Taegu 702701, South Korea.
   Pusan Natl Univ, Coll Pharm, Dept Pharm, Pusan 609735, South Korea.
   Korea Res Inst Biosci & Biotechnol, Taejon 305333, South Korea.
C3 Kyungpook National University; Kyungpook National University; Pusan
   National University; Korea Research Institute of Bioscience &
   Biotechnology (KRIBB)
RP Lee, YS (corresponding author), Kyungpook Natl Univ, Dept Biochem, Coll Nat Sci, Taegu 702701, South Korea.
EM yselee@knu.ac.kr
OI Bae, Young-Seuk/0000-0002-5520-4444
FU NIA NIH HHS [AG 01188] Funding Source: Medline
CR AVALLET O, 1987, BIOCHEM BIOPH RES CO, V146, P575, DOI 10.1016/0006-291X(87)90567-5
   Baillie R, 1996, EUR J CANCER, V32A, P1566, DOI 10.1016/0959-8049(96)00115-3
   BENTON L, 1995, J STEROID BIOCHEM, V53, P61, DOI 10.1016/0960-0760(95)00022-R
   Chan CW, 1999, ALZHEIMERS REP, V2, P113
   Embree-Ku M, 2002, BIOL REPROD, V66, P1456, DOI 10.1095/biolreprod66.5.1456
   FLAUMENHAFT R, 1993, J CELL BIOL, V120, P995, DOI 10.1083/jcb.120.4.995
   Gautier C, 1997, BIOCHEM BIOPH RES CO, V236, P135, DOI 10.1006/bbrc.1997.6914
   Han ZY, 2002, J BIOL CHEM, V277, P17154, DOI 10.1074/jbc.M112401200
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   HUHTANIEMI IT, 1981, ENDOCRINOLOGY, V109, P588, DOI 10.1210/endo-109-2-588
   Ingman WV, 2002, BIOESSAYS, V24, P904, DOI 10.1002/bies.10155
   LEMAGUERESSEBATTISTONI B, 1995, ENDOCRINOLOGY, V136, P2788, DOI 10.1210/en.136.6.2788
   Lin PL, 2002, INT J ONCOL, V21, P261
   LORDING DW, 1972, J REPROD FERTIL, V29, P261
   Lui WY, 2001, ENDOCRINOLOGY, V142, P1865, DOI 10.1210/en.142.5.1865
   Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660
   MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x
   MULLANEY BP, 1993, MOL ENDOCRINOL, V7, P67, DOI 10.1210/me.7.1.67
   Narula A, 2002, AM J PATHOL, V161, P1723, DOI 10.1016/S0002-9440(10)64449-5
   OHTA H, 2003, BIOL REPROD, V27, P299
   Ohta Y, 1996, ACTA ANAT, V157, P195
   Olaso R, 1998, HISTOCHEM CELL BIOL, V110, P613, DOI 10.1007/s004180050324
   Robinson LLL, 2001, MOL HUM REPROD, V7, P845, DOI 10.1093/molehr/7.9.845
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   TEERDS KJ, 1993, BIOL REPROD, V48, P40, DOI 10.1095/biolreprod48.1.40
   WATRIN F, 1991, CELL GROWTH DIFFER, V2, P77
   Yin YZ, 2002, J ANDROL, V23, P64, DOI 10.1002/jand.2002.23.1.64
NR 27
TC 10
Z9 13
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0730-2312
EI 1097-4644
J9 J CELL BIOCHEM
JI J. Cell. Biochem.
PD MAY 1
PY 2004
VL 92
IS 1
BP 92
EP 98
DI 10.1002/jcb.20042
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 818IT
UT WOS:000221239500009
PM 15095406
DA 2024-02-19
ER

PT J
AU Mármol, F
   Sánchez, J
   López, D
   Martínez, N
   Xaus, C
   Peralta, C
   Roselló-Catafau, J
   Mitjavila, MT
   Puig-Parellada, P
AF Marmol, F.
   Sanchez, J.
   Lopez, D.
   Martinez, N.
   Xaus, C.
   Peralta, C.
   Rosello-Catafau, J.
   Mitjavila, M. T.
   Puig-Parellada, P.
TI Role of Oxidative Stress and Adenosine Nucleotides in the Liver of Aging
   Rats
SO PHYSIOLOGICAL RESEARCH
LA English
DT Article
DE Adenosine nucleotides; Liver; Nitric oxide; Oxidative stress; Rats
ID SUPEROXIDE-DISMUTASE ACTIVITY; NITRIC-OXIDE; ANTIOXIDANT ENZYMES;
   LIPID-PEROXIDATION; REACTIVE OXYGEN; NADPH OXIDASE; LIFE-SPAN; DAMAGE;
   CATALASE; BRAIN
AB We studied the response of several parameters related to oxidative stress in the liver of aging rats. Male Wistar rats aged 1.5, 3, 18 and 24 months were used. Livers showed an increase in superoxide anion (O-2(-)) concentration at 1.5 and 18 months of age compared to the 3-month-old group; a decrease in superoxide dismutase (SOD) was seen at 1.5 months and catalase concentrations remained unaltered throughout the aging process. Nitric oxide (NO) progressively declined with age; a significant decrease was particularly apparent at 18 and 24 months of age. Thiobarbituric acid reactive substances (TBARS) decreased significantly at 1.5 months, whereas it increased at 18 and 24 months of age. Concentrations of prostaglandin E-2 (PGE(2)), and adenine nucleotides, and their metabolites, remained unchanged throughout the aging process. Although the mitochondrial damage caused by oxidative stress can result in reduced ATP production and compromised cell function, our results on adenosine nucleotides and their metabolites support the notion that the integrity of mitochondria and enzymatic activity remain mostly unchanged with aging. In conclusion, we observed a significant decrease in the levels of NO in the older groups of rats and hence in its antioxidant activity. This could explain the observed increase in lipid peroxides which suggests an important role for NO in oxidative stress in the liver of older rats.
C1 [Marmol, F.; Sanchez, J.; Puig-Parellada, P.] Univ Barcelona, Fac Med, Pharmacol Unit, IDIBAPS, Casanova 143, Barcelona 08036, Spain.
   [Lopez, D.; Martinez, N.; Mitjavila, M. T.] Univ Barcelona, Fac Biol, Dept Physiol, Barcelona 08036, Spain.
   [Xaus, C.; Rosello-Catafau, J.] IDIBAPS, Hepatol Unit, Barcelona, Spain.
   [Peralta, C.] IDIBAPS, Sect Biol Aggress & Mech Def, Barcelona, Spain.
C3 University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS;
   University of Barcelona; University of Barcelona; Hospital Clinic de
   Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de
   Barcelona; IDIBAPS
RP Puig-Parellada, P (corresponding author), Univ Barcelona, Fac Med, Pharmacol Unit, IDIBAPS, Casanova 143, Barcelona 08036, Spain.
EM ppuigp@ub.edu
RI Peralta, Carmen/M-8170-2014; Mitjavila, Maria Teresa/D-7474-2014;
   Catafau, Joan Roselló/Z-4638-2019
OI Peralta, Carmen/0000-0002-5767-0676; Mitjavila, Maria
   Teresa/0000-0002-1550-6253; Rosello-Catafau, Joan/0000-0001-7127-4883
FU FIS [PI 05/2629]
FX This paper was supported by the FIS PI 05/2629. We are grateful to Robin
   Rycroft for valuable assistance in the preparation of the manuscript.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Cutler RG, 1995, AGE, V18, P91, DOI 10.1007/BF02436084
   De Minicis S, 2006, GASTROENTEROLOGY, V131, P272, DOI 10.1053/j.gastro.2006.05.048
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DEVASAGAYAM TPA, 1986, FEBS LETT, V199, P203, DOI 10.1016/0014-5793(86)80480-X
   Di Massimo C, 2006, LIFE SCI, V78, P1163, DOI 10.1016/j.lfs.2005.06.037
   DogruAbbasoglu S, 1997, MECH AGEING DEV, V98, P177, DOI 10.1016/S0047-6374(97)00082-1
   Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003
   Ehrenbrink G, 2006, EXP GERONTOL, V41, P368, DOI 10.1016/j.exger.2006.02.007
   Faraci FM, 2004, ARTERIOSCL THROM VAS, V24, P1367, DOI 10.1161/01.ATV.0000133604.20182.cf
   Farzaneh-Far R, 2001, LIVER, V21, P161, DOI 10.1034/j.1600-0676.2001.021003161.x
   Gudkov SV, 2006, RADIAT RES, V165, P538, DOI 10.1667/RR3552.1
   Harper ME, 2004, ACTA PHYSIOL SCAND, V182, P321, DOI 10.1111/j.1365-201X.2004.01370.x
   Hossain MA, 2006, CURR PHARM DESIGN, V12, P2935, DOI 10.2174/138161206777947678
   Hummel SG, 2006, FREE RADICAL BIO MED, V40, P501, DOI 10.1016/j.freeradbiomed.2005.08.047
   Jaeschke H, 2000, J GASTROEN HEPATOL, V15, P718, DOI 10.1046/j.1440-1746.2000.02207.x
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   Krause KH, 2007, EXP GERONTOL, V42, P256, DOI 10.1016/j.exger.2006.10.011
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maria CS, 1996, FREE RADICAL RES, V25, P401, DOI 10.3109/10715769609149062
   MARKLUND L, 1985, HDB METHODS OXYGEN R, P243
   Mármol F, 2007, J PHYSIOL BIOCHEM, V63, P239, DOI 10.1007/BF03165787
   Mármol F, 2009, J PHARM PHARMACOL, V61, P201, DOI 10.1211/jpp/61.02.0009
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   Orr WC, 2003, EXP GERONTOL, V38, P227, DOI 10.1016/S0531-5565(02)00263-2
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PAGANO PJ, 1995, AM J PHYSIOL-HEART C, V268, pH2274, DOI 10.1152/ajpheart.1995.268.6.H2274
   PARK SW, 1986, BIOCHEM INT, V13, P827
   PIEPER GM, 1995, DIABETES, V44, P884, DOI 10.2337/diabetes.44.8.884
   Puerto M, 2005, J NEUROIMMUNOL, V165, P33, DOI 10.1016/j.jneuroim.2005.03.021
   RECKELHOFF JF, 1994, LIFE SCI, V55, P1895, DOI 10.1016/0024-3205(94)00521-4
   Schneider L, 2006, AM J SURG, V191, P510, DOI 10.1016/j.amjsurg.2005.09.009
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9
   Suzuki H, 1995, ADV NEUROIMMUNOL, V5, P379, DOI 10.1016/0960-5428(95)00024-0
   Van Remmen H, 2001, EXP GERONTOL, V36, P957
   Vanin AF, 1999, METHOD ENZYMOL, V301, P269
NR 39
TC 17
Z9 24
U1 1
U2 5
PU ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY
PI PRAGUE 4
PA VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0862-8408
EI 1802-9973
J9 PHYSIOL RES
JI Physiol. Res.
PY 2010
VL 59
IS 4
BP 553
EP 560
DI 10.33549/physiolres.931768
PG 8
WC Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology
GA 653AQ
UT WOS:000282054700009
PM 19929140
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Ma, JL
   Hong, Y
   Zheng, NN
   Xie, GX
   Lyu, YZ
   Gu, Y
   Xi, CC
   Chen, LL
   Wu, GS
   Li, Y
   Tao, X
   Zhong, J
   Huang, ZZ
   Wu, WB
   Yuan, L
   Lin, M
   Lu, X
   Zhang, WD
   Jia, W
   Sheng, LL
   Li, HK
AF Ma, Junli
   Hong, Ying
   Zheng, Ningning
   Xie, Guoxiang
   Lyu, Yuanzhi
   Gu, Yu
   Xi, Chuchu
   Chen, Linlin
   Wu, Gaosong
   Li, Yue
   Tao, Xin
   Zhong, Jing
   Huang, Zhenzhen
   Wu, Wenbin
   Yuan, Lin
   Lin, Min
   Lu, Xiong
   Zhang, Weidong
   Jia, Wei
   Sheng, Lili
   Li, Houkai
TI Gut microbiota remodeling reverses aging-associated inflammation and
   dysregulation of systemic bile acid homeostasis in mice sex-specifically
SO GUT MICROBES
LA English
DT Article
DE Aging; inflammation; gut microbiota; bile acid composition; sex
   difference
ID ALZHEIMERS-DISEASE; GENE-EXPRESSION; RECEPTOR ACTIVATION; PRIMARY
   HEPATOCYTES; LIVER-CANCER; FAS RECEPTOR; AGE; METABOLISM; DIET; FXR
AB Aging is usually characterized with inflammation and disordered bile acids (BAs) homeostasis, as well as gut dysbiosis. The pathophysiological changes during aging are also sexual specific. However, it remains unclear about the modulating process among gut microbiota, BA metabolism, and inflammation during aging. In this study, we established a direct link between gut microbiota and BA profile changes in the liver, serum, and four intestinal segments of both sexes during aging and gut microbiota remodeling by co-housing old mice with young ones. We found aging reduced Actinobacteria in male mice but increased Firmicutes in female mice. Among the top 10 altered genera with aging, 4 genera changed oppositely between male and female mice, and most of the changes were reversed by co-housing in both sexes. Gut microbiota remodeling by co-housing partly rescued the systemically dysregulated BA homeostasis induced by aging in a sex- and tissue-specific manner. Aging had greater impacts on hepatic BA profile in females, but intestinal BA profile in males. In addition, aging increased hepatic and colonic deoxycholic acid in male mice, but reduced them in females. Moreover, muricholic acids shifted markedly in the intestine, especially in old male mice, and partially reversed by co-housing. Notably, the ratios of primary to secondary BAs in the liver, serum, and all four intestinal segments were increased in old mice and reduced by co-housing in both sexes. Together, the presented data revealed that sex divergent changes of gut microbiota and BA profile in multiple body compartments during aging and gut microbiota remodeling, highlighting the sex-specific prevention and treatment of aging-related disorders by targeting gut microbiota-regulated BA metabolism should particularly be given more attention.
C1 [Ma, Junli; Hong, Ying; Zheng, Ningning; Gu, Yu; Xi, Chuchu; Chen, Linlin; Wu, Gaosong; Tao, Xin; Zhong, Jing; Zhang, Weidong; Sheng, Lili; Li, Houkai] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Funct Metabol & Gut Microbiome Lab, Shanghai 201203, Peoples R China.
   [Xie, Guoxiang] Human Metabol Inst Inc, Shenzhen, Guangdong, Peoples R China.
   [Lyu, Yuanzhi] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.
   [Li, Yue] Fudan Univ, Shanghai Peoples Hosp 5, Dept Endocrinol, Shanghai, Peoples R China.
   [Zhong, Jing] Huzhou Univ, Affiliated Cent Hosp, Huzhou Cent Hosp, Huzhou Key Lab Mol Med, Huzhou, Peoples R China.
   [Huang, Zhenzhen; Wu, Wenbin; Yuan, Lin; Lin, Min; Lu, Xiong] Shanghai Univ Tradit Chinese Med, Expt Ctr Sci & Technol, Shanghai, Peoples R China.
   [Zhang, Weidong] Second Mil Med Univ, Coll Pharm, Dept Phytochem, Shanghai, Peoples R China.
   [Jia, Wei] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China.
   [Jia, Wei] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China.
   [Jia, Wei] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong Tradit Chinese Med Phenome Res Ctr, Kowloon Tong, Hong Kong, Peoples R China.
C3 Shanghai University of Traditional Chinese Medicine; University of
   California System; University of California Davis; Fudan University;
   Huzhou University; Shanghai University of Traditional Chinese Medicine;
   Naval Medical University; Shanghai Jiao Tong University; Shanghai Jiao
   Tong University; Hong Kong Baptist University
RP Sheng, LL; Li, HK (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Funct Metabol & Gut Microbiome Lab, Shanghai 201203, Peoples R China.; Jia, W (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Chinese Med Clin Study Ctr, Hong Kong, Peoples R China.
EM weijia1@hkbu.edu.hk; fine919@163.com; houkai1976@126.com
RI Wu, Gaosong/L-8844-2019; li, houkai/S-6785-2019
OI Wu, Gaosong/0000-0002-7548-1588; li, houkai/0000-0003-2846-7895; Jia,
   Wei/0000-0002-3739-8994; Yue, Li/0000-0001-5603-104X
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bäuerl C, 2018, LETT APPL MICROBIOL, V66, P464, DOI 10.1111/lam.12882
   Bárcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5
   Belikov AV, 2019, AGEING RES REV, V49, P11, DOI 10.1016/j.arr.2018.11.002
   Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016
   Bodogai M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat4271
   BOHNSACK JF, 1986, ANNU REV MED, V37, P49, DOI 10.1146/annurev.me.37.020186.000405
   Canfora EE, 2019, NAT REV ENDOCRINOL, V15, P261, DOI 10.1038/s41574-019-0156-z
   Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002
   DAI ZC, 1991, CHINESE MED J-PEKING, V104, P795
   de La Cuesta-Zuluag J, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00261-19
   De Wolfe TJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204253
   Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01385
   Fu ZD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032551
   Gadaleta RM, 2015, BBA-MOL CELL BIOL L, V1851, P30, DOI 10.1016/j.bbalip.2014.08.005
   Gao XH, 2018, P NATL ACAD SCI USA, V115, pE2960, DOI 10.1073/pnas.1720696115
   Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002
   Gentile CL, 2018, SCIENCE, V362, P776, DOI 10.1126/science.aau5812
   Gerard Philippe, 2013, Pathogens, V3, P14, DOI 10.3390/pathogens3010014
   Grut M, 1998, EUR J EPIDEMIOL, V14, P311, DOI 10.1023/A:1007431627515
   Gupta S, 2004, J BIOL CHEM, V279, P5821, DOI 10.1074/jbc.M310979200
   Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809
   HILL MJ, 1983, GUT, V24, P871, DOI 10.1136/gut.24.10.871
   Hu X, 2014, J INTERN MED, V275, P27, DOI 10.1111/joim.12140
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103
   Islami F, 2017, CA-CANCER J CLIN, V67, P273, DOI 10.3322/caac.21402
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   Jena PK, 2018, J NUTR BIOCHEM, V57, P246, DOI 10.1016/j.jnutbio.2018.04.007
   Jia W, 2020, MED RES REV, V40, P1496, DOI 10.1002/med.21653
   Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119
   Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003
   Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200
   Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249
   Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9
   Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008
   Lepercq P, 2004, FEMS MICROBIOL LETT, V235, P65, DOI [10.1111/j.1574-6968.2004.tb09568.x, 10.1016/j.femsle.2004.04.011]
   Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384
   Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x
   Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   Martínez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09
   Martínez-Augustin O, 2008, WORLD J GASTROENTERO, V14, P5630, DOI 10.3748/wjg.14.5630
   Messaoudi M, 2011, GUT MICROBES, V2, P256, DOI 10.4161/gmic.2.4.16108
   Morris A, 2018, NAT REV ENDOCRINOL, V15, P4, DOI 10.1038/s41574-018-0127-9
   Munro CA, 2014, INT PSYCHOGERIATR, V26, P1579, DOI 10.1017/S1041610214001549
   NAGENGAST FM, 1988, DIGEST DIS SCI, V33, P673, DOI 10.1007/BF01540429
   Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502
   Parséus A, 2017, GUT, V66, P429, DOI 10.1136/gutjnl-2015-310283
   Purim O, 2013, MED SCI MONITOR, V19, P203, DOI 10.12659/MSM.883842
   Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629
   Rea IM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00586
   Rehman Tayyab, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P361
   Ridlon JM, 2013, GUT MICROBES, V4, P382, DOI 10.4161/gmic.25723
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Rizzetto L, 2018, J AUTOIMMUN, V92, P12, DOI 10.1016/j.jaut.2018.05.008
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sânchez B, 2018, NAT REV GASTRO HEPAT, V15, DOI 10.1038/nrgastro.2018.23
   Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003
   Sheng LL, 2018, FASEB J, V32, P6371, DOI 10.1096/fj.201800370R
   Sheng LL, 2017, J PATHOL, V243, P431, DOI 10.1002/path.4983
   Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9
   Song PZ, 2015, TOXICOL APPL PHARM, V283, P57, DOI 10.1016/j.taap.2014.12.005
   Song ZW, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0628-3
   Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Tower J, 2017, TRENDS ENDOCRIN MET, V28, P735, DOI 10.1016/j.tem.2017.07.002
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Vaiserman AM, 2017, AGEING RES REV, V35, P36, DOI 10.1016/j.arr.2017.01.001
   Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013
   van der Lugt B, 2018, AGING-US, V10, P930, DOI 10.18632/aging.101439
   Wahlström A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005
   Wan Yu-Jui Yvonne, 2018, Liver Res, V2, P180, DOI 10.1016/j.livres.2018.09.008
   Wang HW, 2011, J CLIN INVEST, V121, P3220, DOI 10.1172/JCI41514
   WINGARD DL, 1984, ANNU REV PUBL HEALTH, V5, P433, DOI 10.1146/annurev.pu.05.050184.002245
   Wong MW, 2017, ALZHEIMERS DEMENT, V13, P810, DOI 10.1016/j.jalz.2017.01.008
   Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x
   Xie GX, 2016, INT J CANCER, V139, P1764, DOI 10.1002/ijc.30219
   Xie GX, 2015, J PROTEOME RES, V14, P850, DOI 10.1021/pr500920q
   Xie GX, 2013, FASEB J, V27, P3583, DOI 10.1096/fj.13-231860
   Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078
   Yang H, 2016, PHYSIOL BEHAV, V163, P167, DOI 10.1016/j.physbeh.2016.05.031
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yui S, 2009, NUTR CANCER, V61, P374, DOI 10.1080/01635580802582744
NR 91
TC 57
Z9 62
U1 8
U2 47
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1949-0976
EI 1949-0984
J9 GUT MICROBES
JI Gut Microbes
PY 2020
VL 11
IS 5
BP 1450
EP 1474
DI 10.1080/19490976.2020.1763770
PG 25
WC Gastroenterology & Hepatology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Microbiology
GA OS5XC
UT WOS:000590235500022
PM 32515683
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Brain, JG
   Robertson, H
   Thompson, E
   Humphreys, EH
   Gardner, A
   Booth, TA
   Jones, DEJ
   Afford, SC
   von Zglinicki, T
   Burt, AD
   Kirby, JA
AF Brain, J. G.
   Robertson, H.
   Thompson, E.
   Humphreys, E. H.
   Gardner, A.
   Booth, T. A.
   Jones, D. E. J.
   Afford, S. C.
   von Zglinicki, T.
   Burt, A. D.
   Kirby, J. A.
TI Biliary Epithelial Senescence and Plasticity in Acute Cellular Rejection
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Article
DE Liver; epithelial de-differentiation; biliary disease; allograft
   rejection
ID LIVER-ALLOGRAFT-REJECTION; SMALL BILE-DUCTS; MESENCHYMAL TRANSITION;
   TGF-BETA; CELLS; GROWTH; ACTIVATION; THROMBOSPONDIN-1; TRANSPLANTATION;
   FIBROGENESIS
AB Biliary epithelial cells (BEC) are important targets in some liver diseases, including acute allograft rejection. Although some injured BEC die, many can survive in function compromised states of senescence or phenotypic de-differentiation. This study was performed to examine changes in the phenotype of BEC during acute liver allograft rejection and the mechanism driving these changes. Liver allograft sections showed a positive correlation (p<0.0013) between increasing T cell mediated acute rejection and the number of BEC expressing the senescence marker p21WAF1/Cip or the mesenchymal marker S100A4. This was modeled in vitro by examination of primary or immortalized BEC after acute oxidative stress. During the first 48h, the expression of p21WAF1/Cip was increased transiently before returning to baseline. After this time BEC showed increased expression of mesenchymal proteins with a decrease in epithelial markers. Analysis of TGF- expression at mRNA and protein levels also showed a rapid increase in TGF-2 (p<0.006) following oxidative stress. The epithelial de-differentiation observed in vitro was abrogated by pharmacological blockade of the ALK-5 component of the TGF- receptor. These data suggest that stress induced production of TGF-2 by BEC can modify liver allograft function by enhancing the de-differentiation of local epithelial cells.
C1 [Brain, J. G.; Robertson, H.; Thompson, E.; Gardner, A.; Booth, T. A.; Jones, D. E. J.; Kirby, J. A.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Humphreys, E. H.; Afford, S. C.] Univ Birmingham, Liver Res Ctr, Sch Infect & Immun, Birmingham, W Midlands, England.
   [von Zglinicki, T.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Burt, A. D.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
C3 Newcastle University - UK; University of Birmingham; Newcastle
   University - UK; Newcastle University - UK
RP Kirby, JA (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM john.kirby@ncl.ac.uk
RI Humphreys, Elizabeth H/I-5090-2015; Burt, Alastair D/D-3634-2013;
   Gardner, Aaron/H-1511-2012
OI Humphreys, Elizabeth H/0000-0002-6742-7485; Burt, Alastair
   D/0000-0002-3011-7774; Gardner, Aaron/0000-0001-8729-9823; von
   Zglinicki, Thomas/0000-0002-5939-0248; Kirby, John/0000-0003-2543-4131
FU Wellcome Trust; NIHR Biomedical Research Centre for Ageing and
   Age-related Disease; NIHR Biomedical Research Centre (BRC);
   Biotechnology and Biological Sciences Research Council [BB/F010966/1,
   BB/I020748/1] Funding Source: researchfish; Medical Research Council
   [G0601333, MR/K501037/1, MR/L001489/1] Funding Source: researchfish;
   National Institute for Health Research [IS-BRC-0211-10046,
   ACF-2008-01-009] Funding Source: researchfish; NIHR Newcastle Biomedical
   Research Centre [BH121729] Funding Source: researchfish; BBSRC
   [BB/I020748/1, BB/F010966/1] Funding Source: UKRI; MRC [G0601333,
   MR/L001489/1] Funding Source: UKRI
FX J.G.B. is in receipt of a Wellcome Trust Clinical Fellowship in
   Translational Medicine and Therapeutics.; This work has also been
   supported by the NIHR Biomedical Research Centre for Ageing and
   Age-related Disease and NIHR Biomedical Research Centre (BRC).
CR Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342
   Ali S, 2012, TRANSPL IMMUNOL, V26, P62, DOI 10.1016/j.trim.2011.08.005
   Bellamy COC, 2007, HISTOPATHOLOGY, V50, P739, DOI 10.1111/j.1365-2559.2007.02677.x
   Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744
   Cannito S, 2010, ANTIOXID REDOX SIGN, V12, P1383, DOI 10.1089/ars.2009.2737
   Chiba M, 2011, J CLIN PATHOL, V64, P564, DOI 10.1136/jcp.2011.090175
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Demetris AJ, 2002, TRANSPLANTATION, V74, P1290, DOI 10.1097/00007890-200211150-00016
   Díaz R, 2008, HUM PATHOL, V39, P102, DOI 10.1016/j.humpath.2007.05.021
   Egyed-Zsigmond I, 2010, ROM J MORPHOL EMBRYO, V51, P265
   Erol A, 2011, CELL SIGNAL, V23, P1076, DOI 10.1016/j.cellsig.2010.11.023
   Fleig SV, 2007, LAB INVEST, V87, P1227, DOI 10.1038/labinvest.3700689
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Gardner Aaron, 2010, Expert Rev Respir Med, V4, P647, DOI 10.1586/ers.10.62
   GRUBMAN SA, 1994, AM J PHYSIOL, V266, pG1060, DOI 10.1152/ajpgi.1994.266.6.G1060
   Hubscher SG, 2011, MACSWEENS PATHOLOGY, P854
   Humphreys EH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014037
   Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018
   Liu XW, 2012, HEPATOL RES, V42, P1024, DOI 10.1111/j.1872-034X.2012.01011.x
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   MILANI S, 1991, AM J PATHOL, V139, P1221
   Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8
   Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5
   Neuberger JM, 2009, AM J TRANSPLANT, V9, P327, DOI 10.1111/j.1600-6143.2008.02493.x
   Omenetti A, CURR OPIN GASTROENTE, V27, P268
   Omenetti A, 2007, LAB INVEST, V87, P499, DOI 10.1038/labinvest.3700537
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Pinzani M, 2011, J HEPATOL, V55, P459, DOI 10.1016/j.jhep.2011.02.001
   Rautou PE, 2010, J HEPATOL, V53, P1123, DOI 10.1016/j.jhep.2010.07.006
   Ray M B, 1996, Liver Transpl Surg, V2, P337, DOI 10.1002/lt.500020502
   Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586
   Rygiel KA, 2010, LIVER TRANSPLANT
   Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768
   Sasaki M, 2008, HEPATOLOGY, V48, P186, DOI 10.1002/hep.22348
   Sasaki M, 2010, LAB INVEST, V90, P835, DOI 10.1038/labinvest.2010.56
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Shaked A, 2009, AM J TRANSPLANT, V9, P301, DOI 10.1111/j.1600-6143.2008.02487.x
   Tippner C, 2001, TRANSPLANTATION, V72, P1122, DOI 10.1097/00007890-200109270-00024
   van den Heuvel MC, 2004, LIVER TRANSPLANT, V10, P28, DOI 10.1002/lt.20029
   Wiesner RH, LIVER TRANSPL S3, V17, pS1
   Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004
   Yoshitomi M, 2009, TRANSPLANTATION, V87, P606, DOI 10.1097/TP.0b013e318195a7cb
NR 46
TC 23
Z9 23
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD JUL
PY 2013
VL 13
IS 7
BP 1688
EP 1702
DI 10.1111/ajt.12271
PG 15
WC Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Transplantation
GA 171LD
UT WOS:000320928800013
PM 23750746
OA Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Ritschka, B
   Storer, M
   Mas, A
   Heinzmann, F
   Ortells, MC
   Morton, JP
   Sansom, OJ
   Zender, L
   Keyes, WM
AF Ritschka, Birgit
   Storer, Mekayla
   Mas, Alba
   Heinzmann, Florian
   Ortells, Mari Carmen
   Morton, Jennifer P.
   Sansom, Owen J.
   Zender, Lars
   Keyes, William M.
TI The senescence-associated secretory phenotype induces cellular
   plasticity and tissue regeneration
SO GENES & DEVELOPMENT
LA English
DT Article
DE senescence; plasticity; stem cells; papilloma; CD34; SASP
ID STEM-CELLS; LIVER-CANCER; TUMOR SUPPRESSION; SKIN; P53; GROWTH;
   P16(INK4A); NESTIN; CARCINOGENESIS; PROLIFERATION
AB Senescence is a form of cell cycle arrest induced by stress such as DNA damage and oncogenes. However, while arrested, senescent cells secrete a variety of proteins collectively known as the senescence-associated secretory phenotype (SASP), which can reinforce the arrest and induce senescence in a paracrine manner. However, the SASP has also been shown to favor embryonic development, wound healing, and even tumor growth, suggesting more complex physiological roles than currently understood. Here we uncover timely new functions of the SASP in promoting a proregenerative response through the induction of cell plasticity and stemness. We show that primary mouse keratinocytes transiently exposed to the SASP exhibit increased expression of stem cell markers and regenerative capacity in vivo. However, prolonged exposure to the SASP causes a subsequent cell-intrinsic senescence arrest to counter the continued regenerative stimuli. Finally, by inducing senescence in single cells in vivo in the liver, we demonstrate that this activates tissue-specific expression of stem cell markers. Together, this work uncovers a primary and beneficial role for the SASP in promoting cell plasticity and tissue regeneration and introduces the concept that transient therapeutic delivery of senescent cells could be harnessed to drive tissue regeneration.
C1 [Ritschka, Birgit; Storer, Mekayla; Mas, Alba; Ortells, Mari Carmen; Keyes, William M.] Barcelona Inst Sci & Technol, CRG, Barcelona 08003, Spain.
   [Ritschka, Birgit; Storer, Mekayla; Mas, Alba; Ortells, Mari Carmen; Keyes, William M.] Univ Pompeu Fabra UPF, Barcelona 08003, Spain.
   [Heinzmann, Florian; Zender, Lars] Univ Hosp Tubingen, Dept Internal Med 8, D-72076 Tubingen, Germany.
   [Heinzmann, Florian; Zender, Lars] Eberhard Karls Univ Tubingen, Inst Physiol, Dept Physiol 1, D-72076 Tubingen, Germany.
   [Morton, Jennifer P.; Sansom, Owen J.] Canc Res UK Beatson Inst, Glasgow G61 1BD, Lanark, Scotland.
   [Morton, Jennifer P.; Sansom, Owen J.] Univ Glasgow, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland.
   [Zender, Lars] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, D-69120 Heidelberg, Germany.
   [Keyes, William M.] Univ Strasbourg, Inst Natl Sante & Rech Med, CNRS, Inst Gen & Biol Mol & Cellulaire,UMR7104,U964, F-67404 Illkirch Graffenstaden, France.
   [Storer, Mekayla] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 0A4, Canada.
C3 Barcelona Institute of Science & Technology; Pompeu Fabra University;
   Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Eberhard
   Karls University of Tubingen; Eberhard Karls University Hospital;
   Eberhard Karls University of Tubingen; Beatson Institute; University of
   Glasgow; Helmholtz Association; German Cancer Research Center (DKFZ);
   Universites de Strasbourg Etablissements Associes; Universite de
   Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS -
   National Institute for Biology (INSB); Institut National de la Sante et
   de la Recherche Medicale (Inserm); University of Toronto; Hospital for
   Sick Children (SickKids)
RP Keyes, WM (corresponding author), Barcelona Inst Sci & Technol, CRG, Barcelona 08003, Spain.; Keyes, WM (corresponding author), Univ Pompeu Fabra UPF, Barcelona 08003, Spain.; Keyes, WM (corresponding author), Univ Strasbourg, Inst Natl Sante & Rech Med, CNRS, Inst Gen & Biol Mol & Cellulaire,UMR7104,U964, F-67404 Illkirch Graffenstaden, France.
EM bill.keyes@igbmc.fr
RI Morton, Jennifer/AAJ-5113-2021; Morton, Jennifer P/E-1633-2011; Storer,
   Mekayla/JFA-9089-2023; Ritschka, Birgit/O-1774-2015
OI Morton, Jennifer/0000-0001-5766-9141; Morton, Jennifer
   P/0000-0001-5766-9141; Storer, Mekayla/0000-0003-0242-1418; Ritschka,
   Birgit/0000-0001-8889-6224; Sansom, Owen J./0000-0001-9540-3010; Keyes,
   William M./0000-0002-8917-2268
FU "La Caixa" foundation; Spanish Ministry for Economy and Competitiveness
   [SAF2010-18829, SAF2013-49082-P]; Agencia de Gestio d'Ajuts
   Universitaris i de Recerca (AGAUR) from the Generalitat de Catalunya;
   Centre for Genomic Regulation; Cancer Research UK [22311] Funding
   Source: researchfish; Cancer Research UK; Versus Arthritis [21139]
   Funding Source: researchfish
FX We thank Ryan Driskell and Fiona Watt for technical advice, Guillaume
   Filion and Panagiotis Papasaikas for advice on statistics, Pura
   Munoz-Canoves for beta-actin GFP mice, the Centre for Genomic Regulation
   Bioinformatics unit for assistance, and Pura Munoz-Canoves and Juan
   Valcarcel for critical reading of the manuscript. M.S. and B.R. were
   supported with fellowships from the "La Caixa" foundation. This work was
   funded by grants SAF2010-18829 and SAF2013-49082-P (to W.M.K.) from the
   Spanish Ministry for Economy and Competitiveness, the Agencia de Gestio
   d'Ajuts Universitaris i de Recerca (AGAUR) from the Generalitat de
   Catalunya, and Centre for Genomic Regulation core funding.
CR Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120
   Achuthan S, 2011, J BIOL CHEM, V286, P37813, DOI 10.1074/jbc.M110.200675
   Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   BALMAIN A, 1984, NATURE, V307, P658, DOI 10.1038/307658a0
   Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen CC, 2015, CELL, V161, P277, DOI 10.1016/j.cell.2015.02.016
   Coppé JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159
   Jensen KB, 2010, NAT PROTOC, V5, P898, DOI 10.1038/nprot.2010.39
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835
   Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091
   Morris RJ, 2004, DIFFERENTIATION, V72, P381, DOI 10.1111/j.1432-0436.2004.07208004.x
   Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Myant KB, 2013, CELL CYCLE, V12, P2973, DOI 10.4161/cc.26031
   Neradil J, 2015, CANCER SCI, V106, P803, DOI 10.1111/cas.12691
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Schmidt-Ullrich R, 2001, DEVELOPMENT, V128, P3843
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241
   Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134
   Tschaharganeh DF, 2014, CELL, V158, P579, DOI 10.1016/j.cell.2014.05.051
   Varga J, 2014, FEBS LETT, V588, P2422, DOI 10.1016/j.febslet.2014.06.019
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011
NR 50
TC 388
Z9 415
U1 9
U2 92
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD JAN 15
PY 2017
VL 31
IS 2
BP 172
EP 183
DI 10.1101/gad.290635.116
PG 12
WC Cell Biology; Developmental Biology; Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA EL2LO
UT WOS:000394451400007
PM 28143833
OA gold, Green Accepted, Green Published, Green Submitted
HC Y
HP N
DA 2024-02-19
ER

PT J
AU FROMENTY, B
   GRIMBERT, S
   MANSOURI, A
   BEAUGRAND, M
   ERLINGER, S
   ROTIG, A
   PESSAYRE, D
AF FROMENTY, B
   GRIMBERT, S
   MANSOURI, A
   BEAUGRAND, M
   ERLINGER, S
   ROTIG, A
   PESSAYRE, D
TI HEPATIC MITOCHONDRIAL-DNA DELETION IN ALCOHOLICS - ASSOCIATION WITH
   MICROVESICULAR STEATOSIS
SO GASTROENTEROLOGY
LA English
DT Article
ID CHRONIC ETHANOL-CONSUMPTION; AGING HUMAN TISSUES; CHAIN FATTY-ACIDS;
   BETA-OXIDATION; LIPID-PEROXIDATION; REYES-SYNDROME; TRICYCLIC
   ANTIDEPRESSANT; DEGENERATIVE DISEASES; RESPIRATORY-CHAIN; LIVER
AB Background/Aims: Alcohol abuse may lead to microvesicular steatosis, a lesion ascribed to impaired mitochondrial function. Because alcohol abuse leads to reactive oxygen species in the hepatic mitochondria, it may damage mitochondrial DNA. The aim of this study was to look for the presence of the ''common'' 4977-base pair deletion in the hepatic mitochondrial DNA of alcoholic patients and age-matched, nonalcoholic controls. Methods: Hepatic DNA was subjected to two polymerase chain reactions that amplified non-deleted and deleted mitochondrial DNA, respectively. Results: The deletion was found in 6 of 10 alcoholics with microvesicular steatosis, 2 of 17 alcoholic patients with macrovacuolar steatosis, but in none of 12 patients with acute alcoholic hepatitis, 11 patients with alcoholic cirrhosis, or 62 nonalcoholic patients of comparable ages with various other liver diseases or normal liver histology. In all patients with the deletion, restriction fragments of deleted mitochondrial DNA co-migrated with those of reference Pearson bone marrow-pancreas syndrome patients with the common mitochondrial DNA deletion. Conclusions: The common deletion is frequent in the hepatic DNA of alcoholic patients with microvesicular steatosis. Alcohol-induced mitochondrial DNA damage may contribute to the occurrence of this lesion in some alcoholics.
C1 HOP BEAUJON, CTR RECH PHYSIOPATHOL HEPAT, ASSOC CLAUDE BERNARD, F-92118 CLICHY, FRANCE.
   HOP NECKER ENFANTS MALAD, INSERM, U393, PARIS, FRANCE.
   HOP JEAN VERDIER, SERV HEPATOGASTROENTEROL, BONDY, FRANCE.
C3 Assistance Publique Hopitaux Paris (APHP); Universite Paris Cite;
   Hopital Universitaire Beaujon - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris Cite; Hopital Universitaire Necker-Enfants
   Malades - APHP; Institut National de la Sante et de la Recherche
   Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital
   Universitaire Jean-Verdier - APHP
RP FROMENTY, B (corresponding author), HOP BEAUJON, INSERM, U24, F-92118 CLICHY, FRANCE.
RI Fromenty, Bernard/E-5052-2016; Rötig, Agnès/G-9592-2017; Fromenty,
   Bernard/Y-8621-2019; Mansouri, Abdelhak/D-9100-2013; Abdellah,
   Mansouri/B-3002-2017
OI Fromenty, Bernard/0000-0003-2994-5465; Rötig, Agnès/0000-0003-0589-0703;
   Mansouri, Abdelhak/0000-0003-4471-7276; Abdellah,
   Mansouri/0000-0003-3856-5771
CR ALPERS DH, 1975, DISEASES LIVER, P815
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ARAI M, 1984, HEPATOLOGY, V4, P165, DOI 10.1002/hep.1840040201
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   BACON BR, 1983, J CLIN INVEST, V71, P429, DOI 10.1172/JCI110787
   BALLARDINI G, 1994, J HEPATOL, V20, P218, DOI 10.1016/S0168-8278(05)80061-3
   BIOULACSAGE P, 1993, HEPATOLOGY, V18, P839, DOI 10.1002/hep.1840180414
   BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991
   BOURGERON T, 1993, J BIOL CHEM, V268, P19369
   CLAYTON DA, 1992, J INHERIT METAB DIS, V15, P439, DOI 10.1007/BF01799602
   COLEMAN WB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P142, DOI 10.1016/0005-2728(90)90136-R
   COLEMAN WB, 1991, BIOCHIM BIOPHYS ACTA, V1058, P178, DOI 10.1016/S0005-2728(05)80235-X
   CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   DESCHAMPS D, 1991, J PHARMACOL EXP THER, V259, P894
   FEMANDEZCHECZ JC, 1991, J CLIN INVEST, V87, P397
   FRENEAUX E, 1990, J PHARMACOL EXP THER, V255, P529
   FRENEAUX E, 1988, HEPATOLOGY, V8, P1056, DOI 10.1002/hep.1840080513
   FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1371
   FROMENTY B, 1990, J PHARMACOL EXP THER, V255, P1377
   FROMENTY B, 1993, BIOCHEM PHARMACOL, V46, P421, DOI 10.1016/0006-2952(93)90518-2
   FROMENTY B, 1989, BIOCHEM PHARMACOL, V38, P3743, DOI 10.1016/0006-2952(89)90580-7
   GENEVE J, 1987, J PHARMACOL EXP THER, V242, P1133
   GRIMBERT S, 1993, HEPATOLOGY, V17, P628, DOI 10.1002/hep.1840170417
   GROSOVSKY AJ, 1988, P NATL ACAD SCI USA, V85, P185, DOI 10.1073/pnas.85.1.185
   GRUNNET N, 1986, ALCOHOL CLIN EXP RES, V10, pS64, DOI 10.1111/j.1530-0277.1986.tb05182.x
   HEUBI JE, 1987, HEPATOLOGY, V7, P155, DOI 10.1002/hep.1840070130
   HRUSZKEWYCZ AM, 1988, BIOCHEM BIOPH RES CO, V153, P191, DOI 10.1016/S0006-291X(88)81207-5
   KESTERSON JW, 1984, HEPATOLOGY, V4, P1143, DOI 10.1002/hep.1840040609
   KUCHINO Y, 1987, NATURE, V327, P77, DOI 10.1038/327077a0
   KUKIELKA E, 1994, ARCH BIOCHEM BIOPHYS, V309, P377, DOI 10.1006/abbi.1994.1127
   LABBE G, 1991, BIOCHEM PHARMACOL, V41, P638, DOI 10.1016/0006-2952(91)90640-Q
   LEDINH T, 1988, J PHARMACOL EXP THER, V247, P745
   LETTERON P, 1993, GUT, V34, P409, DOI 10.1136/gut.34.3.409
   LIEBER CS, 1988, NEW ENGL J MED, V319, P1639
   LIEBER CS, 1991, ALCOHOL CLIN EXP RES, V15, P573, DOI 10.1111/j.1530-0277.1991.tb00563.x
   MCSHANE MA, 1991, AM J HUM GENET, V48, P39
   MONTGOMERY RI, 1987, J BIOL CHEM, V262, P13285
   MORAES CT, 1989, BIOCHEM BIOPH RES CO, V160, P765, DOI 10.1016/0006-291X(89)92499-6
   MORGAN MY, 1978, SCAND J GASTROENTERO, V13, P299, DOI 10.3109/00365527809179824
   MUNNICH A, 1992, J INHERIT METAB DIS, V15, P448, DOI 10.1007/BF01799603
   NORDMANN R, 1992, FREE RADICAL BIO MED, V12, P219, DOI 10.1016/0891-5849(92)90030-K
   PESSAYRE D, 1994, HEPATOLOGY, V19, P948
   ROSMORDUC O, 1992, GASTROEN CLIN BIOL, V16, P801
   ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881
   SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   THAYER WS, 1981, J BIOL CHEM, V256, P6090
   TREEM WR, 1986, HEPATOLOGY, V6, P1270, DOI 10.1002/hep.1840060608
   WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
NR 54
TC 123
Z9 127
U1 0
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD JAN
PY 1995
VL 108
IS 1
BP 193
EP 200
DI 10.1016/0016-5085(95)90024-1
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA PZ135
UT WOS:A1995PZ13500023
PM 7806041
DA 2024-02-19
ER

PT J
AU PODOLIN, DA
   GLEESON, TT
   MAZZEO, RS
AF PODOLIN, DA
   GLEESON, TT
   MAZZEO, RS
TI ROLE OF NOREPINEPHRINE IN HEPATIC GLUCONEOGENESIS - EVIDENCE OF AGING
   AND TRAINING EFFECTS
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE LACTATE; CATECHOLAMINES; EXERCISE; GLUCOSE
ID BETA-ADRENERGIC RECEPTORS; SYMPATHETIC INNERVATION; OLD RATS; AGE;
   EXERCISE; ISOPROTERENOL; SENSITIVITY; RESPONSES; TISSUES; SPLEEN
AB This study examined the relationship among the sympathetic neurotransmitter norepinephrine (NE), hepatic gluconeogenesis, and glyconeogenesis in 63 (30 trained and 33 untrained) young (7 mo), middle-aged (15 mo), and old (25 mo) male Fischer 344 rats. Animals were trained 1 h/day, 5 days/wk for 10 wk at treadmill speeds of 75% of age-specific maximal capacity. Liver sections, removed at rest, were sliced and incubated in [C-14]lactic acid and 0, 0.5, 1.0, 3.0, or 6.0 ng/ml NE, The rate of [C-14]lactate incorporation into glucose was significantly greater in young compared with old animals in both training groups and at all NE concentrations. All trained animals had greater rates of glucose production from lactate than their untrained counterparts at 0.5, 1.0, 3.0, and 6.0 ng/ml NE. At each NE concentration, the old rats showed the lowest rates of glycogen synthesis from lactate. The untrained rats in all age groups were the least responsive to increases in NE concentration. Total hepatic glycogen synthase activity exhibited age-related declines as the young and middle-aged had significantly greater total activity compared with the old animals: 620.4 +/- 27.5, 590.0 +/- 37.9, and 436.3 +/- 44.5 disintegrations/min, respectively. No differences with training were found in total activity. The percent of glycogen synthase in the active form was significantly greater in young compared with old in both the trained (48.6 +/- 2.0 vs. 40.0 +/- 1.3% active) and untrained animals (44.7 +/- 2.2 vs. 35.4 +/- 1.5% active). Phosphoenolpyruvate carboxykinase activity declined with age as the old animals in both training groups had significantly lower activity compared with the young animals (decreased 42 and 59% in the trained and untrained, respectively). No significant differences in activity existed with training. These data suggest an age-related decline in the ability of the liver to synthesize both glycogen and glucose from lactate. The training effect in glyconeogenesis is most likely occurring in the gluconeogenic pathway as endurance training had little effect on glycogen synthase activity and trained animals had greater rates of lactate incorporation into glucose than untrained at all NE doses.
C1 UNIV COLORADO, DEPT ENVIRONM POPULAT & ORGANISM BIOL, BOULDER, CO 80309 USA.
C3 University of Colorado System; University of Colorado Boulder
RP PODOLIN, DA (corresponding author), UNIV COLORADO, DEPT KINESIOL, BOX 354, BOULDER, CO 80309 USA.
FU NIA NIH HHS [AG-07180] Funding Source: Medline
CR ABRASS IB, 1982, J GERONTOL, V37, P156, DOI 10.1093/geronj/37.2.156
   ADELMAN RC, 1970, J BIOL CHEM, V245, P1032
   AMENTA F, 1988, J AUTONOM NERV SYST, V22, P247, DOI 10.1016/0165-1838(88)90114-2
   BELLINGER DL, 1992, EXP NEUROL, V116, P295, DOI 10.1016/0014-4886(92)90009-F
   Bergmeyer HU, 1974, METHOD ENZYMAT AN, P1205
   DAVIDSON MB, 1979, METABOLISM, V28, P687
   EDWARDS AV, 1970, J PHYSIOL-LONDON, V211, P109, DOI 10.1113/jphysiol.1970.sp009269
   FELTEN SY, 1987, NEUROBIOL AGING, V8, P159, DOI 10.1016/0197-4580(87)90026-1
   GIUDICELLI Y, 1978, EUR J BIOCHEM, V90, P413, DOI 10.1111/j.1432-1033.1978.tb12619.x
   GREENBERG LH, 1978, SCIENCE, V201, P61, DOI 10.1126/science.208145
   HALLMAN H, 1978, LIFE SCI, V23, P1049, DOI 10.1016/0024-3205(78)90665-3
   HASSID WZ, 1957, METHOD ENZYMOL, V3, P34, DOI 10.1016/S0076-6879(57)03345-5
   LAKATTA EG, 1982, AM J PHYSIOL, V242, pH927, DOI 10.1152/ajpheart.1982.242.6.H927
   MAZZEO RS, 1989, METABOLISM, V38, P479, DOI 10.1016/0026-0495(89)90202-3
   MAZZEO RS, 1984, J APPL PHYSIOL, V57, P1369, DOI 10.1152/jappl.1984.57.5.1369
   MAZZEO RS, 1989, J APPL PHYSIOL, V66, P1506, DOI 10.1152/jappl.1989.66.3.1506
   MCLEAN MR, 1983, J MOL CELL CARDIOL, V15, P75, DOI 10.1016/0022-2828(83)90284-5
   MYSLIWSKI A, 1992, ARCH GERONTOL GERIAT, V14, P85, DOI 10.1016/0167-4943(92)90009-S
   PETRESCU I, 1979, ANAL BIOCHEM, V96, P279, DOI 10.1016/0003-2697(79)90582-7
   PODOLIN DA, 1994, MECH AGEING DEV, V75, P81, DOI 10.1016/0047-6374(94)90030-2
   ROBERTS J, 1987, REV BIOL RES AGING, V3, P257
   SCARPACE PJ, 1986, MECH AGEING DEV, V35, P255, DOI 10.1016/0047-6374(86)90128-4
   Srere P.A., 1969, METHOD ENZYMOL, V13, P3, DOI DOI 10.1016/0076-6879(69)13005-0
   STITH RD, 1985, MECH AGEING DEV, V30, P73, DOI 10.1016/0047-6374(85)90060-0
   SUMIDA KD, 1993, J APPL PHYSIOL, V74, P782, DOI 10.1152/jappl.1993.74.2.782
   THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9
   VEGA JA, 1990, MECH AGEING DEV, V54, P185, DOI 10.1016/0047-6374(90)90049-L
   VESTAL RE, 1979, CLIN PHARMACOL THER, V26, P181
   WINDER WW, 1982, AM J PHYSIOL, V243, pR179, DOI 10.1152/ajpregu.1982.243.1.R179
   YIN FCP, 1979, MECH AGEING DEV, V10, P17, DOI 10.1016/0047-6374(79)90067-8
NR 30
TC 21
Z9 25
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD NOV
PY 1994
VL 267
IS 5
BP E680
EP E686
DI 10.1152/ajpendo.1994.267.5.E680
PG 7
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA PW563
UT WOS:A1994PW56300008
PM 7977718
DA 2024-02-19
ER

PT J
AU Chou, ST
   Ko, LE
   Yang, CS
AF Chou, ST
   Ko, LE
   Yang, CS
TI Determination of tissue α-tocopherol in senescence-accelerated mice by
   high-performance liquid chromatography with fluorimetric detection
SO ANALYTICA CHIMICA ACTA
LA English
DT Article
DE HPLC; alpha-tocopherol; fluorimetric detection; aging;
   senescence-accelerated mice
ID VITAMIN-E; ELECTROCHEMICAL DETECTION; RETINOL; PLASMA; CAROTENOIDS;
   SERUM; EXTRACTION; RATS; FAT
AB alpha-Tocopherol (alpha-Toc) plays an important role in various distinct physiological functions. A convenient assay using high-performance liquid chromatography with fluorimetric detection (the excitation and emission wavelength was 296 and 340 nm, respectively) was developed for the accurate determination of the alpha-Toe in biological samples. Methanol (1/7; v/v) was used to extract alpha-Toe in tissue samples by precipitating the proteins. The assay obtained a recovery rate between 97.3 and 104.2% by adding pure alpha-Toe to mice liver homogenate. The R.S.D. for intra-day (n=7) and inter-day (n=6, three consecutive days) analysis was 0.7-2.8 and 0.5-3.7%, respectively. The effect of age on the alpha-Toe levels in the liver, brain and heart homogenates of senescence-accelerated mice (SAM) was also studied. The alpha-Toe levels in the tissue homogenates increased gradually with age for both male and female mice, while the female had higher or-Toe levels than the males of the same age. (C) 2000 Elsevier Science B.V. All rights reserved.
C1 Providence Univ, Dept Food & Nutr, Taichung, Taiwan.
C3 Providence University - Taiwan
RP Chou, ST (corresponding author), Providence Univ, Dept Food & Nutr, Taichung, Taiwan.
EM stchou@pu.edu.tw
RI Chou, Su-Tze/AAR-7175-2021; Yang, Chung-Shi/E-3999-2010
OI Chou, Su-Tze/0000-0002-6588-0358; 
CR AZHAR S, 1995, J CLIN INVEST, V96, P1414, DOI 10.1172/JCI118177
   CATIGNANI GL, 1983, CLIN CHEM, V29, P708
   CHAN KY, 1994, J CHROMATOGR B, V656, P359, DOI 10.1016/0378-4347(94)00120-0
   CHOI JH, 1994, INT CONGR SER, V1062, P321
   DELEENHEER AP, 1988, J CHROMATOGR-BIOMED, V429, P3, DOI 10.1016/S0378-4347(00)83866-9
   EPLER KS, 1993, J CHROMATOGR-BIOMED, V619, P37, DOI 10.1016/0378-4347(93)80444-9
   ERICKSON MC, 1991, J FOOD SCI, V56, P1113, DOI 10.1111/j.1365-2621.1991.tb14657.x
   HALLIWELL B, 1994, NUTR REV, V52, P253
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   Harman D, 1987, MODERN BIOL THEORIES, P81
   HOLLANDER D, 1989, DIGEST DIS SCI, V34, P768, DOI 10.1007/BF01540352
   Huo JZ, 1996, ANAL BIOCHEM, V242, P123, DOI 10.1006/abio.1996.0437
   ITO Y, 1990, CLIN CHIM ACTA, V194, P131, DOI 10.1016/0009-8981(90)90128-F
   KASPAREK CW, 1980, COMPR TREAT, P7
   NAKAMOTO H, 1994, SAM MODEL SENESCENCE, P321
   NIERENBERG DW, 1992, AM J CLIN NUTR, V56, P417, DOI 10.1093/ajcn/56.2.417
   PARK JW, 1976, GERONTOL BIOL SCI A, V51, pB337
   RETTENMAIER R, 1992, INT J VITAM NUTR RES, V62, P312
   Rupérez FJ, 1998, J CHROMATOGR A, V823, P483, DOI 10.1016/S0021-9673(98)00206-4
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TANGNEY CC, 1987, AM J CLIN NUTR, V45, P764, DOI 10.1093/ajcn/45.4.764
   TAPPEL AL, 1973, FED PROC, V32, P1870
   UEDA T, 1987, J MICRONUTR ANAL, V3, P15
   WEGLICKI WB, 1969, NATURE, V221, P185, DOI 10.1038/221185a0
   ZAMARRENO MMD, 1992, J CHROMATOGR, V623, P69, DOI 10.1016/0021-9673(92)85300-I
NR 26
TC 13
Z9 13
U1 2
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2670
J9 ANAL CHIM ACTA
JI Anal. Chim. Acta
PD AUG 15
PY 2000
VL 419
IS 1
BP 81
EP 86
DI 10.1016/S0003-2670(00)00972-7
PG 6
WC Chemistry, Analytical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA 341LK
UT WOS:000088591700011
DA 2024-02-19
ER

PT J
AU Ando, K
   Higami, Y
   Tsuchiya, T
   Kanematsu, T
   Shimokawa, I
AF Ando, K
   Higami, Y
   Tsuchiya, T
   Kanematsu, T
   Shimokawa, I
TI Impact of aging and life-long calorie restriction on expression of
   apoptosis-related genes in male F344 rat liver
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE hepatocytes; p53; Fas receptor; Fas ligand; TNF receptor 1; TNF alpha;
   Bcl-2; Bcl-XL; Bax; TGF beta 1
ID DIETARY RESTRICTION; HEPATOCYTE PROLIFERATION; OXIDATIVE STRESS; B6C3F1
   MICE; FAS LIGAND; DNA-DAMAGE; AGE; INCREASE; DEATH; FAILURE
AB Aging enhances apoptosis of hepatocytes under normal physiological conditions and increases the susceptibility to apoptosis of hepatocytes, whereas chronic calorie restriction (CR) suppresses the age-enhanced susceptibility to apoptosis. To clarify the subcellular mechanisms of age-associated dysregulation of apoptosis and the effects of CR, we analyzed the expression of genes promoting apoptosis (p53, Fas receptor, Fas ligand, TNF receptor 1, TNFalpha, Bax, TGFbeta1) and genes preventing apoptosis (Bcl-2 and Bcl-XL) in the livers of 3-, 6-, 15-, and 24-month-old male F344 rats that were either fed ad libitum or subjected to a 30% reduction in food intake (CR). After the age of 6 months, expression of p53, Fas receptor, Fas ligand, and TNFalpha mRNAs was up-regulated with aging. CR suppressed this age-enhanced p53 and Fas receptor mRNA expression, but expression of the other genes was not altered significantly by aging or CR. Expression of Fas receptor in hepatocytes, as detected immunohistochemically, increased with age, but CR suppressed age-accelerated Fas receptor expression. Our findings suggest that TNF ligand/TNF receptor family signaling, particularly Fas receptor expression, is important in age- and CR-modulated apoptosis of hepatocytes. Hepatocytes that were immunoreactive for p53 had slightly increased with aging, suggesting that p53 may mediate the age-enhanced up-regulation of Fas receptor in hepatocytes. (C) 2002 Wiley-Liss.
C1 Nagasaki Univ, Sch Med, Dept Resp & Digest Med, Div Expt Med Pathol & Gerontol, Nagasaki 8528523, Japan.
   Nagasaki Univ, Sch Med, Dept Surg 2, Nagasaki 8528523, Japan.
C3 Nagasaki University; Nagasaki University
RP Higami, Y (corresponding author), Nagasaki Univ, Sch Med, Dept Resp & Digest Med, Div Expt Med Pathol & Gerontol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
EM higami@net.nagasaki-u.ac.jp
OI Shimokawa, Isao/0000-0001-8901-1029; Tsuchiya,
   Tomoshi/0000-0002-8419-1478; Higami, Yoshikazu/0000-0003-1381-0777
CR ADACHI M, 1995, NAT GENET, V11, P294, DOI 10.1038/ng1195-294
   Aggarwal S, 1998, J IMMUNOL, V160, P1627
   Cain K, 2001, TOXICOL LETT, V120, P307, DOI 10.1016/S0378-4274(01)00283-1
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461
   HIGAMI Y, 1994, MUTAT RES-DNAGING G, V316, P59, DOI 10.1016/0921-8734(94)90008-6
   Higami Y, 1997, AM J PATHOL, V151, P659
   Higami Y, 1997, CELL TISSUE RES, V288, P69, DOI 10.1007/s004410050793
   Higami Y, 2000, CELL TISSUE RES, V299, P363, DOI 10.1007/s004410050034
   Higami Y, 1996, MUTAT RES-FUND MOL M, V357, P225, DOI 10.1016/0027-5107(96)00127-3
   Higami Y, 2000, CELL TISSUE RES, V301, P125, DOI 10.1007/s004419900156
   Ikeyama S, 2002, FASEB J, V16, pA1163, DOI 10.1096/fj.01-0409fje
   Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098
   Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015
   LEIST M, 1995, AM J PATHOL, V146, P1220
   Liu LX, 1998, AM J PHYSIOL-REG I, V275, pR315, DOI 10.1152/ajpregu.1998.275.1.R315
   Muskhelishvili L, 1996, AM J PATHOL, V149, P1585
   MUSKHELISHVILI L, 1995, AM J PATHOL, V147, P20
   Obonai T, 1998, BRAIN RES, V783, P167, DOI 10.1016/S0006-8993(97)01361-9
   Razzaque M S, 1999, Mol Cell Biol Res Commun, V1, P82, DOI 10.1006/mcbr.1999.0104
   Shiraiwa N, 1996, J BIOL CHEM, V271, P13258, DOI 10.1074/jbc.271.22.13258
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Spaulding CC, 1997, MECH AGEING DEV, V93, P87, DOI 10.1016/S0047-6374(96)01824-6
   Strand S, 1998, NAT MED, V4, P588, DOI 10.1038/nm0598-588
   SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L
   Tanuma N, 1997, J NEUROIMMUNOL, V73, P197, DOI 10.1016/S0165-5728(96)00199-3
   Weindruch R., 1988, RETARDATION AGING DI
   Yu BP, 1994, MODULATION AGING PRO
   Yu CL, 1998, SCAND J RHEUMATOL, V27, P54
NR 29
TC 33
Z9 35
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD NOV 15
PY 2002
VL 59
IS 4
BP 293
EP 300
DI 10.1002/jemt.10207
PG 8
WC Anatomy & Morphology; Biology; Microscopy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA 615CZ
UT WOS:000179229400006
PM 12424791
OA Bronze
DA 2024-02-19
ER

PT J
AU Suttner, SW
   Sürder, C
   Lang, K
   Piper, SN
   Kumle, B
   Boldt, J
AF Suttner, SW
   Sürder, C
   Lang, K
   Piper, SN
   Kumle, B
   Boldt, J
TI RETRACTED: Does age affect liver function and the hepatic acute phase
   response after major abdominal surgery? (Retracted Article)
SO INTENSIVE CARE MEDICINE
LA English
DT Article; Retracted Publication
DE acute phase response; serum amyloid A; C-reactive protein; aging; MEGX
   test; alpha glutathione S-transferase
ID C-REACTIVE PROTEIN; METABOLITE FORMATION; CYTOKINES; INTERLEUKIN-6;
   DYSFUNCTION; ANESTHESIA; RESECTION; INDICATOR; KINETICS
AB Objective: The liver plays a key role in the inflammatory response during major surgery or infection. The influence of age on liver function and hepatic acute phase protein (APP) synthesis should be serially studied in elderly patients undergoing major abdominal surgery.
   Design and setting: Prospective and descriptive study over 3 days. Clinical investigation in the operating room and surgical intensive care unit (ICU) of a tertiary care hospital.
   Patients and interventions: 42 consecutive patients were grouped according to age: less than 60 years (''adult'') or over 65 years (''elderly'') and prospectively studied. All patients received standardized general anesthesia and were treated afterwards according to the standard protocols of our ICU. Intensivists caring for the patients were not involved in the study and were blinded to data analysis.
   Measurements and results: Concentrations of interleukin (IL)-6, serum amyloid A (SAA), C-reactive protein (CRP), alpha1-antitrypsin (alpha1-AT), and haptoglobin were measured to assess the APP response. Liver function was evaluated by the monoethylglycinexylidide (MEGX) test and by measuring alpha-glutathione S-transferase (alpha-GST). All measurements were performed at induction of anesthesia (T0), at the end of surgery (T1), and 2 h (T2), 24 h (T3), and 48 h (T4) postoperatively. There was no difference in the incidence of postoperative septic complications between the two groups. Baseline values of IL-6 and the four APPs were normal in all patients and did not differ between the groups. IL-6 levels increased significantly in all patients at T1 and T2, with a significantly higher increase in the older patients (elderly: from 7.4 +/-3.4 pg/ml to 220.6 +/- 49.5 pg/ml; adult: from 6.2 +/-2.5 pg/ml to 189.9 +/- 36.8 pg/ml). A return to baseline values was seen at T3 in both groups. Concentrations of all APPs. except for haptoglobin. started to increase at T3. Peak concentrations were significantly lower in the elderly patients (elderly: SAA 358 +/- 133 mug/l, CRP 5.1 +/-2.3 mg/dl, alpha1-AT 160 +/- 96 mg/1; adult: SAA +/- 444 +/- 100 mug/l, CRP 8.5 +/-3.2 mg/dl, cti-AT 223 +/- 85 mg/dl). Baseline alpha-GST and MEGX concentrations were normal in all patients. Alpha-GST concentrations increased in both groups at T1 and T2, with a significantly higher increase in the older patients (elderly: 3.7 +/-1.4 mug/l to 10.2 +/-2.9 mug/l; adult 4.5 +/-2.1 mug/l to 8.5 +/-1.7 mug/l) to baseline values was seen at T3 in both groups. MEGX concentrations were significantly lower and abnormal (< 50 ng/ml) in the older patients at T3 and T4.
   Conclusions: Our observations suggest that the postoperative hepatic acute phase response is reduced in patients undergoing major abdominal surgery. The decreased release of liver-synthesized APPs was associated with an impaired hepatocyte function and a disturbance of hepatocellular integrity. Further work needs to be done to determine whether these findings might have an impact on the incidence of postoperative septic complications or prognostic significance for survival in aged patients.
C1 Univ Mainz, Klinikum Stadt Ludwigshafen, Dept Anesthesiol & Intens Care Med, Akad Lehrkrankenhaus, D-67063 Ludwigshafen, Germany.
C3 Ludwigshafen Hospital; Johannes Gutenberg University of Mainz
RP Suttner, SW (corresponding author), Univ Mainz, Klinikum Stadt Ludwigshafen, Dept Anesthesiol & Intens Care Med, Akad Lehrkrankenhaus, Bremserstr 79, D-67063 Ludwigshafen, Germany.
EM suttner@gmx.de
CR BECKETT GJ, 1993, ADV CLIN CHEM, V30, P281, DOI 10.1016/S0065-2423(08)60198-5
   Bistrian BR, 1999, CRIT CARE MED, V27, P452, DOI 10.1097/00003246-199903000-00004
   BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025
   Bruunsgaard H, 1999, J INFECT DIS, V180, P551, DOI 10.1086/314873
   Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947
   CRUICKSHANK AM, 1990, CLIN SCI, V79, P161, DOI 10.1042/cs0790161
   FABBRI A, 1994, LIVER, V14, P288
   GEOKAS MC, 1990, ANN INTERN MED, V113, P455, DOI 10.7326/0003-4819-113-6-455
   GOODWIN JS, 1995, NUTR REV, V53, pS41
   Harwood T N, 2000, Curr Opin Anaesthesiol, V13, P327, DOI 10.1097/00001503-200006000-00017
   Kimura F, 1996, BRIT J SURG, V83, P1002, DOI 10.1002/bjs.1800830738
   KIMURA F, 1996, RES EXP MED, V195, P281
   Koperna T, 1998, WORLD J SURG, V22, P406, DOI 10.1007/s002689900405
   Lin E, 1999, INTENS CARE MED, V25, P255, DOI 10.1007/s001340050832
   Maynard ND, 1997, CHEST, V111, P180, DOI 10.1378/chest.111.1.180
   Miki C, 1997, ARCH SURG-CHICAGO, V132, P136
   NAKAYAMA T, 1993, CLIN CHEM, V39, P293
   OELLERICH M, 1987, J CLIN CHEM CLIN BIO, V25, P845
   OHZATO H, 1992, SURGERY, V111, P201
   Pastor CM, 1999, ANESTH ANALG, V89, P344, DOI 10.1097/00000539-199908000-00019
   Priebe HJ, 2000, BRIT J ANAESTH, V85, P763, DOI 10.1093/bja/85.5.763
   RAJA SN, 1991, ANESTHESIOLOGY, V91, P909
   REICHEN J, 1993, J HEPATOL, V19, P4, DOI 10.1016/S0168-8278(05)80169-2
   SCHROEDER TJ, 1990, MEGX MONOGRAPH, P1
   SCHROTER J, 1995, ANAESTHESIA, V50, P850, DOI 10.1111/j.1365-2044.1995.tb05849.x
   Sheeran P, 1997, BRIT J ANAESTH, V78, P201, DOI 10.1093/bja/78.2.201
   SHIMANUKI K, 1993, SURG TODAY, V23, P315, DOI 10.1007/BF00309048
   Suttner SW, 2000, ANESTH ANALG, V91, P206, DOI 10.1097/00000539-200007000-00039
   Veering B T, 1999, Curr Opin Anaesthesiol, V12, P333, DOI 10.1097/00001503-199906000-00014
   WEI JY, 1992, NEW ENGL J MED, V327, P1735, DOI 10.1056/NEJM199212103272408
   WHITWAM JG, 1993, CURRENT OPINION ANAE, V6, pS1
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 32
TC 24
Z9 26
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0342-4642
EI 1432-1238
J9 INTENS CARE MED
JI Intensive Care Med.
PD NOV
PY 2001
VL 27
IS 11
BP 1762
EP 1769
DI 10.1007/s00134-001-1126-0
PG 8
WC Critical Care Medicine
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 502HV
UT WOS:000172738800012
PM 11810120
DA 2024-02-19
ER

PT J
AU Chiba, M
   Sasaki, M
   Kitamura, S
   Ikeda, H
   Sato, Y
   Nakanuma, Y
AF Chiba, Mayumi
   Sasaki, Motoko
   Kitamura, Seiko
   Ikeda, Hiroko
   Sato, Yasunori
   Nakanuma, Yasuni
TI Participation of bile ductular cells in the pathological progression of
   non-alcoholic fatty liver disease
SO JOURNAL OF CLINICAL PATHOLOGY
LA English
DT Article
ID BILIARY EPITHELIAL-CELLS; CELLULAR SENESCENCE; DUCTS; HEPATITIS;
   FIBROSIS; HUMANS; TRACT
AB Aims Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of pathological conditions, ranging from simple steatosis to hepatic fibrosis with progression to cirrhosis. While activated hepatic stellate cells (HSC) are known to be involved in intralobular, perisinuosidal fibrosis, the mechanisms of portal and bridging fibrosis remain speculative. This study investigated the roles of bile ductules in portal and septal fibrosis.
   Methods 48 liver biopsies were obtained from NAFLD patients. These cases were divided into four stages according to the Brunt classification.
   Results Bile ductules positive for CK19 were increased along with the progression of staging and fibrosis of NAFLD, and the increased bile ductules were associated with portal inflammation and fibrosis. The cellular senescence marker; p16(INK4a) and p21(WAF1/Cip1)-positive bile ductular cells were increased in stages 3 and 4. Such senescent bile ductules frequently express chemotactic protein, CCL2 (MCP-1), which may be responsible for chemoattraction of activated HSC around the bile ductules in portal and septal fibrosis and for portal inflammation. The migration of cultured mouse HSC was significantly facilitated in the presence of cultured senescent mouse biliary epithelial cells (BEC), and this migration was mediated by CCL2 secreted from senescent cultured BEC. Small spindle-like cells positive for CK7 alone in the hepatic parenchyma in the advanced stage seem to differentiate to periportal bile ductular cells positive for CK19 and CK7.
   Conclusions It seems possible that increased bile ductules expressing cellular senescence markers and chemokines are at least partly involved in the progressive portal and bridging fibrosis in NAFLD.
C1 [Chiba, Mayumi; Sasaki, Motoko; Kitamura, Seiko; Ikeda, Hiroko; Sato, Yasunori; Nakanuma, Yasuni] Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
   [Chiba, Mayumi; Sasaki, Motoko; Kitamura, Seiko; Ikeda, Hiroko; Sato, Yasunori; Nakanuma, Yasuni] Kanazawa Univ Hosp, Sect Diagnost Pathol, Kanazawa, Ishikawa, Japan.
C3 Kanazawa University; Kanazawa University
RP Nakanuma, Y (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Human Pathol, Kanazawa, Ishikawa 9208640, Japan.
EM pbcpsc@kenroku.kanazawa-u.ac.jp
RI Sasaki, Motoko/K-5913-2015
OI Sasaki, Motoko/0000-0003-2514-760X
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Berres ML, 2010, DIGEST DIS, V28, P192, DOI 10.1159/000282085
   Beuers U, 2009, CLIN REV ALLERG IMMU, V36, P1, DOI 10.1007/s12016-008-8084-z
   Brunt EM, 2000, HEPATOLOGY, V31, P241, DOI 10.1002/hep.510310136
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Gramlich T, 2004, HUM PATHOL, V35, P196, DOI 10.1016/j.humpath.2003.09.018
   Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011
   Isse K, 2005, HEPATOLOGY, V41, P506, DOI 10.1002/hep.20582
   Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161
   Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8
   McCullough AJ, 2002, J CLIN GASTROENTEROL, V34, P255, DOI 10.1097/00004836-200203000-00013
   Nakanuma Y, 1997, MICROSC RES TECHNIQ, V38, P552, DOI 10.1002/(SICI)1097-0029(19970915)38:6<552::AID-JEMT2>3.0.CO;2-H
   Niwa H, 2007, HEPATOL RES, V37, P923, DOI 10.1111/j.1872-034X.2007.00150.x
   Ohira S, 2006, AM J PATHOL, V168, P1155, DOI 10.2353/ajpath.2006.050204
   Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012
   Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
   Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704
   Sasaki M, 2005, J PATHOL, V205, P451, DOI 10.1002/path.1729
   Sasaki M, 2006, AM J PATHOL, V169, P831, DOI 10.2353/ajpath.2006.051237
   Sasaki M, 2010, J HEPATOL, V53, P318, DOI 10.1016/j.jhep.2010.03.008
   Sasaki M, 2010, AM J CLIN PATHOL, V133, P212, DOI 10.1309/AJCPWMX47TREYWZG
   Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349
   Zen Y, 2002, AM J PATHOL, V161, P1475, DOI 10.1016/S0002-9440(10)64423-9
NR 28
TC 38
Z9 41
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0021-9746
EI 1472-4146
J9 J CLIN PATHOL
JI J. Clin. Pathol.
PD JUL
PY 2011
VL 64
IS 7
BP 564
EP 570
DI 10.1136/jcp.2011.090175
PG 7
WC Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology
GA 778QO
UT WOS:000291719800003
PM 21486894
DA 2024-02-19
ER

PT J
AU Panda, H
   Zaidi, G
   Supakar, PC
AF Panda, H
   Zaidi, G
   Supakar, PC
TI Decreased expression of the pancreatic secretory trypsin inhibitor II
   gene during aging of the rat liver
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
DE aging; differential display; gene expression; liver pancreatic secretory
   trypsin inhibitor II; trypsin
ID AGE-RELATED-CHANGES; DIFFERENTIAL DISPLAY; BRAIN
AB The genetic constitution and differential gene expression of an organism play important roles in controlling the species-specific rate of aging and the maximum life span potential. We utilized a differential-display polymerase chain reaction technique to identify the age-dependent expression of genes in the rat liver. We demonstrate in this report, for the first time, that expression of the pancreatic secretory trypsin inhibitor II (PSTI-II) gene declines drastically during aging. We confirmed this decrease by Northern blot analysis. Low PSTI-II levels in aged animals might result in a lack of protection from prematurely activated trypsin-like proteases, which would thus enhance inflammation. Copyright (C) 2004 National Science Council, ROC and S. Karger AG, Basel.
C1 Inst Life Sci, Bhubaneswar 751023, Orissa, India.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS)
RP Supakar, PC (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Orissa, India.
EM pcsupakar@hotmail.com
CR Goyns MH, 1998, MECH AGEING DEV, V101, P73, DOI 10.1016/S0047-6374(97)00166-8
   HORII A, 1989, BIOCHEM BIOPH RES CO, V162, P151, DOI 10.1016/0006-291X(89)91975-X
   Kobayashi K, 1997, HEPATOLOGY, V25, P1160, DOI 10.1002/hep.510250519
   Lavery LW, 2002, BIOGERONTOLOGY, V3, P207, DOI 10.1023/A:1016251929165
   Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   ROY AK, 1983, J BIOL CHEM, V258, P123
   Salehi M, 1996, EXPERIENTIA, V52, P888, DOI 10.1007/BF01938876
   Sambrook J, 2001, MOL CLONING
   Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
NR 13
TC 2
Z9 2
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PY 2004
VL 11
IS 4
BP 528
EP 530
DI 10.1159/000077903
PG 3
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 823BI
UT WOS:000221584300012
PM 15153788
DA 2024-02-19
ER

PT J
AU Sebastian, T
   Malik, R
   Thomas, S
   Sage, J
   Johnson, PF
AF Sebastian, T
   Malik, R
   Thomas, S
   Sage, J
   Johnson, PF
TI C/EBPβ cooperates with RB:E2F to implement Ras<SUP>V12</SUP>-induced
   cellular senescence
SO EMBO JOURNAL
LA English
DT Article
DE C/EBP beta; cell cycle arrest; cellular senescence; oncogenic Ras; RB :
   E2F
ID BINDING-PROTEIN-BETA; TRANSCRIPTIONAL ACTIVATOR PROTEIN; RETINOBLASTOMA
   PROTEIN; GROWTH ARREST; ADIPOCYTE DIFFERENTIATION; HEPATOCYTE
   PROLIFERATION; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; TARGETED
   DISRUPTION; TUMOR SUPPRESSION
AB In primary cells, overexpression of oncogenes such as Ras(V12) induces premature senescence rather than transformation. Senescence is an irreversible form of G(1) arrest that requires the p19(ARF)/p53 and p16(INK4a)/pRB pathways and may suppress tumorigenesis in vivo. Here we show that the transcription factor C/EBP beta is required for Ras(V12)-induced senescence. C/EBP beta(-/-) mouse embryo fibroblasts (MEFs) expressing Ras(V12) continued to proliferate despite unimpaired induction of p19(ARF) and p53, and lacked morphological features of senescent fibroblasts. Enforced C/EBP beta expression inhibited proliferation of wild-type MEFs and also slowed proliferation of p19(Arf-/-) and p53(-/-) cells, indicating that C/EBP beta acts downstream or independently of p19(ARF)/p53 to suppress growth. C/EBP beta was unable to inhibit proliferation of MEFs lacking all three RB family proteins or wild-type cells expressing dominant negative E2F-1 and, instead, stimulated their growth. C/EBP beta decreased expression of several E2F target genes and was associated with their promoters in chromatin immunoprecipitation assays, suggesting that C/EBP beta functions by repressing genes required for cell cycle progression. C/EBP beta is therefore a novel component of the RB: E2F-dependent senescence program activated by oncogenic stress in primary cells.
C1 NCI, Lab Prot Dynam & Signaling, Frederick, MD 21702 USA.
   Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.
   Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.
C3 National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Stanford University; Stanford University
RP Johnson, PF (corresponding author), NCI, Lab Prot Dynam & Signaling, Bldg 539,Room 122,7th Mil St, Frederick, MD 21702 USA.
EM johnsopf@ncifcrf.gov
RI Malik, Radek/G-3578-2014; Vickers, Michael M/E-4095-2010; Johnson,
   Peter/A-1940-2012
OI Malik, Radek/0000-0002-6783-1146; Johnson, Peter/0000-0002-4145-4725
FU Intramural NIH HHS Funding Source: Medline
CR Alexander K, 2001, MOL CELL BIOL, V21, P3616, DOI 10.1128/MCB.21.11.3616-3631.2001
   Baer M, 1998, BLOOD, V92, P4353, DOI 10.1182/blood.V92.11.4353.423k21_4353_4365
   BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x
   Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3
   Bundy LM, 2003, ONCOGENE, V22, P869, DOI 10.1038/sj.onc.1206216
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538
   Chen PL, 1996, P NATL ACAD SCI USA, V93, P465, DOI 10.1073/pnas.93.1.465
   Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794
   Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700
   DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3
   DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135
   Groth A, 2000, J BIOL CHEM, V275, P27473
   Hanlon M, 1999, J BIOL CHEM, V274, P14224, DOI 10.1074/jbc.274.20.14224
   HARVEY M, 1993, ONCOGENE, V8, P2457
   HENDRICKSTAYLOR LR, 1995, NUCLEIC ACIDS RES, V23, P4726, DOI 10.1093/nar/23.22.4726
   Iakova P, 2003, CELL, V113, P495, DOI 10.1016/S0092-8674(03)00318-0
   Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001
   Johnston A, 2000, STAND, V2, P27
   Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3
   KOWENZLEUTZ E, 1994, GENE DEV, V8, P2781, DOI 10.1101/gad.8.22.2781
   Krek W, 1995, CELL, V83, P1149, DOI 10.1016/0092-8674(95)90141-8
   Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008
   Lin AW, 2001, P NATL ACAD SCI USA, V98, P5025, DOI 10.1073/pnas.091100298
   Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5
   NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207
   Nerlov C, 2004, NAT REV CANCER, V4, P394, DOI 10.1038/nrc1363
   Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4
   Peeper DS, 2001, NAT CELL BIOL, V3, P198, DOI 10.1038/35055110
   POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R
   Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5
   Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907
   Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5
   Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200
   Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X
   Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592
   Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074
   Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5
   Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6
   Shuman JD, 2004, MOL CELL BIOL, V24, P7380, DOI 10.1128/MCB.24.17.7380-7391.2004
   Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000
   Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6
   Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153
   Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432
   TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2
   Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100
   Timchenko NA, 1999, MOL CELL BIOL, V19, P2936
   TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299
   Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6
   UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644
   WEINBERG RA, 1989, CANCER RES, V49, P3713
   Wessells J, 2004, MOL CELL BIOL, V24, P3238, DOI 10.1128/MCB.24.8.3238-3250.2004
   WILLIAMS SC, 1991, GENE DEV, V5, P1553, DOI 10.1101/gad.5.9.1553
   WILLS G, 1995, LEARNING ORG, V2, P14
   Xu HJ, 1997, ONCOGENE, V15, P2589, DOI 10.1038/sj.onc.1201446
   Zhu SY, 2002, P NATL ACAD SCI USA, V99, P207, DOI 10.1073/pnas.012437299
   Zhu SY, 1999, MOL CELL BIOL, V19, P7181
NR 61
TC 121
Z9 138
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD SEP 21
PY 2005
VL 24
IS 18
BP 3301
EP 3312
DI 10.1038/sj.emboj.7600789
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 973VV
UT WOS:000232551600014
PM 16107878
OA Green Published
DA 2024-02-19
ER

PT J
AU Berzigotti, A
   Castaldini, N
   Rossi, V
   Magalotti, D
   Tiani, C
   Zappoli, P
   Zoli, M
AF Berzigotti, A.
   Castaldini, N.
   Rossi, V.
   Magalotti, D.
   Tiani, C.
   Zappoli, P.
   Zoli, M.
TI Age Dependency of Regional Impedance Indices Regardless of Clinical
   Stage in Patients with Cirrhosis of the Liver
SO ULTRASCHALL IN DER MEDIZIN
LA English
DT Article
DE abdomen; ultrasound-color doppler; liver cirrhosis
ID PORTAL-HYPERTENSION; DOPPLER SONOGRAPHY; CHRONIC HEPATITIS; RESISTIVE
   INDEX; BLOOD-FLOW; ARTERIAL; HEMODYNAMICS; DISEASE; RESISTANCE; PRESSURE
AB Purpose: To prospectively assess if ageing itself induces modifications of the impedance indices (resistance and pulsatility indexes) of hepatic, splenic, superior mesenteric and renal arteries in patients with liver cirrhosis.
   Materials and Methods: 78 consecutive patients with cirrhosis (41 males, 37 females, Child-Pugh score 7 [range 5 - 12]) were studied by colour-Doppler ultrasound. The resistance index (RI) and pulsatility index (PI) were determined in the main hepatic artery, intraparenchymal branches of hepatic, splenic, and renal arteries, and superior mesenteric artery; clinical data were simultaneously collected. Logistic regression analysis was performed to assess the relative impact of age, severity of liver disease and other relevant variables on the increase of impedance indices. Linear regression analysis Was Used to identify a coefficient to adjust RIs and PIS to age.
   Results: Resistance and pulsatility indices of all the vessels studied except of the superior mesenteric artery showed a direct correlation with age (e.g. splenic artery RI: R=0.520, p<0.0001), and correlated most strongly with Child-Pugh score (e.g. right renal artery PI: R=0.462, p<0.0001). Age was associated independently with increased PI and RI in hepatic, splenic and renal arterial districts. In these vessels, the RI threshold of normality can be adjusted to the decade of age adding a correction of 0.03.
   Conclusion: Ageing itself induces an increase of hepatic, splenic and renal impedance indices in cirrhotic patients. The threshold of normality for these indices in cirrhosis should be adjusted according to the patients' age.
C1 [Berzigotti, A.; Castaldini, N.; Rossi, V.; Magalotti, D.; Tiani, C.; Zappoli, P.; Zoli, M.] Univ Bologna, Dip Med Interna, I-40138 Bologna, Italy.
C3 University of Bologna
RP Berzigotti, A (corresponding author), Univ Bologna, Dip Med Interna, Via Massarenti 9, I-40138 Bologna, Italy.
EM aberzigo@clinic.ub.es
RI Berzigotti, Annalisa/AAB-8999-2019; Berzigotti, Annalisa/AGJ-9475-2022
OI Berzigotti, Annalisa/0000-0003-4562-9016; Castaldini,
   Nicola/0000-0002-8987-9060
FU Dipartimento di Medicina Interna, Cardiciangiologia, Epatologia,
   Universita' di Bologna, Italy
FX Authors are indebt with Dr. Juan G. Abraldes for his suggestions on
   statistical methods.; The authors express their gratitude to Dr. Jean
   Jimenez for revising English language, and to Mrs. Assunta Galizia for
   her help as a nurse in the Colour-Doppler Ultrasound Laboratory.; Dr.
   Annalisa Berzigotti receives financial support by a research grant by
   Dipartimento di Medicina Interna, Cardiciangiologia, Epatologia,
   Universita' di Bologna, Italy.
CR Berzigotti A, 2005, LIVER INT, V25, P331, DOI 10.1111/j.1478-3231.2005.01002.x
   Berzigotti A, 2006, RADIOLOGY, V240, P581, DOI 10.1148/radiol.2401050585
   BIANCHI G, 1994, HEPATOLOGY, V20, P119, DOI 10.1002/hep.1840200119
   Bolognesi M, 1996, HEPATOLOGY, V23, P1035
   Boozari B, 2007, ULTRASCHALL MED, V28, P587, DOI 10.1055/s-2007-963580
   García-Criado A, 2003, AM J ROENTGENOL, V181, P831, DOI 10.2214/ajr.181.3.1810831
   Garcia-Tsao G, 2001, GASTROENTEROLOGY, V120, P726, DOI 10.1053/gast.2001.22580
   GOSLING RG, 1974, P ROY SOC MED, V67, P447, DOI 10.1177/00359157740676P113
   Hoshida Y, 1999, J HEPATOL, V31, P860, DOI 10.1016/S0168-8278(99)80287-6
   Iwao T, 1997, J HEPATOL, V27, P817, DOI 10.1016/S0168-8278(97)80318-2
   Junaidi O, 2007, CLIN GERIATR MED, V23, P889, DOI 10.1016/j.cger.2007.06.006
   Jurasic MJ, 2007, J NEUROL SCI, V257, P139, DOI 10.1016/j.jns.2007.01.027
   Kawakami M, 2007, HEPATOL RES, V37, P152, DOI 10.1111/j.1872-034X.2007.00023.x
   Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58
   LEGARTH J, 1989, SCAND J CLIN LAB INV, V49, P459, DOI 10.3109/00365518909089122
   Lin ZY, 2002, ABDOM IMAGING, V28, P230, DOI 10.1007/s00261-002-0024-4
   MAROTO A, 1994, HEPATOLOGY, V20, P839, DOI 10.1002/hep.1840200411
   MORIYASU F, 1986, J CLIN ULTRASOUND, V14, P579, DOI 10.1002/jcu.1870140802
   MORIYASU F, 1986, AM J ROENTGENOL, V146, P735, DOI 10.2214/ajr.146.4.735
   Okura T, 2004, AM J HYPERTENS, V17, P240, DOI 10.1016/j.amjhyper.2003.10.005
   Piscaglia F, 2002, SCAND J GASTROENTERO, V37, P1220, DOI 10.1080/003655202760373452
   Piscaglia F, 2001, SCAND J GASTROENTERO, V36, P647, DOI 10.1080/003655201750163178
   Piscaglia F, 1997, ULTRASOUND MED BIOL, V23, P675, DOI 10.1016/S0301-5629(97)00012-4
   Piscaglia F, 1997, EUR J GASTROEN HEPAT, V9, P799, DOI 10.1097/00042737-199708000-00012
   PLATT JF, 1992, AM J ROENTGENOL, V158, P1035, DOI 10.2214/ajr.158.5.1566663
   PLATT JF, 1992, RADIOLOGY, V183, P801, DOI 10.1148/radiology.183.3.1584937
   PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817
   Sacerdoti D, 1997, J HEPATOL, V27, P986, DOI 10.1016/S0168-8278(97)80141-9
   Schneider AW, 1999, J HEPATOL, V30, P876, DOI 10.1016/S0168-8278(99)80142-1
   Staub D, 2007, ULTRASCHALL MED, V28, P45, DOI 10.1055/s-2007-962881
   Taourel P, 1998, HEPATOLOGY, V28, P932, DOI 10.1002/hep.510280406
   TERRY JD, 1992, J ULTRAS MED, V11, P647
   Wicklein S, 2007, Z GERONTOL GERIATR, V40, P37, DOI 10.1007/s00391-007-0431-9
   ZIRONI G, 1992, J HEPATOL, V16, P298, DOI 10.1016/S0168-8278(05)80660-9
   Zoli M, 1996, J ULTRAS MED, V15, P99
NR 35
TC 2
Z9 2
U1 0
U2 0
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0172-4614
EI 1438-8782
J9 ULTRASCHALL MED
JI Ultraschall Med.
PD JUN
PY 2009
VL 30
IS 3
BP 277
EP 285
DI 10.1055/s-2008-1027742
PG 9
WC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Acoustics; Radiology, Nuclear Medicine & Medical Imaging
GA 463MT
UT WOS:000267437000007
PM 19253207
DA 2024-02-19
ER

PT J
AU Parker, SM
   Goriwiec, MR
   Borthwick, LA
   Johnson, G
   Ward, C
   Lordan, JL
   Corris, PA
   Saretzki, GC
   Fisher, AJ
AF Parker, S. M.
   Goriwiec, M. R.
   Borthwick, L. A.
   Johnson, G.
   Ward, C.
   Lordan, J. L.
   Corris, P. A.
   Saretzki, G. C.
   Fisher, A. J.
TI Airway epithelial cell senescence in the lung allograft
SO AMERICAN JOURNAL OF TRANSPLANTATION
LA English
DT Article
ID BRONCHIOLITIS OBLITERANS; REPLICATIVE SENESCENCE; TRANSPLANT RECIPIENTS;
   INCREASED EXPRESSION; GROWTH-FACTOR; FIBROBLASTS; DISEASE; NEPHROPATHY;
   MECHANISMS; REJECTION
AB Chronic lung allograft dysfunction, manifesting as bronchiolitis obliterans syndrome (BOS), is characterized by airway epithelial injury, impaired epithelial regeneration and subsequent airway remodeling. Increased cellular senescence has been reported in renal and liver allografts affected by chronic allograft dysfunction but the significance of cellular senescence in the airway epithelium of the transplanted lung is unknown. Thirty-four lung transplant recipients, 20 with stable graft function and 14 with BOS, underwent transbronchial lung biopsy and histochemical studies for senescence markers in small airways. Compared to nontransplant control lung tissue (n = 9), lung allografts demonstrate significantly increased airway epithelial staining for senescence-associated beta galactosidase (SA beta-gal) (p = 0.0215), p16(ink4a) (p = 0.0002) and p21(waf1/cip) (p = 0.0138) but there was no difference in expression of these markers between stable and BOS affected recipients (p > 0.05). This preliminary cross-sectional study demonstrates that cellular senescence occurs with increased frequency in the airway epithelium of the lung allograft but does not establish any association between airway epithelial senescence and BOS. A prospective longitudinal study is required to better address any potential causal association between airway epithelial senescence in stable allograft recipients and the subsequent development of BOS.
EM a.j.fisher@ncl.ac.uk
RI Ward, Christopher/B-8175-2013; Saretzki, Gabriele Christine/I-7175-2019;
   Fisher, Andrew J/A-2160-2012
OI Ward, Christopher/0000-0002-6954-9611; Saretzki, Gabriele
   Christine/0000-0003-2100-8223; Borthwick, Lee/0000-0003-2885-3382
CR Adams BF, 2000, TRANSPLANTATION, V69, P661, DOI 10.1097/00007890-200002270-00031
   Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013
   Boehler A, 2003, EUR RESPIR J, V22, P1007, DOI 10.1183/09031936.03.00039103
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Castro P, 2004, PROSTATE, V60, P153, DOI 10.1002/pros.20051
   Chkhotua AB, 2003, TRANSPL INT, V16, P600, DOI 10.1007/s00147-003-0587-1
   Coates PJ, 2002, J PATHOL, V196, P371, DOI 10.1002/path.1073
   Coppé JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Ferlicot S, 2003, HUM PATHOL, V34, P924, DOI 10.1016/S0046-8177(03)00340-X
   Halloran PF, 1999, J AM SOC NEPHROL, V10, P167
   Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061
   Joosten SA, 2003, AM J PATHOL, V162, P1305, DOI 10.1016/S0002-9440(10)63926-0
   Lama VN, 2007, AM J RESP CRIT CARE, V175, P1192, DOI 10.1164/rccm.200609-1344OC
   Lunz JG, 2001, AM J PATHOL, V158, P1379, DOI 10.1016/S0002-9440(10)64089-8
   Melk A, 2005, AM J TRANSPLANT, V5, P1375, DOI 10.1111/j.1600-6143.2005.00846.x
   MIYAZAKI M, 1994, EXP CELL RES, V212, P22, DOI 10.1006/excr.1994.1113
   Nicod Laurent P, 2006, Proc Am Thorac Soc, V3, P444, DOI 10.1513/pats.200601-007AW
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009
   Ward C, 2004, CLIN EXP ALLERGY, V34, P1905, DOI 10.1111/j.1365-2222.2004.02121.x
NR 20
TC 13
Z9 14
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1600-6135
EI 1600-6143
J9 AM J TRANSPLANT
JI Am. J. Transplant.
PD JUL
PY 2008
VL 8
IS 7
BP 1544
EP 1549
DI 10.1111/j.1600-6143.2008.02284.x
PG 6
WC Surgery; Transplantation
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Surgery; Transplantation
GA 324WJ
UT WOS:000257549800026
PM 18557742
OA hybrid
DA 2024-02-19
ER

PT J
AU Ventura, B
   Genova, ML
   Bovina, C
   Formiggini, G
   Lenaz, G
AF Ventura, B
   Genova, ML
   Bovina, C
   Formiggini, G
   Lenaz, G
TI Control of oxidative phosphorylation by Complex I in rat liver
   mitochondria: implications for aging
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
LA English
DT Article
DE rat liver mitochondria; aging; respiratory chain; flux control; complex
   I
ID COENZYME-Q REDUCTASE; RESPIRATORY-CHAIN; ELECTRON-TRANSFER;
   SKELETAL-MUSCLE; DNA MUTATIONS; DIRECT ASSAY; AGED RATS; STRESS; NADH;
   BIOENERGETICS
AB We compared NAD-dependent state 4 and state 3 respiration, NADH oxidation and Complex I specific activity in liver mitochondria from 4- and 30-month-old rats. All the activities examined were significantly decreased with aging, In both groups of animals, the flux control coefficients measured by rotenone titration indicated that Complex I is largely rate controlling upon NADH aerobic oxidation while, in state 3 respiration, it shares the control with other steps in the pathway. Moreover, we observed a trend wherein flux control coefficients of Complex I became higher with age. This indication was strengthened by examining the rotenone inhibition thresholds showing that Complex I becomes more rate controlling, over all the examined activities, during aging. Our results point out that age-related alterations of the mitochondrial functions are also present in tissues considered less prone to accumulate mitochondrial DNA mutations. (C) 2002 Elsevier Science B.V. All rights reserved.
C1 Univ Bologna, Dipartimento Biochim G Moruzzi, I-40126 Bologna, Italy.
C3 University of Bologna
RP Lenaz, G (corresponding author), Univ Bologna, Dipartimento Biochim G Moruzzi, Via Irnerio 48, I-40126 Bologna, Italy.
EM lenaz@biocfarm.unibo.it
RI Ventura, Barbara/B-8819-2009; Lenaz, Giorgio/B-5751-2013; Genova, Maria
   Luisa/H-6921-2012
OI Ventura, Barbara/0000-0002-8207-1659; Genova, Maria
   Luisa/0000-0002-9176-3630
CR Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000
   Barogi S, 2000, MECH AGEING DEV, V113, P1, DOI 10.1016/S0047-6374(99)00089-5
   BECHMANN G, 1992, EUR J BIOCHEM, V208, P315, DOI 10.1111/j.1432-1033.1992.tb17189.x
   Brandt U, 1997, BBA-BIOENERGETICS, V1318, P79, DOI 10.1016/S0005-2728(96)00141-7
   Carelli V, 1999, ANN NEUROL, V45, P320, DOI 10.1002/1531-8249(199903)45:3<320::AID-ANA7>3.0.CO;2-L
   CASTELLUCCIO C, 1994, MECH AGEING DEV, V76, P73, DOI 10.1016/0047-6374(94)91583-0
   Cavazzoni M, 1999, FEBS LETT, V449, P53, DOI 10.1016/S0014-5793(99)00400-7
   CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65
   COOPER JM, 1992, J NEUROL SCI, V113, P91, DOI 10.1016/0022-510X(92)90270-U
   De Grey A.D.N.J., 1998, EUR RESPIR J, V1, P53, DOI [10.1089/rej.1.1998.1.53, DOI 10.1089/REJ.1.1998.1.53]
   Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2
   ESPOSTI MD, 1994, BBA-BIOENERGETICS, V1187, P116, DOI 10.1016/0005-2728(94)90095-7
   ESPOSTI MD, 1994, FEBS LETT, V352, P375, DOI 10.1016/0014-5793(94)00971-6
   ESPOSTI MD, 1993, BIOCHEM BIOPH RES CO, V190, P1090, DOI 10.1006/bbrc.1993.1161
   ESTORNELL E, 1993, FEBS LETT, V332, P127, DOI 10.1016/0014-5793(93)80498-J
   Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034
   Fell D. A., 1997, UNDERSTANDING CONTRO, P1
   FRY M, 1981, J BIOL CHEM, V256, P1874
   GENOVA ML, 1995, BIOCHEM J, V311, P105, DOI 10.1042/bj3110105
   Genova ML, 1997, FEBS LETT, V410, P467
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   GROEN AK, 1982, J BIOL CHEM, V257, P2754
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x
   INOMOTO T, 1994, BBA-BIOENERGETICS, V1188, P311, DOI 10.1016/0005-2728(94)90050-7
   *JAND CORP, JAND SIGM PLOT SCI G
   Kacser H, 1979, BIOCHEM SOC T, V7, P1149, DOI 10.1042/bst0071149
   Kacser H., 1973, RATE CONTROL BIOL PR, P65
   KROGER A, 1973, EUR J BIOCHEM, V34, P358, DOI 10.1111/j.1432-1033.1973.tb02767.x
   Kun E, 1979, Methods Enzymol, V55, P115
   Kuznetsov AV, 1997, BBA-MOL BASIS DIS, V1360, P142, DOI 10.1016/S0925-4439(96)00072-5
   Lenaz G, 1997, MOL CELL BIOCHEM, V174, P329, DOI 10.1023/A:1006854619336
   Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0
   Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8
   LENAZ G, 1995, FEBS LETT, V366, P119, DOI 10.1016/0014-5793(95)00508-7
   LETELLIER T, 1993, BIOCHIM BIOPHYS ACTA, V1141, P58, DOI 10.1016/0005-2728(93)90189-M
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   Mazat JP, 1997, MOL CELL BIOCHEM, V174, P143, DOI 10.1023/A:1006875517267
   MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x
   Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774
   MINAKAMI S, 1962, J BIOL CHEM, V237, P569
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   OZAWA T, 1995, BBA-MOL BASIS DIS, V1271, P177, DOI 10.1016/0925-4439(95)00026-Z
   Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427
   PARADIES G, 1991, ARCH BIOCHEM BIOPHYS, V284, P332, DOI 10.1016/0003-9861(91)90304-2
   Pich MM, 1996, FEBS LETT, V380, P176, DOI 10.1016/0014-5793(96)00037-3
   Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426
   SCHON EA, 1996, CELLULAR AGING CELL, P19
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SUGIYAMA S, 1993, BIOCHEM MOL BIOL INT, V30, P937
   VONJAGOW G, 1986, BIOCHEMISTRY-US, V25, P775, DOI 10.1021/bi00352a006
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   Yowe DL, 1998, GENE, V209, P23, DOI 10.1016/S0378-1119(97)00628-8
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
NR 56
TC 83
Z9 91
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2728
EI 0006-3002
J9 BBA-BIOENERGETICS
JI Biochim. Biophys. Acta-Bioenerg.
PD FEB 15
PY 2002
VL 1553
IS 3
BP 249
EP 260
AR PII S0005-2728(01)00246-8
DI 10.1016/S0005-2728(01)00246-8
PG 12
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 552FA
UT WOS:000175607600009
PM 11997134
OA hybrid
DA 2024-02-19
ER

PT J
AU Hastings, R
   Li, NC
   Lacy, PS
   Patel, H
   Herbert, KE
   Stanley, AG
   Williams, B
AF Hastings, R
   Li, NC
   Lacy, PS
   Patel, H
   Herbert, KE
   Stanley, AG
   Williams, B
TI Rapid telomere attrition in cardiac tissue of the ageing Wistar rat
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE telomere; molecular ageing; senescence; Wistar rat; cardiovascular
   system
AB Many studies show an association between ageing and mean telomere length in DNA isolated from peripheral blood mononuclear cells, few studies have examined less accessible tissues. This study has two objectives: (i) to define the best method to prepare rodent DNA for telomere length measurement by Southern blotting and (ii) to determine whether there are differential rates of telomere attrition in different rodent tissues. We found that the use of agarose plugs for DNA isolation was essential for the accurate measurement of rodent telomere length. Tissue was collected from neonatal (3 days) or aged (18-24 months) male Wistar rats and terminal restriction fragment (TRF) length was measured by Southern blotting. Cardiac tissue from aged rats showed a 38% loss of TRF length compared with newborn animals (p < 0.001, n = 13), this contrasts with much smaller reductions in brain (1.6%), liver (14.2%), kidney (8.9%) and lung (9.7%). This study demonstrates that the methods of DNA preparation are critical for accurate measurement of telomeres in rodent tissues. Moreover, we show differential rates of telomere attrition in rat tissues, the heart being most susceptible to telomere loss. These observations could have important implications for the study of age-specific changes in tissue function. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England.
C3 University of Leicester
RP Hastings, R (corresponding author), Univ Leicester, Leicester Royal Infirm, Dept Cardiovasc Sci, Robert Kilpatick Clin Sci Bldg, Leicester LE2 7LX, Leics, England.
EM rah22@le.ac.uk
RI Lacy, Peter S/D-6878-2016; Williams, Bryan R. G./A-5021-2009
OI Lacy, Peter S/0000-0002-5916-6465; Williams, Bryan R.
   G./0000-0002-4969-1151; Williams, Bryan/0000-0002-8094-1841; Herbert,
   Karl/0000-0002-6760-7929
CR Anversa P, 2002, NATURE, V415, P240, DOI 10.1038/415240a
   Campisi J, 2001, EXP GERONTOL, V36, P1619, DOI 10.1016/S0531-5565(01)00160-7
   Cherif H, 2003, NUCLEIC ACIDS RES, V31, P1576, DOI 10.1093/nar/gkg208
   CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051
   Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1
   Kajstura J, 2000, AM J PATHOL, V156, P813, DOI 10.1016/S0002-9440(10)64949-8
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331
   Petersen S, 1998, EXP CELL RES, V239, P152, DOI 10.1006/excr.1997.3893
   TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P411, DOI 10.1016/0003-9861(82)90519-7
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
NR 11
TC 21
Z9 23
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD MAY
PY 2004
VL 39
IS 5
BP 855
EP 857
DI 10.1016/j.exger.2004.02.003
PG 3
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 823SM
UT WOS:000221633400020
PM 15130681
DA 2024-02-19
ER

PT J
AU PERICHON, R
   BOURRE, JM
AF PERICHON, R
   BOURRE, JM
TI PEROXISOMAL BETA-OXIDATION ACTIVITY AND CATALASE ACTIVITY DURING
   DEVELOPMENT AND AGING IN MOUSE-LIVER
SO BIOCHIMIE
LA English
DT Article
DE PEROXISOMES; BETA-OXIDATION; CATALASE; MOUSE LIVER; AGING
ID FATTY-ACID COMPOSITION; RAT-LIVER; PLASMA-MEMBRANE; BRAIN; AGE;
   MITOCHONDRIAL; RESTRICTION; CLOFIBRATE; METABOLISM; BIOGENESIS
AB Liver peroxisomal beta-oxidation activity on stearate, oleate, linoleate and alpha-linolenate was investigated as a funtion of age in two mouse strains. Each fatty acid showed a similar beta-oxidation activity pattern with age characterized by a rapid increase (200%) from day 2 to 20 followed by a dramatic weaning-related decrease (70%) from day 20 to 22. There was a new increase (260%) from day 22 to 75, then a plateau up to day 300 days, and finally an age-related decrease (70%) from day 300 to 540. Oleic, linoleic and alpha-linolenic acids were respectively 5-, 7.5- and 9-fold more degraded than stearic acid. Catalase specific activity showed the same age-related pattern as fatty acid beta-oxidation. Both mouse strains showed the age-related decreases. The longer-lived strain exhibited higher activity for both peroxisomal beta-oxidation and catalase and the rate of decrease of these two activities during aging was the same for both strains. The catalase/alpha-linolenic acid beta-oxidation ratio was constant during adulthood and aging. These results suggest that peroxisomal beta-oxidation and catalase activities are closely related throughout and implications for long-chain and very long-chain fatty acid metabolism, maintenance of membrane fatty acid composition and anti-oxidant status during aging are discussed.
RP PERICHON, R (corresponding author), HOP FERNAND WIDAL, NEUROTOXICOL LAB, INSERM, U26, 200 RUE FAUBOURG ST DENIS, F-75010 PARIS, FRANCE.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   ALEXSON SEH, 1984, BIOCHIM BIOPHYS ACTA, V796, P1, DOI 10.1016/0005-2760(84)90231-5
   BEIR K, 1992, VIRCHOW ARCH B, V63, P139
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   BOURRE JM, 1988, BIOCHIM BIOPHYS ACTA, V960, P458, DOI 10.1016/0005-2760(88)90055-0
   BOURRE JM, 1984, J NEUROCHEM, V43, P342, DOI 10.1111/j.1471-4159.1984.tb00906.x
   BOURRE JM, 1992, NEUROSCI LETT, V141, P65, DOI 10.1016/0304-3940(92)90335-5
   BRENNER RR, 1984, PROG LIPID RES, V23, P69, DOI 10.1016/0163-7827(84)90008-0
   CUTLER RG, 1991, AM J CLIN NUTR, V53, pS373, DOI 10.1093/ajcn/53.1.373S
   DEMOZ A, 1993, BIOCHEM PHARMACOL, V45, P257, DOI 10.1016/0006-2952(93)90400-Q
   FAHIMI HD, 1993, BIOCHIMIE, V75, P201, DOI 10.1016/0300-9084(93)90078-7
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HILTUNEN JK, 1986, J BIOL CHEM, V261, P6484
   HOLLOWAY CT, 1975, ARCH BIOCHEM BIOPHYS, V167, P496, DOI 10.1016/0003-9861(75)90492-0
   KRITCHEVSKY D, 1980, P SOC EXP BIOL MED, V165, P193, DOI 10.3181/00379727-165-40957
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LAZAROW PB, 1976, P NATL ACAD SCI USA, V73, P2043, DOI 10.1073/pnas.73.6.2043
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUERS G, 1990, EUR J CELL BIOL, V52, P175
   MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585
   MOHRHAUER H, 1963, J LIPID RES, V4, P151
   SCHWIETERMAN W, 1988, P NATL ACAD SCI USA, V85, P359, DOI 10.1073/pnas.85.2.359
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SINGH I, 1983, J LIPID RES, V24, P662
   STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4
   THIDINH KLK, 1990, LIPIDS, V25, P278, DOI 10.1007/BF02544388
   VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105
   WANDERS RJA, 1987, BIOCHIM BIOPHYS ACTA, V919, P21, DOI 10.1016/0005-2760(87)90213-X
   WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73
NR 30
TC 45
Z9 50
U1 3
U2 6
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PY 1995
VL 77
IS 4
BP 288
EP 293
DI 10.1016/0300-9084(96)88138-7
PG 6
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA RC525
UT WOS:A1995RC52500011
PM 8589059
DA 2024-02-19
ER

PT J
AU Gao, S
   Wang, TZ
   Huang, XK
   Jin, YQ
   Xu, Y
   Xi, YM
   Zhang, J
   Luo, Y
   Xu, HL
   Guo, HL
   Ke, DZ
   Wang, JW
AF Gao, Siting
   Wang, Tongzhuang
   Huang, XueKuan
   Jin, Yaqian
   Xu, Yu
   Xi, Yumeng
   Zhang, Jun
   Luo, Yan
   Xu, Hongling
   Guo, Hongli
   Ke, Dazhi
   Wang, Jianwei
TI Exploring the protective effect of Modified Xiaochaihu Decoction against
   hepatic steatosis and inflammation by network pharmacology and
   validation in ageing rats
SO CHINESE MEDICINE
LA English
DT Article
DE Modified Xiaochaihu Decoction; Non-alcoholic fatty liver disease;
   Network pharmacology
ID FATTY LIVER-DISEASE; HFD-INDUCED NAFLD; LIPID-METABOLISM; ACTIVATION;
   PUERARIN; OBESITY; NRF2; MICE
AB Background Based on therapy with syndrome differentiation and clinical studies on Xiaochaihu decoction (XCHD), we hypothesize that Modified Xiaochaihu Decoction (MXD) has an ability to ameliorate non-alcoholic fatty liver disease (NAFLD). This study aims to elucidate the pharmacological efficacy of MXD and its mechanism in the treatment of NAFLD by network pharmacology and experimental validation. Methods The active ingredients in MXD and their potential targets were identified using network analysis followed by experimental validation. First, we used data on the ingredients and targets obtained from professional database and related literature to do PPI network analysis, GO functional analysis, and KEGG pathway enrichment analysis. Core targets identified by network pharmacology were then tested in natural ageing female rats model. Indexes of lipid and glucose homeostasis were determined enzymatically and/or histologically. Gene expression was analyzed by real-time PCR and/or Western blot (WB). Results In total, 4009 NAFLD-related targets and 1953 chemical ingredients of MXD were obtained. In-depth network analysis of 140 common targets indicated that MXD played a critical role in anti-NAFLD via multiple targets and pathways. Based on the data of PPI analysis, GO functional enrichment analysis, KEGG pathway enrichment analysis, and literatures on the mechanism of NAFLD, we chose the core targets related to lipid metabolism (SREBP-1c, ChREBP, FASN, PPAR alpha, and ACACA) and inflammation (IL-6 and NF-kappa B) to do further study. Significantly, in further animal verification experiment we using naturally ageing rats with NAFLD as a model, we found that MXD administration ameliorated age-related NAFLD and mechanistically down-regulated the mRNA/protein expression of core targets in lipid metabolism and inflammation related pathways such as FASN, ACACA, IL-6, and NF-kappa B. In addition, 12 of 24 potential ingredients acting on verified targets came from BC, and 11 of 24 potential ingredients acting on verified targets were derived from SM, implying that both BC and SM served as the key role in MXD against NAFLD. Conclusion The bioinformatics data and in vivo experimental results suggest that the MXD-induced amelioration of NAFLD may be predominantly related to modulation of lipid metabolism and inflammation. Both BC and SM serve as the key role in MXD against NAFLD. These results may provide novel evidence for clinical implication of MXD.
C1 [Gao, Siting; Wang, Tongzhuang; Huang, XueKuan; Jin, Yaqian; Xu, Yu; Xi, Yumeng; Zhang, Jun; Luo, Yan; Xu, Hongling; Guo, Hongli; Wang, Jianwei] Chongqing Med Univ, Chongqing Key Lab Tradit Chinese Med Prevent & Cu, Chongqing, Peoples R China.
   [Gao, Siting; Wang, Tongzhuang; Huang, XueKuan; Xu, Yu; Xi, Yumeng; Luo, Yan; Xu, Hongling; Guo, Hongli; Wang, Jianwei] Chongqing Med Univ, Coll Tradit Chinese Med, Chongqing, Peoples R China.
   [Jin, Yaqian; Zhang, Jun] Chongqing Med Univ, Fac Basic Med Sci, Chongqing, Peoples R China.
   [Ke, Dazhi] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China.
C3 Chongqing Medical University; Chongqing Medical University; Chongqing
   Medical University; Chongqing Medical University
RP Wang, JW (corresponding author), Chongqing Med Univ, Chongqing Key Lab Tradit Chinese Med Prevent & Cu, Chongqing, Peoples R China.
EM wangjianwei@cqmu.edu.cn
RI Gao, Siting/HTR-9889-2023; LI, JIAN/JAX-3092-2023
OI Gao, Siting/0009-0003-9523-0844
FU National Natural Science Foundation of China [81673659, 81973653];
   Foundation of Chongqing Health and Family Planning Commission
   [ZY201702133]; Natural Science Foundation of Chongqing (municipality)
   [cstc2017jcyjAX0374, cstc2018jcyjAX0176]; Innovation experiment project
   of Chongqing Medical University [SRIEP201918]; Xinglin project of
   College of Traditional Chinese Medicine, Chongqing Medical University
   [201810]; Project of Chongqing Yuzhong district science committee
   [20190117]
FX This work was financially supported by the National Natural Science
   Foundation of China (Grant No: 81673659 and 81973653), the Foundation of
   Chongqing Health and Family Planning Commission (Grant No: ZY201702133),
   the Natural Science Foundation of Chongqing (municipality) (Grant No:
   cstc2017jcyjAX0374; cstc2018jcyjAX0176), Innovation experiment project
   of Chongqing Medical University (Grant No: SRIEP201918), Xinglin project
   of College of Traditional Chinese Medicine, Chongqing Medical University
   (Grant No: 201810), Project of Chongqing Yuzhong district science
   committee (Grant No: 20190117).
CR Abu-Elsaad N, 2019, PHARMACOL REP, V71, P688, DOI 10.1016/j.pharep.2019.03.009
   Banini BA, 2017, CURR OPIN GASTROEN, V33, P134, DOI 10.1097/MOG.0000000000000356
   Brady CW, 2015, WORLD J GASTROENTERO, V21, P7613, DOI 10.3748/wjg.v21.i25.7613
   Buzzetti E, 2016, METABOLISM, V65, P1038, DOI 10.1016/j.metabol.2015.12.012
   Cicero AFG, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091153
   Fan H, 2017, MED SCI MONITOR, V23, P5599, DOI 10.12659/MSM.907530
   Feng XJ, 2017, BIOCHEM PHARMACOL, V136, P136, DOI 10.1016/j.bcp.2017.04.014
   Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   He B, 2002, ZHEJIANG CLIN MED, V2002, P276, DOI [10.3969/j.issn.1008-7664.2002.04.022, DOI 10.3969/J.ISSN.1008-7664.2002.04.022]
   Hong M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030620
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Hu ZJ, 2011, MOD J INTEGR TRADIT, V20, P254, DOI DOI 10.3969/j.issn.1008-8849.2011.02.087
   Kang OH, 2015, INT J MOL MED, V35, P803, DOI 10.3892/ijmm.2015.2074
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kim SB, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0147745, 10.1371/journal.pone.0148908]
   Knebel B, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00248
   Kwon EY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10080979
   Lane EA, 2019, MOL CELL, V75, P357, DOI 10.1016/j.molcel.2019.05.019
   Lee G, 2019, DIABETES, V68, P81, DOI 10.2337/db18-0556
   Li Sai-mei, 2014, Zhongguo Zhong Xi Yi Jie He Za Zhi, V34, P1264
   Li SL, 2019, J ETHNOPHARMACOL, V242, DOI 10.1016/j.jep.2019.112029
   Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]
   Liang XJ, 2014, MOL BIOSYST, V10, P1014, DOI 10.1039/c3mb70507b
   Lin AXH, 2018, CHIN MED-UK, V13, DOI 10.1186/s13020-018-0167-z
   Liu Cheng, 2008, Chin Med, V3, P1, DOI 10.1186/1749-8546-3-1
   Liu L, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800649
   Liu QS, 2017, INT IMMUNOPHARMACOL, V49, P132, DOI 10.1016/j.intimp.2017.05.026
   Lv YA, 2019, J NUTR BIOCHEM, V71, P110, DOI 10.1016/j.jnutbio.2019.05.015
   Ortega-Prieto P, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00472
   Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8
   Porras D, 2019, MOL NUTR FOOD RES, V63, DOI 10.1002/mnfr.201800930
   Qu W, 2012, HENAN CHIN MED, V32, P52, DOI [10.16367/j.issn.1003-5028.2012.07.056, DOI 10.16367/J.ISSN.1003-5028.2012.07.056]
   Sang Ting-Ting, 2018, Zhongguo Zhong Yao Za Zhi, V43, P3235, DOI 10.19540/j.cnki.cjcmm.20180423.003
   Seiva FRF, 2012, FOOD CHEM TOXICOL, V50, P3556, DOI 10.1016/j.fct.2012.07.009
   Takahashi Y, 2014, PATHOL INT, V64, P490, DOI 10.1111/pin.12199
   Takahashi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087279
   Thomas NS, 2017, EUR J NUTR, V56, P2353, DOI 10.1007/s00394-016-1275-0
   Tong SW., 2017, ASIA PACIFIC TRADIT, V13, P133
   Tong XL, 2018, MBIO, V9, DOI 10.1128/mBio.02392-17
   Ulasova E, 2013, REDOX BIOL, V1, P381, DOI 10.1016/j.redox.2013.07.001
   Wang J, 2017, ANN NY ACAD SCI, V1398, P83, DOI 10.1111/nyas.13375
   Wang S, 2019, PHYTOTHER RES, V33, P2347, DOI 10.1002/ptr.6417
   Wang ZQ, 2013, METABOLISM, V62, P1239, DOI 10.1016/j.metabol.2013.03.004
   Xu G, 2018, CURR MED CHEM, V25, P889, DOI 10.2174/0929867324666170404142450
   Yang Z, 2009, CHIN J PRIMARY MED P, V2009, P159, DOI [10.3760/cma.j.issn.1008-6706.2009.01.102, DOI 10.3760/CMA.J.ISSN.1008-6706.2009.01.102]
   Yin Y, 2017, BIOCHEM BIOPH RES CO, V482, P720, DOI 10.1016/j.bbrc.2016.11.101
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Zheng JH, 2018, CANCERS, V10, DOI 10.3390/cancers10110461
   Zheng PY, 2009, AM J CHINESE MED, V37, P69, DOI 10.1142/S0192415X09006692
   Zhu XH, 2018, FOOD CHEM TOXICOL, V114, P52, DOI 10.1016/j.fct.2018.02.019
NR 51
TC 4
Z9 5
U1 3
U2 37
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-8546
J9 CHIN MED-UK
JI Chin. Med.
PD SEP 4
PY 2020
VL 15
IS 1
AR 96
DI 10.1186/s13020-020-00378-y
PG 19
WC Integrative & Complementary Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Integrative & Complementary Medicine; Pharmacology & Pharmacy
GA NO7KB
UT WOS:000569665800001
OA gold
DA 2024-02-19
ER

PT J
AU Sanz, N
   DiezFernandez, C
   Alvarez, A
   Cascales, M
AF Sanz, N
   DiezFernandez, C
   Alvarez, A
   Cascales, M
TI Age-dependent modifications in rat hepatocyte antioxidant defense
   systems
SO JOURNAL OF HEPATOLOGY
LA English
DT Article
DE antioxidant enzymes; DNA ploidy; glutathione; reactive oxygen radicals;
   senescence
ID FREE-RADICAL THEORY; DNA-PLOIDY; MITOCHONDRIAL DECAY; OXIDATIVE DAMAGE;
   GLUTATHIONE; LIVER; APOPTOSIS; GROWTH; BINUCLEATION; STIMULATION
AB Background/Aims: Age-dependent changes in the hepatic antioxidant systems were studied in hepatocytes from newly weaned (21 days) to 30-month-old rats.
   Results: Biphasic changes were observed in superoxide dismutase (SOD), glucose-6-phosphate dehydrogenase (G6PDH) and malic enzyme (ME), in which noticeable decreases were detected in hepatocytes from newly weaned to 6-month-old rats: Cu-Zn SOD decreased to 46% (p<0.001), Mn SOD to 41% (p<0.001), G6PDH to 71% and ME to 19% (p<0.001), and significant increases were observed from 6 to 30 months. In hepatocytes from 6- to 36-month-old rats the enzymes involved in antioxidant defense underwent increases in their activities as well in their mRNA: Cu-Zn SOD (142%, p<0.001), catalase (182%, p<0.001) and glutathione peroxidase (325%, p<0.001). However, chronological decreases were observed in the levels of reduced glutathione (69%, p<0.001), in the GSH/GSSG ratio (78%) and in protein thiol groups (55%, p<0.001), with concomitant increases in peroxides (155%, p<0.001.) and malondialdehyde (142%, p<0.001) levels. DNA ploidy was also assayed by flow cytometry; a sharp increase in tetraploid (2.5-40.1%;p<0.001) and octoploid (0.1-16.1%; p<0.001) populations, and a noticeable decrease in diploid hepatocytes (92.9-34.3%; p<0.001), were observed. Populations involved in 2C-->4C DNA synthesis decreased from 3.6 to 0.9% (p<0.001), while those involved in 4C-->8C increased from 0.9% to 5.2% (p<0.001). A hypodiploid population (apoptotic cells) was detected from 12 months, increasing thereafter.
   Conclusions: These results show that the antioxidant cell defense system increases with age but the rate of reactive oxygen species generation exceeds the induced antioxidant ability, generating a situation that favors oxidative stress and peroxidation. The progressive polyploidization is accompanied by changes in the proliferative potential that decreases from 2C to 4C and increased from 4C to 8C. The relationship between the modifications of the oxidant/antioxidant system and increased polyploidy is not clear and may be interpreted as two independent manifestations of the aging process.
C1 UNIV COMPLUTENSE, FAC FARM, INST BIOQUIM, CSIC, E-28040 MADRID, SPAIN.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); Complutense
   University of Madrid
RI Alvarez-Barrientos, Alberto/L-9299-2014
OI Alvarez-Barrientos, Alberto/0000-0003-4761-0212
CR Aebi H.E., 1987, Methods Enzym. Anal., V3, P273
   AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6
   AMES BN, 1995, BBA-MOL BASIS DIS, V1271, P165, DOI 10.1016/0925-4439(95)00024-X
   BASS DA, 1983, J IMMUNOL, V130, P1910
   BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412
   BIEMOND P, 1986, BIOCHEM J, V239, P169, DOI 10.1042/bj2390169
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BURSCH W, 1992, TRENDS PHARMACOL SCI, V13, P245, DOI 10.1016/0165-6147(92)90077-J
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   DEMAESTRO RF, 1983, OXYGEN RADICALS THEI, V2, P28
   Deutsch J., 1983, METHOD ENZYMAT AN, P190
   DIEZFERNANDEZ C, 1993, HEPATOLOGY, V18, P912, DOI 10.1002/hep.1840180424
   DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P334, DOI 10.1016/0003-9861(84)90206-6
   FERNANDEZCHECA JC, 1992, J BIOL CHEM, V267, P1667
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   GAUBATZ JW, 1994, ANN NY ACAD SCI, V719, P97, DOI 10.1111/j.1749-6632.1994.tb56822.x
   GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x
   Goldberg D.M., 1983, METHOD ENZYMAT AN, VIII, P258, DOI DOI 10.1016/B978-0-12-091302-2.X5001-4
   GOMEZMUNOZ A, 1994, J BIOL CHEM, V269, P8937
   GUNZLER WA, 1974, Z KLIN CHEM KLIN BIO, V12, P444
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HANDLER JA, 1994, HEPATOLOGY, V19, P1496, DOI 10.1002/hep.1840190627
   HANNUN YA, 1995, TRENDS BIOCHEM SCI, V20, P73, DOI 10.1016/S0968-0004(00)88961-6
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V
   JI LL, 1988, ARCH BIOCHEM BIOPHYS, V263, P150, DOI 10.1016/0003-9861(88)90623-6
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   KITANI K, 1994, ARCH GERONTOL GERIAT, V19, P145, DOI 10.1016/0167-4943(94)90036-1
   KITANI K, 1992, GASTROENTEROL JPN, V27, P276, DOI 10.1007/BF02777737
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293
   NICOTERA P, 1992, TOXICOL LETT, V64-5, P563, DOI 10.1016/0378-4274(92)90232-9
   NIEAUS WG, 1969, BIOCHEM J, V113, P315
   OUTLAW WH, 1983, METHOD ENZYMAT AN, V3, P176
   OZAWA T, 1995, EXP GERONTOL, V30, P269, DOI 10.1016/0531-5565(94)00057-A
   PRINCIPE P, 1989, CYTOMETRY, V10, P750, DOI 10.1002/cyto.990100613
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   SAETER G, 1988, CARCINOGENESIS, V9, P939, DOI 10.1093/carcin/9.6.939
   Sanz N, 1996, BBA-MOL BASIS DIS, V1315, P123, DOI 10.1016/0925-4439(95)00113-1
   SANZ N, 1995, CARCINOGENESIS, V16, P1585, DOI 10.1093/carcin/16.7.1585
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SIMPSON JA, 1992, BIOCHEM J, V282, P621, DOI 10.1042/bj2820621
   SLATER TF, 1984, BIOCHEM J, V222, P1
   STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352
   SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343
   TACHINI L, 1996, POSTTRANSLATIONAL CO, V2, P273
   TILLY JL, 1995, ENDOCRINOLOGY, V136, P242, DOI 10.1210/en.136.1.242
   Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701
   VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503
   WAHLEFELD AW, 1987, METHOD ENZYMAT AN, V3, P352
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
   ZIMMERMAN BJ, 1990, AM J PHYSIOL, V258, pG185, DOI 10.1152/ajpgi.1990.258.2.G185
NR 56
TC 63
Z9 65
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-8278
EI 1600-0641
J9 J HEPATOL
JI J. Hepatol.
PD SEP
PY 1997
VL 27
IS 3
BP 525
EP 534
DI 10.1016/S0168-8278(97)80358-3
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA XW335
UT WOS:A1997XW33500014
PM 9314131
DA 2024-02-19
ER

PT J
AU Chowdhury, KK
   Legare, DJ
   Lautt, WW
AF Chowdhury, Kawshik K.
   Legare, Dallas J.
   Lautt, W. Wayne
TI Insulin sensitization by voluntary exercise in aging rats is mediated
   through hepatic insulin sensitizing substance (HISS)
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Exercise; Type 2 diabetes; Insulin; HISS
ID DEPENDENT DIABETES-MELLITUS; ANTIOXIDANT COCKTAIL; SYNDROME-X;
   GLUCOSE-TOLERANCE; SKELETAL-MUSCLE; SENSITIVITY; RESISTANCE; SUCROSE;
   HYPOTHESIS; OBESITY
AB Background: Food in the upper gastrointestinal tract potentiates the glucose uptake response to insulin. Mealinduced insulin sensitization (MIS) occurs as a result of insulin-mediated release of hepatic insulin sensitizing substance (HISS) that increases glucose uptake in peripheral tissues. HISS release decreases with age, and exercise causes metabolic improvements in aging, therefore it is important to analyze the effect of exercise on age-associated decline in HISS-action.
   Objectives: The aim of this study is to test the hypothesis that improved insulin sensitivity, by voluntary running-wheel exercise in aging rats, is attained by preserving the HISS response. We also investigate the possible association of exercise-mediated beneficial changes in metabolic conditions and body composition with improved HISS-action.
   Methods: We measured insulin- and HISS-sensitivity in 9, 14 and 21-week old rats with/without exercise. Metabolic markers were also determined in age-matched control and exercised rats.
   Results: Exercise significantly improved HISS-dependent glucose uptake in all age groups. The direct action of insulin was minimally altered by age or exercise. Body composition and metabolic conditions were beneficially changed with exercise-induced improvements in the HISS response.
   Conclusion: The therapeutic efficacy of voluntary exercise against insulin resistance in aging rats is achieved mainly through restoration of HISS-action. (c) 2010 Elsevier Inc. All rights reserved.
C1 [Chowdhury, Kawshik K.; Legare, Dallas J.; Lautt, W. Wayne] Univ Manitoba, Dept Pharmacol & Therapeut, Fac Med, Winnipeg, MB R3E 0T6, Canada.
C3 University of Manitoba
RP Lautt, WW (corresponding author), Univ Manitoba, Dept Pharmacol & Therapeut, Fac Med, A210-753 McDermot Ave, Winnipeg, MB R3E 0T6, Canada.
EM umchowd5@cc.umanitoba.ca; dlegare@cc.umanitoba.ca;
   wlautt@cc.umanitoba.ca
RI Lautt, W. Wayne/AAC-6106-2021; Legare, Dallas/AAC-3234-2021
OI Lautt, W. Wayne/0000-0002-7239-1798
FU Canadian Institutes of Health Research [CIHR ROP-96705]; CIHR
FX This study was funded by an operating grant from the Canadian Institutes
   of Health Research (CIHR ROP-96705) to W.W. Lautt, and K. K. Chowdhury
   was supported by a CIHR Doctoral Fellowship (2009-2012). Manuscript
   preparation was assisted by Karen Sanders. We acknowledge the excellent
   daily and long-term care and monitoring of the animals provided by Gerry
   Nolette and the staff of the Central Animal Care Services at the
   University of Manitoba.
CR Baron AD, 2001, AM J CARDIOL, V88, p16H, DOI 10.1016/S0002-9149(01)01832-X
   Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1
   Guarino MP, 2003, AM J PHYSIOL-GASTR L, V284, pG588, DOI 10.1152/ajpgi.00423.2002
   HALL CB, 1989, NUTR REP INT, V39, P627
   HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302
   HENRIKSSON J, 1992, DIABETES CARE, V15, P1701, DOI 10.2337/diacare.15.11.1701
   Kirwan JP, 2009, AM J PHYSIOL-ENDOC M, V297, pE151, DOI 10.1152/ajpendo.00210.2009
   Kuk JL, 2008, APPL PHYSIOL NUTR ME, V33, P769, DOI 10.1139/H08-060
   Latour MG, 2002, CAN J PHYSIOL PHARM, V80, P8, DOI 10.1139/Y01-094
   Lautt WW, 2008, EXP GERONTOL, V43, P790, DOI 10.1016/j.exger.2008.04.013
   Lautt WW, 2010, CAN J PHYSIOL PHARM, V88, P313, DOI 10.1139/Y09-130
   Lautt W Wayne, 2007, Ther Clin Risk Manag, V3, P761
   Lautt WW, 1999, CAN J PHYSIOL PHARM, V77, P553, DOI 10.1139/cjpp-77-8-553
   Lautt WW, 1998, CAN J PHYSIOL PHARM, V76, P1080, DOI 10.1139/cjpp-76-12-1080
   Lautt WW, 2004, J PHARMACOL SCI, V95, P9, DOI 10.1254/jphs.95.9
   Lautt WW, 2001, AM J PHYSIOL-GASTR L, V281, pG29, DOI 10.1152/ajpgi.2001.281.1.G29
   MANDROUKAS K, 1986, CLIN PHYSIOL, V6, P39, DOI 10.1111/j.1475-097X.1986.tb00141.x
   Ming Z, 2009, CAN J PHYSIOL PHARM, V87, P873, DOI 10.1139/Y09-079
   Patarrao RS, 2008, CAN J PHYSIOL PHARM, V86, P880, DOI 10.1139/Y08-080
   Praet SFE, 2006, CLIN SCI, V111, P119, DOI 10.1042/CS20060041
   Praet SFE, 2009, ACTA DIABETOL, V46, P263, DOI 10.1007/s00592-009-0129-0
   Ribeiro RT, 2008, J GERONTOL A-BIOL, V63, P560, DOI 10.1093/gerona/63.6.560
   Sadri P, 2006, BRIT J NUTR, V95, P288, DOI 10.1079/BJN20051644
   Schafer J, 2010, J PHARMACOL EXP THER, V333, P621, DOI 10.1124/jpet.109.164509
   Venables MC, 2009, DIABETES-METAB RES, V25, pS18, DOI 10.1002/dmrr.983
   Xie H, 1996, AM J PHYSIOL-ENDOC M, V271, pE587, DOI 10.1152/ajpendo.1996.271.3.E587
NR 26
TC 12
Z9 14
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JAN
PY 2011
VL 46
IS 1
BP 73
EP 80
DI 10.1016/j.exger.2010.10.006
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 710UP
UT WOS:000286542800011
PM 20955773
DA 2024-02-19
ER

PT J
AU HORAN, MA
   BROUWER, A
   BARELDS, RJ
   WIENTJENS, R
   DURHAM, SK
   KNOOK, DL
AF HORAN, MA
   BROUWER, A
   BARELDS, RJ
   WIENTJENS, R
   DURHAM, SK
   KNOOK, DL
TI CHANGES IN ENDOTOXIN SENSITIVITY IN AGING - ABSORPTION, ELIMINATION AND
   MORTALITY
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE ENDOTOXIN; ABSORPTION; ELIMINATION; MORTALITY
ID BODY-TEMPERATURE; LIVER-INJURY; AGED MICE; RATS; SHOCK;
   LIPOPOLYSACCHARIDE; LEUKOTRIENES; CLEARANCE; EXCRETION; SYSTEM
AB In this paper we describe the influence of ageing on responses to intravenously-injected endotoxin in two rat strains. Old age had no apparent effect on the absorption of Cr-51-labelled endotoxin from either jejunum or colon. Notwithstanding, aged animals appeared much more sensitive than their young counterparts to the lethal effects of intravenously injected endotoxin. Old animals exhibited virtually 100% mortality over the dose range 1-4 mg/100 g body weight while only sporadic deaths were seen in young animals. One consistent feature of dying animals was a profound and progressive hypothermia. At post mortem examination, the major findings were in the liver (leukocyte infiltrates and hepatocellular necrosis) and kidneys (acute tubular necrosis). Ageing was associated with slower removal of endotoxin from the circulation but not to an extent that could reasonably account for the enhanced sensitivity to endotoxin toxicity.
C1 TNO, INST EXPTL GERONTOL, 2280 HV RIJSWIJK, NETHERLANDS.
C3 Netherlands Organization Applied Science Research
CR BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437
   BRAUDE AI, 1955, J CLIN INVEST, V34, P850, DOI 10.1172/JCI103140
   BROUWER A, 1983, MECH AGEING DEV, V21, P205, DOI 10.1016/0047-6374(83)90042-8
   BROUWER A, 1985, HEPATOLOGY, V5, P362, DOI 10.1002/hep.1840050304
   BROUWER A, 1986, LIVER DRUGS AGING, P77
   COOK JA, 1982, CIRC SHOCK, V9, P605
   DURHAM SK, 1989, J PATHOL, V157, P339, DOI 10.1002/path.1711570411
   Foster D. O., 1986, BROWN ADIPOSE TISSUE, P31
   FREUDENBERG MA, 1982, BRIT J EXP PATHOL, V63, P56
   HABICHT GS, 1981, MECH AGEING DEV, V16, P97, DOI 10.1016/0047-6374(81)90037-3
   HAGMANN W, 1985, FEBS LETT, V180, P309, DOI 10.1016/0014-5793(85)81092-9
   HENDRIKS HFJ, 1987, MECH AGEING DEV, V41, P241, DOI 10.1016/0047-6374(87)90044-3
   HIRATA K, 1980, LAB INVEST, V43, P165
   HOFFMANGOETZ L, 1985, J GERONTOL, V40, P15, DOI 10.1093/geronj/40.1.15
   HOFFMANGOETZ L, 1984, J GERONTOL, V39, P547, DOI 10.1093/geronj/39.5.547
   HOLLANDER CF, 1976, LAB ANIM SCI, V26, P320
   Hollander M., 1973, Nonparametric statistical methods, P115
   HORAN MA, 1984, MECH AGEING DEV, V26, P165, DOI 10.1016/0047-6374(84)90091-5
   HORAN MA, 1988, EXP GERONTOL, V23, P455, DOI 10.1016/0531-5565(88)90057-5
   HORAN MA, 1986, THESIS U UTRECHT NET
   KEPPLER D, 1985, HEPATOLOGY, V5, P883, DOI 10.1002/hep.1840050530
   KIANGULRICH M, 1985, EXP GERONTOL, V20, P107, DOI 10.1016/0531-5565(85)90046-4
   KLEINE B, 1985, BRIT J EXP PATHOL, V66, P303
   LITTLE RA, 1985, BRIT MED BULL, V41, P226, DOI 10.1093/oxfordjournals.bmb.a072055
   MAITRA SK, 1981, HEPATOLOGY, V1, P401, DOI 10.1002/hep.1840010506
   MATHISON JC, 1979, J IMMUNOL, V123, P2133
   Metchnikoff E., 1908, The prolongation of life: Optimistic studies
   NORDSTOGA K, 1979, ACTA PATH MICRO IM A, V87, P335
   OUWENDIJK RJT, 1985, THESIS U ROTTERDAM N
   REYNOLDS MA, 1985, MECH AGEING DEV, V30, P143, DOI 10.1016/0047-6374(85)90003-X
   RIPPE DF, 1974, J RETICULOENDOTH SOC, V16, P175
   SATO T, 1982, LAB INVEST, V47, P304
   VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845
   VANHOOFT JIM, 1987, SURVEY MOUSE RAT BRE, P15
   WADE AW, 1984, ADV IMMUNOL, V36, P143, DOI 10.1016/S0065-2776(08)60901-3
   WOLTER J, 1978, J RETICULOENDOTH SOC, V23, P145
NR 36
TC 14
Z9 14
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD FEB
PY 1991
VL 57
IS 2
BP 145
EP 162
DI 10.1016/0047-6374(91)90031-T
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EY324
UT WOS:A1991EY32400005
PM 2051787
DA 2024-02-19
ER

PT J
AU Wang, YT
   Zhang, RH
   Li, JW
   Han, XY
   Lu, HJ
   Su, JH
   Liu, YT
   Tian, XL
   Wang, MM
   Xiong, YA
   Lan, T
   Zhang, GL
   Liu, ZY
AF Wang, Yitong
   Zhang, Ronghua
   Li, Jingwu
   Han, Xiangyang
   Lu, Hongjian
   Su, Jinghui
   Liu, Yutan
   Tian, Xiaoli
   Wang, Meimei
   Xiong, Yanan
   Lan, Tao
   Zhang, Guangling
   Liu, Zhiyong
TI MiR-22-3p and miR-29a-3p synergistically inhibit hepatic stellate cell
   activation by targeting AKT3
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article; Early Access
DE Hepatic fibrosis; LX-2; HSC activation; miR-22-3p; miR-29a-3p; AKT3
ID PROLIFERATION; APOPTOSIS; FIBROSIS
AB Hepatic fibrosis (HF) is a worldwide health problem for which there is no medically effective drug treatment at present, and which is characterized by activation of hepatic stellate cells (HSCs) and excessive extracellular matrix (ECM) deposition. The HF model in cholestatic rats by ligating the common bile duct was induced and the differentially expressed miRNAs in the liver tissues were analyzed by microarray, which showed that miR-22-3p and miR-29a-3p were significantly downregulated in bile-duct ligation (BDL) rat liver compared with the sham control. The synergistic anti-HF activity and molecular mechanism of miR-22-3p and miR-29a-3p by targeting AKT serine/threonine kinase 3 (AKT3) in HSCs were explored. The expression levels of miR-22-3p and miR-29a-3p were downregulated in activated LX-2 and human primary normal hepatic fibroblasts (NFs), whereas AKT3 was found to be upregulated in BDL rat liver and activated LX-2 cells. The proliferation, colony-forming, and migration ability of LX-2 were inhibited synergistically by miR-22-3p and miR-29a-3p. In addition, cellular senescence was induced and the expressions of the LX-2 fibrosis markers COL1A1 and alpha-SMA were inhibited by miR-22-3p and miR-29a-3p synergistically. Subsequently, these two miRNAs binding to the 3'UTR of AKT3 mRNA was predicted and evidenced by the luciferase reporter assay. Furthermore, the proliferation, migration, colony-forming ability, and the expression levels of COL1A1 and alpha-SMA were promoted and cellular senescence was inhibited by AKT3 in LX-2 cells. Thus, miR-22-3p/miR-29a-3p/AKT3 regulates the activation of HSCs, providing a new avenue in the study and treatment of HF.
C1 [Wang, Yitong; Zhang, Ronghua; Han, Xiangyang; Lu, Hongjian; Su, Jinghui; Liu, Yutan; Wang, Meimei; Xiong, Yanan] North China Univ Sci & Technol, Sch Basic Med Sci, Tangshan 063210, Peoples R China.
   [Li, Jingwu] Tangshan Peoples Hosp, Canc Inst, Hebei Key Lab Mol Oncol, Tangshan 063001, Peoples R China.
   [Tian, Xiaoli] Paraplegia Sanat Tangshan, Tangshan 063000, Peoples R China.
   [Lan, Tao] Cangzhou Peoples Hosp, Hepatobiliary Pancreat Surg Dept, Cangzhou 061000, Peoples R China.
   [Zhang, Guangling] North China Univ Sci & Technol, Sch Clin Med, Hebei Key Lab Med Ind Integrat Precis Med, Tangshan 063210, Peoples R China.
   [Liu, Zhiyong] North China Univ Sci & Technol, Hlth Sci Ctr, Tangshan 063210, Peoples R China.
C3 North China University of Science & Technology; North China University
   of Science & Technology; North China University of Science & Technology
RP Zhang, GL (corresponding author), North China Univ Sci & Technol, Sch Clin Med, Hebei Key Lab Med Ind Integrat Precis Med, Tangshan 063210, Peoples R China.; Liu, ZY (corresponding author), North China Univ Sci & Technol, Hlth Sci Ctr, Tangshan 063210, Peoples R China.
EM zhanggl@ncst.edu.cn; macromicro@126.com
RI liang, liang/IAO-8518-2023; Liu, Zhiyong/CAF-2366-2022; Yang,
   Fei/JLM-3367-2023
OI Liu, Zhiyong/0000-0001-6473-348X; Li, Jingwu/0009-0005-2755-1042
FU Government Funded Clinical Medicine Talents Training Hebei [[2020] 397];
   Natural Science Foundation of Hebei Province [H2021209026]; Returned
   Overseas Students of Hebei Province [C20210340]; Key Research and
   Development, Innovation and Improvement Projects of Hebei Province
   [213777115D, 205A7701H]; Science and Technology Project of Tangshan
   [19130204C]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by the Government Funded Clinical Medicine Talents
   Training Hebei (grant no. [2020] 397); the Natural Science Foundation of
   Hebei Province (grant no. H2021209026); Returned Overseas Students of
   Hebei Province (grant no. C20210340); Key Research and Development,
   Innovation and Improvement Projects of Hebei Province (grant no.
   213777115D and 205A7701H); and the Science and Technology Project of
   Tangshan (grant no. 19130204C).
CR Bergeron Y, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00102
   Cai LX, 2020, GENES GENOM, V42, P77, DOI 10.1007/s13258-019-00881-z
   Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728
   Debnath T, 2017, FOOD FUNCT, V8, P3432, DOI [10.1039/C7FO00739F, 10.1039/c7fo00739f]
   Dhar S, 2017, FEBS LETT, V591, P924, DOI 10.1002/1873-3468.12603
   Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020
   Dobyns WB, 2019, AM J MED GENET C, V181, P582, DOI 10.1002/ajmg.c.31736
   DuBois JC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01738
   Grabinski N, 2014, CELL SIGNAL, V26, P1021, DOI 10.1016/j.cellsig.2014.01.018
   Han MZ, 2020, BRAIN, V143, P512, DOI 10.1093/brain/awz406
   Harati R, 2021, BREAST CANCER RES TR, V187, P695, DOI 10.1007/s10549-021-06255-y
   Hu XL, 2018, ONCOL LETT, V15, P3998, DOI 10.3892/ol.2018.7803
   Hwang SK, 2013, J AEROSOL MED PULM D, V26, P165, DOI 10.1089/jamp.2011.0959
   Jia XL, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10124
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Lin YQ, 2017, BIOMED PHARMACOTHER, V95, P1718, DOI 10.1016/j.biopha.2017.09.074
   Liu HW, 2018, AM J TRANSL RES, V10, P659
   Mahmoud MF, 2014, EUR J PHARMACOL, V742, P118, DOI 10.1016/j.ejphar.2014.08.021
   Mannaerts I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055786
   Pradhan-Sundd T, 2020, HEPATOLOGY, V71, P1732, DOI 10.1002/hep.30927
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604
   Revathidevi S, 2019, SEMIN CANCER BIOL, V59, P80, DOI 10.1016/j.semcancer.2019.06.002
   Sato K, 2016, AM J PATHOL, V186, P2238, DOI 10.1016/j.ajpath.2016.06.003
   Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321
   Sufletel RT, 2020, ROM J MORPHOL EMBRYO, V61, P615, DOI 10.47162/RJME.61.3.01
   Uko NE, 2020, CURR TOP MED CHEM, V20, P883, DOI 10.2174/1568026620666200224101808
   Wang J, 2015, ONCOTARGET, V6, P7325, DOI 10.18632/oncotarget.2621
   Wang XL, 2021, GUT, V70, P784, DOI 10.1136/gutjnl-2020-322526
   Wang Y, 2021, J ONCOL, V2021, DOI 10.1155/2021/3874478
   Wu H, 2021, CLIN TRANSL ONCOL, V23, P257, DOI 10.1007/s12094-020-02413-8
   Xie XX, 2022, AGING DIS, V13, P157, DOI 10.14336/AD.2021.0729
   Zeng Z, 2020, ARTIF CELL NANOMED B, V48, P683, DOI 10.1080/21691401.2019.1703723
   Zhang TT, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13167
   Zheng X, 2021, NEOPLASMA, V68, P1157, DOI 10.4149/neo_2021_210226N250
NR 34
TC 2
Z9 2
U1 1
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD 2022 OCT
PY 2022
VL 247
IS 19
BP 1712
EP 1731
DI 10.1177/15353702221108379
EA JUL 2022
PG 20
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 5Y1NG
UT WOS:000825044400001
PM 35833537
OA Green Published
DA 2024-02-19
ER

PT J
AU Hamden, K
   Carreau, S
   Ellouz, F
   Masmoudi, H
   El Feki, A
AF Hamden, K.
   Carreau, S.
   Ellouz, F.
   Masmoudi, H.
   El Feki, A.
TI Protective effect of 17β-estradiol on oxidative stress and liver
   dysfunction in aged male rats
SO JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE aging; estrogens; liver dysfunction; male rat
ID ESTROGEN REPLACEMENT THERAPY; GENE-EXPRESSION; DAMAGE; MITOCHONDRIA;
   MECHANISMS; DNA
AB In aging liver oxidative stress increases due to the decrease in antioxidant bio-molecules such as estrogens which can be modified by hormonal replacement therapy (HRT). With this in mind, we hypothesized that age-related decline in steroidogenesis may be associated with the impairment of the antioxidant defense cells in liver, the increase in lipid peroxidation, hepatic dysfunction and histological changes; estrogens prevent all these changes induced by aging. 17 beta-estradiol treatment was initiated in 12 month-old Wistar rats, and continued until 18 months of age. Our results showed that 17 beta-estradiol (E2) level in the serum of the aged untreated rats was reduced by -32% in 18 month-old rats compared to the young animals (4-month-old). The superoxide dismutase (SOD), catalase (CAT), and gluthatione peroxidase (GPX) activities were reduced by -47, -46, and -29% respectively in old rat liver. In addition, the TBARs in liver and hepatic dysfunction parameters in plasma such as gamma-glutamyl transferase (GGT), phosphatase alkalin (PAL) as well as bilirubin level increased significantly in old rats, and histological changes were investigated. In E2-treated rats, protective effects were observed. Indeed, 17 beta-estradiol attenuates all changes induced by aging. The 17 beta-estradiol level was higher in old E2-treated rats compared to the control rats. Moreover, the SOD, CAT and GPX activities were higher by +28, +15, and +11% respectively. This anti-aging effect of estrogens was clarified by a lower level of lipid peroxidation and liver dysfunction parameters as well as by histological observation.
C1 [Hamden, K.; El Feki, A.] Fac Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
   [Carreau, S.] Univ Caen, Biochem Lab, USC 2006, INRA EA 2608, F-14032 Caen, France.
   [Ellouz, F.] CHU H Bourguiba, Biochem Lab, Sfax, Tunisia.
   [Masmoudi, H.] CHU H Bourguiba, Immunol Lab, Sfax, Tunisia.
C3 Universite de Sfax; Faculty of Sciences Sfax; INRAE; Universite de Caen
   Normandie; Universite de Sfax; Ecole Nationale dIngenieurs de Sfax
   (ENIS); Hopital Habib Bourguiba; Universite de Sfax; Hopital Habib
   Bourguiba
RP Hamden, K (corresponding author), Fac Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
EM hamdenkhalid@yahoo.fr
RI Hamden, Khaled/AAM-2452-2020; Masmoudi, Hatem/AAW-3448-2021
OI Hamden, Khaled/0000-0001-5651-3962; 
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   BAQUER NZ, 1993, BIOCHEM MOL BIOL INT, V31, P509
   Borrás C, 2005, AGING CELL, V4, P113, DOI 10.1111/j.1474-9726.2005.00151.x
   Borrás C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4
   Buege J A, 1978, Methods Enzymol, V52, P302
   Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8
   Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2
   Dröge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   GARRET HE, 1956, ELEMENTARY STAT
   Genissel C, 2001, MOL CELL ENDOCRINOL, V178, P141, DOI 10.1016/S0303-7207(01)00409-9
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7
   Moorthy K, 2005, EXP GERONTOL, V40, P295, DOI 10.1016/j.exger.2005.01.004
   Nasr A, 1998, GYNECOL ENDOCRINOL, V12, P43, DOI 10.3109/09513599809024970
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   Pinzani M, 2001, J HEPATOL, V34, P764, DOI 10.1016/S0168-8278(01)00055-1
   Prokai L, 2005, DRUG DEVELOP RES, V66, P118, DOI 10.1002/ddr.20050
   Roberts LJ, 2001, BIOCHEM BIOPH RES CO, V287, P254, DOI 10.1006/bbrc.2001.5583
   RuizLarrea MB, 1997, J PHYSIOL BIOCHEM, V53, P225
   Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5
   SUGIOKA K, 1987, FEBS LETT, V210, P37, DOI 10.1016/0014-5793(87)81293-0
   Valls V, 2005, PROCESS BIOCHEM, V40, P903, DOI 10.1016/j.procbio.2004.02.025
   Viña J, 2005, FEBS LETT, V579, P2541, DOI 10.1016/j.febslet.2005.03.090
NR 25
TC 32
Z9 35
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1138-7548
EI 1877-8755
J9 J PHYSIOL BIOCHEM
JI J. Physiol. Biochem.
PD SEP
PY 2007
VL 63
IS 3
BP 195
EP 201
DI 10.1007/BF03165782
PG 7
WC Biochemistry & Molecular Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Physiology
GA 257MJ
UT WOS:000252802900002
PM 18309775
DA 2024-02-19
ER

PT J
AU Kim, KH
   Chen, CC
   Alpini, G
   Lau, LF
AF Kim, Ki-Hyun
   Chen, Chih-Chiun
   Alpini, Gianfranco
   Lau, Lester F.
TI CCN1 induces hepatic ductular reaction through integrin
   α<sub>v</sub>β<sub>5</sub>-mediated activation of NF-κB
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID MATRICELLULAR PROTEIN CCN1; PRO-ANGIOGENIC ACTIVITIES; CELLULAR
   SENESCENCE; ALAGILLE-SYNDROME; FUNCTIONAL-HETEROGENEITY; EMERGING ROLES;
   HUMAN JAGGED1; SOLUBLE FORM; MOUSE MODEL; OVAL CELLS
AB Liver cholestatic diseases, which stem from diverse etiologies, result in liver toxicity and fibrosis and may progress to cirrhosis and liver failure. We show that CCN1 (also known as CYR61), a matricellular protein that dampens and resolves liver fibrosis, also mediates cholangiocyte proliferation and ductular reaction, which are repair responses to cholestatic injury. In cholangiocytes, CCN1 activated NF-kappa B through integrin alpha(v)beta(5)/alpha(v)beta(3), leading to Jag1 expression, JAG1/NOTCH signaling, and cholangiocyte proliferation. CCN1 also induced Jag1 expression in hepatic stellate cells, whereupon they interacted with hepatic progenitor cells to promote their differentiation into cholangiocytes. Administration of CCN1 protein or soluble JAG1 induced cholangiocyte proliferation in mice, which was blocked by inhibitors of NF-kappa B or NOTCH signaling. Knock-in mice expressing a CCN1 mutant that is unable to bind alpha(v)beta(5)/alpha(v)beta(3) were impaired in ductular reaction, leading to massive hepatic necrosis and mortality after bile duct ligation (BDL), whereas treatment of these mice with soluble JAG1 rescued ductular reaction and reduced hepatic necrosis and mortality. Blockade of integrin alpha(v)beta(5)/alpha(v)beta(3), NF-kappa B, or NOTCH signaling in WT mice also resulted in defective ductular reaction after BBL. These findings demonstrate that CCN1 induces cholangiocyte proliferation and ductular reaction and identify CCN1/alpha(v)beta(5)/NF-kappa B/JAG1 as a critical axis for biliary injury repair.
C1 [Kim, Ki-Hyun; Chen, Chih-Chiun; Lau, Lester F.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA.
   [Alpini, Gianfranco] Cent Texas Vet Hlth Care Syst, Div Res, Temple, TX USA.
   [Alpini, Gianfranco] Scott White Digest Dis Res Ctr, Temple, TX USA.
   [Alpini, Gianfranco] Texas A&M Univ, Hlth Sci Ctr, Dept Internal Med, Temple, TX USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; Texas A&M University System;
   Texas A&M University College Station; Texas A&M Health Science Center
RP Lau, LF (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 South Ashland Ave, Chicago, IL 60607 USA.
EM LFLau@uic.edu
OI Lau, Lester/0000-0002-4364-2914; Kim, Ki-Hyun/0000-0001-8265-6609
FU NIH [R01-GM78492]; Scott White; VA Merit Award
FX We thank Seung Won Shin and Guoqiang Yan for excellent assistance, and
   members of the laboratory for helpful discussion. This work was
   supported by a grant from the NIH (R01-GM78492) to L.F. Lau, and in part
   by the Dr. Nicholas C. Hightower Centennial Chair of Gastroenterology
   from Scott & White and a VA Merit Award to G. Alpini. The views
   expressed herein are those of the authors and do not necessarily reflect
   the views of the NIH or the Department of Veterans Affairs.
CR Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184
   Aho S, 2004, J CELL BIOCHEM, V92, P1271, DOI 10.1002/jcb.20125
   Alpini G, 1998, AM J PHYSIOL-GASTR L, V274, pG767, DOI 10.1152/ajpgi.1998.274.4.G767
   ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   Alpini G, 1996, GASTROENTEROLOGY, V110, P1636, DOI 10.1053/gast.1996.v110.pm8613073
   Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769
   Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792
   Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803
   Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023
   Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667
   Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009
   Campese AF, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113803
   Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596
   Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200
   Desmet VJ, 1998, MAYO CLIN PROC, V73, P80
   Emre Y, 2014, SEMIN IMMUNOPATHOL, V36, P253, DOI 10.1007/s00281-014-0420-1
   Faubion WA, 1999, J CLIN INVEST, V103, P137, DOI 10.1172/JCI4765
   Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133
   Fiorotto R, 2013, J HEPATOL, V59, P124, DOI 10.1016/j.jhep.2013.02.025
   Franchitto A, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2012.10.03
   Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007
   Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381
   Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268
   Glaser SS, 2010, DIGEST LIVER DIS, V42, P245, DOI 10.1016/j.dld.2010.01.008
   Glaser SS, 2009, LAB INVEST, V89, P456, DOI 10.1038/labinvest.2009.6
   Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613
   Hellström M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036
   Jelnes P, 2007, HEPATOLOGY, V45, P1462, DOI 10.1002/hep.21569
   Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Lazaridis KN, 2004, GASTROENTEROLOGY, V127, P1565, DOI 10.1053/j.gastro.2004.08.006
   Len S-J, 2004, J BIOL CHEM, V279, P44177
   Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200
   Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243
   Lozier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001851
   Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021
   Luedde T, 2008, P NATL ACAD SCI USA, V105, P9733, DOI 10.1073/pnas.0800198105
   Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213
   McCright B, 2002, DEVELOPMENT, V129, P1075
   McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332
   Meng FY, 2012, HEPATOLOGY, V55, P209, DOI 10.1002/hep.24673
   Miyoshi H, 2001, AM J PATHOL, V158, P967, DOI 10.1016/S0002-9440(10)64043-6
   Mo FE, 2006, CIRC RES, V99, P961, DOI 10.1161/01.RES.0000248426.35019.89
   Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002
   Monnier Y, 2008, CANCER RES, V68, P7323, DOI 10.1158/0008-5472.CAN-08-0841
   Murphy-Ullrich JE, 2014, MATRIX BIOL, V37, P1, DOI 10.1016/j.matbio.2014.07.005
   NAKANUMA Y, 2012, INT J HEPATOL, V2012, P47840
   OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569
   Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235
   Okamoto M, 2012, INT ARCH ALLERGY IMM, V157, P65, DOI 10.1159/000324836
   Park SM, 2012, GUT LIVER, V6, P295, DOI 10.5009/gnl.2012.6.3.295
   Pelullo M, 2014, NEOPLASIA, V16, P1007, DOI 10.1016/j.neo.2014.10.004
   Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788
   Reardon David A, 2011, Genes Cancer, V2, P1159, DOI 10.1177/1947601912450586
   Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130
   Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811
   Tabibian JH, 2013, COMPR PHYSIOL, V3, P541, DOI 10.1002/cphy.c120019
   Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848
   Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785
   Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008
   Turner R, 2011, HEPATOLOGY, V53, P1035, DOI 10.1002/hep.24157
   Ueno Y, 2003, LIVER INT, V23, P449, DOI 10.1111/j.1478-3231.2003.00876.x
   Wang B, 2007, HEPATOLOGY, V46, P1404, DOI 10.1002/hep.21849
   Weiskirchen R, 2005, METH MOLEC MED, V117, P99
   Williams MJ, 2014, GASTROENTEROLOGY, V146, P349, DOI 10.1053/j.gastro.2013.11.034
   Woolbright BL, 2012, WORLD J GASTROENTERO, V18, P4985, DOI 10.3748/wjg.v18.i36.4985
   Yardeni T, 2011, LAB ANIMAL, V40, P155, DOI 10.1038/laban0511-155
   Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108
NR 73
TC 75
Z9 84
U1 0
U2 9
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD MAY
PY 2015
VL 125
IS 5
BP 1886
EP 1900
DI 10.1172/JCI79327
PG 15
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA CH5JK
UT WOS:000354071700013
PM 25822023
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Chini, CCS
   Peclat, TR
   Warner, GM
   Kashyap, S
   Espindola-Netto, JM
   de Oliveira, GC
   Gomez, LS
   Hogan, KA
   Tarragó, MG
   Puranik, AS
   Agorrody, G
   Thompson, KL
   Dang, K
   Clarke, S
   Childs, BG
   Kanamori, KS
   Witte, MA
   Vidal, P
   Kirkland, AL
   De Cecco, M
   Chellappa, K
   McReynolds, MR
   Jankowski, C
   Tchkonia, T
   Kirkland, JL
   Sedivy, JM
   van Deursen, JM
   Baker, DJ
   van Schooten, W
   Rabinowitz, JD
   Baur, JA
   Chini, EN
AF Chini, Claudia C. S.
   Peclat, Thais R.
   Warner, Gina M.
   Kashyap, Sonu
   Espindola-Netto, Jair Machado
   de Oliveira, Guilherme C.
   Gomez, Lilian S.
   Hogan, Kelly A.
   Tarrago, Mariana G.
   Puranik, Amrutesh S.
   Agorrody, Guillermo
   Thompson, Katie L.
   Dang, Kevin
   Clarke, Starlynn
   Childs, Bennett G.
   Kanamori, Karina S.
   Witte, Micaela A.
   Vidal, Paola
   Kirkland, Anna L.
   De Cecco, Marco
   Chellappa, Karthikeyani
   McReynolds, Melanie R.
   Jankowski, Connor
   Tchkonia, Tamara
   Kirkland, James L.
   Sedivy, John M.
   van Deursen, Jan M.
   Baker, Darren J.
   van Schooten, Wim
   Rabinowitz, Joshua D.
   Baur, Joseph A.
   Chini, Eduardo N.
TI CD38 ecto-enzyme in immune cells is induced during aging and regulates
   NAD<SUP>+</SUP> and NMN levels
SO NATURE METABOLISM
LA English
DT Article
ID CYCLIC ADP-RIBOSE; NICOTINAMIDE MONONUCLEOTIDE; MITOCHONDRIAL
   DYSFUNCTION; SENESCENT CELLS; POTENT; MACROPHAGES; METABOLISM;
   INHIBITORS; CLEARANCE; INFECTION
AB Decreased NAD(+) levels have been shown to contribute to metabolic dysfunction during aging. NAD(+) decline can be partially prevented by knockout of the enzyme CD38. However, it is not known how CD38 is regulated during aging, and how its ecto-enzymatic activity impacts NAD(+) homeostasis. Here we show that an increase in CD38 in white adipose tissue (WAT) and the liver during aging is mediated by accumulation of CD38(+) immune cells. Inflammation increases CD38 and decreases NAD(+). In addition, senescent cells and their secreted signals promote accumulation of CD38(+) cells in WAT, and ablation of senescent cells or their secretory phenotype decreases CD38, partially reversing NAD(+) decline. Finally, blocking the ecto-enzymatic activity of CD38 can increase NAD(+) through a nicotinamide mononucleotide (NMN)-dependent process. Our findings demonstrate that senescence-induced inflammation promotes accumulation of CD38 in immune cells that, through its ecto-enzymatic activity, decreases levels of NMN and NAD(+). Chini et al. demonstrate that CD38(+) expression in immune cells increases during aging, owing to the senescence-associated secretory phenotype of senescent cells, and the ecto-enzymatic activity of CD38(+) affects intracellular NAD(+) levels in vivo by hydrolyzing the NAD(+) intermediate nicotinamide mononucleotide extracellularly.
C1 [Chini, Claudia C. S.; Peclat, Thais R.; Warner, Gina M.; Kashyap, Sonu; Espindola-Netto, Jair Machado; de Oliveira, Guilherme C.; Gomez, Lilian S.; Hogan, Kelly A.; Tarrago, Mariana G.; Puranik, Amrutesh S.; Agorrody, Guillermo; Thompson, Katie L.; Kanamori, Karina S.; Witte, Micaela A.; Vidal, Paola; Kirkland, Anna L.; Chini, Eduardo N.] Mayo Clin, Signal Transduct & Mol Nutr Lab, Kogod Aging Ctr, Dept Anesthesiol & Perioperat Med,Coll Med, Rochester, MN 55905 USA.
   [Dang, Kevin; Clarke, Starlynn; van Schooten, Wim] Teneobio, Newark, CA USA.
   [Childs, Bennett G.; van Deursen, Jan M.; Baker, Darren J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA.
   [De Cecco, Marco; Sedivy, John M.] Brown Univ, Ctr Biol Aging, Providence, RI 02912 USA.
   [De Cecco, Marco; Sedivy, John M.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.
   [Chellappa, Karthikeyani; Baur, Joseph A.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Chellappa, Karthikeyani; Baur, Joseph A.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [McReynolds, Melanie R.; Jankowski, Connor; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.
   [Tchkonia, Tamara; Kirkland, James L.] Mayo Clin, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA.
   [Puranik, Amrutesh S.] NYU Langone Hlth, Div Rheumatol, Dept Med, New York, NY USA.
   [De Cecco, Marco] Astellas Inst Regenerat Med, Marlborough, MA USA.
C3 Mayo Clinic; Mayo Clinic; Brown University; Brown University; University
   of Pennsylvania; University of Pennsylvania; Princeton University; Mayo
   Clinic; NYU Langone Medical Center
RP Chini, EN (corresponding author), Mayo Clin, Signal Transduct & Mol Nutr Lab, Kogod Aging Ctr, Dept Anesthesiol & Perioperat Med,Coll Med, Rochester, MN 55905 USA.
EM chini.eduardo@mayo.edu
RI Puranik, Amrutesh S./C-1365-2009; Rabinowitz, Joshua/GPP-4019-2022;
   Kirkland, James/F-9159-2016
OI Puranik, Amrutesh S./0000-0001-7249-5602; Rabinowitz,
   Joshua/0000-0002-1247-4727; Baker, Darren/0000-0001-9006-1939; de
   Oliveira, Guilherme/0000-0003-4574-4516; Peclat,
   Thais/0000-0002-8907-5548; Jankowski, Connor/0000-0003-1247-4548; Sales
   Gomez, Lilian/0000-0002-5309-7438
FU Helen Diller Family Foundation; Ted Nash Long Life Foundation; Glenn
   Foundation for Medical Research via the Paul F. Glenn Laboratories for
   the Biology of Aging at the Mayo Clinic from Calico Life Sciences; Mayo
   Foundation; Noaber Foundation; NIH National Institute of Aging (NIA)
   [AG-26094, AG58812, CA233790, AG13925, AG057493, AG016694, P01
   AG051449]; National Institute of Diabetes, Digestive and Kidney disease
   [DK098656]; Connor Group; Colton Center for Auto-Immunity at NYU Langone
FX This work was supported in part by grants from the Helen Diller Family
   Foundation, Ted Nash Long Life Foundation, the Glenn Foundation for
   Medical Research via the Paul F. Glenn Laboratories for the Biology of
   Aging at the Mayo Clinic (E.N.C, J.M.v.D. and D.B), sponsored research
   funding from Calico Life Sciences, the Mayo and Noaber Foundations, NIH
   National Institute of Aging (NIA) grants AG-26094 (to E.N.C.), AG58812
   (to E.N.C.), CA233790 (to E.N.C.), AG13925 (to J.L.K.), AG057493 (to
   J.M.v.D.), AG016694 (to J.M.S.) and P01 AG051449 (to J.M.S). This work
   was also supported by grants from the National Institute of Diabetes,
   Digestive and Kidney disease (DK098656 to J.A.B.) R.J. Ryan and T.W.
   Ryan (to J.L.K.) and the Connor Group (to J.L.K.). A.S.P. thanks the
   Colton Center for Auto-Immunity at NYU Langone for funding support.
CR Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066
   Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042
   Andriani GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35218
   Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Becherer JD, 2015, J MED CHEM, V58, P7021, DOI 10.1021/acs.jmedchem.5b00992
   Billington RA, 2006, MOL MED, V12, P324, DOI 10.2119/2006-00075.Billington
   Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592
   Boslett J, 2018, J MOL CELL CARDIOL, V118, P81, DOI 10.1016/j.yjmcc.2018.02.015
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Cartwright MJ, 2010, J GERONTOL A-BIOL, V65, P242, DOI 10.1093/gerona/glp213
   Chatterjee S, 2018, CELL METAB, V27, P85, DOI 10.1016/j.cmet.2017.10.006
   Chini C, 2019, BIOCHEM BIOPH RES CO, V513, P486, DOI 10.1016/j.bbrc.2019.03.199
   Covarrubias AJ, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00305-3
   da Silva CP, 1998, FEBS LETT, V439, P291, DOI 10.1016/S0014-5793(98)01396-9
   De Cecco M, 2019, NATURE, V566, P73, DOI 10.1038/s41586-018-0784-9
   De Flora A, 1997, INT J BIOCHEM CELL B, V29, P1149, DOI 10.1016/S1357-2725(97)00062-9
   de Picciotto NE, 2016, AGING CELL, V15, P522, DOI 10.1111/acel.12461
   Deckert J, 2014, CLIN CANCER RES, V20, P4574, DOI 10.1158/1078-0432.CCR-14-0695
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Detalle L, 2016, ANTIMICROB AGENTS CH, V60, P6, DOI 10.1128/AAC.01802-15
   Enever C, 2009, CURR OPIN BIOTECH, V20, P405, DOI 10.1016/j.copbio.2009.07.002
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Funaro A, 1996, INT IMMUNOL, V8, P1643
   Ghosh S, 2015, J GERONTOL A-BIOL, V70, P232, DOI 10.1093/gerona/glu067
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Grozio A, 2019, NAT METAB, V1, P47, DOI 10.1038/s42255-018-0009-4
   Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435
   Guan Y, 2017, J AM SOC NEPHROL, V28, P2337, DOI 10.1681/ASN.2016040385
   HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0
   Harris KE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00889
   Hogan KA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01187
   Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142
   Horenstein AL, 2016, MOL MED, V22, P694, DOI 10.2119/molmed.2016.00198
   Horenstein AL, 2015, CELLS-BASEL, V4, P520, DOI 10.3390/cells4030520
   Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342
   Johnson S, 2018, NPJ AGING MECH DIS, V4, DOI 10.1038/s41514-018-0029-z
   Johnson Sean, 2018, F1000Res, V7, P132, DOI 10.12688/f1000research.12120.1
   Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5
   Kim KA, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0625-7
   Könning D, 2017, CURR OPIN STRUC BIOL, V45, P10, DOI 10.1016/j.sbi.2016.10.019
   Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512
   Lee CU, 2012, MOL CELLS, V34, P573, DOI 10.1007/s10059-012-0263-3
   Li J, 2017, SCIENCE, V355, P1312, DOI 10.1126/science.aad8242
   Liang M, 1999, ARCH BIOCHEM BIOPHYS, V371, P317, DOI 10.1006/abbi.1999.1463
   Liu L, 2018, CELL METAB, V27, P1067, DOI 10.1016/j.cmet.2018.03.018
   Liu LL, 2012, HUM IMMUNOL, V73, P439, DOI 10.1016/j.humimm.2012.02.002
   Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188
   Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404
   Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007
   Matalonga J, 2017, CELL REP, V18, P1241, DOI 10.1016/j.celrep.2017.01.007
   McReynolds MR, 2020, EXP GERONTOL, V134, DOI 10.1016/j.exger.2020.110888
   Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3
   Mottahedeh J, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0186-3
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Osborn MJ, 2013, J IMMUNOL, V190, P1481, DOI 10.4049/jimmunol.1203041
   Partida-Sánchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209
   Preugschat F, 2014, ARCH BIOCHEM BIOPHYS, V564, P156, DOI 10.1016/j.abb.2014.09.008
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917
   Sun L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0705com
   Tarrago MG, 2018, CELL METAB, V27, P1081, DOI 10.1016/j.cmet.2018.03.016
   Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035
   van de Donk NWCJ, 2018, BLOOD, V131, P13, DOI 10.1182/blood-2017-06-740944
   Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112
   Yoshida M, 2019, CELL METAB, V30, P329, DOI 10.1016/j.cmet.2019.05.015
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yoshino J, 2013, METHODS MOL BIOL, V1077, P203, DOI 10.1007/978-1-62703-637-5_14
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Yu Y, 2017, INT J NANOMED, V12, P1969, DOI 10.2147/IJN.S127575
   Zhao YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002700
   Zielinska W, 2004, LIFE SCI, V74, P1781, DOI 10.1016/j.lfs.2003.08.033
NR 79
TC 131
Z9 147
U1 6
U2 40
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2522-5812
J9 NAT METAB
JI Nat. Metab.
PD NOV
PY 2020
VL 2
IS 11
DI 10.1038/s42255-020-00298-z
PG 43
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA PA9EZ
UT WOS:000595931800002
PM 33199925
OA Green Accepted
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Sengupta, A
   Tudor, JC
   Cusmano, D
   Baur, JA
   Abel, T
   Weljie, AM
AF Sengupta, Arjun
   Tudor, Jennifer C.
   Cusmano, Danielle
   Baur, Joseph A.
   Abel, Ted
   Weljie, Aalim M.
TI Sleep deprivation and aging are metabolically linked across tissues
SO SLEEP
LA English
DT Article; Early Access
DE sleep deprivation; aging; metabolomics; metabolites; UPLC-MS/MS
ID TELOMERE LENGTH; OBESE MEN; RESTRICTION; MEMORY; YOUNG; METABOLOMICS;
   DISORDERS; QUALITY; COHORT; SIRT5
AB Study objectives Insufficient sleep is a concerning hallmark of modern society because sleep deprivation (SD) is a risk factor for neurodegenerative and cardiometabolic disorders. SD imparts an aging-like effect on learning and memory, although little is known about possible common molecular underpinnings of SD and aging. Here, we examine this question by profiling metabolic features across different tissues after acute SD in young adult and aged mice.Methods Young adult and aged mice were subjected to acute SD for 5 hours. Blood plasma, hippocampus, and liver samples were subjected to UPLC-MS/MS-based metabolic profiling.Results SD preferentially impacts peripheral plasma and liver profiles (e.g. ketone body metabolism) whereas the hippocampus is more impacted by aging. We further demonstrate that aged animals exhibit SD-like metabolic features at baseline. Hepatic alterations include parallel changes in nicotinamide metabolism between aging and SD in young animals. Overall, metabolism in young adult animals is more impacted by SD, which in turn induces aging-like features. A set of nine metabolites was classified (79% correct) based on age and sleep status across all four groups.Conclusions Our metabolic observations demonstrate striking parallels to previous observations in studies of learning and memory and define a molecular metabolic signature of sleep loss and aging.
   Graphical Abstract
C1 [Sengupta, Arjun; Weljie, Aalim M.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.
   [Tudor, Jennifer C.; Cusmano, Danielle; Abel, Ted] Univ Penn, Dept Biol, Philadelphia, PA USA.
   [Baur, Joseph A.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA USA.
   [Baur, Joseph A.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA USA.
   [Tudor, Jennifer C.] St Josephs Univ, Dept Biol, Philadelphia, PA USA.
   [Abel, Ted] Univ Iowa, Iowa Neurosci Inst, Carver Coll Med, Dept Neurosci & Pharmacol, 2312 PBDB, Iowa City, IA USA.
C3 University of Pennsylvania; University of Pennsylvania; University of
   Pennsylvania; University of Pennsylvania; Saint Joseph's University;
   University of Iowa
RP Sengupta, A; Weljie, AM (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.
EM arjunsen@upenn.edu; aalim@upenn.edu
RI Weljie, Aalim M/B-6203-2012; Tudor, Jennifer/L-2104-2013
OI Weljie, Aalim M/0000-0002-7145-4494; Tudor,
   Jennifer/0000-0002-3826-3012; Sengupta, Arjun/0000-0003-2210-1876; Abel,
   Ted/0000-0003-2423-4592
FU TA and JT are supported by R01 AG 062398. TA was supported by the Brush
   Family Chair in Biology at the University of Pennsylvania and the Roy J.
   Carver Chair in Neuroscience at the University of Iowa. AMW and AS are
   supported by 5R21AG052905. [R01 AG 062398]; Brush Family Chair in
   Biology at the University of Pennsylvania [5R21AG052905]
FX TA and JT are supported by R01 AG 062398. TA was supported by the Brush
   Family Chair in Biology at the University of Pennsylvania and the Roy J.
   Carver Chair in Neuroscience at the University of Iowa. AMW and AS are
   supported by 5R21AG052905.
CR Adam M, 2006, SLEEP, V29, P55, DOI 10.1093/sleep/29.1.55
   Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798
   Anafi RC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-362
   Avanesov AS, 2014, ELIFE, V3, DOI 10.7554/eLife.02077
   Bazil CW, 2019, BRAIN RES, V1703, P13, DOI 10.1016/j.brainres.2018.05.003
   Bishir M, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/5764017
   Buxton OM, 2010, DIABETES, V59, P2126, DOI 10.2337/db09-0699
   Bylesjö M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006
   Camacho-Pereira J, 2016, CELL METAB, V23, P1127, DOI 10.1016/j.cmet.2016.05.006
   Chaleckis R, 2016, P NATL ACAD SCI USA, V113, P4252, DOI 10.1073/pnas.1603023113
   Chikahisa S, 2014, NEUROPHARMACOLOGY, V79, P399, DOI 10.1016/j.neuropharm.2013.12.009
   Chini CCS, 2017, MOL CELL ENDOCRINOL, V455, P62, DOI 10.1016/j.mce.2016.11.003
   Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Chua ECP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187098
   Collino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056564
   Cordeira J, 2018, BEHAV BRAIN RES, V339, P124, DOI 10.1016/j.bbr.2017.11.033
   Dai XM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09544-9
   Davies SK, 2014, P NATL ACAD SCI USA, V111, P10761, DOI 10.1073/pnas.1402663111
   Depner CM, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz321
   Dickerman BA, 2016, CANCER CAUSE CONTROL, V27, P1361, DOI 10.1007/s10552-016-0815-5
   Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861
   Endo F, 2004, J NUTR, V134, p1605S, DOI 10.1093/jn/134.6.1605S
   Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187
   Fountain NB, 1998, J CLIN NEUROPHYSIOL, V15, P69, DOI 10.1097/00004691-199801000-00009
   Giskeodegard Guro F, 2015, Methods Mol Biol, V1277, P37, DOI 10.1007/978-1-4939-2377-9_4
   Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803
   Guo XF, 2019, AGING CELL, V18, DOI 10.1111/acel.13021
   Havekes R, 2016, ELIFE, V5, DOI 10.7554/eLife.13424
   Holst S.C., 2015, Curr Sleep Med Reports, V1, P27, DOI 10.1007/S40675-014-0007-3/FIGURES/1
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Irwin MR, 2016, BIOL PSYCHIAT, V80, P40, DOI 10.1016/j.biopsych.2015.05.014
   Ito Y, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-456
   Jové M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091
   Kaiser H, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9894238
   Kim BJ, 2019, J CLIN ENDOCR METAB, V104, P2334, DOI 10.1210/jc.2018-02481
   Klein LW, 2003, J AM COLL CARDIOL, V41, P529, DOI 10.1016/S0735-1097(02)02861-9
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Malik DM, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2715
   McNally MA, 2012, J NEUROCHEM, V121, P28, DOI 10.1111/j.1471-4159.2012.07670.x
   McReynolds MR, 2021, CELL SYST, V12, P1160, DOI 10.1016/j.cels.2021.09.001
   Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110
   Moraes W, 2014, SLEEP MED, V15, P401, DOI 10.1016/j.sleep.2013.11.791
   Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026
   Nawi A, 2020, EXP PHYSIOL, V105, P1223, DOI 10.1113/EP088667
   Pasula EY, 2018, SLEEP, V41, DOI 10.1093/sleep/zsx213
   Pellegrino R, 2012, PHYSIOL GENOMICS, V44, P1003, DOI 10.1152/physiolgenomics.00058.2012
   Prather AA, 2015, BRAIN BEHAV IMMUN, V47, P155, DOI 10.1016/j.bbi.2014.12.011
   Prather AA, 2014, PSYCHOSOM MED, V76, pA55
   Rao MN, 2015, J CLIN ENDOCR METAB, V100, P1664, DOI 10.1210/jc.2014-3911
   Rhoades SD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1132-4
   Rubio-Arias JA, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122156
   Schmid SM, 2015, LANCET DIABETES ENDO, V3, P52, DOI 10.1016/S2213-8587(14)70012-9
   Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025
   Sengupta Arjun, 2019, Curr Protoc Protein Sci, V98, pe98, DOI 10.1002/cpps.98
   Sengupta A, 2017, INT J BIOCHEM CELL B, V93, P129, DOI 10.1016/j.biocel.2017.08.014
   Sonn JY, 2018, P NATL ACAD SCI USA, V115, P7129, DOI 10.1073/pnas.1719033115
   Sorgdrager FJH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02565
   Spaeth AM, 2013, SLEEP, V36, P981, DOI 10.5665/sleep.2792
   Stenholm S, 2015, J GERONTOL A-BIOL, V70, P330, DOI 10.1093/gerona/glu113
   Thomann J, 2014, J CLIN SLEEP MED, V10, P1019, DOI 10.5664/jcsm.4042
   Tudor JC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4949
   Vanella A, 2000, CELL BIOL TOXICOL, V16, P99, DOI 10.1023/A:1007638025856
   Vecsey CG, 2015, LEARN MEMORY, V22, P197, DOI 10.1101/lm.036590.114
   Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g
   Weljie AM, 2015, P NATL ACAD SCI USA, V112, P2569, DOI 10.1073/pnas.1417432112
   Wimmer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081880
   Wu Q, 2020, AGING DIS, V11, P1640, DOI 10.14336/AD.2020.0314
   Xu JL, 2016, J SLEEP RES, V25, P169, DOI 10.1111/jsr.12354
   Zimmerman FJ, 2004, SOC SCI MED, V58, P1889, DOI 10.1016/S0277-9536(03)00410-6
NR 70
TC 0
Z9 0
U1 7
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0161-8105
EI 1550-9109
J9 SLEEP
JI Sleep
PD 2023 SEP 20
PY 2023
DI 10.1093/sleep/zsad246
EA SEP 2023
PG 12
WC Clinical Neurology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA T2UI7
UT WOS:001076582500001
PM 37738102
OA Bronze
DA 2024-02-19
ER

PT J
AU Zubrzycki, A
   Wronska, A
   Wierzbicki, PM
   Kmiec, Z
AF Zubrzycki, Adrian
   Wronska, Agata
   Wierzbicki, Piotr M.
   Kmiec, Zbigniew
TI Age-related effects of fenofibrate on the hepatic expression of sirtuin
   1, sirtuin 3, and lipid metabolism-related genes
SO ACTA BIOCHIMICA POLONICA
LA English
DT Article; Early Access
DE aging; liver; fenofibrate; sirtuin; lipid metabolism
ID PROLIFERATOR-ACTIVATED RECEPTOR; FATTY-ACID OXIDATION; PPAR-ALPHA
   AGONIST; INDUCED CD40 EXPRESSION; LIVER; INHIBITION; PROTECTS; GLUCOSE;
   HYPERACETYLATION; DEACETYLATION
AB Background: Sirtuin 1 (Sirt1) and sirtuin 3 (Sirt3) par-ticipate in the regulation of lipid metabolism. Our aim was to investigate the effects of the hypolipemic drug fenofibrate (FN) on hepatic Sirt1 and Sirt3 expression, in relation to the expression of lipid metabolism-relat-ed genes and in the context of aging. Methods and Re-sults: Young and old male Wistar rats were fed standard chow or supplemented with 0.1% or 0.5% FN for 30 days (n=7-10 in each group). In young rats, 0.1% FN did not affect Sirt1 expression, however, 0.5% FN decreased Sirt1 and both doses reduced Sirt3 protein levels. In old rats, 0.5% FN decreased hepatic Sirt1 mRNA and both doses reduced Sirt1 protein levels, but not Sirt3 expression. Although hepatic Ppar alpha protein levels did not change, FN treatment of young rats induced Cpt1b expression, whereas Lcad, Acox1, Pmp70, and Hmgcs2 expression increased only after 0.1% FN, and Fas2 ex-pression decreased after 0.5% FN. In the liver of old rats, both doses increased Cpt1b and Lcad expression. Only 0.1% FN increased Pmp70 and Hmgcs2 expression, and only 0.5% FN increased Acox1 and Fas2 mRNA levels. Conclusions: Treatment with fenofibrate at low or high doses may downregulate the expression of Sirt1 and Sirt3 proteins in the rat liver. The dosage of FN af-fects molecular changes, and aging alters the response to 0.5% FN.
C1 [Zubrzycki, Adrian; Wronska, Agata; Wierzbicki, Piotr M.; Kmiec, Zbigniew] Med Univ Gdansk, Fac Med, Dept Histol, Gdansk, Poland.
C3 Fahrenheit Universities; Medical University Gdansk
RP Wronska, A (corresponding author), Med Univ Gdansk, Fac Med, Dept Histol, Gdansk, Poland.
EM agata.wronska@gumed.edu.pl
FU Polish Ministry of Science and Higher Education [02-0012]
FX The research was financed by the Polish Ministry of Science and Higher
   Education in the form of a statutory grant for the Department of
   Histology, Medical University of Gdansk, Poland (02-0012) to ZK.
CR Abd El-Haleim EA, 2016, WORLD J GASTROENTERO, V22, P2931, DOI 10.3748/wjg.v22.i10.2931
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Balakumar P, 2019, PHARMACOL RES, V144, P132, DOI 10.1016/j.phrs.2019.03.025
   Balanarasimha M, 2014, BIOCHEMISTRY-US, V53, P2632, DOI 10.1021/bi401679y
   Barger JL, 2017, AGING CELL, V16, P750, DOI 10.1111/acel.12608
   Bonzo JA, 2014, AM J PHYSIOL-ENDOC M, V306, pE824, DOI 10.1152/ajpendo.00175.2013
   CALDWELL J, 1989, CARDIOLOGY, V76, P33, DOI 10.1159/000174545
   Colton HM, 2004, TOXICOL SCI, V80, P183, DOI 10.1093/toxsci/kfh144
   Fang J, 2017, P NATL ACAD SCI USA, V114, pE8352, DOI 10.1073/pnas.1706945114
   Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017
   GEBEL T, 1992, FEBS LETT, V309, P37, DOI 10.1016/0014-5793(92)80734-X
   Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005
   Guo R, 2015, INT J CARDIOL, V191, P36, DOI 10.1016/j.ijcard.2015.04.245
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778
   Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200
   Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471
   Jo EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173676
   Karahashi M, 2013, J PHARMACOL SCI, V123, P356, DOI 10.1254/jphs.13149FP
   Kim EN, 2016, EXP GERONTOL, V81, P42, DOI 10.1016/j.exger.2016.04.021
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/713608372
   Kobilo T, 2014, LEARN MEMORY, V21, P119, DOI 10.1101/lm.033332.113
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   Kwon S, 2017, J BIOL CHEM, V292, P17312, DOI 10.1074/jbc.M117.778720
   Lantier L, 2015, DIABETES, V64, P3081, DOI 10.2337/db14-1810
   Lawniczak A, 2022, BIOGERONTOLOGY, V23, P325, DOI 10.1007/s10522-022-09965-y
   Le TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087179
   Li HT, 2012, DIABETES, V61, P797, DOI 10.2337/db11-0846
   Li YN, 2018, MOL CELL BIOCHEM, V448, P175, DOI 10.1007/s11010-018-3324-x
   Liu GZ, 2016, BRIT J PHARMACOL, V173, P1095, DOI 10.1111/bph.13438
   Liu HH, 2015, AGEING RES REV, V19, P43, DOI 10.1016/j.arr.2014.12.001
   Mandala A, 2021, AM J PHYSIOL-GASTR L, V321, pG262, DOI 10.1152/ajpgi.00129.2021
   Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI [10.1007/s00018-003-3216-3, 10.1155/2010/612089]
   Meertens LM, 1998, EMBO J, V17, P6972, DOI 10.1093/emboj/17.23.6972
   Murray RK., 2012, HARPERS ILLUSTRATED, V28th
   Nakamura M, 2019, CELL METAB, V29, P1119, DOI 10.1016/j.cmet.2019.01.005
   Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052
   Peters JM, 2005, J MOL MED-JMM, V83, P774, DOI 10.1007/s00109-005-0678-9
   Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Pyo IS, 2020, MOLECULES, V25, DOI 10.3390/molecules25204649
   Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Rodriguez MA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4834-3
   Sahebkar A, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0787-7
   Shimazu T, 2010, CELL METAB, V12, P654, DOI 10.1016/j.cmet.2010.11.003
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Vilà-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044
   Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210
   Wang WR, 2014, INFLAMMATION, V37, P177, DOI 10.1007/s10753-013-9728-6
   Wang WR, 2013, EXP CELL RES, V319, P1523, DOI 10.1016/j.yexcr.2013.04.007
   Xu CY, 2020, NAT CELL BIOL, V22, P1170, DOI 10.1038/s41556-020-00579-5
   Zhao LJ, 2020, AGING DIS, V11, P927, DOI 10.14336/AD.2019.0820
   Zhao Q, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10524-6
   Zhao SZ, 2015, MOL MED REP, V12, P6112, DOI 10.3892/mmr.2015.4164
   Zubrzycki A, 2021, FOLIA HISTOCHEM CYTO, V59, P167, DOI 10.5603/FHC.a2021.0018
   Zubrzycki A, 2020, ARCH GERONTOL GERIAT, V91, DOI 10.1016/j.archger.2020.104244
NR 57
TC 0
Z9 0
U1 0
U2 1
PU ACTA BIOCHIMICA POLONICA
PI WARSAW
PA PASTEURA 3, 02-093 WARSAW, POLAND
SN 0001-527X
EI 1734-154X
J9 ACTA BIOCHIM POL
JI Acta Biochim. Pol.
PD 2023 
PY 2023
VL 70
IS 2
BP 285
EP 293
DI 10.18388/abp.2020_6538
EA APR 2023
PG 9
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA CD2P4
UT WOS:000968186000001
PM 37023116
OA gold, Green Submitted
DA 2024-02-19
ER

PT J
AU Echchgadda, I
   Song, CS
   Oh, TS
   Cho, SH
   Rivera, OJ
   Chatterjee, B
AF Echchgadda, I
   Song, CS
   Oh, TS
   Cho, SH
   Rivera, OJ
   Chatterjee, B
TI Gene regulation for the senescence marker protein DHEA-sulfotransferase
   by the xenobiotic-activated nuclear pregnane X receptor (PXR)
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; Sult2A1; xenobiotic metabolism; nuclear receptors; PXR;
   sulfonation
ID CONSTITUTIVE ANDROSTANE RECEPTOR; HUMAN CYTOSOLIC SULFOTRANSFERASES;
   RAT-LIVER; DEHYDROEPIANDROSTERONE-SULFOTRANSFERASE; MOLECULAR-CLONING;
   HYDROXYSTEROID SULFOTRANSFERASE; ANDROGEN RECEPTOR; LITHOCHOLIC ACID;
   MESSENGER-RNA; BILE-ACIDS
AB Dehydroepiandrosterone (DHEA)-sulfotransferase (SULT2A1) is a phase 11 metabolizing/detoxifying enzyme with substrate preference for physiological hydroxysteroids, diverse drugs and other xenobiotics. The first-pass,tissues (liver and intestine) express SULT2A1 at high levels. In senescent male rodents, Sult2A1 gene transcription in the liver is markedly enhanced and calorie restriction retards this increase. Age-associated loss of the liver expression of androgen receptor in part explains the up-regulation of Sult2A1 expression at late life, since androgen receptor is a negative regulator of this gene. In line with its role in xenobiotic metabolism, the Sidt2A1 gene is induced by the pregnane X receptor (PXR). PXR is a xenosensing nuclear receptor that is activated by endobiotic (natural steroids) and xenobiotic (therapeutic drugs and environmental chemicals) molecules. An inverted-repeat arrangement (IR0) of the consensus half site binding sequence for nuclear receptors mediates the xenobiotic induction of the Sult2A1 promoter. The IR0 element is a specific binding site for PXR and its heterodimer partner retinoid X receptor (RXR-alpha) and it directs PXR-mediated induction of a heterologous promoter. In contrast to the loss of androgen receptor expression, PXR and RXR-alpha mRNA expression is invariant during aging. Repression by the androgen receptor and induction by PXR may act coordinately to cause the senescence associated and xenobiotic mediated stimulation of Sult2A1 transcription. Increased Sult2A1 expression appears to be an adaptive response to ensure optimal metabolism of Sult2A1 substrates at old age. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
C1 Univ Texas, Hlth Sci Ctr, Dept Mol Med, San Antonio, TX 78245 USA.
   Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.
   S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; US Department of Veterans Affairs;
   Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans
   Hospital
RP Chatterjee, B (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Mol Med, 15355 Lambda Dr, San Antonio, TX 78245 USA.
EM chatterjee@uthscsa.edu
FU NIA NIH HHS [T32 AG 00165, R01 AG 10486] Funding Source: Medline
CR Adigun AQ, 2002, J NATL MED ASSOC, V94, P276
   Assem M, 2004, J BIOL CHEM, V279, P22250, DOI 10.1074/jbc.M314111200
   Blanchard RL, 2004, PHARMACOGENETICS, V14, P199, DOI 10.1097/00008571-200403000-00009
   Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195
   CHATTERJEE B, 1990, BIOCHIM BIOPHYS ACTA, V1034, P162, DOI 10.1016/0304-4165(90)90071-4
   CHATTERJEE B, 1981, J BIOL CHEM, V256, P5939
   CHATTERJEE B, 1994, CHEM-BIOL INTERACT, V92, P273, DOI 10.1016/0009-2797(94)90069-8
   CHATTERJEE B, 1989, FASEB J, V3, P169, DOI 10.1096/fasebj.3.2.2464518
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x
   DEMYAN WF, 1992, MOL ENDOCRINOL, V6, P589, DOI 10.1210/me.6.4.589
   Dhir RN, 2003, P NATL ACAD SCI USA, V100, P15224, DOI 10.1073/pnas.2434273100
   Duanmu ZB, 2002, DRUG METAB DISPOS, V30, P997, DOI 10.1124/dmd.30.9.997
   Echchgadda I, 2004, MOL PHARMACOL, V65, P720, DOI 10.1124/mol.65.3.720
   ECHCHGADDA I, 2003, P 85 END SOC M
   ECHCHGADDA I, 2002, P 84 ANN END SOC M
   Eichelbaum M, 2001, NAT MED, V7, P285, DOI 10.1038/85417
   Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609
   Flanagan Dennis, 2004, J Oral Implantol, V30, P93, DOI 10.1563/1548-1336(2004)30<93:OTSIID>2.0.CO;2
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   Gerbal-Chaloin S, 2002, J BIOL CHEM, V277, P209, DOI 10.1074/jbc.M107228200
   Glatt H, 1997, FASEB J, V11, P314, DOI 10.1096/fasebj.11.5.9141497
   GONZALEZ FJ, 1986, MOL CELL BIOL, V6, P2969, DOI 10.1128/MCB.6.8.2969
   Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329
   Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051
   Gurley BJ, 2002, CLIN PHARMACOL THER, V72, P276, DOI 10.1067/mcp.2002.126913
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   He DN, 2004, BIOCHEM J, V379, P533, DOI 10.1042/BJ20031524
   Ho PC, 2001, J PHARM PHARM SCI, V4, P217
   HOFMANN AF, 1994, HEPATOLOGY, V20, P1375
   Ioannides C, 2002, XENOBIOTICA, V32, P451, DOI 10.1080/00498250210124147
   Javitt NB, 2001, ENDOCRINOLOGY, V142, P2978, DOI 10.1210/en.142.7.2978
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   Kim SY, 2004, DRUG METAB REV, V36, P199, DOI 10.1081/DMR-120033997
   Kitada H, 2003, J BIOL CHEM, V278, P17838, DOI 10.1074/jbc.M210634200
   Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Kliewer SA, 2003, J NUTR, V133, p2444S, DOI 10.1093/jn/133.7.2444S
   KONG ANT, 1994, CHEM-BIOL INTERACT, V92, P161, DOI 10.1016/0009-2797(94)90061-2
   Kozoni V, 2000, CARCINOGENESIS, V21, P999, DOI 10.1093/carcin/21.5.999
   Lee JH, 2004, AM J MED GENET A, V128A, P159, DOI 10.1002/ajmg.a.30062
   Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827
   Lilja JJ, 2000, EUR J CLIN PHARMACOL, V56, P411, DOI 10.1007/s002280000156
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215
   Meloche CA, 2002, DRUG METAB DISPOS, V30, P582, DOI 10.1124/dmd.30.5.582
   MULDER GJ, 1990, CONJUGATION REACTION, P107
   Müller M, 1998, J HEPATOL, V28, P344, DOI 10.1016/0168-8278(88)80024-2
   OGURA K, 1990, BIOCHEM BIOPH RES CO, V166, P1494, DOI 10.1016/0006-291X(90)91036-R
   Ohtani M, 2002, YAKUGAKU ZASSHI, V122, P323, DOI 10.1248/yakushi.122.323
   OWEN R W, 1987, Nutrition and Cancer, V9, P73
   Pai TG, 2002, BBA-GEN SUBJECTS, V1573, P165, DOI 10.1016/S0304-4165(02)00416-6
   Pascussi JM, 2000, MOL PHARMACOL, V58, P361, DOI 10.1124/mol.58.2.361
   Pascussi JM, 2003, DRUG METAB REV, V35, P255, DOI 10.1081/DMR-120026394
   Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200
   RADOMINSKA A, 1990, BIOCHEM J, V272, P597, DOI 10.1042/bj2720597
   Rivera OJ, 2003, MOL ENDOCRINOL, V17, P128, DOI 10.1210/me.2002-0165
   Roy AK, 1999, VITAM HORM, V55, P309
   Runge-Morris M, 1999, MOL PHARMACOL, V56, P1198, DOI 10.1124/mol.56.6.1198
   Saini SPS, 2004, MOL PHARMACOL, V65, P292, DOI 10.1124/mol.65.2.292
   Schmiedlin-Ren P, 2001, DRUG METAB DISPOS, V29, P1446
   Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200
   Song CS, 1998, J BIOL CHEM, V273, P21856, DOI 10.1074/jbc.273.34.21856
   SONG CS, 1990, BIOCHEMISTRY-US, V29, P542, DOI 10.1021/bi00454a031
   SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349
   Song CS, 2001, J BIOL CHEM, V276, P42549, DOI 10.1074/jbc.M107557200
   Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599
   SQUIRES EJ, 2004, J BIOL CHEM     0902
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001-0040
   SUPAKAR PC, 1993, J BIOL CHEM, V268, P26400
   Thomas O, 1902, P ZOOL SOC LOND, V1902, P2
   Vermes Andras, 2004, Am J Cardiovasc Drugs, V4, P247, DOI 10.2165/00129784-200404040-00005
   Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762
   Weinshilboum RM, 1997, FASEB J, V11, P3, DOI 10.1096/fasebj.11.1.9034160
   Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753
   Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
NR 81
TC 37
Z9 40
U1 0
U2 4
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD OCT-NOV
PY 2004
VL 125
IS 10-11
BP 733
EP 745
DI 10.1016/j.mad.2004.08.008
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 877ZM
UT WOS:000225614800009
PM 15541768
DA 2024-02-19
ER

PT J
AU Miao, RY
   Wu, Y
   Zhang, HH
   Zhou, HD
   Sun, XF
   Csizmadia, E
   He, L
   Zhao, Y
   Jiang, CY
   Miksad, RA
   Ghaziani, T
   Robson, SC
   Zhao, HT
AF Miao, Ruoyu
   Wu, Yan
   Zhang, Haohai
   Zhou, Huandi
   Sun, Xiaofeng
   Csizmadia, Eva
   He, Lian
   Zhao, Yi
   Jiang, Chengyu
   Miksad, Rebecca A.
   Ghaziani, Tahereh
   Robson, Simon C.
   Zhao, Haitao
TI Utility of the dual-specificity protein kinase TTK as a therapeutic
   target for intrahepatic spread of liver cancer
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MITOTIC CHECKPOINT GENES; HEPATOCELLULAR-CARCINOMA; INTRACELLULAR
   ANTIBODIES; VASCULAR CD39/ENTPD1; INHIBITORS; CELLS; RESPONSES;
   SENESCENCE; EXPRESSION; DISCOVERY
AB Therapies for primary liver cancer, the third leading cause of cancer-related death worldwide, remain limited. Following multi-omics analysis (including whole genome and transcriptome sequencing), we were able to identify the dual-specific protein kinase TTK as a putative new prognostic biomarker for liver cancer. Herein, we show that levels of TTK protein are significantly elevated in neoplastic tissues from a cohort of liver cancer patients, when compared with adjacent hepatic tissues. We also tested the utility of TTK targeted inhibition and have demonstrated therapeutic potential in an experimental model of liver cancer in vivo. Following lentiviral shRNA knockdown in several human liver cancer cell lines, we demonstrated that TTK boosts cell growth and promotes cell spreading; as well as protects against senescence and decreases autophagy. In an experimental animal model, we show that in vitro knockdown of TTK effectively blocks intrahepatic growth of human HCC xenografts. Furthermore, we note that, in vivo silencing of TTK, by systemically delivering TTK siRNAs to already tumor-bearing liver, limits intrahepatic spread of liver cancer cells. This intervention is associated with decreased tumor aggressiveness, as well as increased senescence and autophagy. Taken together, our data suggest that targeted TTK inhibition might have clinical utility as an adjunct therapy in management of liver cancer.
C1 [Miao, Ruoyu; Zhang, Haohai; He, Lian; Zhao, Haitao] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing 100730, Peoples R China.
   [Miao, Ruoyu; Zhang, Haohai; He, Lian; Zhao, Haitao] Peking Union Med Coll, Beijing 100730, Peoples R China.
   [Miao, Ruoyu; Wu, Yan; Sun, Xiaofeng; Csizmadia, Eva; Ghaziani, Tahereh; Robson, Simon C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Liver, Boston, MA 02115 USA.
   [Miao, Ruoyu; Wu, Yan; Sun, Xiaofeng; Csizmadia, Eva; Ghaziani, Tahereh; Robson, Simon C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Transplant Inst, Dept Med, Boston, MA 02115 USA.
   [Zhou, Huandi; Jiang, Chengyu] Chinese Acad Med Sci, State Key Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100005, Peoples R China.
   [Zhou, Huandi; Jiang, Chengyu] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Zhao, Yi] Chinese Acad Sci, Inst Comp Technol, Key Lab Intelligent Informat Proc, Beijing 100190, Peoples R China.
   [Miksad, Rebecca A.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA.
C3 Chinese Academy of Medical Sciences - Peking Union Medical College;
   Peking Union Medical College Hospital; Chinese Academy of Medical
   Sciences - Peking Union Medical College; Peking Union Medical College;
   Harvard University; Beth Israel Deaconess Medical Center; Harvard
   Medical School; Harvard University; Beth Israel Deaconess Medical
   Center; Harvard Medical School; Institute of Basic Medical Sciences -
   CAMS; Chinese Academy of Medical Sciences - Peking Union Medical
   College; Chinese Academy of Medical Sciences - Peking Union Medical
   College; Peking Union Medical College; Chinese Academy of Sciences;
   Institute of Computing Technology, CAS; Harvard University; Beth Israel
   Deaconess Medical Center; Harvard Medical School
RP Zhao, HT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Liver Surg, Beijing 100730, Peoples R China.; Zhao, HT (corresponding author), Peking Union Med Coll, Beijing 100730, Peoples R China.; Robson, SC (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Liver, Boston, MA 02115 USA.; Robson, SC (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Transplant Inst, Dept Med, Boston, MA 02115 USA.
EM srobson@bidmc.harvard.edu; ZhaoHT@pumch.cn
RI Miksad, Rebecca Anne/GPF-9176-2022; Wang, Tianqi/JJD-7473-2023; Robson,
   Simon C./AAA-8537-2021; Zhao, Yi/A-2962-2011
OI Zhao, Yi/0000-0001-6046-8420; Miksad, Rebecca/0000-0003-3194-5122
FU NIH [P01HL107152-01, R21 CA164970]; Ben and Rose Cole PRIA Foundation;
   Pancreatic Cancer Research Fund; International Science and Technology
   Cooperation Projects [2015DFA30650]; Capital Special Research Project
   for Health Development [2014-2-4012]; Capital Research Project for the
   Characteristics Clinical Application [Z151100004015170]
FX This study was supported by NIH (P01HL107152-01 and R21 CA164970) and
   the Ben and Rose Cole PRIA Foundation, Pancreatic Cancer Research Fund;
   and by the International Science and Technology Cooperation Projects
   (2015DFA30650), Capital Special Research Project for Health Development
   (2014-2-4012), and Capital Research Project for the Characteristics
   Clinical Application (Z151100004015170).
CR Bai AP, 2014, J IMMUNOL, V193, P3366, DOI 10.4049/jimmunol.1400346
   Balakrishnan L, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-6
   Beldi G, 2008, GASTROENTEROLOGY, V135, P1751, DOI 10.1053/j.gastro.2008.07.025
   Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401
   Bialecki Eldad S, 2005, HPB (Oxford), V7, P26, DOI 10.1080/13651820410024049
   Bian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060184
   Bursavich MG, 2013, BIOORG MED CHEM LETT, V23, P6829, DOI 10.1016/j.bmcl.2013.10.008
   Colli A, 2006, AM J GASTROENTEROL, V101, P513, DOI 10.1111/j.1572-0241.2006.00467.x
   Colombo R, 2010, CANCER RES, V70, P10255, DOI 10.1158/0008-5472.CAN-10-2101
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Eng KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111586
   Feng LL, 2011, NEOPLASIA, V13, P206, DOI 10.1593/neo.101332
   Fratta E, 2011, MOL ONCOL, V5, P164, DOI 10.1016/j.molonc.2011.02.001
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   JEMAL A, 2011, CA-CANCER J CLIN, V61, P69, DOI DOI 10.3322/CAAC.20107
   Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692
   Kono K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-141
   Kumar DV, 2012, BIOORG MED CHEM LETT, V22, P4377, DOI 10.1016/j.bmcl.2012.04.131
   Kusakabe K, 2015, BIOORGAN MED CHEM, V23, P2247, DOI 10.1016/j.bmc.2015.02.042
   Kusakabe K, 2015, J MED CHEM, V58, P1760, DOI 10.1021/jm501599u
   Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345
   Lagiou P, 2000, J NATL CANCER I, V92, P1096, DOI 10.1093/jnci/92.13.1096
   Liang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097739
   Liu LG, 2012, AM J SURG, V203, P741, DOI 10.1016/j.amjsurg.2011.05.010
   Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435
   Liu Y, 2015, J MED CHEM, V58, P3366, DOI 10.1021/jm501740a
   Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506
   Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857
   Lo YL, 2007, CARCINOGENESIS, V28, P1079, DOI 10.1093/carcin/bgl256
   Lobato MN, 2003, TRENDS MOL MED, V9, P390, DOI 10.1016/S1471-4914(03)00163-1
   Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161
   Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254
   Miao RY, 2014, J HEPATOL, V61, P840, DOI 10.1016/j.jhep.2014.05.025
   Mizukami Y, 2008, CANCER SCI, V99, P1448, DOI 10.1111/j.1349-7006.2008.00844.x
   Sato M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03003
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669
   Sun XF, 2013, HEPATOLOGY, V57, P205, DOI 10.1002/hep.25989
   Sun XF, 2010, GASTROENTEROLOGY, V139, P1030, DOI 10.1053/j.gastro.2010.05.007
   Suzuki H, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-97
   Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2
   Tardif KD, 2011, MOL CANCER THER, V10, P2267, DOI 10.1158/1535-7163.MCT-11-0453
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Yoshida S, 2013, HEPATOLOGY, V58, P1667, DOI 10.1002/hep.26526
   Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903
   Zhang XB, 2009, CANCER-AM CANCER SOC, V115, P1245, DOI 10.1002/cncr.24139
NR 47
TC 31
Z9 34
U1 1
U2 14
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 13
PY 2016
VL 6
AR 33121
DI 10.1038/srep33121
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DV4YO
UT WOS:000382932000001
PM 27618777
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Da Silva-Alvarez, S
   Guerra-Varela, J
   Sobrido-Cameán, D
   Quelle, A
   Barreiro-Iglesias, A
   Sánchez, L
   Collado, M
AF Da Silva-Alvarez, Sabela
   Guerra-Varela, Jorge
   Sobrido-Camean, Daniel
   Quelle, Ana
   Barreiro-Iglesias, Anton
   Sanchez, Laura
   Collado, Manuel
TI Developmentally-programmed cellular senescence is conserved and
   widespread in zebrafish
SO AGING-US
LA English
DT Article
DE cellular senescence; development; zebrafish
ID CELLS
AB Cellular senescence is considered a stress response imposing a stable cell cycle arrest to restrict the growth of damaged cells. More recently however, cellular senescence was identified during mouse embryo development at particular structures during specific periods of time. This programmed cell senescence has been proposed to serve developmental and morphogenetic functions and to potentially represent an evolutionary origin of senescence. Cellular senescence has also been described to take place during bird (chick and quail) and amphibian (xenopus and axoltl) development. Fish however, have been described to show a very narrow and restricted pattern of developmental cell senescence. Here we carried out a detailed characterization of senescence during zebrafish development and found it to be conserved and widespread. Apart from yolk and cloaca, previously described structures, we also identified senescence in the developing central nervous system, intestine, liver, pronephric ducts, and crystalline. Interestingly, senescence at these developing structures disappeared upon treatment with senolytic compound ABT-263, supporting their senescent identity and opening the possibility of studying the contribution of this process to development. In summary, our findings extend the description of developmentally-programmed cell senescence to lower vertebrates contributing to the notion of the relevance of this process for embryo development.
C1 [Da Silva-Alvarez, Sabela; Collado, Manuel] Hlth Res Inst Santiago de Compostela IDIS, Lab Stem Cells Canc & Aging, Xerencia Xest Integrada Santiago XXIS SERGAS, Santiago De Compostela, Spain.
   [Guerra-Varela, Jorge; Quelle, Ana; Sanchez, Laura] Univ Santiago de Compostela, Sch Vet, Dept Zool Genet & Phys Anthropol, Lugo, Spain.
   [Guerra-Varela, Jorge] Geneaqua SL, Lugo, Spain.
   [Sobrido-Camean, Daniel; Barreiro-Iglesias, Anton] Univ Santiago de Compostela, Fac Biol, Dept Funct Biol, CIBUS, Santiago De Compostela, Spain.
C3 Complexo Hospitalario Universitario de Santiago de Compostela;
   Universidade de Santiago de Compostela; Universidade de Santiago de
   Compostela
RP Collado, M (corresponding author), Hlth Res Inst Santiago de Compostela IDIS, Lab Stem Cells Canc & Aging, Xerencia Xest Integrada Santiago XXIS SERGAS, Santiago De Compostela, Spain.; Sánchez, L (corresponding author), Univ Santiago de Compostela, Sch Vet, Dept Zool Genet & Phys Anthropol, Lugo, Spain.; Barreiro-Iglesias, A (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Funct Biol, CIBUS, Santiago De Compostela, Spain.
EM anton.barreiro@usc.es; lauraelena.sanchez@usc.es;
   manuel.collado.rodriguez@sergas.es
RI Regaldie, Ana Quelle/AAD-5907-2021; Sabela, Da Silva
   Álvarez/HMV-6563-2023; Barreiro-Iglesias, Antón/G-5281-2010; Gómez,
   ACUIGEN/ABD-5337-2020; Sánchez, Laura/L-2411-2014; Sobrido-Cameán,
   Daniel/T-8395-2019; Collado, Manuel/K-8140-2014
OI Regaldie, Ana Quelle/0000-0003-0498-8741; Sabela, Da Silva
   Álvarez/0000-0003-2702-8524; Barreiro-Iglesias,
   Antón/0000-0002-7507-080X; Sánchez, Laura/0000-0001-7927-5303;
   Sobrido-Cameán, Daniel/0000-0001-8239-2965; Collado,
   Manuel/0000-0002-0330-0880
FU Ministerio de Ciencia, Innovacion y Universidades, Fondos Europeos de
   Desarrollo Regional (FEDER) [RTI2018-095818-B-100]; Xunta de Galicia
   [2016-PG008, ED431C2018/28]; crowdfunding platform Precipita (FECYT)
   [2017-CP081]
FX Funding at the laboratory of M.C. is provided by the Ministerio de
   Ciencia, Innovacion y Universidades, Fondos Europeos de Desarrollo
   Regional (FEDER) (RTI2018-095818-B-100). Work in the laboratory of
   A.B.-I. was funded by grants from the Xunta de Galicia (2016-PG008) and
   the crowdfunding platform Precipita (FECYT; 2017-CP081). Funding at
   laboratory of L.S. is provided by Xunta de Galicia (ED431C2018/28).
CR Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Czarkwiani A, 2018, CURR OPIN CELL BIOL, V55, P74, DOI 10.1016/j.ceb.2018.05.014
   Da Silva-Alvarez S, 2019, EXP GERONTOL, V128, DOI 10.1016/j.exger.2019.110742
   Davaapil H, 2017, DEVELOPMENT, V144, P106, DOI 10.1242/dev.138222
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Nacher V, 2006, J VASC RES, V43, P581, DOI 10.1159/000096076
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Villiard E, 2017, BIOL OPEN, V6, P891, DOI 10.1242/bio.025809
   Westerfield M., 2007, GUIDE LAB USE ZEBRAF
   Yun MH, 2015, ELIFE, V4, DOI 10.7554/eLife.05505
NR 15
TC 12
Z9 13
U1 0
U2 6
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD SEP 30
PY 2020
VL 12
IS 18
BP 17895
EP 17901
DI 10.18632/aging.103968
PG 7
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA OD4MR
UT WOS:000579827100010
PM 32991320
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wu, ZM
   Lu, MM
   Liu, D
   Shi, Y
   Ren, J
   Wang, S
   Jing, Y
   Zhang, S
   Zhao, Q
   Li, HY
   Yu, ZH
   Liu, ZP
   Bi, SJ
   Wei, T
   Yang, YG
   Xiao, JF
   Belmonte, JCI
   Qu, J
   Zhang, WQ
   Ci, WM
   Liu, GH
AF Wu, Zeming
   Lu, Mingming
   Liu, Di
   Shi, Yue
   Ren, Jie
   Wang, Si
   Jing, Ying
   Zhang, Sheng
   Zhao, Qian
   Li, Hongyu
   Yu, Zihui
   Liu, Zunpeng
   Bi, Shijia
   Wei, Tuo
   Yang, Yun-Gui
   Xiao, Jingfa
   Belmonte, Juan Carlos Izpisua
   Qu, Jing
   Zhang, Weiqi
   Ci, Weimin
   Liu, Guang-Hui
TI m<SUP>6</SUP>A epitranscriptomic regulation of tissue homeostasis during
   primate aging
SO NATURE AGING
LA English
DT Article; Early Access
ID MESSENGER-RNA; N-6-METHYLADENOSINE; METABOLISM; LANDSCAPE;
   DIFFERENTIATION; METTL3
AB The authors characterized m(6)A dynamics in primate tissue aging and revealed a new role for the METTL3-m(6)A-NPNT axis in maintaining skeletal muscle homeostasis, thereby providing insight into the epitranscriptomic machinery underlying primate aging.
   How N-6-methyladenosine (m(6)A), the most abundant mRNA modification, contributes to primate tissue homeostasis and physiological aging remains elusive. Here, we characterize the m(6)A epitranscriptome across the liver, heart and skeletal muscle in young and old nonhuman primates. Our data reveal a positive correlation between m(6)A modifications and gene expression homeostasis across tissues as well as tissue-type-specific aging-associated m(6)A dynamics. Among these tissues, skeletal muscle is the most susceptible to m(6)A loss in aging and shows a reduction in the m(6)A methyltransferase METTL3. We further show that METTL3 deficiency in human pluripotent stem cell-derived myotubes leads to senescence and apoptosis, and identify NPNT as a key element downstream of METTL3 involved in myotube homeostasis, whose expression and m(6)A levels are both decreased in senescent myotubes. Our study provides a resource for elucidating m(6)A-mediated mechanisms of tissue aging and reveals a METTL3-m(6)A-NPNT axis counteracting aging-associated skeletal muscle degeneration.
C1 [Wu, Zeming; Liu, Di; Zhang, Sheng; Li, Hongyu; Liu, Guang-Hui] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China.
   [Wu, Zeming; Ren, Jie; Wei, Tuo; Yang, Yun-Gui; Qu, Jing; Zhang, Weiqi; Ci, Weimin; Liu, Guang-Hui] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China.
   [Wu, Zeming; Wei, Tuo; Qu, Jing; Liu, Guang-Hui] Beijing Inst Stem Cell & Regenerat Med, Beijing, Peoples R China.
   [Lu, Mingming; Xiao, Jingfa] Chinese Acad Sci, Beijing Inst Genom, Natl Genom Data Ctr, Beijing, Peoples R China.
   [Lu, Mingming; Shi, Yue; Ren, Jie; Yu, Zihui; Yang, Yun-Gui; Xiao, Jingfa; Zhang, Weiqi; Ci, Weimin] China Natl Ctr Bioinformat, Beijing, Peoples R China.
   [Lu, Mingming; Liu, Di; Ren, Jie; Jing, Ying; Zhang, Sheng; Li, Hongyu; Yu, Zihui; Liu, Zunpeng; Bi, Shijia; Wei, Tuo; Yang, Yun-Gui; Xiao, Jingfa; Qu, Jing; Zhang, Weiqi; Ci, Weimin; Liu, Guang-Hui] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Shi, Yue; Ren, Jie; Yu, Zihui; Yang, Yun-Gui; Zhang, Weiqi; Ci, Weimin] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China.
   [Ren, Jie; Yang, Yun-Gui; Liu, Guang-Hui] Univ Chinese Acad Sci, Sino Danish Coll, Beijing, Peoples R China.
   [Wang, Si; Zhao, Qian; Liu, Guang-Hui] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Xuanwu Hosp, Beijing, Peoples R China.
   [Wang, Si; Zhao, Qian; Liu, Guang-Hui] Capital Med Univ, Natl Clin Res Ctr Geriatr Disorders, Xuanwu Hosp, Beijing, Peoples R China.
   [Wang, Si; Zhao, Qian; Liu, Guang-Hui] Capital Med Univ, Xuanwu Hosp, Aging Translat Med Ctr, Int Ctr Aging & Canc, Beijing, Peoples R China.
   [Wang, Si] Fifth Peoples Hosp Chongqing, Chongqing, Peoples R China.
   [Jing, Ying; Liu, Zunpeng; Bi, Shijia; Wei, Tuo; Qu, Jing] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China.
   [Zhang, Sheng] Chinese Acad Sci, Inst Brain Intelligence Technol Shanghai, Inst Biophys,State Key Lab Brain & Cognit Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Beijing, Peoples R China.
   [Li, Hongyu] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Natl Lab Biomacromol, Beijing, Peoples R China.
   [Belmonte, Juan Carlos Izpisua] Altos Labs, San Diego, CA USA.
C3 Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy
   of Sciences; Chinese Academy of Sciences; Beijing Institute of Genomics,
   CAS; Chinese Academy of Sciences; University of Chinese Academy of
   Sciences, CAS; Chinese Academy of Sciences; Beijing Institute of
   Genomics, CAS; Chinese Academy of Sciences; University of Chinese
   Academy of Sciences, CAS; Capital Medical University; Capital Medical
   University; Capital Medical University; Chinese Academy of Sciences;
   Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of
   Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics,
   CAS
RP Liu, GH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China.; Qu, J; Zhang, WQ; Ci, WM; Liu, GH (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China.; Qu, J; Liu, GH (corresponding author), Beijing Inst Stem Cell & Regenerat Med, Beijing, Peoples R China.; Zhang, WQ; Ci, WM (corresponding author), China Natl Ctr Bioinformat, Beijing, Peoples R China.; Qu, J; Zhang, WQ; Ci, WM; Liu, GH (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Zhang, WQ; Ci, WM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China.; Liu, GH (corresponding author), Univ Chinese Acad Sci, Sino Danish Coll, Beijing, Peoples R China.; Liu, GH (corresponding author), Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Xuanwu Hosp, Beijing, Peoples R China.; Liu, GH (corresponding author), Capital Med Univ, Natl Clin Res Ctr Geriatr Disorders, Xuanwu Hosp, Beijing, Peoples R China.; Liu, GH (corresponding author), Capital Med Univ, Xuanwu Hosp, Aging Translat Med Ctr, Int Ctr Aging & Canc, Beijing, Peoples R China.; Qu, J (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China.
EM qujing@ioz.ac.cn; zhangwq@big.ac.cn; ciwm@big.ac.cn; ghliu@ioz.ac.cn
RI wang, hongyuan/JWP-2279-2024; zhao, weiwei/JUU-6585-2023; lu,
   yuan/JZD-0832-2024; Ci, Weimin/AAS-5984-2021; liu, xinyu/IWD-6630-2023;
   zheng, liang/JVO-2610-2024; Wang, Zhuo/JVO-1874-2024; Liu,
   Zunpeng/GYR-0792-2022; wang, chen/JED-7289-2023; Yang,
   Yungui/ABF-2507-2021; zhang, chen/JES-0371-2023; li, qing/JEF-9044-2023;
   WANG, Bin/JGM-2639-2023; zhan, y/ISA-2807-2023; chen, si/JPK-4258-2023;
   Wang, lingyu/JLM-2013-2023
OI Ci, Weimin/0000-0002-4111-5360; Zhang, Weiqi/0000-0002-8885-5104
FU Data Center for Stem Cell and Regeneration (DCSCR); National Key
   Research and Development Program of China [2020YFA0804000,
   2018YFC2000100, 2018YFA0107203, 2020YFA0112200, 2021YFF1201005,
   2019YFA0110900, 2022YFA1103800, 2019YFA0802202, 2020YFA0803401];
   Strategic Priority Research Program of the Chinese Academy of Sciences
   [XDA16000000]; National Natural Science Foundation of China [32100937,
   81921006, 92149301, 92168201, 82125011, 92049304, 91949209, 92049116,
   32121001, 82192863, 82122024, 82071588, 31970597, 82173061, 82001477];
   STI2030-Major Projects [2021ZD0202400]; CAS Project for Young Scientists
   in Basic Research [YSBR-076, YSBR-012]; Program of the Beijing Natural
   Science Foundation [Z190019]; K. C. Wong Education Foundation
   [GJTD-2019-06, GJTD-2019-08]; Pilot Project for Public Welfare
   Development and Reform of Beijing-affiliated Medical Research Institutes
   [11000022T000000461062]; Youth Innovation Promotion Association of CAS
   [E1CAZW0401]; Young Elite Scientists Sponsorship Program by CAST
   [YESS20200012]; Informatization Plan of Chinese Academy of Sciences
   [CAS-WX2021SF-0301, CAS-WX2022SDC-XK14, CAS-WX2021SF-0101]; Tencent
   Foundation [2021-1045]
FX We are grateful to L. Bai, Q. Chu, R. Bai, S. Ma, J. Lu, L. Tian, Y.
   Yang, J. Chen and X. Jin for their administrative assistance. We thank
   Q. Ji, Y. Zhang, S. Yang, L. Li, P. Yan, X. Jiang, J. Li, S. Li, H.
   Zhao, C. Liang, Y. He, H. Hu, Z. Wang, L. Fu, S. Ma, H. Yan and Z. Diao
   for their technical support. We also thank the Data Center for Stem Cell
   and Regeneration (DCSCR) for supporting the data analysis. This work was
   supported by the National Key Research and Development Program of China
   (2022YFA1103700 to W.Z. and J.Q.), the Strategic Priority Research
   Program of the Chinese Academy of Sciences (XDA16000000 to G.-H.L.,
   J.Q., W.Z., W.C., J.R., S.W. and Y.-G.Y.), the National Key Research and
   Development Program of China (2020YFA0804000 to G.-H.L. and S.W.,
   2018YFC2000100 to J.Q., 2018YFA0107203 to J.Q., 2020YFA0112200 to
   G.-H.L., 2021YFF1201005 to W.Z., 2019YFA0110900 to W.C., 2022YFA1103800
   to Z.W. and T.W., 2019YFA0802202 to J.R., 2020YFA0803401 to J.R.), the
   National Natural Science Foundation of China (32100937 to Z.W., 81921006
   to G.-H.L. and J.Q., 92149301 to G.-H.L. and S.W., 92168201 to G.-H.L.,
   82125011 to J.Q., 92049304 to J.Q., 91949209 to J.Q., 92049116 to W.Z.,
   32121001 to W.Z. and J.R., 82192863 to W.Z., 82122024 to S.W., 82071588
   to S.W., 31970597 to J.R., 82173061 to W.C., 82001477 to Q.Z.), the
   STI2030-Major Projects (2021ZD0202400 to S.W.), CAS Project for Young
   Scientists in Basic Research (YSBR-076 to G.-H.L., J.Q. and J.R.,
   YSBR-012 to W.Z.), CAS Special Research Assistant Program (to Z.W.), the
   Program of the Beijing Natural Science Foundation (Z190019 to G.-H.L.
   and W.Z.), K. C. Wong Education Foundation (GJTD-2019-06 to J.Q.,
   GJTD-2019-08 to W.Z.), the Pilot Project for Public Welfare Development
   and Reform of Beijing-affiliated Medical Research Institutes
   (11000022T000000461062 to S.W.), Youth Innovation Promotion Association
   of CAS (E1CAZW0401 to W.Z.), Young Elite Scientists Sponsorship Program
   by CAST (YESS20200012 to S.W.), the Informatization Plan of Chinese
   Academy of Sciences (CAS-WX2021SF-0301 to G.-H.L., CAS-WX2022SDC-XK14 to
   G.-H.L., CAS-WX2021SF-0101 to J.Q.) and the Tencent Foundation
   (2021-1045 to G.-H.L.).
CR Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Cai Y., 2022, Life Med., V1, P307, DOI [10.1093/lifemedi/lnac054, DOI 10.1093/LIFEMEDI/LNAC054]
   Cai YS, 2022, SCI CHINA LIFE SCI, V65, P2354, DOI 10.1007/s11427-022-2161-3
   Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8
   Chen XC, 2019, ACS CHEM NEUROSCI, V10, P2355, DOI 10.1021/acschemneuro.8b00657
   Danecek P, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giab008
   De Jesus DF, 2019, NAT METAB, V1, P765, DOI 10.1038/s42255-019-0089-9
   Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6
   Deshmukh DV, 2020, BIOENG TRANSL MED, V5, DOI 10.1002/btm2.10181
   Emde B, 2014, EUR J HISTOCHEM, V58, P315, DOI 10.4081/ejh.2014.2448
   Morales PE, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/1789395
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Gache V, 2017, MOL BIOL CELL, V28, P865, DOI 10.1091/mbc.E16-06-0405
   Geng L., 2023, Life Medicine, V2, DOI [10.1093/lifemedi/lnac045, DOI 10.1093/LIFEMEDI/LNAC045]
   Girardi F, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20289-8
   Ham DJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18140-1
   Han M, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00098
   He YF, 2023, PROTEIN CELL, V14, P202, DOI 10.1093/procel/pwac037
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Hu LL, 2022, NAT BIOTECHNOL, V40, P1210, DOI 10.1038/s41587-022-01243-z
   Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Jing Y, 2023, PROTEIN CELL, V14, P499, DOI 10.1093/procel/pwac061
   Kan CY, 2018, TRANSPLANTATION, V102, P368, DOI 10.1097/TP.0000000000001999
   Kapitansky O, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186715
   Kapitansky O, 2019, GEROSCIENCE, V41, P321, DOI 10.1007/s11357-019-00079-x
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kitada M, 2021, NAT REV ENDOCRINOL, V17, P647, DOI 10.1038/s41574-021-00551-9
   Kuek V, 2016, SCI REP-UK, V6, DOI 10.1038/srep36210
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Liang Y, 2021, STEM CELLS INT, V2021, DOI 10.1155/2021/9955691
   Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021
   Liu GH, 2021, NUCLEIC ACIDS RES, V49, pD825, DOI 10.1093/nar/gkaa894
   Liu J, 2020, SCIENCE, V367, P580, DOI 10.1126/science.aay6018
   Liu JE, 2020, MOL CELL, V77, P426, DOI 10.1016/j.molcel.2019.09.032
   Liu PY, 2021, NAT CELL BIOL, V23, P355, DOI 10.1038/s41556-021-00656-3
   Liu XQ, 2023, CELL, V186, P287, DOI 10.1016/j.cell.2022.12.017
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   Lovric J, 2012, MOL THER, V20, P2087, DOI 10.1038/mt.2012.144
   Lu Y, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007875
   Ma LJ, 2017, GENOME RES, V27, P385, DOI 10.1101/gr.212563.116
   Ma S, 2021, CELL RES, V31, P415, DOI 10.1038/s41422-020-00412-6
   Ma S, 2020, CELL, V180, P984, DOI 10.1016/j.cell.2020.02.008
   Maffioletti SM, 2015, NAT PROTOC, V10, P941, DOI 10.1038/nprot.2015.057
   Martin M., 2011, EMBnet. J., V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]
   McMahon M, 2021, NATURE AGING, V1, P335, DOI 10.1038/s43587-021-00058-y
   Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758
   Min KW, 2018, AGING CELL, V17, DOI 10.1111/acel.12753
   Moustogiannis A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073721
   Nehlin JO, 2011, BIOGERONTOLOGY, V12, P349, DOI 10.1007/s10522-011-9336-5
   Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002
   OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560
   Ottenheijm CAC, 2010, ADV EXP MED BIOL, V682, P105, DOI 10.1007/978-1-4419-6366-6_6
   Petrosino Jennifer M, 2022, Nat Commun, V13, P168, DOI 10.1038/s41467-021-27848-7
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Roignant JY, 2017, TRENDS GENET, V33, P380, DOI 10.1016/j.tig.2017.04.003
   Shafik AM, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-020-02249-z
   Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111
   Siparsky PN, 2014, SPORTS HEALTH, V6, P36, DOI 10.1177/1941738113502296
   Sithara T, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.669497
   Stern S, 2003, CIRCULATION, V108, pE99, DOI 10.1161/01.CIR.0000086898.96021.B9
   Sun Yu, 2022, Life Med, V1, P103, DOI 10.1093/lifemedi/lnac030
   Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005
   Swist S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18131-2
   Tian X, 2017, CELL METAB, V25, P991, DOI 10.1016/j.cmet.2017.04.022
   Tidball JG, 2021, EXP GERONTOL, V145, DOI 10.1016/j.exger.2020.111200
   Tzahor E, 2017, SCIENCE, V356, P1035, DOI 10.1126/science.aam5894
   Wang S, 2020, CELL, V180, P585, DOI 10.1016/j.cell.2020.01.009
   Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298
   Wang Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12828
   Welch AA, 2020, P NUTR SOC, V79, P158, DOI 10.1017/S0029665119001150
   Wu WC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41606
   Wu Z., 2022, CURRENT MED, V1, P8, DOI [DOI 10.1007/S44194-022-00009-8, 10.1007/s44194-022-00009-8]
   Wu ZM, 2020, NUCLEIC ACIDS RES, V48, P11083, DOI 10.1093/nar/gkaa816
   Xiao S, 2019, NAT CELL BIOL, V21, P651, DOI 10.1038/s41556-019-0315-4
   Xiong XS, 2021, NAT GENET, V53, P1156, DOI 10.1038/s41588-021-00890-3
   Yang Y., 2022, LIFE MED, V1, P2, DOI [DOI 10.1093/LIFEMEDI/LNAC003, 10.1093/lifemedi/lnac003]
   Yankova E, 2021, NATURE, V593, P597, DOI 10.1038/s41586-021-03536-w
   Yao YP, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21594-6
   Zhang J, 2020, AGING CELL, V19, DOI 10.1111/acel.13215
   Zhang S, 2022, PROTEIN CELL, V13, P954, DOI 10.1007/s13238-022-00914-6
   Zhang WQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15997-0
   Zhang YY, 2023, PROTEIN CELL, V14, P279, DOI 10.1093/procel/pwac038
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
   Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132
   Zhao HK, 2022, NATURE AGING, V2, P303, DOI 10.1038/s43587-022-00186-z
   ZHOU YY, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-019-09234-6, DOI 10.1038/S41467-019-09234-6, DOI 10.1038/S41467-019-13698-X]
   Zou X., 2022, Life Med, V1, P254, DOI [10.1093/lifemedi/lnac028, DOI 10.1093/LIFEMEDI/LNAC028]
NR 92
TC 10
Z9 11
U1 25
U2 41
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 2662-8465
J9 NATURE AGING
JI Nature Aging
PD 2023 JUN
PY 2023
VL 3
IS 6
BP 705
EP +
DI 10.1038/s43587-023-00393-2
EA APR 2023
PG 34
WC Cell Biology; Geriatrics & Gerontology; Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology; Neurosciences & Neurology
GA J0JW9
UT WOS:000964902900008
PM 37118553
DA 2024-02-19
ER

PT J
AU Clark, RM
   Balakrishnan, A
   Waters, D
   Aggarwal, D
   Owen, KQ
   Koo, SI
AF Clark, Richard M.
   Balakrishnan, Anju
   Waters, David
   Aggarwal, Dimple
   Owen, Kevin Q.
   Koo, Sung I.
TI L-carnitine increases liver α-tocopherol and lowers liver and plasma
   triglycerides in aging ovariectomized rats
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE carnitine; menopause; alpha-tocopherol; retinol; triglyceride; fatty
   acids
ID DIETARY L-CARNITINE; FATTY-ACID OXIDATION; PROMOTE WEIGHT-LOSS;
   VITAMIN-A STATUS; ENZYMATIC DETERMINATION; LIPID-PEROXIDATION;
   SKELETAL-MUSCLE; SUPPLEMENTATION; METABOLISM; SERUM
AB The objective of this study was to determine whether dietary L-carnitine can influence the status of a-tocopherol, retinol and selected lipid parameters in aging ovariectomized rats, an animal model for the menopausal state. Fourteen Fisher-344 female rats 18 months old were acclimated for 4 weeks and ovarectomized. Seven rats per treatment were assigned to either a control group fed ad libitum AIN-93M diet or a carinitine group fed the same diet supplemented with L-carnitine. After an 8-week feeding period, blood and selected tissues were taken for analyses. No differences were noted in food intake, body weight, or organ weights due to L-camitine. Dietary carnitine significantly increased liver a-tocopherol and tended to increase plasma alpha-tocopherol (P <.09). No changes in alpha-tocopherol were observed in other tissues including the brain, lungs and retroperitoneal fat. Retinol levels in plasma and tissues were not affected by supplemental L-camitine. Significant decreases in liver and plasma triglyceride (TG) levels were noted, suggesting increased utilization of fatty acids. No differences were observed in the fatty acid profile of tissues. The results provide evidence that dietary supplementation of L-camitine enhances the a-tocopherol status and improves the utilization of fat leading to lowering of the liver and plasma levels of TG in aging ovariectomized rats. Whether supplemental L-camitine may be of benefit to postmenopausal women in lowering plasma TG and improving the antioxidant status remains to be studied. (c) 2007 Elsevier Inc. All rights reserved.
C1 Univ Connecticut, Dept Nutr Sci, Allendale, NJ 07401 USA.
   Lonza Inc, Allendale, NJ 07401 USA.
C3 University of Connecticut; Lonza Group
RP Clark, RM (corresponding author), Univ Connecticut, Dept Nutr Sci, Allendale, NJ 07401 USA.
EM richard.m.clark@uconn.edu
CR ALLAIN CC, 1974, CLIN CHEM, V20, P470
   Bahçecioglu IH, 1999, MED SCI RES, V27, P475
   BARUA AB, 1993, FOOD CHEM, V46, P419, DOI 10.1016/0308-8146(93)90015-8
   BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420
   Calabrese V, 2006, J NUTR BIOCHEM, V17, P73, DOI 10.1016/j.jnutbio.2005.03.027
   CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X
   Clouet P, 1996, BBA-LIPID LIPID MET, V1299, P191, DOI 10.1016/0005-2760(95)00206-5
   COSTELL M, 1989, BIOCHEM BIOPH RES CO, V161, P1135, DOI 10.1016/0006-291X(89)91360-0
   Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9
   Dawson HD, 2000, J NUTR, V130, P1280, DOI 10.1093/jn/130.5.1280
   Dayanandan A, 2001, J NUTR BIOCHEM, V12, P254, DOI 10.1016/S0955-2863(00)00151-0
   Doh KO, 2005, LIFE SCI, V77, P435, DOI 10.1016/j.lfs.2004.11.032
   Eskandari HG, 2004, DIABETES RES CLIN PR, V66, P129, DOI 10.1016/j.diabres.2004.03.005
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   GREEN MH, 1987, J NUTR, V117, P694, DOI 10.1093/jn/117.4.694
   HICKS VA, 1984, J NUTR, V114, P1327, DOI 10.1093/jn/114.7.1327
   Hill K, 1996, MATURITAS, V23, P113, DOI 10.1016/0378-5122(95)00968-X
   Iossa S, 2002, J NUTR, V132, P636, DOI 10.1093/jn/132.4.636
   Kalaiselvi T, 1998, J NUTR BIOCHEM, V9, P575, DOI 10.1016/S0955-2863(98)00052-7
   Kaplan JR, 2004, ILAR J, V45, P89, DOI 10.1093/ilar.45.2.89
   Karlic H, 2002, J HISTOCHEM CYTOCHEM, V50, P205, DOI 10.1177/002215540205000208
   Kumaran S, 2005, EXP AGING RES, V31, P55, DOI 10.1080/03610730590882846
   LEPAGE G, 1986, J LIPID RES, V27, P114
   MACCARI F, 1990, EXP GERONTOL, V25, P127, DOI 10.1016/0531-5565(90)90043-2
   Melton SA, 2005, INT J VITAM NUTR RES, V75, P156, DOI 10.1024/0300-9831.75.2.156
   Rabie MH, 1997, ACTA BIOL HUNG, V48, P241
   Ramsay RR, 2000, BIOCHEM SOC T, V28, P182, DOI 10.1042/bst0280182
   Rebouche C., 1999, MODERN NUTR HLTH DIS, P505
   REBOUCHE CJ, 1992, FASEB J, V6, P3379, DOI 10.1096/fasebj.6.15.1464372
   Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39
   Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005
   REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939
   SACHAN DS, 1984, AM J CLIN NUTR, V39, P738, DOI 10.1093/ajcn/39.5.738
   Sowers MR, 1995, EPIDEMIOL REV, V17, P287, DOI 10.1093/oxfordjournals.epirev.a036194
   Tanaka Y, 2004, J LIPID RES, V45, P729, DOI 10.1194/jlr.M300425-JLR200
   Terada R, 1998, EUR J PHARMACOL, V357, P185, DOI 10.1016/S0014-2999(98)00539-1
   VARMA RN, 1972, CAN J PHYSIOL PHARM, V50, P1026, DOI 10.1139/y72-149
   Villani RG, 2000, INT J SPORT NUTR, V10, P199, DOI 10.1123/ijsnem.10.2.199
   VOSS A, 1991, J BIOL CHEM, V266, P19995
   Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250
   Washington L, 2003, J LIPID RES, V44, P1395, DOI 10.1194/jlr.M300123-JLR200
   Zou W, 2005, J NUTR, V135, P753, DOI 10.1093/jn/135.4.753
NR 42
TC 6
Z9 6
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD SEP
PY 2007
VL 18
IS 9
BP 623
EP 628
DI 10.1016/j.jnutbio.2006.11.007
PG 6
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA 204HW
UT WOS:000249035600007
PM 17368883
DA 2024-02-19
ER

PT J
AU Chen, WY
   Mehlkop, O
   Scharn, A
   Nolte, H
   Klemm, P
   Henschke, S
   Steuernagel, L
   Sotelo-Hitschfeld, T
   Kaya, E
   Wunderlich, CM
   Langer, T
   Kononenko, NL
   Giavalisco, P
   Brüning, JC
AF Chen, Weiyi
   Mehlkop, Oliver
   Scharn, Alexandra
   Nolte, Hendrik
   Klemm, Paul
   Henschke, Sinika
   Steuernagel, Lukas
   Sotelo-Hitschfeld, Tamara
   Kaya, Ecem
   Wunderlich, Claudia Maria
   Langer, Thomas
   Kononenko, Natalia L.
   Giavalisco, Patrick
   Bruening, Jens Claus
TI Nutrient-sensing AgRP neurons relay control of liver autophagy during
   energy deprivation
SO CELL METABOLISM
LA English
DT Article
ID NEUROPEPTIDE-Y; STIMULATES AUTOPHAGY; HYPOTHALAMIC CIRCUIT; EXPRESSING
   NEURONS; MASS-SPECTROMETRY; LIPID-METABOLISM; POMC NEURONS; GHRELIN;
   GABA; GLUCOCORTICOIDS
AB Autophagy represents a key regulator of aging and metabolism in sensing energy deprivation. We find that fasting in mice activates autophagy in the liver paralleled by activation of hypothalamic AgRP neurons. Optogenetic and chemogenetic activation of AgRP neurons induces autophagy, alters phosphorylation of autophagy regulators, and promotes ketogenesis. AgRP neuron-dependent induction of liver autophagy re-lies on NPY release in the paraventricular nucleus of the hypothalamus (PVH) via presynaptic inhibition of NPY1R-expressing neurons to activate PVHCRH neurons. Conversely, inhibiting AgRP neurons during energy deprivation abrogates induction of hepatic autophagy and rewiring of metabolism. AgRP neuron activation increases circulating corticosterone concentrations, and reduction of hepatic glucocorticoid receptor expression attenuates AgRP neuron-dependent activation of hepatic autophagy. Collectively, our study re-veals a fundamental regulatory principle of liver autophagy in control of metabolic adaptation during nutrient deprivation.
C1 [Chen, Weiyi; Mehlkop, Oliver; Scharn, Alexandra; Klemm, Paul; Henschke, Sinika; Steuernagel, Lukas; Sotelo-Hitschfeld, Tamara; Kaya, Ecem; Wunderlich, Claudia Maria; Bruening, Jens Claus] Max Planck Inst Metab Res, Dept Neuronal Control Metab, Gleueler Str 50, D-50931 Cologne, Germany.
   [Chen, Weiyi; Mehlkop, Oliver; Scharn, Alexandra; Klemm, Paul; Henschke, Sinika; Steuernagel, Lukas; Sotelo-Hitschfeld, Tamara; Kaya, Ecem; Bruening, Jens Claus] Univ Hosp Cologne, Policlin Endocrinol Diabet & Prevent Med PEDP, Kerpener Str 26, D-50924 Cologne, Germany.
   [Chen, Weiyi; Mehlkop, Oliver; Scharn, Alexandra; Klemm, Paul; Henschke, Sinika; Steuernagel, Lukas; Sotelo-Hitschfeld, Tamara; Kaya, Ecem; Kononenko, Natalia L.; Bruening, Jens Claus] Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.
   [Chen, Weiyi; Mehlkop, Oliver; Scharn, Alexandra; Klemm, Paul; Henschke, Sinika; Steuernagel, Lukas; Sotelo-Hitschfeld, Tamara; Kaya, Ecem; Bruening, Jens Claus] Univ Cologne, Ctr Mol Med Cologne CMMC, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.
   [Nolte, Hendrik; Langer, Thomas; Giavalisco, Patrick] Max Planck Inst Biol Ageing, Joseph Stelzmann Str 9B, D-50931 Cologne, Germany.
   [Kononenko, Natalia L.] Univ Hosp Cologne, Fac Med, Ctr Physiol & Pathophysiol, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.
   [Bruening, Jens Claus] Natl Ctr Diabet Res DZD, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
C3 University of Cologne; University of Cologne; University of Cologne; Max
   Planck Society; University of Cologne
RP Brüning, JC (corresponding author), Max Planck Inst Metab Res, Dept Neuronal Control Metab, Gleueler Str 50, D-50931 Cologne, Germany.; Brüning, JC (corresponding author), Univ Hosp Cologne, Policlin Endocrinol Diabet & Prevent Med PEDP, Kerpener Str 26, D-50924 Cologne, Germany.; Brüning, JC (corresponding author), Univ Cologne, Excellence Cluster Cellular Stress Responses Agin, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Brüning, JC (corresponding author), Univ Cologne, Ctr Mol Med Cologne CMMC, Joseph Stelzmann Str 26, D-50931 Cologne, Germany.; Brüning, JC (corresponding author), Natl Ctr Diabet Res DZD, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
EM bruening@sf.mpg.de
OI Kononenko, Natalia/0000-0002-3425-6659; Nolte,
   Hendrik/0000-0003-1560-5099; Steuernagel, Lukas/0000-0003-0043-1436
FU Alexander Von Humboldt Foundation; European Research Council (ERC) under
   the European Union [742106]; BMBF through the German Center for Diabetes
   Research; EASD-Novo Nordisk Foundation Diabetes Prize for Excellence of
   the European Diabetes Association (EASD); CECAD; European Research
   Council (ERC) [742106] Funding Source: European Research Council (ERC)
FX We thank Jens Alber, Nadine Evers, Nadine Spenrath, and Pia Scholl for
   their technical assistance. We thank Peter Wienand and Jakob Nissen for
   advice relating to cell cultures. We thank Dr. Astrid Schauss and Janine
   Heise from the CECAD Imaging Facility for their support in assessing
   auto-phagosomes via TEM. We thank Dr. Henning Fenselau for providing the
   AAV-Flex-hGlyRa1AG virus for the chemogenetic inhibition of AgRP
   neurons. All the schematic diagrams in this manuscript were created with
   www.biorender.com . W.C. was supported by the Humboldt research
   fellowship program of the Alexander Von Humboldt Foundation and received
   a senior postdoctoral grant from CECAD. This project has received
   funding from the European Research Council (ERC) under the European
   Union's Horizon 2020 research and innovation program (grant agreement no
   742106) , funding by BMBF through the German Center for Diabetes
   Research (DZD) , and support through the EASD-Novo Nordisk Foundation
   Diabetes Prize for Excellence of the European Diabetes Association
   (EASD) to J.C.B.
CR Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739
   Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270
   Aveleira CA, 2015, P NATL ACAD SCI USA, V112, pE1642, DOI 10.1073/pnas.1416609112
   Betley JN, 2013, CELL, V155, P1337, DOI 10.1016/j.cell.2013.11.002
   Brandt C, 2018, CELL, V175, P1321, DOI 10.1016/j.cell.2018.10.015
   Cavalcanti-de-Albuquerque JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08239-x
   Chen YM, 2019, ELIFE, V8, DOI 10.7554/eLife.46348
   Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033
   Coupé B, 2012, CELL METAB, V15, P247, DOI 10.1016/j.cmet.2011.12.016
   Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1
   Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085
   Deng JL, 2020, AUTOPHAGY, V16, P451, DOI 10.1080/15548627.2019.1628537
   Dimitrov EL, 2007, ENDOCRINOLOGY, V148, P3666, DOI 10.1210/en.2006-1730
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371
   Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0
   Ewbank SN, 2020, P NATL ACAD SCI USA, V117, P20874, DOI 10.1073/pnas.2004941117
   Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x
   Ezaki J, 2011, AUTOPHAGY, V7, P727, DOI 10.4161/auto.7.7.15371
   Ferreira-Marques M, 2016, AGING-US, V8, P1470, DOI 10.18632/aging.100996
   Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005
   Gannaban RB, 2021, DIABETES, V70, P62, DOI 10.2337/db20-0510
   Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548
   Hansen M, 2018, NAT REV MOL CELL BIO, V19, P579, DOI 10.1038/s41580-018-0033-y
   He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910
   Herman JP, 2004, ANN NY ACAD SCI, V1018, P35, DOI 10.1196/annals.1296.004
   Imanikia S, 2019, CELL REP, V28, P581, DOI 10.1016/j.celrep.2019.06.057
   Imanikia S, 2019, CURR BIOL, V29, P2322, DOI 10.1016/j.cub.2019.06.031
   Jais A, 2022, ENDOCR REV, V43, P314, DOI 10.1210/endrev/bnab025
   Jais A, 2020, NEURON, V106, P1009, DOI 10.1016/j.neuron.2020.03.022
   Jiang YT, 2019, NEUROSCIENCE, V411, P11, DOI 10.1016/j.neuroscience.2019.05.035
   Joly-Amado A, 2012, EMBO J, V31, P4276, DOI 10.1038/emboj.2012.250
   Kaushik S, 2021, AGEING RES REV, V72, DOI 10.1016/j.arr.2021.101468
   Kaushik S, 2011, CELL METAB, V14, P173, DOI 10.1016/j.cmet.2011.06.008
   Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280
   Klionsky DJ, 2021, EMBO J, V40, DOI 10.15252/embj.2021108863
   Könner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004
   Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230
   Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022
   Kotoulas OB, 2006, PATHOL RES PRACT, V202, P631, DOI 10.1016/j.prp.2006.04.001
   Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009
   Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229
   Lapierre LR, 2012, AUTOPHAGY, V8, P144, DOI 10.4161/auto.8.1.18722
   Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524
   Lynagh T, 2010, J BIOL CHEM, V285, P14890, DOI 10.1074/jbc.M110.107789
   Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078
   Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200
   Martinez-Lopez N, 2017, CELL METAB, V26, P856, DOI 10.1016/j.cmet.2017.09.020
   Martinez-Lopez N, 2016, CELL METAB, V23, P113, DOI 10.1016/j.cmet.2015.10.008
   MORTIMORE GE, 1988, J BIOL CHEM, V263, P2506
   Najt CP, 2020, MOL CELL, V77, P810, DOI 10.1016/j.molcel.2019.12.003
   Nieto-Torres JL, 2021, MOL ASPECTS MED, V82, DOI 10.1016/j.mam.2021.101020
   Nolte H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31154-6
   Padilla SL, 2016, NAT NEUROSCI, V19, P734, DOI 10.1038/nn.4274
   Patel H, 2020, NF CORE RNASEQ NF CO, DOI [10.5281/zenodo, DOI 10.5281/ZENODO]
   Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106
   Rau AR, 2017, J NEUROSCI, V37, P7362, DOI 10.1523/JNEUROSCI.0647-17.2017
   Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100
   Ruud LE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14291-3
   Saito T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08829-3
   Sato M, 2020, BIOCHEM BIOPH RES CO, V528, P199, DOI 10.1016/j.bbrc.2020.04.132
   Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489
   Schulze RJ, 2017, HEPATOL COMMUN, V1, P359, DOI 10.1002/hep4.1056
   Schwaiger M, 2017, ANAL CHEM, V89, P7667, DOI 10.1021/acs.analchem.7b01624
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383
   Steculorum SM, 2016, CELL, V165, P125, DOI 10.1016/j.cell.2016.02.044
   Takagi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18944
   Taylor RC, 2020, AGING CELL, V19, DOI 10.1111/acel.13265
   Taylor RC, 2013, CELL, V153, P1435, DOI 10.1016/j.cell.2013.05.042
   Tiesjema B, 2007, J NEUROSCI, V27, P14139, DOI 10.1523/JNEUROSCI.3280-07.2007
   Timper K, 2017, DIS MODEL MECH, V10, P679, DOI 10.1242/dmm.026609
   Todd WD, 2018, NAT NEUROSCI, V21, P717, DOI 10.1038/s41593-018-0126-0
   Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167
   Troncoso R, 2014, CELL CYCLE, V13, P2281, DOI 10.4161/cc.29272
   Tschöp M, 2000, NATURE, V407, P908, DOI 10.1038/35038090
   van den Hoek AM, 2008, DIABETES, V57, P2304, DOI 10.2337/db07-1658
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118
   Yuan Y, 2019, CURR BIOL, V29, P1243, DOI 10.1016/j.cub.2019.02.048
   Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200
NR 86
TC 9
Z9 8
U1 11
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1550-4131
EI 1932-7420
J9 CELL METAB
JI Cell Metab.
PD MAY 2
PY 2023
VL 35
IS 5
BP 786
EP +
DI 10.1016/j.cmet.2023.03.019
EA MAY 2023
PG 35
WC Cell Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Endocrinology & Metabolism
GA H2AK4
UT WOS:000994042000001
PM 37075752
OA hybrid, Green Published
DA 2024-02-19
ER

PT J
AU Park, JW
   Choi, CH
   Kim, MS
   Chung, MH
AF Park, JW
   Choi, CH
   Kim, MS
   Chung, MH
TI Oxidative status in senescence-accelerated mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID CHRONIC FOOD RESTRICTION; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION;
   DIETARY RESTRICTION; METABOLIC-RATE; MURINE MODEL; MOUSE SAM; AGE;
   LIVER; DNA
AB The lipid peroxidation and activities of antioxidant enzymes were examined in the livers of two substrains of senescence-accelerated mice (SAM): senescence-resistant SAM-R/1 and senescence-prone SAM-P/1. Fluorescent age pigment and conjugated diene levels in both substrains increased gradually with age, hut we found higher levels in SAM-P/1 at all ages tested. Differences in the levels of lipid peroxidation products became more marked with age. Among the enzymes studied, only mitochondrial superoxide dismutase (SOD) in SAM-P/1 showed decreased activity in all age groups. The specific mitochondrial SOD in that case was Cu,Zn-SOD. The amount of Cu,Zn-SOD in mitochondrial fractions of SAM-P/1 was only half that of SAM-R/1, whereas there were no apparent differences in the mRNA levels of both SAM groups. Our study indicates that impaired transport of Cu,Zn-SOD into mitochondria after cytosolic synthesis reduces defense against oxidative stress. That reduction may he one of the factors contributing to accelerated senescence in the SAM-P/1.
C1 SEOUL NATL UNIV, COLL MED, DEPT PHARMACOL, CHONGNO GU, SEOUL 110799, SOUTH KOREA.
   CHOSUN UNIV, COLL MED, DEPT PHARMACOL, TONG GU, KWANGJU 501759, SOUTH KOREA.
C3 Seoul National University (SNU); Chosun University
RI Park, Jong-Wan/J-2758-2012
CR AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408
   Beauchamp C., 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8
   CHOI JH, 1994, INT CONGR SER, V1062, P321
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   CIAIBORNE A, 1986, CRC HDB METHODS OXYG, P283
   CUTLER RG, 1985, MOL BIOL AGING, P15, DOI DOI 10.2307/2499207
   DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x
   Del Maestro R., 1989, CRC handbook of methods for oxygen radical research, V4, P291
   FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9
   FORMAN HJ, 1982, FREE RADICAL BIO MED, V5, P65
   Goldberg D.M., 1983, METHOD ENZYMAT AN, VIII, P258, DOI DOI 10.1016/B978-0-12-091302-2.X5001-4
   HALLEWELL RA, 1986, NUCLEIC ACIDS RES, V14, P9539, DOI 10.1093/nar/14.23.9539
   HALLIWELL B, 1989, FREE RADICAL BIO MED, P416
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   HEICKLEN J, 1987, J GERONTOL, V42, P674, DOI 10.1093/geronj/42.6.674
   KOHNO A, 1985, J NUTR, V115, P1259, DOI 10.1093/jn/115.10.1259
   LAGANIERE S, 1989, MECH AGEING DEV, V48, P207, DOI 10.1016/0047-6374(89)90083-3
   LIPPMAN RD, 1989, CRC HDB FREE RADICAL, P187
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUHTALA TA, 1994, J GERONTOL, V49, pB231, DOI 10.1093/geronj/49.5.B231
   MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560
   MCARTHUR MC, 1982, J GERONTOL, V37, P268, DOI 10.1093/geronj/37.3.268
   MCKUSICK VA, 1977, SCIENCE, V196, P390, DOI 10.1126/science.850784
   MEYDANI M, 1994, FREE RADICALS AGING, P183
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Misra HP., 1985, HDB METHODS OXYGEN R, P237
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   POWERS SK, 1993, AM J PHYSIOL, V265, pH2094, DOI 10.1152/ajpheart.1993.265.6.H2094
   RECKNAGEL RO, 1984, METHOD ENZYMOL, V105, P331
   SAGAI M, 1980, LIFE SCI, V27, P731, DOI 10.1016/0024-3205(80)90326-4
   Sambrook J.E., 1989, MOL CLONING LAB MANU, V2nd ed., P182, DOI [10.1016/0003-2697(90)90595-Z, DOI 10.1016/0003-2697(90)90595-Z]
   SHELDAHL JA, 1974, EXP GERONTOL, V9, P33, DOI 10.1016/0531-5565(74)90005-9
   SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I
   SOHAL RS, 1981, MECH AGEING DEV, V16, P159, DOI 10.1016/0047-6374(81)90092-0
   STREHLER BL, 1961, J GERONTOL, V16, P2, DOI 10.1093/geronj/16.1.2
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKESHIGE K, 1979, BIOCHEM J, V180, P129, DOI 10.1042/bj1800129
   TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421
   WEISIGER RA, 1973, J BIOL CHEM, V248, P4793
   YOSHIKAWA M, 1967, J GERONTOL, V22, P162, DOI 10.1093/geronj/22.2.162
   Yu B.P., 1993, FREE RADICALS AGING, P57
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 45
TC 47
Z9 51
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD SEP
PY 1996
VL 51
IS 5
BP B337
EP B345
DI 10.1093/gerona/51A.5.B337
PG 9
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA VN951
UT WOS:A1996VN95100006
PM 8808982
OA Bronze
DA 2024-02-19
ER

PT J
AU Talbot, NC
   Wang, L
   Garrett, WM
   Caperna, TJ
   Tang, Y
AF Talbot, Neil C.
   Wang, Ling
   Garrett, Wesley M.
   Caperna, Thomas J.
   Tang, Young
TI Establishment and characterization of feeder cell-dependent bovine fetal
   liver cell lines
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Article
DE Bovine; Cell line; Feeder cells; Hepatocyte; Liver; STO
ID GROWTH-FACTOR-BETA; HEPATOCYTES IN-VITRO; EMBRYONIC STEM-CELLS; PRIMARY
   CULTURES; PORCINE HEPATOCYTES; EPITHELIAL-CELLS; RAT HEPATOCYTES;
   TGF-BETA; TRIGLYCERIDE ACCUMULATION; DNA-SYNTHESIS
AB The establishment and initial characterization of bovine fetal liver cell lines are described. Bovine fetal hepatocytes were cultured from the liver of a 34-d bovine fetus by physical disruption of the liver tissue. Released liver cells and clumps of cells were plated on STO (SIMS mouse strain, thioguanine-and ouabain-resistant) feeder layers and were cultured in a medium supplemented with 10% fetal bovine serum. After 2-3 wk, primary colonies of hepatocytes were observed by phase-contrast microscopic observation. Individual hepatocyte colonies were colony-cloned into independent bovine fetal liver (BFL) cell lines. Two cell lines, BFL-6 and BFL-9, grew the best of several isolates, and they were further characterized for growth potential and for hepatocyte morphology and function. The two cell lines were found to grow markedly better in the presence of the transforming growth factor (TGF)-beta inhibitor, SB431542 (1 mu M). Their continuous culture also depended on a particular medium height-for T12.5 flasks, 3 ml total medium produced optimum growth. Higher or lower amounts of medium caused less cell growth or cessation of growth. The cell lines were propagated for over a year at split ratios of 1: 2 or 1: 3 at each passage until reaching senescence at approximately 30 passages. The cells were laterally polarized with well-developed canalicular spaces occurring between adjacent BFL cells. Treatment of the cultures with cyclic adenosine monophosphate (cAMP)-stimulating chemicals or peptides (e.g., forskolin or glucagon) caused physical expansion of the canaliculi between the cells within 15 min. The cells secreted a spectrum of serum proteins, were positive for the expression of several hepatocyte-specific genes, and converted ammonia to urea, although at a relatively low rate. The culture system provides an in vitro model of fetal bovine hepatocytes and is the first demonstration of the continuous culture of normal bovine hepatocytes as cell lines.
C1 [Talbot, Neil C.; Garrett, Wesley M.; Caperna, Thomas J.] ARS, Anim Biosci & Biotechnol Lab, Beltsville Agr Res Ctr, NEA,USDA,BARC East, Bldg 200,Rm 13, Beltsville, MD 20705 USA.
   [Wang, Ling; Tang, Young] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.
C3 United States Department of Agriculture (USDA); University of
   Connecticut
RP Talbot, NC (corresponding author), ARS, Anim Biosci & Biotechnol Lab, Beltsville Agr Res Ctr, NEA,USDA,BARC East, Bldg 200,Rm 13, Beltsville, MD 20705 USA.
EM neil.talbot@ars.usda.gov
RI Tang, Young/GXF-6129-2022
OI Wang, Ling/0000-0002-0787-3352
CR ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0
   AKEO K, 1992, OPHTHALMIC RES, V24, P357, DOI 10.1159/000267194
   Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569
   Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229
   Asahina Kinji, 2006, Curr Stem Cell Res Ther, V1, P139, DOI 10.2174/157488806776956878
   Baldini E, 2009, TRANSPL P, V41, P1367, DOI 10.1016/j.transproceed.2009.02.061
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133
   Caperna TJ, 2013, DOMEST ANIM ENDOCRIN, V45, P154, DOI 10.1016/j.domaniend.2013.08.003
   Caperna TJ, 2011, IN VITRO CELL DEV-AN, V47, P218, DOI 10.1007/s11626-010-9382-3
   Caperna TJ, 2010, COMP BIOCHEM PHYS B, V156, P189, DOI 10.1016/j.cbpb.2010.03.006
   Chang KH, 2008, EXP CELL RES, V314, P2930, DOI 10.1016/j.yexcr.2008.07.019
   DEJUAN C, 1992, EXP CELL RES, V202, P495, DOI 10.1016/0014-4827(92)90104-G
   DONKIN SS, 1993, J ANIM SCI, V71, P2218, DOI 10.2527/1993.7182218x
   Ehmann UK, 2001, IN VITRO CELL DEV-AN, V37, P100, DOI 10.1290/1071-2690(2001)037<0100:GJCBFC>2.0.CO;2
   FICO ME, 1984, J NUTR, V114, P613, DOI 10.1093/jn/114.3.613
   GERMAIN L, 1988, CANCER RES, V48, P4909
   Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190
   GRIENINGER G, 1975, P NATL ACAD SCI USA, V72, P5007, DOI 10.1073/pnas.72.12.5007
   Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699
   Gstraunthaler G, 1999, CELL PHYSIOL BIOCHEM, V9, P150, DOI 10.1159/000016312
   Heng BC, 2004, IN VITRO CELL DEV-AN, V40, P255
   Huch M, 2015, CELL, V160, P299, DOI 10.1016/j.cell.2014.11.050
   Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65
   Gómez-Lechón MJ, 2012, METHODS MOL BIOL, V806, P87, DOI 10.1007/978-1-61779-367-7_7
   Junqueira CL, 1992, BASIC HISTOLOGY, P320
   Khan Shaukat A, 2012, BMC Res Notes, V5, P636, DOI 10.1186/1756-0500-5-636
   Kia R, 2013, BRIT J CLIN PHARMACO, V75, P885, DOI 10.1111/j.1365-2125.2012.04360.x
   Kumar N, 2010, INT J DEV BIOL, V54, P1329, DOI 10.1387/ijdb.092854nk
   Kuntz E, 2008, HEPATOLOGY TXB ATLAS, P35
   KURIHARCUCH W, 1989, DIFFERENTIATION, V41, P148, DOI 10.1111/j.1432-0436.1989.tb00742.x
   LaRusso NF, 2011, DIGEST DIS, V29, P6, DOI 10.1159/000324121
   Lee JK, 2014, DRUG METAB DISPOS, V42, P492, DOI 10.1124/dmd.113.055384
   LEFFERT HL, 1972, J CELL BIOL, V52, P559, DOI 10.1083/jcb.52.3.559
   LENZEN R, 1990, AM J PHYSIOL, V259, pG736, DOI 10.1152/ajpgi.1990.259.5.G736
   Liu L, 2014, J DAIRY SCI, V97, P1328, DOI 10.3168/jds.2013-6654
   Lv LJ, 2015, HEPATOLOGY, V61, P337, DOI 10.1002/hep.27421
   Meister A, 1976, ENZYMES BIOL MEMBR, P315
   MENNONE A, 1995, P NATL ACAD SCI USA, V92, P6527, DOI 10.1073/pnas.92.14.6527
   Oze H, 2012, IN VITRO CELL DEV-AN, V48, P123, DOI 10.1007/s11626-011-9479-3
   Pettersen EO, 2005, CELL PROLIFERAT, V38, P257, DOI 10.1111/j.1365-2184.2005.00345.x
   Raucy JL, 2004, TOXICOL SCI, V79, P233, DOI 10.1093/toxsci/kfh126
   Robertson E.J., 1987, TERATOCARCINOMAS EMB, P71
   RUTENBURG AM, 1969, J HISTOCHEM CYTOCHEM, V17, P517, DOI 10.1177/17.8.517
   Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416
   SATO G, 1960, P NATL ACAD SCI USA, V46, P963, DOI 10.1073/pnas.46.7.963
   Sauer Vanessa, 2014, Curr Pathobiol Rep, V2, P11
   Sheng X, 2014, INT J OBESITY, V38, P315, DOI 10.1038/ijo.2013.96
   STRAIN AJ, 1986, CELL BIOL INT REP, V10, P855, DOI 10.1016/0309-1651(86)90102-5
   STRAIN AJ, 1991, J CLIN INVEST, V87, P1853, DOI 10.1172/JCI115207
   Strang BD, 1998, J DAIRY SCI, V81, P728, DOI 10.3168/jds.S0022-0302(98)75629-2
   TALBOT NC, 1994, IN VITRO CELL DEV-AN, V30A, P851
   TALBOT NC, 1994, IN VITRO CELL DEV-AN, V30A, P843
   Talbot NC, 2002, CELLS TISSUES ORGANS, V171, P99, DOI 10.1159/000063704
   Talbot NC, 2000, BIOL REPROD, V62, P235, DOI 10.1095/biolreprod62.2.235
   Talbot NC, 1998, IN VITRO CELL DEV-AN, V34, P785, DOI 10.1007/s11626-998-0033-x
   Talbot NC, 2007, IN VITRO CELL DEV-AN, V43, P72, DOI 10.1007/s11626-007-9014-8
   Talbot NC, 2012, IN VITRO CELL DEV-AN, V48, P1, DOI 10.1007/s11626-011-9467-7
   Talbot NC, 2010, INT J ARTIF ORGANS, V33, P348, DOI 10.1177/039139881003300603
   Talbot Neil C., 1996, Methods in Cell Science, V18, P315, DOI 10.1007/BF00127909
   Tang Y, 2014, J CELL SCI, V127, P3998, DOI 10.1242/jcs.150029
   Vuoristo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076205
   Walker L, 1999, STEM CELLS, V17, P162, DOI 10.1002/stem.170162
   Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016
   WYBENGA DR, 1971, CLIN CHEM, V17, P891
   Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744
   Yanagida A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067541
   ZAGORSKI Z, 1989, OPHTHALMIC RES, V21, P440, DOI 10.1159/000266935
   Zhang ZG, 2011, CELL PHYSIOL BIOCHEM, V27, P637, DOI 10.1159/000330072
   Zhu LH, 2000, J ANIM SCI, V78, P1659
NR 70
TC 2
Z9 3
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1071-2690
EI 1543-706X
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD MAR
PY 2016
VL 52
IS 3
BP 314
EP 326
DI 10.1007/s11626-015-9982-z
PG 13
WC Cell Biology; Developmental Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Developmental Biology
GA DJ6VG
UT WOS:000374350700007
PM 26659396
DA 2024-02-19
ER

PT J
AU Goh, KJ
   Chen, JH
   Rocha, N
   Semple, RK
AF Goh, Kim Jee
   Chen, Jian-Hua
   Rocha, Nuno
   Semple, Robert K.
TI Human pluripotent stem cell-based models suggest preadipocyte senescence
   as a possible cause of metabolic complications of Werner and Bloom
   Syndromes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INSULIN-RESISTANCE SYNDROME; SHORT STATURE; ADIPOGENESIS; INFLAMMATION;
   FEATURES; OBESITY; DIFFERENTIATION; CARBOHYDRATE; HERITABILITY;
   DISRUPTION
AB Werner Syndrome (WS) and Bloom Syndrome (BS) are disorders of DNA damage repair caused by biallelic disruption of the WRN or BLM DNA helicases respectively. Both are commonly associated with insulin resistant diabetes, usually accompanied by dyslipidemia and fatty liver, as seen in lipodystrophies. In keeping with this, progressive reduction of subcutaneous adipose tissue is commonly observed. To interrogate the underlying cause of adipose tissue dysfunction in these syndromes, CRISPR/Cas9 genome editing was used to generate human pluripotent stem cell (hPSC) lacking either functional WRN or BLM helicase. No deleterious effects were observed in WRN-/- or BLM-/- embryonic stem cells, however upon their differentiation into adipocyte precursors (AP), premature senescence emerged, impairing later stages of adipogenesis. The resulting adipocytes were also found to be senescent, with increased levels of senescent markers and senescence-associated secretory phenotype (SASP) components. SASP components initiate and reinforce senescence in adjacent cells, which is likely to create a positive feedback loop of cellular senescence within the adipocyte precursor compartment, as demonstrated in normal ageing. Such a scenario could progressively attenuate adipose mass and function, giving rise to "lipodystrophy-like" insulin resistance. Further assessment of pharmacological senolytic strategies are warranted to mitigate this component of Werner and Bloom syndromes.
C1 [Goh, Kim Jee; Chen, Jian-Hua; Rocha, Nuno; Semple, Robert K.] Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, Metab Res Labs, Cambridge, England.
   [Chen, Jian-Hua; Rocha, Nuno; Semple, Robert K.] Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge, England.
   [Semple, Robert K.] Univ Edinburgh, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.
C3 University of Cambridge; University of Cambridge; University of
   Edinburgh
RP Semple, RK (corresponding author), Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, Metab Res Labs, Cambridge, England.; Semple, RK (corresponding author), Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge, England.; Semple, RK (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.
EM rsemple@exseed.ed.ac.uk
RI Semple, Robert K/E-5253-2015
OI Semple, Robert K/0000-0001-6539-3069
FU Agency for Science, Technology and Research Singapore (A*STAR); Wellcome
   Trust [210752/Z/18/Z]; MRC [MC_UU_00014/5] Funding Source: UKRI
FX K.J.G is supported by the Agency for Science, Technology and Research
   Singapore (A*STAR). R.K.S. is supported by the Wellcome Trust (grant
   210752/Z/18/Z).
CR Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411
   [Anonymous], 2017, IDF DIABETES ATLAS
   Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003
   Caso G, 2013, METABOLISM, V62, P337, DOI 10.1016/j.metabol.2012.08.007
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508
   Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389
   Chen JH, 2017, DIS MODEL MECH, V10, P1411, DOI 10.1242/dmm.030981
   Chen JH, 2015, J MOL ENDOCRINOL, V55, P147, DOI 10.1530/JME-15-0090
   Chen Lishan, 2002, Journal of Biomedicine & Biotechnology, V2, P46, DOI 10.1155/S1110724302201011
   Chester N, 1998, GENE DEV, V12, P3382, DOI 10.1101/gad.12.21.3382
   Cheung HH, 2014, STEM CELL REP, V2, P534, DOI 10.1016/j.stemcr.2014.02.006
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   de Renty C, 2017, AGEING RES REV, V33, P36, DOI 10.1016/j.arr.2016.05.010
   Diaz A, 2006, HORM RES, V66, P111, DOI 10.1159/000093826
   EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001
   Esser N, 2014, DIABETES RES CLIN PR, V105, P141, DOI 10.1016/j.diabres.2014.04.006
   Falchi M, 2008, DIABETES, V57, P1120, DOI 10.2337/db07-0708
   Freeman MS, 2002, DIABETIC MED, V19, P994, DOI 10.1046/j.1464-5491.2002.00843.x
   Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003
   GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003
   Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239
   Goto M, 1997, MECH AGEING DEV, V98, P239, DOI 10.1016/S0047-6374(97)00111-5
   Goto M, 2013, BIOSCI TRENDS, V7, P13, DOI 10.5582/bst.2013.v7.1.13
   Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200
   Gustafson B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10688-x
   Huang SR, 2006, HUM MUTAT, V27, P558, DOI 10.1002/humu.20337
   Huang-Doran I, 2011, DIABETES, V60, P925, DOI 10.2337/db10-1334
   Karagiannides I, 2001, AM J PHYSIOL-REG I, V280, pR1772, DOI 10.1152/ajpregu.2001.280.6.R1772
   Kim CS, 2006, INT J OBESITY, V30, P1347, DOI 10.1038/sj.ijo.0803259
   Larsen NB, 2013, ADV EXP MED BIOL, V973, P161, DOI 10.1007/978-1-4614-5037-5_8
   Lu H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.168
   McDaniel LD, 2003, DNA REPAIR, V2, P1387, DOI 10.1016/j.dnarep.2003.08.006
   Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2
   Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0
   Okada A, 2012, CLIN EXP RHEUMATOL, V30, P332
   Payne F, 2014, J CLIN INVEST, V124, P4028, DOI 10.1172/JCI73264
   RAY JH, 1984, CHROMOSOMA, V90, P383, DOI 10.1007/BF00294165
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Shimamoto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112900
   Souren NY, 2007, DIABETOLOGIA, V50, P2107, DOI 10.1007/s00125-007-0784-z
   Szekely AM, 2005, MOL CELL BIOL, V25, P10492, DOI 10.1128/MCB.25.23.10492-10506.2005
   Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Utsal L, 2012, HORM RES PAEDIAT, V78, P31, DOI 10.1159/000339831
   Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199
   Weedon MN, 2013, NAT GENET, V45, P947, DOI 10.1038/ng.2670
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997
   Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112
   Yusa K, 2004, NATURE, V429, P896, DOI 10.1038/nature02646
   Zaragosi LE, 2010, DIABETES, V59, P2513, DOI 10.2337/db10-0013
   Zhang WQ, 2015, SCIENCE, V348, P1160, DOI 10.1126/science.aaa1356
NR 54
TC 8
Z9 8
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 4
PY 2020
VL 10
IS 1
AR 7490
DI 10.1038/s41598-020-64136-8
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA NA7XJ
UT WOS:000560030700036
PM 32367056
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU MATOCHA, MF
   COSGROVE, JW
   ATACK, JR
   RAPOPORT, SI
AF MATOCHA, MF
   COSGROVE, JW
   ATACK, JR
   RAPOPORT, SI
TI SELECTIVE ELEVATION OF C-MYC TRANSCRIPT LEVELS IN THE LIVER OF THE AGING
   FISCHER-344 RAT
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
RP MATOCHA, MF (corresponding author), NIA,NEUROSCI LAB,BETHESDA,MD 20892, USA.
OI Atack, John/0000-0002-3410-791X
CR BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505
   BLANCHARD JM, 1985, NATURE, V317, P443, DOI 10.1038/317443a0
   CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   COLBY WW, 1983, NATURE, V301, P722, DOI 10.1038/301722a0
   COLEMAN GL, 1977, J GERONTOL, V32, P258, DOI 10.1093/geronj/32.3.258
   Conover W, 1980, PRACTICAL NONPARAMET, P229
   COTTON PC, 1983, MOL CELL BIOL, V3, P1157, DOI 10.1128/MCB.3.6.1157
   CZERNILOFSKY AP, 1980, NATURE, V287, P198, DOI 10.1038/287198a0
   DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883
   EINAT M, 1985, P NATL ACAD SCI USA, V82, P7608, DOI 10.1073/pnas.82.22.7608
   EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0
   GOLDSTEIN S, 1984, MOL CELL BIOCHEM, V64, P15, DOI 10.1007/BF00420924
   GOYETTE M, 1984, MOL CELL BIOL, V4, P1493, DOI 10.1128/MCB.4.8.1493
   HELDIN CH, 1981, P NATL ACAD SCI-BIOL, V78, P3664, DOI 10.1073/pnas.78.6.3664
   HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311
   JONES T. C., 1967, P1
   JOSEPHS SF, 1983, SCIENCE, V219, P503, DOI 10.1126/science.6297002
   KAWAKAMI T, 1986, MOL CELL BIOL, V6, P4195, DOI 10.1128/MCB.6.12.4195
   KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2
   KITAMURA N, 1982, NATURE, V297, P205, DOI 10.1038/297205a0
   LEFFERT HL, 1979, GASTROENTEROLOGY, V76, P1470
   LEVINSON AD, 1981, P NATL ACAD SCI-BIOL, V78, P1624, DOI 10.1073/pnas.78.3.1624
   MAKINO R, 1984, NATURE, V310, P697, DOI 10.1038/310697a0
   Maniatis T, 1982, MOL CLONING LABORATO
   MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2
   NAHARRO G, 1983, VIROLOGY, V125, P502, DOI 10.1016/0042-6822(83)90223-4
   PARKER RC, 1985, MOL CELL BIOL, V5, P831, DOI 10.1128/MCB.5.4.831
   RAN W, 1986, P NATL ACAD SCI USA, V83, P8216, DOI 10.1073/pnas.83.21.8216
   RESNITZKY D, 1986, CELL, V46, P31, DOI 10.1016/0092-8674(86)90857-3
   SEMBA K, 1986, P NATL ACAD SCI USA, V83, P5459, DOI 10.1073/pnas.83.15.5459
   STUDZINSKI GP, 1986, SCIENCE, V234, P467, DOI 10.1126/science.3532322
   VENNSTROM B, 1982, J VIROL, V42, P773, DOI 10.1128/JVI.42.3.773-779.1982
   VORONOVA AF, 1986, NATURE, V319, P682, DOI 10.1038/319682a0
   WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0
   WEISS PA, 1968, DYNAMICS DEV EXPT IN, P329
   YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237
NR 37
TC 29
Z9 29
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 31
PY 1987
VL 147
IS 1
BP 1
EP 7
DI 10.1016/S0006-291X(87)80078-5
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA J7539
UT WOS:A1987J753900001
PM 3307772
DA 2024-02-19
ER

PT J
AU Zhang, MM
   Gong, WL
   Zhang, DJ
   Ji, M
   Chen, BJ
   Chen, BN
   Li, XY
   Zhou, YF
   Dong, CY
   Wen, GH
   Zhan, XN
   Wu, XF
   Cui, LL
   Feng, YL
   Wang, SM
   Yuan, HY
   Xu, EY
   Xia, MS
   Verkhratsky, A
   Li, BM
AF Zhang, Manman
   Gong, Wenliang
   Zhang, Dianjun
   Ji, Ming
   Chen, Binjie
   Chen, Beina
   Li, Xinyu
   Zhou, Yuefei
   Dong, Chengyi
   Wen, Gehua
   Zhan, Xiaoni
   Wu, Xiafang
   Cui, Lulu
   Feng, Yuliang
   Wang, Siman
   Yuan, Huiya
   Xu, Enyu
   Xia, Maosheng
   Verkhratsky, Alexei
   Li, Baoman
TI Ageing related thyroid deficiency increases brain-targeted transport of
   liver-derived ApoE4-laden exosomes leading to cognitive impairment
SO CELL DEATH & DISEASE
LA English
DT Article
ID ALZHEIMERS ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL
   INSTITUTE; GASDERMIN D; DISEASE; DEPRESSION; DEMENTIA; BETA; RISK;
   RECOMMENDATIONS
AB Alzheimer's disease (AD) is the prevalent cause of dementia in the ageing world population. Apolipoprotein E4 (ApoE4) allele is the key genetic risk factor for AD, although the mechanisms linking ApoE4 with neurocognitive impairments and aberrant metabolism remains to be fully characterised. We discovered a significant increase in the ApoE4 content of serum exosomes in old healthy subjects and AD patients carrying ApoE4 allele as compared with healthy adults. Elevated exosomal ApoE4 demonstrated significant inverse correlation with serum level of thyroid hormones and cognitive function. We analysed effects of ApoE4-containing peripheral exosomes on neural cells and neurological outputs in aged or thyroidectomised young mice. Ageing-associated hypothyroidism as well as acute thyroidectomy augmented transport of liver-derived ApoE4 reach exosomes into the brain, where ApoE4 activated nucleotide-binding oligomerisation domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome by increasing cholesterol level in neural cells. This, in turn, affected cognition, locomotion and mood. Our study reveals pathological potential of exosomes-mediated relocation of ApoE4 from the periphery to the brain, this process can represent potential therapeutic target.
C1 [Zhang, Manman; Gong, Wenliang; Zhang, Dianjun; Ji, Ming; Chen, Binjie; Chen, Beina; Li, Xinyu; Wen, Gehua; Zhan, Xiaoni; Wu, Xiafang; Cui, Lulu; Feng, Yuliang; Wang, Siman; Yuan, Huiya; Xu, Enyu; Verkhratsky, Alexei; Li, Baoman] China Med Univ, Sch Forens Med, Dept Forens Analyt Toxicol, Shenyang, Peoples R China.
   [Zhou, Yuefei; Dong, Chengyi; Xia, Maosheng] China Med Univ, Hosp 1, Dept Orthopaed, Shenyang, Peoples R China.
   [Verkhratsky, Alexei] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.
   [Verkhratsky, Alexei] Ikerbasque, Achucarro Ctr Neurosci, Bilbao 48011, Spain.
   [Verkhratsky, Alexei] Ctr Innovat Med, Dept Stem Cell Biol, State Res Inst, LT-01102 Vilnius, Lithuania.
C3 China Medical University; China Medical University; University of
   Manchester; Basque Foundation for Science; State Research Institute
   Centre for Innovative Medicine
RP Verkhratsky, A; Li, BM (corresponding author), China Med Univ, Sch Forens Med, Dept Forens Analyt Toxicol, Shenyang, Peoples R China.; Verkhratsky, A (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.; Verkhratsky, A (corresponding author), Ikerbasque, Achucarro Ctr Neurosci, Bilbao 48011, Spain.; Verkhratsky, A (corresponding author), Ctr Innovat Med, Dept Stem Cell Biol, State Res Inst, LT-01102 Vilnius, Lithuania.
EM Alexej.Verkhratsky@manchester.ac.uk; bmli@cmu.edu.cn
RI li, baoman/JDQ-7836-2023; xey626, xey626/IYJ-6503-2023; Wang,
   Jin/GYA-2019-2022; liang, liang/IAO-8518-2023; wu, jun/ISB-8607-2023;
   zhao, yujie/JLL-1283-2023; luo, yuan/JLS-6416-2023; li,
   yang/IQV-3559-2023; Wang, Jing/IQW-3496-2023; LI, XIAO/IQV-9318-2023;
   Wang, Jiacheng/ABE-5948-2020
OI Wang, Jing/0000-0002-8296-2961; Wang, Jiacheng/0000-0003-4327-1508
FU National Natural Science Foundation of China [81871852]; Liaoning
   Revitalization Talents Program [XLYC1807137]; Scientific Research
   Foundation for Returned Scholars of Education Ministry of China
   [20151098]; LiaoNing Thousands Talents Program [202078]; "ChunHui"
   Program of Education Ministry [2020703]
FX This work was supported by the National Natural Science Foundation of
   China, BL [grant number 81871852]; Liaoning Revitalization Talents
   Program, BL [grant number XLYC1807137], the Scientific Research
   Foundation for Returned Scholars of Education Ministry of China, BL
   [grant number 20151098], LiaoNing Thousands Talents Program, BL [grant
   number 202078], "ChunHui" Program of Education Ministry, BL [grant
   number 2020703].
CR Abbas YM, 2020, SCIENCE, V367, P1240, DOI 10.1126/science.aaz2924
   Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
   Alzoubi KH, 2009, HIPPOCAMPUS, V19, P66, DOI 10.1002/hipo.20476
   Bojar I, 2016, DEMENT GERIATR COGN, V42, P169, DOI 10.1159/000449373
   Borges CG, 2015, NEUROSCIENCE, V304, P122, DOI 10.1016/j.neuroscience.2015.07.028
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380
   Burcklé C, 2006, HYPERTENSION, V48, P549, DOI 10.1161/01.HYP.0000241132.48495.df
   Chahal HS, 2007, J PATHOL, V211, P173, DOI 10.1002/path.2110
   Chandan VS, 2016, HUM PATHOL, V55, P11, DOI 10.1016/j.humpath.2016.04.008
   Choi HJ, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0291-5
   de Jong FJ, 2006, J CLIN ENDOCR METAB, V91, P2569, DOI 10.1210/jc.2006-0449
   de Jong FJ, 2009, NEUROBIOL AGING, V30, P600, DOI 10.1016/j.neurobiolaging.2007.07.019
   Fernandez A, 2009, J NEUROSCI, V29, P6394, DOI 10.1523/JNEUROSCI.4909-08.2009
   Flowers SA, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104724
   Goddard ET, 2016, JOVE-J VIS EXP, DOI 10.3791/54903
   Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036
   Gong JS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-9
   He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139
   Ho PWL, 2005, J NEUROSCI RES, V81, P261, DOI 10.1002/jnr.20569
   Holtzman DM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006312
   Jansen EJR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11600
   Jung YS, 2021, HEPATOLOGY, V73, P776, DOI 10.1002/hep.31305
   Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045
   Kim B, 2020, PSYCHIAT INVEST, V17, P1006, DOI 10.30773/pi.2020.0182
   Kmiec Z, 2001, GERONTOLOGY, V47, P282, DOI 10.1159/000052813
   Kvitting AS, 2019, J AM GERIATR SOC, V67, P534, DOI 10.1111/jgs.15694
   Lässer C, 2012, JOVE-J VIS EXP, DOI 10.3791/3037
   Li BM, 2016, J NEUROSCI RES, V94, P924, DOI 10.1002/jnr.23795
   Li XW, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00734
   Li ZX, 2020, NEUROCHEM INT, V134, DOI 10.1016/j.neuint.2020.104689
   Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072
   Liu D, 2006, NEUROMOL MED, V8, P389, DOI 10.1385/NMM:8:3:389
   Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629
   Lynch AM, 2010, AGING DIS, V1, P262
   Manaye KF, 2005, J NEUROPATH EXP NEUR, V64, P224, DOI 10.1093/jnen/64.3.224
   Matsumoto J, 2017, CURR PHARM DESIGN, V23, P6206, DOI 10.2174/1381612823666170913164738
   McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005
   Montesanto A, 2018, AGING-US, V10, P3283, DOI 10.18632/aging.101632
   Montesanto A, 2016, J ALZHEIMERS DIS, V51, P1265, DOI 10.3233/JAD-150993
   Mori Yutaka, 2004, J Atheroscler Thromb, V11, P224
   Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x
   Ng A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30487-6
   Park GC, 2017, ONCOTARGET, V8, P89431, DOI 10.18632/oncotarget.19851
   Park J, 2018, NAT NEUROSCI, V21, P941, DOI 10.1038/s41593-018-0175-4
   Ross JA, 2018, PROG NEURO-PSYCHOPH, V85, P136, DOI 10.1016/j.pnpbp.2017.08.004
   Sharma VK, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11050678
   STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977
   Stukas S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001156
   Sun XL, 2011, NEUROSCIENCE, V192, P507, DOI 10.1016/j.neuroscience.2011.05.047
   Vella LJ, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1348885
   Wu CS, 2021, FRONT NEUROINFORM, V15, DOI 10.3389/fninf.2021.662967
   Xia MS, 2020, NEUROSCI BULL, V36, P1259, DOI 10.1007/s12264-020-00524-4
   Xia MS, 2017, PSYCHOPHARMACOLOGY, V234, P365, DOI 10.1007/s00213-016-4473-9
   Yan BC, 2010, AM J SURG PATHOL, V34, P1147, DOI 10.1097/PAS.0b013e3181e5dffa
   Yang SJ, 2017, CANCER BIOL THER, V18, P158, DOI 10.1080/15384047.2017.1281499
   Zhang CS, 2017, NATURE, V548, P112, DOI 10.1038/nature23275
   Zhang XQ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00388
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
NR 59
TC 5
Z9 5
U1 2
U2 16
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD APR 25
PY 2022
VL 13
IS 4
AR 406
DI 10.1038/s41419-022-04858-x
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 0U0CM
UT WOS:000787327700002
PM 35468877
OA Green Submitted, gold, Green Published
DA 2024-02-19
ER

PT J
AU Dwyer, JR
   Donkor, J
   Zhang, PX
   Csaki, LS
   Vergnes, L
   Lee, JM
   Dewald, J
   Brindley, DN
   Atti, E
   Tetradis, S
   Yoshinaga, Y
   De Jong, PJ
   Fong, LG
   Young, SG
   Reue, K
AF Dwyer, Jennifer R.
   Donkor, Jimmy
   Zhang, Peixiang
   Csaki, Lauren S.
   Vergnes, Laurent
   Lee, Jessica M.
   Dewald, Jay
   Brindley, David N.
   Atti, Elisa
   Tetradis, Sotirios
   Yoshinaga, Yuko
   De Jong, Pieter J.
   Fong, Loren G.
   Young, Stephen G.
   Reue, Karen
TI Mouse lipin-1 and lipin-2 cooperate to maintain glycerolipid homeostasis
   in liver and aging cerebellum
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID CONGENITAL DYSERYTHROPOIETIC ANEMIA; RECURRENT MULTIFOCAL OSTEOMYELITIS;
   PHOSPHATIDIC-ACID PHOSPHATASE; ACTIVATED RECEPTOR-GAMMA;
   GENE-EXPRESSION; PHOSPHOLIPASE-D; MUTATIONS; ENZYMES; ATHEROSCLEROSIS;
   LIPODYSTROPHY
AB The three lipin phosphatidate phosphatase (PAP) enzymes catalyze a step in glycerolipid biosynthesis, the conversion of phosphatidate to diacylglycerol. Lipin-1 is critical for lipid synthesis and homeostasis in adipose tissue, liver, muscle, and peripheral nerves. Little is known about the physiological role of lipin-2, the predominant lipin protein present in liver and the deficient gene product in the rare disorder Majeed syndrome. By using lipin-2-deficient mice, we uncovered a functional relationship between lipin-1 and lipin-2 that operates in a tissue-specific and age-dependent manner. In liver, lipin-2 deficiency led to a compensatory increase in hepatic lipin-1 protein and elevated PAP activity, which maintained lipid homeostasis under basal conditions, but led to diet-induced hepatic triglyceride accumulation. As lipin-2-deficient mice aged, they developed ataxia and impaired balance. This was associated with the combination of lipin-2 deficiency and an age-dependent reduction in cerebellar lipin-1 levels, resulting in altered cerebellar phospholipid composition. Similar to patients with Majeed syndrome, lipin-2-deficient mice developed anemia, but did not show evidence of osteomyelitis, suggesting that additional environmental or genetic components contribute to the bone abnormalities observed in patients. Combined lipin-1 and lipin-2 deficiency caused embryonic lethality. Our results reveal functional interactions between members of the lipin family in vivo, and a unique role for lipin-2 in central nervous system biology that may be particularly important with advancing age. Additionally, as has been observed in mice and humans with lipin-1 deficiency, the pathophysiology in lipin-2 deficiency is associated with dysregulation of lipid intermediates.
C1 [Dwyer, Jennifer R.; Young, Stephen G.; Reue, Karen] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.
   [Donkor, Jimmy; Zhang, Peixiang; Csaki, Lauren S.; Vergnes, Laurent; Lee, Jessica M.; Young, Stephen G.; Reue, Karen] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Dewald, Jay; Brindley, David N.] Univ Alberta, Dept Cell Signaling, Edmonton, AB T6G 2H7, Canada.
   [Atti, Elisa; Tetradis, Sotirios] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90095 USA.
   [Yoshinaga, Yuko; De Jong, Pieter J.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA.
   [Fong, Loren G.; Young, Stephen G.; Reue, Karen] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Los Angeles, CA 90095 USA.
C3 University of California System; University of California Los Angeles;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of Alberta; University of California
   System; University of California Los Angeles; University of California
   System; University of California San Francisco; UCSF Medical Center;
   UCSF Benioff Children's Hospital Oakland; Children's Hospital Oakland
   Research Institute; University of California System; University of
   California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA
RP Reue, K (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.
EM reuek@ucla.edu
OI vergnes, laurent/0000-0002-8804-589X; Young, Stephen/0000-0001-7270-3176
FU National Institutes of Health (NIH) [P01 HL090553]; Canadian Institutes
   of Health Research; Canadian Heart and Stroke Foundation; Ruth L.
   Kirschstein National Research Service Awards [GM007185, T32 HG002536];
   Kansas Technology Enterprise Corporation; Kansas State University;
   National Science Foundation [EPS 0236913, MCB 0455318, MCB 0920663, DBI
   0521587]; K-IDeA Networks of Biomedical Research Excellence (NIH)
   [P20RR16475]; Div Of Molecular and Cellular Bioscience; Direct For
   Biological Sciences [0920663] Funding Source: National Science
   Foundation
FX We thank Ping Xu and Yan Hu for technical assistance, Dr. Maroun Bou
   Khalil for lipin-1 antibody, Dr. Brian Finck for lipin-2 antibody, and
   Bernard Kok for advice on the phosphatidate phosphatase assay. This work
   was supported by National Institutes of Health (NIH) Grant P01 HL090553
   (to L.G.F., S.G.Y, and K.R.), the Canadian Institutes of Health Research
   (D.N.B.), the Canadian Heart and Stroke Foundation (D.N.B.), and Ruth L.
   Kirschstein National Research Service Awards GM007185 (pre-doctoral
   training support; to J.R.D.) and T32 HG002536 (to J. Donkor and L.S.C.).
   The lipidomic analyses by MS were performed at the Kansas Lipidomics
   Research Center Analytical Laboratory, which had instrument acquisition
   and methods development supported by Kansas Technology Enterprise
   Corporation; Kansas State University; National Science Foundation Grants
   EPS 0236913, MCB 0455318, MCB 0920663, and DBI 0521587; and K-IDeA
   Networks of Biomedical Research Excellence (NIH) Grant P20RR16475.
CR Al-Mosawi ZS, 2007, ARTHRITIS RHEUM, V56, P960, DOI 10.1002/art.22431
   Barajas B, 2011, ARTERIOSCL THROM VAS, V31, P58, DOI 10.1161/ATVBAHA.110.210906
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Brindley DN, 2009, BBA-MOL CELL BIOL L, V1791, P956, DOI 10.1016/j.bbalip.2009.02.007
   Brusse E, 2007, CLIN GENET, V71, P12, DOI 10.1111/j.1399-0004.2006.00722.x
   Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200
   Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1
   Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729
   Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005
   Donkor J, 2008, J CLIN ENDOCR METAB, V93, P233, DOI 10.1210/jc.2007-1535
   Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200
   Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663
   Ferguson PJ, 2005, J MED GENET, V42, P551, DOI 10.1136/jmg.2005.030759
   Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005
   Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102
   Friedel RH, 2010, METHOD ENZYMOL, V477, P243, DOI 10.1016/S0076-6879(10)77013-0
   Giusto NM, 2002, NEUROCHEM RES, V27, P1513, DOI 10.1023/A:1021604623208
   Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200
   Grkovich A, 2009, ADV ENZYME REGUL, V49, P214
   Gropler MC, 2009, J BIOL CHEM, V284, P6763, DOI 10.1074/jbc.M807882200
   Grüsser-Cornehls U, 2001, PROG NEUROBIOL, V63, P489, DOI 10.1016/S0301-0082(00)00024-1
   Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200
   Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006
   Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692
   Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094
   Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200
   Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09
   Kok BPC, 2012, J LIPID RES, V53, P105, DOI 10.1194/jlr.M019430
   Liu GH, 2010, BIOCHEM J, V432, P65, DOI 10.1042/BJ20100584
   Lusis AJ, 2008, NAT REV GENET, V9, P819, DOI 10.1038/nrg2468
   MAJEED HA, 1989, J PEDIATR-US, V115, P730, DOI 10.1016/S0022-3476(89)80650-X
   Majeed HA, 2001, EUR J PEDIATR, V160, P705, DOI 10.1007/s004310100799
   Majeed HA, 2008, GENEREVIEWS
   Michot C, 2010, HUM MUTAT, V31, pE1564, DOI 10.1002/humu.21282
   Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517
   Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008
   Pasquaré SJ, 2004, LIPIDS, V39, P553, DOI 10.1007/s11745-004-1262-y
   Pasquaré SJ, 2001, EXP GERONTOL, V36, P1387, DOI 10.1016/S0531-5565(01)00106-1
   Péterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685
   Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200
   Reue K, 2000, J LIPID RES, V41, P1067
   Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200
   Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551
   Ryu D, 2011, DIABETES, V60, P1072, DOI 10.2337/db10-1046
   Stapleton CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018932
   Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008
   Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200
   Vergnes L, 2011, J BIOL CHEM, V286, P380, DOI 10.1074/jbc.M110.184754
   Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200
   Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002
   Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109
   Zhang P, 2008, J LIPID RES, V49, P1519, DOI 10.1194/jlr.M800061-JLR200
   Zhang PX, 2012, J BIOL CHEM, V287, P3485, DOI 10.1074/jbc.M111.296681
NR 53
TC 61
Z9 70
U1 0
U2 13
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 11
PY 2012
VL 109
IS 37
BP E2486
EP E2495
DI 10.1073/pnas.1205221109
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 012AP
UT WOS:000309208000013
PM 22908270
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Yamagiwa, Y
   Meng, F
   Patel, T
AF Yamagiwa, Y
   Meng, F
   Patel, T
TI Interleukin-6 decreases senescence and increases telomerase activity in
   malignant human cholangiocytes
SO LIFE SCIENCES
LA English
DT Article
DE cholangiocarcinoma; p38 MAPK; proliferation; biliary tract; cytokines
ID BILIARY EPITHELIAL-CELLS; HEPATOCYTE GROWTH-FACTOR; INTRAHEPATIC
   CHOLANGIOCARCINOMA; TUMOR-CELLS; LIFE-SPAN; IN-VITRO; CANCER; CLOCK;
   INHIBITION; ACTIVATION
AB Background/aims- Cellular senescence results in irreversible growth arrest. In malignant cells, senescence is prevented by maintenance of chromosomal length by telomerase activity. Telomerase activity is increased in malignant, but not in normal cholangiocytes. Interleukin-6 (IL-6) is an autocrine promoter of cholangiocarcinoma growth. Our aims were to assess the relationship between IL-6 activated p38 mitogen-activated protein kinase (MAPK) pathways and senescence in malignant cholangiocytes.
   Methods: Cell senescence and telomerase activity was assessed in Mz-ChA-1 malignant human cholangiocytes. The effect of inhibitors of p38 MAPK and telomerase activity on cell proliferation was assessed, and the interaction between these inhibitors was quantitated by median effects analysis.
   Results. Mz-ChA-1 cells rapidly underwent senescence during repeated passaging. IL-6 increased telomerase activity and decreased cellular senescence during repeated passaging. However, basal telomerase activity was increased by inhibition of p38 MAPK. Inhibition of telomerase activity decreased IL-6 induced proliferation and had a synergistic effect with p38 MAPK inhibitors. Thus, IL-6 increases telomerase activity independent of p38 MAPK signaling and maintenance of telomerase activity promotes cholangiocarcinoma growth.
   Conclusion. Enhanced telomerase activity in response to IL-6 stimulation can prevent cellular senescence and thereby contribute to cholangiocarcinoma growth. Inhibition of telomerase activity may therefore be therapeutically useful in biliary tract malignancies (c) 2005 Elsevier Inc. All fights reserved.
C1 Texas A&M Univ, Hlth Sci Ctr, Coll Med, Scott & White Clin, Temple, TX 76508 USA.
C3 Texas A&M University System; Texas A&M University College Station; Texas
   A&M Health Science Center; Scott & White Medical Center
RP Patel, T (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Coll Med, Scott & White Clin, 2401 S 31st St, Temple, TX 76508 USA.
EM tpatel@medicine.tamu.edu
RI patel, tushar/A-6382-2008; patel, tushar/J-3976-2013
OI patel, tushar/0000-0001-7021-9532
FU NIDDK NIH HHS [DK069370, R01 DK069370] Funding Source: Medline
CR Akiyama M, 2002, CANCER RES, V62, P3876
   Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002
   BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082
   CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4
   Dhaene K, 2000, VIRCHOWS ARCH, V437, P1, DOI 10.1007/s004280000189
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081
   Fu WM, 1999, J BIOL CHEM, V274, P7264, DOI 10.1074/jbc.274.11.7264
   Gores GJ, 2003, HEPATOLOGY, V37, P961, DOI 10.1053/jhep.2003.50200
   Greider CW, 1998, CURR BIOL, V8, pR178, DOI 10.1016/S0960-9822(98)70105-8
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Holt SE, 1999, MOL CARCINOGEN, V25, P241, DOI 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.3.CO;2-0
   Iki K, 1998, CANCER LETT, V131, P185, DOI 10.1016/S0304-3835(98)00148-7
   Ishikawa F, 2000, CELL MOL LIFE SCI, V57, P698, DOI 10.1007/s000180050034
   Itoi T, 2000, GASTROINTEST ENDOSC, V52, P380, DOI 10.1067/mge.2000.108303
   Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085
   Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Li H, 1998, J BIOL CHEM, V273, P33436, DOI 10.1074/jbc.273.50.33436
   Li H, 1997, J BIOL CHEM, V272, P16729, DOI 10.1074/jbc.272.27.16729
   MATSUMOTO K, 1994, HEPATOLOGY, V20, P376
   Meyerson M, 2000, J CLIN ONCOL, V18, P2626, DOI 10.1200/JCO.2000.18.13.2626
   Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3
   Minamino T, 2001, MOL CELL BIOL, V21, P3336, DOI 10.1128/MCB.21.10.3336-3342.2001
   Morales CP, 1998, GASTROINTEST ENDOSC, V48, P402, DOI 10.1016/S0016-5107(98)70011-2
   Nakahara Y, 1998, INT J CLIN PHARM RES, V18, P1
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   OKADA K, 1994, J GASTROEN HEPATOL, V9, P462, DOI 10.1111/j.1440-1746.1994.tb01275.x
   Ozaki S, 1999, HEPATOLOGY, V30, P914, DOI 10.1002/hep.510300419
   Park J, 1999, HEPATOLOGY, V30, P1128, DOI 10.1002/hep.510300522
   Park J, 1999, HEPATOLOGY, V29, P1037, DOI 10.1002/hep.510290423
   Patel T, 2001, HEPATOLOGY, V33, P1353, DOI 10.1053/jhep.2001.25087
   Patel T, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-10
   Reddel RR, 2000, CARCINOGENESIS, V21, P477, DOI 10.1093/carcin/21.3.477
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537
   Tadlock L, 2001, HEPATOLOGY, V33, P43, DOI 10.1053/jhep.2001.20676
   te Poele RH, 2002, CANCER RES, V62, P1876
   Uehara H, 1999, BIOTECHNIQUES, V26, P552, DOI 10.2144/99263pf01
   VARIZI H, 1998, CURR BIOL, V8, P279
   Yamagiwa Y, 2003, HEPATOLOGY, V38, P158, DOI 10.1053/jhep.2003.50257
   Yokomuro S, 2000, HEPATOLOGY, V32, P26, DOI 10.1053/jhep.2000.8535
NR 46
TC 37
Z9 43
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD APR 18
PY 2006
VL 78
IS 21
BP 2494
EP 2502
DI 10.1016/j.lfs.2005.10.015
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 034LU
UT WOS:000236931300012
PM 16336976
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Helenius, M
   Kyrylenko, S
   Vehviläinen, P
   Salminen, A
AF Helenius, M
   Kyrylenko, S
   Vehviläinen, P
   Salminen, A
TI Characterization of aging-associated up-regulation of constitutive
   nuclear factor-κB binding activity
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article
ID TRANSCRIPTION FACTOR; IKK-ALPHA; TYROSINE PHOSPHORYLATION; KINASE-ALPHA;
   PROTEINS; AGE; ACTIVATION; BETA; APOPTOSIS; ANKYRIN
AB Changes occur in gene expression during aging in vivo and in replicative senescence in vitro, suggesting that aging can affect gene regulation. We have recently observed age-related changes in ubiquitously expressed, oxidative stress-responsive nuclear factor-kappaB (NF-kappaB) pathway during aging. Here we report a significant age-related increase in nuclear NF-kappaB binding activity together with increased protein levels of p52 and p65 components in rat liver. An additional, higher molecular weight protein band seen in their western blots suggests that their post-translational modification (but not phosphorylation) occurs in liver, which might affect their nuclear localization and binding activity during aging. However, aging did not affect the protein levels of the main IkappaB inhibitors (IkappaBalpha and IkappaBbeta) or IkappaB kinase (IKK)-complex subunits (IKKalpha, -beta, and -gamma) involved in NF-kappaB activation. In addition, the level of Ser(32)-phosphorylated IkappaBalpha was unaffected by age, suggesting that neither the IKK complex nor altered level of the main inhibitors is involved in the observed up-regulation of NF-kappaB binding activity. Furthermore, the expression of NF-kappaB mRNAs (p50, p52, p65, and c-rel) and the mRNAs of their inhibitors (IkappaBalpha and IkappaBbeta) did not show any statistically significant age-related changes. These results indicate that the expression level of NF-kappaB genes is not significantly affected by aging. The up-regulation of constitutive nuclear NF-kappaB binding activity and increased levels of nuclear p52 and p65 proteins might affect the expression of some NF-kappaB target genes in the aging liver.
C1 Univ Kuopio, Dept Neurosci & Neurol, FIN-70211 Kuopio, Finland.
   Univ Jyvaskyla, Dept Biol & Environm Sci, FIN-40351 Jyvaskyla, Finland.
   Ukrainian Acad Sci, Inst Mol Biol & Genet, UA-252627 Kiev, Ukraine.
   Kuopio Univ Hosp, Dept Neurol, Kuopio, Finland.
C3 University of Eastern Finland; University of Jyvaskyla; National Academy
   of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU;
   University of Eastern Finland; Kuopio University Hospital
RP Salminen, A (corresponding author), Univ Kuopio, Dept Neurosci & Neurol, POB 1627, FIN-70211 Kuopio, Finland.
CR Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Betts JC, 1996, MOL CELL BIOL, V16, P6363
   BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405
   CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991
   DICE JF, 1993, PHYSIOL REV, V73, P149, DOI 10.1152/physrev.1993.73.1.149
   DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   GILMORE TD, 1993, TRENDS GENET, V9, P427, DOI 10.1016/0168-9525(93)90106-R
   Helenius M, 1996, J MOL CELL CARDIOL, V28, P487, DOI 10.1006/jmcc.1996.0045
   Helenius M, 1996, BIOCHEM J, V318, P603, DOI 10.1042/bj3180603
   Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1
   Korhonen P, 1997, NEUROSCI LETT, V225, P61, DOI 10.1016/S0304-3940(97)00190-0
   Kretz-Remy C, 1998, J BIOL CHEM, V273, P3180, DOI 10.1074/jbc.273.6.3180
   Lee FS, 1998, P NATL ACAD SCI USA, V95, P9319, DOI 10.1073/pnas.95.16.9319
   Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012
   Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792
   Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6
   Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0
   Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860
   Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X
   PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0
   Sen CK, 1996, FASEB J, V10, P709, DOI 10.1096/fasebj.10.7.8635688
   SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201
   Singh S, 1996, J BIOL CHEM, V271, P31049, DOI 10.1074/jbc.271.49.31049
   SOHAL RS, 1992, MUTAT RES, V275, P295, DOI 10.1016/0921-8734(92)90033-L
   Spencer NFL, 1997, INT IMMUNOL, V9, P1581, DOI 10.1093/intimm/9.10.1581
   SUPAKAR PC, 1995, J BIOL CHEM, V270, P837, DOI 10.1074/jbc.270.2.837
   ToliverKinsky T, 1997, J NEUROSCI RES, V48, P580, DOI 10.1002/(SICI)1097-4547(19970615)48:6<580::AID-JNR11>3.0.CO;2-Z
   VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787
   Walter R, 1998, J GERONTOL A-BIOL, V53, pB102, DOI 10.1093/gerona/53A.2.B102
   WANG E, 1995, CANCER RES, V55, P2284
   Wang E, 1997, EXP GERONTOL, V32, P471, DOI 10.1016/S0531-5565(96)00156-8
   Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866
   Yin MJ, 1998, CELL, V93, P875, DOI 10.1016/S0092-8674(00)81447-6
   Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7
   Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360
   Zhang XM, 1999, J BIOL CHEM, V274, P20235, DOI 10.1074/jbc.274.29.20235
NR 38
TC 81
Z9 87
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD FEB
PY 2001
VL 3
IS 1
BP 147
EP 156
DI 10.1089/152308601750100669
PG 10
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 532WV
UT WOS:000174498800014
PM 11291593
DA 2024-02-19
ER

PT J
AU Roake, CM
   Artandi, SE
AF Roake, Caitlin M.
   Artandi, Steven E.
TI Control of Cellular Aging, Tissue Function, and Cancer by p53 Downstream
   of Telomeres
SO COLD SPRING HARBOR PERSPECTIVES IN MEDICINE
LA English
DT Article
ID TERT PROMOTER MUTATIONS; POLY(A)-SPECIFIC RIBONUCLEASE PARN; DOMINANT
   DYSKERATOSIS-CONGENITA; DNA-DAMAGE RESPONSE; REVERSE-TRANSCRIPTASE;
   MAMMALIAN TELOMERES; CATALYTIC SUBUNIT; HUMAN-CELLS; DYSFUNCTIONAL
   TELOMERES; PULMONARY-FIBROSIS
AB Telomeres, the nucleoprotein complex at the ends of eukaryotic chromosomes, perform an essential cellular role in part by preventing the chromosomal end from initiating a DNAdamage response. This function of telomeres can be compromised as telomeres erode either as a consequence of cell division in culture or as a normal part of cellular ageing in proliferative tissues. Telomere dysfunction in this context leads to DNA-damage signaling and activation of the tumor-suppressor protein p53, which then can prompt either cellular senescence or apoptosis. By culling cells with dysfunctional telomeres, p53 plays a critical role in protecting tissues against the effects of critically short telomeres. However, as telomere dysfunction worsens, p53 likely exacerbates short telomere-driven tissue failure diseases, including pulmonary fibrosis, aplastic anemia, and liver cirrhosis. In cells lacking p53, unchecked telomere shortening drives chromosomal end-to-end fusions and cycles of chromosome fusion-bridge-breakage. Incipient cancer cells confronting these telomere barriers must disable p53 signaling to avoid senescence and eventually up-regulate telomerase to achieve cellular immortality. The recent findings of highly recurrent activating mutations in the promoter for the telomerase reverse transcriptase (TERT) gene in diverse human cancers, together with the widespread mutations in p53 in cancer, provide support for the idea that circumvention of a telomere-p53 checkpoint is essential for malignant progression in human cancer.
C1 [Roake, Caitlin M.; Artandi, Steven E.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.
   [Roake, Caitlin M.; Artandi, Steven E.] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA.
   [Artandi, Steven E.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.
C3 Stanford University; Stanford University; Stanford University
RP Artandi, SE (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Artandi, SE (corresponding author), Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA.; Artandi, SE (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.
EM sartandi@stanford.edu
FU Medical Scientist Training Program [GM007365]; National Cancer Institute
   [CA197563]
FX C.M.R. is supported by Medical Scientist Training Program Grant
   GM007365. We acknowledge support from the National Cancer Institute
   CA197563.
CR Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10
   Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880
   Anderson BH, 2012, NAT GENET, V44, P338, DOI 10.1038/ng.1084
   Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102
   Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246
   Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157
   Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592
   Ballew BJ, 2013, HUM GENET, V132, P473, DOI 10.1007/s00439-013-1265-8
   Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036
   Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015
   BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Borah S, 2015, SCIENCE, V347, P1006, DOI 10.1126/science.1260200
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173
   Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275
   Cesare AJ, 2013, MOL CELL, V51, P141, DOI 10.1016/j.molcel.2013.06.006
   Chen LY, 2013, GENE DEV, V27, P2099, DOI 10.1101/gad.222893.113
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x
   d'Adda diFagagna F., 2003, Nature, V426, P194, DOI DOI 10.1038/NATURE02118
   Davoli T, 2012, CANCER CELL, V21, P765, DOI 10.1016/j.ccr.2012.03.044
   Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031
   de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005
   Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065
   Dhanraj S, 2015, J MED GENET, V52, P738, DOI 10.1136/jmedgenet-2015-103292
   Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048
   Else T, 2009, CANCER CELL, V15, P465, DOI 10.1016/j.ccr.2009.04.011
   Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026
   González-Suárez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089
   Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8
   GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9
   Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6
   HARA E, 1991, BIOCHEM BIOPH RES CO, V179, P528, DOI 10.1016/0006-291X(91)91403-Y
   Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Hartmann D, 2011, HEPATOLOGY, V53, P1608, DOI 10.1002/hep.24217
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733
   Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270
   Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044
   Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062
   Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259
   Kabir S, 2014, CELL REP, V9, P1273, DOI 10.1016/j.celrep.2014.10.014
   Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3
   Keegan CE, 2005, HUM MOL GENET, V14, P113, DOI 10.1093/hmg/ddi011
   Khoo CM, 2007, P NATL ACAD SCI USA, V104, P3931, DOI 10.1073/pnas.0700093104
   Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508
   Kinde I, 2013, CANCER RES, V73, P7162, DOI 10.1158/0008-5472.CAN-13-2498
   KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0
   Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446
   Kocak H, 2014, GENE DEV, V28, P2090, DOI 10.1101/gad.248567.114
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2
   Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561
   Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142
   Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688
   LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H
   Maciejowski J, 2015, CELL, V163, P1641, DOI 10.1016/j.cell.2015.11.054
   Martínez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509
   Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Moon DH, 2015, NAT GENET, V47, P1482, DOI 10.1038/ng.3423
   Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955
   Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648
   O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6
   OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7
   Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871
   Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004
   Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X
   Sexton AN, 2014, GENE DEV, V28, P1885, DOI 10.1101/gad.246819.114
   Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100
   Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021
   Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   Simeonova I, 2013, CELL REP, V3, P2046, DOI 10.1016/j.celrep.2013.05.028
   Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X
   Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000
   Stern JL, 2015, GENE DEV, V29, P2219, DOI 10.1101/gad.269498.115
   Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0
   Vannier JB, 2013, SCIENCE, V342, P239, DOI 10.1126/science.1241779
   vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0
   Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357
   Vlangos CN, 2009, DEV BIOL, V334, P418, DOI 10.1016/j.ydbio.2009.07.038
   Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585
   Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346
   Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105
   Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111
   Walne AJ, 2013, AM J HUM GENET, V92, P448, DOI 10.1016/j.ajhg.2013.02.001
   Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454
   WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0
   Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101
   Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232
   Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037
   Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469
   Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980
   Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335
   Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404
   Yeung F, 2013, CELL REP, V3, P1847, DOI 10.1016/j.celrep.2013.05.032
   YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0
   Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411
   Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012
NR 111
TC 31
Z9 35
U1 0
U2 25
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 2157-1422
J9 CSH PERSPECT MED
JI Cold Spring Harb. Perspect. Med.
PD MAY
PY 2017
VL 7
IS 5
AR a026088
DI 10.1101/cshperspect.a026088
PG 16
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA EW9LT
UT WOS:000402842000005
PM 28289249
OA Green Accepted, Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Kronfol, MM
   Jahr, FM
   Dozmorov, MG
   Phansalkar, PS
   Xie, LY
   Aberg, KA
   McRae, M
   Price, ET
   Slattum, PW
   Gerk, PM
   McClay, JL
AF Kronfol, Mohamad M.
   Jahr, Fay M.
   Dozmorov, Mikhail G.
   Phansalkar, Palak S.
   Xie, Lin Y.
   Aberg, Karolina A.
   McRae, MaryPeace
   Price, Elvin T.
   Slattum, Patricia W.
   Gerk, Philip M.
   McClay, Joseph L.
TI DNA methylation and histone acetylation changes to cytochrome P450 2E1
   regulation in normal aging and impact on rates of drug metabolism in the
   liver
SO GEROSCIENCE
LA English
DT Article; Early Access
DE DNA methylation; Histone acetylation; Aging; Cyp2e1; Pharmacokinetics;
   Drug metabolism
ID EXPRESSION; WIDE; AGE; HEPATOTOXICITY
AB Aging is associated with reduced liver function that may increase the risk for adverse drug reactions in older adults. We hypothesized that age-related changes to epigenetic regulation of genes involved in drug metabolism may contribute to this effect. We reviewed published epigenome-wide studies of human blood and identified the cytochrome P450 2E1 (CYP2E1) gene as a top locus exhibiting epigenetic changes with age. To investigate potential functional changes with age in the liver, the primary organ of drug metabolism, we obtained liver tissue from mice aged 4-32 months from the National Institute on Aging. We assayed global DNA methylation (5-methylcytosine, 5mC), hydroxymethylation (5-hydroxymethylcytosine, 5hmC), and locus-specific 5mC and histone acetylation changes around mouse Cyp2e1. The mouse livers exhibit significant global decreases in 5mC and 5hmC with age. Furthermore, 5mC significantly increased with age at two regulatory regions of Cyp2e1 in tandem with decreases in its gene and protein expressions. H3K9ac levels also changed with age at both regulatory regions of Cyp2e1 investigated, while H3K27ac did not. To test if these epigenetic changes are associated with varying rates of drug metabolism, we assayed clearance of the CYP2E1-specific probe drug chlorzoxazone in microsome extracts from the same livers. CYP2E1 intrinsic clearance is associated with DNA methylation and H3K9ac levels at the Cyp2e1 locus but not with chronological age. This suggests that age-related epigenetic changes may influence rates of hepatic drug metabolism. In the future, epigenetic biomarkers could prove useful to guide dosing regimens in older adults.
C1 [Kronfol, Mohamad M.; Jahr, Fay M.; McRae, MaryPeace; Price, Elvin T.; Slattum, Patricia W.; McClay, Joseph L.] Virginia Commonwealth Univ, Sch Pharm, Dept Pharmacotherapy & Outcomes Sci, Smith Bldg,410 North 12th St, Richmond, VA 23298 USA.
   [Dozmorov, Mikhail G.] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA.
   [Phansalkar, Palak S.; Gerk, Philip M.] Virginia Commonwealth Univ, Sch Pharm, Dept Pharmaceut, Richmond, VA USA.
   [Xie, Lin Y.; Aberg, Karolina A.] Virginia Commonwealth Univ, Sch Pharm, Ctr Biomarker Res & Precis Med, Richmond, VA USA.
C3 Virginia Commonwealth University; Virginia Commonwealth University;
   Virginia Commonwealth University; Virginia Commonwealth University
RP McClay, JL (corresponding author), Virginia Commonwealth Univ, Sch Pharm, Dept Pharmacotherapy & Outcomes Sci, Smith Bldg,410 North 12th St, Richmond, VA 23298 USA.
EM jlmcclay@vcu.edu
RI Kronfol, Mohamad/Y-7953-2019; Aberg, Karolina/A-6772-2010; McClay,
   Joseph/C-9931-2009
OI Kronfol, Mohamad/0000-0002-0283-2420; Aberg,
   Karolina/0000-0001-6103-5168; McClay, Joseph/0000-0002-3628-2447;
   Phansalkar, Palak/0000-0003-4394-3570; Gerk, Phillip
   M./0000-0001-9861-1018
FU Virginia Commonwealth University (VCU) School of Pharmacy [R15AG061649];
   US National Institute on Aging; National Institute on Aging of the
   National Institutes of Health [R15AG061649]
FX MMK was funded through a graduate studentship from Virginia Commonwealth
   University (VCU) School of Pharmacy and through R15AG061649 from the US
   National Institute on Aging. Research reported in this publication was
   supported by the National Institute on Aging of the National Institutes
   of Health under Award Number R15AG061649 to JLM.
CR [Anonymous], 2006, PATT MED US US REP S
   Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808
   Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300
   Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048
   Bonder MJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-860
   Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013
   Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858
   Budnitz DS., 2012, Surv Anesthesiol, V56, P65, DOI [10.1097/01.sa.0000412401.21757.36, DOI 10.1097/01.SA.0000412401.21757.36, DOI 10.1056/NEJMsa1103053]
   Cardelli M, 2018, MECH AGEING DEV, V174, P30, DOI 10.1016/j.mad.2018.02.002
   Caro AA, 2004, ANNU REV PHARMACOL, V44, P27, DOI 10.1146/annurev.pharmtox.44.101802.121704
   Dozmorov MG, 2015, EPIGENETICS-US, V10, P484, DOI 10.1080/15592294.2015.1040619
   Duron E, 2008, ARCH CARDIOVASC DIS, V101, P181, DOI 10.1016/S1875-2136(08)71801-1
   ElDesoky Ehab S, 2007, Am J Ther, V14, P488, DOI 10.1097/01.mjt.0000183719.84390.4d
   Fick DM, 2019, J AM GERIATR SOC, V67, P674, DOI 10.1111/jgs.15767
   Fisel P, 2016, CLIN PHARMACOL THER, V99, P512, DOI 10.1002/cpt.343
   Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028
   French Samuel W, 2013, Subcell Biochem, V67, P145, DOI 10.1007/978-94-007-5881-0_4
   Gravina S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1011-3
   Hahn O, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1187-1
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109
   Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3
   Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115
   HOUSTON JB, 1994, BIOCHEM PHARMACOL, V47, P1469
   HUNT CM, 1990, BIOCHEM PHARMACOL, V40, P1666, DOI 10.1016/0006-2952(90)90470-6
   Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z
   Issa JP, 2002, J NUTR, V132, p2388S, DOI 10.1093/jn/132.8.2388S
   Jia L, 2018, MOL METAB, V14, P121, DOI 10.1016/j.molmet.2018.05.015
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Knights Kathleen M, 2016, Curr Protoc Pharmacol, V74, DOI 10.1002/cpph.9
   Koh KH, 2011, DRUG METAB DISPOS, V39, P165, DOI 10.1124/dmd.110.035790
   Kronfol MM, 2017, EXPERT REV PRECIS ME, V2, P33, DOI 10.1080/23808993.2017.1284557
   Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200
   Lee WM, 2017, J HEPATOL, V67, P1324, DOI 10.1016/j.jhep.2017.07.005
   Lesurf R, 2016, NUCLEIC ACIDS RES, V44, pD126, DOI 10.1093/nar/gkv1203
   Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517
   Lucas D, 1999, PHARMACOGENETICS, V9, P377, DOI 10.1097/00008571-199906000-00013
   Mach J, 2016, FUND CLIN PHARMACOL, V30, P23, DOI 10.1111/fcp.12157
   Martinez SM, 2010, TOXICOL APPL PHARM, V249, P208, DOI 10.1016/j.taap.2010.09.012
   Marttila S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1381-z
   McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291
   McClay JL, 2014, HUM MOL GENET, V23, P1175, DOI 10.1093/hmg/ddt511
   McLachlan AJ, 2009, CLIN PHARMACOL THER, V85, P431, DOI 10.1038/clpt.2009.1
   McLachlan AJ, 2012, J GERONTOL A-BIOL, V67, P175, DOI 10.1093/gerona/glr118
   McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4
   Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418
   Newman MR, 2012, EPIGENETICS-US, V7, P92, DOI 10.4161/epi.7.1.18815
   Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584
   Park HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132992
   Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200
   Reynolds LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6366
   Ruoss M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020347
   Scarzello AJ, 2016, GUT, V65, P1765, DOI 10.1136/gutjnl-2014-308810
   SCHMUCKER DL, 1990, CLIN PHARMACOL THER, V48, P365, DOI 10.1038/clpt.1990.164
   Seripa D, 2015, EXPERT OPIN DRUG MET, V11, P1073, DOI 10.1517/17425255.2015.1041919
   Sommer D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6927
   Spiers H, 2016, MECH AGEING DEV, V154, P20, DOI 10.1016/j.mad.2016.02.001
   Steegenga Wilma T, 2014, Age (Dordr), V36, P9648, DOI 10.1007/s11357-014-9648-x
   Sultana J, 2013, J PHARMACOL PHARMACO, V4, pS73, DOI 10.4103/0976-500X.120957
   Tammen SA, 2014, ALCOHOL CLIN EXP RES, V38, P2178, DOI 10.1111/acer.12477
   Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8
   Wilhelm A, 2016, GUT, V65, P1175, DOI 10.1136/gutjnl-2014-308325
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007
   Zhu TY, 2018, AGING-US, V10, P3541, DOI 10.18632/aging.101666
NR 68
TC 21
Z9 22
U1 2
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD 2020 JUN
PY 2020
VL 42
IS 3
SI SI
BP 819
EP 832
DI 10.1007/s11357-020-00181-5
EA MAR 2020
PG 14
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA LX9MV
UT WOS:000521897800002
PM 32221779
OA Green Published
DA 2024-02-19
ER

PT J
AU Ahn, JS
   Jang, IS
   Kim, DI
   Cho, KA
   Park, YH
   Kim, K
   Kwak, CS
   Park, SC
AF Ahn, JS
   Jang, IS
   Kim, DI
   Cho, KA
   Park, YH
   Kim, K
   Kwak, CS
   Park, SC
TI Aging-associated increase of gelsolin for apoptosis resistance
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE apoptosis resistance; senescence; gelsolin
ID REPLICATIVE SENESCENCE; HUMAN FIBROBLASTS; DEATH; INHIBITION; CELLS;
   EFFECTOR; MOTILITY; CALCIUM; COMPLEX; GROWTH
AB Gelsolin, a Ca2+-dependent actin regulatory protein, was recently suggested to participate in apoptosis regulation. In this study, we found that the level of gelsolin is elevated in senescent human diploid fibroblasts (HDFs) and also in the tissues of old rats, i.e., in the liver, kidney, heart, spleen, stomach, and brain, etc. The ubiquitous increase of gelsolin in the aged organs and cells led us to assume that it might be related with one of the cardinal senescent phenotypes, aging-associated apoptosis resistency. Thus, we tested the sensitivity of senescent cells to apoptosis by menadione, an apoptosis-inducing agent, before and after the down-regulation of gelsolin. The down-regulation of gelsolin in senescent HDFs, independently of Bcl-2 family expression, resulted in an increased sensitivity to menadione-induced apoptotic cell death. The observed ubiquitous increase of gelsolin in the senescent states of cells and tissues, and the increased sensitivity to apoptosis-induction by gelsolin down-regulation, suggests that gelsolin would be partly responsible for age-related apoptosis resistance. (C) 2003 Elsevier Inc. All rights reserved.
C1 Seoul Natl Univ, Coll Med, Aging & Apoptosis Res Ctr, Dept Biochem & Mol Biol, Seoul, South Korea.
C3 Seoul National University (SNU)
RP Park, SC (corresponding author), Seoul Natl Univ, Coll Med, Aging & Apoptosis Res Ctr, Dept Biochem & Mol Biol, Seoul, South Korea.
EM scpark@snu.ac.kr
OI Jang, Ik Soon/0000-0003-2092-6372
CR Asch HL, 1996, CANCER RES, V56, P4841
   Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362
   Azuma T, 2000, J BIOL CHEM, V275, P3761, DOI 10.1074/jbc.275.6.3761
   BETTGER WJ, 1981, P NATL ACAD SCI-BIOL, V78, P5588, DOI 10.1073/pnas.78.9.5588
   Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Darzynkiewicz Z, 2000, METHOD ENZYMOL, V322, P18
   DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Gansauge S, 1997, FEBS LETT, V404, P6, DOI 10.1016/S0014-5793(97)00059-8
   GOLDSTEIN S, 1990, SCIENCE, V249, P1129, DOI 10.1126/science.2204114
   Green D, 1998, TRENDS CELL BIOL, V8, P267, DOI 10.1016/S0962-8924(98)01273-2
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N
   KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659
   Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294
   Koya RC, 2000, J BIOL CHEM, V275, P15343, DOI 10.1074/jbc.275.20.15343
   Kusano H, 2000, ONCOGENE, V19, P4807, DOI 10.1038/sj.onc.1203868
   Kuzumaki N, 1998, MOL B INT U, P121
   Kwiatkowski DJ, 1999, CURR OPIN CELL BIOL, V11, P103, DOI 10.1016/S0955-0674(99)80012-X
   KWIATKOWSKI DJ, 1989, NUCLEIC ACIDS RES, V17, P4425, DOI 10.1093/nar/17.11.4425
   KWIATKOWSKI DJ, 1988, J CELL BIOL, V106, P375, DOI 10.1083/jcb.106.2.375
   KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0
   MCLAUGHLIN PJ, 1993, NATURE, V364, P685, DOI 10.1038/364685a0
   Moon IJ, 2000, J BIOL CHEM, V275, P4647, DOI 10.1074/jbc.275.7.4647
   Nicoletti A, 1996, ANAL BIOCHEM, V236, P229, DOI 10.1006/abio.1996.0161
   Ohtsu M, 1997, EMBO J, V16, P4650, DOI 10.1093/emboj/16.15.4650
   PETERSON C, 1986, P NATL ACAD SCI USA, V83, P7999, DOI 10.1073/pnas.83.20.7999
   QISO H, 1999, J BIOL CHEM, V274, P33179
   Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6
   Sasaki M, 2001, MECH AGEING DEV, V122, P1695, DOI 10.1016/S0047-6374(01)00281-0
   Shieh DB, 1999, CANCER-AM CANCER SOC, V85, P47, DOI 10.1002/(SICI)1097-0142(19990101)85:1<47::AID-CNCR7>3.0.CO;2-L
   Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217
   Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5
   WANG E, 1995, CANCER RES, V55, P2284
   Wolf BB, 1999, BLOOD, V94, P1683, DOI 10.1182/blood.V94.5.1683.417k37_1683_1692
   YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0
   Zhang YP, 2002, MECH AGEING DEV, V123, P245, DOI 10.1016/S0047-6374(01)00349-9
NR 39
TC 25
Z9 31
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD DEC 26
PY 2003
VL 312
IS 4
BP 1335
EP 1341
DI 10.1016/j.bbrc.2003.11.061
PG 7
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA 753VW
UT WOS:000187252300070
PM 14652020
DA 2024-02-19
ER

PT J
AU Dudas, J
   Saile, B
   El-Armouche, H
   Aprigliano, I
   Ramadori, G
AF Dudas, J
   Saile, B
   El-Armouche, H
   Aprigliano, I
   Ramadori, G
TI Endoreplication and polyploidy in primary culture of rat hepatic
   stellate cells
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE HSC; endoreplication; myofibroblast; pRb; cyclin D-1; rat (Wistar)
ID FAT-STORING CELLS; TUMOR-NECROSIS-FACTOR; LIVER MYOFIBROBLASTS;
   TISSUE-REPAIR; REPLICATIVE SENESCENCE; ENDOTHELIAL-CELLS; TNF-ALPHA; ITO
   CELLS; IN-VITRO; EXPRESSION
AB Hepatic stellate cells (HSCs), the pericytes of hepatic sinusoids, and liver myofibroblasts (rMFs), cells located in the portal field and around the pericentral area, are the principal fibrogenic cell types of the liver. In cases of liver damage HSCs undergo 'activation,' i.e., they acquire a myofibroblast-like appearance and synthesize huge amounts of extracellular matrix proteins (ECMs). Their proliferation ability, however, is a matter of debate. In fact, during culture the number of rat HSCs decreases, while DNA synthesis activity and DNA content per cell increase (4+/-0.6 times). Together with the decrease in cell number (60+/-19% at day 6 of primary culture compared to day 3), cell volume increases and many HSCs become multinuclear. On the other hand, in cultures of rMFs, cell number increases along with DNA synthesis, and these cells do not become multinuclear. 'Activated' HSCs produce higher levels of cyclin D-1 and E-1 transcripts than rMFs, which correlates with their increased levels of phosphorylated retinoblastoma (Rb) protein. In activated HSCs DNA synthesis seems to be associated with polyploidy and increase in cell volume, while DNA synthesis is followed by mitosis in rMFs.
C1 Univ Gottingen, Dept Internal Med, Sect Gastroenterol & Endocrinol, D-37075 Gottingen, Germany.
C3 University of Gottingen
RP Ramadori, G (corresponding author), Univ Gottingen, Dept Internal Med, Sect Gastroenterol & Endocrinol, Robert Koch Str 40, D-37075 Gottingen, Germany.
EM gramado@med.uni-goettingen.de
RI Dudás, József/AAY-9352-2020
OI Dudás, József/0000-0002-9877-3399
CR BISSELL DM, 1992, GASTROENTEROLOGY, V102, P1803, DOI 10.1016/0016-5085(92)91747-R
   CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005
   CROWE WE, 1995, NEUROSCIENCE, V69, P283, DOI 10.1016/0306-4522(95)00219-9
   DARZYNKIEWICZ Z, 1984, CANCER RES, V44, P83
   DELEEUW AM, 1984, HEPATOLOGY, V4, P392
   DELEEUW AM, 1983, HEPATOLOGY, V3, P497
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8
   Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788
   Gandarillas A, 2000, ONCOGENE, V19, P3278, DOI 10.1038/sj.onc.1203630
   Garcia P, 1996, ONCOGENE, V13, P695
   Gupta S, 2000, SEMIN CANCER BIOL, V10, P161
   Hanselmann RG, 2001, MED HYPOTHESES, V56, P58, DOI 10.1054/mehy.2000.1111
   Hautekeete ML, 1997, VIRCHOWS ARCH, V430, P195, DOI 10.1007/BF01324802
   Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557
   JACK EM, 1990, HEPATOLOGY, V11, P286, DOI 10.1002/hep.1840110220
   Jiang Z, 2000, DEV BIOL, V227, P28, DOI 10.1006/dbio.2000.9892
   Knittel T, 1999, AM J PATHOL, V154, P153, DOI 10.1016/S0002-9440(10)65262-5
   Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5
   Knittel T, 1999, HISTOCHEM CELL BIOL, V112, P387, DOI 10.1007/s004180050421
   KNOOK DL, 1977, EXP CELL RES, V109, P317, DOI 10.1016/0014-4827(77)90011-8
   Kobold D, 2002, J HEPATOL, V36, P607, DOI 10.1016/S0168-8278(02)00050-8
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Larkins BA, 2001, J EXP BOT, V52, P183, DOI 10.1093/jexbot/52.355.183
   Li X, 1995, CELL PROLIFERAT, V28, P571, DOI 10.1111/j.1365-2184.1995.tb00045.x
   MAK KM, 1988, HEPATOLOGY, V8, P1027, DOI 10.1002/hep.1840080508
   MENDOZAFIGUEROA T, 1988, BIOL CELL, V64, P29, DOI 10.1016/0248-4900(88)90090-1
   MURAKAMI K, 1995, LAB INVEST, V72, P731
   NAKANO M, 1982, AM J PATHOL, V106, P145
   Neubauer K, 1996, J HEPATOL, V24, P719, DOI 10.1016/S0168-8278(96)80269-8
   Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629
   Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1
   Paunesku T, 2001, INT J RADIAT BIOL, V77, P1007, DOI 10.1080/09553000110069335
   Ramadori G, 2002, LIVER, V22, P283, DOI 10.1034/j.1600-0676.2002.01726.x
   RAMADORI G, 1990, VIRCHOWS ARCH B, V59, P349, DOI 10.1007/BF02899424
   Saile B, 1999, HEPATOLOGY, V30, P196, DOI 10.1002/hep.510300144
   Saile B, 1997, AM J PATHOL, V151, P1265
   Saile B, 2002, AM J PHYSIOL-GASTR L, V283, pG435, DOI 10.1152/ajpgi.00441.2001
   Saile B, 2001, EUR J CELL BIOL, V80, P554, DOI 10.1078/0171-9335-00182
   Sasaki T, 1996, J CELL SCI, V109, P2895
   Schnabl B, 2003, HEPATOLOGY, V37, P653, DOI 10.1053/jhep.2003.50097
   SCOTT FW, 1978, BIOCHEM J, V170, P545, DOI 10.1042/bj1700545
   SENOO H, 1994, BIOCHEM BIOPH RES CO, V200, P999, DOI 10.1006/bbrc.1994.1549
   Sun S, 2001, HAEMATOLOGICA, V86, P17
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Wagner M, 2001, EXP GERONTOL, V36, P1327, DOI 10.1016/S0531-5565(01)00105-X
NR 47
TC 16
Z9 19
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD SEP
PY 2003
VL 313
IS 3
BP 301
EP 311
DI 10.1007/s00441-003-0768-3
PG 11
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 723XN
UT WOS:000185457000006
PM 12898209
DA 2024-02-19
ER

PT J
AU RIKANS, LE
   KLING, OR
AF RIKANS, LE
   KLING, OR
TI EFFECTS OF AGING AND TESTOSTERONE ADMINISTRATION ON LIVER
   ALCOHOL-DEHYDROGENASE ACTIVITY IN MALE FISCHER-344 RATS
SO ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article
C1 UNIV OKLAHOMA,HLTH SCI CTR,COLL MED,DEPT OBSTET & GYNECOL,OKLAHOMA CITY,OK 73190.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA,HLTH SCI CTR,COLL MED,DEPT PHARMACOL,POB 26901,OKLAHOMA CITY,OK 73190, USA.
FU NIA NIH HHS [AG04984] Funding Source: Medline
CR ABEL EL, 1979, PHYSIOL PSYCHOL, V7, P391
   BETHEA CL, 1979, J GERONTOL, V34, P21, DOI 10.1093/geronj/34.1.21
   CECCHINI DJ, 1983, ENDOCRINOLOGY, V112, P1122, DOI 10.1210/endo-112-3-1122
   CICERO TJ, 1980, J PHARMACOL EXP THER, V215, P317
   CRABB DW, 1983, ARCH BIOCHEM BIOPHYS, V224, P299, DOI 10.1016/0003-9861(83)90213-8
   CRABB DW, 1985, BIOCHEM BIOPH RES CO, V128, P12, DOI 10.1016/0006-291X(85)91637-7
   CRABB DW, 1986, BIOCHEM PHARMACOL, V35, P1527, DOI 10.1016/0006-2952(86)90120-6
   CRABB DW, 1985, LIFE SCI, V37, P2381, DOI 10.1016/0024-3205(85)90105-5
   ERICKSON CK, 1984, ALCOHOL CLIN EXP RES, V8, P491, DOI 10.1111/j.1530-0277.1984.tb05710.x
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   GHANADIAN R, 1975, STEROIDS, V25, P753, DOI 10.1016/0039-128X(75)90039-2
   GREENSTEIN BD, 1979, J ENDOCRINOL, V81, P75, DOI 10.1677/joe.0.0810075
   HAHN HKJ, 1983, ALCOHOL CLIN EXP RES, V7, P299, DOI 10.1111/j.1530-0277.1983.tb05464.x
   HAJI M, 1981, BRAIN RES, V204, P373, DOI 10.1016/0006-8993(81)90596-5
   HUANG HH, 1978, ENDOCRINOLOGY, V103, P1835
   ISRAEL Y, 1979, DRUG ALCOHOL DEPEN, V4, P109
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   MARDH G, 1986, P NATL ACAD SCI USA, V83, P2836
   MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9
   MARQUETTE BW, 1984, EXP AGING RES, V10, P7, DOI 10.1080/03610738408258534
   MEZEY E, 1983, BIOCHEM PHARMACOL, V32, P1132, DOI 10.1016/0006-2952(83)90640-8
   MEZEY E, 1986, BIOCHEM PHARMACOL, V35, P335, DOI 10.1016/0006-2952(86)90535-6
   MEZEY E, 1980, BIOCHEM PHARMACOL, V29, P3175, DOI 10.1016/0006-2952(80)90582-1
   MEZEY E, 1980, GASTROENTEROLOGY, V80, P566
   OTT JF, 1985, ALCOHOL CLIN EXP RES, V9, P59, DOI 10.1111/j.1530-0277.1985.tb05051.x
   RACHAMIN G, 1980, BIOCHEM J, V186, P483, DOI 10.1042/bj1860483
   RITZMANN RF, 1980, AGE, V3, P15, DOI 10.1007/BF02435001
   SAKSENA SK, 1979, EXP AGING RES, V5, P179, DOI 10.1080/03610737908257197
   SIMPKINS JW, 1981, EXP AGING RES, V7, P25, DOI 10.1080/03610738108259783
   SONNTAG WE, 1982, NEUROENDOCRINOLOGY, V34, P163, DOI 10.1159/000123295
   SONNTAG WE, 1980, ENDOCRINOLOGY, V107, P1875, DOI 10.1210/endo-107-6-1875
   TESCHKE R, 1982, J ENDOCRINOL INVEST, V5, P243, DOI 10.1007/BF03348330
   WIBERG GS, 1970, TOXICOL APPL PHARM, V16, P718, DOI 10.1016/0041-008X(70)90077-3
   YORK JL, 1982, DEV PHARMACOL THERAP, V4, P106, DOI 10.1159/000457395
   YORK JL, 1983, PHARMACOL BIOCHEM BE, V19, P687
NR 35
TC 15
Z9 15
U1 0
U2 0
PU WILLIAMS & WILKINS
PI BALTIMORE
PA 351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436
SN 0145-6008
J9 ALCOHOL CLIN EXP RES
JI Alcoholism (NY)
PD DEC
PY 1987
VL 11
IS 6
BP 562
EP 566
DI 10.1111/j.1530-0277.1987.tb00175.x
PG 5
WC Substance Abuse
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Substance Abuse
GA L2999
UT WOS:A1987L299900014
PM 3324810
DA 2024-02-19
ER

PT J
AU Yin, C
   Lin, Y
   Zhang, X
   Chen, YX
   Zeng, X
   Yue, HY
   Hou, JL
   Deng, X
   Zhang, JP
   Han, ZG
   Xie, WF
AF Yin, Chuan
   Lin, Yong
   Zhang, Xin
   Chen, Yue-Xiang
   Zeng, Xin
   Yue, Hai-Yan
   Hou, Jun-Liang
   Deng, Xing
   Zhang, Jun-Ping
   Han, Ze-Guang
   Xie, Wei-Fen
TI Differentiation Therapy of Hepatocellular Carcinoma in Mice with
   Recombinant Adenovirus Carrying Hepatocyte Nuclear Factor-4α Gene
SO HEPATOLOGY
LA English
DT Article
ID ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; CELL BIOLOGY;
   STEM-CELLS; EXPRESSION; CANCER; MYC; SENESCENCE
AB Previous studies have shown that hepatocyte nuclear factor-4 alpha (HNF4 alpha) is a central regulator of differentiated hepatocyte phenotype and forced expression of HNF4 alpha could promote reversion of tumors toward a less invasive phenotype. However, the effect of HNF4 alpha on cancer stem cells (CSCs) and the treatment of hepatocetlular carcinoma (HCC) with HNF4 alpha have not been reported. In this study, an adenovirus-mediated gene delivery system, which could efficiently transfer and express HNF4 alpha, was generated to determine its effect on hepatoma cells (Hep3B and HepG2) in vitro and investigate the anti-tumor effect of HN174 alpha in mice. Our results demonstrated that forced re-expression of HNF4 alpha induced the differentiation of hepatoma cells into hepatocytes, dramatically decreased "stemness" gene expression and the percentage of CD133(+) and CD90(+) cells, which are considered as cancer stem cells in HCC. Meanwhile, HNF4 alpha reduced cell viability through inducing apparent apoptosis in Hep3B, while it induced cell cycle arrest and cellular senescence in HepG2. Moreover, infection of hepatoma cells by HNF4 alpha abolished their tumorigenesis in mice. Most interestingly, systemic administration of adenovirus carrying the HNF4 alpha gene protected mice from liver metastatic tumor formation, and intratumoral injection of HNF4 alpha also displayed significant antitumor effects on transplanted tumor models. Conclusion. The striking suppression effect of HNF4 alpha on tumorigenesis and tumor development is attained by inducing the differentiation of hepatoma cells-especially CSCs-into mature hepatocytes, suggesting that differentiation therapy with HNF4 alpha may be an effective treatment for HCC patients. Our study also implies that differentiation therapy may present as one of the best strategies for cancer treatment through the induction of cell differentiation by key transcription factors. (HEPATOLOGY 2008,48:1528-1539.)
C1 [Yin, Chuan; Lin, Yong; Chen, Yue-Xiang; Zeng, Xin; Yue, Hai-Yan; Hou, Jun-Liang; Deng, Xing; Xie, Wei-Fen] Second Mil Med Univ, Changzheng Hosp, Dept Gastroenterol, Shanghai 200003, Peoples R China.
   [Zhang, Jun-Ping] Second Mil Med Univ, Sch Pharm, Shanghai 200003, Peoples R China.
   [Zhang, Xin; Han, Ze-Guang] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China.
C3 Naval Medical University; Naval Medical University
RP Xie, WF (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Gastroenterol, Shanghai 200003, Peoples R China.
EM weifenxie@medmail.com.cn
OI Han, Ze-Guang/0000-0002-1018-1752
FU National Natural Science Foundation of China [30400205, 30570838]
FX Supported by grants from the National Natural Science Foundation of
   China (No. 30400205 and No. 30570838).
CR Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   CASTAIGNE S, 1990, BLOOD, V76, P1704
   Chiba H, 2005, EXP CELL RES, V302, P11, DOI 10.1016/j.yexcr.2004.08.014
   Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025
   Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567
   Hwang-Verslues WW, 2008, MOL ENDOCRINOL, V22, P78, DOI 10.1210/me.2007-0298
   Ishiyama T, 2003, CANCER SCI, V94, P757, DOI 10.1111/j.1349-7006.2003.tb01515.x
   Jordan CT, 2004, CURR OPIN CELL BIOL, V16, P708, DOI 10.1016/j.ceb.2004.09.002
   Kawamata H, 2006, CURR PHARM DESIGN, V12, P379, DOI 10.2174/138161206775201947
   Lazarevich N, 2004, HEPATOLOGY, V39, P1038, DOI 10.1002/hep.20155
   Li JX, 2000, GENE DEV, V14, P464
   Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025
   McGlynn KA, 2006, CANCER EPIDEM BIOMAR, V15, P1198, DOI 10.1158/1055-9965.EPI-05-0811
   Naiki T, 2002, J BIOL CHEM, V277, P14011, DOI 10.1074/jbc.M105403200
   Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769
   Ohno R, 2003, LEUKEMIA, V17, P1454, DOI 10.1038/sj.leu.2403031
   Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232
   Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175
   Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007
   Sell S, 2006, CURR GENE THER, V6, P579, DOI 10.2174/156652306778520674
   Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043
   Späth GF, 1998, J CELL BIOL, V140, P935, DOI 10.1083/jcb.140.4.935
   Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284
   WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002
   Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603
   Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013
   Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
NR 32
TC 162
Z9 188
U1 1
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD NOV
PY 2008
VL 48
IS 5
BP 1528
EP 1539
DI 10.1002/hep.22510
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 368BP
UT WOS:000260596600022
PM 18925631
OA Bronze
DA 2024-02-19
ER

PT J
AU DAX, EM
   PARTILLA, JS
   PINEYRO, MA
   GREGERMAN, RI
AF DAX, EM
   PARTILLA, JS
   PINEYRO, MA
   GREGERMAN, RI
TI BETA-ADRENERGIC RECEPTORS, GLUCAGON RECEPTORS, AND THEIR RELATIONSHIP TO
   ADENYLATE-CYCLASE IN RAT-LIVER DURING AGING
SO ENDOCRINOLOGY
LA English
DT Article
C1 NIA,FRANCIS SCOTT KEY MED CTR,GERONTOL RES CTR,ENDOCRINOL SECT,BALTIMORE,MD 21224.
C3 National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
CR BAROVSKY K, 1980, J CYCLIC NUCL PROT, V6, P297
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CERIONE RA, 1985, NATURE, V318, P293, DOI 10.1038/318293a0
   CONN PM, 1980, ENDOCRINOLOGY, V106, P1549
   DAX EM, 1986, J RECEPTOR RES, V6, P165, DOI 10.3109/10799898609073931
   DAX EM, 1981, J RECEPTOR RES, V2, P267, DOI 10.3109/10799898109038804
   HEGNER HW, 1980, MECH AGEING DEV, V14, P427
   HERSHKOWITZ M, 1982, PROG BRAIN RES, V56, P419
   KALISH MI, 1977, BIOCHIM BIOPHYS ACTA, V483, P452, DOI 10.1016/0005-2744(77)90073-0
   KATZ MS, 1978, J CYCLIC NUCL PROT, V4, P389
   KATZ MS, 1978, BIOCHIM BIOPHYS ACTA, V540, P205, DOI 10.1016/0304-4165(78)90133-2
   KATZ MS, 1983, 65TH ANN M END SOC S, P250
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1
   NARAYANAN N, 1982, MECH AGEING DEV, V19, P127, DOI 10.1016/0047-6374(82)90004-5
   NEVILLE DM, 1968, BIOCHIM BIOPHYS ACTA, V154, P540, DOI 10.1016/0005-2795(68)90014-7
   NOKUBO M, 1985, J GERONTOL, V40, P409, DOI 10.1093/geronj/40.4.409
   PITHA J, 1982, P NATL ACAD SCI-BIOL, V79, P4424, DOI 10.1073/pnas.79.14.4424
   REFNES M, 1983, FEBS LETT, V164, P291
   ROJAS FJ, 1983, ENDOCRINOLOGY, V113, P711, DOI 10.1210/endo-113-2-711
   ROTH GS, 1982, MECH AGEING DEV, V20, P175, DOI 10.1016/0047-6374(82)90086-0
   ROTH GS, 1981, J GERONTOL, V36, P391, DOI 10.1093/geronj/36.4.391
   SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X
   SCARPACE PJ, 1983, J GERONTOL, V38, P143, DOI 10.1093/geronj/38.2.143
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x
   SEAMON K, 1981, J BIOL CHEM, V256, P9799
   SZAMEL M, 1981, J BIOL CHEM, V256, P1618
NR 27
TC 41
Z9 41
U1 0
U2 0
PU ENDOCRINE SOC
PI BETHESDA
PA 4350 EAST WEST HIGHWAY SUITE 500, BETHESDA, MD 20814-4110
SN 0013-7227
J9 ENDOCRINOLOGY
JI Endocrinology
PD APR
PY 1987
VL 120
IS 4
BP 1534
EP 1541
DI 10.1210/endo-120-4-1534
PG 8
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA G5710
UT WOS:A1987G571000042
PM 3030705
DA 2024-02-19
ER

PT J
AU Imai, A
   Fujimoto, E
   Tamura, K
   Utsuyama, M
   Sato, K
AF Imai, Atsuko
   Fujimoto, Eka
   Tamura, Kaho
   Utsuyama, Masanori
   Sato, Kazuto
TI A maternal high-fat diet may accelerate adipo-immunologic aging in
   offspring
SO LIFE SCIENCES
LA English
DT Article
DE Maternal high-fat diet; Offspring; Adipose tissue; Inflammation;
   Immunologic aging; Non-alcoholic fatty liver disease
ID KILLER T-CELLS; OBESITY; ADIPONECTIN; EXPRESSION; TISSUE; LIPOTOXICITY;
   DYSFUNCTION; SENESCENCE; ALGORITHM; MICE
AB Aim: Maternal obesity and improper nutrition predispose offspring to chronic metabolic diseases. Although the frequency of these diseases increases with aging, the effect of a maternal high-fat diet on aged offspring remains elusive.
   Main methods: C57BL/6J female mice were fed a high-fat (HF) diet or a control (CON) diet and then mated. All offspring remained with their birth dam until weaning at 3 weeks. After weaning, the offspring from the HF and CON diet-fed dams were given either the HF diet or CON diet, which resulted in four groups: CON/CON, CON/HF, HF/CON, and HF/HF. All mice were immunized with ovalbumin and then sacrificed at 70 weeks.
   Key findings: The body weights in offspring from dam exposed to a HF diet were significantly higher than those in offspring from dam fed a CON diet in the early stage of life but then became lower in the later stage of life. The serum adiponectin levels were lower in offspring from dam exposed to a HF diet and were correlated with adiposity measured by visceral and subcutaneous fat mass. Non-alcoholic fatty liver disease was much more severe in the livers of offspring from the maternal HF groups. In particular, lobular inflammation and fibrosis were prominent in the HF/HF group. Regarding immunological parameters, senescence-associated T cells were increased, and natural killer T cells were decreased by the effect of both maternal and offspring HF diet.
   Significance: We have demonstrated that a maternal high-fat diet may accelerate the adipo-immunologic aging process.
C1 [Imai, Atsuko; Fujimoto, Eka; Tamura, Kaho; Utsuyama, Masanori; Sato, Kazuto] Japan Womens Univ, Dept Food & Nutr, Div Clin Nutr, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.
C3 Japan Womens University
RP Sato, K (corresponding author), Japan Womens Univ, Dept Food & Nutr, Div Clin Nutr, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.
EM sato-k@fc.jwu.ac.jp
FU Japan Society for the Promotion of Science KAKENHI [16K16290];
   Grants-in-Aid for Scientific Research [16K16290] Funding Source: KAKEN
FX The authors would like to thank Oide A, Tadenuma R and Miyazawa R for
   technical assistance and support. This study was supported in part by a
   grant from the Japan Society for the Promotion of Science KAKENHI
   (16K16290; 2016-2018).
CR Adler M, 2011, WORLD J GASTROENTERO, V17, P1725, DOI 10.3748/wjg.v17.i13.1725
   Bedossa P, 2014, HEPATOLOGY, V60, P565, DOI 10.1002/hep.27173
   Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889
   Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205
   Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008
   Gulcelik NE, 2013, MINERVA ENDOCRINOL, V38, P203
   Hori H, 2014, J PERINAT MED, V42, P83, DOI 10.1515/jpm-2013-0091
   Imai A, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00327
   Kamimae-Lanning AN, 2015, MOL METAB, V4, P25, DOI 10.1016/j.molmet.2014.11.001
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292
   Li M, 2011, EXP DIABETES RES, DOI [10.1155/2011/592408, 10.4061/2011/179819]
   Liang X., 2016, SCI REP, V6
   Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033
   Mauro C, 2017, CELL METAB, V25, P593, DOI 10.1016/j.cmet.2017.01.008
   McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661
   Miller KN, 2017, AGING CELL, V16, P497, DOI 10.1111/acel.12575
   Miller M, 2009, J IMMUNOL, V182, P684, DOI 10.4049/jimmunol.182.1.684
   Odaka Y, 2010, OBESITY, V18, P1688, DOI 10.1038/oby.2009.513
   Pararasa C, 2015, BIOGERONTOLOGY, V16, P235, DOI 10.1007/s10522-014-9536-x
   Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106
   Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Tajiri K, 2009, EUR J GASTROEN HEPAT, V21, P673, DOI 10.1097/MEG.0b013e32831bc3d6
   Takahashi T, 2006, INT HEART J, V47, P107, DOI 10.1536/ihj.47.107
   Umekawa T, 2015, J NUTR BIOCHEM, V26, P259, DOI 10.1016/j.jnutbio.2014.10.012
   Wakabayashi A, 2006, J NUTR HEALTH AGING, V10, P183
   Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006
   Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149
   Yoda-Murakami M, 2001, BIOCHEM BIOPH RES CO, V285, P372, DOI 10.1006/bbrc.2001.5134
NR 30
TC 5
Z9 6
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD FEB 15
PY 2019
VL 219
BP 100
EP 108
DI 10.1016/j.lfs.2019.01.008
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA HK7PY
UT WOS:000458182700009
PM 30630004
DA 2024-02-19
ER

PT J
AU NANJEE, MN
   MILLER, NE
AF NANJEE, MN
   MILLER, NE
TI SEX DIFFERENCE IN THE SATURABLE BINDING OF LOW-DENSITY LIPOPROTEIN BY
   LIVER MEMBRANES IN AGING RATS
SO BIOCHIMICA ET BIOPHYSICA ACTA
LA English
DT Article
C1 UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,DEPT CHEM PATHOL & METAB DISORDERS,LONDON,ENGLAND.
C3 University of London; King's College London
RI Miller, Norman E/P-6032-2017
OI Miller, Norman E/0000-0001-7087-3390
CR ABBOTT RD, 1983, ARTERIOSCLEROSIS, V3, P260, DOI 10.1161/01.ATV.3.3.260
   BARR D P, 1955, J Chronic Dis, V1, P63, DOI 10.1016/0021-9681(55)90022-9
   Brown M S, 1979, Recent Prog Horm Res, V35, P215
   CHAPMAN MJ, 1986, METHOD ENZYMOL, V128, P70
   COOPER AD, 1987, J LIPID RES, V28, P59
   EISENBERG S, 1973, BIOCHIM BIOPHYS ACTA, V326, P361, DOI 10.1016/0005-2760(73)90138-0
   ERIKSSON M, 1985, EUR J CLIN INVEST, V15, P360
   GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341
   HARKES L, 1982, BIOCHIM BIOPHYS ACTA, V712, P677, DOI 10.1016/0005-2760(82)90297-1
   HARKES L, 1984, BIOCHIM BIOPHYS ACTA, V794, P340, DOI 10.1016/0005-2760(84)90165-6
   HAYASHI K, 1986, BIOCHIM BIOPHYS ACTA, V879, P140, DOI 10.1016/0005-2760(86)90096-2
   HEISS G, 1980, CIRCULATION, V61, P302, DOI 10.1161/01.CIR.61.2.302
   HOEG JM, 1986, BIOCHIM BIOPHYS ACTA, V876, P13, DOI 10.1016/0005-2760(86)90312-7
   INNERARITY TL, 1978, BIOCHEMISTRY-US, V17, P1440, DOI 10.1021/bi00601a013
   KEIGHTLEY DD, 1983, J STEROID BIOCHEM, V19, P1407, DOI 10.1016/0022-4731(83)91115-9
   KOELZ HR, 1982, J BIOL CHEM, V257, P8061
   KOVANEN PT, 1979, J BIOL CHEM, V254, P12367
   LANGER T, 1972, J CLIN INVEST, V51, P1528, DOI 10.1172/JCI106949
   MA PTS, 1986, P NATL ACAD SCI USA, V83, P792, DOI 10.1073/pnas.83.3.792
   MAHLEY RW, 1981, J CLIN INVEST, V68, P1197, DOI 10.1172/JCI110365
   Markwell M A, 1981, Methods Enzymol, V72, P296
   MILLER NE, 1984, LANCET, V1, P263
   Mills GL, 1984, GUIDEBOOK LIPOPROTEI, P18
   PITTMAN RC, 1979, P NATL ACAD SCI USA, V76, P5345, DOI 10.1073/pnas.76.10.5345
   PITTMAN RC, 1983, BIOCHEM J, V212, P791, DOI 10.1042/bj2120791
   ROACH PD, 1985, J LIPID RES, V26, P713
   RUDLING MJ, 1985, BIOCHIM BIOPHYS ACTA, V833, P359, DOI 10.1016/0005-2760(85)90091-8
   SALTER AM, 1986, BIOCHEM J, V240, P549, DOI 10.1042/bj2400549
   SEMENKOVICH CF, 1987, BIOCHEMISTRY-US, V26, P4987, DOI 10.1021/bi00390a016
   TAMAI T, 1983, J LIPID RES, V24, P1568
   VANBERKEL TJC, 1986, RECEPTOR MEDIATED UP, P33
   VANTHOOFT FM, 1985, FEBS LETT, V183, P138, DOI 10.1016/0014-5793(85)80971-6
   WEINSTEIN I, 1986, BIOCHIM BIOPHYS ACTA, V876, P450, DOI 10.1016/0005-2760(86)90031-7
   WINDLER EET, 1980, J BIOL CHEM, V255, P464
NR 34
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-3002
J9 BIOCHIM BIOPHYS ACTA
PD APR 15
PY 1988
VL 959
IS 3
BP 378
EP 385
DI 10.1016/0005-2760(88)90212-3
PG 8
WC Biochemistry & Molecular Biology; Biophysics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics
GA M9901
UT WOS:A1988M990100022
PM 3355857
DA 2024-02-19
ER

PT J
AU MAKRIDES, SC
   GOLDTHWAITE, J
AF MAKRIDES, SC
   GOLDTHWAITE, J
TI THE CONTENT AND SIZE DISTRIBUTION OF MEMBRANE-BOUND AND FREE
   POLYRIBOSOMES IN MOUSE-LIVER DURING AGING
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 BOSTON COLL,DEPT BIOL,CHESTNUT HILL,MA 02167.
C3 Boston College
CR BARROWS CH, 1981, CRC HDB BIOCH AGING, P115
   BECKER H, 1971, J CELL PHYSIOL, V77, P43, DOI 10.1002/jcp.1040770106
   BLAZEJOWSKI CA, 1983, MECH AGEING DEV, V21, P345, DOI 10.1016/0047-6374(83)90051-9
   BLOBEL G, 1967, J MOL BIOL, V26, P279, DOI 10.1016/0022-2836(67)90297-5
   BLOBEL G, 1966, P NATL ACAD SCI USA, V55, P1283, DOI 10.1073/pnas.55.5.1283
   CHANG WC, 1981, J GERONTOL, V36, P386, DOI 10.1093/geronj/36.4.386
   CHATTERJEE B, 1981, J BIOL CHEM, V256, P5939
   CLAESRECKINGER N, 1982, EXP GERONTOL, V17, P281, DOI 10.1016/0531-5565(82)90017-1
   COMOLLI R, 1983, CELL BIOL INT REP, V7, P161, DOI 10.1016/0309-1651(83)90029-2
   COMOLLI R, 1981, CANCER BIOCHEM BIOPH, V5, P239
   COOK JR, 1981, MECH AGEING DEV, V17, P41, DOI 10.1016/0047-6374(81)90127-5
   DARZYNKIEWICZ Z, 1979, J CELL PHYSIOL, V100, P425, DOI 10.1002/jcp.1041000306
   FISHMAN B, 1969, P NATL ACAD SCI USA, V64, P677, DOI 10.1073/pnas.64.2.677
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   ISBERNER P, 1983, J CELL SCI, V59, P121
   JUNGERMANN K, 1978, TRENDS BIOCHEM SCI, V3, P198, DOI 10.1016/S0968-0004(78)91764-4
   KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464
   KURTZ DI, 1978, EXP GERONTOL, V13, P397, DOI 10.1016/0531-5565(78)90050-5
   LAUGHREA M, 1982, EXP GERONTOL, V17, P305, DOI 10.1016/0531-5565(82)90020-1
   LAYMAN DK, 1976, ARCH BIOCHEM BIOPHYS, V173, P246, DOI 10.1016/0003-9861(76)90256-3
   LEWIN B, 1980, GENE EXPRESSION, V2
   Lowe D, 1970, FEBS Lett, V6, P114, DOI 10.1016/0014-5793(70)80015-1
   MAINWARING WI, 1968, BIOCHEM J, V110, P79, DOI 10.1042/bj1100079
   MAINWARING WI, 1969, BIOCHEM J, V113, P869, DOI 10.1042/bj1130869
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MARCANTONIO EE, 1982, EUR J BIOCHEM, V124, P217, DOI 10.1111/j.1432-1033.1982.tb05928.x
   MEEDEL TH, 1978, J CELL PHYSIOL, V94, P229, DOI 10.1002/jcp.1040940212
   MEYER DI, 1982, TRENDS BIOCHEM SCI, V7, P320, DOI 10.1016/0968-0004(82)90262-6
   MORI N, 1979, MECH AGEING DEV, V10, P379, DOI 10.1016/0047-6374(79)90020-4
   MORTON B, 1974, ANAL BIOCHEM, V58, P642, DOI 10.1016/0003-2697(74)90235-8
   MOUDGIL PG, 1979, GERONTOLOGY, V25, P322, DOI 10.1159/000212360
   Myers D D, 1978, Birth Defects Orig Artic Ser, V14, P41
   Preobrazhensky A A, 1978, Prog Nucleic Acid Res Mol Biol, V21, P1, DOI 10.1016/S0079-6603(08)60265-2
   RAMSEY JC, 1976, BIOCHEMISTRY-US, V15, P1704, DOI 10.1021/bi00653a018
   RAMSEY JC, 1977, J NEUROCHEM, V28, P517, DOI 10.1111/j.1471-4159.1977.tb10422.x
   RAMSEY JC, 1979, ANAL BIOCHEM, V92, P305, DOI 10.1016/0003-2697(79)90663-8
   RAMSEY JC, 1977, BIOCHEM J, V168, P1
   REIS RJS, 1981, MECH AGEING DEV, V17, P311, DOI 10.1016/0047-6374(81)90049-X
   Richardson A, 1981, CRC HDB BIOCH AGING, P79
   Rosner B, 1982, Fundamentals of Biostatistics
   ROTH JS, 1967, METHOD CANCER RES, V3, P153
   SARGENT JR, 1965, BIOCHEM J, V96, P134, DOI 10.1042/bj0960134
   SCORNIK OA, 1973, ANAL BIOCHEM, V52, P56, DOI 10.1016/0003-2697(73)90330-8
   SCORNIK OA, 1974, BIOCHIM BIOPHYS ACTA, V374, P76, DOI 10.1016/0005-2787(74)90200-7
   SMITHKIELLAND A, 1982, J CELL PHYSIOL, V110, P262, DOI 10.1002/jcp.1041100307
   STANNERS CP, 1979, J CELL PHYSIOL, V100, P127, DOI 10.1002/jcp.1041000113
   SYMMONS RA, 1972, J NUTR, V102, P639, DOI 10.1093/jn/102.5.639
   TUSHINSKI RJ, 1982, J CELL PHYSIOL, V112, P128, DOI 10.1002/jcp.1041120119
   VENKATESAN N, 1972, BIOCHIM BIOPHYS ACTA, V287, P526, DOI 10.1016/0005-2787(72)90298-5
   WEIBEL ER, 1969, J CELL BIOL, V42, P68, DOI 10.1083/jcb.42.1.68
   WILSON SH, 1967, BIOCHEM J, V103, P567, DOI 10.1042/bj1030567
   YENOFSKY R, 1982, P NATL ACAD SCI-BIOL, V79, P5876, DOI 10.1073/pnas.79.19.5876
   ZAHRINGER J, 1979, FEBS LETT, V108, P317, DOI 10.1016/0014-5793(79)80554-2
NR 53
TC 11
Z9 11
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PY 1984
VL 27
IS 1
BP 111
EP 134
DI 10.1016/0047-6374(84)90088-5
PG 24
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TK641
UT WOS:A1984TK64100011
PM 6492884
DA 2024-02-19
ER

PT J
AU Sambeat, A
   Ratajczak, J
   Joffraud, M
   Sanchez-Garcia, JL
   Giner, MP
   Valsesia, A
   Giroud-Gerbetant, J
   Valera-Alberni, M
   Cercillieux, A
   Boutant, M
   Kulkarni, SS
   Moco, S
   Canto, C
AF Sambeat, Audrey
   Ratajczak, Joanna
   Joffraud, Magali
   Sanchez-Garcia, Jose L.
   Giner, Maria P.
   Valsesia, Armand
   Giroud-Gerbetant, Judith
   Valera-Alberni, Miriam
   Cercillieux, Angelique
   Boutant, Marie
   Kulkarni, Sameer S.
   Moco, Sofia
   Canto, Caries
TI Endogenous nicotinamide riboside metabolism protects against
   diet-induced liver damage
SO NATURE COMMUNICATIONS
LA English
DT Article
ID HEPATIC GLUCONEOGENESIS; LIFE-SPAN; NAD(+); MONONUCLEOTIDE; HOMEOSTASIS;
   DEFICIENCY; ACTIVATION; NUTRIENT; PATHWAY; DISEASE
AB Supplementation with the NAD(+) precursor nicotinamide riboside (NR) ameliorates and prevents a broad array of metabolic and aging disorders in mice. However, little is known about the physiological role of endogenous NR metabolism. We have previously shown that NR kinase 1 (NRK1) is rate-limiting and essential for NR-induced NAD(+) synthesis in hepatic cells. To understand the relevance of hepatic NR metabolism, we generated whole body and liver-specific NRK1 knockout mice. Here, we show that NRK1 deficiency leads to decreased gluconeogenic potential and impaired mitochondrial function. Upon high-fat feeding, NRK1 deficient mice develop glucose intolerance, insulin resistance and hepatosteatosis. Furthermore, they are more susceptible to diet-induced liver DNA damage, due to compromised PARP1 activity. Our results demonstrate that endogenous NR metabolism is critical to sustain hepatic NAD(+) levels and hinder diet-induced metabolic damage, highlighting the relevance of NRK1 as a therapeutic target for metabolic disorders.
C1 [Sambeat, Audrey; Ratajczak, Joanna; Joffraud, Magali; Sanchez-Garcia, Jose L.; Giner, Maria P.; Valsesia, Armand; Giroud-Gerbetant, Judith; Valera-Alberni, Miriam; Cercillieux, Angelique; Boutant, Marie; Kulkarni, Sameer S.; Moco, Sofia; Canto, Caries] EPFL Innovat Pk, Nestle Res, CH-1015 Lausanne, Switzerland.
   [Ratajczak, Joanna; Valera-Alberni, Miriam; Cercillieux, Angelique; Canto, Caries] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.
C3 Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole
   Polytechnique Federale de Lausanne; Swiss Federal Institutes of
   Technology Domain; Ecole Polytechnique Federale de Lausanne
RP Canto, C (corresponding author), EPFL Innovat Pk, Nestle Res, CH-1015 Lausanne, Switzerland.; Canto, C (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.
EM carlos.cantoalvarez@rd.nestle.com
RI Moco, Sofia/AAN-7187-2021; Valsesia, Armand/F-1724-2010; Kulkarni,
   Sameer/HTS-4583-2023; Sambeat, Audrey/O-4489-2016
OI Moco, Sofia/0000-0001-8170-8876; Giroud-Gerbetant,
   Judith/0000-0001-6847-5721; Canto, Carles/0000-0002-5167-7922; Valsesia,
   Armand/0000-0003-0746-9664; Valera-Alberni, Miriam/0000-0002-1144-573X
FU EU Marie Sklodowska-Curie ITN-ChroMe (H2020-MSCA-ITN) [675610]; Marie
   Curie Actions (MSCA) [675610] Funding Source: Marie Curie Actions (MSCA)
FX We thank members of the Canto laboratory for helpful discussions, the
   members of the EPFL animal facility for technical support and the EPFL
   Histology Core Facility. M.V.-A. is supported by the EU Marie
   Sklodowska-Curie ITN-ChroMe (H2020-MSCA-ITN-Project number 675610).
CR Agerholm M, 2018, AM J PHYSIOL-ENDOC M, V314, pE377, DOI 10.1152/ajpendo.00213.2017
   Belenky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019710
   Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Cantó C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022
   Cantó C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023
   Canto Carles, 2015, Curr Protoc Mouse Biol, V5, P135, DOI 10.1002/9780470942390.mo140061
   Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001
   Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004
   FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2
   Frederick DW, 2016, CELL METAB, V24, P269, DOI 10.1016/j.cmet.2016.07.005
   Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024
   Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019
   Hong SY, 2015, NAT MED, V21, P887, DOI 10.1038/nm.3882
   Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943
   KUNJARA S, 1987, BIOCHEM J, V244, P101, DOI 10.1042/bj2440101
   Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010
   Massudi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042357
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Mukherjee S, 2017, HEPATOLOGY, V65, P616, DOI 10.1002/hep.28912
   Mukhopadhyay P, 2017, J HEPATOL, V66, P589, DOI 10.1016/j.jhep.2016.10.023
   Nielsen KN, 2018, MOL METAB, V11, P178, DOI 10.1016/j.molmet.2018.02.014
   Petersen MC, 2017, TRENDS PHARMACOL SCI, V38, P649, DOI 10.1016/j.tips.2017.04.004
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103
   Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002
   Schipke J, 2017, J APPL PHYSIOL, V122, P1019, DOI 10.1152/japplphysiol.00987.2016
   Schöndorf DC, 2018, CELL REP, V23, P2979, DOI 10.1016/j.celrep.2018.05.009
   Shi W, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600878
   Sorrentino V, 2017, NATURE, V552, P187, DOI 10.1038/nature25143
   Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014
   Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933
   Vannini N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13125
   Vidakovic M, 2009, J MOL BIOL, V388, P730, DOI 10.1016/j.jmb.2009.03.032
   Xu WJ, 2015, CELL REP, V13, P533, DOI 10.1016/j.celrep.2015.09.023
   Yamamoto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147037
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513
NR 43
TC 24
Z9 27
U1 0
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 20
PY 2019
VL 10
AR 4291
DI 10.1038/s41467-019-12262-x
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA IZ3OP
UT WOS:000486995200001
PM 31541116
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU von Loeffelholz, C
   Lieske, S
   Neuschäfer-Rube, F
   Willmes, DM
   Raschzok, N
   Sauer, IM
   König, J
   Fromm, MF
   Horn, P
   Chatzigeorgiou, A
   Pathe-Neuschäfer-Rube, A
   Jordan, J
   Pfeiffer, AFH
   Mingrone, G
   Bornstein, SR
   Stroehle, P
   Harms, C
   Wunderlich, FT
   Helfand, SL
   Bernier, M
   de Cabo, R
   Shulman, GI
   Chavakis, T
   Püschel, GP
   Birkenfeld, AL
AF von Loeffelholz, Christian
   Lieske, Stefanie
   Neuschaefer-Rube, Frank
   Willmes, Diana M.
   Raschzok, Nathanael
   Sauer, Igor M.
   Koenig, Joerg
   Fromm, Martin F.
   Horn, Paul
   Chatzigeorgiou, Antonios
   Pathe-Neuschaefer-Rube, Andrea
   Jordan, Jens
   Pfeiffer, Andreas F. H.
   Mingrone, Geltrude
   Bornstein, Stefan R.
   Stroehle, Peter
   Harms, Christoph
   Wunderlich, F. Thomas
   Helfand, Stephen L.
   Bernier, Michel
   de Cabo, Rafael
   Shulman, Gerald I.
   Chavakis, Triantafyllos
   Pueschel, Gerhard P.
   Birkenfeld, Andreas L.
TI The Human Longevity Gene Homolog <i>INDY</i> and Interleukin-6 Interact
   in Hepatic Lipid Metabolism
SO HEPATOLOGY
LA English
DT Article
ID COUPLED CITRATE TRANSPORTER; FATTY LIVER-DISEASE; SYSTEMIC
   INSULIN-RESISTANCE; LIFE-SPAN; ADIPOSE-TISSUE; CAENORHABDITIS-ELEGANS;
   IL-6-DEFICIENT MICE; FUNCTIONAL FEATURES; INDUCED STEATOSIS;
   SKELETAL-MUSCLE
AB Reduced expression of the Indy ("I am Not Dead, Yet") gene in lower organisms promotes longevity in a manner akin to caloric restriction. Deletion of the mammalian homolog of Indy (mIndy, Slc13a5) encoding for a plasma membrane-associated citrate transporter expressed highly in the liver, protects mice from high-fat diet-induced and aging-induced obesity and hepatic fat accumulation through a mechanism resembling caloric restriction. We studied a possible role of mIndy in human hepatic fat metabolism. In obese, insulin-resistant patients with nonalcoholic fatty liver disease, hepatic mIndy expression was increased and mIndy expression was also independently associated with hepatic steatosis. In nonhuman primates, a 2-year high-fat, high-sucrose diet increased hepatic mIndy expression. Liver microarray analysis showed that high mIndy expression was associated with pathways involved in hepatic lipid metabolism and immunological processes. Interleukin-6 (IL-6) was identified as a regulator of mIndy by binding to its cognate receptor. Studies in human primary hepatocytes confirmed that IL-6 markedly induced mIndy transcription through the IL-6 receptor and activation of the transcription factor signal transducer and activator of transcription 3, and a putative start site of the human mIndy promoter was determined. Activation of the IL-6-signal transducer and activator of transcription 3 pathway stimulated mIndy expression, enhanced cytoplasmic citrate influx, and augmented hepatic lipogenesis in vivo. In contrast, deletion of mIndy completely prevented the stimulating effect of IL-6 on citrate uptake and reduced hepatic lipogenesis. These data show that mIndy is increased in liver of obese humans and nonhuman primates with NALFD. Moreover, our data identify mIndy as a target gene of IL-6 and determine novel functions of IL-6 through mINDY. Conclusion: Targeting human mINDY may have therapeutic potential in obese patients with nonalcoholic fatty liver disease. German Clinical Trials Register: DRKS00005450.
C1 [von Loeffelholz, Christian; Horn, Paul] Friedrich Schiller Univ, Ctr Sepsis Control & Care, Integrated Res & Treatment Ctr, Jena, Germany.
   [von Loeffelholz, Christian; Horn, Paul] Jena Univ Hosp, Dept Anesthesiol & Intens Care, Jena, Germany.
   [Lieske, Stefanie; Willmes, Diana M.; Bornstein, Stefan R.; Birkenfeld, Andreas L.] Tech Univ Dresden, Univ Hosp Dresden, Med Clin 3, Sect Metab Vasc Med, Dresden, Germany.
   [Lieske, Stefanie; Neuschaefer-Rube, Frank; Pathe-Neuschaefer-Rube, Andrea; Pueschel, Gerhard P.] Univ Potsdam, Lehrstuhl Biochem Ernahrung, Potsdam, Germany.
   [Raschzok, Nathanael; Sauer, Igor M.] Charite, Sch Med, Gen Visceral & Transplantat Surg, Berlin, Germany.
   [Koenig, Joerg; Fromm, Martin F.] Friedrich Alexander Univ, Inst Expt & Clin Pharmacol & Toxic, Erlangen, Germany.
   [Chatzigeorgiou, Antonios; Chavakis, Triantafyllos] Tech Univ Dresden, Univ Clin Dresden, Dept Clin Pathobiochem, Dresden, Germany.
   [Chatzigeorgiou, Antonios; Chavakis, Triantafyllos] Tech Univ Dresden, Univ Clin Dresden, Inst Clin Chem & Lab Med, Dresden, Germany.
   [Jordan, Jens] Univ Cologne, German Aerosp Ctr, Inst Aerosp Med, Cologne, Germany.
   [Jordan, Jens] Univ Cologne, Chair Aerosp Med, Cologne, Germany.
   [Pfeiffer, Andreas F. H.] Charite, Sch Med, Dept Endocrinol Diabet & Nutr, Berlin, Germany.
   [Pfeiffer, Andreas F. H.; Bornstein, Stefan R.; Birkenfeld, Andreas L.] German Ctr Diabet Res, Neuherberg, Germany.
   [Mingrone, Geltrude; Bornstein, Stefan R.; Birkenfeld, Andreas L.] Kings Coll London, Fac Life Sci & Med, Div Diabet & Nutr Sci, London, England.
   [Mingrone, Geltrude] Univ Cattolica Sacro Cuore, Dept Internal Med, Rome, Italy.
   [Stroehle, Peter; Wunderlich, F. Thomas] Max Planck Inst Metab Res, Excellence Cluster Cellular Stress Responses Agin, Cologne, Germany.
   [Harms, Christoph] Charite, Sch Med, Ctr Stroke Res, Dept Expt Neurol, Berlin, Germany.
   [Helfand, Stephen L.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI USA.
   [Bernier, Michel; de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA.
   [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA.
   [Birkenfeld, Andreas L.] GWT TU Dresden, Study Ctr Metab Vasc Med, Dresden, Germany.
   [Birkenfeld, Andreas L.] Univ Hosp, Helmholtz Ctr Munich, Paul Langerhans Inst Dresden, Dresden, Germany.
   [Birkenfeld, Andreas L.] Tech Univ Dresden, Fac Med, Dresden, Germany.
C3 Friedrich Schiller University of Jena; Friedrich Schiller University of
   Jena; Technische Universitat Dresden; Carl Gustav Carus University
   Hospital; University of Potsdam; Free University of Berlin; Humboldt
   University of Berlin; Charite Universitatsmedizin Berlin; University of
   Erlangen Nuremberg; Technische Universitat Dresden; Carl Gustav Carus
   University Hospital; Technische Universitat Dresden; Carl Gustav Carus
   University Hospital; Helmholtz Association; German Aerospace Centre
   (DLR); University of Cologne; University of Cologne; Free University of
   Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; University of London; King's College London; Catholic University
   of the Sacred Heart; IRCCS Policlinico Gemelli; Free University of
   Berlin; Humboldt University of Berlin; Charite Universitatsmedizin
   Berlin; Brown University; National Institutes of Health (NIH) - USA; NIH
   National Institute on Aging (NIA); Howard Hughes Medical Institute; Yale
   University; Technische Universitat Dresden; Helmholtz Association;
   Helmholtz-Center Munich - German Research Center for Environmental
   Health; Technische Universitat Dresden; Carl Gustav Carus University
   Hospital; Technische Universitat Dresden
RP Birkenfeld, AL (corresponding author), Tech Univ Dresden, Sect Metab Vasc Med, Med Clin 3, Univ Hosp Dresden,Metab Vasc Med, Dresden, Germany.
EM andreas.birkenfeld@uniklinikum-dresden.de
RI Horn, Paul/O-6885-2015; von Loeffelholz, Christian/AAQ-3808-2021;
   Chavakis, Triantafyllos/ABE-8845-2020; Pfeiffer, Andreas
   F.H./AAJ-2311-2020; Bernier, Michel/AAO-3983-2021; Bernier,
   Michel/Y-7139-2019; Shulman, Gerald I./P-7176-2019; Birkenfeld, Andreas
   L./U-3954-2019; Sauer, Igor/AAM-4217-2021; Harms,
   Christoph/HIK-2989-2022; Mingrone, Geltrude/AAB-9681-2019; Fromm, Martin
   F./JWA-1369-2024; de Cabo, Rafael Carlos/E-7996-2010; Harms,
   Christoph/AAD-7895-2021; Chatzigeorgiou, Antonios/G-1581-2010
OI Horn, Paul/0000-0002-8755-7703; Pfeiffer, Andreas
   F.H./0000-0002-6887-0016; Bernier, Michel/0000-0002-5948-368X; Shulman,
   Gerald I./0000-0003-1529-5668; Birkenfeld, Andreas
   L./0000-0003-1407-9023; Fromm, Martin F./0000-0002-0334-7478; de Cabo,
   Rafael Carlos/0000-0003-2830-5693; Harms, Christoph/0000-0002-2063-2860;
   Chatzigeorgiou, Antonios/0000-0002-7039-4223; Sauer,
   Igor/0000-0001-9355-937X; Raschzok, Nathanael/0000-0001-5074-7063;
   Mingrone, Geltrude/0000-0003-2021-528X; Koenig,
   Joerg/0000-0001-7016-5482
FU German Research Foundation [BI1292/4-2, IRTG 2251]; German Diabetes
   Research Center; National Institutes of Health, National Institute on
   Aging [AG16667, AG24353, AG25277]; Glenn Award for Research in
   Biological Mechanisms of Aging; National Institutes of Health, National
   Institute of Diabetes and Digestive and Kidney Diseases [DK 40936, DK
   49230, DK-45735, DK-059635]
FX Supported by the German Research Foundation (BI1292/4-2, IRTG 2251) and
   the German Diabetes Research Center (to A.L.B.); the National Institutes
   of Health, National Institute on Aging (AG16667, AG24353, and AG25277)
   and a Glenn Award for Research in Biological Mechanisms of Aging (to
   S.L.H.); and National Institutes of Health, National Institute of
   Diabetes and Digestive and Kidney Diseases (DK 40936, DK 49230,
   DK-45735, DK-059635, to G.I.S.).
CR Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672
   Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009
   Brachs S, 2016, MOL METAB, V5, P1072, DOI 10.1016/j.molmet.2016.08.004
   Döcke S, 2013, EUR J ENDOCRINOL, V169, P547, DOI 10.1530/EJE-13-0112
   Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925
   El-Assal O, 2004, CELL MOL IMMUNOL, V1, P205
   Febbraio MA, 2004, DIABETES, V53, P1643, DOI 10.2337/diabetes.53.7.1643
   Fei YJ, 2004, BIOCHEM J, V379, P191, DOI 10.1042/BJ20031807
   Frankel Stewart, 2012, Frontiers in Genetics, V3, P13, DOI 10.3389/fgene.2012.00013
   Fuster JJ, 2014, EMBO J, V33, P1425, DOI 10.15252/embj.201488856
   García-Galiano D, 2007, OBES SURG, V17, P493, DOI 10.1007/s11695-007-9087-1
   Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006
   GRUNFELD C, 1990, CANCER RES, V50, P4233
   Henkel J, 2009, HEPATOLOGY, V50, P781, DOI 10.1002/hep.23064
   Hong F, 2004, HEPATOLOGY, V40, P933, DOI 10.1002/hep.20400
   Huard K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17391
   Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271
   Inoue K, 2004, BIOCHEM J, V378, P949, DOI 10.1042/BJ20031261
   Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200
   Inoue K, 2002, BIOCHEM J, V367, P313, DOI 10.1042/BJ20021132
   Inoue K, 2003, BIOCHEM J, V374, P21, DOI 10.1042/BJ20030827
   Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004
   Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305
   Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784
   Knauf F, 2002, P NATL ACAD SCI USA, V99, P14315, DOI 10.1073/pnas.222531899
   Li LH, 2015, MOL PHARMACOL, V87, P674, DOI 10.1124/mol.114.097287
   Gavito AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157956
   Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132
   Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542
   Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046
   Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922
   Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y
   Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865
   Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106
   Neuschäfer-Rube F, 2014, DIABETES, V63, P1048, DOI 10.2337/db13-0749
   Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y
   Pearce SG, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-7
   Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012
   Pesta DH, 2015, AGING-US, V7, P1086, DOI 10.18632/aging.100854
   Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137
   Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794
   Sadagurski M, 2010, DIABETOLOGIA, V53, P525, DOI 10.1007/s00125-009-1580-8
   Schwarz F, 2015, AGING-US, V7, P553, DOI 10.18632/aging.100791
   Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200
   Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095
   Vida M, 2015, DIS MODEL MECH, V8, P721, DOI 10.1242/dmm.019166
   Wang PY, 2009, P NATL ACAD SCI USA, V106, P9262, DOI 10.1073/pnas.0904115106
   Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011
   Yamaguchi K, 2015, LIVER INT, V35, P550, DOI 10.1111/liv.12645
   Zwart R, 2015, J PHARMACOL EXP THER, V355, P247, DOI 10.1124/jpet.115.226902
NR 50
TC 43
Z9 47
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD AUG
PY 2017
VL 66
IS 2
BP 616
EP 630
DI 10.1002/hep.29089
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FB0EH
UT WOS:000405817200028
PM 28133767
OA Green Accepted, Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Idrovo, JP
   Boe, DM
   Kaahui, S
   Walrath, T
   McMahan, RH
   Kovacs, EJ
AF Idrovo, Juan-Pablo
   Boe, Devin M.
   Kaahui, Soncy
   Walrath, Travis
   McMahan, Rachel H.
   Kovacs, Elizabeth J.
TI Advanced age heightens hepatic damage in a murine model of scald burn
   injury
SO JOURNAL OF TRAUMA AND ACUTE CARE SURGERY
LA English
DT Article
DE Mice; burn injury; aging; hepatic damage; peroxidation
AB BACKGROUND
   Elderly burn patients exhibit a lower survival rate compared with younger counterparts. The liver is susceptible to damage after burn injury, which predisposes to poor outcomes. Lipid homeostasis and the antioxidant glutathione system play fundamental roles in preserving liver integrity. Herein, we explored changes in these major pathways associated with liver damage in the aging animals after burn injury. METHODS
   We compared liver enzymes, histology, lipid-peroxidation, and glutathione-metabolism profiles from young and aged female mice after a 15% total body surface area burn. Mice were euthanized at 24 hours after injury, and livers and serum were collected. RESULTS
   Aged burn animals exhibited elevated (p < 0.05) aspartate aminotransferase and alanine aminotransferase levels and increased inflammatory cell infiltration, edema, and necrosis compared with their younger counterparts. The percentage of adipophilin-stained area in livers from young sham, young burn, aged sham, and aged burn groups was 10%, 44%, 16%, and 78% (p < 0.05), respectively. Liver malondialdehyde levels were 1.4 +/- 0.5 nmol/mg, 2.06 +/- 0.2 nmol/mg, 1.81 +/- 0.12 nmol/mg, and 3.45 +/- 0.2 nmol/mg (p < 0.05) in young sham, young burn, aged sham, and aged burn mice, respectively. Oxidized glutathione (GSSG) content increased 50% in the young burn, and 88% in aged burn animals compared with the young sham group (p < 0.05). The reduced glutathione GSH/GSSG ratio was significantly reduced by 54% in aged burn mice compared with young sham animals (p < 0.05). Furthermore, glutathione peroxidase gene expression showed a 96% decrease in the aged burn group compared with young sham mice (p < 0.05). CONCLUSION
   Aged burn animals exhibit severe liver damage from heightened lipid peroxidation and inadequate antioxidative response. The increased peroxidation is associated with abundant lipid deposits in hepatic tissue postburn and a weak antioxidative response due to hepatic glutathione peroxidase downregulation. Further studies will focus on the functional significance of these findings concerning hepatic homeostasis.
C1 [Idrovo, Juan-Pablo; Boe, Devin M.; Kaahui, Soncy; Walrath, Travis; McMahan, Rachel H.; Kovacs, Elizabeth J.] Univ Colorado, Div GI Trauma & Endocrine Surg, Aurora, CO USA.
   [Boe, Devin M.; Walrath, Travis; McMahan, Rachel H.; Kovacs, Elizabeth J.] Univ Colorado, Dept Surg, Div Burn Res, Aurora, CO USA.
   [Boe, Devin M.; Walrath, Travis; Kovacs, Elizabeth J.] Univ Colorado, Dept Immunol & Microbiol, Aurora, CO USA.
   [McMahan, Rachel H.; Kovacs, Elizabeth J.] Univ Colorado, Dept Surg, Div Alcohol Res, Aurora, CO USA.
C3 University of Colorado System; University of Colorado Anschutz Medical
   Campus; University of Colorado System; University of Colorado Anschutz
   Medical Campus; University of Colorado System; University of Colorado
   Anschutz Medical Campus; University of Colorado System; University of
   Colorado Anschutz Medical Campus
RP Idrovo, JP (corresponding author), Univ Colorado Denver, Anschutz Med Campus,Room 6001,12631 E 17th Ave, Aurora, CO 80045 USA.
EM idrovo@cuanschutz.edu; devin.boe@cuanschutz.edu;
   soncy.kaahui@cuanschutz.edu; travis.walrath@cuanschutz.edu;
   rachel.mcmahan@cuanschutz.edu; elizabeth.kovacs@cuanschutz.edu
RI Idrovo, Juan-Pablo/AAA-4949-2021
OI Idrovo, Juan Pablo/0000-0002-2034-2740
FU [K08GM134185];  [R01AG018859];  [R01GM115257];  [R35GM131831];  [1 I01
   BX004335]
FX The research in this publication was supported by K08GM134185 (JPI) and
   R01AG018859, R01GM115257, R35GM131831, and 1 I01 BX004335 (EJK). The
   content in this report is the responsibility of the authors and does not
   primarily represent the formal National Institutes of Health opinion.
CR Aarsland A, 1996, ANN SURG, V223, P777, DOI 10.1097/00000658-199606000-00016
   Adiga U., 2015, International Journal of Research Studies in Biosciences (IJRSB), V3, P88
   Anurag P, 2002, DIABETES OBES METAB, V4, P36, DOI 10.1046/j.1463-1326.2002.00178.x
   Asaoka Y, 2013, EXP TOXICOL PATHOL, V65, P817, DOI 10.1016/j.etp.2012.11.008
   Association AB, 2016, BURN INCIDENCE FACT
   Barret JP, 2001, J TRAUMA, V51, P736, DOI 10.1097/00005373-200110000-00019
   Bekyarova G, 2014, CENT EUR J MED, V9, P148, DOI 10.2478/s11536-013-0253-7
   Branski LK, 2007, CRIT CARE MED, V35, P2615, DOI 10.1097/01.CCM.0000285991.36698.E2
   Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200
   Cetinkale O, 1997, BURNS, V23, P114, DOI 10.1016/S0305-4179(96)00084-8
   Chen MM, 2015, SHOCK, V43, P80, DOI 10.1097/SHK.0000000000000265
   Chen MM, 2014, AM J PHYSIOL-GASTR L, V307, pG711, DOI 10.1152/ajpgi.00185.2014
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517
   Faunce DE, 1997, J LEUKOCYTE BIOL, V62, P733, DOI 10.1002/jlb.62.6.733
   Gan Lay, 2011, Curr Gerontol Geriatr Res, V2011, P831536, DOI 10.1155/2011/831536
   Gomez CR, 2007, EXP GERONTOL, V42, P451, DOI 10.1016/j.exger.2006.11.013
   Gomez CR, 2009, SHOCK, V31, P178, DOI 10.1097/SHK.0b013e318180feb8
   GOODE HF, 1995, CRIT CARE MED, V23, P646, DOI 10.1097/00003246-199504000-00011
   He SQ, 2006, LIVER TRANSPLANT, V12, P1869, DOI 10.1002/lt.21001
   Höhn A, 2017, REDOX BIOL, V11, P482, DOI 10.1016/j.redox.2016.12.001
   HUNT JL, 1992, AM J SURG, V164, P472, DOI 10.1016/S0002-9610(05)81183-3
   Idrovo JP, 2012, SHOCK, V37, P39, DOI 10.1097/SHK.0b013e31823185d7
   Jeschke MG, 2009, MOL MED, V15, P337, DOI 10.2119/molmed.2009.00005
   Jeschke MG., 2018, TOTAL BURN CARE, P259, DOI [10.1016/B978-0-323-47661-4.00024-1, DOI 10.1016/B978-0-323-47661-4.00024-1]
   Kallinen O, 2012, J BURN CARE RES, V33, P206, DOI 10.1097/BCR.0b013e3182331e73
   Knight JA, 1998, ANN CLIN LAB SCI, V28, P331
   Kovacs EJ, 2004, J LEUKOCYTE BIOL, V76, P36, DOI 10.1189/jlb.1103538
   Kovacs EJ, 2002, J AM AGING ASSOC, V25, P3, DOI 10.1007/s11357-002-0001-4
   Lionelli GT, 2005, BURNS, V31, P958, DOI 10.1016/j.burns.2005.06.006
   Lumenta DB, 2008, BURNS, V34, P965, DOI 10.1016/j.burns.2007.12.004
   Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837
   Martini WZ, 2001, JPEN-PARENTER ENTER, V25, P310, DOI 10.1177/0148607101025006310
   McGill MR, 2016, EXCLI J, V15, P817, DOI 10.17179/excli2016-800
   Muthusamy K, 2006, J CLIN PATHOL, V59, P1166, DOI 10.1136/jcp.2005.033381
   Nomellini V, 2008, J LEUKOCYTE BIOL, V83, P1493, DOI 10.1189/jlb.1007672
   Obert LA, 2007, TOXICOL PATHOL, V35, P728, DOI 10.1080/01926230701481956
   Ostler DA, 2010, MODERN PATHOL, V23, P567, DOI 10.1038/modpathol.2010.1
   Owen JB, 2010, METHODS MOL BIOL, V648, P269, DOI 10.1007/978-1-60761-756-3_18
   Pham TN, 2009, J BURN CARE RES, V30, P30, DOI 10.1097/BCR.0b013e3181921efc
   Plackett TP, 2003, FASEB J, V17, P688, DOI 10.1096/fj.02-0452fje
   Rani M, 2012, AGING DIS, V3, P171
   SAFFLE JR, 1993, CRIT CARE MED, V21, P1673, DOI 10.1097/00003246-199311000-00016
   Shallo H, 2003, BURNS, V29, P641, DOI 10.1016/S0305-4179(03)00070-6
   Taylor SL, 2014, BURNS, V40, P1106, DOI 10.1016/j.burns.2014.03.010
   TREDGET EE, 1992, WORLD J SURG, V16, P68, DOI 10.1007/BF02067117
   Wheatley EG, 2020, SHOCK, V53, P71, DOI 10.1097/SHK.0000000000001321
   Yamaguchi J, 2018, AUTOPHAGY, V14, P764, DOI 10.1080/15548627.2017.1314897
   Zhao GF, 2013, ANN SURG, V257, P1129, DOI 10.1097/SLA.0b013e318273fdca
   Zheng H, 2006, BURNS, V32, P328, DOI 10.1016/j.burns.2005.10.007
NR 49
TC 3
Z9 3
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2163-0755
EI 2163-0763
J9 J TRAUMA ACUTE CARE
JI J. Trauma Acute Care Surg.
PD APR
PY 2021
VL 90
IS 4
BP 731
EP 737
DI 10.1097/TA.0000000000003048
PG 7
WC Critical Care Medicine; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Surgery
GA RI2EP
UT WOS:000636723100019
PM 33306599
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Nagata, T
AF Nagata, Tetsuji
TI Electron microscopic radioautographic study on protein synthesis in
   mitochondria of binucleate hepatocytes of aging mice
SO THESCIENTIFICWORLDJOURNAL
LA English
DT Article
DE mitochondria; EM radioautography; protein syntheses; mouse binucleate
   hepatocytes; aging
ID DRY-MOUNTING AUTORADIOGRAPHY; NUCLEIC-ACID SYNTHESIS; DNA-SYNTHESIS;
   MACROMOLECULAR-SYNTHESIS; RNA-SYNTHESIS; LIGHT; CELLS; MOUSE; LIVER;
   THYMIDINE
AB In order to study the aging changes of intramitochondrial protein synthesis in mouse hepatocytes, 10 groups of aging mice, each consisting of three individuals, total 30, from fetal day 19 to postnatal year 2, were injected with H-3-leucine, a protein precursor, sacrificed 1 h later, and the liver tissues processed for electron microscopic radioautography. On electron microscopic radioautograms obtained from each animal, the numbers of mitochondria, the numbers of labeled mitochondria, and the mitochondrial labeling index labeled with H-3-leucine that showed protein synthesis in each hepatocyte, both mononucleate and binucleate cells, were counted and the averages in respective aging groups were compared. From the results, it was demonstrated that the numbers of mitochondria, the numbers of labeled mitochondria, and the labeling indices of intramitochondrial protein syntheses in both mononucleate and binucleate hepatocytes of mice at various ages increased due to development of animals. The numbers of mitochondria, the numbers of labeled mitochondria, and the labeling indices of intramitochondrial protein synthesis in binucleate hepatocytes were more than those of mononucleate hepatocytes at the same aging stages.
C1 Shinshu Univ, Sch Med, Dept Anat & Cell Biol, Matsumoto, Nagano 3908621, Japan.
   Shinshu Inst Alternat Med, Dept Anat, Nagano 3800816, Japan.
C3 Shinshu University
RP Nagata, T (corresponding author), Shinshu Univ, Sch Med, Dept Anat & Cell Biol, Matsumoto, Nagano 3908621, Japan.
EM nagatas@po.cnet.ne.jp
CR CARO LG, 1962, J CELL BIOL, V15, P189, DOI 10.1083/jcb.15.2.189
   CHEVREMONT J, 1963, CELL GROWTH CELL DIV, V2, P323
   Cui H, 1996, P 4 CHIN JAP JOINT H, P111
   Cui HX, 2000, ACTA HISTOCHEM CYTOC, V33, P31, DOI 10.1267/ahc.33.31
   GAO FL, 1995, CELL MOL BIOL, V41, P145
   Gao Fulu, 1994, Medical Electron Microscopy, V27, P360, DOI 10.1007/BF02349697
   Goswami C, 2004, J BIOSCIENCES, V29, P337, DOI 10.1007/BF02702616
   Gunarso W, 1997, CELL MOL BIOL, V43, P189
   Gunarso W, 1996, ACTA HISTOCHEM, V98, P309, DOI 10.1016/S0065-1281(96)80024-9
   Gunarso W., 1984, SHINSHU MED J, V32, P241
   GUTTES E, 1964, SCIENCE, V145, P1057, DOI 10.1126/science.145.3636.1057
   Hanai Toru, 1994, Medical Electron Microscopy, V27, P355, DOI 10.1007/BF02349695
   Ito Masayuki, 1996, Medical Electron Microscopy, V29, P145, DOI 10.1007/BF02348068
   Juang HH, 2004, MOL CELL BIOCHEM, V265, P185, DOI 10.1023/B:MCBI.0000044395.59739.1f
   Kong Yongli, 1994, Medical Electron Microscopy, V27, P366, DOI 10.1007/BF02349699
   Korr H, 1997, ACTA NEUROPATHOL, V94, P557, DOI 10.1007/s004010050750
   Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012
   Liang Yan, 1999, Acta Anatomica Nipponica, V74, P291
   MA H, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P335
   MA H, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P715
   Ma H., 2000, ANN MICROSC, V1, P13
   Ma H., 2005, ANN MICROSC, V5, P4
   Ma H, 1994, MED ELECT MICROSC, V27, P349
   MA HJ, 1991, CELL MOL BIOL, V37, P607
   Mahata B, 2005, J BIOL CHEM, V280, P5141, DOI 10.1074/jbc.C400572200
   Maneiro E, 2005, ANN RHEUM DIS, V64, P388, DOI 10.1136/ard.2004.022152
   MEYER RR, 1966, J CELL BIOL, V31, pA151
   Millar AH, 2005, TRENDS PLANT SCI, V10, P36, DOI 10.1016/j.tplants.2004.12.002
   MURATA F, 1979, ACTA HISTOCHEM CYTOC, V12, P443, DOI 10.1267/ahc.12.443
   Nadler NJ, 1971, J CELL BIOL, V49, P377
   NAGATA T, 1969, Acta Anatomica Nipponica, V44, P126
   Nagata T, 2005, MICROSC RES TECHNIQ, V67, P55, DOI 10.1002/jemt.20183
   Nagata T, 1997, HISTOL HISTOPATHOL, V12, P1091
   Nagata T, 1996, J ELECTRON MICROSC, V45, P258, DOI 10.1093/oxfordjournals.jmicro.a023442
   NAGATA T, 1995, CELL MOL BIOL, V41, P21
   Nagata T, 2003, CELL MOL BIOL, V49, P591
   Nagata T, 2002, PROG HISTOCHEM CYTO, V37, P67, DOI 10.1016/S0079-6336(02)80003-1
   Nagata T, 1977, J Electron Microsc (Tokyo), V26 Suppl, P347
   NAGATA T, 1972, Acta Histochemica et Cytochemica, V5, P201
   NAGATA T, 1977, ACTA PHARMACOL TOX, V41, P64
   Nagata T, 2001, INT REV CYTOL, V211, P33, DOI 10.1016/S0074-7696(01)11017-X
   NAGATA T, 1979, ACTA HISTOCHEM CYTOC, V12, P610
   NAGATA T, 1977, HISTOCHEMISTRY, V54, P75, DOI 10.1007/BF00493331
   NAGATA T, 1977, ACTA PHARMACOL TOX, V41, P62
   NAGATA T, 1982, HISTOCHEM J, V14, P197, DOI 10.1007/BF01041214
   Nagata T, 1999, METHOD FIND EXP CLIN, V21, P683, DOI 10.1358/mf.1999.21.10.795781
   NAGATA T, 1972, HISTOCHEMISTRY, V32, P163, DOI 10.1007/BF00303731
   NAGATA T, 1967, HISTOCHEMISTRY, V10, P305, DOI 10.1007/BF00304312
   NAGATA T, 1976, P 5 INT C HIST CYT B, P242
   Nagata T, 2000, ANN MICROSC, V1, P13
   Nagata T., 1984, J CLIN ELECT MICROSC, V17, P589
   NAGATA T, 2000, B NAGANO WOMENS JR C, V8, P1
   NAGATA T, 2004, HISTOCHEMISTRY, V28, P540
   NAGATA T, 1972, P 4 INT C HIST CYT K, P43
   NAGATA T, 1974, P 8 INT C EL MICR CA, V2, P346
   NAGATA T, 1984, P 11 INT C EL MICR, V3, P2281
   Nagata T., 1967, ARCH HISTOL JAPON, V28, P540
   NAGATA T, 1992, RECENT ADV CELLULAR, V6, P9
   Nagata T., 1982, P 10 INT C EL MICR, V2, P305
   NAGATA T, 1994, RADIOAUTOGRAPHY MED
   Nagata T., 2003, ANN MICROSC, V3, P53
   Nagata T., 1993, CHINESE J HISTOCHEM, V2, P106
   NAGATA T, 1975, P 10 INT C AN TOK, P474
   Nagata Tetsuji, 2005, ARBS Annual Review of Biomedical Sciences, V7, P7
   Nagata Tetsuji, 2004, Medical Electron Microscopy, V37, P62, DOI 10.1007/s00795-003-0232-1
   Nagata T, 2006, THESCIENTIFICWORLDJO, V6, P1583, DOI 10.1100/tsw.2006.265
   Nagata Tetsuji, 2003, Medical Electron Microscopy, V36, P263, DOI 10.1007/s00795-003-0224-1
   OLEA MT, 2003, ANN MICROSC, V3, P70
   Pilichos C, 2005, INT IMMUNOPHARMACOL, V5, P93, DOI 10.1016/j.intimp.2004.09.004
   Polak U, 2004, Rocz Akad Med Bialymst, V49 Suppl 1, P11
   Rudhe C, 2004, J MOL BIOL, V343, P639, DOI 10.1016/j.jmb.2004.08.053
   SALPETER MM, 1969, J CELL BIOL, V41, P1, DOI 10.1083/jcb.41.1.1
   Schmitz C, 1999, ACTA NEUROPATHOL, V97, P71, DOI 10.1007/s004010050957
   Schmitz Christoph, 1999, J Alzheimers Dis, V1, P387
   SCHUSTER FL, 1965, EXP CELL RES, V39, P329, DOI 10.1016/0014-4827(65)90038-8
   STONE GE, 1965, EXP ZOOL, V159, P33
   Sun L, 1997, ACTA HISTOCHEM CYTOC, V30, P211, DOI 10.1267/ahc.30.211
   UCHIDA K, 1971, ARCH HISTOL JAPON, V31, P291
   YAMADA AT, 1993, CELL MOL BIOL, V39, P1
   YAMADA AT, 1993, CELL MOL BIOL, V39, P221
   Yamada Aureo T., 1994, Medical Electron Microscopy, V27, P363, DOI 10.1007/BF02349698
   Yamada Aureo T., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P763
NR 82
TC 5
Z9 7
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1537-744X
J9 THESCIENTIFICWORLDJO
JI TheScientificWorldJOURNAL
PY 2007
VL 7
BP 1008
EP 1023
DI 10.1100/tsw.2007.140
PG 16
WC Environmental Sciences; Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Science & Technology - Other Topics
GA 182AB
UT WOS:000247476400001
PM 17619783
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU Brown-Borg, HM
   Rakoczy, SG
   Romanick, MA
   Kennedy, MA
AF Brown-Borg, HM
   Rakoczy, SG
   Romanick, MA
   Kennedy, MA
TI Effects of growth hormone and insulin-like growth factor-1 on hepatocyte
   antioxidative enzymes
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE hormones; aging; growth factors; catalase; glutathione peroxidase
ID HYDROGEN-PEROXIDE PRODUCTION; PEROXISOMAL BETA-OXIDATION; LIFE-SPAN;
   LIPID-PEROXIDATION; MONOAMINE-OXIDASE; TRANSGENIC MICE; DWARF MICE; RAT;
   MITOCHONDRIAL; LIVER
AB The physiological decline that occurs in aging is thought to result, in part, from accumulation of oxidative damage generated by reactive oxygen species during normal metabolic processes. Elevated levels of antioxidative enzymes in liver tissues are present in the Ames dwarf, a growth hormone (GH)-deficient mouse that lives more than I year longer than wild-type mice from the same line. In contrast, transgenic mice that overexpress GH exhibit depressed hepatic levels of catalase and have significantly shortened life spans. In this study, we evaluated the in vitro effects of GH and insulin-like growth factor 1 (IGF-1) on antioxidative enzymes in mouse hepatocytes. Hepatocytes were isolated from wild-type mice following perfusion of livers with a collagenase-based buffer. Dispersed cells were plated on Matrigel and treated with rat GH (0.1, 1.0, or 10 mug/ml) or IGF-1 (0.5, 5.0, or 50 nM) for 24 hr. Hepatocytes were recovered and protein was extracted for immunoblotting and enzyme activity assays of catalase (CAT), glutathione peroxidase (GPX), and manganese superoxide dismutase (MnSOD). A 41% and 27% decrease in catalase activity was detected in cells treated with GH, whereas IGF-1 reduced CAT activity levels to a greater extent than GH (P < 0.0001). The activity and protein levels of GPX were also significantly depressed in cells treated with GH, whereas activity alone was decreased in cells treated with IGF-1 (P < 0.04). GH significantly suppressed MnSOD levels by 40% and 66% in 1.0 and 0.1 mug/ml concentrations, respectively. Similarly, IGF-1 decreased MnSOD protein levels (5 nM; P < 0.05). These results suggest that GH and IGF-1 may decrease the ability of hepatocytes to counter oxidative stress. In addition, these experiments provide an explanation for the differing antioxidative defense capacity of GH-deficient versus GH-over-expressing mice, and they suggest that GH is directly involved in antioxidant regulation and the aging process.
C1 Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, Grand Forks, ND 58203 USA.
C3 University of North Dakota Grand Forks
RP Brown-Borg, HM (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Pharmacol Physiol & Therapeut, 501 N Columbia Rd, Grand Forks, ND 58203 USA.
EM brownbrg@medicine.nodak.edu
RI Brown-Borg, Holly/IQV-8650-2023
CR [Anonymous], 1984, METHOD ENZYMOL
   [Anonymous], GENETIC VARIATION HO
   ASAYAMA K, 1987, ENDOCRINOLOGY, V121, P2112, DOI 10.1210/endo-121-6-2112
   BOLZAN AD, 1995, EXP GERONTOL, V30, P169, DOI 10.1016/0531-5565(94)00053-0
   Bolzan AD, 1997, EXP GERONTOL, V32, P297, DOI 10.1016/S0531-5565(96)00101-5
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brown-Borg HM, 2000, EXP GERONTOL, V35, P199, DOI 10.1016/S0531-5565(00)00079-6
   Brown-Borg HM, 1999, ENDOCRINE, V11, P41, DOI 10.1385/ENDO:11:1:41
   BrownBorg HM, 1996, NATURE, V384, P33, DOI 10.1038/384033a0
   CARO JF, 1988, J CLIN INVEST, V81, P976, DOI 10.1172/JCI113451
   CastillaCortazar I, 1997, GASTROENTEROLOGY, V113, P1682, DOI 10.1053/gast.1997.v113.pm9352873
   CHANDRASHEKAR V, 1993, BIOL REPROD, V48, P544, DOI 10.1095/biolreprod48.3.544
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Coschigano KT, 2000, ENDOCRINOLOGY, V141, P2608, DOI 10.1210/en.141.7.2608
   Davidovic V, 1997, COMP BIOCHEM PHYS C, V117, P181, DOI 10.1016/S0742-8413(97)00065-0
   Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820
   Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1
   Esworthy RS, 1998, BBA-GEN SUBJECTS, V1381, P213, DOI 10.1016/S0304-4165(98)00032-4
   Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497
   Facchini FS, 2000, FREE RADICAL BIO MED, V29, P1302, DOI 10.1016/S0891-5849(00)00438-X
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   HAINING JL, 1973, EXP GERONTOL, V8, P85, DOI 10.1016/0531-5565(73)90018-1
   Hauck SJ, 2000, FREE RADICAL BIO MED, V28, P970, DOI 10.1016/S0891-5849(00)00186-6
   Hauck SJ, 2001, J GERONTOL A-BIOL, V56, pB153, DOI 10.1093/gerona/56.4.B153
   KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0
   Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654
   Komosinska-Vassev K, 2000, CLIN CHIM ACTA, V300, P107, DOI 10.1016/S0009-8981(00)00306-5
   KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201
   Krzisnik C, 1999, J ENDOCR GENET, V1, P9, DOI [10.1515/IJDHD.1999.1.1.9, DOI 10.1515/IJDHD.1999.1.1.9]
   LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703
   MAY JM, 1979, J BIOL CHEM, V254, P2214
   MCGRANE MM, 1988, J BIOL CHEM, V263, P11443
   NEDERGAARD J, 1980, AM J PHYSIOL, V239, pC208, DOI 10.1152/ajpcell.1980.239.5.C208
   Paul C, 2000, EUR J BIOCHEM, V267, P5849, DOI 10.1046/j.1432-1327.2000.01395.x
   Radojicic R, 1997, COMP BIOCHEM PHYS C, V117, P187, DOI 10.1016/S0742-8413(97)89893-3
   Rollo CD, 1996, CAN J ZOOL, V74, P606, DOI 10.1139/z96-070
   Sornson MW, 1996, NATURE, V384, P327, DOI 10.1038/384327a0
   Steger R W, 1993, J Reprod Fertil Suppl, V46, P61
   Sugino N, 1998, BIOL REPROD, V59, P599, DOI 10.1095/biolreprod59.3.599
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   XU L, 1995, HORM METAB RES, V27, P76, DOI 10.1055/s-2007-979912
   Xu L, 1999, HORM METAB RES, V31, P278, DOI 10.1055/s-2007-978733
   Yan T, 1998, FREE RADICAL BIO MED, V25, P688, DOI 10.1016/S0891-5849(98)00112-9
   Youn YK, 1998, J BURN CARE REHABIL, V19, P542, DOI 10.1097/00004630-199811000-00015
   Youssef J, 1998, CRIT REV TOXICOL, V28, P1, DOI 10.1080/10408449891344182
   Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215
   DIABETOLOGIA
   TRANSGENICS
NR 50
TC 92
Z9 103
U1 0
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD FEB
PY 2002
VL 227
IS 2
BP 94
EP 104
DI 10.1177/153537020222700203
PG 11
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 514JV
UT WOS:000173436500003
PM 11815672
DA 2024-02-19
ER

PT J
AU Heo, HJ
   Tozour, JN
   Delahaye, F
   Zhao, YM
   Cui, LG
   Barzilai, N
   Einstein, FH
AF Heo, Hye J.
   Tozour, Jessica N.
   Delahaye, Fabien
   Zhao, Yongmei
   Cui, Lingguang
   Barzilai, Nir
   Einstein, Francine Hughes
TI Advanced aging phenotype is revealed by epigenetic modifications in rat
   liver after <i>in utero</i> malnutrition
SO AGING CELL
LA English
DT Article
DE aging; DNA methylation; liver; maternal overnutrition; maternal
   undernutrition
ID DNA METHYLATION; PYRUVATE-CARBOXYLASE; ADIPOSE-TISSUE; STEM-CELLS;
   EXPRESSION; DISEASE; GLUCOSE; OVERNUTRITION; METABOLISM; CHILDHOOD
AB Adverse environmental exposures of mothers during fetal period predispose offspring to a range of age-related diseases earlier in life. Here, we set to determine whether a deregulated epigenetic pattern is similar in young animals whose mothers' nutrition was modulated during fetal growth to that acquired during normal aging in animals. Using a rodent model of maternal undernutrition (UN) or overnutrition (ON), we examined cytosine methylation profiles of liver from young female offspring and compared them to age-matched young controls and aged (20-month-old) animals. HELP-tagging, a genomewide restriction enzyme and sequencing assay demonstrates that fetal exposure to two different maternal diets is associated with nonrandom dysregulation of methylation levels with profiles similar to those seen in normal aging animals and occur in regions mapped to genes relevant to metabolic diseases and aging. Functional consequences were assessed by gene expression at 9weeks old with more significant changes at 6months of age. Early developmental exposures to unfavorable maternal diets result in altered methylation profiles and transcriptional dysregulation in Prkcb, Pc, Ncor2, and Smad3 that is also seen with normal aging. These Notch pathway and lipogenesis genes may be useful for prediction of later susceptibility to chronic disease.
C1 [Heo, Hye J.; Delahaye, Fabien; Zhao, Yongmei; Cui, Lingguang; Einstein, Francine Hughes] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
   [Tozour, Jessica N.; Delahaye, Fabien; Barzilai, Nir] Albert Einstein Coll Med, Dept Genet, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
   [Barzilai, Nir; Einstein, Francine Hughes] Albert Einstein Coll Med, Dept Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine; Yeshiva University;
   Albert Einstein College of Medicine
RP Heo, HJ (corresponding author), Winthrop Univ Hosp, Dept Obstet & Gynecol, 259 First St, Mineola, NY 11501 USA.
EM hheo@winthrop.org
OI Delahaye, Fabien/0000-0002-9921-8653
FU Reproductive Scientist Development Program (NICHD) [K12HD00849-26];
   March of dimes; core laboratories of the Einstein Diabetes Research
   Center [DK020541]; Einstein Nathan Shock Center [P30AG038072];
   Einstein's Medical Student Training Program award [NIH NIGMS T32
   GM007288]; Einstein's Center for Epigenomics, including the Epigenomics
   Shared Facility and Computational Epigenomics Group
FX Support for this project was provided by Reproductive Scientist
   Development Program (NICHD K12HD00849-26) and March of dimes. Support
   was also provided by core laboratories of the Einstein Diabetes Research
   Center (DK020541), the Einstein Nathan Shock Center (P30AG038072), the
   Einstein's Medical Student Training Program award (NIH NIGMS T32
   GM007288), and Einstein's Center for Epigenomics, including the
   Epigenomics Shared Facility and Computational Epigenomics Group. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Alisi A, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/269853
   Aryee MJ, 2011, BIOSTATISTICS, V12, P197, DOI 10.1093/biostatistics/kxq055
   BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564
   BARKER DJP, 1986, LANCET, V1, P1077
   Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725
   Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025
   Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045
   Byun HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039220
   Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001
   Delahaye F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6187
   Desai M, 2015, J DEV ORIG HLTH DIS, V6, P530, DOI 10.1017/S2040174415001440
   Dudley KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021662
   Duscher D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07144
   Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521
   Everett LJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-337
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x
   Golson ML, 2009, MECH DEVELOP, V126, P687, DOI 10.1016/j.mod.2009.05.005
   Hales CN, 2013, INT J EPIDEMIOL, V42, P1215, DOI 10.1093/ije/dyt133
   Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016
   HANSON RW, 1967, BIOCHEM J, V105, P529, DOI 10.1042/bj1050529
   Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111
   Huang W, 2012, J LIPID RES, V53, P368, DOI 10.1194/jlr.M019687
   Jitrapakdee S, 1999, BIOCHEM J, V340, P1, DOI 10.1042/bj3400001
   Jitrapakdee S, 1998, J BIOL CHEM, V273, P34422, DOI 10.1074/jbc.273.51.34422
   Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269
   Kunxin L, 2008, REGULATION SMAD PATH
   Lahmann PH, 2004, BRIT J CANCER, V91, P1666, DOI 10.1038/sj.bjc.6602203
   Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131
   Ma XR, 2014, P NATL ACAD SCI USA, V111, P14289, DOI 10.1073/pnas.1407640111
   Torrens JM, 2014, CELL PHYSIOL BIOCHEM, V33, P1498, DOI 10.1159/000358714
   Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9
   Reilly SM, 2010, CELL METAB, V12, P643, DOI 10.1016/j.cmet.2010.11.007
   Schmucker DL, 1998, J GERONTOL A-BIOL, V53, pB315, DOI 10.1093/gerona/53A.5.B315
   Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301
   Shah S, 2014, GENOME RES, V24, P1725, DOI 10.1101/gr.176933.114
   Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x
   Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133
   Valenti L, 2013, DIABETES, V62, P4052, DOI 10.2337/db13-0769
   Wijetunga NA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6195
   Xie XM, 2015, PEDIATR RES, V77, P625, DOI 10.1038/pr.2015.32
   Yang BT, 2012, MOL ENDOCRINOL, V26, P1203, DOI 10.1210/me.2012-1004
   Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14
   Zhang XY, 2011, J NUTR, V141, P1254, DOI 10.3945/jn.111.139576
NR 46
TC 17
Z9 20
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD OCT
PY 2016
VL 15
IS 5
BP 964
EP 972
DI 10.1111/acel.12505
PG 9
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA DW5VN
UT WOS:000383715600017
PM 27470058
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Chen, SS
   Wang, HL
   Hu, N
AF Chen, Shasha
   Wang, Honglun
   Hu, Na
TI Long-Term Dietary <i>Lycium ruthenicum</i> Murr. Anthocyanins Intake
   Alleviated Oxidative Stress-Mediated Aging-Related Liver Injury and
   Abnormal Amino Acid Metabolism
SO FOODS
LA English
DT Article
DE Lycium ruthenicum Murr; dietary anthocyanins; anti-aging function;
   liver-protection; serum metabolomics
ID FRUIT; DISEASE; CELL
AB In recent years, the relationship between Lycium ruthenicum Murr. anthocyanins (LRA) and health has attracted increasing attention. The purpose of this study is to investigate the anti-aging effect and mechanism of LRA through a D-galactose (DG)-induced aging rat model. Our results showed that the long-term intake of LRA, for 8 weeks, improved motor function, reduced serum aging markers, promoted the endogenous antioxidant system, and suppressed the serum inflammatory cytokines in aging rats. Besides, the LRA treatment alleviated DG-induced liver injuries by relieving the inflammation and inhibiting Fas/FasL-mediated cell death. More importantly, the abnormal serum metabolome profiles of the aging rats were restored by the LRA, relating to 38 metabolites and 44 pathways. Specifically, the LRA significantly affected the amino acid and protein-related metabolic pathways by regulating the levels of L-threonine, L-aspartic acid, glycine, L-histidine, D-homocysteine, L-homocitrulline, L-homoserine, guanidineacetic acid, and kynurenine. These results have important implications for the development of LRA as an anti-aging and liver-protective ingredient.
C1 [Chen, Shasha; Wang, Honglun; Hu, Na] Northwest Inst Plateau Biol, Qinghai Prov Key Lab Tibetan Med Res, Xining 810008, Peoples R China.
   [Chen, Shasha; Wang, Honglun; Hu, Na] Northwest Inst Plateau Biol, CAS Key Lab Tibetan Med Res, Xining 810008, Peoples R China.
   [Chen, Shasha] Shaanxi Univ Sci & Technol, Sch Food & Biol Engn, Xian 710021, Peoples R China.
   [Wang, Honglun; Hu, Na] Huzhou China Sci Innovat Ctr Plateau Biol, Huzhou 313000, Peoples R China.
C3 Shaanxi University of Science & Technology
RP Hu, N (corresponding author), Northwest Inst Plateau Biol, Qinghai Prov Key Lab Tibetan Med Res, Xining 810008, Peoples R China.; Hu, N (corresponding author), Northwest Inst Plateau Biol, CAS Key Lab Tibetan Med Res, Xining 810008, Peoples R China.; Hu, N (corresponding author), Huzhou China Sci Innovat Ctr Plateau Biol, Huzhou 313000, Peoples R China.
EM huna@nwipb.cas.cn
RI wang, honglun/IAM-8267-2023
OI wang, honglun/0000-0002-9882-9604
FU China Postdoctoral Science Foundation [2020M683413]; Youth Innovation
   Promotion Association, CAS [2020426]; Natural Science Foundation of
   Shaanxi Province [2022JQ-167]; Zhejiang Provincial Natural Science
   Foundation [LQ21C020002]
FX This research was funded by the China Postdoctoral Science Foundation
   (2020M683413), Youth Innovation Promotion Association, CAS (2020426),
   Natural Science Foundation of Shaanxi Province (2022JQ-167), and
   Zhejiang Provincial Natural Science Foundation (No. LQ21C020002).
CR Aon MA, 2020, CELL METAB, V32, P100, DOI 10.1016/j.cmet.2020.04.018
   Azman KF, 2019, BIOGERONTOLOGY, V20, P763, DOI 10.1007/s10522-019-09837-y
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Chen SS, 2022, J FUNCT FOODS, V94, DOI 10.1016/j.jff.2022.105104
   Chen SS, 2019, J AGR FOOD CHEM, V67, P3140, DOI 10.1021/acs.jafc.8b06402
   Chen SS, 2018, FOOD CHEM, V242, P1, DOI 10.1016/j.foodchem.2017.08.105
   DeBerardinis RJ, 2012, CELL, V148, P1132, DOI 10.1016/j.cell.2012.02.032
   Fallah AA, 2020, FOOD CHEM TOXICOL, V135, DOI 10.1016/j.fct.2019.110922
   Goda Y, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101179
   Gong P, 2021, PHYTOMEDICINE, V84, DOI 10.1016/j.phymed.2021.153509
   Johnson LC, 2019, GEROSCIENCE, V41, P895, DOI 10.1007/s11357-019-00123-w
   Jové M, 2016, J GERONTOL A-BIOL, V71, P578, DOI 10.1093/gerona/glv074
   Krishnamurthy K, 2021, LAB MED, V52, pE17, DOI 10.1093/labmed/lmaa059
   Lin JY, 2015, MOL MED REP, V12, P3835, DOI 10.3892/mmr.2015.3840
   Liu H, 2020, FOOD FUNCT, V11, P4103, DOI [10.1039/d0fo00633e, 10.1039/D0FO00633E]
   Liu Jiang-Feng, 2021, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V43, P536, DOI 10.3881/j.issn.1000-503X.13966
   Liu PY, 2022, FOODS, V11, DOI 10.3390/foods11010098
   Martin KS, 2020, AM J PHYSIOL-CELL PH, V318, pC818, DOI 10.1152/ajpcell.00580.2019
   Moldogazieva NT, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3085756
   Nedic O, 2013, FREE RADICAL RES, V47, P28, DOI 10.3109/10715762.2013.806798
   Pan YM, 2022, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.830723
   Peng YJ, 2020, FOOD RES INT, V130, DOI 10.1016/j.foodres.2019.108952
   Peng YJ, 2019, FREE RADICAL BIO MED, V136, P96, DOI 10.1016/j.freeradbiomed.2019.04.005
   Cognuck SQ, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14597
   Rinschen MM, 2019, NAT REV MOL CELL BIO, V20, P353, DOI 10.1038/s41580-019-0108-4
   Rivero-Segura NA, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101164
   Romualdo GR, 2021, FOOD RES INT, V139, DOI 10.1016/j.foodres.2020.109964
   Ros M, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165612
   Rupasinghe HPV, 2019, FOOD CHEM FUNCT ANAL, V12, P123
   Sharma R, 2020, PROTEOMICS, V20, DOI 10.1002/pmic.201800407
   Song HZ, 2016, NUTRITION, V32, P827, DOI 10.1016/j.nut.2016.01.007
   Srivastava S, 2019, METABOLITES, V9, DOI 10.3390/metabo9120301
   Stabler SP, 2020, J NUTR, V150, p2532S, DOI 10.1093/jn/nxaa118
   Tang JL, 2017, J FUNCT FOODS, V30, P97, DOI 10.1016/j.jff.2017.01.015
   Wang HQ, 2018, FOOD CHEM, V240, P759, DOI 10.1016/j.foodchem.2017.08.026
   Wang ZC, 2021, FOOD BIOSCI, V41, DOI 10.1016/j.fbio.2021.100949
   Yin JJ, 2017, RSC ADV, V7, P47848, DOI 10.1039/c7ra09846d
   Zhang G, 2019, IND CROP PROD, V129, P414, DOI 10.1016/j.indcrop.2018.12.026
   Zhao XQ, 2022, AGING CELL, V21, DOI 10.1111/acel.13548
   Zhu X, 2022, CLIN RES HEPATOL GAS, V46, DOI 10.1016/j.clinre.2021.101843
NR 40
TC 3
Z9 3
U1 10
U2 39
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2304-8158
J9 FOODS
JI Foods
PD NOV
PY 2022
VL 11
IS 21
AR 3377
DI 10.3390/foods11213377
PG 14
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA 6F2YB
UT WOS:000883931900001
PM 36359989
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Famularo, S
   Di Sandro, S
   Giani, A
   Angrisani, M
   Lauterio, A
   Romano, F
   Gianotti, L
   De Carlis, L
AF Famularo, Simone
   Di Sandro, Stefano
   Giani, Alessandro
   Angrisani, Marco
   Lauterio, Andrea
   Romano, Fabrizio
   Gianotti, Luca
   De Carlis, Luciano
TI The impact of age and ageing on hepatocarcinoma surgery: Short- and
   long-term outcomes in a multicentre propensity-matched cohort
SO LIVER INTERNATIONAL
LA English
DT Article
DE age; ageing; elderly; HCC; outcomes; potential years of life lost;
   surgery; survival
ID HEPATOCELLULAR-CARCINOMA; ELDERLY-PATIENTS; HEPATIC RESECTION; LIVER
   VOLUME; BLOOD-FLOW; LIFE LOST; COMPLICATIONS; METAANALYSIS; HEPATECTOMY;
   MORTALITY
AB Background Management of malignancy in elderly patients is challenging. We aimed to assess the impact of age and ageing on overall survival (OS), recurrence-free survival (RFS), tumour-specific survival (TSS) and potential years of life lost (PYLL) after surgery for hepatocarcinoma (HCC). Methods Consecutive patients treated for HCC between 2005 and 2015 were evaluated. Patients were divided according to age-decade. Afterwards, elderly patients (>= 75 years) were compared with patients Four hundred and thirty-nine patients were stratified: group 1 (age <= 55, n = 72), group 2 (age: 56-65, n = 133), group 3 (age: 66-74, n = 141) and group 4 (age >= 75, n = 93). Group 1 had the highest median PYLL (27.6, IQR 24.6-32.5) while group 4 the lowest (2.0, IQR 0-9.6; P < 0.001). Comparing elderly vs younger, there were no significant differences in terms of OS (P = 0.054), TSS (P = 0.321) and RFS (P = 0.240). Ageing was the only variable associated with post-operative complications (OR: 2.51; 95% CI: 1.23-5.13; P = 0.025) and liver-related morbidity was an independent predictor of OS. (HR 2.49, 95% CI: 1.34-4.64, P = 0.004). Conclusion Ageing per se is not an absolute contraindication for liver resection, given the acceptable oncologic long-term prognosis, but the worse short-term outcomes in the elderly should induce an accurate patient selection.
C1 [Famularo, Simone; Giani, Alessandro; Angrisani, Marco; Romano, Fabrizio; Gianotti, Luca; De Carlis, Luciano] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy.
   [Famularo, Simone; Di Sandro, Stefano; Lauterio, Andrea; De Carlis, Luciano] Grande Osped Metropolitano Niguarda, Gen & Transplant Surg Unit, Milan, Italy.
   [Giani, Alessandro; Angrisani, Marco; Romano, Fabrizio; Gianotti, Luca] San Gerardo Hosp, Dept Surg, Monza, Italy.
C3 University of Milano-Bicocca; San Gerardo Hospital
RP Gianotti, L (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Monza, Italy.
EM luca.gianotti@unimib.it
RI LAUTERIO, ANDREA/ABE-7865-2020; Angrisani, Marco/GYJ-1332-2022;
   Famularo, Simone/AAA-6544-2022; Famularo, Simone/JYP-4410-2024; Giani,
   Alessandro/AAG-3164-2020
OI LAUTERIO, ANDREA/0000-0001-6110-8582; Famularo,
   Simone/0000-0002-9721-6304; Giani, Alessandro/0000-0003-0718-2321; Di
   Sandro, Stefano/0000-0002-5217-8885
CR Adam R, 2010, BRIT J SURG, V97, P366, DOI 10.1002/bjs.6889
   [Anonymous], 2007, ATLAS UPPER GASTROIN
   [Anonymous], ANN SURG
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321
   Cesari M, 2016, J AM MED DIR ASSOC, V17, P188, DOI 10.1016/j.jamda.2015.12.016
   Cucchetti A, 2016, BRIT J SURG, V103, pE93, DOI 10.1002/bjs.10056
   Deuffic S, 1998, LANCET, V351, P214, DOI 10.1016/S0140-6736(05)78179-4
   Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae
   European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
   Famularo S, 2018, ANN SURG ONCOL, V25, P3974, DOI 10.1245/s10434-018-6730-0
   Famularo S, 2018, EJSO-EUR J SURG ONC, V44, P1580, DOI 10.1016/j.ejso.2018.05.018
   Famularo S, 2018, J SURG ONCOL, V117, P198, DOI 10.1002/jso.24819
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   Gardner J W, 1990, Epidemiology, V1, P322, DOI 10.1097/00001648-199007000-00012
   Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048
   Hung AK, 2015, WORLD J GASTROENTERO, V21, P12197, DOI 10.3748/wjg.v21.i42.12197
   Kishida N, 2015, ANN SURG ONCOL, V22, P3094, DOI 10.1245/s10434-014-4350-x
   Lee CR, 2012, J GASTROINTEST SURG, V16, P1736, DOI 10.1007/s11605-012-1966-7
   Mackenbach JP, 2013, SOC SCI MED, V82, P134, DOI 10.1016/j.socscimed.2012.12.022
   Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   Miki D, 2008, J GASTROENTEROL, V43, P550, DOI 10.1007/s00535-008-2194-5
   Motoyama H, 2015, AM J SURG, V209, P733, DOI 10.1016/j.amjsurg.2014.05.026
   Nozawa A, 2015, SURG TODAY, V45, P851, DOI 10.1007/s00595-014-0994-1
   Oishi K, 2014, WORLD J GASTROENTERO, V20, P15028, DOI 10.3748/wjg.v20.i41.15028
   Pecorelli N, 2018, ANN SURG ONCOL, V25, P308, DOI 10.1245/s10434-017-6216-5
   Petrowsky H, 2005, WORLD J SURG, V29, P1093, DOI 10.1007/s00268-005-1130-6
   POPPER H, 1986, PROG LIVER DIS, V8, P659
   Rahbari NN, 2011, SURGERY, V149, P713, DOI 10.1016/j.surg.2010.10.001
   Revenig LM, 2015, J SURG RES, V193, P583, DOI 10.1016/j.jss.2014.07.069
   Robinson TN, 2013, AM J SURG, V206, P544, DOI 10.1016/j.amjsurg.2013.03.012
   ROMEDER JM, 1977, INT J EPIDEMIOL, V6, P143, DOI 10.1093/ije/6.2.143
   Sandini M, 2017, BJS OPEN, V1, P128, DOI 10.1002/bjs5.22
   Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049
   Santambrogio R, 2017, J GASTROINTEST SURG, V21, P657, DOI 10.1007/s11605-016-3354-1
   Santi V, 2012, J HEPATOL, V56, P397, DOI 10.1016/j.jhep.2011.05.026
   Silber JH, 2007, MED CARE, V45, P918, DOI 10.1097/MLR.0b013e31812e01cc
   Smetana K, 2016, ANTICANCER RES, V36, P5009, DOI 10.21873/anticanres.11069
   Symeonidis D, 2011, TECH COLOPROCTOL, V15, pS47, DOI 10.1007/s10151-011-0751-z
   Tamirisa NP, 2016, ANN SURG, V263, P385, DOI 10.1097/SLA.0000000000001093
   Tsukioka G, 2006, WORLD J GASTROENTERO, V12, P48, DOI 10.3748/wjg.v12.i1.48
   vonsElm E, 2007, PLOS MED, V4, P296
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
   Xu XL, 2018, RADIOLOGY, V287, P461, DOI 10.1148/radiol.2017162756
   Zhou YM, 2013, WORLD J SURG, V37, P2899, DOI 10.1007/s00268-013-2184-5
   Zoli M, 1999, AGE AGEING, V28, P29, DOI 10.1093/ageing/28.1.29
NR 47
TC 15
Z9 15
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD MAY
PY 2019
VL 39
IS 5
BP 894
EP 904
DI 10.1111/liv.14075
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA HW6LL
UT WOS:000466801400014
PM 30790410
DA 2024-02-19
ER

PT J
AU Alsuraih, M
   O'Hara, SP
   Woodrum, JE
   Pirius, NE
   LaRusso, NF
AF Alsuraih, Mohammed
   O'Hara, Steven P.
   Woodrum, Julie E.
   Pirius, Nicholas E.
   LaRusso, Nicholas F.
TI Genetic or pharmacological reduction of cholangiocyte senescence
   improves inflammation and fibrosis in the <i>Mdr2</i><SUP>-/-</SUP>
   mouse
SO JHEP REPORTS
LA English
DT Article; Early Access
DE Primary sclerosing cholangitis; Cellular senescence; Apoptosis
   resistance; Cholestatic liver disease; Biliary epithelial cell;
   Senolytics; Senescence-associated secretory phenotype
ID CELLULAR SENESCENCE; SCLEROSING CHOLANGITIS; SECRETORY PHENOTYPE; BCL-2
   FAMILY; CELLS; INHIBITORS; DISEASE; ABSENCE; BILE
AB Background & Aims: Cholangiocyte senescence is important in the pathogenesis of primary sclerosing cholangitis (PSC). We found that CDKN2A (p16), a cyclin-dependent kinase inhibitor and mediator of senescence, was increased in cholangiocytes of patients with PSC and from a PSC mouse model (multidrug resistance 2; Mdr2(-/-)). Given that recent data suggest that a reduction of senescent cells is beneficial in different diseases, we hypothesised that inhibition of cholangiocyte senescence would ameliorate disease in Mdr2(-/-) mice.
   Methods: We used 2 novel genetic murine models to reduce cholangiocyte senescence: (i) p16(Ink4a) apoptosis through targeted activation of caspase (INK-ATTAC)xMdr2(-/-), in which the dimerizing molecule AP20187 promotes selective apoptotic removal of p16-expressing cells; and (ii) mice deficient in both p16 and Mdr2. Mdr2(-/-) mice were also treated with fisetin, a flavonoid molecule that selectively kills senescent cells. p16, p21, and inflammatory markers (tumour necrosis factor [TNF]-alpha, IL-1 beta, and monocyte chemoattractant protein-1 [MCP-1]) were measured by PCR, and hepatic fibrosis via a hydroxyproline assay and Sirius red staining.
   Results: AP20187 treatment reduced p16 and p21 expression by similar to 35% and similar to 70% (p >0.05), respectively. Expression of inflammatory markers (TNF-alpha, IL-1 beta, and MCP-1) decreased (by 60%, 40%, and 60%, respectively), and fibrosis was reduced by similar to 60% (p >0.05). Similarly, p16(-/-)xMdr2(-/-) mice exhibited reduced p21 expression (70%), decreased expression of TNF-alpha, IL-1 beta (60%), and MCP-1 (65%) and reduced fibrosis (similar to 50%) (p >0.05) compared with Mdr2(-/-) mice. Fisetin treatment reduced expression of p16 and p21 (80% and 90%, respectively), TNF-alpha (50%), IL-1 beta (50%), MCP-1 (70%), and fibrosis (60%) (p >0.05).
   Conclusions: Our data support a pathophysiological role of cholangiocyte senescence in the progression of PSC, and that targeted removal of senescent cholangiocytes is a plausible therapeutic approach.
   Lay summary: Primary sclerosing cholangitis is a fibroinflammatory, incurable biliary disease. We previously reported that biliary epithelial cell senescence (cell-cycle arrest and hypersecretion of profibrotic molecules) is an important phenotype in primary sclerosing cholangitis. Herein, we demonstrate that reducing the number of senescent cholangiocytes leads to a reduction in the expression of inflammatory, fibrotic, and senescence markers associated with the disease. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
C1 [Alsuraih, Mohammed] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.
   [Alsuraih, Mohammed] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN 55905 USA.
   [O'Hara, Steven P.; Woodrum, Julie E.; Pirius, Nicholas E.; LaRusso, Nicholas F.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.
   [O'Hara, Steven P.; Woodrum, Julie E.; Pirius, Nicholas E.; LaRusso, Nicholas F.] Mayo Clin, Ctr Cell Signaling Gastroenterol, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic
RP LaRusso, NF (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA.
EM alsuraih.mohammed@mayo.edu; ohara.steven@mayo.edu;
   broadcampiing@kmtel.com; Pirius.Nicholas@mayo.edu;
   larusso.nicholas@myo.edu
FU National Institutes of Health [DK57993]; Mayo Foundation; Clinical Core
   of the Mayo Clinic Center for Cell Signaling in Gastroenterology
   [P30DK084567]; Optical Microscopy Core of the Mayo Clinic Center for
   Cell Signaling in Gastroenterology [P30DK084567]
FX This work was supported by National Institutes of Health Grant DK57993
   (to N.F.L), the Mayo Foundation, and the Clinical and Optical Microscopy
   Cores of the Mayo Clinic Center for Cell Signaling in Gastroenterology
   (P30DK084567).
CR Al Suraih MS, 2020, LIVER INT, V40, P2455, DOI 10.1111/liv.14569
   Ashkenazi A, 2017, NAT REV DRUG DISCOV, V16, P273, DOI 10.1038/nrd.2016.253
   Azad AI, 2020, HEPATOLOGY, V72, P1013, DOI 10.1002/hep.31211
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Ferreira-Gonzalez S, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-03299-5, 10.1038/s41467-018-06183-4]
   Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009
   Grosse L, 2020, CELL METAB, V32, P87, DOI 10.1016/j.cmet.2020.05.002
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3
   Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022
   Kirkland JL, 2017, EBIOMEDICINE, V21, P21, DOI 10.1016/j.ebiom.2017.04.013
   Kyritsi K, 2020, GENE EXPRESSION, V20, P89, DOI 10.3727/105221620X15889714507961
   Lazaridis KN, 2016, NEW ENGL J MED, V375, P1161, DOI 10.1056/NEJMra1506330
   Leverson JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4642
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532
   Serrano M, 2018, NAT MED, V24, P1092, DOI 10.1038/s41591-018-0141-4
   SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9
   Tabibian JH, 2016, HEPATOLOGY, V63, P185, DOI 10.1002/hep.27927
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Wan Y, 2017, HEPATOLOGY, V66, P528, DOI 10.1002/hep.29138
   Zhu Y, 2017, AGING-US, V9, P955, DOI 10.18632/aging.101202
   Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
NR 33
TC 16
Z9 17
U1 0
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2589-5559
J9 JHEP REP
JI JHEP Rep.
PD 2021 JUN
PY 2021
VL 3
IS 3
DI 10.1016/j.jhepr.2021.100250
EA APR 2021
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA SN4VX
UT WOS:000658290100002
PM 33870156
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Mori, M
   Toyokuni, S
   Kondo, S
   Kasai, H
   Naiki, H
   Toichi, E
   Hosokawa, M
   Higuchi, K
AF Mori, M
   Toyokuni, S
   Kondo, S
   Kasai, H
   Naiki, H
   Toichi, E
   Hosokawa, M
   Higuchi, K
TI Spontaneous loss-of-function mutations of the 8-oxoguanine DNA
   glycosylase gene in mice and exploration of the possible implication of
   the gene in senescence
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE OGG1; oxidative DNA damage; 8-oxoguanine; senescence; mutation; free
   radicals
ID TRANSCRIPTION-COUPLED REPAIR; ACCELERATED MOUSE SAM; COCKAYNE-SYNDROME;
   ESCHERICHIA-COLI; MMH/OGG1 GENE; MURINE MODEL; OGG1 GENE;
   8-HYDROXYGUANINE; DAMAGE; CELLS
AB 8-Oxoguanine is one of the major premutagenic oxidative base legions in vivo and is suspected to play a crucial role in various pathophysiological processes, such as cancer and aging. Mammalian 8-oxoguanine DNA glycosylase (OOG1) is thought to play a major role in the removal of 8-oxoguanine adducts in vivo. We have identified several inbred mouse strains with a spontaneous mutation, OGG1-R336H or double mutations, OGC1-R304W/R336H. R304W mutation caused a complete loss of OGG1 activity, while the R336H mutation led to disruption of nuclear localization of the enzyme although the activity remained normal. Among the double mutants was SAMP1, which exhibits accelerated senescence and short lifespan. We assessed the possible implication of the mutant OGG1 and 8-oxoguanine in aging utilizing SAMP1 mice. SAMP1 retained 1.5- to 1.9-fold increase in 8-oxoguanine level of hepatic nuclear DNA as compared with normal mice, until at least 12 months of age. A genetic association study, however, indicated that the mutant Ogg1 gene per se is not responsible for the accelerated senescence and short lifespan of SAMP1. Mutant OGG1 may be associated with pathologic conditions in other mouse strains. (C) 2001 Elsevier Science Inc.
C1 Shinshu Univ, Sch Med, Res Ctr Aging & Adaptat, Dept Aging Angiol, Matsumoto, Nagano 3908621, Japan.
   Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan.
   Univ Occupat & Environm Hlth, Dept Occupat Oncol, Kitakyushu, Fukuoka 807, Japan.
   Fukui Med Univ, Dept Pathol, Fukui, Japan.
   Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan.
   Kyoto Univ, Inst Frontier Med Sci, Field Regenerat Control, Kyoto, Japan.
C3 Shinshu University; Kyoto University; University of Occupational &
   Environmental Health - Japan; University of Fukui; Kyoto University;
   Kyoto University
RP Mori, M (corresponding author), Shinshu Univ, Sch Med, Res Ctr Aging & Adaptat, Dept Aging Angiol, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.
EM masamori@sch.md.shinshu-u.ac.jp
RI Naiki, Hironobu/G-5599-2014; Toyokuni, Shinya/ABE-7714-2021; Toyokuni,
   Shinya/C-1358-2010
OI Toyokuni, Shinya/0000-0002-5757-1109; Toyokuni,
   Shinya/0000-0002-5757-1109
CR Aburatani H, 1997, CANCER RES, V57, P2151
   Arai K, 1997, ONCOGENE, V14, P2857, DOI 10.1038/sj.onc.1201139
   BESSHO T, 1993, J BIOL CHEM, V268, P19416
   Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773
   Butterfield DA, 1997, P NATL ACAD SCI USA, V94, P674, DOI 10.1073/pnas.94.2.674
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096
   CHOI JH, 1994, INT CONGR SER, V1062, P321
   Choi JY, 1999, FREE RADICAL BIO MED, V27, P848, DOI 10.1016/S0891-5849(99)00141-0
   CHUNG MH, 1991, BIOCHEM BIOPH RES CO, V178, P1472, DOI 10.1016/0006-291X(91)91059-L
   Dianov G, 1999, NUCLEIC ACIDS RES, V27, P1365, DOI 10.1093/nar/27.5.1365
   EDAMATSU R, 1995, BIOCHEM BIOPH RES CO, V211, P847, DOI 10.1006/bbrc.1995.1889
   FESTING M F W, 1971, Laboratory Animals (London), V5, P179, DOI 10.1258/002367771781006564
   GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z
   HATTORINAKAKUKI Y, 1994, BIOCHEM BIOPH RES CO, V201, P1132, DOI 10.1006/bbrc.1994.1823
   HE PM, 1994, MECH AGEING DEV, V76, P43, DOI 10.1016/0047-6374(94)90006-X
   HOSOKAWA M, 1984, MECH AGEING DEV, V26, P91, DOI 10.1016/0047-6374(84)90168-4
   Ishida T, 1999, INT J CANCER, V80, P18
   Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300
   Le Page F, 2000, P NATL ACAD SCI USA, V97, P8397, DOI 10.1073/pnas.140137297
   Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2
   Lilly F., 1973, Advances in Cancer Research, V17, P231, DOI 10.1016/S0065-230X(08)60532-1
   LIU JK, 1993, MECH AGEING DEV, V71, P23, DOI 10.1016/0047-6374(93)90032-M
   Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4
   Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497
   MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y
   MURPHY ED, 1981, IMMUNOLOGIC DEFECTS, V1, P143
   MURPHY EDWIN D., 1963, PROC AMER ASSOC CANCER RES, V4, P46
   Nagashima M, 1997, MUTAT RES-DNA REPAIR, V383, P49, DOI 10.1016/S0921-8777(96)00045-6
   NAIKI H, 1993, LAB INVEST, V68, P332
   NISITANI S, 1990, MUTAT RES, V237, P221, DOI 10.1016/0921-8734(90)90003-A
   Odagiri Y, 1998, NAT GENET, V19, P116, DOI 10.1038/468
   Onda M, 1999, GENETICS, V151, P439
   PARK JW, 1996, J GERONTOL, V51, P337
   Rosenquist TA, 1997, P NATL ACAD SCI USA, V94, P7429, DOI 10.1073/pnas.94.14.7429
   SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0
   Shinmura K, 1998, JPN J CANCER RES, V89, P825, DOI 10.1111/j.1349-7006.1998.tb00635.x
   SIMPSON L O, 1976, Laboratory Animals (London), V10, P249, DOI 10.1258/002367776781035288
   Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8
   TOBITA M, 1994, INT CONGR SER, V1062, P125
   WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011
   YAMAGISHI H, 1985, MECH AGEING DEV, V29, P101, DOI 10.1016/0047-6374(85)90051-X
   YAMAMOTO F, 1992, JPN J CANCER RES, V83, P351, DOI 10.1111/j.1349-7006.1992.tb00114.x
NR 43
TC 12
Z9 13
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD MAY 15
PY 2001
VL 30
IS 10
BP 1130
EP 1136
DI 10.1016/S0891-5849(01)00511-1
PG 7
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 431WL
UT WOS:000168654700009
PM 11369503
DA 2024-02-19
ER

PT J
AU MERRY, BJ
   HOLEHAN, AM
AF MERRY, BJ
   HOLEHAN, AM
TI EFFECT OF AGE AND RESTRICTED FEEDING ON POLYPEPTIDE-CHAIN ASSEMBLY
   KINETICS IN LIVER PROTEIN-SYNTHESIS INVIVO
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE DIETARY RESTRICTION; ELONGATION RATES; PROTEIN SYNTHESIS;
   3,5,3'-L-TRIIODOTHYRONINE; RNA
ID DIETARY RESTRICTION; ACID-PHOSPHATASES; RATS; MICE
AB Polypeptide assembly rates during in vivo hepatic protein synthesis were studied as a function of age and restricted feeding in male rats. With ageing the time to assemble the average peptide in the liver of fully-fed rats significantly increased. In young rats maintained on a restricted feeding regime known to retard ageing, the time to assemble the average polypeptide was increased 2.5 times. With ageing the rate of peptide elongation increased so that at 2 years of age the underfed animals assembled peptides at a significantly faster rate than their age-matched controls. The rate of elongation of peptides during hepatic protein synthesis was shown to be directly dependent upon circulating T3 levels rather than the dietary status of the animal. On refeeding young diet restricted rats, polypeptide assembly kinetics did not immediately return to control values although the rate of protein synthesis was significantly increased. Total liver RNA content increased significantly in refed animals allowing for a greater rate of chain initiation to offset the slow rate of chain elongation. A period of 28 days of ad libitum feeding was required before assembly kinetics returned to control values and is probably indicative of a persistent impaired monodeiodination of T4 to T3.
RP MERRY, BJ (corresponding author), UNIV LIVERPOOL,INST HUMAN AGEING,POB 147,LIVERPOOL L69 3BX,ENGLAND.
CR Barsano C. P., 1983, MOL BASIS THYROID HO, P139
   BOLLUM FJ, 1959, J BIOL CHEM, V234, P2733
   CAVALLIUS J, 1986, EXP GERONTOL, V21, P149, DOI 10.1016/0531-5565(86)90068-9
   CHENEY KE, 1983, J GERONTOL, V38, P420, DOI 10.1093/geronj/38.4.420
   DISTEFANO JJ, 1982, ENDOCRINOLOGY, V110, P198, DOI 10.1210/endo-110-1-198
   GABIUS HJ, 1983, FEBS LETT, V160, P115, DOI 10.1016/0014-5793(83)80948-X
   GAHAN PB, 1986, MOD TRENDS AGEING RE, V147, P169
   HASCHEME.AE, 1969, P NATL ACAD SCI USA, V62, P128, DOI 10.1073/pnas.62.1.128
   HASCHEMEYER AEV, 1968, BIOL BULL, P130
   HUNT T, 1969, J MOL BIOL, V43, P123, DOI 10.1016/0022-2836(69)90083-7
   Jagus R, 1981, Prog Nucleic Acid Res Mol Biol, V25, P127, DOI 10.1016/S0079-6603(08)60484-5
   KAPLAN MM, 1979, ENDOCRINOLOGY, V104, P58, DOI 10.1210/endo-104-1-58
   MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x
   MATHEWS RW, 1976, BIOCHIM BIOPHYS ACTA, V425, P220, DOI 10.1016/0005-2787(76)90028-9
   MATHEWS RW, 1973, BIOL CHEM, V248, P1329
   Merry B J, 1985, Basic Life Sci, V35, P117
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   MERRY BJ, 1981, EXP GERONTOL, V16, P431, DOI 10.1016/0531-5565(81)90025-5
   MERRY BJ, 1988, REGULATION NEUROENDO, V24, P61
   MIDDLETON J, 1979, HISTOCHEM J, V11, P649, DOI 10.1007/BF01004729
   MIDDLETON J, 1982, EXP GERONTOL, V17, P267, DOI 10.1016/0531-5565(82)90015-8
   MUNRO HN, 1966, ANALYST, V91, P78, DOI 10.1039/an9669100078
   NELSON W, 1986, J NUTR, V116, P2244, DOI 10.1093/jn/116.11.2244
   SHEPHERD JCW, 1989, P NATL ACAD SCI USA, V86, P7520, DOI 10.1073/pnas.86.19.7520
   SONG JM, 1989, MOL CELL BIOL, V9, P4571, DOI 10.1128/MCB.9.10.4571
   Towle H.C., 1983, MOLE BASIS THYROID H, P179
   VANDOORN J, 1984, ENDOCRINOLOGY, V115, P174, DOI 10.1210/endo-115-1-174
   VUUST J, 1970, J BIOL CHEM, V245, P6201
   WEBSTER GC, 1985, MOL BIOL AGING GENE, P263
   Weindruch R., 1988, RETARDATION AGING DI, P231
NR 30
TC 21
Z9 25
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAY
PY 1991
VL 58
IS 2-3
BP 139
EP 150
DI 10.1016/0047-6374(91)90088-H
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA FP286
UT WOS:A1991FP28600003
PM 1715006
DA 2024-02-19
ER

PT J
AU Chen, HA
   Ho, YJ
   Mezzadra, R
   Adrover, JM
   Smolkin, R
   Zhu, CY
   Woess, K
   Bernstein, N
   Schmitt, G
   Fong, L
   Luan, W
   Wuest, A
   Tian, S
   Li, X
   Broderick, C
   Hendrickson, RC
   Egeblad, M
   Chen, ZH
   Alonso-Curbelo, D
   Lowe, SW
AF Chen, Hsuan-An
   Ho, Yu-Jui
   Mezzadra, Riccardo
   Adrover, Jose M.
   Smolkin, Ryan
   Zhu, Changyu
   Woess, Katharina
   Bernstein, Nicholas
   Schmitt, Georgia
   Fong, Linda
   Luan, Wei
   Wuest, Alexandra
   Tian, Sha
   Li, Xiang
   Broderick, Caroline
   Hendrickson, Ronald C.
   Egeblad, Mikala
   Chen, Zhenghao
   Alonso-Curbelo, Direna
   Lowe, Scott W.
TI Senescence Rewires Microenvironment Sensing to Facilitate Antitumor
   Immunity
SO CANCER DISCOVERY
LA English
DT Article
ID CELLULAR SENESCENCE; IFN-GAMMA; SECRETORY PHENOTYPE; TUMOR-CELLS;
   RNA-SEQ; P53; THERAPY; MECHANISMS; RESISTANCE; DYNAMICS
AB Cellular senescence involves a stable cell-cycle arrest coupled to a secretory pro-gram that, in some instances, stimulates the immune clearance of senescent cells. Using an immune-competent liver cancer model in which senescence triggers CD8 T cell-mediated tumor rejection, we show that senescence also remodels the cell-surface proteome to alter how tumor cells sense environmental factors, as exemplifi ed by type II interferon (IFN gamma). Compared with proliferat-ing cells, senescent cells upregulate the IFN gamma receptor, become hypersensitized to microenvironmental IFN gamma , and more robustly induce the antigen-presenting machinery-effects also recapitulated in human tumor cells undergoing therapy-induced senescence. Disruption of IFN gamma sensing in senescent cells blunts their immune-mediated clearance without disabling the senescence state or its characteristic secretory program. Our results demonstrate that senescent cells have an enhanced ability to both send and receive environmental signals and imply that each process is required for their effective immune surveillance.SIGNIFICANCE: Our work uncovers an interplay between tissue remodeling and tissue-sensing pro-grams that can be engaged by senescence in advanced cancers to render tumor cells more visible to the adaptive immune system. This new facet of senescence establishes reciprocal heterotypic signaling interactions that can be induced therapeutically to enhance antitumor immunity.
C1 [Chen, Hsuan-An; Ho, Yu-Jui; Mezzadra, Riccardo; Zhu, Changyu; Luan, Wei; Wuest, Alexandra; Tian, Sha; Li, Xiang; Broderick, Caroline; Alonso-Curbelo, Direna; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY USA.
   [Chen, Hsuan-An; Smolkin, Ryan] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY USA.
   [Adrover, Jose M.; Egeblad, Mikala] Cold Spring Harbor Lab, Cold Spring Harbor, NY USA.
   [Woess, Katharina] Barcelona Inst Sci & Technol BIST, Inst Res Biomed IRB Barcelona, Barcelona, Spain.
   [Bernstein, Nicholas; Schmitt, Georgia; Fong, Linda; Chen, Zhenghao] Calico Life Sci, South San Francisco, CA USA.
   [Hendrickson, Ronald C.] Mem Sloan Kettering Canc Ctr, Microchem & Prote Core Lab, New York, NY USA.
   [Lowe, Scott W.] Howard Hughes Med Inst, Chevy Chase, MD USA.
   [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, 417 East 68th St, New York, NY 10065 USA.
   [Alonso-Curbelo, Direna] Inst Res Biomed IRB Barcelona, Carrer de Baldiri Reixac 10, Barcelona 08028, Spain.
C3 Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer
   Center; Cold Spring Harbor Laboratory; Barcelona Institute of Science &
   Technology; Institute for Research in Biomedicine - IRB Barcelona;
   Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute;
   Memorial Sloan Kettering Cancer Center; Barcelona Institute of Science &
   Technology; Institute for Research in Biomedicine - IRB Barcelona
RP Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, 417 East 68th St, New York, NY 10065 USA.; Alonso-Curbelo, D (corresponding author), Inst Res Biomed IRB Barcelona, Carrer de Baldiri Reixac 10, Barcelona 08028, Spain.
EM direna.alonso-curbelo@irbbarcelona.org; lowes@mskcc.org
RI Zhang, Zixuan/JSL-3603-2023; Wang, Yanan/JVZ-7957-2024; Li,
   Xiang/HKE-2548-2023; Adrover, Jose M/G-9741-2017; Yuan,
   Fang/JQV-7426-2023; Alonso Curbelo, Direna/AFT-1035-2022; Chen,
   Feng/JQW-8742-2023; LI, SHA/JNR-9956-2023; wu, jialin/JPY-4408-2023; Ho,
   Yu-Jui/HNS-9777-2023; qi, qi/JWP-1757-2024; Egeblad,
   Mikala/GNP-0620-2022
OI Adrover, Jose M/0000-0002-1395-5477; Alonso Curbelo,
   Direna/0000-0001-6674-3059; Schmitt, Georgia/0000-0001-7554-9880; Chen,
   Hsuan-An/0000-0002-8979-3670; Woess, Katharina/0000-0001-6189-2733; Ho,
   Yu-jui/0000-0002-7540-024X; Mezzadra, Riccardo/0000-0002-7737-8461; Zhu,
   Changyu/0000-0003-3583-3638
FU NIH F99 Fellowship [F99CA245797]; "la Caixa" Foundation Junior Leader
   Fellowship [LCF/BQ/PI20/11760006]; NWO (Dutch Research Council-Rubicon
   Fellowship) [452182318]; Cancer Research Institute (CRI Award) [3441];
   Cancer Research Institute/Irvington Postdoctoral Fel-lowship [3435]; F32
   Postdoc-toral Fellowship from the NIH/NCI [1F32CA257103]; NCI
   [1R01CA237413]; Cold Spring Harbor Laboratory Cancer Center
   [P30CA045508]; IRB Bar-celona; Calico Life Sciences; Geoffrey Beene
   Chair for Cancer Biology; "la Caixa" Foundation
FX We thank J. Simon and the MSKCC animal facility for technical support
   with animal colonies; J.E. Wilkinson and J. Shia for mouse liver cancer
   pathology consulting; E. de Stanchina and A. Kulick from the MSKCC
   Antitumor Assessment Core Facility for animal treatment support; Z. Li,
   A. Gaito, and M. Miele from the MSKCC Microchemistry and Proteomics Core
   for proteomic profiling technical support; N. Prats and M. Aguilera from
   the IRB Barcelona Histopathology Facility for the support of
   immu-nofluorescence staining protocol; and J.P. Morris IV, S. Houlihan,
   J. Novak, and other members of the Lowe laboratory for advice,
   manuscript editing, and discussions. H.-A. Chen was supported by an NIH
   F99 Fellowship (F99CA245797) . D. Alonso-Curbelo is supported by the "la
   Caixa" Foundation Junior Leader Fellowship (LCF/BQ/PI20/11760006) . R.
   Mezzadra was supported by NWO (Dutch Research Council-Rubicon Fellowship
   452182318) and is a Cancer Research Institute Irvington Fellow supported
   by the Cancer Research Institute (CRI Award #3441) . J.M. Adrover is the
   recipient of a Cancer Research Institute/Irvington Postdoctoral
   Fel-lowship (CRI Award #3435) . C. Zhu is supported by an F32
   Postdoc-toral Fellowship (1F32CA257103) from the NIH/NCI. M. Egeblad is
   supported by a grant from the NCI (1R01CA237413) and the work was
   supported by the Cold Spring Harbor Laboratory Cancer Center
   (P30CA045508) . This work was also supported by IRB Bar-celona and "la
   Caixa" Foundation (to D. Alonso-Curbelo) and NIH/NCI P01CA087497 and
   Calico Life Sciences grants (to S.W. Lowe) . S.W. Lowe is an
   investigator at the Howard Hughes Medical Institute and the Geoffrey
   Beene Chair for Cancer Biology. The publication costs of this article
   were defrayed in part by the payment of publication fees. Therefore, and
   solely to indicate this fact, this article is hereby marked
   "advertisement" in accordance with 18 USC section 1734.
CR Adrover JM, 2020, NAT IMMUNOL, V21, P135, DOI 10.1038/s41590-019-0571-2
   Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Bernstein NJ, 2020, CELL SYST, V11, P95, DOI 10.1016/j.cels.2020.05.010
   Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003
   Binder JX, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau012
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bruix J, 2017, J HEPATOL, V67, P999, DOI 10.1016/j.jhep.2017.06.026
   Castro F, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00847
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dann E, 2022, NAT BIOTECHNOL, V40, P245, DOI 10.1038/s41587-021-01033-z
   De Simone G, 2021, IMMUNITY, V54, P2089, DOI 10.1016/j.immuni.2021.05.005
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Demir Ö, 2021, CURR OPIN STRUC BIOL, V67, P187, DOI 10.1016/j.sbi.2020.11.005
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638
   DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Efeyan A, 2007, CANCER RES, V67, P7350, DOI 10.1158/0008-5472.CAN-07-0200
   Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364
   Foroutan M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2435-4
   Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069
   Hänzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Hoekstra ME, 2020, NAT CANCER, V1, P291, DOI 10.1038/s43018-020-0036-4
   Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089
   Jochems F, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109441
   Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X
   Kalaora S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14639-9
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kim HD, 2020, HEPATOLOGY, V71, P955, DOI 10.1002/hep.30881
   Kleppe M, 2011, BLOOD, V117, P7090, DOI 10.1182/blood-2010-10-314286
   Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0
   Kuang DM, 2009, J EXP MED, V206, P1327, DOI 10.1084/jem.20082173
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Levine AJ, 2022, CANCER RES, V82, P362, DOI 10.1158/0008-5472.CAN-21-2709
   Li YH, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1838141
   Llovet JM, 2022, NAT REV CLIN ONCOL, V19, P151, DOI 10.1038/s41571-021-00573-2
   Llovet JM, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-020-00240-3
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lu LG, 2022, GUT, V71, P2551, DOI 10.1136/gutjnl-2021-326350
   Lujambio A, 2016, BIOESSAYS, V38, pS56, DOI 10.1002/bies.201670910
   Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270
   McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021
   McInnes L., 2018, ARXIV, V3, P861, DOI [arXiv:1802.03426, DOI 10.21105/JOSS.00861, 10.21105/joss.00861]
   Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Ovadya Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07825-3
   Paffenholz SV, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2117754119
   Perna F, 2017, CANCER CELL, V32, P506, DOI 10.1016/j.ccell.2017.09.004
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Rapisarda V, 2017, CELL REP, V18, P2480, DOI 10.1016/j.celrep.2017.02.012
   Ruscetti M, 2020, CELL, V181, P424, DOI 10.1016/j.cell.2020.03.008
   Ruscetti M, 2018, SCIENCE, V362, P1416, DOI 10.1126/science.aas9090
   Sangro B, 2021, NAT REV GASTRO HEPAT, V18, P525, DOI 10.1038/s41575-021-00438-0
   Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004
   Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056
   Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314
   Susaki EA, 2015, NAT PROTOC, V10, P1709, DOI 10.1038/nprot.2015.085
   Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217
   Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z
   Xiao YL, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28279-8
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yoshihama S, 2017, TRENDS CANCER, V3, P28, DOI 10.1016/j.trecan.2016.12.003
   Yousef H, 2019, NAT MED, V25, P988, DOI 10.1038/s41591-019-0440-4
   Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240
   Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120
   Zhu CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0344
NR 80
TC 15
Z9 16
U1 15
U2 51
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 2159-8274
EI 2159-8290
J9 CANCER DISCOV
JI Cancer Discov.
PD FEB
PY 2023
VL 13
IS 2
BP 432
EP 453
DI 10.1158/2159-8290.CD-22-0528
PG 22
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 8S3CH
UT WOS:000928460200001
OA Green Published, Green Submitted, Green Accepted, hybrid
HC Y
HP N
DA 2024-02-19
ER

PT J
AU Jacob, MHVM
   Janner, DD
   Araújo, ASD
   Jahn, MP
   Kucharski, LCR
   Moraes, TB
   Dutra, CS
   Ribeiro, MFM
   Belló-Klein, A
AF Vianna Metello Jacob, Maria Helena
   Janner, Daiane da Rocha
   da Rosa Araujo, Alex Sander
   Jahn, Matheus Parmegiani
   Rios Kucharski, Luiz Carlos
   Moraes, Tarsila Barros
   Dutra Filho, Carlos Severo
   Marques Ribeiro, Maria Flavia
   Bello-Klein, Adriane
TI Dehydroepiandrosterone improves hepatic antioxidant reserve and
   stimulates Akt signaling in young and old rats
SO JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE DHEA; Aging; Liver; GSH; Hydrogen peroxide; Akt
ID LIVER; GLUTATHIONE; ACTIVATION; REDOX; DHEA; ENZYMES; CELLS
AB This study examined, in the liver of young and old (3- and 24-month-old, respectively) healthy Wistar rats, the in vivo effect of dehydroepiandrosterone (DHEA) (10 mg/kg body weight) administered subcutaneously for 5 weeks. Reduced (GSH) and oxidized (GSSG) glutathione levels, glucose-6-phosphate dehydrogenase (G6PDH), glutathione-S-transferase (GST), glutathione peroxidase (GPx) and catalase (CAT) activities, hydrogen peroxide concentration, GST and p-Akt/Akt immunocontent ratio were assessed in hepatic tissue. DHEA treatment significantly increased total glutathione content (17%) and GSH (22%) in 3- and 24-month-old treated groups when compared to control groups. The aging factor increased G6PDH (51%) and GPx (22%) activities as well as the hydrogen peroxide concentration (33%), independently of treatment. DHEA treatment increased p-Akt (54%) and p-Akt/Akt ratio (36%) immuno-contents in both treated groups. Increased serum levels of alanine aminotransferase (ALT) in aged rats were reduced by DHEA treatment (34%). (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Vianna Metello Jacob, Maria Helena; da Rosa Araujo, Alex Sander; Bello-Klein, Adriane] ICBS UFRGS, Lab Fisiol Cardiovasc, BR-90050170 Porto Alegre, RS, Brazil.
   [Vianna Metello Jacob, Maria Helena; Janner, Daiane da Rocha; Marques Ribeiro, Maria Flavia] ICBS UFRGS, Lab Interacao Neurohumoral, BR-90050170 Porto Alegre, RS, Brazil.
   [Jahn, Matheus Parmegiani; Rios Kucharski, Luiz Carlos] ICBS UFRGS, Lab Metab & Endocrinol Comparada, BR-90050170 Porto Alegre, RS, Brazil.
   [Moraes, Tarsila Barros; Dutra Filho, Carlos Severo] ICBS UFRGS, Lab Erros Inatos Metab, BR-90035003 Porto Alegre, RS, Brazil.
C3 Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio
   Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade
   Federal do Rio Grande do Sul
RP Jacob, MHVM (corresponding author), ICBS UFRGS, Lab Fisiol Cardiovasc, Av Sarmento Leite 500, BR-90050170 Porto Alegre, RS, Brazil.
EM mhvmjacob@hotmail.com
RI da Rosa Araujo, Alex Sander/E-7519-2011; DUTRA-FILHO, CARLOS
   S/G-7979-2015; Kucharski, Luiz Carlos/AAC-2036-2020
OI da Rosa Araujo, Alex Sander/0000-0002-9482-7388; DUTRA-FILHO, CARLOS
   S/0000-0002-6129-8758; Parmegiani Jahn, Matheus/0000-0003-4831-6760;
   Kucharski, Luiz Carlos/0000-0002-7868-8840; Marques Ribeiro, Maria
   Flavia/0000-0002-2265-7332
FU CAPES; CNPq; FAPERGS
FX This work was supported by CAPES, CNPq and FAPERGS (Brazilian Research
   Agencies).
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Akerboom T P, 1981, Methods Enzymol, V77, P373
   Aragno M, 1999, FREE RADICAL BIO MED, V26, P1467, DOI 10.1016/S0891-5849(99)00012-X
   Bacsi Krisztian, 2007, Orvosi Hetilap, V148, P1273, DOI 10.1556/OH.2007.28102
   Bayorh MA, 2004, AM J HYPERTENS, V17, P31, DOI 10.1016/j.amjhyper.2003.08.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cai H, 2003, MOL PHARMACOL, V63, P325, DOI 10.1124/mol.63.2.325
   Campbell CSG, 2004, LIFE SCI, V76, P57, DOI 10.1016/j.lfs.2004.06.017
   Dalla Valle L, 1995, MOL CELL ENDOCRINOL, V111, P83, DOI 10.1016/0303-7207(95)03553-J
   DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   Genazzani AD, 2007, DRUG AGING, V24, P173, DOI 10.2165/00002512-200724030-00001
   Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040
   HENRY RJ, 1960, AM J CLIN PATHOL, V34, P381
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Jacob MHVM, 2008, J STEROID BIOCHEM, V112, P138, DOI 10.1016/j.jsbmb.2008.09.008
   Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383
   Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Laurine E, 2003, J BIOL CHEM, V278, P29979, DOI 10.1074/jbc.M303242200
   LEONG SF, 1984, BIOCHEM J, V218, P131, DOI 10.1042/bj2180131
   Liu DM, 2007, ENDOCRINOLOGY, V148, P3068, DOI 10.1210/en.2006-1378
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mannervik B, 1981, Methods Enzymol, V77, P231
   Martin M, 2010, J GASTROINTEST SURG, V14, P511, DOI 10.1007/s11605-009-1104-3
   Mastrocola R, 2003, LIFE SCI, V73, P289, DOI 10.1016/S0024-3205(03)00287-X
   Medina MC, 2006, FEBS LETT, V580, P285, DOI 10.1016/j.febslet.2005.12.014
   Mo QX, 2006, J STEROID BIOCHEM, V99, P50, DOI 10.1016/j.jsbmb.2005.11.011
   Nakamura S, 2004, CIRCULATION, V110, P1787, DOI 10.1161/01.CIR.0000143072.36782.51
   Paravicini TM, 2006, CARDIOVASC RES, V71, P247, DOI 10.1016/j.cardiores.2006.05.001
   Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6
   Pelissier MA, 2004, STEROIDS, V69, P137, DOI 10.1016/j.steroids.2003.12.006
   PICK E, 1980, J IMMUNOL METHODS, V38, P161, DOI 10.1016/0022-1759(80)90340-3
   Robel P., 1987, NEUROSTEROIDS, V27, P649
   Sanz N, 1999, TOXICOL APPL PHARM, V154, P40, DOI 10.1006/taap.1998.8541
   Schwartz AG, 2004, AGEING RES REV, V3, P171, DOI 10.1016/j.arr.2003.05.001
   TSUKAMOTO I, 1993, BIOCHEM MOL BIOL INT, V30, P773
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Jacob MHVM, 2010, EXP GERONTOL, V45, P957, DOI 10.1016/j.exger.2010.08.017
   Jacob MHVM, 2009, STEROIDS, V74, P1045, DOI 10.1016/j.steroids.2009.08.005
   von Mühlen D, 2007, CONTEMP CLIN TRIALS, V28, P153, DOI 10.1016/j.cct.2006.04.009
   Wu SZ, 2007, GERONTOLOGY, V53, P234, DOI 10.1159/000100961
   Yamada Y, 2007, ENDOCR J, V54, P153, DOI 10.1507/endocrj.K05-132
   Yoshioka J, 2006, ANTIOXID REDOX SIGN, V8, P2143, DOI 10.1089/ars.2006.8.2143
NR 45
TC 13
Z9 14
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-0760
EI 1879-1220
J9 J STEROID BIOCHEM
JI J. Steroid Biochem. Mol. Biol.
PD NOV
PY 2011
VL 127
IS 3-5
SI SI
BP 331
EP 336
DI 10.1016/j.jsbmb.2011.07.007
PG 6
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 868NZ
UT WOS:000298531300025
PM 21831349
DA 2024-02-19
ER

PT J
AU LEAKEY, JEA
   CUNNY, HC
   BAZARE, J
   WEBB, PJ
   FEUERS, RJ
   DUFFY, PH
   HART, RW
AF LEAKEY, JEA
   CUNNY, HC
   BAZARE, J
   WEBB, PJ
   FEUERS, RJ
   DUFFY, PH
   HART, RW
TI EFFECTS OF AGING AND CALORIC RESTRICTION ON HEPATIC DRUG-METABOLIZING
   ENZYMES IN THE FISCHER-344 RAT .1. THE CYTOCHROME-P-450 DEPENDENT
   MONOOXYGENASE SYSTEM
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 NATL CTR TOXICOL RES,DIV GENET TOXICOL,JEFFERSON,AR 72079.
   NATL CTR TOXICOL RES,OFF DIRECTOR,JEFFERSON,AR 72079.
   UNIV ARKANSAS MED SCI,DEPT PHARMACOL & INTERDISCIPLINARY TOXICOL,LITTLE ROCK,AR 72205.
C3 US Food & Drug Administration (FDA); US Food & Drug Administration
   (FDA); University of Arkansas System; University of Arkansas Medical
   Sciences
RP LEAKEY, JEA (corresponding author), NATL CTR TOXICOL RES,DIV REPROD & DEV TOXICOL,JEFFERSON,AR 72079, USA.
CR ADESNIK M, 1986, CRIT REV BIOCHEM MOL, V19, P247, DOI 10.3109/10409238609084657
   ARMARIO A, 1987, ANN NUTR METAB, V31, P81, DOI 10.1159/000177254
   BAINS SK, 1985, BIOCHEM PHARMACOL, V34, P3221, DOI 10.1016/0006-2952(85)90338-7
   BAIZER MM, 1950, J AM PHARM ASSOC SCI, V39, P581, DOI 10.1002/jps.3030391013
   CAMPBELL TC, 1974, PHARMACOL REV, V26, P171
   CROOKS J, 1976, Clinical Pharmacokinetics, V1, P280
   DUFFY PH, 1989, MECH AGEING DEV, V48, P117, DOI 10.1016/0047-6374(89)90044-4
   EDEN S, 1979, ENDOCRINOLOGY, V105, P555, DOI 10.1210/endo-105-2-555
   FEUERS RJ, 1989, MECH AGEING DEV, V48, P179, DOI 10.1016/0047-6374(89)90049-3
   GALINSKY RE, 1986, J PHARMACOL EXP THER, V237, P107
   Guengerich F P, 1986, Adv Exp Med Biol, V197, P83
   GUENGERICH FP, 1984, ANNU REV NUTR, V4, P207, DOI 10.1146/annurev.nu.04.070184.001231
   GUENGERICH FP, 1982, XENOBIOTICA, V12, P701, DOI 10.3109/00498258209038945
   INGELMANSUNDBERG M, 1982, XENOBIOTICA, V12, P673, DOI 10.3109/00498258209038943
   JANSSON JO, 1984, ENDOCRINOLOGY, V114, P1287, DOI 10.1210/endo-114-4-1287
   JOHANSSON I, 1988, BIOCHEMISTRY-US, V27, P1925, DOI 10.1021/bi00406a019
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO R, 1977, XENOBIOTICA, V7, P25, DOI 10.3109/00498257709036242
   KITANI K, 1988, GERONTOLOGY, V34, P55, DOI 10.1159/000212931
   Leakey JE, 1983, BIOL BASIS DETOXICAT, P77
   LEAKEY JEA, 1987, BIOCHEM J, V243, P859, DOI 10.1042/bj2430859
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LUBET RA, 1985, ARCH BIOCHEM BIOPHYS, V238, P43, DOI 10.1016/0003-9861(85)90138-9
   MACGEOCH C, 1984, J BIOL CHEM, V259, P5433
   MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671
   MASERO EJ, 1985, J NUTR, V115, P842
   MASERO EJ, 1988, J GERONTOL, V43, pB59
   MATSUBARA T, 1977, JPN J PHARMACOL, V27, P127, DOI 10.1254/jjp.27.127
   MILLARD WJ, 1987, ACROMEGALY, V45, P139
   MODE A, 1982, ENDOCRINOLOGY, V111, P1692, DOI 10.1210/endo-111-5-1692
   MORGAN ET, 1985, J BIOL CHEM, V260, P1895
   NEBERT DW, 1987, DNA-J MOLEC CELL BIO, V6, P1, DOI 10.1089/dna.1987.6.1
   NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.bi.56.070187.004501
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652
   Prough R A, 1978, Methods Enzymol, V52, P372
   REINKE LA, 1985, DRUG METAB DISPOS, V13, P548
   RIKANS LE, 1982, BIOCHEM PHARMACOL, V31, P2339, DOI 10.1016/0006-2952(82)90527-5
   RYAN DE, 1982, XENOBIOTICA, V12, P727, DOI 10.3109/00498258209038947
   SACHAN DS, 1982, J NUTR, V112, P2301, DOI 10.1093/jn/112.12.2301
   Schmucker D. L., 1979, PHARMACOL REV, V30, P445
   SHIVERICK KT, 1979, DRUG METAB DISPOS, V7, P290
   SUN J, 1986, EXP GERONTOL, V21, P523, DOI 10.1016/0531-5565(86)90005-7
   Thomas P E, 1986, Adv Exp Med Biol, V197, P95
   THOMAS PE, 1987, BIOCHEMISTRY-US, V26, P2280, DOI 10.1021/bi00382a031
   TU YY, 1983, CANCER RES, V43, P623
   TU YY, 1983, CHEM-BIOL INTERACT, V44, P247, DOI 10.1016/0009-2797(83)90053-4
   ULLRICH V, 1972, H-S Z PHYSIOL CHEM, V353, P1171, DOI 10.1515/bchm2.1972.353.2.1171
   WATKINS PB, 1986, J BIOL CHEM, V261, P6264
   WAXMAN DJ, 1988, BIOCHEM PHARMACOL, V37, P71, DOI 10.1016/0006-2952(88)90756-3
   WAXMAN DJ, 1985, BIOCHEMISTRY-US, V24, P4409, DOI 10.1021/bi00337a023
   WOOD AW, 1983, J BIOL CHEM, V258, P8839
   YAMAZOE Y, 1986, J BIOCHEM-TOKYO, V100, P1095, DOI 10.1093/oxfordjournals.jbchem.a121790
NR 53
TC 95
Z9 95
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAY
PY 1989
VL 48
IS 2
BP 145
EP 155
DI 10.1016/0047-6374(89)90046-8
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA U7806
UT WOS:A1989U780600005
PM 2661932
DA 2024-02-19
ER

PT J
AU Savary, I
   Debras, E
   Dardevet, D
   Rambourdin, F
   Vasson, MP
   Obled, C
   Grizard, J
AF Savary, I
   Debras, E
   Dardevet, D
   Rambourdin, F
   Vasson, MP
   Obled, C
   Grizard, J
TI Evidence for an alteration of plasma and liver proteins response to
   dexamethasone in aging rats
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; rats; glucocorticoids; dexamethasone; plasma proteins; protein
   metabolism
ID ACUTE-PHASE PROTEINS; C-REACTIVE PROTEIN; SKELETAL-MUSCLE; OLD RATS;
   GLUCOCORTICOIDS; IL-6; AGE; CORTICOSTERONE; ALPHA; ADULT
AB The aim of this study was carried out to analyse the liver and plasma proteins response to dexamethasone in adult (6-8 months) and old (24 months) rats in order to ascertain the involvement of glucocorticoids in the aging process. The animals received dexamethasone (Dex) for 5 or 6 days. As Dex decreased food intake, all groups were pair Fed to dexamethasone-treated old rats. The synthesis of mixed plasma and liver proteins (assessed by a flooding dose of [C-13] valine) was similarly greatly improved in adult and old rats after Dex treatment. However. the level of mixed plasma proteins was only slightly increased. When specific plasma proteins were assessed, a similar increase in the concentration of albumin and alpha1 acid glycoprotein was observed in adult and old rats. By contrast, fibrinogen decreased to a greater extend in old rats and alpha2 macroglobulin became undetectable in old animals. It was concluded that the response of plasma and liver proteins: to Dex was altered in old rats and may contribute to the pathogenesis of several diseases which occur during aging. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
C1 INRA, Ctr Rech Clermont Ferrand Theix, Equipe Nutriments & Metab, Unite Rech Herbivores, F-63122 St Genes Champanelle, France.
   INRA, Ctr Rech Clermont Ferrand Theix, Unite Etud Metab Azote, F-63122 St Genes Champanelle, France.
   Univ Auvergne, Fac Pharm, Lab Biochim Biol Mol & Nutr, F-63000 Clermont Ferrand, France.
C3 INRAE; INRAE; Universite Clermont Auvergne (UCA)
RP Savary, I (corresponding author), INRA, Ctr Rech Clermont Ferrand Theix, Equipe Nutriments & Metab, Unite Rech Herbivores, F-63122 St Genes Champanelle, France.
RI Dardevet, Dominique/IAM-3666-2023; vasson, marie-paule/ABA-2486-2021
OI Savary-Auzeloux, Isabelle/0000-0002-3298-9787; Dardevet,
   Dominique/0000-0001-7320-9970
CR Almawi WY, 1996, J LEUKOCYTE BIOL, V60, P563, DOI 10.1002/jlb.60.5.563
   ANDUS T, 1988, EUR J IMMUNOL, V18, P739, DOI 10.1002/eji.1830180513
   Ballou SP, 1996, AGE AGEING, V25, P224, DOI 10.1093/ageing/25.3.224
   BENEDIKT HJ, 1995, NEW HORIZONS, V3, P183
   Breuillé D, 1998, CLIN SCI, V94, P413, DOI 10.1042/cs0940413
   CASWELL M, 1993, ARCH PATHOL LAB MED, V117, P906
   Dardevet D, 1998, J ENDOCRINOL, V156, P83, DOI 10.1677/joe.0.1560083
   DARDEVET D, 1995, J CLIN INVEST, V96, P2113, DOI 10.1172/JCI118264
   Dardevet D, 1999, J ENDOCRINOL, V162, P77, DOI 10.1677/joe.0.1620077
   DAYNES RA, 1993, J IMMUNOL, V150, P5219
   ERSHLER WB, 1993, J AM GERIATR SOC, V41, P176, DOI 10.1111/j.1532-5415.1993.tb02054.x
   Fey Georg H., 1994, P113
   GANAPATHI MK, 1991, J IMMUNOL, V147, P1261
   GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719
   KALIMI M, 1983, ENDOCRINOLOGY, V112, P341, DOI 10.1210/endo-112-1-341
   KLONOFFCOHEN H, 1992, J CLIN EPIDEMIOL, V45, P207, DOI 10.1016/0895-4356(92)90080-7
   Kushner I, 1993, ACUTE PHASE PROTEINS, P3
   LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791
   MANCHESTER KL, 1968, BIOCHEM J, V108, P177, DOI 10.1042/bj1080177
   Mansoor O, 1997, AM J PHYSIOL-ENDOC M, V273, pE898, DOI 10.1152/ajpendo.1997.273.5.E898
   MARINKOVIC S, 1989, J IMMUNOL, V142, P808
   Masoro EJ, 1995, AGING-CLIN EXP RES, V7, P407, DOI 10.1007/BF03324354
   MeynialDenis D, 1996, AM J PHYSIOL-ENDOC M, V271, pE1061, DOI 10.1152/ajpendo.1996.271.6.E1061
   MILLWARD DJ, 1976, P NUTR SOC, V35, pA47
   MILMAN N, 1988, CLIN CHIM ACTA, V176, P59, DOI 10.1016/0009-8981(88)90174-X
   Mobbs Charles V., 1996, P234
   MOSONI L, 1995, AM J PHYSIOL, V268, pE238
   ODEDRA BR, 1983, BIOCHEM J, V214, P617, DOI 10.1042/bj2140617
   PEDERSEN P, 1989, METABOLISM, V38, P927, DOI 10.1016/0026-0495(89)90001-2
   POST DJ, 1991, ANN NY ACAD SCI, V621, P66
   ROSS RD, 1992, J AM GERIATR SOC, V40, P104, DOI 10.1111/j.1532-5415.1992.tb01843.x
   SANTIDRIAN S, 1981, METABOLISM, V30, P798, DOI 10.1016/0026-0495(81)90026-3
   SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284
   SAPOLSKY RM, 1983, EXP GERONTOL, V18, P55, DOI 10.1016/0531-5565(83)90051-7
   Savary I, 1998, BRIT J NUTR, V79, P297, DOI 10.1079/BJN19980047
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Spaulding CC, 1997, MECH AGEING DEV, V93, P87, DOI 10.1016/S0047-6374(96)01824-6
   VANGOOL J, 1984, BIOCHEM J, V220, P125, DOI 10.1042/bj2200125
   VIRCA GD, 1978, ANAL BIOCHEM, V89, P274, DOI 10.1016/0003-2697(78)90750-9
   Ward W. F., 1992, Age & Nutrition, V3, P212
   WEI J, 1992, LIFE SCI, V51, P1953, DOI 10.1016/0024-3205(92)90112-3
   YOSHIKAWA TT, 1984, GERONTOLOGY, V30, P275, DOI 10.1159/000212646
NR 42
TC 11
Z9 11
U1 0
U2 6
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD JAN
PY 2001
VL 122
IS 1
BP 105
EP 120
DI 10.1016/S0047-6374(00)00224-4
PG 16
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 396GE
UT WOS:000166627300007
PM 11163627
DA 2024-02-19
ER

PT J
AU Silvestri, E
   Lombardi, A
   de Lange, P
   Schiavo, L
   Lanni, A
   Goglia, F
   Visser, TJ
   Moreno, M
AF Silvestri, Elena
   Lombardi, Assunta
   de Lange, Pieter
   Schiavo, Luigi
   Lanni, Antonia
   Goglia, Fernando
   Visser, Theo J.
   Moreno, Maria
TI Age-related changes in renal and hepatic cellular mechanisms associated
   with variations in rat serum thyroid hormone levels
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE aging; deiodinase; liver; kidney
ID IODOTHYRONINE DEIODINASE; IN-VIVO; MONOCARBOXYLATE TRANSPORTER-8;
   RECEPTOR ISOFORMS; MOLECULAR-BASIS; TRIIODOTHYRONINE; HYPOTHYROIDISM;
   THYROTROPIN; EXPRESSION; LIVER
AB Aging is associated with changes in thyroid gland physiology. Age-related changes in the contribution of peripheral tissues to thyroid hormone serum levels have yet to be systematically assessed. Here, we investigated age-related alterations in the contributions of the liver and kidney to thyroid hormone homeostasis using 6-, 12-, and 24-mo-old male Wistar rats. A significant and progressive decline in plasma thyroxine occurred with age, but triiodothyronine (T-3) was decreased only at 24 mo. This was associated with an unchanged protein level of the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) in the kidney and with a decreased MCT8 level in the liver at 24 mo. Hepatic type I deiodinase (D1) protein level and activity declined progressively with age. Renal D1 levels were decreased at both 12 and 24 mo but D1 activity was decreased only at 24 mo. In the liver, no changes occurred in thyroid hormone receptor (TR) TR alpha(1), whereas a progressive increase in TR beta(1) occurred at both mRNA and total protein levels. In the kidney, both TR alpha(1) and TR beta(1) mRNA and total protein levels were unchanged between 6 and 12 mo but increased at 24 mo. Interestingly, nuclear TR beta 1 levels were decreased in both liver and kidney at 12 and 24 mo, whereas nuclear TR alpha 1 levels were unchanged. Collectively, our data show differential age-related changes among hepatic and renal MCT8 and D1 and TR expressions, and they suggest that renal D1 activity is maintained with age to compensate for the decrease in hepatic T-3 production.
C1 [Silvestri, Elena; Schiavo, Luigi; Goglia, Fernando; Moreno, Maria] Univ Sannio, Dip Sci Biol & Ambientali, I-82100 Benevento, Italy.
   [Lombardi, Assunta] Univ Naples Federico II, Dip Sci Biol, Sez Fisiol, Naples, Italy.
   [de Lange, Pieter; Lanni, Antonia] Univ Naples 2, Dip Sci Vita, Caserta, Italy.
   [Visser, Theo J.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.
C3 University of Sannio; University of Naples Federico II; Universita della
   Campania Vanvitelli; Erasmus University Rotterdam; Erasmus MC
RP Moreno, M (corresponding author), Univ Sannio, Dip Sci Biol & Ambientali, Via Port Arsa 11, I-82100 Benevento, Italy.
EM moreno@unisannio.it
RI Lombardi, Assunta/IAS-1054-2023; Visser, Theo J/C-8059-2013; de Lange,
   Pieter/GXA-3052-2022; Schiavo, Luigi/AAO-7168-2021; Schiavo,
   Luigi/K-5202-2016
OI Lombardi, Assunta/0009-0002-0553-1655; Visser, Theo
   J/0000-0002-6997-284X; Schiavo, Luigi/0000-0003-3639-6847; LANNI,
   Antonia/0000-0001-5797-0348; Silvestri, Elena/0000-0002-0592-9033; DE
   LANGE, Pieter/0000-0002-5256-3599; GOGLIA, Fernando/0000-0003-0468-9645;
   MORENO, Maria/0000-0002-6218-5501
CR Amma LL, 2001, MOL ENDOCRINOL, V15, P467, DOI 10.1210/me.15.3.467
   BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0
   Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38
   Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812
   Boelen A, 2005, ENDOCRINOLOGY, V146, P5128, DOI 10.1210/en.2005-0608
   CIZZA G, 1992, ENDOCRINOLOGY, V131, P2672, DOI 10.1210/en.131.6.2672
   Clark B, 2000, ADV RENAL REPLACE TH, V7, P11, DOI 10.1016/S1073-4449(00)70002-1
   DAVIS PJ, 1979, CLIN ENDOCRINOL META, V8, P603, DOI 10.1016/S0300-595X(79)80033-X
   de Lange P, 2007, ENDOCRINOLOGY, V148, P4064, DOI 10.1210/en.2007-0206
   DONDA A, 1987, MOL CELL ENDOCRINOL, V54, P29, DOI 10.1016/0303-7207(87)90136-5
   DONDA A, 1989, ENDOCRINOLOGY, V124, P1305, DOI 10.1210/endo-124-3-1305
   Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947
   FORCIEA MA, 1981, J CLIN INVEST, V67, P1739, DOI 10.1172/JCI110212
   Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200
   Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   GOODMAN MN, 1980, AM J PHYSIOL, V239, pE277
   Habra M, 2005, REV ENDOCR METAB DIS, V6, P145, DOI 10.1007/s11154-005-1494-9
   Hennemann G, 2007, BEST PRACT RES CL EN, V21, P323, DOI 10.1016/j.beem.2007.03.007
   HUANG HH, 1980, EXP AGING RES, V6, P3, DOI 10.1080/03610738008258342
   JANG M, 1985, ENDOCRINOLOGY, V116, P457, DOI 10.1210/endo-116-1-457
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   KLUG TL, 1979, ENDOCRINOLOGY, V104, P1136, DOI 10.1210/endo-104-4-1136
   Köhrle J, 2002, METHOD ENZYMOL, V347, P125
   KOHRLE J, 1995, MOL CELL ENDOCRINOL, V108, P17, DOI 10.1016/0303-7207(95)92574-8
   Kuiper GGJM, 2003, ENDOCRINOLOGY, V144, P5411, DOI 10.1210/en.2003-0728
   Kuiper GGJM, 2002, ENDOCRINOLOGY, V143, P1190, DOI 10.1210/en.143.4.1190
   Lanni A, 1996, J PHYSIOL-LONDON, V494, P831, DOI 10.1113/jphysiol.1996.sp021536
   Marassi MP, 2007, J ENDOCRINOL, V192, P121, DOI 10.1677/joe.1.06901
   MARIOTTI S, 1995, ENDOCR REV, V16, P686, DOI 10.1210/er.16.6.686
   MOORADIAN AD, 1990, BIOCHIM BIOPHYS ACTA, V1054, P1, DOI 10.1016/0167-4889(90)90197-L
   MOORADIAN AD, 1995, CLIN GERIATR MED, V11, P159, DOI 10.1016/S0749-0690(18)30288-X
   MOORADIAN AD, 1990, MECH AGEING DEV, V52, P141, DOI 10.1016/0047-6374(90)90120-5
   NAYER P, 1991, HORM METAB RES, V23, P12
   Pallet V, 1997, MECH AGEING DEV, V99, P123, DOI 10.1016/S0047-6374(97)00098-5
   Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P3202, DOI 10.1210/jc.2002-022013
   PEKARY AE, 1984, NEUROBIOL AGING, V5, P221, DOI 10.1016/0197-4580(84)90066-6
   QUIGLEY K, 1990, EXP GERONTOL, V25, P447, DOI 10.1016/0531-5565(90)90033-X
   Ritchie JWA, 2003, MOL ENDOCRINOL, V17, P653, DOI 10.1210/me.2002-0179
   ROBUSCHI G, 1987, ENDOCR REV, V8, P142, DOI 10.1210/edrv-8-2-142
   RODD C, 1992, ENDOCRINOLOGY, V131, P2559, DOI 10.1210/en.131.6.2559
   SAVU L, 1991, BIOCHIM BIOPHYS ACTA, V1097, P19, DOI 10.1016/0925-4439(91)90017-4
   Starling RD, 2001, INT J SPORT NUTR EXE, V11, pS208, DOI 10.1123/ijsnem.11.s1.s208
   STGERMAIN DL, 1989, ENDOCRINOLOGY, V125, P2735
   TIMIRAS PS, 1994, PHYSL BASIS AGING GE, P189
   Vandenberghe J., 1990, LIFE SPAN DATA HIST
   VAUGHAN L, 1991, AM J CLIN NUTR, V53, P821, DOI 10.1093/ajcn/53.4.821
   VISSER TJ, 1998, J CLIN ENDOCR METAB, V67, P17
   Visser W, 2007, BEST PRACT RES CL EN, V21, P223, DOI 10.1016/j.beem.2007.03.008
   Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097
   ZANDIEH DB, 2002, ENDOCRINOLOGY, V143, P979
   Zandieh-Doulabi B, 2004, MOL CELL ENDOCRINOL, V219, P69, DOI 10.1016/j.mce.2004.01.008
NR 52
TC 28
Z9 29
U1 0
U2 5
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JUN
PY 2008
VL 294
IS 6
BP E1160
EP E1168
DI 10.1152/ajpendo.00044.2008
PG 9
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA 309OD
UT WOS:000256469200018
PM 18430970
DA 2024-02-19
ER

PT J
AU Bates, DJ
   Li, N
   Liang, RQ
   Sarojini, H
   An, J
   Masternak, MM
   Bartke, A
   Wang, E
AF Bates, David J.
   Li, Na
   Liang, Ruqiang
   Sarojini, Harshini
   An, Jin
   Masternak, Michal M.
   Bartke, Andrzej
   Wang, Eugenia
TI MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed
   aging
SO AGING CELL
LA English
DT Article
DE aging; dwarf mouse; intermediate metabolism; microRNA
ID ORNITHINE DECARBOXYLASE ACTIVITY; RECEPTOR KNOCKOUT MICE;
   GROWTH-HORMONE; BREAST-CANCER; RAT LIVER; STRESS RESISTANCE; TRANSGENIC
   MICE; EXPRESSION; CELLS; METABOLISM
AB P>The Ames dwarf mouse is well known for its remarkable propensity to delay the onset of aging. Although significant advances have been made demonstrating that this aging phenotype results primarily from an endocrine imbalance, the post-transcriptional regulation of gene expression and its impact on longevity remains to be explored. Towards this end, we present the first comprehensive study by microRNA (miRNA) microarray screening to identify dwarf-specific lead miRNAs, and investigate their roles as pivotal molecular regulators directing the long-lived phenotype. Mapping the signature miRNAs to the inversely expressed putative target genes, followed by in situ immunohistochemical staining and in vitro correlation assays, reveals that dwarf mice post-transcriptionally regulate key proteins of intermediate metabolism, most importantly the biosynthetic pathway involving ornithine decarboxylase and spermidine synthase. Functional assays using 3'-untranslated region reporter constructs in co-transfection experiments confirm that miRNA-27a indeed suppresses the expression of both of these proteins, marking them as probable targets of this miRNA in vivo. Moreover, the putative repressed action of this miRNA on ornithine decarboxylase is identified in dwarf mouse liver as early as 2 months of age. Taken together, our results show that among the altered aspects of intermediate metabolism detected in the dwarf mouse liver - glutathione metabolism, the urea cycle and polyamine biosynthesis - miRNA-27a is a key post-transcriptional control. Furthermore, compared to its normal siblings, the dwarf mouse exhibits a head start in regulating these pathways to control their normality, which may ultimately contribute to its extended healthspan and longevity.
C1 [Bates, David J.; Wang, Eugenia] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40202 USA.
   [Bates, David J.; Li, Na; Liang, Ruqiang; Sarojini, Harshini; An, Jin; Wang, Eugenia] Univ Louisville, Sch Med, Gheens Ctr Aging, Louisville, KY 40292 USA.
   [Masternak, Michal M.; Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Internal Med, Springfield, IL USA.
   [Masternak, Michal M.; Bartke, Andrzej] So Illinois Univ, Sch Med, Dept Physiol, Springfield, IL USA.
C3 University of Louisville; University of Louisville; Southern Illinois
   University System; Southern Illinois University; Southern Illinois
   University System; Southern Illinois University
RP Wang, E (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, 580 S Preston St, Louisville, KY 40202 USA.
EM eugenia.wang@louisville.edu
RI Liang, Ruqiang/C-2326-2013; Sarojini, Harshini/AAD-4870-2019; Bartke,
   Andzej/D-6640-2017
OI Sarojini, Harshini/0000-0002-3103-9712; Bartke,
   Andzej/0000-0002-2569-557X; Liang, Ruqiang/0000-0002-3075-4554
FU National Institute on Aging [AG019899]
FX We thank Mrs Vickie Chen and Mr Al Bloch for proofreading, and Mr
   Patrick R. Lyninger for computational and technical services. This work
   was supported by grants from the Kentucky 'Bucks-for-Brains' program to
   EW, and grant AG019899 from the National Institute on Aging to AB.
CR Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Andersen B, 1995, DEV BIOL, V172, P495, DOI 10.1006/dbio.1995.8040
   Arisawa T, 2007, DIGEST DIS SCI, V52, P1691, DOI 10.1007/s10620-006-9648-5
   Brown-Borg HM, 2005, MECH AGEING DEV, V126, P389, DOI 10.1016/j.mad.2004.09.005
   Brown-Borg HM, 2009, MOL CELL ENDOCRINOL, V299, P64, DOI 10.1016/j.mce.2008.07.001
   Brown-Borg HM, 2009, EXP GERONTOL, V44, P10, DOI 10.1016/j.exger.2008.07.002
   Byun JA, 2009, CANCER LETT, V273, P300, DOI 10.1016/j.canlet.2008.08.024
   Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598
   Cong YS, 2006, MECH AGEING DEV, V127, P332, DOI 10.1016/j.mad.2005.12.005
   Cremades A, 2004, J ENDOCRINOL, V183, P343, DOI 10.1677/joe.1.05783
   Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081
   Dominici FP, 2000, J ENDOCRINOL, V166, P579, DOI 10.1677/joe.0.1660579
   Fiedler SD, 2008, BIOL REPROD, V79, P1030, DOI 10.1095/biolreprod.108.069690
   GONZALEZ SI, 1991, BIOL REPROD, V44, P321, DOI 10.1095/biolreprod44.2.321
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   GritliLinde A, 1997, MOL CELL ENDOCRINOL, V126, P49, DOI 10.1016/S0303-7207(96)03969-X
   Hauck SJ, 2000, FREE RADICAL BIO MED, V28, P970, DOI 10.1016/S0891-5849(00)00186-6
   Ignarro LJ, 2001, P NATL ACAD SCI USA, V98, P4202, DOI 10.1073/pnas.071054698
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002
   Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180
   KOSTYO JL, 1966, BIOCHEM BIOPH RES CO, V23, P150, DOI 10.1016/0006-291X(66)90520-1
   Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004
   MANTEUFFELCYMBOROWSKA M, 1995, INT J BIOCHEM CELL B, V27, P287, DOI 10.1016/1357-2725(94)00070-R
   Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416
   Morimoto S, 2001, ENDOCRINOLOGY, V142, P1442, DOI 10.1210/en.142.4.1442
   Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje
   Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153
   Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028
   ROSENFELD RG, 1994, ENDOCR REV, V15, P369, DOI 10.1210/er.15.3.369
   RUSSELL DH, 1970, ENDOCRINOLOGY, V86, P1414, DOI 10.1210/endo-86-6-1414
   RUSSELL DH, 1969, ENDOCRINOLOGY, V84, P223, DOI 10.1210/endo-84-2-223
   Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004
   Sarojini HII, 2007, BIOTECHNIQUES, V43, P213, DOI 10.2144/000112493
   Schaible R., 1961, Genetics, V46, P896
   Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SOGANI RK, 1972, BIOCHIM BIOPHYS ACTA, V279, P377, DOI 10.1016/0304-4165(72)90156-0
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Wang E, 2002, J GERONTOL A-BIOL, V57, pB400, DOI 10.1093/gerona/57.11.B400
   Wang E, 2007, AGEING RES REV, V6, P1, DOI 10.1016/j.arr.2007.02.004
   Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557
   Wang ZH, 2007, ENDOCRINOLOGY, V148, P2845, DOI 10.1210/en.2006-1313
   Young L, 2006, J HISTOCHEM CYTOCHEM, V54, P223, DOI 10.1369/jhc.5A6672.2005
   Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007
NR 52
TC 76
Z9 90
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9726
J9 AGING CELL
JI Aging Cell
PD FEB
PY 2010
VL 9
IS 1
BP 1
EP 18
DI 10.1111/j.1474-9726.2009.00529.x
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 564TK
UT WOS:000275240100001
PM 19878148
OA Green Accepted, hybrid
DA 2024-02-19
ER

PT J
AU Okudan, N
   Belviranli, M
AF Okudan, Nilsel
   Belviranli, Muaz
TI Effects of exercise training on hepatic oxidative stress and antioxidant
   status in aged rats
SO ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE Exercise; aging; liver; oxidative damage; antioxidant defense
ID PHYSICAL-EXERCISE; REGULAR EXERCISE; DNA-DAMAGE; OLD MICE; LIVER;
   KIDNEY; RESTRICTION; INCREASE; EXTRACT; TISSUE
AB This study investigated the effects of exercise training on oxidative stress, and antioxidant defense markers in the liver tissues of young and aged rats. Two age groups of 4-(young) and 20-months-(aged) old male Wistar rats were performed exercise training program consisted of swimming exercise for 8 weeks. The biomarkers of pro/antioxidant status malondialdehyde (MDA), protein carbonyl (PC), 8-hydroxy-2-deoxyguanosine (8-OHdG), total glutathione (GSH) and superoxide dismutase (SOD) were assessed by commercially available kits. PC levels were higher in the untrained aged rats compared to the young groups and exercise training decreased PC levels (p<0.05). 8-OHdG levels were higher in the aged groups (p<0.05). MDA and GSH levels and SOD activity did not differ significantly between the groups (p>0.05). The present findings indicate that exercise training prevents aging-induced hepatic oxidative damage especially in the proteins.
C1 [Okudan, Nilsel; Belviranli, Muaz] Selcuk Univ, Div Sports Physiol, Dept Physiol, Sch Med, Konya, Turkey.
C3 Selcuk University
RP Belviranli, M (corresponding author), Selcuk Univ, Sch Med, Dept Physiol, Konya, Turkey.
EM mbelviranli@yahoo.com
RI Belviranlı, Muaz/AEP-3156-2022; Okudan, Nilsel/GPF-4217-2022
OI Belviranlı, Muaz/0000-0002-2454-8818; Okudan, Nilsel/0000-0001-9879-503X
CR Aydin AF, 2010, BIOGERONTOLOGY, V11, P103, DOI 10.1007/s10522-009-9232-4
   Aydin C, 2007, CELL BIOCHEM FUNCT, V25, P129, DOI 10.1002/cbf.1279
   Belviranli M, 2015, BEHAV BRAIN RES, V278, P453, DOI 10.1016/j.bbr.2014.10.032
   Belviranli M, 2013, BIOGERONTOLOGY, V14, P187, DOI 10.1007/s10522-013-9422-y
   Belviranli M, 2013, PHYTOTHER RES, V27, P672, DOI 10.1002/ptr.4772
   Belviranli M, 2012, BRIT J NUTR, V108, P249, DOI 10.1017/S0007114511005496
   Tung BT, 2015, AGING CLIN EXP RES, V27, P775, DOI 10.1007/s40520-015-0366-8
   Burneiko RCM, 2006, FOOD CHEM TOXICOL, V44, P1167, DOI 10.1016/j.fct.2006.01.004
   Çoban J, 2014, GERIATR GERONTOL INT, V14, P996, DOI 10.1111/ggi.12192
   da Silva LA, 2009, APPL PHYSIOL NUTR ME, V34, P60, DOI 10.1139/H08-132
   Dkhar P, 2013, MOL CELL BIOCHEM, V380, P153, DOI 10.1007/s11010-013-1668-9
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hoare M, 2010, J HEPATOL, V53, P950, DOI 10.1016/j.jhep.2010.06.009
   Horner Kristen A, 2011, Front Syst Neurosci, V5, P27, DOI 10.3389/fnsys.2011.00027
   Husain K, 1997, J APPL TOXICOL, V17, P189, DOI 10.1002/(SICI)1099-1263(199705)17:3<189::AID-JAT431>3.0.CO;2-7
   Husain K, 2002, MOL CELL BIOCHEM, V231, P129, DOI 10.1023/A:1014416915643
   Kakarla P, 2005, J EXP ZOOL PART A, V303A, P203, DOI 10.1002/jez.a.149
   Liu JK, 2000, J APPL PHYSIOL, V89, P21
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mallikarjuna K, 2009, ALCOHOL, V43, P59, DOI 10.1016/j.alcohol.2008.09.003
   Moller P, 2010, FREE RADICAL BIO MED, V48, P1275, DOI 10.1016/j.freeradbiomed.2010.02.003
   Nakamoto H, 2007, EXP GERONTOL, V42, P287, DOI 10.1016/j.exger.2006.11.006
   Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003
   Okudan N, 2012, BRATISL MED J, V113, P393, DOI 10.4149/BLL_2012_089
   Pinzani P, 1997, CLIN CHEM, V43, P855
   Polidori MC, 2000, INT J SPORTS MED, V21, P154, DOI 10.1055/s-2000-8881
   Radak Z, 1996, EUR J APPL PHYSIOL, V72, P189, DOI 10.1007/BF00838637
   Radak Z, 2008, FREE RADICAL BIO MED, V44, P153, DOI 10.1016/j.freeradbiomed.2007.01.029
   Safwat MH, 2014, BIOCHEMISTRY-MOSCOW+, V79, P450, DOI 10.1134/S0006297914050095
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Toshinai K, 1997, RES COMMUN MOL PATH, V95, P259
   Viña J, 2013, ANTIOXID REDOX SIGN, V19, P779, DOI 10.1089/ars.2012.5111
   Wolf FI, 2005, EXP GERONTOL, V40, P181, DOI 10.1016/j.exger.2004.11.002
   Wong YT, 2006, FREE RADICAL RES, V40, P393, DOI 10.1080/10715760600556074
   Yamamoto T, 2003, COMP BIOCHEM PHYS C, V135, P163, DOI 10.1016/S1532-0456(03)00087-5
NR 40
TC 13
Z9 15
U1 0
U2 14
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1381-3455
EI 1744-4160
J9 ARCH PHYSIOL BIOCHEM
JI Arch. Physiol. Biochem.
PD OCT
PY 2016
VL 122
IS 4
BP 180
EP 185
DI 10.1080/13813455.2016.1199574
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Endocrinology &
   Metabolism; Physiology
GA EA7SB
UT WOS:000386831100002
PM 27424521
DA 2024-02-19
ER

PT J
AU Sar, P
   Rath, B
   Subudhi, U
   Chainy, GBN
   Supakar, PC
AF Sar, Pranati
   Rath, Bandita
   Subudhi, Umakanta
   Chainy, Gagan Bihari Nityananda
   Supakar, Prakash Chandra
TI Alterations in expression of senescence marker protein-30 gene by
   3,3′,5-triiodo-L-thyronine (T<sub>3</sub>)
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE aging; SMP30; 3,3 ',5-triiodo-L-thyronine (T-3); oxidative stress; Ca2+
   pump activity
ID ANTIOXIDANT DEFENSE SYSTEM; THYROID-HORMONE; RAT-LIVER; MEDIATED
   APOPTOSIS; OXIDATIVE STRESS; SMP30; HYPERTHYROIDISM; PATTERNS; ALPHA;
   PHOSPHORYLATION
AB Thyroid hormone (T-3) is essential for normal development, differentiation, and metabolic balance of the body. A toxic dose of T-3 in animals increases the basal metabolic rate and reactive oxygen species production, resulting more oxidative stress through Ca2+ influx to cytoplasm. Senescence Marker Protein-30 (SMP30) is preferentially expressed in the liver and protects cells against various injuries by enhancement of Ca2+ efflux to either extra cellular space or intraorganellar spaces through membrane Ca2+ pump activity. In this paper we report an alteration in the level of SMP30 gene expression using RT-PCR and western blot analysis in T-3 treated female Wistar rats. The results indicate that there is an induction of SMP30 expression during early hours of T-3 treatment and it declines in severe hyperthyroidism. Therefore, we speculate that SMP30 is regulated by T-3 and might play a protective role in hyperthyroidism.
C1 Inst Life Sci, Bhubaneswar 751023, Orissa, India.
   Utkal Univ, Dept Biotechnol & Zool, Bhubaneswar 751004, Orissa, India.
C3 Department of Biotechnology (DBT) India; Institute of Life Sciences
   India (ILS); Utkal University
RP Supakar, PC (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Orissa, India.
EM pcsupakar@yahoo.com
RI Sar, Pranati/AAE-5045-2022; Chainy, Gagan B N/G-7020-2012
OI Chainy, Gagan B N/0000-0002-6418-0480; Subudhi,
   Umakanta/0000-0002-8271-1513
CR BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466
   Das K, 2001, BBA-MOL BASIS DIS, V1537, P1, DOI 10.1016/S0925-4439(01)00048-5
   Fadel BM, 2000, CLIN CARDIOL, V23, P402, DOI 10.1002/clc.4960230605
   Fernández V, 2005, J ENDOCRINOL, V186, P539, DOI 10.1677/joe.1.06261
   Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   Fujita T, 1996, MECH AGEING DEV, V87, P219, DOI 10.1016/0047-6374(96)01711-3
   Fujita T, 1996, BBA-GENE STRUCT EXPR, V1308, P49, DOI 10.1016/0167-4781(96)00064-4
   Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Gulcelik MA, 2006, J SURG ONCOL, V94, P35, DOI 10.1002/jso.20508
   Ishigami A, 2003, BIOSCI BIOTECH BIOCH, V67, P158, DOI 10.1271/bbb.67.158
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   KALDERON B, 1995, ENDOCRINOLOGY, V136, P3552, DOI 10.1210/en.136.8.3552
   LAZER MA, 1993, ENDOCR REV, V14, P184
   Majima T, 2006, J BONE MINER METAB, V24, P105, DOI 10.1007/s00774-005-0655-y
   Roffi M, 2005, Minerva Endocrinol, V30, P47
   Saicic ZS, 2006, PHYSIOL RES, V55, P561, DOI 10.33549/physiolres.930789
   Upadhyay G, 2004, HEPATOLOGY, V39, P1120, DOI 10.1002/hep.20085
   Venditti P, 2006, J EXP BIOL, V209, P817, DOI 10.1242/jeb.02045
   Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9
   Videla LA, 2000, REDOX REP, V5, P265, DOI 10.1179/135100000101535807
   VILE GF, 1995, FREE RADICAL BIO MED, V18, P721, DOI 10.1016/0891-5849(94)00192-M
   Weitzel JM, 2003, J MOL ENDOCRINOL, V31, P291, DOI 10.1677/jme.0.0310291
   Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148
NR 27
TC 13
Z9 17
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD SEP
PY 2007
VL 303
IS 1-2
BP 239
EP 242
DI 10.1007/s11010-007-9462-1
PG 4
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 201DM
UT WOS:000248811700028
PM 17426926
DA 2024-02-19
ER

PT J
AU Cheng, X
   Tan, XS
   Wang, W
   Zhang, ZY
   Zhu, RF
   Wu, M
   Li, MY
   Chen, YQ
   Liang, ZH
   Zhu, P
   Wu, XW
   Weng, XF
AF Cheng, Xue
   Tan, Xiaosheng
   Wang, Wei
   Zhang, Ziyao
   Zhu, Rongfei
   Wu, Mi
   Li, Mingyu
   Chen, Yiqing
   Liang, Zhihui
   Zhu, Peng
   Wu, Xiongwen
   Weng, Xiufang
TI Long-Chain Acylcarnitines Induce Senescence of Invariant Natural Killer
   T Cells in Hepatocellular Carcinoma
SO CANCER RESEARCH
LA English
DT Article
ID NKT CELLS; ANTITUMOR; CANCER; METABOLISM; IMMUNITY
AB CD1d-restricted invariant natural killer T (iNKT) cells actively patrol the liver and possess valuable antitumor potential. However, clinical trials evaluating administration of iNKT cell-specific ago-nist a-galactosylceramide (a-GalCer) have failed to achieve obvious tumor regression. Improving the efficacy of iNKT cell-based immunotherapy requires a better understanding of the factors restraining the clinical benefits. In the context of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC), we found circu-lating and hepatic iNKT cells were hyperactivated but demonstrated imbalances in ratio and defective a-GalCer responsiveness. Exog-enous IL2 helped to expand residual a-GalCer-responsive clones with reduced T-cell receptor diversity. However, transcriptome-wide analysis revealed activation of the senescence-associated secretory phenotype and dampened cytotoxicity in iNKT cells, weakening their immune surveillance capacity. The senescent status of iNKT cells from the patients was further illustrated by cell-cycle arrest, impaired telomere maintenance, perturbed calcium trans-port-related biological processes, and altered metabolism. Lipidomic profiling revealed the accumulation of long-chain acylcarnitines (LCAC) and aberrant lipid metabolism in HCC tissue. Exogenous LCACs, especially palmitoyl-carnitine and stearoyl-carnitine, inhib-ited iNKT cell expansion and promoted senescence. Collectively, our results provide deeper insights into iNKT cell dysregulation and identify a cell senescence-associated challenge for iNKT cell-based immunotherapy in HBV-related HCC. The mechanistic links between iNKT cell senescence and accumulated LCACs suggest new targets for anti-HCC immunotherapies.Significance: Patients with HBV-related HCC exhibit a cell senescence-associated dysregulation of invariant natural killer cells that is related to altered lipid metabolism and accumulated LCACs in tumor tissue.
C1 [Cheng, Xue; Wang, Wei; Zhang, Ziyao; Wu, Mi; Li, Mingyu; Chen, Yiqing; Liang, Zhihui; Wu, Xiongwen; Weng, Xiufang] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Immunol, Wuhan, Peoples R China.
   [Tan, Xiaosheng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Organ Transplantat, Wuhan, Peoples R China.
   [Tan, Xiaosheng] NHC, Key Lab Organ Transplantat, Minist Educ, Beijing, Peoples R China.
   [Tan, Xiaosheng] Chinese Acad Med Sci, Beijing, Peoples R China.
   [Zhu, Rongfei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Allergy, Wuhan, Peoples R China.
   [Zhu, Peng] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Surg, Wuhan, Peoples R China.
   [Weng, Xiufang] Huazhong Univ Sci & Technol, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.
C3 Huazhong University of Science & Technology; Huazhong University of
   Science & Technology; Chinese Academy of Medical Sciences - Peking Union
   Medical College; Huazhong University of Science & Technology; Huazhong
   University of Science & Technology; Huazhong University of Science &
   Technology
RP Wu, XW; Weng, XF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Immunol, Wuhan, Peoples R China.; Zhu, P (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Surg, Wuhan, Peoples R China.; Weng, XF (corresponding author), Huazhong Univ Sci & Technol, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.
EM zhupeng@tjh.tjmu.edu.cn; xiongwenwu@hotmail.com; wengxiufang@hust.edu.cn
RI liang, zhihui/HPG-8064-2023; Zhu, Rongfei/AAC-5570-2022; Shi,
   Z/ISB-4324-2023; Tan, Xiaosheng/HMD-6142-2023; wang, ya/HQZ-7558-2023
OI Zhu, Rongfei/0000-0003-2103-3381; Tan, Xiaosheng/0000-0001-9920-1555;
   Li, Mingyu/0000-0001-8032-0319; Peng, Zhu/0000-0001-8088-0615; Yiqing,
   Chen/0000-0001-8045-9302
FU NIH [PBS57/hCD1]; National Nature Science Foundation of China
   [81871235]; Hubei Natural Science Foundation for Distinguished Young
   Scholars [2020CFA074]; China Postdoctoral Science Foundation
   [2019M662642]
FX The authors thank the NIH Tetramer Facility for PBS57/hCD1d tetramers.
   This work was supported by National Nature Science Foundation of China
   (NSFC grant 81871235 to X. Weng) , Hubei Natural Science Foundation for
   Distinguished Young Scholars (grant no. 2020CFA074) , and China
   Postdoctoral Science Founda-tion (no. 2019M662642 to X. Tan) .
CR Ali Tahir SM, 2001, J IMMUNOL, V167, P4046
   Berezhnov AV, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207461
   Berzofsky JA, 2008, J IMMUNOL, V180, P3627, DOI 10.4049/jimmunol.180.6.3627
   Calcinotto A, 2019, PHYSIOL REV, V99, P1047, DOI 10.1152/physrev.00020.2018
   Callender LA, 2020, AGING CELL, V19, DOI 10.1111/acel.13067
   Cameron G, 2015, J IMMUNOL, V195, P4604, DOI 10.4049/jimmunol.1501222
   Chen YB, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0568-z
   Chibaya L, 2022, SEMIN CANCER BIOL, V86, P827, DOI 10.1016/j.semcancer.2022.02.005
   Desdín-Micó G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860
   El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061
   Erickson S, 1998, ONCOGENE, V17, P595, DOI 10.1038/sj.onc.1201965
   Exley MA, 2017, CLIN CANCER RES, V23, P3510, DOI 10.1158/1078-0432.CCR-16-0600
   Heczey A, 2020, NAT MED, V26, P1686, DOI 10.1038/s41591-020-1074-2
   Huang JW, 2022, THERANOSTICS, V12, P2445, DOI 10.7150/thno.70588
   Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661
   Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691
   Jimeno R, 2019, ELIFE, V8, DOI 10.7554/eLife.51663
   Knottnerus SJG, 2018, REV ENDOCR METAB DIS, V19, P93, DOI 10.1007/s11154-018-9448-1
   Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x
   Lian JY, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00986-z
   Liu X, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aaz6314
   Liu X, 2020, J CLIN INVEST, V130, P1073, DOI 10.1172/JCI133679
   Liu Y, 2021, HEPATOLOGY, V73, P1671, DOI 10.1002/hep.31602
   Ma XZ, 2021, CELL METAB, V33, P1001, DOI 10.1016/j.cmet.2021.02.015
   Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003
   Manzo T, 2020, J EXP MED, V217, DOI 10.1084/jem.20191920
   Mittelbrunn M, 2021, NAT IMMUNOL, V22, P687, DOI 10.1038/s41590-021-00927-z
   Miwa S, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI158447
   Molling JW, 2005, INT J CANCER, V116, P87, DOI 10.1002/ijc.20998
   Nakano S, 2020, CANCERS, V12, DOI 10.3390/cancers12040775
   NATORI T, 1994, TETRAHEDRON, V50, P2771, DOI 10.1016/S0040-4020(01)86991-X
   Neparidze N, 2009, ANN NY ACAD SCI, V1174, P61, DOI 10.1111/j.1749-6632.2009.04931.x
   Passos-Castilho AM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1995-1
   Patterson AD, 2011, CANCER RES, V71, P6590, DOI 10.1158/0008-5472.CAN-11-0885
   Pereyra AS, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108374
   Ringel AE, 2020, CELL, V183, P1848, DOI 10.1016/j.cell.2020.11.009
   Ringelhan M, 2018, NAT IMMUNOL, V19, P222, DOI 10.1038/s41590-018-0044-z
   Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328
   Sandhu C, 2000, ONCOGENE, V19, P5314, DOI 10.1038/sj.onc.1203908
   Schwarze SR, 2001, ONCOGENE, V20, P8184, DOI 10.1038/sj.onc.1205049
   Setoyama D, 2022, J CACHEXIA SARCOPENI, V13, P355, DOI 10.1002/jcsm.12889
   Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599
   Tan XS, 2018, J IMMUNOL, V200, P3530, DOI 10.4049/jimmunol.1701801
   Waldowska M, 2017, CENT EUR J IMMUNOL, V42, P181, DOI 10.5114/ceji.2017.69361
   Weng XF, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021385118
   Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792
   Zhang HM, 2021, CELL MOL IMMUNOL, V18, P1077, DOI 10.1038/s41423-020-0479-7
   Zhang YT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01126
   Zhao YJ, 2020, CELL MOL IMMUNOL, V17, P27, DOI 10.1038/s41423-019-0344-8
   Zhu YN, 2019, CELL STEM CELL, V25, P542, DOI 10.1016/j.stem.2019.08.004
   Ziegler DV, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20993-z
NR 51
TC 6
Z9 6
U1 4
U2 16
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD FEB 15
PY 2023
VL 83
IS 4
BP 582
EP 594
DI 10.1158/0008-5472.CAN-22-2273
PG 13
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 8Z8DO
UT WOS:000933602800001
PM 36512635
OA Green Submitted
DA 2024-02-19
ER

PT J
AU TOLLEFSBOL, TO
   ANDREWS, LG
AF TOLLEFSBOL, TO
   ANDREWS, LG
TI MECHANISMS FOR METHYLATION-MEDIATED GENE SILENCING AND AGING
SO MEDICAL HYPOTHESES
LA English
DT Article
ID INTEGRATED ADENOVIRUS-TYPE-12 DNA; MURINE ERYTHROLEUKEMIA-CELLS; HAMSTER
   TUMOR-CELLS; SEQUENCE SPECIFICITY; PROTEIN INTERACTIONS; RAT-LIVER;
   EXPRESSION; BINDING; CPG; PATTERNS
AB Gene silencing is often mediated by CpG methylation of key protein binding sites within gene regulatory sequences (GRSs). An aging mechanism is proposed based on this gene-silencing phenomenon whereby accumulation over time of methylation within GRSs contributes to cellular senescence. The proposed molecular mechanism for age-related gene silencing is the spreading of methylation through the regulatory sequences of genes resulting in progressive reduction of gene transcription. There is considerable experimental evidence for methylation spreading and its role in gene silencing, but the mechanism responsible for this process has not been elucidated. A four-step mechanism is proposed whereby an original methylation occurs, methyltransferase (MTase) molecules progressively move 5' to 3' from this site, neighboring CpG dinucleotides become methylated, and diminished gene expression ensues. Over time, this process may lead to widespread gene silencing in diverse dividing and nondividing cell types contributing to aging of the organism.
C1 DUKE UNIV, MED CTR, DEPT MICROBIOL & IMMUNOL, DURHAM, NC 27710 USA.
C3 Duke University
RP TOLLEFSBOL, TO (corresponding author), UNIV N CAROLINA, DEPT MICROBIOL & IMMUNOL, CHAPEL HILL, NC 27599 USA.
OI Tollefsbol, Trygve/0000-0002-0284-1511
FU NIAID NIH HHS [AI08998] Funding Source: Medline; NIGMS NIH HHS [GM21313]
   Funding Source: Medline
CR ADAMS RLP, 1990, BIOCHEM J, V265, P309, DOI 10.1042/bj2650309
   BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8
   BENVENISTY N, 1989, J ROY COLL PHYS LOND, V23, P156
   BESTOR TH, 1985, P NATL ACAD SCI USA, V82, P2674, DOI 10.1073/pnas.82.9.2674
   BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559
   BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0
   BOLDEN A, 1984, J BIOL CHEM, V259, P2437
   BOLDEN AH, 1986, PROG NUCLEIC ACID RE, V33, P231, DOI 10.1016/S0079-6603(08)60025-2
   BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3
   CARBONE AM, 1988, J IMMUNOL, V141, P1369
   CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5
   COMB M, 1990, NUCLEIC ACIDS RES, V18, P3975, DOI 10.1093/nar/18.13.3975
   DOERFLER W, 1990, FEBS LETT, V268, P329, DOI 10.1016/0014-5793(90)81280-2
   DRAHOVSKY D, 1971, J MOL BIOL, V61, P343, DOI 10.1016/0022-2836(71)90384-6
   DRAHOVSKY D, 1971, J MOL BIOL, V57, P475, DOI 10.1016/0022-2836(71)90104-5
   FLATAU E, 1983, CANCER RES, V43, P4901
   FRANK D, 1990, PHILOS T ROY SOC B, V326, P241, DOI 10.1098/rstb.1990.0008
   GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9
   GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103
   GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0
   GRUNWALD S, 1989, PROG CLIN BIOCH MED, V9, P61, DOI DOI 10.1007/978-3-642-74734-2_3
   HANSEN RS, 1990, P NATL ACAD SCI USA, V87, P4174, DOI 10.1073/pnas.87.11.4174
   HAYFLICK L, 1985, EXP GERONTOL, V20, P145, DOI 10.1016/0531-5565(85)90032-4
   HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230
   HOLLIDAY R, 1989, SCI AM, V260, P60, DOI 10.1038/scientificamerican0689-60
   HORNSBY PJ, 1987, P NATL ACAD SCI USA, V84, P1580, DOI 10.1073/pnas.84.6.1580
   Jones P A, 1990, Adv Cancer Res, V54, P1, DOI 10.1016/S0065-230X(08)60806-4
   KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083
   KOVESDI I, 1987, P NATL ACAD SCI USA, V84, P2180, DOI 10.1073/pnas.84.8.2180
   KUHLMANN I, 1982, VIROLOGY, V118, P169, DOI 10.1016/0042-6822(82)90330-0
   KUHLMANN I, 1983, J VIROL, V47, P631, DOI 10.1128/JVI.47.3.631-636.1983
   MCGHEE JD, 1979, NATURE, V280, P419, DOI 10.1038/280419a0
   MONK M, 1990, PHILOS T R SOC B, V326, P299, DOI 10.1098/rstb.1990.0013
   OREND G, 1991, J VIROL, V65, P4301, DOI 10.1128/JVI.65.8.4301-4308.1991
   PAROUSH Z, 1990, CELL, V63, P1229, DOI 10.1016/0092-8674(90)90418-E
   PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502
   RIGGS AD, 1990, PHILOS T R SOC B, V326, P285, DOI 10.1098/rstb.1990.0012
   SALUZ H, 1989, P NATL ACAD SCI USA, V86, P2602, DOI 10.1073/pnas.86.8.2602
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SMITH CL, 1989, MOL CARCINOGEN, V2, P287, DOI 10.1002/mc.2940020509
   STEIN R, 1983, P NATL ACAD SCI-BIOL, V80, P2422, DOI 10.1073/pnas.80.9.2422
   SUDA Y, 1987, J CELL PHYSIOL, V133, P197, DOI 10.1002/jcp.1041330127
   SUTTER D, 1979, COLD SPRING HARB SYM, V44, P565, DOI 10.1101/SQB.1980.044.01.058
   SUTTER D, 1980, P NATL ACAD SCI-BIOL, V77, P253, DOI 10.1073/pnas.77.1.253
   SUTTER D, 1978, CELL, V14, P569, DOI 10.1016/0092-8674(78)90243-X
   TASSERONDEJONG JG, 1989, BIOCHIM BIOPHYS ACTA, V1007, P215, DOI 10.1016/0167-4781(89)90042-0
   TOLLEFSBOL TO, 1987, MOL CELL BIOCHEM, V75, P113
   TOLLEFSBOL TO, 1986, EXP GERONTOL, V21, P129, DOI 10.1016/0531-5565(86)90067-7
   TOLLEFSBOL TO, 1987, MOL BIOL MED, V4, P251
   TOTH M, 1989, P NATL ACAD SCI USA, V86, P3728, DOI 10.1073/pnas.86.10.3728
   TOTH M, 1990, J MOL BIOL, V214, P673, DOI 10.1016/0022-2836(90)90285-T
   TURKER MS, 1990, SOMAT CELL MOLEC GEN, V16, P331, DOI 10.1007/BF01232461
   VANDERPLOEG LHT, 1980, CELL, V19, P947, DOI 10.1016/0092-8674(80)90086-0
   WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136
   WILSON VL, 1983, SCIENCE, V220, P1054
NR 55
TC 17
Z9 19
U1 0
U2 1
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0306-9877
EI 1532-2777
J9 MED HYPOTHESES
JI Med. Hypotheses
PD JUL
PY 1993
VL 41
IS 1
BP 83
EP 92
DI 10.1016/0306-9877(93)90040-W
PG 10
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA LQ100
UT WOS:A1993LQ10000016
PM 8231986
DA 2024-02-19
ER

PT J
AU Douglass, AN
   Kain, HS
   Abdullahi, M
   Arang, N
   Austin, LS
   Mikolajczak, SA
   Billman, ZP
   Hume, JCC
   Murphy, SC
   Kappe, SHI
   Kaushansky, A
AF Douglass, Alyse N.
   Kain, Heather S.
   Abdullahi, Marian
   Arang, Nadia
   Austin, Laura S.
   Mikolajczak, Sebastian A.
   Billman, Zachary P.
   Hume, Jen C. C.
   Murphy, Sean C.
   Kappe, Stefan H. I.
   Kaushansky, Alexis
TI Host-based Prophylaxis Successfully Targets Liver Stage Malaria
   Parasites
SO MOLECULAR THERAPY
LA English
DT Article
ID PLASMODIUM-FALCIPARUM; PHASE-I; OBATOCLAX MESYLATE; DRUG-RESISTANCE;
   VIRUS-INFECTION; SOLID TUMORS; BH3 MIMETICS; P53; APOPTOSIS; SENESCENCE
AB Eliminating malaria parasites during the asymptomatic but obligate liver stages (LSs) of infection would stop disease and subsequent transmission. Unfortunately, only a single licensed drug that targets all LSs, Primaquine, is available. Targeting host proteins might significantly expand the repertoire of prophylactic drugs against malaria. Here, we demonstrate that both Bcl-2 inhibitors and P53 agonists dramatically reduce LS burden in a mouse malaria model in vitro and in vivo by altering the activity of key hepatocyte factors on which the parasite relies. Bcl-2 inhibitors act primarily by inducing apoptosis in infected hepatocytes, whereas P53 agonists eliminate parasites in an apoptosis-independent fashion. In combination, Bcl-2 inhibitors and P53 agonists act synergistically to delay, and in some cases completely prevent, the onset of blood stage disease. Both families of drugs are highly effective at doses that do not cause substantial hepatocyte cell death in vitro or liver damage in vivo. P53 agonists and Bcl-2 inhibitors were also effective when administered to humanized mice infected with Plasmodium falciparum. Our data demonstrate that host-based prophylaxis could be developed into an effective intervention strategy that eliminates LS parasites before the onset of clinical disease and thus opens a new avenue to prevent malaria.
C1 [Douglass, Alyse N.; Kain, Heather S.; Abdullahi, Marian; Arang, Nadia; Austin, Laura S.; Mikolajczak, Sebastian A.; Hume, Jen C. C.; Kappe, Stefan H. I.; Kaushansky, Alexis] Seattle Biomed Res Inst, Seattle, WA 98109 USA.
   [Austin, Laura S.; Kappe, Stefan H. I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Billman, Zachary P.; Murphy, Sean C.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.
   [Billman, Zachary P.; Murphy, Sean C.] Univ Washington, Ctr Emerging & Reemerging Infect Dis, Seattle, WA 98195 USA.
C3 Center for Infectious Disease Research; University of Washington;
   University of Washington Seattle; University of Washington; University
   of Washington Seattle; University of Washington; University of
   Washington Seattle
RP Kaushansky, A (corresponding author), Seattle Biomed Res Inst, 307 Westlake Ave,N Suite 500, Seattle, WA 98109 USA.
EM alexis.kaushansky@seattlebiomed.org
RI Kaushansky, Alexis/U-6695-2019; Billman, Zachary/AAE-4245-2019; Murphy,
   Sean C./AAC-7531-2019
OI Kaushansky, Alexis/0000-0001-5721-258X; Murphy, Sean
   C./0000-0002-2048-0131; Arang, Nadia/0000-0002-8167-2188; Mikolajczak,
   Sebastian/0000-0003-1996-9703
FU NRSA Ruth L. Kirschstein National Research Service Award [F32 AI091129];
   NIH Training Grant [T32 AI007509-13]; Department of Defense (DoD)
   through the National Defense Science & Engineering Graduate Fellowship
   (NDSEG) Program;  [1R01GM101183-01A1]
FX The authors are grateful to William W. Betz for mosquito and sporozoite
   production. The authors thank Roberto Guirnalda, Lynett Robertson,
   Elizabeth Cromwell, Bruce Wayne, and Seattle Biomedical Research
   Institute vivarium staff for their work with mice. A.K. is a recipient
   of a NRSA Ruth L. Kirschstein National Research Service Award (F32
   AI091129), which has partially funded this work. L.S.A. is a recipient
   of NIH Training Grant T32 AI007509-13, and further supported by the
   Department of Defense (DoD) through the National Defense Science &
   Engineering Graduate Fellowship (NDSEG) Program, both of which have
   partially funded this work. This work has also been partially funded by
   1R01GM101183-01A1 to S.H.I.K. The authors declare no conflicts of
   interest.
CR Albuquerque SS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-270
   Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876
   Arrow K.J., 2004, Saving lives, buying time Economics of malaria drugs in an age of resistance
   Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981
   Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019
   Billard C, 2013, MOL CANCER THER, V12, P1691, DOI 10.1158/1535-7163.MCT-13-0058
   Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763
   Chiappori AA, 2012, BRIT J CANCER, V106, P839, DOI 10.1038/bjc.2012.21
   Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220
   DELGAIZO M, 2013, CANC LETT, V332, P202, DOI DOI 10.1016/J.CANLET.2011.12.021
   Denisova OV, 2012, J BIOL CHEM, V287, P35324, DOI 10.1074/jbc.M112.392142
   Fauci AS, 2005, J CLIN INVEST, V115, P231, DOI 10.1172/JCI200524270
   Hartman ML, 2012, ANTI-CANCER AGENT ME, V12, P966
   Hawn TR, 2013, MICROBIOL MOL BIOL R, V77, P608, DOI 10.1128/MMBR.00032-13
   Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002
   Kaiser K, 2003, J EXP MED, V197, P1045, DOI 10.1084/jem.20022100
   Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785
   Kaushansky A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.286
   Kaushansky A, 2013, CELL REP, V3, P630, DOI 10.1016/j.celrep.2013.02.010
   Kaushansky A, 2011, NAT MED, V17, P1180, DOI 10.1038/nm.2456
   Law GL, 2013, NAT REV MICROBIOL, V11, P455, DOI 10.1038/nrmicro3036
   Lee SMY, 2012, ANTIVIR RES, V96, P391, DOI 10.1016/j.antiviral.2012.09.013
   Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026
   Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410
   Muregi Francis W, 2010, Curr Drug Discov Technol, V7, P280
   Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104
   Oki Y, 2012, BLOOD, V119, P2171, DOI 10.1182/blood-2011-11-391037
   Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579
   Polo-Hernández E, 2014, BRAIN RES, V1570, P13, DOI 10.1016/j.brainres.2014.04.038
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Schimmer AD, 2008, CLIN CANCER RES, V14, P8295, DOI 10.1158/1078-0432.CCR-08-0999
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   Sibley CH, 2014, MOL BIOCHEM PARASIT, V195, P107, DOI 10.1016/j.molbiopara.2014.06.001
   Sibley CH, 2012, INT J PARASITOL-DRUG, V2, P126, DOI 10.1016/j.ijpddr.2012.03.004
   Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808
   Tabernero J, 2011, CLIN CANCER RES, V17, P6313, DOI 10.1158/1078-0432.CCR-11-1101
   Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139
   Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019
   Vaughan AM, 2012, J CLIN INVEST, V122, P3618, DOI 10.1172/JCI62684
   White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297
   Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6
   Yang HL, 2005, J CLIN INVEST, V115, P379, DOI 10.1172/jc1200523200
   Yuan Y, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-16
NR 43
TC 27
Z9 30
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY
PY 2015
VL 23
IS 5
BP 857
EP 865
DI 10.1038/mt.2015.18
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA CH3LW
UT WOS:000353933200009
PM 25648263
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Batalha, CMPF
   Vercesi, AE
   Souza-Pinto, NC
AF Batalha, Caio M. P. F.
   Vercesi, Anibal Eugenio
   Souza-Pinto, Nadja C.
TI The Many Roles Mitochondria Play in Mammalian Aging
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Article; Early Access
DE aging; mitochondrial dysfunction; mtDNA; mitophagy; redox imbalance
ID LIFE-SPAN EXTENSION; PERMEABILITY TRANSITION PORE; TERM CALORIE
   RESTRICTION; RAT-LIVER MITOCHONDRIA; T-BUTYL HYDROPEROXIDE; THIOL
   CROSS-LINKING; KAPPA-B ACTIVATION; REACTIVE OXYGEN; OXIDATIVE STRESS;
   CELLULAR SENESCENCE
AB Significance: Aging is a natural process that affects most living organisms, resulting in increased mortality. As the world population ages, the prevalence of age-associated diseases, and their associated health care costs, has increased sharply. A better understanding of the molecular mechanisms that lead to cellular dysfunction may provide important targets for interventions to prevent or treat these diseases.Recent Advances: Although the mitochondrial theory of aging had been proposed more than 40 years ago, recent new data have given stronger support for a central role for mitochondrial dysfunction in several pathways that are deregulated during normal aging and age-associated disease.Critical Issues: Several of the experimental evidence linking mitochondrial alterations to age-associated loss of function are correlative and mechanistic insights are still elusive. Here, we review how mitochondrial dysfunction may be involved in many of the known hallmarks of aging, and how these pathways interact in an intricate net of molecular relationships.Future Directions: As it has become clear that mitochondrial dysfunction plays causative roles in normal aging and age-associated diseases, it is necessary to better define the molecular interactions and the temporal and causal relationship between these changes and the relevant phenotypes seen during the aging process.
C1 [Batalha, Caio M. P. F.; Souza-Pinto, Nadja C.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Lab Genet Mitocondrial, Ave Prof Lineu Prestes,748 Bloco 10S,Sala 1070, BR-05508000 Sao Paulo, SP, Brazil.
   [Vercesi, Anibal Eugenio] Univ Estadual Campinas, Fac Med, Dept Patol Clin, Campinas, Brazil.
C3 Universidade de Sao Paulo; Universidade Estadual de Campinas
RP Souza-Pinto, NC (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Lab Genet Mitocondrial, Ave Prof Lineu Prestes,748 Bloco 10S,Sala 1070, BR-05508000 Sao Paulo, SP, Brazil.
EM nadja@iq.usp.br
RI Vercesi, Aníbal E/C-8767-2012
OI Souza-Pinto, Nadja C. de/0000-0003-4206-964X
FU Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/04372-0, 2017/17728-8]; Conselho Nacional de Pesquisa e
   Desenvolvimento (CNPq)
FX This work was supported by Fundacao de Apoio a Pesquisa do Estado de Sao
   Paulo (FAPESP) grants 2017/04372-0 to NCSP and 2017/17728-8 to AEV. Caio
   M.P.F. Batalha is supported by Conselho Nacional de Pesquisa e
   Desenvolvimento (CNPq).
CR Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994
   ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230, DOI 10.1016/0003-9861(92)90511-T
   Aldridge JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000874
   Alencar RR, 2019, ENZYMES, V45, P257, DOI 10.1016/bs.enz.2019.06.002
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   [Anonymous], 1990, Longevity, senescence and the genome
   Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com
   Barnes RP, 2019, MECH AGEING DEV, V177, P37, DOI 10.1016/j.mad.2018.03.013
   Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024
   BERNARDES CF, 1986, BIOCHIM BIOPHYS ACTA, V850, P41, DOI 10.1016/0005-2728(86)90006-X
   Bertholet AM, 2019, NATURE, V571, P515, DOI 10.1038/s41586-019-1400-3
   Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017
   Braidy N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019194
   Brunet A, 2014, J GERONTOL A-BIOL, V69, pS17, DOI 10.1093/gerona/glu042
   Bruss MD, 2011, AM J PHYSIOL-ENDOC M, V300, pE735, DOI 10.1152/ajpendo.00661.2010
   Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cantó C, 2018, INT REV CEL MOL BIO, V340, P129, DOI 10.1016/bs.ircmb.2018.05.004
   Canty TG, 1999, CIRCULATION, V100, P361
   CARBONERA D, 1988, BIOCHIM BIOPHYS ACTA, V936, P139, DOI 10.1016/0005-2728(88)90261-7
   Cardoso AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077088
   Caro P, 2008, BIOGERONTOLOGY, V9, P183, DOI 10.1007/s10522-008-9130-1
   Carraro M, 2019, FEBS LETT, V593, P1542, DOI 10.1002/1873-3468.13485
   Carvalho G, 2022, ANTIOXID REDOX SIGN, V36, P885, DOI 10.1089/ars.2021.0091
   CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P479, DOI 10.1016/0891-5849(94)00166-H
   CASTILHO RF, 1995, FREE RADICAL BIO MED, V18, P55, DOI 10.1016/0891-5849(94)00098-5
   Chakravarti D, 2021, CELL, V184, P306, DOI 10.1016/j.cell.2020.12.028
   Chakravarty EF, 2008, ARCH INTERN MED, V168, P1638, DOI 10.1001/archinte.168.15.1638
   Chaudhari SN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00274-4
   Chaung WW, 2012, INT J MOL MED, V30, P199, DOI 10.3892/ijmm.2012.959
   Chen CJ, 2013, BIOCHEM BIOPH RES CO, V430, P798, DOI 10.1016/j.bbrc.2012.11.066
   CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Clark EH, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.REV120.014294
   Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635
   Cui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069720
   Dai DF, 2010, AGING CELL, V9, P536, DOI 10.1111/j.1474-9726.2010.00581.x
   David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450
   Del Pozo-Cruz J, 2014, EXP GERONTOL, V52, P46, DOI 10.1016/j.exger.2014.01.026
   Delaney JR, 2013, EXP GERONTOL, V48, P1006, DOI 10.1016/j.exger.2012.12.001
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308
   Efimova EV, 2010, CANCER RES, V70, P6277, DOI 10.1158/0008-5472.CAN-09-4224
   Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012
   Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0
   ESPOSITO D, 1989, P NATL ACAD SCI USA, V86, P1302, DOI 10.1073/pnas.86.4.1302
   Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497
   FAGIAN MM, 1990, J BIOL CHEM, V265, P19955
   FAILLA G, 1958, ANN NY ACAD SCI, V71, P1124, DOI 10.1111/j.1749-6632.1958.tb46828.x
   Fakouri NB, 2019, FEBS J, V286, P1058, DOI 10.1111/febs.14663
   Fang EF, 2017, SCI REP-UK, V7, DOI 10.1038/srep46208
   Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026
   Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729
   Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109
   Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002
   Fischer A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167124
   Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Francisco A, 2022, ANTIOXID REDOX SIGN, V36, P864, DOI 10.1089/ars.2021.0111
   Gadelha FR, 1997, ARCH BIOCHEM BIOPHYS, V345, P243, DOI 10.1006/abbi.1997.0259
   Garcia AM, 2008, MECH AGEING DEV, V129, P528, DOI 10.1016/j.mad.2008.04.013
   Garg A, 2017, AM J MED, V130, P173, DOI 10.1016/j.amjmed.2016.07.038
   Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024
   Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7
   George AndrewR., 2003, EPIC GILGAMESH BABYL
   Goldsmith TC, 2008, J THEOR BIOL, V252, P764, DOI 10.1016/j.jtbi.2008.02.035
   Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037
   Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059
   Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346
   Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hauser CJ, 2010, J ORTHOP TRAUMA, V24, P534, DOI 10.1097/BOT.0b013e3181ec4991
   HE F, 2016, FRONT PHYSIOL, V7, DOI DOI 10.3389/FPHYS.2016.00486
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001
   Holley AK, 2011, INT J MOL SCI, V12, P7114, DOI 10.3390/ijms12107114
   HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278
   Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188
   Huang JH, 2010, J GERONTOL A-BIOL, V65, P138, DOI 10.1093/gerona/glp201
   Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611
   Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4
   Itsara LS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003974
   Iyer SS, 2013, IMMUNITY, V39, P311, DOI 10.1016/j.immuni.2013.08.001
   Javadov S, 2017, CELL MOL LIFE SCI, V74, P2795, DOI 10.1007/s00018-017-2502-4
   Jensen MB, 2014, CELL METAB, V20, P214, DOI 10.1016/j.cmet.2014.05.006
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776
   Johnson SC, 2018, SUBCELL BIOCHEM, V90, P49, DOI 10.1007/978-981-13-2835-0_3
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395
   Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200
   Kaniak-Golik A, 2015, FREE RADICAL BIO MED, V82, P73, DOI 10.1016/j.freeradbiomed.2015.01.013
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Katajisto P, 2015, SCIENCE, V348, P340, DOI 10.1126/science.1260384
   Kauppila JHK, 2018, NUCLEIC ACIDS RES, V46, P6642, DOI 10.1093/nar/gky456
   KENNEDY EP, 1949, J BIOL CHEM, V179, P957
   Kipling D, 2004, SCIENCE, V305, P1426, DOI 10.1126/science.1102587
   KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0
   KIRKWOOD TBL, 1984, INT REV CYTOL, V92, P93
   Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011
   Klingenberg M, 2017, BIOCHIMIE, V134, P19, DOI 10.1016/j.biochi.2016.10.012
   Kowald A, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030126
   Kowaltowski AJ, 1998, J BIOL CHEM, V273, P12766, DOI 10.1074/jbc.273.21.12766
   Kowaltowski AJ, 1996, FEBS LETT, V378, P150, DOI 10.1016/0014-5793(95)01449-7
   Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X
   Kowaltowski AJ, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.100841
   Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004
   Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198
   Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200
   Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936
   Lee SM, 2012, BIOGERONTOLOGY, V13, P525, DOI 10.1007/s10522-012-9397-0
   LEHNINGER AL, 1978, P NATL ACAD SCI USA, V75, P1690, DOI 10.1073/pnas.75.4.1690
   Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002
   Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008
   Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008
   Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x
   Liu YJ, 2020, MECH AGEING DEV, V186, DOI 10.1016/j.mad.2020.111212
   Liu Y, 2014, GERIATR GERONTOL INT, V14, P740, DOI 10.1111/ggi.12296
   Longo Valter D, 2005, Nat Rev Genet, V6, P866
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   MacKenzie JA, 2007, BBA-MOL BASIS DIS, V1772, P509, DOI 10.1016/j.bbadis.2006.12.002
   Mailloux RJ, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9060472
   Mailloux RJ, 2014, J BIOL CHEM, V289, P14812, DOI 10.1074/jbc.M114.550574
   Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059
   Marcuello A, 2005, J APPL PHYSIOL, V99, P1372, DOI 10.1152/japplphysiol.00289.2005
   Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100
   Markesbery WR, 2006, ANTIOXID REDOX SIGN, V8, P2039, DOI 10.1089/ars.2006.8.2039
   MARTIN GM, 1985, ISRAEL J MED SCI, V21, P296
   Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046
   Mattson MP, 2017, AGEING RES REV, V39, P46, DOI 10.1016/j.arr.2016.10.005
   Maynard S, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a025130
   Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107
   Michel S, 2015, MITOCHONDRION, V21, P58, DOI 10.1016/j.mito.2015.01.005
   Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036
   MITCHELL P, 1970, BIOCHEM J, V116, pP5, DOI 10.1042/bj1160005P
   MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0
   MIYAKAWA I, 1984, J CELL SCI, V66, P21
   Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361
   Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08
   Monaghan RM, 2015, NAT CELL BIOL, V17, P782, DOI 10.1038/ncb3170
   Mottis A, 2014, MAMM GENOME, V25, P424, DOI 10.1007/s00335-014-9525-z
   Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016
   Muftuoglu M, 2014, MITOCHONDRION, V17, P164, DOI 10.1016/j.mito.2014.03.007
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858
   NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1
   NOHL H, 1978, FEBS LETT, V89, P126, DOI 10.1016/0014-5793(78)80537-7
   Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013
   Ochoa JJ, 2011, FREE RADICAL BIO MED, V50, P1053, DOI 10.1016/j.freeradbiomed.2011.02.004
   Oliveira HCF, 2020, MOL ASPECTS MED, V71, DOI 10.1016/j.mam.2019.100840
   Onishi M, 2021, EMBO J, V40, DOI 10.15252/embj.2020104705
   Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002
   PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0
   PALADE GE, 1952, ANAT RECORD, V114, P427, DOI 10.1002/ar.1091140304
   Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5
   Picca A, 2017, CLIN INTERV AGING, V12, P1887, DOI 10.2147/CIA.S126458
   Pinti M, 2014, EUR J IMMUNOL, V44, P1552, DOI 10.1002/eji.201343921
   Price JC, 2012, MOL CELL PROTEOMICS, V11, P1801, DOI 10.1074/mcp.M112.021204
   Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200
   Quiles JL, 2005, BIOFACTORS, V25, P73, DOI 10.1002/biof.5520250109
   Quirós PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058
   RADI R, 1991, J BIOL CHEM, V266, P22028
   Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936
   Rainbolt TK, 2013, CELL METAB, V18, P908, DOI 10.1016/j.cmet.2013.11.006
   Rana A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00525-4
   Rao KS, 2007, NEUROSCIENCE, V145, P1330, DOI 10.1016/j.neuroscience.2006.09.032
   Rasmussen AK, 2003, NUCLEIC ACIDS RES, V31, P3909, DOI 10.1093/nar/gkg446
   Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037
   Rose MR, 1991, EVOLUTIONARY BIOL AG
   Rottenberg H, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010079
   Roubicek DA, 2017, TOXICOLOGY, V391, P100, DOI 10.1016/j.tox.2017.06.012
   Rydström J, 2006, BBA-BIOENERGETICS, V1757, P721, DOI 10.1016/j.bbabio.2006.03.010
   Safdar A, 2011, P NATL ACAD SCI USA, V108, P4135, DOI 10.1073/pnas.1019581108
   Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200
   Santra M, 2019, P NATL ACAD SCI USA, V116, P22173, DOI 10.1073/pnas.1906592116
   Saretzki G, 2003, AGING CELL, V2, P141, DOI 10.1046/j.1474-9728.2003.00040.x
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Scheibye-Knudsen M, 2013, AGING-US, V5, P192, DOI 10.18632/aging.100546
   Schiavi A, 2015, CURR BIOL, V25, P1810, DOI 10.1016/j.cub.2015.05.059
   Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096
   Schulz AM, 2015, BBA-BIOENERGETICS, V1847, P1448, DOI 10.1016/j.bbabio.2015.03.008
   Schulz E, 2014, ANTIOXID REDOX SIGN, V20, P308, DOI 10.1089/ars.2012.4609
   Sebastián D, 2017, TRENDS MOL MED, V23, P201, DOI 10.1016/j.molmed.2017.01.003
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X
   Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539
   SJOSTRAND FS, 1956, EXPERIENTIA, V12, P196, DOI 10.1007/BF02170794
   Skulachev VP, 1996, Q REV BIOPHYS, V29, P169, DOI 10.1017/S0033583500005795
   SLATER EC, 1953, BIOCHEM J, V53, P557, DOI 10.1042/bj0530557
   Smith HJ, 2020, DEV CELL, V54, P196, DOI 10.1016/j.devcel.2020.06.011
   Soare Andreea, 2011, Aging (Albany NY), V3, P374
   Soares JP, 2014, AGING-US, V6, P432, DOI 10.18632/aging.100667
   Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002
   Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007
   Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004
   Stein LR, 2014, EMBO J, V33, P1321, DOI 10.1002/embj.201386917
   Stenvinkel P, 2019, BIOCHEM SOC T, V47, P1157, DOI 10.1042/BST20190105
   Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248
   Stewart JB, 2021, NAT REV GENET, V22, P106, DOI 10.1038/s41576-020-00284-x
   Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010
   Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002
   SZILARD L, 1959, P NATL ACAD SCI USA, V45, P30, DOI 10.1073/pnas.45.1.30
   Takahashi M, 1996, J BIOL CHEM, V271, P27285, DOI 10.1074/jbc.271.44.27285
   Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440
   Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920
   Tian G, 2014, ANTIOXID REDOX SIGN, V20, P2606, DOI 10.1089/ars.2013.5406
   Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104
   Toyama K, 2011, ATHEROSCLEROSIS, V217, P158, DOI 10.1016/j.atherosclerosis.2011.02.050
   Tran M, 2021, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.612757
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478
   Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310
   Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006
   Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014
   VERCESI AE, 1984, ARCH BIOCHEM BIOPHYS, V232, P86, DOI 10.1016/0003-9861(84)90523-X
   VERCESI AE, 1987, ARCH BIOCHEM BIOPHYS, V252, P171, DOI 10.1016/0003-9861(87)90021-X
   Vercesi AE, 2018, FREE RADICAL BIO MED, V129, P1, DOI 10.1016/j.freeradbiomed.2018.08.034
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200
   Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013
   Weir HJ, 2017, CELL METAB, V26, P884, DOI 10.1016/j.cmet.2017.09.024
   Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106
   White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Winterbourn CC, 2013, METHOD ENZYMOL, V528, P3, DOI 10.1016/B978-0-12-405881-1.00001-X
   Wong HS, 2017, J BIOL CHEM, V292, P16804, DOI 10.1074/jbc.R117.789271
   Woodcox A, 2018, CAH ETUDES ANC, P65
   Xia SJ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8426874
   Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275
   Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014
   Zago EB, 2000, FEBS LETT, V478, P29, DOI 10.1016/S0014-5793(00)01815-9
   Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073
   Zhang C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44708
   Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420
   Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693
   Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780
   Zhao DJ, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4079041
   Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445
   Zheng Q, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00274
   Zhu XH, 2015, P NATL ACAD SCI USA, V112, P2876, DOI 10.1073/pnas.1417921112
   ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A
NR 259
TC 3
Z9 3
U1 2
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD 2022 MAY 1
PY 2022
VL 36
IS 13
BP 824
EP 843
DI 10.1089/ars.2021.0074
EA JAN 2022
PG 20
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 1E2CA
UT WOS:000739217700001
PM 34715739
DA 2024-02-19
ER

PT J
AU Kolodziejczyk, AA
   Federici, S
   Zmora, N
   Mohapatra, G
   Dori-Bachash, M
   Hornstein, S
   Leshem, A
   Reuveni, D
   Zigmond, E
   Tobar, A
   Salame, TM
   Harmelin, A
   Shlomai, A
   Shapiro, H
   Amit, I
   Elinav, E
AF Kolodziejczyk, Aleksandra A.
   Federici, Sara
   Zmora, Niv
   Mohapatra, Gayatree
   Dori-Bachash, Mally
   Hornstein, Shanni
   Leshem, Avner
   Reuveni, Debby
   Zigmond, Ehud
   Tobar, Ana
   Salame, Tomer Meir
   Harmelin, Alon
   Shlomai, Amir
   Shapiro, Hagit
   Amit, Ido
   Elinav, Eran
TI Acute liver failure is regulated by MYC- and microbiome-dependent
   programs
SO NATURE MEDICINE
LA English
DT Article; Early Access
ID HEPATIC STELLATE CELLS; INTESTINAL MICROBIOTA; HOMEOSTASIS; SENESCENCE;
   PATHWAY; INJURY; P38
AB A single-cell map of transcriptomic changes during acute liver failure unveils new insights into pathogenesis and potential therapeutic targets.
   Acute liver failure (ALF) is a fulminant complication of multiple etiologies, characterized by rapid hepatic destruction, multi-organ failure and mortality. ALF treatment is mainly limited to supportive care and liver transplantation. Here we utilize the acetaminophen (APAP) and thioacetamide (TAA) ALF models in characterizing 56,527 single-cell transcriptomes to define the mouse ALF cellular atlas. We demonstrate that unique, previously uncharacterized stellate cell, endothelial cell, Kupffer cell, monocyte and neutrophil subsets, and their intricate intercellular crosstalk, drive ALF. We unravel a common MYC-dependent transcriptional program orchestrating stellate, endothelial and Kupffer cell activation during ALF, which is regulated by the gut microbiome through Toll-like receptor (TLR) signaling. Pharmacological inhibition of MYC, upstream TLR signaling checkpoints or microbiome depletion suppress this cell-specific, MYC-dependent program, thereby attenuating ALF. In humans, we demonstrate upregulated hepatic MYC expression in ALF transplant recipients compared to healthy donors. Collectively we demonstrate that detailed cellular/genetic decoding may enable pathway-specific ALF therapeutic intervention.
C1 [Kolodziejczyk, Aleksandra A.; Federici, Sara; Zmora, Niv; Mohapatra, Gayatree; Dori-Bachash, Mally; Hornstein, Shanni; Leshem, Avner; Shapiro, Hagit; Amit, Ido; Elinav, Eran] Weizmann Inst Sci, Immunol Dept, Rehovot, Israel.
   [Zmora, Niv; Reuveni, Debby; Zigmond, Ehud; Tobar, Ana; Shlomai, Amir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.
   [Zmora, Niv; Reuveni, Debby; Zigmond, Ehud] Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, Tel Aviv, Israel.
   [Leshem, Avner] Tel Aviv Sourasky Med Ctr, Dept Surg, Tel Aviv, Israel.
   [Tobar, Ana] Beilinson Med Ctr, Dept Pathol, Rabin Med Ctr, Petah Tiqwa, Israel.
   [Salame, Tomer Meir] Weizmann Inst Sci, Dept Biol Serv, Rehovot, Israel.
   [Harmelin, Alon] Weizmann Inst Sci, Dept Vet Resources, Rehovot, Israel.
   [Shlomai, Amir] Beilinson Med Ctr, Rabin Med Ctr, Dept Med D, Petah Tiqwa, Israel.
   [Shlomai, Amir] Beilinson Med Ctr, Rabin Med Ctr, Liver Inst, Petah Tiqwa, Israel.
   [Elinav, Eran] DKFZ, Div Canc Microbiome Res, Heidelberg, Germany.
C3 Weizmann Institute of Science; Sackler Faculty of Medicine; Sackler
   Faculty of Medicine; Tel Aviv Sourasky Medical Center; Sackler Faculty
   of Medicine; Tel Aviv Sourasky Medical Center; Rabin Medical Center;
   Weizmann Institute of Science; Weizmann Institute of Science; Rabin
   Medical Center; Rabin Medical Center; Helmholtz Association; German
   Cancer Research Center (DKFZ)
RP Amit, I; Elinav, E (corresponding author), Weizmann Inst Sci, Immunol Dept, Rehovot, Israel.; Elinav, E (corresponding author), DKFZ, Div Canc Microbiome Res, Heidelberg, Germany.
EM ido.amit@weizmann.ac.il; eran.elinav@weizmann.ac.il
RI Shapiro, Hagit/F-8648-2015; Elinav, Eran/ABE-8881-2020; Federici,
   Sara/ABD-4056-2021; Kolodziejczyk, Aleksandra A/K-1985-2014
OI Elinav, Eran/0000-0002-5775-2110; Kolodziejczyk, Aleksandra
   A/0000-0002-2903-8884; Shapiro Levi, Hagit/0000-0002-0444-1781; Leshem,
   Avner/0000-0003-4082-2036; Amit, Ido/0000-0003-2968-877X; Federici,
   Sara/0000-0002-3663-5142
FU EMBO Long Term Fellowship [2016-1088]; European Union's Horizon 2020
   research and innovation program under Marie Sklodowska-Curie grant
   [747114]; Chan Zuckerberg Initiative; HHMI international scholar award;
   European Research Council consolidator grant (ERC-COG)
   [724471-Hem-Tree2.0]; Thompson Family Foundation; MRA established
   investigator award [509044]; Israel Science Foundation [703/15]; Ernest
   and Bonnie Beutler Research Program for Excellence in Genomic Medicine;
   Helen and Martin Kimmel award for innovative investigation; NeuroMac
   DFG/Transregional Collaborative Research Center grant; International
   Progressive MS Alliance/NMSS [PA-1604-08459]; Adelis Foundation; SCA
   award of the Wolfson Foundation; Leona M. and Harry B. Helmsley
   Charitable Trust; Pearl Welinsky Merlo Scientific Progress Research
   Fund; Lawrence and Sandra Post Family Foundation; Daniel Morris Trust;
   Park Avenue Charitable Fund; Hanna and Dr Ludwik Wallach Cancer Research
   Fund; Howard and Nancy Marks Charitable Fund; estate of Malka Moskowitz;
   estate of Myron H. Ackerman; estate of Bernard Bishin; V. R. Schwartz
   Research Fellow Chair; European Research Council; Israel Science
   Foundation; Israel Ministry of Science and Technology; Israel Ministry
   of Health; Helmholtz Foundation; Else Kroener Fresenius Foundation;
   Garvan Institute; European Crohn's and Colitis Organization;
   Deutsch-Israelische Projektkooperation; Welcome Trust; Marie Curie
   Actions (MSCA) [747114] Funding Source: Marie Curie Actions (MSCA)
FX We thank members of the Elinav laboratory and the DKFZ cancer-microbiome
   division for discussions. We thank C. Bar-Nathan for dedicated
   assistance with animal work. A.A.K. is a recipient of EMBO Long Term
   Fellowship no. 2016-1088 and the European Union's Horizon 2020 research
   and innovation program under Marie Sklodowska-Curie grant agreement no.
   747114. I.A. is supported by the Chan Zuckerberg Initiative, an HHMI
   international scholar award, a European Research Council consolidator
   grant (ERC-COG, no. 724471-Hem-Tree2.0), the Thompson Family Foundation,
   an MRA established investigator award (no. 509044), the Israel Science
   Foundation (no. 703/15), the Ernest and Bonnie Beutler Research Program
   for Excellence in Genomic Medicine, a Helen and Martin Kimmel award for
   innovative investigation, a NeuroMac DFG/Transregional Collaborative
   Research Center grant, International Progressive MS Alliance/NMSS (no.
   PA-1604-08459), an Adelis Foundation grant and the SCA award of the
   Wolfson Foundation. E.E. is supported by Yael and Rami Ungar; the Leona
   M. and Harry B. Helmsley Charitable Trust; the Adelis Foundation; the
   Pearl Welinsky Merlo Scientific Progress Research Fund; the Lawrence and
   Sandra Post Family Foundation; the Daniel Morris Trust; the Park Avenue
   Charitable Fund; the Hanna and Dr Ludwik Wallach Cancer Research Fund;
   the Howard and Nancy Marks Charitable Fund; Aliza Moussaieff; the
   estates of Malka Moskowitz, Myron H. Ackerman and Bernard Bishin (for
   the WIS-Clalit Program); Donald and Susan Schwarz; the V. R. Schwartz
   Research Fellow Chair; grants funded by the European Research Council;
   Israel Science Foundation; Israel Ministry of Science and Technology;
   Israel Ministry of Health; the Helmholtz Foundation; the Else Kroener
   Fresenius Foundation; the Garvan Institute; the European Crohn's and
   Colitis Organization; Deutsch-Israelische Projektkooperation; and
   Welcome Trust. E.E. is the incumbent of the Sir Marc and Lady Tania
   Feldmann Professorial Chair; a senior fellow, Canadian Institute of
   Advanced Research and an international scholar; and The Bill & Melinda
   Gates Foundation and Howard Hughes Medical Institute.
CR Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715
   Berger SB, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.9
   Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Brempelis KJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.62
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cavalli M, 2020, OMICS, V24, P180, DOI 10.1089/omi.2019.0215
   Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022
   Fabregat I, 2016, FEBS J, V283, P2219, DOI 10.1111/febs.13665
   Hajovsky H, 2012, CHEM RES TOXICOL, V25, P1955, DOI 10.1021/tx3002719
   Hari P, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw0254
   Hart JR, 2014, P NATL ACAD SCI USA, V111, P12556, DOI 10.1073/pnas.1319488111
   Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809
   Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091
   Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12
   Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887
   Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x
   Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015
   Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233
   Krenkel O, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050503
   Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11
   Llopis M, 2016, GUT, V65, P830, DOI 10.1136/gutjnl-2015-310585
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7
   Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507
   Maeshima K, 2004, SHOCK, V21, P134, DOI 10.1097/01.shk.0000103386.98235.f6
   Mannangatti P, 2015, J BIOL CHEM, V290, P10814, DOI 10.1074/jbc.M114.612192
   Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023
   McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491
   Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017
   Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200
   Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009
   Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3
   Ramilowski JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8866
   Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226
   Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571
   Rühlemann MC, 2017, GUT, V66, P753, DOI 10.1136/gutjnl-2016-312180
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   Schmidt-Arras D, 2016, J HEPATOL, V64, P1403, DOI 10.1016/j.jhep.2016.02.004
   Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663
   Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131
   Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887
   Strauss O, 2017, SCI REP-UK, V7, DOI 10.1038/srep44356
   Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031
   Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003
   Thomas MP, 2015, CELL REP, V11, P1079, DOI 10.1016/j.celrep.2015.04.026
   Vyrla D, 2016, J IMMUNOL, V196, P4298, DOI 10.4049/jimmunol.1501609
   Woolbright Benjamin L, 2017, J Clin Transl Res, V3, P170, DOI 10.18053/jctres.03.2017S1.003
   Wu C, 2017, BLOOD, V130
   Wu X, 2011, J CLIN INVEST, V121, P1009, DOI 10.1172/JCI44929
   Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262
   Yang CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065070
   Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138
   Zhou J, 2018, J CELL MOL MED, V22, P2908, DOI 10.1111/jcmm.13585
NR 58
TC 72
Z9 74
U1 1
U2 21
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD 2020 DEC
PY 2020
VL 26
IS 12
DI 10.1038/s41591-020-1102-2
EA OCT 2020
PG 35
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA PB8QO
UT WOS:000584042900001
PM 33106666
OA Green Published
DA 2024-02-19
ER

PT J
AU Iakova, P
   Awad, SS
   Timchenko, NA
AF Iakova, P
   Awad, SS
   Timchenko, NA
TI Aging reduces proliferative capacities of liver by switching pathways of
   C/EBPα growth arrest
SO CELL
LA English
DT Article
ID TERMINAL ADIPOCYTE DIFFERENTIATION; ENHANCER BINDING-PROTEIN;
   RETINOBLASTOMA PROTEIN; NEWBORN MICE; C-MYC; REGENERATION; TARGET;
   GRANULOPOIESIS; ADIPOGENESIS; EXPRESSION
AB The liver is capable of completely regenerating itself in response to injury and after partial hepatectomy. In liver of old animals, the proliferative response is dramatically reduced, the mechanism for which is unknown. The liver specific protein, C/EBPalpha, normally arrests proliferation of hepatocytes through inhibiting cyclin dependent kinases (cdks). We present evidence that aging switches the liver-specific pathway of C/EBPalpha growth arrest to repression of E2F transcription. We identified an age-specific C/EBPalpha-Rb-E2F4 complex that binds to E2F-dependent promoters and represses these genes. The C/EBPalpha-Rb-E2F4 complex occupies the c-myc promoter and blocks induction of c-myc in livers of old animals after partial hepatectomy. Our results show that the age-dependent switch from cdk inhibition to repression of E2F transcription causes a loss of proliferative response in the liver because of an inability to induce E2F target genes after partial hepatectomy providing a possible mechanism for the age-dependent loss of liver regenerative capacity.
C1 Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA.
   Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine
RP Timchenko, NA (corresponding author), Baylor Coll Med, Huffington Ctr Aging, 1 Baylor Plaza, Houston, TX 77030 USA.
FU NIA NIH HHS [AG00765, AG20752-01] Funding Source: Medline; NIGMS NIH HHS
   [GM55188] Funding Source: Medline
CR Arora V, 2000, J PHARMACOL EXP THER, V292, P921
   BIRKENMEIER EH, 1989, GENE DEV, V3, P1146, DOI 10.1101/gad.3.8.1146
   BUCHER NLR, 1964, CANCER RES, V24, P509
   Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794
   DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   FREYTAG SO, 1992, SCIENCE, V256, P379, DOI 10.1126/science.256.5055.379
   FRY M, 1984, J CELL PHYSIOL, V118, P225, DOI 10.1002/jcp.1041180302
   JANSENDURR P, 1994, CELL CYCLE MAT METHO, P243
   Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001
   Pedersen TÅ, 2001, GENE DEV, V15, P3208, DOI 10.1101/gad.209901
   Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5
   Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979
   Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000
   STROBER BE, 1996, MOL CELL BIOL, V16, P1567
   Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340
   Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P3621, DOI 10.1093/nar/27.17.3621
   Timchenko NA, 1998, NUCLEIC ACIDS RES, V26, P3293, DOI 10.1093/nar/26.13.3293
   Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804
   Timchenko NA, 1997, MOL CELL BIOL, V17, P7353, DOI 10.1128/MCB.17.12.7353
   Timchenko NA, 1999, MOL CELL BIOL, V19, P2936
   UMEK RM, 1991, SCIENCE, V251, P288, DOI 10.1126/science.1987644
   Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930
   Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000
   Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499
   YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168
NR 26
TC 201
Z9 221
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0092-8674
J9 CELL
JI Cell
PD MAY 16
PY 2003
VL 113
IS 4
BP 495
EP 506
DI 10.1016/S0092-8674(03)00318-0
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 680MG
UT WOS:000182981500011
PM 12757710
OA hybrid
DA 2024-02-19
ER

PT J
AU Yang, JQ
   He, YQ
   Zou, JY
   Xu, L
   Fan, F
   Ge, ZL
AF Yang, Jiangquan
   He, Yuqi
   Zou, Jiayi
   Xu, Lin
   Fan, Fang
   Ge, Zhenglong
TI Effect of <i>Polygonum Multiflorum Thunb</i> on liver fatty acid content
   in aging mice induced by D-galactose
SO LIPIDS IN HEALTH AND DISEASE
LA English
DT Article
DE Polygonum Multiflorum Thunb; Aging; Fatty acids; Gas chromatography mass
   spectrometry; D-galactose
ID EPOXYEICOSATRIENOIC ACIDS; ANTIOXIDANT ACTIVITY; COGNITIVE DECLINE;
   LIPID-METABOLISM; IN-VIVO; NEUROPATHOLOGY
AB Background: Polygonum Multiflorum Thunb(PMT) has multiple biological effects, such as anti-inflammatory, lipid-lowering, anti-aging and so on. Therefore, D-galactose-induced aging mice were used to study the effect of PMT on fatty acid metabolism and its underlying mechanism.
   Methods: C57BL/6 male mice were randomly divided into normal group, aging model group, PMT intragastrical administration group (high, Medium, low); model group and PMT intragastrical administration group Daily intraperitoneal injection D-galactose 800 mg.ml(- 1).Kg(- 1) to establish subacute aging model; PMT intragastrical administration group at the same time to intragastrical PMT extract (1 g.ml(- 1).Kg(- 1), 0.6 g.ml(- 1).Kg(- 1), 0.3 g.ml(- 1).Kg(- 1)), normal group injection and intragastrical equivalent saline for 60 consecutive days. By detecting the oxidation index of liver to judge the efficacy of PMT, gas chromatography-mass spectrometry (GC-MS) analysis was used to quantitatively analyze the fatty acid content in liver.
   Results: Finally, we found that PMT improved the enzyme activity of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in aging mice, and reduce the enzyme activity of malondialdehyde (MDA), aspartate aminotransferase (AST) and alanine aminotransferase (ALT). The content of fatty acids such as C18:1, C18:2, C18:3 N3, C20:2 and C20:3 N3 decreased significantly in senescent mice (P < 0.05) as evidenced by GC-MS analysis, whereas, these fatty acids increased significantly after treatment of PMT (P < 0.05).
   Conclusion: PMT improves the content of liver fatty acids in aging mice induced by D-galactose through, enhancing the activity of anti-oxidant enzymes.
C1 [Yang, Jiangquan; Zou, Jiayi; Xu, Lin; Fan, Fang; Ge, Zhenglong] Zunyi Med Univ, Dept Biochem & Mol Biol, Zunyi, Guizhou, Peoples R China.
   [He, Yuqi] Zunyi Med Univ, Dept Pharmaceut Anal, Zunyi, Guizhou, Peoples R China.
C3 Zunyi Medical University; Zunyi Medical University
RP Ge, ZL (corresponding author), Zunyi Med Univ, Dept Biochem & Mol Biol, Zunyi, Guizhou, Peoples R China.
EM 1908754624@qq.com
RI Fan, Fang/GRO-2696-2022; fan, fang/GQY-9173-2022
FU National Natural Science Foundation of China [81660756]; Guizhou
   Provincial Science and Technology Department [[2016] 1169]
FX This work was supported by National Natural Science Foundation of China
   (81660756); and Guizhou Provincial Science and Technology Department
   ([2016] 1169).
CR Barrera G, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080102
   Cederholm T, 2013, ADV NUTR, V4, P672, DOI 10.3945/an.113.004556
   Dizdaroglu M, 2012, FREE RADICAL RES, V46, P382, DOI 10.3109/10715762.2011.653969
   Edith AR, 2016, REPROD BIOL, V16, P78, DOI 10.1016/j.repbio.2016.01.001
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Gao H, 2016, BRAIN BEHAV IMMUN, V57, P314, DOI 10.1016/j.bbi.2015.09.012
   Gong ZW, 2017, MOL CELL ENDOCRINOL, V455, P115, DOI 10.1016/j.mce.2016.12.022
   Halliwell B, 2009, FREE RADICAL BIO MED, V46, P531, DOI 10.1016/j.freeradbiomed.2008.11.008
   Hao XW, 2017, CHIN J GERONTOL, V37, P1346
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Huang Qing, 2009, Yaoxue Xuebao, V44, P1095
   Ip SP, 1997, PHYTOTHER RES, V11, P42, DOI 10.1002/(SICI)1099-1573(199702)11:1<42::AID-PTR940>3.3.CO;2-X
   Jenkins NDM, 2016, EXP GERONTOL, V84, P1, DOI 10.1016/j.exger.2016.08.004
   Keller JN, 2006, AGEING RES REV, V5, P1, DOI 10.1016/j.arr.2005.06.002
   Kim KB, 2014, FOOD CHEM TOXICOL, V70, P163, DOI 10.1016/j.fct.2014.05.009
   Lei LH, 2016, J CHIN MED ASSOC, V79, P205, DOI 10.1016/j.jcma.2015.06.023
   Lei Xiang, 2015, EVID-BASED COMPL ALT, DOI [DOI 10.1155/2015/459749, 10.1155/2015/459749]
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Lv LS, 2014, CARBOHYD POLYM, V99, P765, DOI 10.1016/j.carbpol.2013.09.007
   Montoliu I, 2014, AGING-US, V6, P9, DOI 10.18632/aging.100630
   Oltman CL, 1998, CIRC RES, V83, P932
   Shen YB, 2016, FOOD CHEM, V194, P1003, DOI 10.1016/j.foodchem.2015.08.083
   Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3
   Um MY, 2006, J ETHNOPHARMACOL, V104, P144, DOI 10.1016/j.jep.2005.08.054
   Verdier V, 2012, GLIA, V60, P751, DOI 10.1002/glia.22305
   Vitetta L, 2014, INFLAMMOPHARMACOLOGY, V22, P69, DOI 10.1007/s10787-014-0199-7
   Wang T, 2009, FREE RADICAL BIO MED, V47, P229, DOI 10.1016/j.freeradbiomed.2009.02.027
   Yan SK, 2009, MOL BIOSYST, V5, P1204, DOI 10.1039/b816407j
   Zhang ZD, 2012, ECOL INFORM, V8, P37, DOI 10.1016/j.ecoinf.2011.12.002
   Zhou XX, 2015, NEUROBIOL AGING, V36, P1462, DOI 10.1016/j.neurobiolaging.2014.11.002
   Zhou Y, 2014, LANGMUIR, V30, P13301, DOI 10.1021/la5032366
   刘惠敏, 2002, [中国老年学杂志, Chinese Journal of Gerontology], V22, P42
NR 32
TC 11
Z9 12
U1 3
U2 25
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-511X
J9 LIPIDS HEALTH DIS
JI Lipids Health Dis.
PD JUN 1
PY 2019
VL 18
AR 128
DI 10.1186/s12944-019-1055-y
PG 8
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA IA8LE
UT WOS:000469809500004
PM 31153380
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Parker, GA
   Picut, CA
AF Parker, George A.
   Picut, Catherine A.
TI Immune Functioning in Non lymphoid Organs: The Liver
SO TOXICOLOGIC PATHOLOGY
LA English
DT Article
DE liver; hepatic; immunology; toxicology; pathology; aging
ID ACUTE-PHASE RESPONSE; CD8(+) T-CELLS; SINUSOIDAL LINING CELLS; KUPFFER
   CELLS; ENDOTHELIAL-CELLS; IN-VIVO; MOUSE-LIVER; RAT-LIVER; EXTRATHYMIC
   PATHWAYS; MANNOSE RECEPTOR
AB The liver is the primary hematopoietic organ of the mammalian body during the fetal stage. The postnatal liver retains immunologically important functions and contains a substantial population of immunologically active cells, including T and B lymphocytes, Kupffer cells, liver-adapted natural killer (NK) cells (pit cells), natural killer cells expressing T cell receptor (NKT cells), stellate cells, and dendritic cells. The liver is the major site of production of the acute phase proteins that are associated with acute inflammatory reactions. Kupffer cells have an important role in the nonspecific phagocytosis that comprises a major component of the barrier to invasion of pathogenic organisms from the intestine. Hepatic NK and NKT cells are important in the nonspecific cell killing that is important in resistance to tumor cell invasion. The liver has a major role in deletion of activated T cells and induction of tolerance to ingested and self-antigens. Disposal of waste molecules generated through inflammatory, immunologic, or general homeostatic processes is accomplished via the action of specific endocytic receptors on sinusoidal endothelial cells of the liver. Age-related changes in sinusoids (pseudocapillarization), autophagy, and functions of various hepatic cell populations result in substantial alterations in many of these immunologically important functions.
C1 [Parker, George A.; Picut, Catherine A.] WIL Res Labs LLC, Hillsborough, NC 27278 USA.
C3 WIL Research Laboratories, LLC
RP Parker, GA (corresponding author), WIL Res Labs LLC, 310 Millstone Dr, Hillsborough, NC 27278 USA.
EM gparker@wilresearch.com
CR ABO T, 1993, MICROBIOL IMMUNOL, V37, P247, DOI 10.1111/j.1348-0421.1993.tb03207.x
   Abo T, 2001, INT IMMUNOPHARMACOL, V1, P1261, DOI 10.1016/S1567-5769(01)00057-1
   Amador-Noguez D, 2004, AGING CELL, V3, P423, DOI 10.1111/j.1474-9728.2004.00125.x
   Bejarano Eloy, 2010, Proc Am Thorac Soc, V7, P29, DOI 10.1513/pats.200909-102JS
   Bertolino P, 1999, INT IMMUNOL, V11, P1225, DOI 10.1093/intimm/11.8.1225
   Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO;2-6
   BERTOLINO P, 1995, EUR J IMMUNOL, V25, P1932, DOI 10.1002/eji.1830250721
   BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430
   Burns-Naas LA, 2008, INT J TOXICOL, V27, P223, DOI 10.1080/10915810801978110
   CARTER KC, 1991, BIOCHIM BIOPHYS ACTA, V1089, P197, DOI 10.1016/0167-4781(91)90008-A
   Cogger VC, 2003, EXP GERONTOL, V38, P1101, DOI 10.1016/j.exger.2003.07.002
   COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331
   Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102
   Deretic V, 2011, IMMUNOL REV, V240, P92, DOI 10.1111/j.1600-065X.2010.00995.x
   DURHAM SK, 1990, J PATHOL, V162, P341, DOI 10.1002/path.1711620412
   Emoto M, 2001, HEPATOLOGY, V33, P887, DOI 10.1053/jhep.2001.23504
   English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720
   Fan MH, 2002, SHOCK, V18, P248, DOI 10.1097/00024382-200209000-00008
   Fey Georg H., 1994, P113
   Gomez CR, 2008, J GERONTOL A-BIOL, V63, P1299, DOI 10.1093/gerona/63.12.1299
   Hilmer SN, 2007, J GERONTOL A-BIOL, V62, P973, DOI 10.1093/gerona/62.9.973
   Holt SV, 2011, TOXICOL PATHOL, V39, P516, DOI 10.1177/0192623310396903
   Hsu HC, 2001, MECH AGEING DEV, V122, P305, DOI 10.1016/S0047-6374(00)00247-5
   HUANG L, 1994, IMMUNITY, V1, P741, DOI 10.1016/S1074-7613(94)80016-2
   Ito Y, 2007, EXP GERONTOL, V42, P789, DOI 10.1016/j.exger.2007.04.008
   ITOH H, 1988, J IMMUNOL, V141, P315
   Jamieson HA, 2007, EXP GERONTOL, V42, P374, DOI 10.1016/j.exger.2006.11.004
   John B, 2004, J IMMUNOL, V172, P5222, DOI 10.4049/jimmunol.172.9.5222
   JYONOUCHI H, 1983, J IMMUNOL, V130, P1616
   Kawabata T, 2008, HEPATOLOGY, V48, P1586, DOI 10.1002/hep.22489
   KIMURA M, 1995, CELL IMMUNOL, V162, P16, DOI 10.1006/cimm.1995.1046
   KIMURA M, 1994, IMMUNOL LETT, V39, P259, DOI 10.1016/0165-2478(94)90167-8
   Kuiper J, 1994, LIVER BIOL PATHOBIOL, P789
   Kuniyasu Y, 2004, HEPATOLOGY, V39, P1017, DOI 10.1002/hep.20153
   La Porta CAM, 1998, MECH AGEING DEV, V103, P317, DOI 10.1016/S0047-6374(98)00053-0
   Landreth KS, 2002, HUM EXP TOXICOL, V21, P493, DOI 10.1191/0960327102ht287oa
   LANGLEY SC, 1994, J NUTR, V124, P1588, DOI 10.1093/jn/124.9.1588
   Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661
   Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540
   Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161
   LOTAN R, 1994, GLYCOCONJUGATE J, V11, P462, DOI 10.1007/BF00731282
   MACPHEE PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG692, DOI 10.1152/ajpgi.1995.269.5.G692
   Mayot G, 2007, EXP GERONTOL, V42, P498, DOI 10.1016/j.exger.2007.01.003
   McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521
   McCuskey RS, 2008, ANAT REC, V291, P661, DOI 10.1002/ar.20663
   Mehal WZ, 1999, J IMMUNOL, V163, P3202
   MELKKO J, 1994, J EXP MED, V179, P405, DOI 10.1084/jem.179.2.405
   Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P679, DOI 10.1016/j.intimp.2004.01.008
   Naito Makoto, 2004, Medical Electron Microscopy, V37, P16, DOI 10.1007/s00795-003-0228-x
   Nakatani Kazuki, 2004, Medical Electron Microscopy, V37, P29, DOI 10.1007/s00795-003-0229-9
   Norris S, 1998, J HEPATOL, V28, P84, DOI 10.1016/S0168-8278(98)80206-7
   OGAWA M, 1988, EMBO J, V7, P1337, DOI 10.1002/j.1460-2075.1988.tb02949.x
   Ohmura K, 1999, J IMMUNOL, V163, P4788
   OHTEKI T, 1992, J IMMUNOL, V149, P1562
   OKUYAMA R, 1992, J EXP MED, V175, P661, DOI 10.1084/jem.175.3.661
   ORME IM, 1987, J IMMUNOL, V138, P4414
   PALACIOS R, 1991, EUR J IMMUNOL, V21, P109, DOI 10.1002/eji.1830210117
   Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365
   PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0
   Rabinovich GA, 1998, J IMMUNOL, V160, P4831
   RAVETCH JV, 1994, CELL, V78, P553, DOI 10.1016/0092-8674(94)90521-5
   RUBINSTEIN D, 1986, J IMMUNOL, V137, P1803
   RUBINSTEIN D, 1987, J IMMUNOL, V138, P1377
   SATO K, 1995, J EXP MED, V182, P759, DOI 10.1084/jem.182.3.759
   Sato K, 2005, EUR J IMMUNOL, V35, P593, DOI 10.1002/eji.200425520
   SCHWARZENBERG SJ, 1991, AM J PHYSIOL, V261, pC461, DOI 10.1152/ajpcell.1991.261.3.C461
   Shimamura M, 1997, J IMMUNOL, V158, P3682
   Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224
   SLEYSTER EC, 1982, LAB INVEST, V47, P484
   SMEDSROD B, 1985, BIOCHEM J, V228, P415, DOI 10.1042/bj2280415
   SMEDSROD B, 1990, BIOCHEM J, V271, P345, DOI 10.1042/bj2710345
   SMEDSROD B, 1985, CELL TISSUE RES, V241, P639
   SMEDSROD B, 1990, BIOCHEM J, V266, P313, DOI 10.1042/bj2660313
   Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753
   Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001
   Sugahara S, 1999, IMMUNOLOGY, V96, P57
   THOMAS T, 1985, INFLAMMATION, V9, P1, DOI 10.1007/BF00915406
   Tsukahara A, 1997, HEPATOLOGY, V26, P301, DOI 10.1002/hep.510260208
   Uddin M. N., 2011, AGE
   VANREES EP, 1988, IMMUNOLOGY, V63, P79
   VELARDI A, 1984, J IMMUNOL, V133, P672
   Videla LA, 2001, REDOX REP, V6, P155, DOI 10.1179/135100001101536265
   Warren A, 2005, EXP GERONTOL, V40, P807, DOI 10.1016/j.exger.2005.06.012
   Weinstock D, 2010, TOXICOL PATHOL, V38, P1111, DOI 10.1177/0192623310382436
   WINNOCK M, 1993, SEMIN LIVER DIS, V13, P81, DOI 10.1055/s-2007-1007340
   Wong J, 1997, J CLIN INVEST, V99, P2782, DOI 10.1172/JCI119468
   Wu DY, 2008, J LEUKOCYTE BIOL, V84, P900, DOI 10.1189/jlb.0108023
   Yamano T, 2000, TOXICOL APPL PHARM, V162, P68, DOI 10.1006/taap.1999.8833
   Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814
NR 91
TC 40
Z9 52
U1 0
U2 12
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0192-6233
EI 1533-1601
J9 TOXICOL PATHOL
JI Toxicol. Pathol.
PD FEB
PY 2012
VL 40
IS 2
BP 237
EP 247
DI 10.1177/0192623311428475
PG 11
WC Pathology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pathology; Toxicology
GA 961JL
UT WOS:000305460600012
PM 22089842
DA 2024-02-19
ER

PT J
AU Ikawa-Yoshida, A
   Matsumoto, T
   Okano, S
   Aoyagi, Y
   Matsubara, Y
   Furuyama, T
   Nakatsu, Y
   Tsuzuki, T
   Onimaru, M
   Ohkusa, T
   Nomura, M
   Maehara, Y
AF Ikawa-Yoshida, Ayae
   Matsumoto, Takuya
   Okano, Shinji
   Aoyagi, Yukihiko
   Matsubara, Yutaka
   Furuyama, Tadashi
   Nakatsu, Yoshimichi
   Tsuzuki, Teruhisa
   Onimaru, Mitsuho
   Ohkusa, Tomoko
   Nomura, Masatoshi
   Maehara, Yoshihiko
TI BubR1 Insufficiency Impairs Liver Regeneration in Aged Mice after
   Hepatectomy through Intercalated Disc Abnormality
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PORTAL-HYPERTENSION; CELL-PROLIFERATION; EXPRESSION; MECHANISM;
   NECROSIS; FAILURE; MOUSE; PHASE
AB A delay in liver regeneration after partial hepatectomy (PHx) leads to acute liver injury, and such delays are frequently observed in aged patients. BubR1 (budding uninhibited by benzimidazole-related 1) controls chromosome mitotic segregation through the spindle assembly checkpoint, and BubR1 down-regulation promotes aging-associated phenotypes. In this study we investigated the effects of BubR1 insufficiency on liver regeneration in mice. Low-BubR1-expressing mutant (BubR1(L/L)) mice had a delayed recovery of the liver weight-to-body weight ratio and increased liver deviation enzyme levels after PHx. Microscopic observation of BubR1(L/L) mouse liver showed an increased number of necrotic hepatocytes and intercalated disc anomalies, resulting in widened inter-hepatocyte and perisinusoidal spaces, smaller hepatocytes and early-stage microvilli atrophy. Up-regulation of desmocollin-1 (DSC1) was observed in wild-type, but not BubR1(L/L), mice after PHx. In addition, knockdown of BubR1 expression caused down-regulation of DSC1 in a human keratinocyte cell line. BubR1 insufficiency results in the impaired liver regeneration through weakened microstructural adaptation against PHx, enhanced transient liver failure and delayed hepatocyte proliferation. Thus, our data suggest that a reduction in BubR1 levels causes failure of liver regeneration through the DSC1 abnormality.
C1 [Ikawa-Yoshida, Ayae; Matsumoto, Takuya; Okano, Shinji; Aoyagi, Yukihiko; Matsubara, Yutaka; Furuyama, Tadashi; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan.
   [Nakatsu, Yoshimichi; Tsuzuki, Teruhisa] Kyushu Univ, Grad Sch Med Sci, Dept Med Biophys & Radiat Biol, Fukuoka, Japan.
   [Onimaru, Mitsuho] Kyushu Univ, Grad Sch Med Sci, Dept Pathol, Div Pathophysiol & Expt Pathol, Fukuoka, Japan.
   [Ohkusa, Tomoko] Kyushu Univ, Ctr Clin & Translat Res, Fukuoka, Japan.
   [Nomura, Masatoshi] Kyushu Univ, Dept Endocrine & Metab Dis Diabet Mellitus, Fukuoka, Japan.
C3 Kyushu University; Kyushu University; Kyushu University; Kyushu
   University; Kyushu University
RP Matsumoto, T (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan.
EM takum@surg2.med.kyushu-u.ac.jp
RI Furuyama, Tadashi/Y-4634-2019
OI Furuyama, Tadashi/0000-0003-0042-2986; Matsubara,
   Yutaka/0000-0002-9187-8403; Nakatsu, Yoshimichi/0000-0001-7408-7071
FU Japan Society for the Promotion of Science (JSPS) [25462164, 15H05792];
   Grants-in-Aid for Scientific Research [24108009, 25462164, 26340025,
   16H05109, 25241012, 15H00897, 16K12605] Funding Source: KAKEN
FX The authors thank Prof. Genzou Takemura, Department of Internal Medicine
   Asahi University School of Dentistry, for professional comments on the
   electron microphotographs, and Junji Kishimoto, Department of Research
   and Development of Next Generation Medicine Faculty of Medical Sciences,
   Kyushu University, for statistical advice. This work was supported in
   part by the Japan Society for the Promotion of Science (JSPS)
   Grant-in-Aid for Scientific Research (C) Grant Number 25462164 and a
   Scientific Research (S) Grant Number 15H05792 (to T.M. and Y.M.).
CR Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382
   Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004
   BOSCH J, 1992, GASTROENTEROL CLIN N, V21, P1
   Collins NL, 2005, MOL CELL BIOL, V25, P5282, DOI 10.1128/MCB.25.12.5282-5291.2005
   Donetti E, 2004, EXP DERMATOL, V13, P289, DOI 10.1111/j.0906-6705.2004.00152.x
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Fausto N., 1994, LIVER BIOL PATHOBIOL, P53
   FORTNER JG, 1990, ANN SURG, V211, P141, DOI 10.1097/00000658-199002000-00005
   Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014
   Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424
   Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713
   GRISHAM JW, 1962, CANCER RES, V22, P842
   Guicciardi ME, 2013, COMPR PHYSIOL, V3, P977, DOI 10.1002/cphy.c120020
   Haga S, 2010, LAB INVEST, V90, P1718, DOI 10.1038/labinvest.2010.119
   Hui TT, 2002, AM J SURG, V183, P457, DOI 10.1016/S0002-9610(02)00822-X
   Kyuragi R, 2015, ARTERIOSCL THROM VAS, V35, P341, DOI 10.1161/ATVBAHA.114.304737
   Lehmann K, 2012, GASTROENTEROLOGY, V143, P1609, DOI 10.1053/j.gastro.2012.08.043
   Liu XH, 2012, ATHEROSCLEROSIS, V222, P34, DOI 10.1016/j.atherosclerosis.2011.04.027
   Sánchez-Hidalgo JM, 2012, J SURG RES, V175, pE1, DOI 10.1016/j.jss.2011.11.1022
   Matsumoto T, 2007, STROKE, V38, P1050, DOI 10.1161/01.STR.0000257967.86132.01
   Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271
   Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   MUSCHEL RJ, 1993, CANCER RES, V53, P1128
   RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Sato Y, 1997, SURG TODAY, V27, P518, DOI 10.1007/BF02385805
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Su AI, 2002, P NATL ACAD SCI USA, V99, P11181, DOI 10.1073/pnas.122359899
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005
   Wang XH, 2002, P NATL ACAD SCI USA, V99, P16881, DOI 10.1073/pnas.252570299
   Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4
NR 37
TC 9
Z9 11
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 26
PY 2016
VL 6
AR 32399
DI 10.1038/srep32399
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DU1NJ
UT WOS:000381974100001
PM 27561386
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Wronska, A
   Zubrzycki, A
   Kmiec, Z
AF Wronska, Agata
   Zubrzycki, Adrian
   Kmiec, Zbigniew
TI Sestrins' Expression in the Liver Is Not Altered by Short-Term Calorie
   Restriction in Young and Old Rats
SO GERONTOLOGY
LA English
DT Article; Early Access
DE Sestrin; Short-term calorie restriction; Liver; Rat; Aging
ID HEPATIC INSULIN SENSITIVITY; METABOLISM; ACTIVATION; TARGET; MTORC1;
   P53; SENESCENCE; PROTECTS; STRESS
AB Introduction: Short-term calorie restriction (SCR) may have a positive impact on health. We hypothesized that sestrins, a family of stress-inducible proteins (Sesn1, Sesn2, Sesn3) are involved in the response to SCR in the liver. Methods: Young-adult (4-month) and old (24-month) male Wistar rats were either fed ad libitum (control groups) or received 60% of food intake on a daily basis for 30 days (SCR groups). In blood sera, biochemical parameters and fibroblast growth factor 21 (FGF21) concentration were measured (ELISA). Liver samples were collected for analyses of genes' expression (real-time PCR) and protein levels (Western blotting). Results: SCR caused improvements in blood glucose and lipids and parameters of liver function but did not affect the serum FGF21 concentration. SCR caused changes typically associated with calorie restriction in the gene expression of fatty acid synthase (fasn), ATP-citrate lyase (acly), and sirtuin 1 (sirt1). In the liver of young SCR rats, protein level of Sesn2 tended to increase, while Sesn3 tended to decrease, accompanied by reduced sesn3 expression. In old SCR rats, reduced sesn1 expression was reflected by decreasing trend for Sesn1 content. Activation of AMP-activated protein kinase (phospho-Thr172) and protein content of peroxisome proliferator-activated receptor gamma coactivator 1-alpha were not affected by SCR. Conclusion: Sestrins' hepatic expression is only minimally affected by SCR in young and old rats. We propose that sestrins may not be a major effector of mild SCR in the liver of young or old rats.
C1 [Wronska, Agata; Zubrzycki, Adrian; Kmiec, Zbigniew] Med Univ Gdansk, Dept Histol, Fac Med, Gdansk, Poland.
C3 Fahrenheit Universities; Medical University Gdansk
RP Wronska, A (corresponding author), Med Univ Gdansk, Dept Histol, Fac Med, Gdansk, Poland.
EM agata.wronska@gumed.edu.pl
RI Zubrzycki, Adrian/N-5937-2018; Wronska, Agata/GMW-4913-2022
OI Zubrzycki, Adrian/0000-0002-4303-5620; Kmiec,
   Zbigniew/0000-0002-9801-8166
FU Polish National Science Centre [2018/02/X/NZ4/01313, ST-12]
FX The study was financed by the Polish National Science Centre funding for
   single activities MINIATURA to A.W. (No. 2018/02/X/NZ4/01313) and
   statutory Grant ST-12 to Z.K.
CR Bae SH, 2013, CELL METAB, V17, P73, DOI 10.1016/j.cmet.2012.12.002
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Chai DD, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/505849
   Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196
   Foretz M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092826
   Goberdhan DCI, 2016, CELL METAB, V23, P580, DOI 10.1016/j.cmet.2016.03.013
   Gong Q, 2016, HEPATOLOGY, V64, P425, DOI 10.1002/hep.28523
   Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200
   Jin SH, 2013, TOXICOL APPL PHARM, V271, P95, DOI 10.1016/j.taap.2013.04.023
   Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]
   Kim SJ, 2017, CHEM-BIOL INTERACT, V269, P50, DOI 10.1016/j.cbi.2017.02.002
   Kimball SR, 2015, J NUTR, V145, P2496, DOI 10.3945/jn.115.215491
   Komatsu T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11123068
   Kuhla A, 2014, J GERONTOL A-BIOL, V69, P915, DOI 10.1093/gerona/glt160
   Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018
   Lee JH, 2012, CELL METAB, V16, P311, DOI 10.1016/j.cmet.2012.08.004
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   López-Lluch G, 2016, J PHYSIOL-LONDON, V594, P2043, DOI 10.1113/JP270543
   Morrison A, 2015, FASEB J, V29, P408, DOI 10.1096/fj.14-258814
   Ning YC, 2013, MECH AGEING DEV, V134, P570, DOI 10.1016/j.mad.2013.11.006
   Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003
   Noyan H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130658
   Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5233
   Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038
   Prokesch A, 2017, FASEB J, V31, P732, DOI 10.1096/fj.201600845R
   Rai N, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101186
   Ro SH, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00114
   Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024
   Saito K, 2021, NUTRIENTS, V13, DOI 10.3390/nu13072277
   Sheng YL, 2017, AGING CELL, V16, P1155, DOI 10.1111/acel.12652
   Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166
   Tabibzadeh S, 2021, FRONT BIOSCI-LANDMRK, V26, P50, DOI 10.2741/4889
   Tao RY, 2015, DIABETES, V64, P1211, DOI 10.2337/db14-0539
   Thompson ACS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111418
   Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274
   Wang ML, 2017, CELL PHYSIOL BIOCHEM, V43, P1731, DOI 10.1159/000484060
   Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674
   Wronska A, 2014, J PHYSIOL PHARMACOL, V65, P117
   Xu DD, 2019, AM J PHYSIOL-ENDOC M, V316, pE817, DOI 10.1152/ajpendo.00522.2018
   Zubrzycki A, 2018, J PHYSIOL PHARMACOL, V69, P663, DOI 10.26402/jpp.2018.5.02
NR 40
TC 0
Z9 0
U1 1
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0304-324X
EI 1423-0003
J9 GERONTOLOGY
JI Gerontology
PD 2022 JUL
PY 2022
VL 68
IS 7
BP 790
EP 798
DI 10.1159/000521639
EA JAN 2022
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 8M4XU
UT WOS:000752666200001
PM 35086105
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU Price, J
   Ma, YF
   Adimora, A
   Fischl, M
   French, AL
   Golub, ET
   Konkle-Parker, D
   Kuniholm, MH
   Ofotokun, I
   Plankey, M
   Sharma, A
   Tien, PC
AF Price, Jennifer
   Ma, Yifei
   Adimora, Adaora
   Fischl, Margaret
   French, Audrey L.
   Golub, Elizabeth T.
   Konkle-Parker, Deborah
   Kuniholm, Mark H.
   Ofotokun, Ighovwerha
   Plankey, Michael
   Sharma, Anjali
   Tien, Phyllis C.
TI Multisite prospective Liver Disease and Reproductive Ageing (LIVRA)
   study in US women living with and without HIV
SO BMJ OPEN
LA English
DT Article
DE hepatology; infectious diseases; HIV & AIDS
ID HEPATITIS-C VIRUS; TRANSIENT ELASTOGRAPHY; CIRRHOSIS; ASSOCIATION;
   FIBROSIS; INJURY; COHORT; HCV
AB Purpose The Liver Disease and Reproductive Ageing (LIVRA) study leverages the infrastructure of the decades-long multicentre prospective Women's Interagency HIV Study (WIHS) to examine the contributions of HIV, hepatitis C virus (HCV) and ageing to liver disease progression in women. Participants From 2013 to 2018, LIVRA enrolled 1576 participants (77 HCV-seropositive only, 248 HIV/HCV-seropositive, 868 HIV-seropositive only and 383 HIV/HCV-seronegative) who underwent vibration controlled transient elastography (VCTE). A VCTE quality assurance programme was established to ensure consistency and accuracy for longitudinal assessment of steatosis (fatty liver) via the controlled attenuation parameter (CAP) and fibrosis via liver stiffness (LS). Demographic, lifestyle factors, anthropometry, clinical and medication history, host genetics, immune markers and hormone levels were collected as part of the WIHS. Findings to date At baseline, 737 of 1543 women with CAP measurements had steatosis (CAP >= 248 dB/m) and 375 of 1576 women with LS measurements had significant fibrosis (LS >= 7.1 kPa), yielding a prevalence of 48% and 24%, respectively. On multivariable analysis, waist circumference (WC) and insulin resistance were independently associated with higher CAP (17.8 dB/m per 10 cm (95% CI:16.2 to 19.5) and 1.2 dB/m per doubling (95% CI:0.8 to 1.6), respectively). By contrast, HIV/HCV seropositivity and HCV seropositivity alone were associated with less steatosis compared with HIV/HCV-seronegative women, although the latter did not reach statistical significance (-9.2 dB/m (95% CI:-18.2 to -0.3) and -10.4 dB/m (95% CI: -23.8 to 3.1), respectively). Factors independently associated with higher LS were age (4.4% per 10 years (95% CI: 0.4% to 8.4%)), WC (5.0% per 10 cm (95% CI: 3.3% to 6.6%)), CAP steatosis (0.6% per 10 dB/m (95% CI: 0.1% to 1.0%)), HIV/HCV seropositivity (33% (95% CI: 24% to 44%)) and HCV seropositivity alone (43% (95% CI: 28% to 60%)). Excluding scans that were invalid based on traditional criteria for unreliability did not affect the results. Future plans Enrolled women undergo VCTE at 3-year intervals unless LS is >= 9.5 kPa, indicating advanced fibrosis, in which case VCTE is performed annually. Participants also undergo VCTE every 6 months until 18 months after HCV treatment initiation. Analysis of the data collected will provide insights into the impact of ageing/ovarian function, host genetics, immune function and contemporary HIV and HCV treatments on liver disease progression.
C1 [Price, Jennifer; Ma, Yifei] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Adimora, Adaora] Univ N Carolina, Dept Med, Sch Med, Chapel Hill, NC 27515 USA.
   [Fischl, Margaret] Univ Miami, Dept Med, Miami, FL USA.
   [French, Audrey L.] John H Stroger Jr Hosp Cook Cty, Dept Med, CORE Ctr, Chicago, IL USA.
   [Golub, Elizabeth T.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Konkle-Parker, Deborah] Univ Mississippi, Sch Nursing Med & Populat Hlth, Jackson, MS 39216 USA.
   [Kuniholm, Mark H.] Univ Albany State Univ New York, Dept Epidemiol & Biostat, Rensselaer, NY USA.
   [Ofotokun, Ighovwerha] Emory Univ, Dept Med, Atlanta, GA 30322 USA.
   [Plankey, Michael] Georgetown Univ, Dept Med, Washington, DC USA.
   [Sharma, Anjali] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.
   [Tien, Phyllis C.] Univ Calif San Francisco, Dept Vet Affairs, San Francisco, CA 94143 USA.
C3 University of California System; University of California San Francisco;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina School of Medicine; University of Miami;
   John H Stroger Junior Hospital Cook County; University of Illinois
   System; University of Illinois Chicago; University of Illinois Chicago
   Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of
   Public Health; University of Mississippi; State University of New York
   (SUNY) System; Emory University; Georgetown University; Yeshiva
   University; Albert Einstein College of Medicine; University of
   California System; University of California San Francisco
RP Price, J (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
EM jennifer.price@ucsf.edu
RI Tien, Phyllis/ISU-1065-2023
FU National Heart, Lung, and Blood Institute (NHLBI) [U01-HL146241,
   U01-HL146201, U01-HL146204, U01-HL146202, U01-HL146193, U01-HL146240,
   U01-HL146242, U01-HL146333, U01-HL146205, HL146203, U01-HL146192,
   U01-HL146194]; Eunice Kennedy Shriver National Institute of Child Health
   & Human Development (NICHD); National Institute on Aging (NIA); National
   Institute of Dental & Craniofacial Research (NIDCR); National Institute
   of Allergy and Infectious Diseases (NIAID); National Institute of
   Neurological Disorders and Stroke (NINDS); National Institute on Drug
   Abuse (NIDA); National Institute of Nursing Research (NINR); National
   Cancer Institute (NCI); National Institute on Alcohol Abuse and
   Alcoholism (NIAAA); National Institute on Deafness and Other
   Communication Disorders (NIDCD); National Institute of Diabetes and
   Digestive and Kidney Diseases (NIDDK); National Institutes of Health,
   Office of AIDS Research (OAR); National Institute of Allergy and
   Infectious Diseases [K24 AI 108516]; National Institute of Diabetes and
   Digestive and Kidney Diseases [5R01DK109823]; American College of
   Gastroenterology Junior Faculty Development Award; National Institute of
   Mental Health (NIMH); National Institute on Minority Health and Health
   Disparities (NIMHD);  [UL1-TR000004];  [UL1-TR003098];  [UL1-TR001881]; 
   [P30-AI-050409];  [P30-AI-073961];  [P30-AI-050410];  [P30-AI-027767]; 
   [P30-MH-116867]
FX Data in this manuscript were collected by the Women's Interagency HIV
   Study (WIHS), now the MACS/WIHS Combined Cohort Study (MWCCS). MWCCS
   (Principal Investigators): Atlanta CRS ((IO, AS and Gina Wingood),
   U01-HL146241; Baltimore CRS (Todd Brown and Joseph Margolick),
   U01-HL146201; Bronx CRS (Kathryn Anastos and Anjali Sharma),
   U01-HL146204; Brooklyn CRS (Deborah Gustafson and Tracey Wilson), U01-
   HL146202; Data Analysis and Coordination Center (Gypsyamber D'Souza,
   Stephen Gange and Elizabeth Golub), U01-HL146193; Chicago-Cook County
   CRS (Mardge Cohen and Audrey French), U01-HL146245; Chicago-Northwestern
   CRS (Steven Wolinsky), U01-HL146240; Northern California CRS (Bradley
   Aouizerat, JP and Phyllis Tien), U01-HL146242; Los Angeles CRS (Roger
   Detels and Matthew Mimiaga), U01-HL146333; Metropolitan Washington CRS
   (Seble Kassaye and Daniel Merenstein), U01-HL146205; Miami CRS (Maria
   Alcaide, MF and Deborah Jones), U01-HL146203; Pittsburgh CRS (Jeremy
   Martinson and Charles Rinaldo), U01-HL146208; UAB-MS CRS (Mirjam-Colette
   Kempf, Jodie Dionne-Odom and DK-P), U01-HL146192; UNC CRS (Adaora
   Adimora), U01-HL146194. The MWCCS is funded primarily by the National
   Heart, Lung, and Blood Institute (NHLBI), with additional co-funding
   from the Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD), National Institute on Aging (NIA), National
   Institute of Dental & Craniofacial Research (NIDCR), National Institute
   of Allergy and Infectious Diseases (NIAID), National Institute of
   Neurological Disorders and Stroke (NINDS), National Institute of Mental
   Health (NIMH), National Institute on Drug Abuse (NIDA), National
   Institute of Nursing Research (NINR), National Cancer Institute (NCI),
   National Institute on Alcohol Abuse and Alcoholism (NIAAA), National
   Institute on Deafness and Other Communication Disorders (NIDCD),
   National Institute of Diabetes and Digestive and Kidney Diseases
   (NIDDK), National Institute on Minority Health and Health Disparities
   (NIMHD) and in coordination and alignment with the research priorities
   of the National Institutes of Health, Office of AIDS Research (OAR).
   MWCCS data collection is also supported by UL1-TR000004 (UCSF CTSA),
   UL1-TR003098 (JHU ICTR), UL1-TR001881 (UCLA CTSI), P30-AI-050409
   (Atlanta CFAR), P30-AI-073961 (Miami CFAR), P30-AI-050410 (UNC CFAR),
   P30-AI-027767 (UAB CFAR) and P30-MH-116867 (Miami CHARM). The study was
   also supported by the National Institute of Allergy and Infectious
   Diseases (K24 AI 108516 (PCT)), the National Institute of Diabetes and
   Digestive and Kidney Diseases (5R01DK109823 (PCT)) and an American
   College of Gastroenterology Junior Faculty Development Award (JP).
CR Adimora AA, 2018, INT J EPIDEMIOL, V47, P393, DOI 10.1093/ije/dyy021
   Al-Harthi L, 2006, J INFECT DIS, V193, P1202, DOI 10.1086/500843
   Allison PD, 2012, HANDLING MISSING DAT
   Balakrishnan M, 2021, CLIN GASTROENTEROL H, V19, P61, DOI 10.1016/j.cgh.2020.04.067
   Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491
   Castéra L, 2010, HEPATOLOGY, V51, P828, DOI 10.1002/hep.23425
   Centers for Disease Control and Prevention, 2019, HIV SURVEILLANCE S, V24
   Cervo A, 2020, CLIN INFECT DIS
   D'Souza G., 2019, AM J EPIDEMIOL
   D'Souza G, 2021, AM J EPIDEMIOL, V190, P1457, DOI 10.1093/aje/kwab050
   de Lédinghen V, 2010, LIVER INT, V30, P1043, DOI 10.1111/j.1478-3231.2010.02258.x
   Duarte M., 2020, AASLD
   Farshidpour M, 2020, INDIAN J GASTROENTER, V39, P232, DOI 10.1007/s12664-020-01068-1
   Gaia S, 2011, J HEPATOL, V54, P64, DOI 10.1016/j.jhep.2010.06.022
   Grishina I, 2014, AGING DIS, V5, P160, DOI 10.14336/AD.2014.0500160
   Harlow SD, 2012, J CLIN ENDOCR METAB, V97, P1159, DOI 10.1210/jc.2011-3362
   Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15
   Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022
   Kettaneh A, 2007, J HEPATOL, V46, P628, DOI 10.1016/j.jhep.2006.11.010
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Laskus T, 2007, HEPATOLOGY, V46, P359, DOI 10.1002/hep.21715
   Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5
   Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90
   Price JC, 2017, HEPATOLOGY, V65, P853, DOI 10.1002/hep.28968
   Sankaran-Walters S, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-10
   Scaglione S, 2015, J CLIN GASTROENTEROL, V49, P690, DOI 10.1097/MCG.0000000000000208
   Singh S, 2017, GASTROENTEROLOGY, V152, P1544, DOI 10.1053/j.gastro.2017.03.016
   Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8
   Sowers M, 2007, J CLIN ENDOCR METAB, V92, P895, DOI 10.1210/jc.2006-1393
   van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350
   World Health Organization, 2019, Global Health Observatory data repository 2019
   Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557
NR 32
TC 1
Z9 1
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
J9 BMJ OPEN
JI BMJ Open
PD APR
PY 2022
VL 12
IS 4
AR e055706
DI 10.1136/bmjopen-2021-055706
PG 9
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA 0J6FT
UT WOS:000780200000011
PM 35393310
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Gyenis, A
   Chang, J
   Demmers, JJPG
   Bruens, ST
   Barnhoorn, S
   Brandt, RMC
   Baar, MP
   Raseta, M
   Derks, KWJ
   Hoeijmakers, JHJ
   Pothof, J
AF Gyenis, Akos
   Chang, Jiang
   Demmers, Joris J. P. G.
   Bruens, Serena T.
   Barnhoorn, Sander
   Brandt, Renata M. C.
   Baar, Marjolein P.
   Raseta, Marko
   Derks, Kasper W. J.
   Hoeijmakers, Jan H. J.
   Pothof, Joris
TI Genome-wide RNA polymerase stalling shapes the transcriptome during
   aging
SO NATURE GENETICS
LA English
DT Article; Early Access
ID SET ENRICHMENT ANALYSIS; DNA-DAMAGE; GENE-EXPRESSION; EXCISION-REPAIR;
   WEB SERVER; SENESCENCE; MICE
AB In aging mouse livers, 40% of elongating RNA polymerases are stalled, biasing transcriptional output dependent on gene length. This transcriptional stress appears to be caused by endogenous DNA damage.
   Gene expression profiling has identified numerous processes altered in aging, but how these changes arise is largely unknown. Here we combined nascent RNA sequencing and RNA polymerase II chromatin immunoprecipitation followed by sequencing to elucidate the underlying mechanisms triggering gene expression changes in wild-type aged mice. We found that in 2-year-old liver, 40% of elongating RNA polymerases are stalled, lowering productive transcription and skewing transcriptional output in a gene-length-dependent fashion. We demonstrate that this transcriptional stress is caused by endogenous DNA damage and explains the majority of gene expression changes in aging in most mainly postmitotic organs, specifically affecting aging hallmark pathways such as nutrient sensing, autophagy, proteostasis, energy metabolism, immune function and cellular stress resilience. Age-related transcriptional stress is evolutionary conserved from nematodes to humans. Thus, accumulation of stochastic endogenous DNA damage during aging deteriorates basal transcription, which establishes the age-related transcriptome and causes dysfunction of key aging hallmark pathways, disclosing how DNA damage functionally underlies major aspects of normal aging.
C1 [Gyenis, Akos; Chang, Jiang; Demmers, Joris J. P. G.; Bruens, Serena T.; Barnhoorn, Sander; Brandt, Renata M. C.; Baar, Marjolein P.; Raseta, Marko; Derks, Kasper W. J.; Hoeijmakers, Jan H. J.; Pothof, Joris] Erasmus MC, Erasmus Univ Med Ctr, Dept Mol Genet, Canc Inst, Rotterdam, Netherlands.
   [Gyenis, Akos; Hoeijmakers, Jan H. J.] Univ Cologne, Inst Genome Stabil Ageing & Dis, Fac Med, Cluster Excellence Aging Res, Cologne, Germany.
   [Baar, Marjolein P.] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.
   [Derks, Kasper W. J.] Maastricht Univ, Sch Oncol & Dev Biol, Dept Clin Genet, Med Ctr, Maastricht, Netherlands.
   [Hoeijmakers, Jan H. J.] Oncode Inst, Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.
C3 Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute;
   University of Cologne; Utrecht University; Utrecht University Medical
   Center; Maastricht University
RP Pothof, J (corresponding author), Erasmus MC, Erasmus Univ Med Ctr, Dept Mol Genet, Canc Inst, Rotterdam, Netherlands.
EM j.pothof@erasmusmc.nl
RI Hoeijmakers, Jan/AAX-6972-2021
OI Brandt, Renata M. C./0000-0003-0514-5623
FU France Genomique' consortium [ANR-10-INBS-0009]; National Institutes of
   Health/National Institute of Aging [P01 AG017242]; European Research
   Council Advanced Grant Dam2Age; European commission EU ITN Address
   [GA-316390]; Dutch research organization ZonMW Memorabel project
   [733050810]; Deutsche Forschungsgemeinschaft (German Research
   Foundation) [73111208-SFB829]; European Joint Programme on Rare Diseases
   (EJPRD TC-NER)
FX We thank M. Tresini, G. Garinis, P. Mastroberardino and C. Milanese for
   providing reagents and protocols. We thank Y. van Loon and W. Vermeij
   for general assistance with mouse experiments. We thank P. van Arp for
   RNA sequencing support. RNA sequencing was done in the ErasmusMC HuGeF
   facility run by A. G. Uitterlinden and J. van Meurs and the ErasmusMC
   Biomics facility run by W. van Ijcken. RNAPII ChIP-seq was performed by
   the GenomEast platform, a member of the France Genomique' consortium
   (ANR-10-INBS-0009). We acknowledge financial support from the National
   Institutes of Health/National Institute of Aging (P01 AG017242; DNA
   repair, mutations and cell aging) to J.H.J.H. and J.P., European
   Research Council Advanced Grant Dam2Age to J.H.J.H., the European
   commission EU ITN Address (GA-316390) to J.H.J.H., Dutch research
   organization ZonMW Memorabel project no. 733050810 to J.P. and J.H.J.H.,
   Deutsche Forschungsgemeinschaft (German Research Foundation) project no.
   73111208-SFB829 to J.H.J.H. and European Joint Programme on Rare
   Diseases (EJPRD TC-NER) to J.H.J.H. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844
   Barnhoorn S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004686
   Bochkis IM, 2014, CELL REP, V9, P996, DOI 10.1016/j.celrep.2014.09.048
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245
   Cortés-López M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4386-y
   Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI [10.1093/nar/gkt1102, 10.1093/nar/gkz1031]
   Davie K, 2018, CELL, V174, P982, DOI 10.1016/j.cell.2018.05.057
   Derks KWJ, 2015, RNA BIOL, V12, P30, DOI 10.1080/15476286.2015.1017202
   Dollé MET, 2011, PATHOBIOL AGING AGE, V1, DOI 10.3402/pba.v1i0.7219
   Foissac S, 2015, METHODS MOL BIOL, V1269, P379, DOI 10.1007/978-1-4939-2291-8_24
   Fuentealba M, 2021, MECH AGEING DEV, V194, DOI 10.1016/j.mad.2021.111437
   Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960
   Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866
   Gyenis A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004483
   Hall H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4304-3
   Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115
   Isildak U, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60998-0
   Jauregui-Lozano J, 2022, AGING CELL, V21, DOI 10.1111/acel.13554
   Johnson AA, 2019, AGING CELL, V18, DOI 10.1111/acel.13048
   Jung HJ, 2012, CURR GENOMICS, V13, P548, DOI 10.2174/138920212803251436
   Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67
   Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103
   Krämer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]
   Lans H, 2019, NAT REV MOL CELL BIO, V20, P766, DOI 10.1038/s41580-019-0169-4
   Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118
   Levy O, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00304-4
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   LINDHOLM DB, 1986, J NEUROCHEM, V47, P1503
   Lopes I, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.559998
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Martinez-Jimenez CP, 2017, SCIENCE, V355, P1433, DOI 10.1126/science.aah4115
   Milanese C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12640-5
   Mori T, 2019, DNA REPAIR, V80, P52, DOI 10.1016/j.dnarep.2019.04.004
   Mozhui K, 2017, MECH AGEING DEV, V162, P27, DOI 10.1016/j.mad.2017.02.006
   Nakazawa Y, 2020, CELL, V180, P1228, DOI 10.1016/j.cell.2020.02.010
   Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025
   Okonechnikov K, 2016, BIOINFORMATICS, V32, P292, DOI 10.1093/bioinformatics/btv566
   Peffers MJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0544-2
   Pomatto LCD, 2020, FREE RADICAL BIO MED, V152, P650, DOI 10.1016/j.freeradbiomed.2020.01.005
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Ramírez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257
   Rangaraju S, 2015, ELIFE, V4, DOI 10.7554/eLife.08833
   Robinson AR, 2018, REDOX BIOL, V17, P259, DOI 10.1016/j.redox.2018.04.007
   Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z
   Sacramento EK, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209596
   Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y
   Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161
   Schumacher B, 2021, NATURE, V592, P695, DOI 10.1038/s41586-021-03307-7
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Soheili-Nezhad S, 2021, ALZHEIMERS DEMENT, V17, P489, DOI 10.1002/alz.12211
   Steurer B, 2018, P NATL ACAD SCI USA, V115, pE4368, DOI 10.1073/pnas.1717920115
   Stoeger T, 2022, NATURE AGING, V2, P1191, DOI 10.1038/s43587-022-00317-6
   Strong R, 2016, AGING CELL, V15, P872, DOI 10.1111/acel.12496
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Svensson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022640
   Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585
   Tamae D, 2011, BIOCHEMISTRY-US, V50, P2321, DOI 10.1021/bi101933p
   Tiwari V, 2019, AM J HUM GENET, V105, P237, DOI 10.1016/j.ajhg.2019.06.005
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Tresini M, 2015, NATURE, V523, P53, DOI 10.1038/nature14512
   Van Houten B, 2000, MUTAT RES-DNA REPAIR, V460, P81, DOI 10.1016/S0921-8777(00)00018-5
   Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329
   Vermeij WP, 2016, ANNU REV PHARMACOL, V56, P427, DOI 10.1146/annurev-pharmtox-010814-124316
   Vidakovic AT, 2020, CELL, V180, P1245, DOI 10.1016/j.cell.2020.02.009
   Wang J, 2012, AGING CELL, V11, P714, DOI 10.1111/j.1474-9726.2012.00828.x
   Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4
   Yousefzadeh M, 2021, ELIFE, V10, DOI 10.7554/eLife.62852
   Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x
   Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115
   Zhu HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185561
   Zhuang JJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42485-3
NR 78
TC 16
Z9 17
U1 5
U2 8
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1061-4036
EI 1546-1718
J9 NAT GENET
JI Nature Genet.
PD 2023 FEB
PY 2023
VL 55
IS 2
BP 268
EP +
DI 10.1038/s41588-022-01279-6
EA JAN 2023
PG 31
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA I5VG9
UT WOS:000923267400004
PM 36658433
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU King, LM
   Song, J
   Wojcinski, ZW
   Baker, KW
   Walker, RM
AF King, LM
   Song, J
   Wojcinski, ZW
   Baker, KW
   Walker, RM
TI Absence of correlation between telomerase activity and hepatic neoplasia
   in B6C3F1 mice
SO TOXICOLOGY LETTERS
LA English
DT Article
DE B6C3F1 mice; hepatic tumors; liver; telomerase
ID NORMAL HUMAN-CELLS; LIFE-SPAN; HEPATOCELLULAR-CARCINOMA; LENGTH
   REGULATION; MOUSE TELOMERASE; TISSUES; CANCER; TUMORIGENESIS; RNA
AB Telomeres are the physical ends of eukaryotic chromosomes, which maintain chromosome stability and are progressively shortened with aging in somatic cells. The enzyme telomerase elongates telometric DNA and while not usually detectable in human somatic cells is expressed in most human tumors. The present study was conducted to determine if telomerase activity is a marker for spontaneous hepatic neoplastic changes in B6C3F1 mice, a strain frequently used in rodent carcinogenicity studies. Telomerase activity was generally higher in microscopically normal liver tissue from 8-week-old compared to aged mice (110-week-old); however, telomerase activity was not consistently increased in hepatocellular adenomas and carcinomas. It is proposed that, while elevated telomerase activity may modulate human tumor development, modulation of telomerase activity is not a feature of hepatic tumors in B6C3F1 mice and therefore is unlikely to have utility as a molecular marker for hepatic neoplasia in this mouse strain. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
C1 Parke Davis Res Inst, Mississauga, ON L5K 1B4, Canada.
C3 Pfizer
RP King, LM (corresponding author), Parke Davis Res Inst, 2270 Speakman Dr, Mississauga, ON L5K 1B4, Canada.
EM lena.king@wl.com
CR ALLSOPP RC, 1995, EXP CELL RES, V220, P194, DOI 10.1006/excr.1995.1306
   BEDNAREK A, 1995, CANCER RES, V55, P4566
   Bednarek AK, 1997, MOL CARCINOGEN, V20, P329, DOI 10.1002/(SICI)1098-2744(199712)20:4<329::AID-MC1>3.0.CO;2-E
   Bednarek AK, 1998, ONCOGENE, V16, P381, DOI 10.1038/sj.onc.1201553
   Blackburn E. H., 1995, TELOMERES, P1
   Blasco MA, 1996, NAT GENET, V12, P200, DOI 10.1038/ng0296-200
   BLASCOMA, 1997, CIBA F SYMP, V211, P160
   Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349
   Broccoli D, 1996, MOL CELL BIOL, V16, P3765
   Burger AM, 1997, BRIT J CANCER, V75, P516, DOI 10.1038/bjc.1997.90
   CHADENEAU C, 1995, ONCOGENE, V11, P893
   CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190
   Counter CM, 1996, MUTAT RES-REV GENET, V366, P45, DOI 10.1016/S0165-1110(96)90006-8
   CovielloMcLaughlin GM, 1997, NUCLEIC ACIDS RES, V25, P3051, DOI 10.1093/nar/25.15.3051
   FRITH CH, 1979, J ENVIRON PATHOL TOX, V3, P329
   Greider CW, 1998, CURR BIOL, V8, pR178, DOI 10.1016/S0960-9822(98)70105-8
   HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307, DOI 10.1101/SQB.1994.059.01.035
   Hytiroglou P, 1998, CANCER, V82, P1831, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1831::AID-CNCR4>3.3.CO;2-H
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kipling D, 1997, EUR J CANCER, V33, P792, DOI 10.1016/S0959-8049(97)00060-9
   Kojima H, 1997, GASTROENTEROLOGY, V112, P493, DOI 10.1053/gast.1997.v112.pm9024303
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   MARONPOT RR, 1987, ARCH TOXICOL, P10
   Nakashio R, 1997, INT J CANCER, V74, P141, DOI 10.1002/(SICI)1097-0215(19970422)74:2<141::AID-IJC1>3.0.CO;2-Z
   NEWBOLD RF, 1993, TOXICOL LETT, V67, P211, DOI 10.1016/0378-4274(93)90057-5
   PIATYSZEK MA, 1995, METHODS CELL SCI, P1
   PROWSE KR, 1993, P NATL ACAD SCI USA, V90, P1493, DOI 10.1073/pnas.90.4.1493
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2
   Taylor RS, 1996, J INVEST DERMATOL, V106, P759, DOI 10.1111/1523-1747.ep12345811
   Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5
   WARD JM, 1980, CANCER LETT, V9, P319, DOI 10.1016/0304-3835(80)90024-5
   Ward JM, 1996, TOXICOL PATHOL, V24, P129, DOI 10.1177/019262339602400117
   Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-4274
EI 1879-3169
J9 TOXICOL LETT
JI Toxicol. Lett.
PD JUN 1
PY 1999
VL 106
IS 2-3
BP 247
EP 254
DI 10.1016/S0378-4274(99)00073-9
PG 8
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA 212LU
UT WOS:000081218800018
PM 10403669
DA 2024-02-19
ER

PT J
AU Chen, J
   Rider, DA
   Ruan, RS
AF Chen, J
   Rider, DA
   Ruan, RS
TI Identification of valid housekeeping genes and antioxidant enzyme gene
   expression change in the aging rat liver
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
ID POLYMERASE CHAIN-REACTION; MESSENGER-RNA EXPRESSION; BETA-ACTIN; RT-PCR;
   GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; AGE; DNA; NORMALIZATION;
   DIFFERENTIATION; QUANTIFICATION
AB Valid housekeeping genes (HKG) are a prerequisite for accurate gene quantification. We performed real-time reverse transcription-polymerase chain reaction to investigate the gene expression of five commonly used HKGs (beta-actin, glyceraldehyde-3-phosphate dehydrogenase [GAPDH], ubiquitin C [UBC], hypoxanthine phosphoribosyl-transferase [HPRT], and cyclophilin A [CYPa]) and antioxidant enzymes in the liver of young and old male Fischer rats. A wide variation in HKG expression existed during the aging process, and HPRT was identified as the most stable HKG in rat liver aging. When Cu/Zn-superoxide dismutase gene expression was normalized to HPRT, there was no detectable difference between young and old rats; however, a significant difference was seen when it was normalized to UBC. The variation of UBC caused the misinterpretation of Cu/Zn-superoxide dismutase expression. Catalase expression was significantly decreased, whereas glutathione peroxidase expression was not altered with age. We demonstrated that HPRT was an appropriate HKG, validation of HKGs was vital for accurate quantification, and decreased catalase expression might be involved in the decline of antioxidant defenses during rat liver aging.
C1 Natl Univ Singapore Hosp, Dept Otolaryngol, Singapore, Singapore.
   Inst Bioengn & Nanotechnol, Canc & Ageing Res, Singapore, Singapore.
C3 National University of Singapore; Agency for Science Technology &
   Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging
   (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN)
RP Ruan, RS (corresponding author), Inst Bioengn & Nanotechnol, 31 Biopolis Way,Nanos,04-01, Singapore 138669, Singapore.
EM rsruan@ibn.a-star.edu.sg
OI Rider, David/0000-0003-1972-2524
CR Aerts JL, 2004, BIOTECHNIQUES, V36, P84, DOI 10.2144/04361ST04
   Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496
   Ball TB, 2003, INT ARCH ALLERGY IMM, V130, P82, DOI 10.1159/000068372
   Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x
   Biederman J, 2004, KIDNEY INT, V66, P2308, DOI 10.1111/j.1523-1755.2004.66016.x
   Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462
   Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023
   Bustin Stephen A, 2004, J Biomol Tech, V15, P155
   CHOI JK, 1991, MOL CELL BIOL, V11, P4473, DOI 10.1128/MCB.11.9.4473
   de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208
   Depreter M, 2002, J ENDOCRINOL, V175, P779, DOI 10.1677/joe.0.1750779
   Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03
   Foss DL, 1998, ANIM BIOTECHNOL, V9, P67, DOI 10.1080/10495399809525893
   Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8
   Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765
   GRUNE T, 2001, HDB BIOL AGING, P25
   Haller F, 2004, ANAL BIOCHEM, V335, P1, DOI 10.1016/j.ab.2004.08.024
   Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369
   Han ES, 2001, MECH AGEING DEV, V122, P999, DOI 10.1016/S0047-6374(01)00215-9
   Ishitani R, 1996, J NEUROCHEM, V66, P928
   Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83
   Jang IS, 2001, MECH AGEING DEV, V122, P561, DOI 10.1016/S0047-6374(01)00236-6
   Kim S, 2003, BIOTECHNIQUES, V35, P456, DOI 10.2144/03353bm03
   Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028
   Martin R, 2002, EXP GERONTOL, V37, P1481, DOI 10.1016/S0531-5565(02)00168-7
   Masternak MM, 2004, J GERONTOL A-BIOL, V59, P784
   Mohamed SA, 2004, EXP GERONTOL, V39, P181, DOI 10.1016/j.exger.2003.10.011
   MOSHIER JA, 1993, EXP GERONTOL, V28, P249, DOI 10.1016/0531-5565(93)90032-9
   Noda M, 2003, LIFE SCI, V72, P1573, DOI 10.1016/S0024-3205(02)02449-9
   PAHLAVANI MA, 1994, MODULATION AGING PRO, P143
   Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3
   Peters IR, 2004, J IMMUNOL METHODS, V286, P203, DOI 10.1016/j.jim.2004.01.003
   Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36
   RAO G, 1990, MECH AGEING DEV, V53, P49, DOI 10.1016/0047-6374(90)90033-C
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   Salles N, 2005, EXP GERONTOL, V40, P353, DOI 10.1016/j.exger.2005.01.007
   Sanz N, 1997, J HEPATOL, V27, P525, DOI 10.1016/S0168-8278(97)80358-3
   SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004
   Song GQ, 2001, J NEUROCHEM, V79, P804, DOI 10.1046/j.1471-4159.2001.00626.x
   Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763
   Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7
   Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5
   Tian LQ, 1998, FREE RADICAL BIO MED, V24, P1477, DOI 10.1016/S0891-5849(98)00025-2
   Van Remmen Holly, 1995, P171
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557
   Wall SJ, 2002, ANAL BIOCHEM, V300, P269, DOI 10.1006/abio.2001.5458
   Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143
   Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01
   Zhang AS, 2004, BLOOD, V103, P1509, DOI 10.1182/blood-2003-07-2378
NR 51
TC 46
Z9 54
U1 2
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JAN
PY 2006
VL 61
IS 1
BP 20
EP 27
DI 10.1093/gerona/61.1.20
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 010VR
UT WOS:000235226500003
PM 16456191
DA 2024-02-19
ER

PT J
AU Sastre, J
   Pallardo, FV
   Pla, R
   Pellin, A
   Juan, G
   OConnor, JE
   Estrela, JM
   Miquel, J
   Vina, J
AF Sastre, J
   Pallardo, FV
   Pla, R
   Pellin, A
   Juan, G
   OConnor, JE
   Estrela, JM
   Miquel, J
   Vina, J
TI Aging of the liver: Age-associated mitochondrial damage in intact
   hepatocytes
SO HEPATOLOGY
LA English
DT Article
ID RAT-LIVER; PYRUVATE-CARBOXYLASE; OXIDATIVE DAMAGE; CELLS; DNA;
   INVOLVEMENT; METABOLISM; INVITRO; ADULT; STATE
AB Mitochondrial damage may be a major cause of cellular aging. So far, this hypothesis had only been tested using isolated mitochondria. The aim of this study was to investigate the involvement of mitochondria in aging using whole liver cells and not isolated mitochondria only. Using now cytometry, we found that age is associated with a decrease in mitochondrial membrane potential (30%), an increase in mitochondrial size, and an increase in mitochondrial peroxide generation (23%). Intracellular peroxide levels were also increased. The number of mitochondria per cell and inner mitochondrial membrane mass did not change. Gluconeogenesis from glycerol or fructose (mitochondrial-independent) did not change with age, whereas it did from lactate (mitochondrial-dependent). The change in the rate of gluconeogenesis was not accompanied by changes in any of the following parameters: phosphoenolpyruvate carboxykinase or pyruvate carboxylase activities or mitochondrial ATP/ADP or cytosolic NADH/NAD(+) ratios. This was caused by a decreased rate of malate export (to 20% of the controls) from mitochondria. The impairment of the mitochondrial malate transporter is posttranscriptional because its expression in Xenopus oocytes using polyadenylated RNA from livers of young or old animals did not change. Ketogenesis from oleate also fell in hepatocytes from old rats. Our results show, for the first time in intact cells, a correlation between age-associated impairment of cell metabolism and specific changes in mitochondrial function and morphology, supporting the hypothesis that mitochondrial damage plays a key role in aging.
C1 UNIV VALENCIA,FAC MED,DEPT FISIOL,VALENCIA 46010,SPAIN.
   UNIV VALENCIA,FAC MED,DEPT PATOL,VALENCIA,SPAIN.
   UNIV VALENCIA,FAC MED,DEPT BIOQUIM & BIOL MOL,VALENCIA,SPAIN.
   UNIV ALICANTE,FAC MED,DEPT NEUROQUIM,E-03080 ALICANTE,SPAIN.
C3 University of Valencia; University of Valencia; University of Valencia;
   Universitat d'Alacant
RI Vina, Jose/AAB-3069-2021; Estrela, Jose Maria/H-4449-2015; Pallardo,
   Federico V./T-1156-2017
OI Vina, Jose/0000-0001-9709-0089; Estrela, Jose Maria/0000-0002-2540-9190;
   Pallardo, Federico V./0000-0003-3715-1980; Sastre,
   Juan/0000-0002-4260-6604
CR AKERBOOM TPM, 1977, FEBS LETT, V74, P50, DOI 10.1016/0014-5793(77)80750-3
   BEAL MF, 1993, TRENDS NEUROSCI, V16, P125, DOI 10.1016/0166-2236(93)90117-5
   BERGEMEYER HU, 1974, MEHTODS ENZYMATIC AN
   BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   CALLEJA M, 1993, J BIOL CHEM, V268, P18891
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cellbio.4.1.155
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Colman A, 1984, TRANSCRIPTION TRANSL, P49
   CORBISIER P, 1990, MECH AGEING DEV, V51, P249, DOI 10.1016/0047-6374(90)90075-Q
   CORBISIER P, 1990, EUR J CELL BIOL, V51, P173
   DAMORE PA, 1987, IN VITRO CELL DEV B, V23, P123
   DELACRUZ J, 1990, INT J BIOCHEM, V22, P729, DOI 10.1016/0020-711X(90)90008-Q
   FREDDICE J, 1985, HEPATOLOGY, V5, P508
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GIBBONS A, 1990, SCIENCE, V250, P622, DOI 10.1126/science.2237413
   GORDILLO E, 1988, J BIOL CHEM, V263, P8053
   HANSFORD RG, 1978, BIOCHEM J, V170, P285, DOI 10.1042/bj1700285
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   KNOOK DL, 1980, P SOC EXP BIOL MED, V165, P170
   LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAFTAH A, 1989, BIOCHEM BIOPH RES CO, V164, P185, DOI 10.1016/0006-291X(89)91700-2
   MCCLURE WR, 1971, J BIOL CHEM, V246, P3569
   MIQUEL J, 1978, J GERONTOL, V33, P5, DOI 10.1093/geronj/33.1.5
   MIQUEL J, 1986, FREE RADICALS AGING, P51
   NISHIMURA H, 1993, J BIOL CHEM, V268, P8514
   PARADIES G, 1978, ARCH BIOCHEM BIOPHYS, V284, P332
   PETIT PX, 1990, EUR J BIOCHEM, V194, P389, DOI 10.1111/j.1432-1033.1990.tb15632.x
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rickwood D., 1987, Mitochondria: a pratical approach, P1
   ROMERO FJ, 1983, BIOCHEM EDUC, V11, P135, DOI 10.1016/0307-4412(83)90093-6
   ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222
   SCALETTAR BA, 1991, P NATL ACAD SCI USA, V88, P8057, DOI 10.1073/pnas.88.18.8057
   SEUBERT W, 1965, BIOCHEM Z, V343, P176
   SIESS EA, 1988, EUR J BIOCHEM, V173, P369, DOI 10.1111/j.1432-1033.1988.tb14007.x
   SOHAL RS, 1991, MECH AGEING DEV, V60, P189, DOI 10.1016/0047-6374(91)90130-R
   SOHAL RS, 1990, FREE RADICAL BIO MED, V9, P495, DOI 10.1016/0891-5849(90)90127-5
   TAKEYAMA N, 1993, BIOCHEM J, V294, P719, DOI 10.1042/bj2940719
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   TUMMINO PJ, 1991, MECH AGEING DEV, V59, P177, DOI 10.1016/0047-6374(91)90083-C
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
NR 43
TC 201
Z9 217
U1 0
U2 12
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD NOV
PY 1996
VL 24
IS 5
BP 1199
EP 1205
DI 10.1002/hep.510240536
PG 7
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA VQ934
UT WOS:A1996VQ93400036
PM 8903398
OA Bronze
DA 2024-02-19
ER

PT J
AU Wang, Y
   Wang, L
   Saxena, R
   Wee, A
   Yang, RY
   Tian, QJ
   Zhang, JP
   Zhao, XY
   Jia, JD
AF Wang, Yan
   Wang, Lan
   Saxena, Romil
   Wee, Aileen
   Yang, Ruiyuan
   Tian, Qiuju
   Zhang, Jiping
   Zhao, Xinyan
   Jia, Jidong
TI Clinicopathological features of He Shou Wu<i>-</i>induced liver injury:
   This ancient anti-aging therapy is not liver-friendly
SO LIVER INTERNATIONAL
LA English
DT Article
DE clinical course; drug-induced liver injury; He Shou Wu; Polygonum
   Multiflorum Thumb
ID HEPATITIS; HEPATOTOXICITY; MEDICINE; INGESTION
AB Background & Aims Polygonum Multiflorum Thumb (PMT), an ancient anti-aging Chinese herb known traditionally as He Shou Wu, has side effects of liver toxicity. To determine the main clinical and pathological characteristics of liver toxicity induced by PMT and the clinical course after its cessation. Methods Data of patients, diagnosed as drug-induced liver injury and hospitalised in Beijing Friendship Hospital from August 2005 to August 2017, were retrospectively reviewed. Clinical, pathological data and outcome after cessation of He Shou Wu were obtained and analysed. Kruskal-Wallis and Chi-square (chi(2)) tests were performed. Results Twenty-nine patients with He Shou Wu-induced liver injury were enrolled. The median age was 53 years (range 15-74) and 75.9% (22/29) were women. The most common symptom was jaundice (79.3%, 23/29). Of nine patients with liver biopsies, six showed acute cholestatic hepatitis, two acute, and one chronic hepatocellular injury pattern. The latency, liver chemistries and outcomes were comparable between pure He Shou Wu (5 patients) and its compounds (24 patients). Twenty-five of 29 patients (86.2%) had normal serum alanine aminotransferase levels after 45 days (range: 10-138 days) and total bilirubin of 46 days (range: 0-551 days). One patient was rechallenged with He Shou Wu and two developed autoimmune features. One patient died of liver failure and three had chronic persistent liver injury. Conclusions The main clinicopathological injury pattern of He Shou Wu-induced liver injury is moderate to severe hepatitis with or without cholestasis. Most patients recover completely; however, chronic disease and death do occur.
C1 [Wang, Yan; Wang, Lan; Yang, Ruiyuan; Tian, Qiuju; Zhao, Xinyan; Jia, Jidong] Capital Med Univ, Liver Res Ctr, Beijing Friendship Hosp, Beijing Key Lab Translat Med Cirrhosis,Natl Clin, 95 Yong An Rd, Beijing, Peoples R China.
   [Saxena, Romil] Indiana Univ Sch Med, Dept Pathol, Indianapolis, IN 46202 USA.
   [Wee, Aileen] Natl Univ Singapore, Natl Univ Hosp, Yong Loo Lin Sch Med, Dept Pathol, Singapore, Singapore.
   [Zhang, Jiping] Guangzhou Kingmed Ctr Clin Lab, Dept Pathol, Guangzhou, Guangdong, Peoples R China.
C3 Capital Medical University; Indiana University System; Indiana
   University Bloomington; National University of Singapore
RP Zhao, XY; Jia, JD (corresponding author), Capital Med Univ, Liver Res Ctr, Beijing Friendship Hosp, Beijing Key Lab Translat Med Cirrhosis,Natl Clin, 95 Yong An Rd, Beijing, Peoples R China.
EM zhao_xinyan@ccmu.edu.cn; jia_jd@ccmu.edu.cn
RI ZHOU, yf/IAO-5497-2023; wu, p/JDW-5015-2023
OI zhao, xinyan/0000-0002-8016-4368
FU Beijing Health System Talents Plan [2013-3-069]
FX This work was supported by Beijing Health System Talents Plan
   (2013-3-069).
CR But PPH, 1996, VET HUM TOXICOL, V38, P280
   Cortez E, 2012, BMJ CASE REPORTS, V2012, DOI [10.1136/bcr-2012-006438, DOI 10.1136/BCR-2012-006438]
   DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6
   Danan G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010014
   Dong HH, 2014, COMPLEMENT THER MED, V22, P70, DOI 10.1016/j.ctim.2013.12.008
   Fontana Robert J, 2010, Hepatology, V52, P730, DOI 10.1002/hep.23696
   Jung KA, 2011, GUT LIVER, V5, P493, DOI 10.5009/gnl.2011.5.4.493
   Kleiner David E, 2018, Surg Pathol Clin, V11, P297, DOI 10.1016/j.path.2018.02.009
   Kleiner DE, 2017, HISTOPATHOLOGY, V70, P81, DOI 10.1111/his.13082
   Kleiner DE, 2017, MACSWEENS PATHOLOGY, P673
   Lee WJ, 2015, FOOD CHEM TOXICOL, V84, P47, DOI 10.1016/j.fct.2015.06.004
   Li HL, 2017, FOOD CHEM TOXICOL, V108, P407, DOI 10.1016/j.fct.2016.07.035
   Lin LF, 2015, J ETHNOPHARMACOL, V159, P158, DOI 10.1016/j.jep.2014.11.009
   Mazzanti G., 2004, ANN INTERN MED, V140, P30
   Medina-Caliz I, 2018, CLIN GASTROENTEROL H, V16, P1495, DOI 10.1016/j.cgh.2017.12.051
   Meng YK, 2017, ACTA PHARMACOL SIN, V38, P1340, DOI 10.1038/aps.2017.32
   National Institute of Health, CLIN RES INF DRUG IN
   National Workshop on Fatty Liver and Alcoholic Liver Disease Chinese Society of Hepatology Chinese Medical Association, 2018, Zhonghua Gan Zang Bing Za Zhi, V26, P188, DOI 10.3760/cma.j.issn.1007-3418.2018.03.007
   Navarro VJ, 2017, HEPATOLOGY, V65, P363, DOI 10.1002/hep.28813
   Panis B, 2005, J PEDIATR GASTR NUTR, V41, P256, DOI 10.1097/01.MPG.0000164699.41282.67
   Park GJH, 2001, J GASTROEN HEPATOL, V16, P115, DOI 10.1046/j.1440-1746.2001.02309.x
   Reuben A, 2004, HEPATOLOGY, V39, P574, DOI 10.1002/hep.20081
   Suk KT, 2012, AM J GASTROENTEROL, V107, P1380, DOI 10.1038/ajg.2012.138
   Teschke R, 2014, ALIMENT PHARM THER, V40, P32, DOI 10.1111/apt.12798
   Vuppalanchi R, 2015, GASTROENTEROLOGY, V148, P480, DOI 10.1053/j.gastro.2015.01.004
   Wang JB, 2018, CHIN J INTEGR MED, V24, P696, DOI 10.1007/s11655-018-3000-8
   Wang JB, 2015, FRONT MED-PRC, V9, P457, DOI 10.1007/s11684-015-0417-8
   Xie X. J., 2012, DRUG EVALUATION, V9, P36
   Xu J., 2009, MIL MED J SE CHIN, V11, P209
   Yuen MF, 2006, ALIMENT PHARM THER, V24, P1179, DOI 10.1111/j.1365-2036.2006.03111.x
   Zhang Y., 2013, HAINAN MED J, V24, P235
   Zhu Y, 2016, J GASTROEN HEPATOL, V31, P1476, DOI 10.1111/jgh.13323
   Zhu Yun, 2015, Zhongguo Zhong Xi Yi Jie He Za Zhi, V35, P1442
NR 33
TC 18
Z9 24
U1 2
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD FEB
PY 2019
VL 39
IS 2
BP 389
EP 400
DI 10.1111/liv.13939
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA HJ8RS
UT WOS:000457468000019
PM 30066422
DA 2024-02-19
ER

PT J
AU Soofi, A
   Wolf, KI
   Ranghini, EJ
   Amin, MA
   Dressler, GR
AF Soofi, Abdul
   Wolf, Katherine I.
   Ranghini, Egon J.
   Amin, Mohammad A.
   Dressler, Gregory R.
TI The kielin/chordin-like protein KCP attenuates nonalcoholic fatty liver
   disease in mice
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE KCP; TGF-beta; hepatic steatosis; mouse model
ID TGF-BETA; HEPATOCELLULAR-CARCINOMA; WHITE ADIPOSE; BMP; CELL; OBESITY;
   PRIORITIZATION; SUPERFAMILY; DEFICIENCY; ACTIVATION
AB Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and is increasing with the rising rate of obesity in the developed world. Signaling pathways known to influence the rate of lipid deposition in liver, known as hepatic steatosis, include the transforming growth factor (TGF) superfamily, which function through the SMAD second messengers. The kielin/chordin-like protein (KCP) is a large secreted protein that can enhance bone morphogenetic protein signaling while suppressing TGF-beta signaling in cells and in genetically modified mice. In this report, we show that aging KCP mutant (Kcp(-/-)) mice are increasingly susceptible to developing hepatic steatosis and liver fibrosis. When young mice are put on a high-fat diet, Kcp(-/-) mice are also more susceptible to developing liver pathology, compared with their wild-type littermates. Furthermore, mice that express a Pepck-KCP transgene (KcpTg) in the liver are resistant to developing liver pathology even when fed a high-fat diet. Analyses of liver tissues reveal a significant reduction of P-Smad3, consistent with a role for KCP in suppressing TGF-beta signaling. Transcriptome analyses show that livers from Kcp(-/-) mice fed a normal diet are more like wild-type livers from mice fed a high-fat diet. However, the KCP transgene can suppress many of the changes in liver gene expression that are due to a high-fat diet. These data demonstrate that shifting the TGF-beta signaling paradigm with the secreted regulatory protein KCP can significantly alter the liver pathology in aging mice and in diet-induced NAFLD.
C1 [Soofi, Abdul; Wolf, Katherine I.; Ranghini, Egon J.; Dressler, Gregory R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Amin, Mohammad A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan
RP Dressler, GR (corresponding author), BSRB 2049,109 Zina Pitcher Dr, Ann Arbor, MI 48109 USA.
EM dressler@umich.edu
FU National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
   [DK-062914, DK-073722]; NIDDK [DK-02057, DK-089503]
FX This work was supported by National Institute of Diabetes and Digestive
   and Kidney Diseases (NIDDK) Grants DK-062914 and DK-073722 to G. R.
   Dressler; the core services were supported by NIDDK Grants DK-02057 and
   DK-089503 to the University of Michigan.
CR Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7
   Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826
   Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229
   Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427
   Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73
   Dooley S, 2012, CELL TISSUE RES, V347, P245, DOI 10.1007/s00441-011-1246-y
   Gressner OA, 2014, CLIN CHIM ACTA, V433, P111, DOI 10.1016/j.cca.2014.02.021
   Gumienny TL, 2002, TRENDS ENDOCRIN MET, V13, P295, DOI 10.1016/S1043-2760(02)00615-X
   He LN, 2010, AM J PATHOL, V176, P2302, DOI 10.2353/ajpath.2010.090931
   Ikeya M, 2006, DEVELOPMENT, V133, P4463, DOI 10.1242/dev.02647
   Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046
   Larraín J, 2000, DEVELOPMENT, V127, P821
   Lin JM, 2006, MOL CELL BIOL, V26, P4577, DOI 10.1128/MCB.02127-05
   Lin JM, 2005, NAT MED, V11, P387, DOI 10.1038/nm1217
   Mittal S, 2015, CLIN GASTROENTEROL H, V13, P594, DOI 10.1016/j.cgh.2014.08.013
   PHAN SH, 1980, AM REV RESPIR DIS, V121, P501, DOI 10.1164/arrd.1980.121.3.501
   Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   Riordan JD, 2014, MAMM GENOME, V25, P473, DOI 10.1007/s00335-014-9521-3
   SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0
   SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X
   Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943
   Shen JJ, 2009, MOL ENDOCRINOL, V23, P113, DOI 10.1210/me.2007-0322
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   Soofi A, 2013, J AM SOC NEPHROL, V24, P897, DOI 10.1681/ASN.2012070759
   Tan CK, 2011, DIABETES, V60, P464, DOI 10.2337/db10-0801
   Westerbacka J, 2007, DIABETES, V56, P2759, DOI 10.2337/db07-0156
   Yadav Hariom, 2012, Front Endocrinol (Lausanne), V3, P35, DOI 10.3389/fendo.2012.00035
   Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013
   Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698
   Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017057
   Younossi ZM, 2015, HEPATOLOGY, V62, P1723, DOI 10.1002/hep.28123
   Zamani N, 2011, ENDOCR REV, V32, P387, DOI 10.1210/er.2010-0018
   Zhang P, 2012, J BIOL CHEM, V287, P21290, DOI 10.1074/jbc.M112.357202
NR 34
TC 6
Z9 6
U1 1
U2 4
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD OCT 1
PY 2016
VL 311
IS 4
BP G587
EP G598
DI 10.1152/ajpgi.00165.2016
PG 12
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA EC2AH
UT WOS:000387910800002
PM 27514479
OA Green Published
DA 2024-02-19
ER

PT J
AU Bezy, O
   Tran, TT
   Pihlajämaki, J
   Suzuki, R
   Emanuelli, B
   Winnay, J
   Mori, MA
   Haas, J
   Biddinger, SB
   Leitges, M
   Goldfine, AB
   Patti, ME
   King, GL
   Kahn, CR
AF Bezy, Olivier
   Tran, Thien T.
   Pihlajamaki, Jussi
   Suzuki, Ryo
   Emanuelli, Brice
   Winnay, Jonathan
   Mori, Marcelo A.
   Haas, Joel
   Biddinger, Sudha B.
   Leitges, Michael
   Goldfine, Allison B.
   Patti, Mary Elizabeth
   King, George L.
   Kahn, C. Ronald
TI PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice
   and humans
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID PROTEIN-KINASE-C; DIET-INDUCED OBESITY; RECEPTOR SUBSTRATE-1;
   SKELETAL-MUSCLE; PHOSPHOINOSITIDE 3-KINASE; METABOLIC SYNDROME;
   GLUCOSE-TRANSPORT; OXIDATIVE STRESS; RESISTANT MICE; FATTY LIVER
AB C57BL/6J and 129S6/Sv (B6 and 129) mice differ dramatically in their susceptibility to developing diabetes in response to diet- or genetically induced insulin resistance. A major locus contributing to this difference has been mapped to a region on mouse chromosome 14 that contains the gene encoding PKC delta. Here, we found that PKC delta expression in liver was 2-fold higher in B6 versus 129 mice from birth and was further increased in B6 but not 129 mice in response to a high-fat diet. PRKCD gene expression was also elevated in obese humans and was positively correlated with fasting glucose and circulating triglycerides. Mice with global or liver-specific inactivation of the Prkcd gene displayed increased hepatic insulin signaling and reduced expression of gluconeogenic and lipogenic enzymes. This resulted in increased insulin-induced suppression of hepatic gluconeogenesis, improved glucose tolerance, and reduced hepatosteatosis with aging. Conversely, mice with liver-specific overexpression of PKC delta developed hepatic insulin resistance characterized by decreased insulin signaling, enhanced lipogenic gene expression, and hepatosteatosis. Therefore, changes in the expression and regulation of PKC delta between strains of mice and in obese humans play an important role in the genetic risk of hepatic insulin resistance, glucose intolerance, and hepatosteatosis; and thus PKC delta may be a potential target in the treatment of metabolic syndrome.
C1 [Bezy, Olivier; Tran, Thien T.; Suzuki, Ryo; Emanuelli, Brice; Winnay, Jonathan; Mori, Marcelo A.; Haas, Joel; Biddinger, Sudha B.; Goldfine, Allison B.; Patti, Mary Elizabeth; King, George L.; Kahn, C. Ronald] Joslin Diabet Ctr, Boston, MA 02215 USA.
   [Bezy, Olivier; Tran, Thien T.; Suzuki, Ryo; Emanuelli, Brice; Winnay, Jonathan; Mori, Marcelo A.; Haas, Joel; Biddinger, Sudha B.; Goldfine, Allison B.; Patti, Mary Elizabeth; King, George L.; Kahn, C. Ronald] Harvard Univ, Sch Med, Boston, MA 02215 USA.
   [Pihlajamaki, Jussi] Univ Eastern Finland, Dept Med, Kuopio, Finland.
   [Pihlajamaki, Jussi] Univ Eastern Finland, Dept Clin Nutr, Kuopio, Finland.
   [Pihlajamaki, Jussi] Kuopio Univ Hosp, SF-70210 Kuopio, Finland.
   [Biddinger, Sudha B.] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Endocrinol, Boston, MA USA.
   [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway.
C3 Harvard University; Joslin Diabetes Center, Inc.; Harvard University;
   Harvard Medical School; University of Eastern Finland; University of
   Eastern Finland; Kuopio University Hospital; University of Eastern
   Finland; Harvard University; Harvard Medical School; Boston Children's
   Hospital; University of Oslo
RP Kahn, CR (corresponding author), Joslin Diabet Ctr, 1 Joslin Pl, Boston, MA 02215 USA.
EM c.ronald.kahn@joslin.harvard.edu
RI Leitges, Michael/AAN-1953-2021; Mori, Marcelo A/R-2881-2018; Haas, Joel
   T/R-6379-2018; Emanuelli, Brice/M-2097-2016; Kahn, Ronald/AAY-2435-2021;
   Suzuki, Ryo/AAA-2736-2019
OI Leitges, Michael/0000-0003-4203-6995; Mori, Marcelo
   A/0000-0001-7112-5263; Haas, Joel T/0000-0002-0028-5988; Emanuelli,
   Brice/0000-0001-5795-5666; Kahn, Ronald/0000-0002-7583-9228; Suzuki,
   Ryo/0000-0002-2965-6906; Bezy, Olivier/0000-0003-4367-5043; Pihlajamaki,
   Jussi/0000-0002-6241-6859
FU NIH [DK31036, DK33201]; American Diabetes Association; Grants-in-Aid for
   Scientific Research [23689047] Funding Source: KAKEN
FX The authors thank Michael Rourk and Graham Smith for animal technical
   assistance. This work was supported by the NIH grants DK31036 and
   DK33201, an American Diabetes Association mentor-based award, and the
   Mary K. Iacocca Professorship to C.R. Kahn.
CR Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274
   Almind K, 2003, DIABETES, V52, P1535, DOI 10.2337/diabetes.52.6.1535
   Bowden DW, 2006, DIABETES, V55, P1985, DOI 10.2337/db06-0003
   Braiman L, 1999, MOL ENDOCRINOL, V13, P2002, DOI 10.1210/me.13.12.2002
   Braiman L, 2001, MOL ENDOCRINOL, V15, P565, DOI 10.1210/me.15.4.565
   Brand C, 2006, BIOCHEM BIOPH RES CO, V349, P954, DOI 10.1016/j.bbrc.2006.08.100
   Brand C, 2010, BBA-MOL CELL RES, V1803, P1265, DOI 10.1016/j.bbamcr.2010.07.006
   Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009
   Colombo C, 2003, J BIOL CHEM, V278, P3992, DOI 10.1074/jbc.M207665200
   Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003
   Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845
   Farese RV, 2007, J CLIN INVEST, V117, P2289, DOI 10.1172/JCI31408
   Formisano P, 2001, J ENDOCRINOL INVEST, V24, P460, DOI 10.1007/BF03351048
   Frangioudakis G, 2009, DIABETOLOGIA, V52, P2616, DOI 10.1007/s00125-009-1543-0
   Gao ZG, 2007, AM J PHYSIOL-ENDOC M, V292, pE84, DOI 10.1152/ajpendo.00178.2006
   Geraldes P, 2009, NAT MED, V15, P1298, DOI 10.1038/nm.2052
   Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158
   Greene MW, 2010, CELL SIGNAL, V22, P274, DOI 10.1016/j.cellsig.2009.09.029
   Haas JT, 2009, CURR OPIN LIPIDOL, V20, P206, DOI 10.1097/MOL.0b013e32832b2024
   Haluzik M, 2004, ENDOCRINOLOGY, V145, P3258, DOI 10.1210/en.2004-0219
   Hennige AM, 2010, DIABETES, V59, P119, DOI 10.2337/db09-0512
   Horovitz-Fried M, 2007, CELL SIGNAL, V19, P556, DOI 10.1016/j.cellsig.2006.08.005
   Ishizuka T, 2004, ENDOCR RES, V30, P287, DOI 10.1081/ERC-120039580
   Jacob AI, 2010, J MOL ENDOCRINOL, V44, P155, DOI 10.1677/JME-09-0119
   Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230
   Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528
   Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002
   Leitges M, 2001, J CLIN INVEST, V108, P1505
   Letiges M, 2002, MOL ENDOCRINOL, V16, P847, DOI 10.1210/me.16.4.847
   Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107
   Mori MA, 2010, DIABETES, V59, P2960, DOI 10.2337/db10-0367
   Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305
   Oriente F, 2005, J BIOL CHEM, V280, P40642, DOI 10.1074/jbc.M508570200
   Özcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160
   Pihlajamäki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212
   Pihlajamaki J, 2010, METABOLISM, V59, P866, DOI 10.1016/j.metabol.2009.10.004
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Qi X, 2008, J CELL SCI, V121, P804, DOI 10.1242/jcs.024653
   Ravichandran LV, 2001, J BIOL CHEM, V276, P3543, DOI 10.1074/jbc.M007231200
   Sajan MP, 2009, DIABETOLOGIA, V52, P1197, DOI 10.1007/s00125-009-1336-5
   Sampson SR, 2006, MOL GENET METAB, V89, P32, DOI 10.1016/j.ymgme.2006.04.017
   Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400
   She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172
   Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5
   Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139
   Standaert ML, 1999, ENDOCRINOLOGY, V140, P4470, DOI 10.1210/en.140.10.4470
   Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004
   Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003
   Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07
   Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005
   Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Wallerstedt E, 2010, DIABETOLOGIA, V53, P946, DOI 10.1007/s00125-010-1668-1
   Yu Andy S, 2002, Rev Gastroenterol Disord, V2, P11
NR 54
TC 107
Z9 126
U1 0
U2 12
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JUN
PY 2011
VL 121
IS 6
BP 2504
EP 2517
DI 10.1172/JCI46045
PG 14
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA 772LB
UT WOS:000291234300049
PM 21576825
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU Xu, XM
   Li, GL
   Zhang, D
   Zhu, HY
   Liu, GH
   Zhang, ZB
AF Xu, Xiaoming
   Li, Guoliang
   Zhang, Da
   Zhu, Hanyi
   Liu, Guang-hui
   Zhang, Zhibin
TI Gut Microbiota is Associated with Aging-Related Processes of a Small
   Mammal Species under High-Density Crowding Stress
SO ADVANCED SCIENCE
LA English
DT Article; Early Access
DE anti-aging; density-dependent aging; gut microbiota; short-chain fatty
   acids; social stress
ID NF-KAPPA-B; ENDOTHELIAL-CELLS; POPULATION-CYCLES; OXIDATIVE STRESS;
   TELOMERE LENGTH; SEX-DIFFERENCES; DEPRESSION; SENESCENCE; NEIGHBORHOOD;
   GLYCOLYSIS
AB Humans and animals frequently encounter high-density crowding stress, which may accelerate their aging processes; however, the roles of gut microbiota in the regulation of aging-related processes under high-density crowding stress remain unclear. In the present study, it is found that high housing density remarkably increases the stress hormone (corticosterone), accelerates aging-related processes as indicated by telomere length (in brain and liver cells) and DNA damage or inflammation (as revealed by tumor necrosis factor-alpha and interleukin-10 levels), and reduces the lifespan of Brandt's vole (Lasiopodomys brandtii). Fecal microbiota transplantation from donor voles of habitats with different housing densities induces similar changes in aging-related processes in recipient voles. The elimination of high housing density or butyric acid administration delays the appearance of aging-related markers in the brain and liver cells of voles housed at high-density. This study suggests that gut microorganisms may play a significant role in regulating the density-dependent aging-related processes and subsequent population dynamics of animals, and can be used as potential targets for alleviating stress-related aging in humans exposed to high-density crowding stress.
C1 [Xu, Xiaoming; Li, Guoliang; Zhang, Da; Zhu, Hanyi; Zhang, Zhibin] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects &, Beijing, Peoples R China.
   [Xu, Xiaoming; Zhang, Da; Zhu, Hanyi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Li, Guoliang; Zhang, Zhibin] Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing 100049, Peoples R China.
   [Liu, Guang-hui] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100049, Peoples R China.
   [Liu, Guang-hui] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China.
   [Liu, Guang-hui] Beijing Inst Stem Cell & Regenerat Med, Beijing 100101, Peoples R China.
C3 Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy
   of Sciences; University of Chinese Academy of Sciences, CAS; Chinese
   Academy of Sciences; University of Chinese Academy of Sciences, CAS;
   Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of
   Zoology, CAS
RP Zhang, ZB (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects &, Beijing, Peoples R China.; Zhang, ZB (corresponding author), Univ Chinese Acad Sci, CAS Ctr Excellence Biot Interact, Beijing 100049, Peoples R China.
EM zhangzb@ioz.ac.cn
RI Zhang, Zhibin/V-1511-2017; li, qing/JEF-9044-2023
OI Zhang, Zhibin/0000-0002-9303-9793; 
FU National Natural Science Foundation of China [32090021, 32070460];
   Strategic Priority Research Program of Chinese Academy of Sciences
   [XDPB16]; Youth Innovation Promotion Association of the Chinese Academy
   of Sciences [2022081]
FX This work was supported by the National Natural Science Foundation of
   China (32090021 and 32070460), the Strategic Priority Research Program
   of Chinese Academy of Sciences (Grant No. XDPB16), and Youth Innovation
   Promotion Association of the Chinese Academy of Sciences (2022081). The
   authors thank Shuhui Sun, Yiran Song, Xin Zhang, Wei Lu, Defeng Bai,
   Yanan Gan, and Yifan Bao for their assistance in the study.
CR Abbas HA, 2010, CELL STEM CELL, V7, P606, DOI 10.1016/j.stem.2010.09.013
   Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507
   [Anonymous], 1963, CAN MED ASSOC J, V88, P1255
   Badgeley A, 2021, BBA-REV CANCER, V1875, DOI 10.1016/j.bbcan.2020.188494
   Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028
   Bárcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5
   Bekhbat M, 2018, BRAIN BEHAV IMMUN, V67, P1, DOI 10.1016/j.bbi.2017.02.006
   Bodogai M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat4271
   Boehme M, 2021, NATURE AGING, V1, P666, DOI 10.1038/s43587-021-00093-9
   BOONSTRA R, 1994, EVOL ECOL, V8, P196, DOI 10.1007/BF01238250
   Burokas A, 2017, BIOL PSYCHIAT, V82, P472, DOI 10.1016/j.biopsych.2016.12.031
   Campisi J, 2019, NATURE, V571, P183, DOI 10.1038/s41586-019-1365-2
   Casella G, 2019, NUCLEIC ACIDS RES, V47, P7294, DOI 10.1093/nar/gkz555
   Cattan V, 2008, FREE RADICAL BIO MED, V44, P1592, DOI 10.1016/j.freeradbiomed.2008.01.007
   Charbonnel N, 2008, PHYSIOL BIOCHEM ZOOL, V81, P63, DOI 10.1086/523306
   Choi S, 2021, NATURE, V592, P428, DOI 10.1038/s41586-021-03417-2
   CHRISTIAN JJ, 1950, J MAMMAL, V31, P247, DOI 10.2307/1375290
   Dai X, 2018, ZOOL STUD, V57, DOI 10.6620/ZS.2018.57-35
   do Carmo Fillipe Luiz Rosa, 2019, Oncotarget, V10, P7198, DOI 10.18632/oncotarget.27319
   Ebi KL, 2021, LANCET, V398, P698, DOI 10.1016/S0140-6736(21)01208-3
   Emmerson MG, 2018, GEN COMP ENDOCR, V256, P71, DOI 10.1016/j.ygcen.2017.07.008
   Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101
   Fang X, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.792746
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   GRAVES JL, 1993, GENETICA, V91, P99, DOI 10.1007/BF01435991
   Harvanek ZM, 2021, TRANSL PSYCHIAT, V11, DOI 10.1038/s41398-021-01735-7
   Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020
   Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790
   Howden-Chapman P, 2004, J EPIDEMIOL COMMUN H, V58, P162, DOI 10.1136/jech.2003.011569
   Huang SL, 2021, FRONT ZOOL, V18, DOI 10.1186/s12983-021-00441-w
   Huang SL, 2021, INTEGR ZOOL, V16, P149, DOI 10.1111/1749-4877.12467
   Hyland NP, 2014, WORLD J GASTROENTERO, V20, P8859, DOI 10.3748/wjg.v20.i27.8859
   De Rosa MJ, 2019, NATURE, V573, P135, DOI 10.1038/s41586-019-1524-5
   Judd FK, 2002, AUST NZ J PSYCHIAT, V36, P104, DOI 10.1046/j.1440-1614.2002.00986.x
   Jurk D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5172
   Kasahara K, 2018, NAT MICROBIOL, V3, P1461, DOI 10.1038/s41564-018-0272-x
   Katsnelson A, 2011, SCI AM, V305, P18, DOI 10.1038/scientificamerican0911-18
   Khan SS, 2017, AGING CELL, V16, P624, DOI 10.1111/acel.12601
   Kim YY, 2017, AGING CELL, V16, P1094, DOI 10.1111/acel.12639
   KREBS CJ, 1973, SCIENCE, V179, P35, DOI 10.1126/science.179.4068.35
   Kundu P, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau4760
   Kuosmanen SM, 2018, NUCLEIC ACIDS RES, V46, P1124, DOI 10.1093/nar/gkx1155
   Lemaitre JF, 2020, P NATL ACAD SCI USA, V117, P8546, DOI 10.1073/pnas.1911999117
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Li GL, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2023691118j1of9, 10.1073/pnas.2023691118]
   Li GL, 2020, ISME J, V14, P1795, DOI 10.1038/s41396-020-0646-y
   Liu J, 2020, HORM BEHAV, V126, DOI 10.1016/j.yhbeh.2020.104838
   Liu M, 2021, MICROBIOL RES, V250, DOI 10.1016/j.micres.2021.126791
   Liu X., 2021, GUT MICROBES, V13
   López-Almela I, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2020.1865706
   López-Otin C, 2023, CELL, V186, P243, DOI 10.1016/j.cell.2022.11.001
   Lu HY, 2022, CELL HOST MICROBE, V30, P1139, DOI 10.1016/j.chom.2022.07.003
   Lynch SM, 2017, CANCER EPIDEM BIOMAR, V26, P553, DOI 10.1158/1055-9965.EPI-16-0554
   Ma S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62497-8
   Matt SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01832
   McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307
   Monaghan P, 2010, ANN NY ACAD SCI, V1206, P130, DOI 10.1111/j.1749-6632.2010.05705.x
   Nagara Y, 2022, ISME J, V16, P1502, DOI 10.1038/s41396-022-01196-w
   Nakao S, 2000, MOL CELL BIOCHEM, V209, P113, DOI 10.1023/A:1007155525020
   Osadchiy V, 2019, CLIN GASTROENTEROL H, V17, P322, DOI 10.1016/j.cgh.2018.10.002
   Paik JY, 2017, NUCL MED BIOL, V45, P8, DOI 10.1016/j.nucmedbio.2016.10.006
   Parker A, 2022, MICROBIOME, V10, DOI 10.1186/s40168-022-01243-w
   Pidcock SE, 2021, MICROB GENOMICS, V7, DOI 10.1099/mgen.0.000638
   Powell-Wiley TM, 2020, SSM-POPUL HLTH, V10, DOI 10.1016/j.ssmph.2019.100517
   Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005
   Rosenberg AM, 2021, ELIFE, V10, DOI 10.7554/eLife.67437
   Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205
   Sato Y, 2021, NATURE, V599, P458, DOI 10.1038/s41586-021-03832-5
   Schnitzler JG, 2020, CIRC RES, V126, P1346, DOI 10.1161/CIRCRESAHA.119.316206
   Shaler CR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26992-4
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Shi Dazhao, 1999, Acta Theriologica Sinica, V19, P48
   Shin J, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01189-5
   Silva M, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.760280
   Sleiman MB, 2022, SCIENCE, V377, P1508, DOI 10.1126/science.abo3191
   Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974
   Sundquist K, 2004, BRIT J PSYCHIAT, V184, P293, DOI 10.1192/bjp.184.4.293
   Tetè S, 2012, INT J IMMUNOPATH PH, V25, P355, DOI 10.1177/039463201202500205
   TILG H, 2020, NAT REV IMMUNOL, V20, P40, DOI DOI 10.1038/S41577-019-0198-4
   Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785
   Vanzo R, 2020, CELL DEATH DIFFER, V27, P1134, DOI 10.1038/s41418-019-0403-9
   von Rosenvinge EC, 2013, ISME J, V7, P1354, DOI 10.1038/ismej.2013.33
   Wei JH, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00990
   Wei XY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22094-2
   Wei ZY, 2022, GENOM PROTEOM BIOINF, V20, P350, DOI 10.1016/j.gpb.2021.09.009
   Woo PCY, 2010, J CLIN MICROBIOL, V48, P319, DOI 10.1128/JCM.01459-09
   Xie XX, 2018, J AFFECT DISORDERS, V229, P254, DOI 10.1016/j.jad.2017.12.073
   Xiong WH, 2022, INTEGR ZOOL, V17, P331, DOI 10.1111/1749-4877.12633
   Yvan-Charvet L, 2019, CARDIOVASC RES, V115, P1393, DOI 10.1093/cvr/cvz127
   Zhang B, 2020, NATURE, V577, P676, DOI 10.1038/s41586-020-1935-3
   Zhang Y., 2016, NEURAL MECH AGGRESSI
   Zhu HY, 2022, MICROBIOME, V10, DOI 10.1186/s40168-022-01381-1
   Zhu W, 2022, INTEGR ZOOL, V17, P346, DOI 10.1111/1749-4877.12590
   Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001
   Zirnniak P, 2011, FREE RADICAL BIO MED, V51, P1087, DOI 10.1016/j.freeradbiomed.2011.05.039
NR 95
TC 3
Z9 3
U1 8
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2198-3844
J9 ADV SCI
JI Adv. Sci.
PD 2023 MAY
PY 2023
VL 10
IS 14
DI 10.1002/advs.202205346
EA MAR 2023
PG 17
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA G4XL5
UT WOS:000952300000001
PM 36965140
OA gold
DA 2024-02-19
ER

PT J
AU Navarro, J
AF Navarro, Jordi
TI HIV and liver disease
SO AIDS REVIEWS
LA English
DT Article
DE HIV; Liver disease; Chemical and drug-induced liver disease;
   Antiretroviral treatment
ID HUMAN-IMMUNODEFICIENCY-VIRUS; ONCE-DAILY DOLUTEGRAVIR;
   TREATMENT-EXPERIENCED PATIENTS; ANTIRETROVIRAL-NAIVE ADULTS;
   CABOTEGRAVIR PLUS RILPIVIRINE; TENOFOVIR DISOPROXIL FUMARATE;
   DOUBLE-BLIND; INFECTED PATIENTS; INITIAL TREATMENT; HEPATITIS-C
AB Liver-related diseases are associated with the high levels of morbidity and mortality in people living with HIV. Between 13% and 18% of all-cause mortality in HIV-infected patients involves a liver-related damage, this being one of the main causes of death not related to acquired immunodeficiency syndrome (AIDS). People living with HIV, even when the disease is under control, are more likely to develop pathologies and complications of a liver-related origin than the general population, both due to common causes such as alcoholism, non-alcoholic fatty liver disease, hepatic viral infections and ageing, in addition to specific HIV-related processes such as antiretroviral treatment toxicity and liver damage inherent to HIV infection. On the other hand, some antiretroviral drugs may have a beneficial effect in reversing liver fibrosis in patients with HIV and chronic liver disease. This paper reviews the main risk factors associated with liver disease in people living with HIV and the role of antiretroviral therapy (ART) in this disease.
C1 [Navarro, Jordi] Hosp Univ Vall dHebron, Infect Dis Dept, Barcelona, Spain.
   [Navarro, Jordi] Inst Recerca Vall dHebron, Barcelona, Spain.
C3 Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona;
   Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca
   (VHIR)
RP Navarro, J (corresponding author), Hosp Univ Vall dHebron, Infect Dis Dept, Barcelona, Spain.; Navarro, J (corresponding author), Inst Recerca Vall dHebron, Barcelona, Spain.
EM jnavarro@vhebron.net
RI Navarro, Jose/JQV-4305-2023; Navarro, Jordi/N-5499-2015
OI Navarro, Jordi/0000-0002-7187-0367
CR [Anonymous], 2018, J INT AIDS SOC
   [Anonymous], GUIAS CLINICAS GESID
   [Anonymous], What's New in the Guidelines? NIH
   Atazanavir, 2012, LIVERTOX CLIN RES IN
   Bakasis AD, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051212
   Benedicto AM, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071687
   Bictegravir, 2012, LIVERTOX CLIN RES IN
   Boyd A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21426
   Boyd A, 2010, ANTIVIR THER, V15, P963, DOI 10.3851/IMP1649
   Brunet L, 2016, CLIN INFECT DIS, V62, P242, DOI 10.1093/cid/civ838
   Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0
   Calza L, 2019, INFECT DIS-NOR, V51, P593, DOI 10.1080/23744235.2019.1629008
   Casado JL, 2016, HIV MED, V17, P62, DOI 10.1111/hiv.12274
   Chou CC, 2016, J MICROBIOL IMMUNOL, V49, P546, DOI 10.1016/j.jmii.2014.08.006
   Christensen ES, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx122
   Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8
   Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2
   Cohen CJ, 2011, LANCET, V378, P229, DOI 10.1016/S0140-6736(11)60983-5
   Daar ES, 2018, LANCET HIV, V5, pE347, DOI 10.1016/S2352-3018(18)30091-2
   Darunavir, 2012, LIVERTOX CLIN RES IN
   Dharan NJ, 2019, HEPATOLOGY, V69, P1135, DOI 10.1002/hep.30296
   Ding Y, 2017, J VIRAL HEPATITIS, V24, P412, DOI 10.1111/jvh.12658
   Dolutegravir, 2012, LIVERTOX CLIN RES IN
   Doravirine, 2012, LIVERTOX CLIN RES IN
   Efavirenz, 2012, LIVERTOX CLIN RES IN
   EHGNA Libro, AEEH
   Emu B, 2018, NEW ENGL J MED, V379, P645, DOI 10.1056/NEJMoa1711460
   Eron JJ, 2018, AIDS, V32, P1431, DOI [10.1097/QAD.0000000000001817, 10.1097/qad.0000000000001817]
   Etravirine, 2012, LIVERTOX CLIN RES IN
   European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021
   Gallant J, 2017, LANCET, V390, P2063, DOI [10.1016/S0140-6736(17)32299-7, 10.1016/s0140-6736(17)32299-7]
   Gao B, 2012, J HEPATOL, V57, P430, DOI 10.1016/j.jhep.2012.01.029
   Gervasoni C, 2019, PHARMACOL RES, V145, DOI 10.1016/j.phrs.2019.104267
   Girard PM, 2012, HIV MED, V13, P427, DOI 10.1111/j.1468-1293.2012.00994.x
   Gonzalez-Serna A, 2021, J ANTIMICROB CHEMOTH, V76, P2375, DOI 10.1093/jac/dkab157
   Hardy WD, 2010, JAIDS-J ACQ IMM DEF, V55, P558, DOI 10.1097/QAI.0b013e3181ee3d82
   Ibuprofen, 2012, LiverTox: Clinical and Research Information on Drug-Induced Liver Injury
   Johnson M, 2019, JAIDS-J ACQ IMM DEF, V81, P463, DOI 10.1097/QAI.0000000000002056
   Karlsen TH, 2022, LANCET, V399, P61, DOI 10.1016/S0140-6736(21)01701-3
   Kaspar MB, 2017, BMJ OPEN GASTROENTER, V4, DOI 10.1136/bmjgast-2017-000166
   Kontana A, 2019, WORLD J GASTROENTERO, V25, P3664, DOI 10.3748/wjg.v25.i28.3664
   Kozal M, 2020, NEW ENGL J MED, V382, P1232, DOI 10.1056/NEJMoa1902493
   Kumar RN, 2022, CURR INFECT DIS REP, V24, P39, DOI 10.1007/s11908-022-00776-3
   Lake JE, 2022, CLIN GASTROENTEROL H, V20, P256, DOI 10.1016/j.cgh.2020.10.018
   Lataillade M, 2020, LANCET HIV, V7, pE740, DOI 10.1016/S2352-3018(20)30240-X
   Lennox JL, 2010, JAIDS-J ACQ IMM DEF, V55, P39, DOI 10.1097/QAI.0b013e3181da1287
   Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1
   Lopinavir, 2012, LIVERTOX CLIN RES IN
   Macías J, 2017, CLIN INFECT DIS, V65, P1012, DOI 10.1093/cid/cix467
   Mallet VO, 2007, ANTIVIR THER, V12, P279
   Manegold C, 2001, CLIN INFECT DIS, V32, P144, DOI 10.1086/317535
   Maraviroc, 2012, LIVERTOX CLIN RES IN
   Markham A, 2020, DRUGS, V80, P915, DOI 10.1007/s40265-020-01326-8
   Markowitz M, 2017, LANCET HIV, V4, pE331, DOI 10.1016/S2352-3018(17)30068-1
   Martí-Rodrigo A, 2020, GUT, V69, P920, DOI 10.1136/gutjnl-2019-318372
   Mayer KH, 2020, LANCET, V396, P239, DOI 10.1016/S0140-6736(20)31065-5
   Merchante N, 2020, CURR HIV-AIDS REP, V17, P6, DOI 10.1007/s11904-019-00475-0
   Molina JM, 2020, LANCET HIV, V7, pE16, DOI 10.1016/S2352-3018(19)30336-4
   Molina JM, 2015, LANCET HIV, V2, pE127, DOI 10.1016/S2352-3018(15)00027-2
   Molina JM, 2011, LANCET, V378, P238, DOI 10.1016/S0140-6736(11)60936-7
   Mondou E, 2005, CLIN INFECT DIS, V41, pE45, DOI 10.1086/432581
   Montes ML, C RETROVIRUS OPPORTU
   Nelson M, 2012, J ANTIMICROB CHEMOTH, V67, P2020, DOI 10.1093/jac/dks130
   Nevirapine, 2012, LIVERTOX CLIN RES IN
   Nhean S, 2019, AIDS, V33, P1261, DOI 10.1097/QAD.0000000000002191
   Oikonomou KG, 2019, CLIN LIVER DIS, V23, P309, DOI 10.1016/j.cld.2018.12.011
   Orkin C, 2020, LANCET HIV, V7, pE389, DOI 10.1016/S2352-3018(20)30099-0
   Orkin C, 2019, CLIN INFECT DIS, V68, P535, DOI 10.1093/cid/ciy540
   Orkin C, 2018, LANCET HIV, V5, pE23, DOI 10.1016/S2352-3018(17)30179-0
   Otto AO, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051263
   Pelchen-Matthews A, 2021, HIV RES CLIN PRACT, V22, P160, DOI 10.1080/25787489.2021.2003132
   Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4
   Raltegravir, 2012, LIVERTOX CLIN RES IN
   Ramirez ML, C RETROVIRUS OPPORTU, P2021
   Rilpivirine, 2012, LIVERTOX CLIN RES IN
   Rizzardini G, 2020, JAIDS-J ACQ IMM DEF, V85, P498, DOI 10.1097/QAI.0000000000002466
   Rockstroh JK, 2012, HIV MED, V13, P127, DOI 10.1111/j.1468-1293.2011.00933.x
   Rockstroh JK, 2011, CLIN INFECT DIS, V53, P807, DOI 10.1093/cid/cir510
   Sax PE, 2017, LANCET, V390, P2073, DOI [10.1016/S0140-6736(17)32340-1, 10.1016/s0140-6736(17)32340-1]
   Sax PE, 2017, LANCET HIV, V4, pE154, DOI 10.1016/S2352-3018(17)30016-4
   Shahriar S, 2022, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.780887
   Sierra-Madero J, 2010, HIV CLIN TRIALS, V11, P127, DOI 10.1310/hct1103-125
   Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8
   Sonderup MW, 2017, GASTROENTEROL CLIN N, V46, P327, DOI 10.1016/j.gtc.2017.01.007
   Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002
   Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319
   Sun J, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37512
   Tenofovir, 2012, LIVERTOX CLIN RES IN
   Terrault NA, 2018, HEPATOLOGY, V67, P1560, DOI 10.1002/hep.29800
   Thorpe J, 2011, AIDS, V25, P967, DOI 10.1097/QAD.0b013e3283455e4b
   van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7
   van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0
   Vinikoor MJ, 2017, CLIN INFECT DIS, V64, P1343, DOI 10.1093/cid/cix122
   Vos T, 2020, LANCET, V396, P1562
   Wang B, 2018, INT J STD AIDS, V29, P414, DOI 10.1177/0956462417734099
   Williams EC, 2016, ALCOHOL CLIN EXP RES, V40, P2056, DOI 10.1111/acer.13204
   World Health Organization, 2016, GLOB HLTH SECT STRAT
NR 97
TC 5
Z9 5
U1 0
U2 3
PU PERMANYER PUBL
PI BARCELONA
PA MALLORCA, 310, BARCELONA, 08037, SPAIN
SN 1139-6121
EI 1698-6997
J9 AIDS REV
JI Aids Rev.
PD APR-JUN
PY 2022
VL 24
IS 2
BP 87
EP 96
DI 10.24875/AIDSRev.M22000052
PG 10
WC Immunology; Infectious Diseases
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Infectious Diseases
GA 3O4PZ
UT WOS:000836823000005
PM 35901073
DA 2024-02-19
ER

PT J
AU Ribeiro, RT
   Afonso, RA
   Guarino, MP
   Macedo, MP
AF Ribeiro, Rogerio Tavares
   Afonso, Ricardo Alexandre
   Guarino, Maria Pedro
   Macedo, Maria Paula
TI Loss of postprandial insulin sensitization during aging
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE insulin resistance; hepatic parasympathetic nerves; hepatic insulin
   sensitizing substance; type 2 diabetes mellitus
ID DIABETES-MELLITUS; GLUCOSE-UPTAKE; VAGAL TONE; AGED RATS; RESISTANCE;
   SENSITIVITY; MUSCLE; RESPONSIVENESS; GLUTATHIONE; METABOLISM
AB With aging, there is a decrease in parasympathetic nervous activity. Since the hepatic parasympathetic nerves (HPNs) are essential to the disposal of nutrients, through the hepatic insulin sensitizing substance (HISS), we tested the hypothesis that aging leads to a lowering of postprandial glucose disposal by a decrease of the HISS-dependent component of insulin action. Insulin sensitivity was quantified in fed or fasted, male and female Wistar rats (from 6 to 52 weeks), using a euglycemic clamp. The HISS-dependent component was quantified by administration of the muscarinic antagonist atropine. Total insulin action decreased gradually up to 52 weeks of age: The HISS-independent component of insulin action decreased until 9 weeks of age and remained unchanged thereafter; the HISS-dependent component decreased from 9 weeks of age throughout aging. The continuous decrease of HISS action, uncovered by blocking the HPN, is the key phenomenon for the gradual decrease of insulin sensitivity with aging.
C1 [Ribeiro, Rogerio Tavares; Afonso, Ricardo Alexandre; Guarino, Maria Pedro; Macedo, Maria Paula] Univ Nova Lisboa, Fac Med Sci, Dept Physiol, P-1169056 Lisbon, Portugal.
   [Afonso, Ricardo Alexandre] Univ Nova Lisboa, Fac Med Sci, Dept Biochem, P-1169056 Lisbon, Portugal.
   [Macedo, Maria Paula] Portuguese Diabet Assoc, Lisbon, Portugal.
C3 Universidade Nova de Lisboa; Universidade Nova de Lisboa
RP Macedo, MP (corresponding author), Univ Nova Lisboa, Fac Med Sci, Dept Physiol, Campo Martires Patria 130, P-1169056 Lisbon, Portugal.
EM mpmacedo.biot@fcm.unl.pt
RI Ribeiro, Rogério JT/N-3656-2016; Guarino, Maria Pedro/B-5594-2015;
   Afonso, Ricardo/D-5515-2019; Macedo, Maria Paula/Q-7827-2018
OI Ribeiro, Rogério JT/0000-0001-8840-7208; Guarino, Maria
   Pedro/0000-0001-6079-1105; Afonso, Ricardo/0000-0001-5990-4539; Macedo,
   Maria Paula/0000-0002-2549-0275
CR Afonso RA, 2007, OBESITY, V15, P314, DOI 10.1038/oby.2007.524
   Armeni T, 1998, MECH AGEING DEV, V101, P101, DOI 10.1016/S0047-6374(97)00167-X
   BARZILAI N, 1995, AM J PHYSIOL-ENDOC M, V269, pE591, DOI 10.1152/ajpendo.1995.269.3.E591
   BRAMANN HU, 1992, Z GERONTOL, V25, P83
   BUWALDA B, 1991, J AUTONOM NERV SYST, V36, P123, DOI 10.1016/0165-1838(91)90108-F
   Carnethon MR, 2003, DIABETES CARE, V26, P3035, DOI 10.2337/diacare.26.11.3035
   DAVIDSON MB, 1979, METABOLISM, V28, P688, DOI 10.1016/0026-0495(79)90024-6
   De Meersman RE, 2007, BIOL PSYCHOL, V74, P165, DOI 10.1016/j.biopsycho.2006.04.008
   DEFRONZO RA, 1981, DIABETES CARE, V4, P493, DOI 10.2337/diacare.4.4.493
   Escriva F, 1997, ENDOCRINOLOGY, V138, P49, DOI 10.1210/en.138.1.49
   Espínola EB, 1999, PHARMACOL BIOCHEM BE, V62, P419, DOI 10.1016/S0091-3057(98)00192-0
   FEMANDES AB, 2007, DIABETOLOGIA, V50, P738
   FRANSSILAKALLUNKI A, 1992, AM J PHYSIOL, V263, pE780, DOI 10.1152/ajpendo.1992.263.4.E780
   GOODMAN MN, 1983, AM J PHYSIOL, V244, pE93, DOI 10.1152/ajpendo.1983.244.1.E93
   Guarino MP, 2006, BRIT J PHARMACOL, V147, P959, DOI 10.1038/sj.bjp.0706691
   Guarino MP, 2004, AM J PHYSIOL-GASTR L, V287, pG527, DOI 10.1152/ajpgi.00085.2004
   Hendrickse M T, 1993, Clin Auton Res, V3, P227, DOI 10.1007/BF01829010
   KURODA N, 1990, DIABETES RES CLIN PR, V9, P49, DOI 10.1016/0168-8227(90)90008-H
   Latour MG, 2002, CAN J PHYSIOL PHARM, V80, P8, DOI 10.1139/Y01-094
   Lautt WW, 2004, J PHARMACOL SCI, V95, P9, DOI 10.1254/jphs.95.9
   Lautt WW, 2001, AM J PHYSIOL-GASTR L, V281, pG29, DOI 10.1152/ajpgi.2001.281.1.G29
   Lee PY, 2004, MED HYPOTHESES, V62, P868, DOI 10.1016/j.mehy.2003.11.024
   LEIGHTON B, 1989, BIOCHEM J, V261, P383, DOI 10.1042/bj2610383
   Liao DP, 1995, DIABETES RES CLIN PR, V30, P211, DOI 10.1016/0168-8227(95)01190-0
   Nakai N, 1996, J APPL PHYSIOL, V80, P1963, DOI 10.1152/jappl.1996.80.6.1963
   NARIMIYA M, 1984, AM J PHYSIOL, V246, pE397, DOI 10.1152/ajpendo.1984.246.5.E397
   NISHIMURA H, 1988, AM J PHYSIOL, V254, pE92, DOI 10.1152/ajpendo.1988.254.1.E92
   Patarrao RS, 2005, DIABETOLOGIA, V48, pA211
   PETERSON HR, 1988, NEW ENGL J MED, V318, P1078
   Quadri R, 1994, Minerva Endocrinol, V19, P105
   REED MJ, 1993, J GERONTOL, V48, pB139, DOI 10.1093/geronj/48.4.B139
   Ribeiro R, 2005, DIABETOLOGIA, V48, P976, DOI 10.1007/s00125-005-1714-6
   Ribeiro RT, 2007, METABOLISM, V56, P227, DOI 10.1016/j.metabol.2006.09.018
   ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914
   Sadri P, 1999, AM J PHYSIOL-GASTR L, V277, pG101, DOI 10.1152/ajpgi.1999.277.1.G101
   Sadri P, 2006, BRIT J NUTR, V95, P288, DOI 10.1079/BJN20051644
   Soltanpour N, 1996, J AUTONOM NERV SYST, V60, P93, DOI 10.1016/0165-1838(96)00038-0
   STOUT RW, 1994, J ROY SOC MED, V87, P608
   SUNDKVIST G, 1981, DIABETES CARE, V4, P529, DOI 10.2337/diacare.4.5.529
   UIJTDEHAAGE SHJ, 1992, PSYCHOPHYSIOLOGY, V29, P193, DOI 10.1111/j.1469-8986.1992.tb01685.x
   XIE H, 1994, P W PHARMACOL SOC, V37, P39
   XIE H, 1995, P W PHARMACOL SOC, V38, P83
   Xie H, 1996, AM J PHYSIOL-ENDOC M, V271, pE587, DOI 10.1152/ajpendo.1996.271.3.E587
   Xie HS, 1996, AM J PHYSIOL-ENDOC M, V270, pE858, DOI 10.1152/ajpendo.1996.270.5.E858
NR 44
TC 16
Z9 18
U1 0
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD JUN
PY 2008
VL 63
IS 6
BP 560
EP 565
DI 10.1093/gerona/63.6.560
PG 6
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA 318IH
UT WOS:000257084300004
PM 18559629
OA Bronze, Green Submitted
DA 2024-02-19
ER

PT J
AU Warman, DJ
   Jia, HJ
   Kato, H
AF Warman, Dwina Juliana
   Jia, Huijuan
   Kato, Hisanori
TI Effects of Thyme (<i>Thymus vulgaris</i> L.) Essential Oil on
   Aging-Induced Brain Inflammation and Blood Telomere Attrition in
   Chronologically Aged C57BL/6J Mice
SO ANTIOXIDANTS
LA English
DT Article
DE inflammaging; chronological aging; telomere shortening; thyme essential
   oil; thymol; p-cymene; antioxidant; anti-inflammation; healthy aging
ID NF-KAPPA-B; P-CYMENE; CELLULAR SENESCENCE; OXIDATIVE STRESS; EXPRESSION;
   ANTIOXIDANT; CANCER; CELLS; APOPTOSIS; INCREASE
AB Chronological aging is commonly accompanied by chronic low-grade inflammation (or "inflammaging"), a contributor to the development of age-related chronic diseases. Aging increases oxidative stress that accelerates telomere shortening, leading to cell senescence and the generation of senescence-associated secretory phenotype (SASP) that exacerbates inflammation. Dietary antioxidants may help protect telomeres and attenuate inflammation. Thyme essential oil (TEO), reported for its potency against neuroinflammation, was fed to chronologically aged C57BL/6J mice for 24 weeks. The TEO diet showed notable impacts on the hippocampus, indicated by lower expression of the aging-related gene p16(INK4A) (p = 0.0783) and significantly lower expression of cyclin D kinase Cdk4 and Cdk6 (p < 0.05) compared to the age-matched control mice. The TEO group also showed significantly lower gene expression of the pro-inflammatory cytokine Il6 (p < 0.05) in the hippocampus and lower Il1b expression in the liver and cerebellum (p < 0.05). In vitro experiments conducted on NIH-3T3 cells expressing SASP revealed the dose-dependent anti-inflammatory activity of TEO. Remarkably, TEO diet-fed mice showed higher survival rates and significantly longer blood telomere lengths than the control mice. Monoterpene antioxidants in TEO, particularly thymol and p-cymene, may primarily contribute to the anti-inflammatory and telomere-protecting activities of TEO.
C1 [Warman, Dwina Juliana; Jia, Huijuan; Kato, Hisanori] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Hlth Nutr, 1-1-1 Yayoi, Bunkyo ku, Tokyo 1138657, Japan.
   [Kato, Hisanori] Kagawa Nutr Univ, Sch Nutr, Dept Appl Nutr, 3-9-21 Chiyoda, Sakado 3500288, Japan.
C3 University of Tokyo; Kagawa Nutrition University
RP Jia, HJ; Kato, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Hlth Nutr, 1-1-1 Yayoi, Bunkyo ku, Tokyo 1138657, Japan.; Kato, H (corresponding author), Kagawa Nutr Univ, Sch Nutr, Dept Appl Nutr, 3-9-21 Chiyoda, Sakado 3500288, Japan.
EM warman-dwina-juliana681@g.ecc.u-tokyo.ac.jp;
   akakeiken@g.ecc.u-tokyo.ac.jp; kato.hisanori@eiyo.ac.jp
CR Aguilera A, 2013, ANNU REV GENET, V47, P1, DOI 10.1146/annurev-genet-111212-133232
   [Anonymous], 2023, ALZHEIMERS DEMENT, V19, P1598, DOI 10.1002/alz.13016
   Baek JH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030247
   Bayatmakoo R, 2017, CRESCENT J MED BIOL, V4, P186
   Beauséjour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417
   Buj R, 2021, AGING-US, V13, P3290, DOI 10.18632/aging.202640
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Cesari M, 2004, J GERONTOL A-BIOL, V59, P242
   Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711
   Collino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056564
   Comartin P.J., 2012, THESIS W U LONDON ON
   Davoli T, 2010, CELL, V141, P81, DOI 10.1016/j.cell.2010.01.031
   de Oliveira TM, 2015, PHARM BIOL, V53, P423, DOI 10.3109/13880209.2014.923003
   de Santana MF, 2015, PHARM BIOL, V53, P1583, DOI 10.3109/13880209.2014.993040
   Fachini-Queiroz FC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/657026
   FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950
   Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599
   Grespan R, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/954136
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   Guo YF, 2021, FOOD CHEM, V345, DOI 10.1016/j.foodchem.2020.128468
   Hayakawa T., 2008, COLOR ATLAS SECTIONA, V1st ed., P5
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Horváth G, 2021, BMC COMPLEMENT MED, V21, DOI 10.1186/s12906-021-03319-w
   Huang Wei-Xing, 2017, Shengli Xuebao, V69, P33, DOI 10.13294/j.aps.2016.0101
   Hung CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112355
   Kaewtunjai N, 2018, ACS OMEGA, V3, P18572, DOI 10.1021/acsomega.8b02853
   Khosravaniardakani S, 2022, FRONT NUTR, V9, DOI 10.3389/fnut.2022.812846
   Kowalczyk A, 2020, MOLECULES, V25, DOI 10.3390/molecules25184125
   Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Liang DJ, 2014, INFLAMMATION, V37, P214, DOI 10.1007/s10753-013-9732-x
   Liao NS, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1404-9
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Miyazawa T, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0250-6
   Nanni V, 2018, PHYTOMEDICINE, V46, P1, DOI 10.1016/j.phymed.2018.06.008
   Nie C, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110459
   Nikolic M, 2014, IND CROP PROD, V52, P183, DOI 10.1016/j.indcrop.2013.10.006
   Pandur E, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11071330
   Paul L, 2011, J NUTR BIOCHEM, V22, P895, DOI 10.1016/j.jnutbio.2010.12.001
   Ragonnaud E, 2021, IMMUN AGEING, V18, DOI 10.1186/s12979-020-00213-w
   Reichert S, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0463
   Rizvi Saliha, 2014, Curr Aging Sci, V7, P161
   Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06
   Rubió L, 2014, FOOD CHEM, V149, P277, DOI 10.1016/j.foodchem.2013.10.075
   Salehi B, 2018, PHYTOTHER RES, V32, P1688, DOI 10.1002/ptr.6109
   Sammi SR, 2017, MOL NEUROBIOL, V54, P5468, DOI 10.1007/s12035-016-0083-0
   Schädel P, 2021, FASEB J, V35, DOI 10.1096/fj.202002684R
   Shammas MA, 2011, CURR OPIN CLIN NUTR, V14, P28, DOI 10.1097/MCO.0b013e32834121b1
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   Shimada A, 2022, NAT PROD RES, V36, P2864, DOI 10.1080/14786419.2021.1921766
   Sparkman NL, 2008, NEUROIMMUNOMODULAT, V15, P323, DOI 10.1159/000156474
   Strub GM, 2008, CELL STRESS CHAPERON, V13, P475, DOI 10.1007/s12192-008-0047-z
   Tsai ML, 2011, BIOSCI BIOTECH BIOCH, V75, P1977, DOI 10.1271/bbb.110377
   Vaiserman A, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.630186
   van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193
   Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023
   Wagner KD, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11121966
   Wang JT, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1972714
   Wang SM, 2021, ANTICANCER RES, V41, P1213, DOI 10.21873/anticanres.14878
   Whittemore K, 2019, P NATL ACAD SCI USA, V116, P15122, DOI 10.1073/pnas.1902452116
   Xie GH, 2012, MOLECULES, V17, P8159, DOI 10.3390/molecules17078159
   Ye SM, 2001, J NEUROIMMUNOL, V117, P87, DOI 10.1016/S0165-5728(01)00316-2
   Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3
   Yu TJ, 2022, ANTIOXIDANTS-BASEL, V11, DOI 10.3390/antiox11030587
   Zanni F, 2003, EXP GERONTOL, V38, P981, DOI 10.1016/S0531-5565(03)00160-8
   Zhang X, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-33226-8
NR 66
TC 0
Z9 0
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3921
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD JUN
PY 2023
VL 12
IS 6
AR 1178
DI 10.3390/antiox12061178
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science
   & Technology
GA K1BR7
UT WOS:001013872200001
PM 37371908
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Dini, L
   Rossi, L
   Marchese, E
   Ruzittu, MT
   Rotilio, G
AF Dini, L
   Rossi, L
   Marchese, E
   Ruzittu, MT
   Rotilio, G
TI Age-related changes in the binding and uptake of Cu, Zn superoxide
   dismutase in rat liver cells
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE superoxide dismutase; liver cells; aging; endocytosis
ID HYDROGEN-PEROXIDE; CULTURED-HEPATOCYTES; TARGETED DELIVERY; OXIDATIVE
   STRESS; LIFE EXPECTANCY; ENDOCYTOSIS; RADICALS; CYTOTOXICITY;
   RECOGNITION; HOUSEFLIES
AB The present paper reports the effect of aging on receptor mediated endocytosis of Cu, Zn superoxide dismutase in rat liver cells. The fate of bovine Cu, Zn superoxide dismutase conjugated to colloidal gold was followed by electron microscopy in young (2 months) and old (24 months) rats in situ, in vivo and in vitro experiments. The use of different models for the study of the binding and internalization of the enzyme allowed to discriminate the contribution of each different liver cell type, The data obtained demonstrate that aging of the liver affects binding and uptake of this enzyme. In particular both the number of binding sites and the rate of internalization were depressed in old rats. Therefore, the hypothesis of therapeutic application of superoxide dismutase for age-related diseases needs to be revalued in view of the fact that receptor-mediated endocytosis of this protein is a mechanism affected by senescence.
C1 UNIV ROMA TOR VERGATA,DEPT BIOL,ROME,ITALY.
C3 University of Rome Tor Vergata
RP Dini, L (corresponding author), UNIV LECCE,DEPT BIOL,VIA PER MONTERONI,I-73100 LECCE,ITALY.
CR AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   AVRAHAM KB, 1988, CELL, V54, P823, DOI 10.1016/S0092-8674(88)91153-1
   BALDINI P, 1988, MECH AGEING DEV, V42, P17, DOI 10.1016/0047-6374(88)90059-0
   BEAUCHAMP CO, 1983, ANAL BIOCHEM, V131, P25, DOI 10.1016/0003-2697(83)90131-8
   BURWEN SJ, 1990, J ELECTRON MICR TECH, V14, P140, DOI 10.1002/jemt.1060140207
   CESSAC AL, 1993, MECH AGEING DEV, V70, P139, DOI 10.1016/0047-6374(93)90065-Y
   CIRIOLO MR, 1991, MECH AGEING DEV, V61, P287, DOI 10.1016/0047-6374(91)90061-4
   COHAL RS, 1991, FREE RADICAL BIO MED, V10, P35
   DARNOLD JR, 1990, MECH AGEING DEV, V53, P157, DOI 10.1016/0047-6374(90)90067-P
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DINI L, 1989, MECH AGEING DEV, V50, P57, DOI 10.1016/0047-6374(89)90059-6
   DINI L, 1989, BIOCHEM BIOPH RES CO, V162, P940, DOI 10.1016/0006-291X(89)90763-8
   Dini L, 1995, CELL MOL BIOL, V41, P1051
   Dini L, 1996, CELL MOL BIOL, V42, P269
   DINI L, 1990, MECH AGEING DEV, V56, P117, DOI 10.1016/0047-6374(90)90003-X
   FRALKIS W, 1984, INTERDISCIP TOP GERO, V18, P122
   FREEMAN BA, 1983, J BIOL CHEM, V258, P2534
   FUJITA T, 1992, J PHARMACOL EXP THER, V263, P971
   HAG JA, 1992, REG IMMUNOL, V2, P138
   HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HORISBERGER M, 1977, J HISTOCHEM CYTOCHEM, V25, P295, DOI 10.1177/25.4.323352
   INOUE M, 1990, FEBS LETT, V269, P89, DOI 10.1016/0014-5793(90)81126-9
   KYLE ME, 1988, J BIOL CHEM, V263, P3784
   LI L, 1992, BIOCHEM BIOPH RES CO, V184, P727, DOI 10.1016/0006-291X(92)90650-A
   MARCOCCI L, 1989, SER SYMP AD, V1, P11
   MARKEY BA, 1990, FREE RADICAL BIO MED, V9, P307, DOI 10.1016/0891-5849(90)90005-4
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   MICHELSON AM, 1981, MOL PHYSIOL, V1, P85
   Moldeus P, 1978, Methods Enzymol, V52, P60
   NAKAE D, 1990, ARCH BIOCHEM BIOPHYS, V279, P315, DOI 10.1016/0003-9861(90)90497-M
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   Omar B A, 1992, Adv Pharmacol, V23, P109, DOI 10.1016/S1054-3589(08)60964-3
   ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730
   PALLUY O, 1991, FREE RADICAL BIO MED, V11, P269, DOI 10.1016/0891-5849(91)90123-K
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RIKANS LE, 1992, J PHARMACOL EXP THER, V262, P271
   SCHUMCKER DL, 1985, GASTROENTEROLOGY, V88, P436
   SOHAL RS, 1991, MECH AGEING DEV, V57, P187, DOI 10.1016/0047-6374(91)90034-W
   SOHAL RS, 1993, P NATL ACAD SCI USA, V90, P7255, DOI 10.1073/pnas.90.15.7255
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   STARKE PE, 1985, J BIOL CHEM, V260, P99
   STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5
   TAKAKURA Y, 1994, BIOCHEM PHARMACOL, V47, P853, DOI 10.1016/0006-2952(94)90485-5
   TAYLOR LV, 1992, P SOC EXP BIOL MED, V199, P441
   WONG K, 1980, AGENTS ACTIONS, V10, P231, DOI 10.1007/BF02025941
NR 48
TC 6
Z9 6
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD SEP 9
PY 1996
VL 90
IS 1
BP 21
EP 33
DI 10.1016/0047-6374(96)01748-4
PG 13
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA VA044
UT WOS:A1996VA04400002
PM 8844646
DA 2024-02-19
ER

PT J
AU Najar, RA
   Rahat, B
   Hussain, A
   Thakur, S
   Kaur, J
   Kaur, J
   Hamid, A
AF Najar, Rauf Ahmad
   Rahat, Beenish
   Hussain, Aashiq
   Thakur, Shilpa
   Kaur, Jaspreet
   Kaur, Jyotdeep
   Hamid, Abid
TI Gene specific epigenetic regulation of hepatic folate transport system
   is responsible for perturbed cellular folate status during aging and
   exogenous modulation
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Article
DE Age; Folate deficiency; Folate over supplementation; Folate transport;
   Liver
ID DNA METHYLATION; ELDERLY-PATIENTS; DEFICIENCY; MECHANISMS; EXPRESSION;
   MEMBRANE; IMPACT; MALABSORPTION; TUMOR; CYCLE
AB Scope: The present study was designed to identify the molecular mechanism of folate modulation and aging on aberrant liver folate transporter system.
   Methods and results: An in vivo rat model was used, in which weanling, young and adult rats were given folate deficient diet for 3 and 5 months and after 3 months of folate deficiency, one group received physiological folate repletion (2 mg/kg diet) and another group received over supplemented folate diet (8 mg/kg diet) for another 2 months. In adult group, 3 and 5 months of folate deficiency decreased serum and tissue folate levels with decreased uptake of folate, further associated with decreased expression levels of reduced folate carrier (RFC) and increased expression levels of folate exporter (ABCG2) at both mRNA and protein levels, which in turn regulated by promoter hypermethylation of RFC and promoter hypomethylation of ABCG2 gene.
   Conclusion: Promoter hypermethylation of RFC and promoter hypomethylation of ABCG2 may be attributed to the down regulation of RFC and up regulation of ABCG2 at mRNA and protein levels in conditions of 3 and 5 months of folate deficiency in the adult group.
C1 [Najar, Rauf Ahmad; Hussain, Aashiq; Hamid, Abid] CSIR Indian Inst Integrat Med, Canc Pharmacol Div, Jammu, India.
   [Rahat, Beenish; Thakur, Shilpa; Kaur, Jyotdeep] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India.
   [Kaur, Jaspreet] Panjab Univ, Univ Inst Engn & Technol, Chandigarh 160014, India.
   [Najar, Rauf Ahmad] Panjab Univ, Dept Biochem, Chandigarh 160014, India.
   [Hamid, Abid] CSIR Acad Sci & Innovat Res, New Delhi, India.
C3 Council of Scientific & Industrial Research (CSIR) - India; CSIR -
   Indian Institute of Integrative Medicine (IIIM); Post Graduate Institute
   of Medical Education & Research (PGIMER), Chandigarh; Panjab University;
   Panjab University; Academy of Scientific & Innovative Research (AcSIR)
RP Hamid, A (corresponding author), CSIR Indian Inst Integrat Med, Canc Pharmacol Div, Jammu, India.; Hamid, A (corresponding author), CSIR Acad Sci & Innovat Res, New Delhi, India.
EM ahdar@iiim.ac.in
RI Najar, Rauf Ahmad/GNM-8372-2022; Rahat, Beenish/K-8719-2019; Kaur,
   Jyotdeep/AFP-1572-2022; Thakur, Shilpa/C-1092-2018
OI Najar, Rauf Ahmad/0000-0003-2445-494X; Thakur,
   Shilpa/0000-0003-3302-3412; Rahat, Beenish/0000-0003-0371-2356
FU Department of Science and Technology (DST), New Delhi, India
   [SR/SO/HS-15/2009]; "Council of Scientific and Industrial Research
   (CSIR)" New Delhi, India
FX This study was funded by the Department of Science and Technology (DST),
   New Delhi, India under grant SR/SO/HS-15/2009 to Abid Hamid. Authors
   would like to acknowledge Nawab John Dar and Javeed Ahmad Bhat for
   helping in raising animal groups. R.A.N is thankful to "Council of
   Scientific and Industrial Research (CSIR)" New Delhi, India for
   providing Senior Research Fellowship. The authors would like to thank
   Director, CSIR-IIIM Jammu, Dr. Ram A Vishwakarma for supporting this
   work (Institutional publication No. IIIM/1878/2016)
CR BAKER H, 1978, J AM GERIATR SOC, V26, P218, DOI 10.1111/j.1532-5415.1978.tb01962.x
   Balamurugan K, 2003, AM J PHYSIOL-GASTR L, V285, pG1068, DOI 10.1152/ajpgi.00188.2003
   Bertani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067756
   COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715
   Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992
   Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002
   Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511
   Fowler B, 2001, KIDNEY INT, V59, pS221, DOI 10.1046/j.1523-1755.2001.07851.x
   Hamid A, 2007, J MEMBRANE BIOL, V220, P69, DOI 10.1007/s00232-007-9075-3
   Hamid A, 2007, FEBS J, V274, P6317, DOI 10.1111/j.1742-4658.2007.06150.x
   Hamid A, 2009, FEBS J, V276, P2175, DOI 10.1111/j.1742-4658.2009.06959.x
   Hillman R S, 1977, Trans Assoc Am Physicians, V90, P145
   HURDLE ADF, 1966, BRIT MED J, V2, P202, DOI 10.1136/bmj.2.5507.202
   Ifergan I, 2004, J BIOL CHEM, V279, P25527, DOI 10.1074/jbc.M401725200
   INOUE M, 1982, HEPATOLOGY, V2, P572
   Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298
   Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703
   Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238
   Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MAZIN AL, 1995, EXP GERONTOL, V30, P475, DOI 10.1016/0531-5565(95)00004-Z
   Migheli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052501
   Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S
   Nishikawa H, 2013, J CANCER, V4, P635, DOI 10.7150/jca.7279
   Ortega RM, 1996, J NUTR, V126, P1992
   Rahat B, 2014, MOL HUM REPROD, V20, P1026, DOI 10.1093/molehr/gau053
   RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Sherman M, 2005, SEMIN LIVER DIS, V25, P143, DOI 10.1055/s-2005-871194
   Sibani S, 2002, CARCINOGENESIS, V23, P61, DOI 10.1093/carcin/23.1.61
   Simon KW, 2012, MECH AGEING DEV, V133, P75, DOI 10.1016/j.mad.2012.01.003
   STEINBERG SE, 1979, J CLIN INVEST, V64, P83, DOI 10.1172/JCI109467
   STEINBERG SE, 1982, BRIT J HAEMATOL, V50, P309, DOI 10.1111/j.1365-2141.1982.tb01921.x
   Thakur S, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0369-z
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Wani NA, 2008, IUBMB LIFE, V60, P834, DOI 10.1002/iub.133
   WEBSTER SGP, 1979, J AM GERIATR SOC, V27, P451, DOI 10.1111/j.1532-5415.1979.tb01725.x
   Wojdacz TK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm013
   Zhao RB, 2011, ANNU REV NUTR, V31, P177, DOI 10.1146/annurev-nutr-072610-145133
NR 39
TC 6
Z9 7
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD JUN
PY 2016
VL 60
IS 6
SI SI
BP 1501
EP 1513
DI 10.1002/mnfr.201500991
PG 13
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA DP5GE
UT WOS:000378523500024
PM 26990146
DA 2024-02-19
ER

PT J
AU Sullivan, DI
   Bello, FM
   Silva, AG
   Redding, KM
   Giordano, L
   Hinchie, AM
   Loughridge, KE
   Mora, AL
   Königshoff, M
   Kaufman, BA
   Jurczak, MJ
   Alder, JK
AF Sullivan, Daniel I.
   Bello, Fiona M.
   Silva, Agustin Gil
   Redding, Kevin M.
   Giordano, Luca
   Hinchie, Angela M.
   Loughridge, Kelly E.
   Mora, Ana L.
   Konigshoff, Melanie
   Kaufman, Brett A.
   Jurczak, Michael J.
   Alder, Jonathan K.
TI Intact mitochondrial function in the setting of telomere-induced
   senescence
SO AGING CELL
LA English
DT Article; Early Access
DE SASP; shelterin; telomerase
ID ONCOGENE-INDUCED SENESCENCE; OXIDATIVE-PHOSPHORYLATION; DAMAGE RESPONSE;
   DYSFUNCTION; HETEROGENEITY; RESPIRATION; EXPRESSION; CELLS; LIVER
AB Mitochondria play essential roles in metabolic support and signaling within all cells. Congenital and acquired defects in mitochondria are responsible for several pathologies, including premature entrance to cellar senescence. Conversely, we examined the consequences of dysfunctional telomere-driven cellular senescence on mitochondrial biogenesis and function. We drove senescence in vitro and in vivo by deleting the telomere-binding protein TRF2 in fibroblasts and hepatocytes, respectively. Deletion of TRF2 led to a robust DNA damage response, global changes in transcription, and induction of cellular senescence. In vitro, senescent cells had significant increases in mitochondrial respiratory capacity driven by increased cellular and mitochondrial volume. Hepatocytes with dysfunctional telomeres maintained their mitochondrial respiratory capacity in vivo, whether measured in intact cells or purified mitochondria. Induction of senescence led to the upregulation of overlapping and distinct genes in fibroblasts and hepatocytes, but transcripts related to mitochondria were preserved. Our results support that mitochondrial function and activity are preserved in telomere dysfunction-induced senescence, which may facilitate continued cellular functions.
C1 [Sullivan, Daniel I.; Silva, Agustin Gil; Hinchie, Angela M.; Loughridge, Kelly E.; Konigshoff, Melanie; Alder, Jonathan K.] Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lun, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.
   [Bello, Fiona M.; Jurczak, Michael J.] Univ Pittsburgh, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA.
   [Bello, Fiona M.; Redding, Kevin M.; Giordano, Luca; Kaufman, Brett A.; Jurczak, Michael J.] Univ Pittsburgh, Ctr Metab & Mitochondrial Med, Pittsburgh, PA USA.
   [Redding, Kevin M.; Giordano, Luca; Kaufman, Brett A.] Univ Pittsburgh, Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA USA.
   [Mora, Ana L.] Ohio State Univ, Davis Heart Lung Res Inst, Div Pulm Crit Care & Sleep Med, Columbus, OH USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of
   Higher Education (PCSHE); University of Pittsburgh; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); University of
   Pittsburgh; University System of Ohio; Ohio State University
RP Alder, JK (corresponding author), Univ Pittsburgh, Dorothy P & Richard P Simmons Ctr Interstitial Lun, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.; Jurczak, MJ (corresponding author), Univ Pittsburgh, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA.
EM jurczakm@pitt.edu; jalder@pitt.edu
RI Kaufman, Brett A/IUP-1225-2023
OI Kaufman, Brett A/0000-0003-4767-4937; Hinchie,
   Angela/0000-0002-4544-4735
FU Cellular Senescence Network [U54AG075931]; National Heart, Lung, and
   Blood Institute [F32HL152503, R01HL135062]; National Institute of
   Diabetes and Digestive and Kidney Diseases [R01DK114012]
FX Cellular Senescence Network, Grant/ Award Number: U54AG075931; National
   Heart, Lung, and Blood Institute, Grant/Award Number: F32HL152503 and
   R01HL135062; National Institute of Diabetes and Digestive and Kidney
   Diseases, Grant/Award Number: R01DK114012
CR Alder JK, 2015, P NATL ACAD SCI USA, V112, P5099, DOI 10.1073/pnas.1504780112
   Alves TC, 2011, HEPATOLOGY, V53, P1175, DOI 10.1002/hep.24170
   Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Basisty N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000599
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162
   Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275
   Cesare Anthony J, 2015, Curr Protoc Cytom, V73, DOI 10.1002/0471142956.cy1240s73
   Chan M, 2022, ELIFE, V11, DOI 10.7554/eLife.70283
   CHANCE B, 1955, J BIOL CHEM, V217, P383
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862
   Dalle Pezze Piero, 2014, PLoS Comput Biol, V10, pe1003728, DOI 10.1371/journal.pcbi.1003728
   de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921
   Denchi EL, 2006, GENE DEV, V20, P2648, DOI 10.1101/gad.1453606
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Edmunds LR, 2020, MOL METAB, V41, DOI 10.1016/j.molmet.2020.101051
   Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478
   Gallage S, 2016, TRENDS BIOCHEM SCI, V41, P207, DOI 10.1016/j.tibs.2016.01.005
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   HOGEBOOM GH, 1948, J BIOL CHEM, V172, P619
   Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095
   Love M., 2014, Genome Biol, V15, P10, DOI DOI 10.1186/S13059-014-0550-8
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0
   Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873
   Passos JF, 2007, PLOS BIOL, V5, P1138, DOI 10.1371/journal.pbio.0050110
   Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011
   Renner K, 2003, BBA-MOL CELL RES, V1642, P115, DOI 10.1016/S0167-4889(03)00105-8
   Russell JO, 2019, HEPATOLOGY, V69, P742, DOI 10.1002/hep.30270
   Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787
   Saul D, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32552-1
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Xie BX, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2022.105569
NR 42
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2023 OCT
PY 2023
VL 22
IS 10
DI 10.1111/acel.13941
EA SEP 2023
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA U5HL2
UT WOS:001064310700001
PM 37688329
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Kondo, Y
   Inai, Y
   Sato, Y
   Handa, S
   Kubo, S
   Shimokado, K
   Goto, S
   Nishikimi, M
   Maruyama, N
   Ishigami, A
AF Kondo, Y
   Inai, Y
   Sato, Y
   Handa, S
   Kubo, S
   Shimokado, K
   Goto, S
   Nishikimi, M
   Maruyama, N
   Ishigami, A
TI Senescence marker protein 30 functions as gluconolactonase in L-ascorbic
   acid biosynthesis, and its knockout mice are prone to scurvy
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE aging; osteogenic disorder; vitamin C
ID ANIMAL TISSUES; LIVER; DEFICIENCY; CARNITINE; SMP30; MOUSE; RATS
AB We originally identified senescence marker protein 30 (SMP30) as a distinctive protein whose expression decreases in an androgen-independent manner with aging. Here, we report its sequence homology found in two kinds of bacterial gluconolactonases (GNLs) by using the BLAST search. Then, through a biochemical study, we identify SMP30 as the lactone-hydrolyzing enzyme GNL of animal species. SMP30 purified from the rat liver had lactonase activity toward various aldonolactones, such as D- and L-glucono-delta-lactone, D- and L-gulono-gamma-lactone, and D- and L-galactono-gamma-lactone, with a requirement for Zn2+ or Mn2+ as a cofactor. Furthermore, in SMP30 knockout mice, no GNL activity was detectable in the liver. Thus, we conclude that SMP30 is a unique GNL in the liver. The lactonase reaction with L-gulono-gamma-lactone is the penultimate step in L-ascorbic acid (AA) biosynthesis, and the essential role of SMP30 in this synthetic process was verified here by a nutritional study using SMP30 knockout mice. These knockout mice (n = 6), fed a vitamin C-deficient diet, did not thrive; i.e., they displayed symptoms of scurvy such as bone fracture and rachitic rosary and then died by 135 days after the start of receiving the deficient diet. The AA levels in their livers and kidneys at the time of death were < 1.6% of those in WT control mice. In addition, by using the SMP30 knockout mouse, we demonstrate that the alternative pathway of AA synthesis involving D-glucurono-gamma-lactone operates in vivo, although its flux is fairly small.
C1 Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, Tokyo 1730015, Japan.
   Tokyo Med & Dent Univ, Tokyo 1138510, Japan.
   Wakayama Med Univ, Dept Biochem, Wakayama 6410012, Japan.
   Toho Univ, Dept Biochem, Chiba 2748510, Japan.
C3 Tokyo Metropolitan Institute of Gerontology; Tokyo Medical & Dental
   University (TMDU); Wakayama Medical University; Toho University
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Dept Mol Pathol, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.
EM nishikim@wakayama-med.ac.jp; ishigami@tmig.or.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429
CR BERNSTEIN SELDON E., 1966, P337
   BUBLITZ C, 1961, BIOCHIM BIOPHYS ACTA, V47, P288, DOI 10.1016/0006-3002(61)90289-X
   BURNS J. J., 1960, Metabolic Pathways, V1, P341
   DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   FUNTA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122
   GROSSMAN SH, 1973, J BIOL CHEM, V248, P4846
   HA TY, 1990, J NUTR SCI VITAMINOL, V36, P227, DOI 10.3177/jnsv.36.227
   HUCHO F, 1972, BIOCHIM BIOPHYS ACTA, V276, P176, DOI 10.1016/0005-2744(72)90018-6
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   KAGAWA Y, 1962, J BIOCHEM-TOKYO, V51, P197, DOI 10.1093/oxfordjournals.jbchem.a127521
   KANAGASUNDARAM V, 1992, BIOCHIM BIOPHYS ACTA, V1171, P198, DOI 10.1016/0167-4781(92)90120-O
   KAWADA M, 1962, J BIOCHEM-TOKYO, V51, P405, DOI 10.1093/oxfordjournals.jbchem.a127554
   KISHIDA E, 1992, ANAL CHEM, V64, P1505, DOI 10.1021/ac00037a035
   KODAKA K, 1985, Vitamins (Kyoto), V59, P451
   Kondo Y, 2004, FEBS LETT, V570, P57, DOI 10.1016/j.febslet.2004.06.028
   KONO K, 1990, VITAMIN C SCURVY PRO, P147
   Lindsay RM, 1997, CLIN CHIM ACTA, V263, P239, DOI 10.1016/S0009-8981(97)00067-3
   Maeda N, 2000, P NATL ACAD SCI USA, V97, P841, DOI 10.1073/pnas.97.2.841
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   NISHIKIMI M, 1988, BIOCHEM INT, V16, P615
   Nishikimi M., 2003, Recent Research Developments in Biophysics & Biochemistry, Vol. 3, Part I, P531
   Nishikimi M, 1996, Subcell Biochem, V25, P17
   REBOUCHE CJ, 1991, AM J CLIN NUTR, V54, pS1147, DOI 10.1093/ajcn/54.6.1147s
   SHIMAZONO N, 1961, ANN NY ACAD SCI, V92, P91, DOI 10.1111/j.1749-6632.1961.tb46109.x
   WINKELMAN J, 1958, J BIOL CHEM, V233, P794
NR 27
TC 189
Z9 228
U1 1
U2 18
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 11
PY 2006
VL 103
IS 15
BP 5723
EP 5728
DI 10.1073/pnas.0511225103
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 034AK
UT WOS:000236896200018
PM 16585534
OA Green Published
DA 2024-02-19
ER

PT J
AU GUIMARAES, ARP
   SITNIK, RH
   CURI, CMON
   CURI, R
AF GUIMARAES, ARP
   SITNIK, RH
   CURI, CMON
   CURI, R
TI METABOLIC CHANGES IN LYMPHOID ORGANS AS INDUCED BY FATTY ACIDS-RICH
   DIETS DURING AGING
SO PHYSIOLOGY & BEHAVIOR
LA English
DT Article
DE POLYUNSATURATED FATTY ACIDS; SATURATED FATTY ACIDS; METABOLISM; IMMUNE
   TISSUES; AGING
ID GLUTAMINE UTILIZATION; HUMAN-LYMPHOCYTES; BLASTIC TRANSFORMATION; MOUSE
   MACROPHAGES; IMMUNE-RESPONSE; ADIPOSE-TISSUE; MAMMARY-GLAND;
   KETONE-BODIES; KEY ENZYMES; RAT
AB Previous reports of our laboratory have shown that w-6 PUFA-rich diets (UC) given to rats during 6 weeks causes important changes of the metabolism of the lymphoid organs. In this study, the effect of saturated fatty acids-rich diet (SC) and also the persistence of the changes caused by (UC) were investigated during ageing (14 months). The major changes previously reported for UC fed rats, during 6 weeks, fully persisted when this feeding condition was maintained for 14 months. Moreover, the SC group also showed modifications of the activities of key enzymes of glucose and glutamine metabolism of the lymphoid organs with ageing. Both groups fed fatty acids-rich diets markedly reduced the rate of lipogenesis in the liver, spleen, and thymus in contrast to slight changes reported for 6 weeks. These results suggest that fatty acids-rich diets, by causing important metabolic alterations, may pronounce the impairment of the immune function observed during ageing.
C1 ESCOLA PAULISTA MED, DEPT PHYSIOL, DIV NEUROPHYSIOL & ENDOCRINE PHYSIOL, BR-04023 SAO PAULO, SP, BRAZIL.
   UNIV SAO PAULO, INST BIOMED SCI, DEPT PHYSIOL & BIOPHYS, BR-05508 SAO PAULO, SP, BRAZIL.
   UNIV ESTADUAL CEARA, EXPTL NUTR & METAB LAB, BR-60715 FORTALEZA, CEARA, BRAZIL.
C3 Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo;
   Universidade Estadual do Ceara
RI Curi, Rui/C-9351-2012; Nascimento, Claudia Maria Oller do/T-4151-2019
OI Nascimento, Claudia Maria Oller do/0000-0001-5755-3392
CR AGIUS L, 1980, BIOCHEM J, V192, P361, DOI 10.1042/bj1920361
   ALMEIDA A F D, 1989, International Journal of Biochemistry, V21, P937
   ANEL A, 1990, BIOCHIM BIOPHYS ACTA, V1044, P323, DOI 10.1016/0005-2760(90)90076-A
   ANEL A, 1990, BIOCHIM BIOPHYS ACTA, V1044, P332, DOI 10.1016/0005-2760(90)90077-B
   [Anonymous], 1980, CIRCULATION, V62, P449
   ARDAWI MSM, 1982, BIOCHEM J, V208, P743, DOI 10.1042/bj2080743
   ARDAWI MSM, 1983, BIOCHEM J, V212, P835, DOI 10.1042/bj2120835
   ARDAWI MSM, 1983, ESSAYS BIOCHEM, V121, P835
   Boyd E, 1932, AM J DIS CHILD, V43, P1162
   CALDER PC, 1991, INT J BIOCHEM, V23, P579
   CALDER PC, 1990, BIOCHEM J, V269, P807, DOI 10.1042/bj2690807
   COONEY GJ, 1981, BIOCHEM J, V200, P701, DOI 10.1042/bj2000701
   COONEY GJ, 1982, FEBS LETT, V148, P198, DOI 10.1016/0014-5793(82)80807-7
   CRABTREE B, 1979, TECHNIQUES METABOLIC, P1
   CURI R, 1987, BIOCHEM SOC T, V15, P1071, DOI 10.1042/bst0151071
   CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383
   CURI R, 1989, BIOCHEM INT, V19, P755
   CURI R, 1989, INT J BIOCHEM, V21, P1133, DOI 10.1016/0020-711X(89)90055-4
   CURI R, 1986, BIOCHEM BIOPH RES CO, V138, P318, DOI 10.1016/0006-291X(86)90282-2
   CURI R, 1989, MOL CELL BIOCHEM, V86, P71
   DONASCIMENTO CMO, 1989, BIOCHEM J, V258, P273
   ERICKSON KL, 1983, LIPIDS, V18, P468, DOI 10.1007/BF02535787
   GILES KW, 1965, NATURE, V206, P93, DOI 10.1038/206093a0
   GUIMARAES ARP, 1991, BIOCHEM INT, V23, P533
   GUIMARAES ARP, 1990, BIOCHEM INT, V22, P1005
   GUIMARAES ARP, 1990, BIOCHEM INT, V22, P1015
   HWANG D, 1989, FASEB J, V3, P2052, DOI 10.1096/fasebj.3.9.2501132
   JOHNSTON DV, 1984, PROG FOOD NUTR SCI, V8, P3
   KELLY JP, 1979, J IMMUNOL, V122, P1556
   KOSTNER GM, 1979, CLIN CHEM, V25, P939
   KOWALCHUK JM, 1988, BIOCHEM J, V249, P705, DOI 10.1042/bj2490705
   LIER GYN, 1961, NATURE, V192, P535
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Makinodan T, 1980, Adv Immunol, V29, P287, DOI 10.1016/S0065-2776(08)60047-4
   MERTIN J, 1975, INT ARCH ALLER A IMM, V48, P203, DOI 10.1159/000231306
   MORGAN CR, 1963, DIABETES, V12, P115, DOI 10.2337/diab.12.2.115
   NEWSHOLME EA, 1988, NUTRITION, V4, P261
   NEWSHOLME EA, 1989, PERSPECTIVES IN CLINICAL NUTRITION, P71
   NEWSHOLME EA, 1983, BIOCH MED SCI, P951
   NEWSHOLME P, 1987, BIOCHEM J, V242, P631, DOI 10.1042/bj2420631
   PAGNAN A, 1992, J AM DIET ASSA, V11, pSS79
   ROBINSON AM, 1977, BIOCHEM J, V164, P153, DOI 10.1042/bj1640153
   SBARRA AJ, 1959, J BIOL CHEM, V234, P1355
   STANLEY JC, 1985, BRIT J NUTR, V53, P215, DOI 10.1079/BJN19850029
   STANSBIE D, 1976, BIOCHEM J, V160, P413, DOI 10.1042/bj1600413
   Trinder P., 1969, J CLIN PATHOL, V22, P158, DOI DOI 10.1177/000456326900600108
   WALDHAUSL W, 1989, HEALTH EFFECTS OF FISH AND FISH OILS, P171
   WAN JMF, 1988, JPEN-PARENTER ENTER, V12, pS43, DOI 10.1177/014860718801200603
NR 48
TC 6
Z9 6
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0031-9384
J9 PHYSIOL BEHAV
JI Physiol. Behav.
PD APR
PY 1994
VL 55
IS 4
BP 691
EP 697
DI 10.1016/0031-9384(94)90046-9
PG 7
WC Psychology, Biological; Behavioral Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Psychology; Behavioral Sciences
GA NA800
UT WOS:A1994NA80000014
PM 8190796
DA 2024-02-19
ER

PT J
AU Brandt, A
   Baumann, A
   Hernández-Arriaga, A
   Jung, F
   Nier, A
   Staltner, R
   Rajcic, D
   Schmeer, C
   Witte, OW
   Wessner, B
   Franzke, B
   Wagner, KH
   Camarinha-Silva, A
   Bergheim, I
AF Brandt, Annette
   Baumann, Anja
   Hernandez-Arriaga, Angelica
   Jung, Finn
   Nier, Anika
   Staltner, Raphaela
   Rajcic, Dragana
   Schmeer, Christian
   Witte, Otto W.
   Wessner, Barbara
   Franzke, Bernhard
   Wagner, Karl-Heinz
   Camarinha-Silva, Amelia
   Bergheim, Ina
TI Impairments of intestinal arginine and NO metabolisms trigger
   aging-associated intestinal barrier dysfunction and 'inflammaging'
SO REDOX BIOLOGY
LA English
DT Article; Early Access
DE Aging; Endotoxin; Nitric oxide; Intestinal permeability; Microbiota
ID GUT MICROBIOTA; PERMEABILITY; BACTERIAL; ACTIVATION; ENDOTOXIN;
   PROTECTS; INCREASE; HEALTH; CELLS; MICE
AB Aging is considered a state of low grade inflammation, occurring in the absence of any overt infection often referred to as 'inflammaging'. Maintaining intestinal homeostasis may be a target to extend a healthier status in older adults. Here, we report that even in healthy older men low grade bacterial endotoxemia is prevalent. In addition, employing multiple mouse models, we also show that while intestinal microbiota composition changes significantly during aging, fecal microbiota transplantation to old mice does not protect against aging-associated intestinal barrier dysfunction in small intestine. Rather, intestinal NO homeostasis and arginine metabolism mediated through arginase and NO synthesis is altered in small intestine of aging mice. Treatment with the arginase inhibitor norNOHA prevented aging-associated intestinal barrier dysfunction, low grade endotoxemia and delayed the onset of senescence in peripheral tissue e.g., liver. Intestinal arginine and NO metabolisms could be a target in the prevention of aging-associated intestinal barrier dysfunction and subsequently decline and 'inflammaging'.
C1 [Brandt, Annette; Baumann, Anja; Jung, Finn; Nier, Anika; Staltner, Raphaela; Rajcic, Dragana; Bergheim, Ina] Univ Vienna, Dept Nutr Sci, RF Mol Nutr Sci, Josef Holaubek Pl 2 UZAII, A-1090 Vienna, Austria.
   [Hernandez-Arriaga, Angelica; Camarinha-Silva, Amelia] Univ Hohenheim, Inst Anim Sci, Stuttgart, Germany.
   [Schmeer, Christian; Witte, Otto W.] Univ Hosp Jena, Hans Berger Dept Neurol, Jena, Germany.
   [Wessner, Barbara] Univ Vienna, Ctr Sport Sci & Univ Sports, Vienna, Austria.
   [Franzke, Bernhard; Wagner, Karl-Heinz] Univ Vienna, Dept Nutr Sci, Vienna, Austria.
C3 University of Vienna; University Hohenheim; Friedrich Schiller
   University of Jena; University of Vienna; University of Vienna
RP Bergheim, I (corresponding author), Univ Vienna, Dept Nutr Sci, RF Mol Nutr Sci, Josef Holaubek Pl 2 UZAII, A-1090 Vienna, Austria.
EM ina.bergheim@univie.ac.at
RI Wessner, Barbara/J-8244-2012; Rajcic, Dagana/HNP-0372-2023; Brandt,
   Annette/HNC-3045-2023
OI Wessner, Barbara/0000-0002-9061-7914; Rajcic,
   Dagana/0000-0002-6844-8878; Nier, Anika/0000-0003-3772-2261; Brandt,
   Annette/0000-0002-3934-747X; Schmeer, Christian/0000-0002-2289-0126
FU German Research Foundation [SPP1656, FKZ: BE2376/8-1, CA1708/1-1];
   European Union's Horizon 2020 research and innovation programme under
   the Marie Sklodowska-Curie grant [859890]; Herzfelder Family
   Foundation/Austrian Science Fund FWF [P35271]; Austrian Science Fund FWF
   [I04844]; Marie Curie Actions (MSCA) [859890] Funding Source: Marie
   Curie Actions (MSCA); Austrian Science Fund (FWF) [P35271] Funding
   Source: Austrian Science Fund (FWF)
FX The present work was funded by grants from German Research Foundation
   within the Priority Program SPP1656 (FKZ: BE2376/8-1 to IB, CA1708/1-1
   to ACS) , the European Union's Horizon 2020 research and innovation
   programme under the Marie Sklodowska-Curie grant agreement no. 859890
   (SmartAge) , the Herzfelder Family Foundation/Austrian Science Fund FWF
   (P35271 to IB) and the Austrian Science Fund FWF (I04844 to IB) .
CR Ash DE, 2004, J NUTR, V134, p2760S, DOI 10.1093/jn/134.10.2760S
   Baier J, 2020, J CLIN INVEST, V130, P5703, DOI 10.1172/JCI126923
   Baumann A, 2022, J CELL MOL MED, V26, P1206, DOI 10.1111/jcmm.17175
   Baumann A, 2021, INT J MED MICROBIOL, V311, DOI 10.1016/j.ijmm.2021.151500
   Brandt A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091013
   BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268
   Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x
   Clarke KR, 2001, CHANGE MARINE COMMUN
   Clarke KR., 2001, Change in marine communities: An approach to statistical analysis and in interpretation, V2nd edn
   Demmer W, 2003, MEMBR SCI T, V8, P283, DOI 10.1016/S0927-5193(03)80017-7
   di Candia AM, 2021, AM HEART J PLUS, V9, DOI 10.1016/j.ahjo.2021.100046
   EBERTS TJ, 1979, CLIN CHEM, V25, P1440
   Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01385
   Hernández-Arriaga A, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090283
   Hochstedler CM, 2013, J HISTOTECHNOL, V36, P128, DOI 10.1179/2046023613Y.0000000032
   Hunter I, 2003, MOL PHARMACOL, V63, P714, DOI 10.1124/mol.63.3.714
   Jin CJ, 2020, AM J PHYSIOL-GASTR L, V318, pG736, DOI 10.1152/ajpgi.00345.2018
   Jin CJ, 2015, BRIT J NUTR, V114, P1745, DOI 10.1017/S0007114515003621
   Josephson AM, 2019, P NATL ACAD SCI USA, V116, P6995, DOI 10.1073/pnas.1810692116
   Jung F, 2021, NUTRIENTS, V13, DOI 10.3390/nu13051659
   Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430
   KATZ D, 1987, DIGEST DIS SCI, V32, P285, DOI 10.1007/BF01297055
   Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13
   Kühn F, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.134049
   Tran L, 2013, J GERONTOL A-BIOL, V68, P1045, DOI 10.1093/gerona/glt106
   Lin MT, 2007, INT J CANCER, V120, P2600, DOI 10.1002/ijc.22599
   LIPSKI PS, 1992, J CLIN PATHOL, V45, P450, DOI 10.1136/jcp.45.5.450
   Liu J, 2019, CHEMOSPHERE, V234, P409, DOI 10.1016/j.chemosphere.2019.06.080
   Mu KW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071755
   Nagpal Ravinder, 2018, Nutr Healthy Aging, V4, P267, DOI 10.3233/NHA-170030
   Nier A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183282
   Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5
   Ojeda P, 2016, J NUTR BIOCHEM, V28, P191, DOI 10.1016/j.jnutbio.2015.08.013
   Puzianowska-Kuznicka M, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0076-x
   Rajcic D, 2021, REDOX BIOL, V41, DOI 10.1016/j.redox.2021.101879
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Regan JC, 2016, ELIFE, V5, DOI 10.7554/eLife.10956
   Ren WY, 2014, AGING CLIN EXP RES, V26, P183, DOI 10.1007/s40520-013-0148-0
   RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492
   SALTZMAN JR, 1995, J AM GERIATR SOC, V43, P160, DOI 10.1111/j.1532-5415.1995.tb06382.x
   Shin HE, 2020, EXP GERONTOL, V141, DOI 10.1016/j.exger.2020.111077
   Sovran B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35228-3
   Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75
   Steegenga WT, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-38
   Takiishi T, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1373208
   Team RC, 2020, R: A Language and Environment for Statistical
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Tremblay S, 2017, IMMUN AGEING, V14, DOI 10.1186/s12979-017-0101-8
   Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653
   Valentini L, 2014, PHYSIOL REP, V2, DOI [10.14814/phy2.281, 10.1002/phy2.281]
   Vancamelbeke M, 2017, EXPERT REV GASTROENT, V11, P821, DOI 10.1080/17474124.2017.1343143
   Vaughan DE, 2017, ARTERIOSCL THROM VAS, V37, P1446, DOI 10.1161/ATVBAHA.117.309451
   Vojdani A, 2013, ALTERN THER HEALTH M, V19, P12
   Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269
   Wilms E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57106-2
   Xiong YY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00682
   Xu CM, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1616-2
   Xu DZ, 2002, SHOCK, V17, P139, DOI 10.1097/00024382-200202000-00010
   Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725
   Zhou D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01751-y
NR 62
TC 9
Z9 10
U1 2
U2 9
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2213-2317
J9 REDOX BIOL
JI Redox Biol.
PD 2022 DEC
PY 2022
VL 58
AR 102528
DI 10.1016/j.redox.2022.102528
EA NOV 2022
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 6W9AF
UT WOS:000896017700003
PM 36356464
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU MA, HJ
   GAO, FL
   OLEA, MT
   NAGATA, T
AF MA, HJ
   GAO, FL
   OLEA, MT
   NAGATA, T
TI PROTEIN-SYNTHESIS IN THE LIVERS OF AGING MICE STUDIED BY
   ELECTRON-MICROSCOPIC AUTORADIOGRAPHY
SO CELLULAR AND MOLECULAR BIOLOGY
LA English
DT Article
DE MOUSE LIVER; PROTEIN SYNTHESIS; ELECTRON MICROSCOPIC AUTORADIOGRAPHY;
   AGING
ID AUTORADIOGRAPHY; CELLS
AB The application of H-3-leucine results in labeling of the liver cells of mice in which protein is synthesized at various ages of the animals. Quantitative changes of protein synthesis in the hepatocytes of aging mice were studied by electron microscopic radioautography. The silver grains in the hepatocytes were mainly located over the rough surfaced endoplasmic reticulum, mitochondria, Golgi apparatus, cytoplasmic matrix, and a few over the nuclei. The number of silver grains in the cytoplasm and nuclei of the hepatocytes gradually increased after birth, reached the maximum at 1 month after birth, thereafter it continued to decrease with aging until the 24th month. The number of silver grains in the hepatocyte cytoplasm was more than that in nuclei at various ages. The number of silver grains in the rough surfaced endoplasmic reticulum and mitochondria gradually increased from embryo to 1 month after birth, thereafter it continued to decrease with aging until the 24th month. The number of silver grains in the Golgi apparatus showed almost no change from fetal stage to 6 months after birth, thereafter it continued to decrease with aging until the 24th month. The number of silver grains in the cytoplasmic matrix gradually increased from fetal stage to 2 months after birth, then decreased with aging until the 24th month. These changes reflect the quantity of protein synthesized in each cell organelle at various ages of animals.
RP MA, HJ (corresponding author), SHINSHU UNIV,SCH MED,DEPT ANAT & CELL BIOL,MATSUMOTO,NAGANO 390,JAPAN.
CR ENZAN H, 1987, ACTA PATHOL JAPON, V37, P225
   FLICKINGER CJ, 1974, ANAT RECORD, V180, P427, DOI 10.1002/ar.1091800303
   HADDAD A, 1987, J HISTOCHEM CYTOCHEM, V35, P1059, DOI 10.1177/35.10.3305700
   HRACHOVEC JP, 1971, GERONTOLOGY, V17, P75, DOI 10.1159/000211810
   LAYMAN DK, 1976, ARCH BIOCHEM BIOPHYS, V173, P246, DOI 10.1016/0003-9861(76)90256-3
   MA H, 1988, Japanese Journal of Clinical Electron Microscopy, V21, P335
   MA H, 1988, Acta Anatomica Nipponica, V63, P137
   MA HJ, 1990, CELL MOL BIOL, V36, P73
   MA HJ, 1990, CELL MOL BIOL, V36, P589
   MAINWARING WI, 1969, BIOCHEM J, V113, P869, DOI 10.1042/bj1130869
   NAGATA T, 1967, Medical Journal of Shinshu University, V12, P247
   NAGATA T, 1990, APPLICATION ELECTRON, P139
   PENZES L, 1975, AKTUEL GERONTOL, V8, P583
   STONE RR, 1981, MECH AGEING DEV, V15, P423, DOI 10.1016/0047-6374(81)90046-4
   VANBEZOOIJEN CFA, 1976, BIOCHEM BIOPH RES CO, V71, P513, DOI 10.1016/0006-291X(76)90817-2
NR 15
TC 25
Z9 27
U1 0
U2 0
PU CELLULAR & MOLECULAR BIOLOGY
PI NOISY-LE-GRAND
PA PROF R WEGMANN RESIDENCE HAUSSMANN 1 AVENUE DU PAVE NEUF, 93160
   NOISY-LE-GRAND, FRANCE
SN 0145-5680
J9 CELL MOL BIOL
JI Cell. Mol. Biol.
PY 1991
VL 37
IS 6
BP 607
EP 615
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA GP046
UT WOS:A1991GP04600005
PM 1747895
DA 2024-02-19
ER

PT J
AU Shi, CY
   Li, Q
   Zhang, XY
AF Shi, Chenyang
   Li, Qin
   Zhang, Xinyue
TI Platycodin D Protects Human Fibroblast Cells from Premature Senescence
   Induced by H<sub>2</sub>O<sub>2</sub>through Improving Mitochondrial
   Biogenesis
SO PHARMACOLOGY
LA English
DT Article
DE Platycodin D; Cellular premature senescence; Oxidative stress;
   Mitochondrial biogenesis
ID INDUCED OXIDATIVE STRESS; LIVER-INJURY; GRANDIFLORUM; LONGEVITY; ROOTS;
   SALIDROSIDE; RESISTANCE; SAPONINS; FIBROSIS; MICE
AB Background:Although Platycodin D (PLD) is the main active saponin ofPlatycodon grandiflorum(PG) and responsible for multiple therapeutic benefits, including antioxidant and antiaging, only few direct demonstrations have been reported on the role of PLD in antiaging process. The present investigation was carried out to elucidate the protection of PLD against aging in vitro and associated molecular mechanisms on H2O2-induced premature senescence model in human -fetal lung diploid fibroblasts 2BS cells.Methods:The cellular morphology, cell cycle, and senescence-associated beta-galactosidase activity assays were used for senescence-like phenotypes determination in the oxidant challenged model. The oxygen-free radicals reactive oxygen species (ROS), 4-hydroxynonenal (4-HNE), and malondialdehyde (MDA) determinations were estimated by enzyme-linked immunosorbent assay assay. The potential of the mitochondria mass and the mitochondrial membrane were used to observe the alteration of mitochondria. Western blot analysis was performed to determine the protein expression.Results:The results showed that PLD significantly reversed senescence-like phenotypes in the oxidant challenged model, as well as related molecules expression such as p53, p21, and p16. Moreover, PLD treatment significantly decreased the levels of ROS, 4-HNE, and MDA in H2O2-treated 2BS cells. The mechanisms responsible for the antioxidant and antiaging effects of PLD were investigated, we found that mitochondria under PLD conditions show increase membrane potential ratio and stimulate the proliferation of mitochondria mass. In addition, the protein expression of peroxisome proliferator activated receptor gamma coactivator 1 alpha and its downstream targets, that is, nuclear respiratory factor and mitochondrial transcription factor A were also increased in mitochondrial biogenesis.Conclusion:These results indicated that PLD prevented H2O2-induced premature senescence in vitro by improving mitochondrial biogenesis to attenuate age-dependent endogenous oxidative damage.Key Message:The study revealed the antioxidant and antiaging potential of PLD against H2O2-induced premature senescence.
C1 [Shi, Chenyang; Li, Qin; Zhang, Xinyue] Zhejiang Acad Med Sci, 182 Tianmushan Rd, Hangzhou 310013, Peoples R China.
   [Shi, Chenyang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Clin Pharm, Shanghai, Peoples R China.
C3 Zhejiang Academy of Medical Sciences; Shanghai Jiao Tong University
RP Zhang, XY (corresponding author), Zhejiang Acad Med Sci, 182 Tianmushan Rd, Hangzhou 310013, Peoples R China.
EM zhangxinyue6815@163.com
RI 石, 晨阳/HGA-8686-2022
FU Medical Health Science and Technology Project of Zhejiang Provincial
   Health Commission [2017KY304]; Key Laboratory of Neuropsychiatric Drug
   Research of Zhejiang Province [2019E10021]; Zhejiang Science and
   Technology Department [2017C37162]
FX This work was supported by grants from the Medical Health Science and
   Technology Project of Zhejiang Provincial Health Commission (2017KY304),
   The Key Laboratory of Neuropsychiatric Drug Research of Zhejiang
   Province (2019E10021), and Zhejiang Science and Technology Department
   (2017C37162).
CR Biala AK, 2015, J MOL CELL CARDIOL, V83, P37, DOI 10.1016/j.yjmcc.2015.04.015
   Chattopadhyay M, 2015, MOL CELL BIOCHEM, V399, P95, DOI 10.1007/s11010-014-2236-7
   Chen T, 2015, INT IMMUNOPHARMACOL, V26, P338, DOI 10.1016/j.intimp.2015.04.001
   Choi JH, 2017, BIOMED PHARMACOTHER, V86, P205, DOI 10.1016/j.biopha.2016.11.107
   Chung JW, 2008, BIOL PHARM BULL, V31, P2114, DOI 10.1248/bpb.31.2114
   Chung MJ, 2012, NUTR RES, V32, P365, DOI 10.1016/j.nutres.2012.02.005
   Davalli P, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3565127
   Esteras N, 2015, BIOPHYS J, V108, p611a
   Gao W, 2017, INT IMMUNOPHARMACOL, V47, P53, DOI 10.1016/j.intimp.2017.03.009
   García-Mesa Y, 2016, J GERONTOL A-BIOL, V71, P40, DOI 10.1093/gerona/glv005
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Huang YF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9573291
   Huang YS, 2015, HEILONGJIANG NONGYE, V4, P148
   Indo HP, 2007, MITOCHONDRION, V7, P106, DOI 10.1016/j.mito.2006.11.026
   Jastroch M, 2010, ESSAYS BIOCHEM, V47, P53, DOI [10.1042/BSE0470053, 10.1042/bse0470053]
   Ki Jung Jin, 2012, [The Korea Journal of Herbology, 대한본초학회지], V27, P123
   Kim Eb, 2015, PLANTA MED, V81, DOI 10.1055/s-0035-1565646.16
   Kim TW, 2013, FOOD CHEM TOXICOL, V51, P364, DOI 10.1016/j.fct.2012.10.017
   Kim TW, 2012, FOOD CHEM TOXICOL, V50, P4254, DOI 10.1016/j.fct.2012.05.022
   Lee KJ, 2004, TOXICOL LETT, V147, P271, DOI 10.1016/j.toxlet.2003.12.002
   Li W, 2015, FOOD FUNCT, V6, P1418, DOI [10.1039/c5fo00094g, 10.1039/C5FO00094G]
   Longo VD, 2002, CELL MOL LIFE SCI, V59, P903, DOI 10.1007/s00018-002-8477-8
   Lopez-Lluch G, P NATL ACAD SCI US
   Mao GX, 2010, MECH AGEING DEV, V131, P723, DOI 10.1016/j.mad.2010.10.003
   Noh JR, 2011, ANN NUTR METAB, V58, P224, DOI 10.1159/000330117
   Nyakudya Elijah, 2014, Prev Nutr Food Sci, V19, P59, DOI 10.3746/pnf.2014.19.2.059
   Pomatto LCD, 2018, FREE RADICAL BIO MED, V124, P420, DOI 10.1016/j.freeradbiomed.2018.06.016
   Porter C, 2015, MED SCI SPORT EXER, V47, P1922, DOI 10.1249/MSS.0000000000000605
   Pu XY, 2015, INT J CLIN EXP PATHO, V8, P4398
   [邱强 Qiu Qiang], 2012, [中国新药杂志, Chinese Journal New Drugs], V21, P82
   Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010
   Sen P, 2016, CELL, V166, P822, DOI 10.1016/j.cell.2016.07.050
   Shaker ME, 2011, FUND CLIN PHARMACOL, V25, P248, DOI 10.1111/j.1472-8206.2010.00824.x
   Sharma DR, 2013, TOXICOL APPL PHARM, V273, P365, DOI 10.1016/j.taap.2013.09.012
   Shi X, 2017, AM J TRANSL RES, V9, P167
   Skochko NS, 2015, RES J PHARM BIOL CHE, V6, P599
   Wu JT, 2012, BIOL PHARM BULL, V35, P1216, DOI 10.1248/bpb.b-y110129
   Wu JT, 2011, AFR J PHARM PHARMACO, V5, P2444, DOI 10.5897/AJPP11.185
   Zhang L, J ETHNOPHARMACOL
NR 39
TC 18
Z9 21
U1 3
U2 12
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0031-7012
EI 1423-0313
J9 PHARMACOLOGY
JI Pharmacology
PD OCT
PY 2020
VL 105
IS 9-10
BP 598
EP 608
DI 10.1159/000505593
PG 11
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA OC4JP
UT WOS:000579124400013
PM 32008007
DA 2024-02-19
ER

PT J
AU HUNT, CM
   WESTERKAM, WR
   STAVE, GM
   WILSON, JAP
AF HUNT, CM
   WESTERKAM, WR
   STAVE, GM
   WILSON, JAP
TI HEPATIC CYTOCHROME-P-4503A (CYP3A) ACTIVITY IN THE ELDERLY
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE CYTOCHROMES-P-450; DRUG METABOLISM IN AGING; ERYTHROMYCIN
   N-DEMETHYLATION
ID LIVER MICROSOMAL CYTOCHROME-P-450; HUMAN-FETAL; INDUCIBLE
   CYTOCHROME-P-450; DRUG-METABOLISM; AGE; IDENTIFICATION; RAT;
   DISPOSITION; MIDAZOLAM; OXIDATION
AB Elderly patients exhibit decreased clearance of multiple drugs biotransformed by the hepatic cytochromes P-450. The cytochromes P-450 are a superfamily of enzymes, which comprise a central component of phase I drug metabolism. Distinct isoforms metabolize specific drugs. In human liver microsomes, the glucocorticoid-inducible cytochrome P-450IIIA, CYP3A, catalyzes the N-demethylation of erythromycin. To examine the activity of hepatic CYP3A in elderly males and females, erythromycin N-demethylation was examined, as reflected by the recently described [C-14]erythromycin breath test in 24 healthy volunteers, age 70-88. The [C-14]erythromycin breath test was measured in normal elderly males and females to: (a) determine persistence of the gender-related dimorphism (evident in younger subjects) of CYP3A activity in the elderly population, (b) examine the effect of % ideal body weight, age, diet, and medication use on the activity of human hepatic CYP3A, and (c) compare breath test results obtained in normal geriatric volunteers with published results obtained in younger subjects, to determine aging-related alterations in CYP3A enzyme activity. Erythromycin N-demethylation varied fivefold among these patients. Similar to earlier studies examining erythromycin N-demethylation in younger subjects, CYP3A activity was found to vary with gender in the geriatric cohort. [C-14]Erythromycin N-demethylation at 60 min was 3.14% +/- 0.75 (n = 13) in females and 2.15% +/- 0.77 (n = 11) in males (P = 0.005). In evaluating the role of % ideal body weight and % dietary fat using multivariable linear regression analyses, [C-14]erythromycin N demethylation, was found to decline significantly as % ideal body weight increased (P = 0.001). This was not confounded by gender. [C-14]Erythromycin N-demethylation was not related to dietary fat intake (P < 0.13). [C-14]Erythromycin N-demethylation in the elderly volunteers was similar to values reported for subjects aged 20-60. Performance of a new non-invasive test of the human hepatic glucocorticoid-inducible CYP3A in a geriatric cohort suggests that: (a) the gender-related heterogeneity in function of the glucocorticoid inducible human CYP3A persists during normal aging, (b) that the activity of CYP3A may decrease in obesity, and (c) that the activity of CYP3A is stable throughout normal aging.
C1 DUKE UNIV,MED CTR,DEPT FAMILY & COMMUNITY MED,DURHAM,NC 27710.
C3 Duke University
RP HUNT, CM (corresponding author), DUKE UNIV,MED CTR,DEPT MED,BOX 3064,DURHAM,NC 27710, USA.
FU NCRR NIH HHS [MO1-RR-30] Funding Source: Medline; NHLBI NIH HHS
   [1-P01-HL-42444-01-A1] Funding Source: Medline
CR ABERNETHY DR, 1986, ANN INTERN MED, V105, P329, DOI 10.7326/0003-4819-105-3-329
   ABERNETHY DR, 1981, J PHARMACOL EXP THER, V217, P681
   ALPERS DH, 1985, MANUAL NUTRITIONAL G, P150
   ANDERSON MS, 1990, ARCH INTERN MED, V150, P2459
   AOYAMA T, 1989, J BIOL CHEM, V264, P10388
   ARLOTTO MP, 1987, BIOCHEM PHARMACOL, V36, P3859, DOI 10.1016/0006-2952(87)90450-3
   AUSTIN KL, 1980, BRIT J CLIN PHARMACO, V10, P273, DOI 10.1111/j.1365-2125.1980.tb01755.x
   BEAUNE PH, 1986, P NATL ACAD SCI USA, V83, P8064, DOI 10.1073/pnas.83.21.8064
   CROWLEY JJ, 1988, J PHARMACOL EXP THER, V245, P513
   DANIEL WF, 1981, WILLIAMS TXB ENDOCRI, P1093
   DRAYER DE, 1980, CLIN PHARMACOL THER, V27, P72, DOI 10.1038/clpt.1980.11
   DUNDEE JW, 1985, ANAESTHESIA, V40, P441
   FABRE G, 1988, BIOCHEM PHARMACOL, V37, P1947, DOI 10.1016/0006-2952(88)90541-2
   GLANTZ SA, 1987, PRIMTER BIOSTATISTIC, P199
   GONZALEZ FJ, 1990, PHARMACOL THERAPEUT, V45, P1, DOI 10.1016/0163-7258(90)90006-N
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   GREENBLATT DJ, 1986, THER DRUG MONIT, V8, P249, DOI 10.1097/00007691-198609000-00001
   GREENBLATT DJ, 1982, J PHARMACOL EXP THER, V220, P120
   GREENBLATT DJ, 1985, CLIN PHARMACOL THER, V38, P697, DOI 10.1038/clpt.1985.248
   GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051
   GUENGERICH FP, 1986, MOL PHARMACOL, V30, P287
   HENDERSON CJ, 1990, BIOCHEM J, V266, P675, DOI 10.1042/bj2660675
   HENDERSON DJ, 1989, MECH AGEING DEV, V49, P287, DOI 10.1016/0047-6374(89)90079-1
   HUNT CM, 1990, BIOCHEM PHARMACOL, V40, P1666, DOI 10.1016/0006-2952(90)90470-6
   KITADA M, 1987, BIOCHEM PHARMACOL, V36, P453, DOI 10.1016/0006-2952(87)90350-9
   KRONBACH T, 1988, CLIN PHARMACOL THER, V43, P630, DOI 10.1038/clpt.1988.87
   LADONA MG, 1989, BIOCHEM PHARMACOL, V38, P3147, DOI 10.1016/0006-2952(89)90607-2
   MOLOWA DT, 1986, P NATL ACAD SCI USA, V83, P5311, DOI 10.1073/pnas.83.14.5311
   MOLOWA DT, 1988, J CELL BIOL, V107, pA1115
   RITTER JK, 1987, DRUG METAB DISPOS, V15, P335
   ROSS GT, 1981, WILLIAMS TXB ENDOCRI, P227
   RYAN DE, 1990, PHARMACOL THERAPEUT, V45, P153, DOI 10.1016/0163-7258(90)90029-2
   SALAZAR DE, 1988, BIOCHEM BIOPH RES CO, V157, P315, DOI 10.1016/S0006-291X(88)80049-4
   VESTAL RF, 1982, J AM GERIATR SOC, V30, P191, DOI 10.1111/j.1532-5415.1982.tb01303.x
   WATKINS PB, 1985, P NATL ACAD SCI USA, V82, P6310, DOI 10.1073/pnas.82.18.6310
   WATKINS PB, 1989, J CLIN INVEST, V83, P688, DOI 10.1172/JCI113933
   WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8
   WRIGHTON SA, 1988, BIOCHEM PHARMACOL, V37, P3053, DOI 10.1016/0006-2952(88)90299-7
   WRIGHTON SA, 1989, MOL PHARMACOL, V36, P97
   WRIGHTON SA, 1985, MOL PHARMACOL, V28, P312
NR 40
TC 81
Z9 81
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD JUN
PY 1992
VL 64
IS 1-2
BP 189
EP 199
DI 10.1016/0047-6374(92)90106-N
PG 11
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA HZ161
UT WOS:A1992HZ16100016
PM 1630156
DA 2024-02-19
ER

PT J
AU Hakimizadeh, E
   Hassanshahi, J
   Kaeidi, A
   Nematollahi, MH
   Taghipour, Z
   Rahmani, M
   Fatemi, I
AF Hakimizadeh, Elham
   Hassanshahi, Jalal
   Kaeidi, Ayat
   Nematollahi, Mohammad Hadi
   Taghipour, Zahra
   Rahmani, Mohammadreza
   Fatemi, Iman
TI Ceftriaxone improves hepatorenal damages in mice subjected to
   D-galactose-induced aging
SO LIFE SCIENCES
LA English
DT Article
DE Aging; Ceftriaxone; D-galactose; Oxidative stress; Inflammation; Liver;
   Kidney
ID GENTAMICIN-INDUCED NEPHROTOXICITY; INDUCED OXIDATIVE STRESS; GLYCATION
   END-PRODUCTS; INDUCED LIVER; AGE; PROTECTS; KIDNEY; MODEL; ACID;
   HYPERTENSION
AB Ceftriaxone (CTX) is a third-generation cephalosporin antibiotic that has broad-spectrum antimicrobial activity. This agent also has anti-inflammatory and antioxidant characteristics. In the current study, the effects of CTX against hepatorenal damages in a D-galactose (DGL) induced aging model were investigated. We used twenty-eight male mice which equally and randomly were separated into four groups as follows: Control, DGL group (treated with 500 mg/kg/day DGL orally for six weeks), DGL + CTX group (treated with 500 mg/kg/day DGL orally plus 200 mg/kg/day CTX intraperitoneally for six weeks), and CTX group (treated with 200 mg/kg/day CTX intraperitoneally for six weeks). The liver and kidney function indices such as serum creatinine, blood urine nitrogen, alanine aminotransferase, and aspartate aminotransferase were measured. Also, levels of malondialdehyde, catalase, and glutathione peroxidase in hepatic and renal tissues were evaluated. Moreover, the expression profiles of interleukin 1 beta and tumor necrosis factor alpha were assessed. The liver and kidney tissues were assessed for histopathological lesions. The results showed that aging induced by DGL leads to abnormalities in functional indices of the liver and kidneys. DGL also induced significant oxidative stress and inflammation, as well as histopathological lesions, in these organs. CTX improved functional indices, as well as the parameters of oxidative stress and inflammation, compared with the DGL-treated animals. These results were also confirmed by histological evaluations of the liver and kidneys. These data provide evidence for the therapeutic value of CTX in clinical practice for mitigating the hepatorenal damages of aging.
C1 [Hakimizadeh, Elham; Hassanshahi, Jalal; Kaeidi, Ayat; Rahmani, Mohammadreza] Rafsanjan Univ Med Sci, Physiol Pharmacol Res Ctr, Res Inst Basic Med Sci, Rafsanjan, Iran.
   [Hassanshahi, Jalal; Kaeidi, Ayat] Rafsanjan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Rafsanjan, Iran.
   [Nematollahi, Mohammad Hadi; Rahmani, Mohammadreza] Kerman Univ Med Sci, Dept Clin Biochem, Kerman, Iran.
   [Taghipour, Zahra] Rafsanjan Univ Med Sci, Dept Anat, Rafsanjan, Iran.
   [Fatemi, Iman] Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran.
C3 Kerman University of Medical Sciences; Kerman University of Medical
   Sciences
RP Fatemi, I (corresponding author), Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran.
EM i.fatemi@kmu.ac.ir
RI Taghipour, Zahra/H-2197-2017; hassanshahi, jalal/Y-9509-2018; Fatemi
   Rabori, Seyediman/I-3054-2017; Hakimizadeh, Elham/N-5810-2018
OI Taghipour, Zahra/0000-0002-6670-724X; hassanshahi,
   jalal/0000-0003-3754-8152; Fatemi Rabori, Seyediman/0000-0002-9666-9651;
   Hakimizadeh, Elham/0000-0002-2811-7716; rahmani,
   mohammad/0000-0002-7408-7992
FU Rafsanjan University of Medical Sciences [98100]; Kerman University of
   Medical Sciences [98000362]
FX The authors acknowledge Rafsanjan University of Medical Sciences (grant
   number: 98100) and Kerman University of Medical Sciences (grant number:
   98000362) for the financial support of this study.
CR Abdel-Daim MM, 2019, ENVIRON SCI POLLUT R, V26, P15248, DOI 10.1007/s11356-019-04801-2
   Abdel-Daim MM, 2017, N-S ARCH PHARMACOL, V390, P301, DOI 10.1007/s00210-016-1332-5
   Abdel-Daim MM, 2016, CYTOTECHNOLOGY, V68, P279, DOI 10.1007/s10616-014-9779-z
   Abdel-Daim MM, 2015, RENAL FAILURE, V37, P297, DOI 10.3109/0886022X.2014.983017
   Ali T, 2015, J PINEAL RES, V58, P71, DOI 10.1111/jpi.12194
   Bazmandegan G, 2019, IRAN J BASIC MED SCI, V22, P563, DOI 10.22038/ijbms.2019.33620.8020
   BEAUCHAMP D, 1994, ANTIMICROB AGENTS CH, V38, P750, DOI 10.1128/AAC.38.4.750
   Clark B, 2000, ADV RENAL REPLACE TH, V7, P11, DOI 10.1016/S1073-4449(00)70002-1
   Dehnamaki F, 2019, ACTA CHIR BELG, V119, P31, DOI 10.1080/00015458.2018.1455418
   Dwivedi Vivek Kumar, 2012, Interdiscip Toxicol, V5, P192, DOI 10.2478/v10102-012-0032-3
   EVERS BM, 1994, SURG CLIN N AM, V74, P23
   Fatemi I, 2018, FUND CLIN PHARMACOL, V32, P392, DOI 10.1111/fcp.12364
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Feng Y, 2016, PHARM BIOL, V54, P1027, DOI 10.3109/13880209.2015.1093510
   Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986
   Gemma C, 2007, EUR J NEUROSCI, V26, P2795, DOI 10.1111/j.1460-9568.2007.05875.x
   Ghaznavi H, 2018, J ASIAN NAT PROD RES, V20, P1182, DOI 10.1080/10286020.2017.1384819
   Goudarzi M, 2017, FUND CLIN PHARMACOL, V31, P625, DOI 10.1111/fcp.12303
   Hagen TM, 2003, ANTIOXID REDOX SIGN, V5, P503, DOI 10.1089/152308603770310149
   Hakimizadeh E, 2020, IRAN J BASIC MED SCI, V23, P368, DOI 10.22038/IJBMS.2019.40344.9556
   Haller H, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1909258
   Hota SK, 2008, NEUROBIOL LEARN MEM, V89, P522, DOI 10.1016/j.nlm.2008.01.003
   Huang J, 2020, NEURAL PLAST, V2020, DOI 10.1155/2020/1273198
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   Karimi H, 2019, SP PROC EARTH ENV SC, P1, DOI 10.1007/978-3-030-18641-8_1
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   LAPENNA D, 1995, BIOCHEM PHARMACOL, V49, P1249, DOI 10.1016/0006-2952(95)00044-Z
   Lebel M., 2011, CURR GERONTOL GERIAT, V2011, P1, DOI [DOI 10.1155/2011/859415, 10.1155/2011/859415]
   Lewerenz J, 2009, J NEUROCHEM, V111, P332, DOI 10.1111/j.1471-4159.2009.06347.x
   Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001
   Mehrzadi S, 2018, PHARMACOL REP, V70, P712, DOI 10.1016/j.pharep.2018.02.007
   Mehrzadi S, 2018, BIOMED PHARMACOTHER, V97, P233, DOI 10.1016/j.biopha.2017.10.113
   NAHATA MC, 1985, DRUG INTEL CLIN PHAR, V19, P900
   PATEL A, 2018, ANTIMICROB AGENTS CH, P626
   Percy CJ, 2009, MECH AGEING DEV, V130, P129, DOI 10.1016/j.mad.2008.10.003
   Priyamvada S, 2008, PROSTAG LEUKOTR ESS, V78, P369, DOI 10.1016/j.plefa.2008.04.008
   Rehman SU, 2017, MOL NEUROBIOL, V54, P255, DOI 10.1007/s12035-015-9604-5
   RENNO T, 1995, J IMMUNOL, V154, P944
   Rybka J, 2011, REDOX REP, V16, P71, DOI 10.1179/174329211X13002357050897
   Subathra M, 2005, EXP GERONTOL, V40, P707, DOI 10.1016/j.exger.2005.06.001
   Taghipour Z, 2019, PHYSIOL PHARMACOL, V23, P36
   Uribarri J, 2003, J AM SOC NEPHROL, V14, P728, DOI 10.1097/01.ASN.0000051593.41395.B9
   Uribarri J, 2007, DIABETES CARE, V30, P2579, DOI 10.2337/dc07-0320
   Wang S, 2018, CELL PHYSIOL BIOCHEM, V49, P1249, DOI 10.1159/000493332
   Xu Y, 2009, BIOGERONTOLOGY, V10, P153, DOI 10.1007/s10522-008-9158-2
   Yang LJ, 2014, INT J NEUROSCI, V124, P657, DOI 10.3109/00207454.2013.856009
   Yilmaz N, 2011, CELL BIOCHEM FUNCT, V29, P102, DOI 10.1002/cbf.1727
   Yoshiyama Y, 1998, BIOL PHARM BULL, V21, P520
   Zumkehr J, 2015, NEUROBIOL AGING, V36, P2260, DOI 10.1016/j.neurobiolaging.2015.04.005
NR 49
TC 8
Z9 8
U1 2
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD OCT 1
PY 2020
VL 258
AR 118119
DI 10.1016/j.lfs.2020.118119
PG 7
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA NW7BP
UT WOS:000575172300006
PM 32682915
DA 2024-02-19
ER

PT J
AU Li, ZQ
   Wu, WR
   Zhao, C
   Zhao, C
   Zhang, XL
   Yang, Z
   Pan, J
   Si, WK
AF Li, Zhi-Qiang
   Wu, Wei-Ru
   Zhao, Chen
   Zhao, Chen
   Zhang, Xiao-Li
   Yang, Zhong
   Pan, Jing
   Si, Wei-Ke
TI CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting
   the progression of hepatocellular carcinoma
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article
DE cysteine-rich 61; hepatic stellate cells; liver fibrosis; hepatocellular
   carcinoma
ID MATRICELLULAR PROTEIN; EXTRACELLULAR-MATRIX; CELLULAR SENESCENCE; LIVER
   FIBROSIS; IN-VITRO; MIGRATION; CANCER; ACTIVATION; APOPTOSIS; CYR61
AB Hepatic stellate cells (HSCs) are the main extracellular matrix (ECM)-producing cells in liver fibrosis. Activated HSCs stimulate the proliferation and migration of hepatocellular carcinoma (HCC) cells. Cysteine-rich 61 (CCN1/Cyr61) is an ECM protein. Our previous studies demonstrated that the expression of CCN1 was significantly higher in benign hepatic cirrhosis tissue and cancer-adjacent hepatic cirrhosis tissues. CCN1 is a target gene of beta-catenin in HCC and promotes the proliferation of HCC cells. The present study aimed to examine whether CCN1 can activate HSCs and affect the function of activated HSCs in promoting the progression of HCC. CCN1 expression was determined during the progression of liver fibrosis in a mouse model. LX-2 cells, which were infected with adenoviruses AdCCN1 or AdRFP, and HepG2 cells were co-cultured or subcutaneously co-implanted into in nude mice. MTT assay, Crystal Violet staining, Boyden chamber, matrigel invasion and monolayer scratch assays were used to analyze the proliferation, migration and invasion capability of HepG2 cells. Xenograft sizes were measured and histological analyses were performed by hematoxylin and eosin, immunohistochemical, immunefluorescence and Sirius Red staining. It was demonstrated that the expression of CCN1 was continually increased in liver fibrosis and the that expression may be correlated with the progression of liver fibrosis. CCN1 affected the function of LX-2 and enhanced the effect of LX-2 on promoting the viability, migration and invasion of HepG2 cells in vitro. CCN1 enhanced the effect of LX-2 on promoting the growth of HepG2 xenografts in vivo. CCN1 also affected the function of activated HSCs and regulated the formation of the xenograft microenvironment, including fibrogenesis and angiogenesis, which are beneficial for the progression of HCC. These findings demonstrated that CCN1 may be involved in the progression of the hepatic cirrhosis-HCC axis through regulating HSCs.
C1 [Li, Zhi-Qiang; Wu, Wei-Ru; Zhao, Chen; Zhang, Xiao-Li; Yang, Zhong; Pan, Jing; Si, Wei-Ke] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Clin Hematol, 30 Gaotanyan St, Chongqing 400038, Peoples R China.
   [Li, Zhi-Qiang] Chengdu Mil Gen Hosp, Dept Clin Lab, Chengdu 610083, Sichuan, Peoples R China.
   [Zhao, Chen] Chongqing Med Univ, Affiliated Hosp 1, Chongqing 400042, Peoples R China.
C3 Army Medical University; Chongqing Medical University
RP Si, WK (corresponding author), Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Clin Hematol, 30 Gaotanyan St, Chongqing 400038, Peoples R China.
EM weikesi@aliyun.com
RI sun, chen/JCP-0396-2023
FU National Natural Science Foundation of China [30672393]; Southwest
   Hospital Routine Management Project of Science and Technology Innovation
   Program [SWH2016JCYB-13]; Chengdu Military General Hospital Routine
   Management Project of Science [2016KC04]
FX This study was supported by The National Natural Science Foundation of
   China (grant no. 30672393), the Southwest Hospital Routine Management
   Project of Science and Technology Innovation Program (grant no.
   SWH2016JCYB-13) and the Chengdu Military General Hospital Routine
   Management Project of Science (grant no. 2016KC04).
CR Amann T, 2009, CANCER SCI, V100, P646, DOI 10.1111/j.1349-7006.2009.01087.x
   Awuah Prince K, 2012, Hepatology, V55, P970, DOI 10.1002/hep.24774
   Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282
   Bian ZL, 2013, J LIPID RES, V54, P44, DOI 10.1194/jlr.M026013
   Borkham-Kamphorst E, 2016, CELL SIGNAL, V28, P34, DOI 10.1016/j.cellsig.2015.10.013
   Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023
   Chen CC, 2016, ONCOGENE, V35, P1314, DOI 10.1038/onc.2015.190
   Chen LF, 2013, INT J GYNECOL CANCER, V23, P256, DOI 10.1097/IGC.0b013e31827ad2b8
   Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Chintala H, 2015, DEVELOPMENT, V142, P2364, DOI 10.1242/dev.121913
   Coulouarn C, 2012, CANCER RES, V72, P2533, DOI 10.1158/0008-5472.CAN-11-3317
   Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200
   Haseley A, 2012, CANCER RES, V72, P1353, DOI 10.1158/0008-5472.CAN-11-2526
   Huang G, J CELL MOL MED, V15, P1087
   Jandova J, 2012, CELL BIOCHEM FUNCT, V30, P687, DOI 10.1002/cbf.2853
   Jia YL, 2011, HEPATOLOGY, V54, P1808, DOI 10.1002/hep.24562
   Ju MJ, 2009, AM J CLIN PATHOL, V131, P498, DOI 10.1309/AJCP86PPBNGOHNNL
   Jun JI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8386
   Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kim KH, 2015, J CLIN INVEST, V125, P1886, DOI 10.1172/JCI79327
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Li JT, 2008, J GASTROENTEROL, V43, P419, DOI 10.1007/s00535-008-2180-y
   Li ZF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028806, 10.1371/journal.pone.0052388]
   Liu ZH, 2013, DIGEST DIS SCI, V58, P1590, DOI 10.1007/s10620-012-2539-z
   Mikula M, 2006, J CELL PHYSIOL, V209, P560, DOI 10.1002/jcp.20772
   Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001
   Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010
   Patsenker E, 2007, J HEPATOL, V46, P878, DOI 10.1016/j.jhep.2006.11.011
   Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927
   Sancho-Bru P, 2010, LIVER INT, V30, P31, DOI 10.1111/j.1478-3231.2009.02161.x
   Santamato A, 2011, CLIN SCI, V121, P159, DOI 10.1042/CS20110002
   Schmitz P, 2013, INT J CLIN PHARM TH, V51, P47, DOI 10.5414/CPP51047
   Schütte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339
   Song PP, 2010, BIOSCI TRENDS, V4, P283
   Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670
   Zhang FQ, 2015, J BIOL CHEM, V290, P8232, DOI 10.1074/jbc.M114.623074
   Zhao WX, 2011, INT J CANCER, V129, P2651, DOI 10.1002/ijc.25920
   Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200
NR 41
TC 26
Z9 27
U1 1
U2 14
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD MAR
PY 2018
VL 41
IS 3
BP 1518
EP 1528
DI 10.3892/ijmm.2017.3356
PG 11
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA FV9ON
UT WOS:000424918000036
PM 29286082
OA Green Published, Green Submitted, hybrid
DA 2024-02-19
ER

PT J
AU Wauthier, V
   Schenten, V
   Verbeeck, RK
   Calderon, PB
AF Wauthier, Valerie
   Schenten, Veronique
   Verbeeck, Roger K.
   Calderon, Pedro Buc
TI Ageing is associated with increased expression but decreased activity of
   CYP2E1 in male Wistar rats
SO LIFE SCIENCES
LA English
DT Article
DE CYP2E1; ageing; oxidative stress; HNF1 alpha
ID ENRICHED TRANSCRIPTION FACTORS; GROWTH-HORMONE; CYTOCHROME P4502E1;
   LIVER-MICROSOMES; NUCLEAR RECEPTORS; INTOXICATED RAT; MESSENGER-RNA;
   PROBE DRUG; CHLORZOXAZONE; METABOLISM
AB The effect of ageing on CYP2E1 activity and its protein and mRNA contents was investigated in both adult (9 months) and senescent (24 months) male Wistar rats. The CYP2E1 activity (as measured by chlorzoxazone hydroxylation) was significantly decreased by 36% in senescent rats as compared to adult rats. However, this decrease of activity was not associated with a loss of protein content because the amount of both CYP2E1 protein and CYP2E1 mRNA did not decrease in senescent rats but rather increased, by 79% and 64% respectively, as compared to adult rats. Lipid peroxidation was increased significantly by 140% with ageing. The decrease in CYP2E1 activity could be explained by post-translational modification of CYP2E1 proteins, due to an increase in oxidative stress in senescent animals, leading to a loss of their functionality. However, no changes in the extent of protein carbonyls were observed in the adult versus senescent rats (16.2 +/- 9.6 vs. 12.7 +/- 7.3 nmol/mg prof) and the major proteasome activity remained unchanged. With regards to the increase of CYP2E1 expression, our results showed that the amount of hepatocyte nuclear factor 1 alpha mRNA, a transcription factor that positively regulates CYP2E1, was strongly increased (154%) in senescent rats. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Catholique Louvain, Unite Pharmacocinet Metab Nutr & Toxicol, Dept Pharmaceut Sci, B-1200 Brussels, Belgium.
C3 Universite Catholique Louvain
RP Calderon, PB (corresponding author), Univ Catholique Louvain, Unite Pharmacocinet Metab Nutr & Toxicol, Dept Pharmaceut Sci, Ave E Mounier 73, B-1200 Brussels, Belgium.
EM calderon@pmnt.ucl.ac.be
OI Buc Calderon, Pedro/0000-0003-0483-2624; Verbeeck,
   Roger/0000-0003-3009-2826
CR Akiyama TE, 2003, BBA-GEN SUBJECTS, V1619, P223, DOI 10.1016/S0304-4165(02)00480-4
   BAUDHUIN P, 1964, BIOCHEM J, V92, P179, DOI 10.1042/bj0920179
   Bogdanov M, 2000, FREE RADICAL BIO MED, V29, P652, DOI 10.1016/S0891-5849(00)00349-X
   Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560
   Chawla A, 2000, CELL, V103, P1, DOI 10.1016/S0092-8674(00)00097-0
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Chen GF, 1999, XENOBIOTICA, V29, P437, DOI 10.1080/004982599238461
   Cheung C, 2003, BIOCHEM PHARMACOL, V66, P2011, DOI 10.1016/S0006-2952(03)00586-0
   Clot P, 1996, GASTROENTEROLOGY, V111, P206, DOI 10.1053/gast.1996.v111.pm8698201
   Clotman F, 2002, DEVELOPMENT, V129, P1819
   Dhir RN, 2003, P NATL ACAD SCI USA, V100, P15224, DOI 10.1073/pnas.2434273100
   EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9
   ELIASSON E, 1990, P NATL ACAD SCI USA, V87, P3225, DOI 10.1073/pnas.87.8.3225
   Fang C, 1998, HEPATOLOGY, V27, P1304, DOI 10.1002/hep.510270516
   FRIGUET B, 1994, J BIOL CHEM, V269, P21639
   Goasduff T, 1999, ARCH BIOCHEM BIOPHYS, V370, P258, DOI 10.1006/abbi.1999.1399
   GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243
   GUENGERICH FP, 1990, CRIT REV BIOCHEM MOL, V25, P97
   Haufroid V, 2001, CLIN CHEM, V47, P1126
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   JOHANSSON I, 1990, BIOCHEM BIOPH RES CO, V173, P331, DOI 10.1016/S0006-291X(05)81061-7
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   Kobayashi K, 2003, DRUG METAB DISPOS, V31, P833, DOI 10.1124/dmd.31.7.833
   Lahuna O, 1997, P NATL ACAD SCI USA, V94, P12309, DOI 10.1073/pnas.94.23.12309
   Leclercq I, 1998, J CHROMATOGR A, V828, P291, DOI 10.1016/S0021-9673(98)00588-3
   Leclercq I, 1997, HEPATOLOGY, V26, P1182
   LEVINE RL, 1990, METHOD ENZYMOL, V186, P464
   Levine RL, 2001, EXP GERONTOL, V36, P1495, DOI 10.1016/S0531-5565(01)00135-8
   LIU SY, 1995, DNA CELL BIOL, V14, P285, DOI 10.1089/dna.1995.14.285
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Mizuno D, 2000, ARCH TOXICOL, V74, P139, DOI 10.1007/s002040050666
   NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1
   OMURA T, 1964, J BIOL CHEM, V239, P2379
   PARK KS, 1993, EUR J PHARM-ENVIRON, V248, P7, DOI 10.1016/0926-6917(93)90019-M
   Poloyac SM, 2004, DRUG METAB DISPOS, V32, P727, DOI 10.1124/dmd.32.7.727
   Poloyac SM, 2001, DRUG METAB DISPOS, V29, P296
   SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5
   SONG BJ, 1987, MOL ENDOCRINOL, V1, P542, DOI 10.1210/mend-1-8-542
   Tanaka E, 2001, HUM EXP TOXICOL, V20, P381, DOI 10.1191/096032701682692937
   Tanaka E, 2000, J CLIN PHARM THER, V25, P165
   TAPER HS, 1988, ARCH TOXICOL, V61, P406, DOI 10.1007/BF00334622
   UENO T, 1990, MOL CELL BIOL, V10, P4495, DOI 10.1128/MCB.10.9.4495
   Warrington JS, 2004, J PHARM PHARMACOL, V56, P819, DOI 10.1211/0022357023529
   Warrington JS, 2004, J PHARMACOL EXP THER, V309, P720, DOI 10.1124/jpet.103.061077
   Wauthier V, 2004, ARCH TOXICOL, V78, P131, DOI 10.1007/s00204-003-0526-z
   WAXMAN DJ, 1989, ENDOCRINOLOGY, V124, P2954, DOI 10.1210/endo-124-6-2954
   Wendel A, 1981, Methods Enzymol, V77, P325
   Zhang SX, 2002, TOXICOL APPL PHARM, V179, P74, DOI 10.1006/taap.2002.9349
NR 49
TC 21
Z9 26
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
J9 LIFE SCI
JI Life Sci.
PD OCT 12
PY 2006
VL 79
IS 20
BP 1913
EP 1920
DI 10.1016/j.lfs.2006.06.046
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 097TP
UT WOS:000241472000004
PM 16904701
DA 2024-02-19
ER

PT J
AU Zhang, XY
   Zhang, YL
   Qiu, GH
   Pian, LL
   Guo, L
   Cao, HL
   Liu, J
   Zhao, YW
   Li, X
   Xu, Z
   Huang, XF
   Huang, JR
   Dong, J
   Shen, BF
   Wang, HX
   Ying, XM
   Zhang, WPJ
   Cao, XT
   Zhang, JY
AF Zhang, Xueying
   Zhang, Yao-Lin
   Qiu, Guihua
   Pian, Lili
   Guo, Lu
   Cao, Huanling
   Liu, Jian
   Zhao, Yawei
   Li, Xin
   Xu, Zhe
   Huang, Xiaofeng
   Huang, Jingru
   Dong, Jie
   Shen, Beifen
   Wang, Hong-Xia
   Ying, Xiaomin
   Zhang, Weiping J.
   Cao, Xuetao
   Zhang, Jiyan
TI Hepatic neddylation targets and stabilizes electron transfer
   flavoproteins to facilitate fatty acid β-oxidation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE neddylation; GA-II; ETFs; ubiquitination; steatosis
ID NEDD8-ACTIVATING ENZYME-INHIBITOR; PEVONEDISTAT TAK-924/MLN4924; NEDD8
   CONJUGATION; PHASE-I; LIVER; METABOLISM; MLN4924; PATHWAY; STRESS;
   STARVATION
AB Neddylation is a ubiquitination-like pathway that controls cell survival and proliferation by covalently conjugating NEDD8 to lysines in specific substrate proteins. However, the physiological role of neddylation in mammalian metabolism remains elusive, and no mitochondrial targets have been identified. Here, we report that mouse models with liver-specific deficiency of NEDD8 or ubiquitin-like modifier activating enzyme 3 (UBA3), the catalytic subunit of the NEDD8-activating enzyme, exhibit neonatal death with spontaneous fatty liver as well as hepatic cellular senescence. In particular, liver-specific UBA3 deficiency leads to systemic abnormalities similar to glutaric aciduria type II (GA-II), a rare autosomal recessive inherited fatty acid oxidation disorder resulting from defects in mitochondrial electron transfer flavoproteins (ETFs: ETFA and ETFB) or the corresponding ubiquinone oxidoreductase. Neddylation inhibition by various strategies results in decreased protein levels of ETFs in neonatal livers and embryonic hepatocytes. Hepatic neddylation also enhances ETF expression in adult mice and prevents fasting-induced steatosis and mortality. Interestingly, neddylation is active in hepatic mitochondria. ETFs are neddylation substrates, and neddylation stabilizes ETFs by inhibiting their ubiquitination and degradation. Moreover, certain mutations of ETFs found in GA-II patients hinder the neddylation of these substrates. Taken together, our results reveal substrates for neddylation and add insight into GA-II.
C1 [Zhang, Xueying; Zhang, Yao-Lin; Qiu, Guihua; Pian, Lili; Guo, Lu; Cao, Huanling; Liu, Jian; Zhao, Yawei; Li, Xin; Xu, Zhe; Huang, Xiaofeng; Huang, Jingru; Dong, Jie; Shen, Beifen; Ying, Xiaomin; Zhang, Jiyan] Inst Basic Med Sci, Dept Mol Immunol, Beijing 100850, Peoples R China.
   [Zhang, Yao-Lin; Pian, Lili; Liu, Jian; Xu, Zhe; Huang, Xiaofeng; Huang, Jingru; Dong, Jie; Shen, Beifen; Ying, Xiaomin; Zhang, Jiyan] Beijing Inst Brain Sci, Dept Neuroimmunol, Beijing 100850, Peoples R China.
   [Pian, Lili; Guo, Lu; Cao, Huanling; Huang, Jingru] Henan Univ, Key Lab Cellular & Mol Immunol, Kaifeng 475001, Peoples R China.
   [Wang, Hong-Xia] Natl Ctr Biomed Anal, Mass Spectrometry Lab, Beijing 100850, Peoples R China.
   [Zhang, Weiping J.] Tianjin Med Univ, Chu Hsien I Mem Hosp, Tianjin Inst Endocrinol, Tianjin Key Lab Metab Dis, Tianjin 300134, Peoples R China.
   [Cao, Xuetao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.
C3 Henan University; Tianjin Medical University; Nankai University
RP Zhang, JY (corresponding author), Inst Basic Med Sci, Dept Mol Immunol, Beijing 100850, Peoples R China.; Zhang, JY (corresponding author), Beijing Inst Brain Sci, Dept Neuroimmunol, Beijing 100850, Peoples R China.
EM zhangjy@nic.bmi.ac.cn
RI Huang, Xiaofeng/AAT-6074-2021; Wang, Peiyun/JVE-1196-2024
OI Huang, Xiaofeng/0000-0001-8571-4667; Zhang, Yaolin/0000-0001-5372-1803;
   Zhang, Jiyan/0000-0002-8649-8035
FU National Natural Science Foundation of China [81625010, 31671482]
FX This work was supported by the National Natural Science Foundation of
   China (Grants 81625010 and 31671482).
CR Barbier-Torres L, 2015, ONCOTARGET, V6, P2509, DOI 10.18632/oncotarget.3191
   Bhatia S, 2016, INVEST NEW DRUG, V34, P439, DOI 10.1007/s10637-016-0348-5
   Chang KT, 2005, STEM CELLS, V23, P230, DOI 10.1634/stemcells.2004-0069
   Cheng QQ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007440
   Christopher R, 2008, ANN INDIAN ACAD NEUR, V11, P68, DOI 10.4103/0972-2327.41873
   Cornelius N, 2012, HUM MOL GENET, V21, P3435, DOI 10.1093/hmg/dds175
   Andérica-Romero AC, 2016, REDOX BIOL, V8, P341, DOI 10.1016/j.redox.2016.02.008
   Dubiel D, 2017, BBA-MOL CELL RES, V1864, P1405, DOI 10.1016/j.bbamcr.2017.05.009
   Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919
   Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08
   Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671
   Houten SM, 2013, HUM MOL GENET, V22, P5249, DOI 10.1093/hmg/ddt382
   Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011
   Jikumaru M, 2007, PHYSIOL CHEM PHYS ME, V39, P247
   Kim SH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003563
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062
   Liu JJ, 2016, YONSEI MED J, V57, P790, DOI 10.3349/ymj.2016.57.3.790
   Luo ZG, 2012, CANCER RES, V72, P3360, DOI 10.1158/0008-5472.CAN-12-0388
   Mahata B, 2012, ONCOGENE, V31, P3060, DOI 10.1038/onc.2011.482
   Mao YY, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-015-0230-0
   McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002
   Nawrocki ST, 2015, CLIN CANCER RES, V21, P439, DOI 10.1158/1078-0432.CCR-14-1960
   Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226
   Oved S, 2006, J BIOL CHEM, V281, P21640, DOI 10.1074/jbc.M513034200
   Park HS, 2016, CELL DEATH DIFFER, V23, P1296, DOI 10.1038/cdd.2016.6
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355
   Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021
   Samali A, 2010, INT J CELL BIOL, V2010, DOI 10.1155/2010/830307
   Sarantopoulos J, 2016, CLIN CANCER RES, V22, P847, DOI 10.1158/1078-0432.CCR-15-1338
   Schiff M, 2006, MOL GENET METAB, V88, P153, DOI 10.1016/j.ymgme.2006.01.009
   Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304
   Shah JJ, 2016, CLIN CANCER RES, V22, P34, DOI 10.1158/1078-0432.CCR-15-1237
   Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884
   Swords RT, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.1
   Swords RT, 2018, BLOOD, V131, P1415, DOI 10.1182/blood-2017-09-805895
   Swords RT, 2015, BRIT J HAEMATOL, V169, P534, DOI 10.1111/bjh.13323
   Swords RT, 2010, BLOOD, V115, P3796, DOI 10.1182/blood-2009-11-254862
   Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035
   Vickers AEM, 2009, TOXICOL PATHOL, V37, P78, DOI 10.1177/0192623308329285
   Vogl AM, 2015, NAT NEUROSCI, V18, P239, DOI 10.1038/nn.3912
   Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802
   Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016
   Zhang J, 2014, ONCOGENE, V33, P246, DOI 10.1038/onc.2012.560
   Zhang J., PROTEOMEXCHANGE CONS
   Zhang Q, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.215
   Zhang XY, 2016, CELL MOL IMMUNOL, V13, P577, DOI 10.1038/cmi.2015.35
   Zhou QY, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.121582
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025
   Zuo W, 2013, MOL CELL, V49, P499, DOI 10.1016/j.molcel.2012.12.002
NR 53
TC 24
Z9 24
U1 3
U2 21
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 4
PY 2020
VL 117
IS 5
BP 2473
EP 2483
DI 10.1073/pnas.1910765117
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA KJ8YB
UT WOS:000512340900039
PM 31941714
OA Bronze, Green Published
DA 2024-02-19
ER

PT J
AU Chen, YC
   Chen, IS
   Huang, GJ
   Kang, CH
   Wang, KC
   Tsao, MJ
   Pan, HW
AF Chen, Yu-Chia
   Chen, I-shu
   Huang, Guan-Jin
   Kang, Chi-hsiang
   Wang, Kuo-Chiang
   Tsao, Min-Jen
   Pan, Hung-Wei
TI Targeting DTL induces cell cycle arrest and senescence and suppresses
   cell growth and colony formation through TPX2 inhibition in human
   hepatocellular carcinoma cells
SO ONCOTARGETS AND THERAPY
LA English
DT Article
DE DTL; cell cycle; senescence; TPX2; hepatocellular carcinoma
ID MATRIX-ASSOCIATED PROTEIN; EARLY RECURRENCE; CANCER-CELLS; REGULATED
   NUCLEAR; UBIQUITIN LIGASE; POOR-PROGNOSIS; EXPRESSION; GENE;
   OVEREXPRESSION; INVASION
AB Background: Hepatocellular carcinoma (HCC) has an increasing incidence and high mortality. Surgical operation is not a comprehensive strategy for liver cancer. Moreover, tolerating systemic chemotherapy is difficult for patients with HCC because hepatic function is often impaired due to underlying cirrhosis. Therefore, a comprehensive strategy for cancer treatment should be developed. DTL (Cdc10-dependent transcript 2) is a critical regulator of cell cycle progression and genomic stability. In our previous study, the upregulation of DTL expression in aggressive HCC correlated positively with tumor grade and poor patient survival. We hypothesize that targeting DTL may provide a novel therapeutic strategy for liver cancer. DTL small interference RNAs were used to knock down DTL protein expression.
   Methods: A clonogenic assay, immunostaining, double thymidine block, imaging flow cytometry analysis, and a tumor spheroid formation assay were used to analyze the role of DTL in tumor cell growth, cell cycle progression, micronucleation, ploidy, and tumorigenicity.
   Results: Our results demonstrated that targeting DTL reduced cell cycle regulators and chromosome segregation genes, resulting in increased cell micronucleation. DTL depletion inhibited liver cancer cell growth, increased senescence, and reduced tumorigenesis. DTL depletion resulted in the disruption of the mitotic proteins cyclin B, CDK1, securin, seprase, Aurora A, and Aurora B as well as the upregulation of the cell cycle arrest gene p21. A rescue assay indicated that DTL should be targeted through TPX2 downregulation for cancer cell growth inhibition. Moreover, DTL silencing inhibited the growth of patient-derived primary cultured HCC cells.
   Conclusion: Our study results indicate that DTL is a potential novel target gene for treating liver cancer through liver cancer cell senescence induction. Furthermore, our results provide insights into molecular mechanisms for targeting DTL in liver cancer cells. The results also indicate several other starting points for future preclinical and clinical studies on liver cancer treatment.
C1 [Chen, Yu-Chia; Chen, I-shu; Kang, Chi-hsiang; Wang, Kuo-Chiang] Kaohsiung Vet Gen Hosp, Div Gen Surg, Dept Surg, Kaohsiung, Taiwan.
   [Huang, Guan-Jin] Natl Chung Kung Univ Hosp, Dept Pathol, Tainan, Taiwan.
   [Tsao, Min-Jen] Kaohsiung Armed Forces Gen Hosp, Dept Gen Surg, Zuoying Branch, Kaohsiung 81362, Taiwan.
   [Pan, Hung-Wei] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 81362, Taiwan.
   [Pan, Hung-Wei] Natl Pingtung Univ, Dept Appl Chem, Pingtung, Taiwan.
C3 Kaohsiung Veterans General Hospital; National Cheng Kung University;
   Kaohsiung Veterans General Hospital; National Pingtung University
RP Tsao, MJ (corresponding author), Kaohsiung Armed Forces Gen Hosp, Dept Gen Surg, Zuoying Branch, Kaohsiung 81362, Taiwan.; Pan, HW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung 81362, Taiwan.
EM tsaoyyyy@gmail.com; d89444001@gmail.com
RI zhang, luyu/JJC-4227-2023
FU Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of
   China [VGHKS104-121, VGHKS105-137, VGHKS106-155]; Zuoying Branch of
   Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan [ZAFGH
   102-10]
FX This study was supported by grants from Kaohsiung Veterans General
   Hospital, Kaohsiung, Taiwan, Republic of China (VGHKS104-121,
   VGHKS105-137, VGHKS106-155 to Hung-Wei Pan) and the Zuoying Branch of
   Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan (ZAFGH 102-10
   to Min-Jen Tsao). We acknowledge Wallace Academic Editing for editing
   this manuscript.
CR Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530
   Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014
   Aravinthan A, 2014, EXP GERONTOL, V60, P37, DOI 10.1016/j.exger.2014.09.011
   Best J, 2017, ANN GASTROENTEROL, V30, P23, DOI 10.20524/aog.2016.0092
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015
   Chan SPL, 2012, J GASTROEN HEPATOL, V27, P862, DOI 10.1111/j.1440-1746.2012.07096.x
   Chang HP, 2012, ONCOL REP, V27, P1353, DOI 10.3892/or.2012.1668
   Cheung WMW, 2001, J BIOL CHEM, V276, P17083, DOI 10.1074/jbc.M010802200
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Garrett S, 2002, CURR BIOL, V12, P2055, DOI 10.1016/S0960-9822(02)01277-0
   Hsu CW, 2017, J CANCER, V8, P1378, DOI 10.7150/jca.17478
   Huh J, 2013, MOL CELL BIOL, V33, P213, DOI 10.1128/MCB.00847-12
   KurzikDumke U, 1996, GENE, V171, P163, DOI 10.1016/0378-1119(95)00885-3
   Lee YC, 2007, EUR J CANCER, V43, P736, DOI 10.1016/j.ejca.2006.11.020
   Li J, 2009, BRIT J CANCER, V101, P691, DOI 10.1038/sj.bjc.6605202
   Lin SY, 2008, CLIN CANCER RES, V14, P4814, DOI 10.1158/1078-0432.CCR-07-5262
   Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461
   Liu HC, 2014, BIOMED PHARMACOTHER, V68, P833, DOI 10.1016/j.biopha.2014.08.008
   Loaiza N, 2016, BBA-REV CANCER, V1865, P155, DOI 10.1016/j.bbcan.2016.01.007
   Marks EI, 2016, CURR CANCER DRUG TAR, V16, P53, DOI 10.2174/1568009615666150916092903
   Mehta IS, 2007, ANN NY ACAD SCI, V1100, P250, DOI 10.1196/annals.1395.027
   Narita M, 2007, BRIT J CANCER, V96, P686, DOI 10.1038/sj.bjc.6603636
   Naylor RM, 2016, ANNU REV GENET, V50, P45, DOI 10.1146/annurev-genet-120215-035303
   Olivero M, 2014, ONCOTARGET, V5, P5992, DOI 10.18632/oncotarget.2042
   Pan HW, 2006, CELL CYCLE, V5, P2676, DOI 10.4161/cc.5.22.3500
   Pan HW, 2017, ONCOTARGETS THER, V10, P3531, DOI 10.2147/OTT.S136491
   Pan HW, 2003, CANCER-AM CANCER SOC, V98, P119, DOI 10.1002/cncr.11487
   Peng SY, 2008, ONCOL REP, V19, P1045
   Rossi M, 2013, MOL CELL, V49, P1159, DOI 10.1016/j.molcel.2013.02.004
   Samonakis DN, 2017, WORLD J HEPATOL, V9, P80, DOI 10.4254/wjh.v9.i2.80
   Song B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-96
   Tomuleasa C, 2010, J GASTROINTEST LIVER, V19, P61
   Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186
   Vitale A, 2017, J HEPATOL, V66, P412, DOI 10.1016/j.jhep.2016.09.012
   Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405
   Yang XL, 2014, PATHOL ONCOL RES, V20, P641, DOI 10.1007/s12253-014-9743-4
   Zhang LJ, 2008, TOXICOLOGY, V252, P49, DOI 10.1016/j.tox.2008.07.059
NR 38
TC 22
Z9 29
U1 0
U2 3
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6930
J9 ONCOTARGETS THER
JI OncoTargets Ther.
PY 2018
VL 11
BP 1601
EP 1616
DI 10.2147/OTT.S147453
PG 16
WC Biotechnology & Applied Microbiology; Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Oncology
GA GA1FQ
UT WOS:000428061400001
PM 29606879
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Gong, CX
   Li, CW
   Qi, XQ
   Song, ZY
   Wu, JG
   Hughes, ME
   Li, XD
AF Gong, Changxia
   Li, Chengwei
   Qi, Xiaoqing
   Song, Zhiyin
   Wu, Jianguo
   Hughes, Michael E.
   Li, Xiaodong
TI The daily rhythms of mitochondrial gene expression and oxidative stress
   regulation are altered by aging in the mouse liver
SO CHRONOBIOLOGY INTERNATIONAL
LA English
DT Article
DE Aging; circadian rhythms; mitochondria; oxidative stress
ID CIRCADIAN CLOCK; CALORIE RESTRICTION; ARCHITECTURE; OXIDANTS; NEXUS
AB The circadian clock regulates many cellular processes, notably including the cell cycle, metabolism and aging. Mitochondria play essential roles in metabolism and are the major sites of reactive oxygen species (ROS) production in the cell. The clock regulates mitochondrial functions by driving daily changes in NAD(+) levels and Sirt3 activity. In addition to this central route, in the present study, we find that the expression of some mitochondrial genes is also rhythmic in the liver, and that there rhythms are disrupted by the Clock(19) mutation in young mice, suggesting that they are regulated by the core circadian oscillator. Related to this observation, we also find that the regulation of oxidative stress is rhythmic in the liver. Since mitochondria and ROS play important roles in aging, and mitochondrial functions are also disturbed by aging, these related observations prompt the compelling hypothesis that circadian oscillators influence aging by regulating ROS in mitochondria. During aging, the expression rhythms of some mitochondrial genes were altered in the liver and the temporal regulation over the dynamics of mitochondrial oxidative stress was disrupted. However, the expression of clock genes was not affected. Our results suggested that mitochondrial functions are combinatorially regulated by the clock and other age-dependent mechanism(s), and that aging disrupts mitochondrial rhythms through mechanisms downstream of the clock.
C1 [Gong, Changxia; Li, Chengwei; Qi, Xiaoqing; Song, Zhiyin; Wu, Jianguo; Li, Xiaodong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei Province, Peoples R China.
   [Hughes, Michael E.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA.
C3 Wuhan University; University of Missouri System; University of Missouri
   Saint Louis
RP Li, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei Province, Peoples R China.
EM xiaodli@whu.edu.cn
RI Wu, Jian/AAU-5221-2020
OI Wu, Jian/0000-0001-9933-7364; Wu, Jianguo/0000-0002-8326-2895
FU National Key Basic Research Program of China [2013CB531200]; National
   Natural Science Foundation of China [30970953, 81271464]
FX The authors report no conflict of interest. This research is supported
   by National Key Basic Research Program of China (2013CB531200), National
   Natural Science Foundation of China (30970953 and 81271464).
CR Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001
   Bell EL, 2011, MOL CELL, V42, P561, DOI 10.1016/j.molcel.2011.05.008
   Bittman EL, 2013, J AM ASSOC LAB ANIM, V52, P437
   Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529
   Cho CS, 2014, P NATL ACAD SCI USA, V111, P12043, DOI 10.1073/pnas.1401100111
   Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032
   Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160
   Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752
   Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008
   Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711
   Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442
   Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724
   Khapre RV, 2014, AGING-US, V6, P675, DOI 10.18632/aging.100686
   Kil IS, 2012, MOL CELL, V46, P584, DOI 10.1016/j.molcel.2012.05.030
   Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339
   Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206
   Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208
   Libert S, 2013, ANNU REV PHYSIOL, V75, P669, DOI 10.1146/annurev-physiol-030212-183800
   Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07
   Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104
   Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317
   Nakamura TJ, 2011, J NEUROSCI, V31, P10201, DOI 10.1523/JNEUROSCI.0451-11.2011
   O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702
   Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5
   Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002
   Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417
   Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381
   Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595
   Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007
   Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959
   Sellix MT, 2012, J NEUROSCI, V32, P16193, DOI 10.1523/JNEUROSCI.3559-12.2012
   Stanley BA, 2011, J BIOL CHEM, V286, P33669, DOI 10.1074/jbc.M111.284612
   Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750
   Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106
   Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017
   Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8
   Xu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044237
   Yamazaki S, 2002, P NATL ACAD SCI USA, V99, P10801, DOI 10.1073/pnas.152318499
   Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206
NR 43
TC 31
Z9 33
U1 0
U2 15
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0742-0528
EI 1525-6073
J9 CHRONOBIOL INT
JI Chronobiol. Int.
PD OCT 21
PY 2015
VL 32
IS 9
BP 1254
EP 1263
DI 10.3109/07420528.2015.1085388
PG 10
WC Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA CX3IO
UT WOS:000365591800009
PM 26512910
DA 2024-02-19
ER

PT J
AU Sanz, N
   DiezFernandez, C
   Cascales, M
AF Sanz, N
   DiezFernandez, C
   Cascales, M
TI Variations of hepatic antioxidant systems and DNA ploidy in rats aged 2
   to 8 months
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
LA English
DT Article
DE development; reactive oxygen radical; glutathione; antioxidant enzyme;
   DNA ploidy
ID REDUCED GLUTATHIONE; HEPATOCYTES; LIVER; METABOLISM; THIOACETAMIDE;
   ACTIVATION; NECROSIS; GROWTH; DAMAGE
AB Oxygen-reactive species are by-products of biological redox reactions and are involved in the development and aging processes. In order to test whether the time-dependent changes in the hepatic antioxidant defense are related to changes in DNA ploidy, we studied in rats, aged 2-8 months, the enzymes and metabolites related to the primary cell defense against oxidative stress, as well as the distribution of DNA into the cell cycle phases. Catalase and glutathione peroxidase, together with glutathione reductase and mitochondrial superoxide dismutase, underwent progressive and significant time course increases. Although no temporal changes were observed in the concentration of protein thiol groups and malondialdehyde in rats in the same age period, glutathione redox state, detected by the GSH/GSSG ratio decreased significantly to 41% (P < 0.001) of the initial value. DNA content was assayed by flow cytometry in isolated hepatocytes, and changes in DNA ploidy and distribution in the cell cycle phases were determined. A sharp decrease in diploid population from rats aged 1-8 months (92.9% --> 11.1%) and a pronounced increase in hepatocyte polyploid populations in the same age period (2.6% --> 87.3%) were observed. However, liver cell population involved in S phase (DNA synthesis) was unchanged. These results indicate that the cell defense mechanisms against oxygen toxicity increased in liver of rats from 2-8 months in order to suppress the oxidative imbalance. During the 6-month period of a rat's life (2-8 months), the significant alterations of GSH/GSSG ratio to a more oxidative state have no influence on the proliferating capacity of the cells.
C1 UNIV COMPLUTENSE MADRID, FAC FARM, CSIC, INST BIOQUIM, E-28040 MADRID, SPAIN.
C3 Complutense University of Madrid; Consejo Superior de Investigaciones
   Cientificas (CSIC)
CR Aebi H.E., 1987, Methods Enzym. Anal., V3, P273
   [Anonymous], METHODS ENZYMATIC AN
   BELLOMO G, 1992, P NATL ACAD SCI USA, V89, P4412, DOI 10.1073/pnas.89.10.4412
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CASCALES M, 1992, HEPATOLOGY, V16, P232, DOI 10.1002/hep.1840160134
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   Del Maestro R.F., 1983, OXYGEN RADICALS THEI, V2, P28
   Deutsch J., 1983, METHOD ENZYMAT AN, P190
   DIEZFERNANDEZ C, 1993, HEPATOLOGY, V18, P912, DOI 10.1002/hep.1840180424
   DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P334, DOI 10.1016/0003-9861(84)90206-6
   EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0
   FERNANDEZCHECA JC, 1992, J BIOL CHEM, V267, P1667
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x
   Goldberg D.M., 1983, Methods of Enzymatic Analysis, Vthird, P258
   GUNZLER WA, 1974, Z KLIN CHEM KLIN BIO, V12, P444
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HASSAN HM, 1988, FREE RADICAL BIO MED, V5, P377, DOI 10.1016/0891-5849(88)90111-6
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V
   KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pharmtox.25.1.715
   KITANI K, 1992, GASTROENTEROL JPN, V27, P276, DOI 10.1007/BF02777737
   LEZZA AMS, 1994, BIOCHEM BIOPH RES CO, V205, P772, DOI 10.1006/bbrc.1994.2732
   MARTINSANZ P, 1989, BIOCHEM J, V257, P795, DOI 10.1042/bj2570795
   MENEGHINI R, 1988, MUTAT RES, V195, P215, DOI 10.1016/0165-1110(88)90001-2
   NICOTERA P, 1992, TOXICOL LETT, V64-5, P563, DOI 10.1016/0378-4274(92)90232-9
   NIEHAUS WG, 1969, BIOCHEM J, V113, P315
   PRINCIPE P, 1989, CYTOMETRY, V10, P750, DOI 10.1002/cyto.990100613
   SAETER G, 1988, CARCINOGENESIS, V9, P939, DOI 10.1093/carcin/9.6.939
   SAWADA M, 1987, MECH AGEING DEV, V41, P125, DOI 10.1016/0047-6374(87)90057-1
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   SIMPSON JA, 1992, BIOCHEM J, V282, P621, DOI 10.1042/bj2820621
   SLATER TF, 1984, BIOCHEM J, V222, P1
   STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943
   SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343
   VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503
   WAHLEFELD AW, 1987, METHOD ENZYMAT AN, V3, P352
   YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139
NR 38
TC 20
Z9 23
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0925-4439
EI 1879-260X
J9 BBA-MOL BASIS DIS
JI Biochim. Biophys. Acta-Mol. Basis Dis.
PD MAR 1
PY 1996
VL 1315
IS 2
BP 123
EP 130
DI 10.1016/0925-4439(95)00113-1
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA TY945
UT WOS:A1996TY94500008
PM 8608169
DA 2024-02-19
ER

PT J
AU Rippo, MR
   Olivieri, F
   Monsurro, V
   Prattichizzo, F
   Albertini, MC
   Procopio, AD
AF Rippo, Maria Rita
   Olivieri, Fabiola
   Monsurro, Vladia
   Prattichizzo, Francesco
   Albertini, Maria Cristina
   Procopio, Antonio Domenico
TI MitomiRs in human inflamm-aging: A hypothesis involving miR-181a,
   miR-34a and miR-146a
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE MicroRNA; Mitochondria; MitomiR; Aging; Inflamm-aging; Bcl-2 family
ID AGE-RELATED DISEASES; MESSENGER-RNA DECAY; LIFE-SPAN; MITOCHONDRIAL
   METABOLISM; MICRORNA EXPRESSION; MOUSE-LIVER; CELL-DEATH; SENESCENCE;
   APOPTOSIS; AUTOPHAGY
AB Mitochondria are intimately involved in the aging process. The decline of autophagic clearance during aging affects the equilibrium between mitochondrial fusion and fission, leading to a build-up of dysfunctional mitochondria, oxidative stress, chronic low-grade inflammation, and increased apoptosis rates, the main hallmarks of aging. Current research suggests that a large number of microRNAs (miRs or miRNAs) are differentially expressed during cell aging. Other lines of evidence indicate that several miRs likely share in "inflamm-aging", an aging-related state characterized by systemic chronic inflammation that in turn provides a biological background favoring susceptibility to age-related diseases and disabilities. Interestingly, miRs can modulate mitochondrial activity, and a discrete miR set has recently been identified in mitochondria of different species and cell types (mitomiRs). Here we show that some mitomiRs (let7b, mir-146a, -133b, -106a, -19b, -20a, -34a, -181a and -221) are also among the miRs primarily involved, in cell aging and in inflamm-aging. Of note, Ingenuity Pathway Analysis (IPA) of aging-related mitomiR targets has disclosed a number of resident mitochondrial proteins playing large roles in energy metabolism, mitochondrial transport and apoptosis. Among these, Bcl-2 family members which are critically involved in maintaining mitochondrial integrity - may play a role in controlling mitochondrial function and dysfunction during cellular aging, also considering that Bcl-2, the master member of the family, is an anti-oxidant and anti-apoptotic factor and regulates mitochondrial fission/fusion and autophagy. This intriguing hypothesis is supported by several observations: i) in endothelial cells undergoing replicative senescence (HUVECs), a well-established model of cell senescence, miR-146a, miR-34a, and miR-181a are over-expressed whereas their target Bcl-2 is down-regulated; ii) IPA of the miR-146a, miR-34a and miR-181a network shows that they are closely linked to each other, to Bcl-2 and to mitochondria; and iii) miR-146a, miR-34a, and miR-181a are involved in important cell functions (growth, proliferation, death, survival, maintenance) and age-related diseases (cancer, skeletal and muscle disorders, neurological, cardiovascular and metabolic diseases). In conclusion several aging-related mitomiRs may play a direct role in controlling mitochondrial function by regulating mitochondrial protein expression. Their modulation could thus mediate the loss of mitochondrial integrity and function in aging cells, inducing or contributing to the inflammatory response and to age-related diseases. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Rippo, Maria Rita; Olivieri, Fabiola; Prattichizzo, Francesco; Procopio, Antonio Domenico] Univ Politecn Marche, Dept Clin & Mol Sci, Lab Expt Pathol, I-60020 Ancona, Italy.
   [Olivieri, Fabiola; Procopio, Antonio Domenico] IRCCS, INRCA, Ctr Clin Pathol & Innovat Therapies, Ancona, Italy.
   [Monsurro, Vladia] Univ Verona, Sch Med, Dept Pathol & Diagnost, I-37100 Verona, Italy.
   [Albertini, Maria Cristina] Univ Urbino Carlo Bo, Dipartimento Sci Biomol, Sez Biochim & Biol Mol, Urbino, Italy.
C3 Marche Polytechnic University; IRCCS INRCA; University of Verona;
   University of Urbino
RP Rippo, MR (corresponding author), Univ Politecn Marche, Dept Clin & Mol Sci, Lab Expt Pathol, Via Tronto 10, I-60020 Ancona, Italy.
EM m.r.rippo@univpm.it
RI Albertini, Maria Cristina/AAG-6980-2019; Procopio, Antonio
   Domenico/AAB-2451-2021; Olivieri, Fabiola/K-6465-2016; Prattichizzo,
   Francesco/J-3046-2018
OI Albertini, Maria Cristina/0000-0003-4549-1475; Procopio, Antonio
   Domenico/0000-0001-6897-8724; Olivieri, Fabiola/0000-0002-9606-1144;
   Prattichizzo, Francesco/0000-0002-2959-2658; RIPPO, Maria
   Rita/0000-0003-3024-3495; MONSURRO', Vladia/0000-0002-9653-8432
FU Universita Politecnica delle Marche; Grande Oriente d'Italia (GOI),
   Massoneria Italiana, Collegio delle Marche, Italy
FX This work was supported by grants from Universita Politecnica delle
   Marche to M.R.R. and by Grande Oriente d'Italia (GOI), Massoneria
   Italiana, Collegio delle Marche, Italy to F.O. and A.D.P.
CR [Anonymous], BIOCH BIOPHYS ACTA
   Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120
   Baldwin AS, 2012, IMMUNOL REV, V246, P327, DOI 10.1111/j.1600-065X.2012.01095.x
   Bandiera S., 2013, FREE RADIC BIOL ME S
   Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746
   Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220
   Baseler WA, 2012, AM J PHYSIOL-CELL PH, V303, pC1244, DOI 10.1152/ajpcell.00137.2012
   Bates DJ, 2010, AGING CELL, V9, P1, DOI 10.1111/j.1474-9726.2009.00529.x
   Bender CE, 2012, P NATL ACAD SCI USA, V109, P4904, DOI 10.1073/pnas.1120680109
   Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042
   Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119
   Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596
   Brady CA, 2010, J CELL SCI, V123, P2527, DOI 10.1242/jcs.064501
   Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016
   Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005
   Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109
   Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13
   Chan SY, 2009, CELL METAB, V10, P273, DOI 10.1016/j.cmet.2009.08.015
   Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868
   Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803
   Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008
   Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732
   Dimmeler S, 2013, EMBO MOL MED, V5, P180, DOI 10.1002/emmm.201201986
   Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010
   Escames G, 2012, HUM GENET, V131, P161, DOI 10.1007/s00439-011-1057-y
   Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109
   Faustin B, 2009, P NATL ACAD SCI USA, V106, P3935, DOI 10.1073/pnas.0809414106
   Favaro E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010345
   Franceschi C, 2000, ANN NY ACAD SCI, V908, P244
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823
   Gelino S., 2012, J CLIN EXP PATHOL, V12
   Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x
   Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936
   Hur JH, 2010, AGING-US, V2, P69, DOI 10.18632/aging.100118
   Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907
   Inukai S, 2013, J MOL BIOL, V425, P3601, DOI 10.1016/j.jmb.2013.01.023
   Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001
   Kinnally KW, 2011, BBA-MOL CELL RES, V1813, P616, DOI 10.1016/j.bbamcr.2010.09.013
   Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534
   Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006
   Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005
   Lambert AJ, 2004, BIOCHEM BIOPH RES CO, V316, P1196, DOI 10.1016/j.bbrc.2004.03.005
   Li GR, 2010, INVEST OPHTH VIS SCI, V51, P2976, DOI 10.1167/iovs.09-4874
   Li N, 2011, NEUROBIOL AGING, V32, P944, DOI 10.1016/j.neurobiolaging.2009.04.020
   Li PF, 2012, J CELL BIOCHEM, V113, P1104, DOI 10.1002/jcb.24004
   Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810
   López-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103
   Machlin ES, 2012, CURR GENE THER, V12, P301, DOI 10.2174/156652312802083558
   Mancini M, 2012, AGING-US, V4, P843, DOI 10.18632/aging.100508
   Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192
   Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013
   Noren Hooten N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010724
   Olivieri F., 2013, AGEING RES REV
   Olivieri F, 2013, AGE, V35, P1157, DOI 10.1007/s11357-012-9440-8
   Olivieri Fabiola, 2013, Frontiers in Genetics, V4, P121, DOI 10.3389/fgene.2013.00121
   Olivieri F, 2012, MECH AGEING DEV, V133, P675, DOI 10.1016/j.mad.2012.09.004
   Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001
   Palikaras Konstantinos, 2012, Frontiers in Genetics, V3, P297, DOI 10.3389/fgene.2012.00297
   Park S, 2013, IMMUNOL INVEST, V42, P179, DOI 10.3109/08820139.2012.717328
   Patron JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035345
   Rao Y., 2013, J HUAZHONG U SCI TEC, V33, P4
   Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x
   Ren J, 2010, J MOL MED, V88, P993, DOI 10.1007/s00109-010-0663-9
   Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014
   Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004
   Salminen A, 2012, CELL MOL LIFE SCI, V69, P2999, DOI 10.1007/s00018-012-0962-0
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Shamas-Din A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008714
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Song D., 2013, BIOCH J
   Sripada L, 2012, MITOCHONDRION, V12, P593, DOI 10.1016/j.mito.2012.10.009
   Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963
   Uraoka M, 2011, HYPERTENSION, V58, P254, DOI 10.1161/HYPERTENSIONAHA.111.176701
   Wahlgren J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks463
   Weil D, 2013, BBA-GENE REGUL MECH, V1829, P725, DOI 10.1016/j.bbagrm.2013.01.002
   Yang F., 2013, TECHNOL CANC RES TRE
   Zhong X., 2013, DIABETOLOGIA
   Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663
   Zhu D., 2013, J ALLERGY CLIN IMMUN, V132, P426
   Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200
NR 86
TC 150
Z9 164
U1 0
U2 40
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 2014
VL 56
SI SI
BP 154
EP 163
DI 10.1016/j.exger.2014.03.002
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AK7KL
UT WOS:000338607100019
PM 24607549
DA 2024-02-19
ER

PT J
AU Ueberham, E
   Lindner, R
   Kamprad, M
   Hiemann, R
   Hilger, N
   Woithe, B
   Mahn, D
   Cross, M
   Sack, U
   Gebhardt, R
   Arendt, T
   Ueberham, U
AF Ueberham, Elke
   Lindner, Ricco
   Kamprad, Manja
   Hiemann, Rico
   Hilger, Nadja
   Woithe, Barbara
   Mahn, Doris
   Cross, Michael
   Sack, Ulrich
   Gebhardt, Rolf
   Arendt, Thomas
   Ueberham, Uwe
TI Oval cell proliferation in p16<SUP>INK4a</SUP> expressing mouse liver is
   triggered by chronic growth stimuli
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE p16(INK4a); hepatic stem cell; oval cell; nodularin; starvation;
   tet-system
ID CYCLIN-DEPENDENT KINASES; HEPATIC STEM-CELLS; GENE-EXPRESSION;
   TRANSGENIC MICE; RAT-LIVER; PROTEIN PHOSPHATASES; PARTIAL-HEPATECTOMY;
   ALZHEIMERS-DISEASE; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS
AB Terminal differentiation requires molecules also involved in aging such as the cell cycle inhibitor p16(INK4a).Like other organs, the adult liver represents a quiescent organ with terminal differentiated cells, hepatocytes and cholangiocytes. These cells retain the ability to proliferate in response to liver injury or reduction of liver mass. However, under conditions which prevent mitotic activation of hepatocytes, regeneration can occur instead from facultative hepatic stem cells.For therapeutic application a non-toxic activation of this stem cell compartment is required. We have established transgenic mice with conditional overexpression of the cell cycle inhibitor p16(INK4a) in hepatocytes and have provoked and examined oval cell activation in adult liver in response to a range of proliferative stimuli.We could show that the liver specific expression of p16(INK4a) leads to a faster differentiation of hepatocytes and an activation of oval cells already in postnatal mice without negative consequences on liver function.
C1 [Lindner, Ricco; Arendt, Thomas; Ueberham, Uwe] Univ Leipzig, Fac Med, Dept Neuroanat, Paul Flechsig Inst Brain Res, D-04105 Leipzig, Germany.
   [Ueberham, Elke; Woithe, Barbara; Mahn, Doris; Gebhardt, Rolf] Univ Leipzig, Fac Med, Inst Biochem, Leipzig, Germany.
   [Kamprad, Manja; Hiemann, Rico; Hilger, Nadja; Sack, Ulrich] Fac Med, Inst Clin Immunol & Transfus Med, Leipzig, Germany.
   [Cross, Michael] Univ Leipzig, Fac Med, Dept Haematol Oncol, Leipzig, Germany.
C3 Leipzig University; Leipzig University; Leipzig University
RP Ueberham, U (corresponding author), Univ Leipzig, Fac Med, Dept Neuroanat, Paul Flechsig Inst Brain Res, D-04105 Leipzig, Germany.
EM Uwe.Ueberham@medizin.uni-leipzig.de
RI Arendt, Thomas/C-8747-2012; Ueberham, Uwe/A-5181-2017; Sack,
   Ulrich/J-6301-2015
OI Ueberham, Uwe/0000-0003-4616-5153; Sack, Ulrich/0000-0002-7813-0492;
   Cross, Michael/0000-0002-8815-7621; Arendt, Thomas/0000-0003-4553-1625
CR Arendt E, 2005, CELL PROLIFERAT, V38, P287, DOI 10.1111/j.1365-2184.2005.00350.x
   Arendt T, 1996, NEUROREPORT, V7, P3047
   Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3
   BURGER HJ, 1989, HEPATOLOGY, V9, P22, DOI 10.1002/hep.1840090105
   Butz S, 1995, CELL ADHES COMMUN, V3, P337, DOI 10.3109/15419069509081018
   Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   ENGELHARDT NV, 1990, DIFFERENTIATION, V45, P29, DOI 10.1111/j.1432-0436.1990.tb00453.x
   ERIKSSON JE, 1990, BIOCHEM BIOPH RES CO, V173, P1347, DOI 10.1016/S0006-291X(05)80936-2
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Fiorino AS, 1998, IN VITRO CELL DEV-AN, V34, P247, DOI 10.1007/s11626-998-0131-9
   Forbes S, 2002, J PATHOL, V197, P510, DOI 10.1002/path.1163
   Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7
   Gorla GR, 2001, J CELL SCI, V114, P2943
   GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547
   GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603
   Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424
   Hara E, 1996, MOL CELL BIOL, V16, P859
   Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x
   Hiemann R, 2006, CYTOM PART A, V69A, P182, DOI 10.1002/cyto.a.20224
   Higgins GM, 1931, ARCH PATHOL, V12, P186
   HONKANEN RE, 1991, MOL PHARMACOL, V40, P577
   Jelnes P, 2007, HEPATOLOGY, V45, P1462, DOI 10.1002/hep.21569
   Jung A, 2001, AM J PATHOL, V159, P1613, DOI 10.1016/S0002-9440(10)63007-6
   Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933
   Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025
   Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584
   Laconi S, 2001, P NATL ACAD SCI USA, V98, P7806, DOI 10.1073/pnas.131210498
   Lüth HJ, 2000, BRAIN RES, V852, P45, DOI 10.1016/S0006-8993(99)02178-2
   Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002
   Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X
   Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221
   MERILUOTO JAO, 1990, TOXICON, V28, P1439, DOI 10.1016/0041-0101(90)90157-3
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223
   Nagy P, 2001, HEPATOLOGY, V33, P339, DOI 10.1053/jhep.2001.21326
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232
   Pascale RM, 2005, HEPATOLOGY, V42, P1310, DOI 10.1002/hep.20962
   Pascale RM, 2002, HEPATOLOGY, V35, P1341, DOI 10.1053/jhep.2002.33682
   Ramsey MR, 2007, CANCER RES, V67, P4732, DOI 10.1158/0008-5472.CAN-06-3437
   Roskams T, 2006, J HEPATOL, V45, P1, DOI 10.1016/j.jhep.2006.05.002
   Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   SCHULTEHERMANN R, 1976, ARCH TOXICOL, V36, P235, DOI 10.1007/BF00340531
   Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025
   Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592
   Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074
   SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149
   Shim YH, 2003, MODERN PATHOL, V16, P430, DOI 10.1097/01.mp.0000066799.99032.A7
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Song KY, 1999, CARCINOGENESIS, V20, P1541, DOI 10.1093/carcin/20.8.1541
   STEER CJ, 1995, FASEB J, V9, P1396, DOI 10.1096/fasebj.9.14.7589980
   Tessitore L, 1999, EUR J CELL BIOL, V78, P573, DOI 10.1016/S0171-9335(99)80023-5
   Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038
   Ueberham E, 2004, J HEPATOL, V41, P75, DOI 10.1016/j.jhep.2004.03.024
   Ueberham E, 2003, HEPATOLOGY, V37, P1067, DOI 10.1053/jhep.2003.50196
   Ueberham E, 2007, J MOL HISTOL, V38, P359, DOI 10.1007/s10735-007-9098-1
   Ueberham U, 2005, CNS NEUROL DISORD-DR, V4, P293, DOI 10.2174/1568007054038175
   vanGijssel HE, 1997, CARCINOGENESIS, V18, P1027, DOI 10.1093/carcin/18.5.1027
   Westmacott A, 2006, INT J DEV BIOL, V50, P653, DOI 10.1387/ijdb.062146aw
   Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917
   Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178
NR 63
TC 5
Z9 6
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD APR
PY 2008
VL 12
IS 2
BP 622
EP 638
DI 10.1111/j.1582-4934.2007.00178.x
PG 17
WC Cell Biology; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Research & Experimental Medicine
GA 289NG
UT WOS:000255060600019
PM 18053084
OA Green Published
DA 2024-02-19
ER

PT J
AU Guimaraes, D
   Carvalho, ML
   Geraldes, V
   Rocha, I
   Alves, LC
   Santos, JP
AF Guimaraes, Diana
   Carvalho, Maria Luisa
   Geraldes, Vera
   Rocha, Isabel
   Alves, Luis Cerqueira
   Santos, Jose Paulo
TI Lead in liver and kidney of exposed rats: Aging accumulation study
SO JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
LA English
DT Article
DE Lead; Aging; Liver; Kidney; X-ray fluorescence
ID X-RAY-FLUORESCENCE; TISSUE DISTRIBUTION; ACETATE; PIXE; SOFTWARE;
   CADMIUM; WORKERS
AB The concentration of lead in liver and kidneys of Wistar rats, fed with lead since fetal period in relation to their age and to a control group, was determined. A group of rats was exposed to lead acetate (n = 30) in drinking water and the other group was exposed to normal water (n = 20). Samples were collected from rats aging between 1 and 11 months and were analyzed by Energy Dispersive X-ray Fluorescence (EDXRF) without any chemical preparation. The EDXRF results were assessed by the PIXE (Proton Induced X-ray Emission) technique. The formaldehyde used to preserve the samples was also analyzed by ETAAS (Electro-Thermal Atomic Absorption Spectrometry) in order to verify if there was any loss of lead from the samples to the formaldehyde. We found that the loss was not significant (<2%).
   Concerning the mean values of the lead concentration measured in the contaminated soft tissues, in liver they range from 6 to 22 mu g g(-1), and in kidneys from 44 to 79 mu g g(-1). The control rats show, in general, values below the EDXRF detection limit (2 mu g g(-1)). The ratio kidney/liver ranges from 2 to 10 and is strongly positively correlated with the age of the animals. A Spearman correlation matrix to investigate the correlation between elemental concentrations and the dependence of these concentrations with age showed that there is a strong positive correlation with age for lead in the liver but not in the kidney. The correlation matrix showed also that the concentration of lead in these two soft tissues is not correlated. The lead accumulation in liver is made by different plateaus that strongly decrease with age. It was verified the existence of two levels of accumulation in kidney, not very highlighted, which might be indicative of a maximum accumulation level for lead in kidney. (C) 2012 Elsevier GmbH. All rights reserved.
C1 [Guimaraes, Diana; Santos, Jose Paulo] Univ Nova Lisboa, Ctr Fis Atom, Dept Fis, Fac Ciencias & Tecnol, P-2829516 Monte De Caparica, Portugal.
   [Carvalho, Maria Luisa] Univ Lisbon, Ctr Fis Atom, Dept Fis, Fac Ciencias, P-1649003 Lisbon, Portugal.
   [Geraldes, Vera; Rocha, Isabel] Fac Med Lisbon, Inst Fisiol, P-1649028 Lisbon, Portugal.
   [Geraldes, Vera; Rocha, Isabel] Inst Mol Med, P-1649028 Lisbon, Portugal.
   [Alves, Luis Cerqueira] Nucl & Technol Inst, LFI, P-2686953 Sacavem, Portugal.
C3 Universidade de Lisboa; Universidade Nova de Lisboa; Universidade de
   Lisboa; Universidade de Lisboa; Universidade de Lisboa; Universidade de
   Lisboa
RP Guimaraes, D (corresponding author), Univ Nova Lisboa, Ctr Fis Atom, Dept Fis, Fac Ciencias & Tecnol, P-2829516 Monte De Caparica, Portugal.
EM dianafcg@gmail.com
RI Santos, José/IAP-5866-2023; geraldes, vera/AFM-0124-2022; geraldes,
   vera/AAH-2456-2022; Alves, Luis C/J-9505-2013; Guimarães,
   Diana/JAN-9662-2023; Carvalho, Maria Luisa/C-6782-2011; Santos, Jose
   Paulo/F-4186-2010; Geraldes, Vera/M-4137-2013
OI Alves, Luis C/0000-0001-5369-5019; Guimarães, Diana/0000-0001-7451-1979;
   Carvalho, Maria Luisa/0000-0002-9004-1134; Santos, Jose
   Paulo/0000-0002-5890-0971; , Maria-Luisa/0000-0002-5062-8723; Geraldes,
   Vera/0000-0003-1275-3459
FU FCT - Fundacao para a Ciencia e a Tecnologia (Portugal)
   [PEstOE/FIS/UI0303/2011]; European Community Fund FEDER through the
   COMPETE - Competitiveness Factors Operational Programme
FX J.P. Santos, D. Guimaraes and M.L. Carvalho acknowledge the support by
   FCT - Fundacao para a Ciencia e a Tecnologia (Portugal) under the
   Project No. PEstOE/FIS/UI0303/2011, financed by the European Community
   Fund FEDER through the COMPETE - Competitiveness Factors Operational
   Programme. The authors acknowledge Professor Jose-Luis Capelo-Martinez,
   REQUIMTE for the technical support in the ETAAS measurements, and also
   to Rute Pinheiro for the support in preparing the samples for PIXE.
CR ADAMS N, 1989, BEHAV PROCESS, V19, P127, DOI 10.1016/0376-6357(89)90036-3
   Adeyemi O, 2009, FOOD CHEM TOXICOL, V47, P885, DOI 10.1016/j.fct.2009.01.023
   ARAUJO MF, 1993, NUCL INSTRUM METH B, V75, P450, DOI 10.1016/0168-583X(93)95694-Z
   Bielarczyk H, 1996, BRAIN RES, V708, P108, DOI 10.1016/0006-8993(95)01315-6
   BOMAN J, 1991, X-RAY SPECTROM, V20, P305, DOI 10.1002/xrs.1300200611
   Conterato GMM, 2007, BASIC CLIN PHARMACOL, V101, P96, DOI 10.1111/j.1742-7843.2007.00084.x
   Custódio PJ, 2005, J TRACE ELEM MED BIO, V19, P151, DOI 10.1016/j.jtemb.2005.09.002
   de Assis HCD, 2005, ENVIRON TOXICOL PHAR, V19, P113, DOI 10.1016/j.etap.2004.05.006
   Gardella C, 2001, OBSTET GYNECOL SURV, V56, P231, DOI 10.1097/00006254-200104000-00024
   Gayer RA, 1995, METAL TOXICOLOGY
   GERHARDSSON L, 1995, J TRACE ELEM MED BIO, V9, P136, DOI 10.1016/S0946-672X(11)80037-4
   Gonick HC, 2002, AM J KIDNEY DIS, V40, P202, DOI 10.1053/ajkd.2002.34681
   Györi Z, 2005, J SCI FOOD AGR, V85, P1049, DOI 10.1002/jsfa.2069
   Hernberg S, 2000, AM J IND MED, V38, P244, DOI 10.1002/1097-0274(200009)38:3<244::AID-AJIM3>3.3.CO;2-6
   Leeder JS, 1997, PEDIATR CLIN N AM, V44, P55, DOI 10.1016/S0031-3955(05)70463-6
   McGowan JA, 1996, OTOLARYNG HEAD NECK, V114, P220, DOI 10.1016/S0194-5998(96)70170-5
   Miller J.N., 2000, STAT CHEMOMETRICS AN
   MYKKANEN HM, 1979, TOXICOL APPL PHARM, V51, P447, DOI 10.1016/0041-008X(79)90369-7
   Pascual-Izarra C, 2006, NUCL INSTRUM METH B, V249, P820, DOI 10.1016/j.nimb.2006.03.147
   Ponce-Canchihuamán JC, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-35
   RADER JI, 1981, ENVIRON HEALTH PERSP, V42, P187, DOI 10.2307/3429208
   Reis MA, 2005, X-RAY SPECTROM, V34, P372, DOI 10.1002/xrs.841
   REIS MA, 1992, NUCL INSTRUM METH B, V68, P300, DOI 10.1016/0168-583X(92)96098-J
   RINDBY A, 1989, X-RAY SPECTROM, V18, P113, DOI 10.1002/xrs.1300180308
   Ronchetti R, 2006, ACTA PAEDIATR, V95, P45, DOI 10.1080/08035320600886224
   SCHROEDER HA, 1965, J NUTR, V86, P51, DOI 10.1093/jn/86.1.51
   Smith DM, 2008, ARCH ENVIRON CON TOX, V55, P518, DOI 10.1007/s00244-008-9138-1
   Sönmez F, 2002, J ADOLESCENT HEALTH, V30, P213, DOI 10.1016/S1054-139X(01)00307-X
   VICTERY W, 1987, FUND APPL TOXICOL, V8, P506, DOI 10.1016/0272-0590(87)90136-9
   Vieira I, 1996, EUR J BIOCHEM, V238, P476, DOI 10.1111/j.1432-1033.1996.0476z.x
NR 30
TC 13
Z9 16
U1 0
U2 13
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0946-672X
J9 J TRACE ELEM MED BIO
JI J. Trace Elem. Med. Biol.
PY 2012
VL 26
IS 4
BP 285
EP 290
DI 10.1016/j.jtemb.2012.02.006
PG 6
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA 059EL
UT WOS:000312687100012
PM 22683051
DA 2024-02-19
ER

PT J
AU Jun, JI
   Lau, LF
AF Jun, Joon-Ii
   Lau, Lester F.
TI CCN2 induces cellular senescence in fibroblasts
SO JOURNAL OF CELL COMMUNICATION AND SIGNALING
LA English
DT Article
DE CCN1/CYR61; CCN2/CTGF; Integrins; Wound healing; Cellular senescence
ID MATRICELLULAR PROTEIN; IN-VIVO; LIVER FIBROSIS; CYR61 CCN1; CELLS;
   MYOFIBROBLASTS; ALPHA(6)BETA(1); ALPHA(V)BETA(3); ANGIOGENESIS;
   CCN1/CYR61
AB The expression of Ccn2 (CTGF) has been linked to fibrosis in many tissues and pathologies, although its activities in fibroblastic cells and precise mechanism of action in fibrogenesis are still controversial. Here, we showed that CCN2 can induce cellular senescence in fibroblasts both in vitro and in vivo, whereupon senescent cells express an anti-fibrotic "senescence-associated secretory phenotype" (SASP) that includes upregulation of matrix metalloproteinases and downregulation of collagen. Mechanistically, CCN2 induces fibroblast senescence through integrin alpha(6)beta(1)-mediated accumulation of reactive oxygen species, leading to activation of p53 and induction of p16(INK4a). In cutaneous wound healing, Ccn2 expression is highly elevated only during the initial inflammatory phase and quickly declines thereafter to a low level during the proliferation and maturation phases of healing when myofibroblasts play a major role. Consistent with this expression kinetics, knockdown of Ccn2 has little effect on the rate of wound closure, formation of senescent cells, or collagen content of the wounds. However, application of purified CCN2 protein on cutaneous wounds leads to induction of senescent cells, expression of SASP, and reduction of collagen content. These results show that CCN2 can induce cellular senescence in fibroblasts and is capable of exerting an anti-fibrotic effect in a context-dependent manner.
C1 [Jun, Joon-Ii; Lau, Lester F.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 South Ashland Ave, Chicago, IL 60607 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital
RP Lau, LF (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 South Ashland Ave, Chicago, IL 60607 USA.
EM lflau@uic.edu
OI Lau, Lester/0000-0002-4364-2914
FU NIH [R01 AR061791]
FX We are grateful to Dr. Woo Jin Park for gifts of adenoviral vectors.
   This work was supported by a grant from the NIH (R01 AR061791) to L.F.L.
CR Babic AM, 1999, MOL CELL BIOL, V19, P2958
   Borkham-Kamphorst E, 2014, BBA-MOL CELL RES, V1843, P902, DOI 10.1016/j.bbamcr.2014.01.023
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Catalano A, 2005, EMBO J, V24, P170, DOI 10.1038/sj.emboj.7600502
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200
   Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596
   Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hall-Glenn F, 2011, CELL MOL LIFE SCI, V68, P3209, DOI 10.1007/s00018-011-0782-7
   Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505
   Jun JI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8386
   Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599
   Jun JI, 2010, AGING-US, V2, P627, DOI 10.18632/aging.100201
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Juric V, 2009, MOL CELL BIOL, V29, P3266, DOI 10.1128/MCB.00064-09
   Kim KH, 2013, MOL CELL BIOL, V33, P2078, DOI 10.1128/MCB.00049-13
   Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Kubota S, 2015, CLIN SCI, V128, P181, DOI 10.1042/CS20140264
   Kurundkar AR, 2016, FASEB J, V30, P2135, DOI 10.1096/fj.201500173
   Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3
   Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230
   Leu SJ, 2003, J BIOL CHEM, V278, P33801, DOI 10.1074/jbc.M305862200
   Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200
   Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24
   Liu SX, 2014, ARTHRITIS RHEUMATOL, V66, P707, DOI 10.1002/art.38276
   Liu SX, 2014, WOUND REPAIR REGEN, V22, P119, DOI 10.1111/wrr.12131
   Meyer K, 2016, J AM COLL CARDIOL, V67, P2018, DOI 10.1016/j.jacc.2016.02.047
   Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002
   Roberts DD, 2011, BIOL EXTRACELL MATR, P369, DOI 10.1007/978-3-642-16555-9_11
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Tsang M, 2015, J CELL COMMUN SIGNAL, V9, P341, DOI 10.1007/s12079-014-0245-7
   Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011
   Yoon PO, 2010, J MOL CELL CARDIOL, V49, P294, DOI 10.1016/j.yjmcc.2010.04.010
NR 41
TC 43
Z9 48
U1 2
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1873-9601
EI 1873-961X
J9 J CELL COMMUN SIGNAL
JI J. Cell Commun. Signal
PD MAR
PY 2017
VL 11
IS 1
BP 15
EP 23
DI 10.1007/s12079-016-0359-1
PG 9
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA FE2HG
UT WOS:000408036800003
PM 27752926
OA Green Published
DA 2024-02-19
ER

PT J
AU MARKLE, RA
AF MARKLE, RA
TI HYDROLASE ACTIVITIES INCREASE IN THE RAT AORTA WITH GROWTH AND AGING BUT
   NOT IN LIVER AND KIDNEY
SO PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
RP MARKLE, RA (corresponding author), NO ARIZONA UNIV,DEPT BIOL SCI,FLAGSTAFF,AZ 86011, USA.
CR Bierman EL, 1977, ATHEROSCLER REV, V2, P79
   BONNER MJ, 1972, P SOC EXP BIOL MED, V139, P1359, DOI 10.3181/00379727-139-36363
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   de Duve C, 1974, Acta Cardiol, VSuppl 20, P9
   FLORKIN M, 1973, COMPREHENSIVE BIOCH
   GOLDFISCHER S, 1975, AM J PATHOL, V78, P497
   HALEY NJ, 1977, LAB INVEST, V37, P287
   JOKINEN MP, 1985, EXP MOL PATHOL, V42, P1, DOI 10.1016/0014-4800(85)90015-2
   KATZFEIGENBAUM D, 1981, CIRC RES, V49, P733, DOI 10.1161/01.RES.49.3.733
   KRITCHEVSKY D, 1980, P SOC EXP BIOL MED, V165, P193, DOI 10.3181/00379727-165-40957
   MARKLE RA, 1983, FED PROC, V42, P807
   Snedecor G.W., 1980, STATISTICAL METHODS
   WOLINSKY H, 1978, CIRC RES, V42, P821, DOI 10.1161/01.RES.42.6.821
   WOLINSKY H, 1978, CIRC RES, V42, P831, DOI 10.1161/01.RES.42.6.831
   WOLINSKY H, 1980, CIRC RES, V47, P301, DOI 10.1161/01.RES.47.3.301
   WOLINSKY H, 1971, CIRC RES, V28, P622, DOI 10.1161/01.RES.28.6.622
   WOLINSKY H, 1980, CIRC RES, V47, P433, DOI 10.1161/01.RES.47.3.433
   WOLINSKY H, 1970, P SOC EXP BIOL MED, V135, P364
   WOLINSKY H, 1975, CIRC RES, V36, P553, DOI 10.1161/01.RES.36.4.553
   WOLINSKY H, 1979, CIRC RES, V45, P546, DOI 10.1161/01.RES.45.4.546
   1982, B BIORAD LABORATORIE, V1069
NR 21
TC 3
Z9 3
U1 0
U2 0
PU BLACKWELL SCIENCE INC
PI MALDEN
PA 350 MAIN ST, MALDEN, MA 02148
SN 0037-9727
J9 P SOC EXP BIOL MED
JI Proc. Soc. Exp. Biol. Med.
PD NOV
PY 1986
VL 183
IS 2
BP 169
EP 176
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA E5325
UT WOS:A1986E532500003
PM 3094018
DA 2024-02-19
ER

PT J
AU RIIS, B
   RATTAN, SIS
   PALMQUIST, K
   CLARK, BFC
   NYGARD, O
AF RIIS, B
   RATTAN, SIS
   PALMQUIST, K
   CLARK, BFC
   NYGARD, O
TI DEPHOSPHORYLATION OF THE PHOSPHORYLATED ELONGATION FACTOR-II IN THE
   LIVERS OF CALORIE-RESTRICTED AND FREELY-FED RATS DURING AGING
SO BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL
LA English
DT Article
ID PROTEIN KINASE-III; CELLS
AB Slowing down of the rate of protein synthesis during ageing is accompanied by alterations in the amounts and activities of elongation factors, eEF-1 and eEF-2. Since the activity of eEF-2 is regulated by phosphorylation, we have determined the changes in the activities of eEF-2-specific phosphorylating and dephosphorylating enzymes during ageing. Previously, we have reported an age-related increase in the activity of eEF-2 kinase (BBRC, 192, 1210, 1993). We have now compared the activities of a dephosphorylating enzyme protein phosphatase 2A (PP2A) in young and old liver extracts from freely-fed or calorie-restricted rats. The activity of PP2A remain unaltered during ageing. Furthermore, there was no change in the kinetics and extent of PP2A-dependent and PP2A-independent dephosphorylation of eEF-2 during ageing.
C1 AARHUS UNIV, DEPT CHEM, CELLULAR AGEING LAB, DK-8000 AARHUS C, DENMARK.
   UNIV STOCKHOLM, WENNER GREN INST, DEPT ZOOL CELL BIOL, S-11345 STOCKHOLM, SWEDEN.
C3 Aarhus University; Stockholm University
OI Rattan, Suresh I.S./0000-0002-3478-1381
CR NAIRN AC, 1987, J BIOL CHEM, V262, P17299
   RATTAN SIS, 1992, ANN NY ACAD SCI, V663, P48, DOI 10.1111/j.1749-6632.1992.tb38648.x
   RATTAN SIS, 1992, EUR J GERONTOL, V1, P128
   REDPATH NT, 1990, BIOCHEM J, V272, P175, DOI 10.1042/bj2720175
   REDPATH NT, 1993, EUR J BIOCHEM, V212, P511, DOI 10.1111/j.1432-1033.1993.tb17688.x
   RICKETTS WG, 1985, J CELL PHYSIOL, V125, P492, DOI 10.1002/jcp.1041250319
   RIIS B, 1993, BIOCHEM BIOPH RES CO, V192, P1210, DOI 10.1006/bbrc.1993.1545
   WARD W, 1991, HEPATOLOGY, V14, P935, DOI 10.1002/hep.1840140529
NR 8
TC 6
Z9 6
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1039-9712
J9 BIOCHEM MOL BIOL INT
JI Biochem. Mol. Biol. Int.
PD APR
PY 1995
VL 35
IS 4
BP 855
EP 859
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA TJ163
UT WOS:A1995TJ16300021
PM 7627135
DA 2024-02-19
ER

PT J
AU Satyanarayana, A
   Greenberg, RA
   Schaetzlein, S
   Buer, J
   Masutomi, K
   Hahn, WC
   Zimmermann, S
   Martens, U
   Manns, MP
   Rudolph, KL
AF Satyanarayana, A
   Greenberg, RA
   Schaetzlein, S
   Buer, J
   Masutomi, K
   Hahn, WC
   Zimmermann, S
   Martens, U
   Manns, MP
   Rudolph, KL
TI Mitogen stimulation cooperates with telomere shortening to activate DNA
   damage responses and senescence signaling
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID HUMAN-DIPLOID FIBROBLASTS; CYCLIN-DEPENDENT KINASES; REPLICATIVE
   LIFE-SPAN; CELL-CYCLE; CHECKPOINT RESPONSE; LIVER-CIRRHOSIS;
   GENE-EXPRESSION; MOUSE CELLS; PROTEIN; MICE
AB Replicative senescence is induced by critical telomere shortening and limits the proliferation of primary cells to a finite number of divisions. To characterize the activity status of the replicative senescence program in the context of cell cycle activity, we analyzed the senescence phenotypes and signaling pathways in quiescent and growth-stimulated primary human fibroblasts in vitro and liver cells in vivo. This study shows that replicative senescence signaling operates at a low level in cells with shortened telomeres but becomes fully activated when cells are stimulated to enter the cell cycle. This study also shows that the dysfunctional telomeres and nontelomeric DNA lesions in senescent cells do not elicit a DNA damage signal unless the cells are induced to enter the cell cycle by mitogen stimulation. The amplification of senescence signaling and DNA damage responses by mitogen stimulation in cells with shortened telomeres is mediated in part through the MEK/mitogen-activated protein kinase pathway. These findings have implications for the further understanding of replicative senescence and analysis of its role in vivo.
C1 Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.
   Hannover Med Sch, Dept Microbiol, D-30625 Hannover, Germany.
   GBF, Dept Cell Biol, Braunschweig, Germany.
   Univ Freiburg, Med Ctr, Dept Hematol & Oncol, Freiburg, Germany.
   Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.
   Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.
C3 Hannover Medical School; Hannover Medical School; Helmholtz Association;
   Helmholtz-Center for Infection Research; University of Freiburg; Harvard
   University; Dana-Farber Cancer Institute; Harvard University;
   Dana-Farber Cancer Institute
RP Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Rudolph.Lenhard@Mh-Hannover.de
OI Buer, Jan/0000-0002-7602-1698; Rudolph, Karl Lenhard/0000-0002-4839-2862
CR Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311
   Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213
   BALAGURUMOORTHY P, 1992, NUCLEIC ACIDS RES, V20, P4061, DOI 10.1093/nar/20.15.4061
   BAYREUTHER K, 1988, P NATL ACAD SCI USA, V85, P5112, DOI 10.1073/pnas.85.14.5112
   Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4
   Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831
   DADLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Duan JM, 2001, J BIOL CHEM, V276, P48325, DOI 10.1074/jbc.M104814200
   DULIC V, 1993, P NATL ACAD SCI USA, V90, P11034, DOI 10.1073/pnas.90.23.11034
   Fang L, 1999, ONCOGENE, V18, P2789, DOI 10.1038/sj.onc.1202615
   Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2
   Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623
   Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884
   Goodarzi Aaron A, 2003, Prog Cell Cycle Res, V5, P393
   Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6
   Hara E, 1996, MOL CELL BIOL, V16, P859
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Itahana K, 2003, MOL CELL BIOL, V23, P389, DOI 10.1128/MCB.23.1.389-401.2003
   Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x
   Kim HG, 2002, EXP CELL RES, V272, P199, DOI 10.1006/excr.2001.5420
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008
   Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180
   Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6
   Matuoka K, 2002, BIOGERONTOLOGY, V3, P365, DOI 10.1023/A:1021324017008
   McConnell BB, 1998, CURR BIOL, V8, P351, DOI 10.1016/S0960-9822(98)70137-X
   NICHOLAS R, IN PRESS AGING CELL
   NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063
   Ouellette MM, 1999, BIOCHEM BIOPH RES CO, V254, P795, DOI 10.1006/bbrc.1998.0114
   PANG JH, 1994, J CELL PHYSIOL, V160, P531, DOI 10.1002/jcp.1041600316
   Paradis V, 2001, HUM PATHOL, V32, P327, DOI 10.1053/hupa.2001.22747
   Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024
   Pignolo RJ, 1998, EXP GERONTOL, V33, P67, DOI 10.1016/S0531-5565(97)00090-9
   RITTLING SR, 1986, P NATL ACAD SCI USA, V83, P3316, DOI 10.1073/pnas.83.10.3316
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   SESHADRI T, 1990, SCIENCE, V247, P205, DOI 10.1126/science.2104680
   SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1
   Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433
   Stein GH, 1999, MOL CELL BIOL, V19, P2109
   STEIN GH, 1990, SCIENCE, V249, P666, DOI 10.1126/science.2166342
   Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446
   Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X
   VEELKEN H, 1994, HUM GENE THER, V5, P1203, DOI 10.1089/hum.1994.5.10-1203
   von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2
   Wei WY, 2001, MOL CELL BIOL, V21, P6748, DOI 10.1128/MCB.21.20.6748-6757.2001
   WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C
   Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997
   ZIMMERMANN S, IN PRESS STEM CELLS
NR 63
TC 63
Z9 74
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD JUN
PY 2004
VL 24
IS 12
BP 5459
EP 5474
DI 10.1128/MCB.24.12.5459-5474.2004
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 826YA
UT WOS:000221864200032
PM 15169907
OA Green Published
DA 2024-02-19
ER

PT J
AU THAKUR, MK
   PRASAD, S
AF THAKUR, MK
   PRASAD, S
TI ADP-RIBOSYLATION OF HMG PROTEINS AND ITS MODULATION BY DIFFERENT
   EFFECTORS IN THE LIVER OF AGING RATS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
RP THAKUR, MK (corresponding author), BANARAS HINDU UNIV,DEPT ZOOL,BIOCHEM & MOLEC BIOL LAB,VARANASI 221005,UTTAR PRADESH,INDIA.
CR ADOLPH KW, 1987, ARCH BIOCHEM BIOPHYS, V253, P175
   ALLFREY VG, 1982, HMG CHROMOSOMAL PROT, P123
   AUBIN RJ, 1983, EMBO J, V2, P1685, DOI 10.1002/j.1460-2075.1983.tb01643.x
   COWMAN MK, 1980, BIOCHEMISTRY-US, V19, P532, DOI 10.1021/bi00544a022
   FERRO AM, 1983, J BIOL CHEM, V258, P6000
   GALL JC, 1986, TIBS, V11, P171
   GARRETT HE, 1966, STATISTICS PSYCHOL E, P43
   GIRI CP, 1978, BIOCHEMISTRY-US, V17, P3495, DOI 10.1021/bi00610a011
   GOODWIN GH, 1977, FEBS LETT, V80, P413, DOI 10.1016/0014-5793(77)80488-2
   KANUNGO MS, 1980, BIOCH AGING, P158
   MANDEL P, 1982, PROG NUCLEIC ACID RE, V27, P1, DOI 10.1016/S0079-6603(08)60596-6
   NICOLAS RH, 1982, HMG CHROMOSOMAL PROT, P41
   NIEDERMULLER H, 1985, MECH AGEING DEV, V29, P221, DOI 10.1016/0047-6374(85)90064-8
   PANYIM S, 1969, ARCH BIOCHEM BIOPHYS, V130, P337, DOI 10.1016/0003-9861(69)90042-3
   PARKER MI, 1986, J BIOL CHEM, V261, P2786
   PRASAD S, 1987, MOL BIOL REP, V12, P273, DOI 10.1007/BF00444679
   PRASAD S, 1988, BIOCHEM INT, V16, P375
   REEVES R, 1981, P NATL ACAD SCI USA, V78, P4067
   TANIGAWA Y, BIOCHEM BIOPH RES CO, V76, P406
   TANUMA S, 1983, J BIOL CHEM, V258, P5371
   TANUMA S, 1983, J BIOL CHEM, V258, P4067
   Thakur M K, 1983, Arch Gerontol Geriatr, V2, P1, DOI 10.1016/0167-4943(83)90012-2
   THAKUR MK, 1984, MECH AGEING DEV, V27, P263, DOI 10.1016/0047-6374(84)90052-6
   THAKUR MK, 1988, MUTAT RES, V219, P107
   TREMETHICK DJ, 1989, FEBS LETT, V242, P346, DOI 10.1016/0014-5793(89)80499-5
   UEDA K, 1985, ANN REV BIOCH, V54, P79
   WAGA S, 1988, BIOCHEM BIOPH RES CO, V153, P334, DOI 10.1016/S0006-291X(88)81227-0
   WANG NCW, 1977, EUR J BIOCHEM, V77, P11
   WEISBROD S, 1979, P NATL ACAD SCI USA, V76, P630, DOI 10.1073/pnas.76.2.630
NR 29
TC 8
Z9 9
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD MAR 31
PY 1990
VL 53
IS 1
BP 91
EP 100
DI 10.1016/0047-6374(90)90037-G
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA CV476
UT WOS:A1990CV47600009
PM 2325444
DA 2024-02-19
ER

PT J
AU Wu, YG
   Green, CL
   Wang, GL
   Yang, DB
   Li, L
   Li, BG
   Wang, L
   Li, M
   Li, JB
   Xu, YC
   Zhang, XY
   Niu, CQ
   Hu, SM
   Togo, J
   Mazidi, M
   Derous, D
   Douglas, A
   Speakman, JR
AF Wu, Yingga
   Green, Cara L.
   Wang, Guanlin
   Yang, Dengbao
   Li, Li
   Li, Baoguo
   Wang, Lu
   Li, Min
   Li, Jianbo
   Xu, Yanchao
   Zhang, Xueying
   Niu, Chaoqun
   Hu, Sumei
   Togo, Jacques
   Mazidi, Mohsen
   Derous, Davina
   Douglas, Alex
   Speakman, John R.
TI Effects of dietary macronutrients on the hepatic transcriptome and serum
   metabolome in mice
SO AGING CELL
LA English
DT Article; Early Access
DE aging; carbohydrate; fat; metabolome; protein; transcriptome
ID UNFOLDED PROTEIN RESPONSE; CALORIE RESTRICTION; GENE-EXPRESSION;
   NITRIC-OXIDE; LIFE-SPAN; SPHINGOLIPID TURNOVER; INSULIN-RESISTANCE;
   OXIDATIVE STRESS; GRADED-LEVELS; LIVER
AB Dietary macronutrient composition influences both hepatic function and aging. Previous work suggested that longevity and hepatic gene expression levels were highly responsive to dietary protein, but almost unaffected by other macronutrients. In contrast, we found expression of 4005, 4232, and 4292 genes in the livers of mice were significantly associated with changes in dietary protein (5%-30%), fat (20%-60%), and carbohydrate (10%-75%), respectively. More genes in aging-related pathways (notably mTOR, IGF-1, and NF-kappaB) had significant correlations with dietary fat intake than protein and carbohydrate intake, and the pattern of gene expression changes in relation to dietary fat intake was in the opposite direction to the effect of graded levels of caloric restriction consistent with dietary fat having a negative impact on aging. We found 732, 808, and 995 serum metabolites were significantly correlated with dietary protein (5%-30%), fat (8.3%-80%), and carbohydrate (10%-80%) contents, respectively. Metabolomics pathway analysis revealed sphingosine-1-phosphate signaling was the significantly affected pathway by dietary fat content which has also been identified as significant changed metabolic pathway in the previous caloric restriction study. Our results suggest dietary fat has major impact on aging-related gene and metabolic pathways compared with other macronutrients.
C1 [Wu, Yingga; Wang, Guanlin; Yang, Dengbao; Li, Li; Li, Baoguo; Wang, Lu; Li, Min; Xu, Yanchao; Zhang, Xueying; Niu, Chaoqun; Hu, Sumei; Togo, Jacques; Mazidi, Mohsen; Speakman, John R.] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.
   [Wu, Yingga; Wang, Guanlin; Li, Li; Li, Baoguo; Wang, Lu; Li, Min; Zhang, Xueying; Togo, Jacques; Mazidi, Mohsen] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Wu, Yingga; Green, Cara L.; Wang, Guanlin; Wang, Lu; Li, Min; Zhang, Xueying; Derous, Davina; Douglas, Alex; Speakman, John R.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 2TZ, Scotland.
   [Li, Min; Zhang, Xueying; Niu, Chaoqun; Speakman, John R.] Chinese Acad Sci, Shenzhen Key Lab Metab Hlth, Shenzhen Inst Adv Technol, Ctr Energy Metab & Reprod, Shenzhen, Peoples R China.
   [Li, Jianbo] Univ Dali, Dali, Yunnan, Peoples R China.
   [Speakman, John R.] CAS Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China.
C3 Chinese Academy of Sciences; Institute of Genetics & Developmental
   Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy
   of Sciences, CAS; University of Aberdeen; Chinese Academy of Sciences;
   Shenzhen Institute of Advanced Technology, CAS
RP Speakman, JR (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen AB24 2TZ, Scotland.
EM j.speakman@abdn.ac.uk
RI zhang, xueying/JMB-7808-2023; John, Speakman R/A-9494-2008; Hu,
   Sumei/GYV-0191-2022; Wang, Guanlin/CAG-5949-2022
OI Hu, Sumei/0000-0002-3618-4492; Niu, Chaoqun/0000-0003-4241-6082; Li,
   Li/0000-0002-8173-7367; Douglas, Alex/0000-0001-6606-1058
FU National Key R&D Program of China [2019YFA0801900]; National
   Postdoctoral Program for Innovative Talents [BX2021357]; Postdoctoral
   Science Foundation [2021M693393]; Chinese Academy of Sciences Strategic
   Program [XDB13030100]; National Natural Science Foundation of China
   [91649108]; CAS; UK Royal Society
FX The study was funded by National Key R&D Program of China
   (2019YFA0801900), National Postdoctoral Program for Innovative Talents
   (BX2021357), Postdoctoral Science Foundation (2021M693393) the Chinese
   Academy of Sciences Strategic Program (XDB13030100), the National
   Natural Science Foundation of China (91649108), a PIFI professorial
   fellowship from CAS and a Wolfson merit award from the UK Royal Society
   (all to J.R.S unless stated).
CR Adachi Y, 2018, MOL METAB, V17, P61, DOI 10.1016/j.molmet.2018.08.002
   Anthony TG, 2013, DIABETES, V62, P2635, DOI 10.2337/db12-1613
   Argentino DP, 2005, J GERONTOL A-BIOL, V60, P28, DOI 10.1093/gerona/60.1.28
   Babenko NA, 2014, ARCH GERONTOL GERIAT, V58, P420, DOI 10.1016/j.archger.2013.12.005
   BREESE CR, 1991, J GERONTOL, V46, pB180, DOI 10.1093/geronj/46.5.B180
   Caligiuri SPB, 2013, J NUTR, V143, P1421, DOI 10.3945/jn.113.177360
   Cedernaes J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-2
   Collino S, 2013, METABOLITES, V3, P881, DOI 10.3390/metabo3040881
   Cui XL, 2020, IN VITRO CELL DEV-AN, V56, P715, DOI 10.1007/s11626-020-00476-z
   de Wit NJW, 2012, J HEPATOL, V57, P1370, DOI 10.1016/j.jhep.2012.07.003
   DELACRUZ J, 1990, INT J BIOCHEM, V22, P729, DOI 10.1016/0020-711X(90)90008-Q
   Della Torre S, 2018, CELL METAB, V28, P256, DOI 10.1016/j.cmet.2018.05.021
   Derous D, 2017, AGING-US, V9, P1770, DOI 10.18632/aging.101269
   Díaz-Rúa R, 2017, J NUTR BIOCHEM, V46, P39, DOI 10.1016/j.jnutbio.2017.04.008
   Dornadula S, 2015, CHEM RES TOXICOL, V28, P1666, DOI 10.1021/acs.chemrestox.5b00171
   Gearing LJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215495
   Gokarn R, 2018, J GERONTOL A-BIOL, V73, P1618, DOI 10.1093/gerona/gly065
   Green CL, 2017, AGING CELL, V16, P529, DOI 10.1111/acel.12570
   Guo FF, 2007, CELL METAB, V5, P103, DOI 10.1016/j.cmet.2007.01.001
   Hanssen NMJ, 2019, CURR OPIN NEPHROL HY, V28, P26, DOI 10.1097/MNH.0000000000000465
   HERBENER GH, 1976, J GERONTOL, V31, P8, DOI 10.1093/geronj/31.1.8
   Hu SM, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwaa177
   Hu SM, 2020, MOL METAB, V32, P27, DOI 10.1016/j.molmet.2019.11.010
   Hu SM, 2018, CELL METAB, V28, P415, DOI 10.1016/j.cmet.2018.06.010
   Husson A, 2003, EUR J BIOCHEM, V270, P1887, DOI 10.1046/j.1432-1033.2003.03559.x
   Ingram DK, 2017, AGEING RES REV, V39, P15, DOI 10.1016/j.arr.2017.05.008
   Ito T, 2018, J PHYSIOL BIOCHEM, V74, P9, DOI 10.1007/s13105-017-0597-6
   Jobgen WS, 2006, J NUTR BIOCHEM, V17, P571, DOI 10.1016/j.jnutbio.2005.12.001
   Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861
   Jovaisaite V, 2014, J EXP BIOL, V217, P137, DOI 10.1242/jeb.090738
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Kowalski GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072449
   Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004
   Laeger T, 2016, CELL REP, V16, P707, DOI 10.1016/j.celrep.2016.06.044
   Laeger T, 2014, J CLIN INVEST, V124, P3913, DOI 10.1172/JCI74915
   Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105
   Li TT, 2020, INT J MED SCI, V17, P720, DOI 10.7150/ijms.42248
   Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3
   Liu N, 2020, J CANCER RES CLIN, V146, P367, DOI 10.1007/s00432-020-03127-8
   Liu YS, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0265-z
   Luiking YC, 2010, CURR OPIN CLIN NUTR, V13, P97, DOI 10.1097/MCO.0b013e328332f99d
   Maida A, 2016, J CLIN INVEST, V126, P3263, DOI 10.1172/JCI85946
   Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005
   Miller RA, 2018, NAT MED, V24, P518, DOI 10.1038/nm.4514
   Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078
   Okun JG, 2021, NAT METAB, V3, P394, DOI 10.1038/s42255-021-00369-9
   Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Praestholm SM, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.109938
   Rajbhandari P, 2018, CELL, V172, P218, DOI 10.1016/j.cell.2017.11.019
   Ravichandran S, 2019, BBA-MOL BASIS DIS, V1865, P570, DOI 10.1016/j.bbadis.2018.12.012
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110
   Sailer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063950
   Saleem M, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14604
   Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379
   Shertzer HG, 2011, J NUTR, V141, P582, DOI 10.3945/jn.110.133736
   Solon-Biet SM, 2019, NAT METAB, V1, P532, DOI 10.1038/s42255-019-0059-2
   Solon-Biet SM, 2016, CELL METAB, V24, P555, DOI 10.1016/j.cmet.2016.09.001
   Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009
   Speakman JR, 2016, EXP GERONTOL, V86, P28, DOI 10.1016/j.exger.2016.03.011
   Tilstra JS, 2011, AGING DIS, V2, P449
   Toyoshima Y, 2020, AM J PHYSIOL-ENDOC M, V318, pE636, DOI 10.1152/ajpendo.00464.2019
   Tyshkovskiy A, 2019, CELL METAB, V30, P573, DOI 10.1016/j.cmet.2019.06.018
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983
   Wu YG, 2021, CELL METAB, V33, P888, DOI 10.1016/j.cmet.2021.01.017
   Yilmaz Z, 2017, ARCH PHYSIOL BIOCHEM, V123, P192, DOI 10.1080/13813455.2017.1296468
   Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036
   Zhuang P, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800448
NR 70
TC 3
Z9 3
U1 0
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1474-9718
EI 1474-9726
J9 AGING CELL
JI Aging Cell
PD 2022 APR
PY 2022
VL 21
IS 4
AR e13585
DI 10.1111/acel.13585
EA MAR 2022
PG 18
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 1X1UP
UT WOS:000766533100001
PM 35266264
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Grunewald, M
   Kumar, S
   Sharife, H
   Volinsky, E
   Gileles-Hillel, A
   Licht, T
   Permyakova, A
   Hinden, L
   Azar, S
   Friedmann, Y
   Kupetz, P
   Tzuberi, R
   Anisimov, A
   Alitalo, K
   Horwitz, M
   Leebhoff, S
   Khoma, OZ
   Hlushchuk, R
   Djonov, V
   Abramovitch, R
   Tam, J
   Keshet, E
AF Grunewald, M.
   Kumar, S.
   Sharife, H.
   Volinsky, E.
   Gileles-Hillel, A.
   Licht, T.
   Permyakova, A.
   Hinden, L.
   Azar, S.
   Friedmann, Y.
   Kupetz, P.
   Tzuberi, R.
   Anisimov, A.
   Alitalo, K.
   Horwitz, M.
   Leebhoff, S.
   Khoma, O. Z.
   Hlushchuk, R.
   Djonov, V
   Abramovitch, R.
   Tam, J.
   Keshet, E.
TI Counteracting age-related VEGF signaling insufficiency promotes healthy
   aging and extends life span
SO SCIENCE
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; LONGEVITY; NEOVASCULARIZATION; MECHANISMS;
   INSIGHTS; PROVIDES; SYSTEM; MUSCLE; LIVER
AB Aging is an established risk factor for vascular diseases, but vascular aging itself may contribute to the progressive deterioration of organ function. Here, we show in aged mice that vascular endothelial growth factor (VEGF) signaling insufficiency, which is caused by increased production of decoy receptors, may drive physiological aging across multiple organ systems. Increasing VEGF signaling prevented age-associated capillary loss, improved organ perfusion and function, and extended life span. Healthier aging was evidenced by favorable metabolism and body composition and amelioration of aging-associated pathologies including hepatic steatosis, sarcopenia, osteoporosis, "inflammaging" (age-related multiorgan chronic inflammation), and increased tumor burden. These results indicate that VEGF signaling insufficiency affects organ aging in mice and suggest that modulating this pathway may result in increased mammalian life span and improved overall health.
C1 [Grunewald, M.; Kumar, S.; Sharife, H.; Volinsky, E.; Gileles-Hillel, A.; Licht, T.; Kupetz, P.; Tzuberi, R.; Horwitz, M.; Leebhoff, S.; Keshet, E.] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel.
   [Gileles-Hillel, A.; Abramovitch, R.] Hadassah Hebrew Univ Hosp, Wohl Inst Translat Med, Jerusalem, Israel.
   [Gileles-Hillel, A.; Abramovitch, R.] Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.
   [Gileles-Hillel, A.] Hadassah Med Ctr, Dept Pediat, Pediat Pulmonol & Sleep Unit, Jerusalem, Israel.
   [Permyakova, A.; Hinden, L.; Azar, S.; Tam, J.] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Obes & Metab Lab,Inst Drug Res, Jerusalem, Israel.
   [Friedmann, Y.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Bio Imaging Unit, Jerusalem, Israel.
   [Anisimov, A.; Alitalo, K.] Univ Helsinki, Res Programs Unit, Translat Canc Biol Program, Fac Med, Helsinki, Finland.
   [Khoma, O. Z.; Hlushchuk, R.; Djonov, V] Univ Bern, Inst Anat, Topog & Clin Anat, Bern, Switzerland.
C3 Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah
   University Medical Center; Hebrew University of Jerusalem; Hadassah
   University Medical Center; Hebrew University of Jerusalem; Hadassah
   University Medical Center; Hebrew University of Jerusalem; Hebrew
   University of Jerusalem; University of Helsinki; University of Bern
RP Grunewald, M; Keshet, E (corresponding author), Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel.
EM myriamg@ekmd.huji.ac.il; elik@ekmd.huji.ac.il
RI Hlushchuk, Ruslan/AAE-7872-2022; Gileles-Hillel, Alexander/K-6674-2019;
   Kumar, Saran/GWQ-9968-2022; Alitalo, Kari K/J-5013-2014; Hinden,
   Liad/ABG-4180-2021; Keshet, Eli/GQR-0445-2022; Kumar, Saran/C-4698-2013
OI Gileles-Hillel, Alexander/0000-0002-0656-905X; Alitalo, Kari
   K/0000-0002-7331-0902; Hinden, Liad/0000-0002-0307-4350; Kumar,
   Saran/0000-0002-5052-0499; Grunewald, Myriam/0000-0001-5394-9218; licht,
   tamar/0000-0003-2333-1665; Hlushchuk, Ruslan/0000-0002-6722-8996
FU Britain Israel Research and Academic Exchange partnership (BIRAX grant)
   [58BX18MMEK]; Israel Science Foundation [783/20, 2779/19]; Novo Nordisk
   Foundation [NNF16C0023554]; Sigrid Juselius Foundation; Hospital
   District of Helsinki; Uusimaa Research Grant
FX This work was supported in part by research grants from the Britain
   Israel Research and Academic Exchange partnership (BIRAX grant no.
   58BX18MMEK), the Israel Science Foundation (grant nos. 783/20 and
   2779/19), the Novo Nordisk Foundation (grant no. NNF16C0023554), The
   Sigrid Juselius Foundation, and the Hospital District of Helsinki. K.A.
   was supported by a Uusimaa Research Grant.
CR Anisimov A, 2009, CIRC RES, V104, P1302, DOI 10.1161/CIRCRESAHA.109.197830
   Ballak SB, 2014, AGEING RES REV, V14, P43, DOI 10.1016/j.arr.2014.01.005
   Barinda AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14387-w
   Chen MB, 2020, CELL REP, V30, P4418, DOI 10.1016/j.celrep.2020.03.012
   Cho KW, 2014, METHOD ENZYMOL, V537, P297, DOI 10.1016/B978-0-12-411619-1.00016-1
   Das A, 2018, CELL, V173, P74, DOI 10.1016/j.cell.2018.02.008
   Del Bo R, 2008, NEUROBIOL AGING, V29, P1917, DOI 10.1016/j.neurobiolaging.2007.05.003
   Dor Y, 2002, EMBO J, V21, P1939, DOI 10.1093/emboj/21.8.1939
   Furrer K, 2011, P NATL ACAD SCI USA, V108, P2945, DOI 10.1073/pnas.1012531108
   Goligorsky MS, 2010, ORGANOGENESIS, V6, P1, DOI 10.4161/org.6.1.10427
   Hasegawa Y, 2012, CIRCULATION, V125, P1122, DOI 10.1161/CIRCULATIONAHA.111.054346
   Hughes BG, 2016, GENETICS, V204, P905, DOI 10.1534/genetics.116.192369
   KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705
   Kim IH, 2015, CURR OPIN GASTROEN, V31, P184, DOI 10.1097/MOG.0000000000000176
   Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933
   Knani I, 2016, MOL METAB, V5, P1187, DOI 10.1016/j.molmet.2016.10.004
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145
   Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003
   Lazarus Alon, 2011, Proc Am Thorac Soc, V8, P508, DOI 10.1513/pats.201102-021MW
   Le Couteur DG, 2010, J GERONTOL A-BIOL, V65, P1025, DOI 10.1093/gerona/glq135
   Leonardi GC, 2018, IMMUN AGEING, V15, DOI 10.1186/s12979-017-0112-5
   Licht T, 2016, P NATL ACAD SCI USA, V113, pE7828, DOI 10.1073/pnas.1609592113
   Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834
   May D, 2008, P NATL ACAD SCI USA, V105, P282, DOI 10.1073/pnas.0707778105
   May D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021478
   Menshikova EV, 2006, J GERONTOL A-BIOL, V61, P534, DOI 10.1093/gerona/61.6.534
   North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Rafii S, 2016, NATURE, V529, P316, DOI 10.1038/nature17040
   Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045
   Riera CE, 2015, NAT CELL BIOL, V17, P196, DOI 10.1038/ncb3107
   Salvioli S, 2006, CURR PHARM DESIGN, V12, P3161, DOI 10.2174/138161206777947470
   Sayed RKA, 2016, EXP GERONTOL, V83, P22, DOI 10.1016/j.exger.2016.07.007
   SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399
   Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102
   Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768
   Tarantini S, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101192
   Ungvari Z, 2018, NAT REV CARDIOL, V15, P555, DOI 10.1038/s41569-018-0030-z
   Wang K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29086-2
   Yousefzadeh MJ, 2018, AGING CELL, V17, DOI 10.1111/acel.12706
   Zhao GX, 2017, AGING DIS, V8, P287, DOI 10.14336/AD.2016.0920
   Zurita E, 2011, TRANSGENIC RES, V20, P481, DOI 10.1007/s11248-010-9403-8
NR 43
TC 109
Z9 118
U1 16
U2 109
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUL 30
PY 2021
VL 373
IS 6554
SI SI
BP 533
EP +
AR eabc8479
DI 10.1126/science.abc8479
PG 57
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA TV4TF
UT WOS:000681716000037
PM 34326210
HC Y
HP N
DA 2024-02-19
ER

PT J
AU VOMEL, T
   HAGER, K
   PLATT, D
AF VOMEL, T
   HAGER, K
   PLATT, D
TI AGING INVIVO AND NEURAMINIDASE TREATMENT OF RAT ERYTHROCYTES AND THEIR
   SEQUESTRATION BY THE ISOLATED PERFUSED RAT-LIVER
SO ARCHIVES OF GERONTOLOGY AND GERIATRICS
LA English
DT Article
RP VOMEL, T (corresponding author), UNIV ERLANGEN NURNBERG,INST GERONTOL,DEPT MED 2,HEIMERICHSTR 58,D-8500 NURNBERG 90,FED REP GER.
RI Hager, Klaus/G-6495-2015
OI Hager, Klaus/0000-0003-4497-3878
CR ALDERMAN EM, 1981, BLOOD, V58, P341
   ALDERMAN EM, 1980, BLOOD, V55, P817
   AMINOFF D, 1977, P NATL ACAD SCI USA, V74, P1521, DOI 10.1073/pnas.74.4.1521
   AMINOFF D, 1961, BIOCHEM J, V81, P384, DOI 10.1042/bj0810384
   BALDUINI CL, 1978, H-S Z PHYSIOL CHEM, V359, P1573, DOI 10.1515/bchm2.1978.359.2.1573
   BALDUINI CL, 1977, H-S Z PHYSIOL CHEM, V358, P1143, DOI 10.1515/bchm2.1977.358.2.1143
   BORUN ER, 1957, J CLIN INVEST, V36, P676, DOI 10.1172/JCI103468
   COHEN NS, 1976, BIOCHIM BIOPHYS ACTA, V419, P229, DOI 10.1016/0005-2736(76)90349-7
   DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0
   DUROCHER JR, 1975, BLOOD, V45, P11
   GATTEGNO L, 1975, H-S Z PHYSIOL CHEM, V356, P391, DOI 10.1515/bchm2.1975.356.1.391
   HOFMANN KH, 1978, THESIS GIESSEN
   JANCIK JM, 1978, CELL TISSUE RES, V186, P209, DOI 10.1007/BF00225532
   KAY MMB, 1975, P NATL ACAD SCI USA, V72, P3521, DOI 10.1073/pnas.72.9.3521
   LUTZ HU, 1981, SCHWEIZ MED WSCHR, V111, P1507
   MARIKOVSKY Y, 1977, MECH AGEING DEV, V6, P233, DOI 10.1016/0047-6374(77)90024-0
   MUNTHEKAAS AC, 1976, EXP CELL RES, V99, P319, DOI 10.1016/0014-4827(76)90589-9
   MUNTHEKAAS AC, 1975, J EXP MED, V141, P1, DOI 10.1084/jem.141.1.1
   MURPHY JR, 1973, J LAB CLIN MED, V82, P334
   PLATT D, 1979, Z GERONTOL, V12, P60
   SCHIMASSEK H, 1963, BIOCHEM Z, V336, P460
   SEAMAN GVF, 1977, BLOOD, V50, P1001
   VOMEL T, 1981, FORTSCHR MED, V99, P1511
   Vomel T, 1983, Aktuelle Gerontol, V13, P122
   Weed R I, 1966, Trans Assoc Am Physicians, V79, P426
NR 25
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0167-4943
J9 ARCH GERONTOL GERIAT
JI Arch. Gerontol. Geriatr.
PY 1985
VL 4
IS 2
BP 125
EP 132
DI 10.1016/0167-4943(85)90026-3
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA APA31
UT WOS:A1985APA3100005
PM 4037931
DA 2024-02-19
ER

PT J
AU Singh, AK
   Pandey, SK
   Saha, G
   Gattupalli, NK
AF Singh, Ashish Kumar
   Pandey, Sumeet Kumar
   Saha, Gourav
   Gattupalli, Naresh Kumar
TI Pyrroloquinoline quinone (PQQ) producing <i>Escherichia coli</i> Nissle
   1917 (EcN) alleviates age associated oxidative stress and
   hyperlipidemia, and improves mitochondrial function in ageing rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Pyrroloquinoline quinone; Escherichia coli Nissle 1917; Ageing; ROS;
   Healthy mitochondria; Hyperlipidemia
ID ACID; EXPRESSION; MASS; INVOLVEMENT; DYSFUNCTION; METABOLISM;
   MICROFLORA; MUTATIONS; APOPTOSIS; PATHWAYS
AB Background: Ageing involves oxidative stress mediated by Reactive Oxygen Species (ROS) and mitochondrial dysfunction. The present work demonstrates the protective effect of PQQ producing EcN against rotenone induced mitochondrial oxidative stress and consequence of mitochondrial and cellular dysfunction in naturally ageing rat model. PQQ is a potent antioxidant molecule also known to stimulate mitochondrial biogenesis and function in mammals.
   Methods: Firstly, adult rats (16-18 weeks old) were treated with rotenone (2.5 mg/kg body weight; i.p.) daily for 28 days along with PQQ (10 mg/kg diet, daily) and modified probiotic EcN strains (10(8) CFU twice weekly). Secondly, ageing rats (48-50 weeks old) were gavaged with probiotic EcN strains (10(8) CFU twice weekly) and PQQ (10 mg/kg diet, daily) for 8 months.
   Results: PQQ producing EcN-5 treatment prevented rotenone induced hepatic oxidative stress and mitochondrial damage in rats as assessed by reduced lipid peroxidation (29%), elevated glutathione (GSH) content (43%), increased catalase (52%) and superoxide dismutase (52%) activities when compared to only rotenone treatment. Moreover, increased hepatic mitochondrial content (41%), peroxisome proliferator-activated receptor-gamma coactivator 1-alpha (PGC-1 alpha) mRNA (25%) and mitochondrial Superoxide Dismutase (Mit-SOD) activity (94%) were also observed in EcN-5 treated rats. Rotenone treated rats did not exhibit gain in body weight, whereas rats co-treated with EcN-5 showed significant restoration in body weight gain. Furthermore, weekly administration of EcN-5 to naturally ageing rats for eight months resulted in significant reduction of oxidative stress in hepatic and colonic tissues ( assessed by lipid peroxidation, GSH content and catalase and SOD enzyme activities) along with increase in hepatic mitochondrial enzyme activities (Mit-SOD and succinate dehydrogenase) and biogenesis, when compared to untreated rats. Additionally, these rats also exhibited reduced expression of fatty acid synthase (50%) and increased expression of acyl coenzyme oxidase (225%) genes in liver in contrast to untreated rats resulting in lowered triglyceride (13% & 13.5%) and cholesterol (21% & 27%) levels in plasma and liver, respectively. Increased levels of butyrate (93%), propionate (45%) and acetate (18%) were also found in colonic content of these rats. PQQ administered daily ( supplemented in diet) exhibited more or less similar effect as weekly gavaged EcN-5 in both the experiments, which substantiate that these effects are mediated by PQQ.
   Conclusion: These results suggest that genetically modified EcN-5 can be used as a nutritional supplement which can reduce age related oxidative stress and hyperlipidemia. Furthermore, it also rejuvenates healthy mitochondria by stimulating mitochondrial biogenesis and metabolism. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Singh, Ashish Kumar; Pandey, Sumeet Kumar; Saha, Gourav; Gattupalli, Naresh Kumar] Maharaja Sayajirao Univ Baroda, Fac Sci, Mol Microbial Biochem Lab, Dept Biochem, Vadodara 390002, Gujarat, India.
C3 Maharaja Sayajirao University Baroda
RP Gattupalli, NK (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Mol Microbial Biochem Lab, Dept Biochem, Vadodara 390002, Gujarat, India.
EM singhashish1186@gmail.com; sumitkumarpandey2@gmail.com;
   gourav.saha@gmail.com; gnaresh_k@yahoo.co.in
RI Gattupalli, Naresh Kumar/AAF-5987-2020
OI Singh, Ashish Kumar/0000-0002-4633-1513; Gattupalli,
   Nareshkumar/0000-0001-7317-7438
FU Council of Scientific and Industrial Research (CSIR), New Delhi, India;
   University Grant commission (UGC), New Delhi, India under Department
   Research Scheme (UGC-DRS)
FX Council of Scientific and Industrial Research (CSIR), New Delhi, India,
   provided Senior Research Fellowship to AKS to carry out the research
   work. University Grant commission (UGC), New Delhi, India, provided
   Junior Research Fellowship to SKP under Department Research Scheme
   (UGC-DRS).
CR Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007
   Arora T, 2011, APPETITE, V56, P511, DOI 10.1016/j.appet.2011.01.016
   Bauerly K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021779
   Campbell JM, 1997, J NUTR, V127, P130, DOI 10.1093/jn/127.1.130
   Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850
   Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130
   Dai Dao-Fu, 2014, Longev Healthspan, V3, P6, DOI 10.1186/2046-2395-3-6
   Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007
   Gyaneshwar P, 1999, FEMS MICROBIOL LETT, V171, P223, DOI 10.1111/j.1574-6968.1999.tb13436.x
   Hara H, 2007, NEUROCHEM RES, V32, P489, DOI 10.1007/s11064-006-9257-x
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008
   Hopkins MJ, 2002, J MED MICROBIOL, V51, P448, DOI 10.1099/0022-1317-51-5-448
   HOPSU V. K., 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P353
   Kamel NS, 2006, CLEV CLIN J MED, V73, P1049, DOI 10.3949/ccjm.73.12.1049
   KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636
   Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852
   Kirkwood TBL, 2004, MECH AGEING DEV, V125, P911, DOI 10.1016/j.mad.2004.09.004
   Kondo T, 2009, J AGR FOOD CHEM, V57, P5982, DOI 10.1021/jf900470c
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Kumar P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/213574
   KUMAZAWA T, 1992, BIOCHIM BIOPHYS ACTA, V1156, P62, DOI 10.1016/0304-4165(92)90096-D
   Kumazawa T, 2007, INT J MOL MED, V19, P765
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lenaz G, 2000, BBA-BIOENERGETICS, V1459, P397, DOI 10.1016/S0005-2728(00)00177-8
   Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200
   Masoro E.J., 1995, HDB PHYSL 11
   Menon VP, 2007, ADV EXP MED BIOL, V595, P105
   Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039
   Nunome K, 2008, BIOL PHARM BULL, V31, P1321, DOI 10.1248/bpb.31.1321
   Pandey S, 2014, APPL BIOCHEM BIOTECH, V173, P775, DOI 10.1007/s12010-014-0897-z
   Patel SP, 2006, INDIAN J CLIN BIOCHE, V21, P129, DOI 10.1007/BF02912927
   Rasbach KA, 2007, BIOCHEM BIOPH RES CO, V355, P734, DOI 10.1016/j.bbrc.2007.02.023
   Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Rucker R, 2009, ALTERN MED REV, V14, P268
   Sanchez RM, 2000, J NEUROSCI, V20, P2409
   Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150
   Singh A.K., 2014, ALCOHOL CLIN EXP RES
   SMIDT CR, 1991, BIOFACTORS, V3, P53
   Sonnenborn Ulrich, 2009, Microbial Ecology in Health and Disease, V21, P122, DOI 10.3109/08910600903444267
   STEINBERG FM, 1994, J NUTR, V124, P744, DOI 10.1093/jn/124.5.744
   Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390
   SUZUKI O, 1990, LIFE SCI, V47, P2135, DOI 10.1016/0024-3205(90)90313-G
   Tchaparian E, 2010, BIOCHEM J, V429, P515, DOI 10.1042/BJ20091649
   Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751
   Zhang P, 2009, ENVIRON TOXICOL PHAR, V27, P103, DOI 10.1016/j.etap.2008.08.010
   Zhang Q, 2014, NEUROSCIENCE, V270, P183, DOI 10.1016/j.neuroscience.2014.04.022
   Zhang Q, 2013, NEUROCHEM RES, V38, P1661, DOI 10.1007/s11064-013-1068-2
   Zhang Q, 2011, TOXICOL APPL PHARM, V252, P62, DOI 10.1016/j.taap.2011.02.006
   Zhang YM, 2002, EUR J NEUROSCI, V16, P1015, DOI 10.1046/j.1460-9568.2002.02169.x
   Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111
NR 54
TC 25
Z9 31
U1 1
U2 32
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD JUN
PY 2015
VL 66
BP 1
EP 9
DI 10.1016/j.exger.2015.04.001
PG 9
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA CH2YK
UT WOS:000353891300001
PM 25843018
DA 2024-02-19
ER

PT J
AU HEIL, MF
   DINGMAN, AD
   GARVEY, JS
AF HEIL, MF
   DINGMAN, AD
   GARVEY, JS
TI ANTIGEN HANDLING IN AGING .3. AGE-RELATED-CHANGES IN ANTIGEN HANDLING BY
   LIVER PARENCHYMAL AND NONPARENCHYMAL CELLS
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 SYRACUSE UNIV,DEPT BIOL,SYRACUSE,NY 13210.
C3 Syracuse University
FU NIA NIH HHS [AG00111] Funding Source: Medline
CR BIJSTERBOSCH MK, 1982, BIOCHEM J, V208, P61, DOI 10.1042/bj2080061
   BOREK C, 1980, ANN NY ACAD SCI, V349
   BRADFIELD JW, 1974, LANCET, V2, P883
   BURGER DR, 1981, HUM IMMUNOL, V3, P209, DOI 10.1016/0198-8859(81)90019-7
   CALLARD RE, 1979, NATURE, V281, P218, DOI 10.1038/281218a0
   CAPERNA TJ, 1982, MECH AGEING DEV, V20, P205, DOI 10.1016/0047-6374(82)90088-4
   DAOUST R, 1958, LIVER FUNCTION, P3
   DEWILDE A, 1982, SINUSOIDAL LIVER CEL, P85
   FERGUSON A, 1976, IMMUNOLOGICAL ASPECT
   GARVEY JS, 1966, NATURE, V209, P1201, DOI 10.1038/2091201a0
   GARVEY JS, 1956, J IMMUNOL, V76, P36
   GARVEY JS, 1980, MECH AGEING DEV, V12, P287, DOI 10.1016/0047-6374(80)90052-4
   GARVEY JS, 1972, IMMUNOCHEMISTRY, V9, P187, DOI 10.1016/0019-2791(72)90039-0
   GARVEY JS, 1957, J EXP MED, V105, P361, DOI 10.1084/jem.105.4.361
   GARVEY JS, 1977, METHODS IMMUNOLOGY, P79
   GARVEY JS, 1984, METHODS ENZYMOL
   HARRIS RA, 1983, ISOLATION CHARACTERI
   HEIL MF, 1982, J RETICULOENDOTH SOC, V32, P287
   HIRSCHBERG H, 1980, J EXP MED, V152, pS249
   KAPLAN PJ, 1981, MECH AGEING DEV, V16, P61, DOI 10.1016/0047-6374(81)90032-4
   KAY MMB, 1981, HDB IMMUNOLOGY AGING
   KNOOK DL, 1976, EXP CELL RES, V99, P444, DOI 10.1016/0014-4827(76)90605-4
   KNOOK DL, 1982, SINUSOIDAL LIVER CEL
   MACKAY IR, 1982, DISEASES LIVER, P747
   MAKINODAN T, 1980, ADV IMMUNOL, V29, P287
   MAKINODAN T, 1977, IMMUNOLOGY AGING
   MUNTHEKAAS AC, 1980, SCAND J IMMUNOL, V11, P523, DOI 10.1111/j.1365-3083.1980.tb00020.x
   PARANETTO F, 1969, CURRENT PROBLEMS IMM, P213
   PLATT D, 1977, LIVER AGEING
   PRAANINGVANDALE.DP, 1982, SINUSOIDAL LIVER CEL, P271
   PULFORD K, 1981, CLIN EXP IMMUNOL, V46, P581
   RAM JS, 1967, J GERONTOL, V22, P92
   REILLY EB, 1978, CELL IMMUNOL, V41, P20, DOI 10.1016/S0008-8749(78)80025-2
   RICHMAN LK, 1979, J IMMUNOL, V123, P2602
   SAHA A, 1964, ARCH BIOCHEM BIOPHYS, V105, P179, DOI 10.1016/0003-9861(64)90251-6
   SAHER MA, 1983, P NATL ACAD SCI US, V80, P4017
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   SEGRE D, 1981, IMMUNOLOGICAL ASPECT
   SMITH MGM, 1971, IMMUNOLOGY LIVER
   Snedecor G.W. Cochran., 1968, STAT METHODS, V7th
   Steel R.G.D., 1980, PRINCIPLES PROCEDURE
   WALKER WS, 1976, IMMUNOBIOLOGY MACROP, P91
   WISSE E, 1977, KUPFFER CELLS OTHER
NR 43
TC 7
Z9 8
U1 0
U2 0
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PY 1984
VL 26
IS 2-3
BP 327
EP 340
DI 10.1016/0047-6374(84)90104-0
PG 14
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA TG518
UT WOS:A1984TG51800016
PM 6482526
DA 2024-02-19
ER

PT J
AU Li, WQ
   Miller, RA
AF Li, Weiquan
   Miller, Richard A.
TI Elevated ATF4 Function in Fibroblasts and Liver of Slow-Aging Mutant
   Mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE ATF4; Slow aging; Cell stress resistance; Life span
ID EXTENDS LIFE-SPAN; SNELL DWARF MICE; GROWTH-HORMONE; TRANSLATIONAL
   REGULATION; STRESS RESISTANCE; MULTIPLE FORMS; PAPP-A; LONGEVITY;
   EXTENSION; GCN2
AB Work in yeast has shown that longevity extension induced by nutrient deprivation, altered ribosomal function, or diminished target of rapamycin action requires the activity of GCN4. We hypothesized that increased activity of ATF4, the mammalian equivalent of yeast GCN4, might be characteristic of mutations that extend mouse life span. Fibroblasts from the skin of two such mutants (Snell dwarf and PAPP-A knockout) were found to have higher levels of ATF4 protein and expression of several ATF4 target genes in responses to amino acid withdrawal, cadmium, hydrogen peroxide, and tunicamycin. ATF4 pathways were also elevated in liver of both kinds of long-lived mutant mice. Thus, a connection between ATF4 pathways and longevity may have deep evolutionary roots, and further studies of ATF4 mechanisms may provide insights into the links between cellular stress resistance, protein translation control, and aging.
C1 [Li, Weiquan; Miller, Richard A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.
   [Miller, Richard A.] Univ Michigan, Geriatr Ctr, Ann Arbor, MI 48109 USA.
C3 University of Michigan System; University of Michigan; University of
   Michigan System; University of Michigan
RP Miller, RA (corresponding author), Univ Michigan, Dept Pathol, BSRB 3001,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.
EM millerr@umich.edu
FU National Institutes of Health [P01-AG031736, P30-AG013283]
FX This work was supported by National Institutes of Health grants
   P01-AG031736 and P30-AG013283.
CR Akha AAS, 2011, J BIOL CHEM, V286, P30344, DOI 10.1074/jbc.M111.220541
   Bartke A, 2001, J GERONTOL A-BIOL, V56, pB340, DOI 10.1093/gerona/56.8.B340
   Bartke A, 2011, PHILOS T R SOC B, V366, P28, DOI 10.1098/rstb.2010.0281
   Boldt HB, 2007, GROWTH HORM IGF RES, V17, P10, DOI 10.1016/j.ghir.2006.11.003
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Conover CA, 2007, AGING CELL, V6, P727, DOI 10.1111/j.1474-9726.2007.00328.x
   Conover CA, 2010, AGING CELL, V9, P942, DOI 10.1111/j.1474-9726.2010.00630.x
   Conover CA, 2010, J GERONTOL A-BIOL, V65, P590, DOI 10.1093/gerona/glq032
   Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213
   Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898
   Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098
   Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002
   Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268
   Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5
   Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833
   Hussain SG, 2007, BIOCHEM BIOPH RES CO, V355, P365, DOI 10.1016/j.bbrc.2007.01.156
   Ikeno Y, 2003, J GERONTOL A-BIOL, V58, P291
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008
   Kim SK, 2007, J EXP BIOL, V210, P1607, DOI 10.1242/jeb.004887
   Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654
   Lee ES, 2007, FEBS LETT, V581, P4325, DOI 10.1016/j.febslet.2007.08.001
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Maynard SP, 2006, AGING CELL, V5, P89, DOI 10.1111/j.1474-9726.2006.00187.x
   Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178
   Murakami S, 2003, FASEB J, V17, P1565, DOI 10.1096/fj.02-1092fje
   Panici JA, 2010, FASEB J, V24, P5073, DOI 10.1096/fj.10-163253
   Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629
   Salmon AB, 2005, AM J PHYSIOL-ENDOC M, V289, pE23, DOI 10.1152/ajpendo.00575.2004
   Salmon AB, 2008, J GERONTOL A-BIOL, V63, P232, DOI 10.1093/gerona/63.3.232
   SILBERBERG R, 1972, PATHOL MICROBIOL, V38, P417, DOI 10.1159/000162458
   Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6
   Smith ED, 2007, MECH AGEING DEV, V128, P106, DOI 10.1016/j.mad.2006.11.017
   Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037
   Sun L, 2009, J GERONTOL A-BIOL, V64, P711, DOI 10.1093/gerona/glp051
   Sun LY, 2009, FREE RADICAL BIO MED, V47, P1753, DOI 10.1016/j.freeradbiomed.2009.09.021
   Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447
   Vergara M, 2004, J GERONTOL A-BIOL, V59, P1244, DOI 10.1093/gerona/59.12.1244
   Wang M, 2012, AGING CELL, V11, P668, DOI 10.1111/j.1474-9726.2012.00833.x
   Yang RJ, 2000, MOL CELL BIOL, V20, P2706, DOI 10.1128/MCB.20.8.2706-2717.2000
NR 44
TC 32
Z9 34
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD MAR
PY 2015
VL 70
IS 3
BP 263
EP 272
DI 10.1093/gerona/glu040
PG 10
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA CC1RZ
UT WOS:000350122200001
PM 24691093
OA Green Published, Bronze
DA 2024-02-19
ER

PT J
AU SUN, J
   STROBEL, HW
AF SUN, J
   STROBEL, HW
TI AGING AFFECTS THE DRUG-METABOLISM SYSTEMS OF RAT-LIVER, KIDNEY, COLON
   AND LUNG IN A DIFFERENTIAL FASHION
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
C1 UNIV TEXAS,SCH MED,DEPT BIOCHEM & MOLEC BIOL,POB 20708,HOUSTON,TX 77225.
C3 University of Texas System
FU NIA NIH HHS [AG 02081] Funding Source: Medline
CR ALTURK WA, 1981, RES COMMUN CHEM PATH, V31, P259
   BAIRD MB, 1979, CANCER RES, V39, P4752
   BAIRD MB, 1975, EXP GERONTOL, V10, P89, DOI 10.1016/0531-5565(75)90039-X
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P469, DOI 10.1016/0531-5565(78)90059-1
   BIRNBAUM LS, 1978, EXP GERONTOL, V13, P299, DOI 10.1016/0531-5565(78)90038-4
   DIGNAM JD, 1977, BIOCHEMISTRY-US, V16, P1116, DOI 10.1021/bi00625a014
   DOMIN BA, 1983, EXTRAHEPATIC DRUG ME, P43
   FANG WF, 1978, ARCH BIOCHEM BIOPHYS, V186, P128, DOI 10.1016/0003-9861(78)90472-1
   GILLETTE JR, 1979, FED PROC, V38, P1900
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO R, 1970, JPN J PHARMACOL, V20, P572, DOI 10.1254/jjp.20.572
   KATO R, 1961, EXPERIENTIA, V17, P520, DOI 10.1007/BF02158634
   KATO R, 1964, BIOCHEM PHARMACOL, V13, P1037, DOI 10.1016/0006-2952(64)90100-5
   KATO R, 1968, J BIOCHEM-TOKYO, V63, P406
   KITAGAWA H, 1985, BIOCHEM PHARMACOL, V34, P579, DOI 10.1016/0006-2952(85)90193-5
   LAU PP, 1982, J BIOL CHEM, V257, P5257
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LU AYH, 1969, BIOCHEM BIOPH RES CO, V36, P545, DOI 10.1016/0006-291X(69)90339-8
   LU AYH, 1972, J BIOL CHEM, V247, P1725
   MIYAKE Y, 1974, J BIOL CHEM, V249, P1980
   MORGAN ET, 1985, MOL PHARMACOL, V27, P471
   NEBERT DW, 1968, J BIOL CHEM, V243, P6242
   NEWAZ SN, 1983, CANCER-AM CANCER SOC, V52, P794, DOI 10.1002/1097-0142(19830901)52:5<794::AID-CNCR2820520507>3.0.CO;2-G
   OMURA T, 1964, J BIOL CHEM, V239, P2370
   PHILLIPS AH, 1962, J BIOL CHEM, V237, P2652
   RYAN DE, 1979, J BIOL CHEM, V254, P1365
   SAITO T, 1981, J BIOL CHEM, V256, P984
   Schmucker D. L., 1979, PHARMACOL REV, V30, P445
   SCHMUCKER DL, 1983, EXP GERONTOL, V18, P313, DOI 10.1016/0531-5565(83)90043-8
   SCHMUCKER DL, 1980, P SOC EXP BIOL MED, V165, P178
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   STOHS SJ, 1980, AGE, V3, P11, DOI 10.1007/BF02435000
   STROBEL HW, 1982, CYTOCHROME P450 BIOC, P321
   SUN JQ, 1986, EXP GERONTOL, V21, P65, DOI 10.1016/0531-5565(86)90054-9
   THOMAS PF, 1973, ARCH BIOCH BIOPHYS, V192, P524
   WILLIAMS GH, 1962, J BIOL CHEM, V287, P587
   WOOD AW, 1976, J BIOL CHEM, V251, P4882
   WOOD AW, 1979, J BIOL CHEM, V254, P4408
NR 38
TC 16
Z9 16
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PY 1986
VL 21
IS 6
BP 523
EP 534
DI 10.1016/0531-5565(86)90005-7
PG 12
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA F5737
UT WOS:A1986F573700005
PM 3556453
DA 2024-02-19
ER

PT J
AU Oakes, CC
   Smiraglia, DJ
   Plass, C
   Trasler, JM
   Robaire, B
AF Oakes, CC
   Smiraglia, DJ
   Plass, C
   Trasler, JM
   Robaire, B
TI Aging results in hypermethylation of ribosomal DNA in sperm and liver of
   male rats
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID BROWN-NORWAY RAT; MALE GERM-CELLS; RNA GENES; MOUSE EMBRYO; METHYLATION;
   AGE; HYPOMETHYLATION; 5-AZACYTIDINE; CHROMATIN; PATTERNS
AB There is a concern that increased paternal age may be associated with altered fertility and an increased incidence of birth defects in man. In previous studies of aged male rats, we have found abnormalities in the fertility and in the embryos sired by older males. Aging in mammals is associated with alterations in the content and patterns of DNA methylation in somatic cells; however, little is known in regard to germ cells. A systematic search for global and gene-specific alterations of DNA methylation in germ cells and liver of male rats was done. Restriction landmark genomic scanning, a method used to determine specific methylation patterns of CpG island sequences, has revealed a region of the ribosomal DNA locus that is preferentially hypermethylated with age in both spermatozoa and liver. in contrast, all single copy CpG island sequences in spermatozoa and in liver remain unaltered with age. We further demonstrate that a large proportion of rat ribosomal DNA is normally methylated and that regional and site-specific differences exist in the patterns of methylation between spermatozoa and liver. We conclude that patterns of ribosomal DNA methylation in spermatozoa are vulnerable to the same age-dependent alterations that we observe in normal aging liver. Failure to maintain normal DNA methylation patterns in male germ cells could be one of the mechanisms underlying age-related abnormalities in fertility and progeny outcome.
C1 McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3H 1P3, Canada.
   McGill Univ, Dept Obstet & Gynecol, Montreal, PQ H3H 1P3, Canada.
   McGill Univ, Dept Pediat, Montreal, PQ H3H 1P3, Canada.
   McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada.
   McGill Univ, Montreal Childrens Hosp, Res Inst, Montreal, PQ H3H 1P3, Canada.
   Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Div Human Canc Genet, Columbus, OH 43210 USA.
C3 McGill University; McGill University; McGill University; McGill
   University; McGill University; James Cancer Hospital & Solove Research
   Institute; University System of Ohio; Ohio State University
RP Trasler, JM (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Drummond St, Montreal, PQ H3H 1P3, Canada.
RI Plass, Christoph/H-7192-2014; Smiraglia, Dominic/R-2069-2019; Oakes,
   Christopher C/H-7288-2014
OI Smiraglia, Dominic/0000-0001-8852-1510; Oakes, Christopher
   C/0000-0001-8000-9694
FU PHS HHS [08321] Funding Source: Medline
CR Arnaud P, 2000, MOL CELL BIOL, V20, P3434, DOI 10.1128/MCB.20.10.3434-3441.2000
   BELLVE AR, 1993, METHOD ENZYMOL, V225, P84
   BESTOR TH, 1984, MOL CELL BIOL, V4, P1800, DOI 10.1128/MCB.4.9.1800
   Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102
   BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1485, DOI 10.1093/nar/8.7.1485
   Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9
   Brock GJR, 1997, HUM MOL GENET, V6, P451, DOI 10.1093/hmg/6.3.451
   CHIKARAISHI DM, 1983, NUCLEIC ACIDS RES, V11, P6437, DOI 10.1093/nar/11.18.6437
   CHRISTMAN JK, 1982, ANAL BIOCHEM, V119, P38, DOI 10.1016/0003-2697(82)90662-5
   Comai L, 1999, BRAZ J MED BIOL RES, V32, P1473, DOI 10.1590/S0100-879X1999001200004
   Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558
   Doerksen T, 1996, BIOL REPROD, V55, P1155, DOI 10.1095/biolreprod55.5.1155
   Doerksen T, 2000, ENDOCRINOLOGY, V141, P3235, DOI 10.1210/en.141.9.3235
   GRUENEWALD DA, 1994, J GERONTOL, V49, pB42, DOI 10.1093/geronj/49.2.B42
   Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8
   Issa JP, 2000, CURR TOP MICROBIOL, V249, P101
   JOHNSON R, 1972, NATURE, V240, P412, DOI 10.1038/240412a0
   JUE K, 1995, BIOL REPROD, V53, P561, DOI 10.1095/biolreprod53.3.561
   KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705
   KUNNATH L, 1982, BIOCHIM BIOPHYS ACTA, V699, P264, DOI 10.1016/0167-4781(82)90116-6
   LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0
   McBurney MW, 2001, GENE CHROMOSOME CANC, V32, P311, DOI 10.1002/gcc.1196
   MONK M, 1987, DEVELOPMENT, V99, P371
   Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490
   OKAZAKI Y, 1995, ELECTROPHORESIS, V16, P197, DOI 10.1002/elps.1150160134
   Olek A, 1997, NAT GENET, V17, P275, DOI 10.1038/ng1197-275
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   PETERSON CRD, 1984, ARCH GERONTOL GERIAT, V3, P115, DOI 10.1016/0167-4943(84)90004-9
   Rattan SIS, 1996, EXP GERONTOL, V31, P33, DOI 10.1016/0531-5565(95)02022-5
   Reinhart B, 2002, MOL CELL BIOL, V22, P2089, DOI 10.1128/MCB.22.7.2089-2098.2002
   Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3
   Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501
   Serre V, 1998, FERTIL STERIL, V70, P625, DOI 10.1016/S0015-0282(98)00259-3
   Stancheva I, 1997, NUCLEIC ACIDS RES, V25, P1727, DOI 10.1093/nar/25.9.1727
   SWISSHELM K, 1990, MUTAT RES, V237, P131, DOI 10.1016/0921-8734(90)90019-N
   Syntin P, 2001, J ANDROL, V22, P235
   Thomas S, 1996, MECH AGEING DEV, V92, P101, DOI 10.1016/S0047-6374(96)01805-2
   Tra J, 2002, MECH AGEING DEV, V123, P1487, DOI 10.1016/S0047-6374(02)00080-5
   TRASLER JM, 1990, MOL CELL BIOL, V10, P1828, DOI 10.1128/MCB.10.4.1828
   Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007
   ZIRKIN BR, 1993, J ANDROL, V14, P118
NR 43
TC 145
Z9 153
U1 0
U2 7
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 18
PY 2003
VL 100
IS 4
BP 1775
EP 1780
DI 10.1073/pnas.0437971100
PG 6
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 647CA
UT WOS:000181073000061
PM 12574505
OA Green Published
DA 2024-02-19
ER

PT J
AU ALEMANY, J
   DELACRUZ, MJ
   RONCERO, I
AF ALEMANY, J
   DELACRUZ, MJ
   RONCERO, I
TI EFFECTS OF AGING ON RESPIRATION, ATP LEVELS AND CALCIUM-TRANSPORT IN
   RAT-LIVER MITOCHONDRIA - RESPONSE TO THEOPHYLLINE
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
C1 UNIV COMPLUTENSE MADRID,SCH MED,DEPT BIOCHEM,E-28040 MADRID,SPAIN.
   UNIV ALICANTE,SCH MED,DEPT BIOCHEM,ALICANTE,SPAIN.
   LINUS PAULING INST SCI & MED,PALO ALTO,CA 94306.
C3 Complutense University of Madrid; Universitat d'Alacant
CR [Anonymous], 1979, MEMBRANE BIOCH LAB M
   BORLE AB, 1975, J MEMBRANE BIOL, V21, P125, DOI 10.1007/BF01941066
   BUCH RM, 1984, AM J PHYSL, V247, P939
   CARAFOLI E, 1975, MOL CELL BIOCHEM, V8, P133, DOI 10.1007/BF01792764
   CARAFOLI E, 1979, MEMBRANE BIOCHEM, P41
   CARNEY JM, 1982, BRIT J PHARMACOL, V75, P451, DOI 10.1111/j.1476-5381.1982.tb09161.x
   CHIU YJD, 1980, EXP GERONTOL, V15, P511, DOI 10.1016/0531-5565(80)90003-0
   DELACRUZ MJ, 1986, BIOCHIM BIOPHYS ACTA, V852, P169, DOI 10.1016/0005-2728(86)90220-3
   DELACRUZ MJ, 1984, REV ESP FISIOL, V40, P289
   DELACRUZ MJ, 1980, REV ESP FISIOL, V36, P127
   DELACRUZ MJ, 1984, REV FISIOL, V40, P296
   FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510
   GRINNA LS, 1972, BIOCHIM BIOPHYS ACTA, V288, P347, DOI 10.1016/0005-2736(72)90255-6
   HANSFORD RG, 1983, BIOCHIM BIOPHYS ACTA, V726, P41, DOI 10.1016/0304-4173(83)90010-1
   HARMAN D, 1983, AGE, V6, P86, DOI 10.1007/BF02432509
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   INNIS SM, 1981, BIOCHEM J, V193, P155, DOI 10.1042/bj1930155
   JOSEPH SK, 1983, J BIOL CHEM, V258, P425
   KATZ AM, 1981, CALCIUM PHOSPHATE TR, P59
   Martonosi A, 1972, CURRENT TOPICS MEMBR, V3, P83
   MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8
   MIQUEL J, 1984, EXP GERONTOL, V19, P31, DOI 10.1016/0531-5565(84)90029-9
   MIQUEL J, 1984, AGING CELL FUNCTION, P217
   MIQUEL J, 1981, AGING CELL STRUCTURE, P347
   MURDOCH RJ, 1978, PHARM BASIS THERAPEU, P309
   NOHL H, 1978, EUR J BIOCHEM, V90, P385, DOI 10.1111/j.1432-1033.1978.tb12615.x
   PALMIERI F, 1967, BIOCHIM BIOPHYS ACTA, V143, P625, DOI 10.1016/0005-2728(67)90068-0
   PRESTIPINO G, 1974, FEBS LETT, V45, P99, DOI 10.1016/0014-5793(74)80820-3
   RENNER E, 1984, HEPATOLOGY, V4, P38, DOI 10.1002/hep.1840040107
   STANLEY PE, 1969, ANAL BIOCHEM, V29, P381, DOI 10.1016/0003-2697(69)90323-6
   TANGLIU DD, 1983, J PHARM EXP THER, V224, P183
   TEOLATO S, 1983, NEUROSCI LETT, V38, P57, DOI 10.1016/0304-3940(83)90110-6
   VITORICA J, 1985, MECH AGEING DEV, V29, P255, DOI 10.1016/0047-6374(85)90066-1
   VORBECK ML, 1982, ARCH BIOCHEM BIOPHYS, V214, P67, DOI 10.1016/0003-9861(82)90009-1
   WEINDRUCH RH, 1980, MECH AGEING DEV, V12, P375, DOI 10.1016/0047-6374(80)90070-6
   WILLIAMSON JR, 1981, BIOCHIM BIOPHYS ACTA, V639, P243, DOI 10.1016/0304-4173(81)90012-4
   WILSON PD, 1972, GERONTOLOGY, V18, P36, DOI 10.1159/000211918
NR 37
TC 19
Z9 19
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0531-5565
J9 EXP GERONTOL
JI Exp. Gerontol.
PY 1988
VL 23
IS 1
BP 25
EP 34
DI 10.1016/0531-5565(88)90017-4
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA M9569
UT WOS:A1988M956900004
PM 3384028
DA 2024-02-19
ER

PT J
AU García-Beltrán, A
   Martínez, R
   Porres, JM
   Arrebola, F
   Artero, IR
   Galisteo, M
   Aranda, P
   Kapravelou, G
   López-Jurado, M
AF Garcia-Beltran, Alejandro
   Martinez, Rosario
   Porres, Jesus M.
   Arrebola, Francisco
   Artero, Inmaculada Ruiz
   Galisteo, Milagros
   Aranda, Pilar
   Kapravelou, Garyfallia
   Lopez-Jurado, Maria
TI Novel insights and mechanisms of diet-induced obesity: Mid-term versus
   long-term effects on hepatic transcriptome and antioxidant capacity in
   Sprague-Dawley rats
SO LIFE SCIENCES
LA English
DT Article; Early Access
DE Obesity; Aging; Liver; Glucose &amp; lipid metabolism; Antioxidant
   capacity; Rats
ID HIGH-FAT-DIET; METABOLIC SYNDROME; LIVER; PARAMETERS; RESISTANCE;
   SYSTEM; ASSAY; GENE; STEP
AB Aims: The study of molecular mechanisms related to obesity and associated pathologies like type 2-diabetes and non-alcoholic fatty liver disease requires animal experimental models in which the type of obesogenic diet and length of the experimental period to induce obesity deeply affect the metabolic alterations. Therefore, this study aimed to test the influence of aging along a rat model of diet-induced obesity in gene expression of the hepatic transcriptome. Main methods: A high-fat/high-fructose diet to induce obesity was used. Mid-(13 weeks) and long-term (21 weeks) periods were established. Caloric intake, bodyweight, hepatic fat, fatty acid profile, histological changes, antioxidant activity, and complete transcriptome were analyzed.Key findings: Excess bodyweight, hepatic steatosis and altered lipid histology, modifications in liver antioxidant activity, and dysregulated expression of transcripts related to cell structure, glucose & lipid metabolism, anti-oxidant & detoxifying capacity were found. Modifications in obese and control rats were accounted for by the different lengths of the experimental period studied. Significance: Main mechanisms of hepatic fat accumulation were de novo lipogenesis or altered fatty acid catabolism for mid-or long-term study, respectively. Therefore, the choice of obesity-induction length is a key factor in the model of obesity used as a control for each specific experimental design.
C1 [Garcia-Beltran, Alejandro; Martinez, Rosario; Porres, Jesus M.; Aranda, Pilar; Kapravelou, Garyfallia; Lopez-Jurado, Maria] Univ Granada, Inst Nutr & Food Technol INyTA, Inst Res Sport & Hlth IMUDS, Ctr Biomed Res CIBM,Dept Physiol, Granada 18016, Spain.
   [Arrebola, Francisco; Artero, Inmaculada Ruiz] Univ Granada, Inst Neurosci, Ctr Biomed Res CIBM, Dept Histol, Granada 18016, Spain.
   [Galisteo, Milagros] Univ Granada, Ctr Biomed Res CIBM, Sch Pharm, Dept Pharmacol, Campus Univ Cartuja S-N, Granada 18071, Spain.
C3 University of Granada; University of Granada; University of Granada
RP Porres, JM (corresponding author), Univ Granada, Inst Nutr & Food Technol, Ctr Biomed Res, Avda Conocimiento S-N, Granada 18016, Spain.
EM jmporres@ugr.es
RI ; Porres Foulquie, Jesus Maria/B-6442-2018
OI Garcia-Beltran, Alejandro/0000-0002-9403-6826; Porres Foulquie, Jesus
   Maria/0000-0001-5657-0764
FU Spanish Ministry of Science, Innovation and Universities
   [RTI-2018-100934-B-I00]; University of Granada; Junta de Andalucia
   through FEDER program [BAGR-662-UGR20]
FX This work was supported by the Spanish Ministry of Science, Innovation
   and Universities [grant number RTI-2018-100934-B-I00] and the University
   of Granada and Junta de Andalucia through FEDER program [grant number
   BAGR-662-UGR20] .
CR Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Andrews S., 2010, FastQC: a quality control tool for high throughput sequence data
   [Anonymous], 2007, Official Journal of the European Union, DOI DOI 10.3000/17252555.L_2010.276.ENG
   Barcena B, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101535
   Benard O, 2016, J NUTR BIOCHEM, V31, P10, DOI 10.1016/j.jnutbio.2015.12.012
   Blüher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909
   Chen XM, 2018, LIFE SCI, V203, P291, DOI 10.1016/j.lfs.2018.04.022
   Ciapaite J, 2007, BBA-MOL BASIS DIS, V1772, P307, DOI 10.1016/j.bbadis.2006.10.018
   Ciapaite J, 2011, BBA-MOL CELL BIOL L, V1811, P441, DOI 10.1016/j.bbalip.2011.05.005
   Cohen G, 1996, J NEUROSCI METH, V67, P53, DOI 10.1016/0165-0270(96)00011-8
   Conte M, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00114
   Di Francesco A, 2020, NPJ AGING MECH DIS, V6, DOI 10.1038/s41514-020-00051-6
   Eberlé D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   Ernster L., 1967, METHODS ENZYMOLOGY, VVolume 10, P309, DOI [10.1016/0076-6879(67)10059-1, DOI 10.1016/0076-6879(67)10059-1]
   Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354
   Flamment M, 2012, J PHYSIOL BIOCHEM, V68, P335, DOI 10.1007/s13105-012-0145-3
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gessner DK, 2019, J NUTR, V149, P566, DOI 10.1093/jn/nxy256
   Gonzalez-Torres L., FOOD NUTR RES
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Hruby A, 2016, AM J PUBLIC HEALTH, V106, P1656, DOI 10.2105/AJPH.2016.303326
   Hubrecht RC, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9100754
   Idilman IS, 2016, SEMIN ULTRASOUND CT, V37, P501, DOI 10.1053/j.sult.2016.08.003
   Kapravelou G, 2015, APPL PHYSIOL NUTR ME, V40, P1242, DOI 10.1139/apnm-2015-0141
   Kapravelou G, 2015, J SCI FOOD AGR, V95, P1207, DOI 10.1002/jsfa.6809
   Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Kristiansen MNB, 2019, LIPIDS, V54, P109, DOI 10.1002/lipd.12121
   Lasker S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56538-0
   de la Garza AL, 2023, NUTRIENTS, V15, DOI 10.3390/nu15010086
   LAWRENCE RA, 1974, EXP EYE RES, V18, P563, DOI 10.1016/0014-4835(74)90062-1
   Lee Yoon Kwang, 2018, Liver Res, V2, P209, DOI 10.1016/j.livres.2018.12.001
   LEPAGE G, 1986, J LIPID RES, V27, P114
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li SR, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186973
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Marschall MJM, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105241
   Martínez R, 2020, J NUTR BIOCHEM, V85, DOI 10.1016/j.jnutbio.2020.108456
   Merchan BB, 2016, PPAR RES, V2016, DOI 10.1155/2016/2308249
   Merroun I, 2013, METABOLISM, V62, P1641, DOI 10.1016/j.metabol.2013.06.011
   Metin NO, 2019, DIAGN INTERV RADIOL, V25, P14, DOI 10.5152/dir.2018.17519
   Okunogbe A, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-006351
   Penning TM, 2017, CHEM RES TOXICOL, V30, P162, DOI 10.1021/acs.chemrestox.6b00319
   Pezeshki A, 2015, J NUTR, V145, P2236, DOI 10.3945/jn.115.213843
   Piazzolla VA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9041005
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Salamanca A, 2015, EXP GERONTOL, V69, P9, DOI 10.1016/j.exger.2015.05.009
   Simoes ICM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122871
   Small L, 2018, AM J PHYSIOL-ENDOC M, V314, pE251, DOI 10.1152/ajpendo.00337.2017
   Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383
   Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008
   Trépo E, 2016, J HEPATOL, V65, P399, DOI 10.1016/j.jhep.2016.03.011
   Ukeda H, 1997, ANAL BIOCHEM, V251, P206, DOI 10.1006/abio.1997.2273
   Ulla A, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1799-8
   Unal E, 2015, DIAGN INTERV RADIOL, V21, P105, DOI 10.5152/dir.2014.14360
   Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044
   Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081
   Xie ZQ, 2010, METABOLISM, V59, P554, DOI 10.1016/j.metabol.2009.08.022
   Xu SF, 2018, REDOX REP, V23, P213, DOI 10.1080/13510002.2018.1546985
   Zhukova NV, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-49
NR 63
TC 0
Z9 0
U1 5
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD 2023 JUL 1
PY 2023
VL 324
AR 121746
DI 10.1016/j.lfs.2023.121746
EA MAY 2023
PG 15
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA H9FD5
UT WOS:000998924900001
PM 37121540
OA Green Published, hybrid
DA 2024-02-19
ER

PT J
AU SCHMUCKER, DL
   WANG, RK
AF SCHMUCKER, DL
   WANG, RK
TI EFFECTS OF AGING ON THE PROPERTIES OF RHESUS-MONKEY LIVER MICROSOMAL
   NADPH-CYTOCHROME-C (P-450) REDUCTASE
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
C1 UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA.
   UNIV CALIF SAN FRANCISCO, CTR LIVER, SAN FRANCISCO, CA 94143 USA.
C3 University of California System; University of California San Francisco;
   University of California System; University of California San Francisco
RP SCHMUCKER, DL (corresponding author), VET ADM MED CTR, CELL BIOL & AGING SECT 151E, 4150 CLEMENT ST, SAN FRANCISCO, CA 94121 USA.
CR Adelman RC, 1972, ADV GERONTOLOGICAL R, V4, P1
   ANTHONY LE, 1973, J NUTR, V103, P811, DOI 10.1093/jn/103.6.811
   BAIRD MB, 1975, EXP GERONTOL, V10, P89, DOI 10.1016/0531-5565(75)90039-X
   BIRNBAUM LS, 1980, EXP GERONTOL, V15, P259, DOI 10.1016/0531-5565(80)90030-3
   BRODIE MJ, 1981, EUR J CLIN PHARMACOL, V20, P39, DOI 10.1007/BF00554665
   DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x
   DEAN WL, 1982, J BIOL CHEM, V257, P4679
   DIGNAM JD, 1977, BIOCHEMISTRY-US, V16, P1116, DOI 10.1021/bi00625a014
   FUJITA S, 1985, BIOCHEM PHARMACOL, V34, P1861, DOI 10.1016/0006-2952(85)90666-5
   GERSHON D, 1979, MECH AGEING DEV, V9, P189, DOI 10.1016/0047-6374(79)90098-8
   GOLD G, 1974, BIOCHIM BIOPHYS ACTA, V334, P75, DOI 10.1016/0005-2744(74)90151-X
   GREENBLATT DJ, 1982, NEW ENGL J MED, V306, P1081
   GUM JR, 1981, J BIOL CHEM, V256, P7478
   JAMES OFW, 1982, LIVER AGING LIVER DR, P395
   KAMATAKI T, 1985, J PHARMACOL EXP THER, V233, P222
   KATO R, 1968, JPN J PHARMACOL, V18, P381, DOI 10.1254/jjp.18.381
   KITANI K, 1984, PHARM MORPHOLOGICAL, P105
   KUWADA M, 1985, BIOCHIM BIOPHYS ACTA, V830, P45
   MALONEY AG, 1986, HEPATOLOGY, V6, P282, DOI 10.1002/hep.1840060221
   MASTERS BS, 1965, METHOD ENZYMOL, V10, P565
   MASTERS BSS, 1975, BIOCHEMISTRY-US, V14, P607, DOI 10.1021/bi00674a022
   MASTERS BSS, 1965, J BIOL CHEM, V240, P921
   PORTER TD, 1985, P NATL ACAD SCI USA, V82, P973, DOI 10.1073/pnas.82.4.973
   ROTHSTEIN M, 1979, MECH AGEING DEV, V9, P197, DOI 10.1016/0047-6374(79)90099-X
   SCHMUCKER DL, 1983, EXP GERONTOL, V18, P313, DOI 10.1016/0531-5565(83)90043-8
   SCHMUCKER DL, 1978, PHARMACOL REV, V30, P445
   SCHMUCKER DL, 1985, PHARMACOL REV, V37, P133
   SCHMUCKER DL, 1980, P SOC EXP BIOL MED, V165, P178
   SCHMUCKER DL, 1983, MECH AGEING DEV, V21, P137, DOI 10.1016/0047-6374(83)90070-2
   Segel I.H., 1975, ENZYME KINETICS
   SELLERS EM, 1983, DRUG METAB REV, V14, P225, DOI 10.3109/03602538308991390
   Strobel H W, 1978, Methods Enzymol, V52, P89
   SUTTER MA, 1985, BIOCHEM PHARMACOL, V34, P2983, DOI 10.1016/0006-2952(85)90025-5
   VANBEZOOIJEN CFA, 1984, MECH AGEING DEV, V25, P1, DOI 10.1016/0047-6374(84)90126-X
   VESTAL RF, 1982, J AM GERIATR SOC, V30, P191, DOI 10.1111/j.1532-5415.1982.tb01303.x
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   WOODHOUSE KW, 1984, AGE AGEING, V13, P328, DOI 10.1093/ageing/13.6.328
   YASUKOCHI Y, 1976, J BIOL CHEM, V251, P5337
NR 38
TC 11
Z9 11
U1 0
U2 0
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
EI 1521-009X
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD MAR-APR
PY 1987
VL 15
IS 2
BP 225
EP 232
PG 8
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA G7033
UT WOS:A1987G703300015
PM 2882983
DA 2024-02-19
ER

PT J
AU CHRISTON, R
   HALOUI, RB
   DURAND, G
AF CHRISTON, R
   HALOUI, RB
   DURAND, G
TI DIETARY POLYUNSATURATED FATTY-ACIDS AND AGING MODULATE
   GLUTATHIONE-RELATED ANTIOXIDANTS IN RAT-LIVER
SO JOURNAL OF NUTRITION
LA English
DT Article
DE POLYUNSATURATED FATTY ACIDS; ALPHA-LINOLENIC ACID DEFICIENCY; AGING;
   GLUTATHIONE ANTIOXIDANT SYSTEM; RATS
ID ALPHA-LINOLENIC ACID; LIPID-PEROXIDATION; TISSUE GLUTATHIONE; OXIDATIVE
   STRESS; GSH METABOLISM; AGED RATS; DEFICIENCY; BRAIN; PARAMETERS;
   INHIBITION
AB The effects of dietary polyunsaturated fatty acids (PUFA) on the age-dependent changes in liver glutathione antioxidant system were investigated in male Wistar rats fed diets supplying either balanced amounts of linoleic and alpha-linolenic acids (control) or deficient in alpha-linolenic acid [(n-3) deficient]. The animals were studied at the age of 6 or 24 mo. Glutathione antioxidative metabolism was markedly affected by aging. Cytosolic concentration of reduced glutathione (GSH) was lower (P < 0.01), whereas that of oxidized glutathione (GSSG) as well as the GSSG:GSH ratio were greater (P < 0.001) in the 24-mo-old as compared with the 6-mo-old rats, regardless of the diet. Glutathione peroxidase activities were lower (P < 0.001) in 24-mo-old rats, though more markedly in those fed the control diet. The lipid composition of rat liver microsomal membranes was strongly modified by both diet and aging. The age-related changes mainly involved the polyunsaturated fatty acids. These results suggest that the nature of dietary PUFA and not only their degree of unsaturation affects the cellular glutathione-dependent antioxidant system and thus may modify the age-related changes in metabolic reactions.
RP CHRISTON, R (corresponding author), INRA,CRJ,NUTR & SECUR ALIMENTAIRE LAB,F-78352 JOUY EN JOSAS,FRANCE.
CR ANGULOMONROY O, 1991, J NUTR BIOCHEM, V2, P484, DOI 10.1016/0955-2863(91)90104-D
   ATTAIX D, 1988, BIOCHEM J, V256, P791, DOI 10.1042/bj2560791
   BOURRE JM, 1993, J NEUROCHEM, V60, P2018, DOI 10.1111/j.1471-4159.1993.tb03486.x
   BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRAY TM, 1993, CAN J PHYSIOL PHARM, V71, P746, DOI 10.1139/y93-111
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   CHAUDIERE J, 1984, J BIOL CHEM, V259, P1043
   CHAUDIERE J, 1988, BIOL LIPIDES CHEZ HO, P275
   CHRISTON R, 1992, J NUTR BIOCHEM, V3, P510, DOI 10.1016/0955-2863(92)90072-Q
   DAQUINO M, 1991, FREE RADICAL RES COM, V12-3, P147, DOI 10.3109/10715769109145779
   DEQUIROGA GB, 1990, BIOCHEM J, V272, P247
   DROR Y, 1970, CLIN CHIM ACTA, V28, P291, DOI 10.1016/0009-8981(70)90093-8
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   FAROOQUI MYH, 1984, LIFE SCI, V34, P2413, DOI 10.1016/0024-3205(84)90430-2
   GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HOLMAN RT, 1982, AM J CLIN NUTR, V35, P617, DOI 10.1093/ajcn/35.3.617
   IANTOMASI T, 1993, MECH AGEING DEV, V70, P65, DOI 10.1016/0047-6374(93)90060-5
   KINSELLA JE, 1991, INFORM, V2, P578
   LANG CA, 1992, J LAB CLIN MED, V120, P720
   MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X
   MERTENS K, 1991, DRUG METABOLISM LIVE, P165
   MEYDANI SN, 1987, LIPIDS, V22, P345, DOI 10.1007/BF02534004
   MEYDANI SN, 1992, J NUTR, V122, P1627, DOI 10.1093/jn/122.8.1627
   MURPHY ME, 1992, EUR J BIOCHEM, V210, P139, DOI 10.1111/j.1432-1033.1992.tb17401.x
   NALBONE G, 1989, LIPIDS, V24, P179, DOI 10.1007/BF02535232
   OOKTENS M, 1987, BIOCHEM PHARMACOL, V36, P4015
   PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
   RIKANS LE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P195, DOI 10.1016/0304-4165(91)90061-K
   SAGAI M, 1980, LIFE SCI, V27, P731, DOI 10.1016/0024-3205(80)90326-4
   SASTRE J, 1992, MECH AGEING DEV, V62, P181, DOI 10.1016/0047-6374(92)90054-H
   SIMOPOULOS AP, 1989, J NUTR, V119, P521, DOI 10.1093/jn/119.4.521
   SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V
   TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5
   WAINWRIGHT PE, 1992, NEUROSCI BIOBEHAV R, V16, P193, DOI 10.1016/S0149-7634(05)80180-0
   YAMAMOTO N, 1991, J GERONTOL, V46, pB17, DOI 10.1093/geronj/46.1.B17
   YU BP, 1990, REV BIOL RES AGING, V4, P349
NR 39
TC 26
Z9 40
U1 0
U2 1
PU AMER INST NUTRITION
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0022-3166
J9 J NUTR
JI J. Nutr.
PD DEC
PY 1995
VL 125
IS 12
BP 3062
EP 3070
PG 9
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA TH990
UT WOS:A1995TH99000018
PM 7500185
DA 2024-02-19
ER

PT J
AU Chaurasia, P
   Thakur, MK
AF Chaurasia, P
   Thakur, MK
TI Nucleosomal organization of the rat liver satellite DNA-containing
   chromatin during aging
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE aging; nuclease; chromatin; satellite; rat liver
ID MICROCOCCAL NUCLEASE; AGE; DIGESTION
AB Nucleosomal organization of the satellite DNA-containing chromatin of the liver of young (18 +/- 2 weeks) and old (100 +/- 5 weeks) rats was examined by nucleases and satellite I DNA probe. The satellite DNA-containing chromatin exhibits lower accessibility to endogenous endonucleases in old rats. The nucleosomal repeat length of this chromatin as investigated from digestion with endogenous endonucleases and MNase differs remarkably from bulk chromatin, though it does not alter with age. However, age-dependent loss of satellite DNA is apparent from hybridization results. Furthermore, DNase I analysis of the satellite DNA-containing chromatin al nucleosomal level reveals a relatively loose organization in young rats than old ones. It also shows an altered 10 bp periodicity as compared to bulk chromatin in both ages. These findings establish organizational differences between rat liver bulk and satellite DNA-containing chromatin. They further show that repeat length and altered 10 bp periodicity are similar in young and old, but accessibility to nucleases declines with age. (C) 1997 Elsevier Science Ireland Ltd.
C1 BANARAS HINDU UNIV,CTR ADV STUDY ZOOL,BIOCHEM & MOL BIOL LAB,VARANASI 221005,UTTAR PRADESH,INDIA.
C3 Banaras Hindu University (BHU)
CR Ausubel FM, 1995, SHORT PROTOCOLS MOL
   BURGOYNE LA, 1978, CELL NUCL, V4
   CHATURVEDI MM, 1983, BIOCHEM INT, V6, P357
   CHAURASIA P, 1996, THESIS BANARAS HINDU
   COMPTON JL, 1976, P NATL ACAD SCI USA, V73, P4382, DOI 10.1073/pnas.73.12.4382
   DELLORCO RT, 1983, MECH AGEING DEV, V21, P273, DOI 10.1016/0047-6374(83)90046-5
   GAUBATZ J, 1979, FED PROC, V38, P1973
   GAUBATZ J, 1979, J GERONTOL, V34, P672, DOI 10.1093/geronj/34.5.672
   Gaubatz JW, 1995, MOL BASIS AGING, VCRC Press, P71
   IGOKEMENES T, 1985, STRUCTURE FUNCTION G
   KANUNGO MS, 1994, GENES AGING
   KORNBERG RD, 1992, ANNU REV CELL BIOL, V8, P563, DOI 10.1146/annurev.cb.08.110192.003023
   LEWIN B, 1994, CELL, V69, P905
   MAKAROV VL, 1993, CELL, V73, P775, DOI 10.1016/0092-8674(93)90256-P
   Mukherjee S, 1996, MOL BIOL REP, V22, P59, DOI 10.1007/BF00996306
   NOLL M, 1974, NUCLEIC ACIDS RES, V1, P1573, DOI 10.1093/nar/1.11.1573
   OMORI A, 1980, NUCLEIC ACIDS RES, V8, P5363, DOI 10.1093/nar/8.22.5363
   PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265
   PEARSON EC, 1984, EUR J BIOCHEM, V144, P353, DOI 10.1111/j.1432-1033.1984.tb08471.x
   SEALY L, 1981, J MOL BIOL, V145, P291, DOI 10.1016/0022-2836(81)90207-2
   THAKUR MK, 1984, MECH AGEING DEV, V27, P263, DOI 10.1016/0047-6374(84)90052-6
   van Holde K. E., 1989, Chromatin
   VANDERBILT JN, 1982, J BIOL CHEM, V257, P3009
   Wolffe AP, 1996, TRENDS GENET, V12, P58, DOI 10.1016/0168-9525(96)81401-6
NR 24
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD APR
PY 1997
VL 95
IS 1-2
BP 63
EP 70
DI 10.1016/S0047-6374(96)01843-X
PG 8
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA WX427
UT WOS:A1997WX42700005
PM 9152961
DA 2024-02-19
ER

PT J
AU RIKANS, LE
   KOSANKE, SD
AF RIKANS, LE
   KOSANKE, SD
TI EFFECT OF AGING ON LIVER GLUTATHIONE LEVELS AND HEPATOCELLULAR INJURY
   FROM CARBON-TETRACHLORIDE, ALLYL ALCOHOL OR GALACTOSAMINE
SO DRUG AND CHEMICAL TOXICOLOGY
LA English
DT Article
C1 UNIV OKLAHOMA,HLTH SCI CTR,DEPT PATHOL,OKLAHOMA CITY,OK 73190.
C3 University of Oklahoma System; University of Oklahoma Health Sciences
   Center
RP RIKANS, LE (corresponding author), UNIV OKLAHOMA,HLTH SCI CTR,DEPT PHARMACOL,OKLAHOMA CITY,OK 73190, USA.
FU NIA NIH HHS [AG03642] Funding Source: Medline
CR BARBER DJ, 1983, TOXICOL LETT, V15, P283, DOI 10.1016/0378-4274(83)90145-5
   BARTOC R, 1975, EXP GERONTOL, V10, P161, DOI 10.1016/0531-5565(75)90026-1
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   BLACK M, 1975, GASTROENTEROLOGY, V69, P289
   DECKER K, 1972, P183
   HARISCH G, 1983, H-S Z PHYSIOL CHEM, V364, P313
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   JONES JK, 1983, PSYCHOPHARMACOL BULL, V19, P24
   PATEL JM, 1983, DRUG METAB DISPOS, V11, P164
   POULSEN HE, 1981, SCAND J CLIN LAB INV, V41, P573, DOI 10.3109/00365518109090500
   RECKNAGE RO, 1967, PHARMACOL REV, V19, P145
   REES KR, 1967, BIOCHEM J, V104, P757, DOI 10.1042/bj1040757
   REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56
   RIKANS LE, 1982, J PHARMACOL EXP THER, V220, P574
   SCHMUCKER DL, 1980, EXP GERONTOL, V15, P321, DOI 10.1016/0531-5565(80)90037-6
   STOHS SJ, 1980, AGE, V3, P11, DOI 10.1007/BF02435000
   UTILI R, 1977, GASTROENTEROLOGY, V72, P610
   YOSHIKAWA T, 1982, DIGESTION, V25, P222, DOI 10.1159/000198836
   ZIMMERMAN HJ, 1982, TOXICOLOGY LIVER, P29
NR 19
TC 28
Z9 28
U1 0
U2 0
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0148-0545
J9 DRUG CHEM TOXICOL
JI Drug Chem. Toxicol.
PY 1984
VL 7
IS 6
BP 595
EP 604
DI 10.3109/01480548409042822
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry; Pharmacology & Pharmacy; Toxicology
GA AFG88
UT WOS:A1984AFG8800006
PM 6534734
DA 2024-02-19
ER

PT J
AU BOURRE, JM
   PICIOTTI, M
AF BOURRE, JM
   PICIOTTI, M
TI DELTA-6 DESATURATION OF ALPHA-LINOLENIC ACID IN BRAIN AND LIVER DURING
   DEVELOPMENT AND AGING IN THE MOUSE
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE BRAIN; DEVELOPMENT; AGING; MEMBRANE; ESSENTIAL FATTY ACID;
   ALPHA-LINOLENIC ACID; CERVONIC ACID; DOCOSAHEXAENOIC ACID; DESATURASE
ID N-3 FATTY-ACIDS; RAT-BRAIN; DELTA-6-DESATURASE ACTIVITY; CHAIN
   ELONGATION; DIETARY-FAT; MICROSOMES; DEFICIENCY; MEMBRANES; RECOVERY;
   PLASMA
AB During pre- and postnatal brain development, delta-6 desaturase decreased dramatically (approx. 4-fold) up to weaning, slowly (2-fold) up to 3 months, and remained nearly constant and extremely low thereafter.  In contrast, in liver, the activity increased approximately 7-fold between day 3 before birth and day 11 after birth, then decreased slightly up to weaning, and was constant up to 9 months.  Subsequently, the activity decreased during aging (4-fold between 9 and 26 months).  During aging, the reduced activity in liver and the very low activity in brain raise the question of the origin of polyunsaturated fatty acids participating in the physiological turnover of brain membranes.
RP BOURRE, JM (corresponding author), HOP FERNAND WIDAL,INSERM,U26,200 RUE FG ST DENIS,F-75475 PARIS 10,FRANCE.
CR BERNSOHN J, 1974, BIOCHEM BIOPH RES CO, V57, P293, DOI 10.1016/S0006-291X(74)80389-X
   BJERVE KS, 1987, AM J CLIN NUTR, V46, P570, DOI 10.1093/ajcn/46.4.570
   BLOND JP, 1984, REPROD NUTR DEV, V24, P1, DOI 10.1051/rnd:19840101
   BORDONI A, 1988, BIOCHEM INT, V17, P1001
   BOURRE JM, 1984, J NEUROCHEM, V43, P342, DOI 10.1111/j.1471-4159.1984.tb00906.x
   BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880
   BOURRE JM, 1989, J NUTR, V119, P15, DOI 10.1093/jn/119.1.15
   BOURRE JM, 1990, LIPIDS, V25, P354, DOI 10.1007/BF02544347
   BOURRE JM, 1983, J NEUROCHEM, V41, P1234, DOI 10.1111/j.1471-4159.1983.tb00817.x
   CARREAU JP, 1981, INT J BIOCHEM, V13, P831, DOI 10.1016/0020-711X(81)90103-8
   CARREAU JP, 1979, J NEUROCHEM, V32, P659, DOI 10.1111/j.1471-4159.1979.tb00403.x
   CHAMBAZ J, 1985, BIOL NEONATE, V47, P136, DOI 10.1159/000242104
   COOK HW, 1978, J NEUROCHEM, V30, P1327, DOI 10.1111/j.1471-4159.1978.tb10463.x
   COOK HW, 1982, ARCH BIOCHEM BIOPHYS, V214, P695, DOI 10.1016/0003-9861(82)90076-5
   CRAWFORD M A, 1981, Progress in Lipid Research, V20, P31, DOI 10.1016/0163-7827(81)90011-4
   FOOT M, 1982, BIOCHEM J, V208, P631, DOI 10.1042/bj2080631
   GARG ML, 1988, BIOCHEM J, V249, P351, DOI 10.1042/bj2490351
   HARGREAVES KM, 1987, BIOCHIM BIOPHYS ACTA, V918, P97, DOI 10.1016/0005-2760(87)90183-4
   HOLMAN RT, 1982, AM J CLIN NUTR, V35, P617, DOI 10.1093/ajcn/35.3.617
   HOLMAN RT, 1986, PROG LIPID RES, V25, P29, DOI 10.1016/0163-7827(86)90008-1
   HOMAYOUN P, 1988, J NEUROCHEM, V51, P45, DOI 10.1111/j.1471-4159.1988.tb04833.x
   HORROBIN DF, 1984, LIPIDS, V19, P806, DOI 10.1007/BF02534476
   HORROBIN DF, 1981, MED HYPOTHESES, V7, P1211, DOI 10.1016/0306-9877(81)90064-5
   LAMPTEY MS, 1976, J NUTR, V106, P86, DOI 10.1093/jn/106.1.86
   NEURINGER M, 1988, ANNU REV NUTR, V8, P517, DOI 10.1146/annurev.nu.08.070188.002505
   PURVIS JM, 1983, COMP BIOCHEM PHYS B, V75, P199, DOI 10.1016/0305-0491(83)90313-9
   RAVEL D, 1985, BIOCHIM BIOPHYS ACTA, V833, P161, DOI 10.1016/0005-2760(85)90264-4
   RUDIN DO, 1982, MED HYPOTHESES, V8, P17, DOI 10.1016/0306-9877(82)90088-3
   SANDERS TAB, 1987, ANN NUTR METAB, V31, P349, DOI 10.1159/000177293
   SARDA N, 1991, BIOCHIM BIOPHYS ACTA, V1081, P75, DOI 10.1016/0005-2760(91)90252-D
   STROUVEVALLET C, 1971, BIOCHIMIE, V53, P699
   ULMANN L, 1991, LIPIDS, V26, P127, DOI 10.1007/BF02544006
   YAMAMOTO N, 1987, J LIPID RES, V28, P144
   YOUYOU A, 1986, J NEUROCHEM, V46, P224, DOI 10.1111/j.1471-4159.1986.tb12950.x
NR 34
TC 59
Z9 63
U1 0
U2 1
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0304-3940
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD JUL 6
PY 1992
VL 141
IS 1
BP 65
EP 68
DI 10.1016/0304-3940(92)90335-5
PG 4
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA JC930
UT WOS:A1992JC93000016
PM 1508402
DA 2024-02-19
ER

PT J
AU Edward, OC
   Thomas, SS
   Cha, KO
   Jung, HA
   Han, AN
   Cha, YS
AF Edward, Olivet Chiamaka
   Thomas, Shalom Sara
   Cha, Kyung-Ok
   Jung, Hyun-Ah
   Han, Anna
   Cha, Youn-Soo
TI Green perilla leaf extract ameliorates long-term oxidative stress
   induced by a high-fat diet in aging mice
SO NUTRITION RESEARCH AND PRACTICE
LA English
DT Article
DE Aging; oxidative stress; antioxidant; high-fat diet; perilla
ID ROSMARINIC ACID; ANTIOXIDANT ACTIVITY; FLAVONOID CONTENT; AQUEOUS
   EXTRACT; FRUTESCENS; SUPPLEMENTATION; SOLVENT; OBESITY; LEAVES; DAMAGE
AB BACKGROUND/OBJECTIVES: Oxidative stress is caused by an imbalance between harmful free radicals and antioxidants. Long-term oxidative stress can lead to an "exhausted" status of antioxidant defense system triggering development of metabolic syndrome and chronic inflammation. Green perilla (Perilla frutescens) is commonly used in Asian cuisines and traditional medicine in southeast Asia. Green perilla possesses numerous beneficial effects including anti-inflammatory and antioxidant functions. To investigate the potentials of green perilla leaf extract (PE) on oxidative stress, we induced oxidative stress by high-fat diet (HFD) in aging mice.MATERIALS/METHODS: C57BL/6J male mice were fed HFD continuously for 53 weeks. Then, mice were divided into three groups for 12 weeks: a normal diet fed reference group (NDcon), high-fat diet fed group (HDcon), and high-fat diet PE treated group (HDPE, 400 mg/kg of body weight). Biochemical analyses of serum and liver tissues were performed to assess metabolic and inflammatory damage and oxidative status. Hepatic gene expression of oxidative stress and inflammation related enzymes were evaluated by quantitative real-time polymerase chain reaction (qRT-PCR).RESULTS: PE improved hepatopathology. PE also improved the lipid profiles and antioxidant enzymes, including hepatic glutathione peroxidase (GPx) and superoxide dismutase (SOD) and catalase (CAT) in serum and liver. Hepatic gene expressions of antioxidant and anti-inflammatory related enzymes, such as SOD-1, CAT, interleukin 4 (IL-4) and nuclear factor erythroid 2-related factor (Nrf2) were significantly enhanced by PE. PE also reduced the levels of hydrogen peroxide (H2O2) and malondialdehyde (MDA) in the serum and liver; moreover, PE suppressed hepatic gene expression involved in pro-inflammatory response; Cyclooxygenase-2 (COX-2), nitric oxide synthase (NOS), interleukin 1 beta (IL-1 beta), and interleukin 6 (IL-6).CONCLUSIONS: This research opens opportunities for further investigations of PE as a functional food and possible anti-aging agent due to its attenuative effects against oxidative stress, resulting from HFD and aging in the future.
C1 [Edward, Olivet Chiamaka; Jung, Hyun-Ah; Han, Anna; Cha, Youn-Soo] Jeonbuk Natl Univ, Dept Food Sci & Human Nutr, Jeonju 54896, South Korea.
   [Thomas, Shalom Sara] Univ Massachusetts, Dept Nutr, Amherst, MA 01007 USA.
   [Cha, Kyung-Ok] Wanju Cty Off, Food & Policy Div, Wonju 55352, South Korea.
   [Han, Anna; Cha, Youn-Soo] Jeonbuk Natl Univ, K Food Res Ctr, Jeonju 54896, South Korea.
   [Cha, Youn-Soo] Jeonbuk Natl Univ, Dept Food Sci & Human Nutr, 567 Baekje Daero, Jeonju 54896, Guam, South Korea.
C3 Jeonbuk National University; University of Massachusetts System;
   University of Massachusetts Amherst; Jeonbuk National University;
   Jeonbuk National University
RP Cha, YS (corresponding author), Jeonbuk Natl Univ, Dept Food Sci & Human Nutr, 567 Baekje Daero, Jeonju 54896, Guam, South Korea.
EM cha8@jbnu.ac.kr
OI Edward, Olivet Chiamaka/0000-0003-4794-5688; Thomas, Shalom
   Sara/0000-0003-1198-3690
CR Al-Dalaen SM., 2014, AM J BIOSCI BIOENG, V2, P60, DOI DOI 10.11648/J.BIO.20140205.11
   Attari VE, 2016, EUR J NUTR, V55, P2129, DOI 10.1007/s00394-015-1027-6
   Ballal K, 2010, MOL CELL BIOCHEM, V344, P221, DOI 10.1007/s11010-010-0546-y
   Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118
   Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205
   Bruunsgaard H, 2003, CLIN EXP IMMUNOL, V132, P24, DOI 10.1046/j.1365-2249.2003.02137.x
   Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016
   Camps J, 2014, ADV EXP MED BIOL, V824, P1, DOI 10.1007/978-3-319-07320-0_1
   Ceriello Antonio, 2006, Endocr Pract, V12 Suppl 1, P60
   Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794
   Cichoz-Lach H, 2014, WORLD J GASTROENTERO, V20, P8082, DOI 10.3748/wjg.v20.i25.8082
   da Silva JK, 2013, FOOD RES INT, V53, P882, DOI 10.1016/j.foodres.2012.12.043
   Do QD, 2014, J FOOD DRUG ANAL, V22, P296, DOI 10.1016/j.jfda.2013.11.001
   Ekor M, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00177
   Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
   GIUGLIANO D, 1995, METABOLISM, V44, P363, DOI 10.1016/0026-0495(95)90167-1
   Heo JC, 2011, INT J MOL MED, V28, P733, DOI 10.3892/ijmm.2011.763
   Hong E, 2011, J FOOD BIOCHEM, V35, P1637, DOI 10.1111/j.1745-4514.2010.00481.x
   Hong E, 2010, INT J FOOD SCI TECH, V45, P1353, DOI 10.1111/j.1365-2621.2010.02250.x
   Huang BP, 2014, MOL MED REP, V10, P1077, DOI 10.3892/mmr.2014.2298
   Jun HI, 2014, FOOD CHEM, V148, P367, DOI 10.1016/j.foodchem.2013.10.028
   Kartha GK, 2008, ACTA DIABETOL, V45, P75, DOI 10.1007/s00592-008-0025-z
   Kharaeva Z, 2009, NUTRITION, V25, P295, DOI 10.1016/j.nut.2008.08.015
   Kim J, 2016, AGING-US, V8, P2392, DOI 10.18632/aging.101060
   Kim MJ, 2009, PHYTOTHER RES, V23, P1685, DOI 10.1002/ptr.2811
   Kim MK, 2007, FOOD CHEM TOXICOL, V45, P1738, DOI 10.1016/j.fct.2007.03.009
   Lee YH, 2017, J FOOD DRUG ANAL, V25, P776, DOI 10.1016/j.jfda.2016.09.003
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Mehta S.K., 2015, BASIC PRINCIPLES CLI, P59, DOI DOI 10.5772/61884
   Moreno-Fernández S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101502
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Osakabe N, 2002, FREE RADICAL BIO MED, V33, P798, DOI 10.1016/S0891-5849(02)00970-X
   Pandareesh MD, 2018, J ALZHEIMERS DIS, V64, P1295, DOI [10.3233/JAD-180361, 10.3233/jad-180361]
   Peng YY, 2005, J AGR FOOD CHEM, V53, P8141, DOI 10.1021/jf051360e
   Pichiah PBT, 2015, J SCI FOOD AGR, V95, P3150, DOI 10.1002/jsfa.7054
   Pizzino G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/8416763
   Raval J, 2006, FREE RADICAL BIO MED, V41, P1645, DOI 10.1016/j.freeradbiomed.2006.07.023
   Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59
   Tepe B, 2005, FOOD CHEM, V90, P333, DOI 10.1016/j.foodchem.2003.09.013
   The State Pharmacopoeia Commission of P. R. China, 2015, PHARMACOPOEIA PEOPLE, P338
   Thomas SS, 2020, NUTR RES PRACT, V14, P425, DOI 10.4162/nrp.2020.14.5.425
   Thomas SS, 2020, J MED FOOD, V23, P818, DOI 10.1089/jmf.2019.4675
   Tian S., 2012, Zhong Hua Yang Sheng Bao Jian, V9, P71
   Webster Guy F, 2017, Dermatol Online J, V23
   Yang SY, 2012, FOOD CHEM, V133, P337, DOI 10.1016/j.foodchem.2012.01.037
   Yokota T, 2009, AM J PHYSIOL-HEART C, V297, pH1069, DOI 10.1152/ajpheart.00267.2009
   Zheleva-Dimitrova D, 2010, PHARMACOGN MAG, V6, P74, DOI 10.4103/0973-1296.62889
   Zhu FX, 2014, J AGR FOOD CHEM, V62, P885, DOI 10.1021/jf404318j
NR 51
TC 1
Z9 1
U1 1
U2 7
PU KOREAN NUTRITION SOC
PI SEOUL
PA 804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-1457
EI 2005-6168
J9 NUTR RES PRACT
JI Nutr. Res. Pract.
PD OCT
PY 2022
VL 16
IS 5
BP 549
EP 564
DI 10.4162/nrp.2022.16.5.549
PG 16
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 5C1UA
UT WOS:000864050800001
PM 36238378
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU YEN, TC
   KING, KL
   LEE, HC
   YEH, SH
   WEI, YH
AF YEN, TC
   KING, KL
   LEE, HC
   YEH, SH
   WEI, YH
TI AGE-DEPENDENT INCREASE OF MITOCHONDRIAL-DNA DELETIONS TOGETHER WITH
   LIPID PEROXIDES AND SUPEROXIDE-DISMUTASE IN HUMAN LIVER-MITOCHONDRIA
SO FREE RADICAL BIOLOGY AND MEDICINE
LA English
DT Article
DE AGING; MITOCHONDRIAL DNA; LIPID PEROXIDES; MANGANESE SUPEROXIDE
   DISMUTASE; FREE RADICALS
ID AGING HUMAN TISSUES; FREE-RADICAL THEORY; RAT-LIVER; DEGENERATIVE
   DISEASES; OXIDATIVE STRESS; DIETARY RESTRICTION; DAMAGE; BRAIN;
   IRRADIATION; MUTATIONS
AB We previously reported an age-dependent deterioration of mitochondrial respiration as well as two age-associated mitochondrial DNA (mtDNA) deletions in the human liver. In this study, we further determined the relative quantities of the deleted mtDNAs in liver biopsies from 64 subjects of different ages. The results showed that both mtDNA deletions increase in frequency and quantity with age. Moreover, we measured hepatic lipid peroxides (malondialdehyde; MDA) of isolated mitochondria and manganese superoxide dismutase (Mn-SOD) activity of submitochondrial particles. We found a significant age-dependent increase in both MDA and Mn-SOD levels in liver mitochondria. These results confirm the previous contention that enhanced generation of lipid peroxides in the mitochondria during the aging process may damage mtDNA, and mtDNA deletions may be one of the important factors contributing to aging in humans.
C1 NATL YANG MING MED COLL, DEPT BIOCHEM, TAIPEI 112, TAIWAN.
   VET GEN HOSP, DEPT NUCL MED, TAIPEI, TAIWAN.
   VET GEN HOSP, DIV NUCL MED, TAIPEI, TAIWAN.
   VET GEN HOSP, DIV GEN SURG, TAIPEI, TAIWAN.
C3 National Yang Ming Chiao Tung University
RI Lee, Hsin-Chen/H-6767-2019; Wei, Yau-Huei/ABA-6841-2021
OI Wei, Yau-Huei/0000-0002-6429-2546; Lee, Hsin-Chen/0000-0001-7455-9593
CR AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P
   ASANO K, 1992, MECH AGEING DEV, V64, P85, DOI 10.1016/0047-6374(92)90098-X
   ASANO K, 1991, MECH AGEING DEV, V60, P275, DOI 10.1016/0047-6374(91)90040-7
   BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CHUNG MH, 1992, FREE RADICAL BIO MED, V12, P523, DOI 10.1016/0891-5849(92)90105-P
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6
   CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812
   CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   Crapo J D, 1978, Methods Enzymol, V53, P382
   DUTTON MS, 1984, BIOELECTROMAGNETICS, V5, P39, DOI 10.1002/bem.2250050105
   ERICKSON GA, 1987, INT J RADIAT BIOL, V51, P147, DOI 10.1080/09553008714550581
   FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706
   GOLDSTEI.AL, 1965, ARCH BIOCHEM BIOPHYS, V109, P442, DOI 10.1016/0003-9861(65)90388-7
   HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I
   HIRAMATSU M, 1992, J NEUROCHEM, V58, P1160, DOI 10.1111/j.1471-4159.1992.tb09375.x
   ITOIZ ME, 1982, HISTOCHEM J, V14, P205, DOI 10.1007/BF01041215
   JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   KRISTAL BS, 1992, J GERONTOL, V47, pB107, DOI 10.1093/geronj/47.4.B107
   LINNANE AW, 1990, BIOCHEM INT, V22, P1067
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NISTICO G, 1992, FREE RADICAL BIO MED, V12, P177, DOI 10.1016/0891-5849(92)90024-B
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   OLIVER PD, 1992, INVEST OPHTH VIS SCI, V33, P1909
   PACIFICI RE, 1991, GERONTOLOGY, V37, P166
   PACKER L, 1989, ANN NY ACAD SCI, V570, P1
   PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1
   POOT M, 1991, MUTAT RES, V256, P177, DOI 10.1016/0921-8734(91)90010-9
   RANAI E, 1984, ACTA PHYSL HUNG, V59, P341
   RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602
   RICHTER C, 1992, MUTAT RES, V275, P249, DOI 10.1016/0921-8734(92)90029-O
   RONAI E, 1984, EXPERIENTIA, V40, P1375
   SANTIAGO LA, 1993, NEUROCHEM RES, V18, P711, DOI 10.1007/BF00966786
   SCAIFE JF, 1962, CAN J BIOCHEM PHYS, V40, P1025
   SCHAPIRA AHV, 1992, MUTAT RES, V275, P133, DOI 10.1016/0921-8734(92)90018-K
   SEMSEI I, 1991, MECH AGEING DEV, V58, P13, DOI 10.1016/0047-6374(91)90116-H
   SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V
   SUMMERS RW, 1989, FREE RADICAL BIO MED, V6, P261, DOI 10.1016/0891-5849(89)90053-1
   THOMSON JF, 1966, RADIAT RES, V29, P121, DOI 10.2307/3572096
   THOMSON JF, 1964, RADIAT RES, V21, P46, DOI 10.2307/3571513
   TOMKINSON AE, 1990, NUCLEIC ACIDS RES, V18, P929, DOI 10.1093/nar/18.4.929
   TORII K, 1992, AM J RESP CELL MOL, V6, P543, DOI 10.1165/ajrcmb/6.5.543
   UYSAL M, 1989, MECH AGEING DEV, V48, P85, DOI 10.1016/0047-6374(89)90028-6
   VANELLA A, 1982, GERONTOLOGY, V28, P108, DOI 10.1159/000212519
   VERCESI A, 1978, J BIOL CHEM, V253, P6379
   WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953
   WALLACE DC, 1987, BIRTH DEFECTS, V23, P883
   WEI YH, 1992, MUTAT RES, V275, P145, DOI 10.1016/0921-8734(92)90019-L
   YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E
   YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0
   YEN TC, 1992, BIOCHEM INT, V26, P457
   YEN TC, 1991, NUCL SCI J, V28, P693
   YUKAWA O, 1985, INT J RADIAT BIOL, V48, P107, DOI 10.1080/09553008514551111
   ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7
NR 62
TC 84
Z9 91
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0891-5849
EI 1873-4596
J9 FREE RADICAL BIO MED
JI Free Radic. Biol. Med.
PD FEB
PY 1994
VL 16
IS 2
BP 207
EP 214
DI 10.1016/0891-5849(94)90145-7
PG 8
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA MW774
UT WOS:A1994MW77400009
PM 8005516
DA 2024-02-19
ER

PT J
AU Kim, HS
   Arai, H
   Arita, M
   Sato, Y
   Ogihara, T
   Tamai, H
   Inoue, K
   Mino, M
AF Kim, HS
   Arai, H
   Arita, M
   Sato, Y
   Ogihara, T
   Tamai, H
   Inoue, K
   Mino, M
TI Age-related changes of alpha-tocopherol transfer protein expression in
   rat liver
SO JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY
LA English
DT Article
DE alpha-tocopherol transfer protein; alpha-tocopherol; gamma-tocopherol;
   discrimination of tocopherols; aging; primary culture; hepatocyte; cell
   differentiation
ID VITAMIN-E-DEFICIENCY; BINDING-PROTEIN; LIPOPROTEINS; HEPATOCYTES; CELLS
AB Developmental changes in expression of alpha-tocopherol transfer protein (alpha-TTP) after birth were investigated using rats with respect to plasma changes of tocopherols. The expression of alpha-TTP in the neonatal rat liver, which was very low immediately after birth, increased steadily during the two weeks of life before weanling and reached the adult level at four weeks. During the suckling period, the plasma ratio of alpha-tocopherol to gamma-tocopherol linearly increased, because plasma alpha-tocopherol which was low immediately after birth, increased rapidly during the period, while gamma-tocopherol remained unchanged. The increase in the ratio seemed to correlate with the developmental expression of alpha-TTP in the liver during this period. The ratio also reached the adult level after four weeks. The expression of alpha-TTP was investigated using primary cultured rat hepatocytes. The expression of alpha-TTP was found to be extremely low after 20 h of culture. The decrease in alpha-TTP expression was exacerbated by adding epidermal growth factor to the culture medium and was inhibited by adding dexamethasone. These observations suggest that expression of alpha-TTP may be affected by the state of hepatic differentiation.
C1 UNIV TOKYO,FAC PHARMACEUT SCI,DEPT HLTH CHEM,TOKYO 113,JAPAN.
C3 University of Tokyo
RP Kim, HS (corresponding author), OSAKA MED COLL,DEPT PEDIAT,TAKATSUKI,OSAKA 569,JAPAN.
RI Kim, Han-Suk/D-5788-2011
OI Ogihara, Tohru/0000-0001-8662-2908; Arita, Makoto/0000-0001-9902-0463
CR ARITA M, 1995, BIOCHEM J, V306, P437, DOI 10.1042/bj3060437
   BAFFET G, 1982, BIOCHEM BIOPH RES CO, V109, P507, DOI 10.1016/0006-291X(82)91750-8
   BJORNEBOE A, 1987, BIOCHIM BIOPHYS ACTA, V922, P199, DOI 10.1016/0005-2760(87)90155-X
   CATIGNANI GL, 1977, BIOCHIM BIOPHYS ACTA, V497, P349, DOI 10.1016/0304-4165(77)90192-1
   KOBAYASHI H, 1975, BIOCHIM BIOPHYS ACTA, V380, P282
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MINO M, 1980, J NUTR SCI VITAMINOL, V26, P103, DOI 10.3177/jnsv.26.103
   OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141
   SATO Y, 1993, J BIOL CHEM, V268, P17705
   SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J
   TAMAI H, 1988, INT J VITAM NUTR RES, V58, P202
   TRABER MG, 1989, AM J CLIN NUTR, V49, P517, DOI 10.1093/ajcn/49.3.517
   TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452
   TRABER MG, 1993, J LIPID RES, V34, P201
   TRABER MG, 1993, J LIPID RES, V34, P343
NR 15
TC 35
Z9 40
U1 0
U2 8
PU CENTER ACAD PUBL JAPAN
PI TOKYO
PA C/O BUSINESS CTR ACAD SOC JPN, 16-9 HONKOMAGOME 5-CHOME BUNKYO-KU, TOKYO
   113, JAPAN
SN 0301-4800
J9 J NUTR SCI VITAMINOL
JI J. Nutr. Sci. Vitaminol.
PD FEB
PY 1996
VL 42
IS 1
BP 11
EP 18
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA TX711
UT WOS:A1996TX71100002
PM 8708817
OA gold
DA 2024-02-19
ER

PT J
AU Counts, JL
   Kaznowski, JM
   McClain, RM
   Goodman, JI
AF Counts, JL
   Kaznowski, JM
   McClain, RM
   Goodman, JI
TI 5-methylcytosine is present in the 5' flanking region of Ha-ras in mouse
   liver and increases with ageing
SO INTERNATIONAL JOURNAL OF CANCER
LA English
DT Article
ID DNA METHYLATION; CPG-ISLAND; GENE; TUMORS; TISSUES; B6C3F1;
   HEPATOCARCINOGENESIS; METHYLTRANSFERASES; EXPRESSION; MUTATIONS
AB Modifications to DNA-5-methylcytosine (5MeC) content (i.e., alterations in the level of 5MeC) constitute epigenetic events. In general, hypomethylation of a gene is necessary but not sufficient far expression, while methylated genes typically are quiescent. Ha-ras is an oncogene commonly implicated in murine liver tumorigenesis, often, though not always, involving mutation. A PCR-based approach using pre-PCR digestion with methylation sensitive enzymes was employed to determine the 5MeC content of the 5' flanking region of this gene in (i) B6C3F(1) and C57BL/6 mouse liver from young animals (4 months old) and (ii) B6C3F(1) mouse liver from aged animals (24 months old). Two segments of the 5' flanking region of Ha-ras were examined. We demonstrate the presence of 5MeC in a portion of the 5' flanking region of Ha-ras that does not share characteristics of a CpG island, while a region that shares CpG island characteristics is primarily unmethylated. Differences in methylation status in these areas of Ha-ras were not observed between B6C3F(1) and C57BL/6 mouse livers. Increases in methylation status were observed with ageing in B6C3F(1) mouse liver. These data provide a role for methylation in regulating Ha-ras expression in mouse liver. Ha-ras in human liver has been reported to be unmethylated. There are substantial sequence differences in a key region of the 5' flanking region of Ha-ras in mice as compared to humans. These differences in DNA methylation and sequence may, in part, provide a basis for the frequent involvement of Ha-ms in mouse liver tumors and its virtual lack of involvement in human tumors. (C) 1997 Wiley-Liss, Inc.
C1 MICHIGAN STATE UNIV,DEPT PHARMACOL & TOXICOL,E LANSING,MI 48824.
   HOFFMANN LA ROCHE INC,PRECLIN DEV,NUTLEY,NJ 07110.
C3 Michigan State University; Roche Holding
FU NIEHS NIH HHS [ES-05299] Funding Source: Medline
CR BORRELLO MG, 1992, ONCOGENE, V7, P269
   BROWN K, 1988, MOL CARCINOGEN, V1, P161, DOI 10.1002/mc.2940010304
   BUCHMANN A, 1991, P NATL ACAD SCI USA, V88, P911, DOI 10.1073/pnas.88.3.911
   CLARK SJ, 1995, NAT GENET, V10, P20, DOI 10.1038/ng0595-20
   COONEY CA, 1993, GROWTH DEVELOP AGING, V57, P261
   COUNTS JL, 1995, CELL, V83, P13, DOI 10.1016/0092-8674(95)90228-7
   COUNTS JL, 1993, CANCER LETT, V75, P129, DOI 10.1016/0304-3835(93)90197-H
   Counts JL, 1995, TOXICOL LETT, V82-3, P663, DOI 10.1016/0378-4274(95)03512-5
   DRAGAN YP, 1993, P SOC EXP BIOL MED, V202, P16
   GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9
   GHAZI H, 1992, GENE, V114, P203, DOI 10.1016/0378-1119(92)90575-A
   GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531
   Issa JPJ, 1996, P NATL ACAD SCI USA, V93, P11757, DOI 10.1073/pnas.93.21.11757
   JENTSCH S, 1981, NUCLEIC ACIDS RES, V9, P2753, DOI 10.1093/nar/9.12.2753
   KIARIS H, 1995, INT J ONCOL, V7, P413
   KORCH C, 1986, EUR J BIOCHEM, V161, P519, DOI 10.1111/j.1432-1033.1986.tb10473.x
   LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F
   MANN MB, 1977, NUCLEIC ACIDS RES, V4, P4211, DOI 10.1093/nar/4.12.4211
   MARONPOT RR, 1995, TOXICOLOGY, V101, P125, DOI 10.1016/0300-483X(95)03112-S
   MAYOL X, 1992, CARCINOGENESIS, V13, P2381, DOI 10.1093/carcin/13.12.2381
   MCCLELLAND M, 1992, NUCLEIC ACIDS RES, V20, P2145, DOI 10.1093/nar/20.suppl.2145
   NEADES R, 1991, MOL CARCINOGEN, V4, P369, DOI 10.1002/mc.2940040508
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   RAY JS, 1994, MOL CARCINOGEN, V9, P155, DOI 10.1002/mc.2940090307
   SINGERSAM J, 1990, MOL CELL BIOL, V10, P4987, DOI 10.1128/MCB.10.9.4987
   VORCE RL, 1991, J TOXICOL ENV HEALTH, V34, P367, DOI 10.1080/15287399109531574
   WILSON VL, 1987, J BIOL CHEM, V262, P9948
   WOODCOCK DM, 1987, BIOCHEM BIOPH RES CO, V145, P888, DOI 10.1016/0006-291X(87)91048-5
NR 28
TC 3
Z9 3
U1 0
U2 1
PU WILEY-LISS
PI NEW YORK
PA DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012
SN 0020-7136
J9 INT J CANCER
JI Int. J. Cancer
PD JUL 29
PY 1997
VL 72
IS 3
BP 491
EP 497
DI 10.1002/(SICI)1097-0215(19970729)72:3<491::AID-IJC18>3.0.CO;2-F
PG 7
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA XM692
UT WOS:A1997XM69200018
PM 9247294
OA Bronze
DA 2024-02-19
ER

PT J
AU Hakimizadeh, E
   Tadayon, S
   Zamanian, MY
   Soltani, A
   Giménez-Llort, L
   Hassanipour, M
   Fatemi, I
AF Hakimizadeh, Elham
   Tadayon, Saeedeh
   Zamanian, Mohammad Yasin
   Soltani, Afsaneh
   Gimenez-Llort, Lydia
   Hassanipour, Mahsa
   Fatemi, Iman
TI Gemfibrozil, a lipid-lowering drug, improves hepatorenal damages in a
   mouse model of aging
SO FUNDAMENTAL & CLINICAL PHARMACOLOGY
LA English
DT Article; Early Access
DE aging; gemfibrozil; kidney; liver; mice; translational research
ID D-GALACTOSE; OXIDATIVE STRESS; ATORVASTATIN; CISPLATIN; AGONIST
AB Gemfibrozil (GFZ) is a medication of the fibrate category with agonistic effects on peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and is effective for hypertriglyceridemia and mixed dyslipidemia. This agent also has anti-inflammatory and antioxidant properties. The current study investigated the effects of GFZ on hepatorenal damages in a D-galactose (D-gal)-induced aging model. We used 28 male mice, which were equally and randomly divided into four groups as follows: normal, D-gal (150 mg/kg/day; intraperitoneal [i.p.], for 6 weeks), GFZ (100 mg/kg/day GFZ, orally [p.o.] for 6 weeks), and the combined D-gal + GFZ. Liver and kidney function indices were measured as serum creatinine, blood urine nitrogen, alanine aminotransferase, and aspartate aminotransferase. Oxidative stress in hepatic and renal tissue was evaluated through malondialdehyde, superoxide dismutase, and glutathione peroxidase levels. Finally, the liver and kidney tissues were assessed for histopathological lesions. The results showed that D-gal-induced aging leads to abnormalities in liver and kidney function indices. D-gal also induced significant oxidative stress and histopathological lesions in these organs. GFZ improved function indices and oxidative stress compared to the D-gal-treated animals. Histological evaluations of the liver and kidney also confirmed these results. These data provide evidence for the potential therapeutic of GFZ in clinical practice for mitigating the hepatorenal damages of aging.
C1 [Hakimizadeh, Elham; Tadayon, Saeedeh; Hassanipour, Mahsa] Rafsanjan Univ Med Sci, Physiol Pharmacol Res Ctr, Res Inst Basic Med Sci, Rafsanjan, Iran.
   [Hakimizadeh, Elham; Hassanipour, Mahsa] Rafsanjan Univ Med Sci, Sch Med, Dept Physiol & Pharmacol, Rafsanjan, Iran.
   [Zamanian, Mohammad Yasin] Hamadan Univ Med Sci, Sch Med, Dept Physiol, Hamadan, Hamadan, Iran.
   [Zamanian, Mohammad Yasin] Hamadan Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Hamadan, Hamadan, Iran.
   [Soltani, Afsaneh] Iran Univ Med Sci, Sch Med, Tehran, Iran.
   [Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain.
   [Gimenez-Llort, Lydia] Univ Autonoma Barcelona, Dept Psychiat & Forens Med, Barcelona, Spain.
   [Fatemi, Iman] Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran.
C3 Hamadan University of Medical Sciences; Hamadan University of Medical
   Sciences; Iran University of Medical Sciences; Autonomous University of
   Barcelona; Autonomous University of Barcelona; Kerman University of
   Medical Sciences
RP Fatemi, I (corresponding author), Kerman Univ Med Sci, Res Ctr Trop & Infect Dis, Kerman, Iran.
EM i.fatemi@kmu.ac.ir
RI Hakimizadeh, Elham/N-5810-2018; Hassanipour, Mahsa/H-1732-2017; Fatemi
   Rabori, Seyediman/I-3054-2017
OI Hakimizadeh, Elham/0000-0002-2811-7716; Hassanipour,
   Mahsa/0000-0003-2350-0326; Fatemi Rabori, Seyediman/0000-0002-9666-9651;
   Gimenez-Llort, Lydia/0000-0002-4091-489X
CR An HJ, 2018, BIOL PHARM BULL, V41, P29, DOI 10.1248/bpb.b17-00371
   Bazmandegan G, 2019, IRAN J BASIC MED SCI, V22, P563, DOI 10.22038/ijbms.2019.33620.8020
   Behiry S, 2018, RENAL FAILURE, V40, P371, DOI 10.1080/0886022X.2018.1455596
   Calkin AC, 2006, DIABETOLOGIA, V49, P766, DOI 10.1007/s00125-005-0102-6
   Chakkarwar VAKP., 2020, INT J CUR RES REV, V12, P91, DOI [10.31782/IJCRR.2020.122326, DOI 10.31782/IJCRR.2020.122326]
   Chen HI, 2020, AM J CHINESE MED, V48, P373, DOI 10.1142/S0192415X20500196
   Cheng HS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205055
   Cheng SM, 2020, AM J CHINESE MED, V48, P391, DOI 10.1142/S0192415X20500202
   Console L, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00794
   de Magalhaes JP, 2021, DRUG DISCOV TODAY, V26, P1559, DOI 10.1016/j.drudis.2021.02.015
   El-Menshawy SSA., 2021, ZAGAZIG U MEDICAL J, V27, P865
   Fatemi I, 2018, FUND CLIN PHARMACOL, V32, P392, DOI 10.1111/fcp.12364
   Fatemi I, 2018, IRAN J BASIC MED SCI, V21, P19, DOI 10.22038/IJBMS.2017.24331.6071
   Ghoreishi FS, 2019, IRAN RED CRESCENT ME, V21, DOI 10.5812/ircmj.83294
   Gottschalk CG, 2021, J NEUROSCI, V41, P2287, DOI 10.1523/JNEUROSCI.3018-19.2021
   Hakimizadeh E, 2022, FUND CLIN PHARMACOL, V36, P501, DOI 10.1111/fcp.12752
   Haybar H, 2019, BIOMED PHARMACOTHER, V109, P530, DOI 10.1016/j.biopha.2018.10.101
   Hosseinzadeh A, 2020, BIOTECH HISTOCHEM, V95, P532, DOI 10.1080/10520295.2020.1730967
   Hunt NJ, 2019, COMPUT STRUCT BIOTEC, V17, P1151, DOI 10.1016/j.csbj.2019.07.021
   Karimi MY, 2020, J DIET SUPPL, V17, P651, DOI 10.1080/19390211.2019.1634175
   Kaviani E, 2017, BEHAV BRAIN RES, V334, P55, DOI 10.1016/j.bbr.2017.07.029
   Khuchua Z, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113464
   Kim MG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54585-1
   Motevalian M, 2021, IRAN J BASIC MED SCI, V24, P1388, DOI [10.22038/ijbms.2021.58502.12996, 10.22038/IJBMS.2021.58502.12996]
   Nikravesh H, 2018, ADV PHARM BULL, V8, P331, DOI 10.15171/apb.2018.038
   Ozansoy G, 2001, MOL CELL BIOCHEM, V216, P59, DOI 10.1023/A:1011000327529
   Papaconstantinou J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111383
   Roy A, 2009, IMMUNOPHARM IMMUNOT, V31, P339, DOI 10.1080/08923970902785253
   Wang YP, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062061
   Weinstein JR, 2010, ADV CHRONIC KIDNEY D, V17, P302, DOI 10.1053/j.ackd.2010.05.002
   Wojtowicz S, 2020, NEUROCHEM RES, V45, P972, DOI 10.1007/s11064-020-02993-5
   Yaribeygi H, 2018, DRUG RES, V68, P355, DOI 10.1055/s-0043-121143
   Zandifar Atefeh, 2021, Iran J Psychiatry, V16, P52, DOI 10.18502/ijps.v16i1.5379
   Zhang J, 2021, AGING-US, V13, P17880, DOI 10.18632/aging.202873
NR 34
TC 3
Z9 3
U1 7
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0767-3981
EI 1472-8206
J9 FUND CLIN PHARMACOL
JI Fundam. Clin. Pharmacol.
PD 2023 JUN
PY 2023
VL 37
IS 3
BP 599
EP 605
DI 10.1111/fcp.12865
EA JAN 2023
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA AQ6K1
UT WOS:000912986400001
PM 36600528
DA 2024-02-19
ER

PT J
AU Kuhla, A
   Hahn, S
   Butschkau, A
   Lange, S
   Wree, A
   Vollmar, B
AF Kuhla, Angela
   Hahn, Steffi
   Butschkau, Antje
   Lange, Sophie
   Wree, Andreas
   Vollmar, Brigitte
TI Lifelong Caloric Restriction Reprograms Hepatic Fat Metabolism in Mice
SO JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL
   SCIENCES
LA English
DT Article
DE Leptin; Adropin; FGF21; Lipolysis; Ketogenesis
ID LIPID-METABOLISM; PPAR-ALPHA; LIVER-DISEASE; LEPTIN; EXPRESSION; ACID;
   FIBROBLAST-GROWTH-FACTOR-21; IDENTIFICATION; HOMEOSTASIS; RECEPTORS
AB Calorie lowering slows the aging process and extends life span in diverse species by so far unknown mechanisms. The inverse linear relationship between calorie intake and life span suggests that regulators of energy metabolism are of importance in aging. The present study shows that lifelong caloric restriction in mice induces a metabolic adaptation with reduced lipogenesis and enhanced lipolysis and ketogenesis. This process, that is, the reprogramming of hepatic fat metabolism, is associated with a marked rise of fibroblastic growth factor 21 as a putative starvation master regulator. Due to the life span-extending properties of fibroblastic growth factor 21, the rise in fibroblastic growth factor 21 might contribute to the markedly better health status found in mice upon lifelong caloric restriction feeding. In addition, adropin, known as a peptide that controls lipid homeostasis, is significantly upregulated, underlining the diminution of lipogenesis that was further substantiated by decreased expression of liver-X-receptor alpha and its target genes sterol regulatory element-binding protein-1c, fatty acid synthase, and member 1 of human transporter subfamily ABCA upon lifelong caloric restriction feeding.
C1 [Kuhla, Angela; Hahn, Steffi; Butschkau, Antje; Vollmar, Brigitte] Univ Rostock, Inst Expt Surg, D-18057 Rostock, Germany.
   [Lange, Sophie; Wree, Andreas] Univ Rostock, Inst Anat, D-18057 Rostock, Germany.
C3 University of Rostock; University of Rostock
RP Kuhla, A (corresponding author), Univ Rostock, Inst Expt Surg, Schillingallee 69a, D-18057 Rostock, Germany.
EM angela.kuhla@uni-rostock.de
FU University of Rostock [FORUN: 889006]
FX This study was supported by a grant of the University of Rostock (FORUN:
   889006).
CR Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232
   Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0
   Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002
   Baranowski M, 2008, J PHYSIOL PHARMACOL, V59, P31
   Barger JL, 2008, EXP GERONTOL, V43, P859, DOI 10.1016/j.exger.2008.06.013
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009
   Domouzoglou EM, 2011, AM J CLIN NUTR, V93, p901S, DOI 10.3945/ajcn.110.001941
   Edwards PA, 2002, VASC PHARMACOL, V38, P249, DOI 10.1016/S1537-1891(02)00175-1
   Feng YM, 2010, CARDIOVASC RES, V88, P376, DOI 10.1093/cvr/cvq204
   FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311
   Fulop T, 2006, PATHOL BIOL, V54, P375, DOI 10.1016/j.patbio.2006.07.002
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x
   Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011
   Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406
   Lecoultre V, 2011, J CLIN ENDOCR METAB, V96, pE1512, DOI 10.1210/jc.2011-1286
   Leibel RL, 2002, NUTR REV, V60, pS15, DOI 10.1301/002966402320634788
   Lundåsen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068
   Mendelsohn AR, 2012, REJUV RES, V15, P624, DOI 10.1089/rej.2012.1392
   Mulligan JD, 2008, EXP GERONTOL, V43, P146, DOI 10.1016/j.exger.2007.10.011
   Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1
   Ozanne Susan E, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005240
   Rosenbaum M, 2010, INT J OBESITY, V34, pS47, DOI 10.1038/ijo.2010.184
   Rosenbaum M, 2008, J CLIN INVEST, V118, P2583, DOI 10.1172/JCI35055
   Sanal MG, 2008, WORLD J GASTROENTERO, V14, P831, DOI 10.3748/wjg.14.831
   Santamarina-Fojo S, 2001, J LIPID RES, V42, P1339
   Shimokawa I, 2001, MECH AGEING DEV, V122, P1511, DOI 10.1016/S0047-6374(01)00284-6
   Song C, 2000, ENDOCRINOLOGY, V141, P4180, DOI 10.1210/en.141.11.4180
   Takemori K, 2011, LIFE SCI, V88, P1088, DOI 10.1016/j.lfs.2011.04.002
   Vilà-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044
   Wang ZH, 2007, ENDOCRINOLOGY, V148, P2845, DOI 10.1210/en.2006-1313
   Weindruch R, 1996, SCI AM, V274, P46, DOI 10.1038/scientificamerican0196-46
   Wolf G, 2006, NUTR REV, V64, P89, DOI [10.1301/nr.2006.feb.89-92, 10.1111/j.1753-4887.2006.tb00192.x]
   Yakubovskaya VI, 1960, BIOCH BIOPHYS, V50, P87
NR 38
TC 53
Z9 57
U1 0
U2 14
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1079-5006
EI 1758-535X
J9 J GERONTOL A-BIOL
JI J. Gerontol. Ser. A-Biol. Sci. Med. Sci.
PD AUG
PY 2014
VL 69
IS 8
BP 915
EP 922
DI 10.1093/gerona/glt160
PG 8
WC Geriatrics & Gerontology; Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Geriatrics & Gerontology
GA AM2GS
UT WOS:000339668700001
PM 24149425
OA Bronze
DA 2024-02-19
ER

PT J
AU Ni, YH
   Wu, T
   Yang, LN
   Xu, Y
   Ota, T
   Fu, ZW
AF Ni, Yinhua
   Wu, Tao
   Yang, Luna
   Xu, Yang
   Ota, Tsuguhito
   Fu, Zhengwei
TI Protective effects of astaxanthin on a combination of D-galactose and
   jet lag-induced aging model in mice
SO ENDOCRINE JOURNAL
LA English
DT Article
DE Aging; D-galactose; Jet lag; Astaxanthin; Antioxidant
ID OXIDATIVE STRESS; SKELETAL-MUSCLE; GENE-EXPRESSION; RATS;
   SUPPLEMENTATION; SENESCENCE; AUTOPHAGY; HEALTHY; ATROPHY; PLASMA
AB Oxidative stress caused free radical and mitochondrial damage plays a critical role in the progression of aging and age-related damage at the cellular and tissue levels. Antioxidant supplementation has received growing attention and the effects of antioxidant on aging are increasingly assessed in both animal and human studies. However, additional and more promising treatments that contribute to the expansion of anti-aging therapies are needed. Astaxanthin, a super antioxidant carotenoid and free radical scavenger, inhibits lipid peroxidation more potently than vitamin E. In the present study, we investigated the preventative effects of astaxanthin on aging using an accelerated aging model: mice chronically treated with a combination of D-galactose and jet lag. After 6 weeks of treatment; astaxanthin administration tended to protect the liver weight loss in aged mice. It is probably by upregulating the mRNA expression of galactose-1-phosphate uridyltransferase, which contribute to the enhancement of D-galactose metabolism. Astaxanthin supplementation also improved muscle endurance of aged mice in a swimming test. These results were associated with reduced oxidative stress in serum and increased anti-oxidative enzymes activities and mRNA expression in vivo. Moreover, astaxanthin reversed the dysregulation of aging-related gene expression caused by the combination of D-galactose and jet lag in the liver and kidney of mice. In conclusion, astaxanthin prevents liver weight loss, ameliorates locomotive muscular function, exerts significant anti-aging effects by reducing oxidative stress and improving the expression of age-related genes in D-galactose and jet lag-induced aging model.
C1 [Ni, Yinhua; Wu, Tao; Yang, Luna; Xu, Yang; Fu, Zhengwei] Zhejiang Univ Technol, Coll Biotechnol & Bioengn, Hangzhou 310014, Zhejiang, Peoples R China.
   [Ota, Tsuguhito] Asahikawa Med Univ, Dept Med, Div Metab & Biosyst Sci, Asahikawa, Hokkaido 0788802, Japan.
C3 Zhejiang University of Technology; Asahikawa Medical College
RP Fu, ZW (corresponding author), Zhejiang Univ Technol, Coll Biol Engn, 6 Dist, Hangzhou, Zhejiang, Peoples R China.
EM azwfu@zjut.edu.cn
RI Wu, Tao/A-7783-2012; Fu, Zhengwei/G-3162-2011; Yinhua, Ni/H-3079-2015;
   wang, hang/JND-8481-2023
OI Fu, Zhengwei/0000-0003-3351-3075; Yinhua, Ni/0000-0001-7738-5971; 
FU Program for Changjiang Scholars and Innovative Research Team in
   University [IRT_17R97]
FX This work was supported by the Program for Changjiang Scholars and
   Innovative Research Team in University (No. IRT_17R97).
CR Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128
   Bagi Z, 2003, AM J PHYSIOL-HEART C, V285, pH2277, DOI 10.1152/ajpheart.00448.2003
   Barja G, 2004, TRENDS NEUROSCI, V27, P595, DOI 10.1016/j.tins.2004.07.005
   Beppu M, 2001, BIOL PHARM BULL, V24, P575, DOI 10.1248/bpb.24.575
   Berger MM, 2005, CLIN NUTR, V24, P172, DOI 10.1016/j.clnu.2004.10.003
   BIERI JG, 1979, J NUTR, V109, P925, DOI 10.1093/jn/109.5.925
   Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282
   Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637
   Cabello-Verrugio C, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8786564
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen Jui-Tung, 2016, J Clin Med Res, V8, P701, DOI 10.14740/jocmr2672w
   Cui X, 2004, BIOGERONTOLOGY, V5, P317, DOI 10.1007/s10522-004-2570-3
   Cui X, 2006, J NEUROSCI RES, V83, P1584, DOI 10.1002/jnr.20845
   Cutler RG, 2006, AGEING RES REV, V5, P221, DOI 10.1016/j.arr.2006.05.002
   Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058
   Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]
   Fan JJ, 2016, J CELL PHYSIOL, V231, P1450, DOI 10.1002/jcp.25260
   Fusco D, 2007, CLIN INTERV AGING, V2, P377
   Golden TR, 2002, AGING CELL, V1, P117, DOI 10.1046/j.1474-9728.2002.00015.x
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Huangfu JQ, 2013, J AGR FOOD CHEM, V61, P7800, DOI 10.1021/jf402224w
   Ikeuchi M, 2006, BIOL PHARM BULL, V29, P2106, DOI 10.1248/bpb.29.2106
   Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603
   Johnson Elizabeth J, 2002, Nutr Clin Care, V5, P56, DOI 10.1046/j.1523-5408.2002.00004.x
   Kou XJ, 2017, BIOMED PHARMACOTHER, V90, P311, DOI 10.1016/j.biopha.2017.03.070
   Kuraji M, 2016, J CLIN BIOCHEM NUTR, V59, P79, DOI 10.3164/jcbn.15-150
   KURASHIGE M, 1990, PHYSIOL CHEM PHYS M, V22, P27
   Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285
   Lai K, 2009, IUBMB LIFE, V61, P1063, DOI 10.1002/iub.262
   Li WJ, 2011, LIFE SCI, V88, P713, DOI 10.1016/j.lfs.2011.02.010
   Liao CH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010098
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Maezawa T, 2017, J PHYSIOL SCI, V67, P603, DOI 10.1007/s12576-016-0492-x
   Mitchell SJ, 2015, ANNU REV ANIM BIOSCI, V3, P283, DOI 10.1146/annurev-animal-022114-110829
   Nabeshima Yoichi, 2002, Clin Calcium, V12, P1114
   Nakamura K, 2016, CLIN REV BONE MINER, V14, P56, DOI 10.1007/s12018-016-9208-2
   Ni YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17192
   Polotow TG, 2014, NUTRIENTS, V6, P5819, DOI 10.3390/nu6125819
   Saw CLL, 2013, FOOD CHEM TOXICOL, V62, P869, DOI 10.1016/j.fct.2013.10.023
   Severino J, 2000, EXP CELL RES, V257, P162, DOI 10.1006/excr.2000.4875
   Shen JH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00067
   Shibaguchi T, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12885
   Skulachev VP, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1385, DOI 10.1134/S0006297907120139
   Tomiyama A Janet, 2017, Nutr Healthy Aging, V4, P147, DOI 10.3233/NHA-160017
   Tosato M, 2007, CLIN INTERV AGING, V2, P401
   Upritchard JE, 2003, AM J CLIN NUTR, V78, P985, DOI 10.1093/ajcn/78.5.985
   Wang HJ, 2007, ASIA PAC J CLIN NUTR, V16, P412
   Wang YH, 2009, AGEING RES REV, V8, P43, DOI 10.1016/j.arr.2008.10.002
   Wu Q, 2014, MAR DRUGS, V12, P6125, DOI 10.3390/md12126125
   Wu WQ, 2014, FOOD FUNCT, V5, P158, DOI 10.1039/c3fo60400d
   Xu Y, 2009, BIOGERONTOLOGY, V10, P153, DOI 10.1007/s10522-008-9158-2
   Yang Y., 2013, J HUM NUTR FOOD SCI, V1, P1003
   Yang Y, 2014, BRIT J NUTR, V112, P1797, DOI 10.1017/S0007114514002554
   Yazaki K, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/596240
   Ye Y, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/185716
   Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829
   Zhen YZ, 2016, EXP THER MED, V11, P303, DOI 10.3892/etm.2015.2858
NR 59
TC 18
Z9 25
U1 5
U2 37
PU JAPAN ENDOCRINE SOC
PI KYOTO
PA 75  YANAGINOBANBA NISHIIRU-MASUYA-CHO, SANJOU-DORI, NAKAGYOU-KU, KYOTO,
   604-8111, JAPAN
SN 0918-8959
EI 1348-4540
J9 ENDOCR J
JI Endocr. J.
PY 2018
VL 65
IS 5
BP 569
EP 578
DI 10.1507/endocrj.EJ17-0500
PG 10
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA HF7AJ
UT WOS:000454389500007
PM 29526991
OA gold
DA 2024-02-19
ER

PT J
AU Hall, DM
   Xu, L
   Drake, VJ
   Oberley, LW
   Oberley, TD
   Moseley, PL
   Kregel, KC
AF Hall, DM
   Xu, L
   Drake, VJ
   Oberley, LW
   Oberley, TD
   Moseley, PL
   Kregel, KC
TI Aging reduces adaptive capacity and stress protein expression in the
   liver after heat stress
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE heat shock proteins; hyperthermia; environmental stress
ID GENE-EXPRESSION; SHOCK PROTEIN-70; MESSENGER-RNA; HSP70; RATS;
   FIBROBLASTS; TISSUES; LIPOPOLYSACCHARIDE; ACCUMULATION; HEATSTROKE
AB A decline in an organism's ability to cope with stress through acute response protein expression may contribute to stress intolerance with aging. We investigated the influence of aging on stress tolerance and the capacity to synthesize the 70-kDa heat shock protein (HSP70) in young and old rats exposed to an environmental heating protocol. Livers were assessed for injury and HSP70 expression after heat stress by use of immunohistochemical and immunoblotting techniques. The inducible HSP70 response in the cytoplasm and nucleus was markedly reduced with age at several time points over a 48-h recovery period, although senescent rats were able to strongly express HSP70 early in recovery. Older animals had extensive zone-specific liver injury, which corresponded to the diminished HSP70 response observed in these regions, and a significant reduction in thermotolerance compared with their young counterparts. These data high light the regional nature of stress-induced injury and HSP70 expression in the liver and the impact of aging on these responses. Furthermore, the results suggest a functional link between the age-related decrements in the expression of inducible HSP70 and the pathophysiological responses to heat stress.
C1 Univ Iowa, Dept Exercise Sci, Iowa City, IA 52242 USA.
   Univ Iowa, Radiat Res Lab, Iowa City, IA 52242 USA.
   Univ Wisconsin, Dept Pathol, Madison, WI 53705 USA.
   Univ Wisconsin, Vet Affairs Hosp & Clin, Madison, WI 53705 USA.
   Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA.
   Univ New Mexico, Lab Environm Stress & Adaptat, Albuquerque, NM 87131 USA.
C3 University of Iowa; University of Iowa; University of Wisconsin System;
   University of Wisconsin Madison; University of Wisconsin System;
   University of Wisconsin Madison; University of New Mexico; University of
   New Mexico
RP Kregel, KC (corresponding author), Univ Iowa, Dept Exercise Sci, 532 FH, Iowa City, IA 52242 USA.
EM kevin-kregel@uiowa.edu
OI Moseley, Pope/0000-0002-3723-9950
FU NIAMS NIH HHS [AR-40771] Funding Source: Medline; NIA NIH HHS [AG-14687,
   AG-12350] Funding Source: Medline
CR BLAKE MJ, 1991, AM J PHYSIOL, V260, P663
   BOUCHAMA A, 1991, J APPL PHYSIOL, V70, P2640, DOI 10.1152/jappl.1991.70.6.2640
   Breloer M, 1999, J IMMUNOL, V162, P3141
   BUCHMAN TG, 1989, SURGERY, V106, P283
   Chen W, 1999, J IMMUNOL, V162, P3212
   CURRIE RW, 1983, CAN J BIOCHEM CELL B, V61, P438, DOI 10.1139/o83-059
   FARGNOLI J, 1990, P NATL ACAD SCI USA, V87, P846, DOI 10.1073/pnas.87.2.846
   FLANAGAN SW, 1995, AM J PHYSIOL-REG I, V268, pR28, DOI 10.1152/ajpregu.1995.268.1.R28
   GATHIRAM P, 1988, CIRC SHOCK, V25, P223
   Hall DM, 2000, FASEB J, V14, P78, DOI 10.1096/fasebj.14.1.78
   HATTORI M, 1990, DNA CELL BIOL, V9, P777, DOI 10.1089/dna.1990.9.777
   HENSCHEL A, 1969, AM J PUBLIC HEALTH N, V59, P2232, DOI 10.2105/AJPH.59.12.2232
   JOHNSTON RN, 1988, SCIENCE, V242, P1551, DOI 10.1126/science.3201244
   JOOTTELO M, 1993, J EXP MED, V177, P231
   KAWAGOE J, 1992, BRAIN RES, V599, P197, DOI 10.1016/0006-8993(92)90391-L
   KEW M, 1970, AM J MED, V49, P192, DOI 10.1016/S0002-9343(70)80075-4
   Kregel K. C., 1996, J APPL PHYSIOL, V80, P262
   KREGEL KC, 1990, J APPL PHYSIOL, V68, P1337, DOI 10.1152/jappl.1990.68.4.1337
   KREGEL KC, 1995, J APPL PHYSIOL, V79, P1673, DOI 10.1152/jappl.1995.79.5.1673
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LI GC, 1985, INT J RADIAT ONCOL, V11, P165, DOI 10.1016/0360-3016(85)90376-1
   LIU AYC, 1989, J BIOL CHEM, V264, P12037
   MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815
   MILLER EK, 1991, J NEUROCHEM, V56, P2060, DOI 10.1111/j.1471-4159.1991.tb03467.x
   MOSELEY PL, 1993, SPORTS MED, V16, P163, DOI 10.2165/00007256-199316030-00001
   NITTA Y, 1994, AM J PHYSIOL-HEART C, V267, pH1795, DOI 10.1152/ajpheart.1994.267.5.H1795
   OBERLEY TD, 1991, AM J PATHOL, V139, P355
   Polla BS, 1996, P NATL ACAD SCI USA, V93, P6458, DOI 10.1073/pnas.93.13.6458
   RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665
   RYAN AJ, 1994, MED SCI SPORT EXER, V26, P687, DOI 10.1249/00005768-199406000-00006
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   SKIDMORE R, 1995, AM J PHYSIOL-REG I, V268, pR92, DOI 10.1152/ajpregu.1995.268.1.R92
   Todryk S, 1999, J IMMUNOL, V163, P1398
   VLASSARA H, 1994, LAB INVEST, V70, P138
   WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063
   WU B, 1993, J GERONTOL, V48, pB50, DOI 10.1093/geronj/48.2.B50
NR 36
TC 108
Z9 126
U1 1
U2 7
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD AUG
PY 2000
VL 89
IS 2
BP 749
EP 759
DI 10.1152/jappl.2000.89.2.749
PG 11
WC Physiology; Sport Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Physiology; Sport Sciences
GA 347LD
UT WOS:000088930200047
PM 10926662
DA 2024-02-19
ER

PT J
AU Eakes, AT
   Hymer, TK
   Rosenthal, MJ
   Moss, J
   Katz, MS
AF Eakes, AT
   Hymer, TK
   Rosenthal, MJ
   Moss, J
   Katz, MS
TI Alterations of adenylyl cyclase-linked G proteins in rat liver during
   aging
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
DE beta-adrenergic receptor; cholera toxin; pertussis toxin; adenosine
   5'-diphosphate ribosylation factor
ID BETA-ADRENERGIC-RECEPTOR; ADP-RIBOSYLATION; HEPATOCYTES; BINDING; GTP;
   IDENTIFICATION; GLYCOGENOLYSIS; SUBUNITS; ENZYME
AB beta-Adrenergic stimulation of adenylyl cyclase in rat liver increases during aging. We examined whether this increase is related to alterations in the stimulatory and inhibitory G proteins (G(s) and G(i)) linked to adenylyl cyclase. Levels of immunoreactive alpha- and beta-subunits of G(s) and G(i) in liver plasma membranes from 6-, 12-, 18-, and 24-mo-old rats were unchanged with age, as was pertussis toxin-catalyzed [P-32]ADP ribosylation of G(i) alpha. Cholera toxin-catalyzed [P-32]ADP ribosylation of G(s) alpha and G(s) bioactivity, assessed as reconstitution of adenylyl cyclase activity in S49 cyc(-) cell membranes, increased two- to threefold between 6 and 12-18 mo, and declined by 24 mo. Recombinant ADP ribosylation factor (ARF) enhanced cholera toxin labeling of G(s) alpha at all ages, yet abolished the increase in toxin labeling at 12-18 mo. Auto-ADP ribosylation of the cholera toxin A(1) peptide also increased transiently with age. Alteration of G(s) alpha, as reflected by increased cholera toxin labeling and G(s) bioactivity, may be involved in the regulation of beta-adrenergic-responsive adenylyl cyclase in rat liver during aging. Moreover, changes in endogenous ARF levels could contribute to age differences in cholera toxin labeling of G(s) alpha.
C1 UNIV TEXAS, GERIATR RES EDUC & CLIN CTR 182, AUDIE L MURPHY MEM VET HOSP,DEPT MED, HLTH SCI CTR, SAN ANTONIO, TX 78284 USA.
   UNIV CALIF LOS ANGELES, SCH MED, SAN FERNANDO VALLEY PROGRAM, SEPULVEDA, CA 91343 USA.
   VET AFFAIRS MED CTR, CTR GERIATR RES EDUC & CLIN, SEPULVEDA, CA 91343 USA.
   NHLBI, NIH, PULM CRIT CARE MED BRANCH, BETHESDA, MD 20892 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Audie L. Murphy Memorial Veterans Hospital;
   Geriatric Research Education & Clinical Center; University of California
   System; University of California Los Angeles; University of California
   Los Angeles Medical Center; David Geffen School of Medicine at UCLA;
   Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); National
   Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood
   Institute (NHLBI)
CR BOKOCH GM, 1983, J BIOL CHEM, V258, P2072
   BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I
   BUSHFIELD M, 1990, BIOCHEM J, V268, P449, DOI 10.1042/bj2680449
   COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961
   DAX EM, 1987, ENDOCRINOLOGY, V120, P1534, DOI 10.1210/endo-120-4-1534
   Dax EM, 1988, GERONTOLOGIST, V28, p137A
   Fleischer S, 1974, Methods Enzymol, V31, P6
   GRAHAM SM, 1987, AM J PHYSIOL, V253, pE277, DOI 10.1152/ajpendo.1987.253.3.E277
   HERNANDEZSOTOMAYOR SMT, 1991, AM J PHYSIOL, V260, pC259, DOI 10.1152/ajpcell.1991.260.2.C259
   JONES DT, 1987, J BIOL CHEM, V262, P14241
   KALISH MI, 1977, BIOCHIM BIOPHYS ACTA, V48, P452
   KATZ MS, 1987, BIOCHEM BIOPH RES CO, V147, P724, DOI 10.1016/0006-291X(87)90990-9
   KATZ MS, 1993, EXP GERONTOL, V28, P329, DOI 10.1016/0531-5565(93)90060-Q
   KATZ MS, 1988, AM J PHYSIOL, V254, pE54, DOI 10.1152/ajpendo.1988.254.1.E54
   KRISTAL BS, 1994, MODULATION AGING PRO, P1
   LINDER ME, 1993, P NATL ACAD SCI USA, V90, P3675, DOI 10.1073/pnas.90.8.3675
   MADER S, 1993, GERONTOLOGIST, V33, P76
   MATSUYAMA S, 1991, J NEUROCHEM, V57, P1380, DOI 10.1111/j.1471-4159.1991.tb08304.x
   MOSS J, 1993, PROG NUCLEIC ACID RE, V45, P47, DOI 10.1016/S0079-6603(08)60866-1
   MOSS J, 1978, P NATL ACAD SCI USA, V75, P3261
   MUMBY S, 1988, J BIOL CHEM, V263, P2020
   OCONNOR SW, 1983, MECH AGEING DEV, V21, P357, DOI 10.1016/0047-6374(83)90052-0
   POBINER BF, 1985, J BIOL CHEM, V260, P6200
   PRICE SR, 1992, J BIOL CHEM, V267, P17766
   QUIST EE, 1994, J MOL CELL CARDIOL, V26, P251, DOI 10.1006/jmcc.1994.1028
   ROSS EM, 1977, J BIOL CHEM, V252, P5761
   ROSS EM, 1978, J BIOL CHEM, V253, P6401
   SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X
   SHU Y, 1994, J CARDIOVASC PHARM, V23, P188, DOI 10.1097/00005344-199402000-00003
   SPIEGEL AM, 1992, ENDOCR REV, V13, P536, DOI 10.1210/er.13.3.536
   TOYOSHIGE M, 1994, BIOCHEMISTRY-US, V33, P4865, DOI 10.1021/bi00182a014
   TSAI SC, 1987, P NATL ACAD SCI USA, V84, P5139, DOI 10.1073/pnas.84.15.5139
NR 32
TC 5
Z9 5
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1849
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD JAN
PY 1996
VL 270
IS 1
BP E126
EP E132
DI 10.1152/ajpendo.1996.270.1.E126
PG 7
WC Endocrinology & Metabolism; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Physiology
GA TT393
UT WOS:A1996TT39300019
PM 8772484
DA 2024-02-19
ER

PT J
AU Zhao, L
   Zou, X
   Feng, ZH
   Luo, C
   Liu, J
   Li, H
   Chang, L
   Wang, H
   Li, Y
   Long, JG
   Gao, F
   Liu, JK
AF Zhao, Lin
   Zou, Xuan
   Feng, Zhihui
   Luo, Cheng
   Liu, Jing
   Li, Hao
   Chang, Liao
   Wang, Hui
   Li, Yuan
   Long, Jiangang
   Gao, Feng
   Liu, Jiankang
TI Evidence for association of mitochondrial metabolism alteration with
   lipid accumulation in aging rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Triglycerides; PGC-1 alpha; Mitochondrial fusion; Autophagy; Aging
ID CALORIE RESTRICTION; LIVER-MITOCHONDRIA; SKELETAL-MUSCLE;
   ADIPOSE-TISSUE; RESPIRATORY-FUNCTION; CELLULAR SENESCENCE;
   INSULIN-RESISTANCE; COACTIVATOR PGC-1; ENZYME-ACTIVITIES;
   GENE-EXPRESSION
AB Adipogenesis and lipid accumulation during aging have a great impact on the aging process and the pathogenesis of chronic, age-related diseases. However, little is known about the age-related molecular changes in lipid accumulation and the mechanisms underlying them. Here, using 5-month- and 25-month-old rats (young and old, respectively), we found that epididymal fat is the only tissue to accumulate during aging. By testing tissues rich with mitochondria in old and young animals, we found that the old animals had elevated levels of triglycerides in their muscle, heart and liver tissues but not in their kidneys, while, the mRNA level of fatty acid synthase remained unchanged among the four tissues. Regarding lipid catabolism, we determined that the activities of mitochondrial ETC. complexes changed in aged rats (muscle: decreased complex! and V activities; heart: decreased complex I activity; liver: increased complex I and III activities; kidney: decreased complex I and increased complex II activities), while changes in mitochondrial content were not observed in the muscle, heart nor in the liver tissue except increased complex IV and V subunits in aged kidneys. Furthermore, decreased mitochondrial fusion marker Mfn2 and decreased PGC-1 alpha level were observed in the aged muscle, heart and liver but remained unchanged in the kidneys. Down-regulation of Mfn2 with siRNA in 293T cells induced significant mitochondrial dysfunction including decreased oxygen consumption, decreased ATP production, and increased ROS production, followed by increased triglyceride content suggesting a contributing role of decreased mitochondrial fusion to lipid deposit. Meanwhile, judging from autophagy marker p62/SQSTM1 and autophagy was suppressed in the aged muscle, heart and liver but remained unchanged in the kidneys. Taken together, these data suggest that reduction in PGC-1 alpha expression and disruption of mitochondrial dynamics and autophagy might contribute to lipid accumulation during aging. (C) 2014 Elsevier Inc All rights reserved.
C1 [Zhao, Lin; Zou, Xuan; Feng, Zhihui; Luo, Cheng; Liu, Jing; Li, Hao; Chang, Liao; Wang, Hui; Li, Yuan; Long, Jiangang; Liu, Jiankang] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Key Lab Biomed Informat Engn, Minist Educ, Xian 710049, Peoples R China.
   [Zhao, Lin; Feng, Zhihui; Luo, Cheng; Liu, Jing; Li, Hao; Chang, Liao; Wang, Hui; Li, Yuan; Long, Jiangang; Liu, Jiankang] Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Frontier Inst Sci & Technol, Xian 710049, Peoples R China.
   [Zou, Xuan] Xi An Jiao Tong Univ, Ctr Translat Med, Frontier Inst Sci & Technol, Xian 710049, Peoples R China.
   [Gao, Feng] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Peoples R China.
C3 Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong
   University; Air Force Military Medical University
RP Feng, ZH (corresponding author), Xi An Jiao Tong Univ, Ctr Mitochondrial Biol & Med, Sch Life Sci & Technol, 28 W Xian Ning Rd, Xian 710049, Peoples R China.
EM zhfeng@mail.xjtu.edu.cn; fgao@fmmu.edu.cn
RI Zhao, Lin/AHD-2506-2022; Liu, Jiankang/A-1610-2011; Li, Hao/K-7001-2017;
   Chang, Liao/JMR-0758-2023; Long, Jiangang/A-7835-2015; Zou,
   Xuan/A-6452-2015; Gao, Feng/X-4385-2019; LIU, JING/ABA-6639-2021; Luo,
   Cheng/C-2849-2013; Feng, Zhihui/E-7408-2011
OI Zhao, Lin/0000-0002-6056-8787; Li, Hao/0000-0001-5677-3377; Long,
   Jiangang/0000-0002-6584-3880; LIU, JING/0000-0002-3113-4015; Luo,
   Cheng/0000-0003-2193-3670; Feng, Zhihui/0000-0002-2448-6565; Jiangang,
   Long/0000-0001-8074-957X
FU National Basic Research Program of China [2013CB531204]; National
   Natural Science Foundation of China [81201023, 30930105]; 985 Project of
   Xi'an Jiaotong University; 211 Project of Xi'an Jiaotong University
FX We thank Dr. Edward Sharman at the University of California, Irvine for
   reading and editing this manuscript. This work was supported by he
   National Basic Research Program of China (No. 2013CB531204), the
   National Natural Science Foundation of China (81201023, 30930105) and
   985 and 211 Projects of Xi'an Jiaotong University.
CR Anantharaju A, 2002, GERONTOLOGY, V48, P343, DOI 10.1159/000065506
   Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003
   Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270
   Couillard C, 2000, J CLIN ENDOCR METAB, V85, P1026, DOI 10.1210/jc.85.3.1026
   DiPietro L, 2010, J APPL PHYSIOL, V109, P1569, DOI 10.1152/japplphysiol.01152.2010
   Eberlé D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   Gastaldelli A, 2009, HEPATOLOGY, V49, P1537, DOI 10.1002/hep.22845
   Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220
   Hansen BC, 2001, J NUTR, V131, p900S, DOI 10.1093/jn/131.3.900S
   Honma T, 2011, J NUTR SCI VITAMINOL, V57, P123, DOI 10.3177/jnsv.57.123
   Ikeda S, 2002, BIOCHEM BIOPH RES CO, V296, P395, DOI 10.1016/S0006-291X(02)00883-5
   Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071
   Kim JY, 2009, AGE, V31, P127, DOI 10.1007/s11357-009-9089-0
   Kita T, 2009, J BIOCHEM, V146, P787, DOI 10.1093/jb/mvp124
   Kowald A, 2011, P NATL ACAD SCI USA, V108, P10237, DOI 10.1073/pnas.1101604108
   Kuk JL, 2009, AGEING RES REV, V8, P339, DOI 10.1016/j.arr.2009.06.001
   Larigauderie G, 2006, FEBS J, V273, P3498, DOI 10.1111/j.1742-4658.2006.05357.x
   Larsen KB, 2010, AUTOPHAGY, V6, P784, DOI 10.4161/auto.6.6.12510
   Lee S, 2007, J BIOL CHEM, V282, P22977, DOI 10.1074/jbc.M700679200
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Long JG, 2006, LIFE SCI, V79, P1466, DOI 10.1016/j.lfs.2006.04.024
   Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004
   Nadeau KJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE90, DOI 10.1152/ajpendo.00543.2005
   Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004
   O'Toole JF, 2010, BIOCHEM J, V427, P105, DOI 10.1042/BJ20091373
   ODIET JA, 1995, MECH AGEING DEV, V79, P127, DOI 10.1016/0047-6374(94)01552-W
   Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200
   Pascot A, 1999, DIABETES CARE, V22, P1471, DOI 10.2337/diacare.22.9.1471
   Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031
   Puca AA, 2008, INT J BIOCHEM CELL B, V40, P324, DOI 10.1016/j.biocel.2007.04.003
   Rosa EF, 2005, J APPL PHYSIOL, V99, P1569, DOI 10.1152/japplphysiol.00417.2005
   Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030
   Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207
   Shen WL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002328
   Shin ES, 2007, J NUTR, V137, P1127, DOI 10.1093/jn/137.5.1127
   Singh R, 2010, RESULTS PROBL CELL D, V52, P35, DOI 10.1007/978-3-642-14426-4_4
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Song ZY, 2009, MOL BIOL CELL, V20, P3525, DOI 10.1091/mbc.E09-03-0252
   Sun LJ, 2006, MITOCHONDRION, V6, P136, DOI 10.1016/j.mito.2006.04.003
   Sun LJ, 2010, LIFE SCI, V86, P39, DOI 10.1016/j.lfs.2009.11.003
   Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013
   Tarling E, 2004, BIOCHEM SOC T, V32, P107, DOI 10.1042/BST0320107
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200
NR 47
TC 62
Z9 67
U1 2
U2 47
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD AUG
PY 2014
VL 56
SI SI
BP 3
EP 12
DI 10.1016/j.exger.2014.02.001
PG 10
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA AK7KL
UT WOS:000338607100002
PM 24518876
DA 2024-02-19
ER

PT J
AU Tang, YC
   Fickert, P
   Trauner, M
   Marcus, N
   Blomenkamp, K
   Teckman, J
AF Tang, Youcai
   Fickert, Peter
   Trauner, Michael
   Marcus, Nancy
   Blomenkamp, Keith
   Teckman, Jeffrey
TI Autophagy induced by exogenous bile acids is therapeutic in a model of
   α-1-AT deficiency liver disease
SO AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
LA English
DT Article
DE liver; protein conformation; alpha-1-antitrypsin; proteolysis
ID MUTANT ALPHA(1)-ANTITRYPSIN Z; Z-PROTEIN POLYMERS; ALPHA-1-ANTITRYPSIN
   DEFICIENCY; ENDOPLASMIC-RETICULUM; MOUSE MODEL; TRANSGENIC MICE; MURINE
   MODEL; HEPATOCYTES; CHOLESTASIS; DEGRADATION
AB The bile acid norursodeoxycholic acid (norUDCA) has many biological actions, including antiapoptotic effects. Homozygous PIZZ alpha-1-antitrypsin (A1AT)-deficient humans are known to be at risk for liver disease, cirrhosis, and liver cancer as a result of the accumulation of the toxic, A1AT mutant Z protein within hepatocytes. This accumulation triggers cell death in the hepatocytes with the largest mutant Z-protein burdens, followed by compensatory proliferation. Proteolysis pathways within the hepatocyte, including autophagy, act to reduce the intracellular burden of A1AT Z protein. We hypothesized that norUDCA would reduce liver cell death and injury in A1AT deficiency. We treated groups of PiZ transgenic mice and wild-type mice with norUDCA or vehicle, orally, and examined the effects on the liver. The PiZ mouse is the best model of A1AT liver injury and recapitulates many features of the human liver disease. Mice treated with norUDCA demonstrated reduced hepatocellular death by compensatory hepatocellular proliferation as determined by bromodeoxyuridine incorporation (3.8% control, 0.88% treated, P < 0.04). Ki-67 staining as a marker for hepatocellular senescence and death was also reduced (P < 0.02). Reduced apoptotic signaling was associated with norUDCA, including reduced cleavage of caspases-3, -7, and -8 (all P < 0.05). We determined that norUDCA was associated with a >70% reduction in intrahepatic mutant Z protein (P < 0.01). A 32% increase in hepatic autophagy associated with norUDCA was the likely mechanism. norUDCA administration is associated with increased autophagy, reduced A1AT protein accumulation, and reduced liver injury in a model of A1AT deficiency.
C1 [Tang, Youcai; Marcus, Nancy; Blomenkamp, Keith; Teckman, Jeffrey] St Louis Univ, Pediat & Biochem, St Louis, MO 63103 USA.
   [Tang, Youcai; Marcus, Nancy; Blomenkamp, Keith; Teckman, Jeffrey] Cardinal Glennon Childrens Med Ctr, St Louis, MO USA.
   [Fickert, Peter] Med Univ Graz, Div Gastroenterol & Hepatol, Dept Internal Med, Res Unit Expt & Mol Hepatol, Graz, Austria.
   [Trauner, Michael] Med Univ Vienna, Gastroenterol & Hepatol, Vienna, Austria.
C3 Saint Louis University; Medical University of Graz; Medical University
   of Vienna
RP Teckman, J (corresponding author), St Louis Univ, Sch Med, 1465 S Grand Blvd, St Louis, MO 63104 USA.
EM teckmanj@slu.edu
RI Tang, Youcai/C-4480-2012
OI Trauner, Michael/0000-0002-1275-6425; Teckman,
   Jeffrey/0000-0002-4870-2621; Fickert, Peter/0000-0003-0906-4636; Tang,
   Youcai/0000-0003-2087-6029
FU Alpha-1 Foundation; Saint Louis University Liver Center; Cardinal
   Glennon Foundation
FX This work was supported by funding from the Alpha-1 Foundation, the
   Saint Louis University Liver Center, and the Cardinal Glennon
   Foundation.
CR An JK, 2005, HEPATOLOGY, V41, P160, DOI 10.1002/hep.20508
   Brunt EM, 2010, J PEDIATR GASTR NUTR, V51, P626, DOI 10.1097/MPG.0b013e3181e7ff55
   CARLSON JA, 1988, J CLIN INVEST, V82, P26, DOI 10.1172/JCI113580
   Denk GU, 2010, HEPATOLOGY, V52, P1758, DOI 10.1002/hep.23911
   Fickert P, 2006, GASTROENTEROLOGY, V130, P465, DOI 10.1053/j.gastro.2005.10.018
   Fickert P, 2013, J HEPATOL, V58, P1201, DOI 10.1016/j.jhep.2013.01.026
   Guo SL, 2014, J CLIN INVEST, V124, P251, DOI 10.1172/JCI67968
   Haddock CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106371
   Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354
   Kaushal S, 2010, EXP BIOL MED, V235, P700, DOI 10.1258/ebm.2010.009297
   Lindblad D, 2007, HEPATOLOGY, V46, P1228, DOI 10.1002/hep.21822
   Marcus NY, 2012, EXP BIOL MED, V237, P1163, DOI 10.1258/ebm.2012.012106
   Marcus NY, 2010, HEPATOL RES, V40, P641, DOI 10.1111/j.1872-034X.2010.00663.x
   Miller SDW, 2007, HEPATOLOGY, V46, P496, DOI 10.1002/hep.21689
   Modica S, 2012, GASTROENTEROLOGY, V142, P355, DOI 10.1053/j.gastro.2011.10.028
   Rudnick DA, 2004, HEPATOLOGY, V39, P1048, DOI 10.1002/hep.20118
   SIFERS RN, 1989, J BIOL CHEM, V264, P15696
   Teckman Jeffrey H, 2014, Curr Gastroenterol Rep, V16, P367, DOI 10.1007/s11894-013-0367-8
   Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961
   Teckman JH, 2004, AM J PHYSIOL-GASTR L, V286, pG851, DOI 10.1152/ajpgi.00175.2003
   Teckman JH, 2002, AM J PHYSIOL-GASTR L, V283, pG1156, DOI 10.1152/ajpgi.00041.2002
   Teckman JH, 2000, AM J PHYSIOL-GASTR L, V278, pG39, DOI 10.1152/ajpgi.2000.278.1.G39
   Teckman JH, 2001, J BIOL CHEM, V276, P44865, DOI 10.1074/jbc.M103703200
NR 23
TC 21
Z9 23
U1 0
U2 9
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0193-1857
EI 1522-1547
J9 AM J PHYSIOL-GASTR L
JI Am. J. Physiol.-Gastroint. Liver Physiol.
PD JUL 1
PY 2016
VL 311
IS 1
BP G156
EP G165
DI 10.1152/ajpgi.00143.2015
PG 10
WC Gastroenterology & Hepatology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Physiology
GA DT4QX
UT WOS:000381466900015
PM 27102560
OA Bronze
DA 2024-02-19
ER

PT J
AU MOSONI, L
   MIRAND, PP
   HOULIER, ML
   ARNAL, M
AF MOSONI, L
   MIRAND, PP
   HOULIER, ML
   ARNAL, M
TI AGE-RELATED-CHANGES IN PROTEIN-SYNTHESIS MEASURED INVIVO IN RAT-LIVER
   AND GASTROCNEMIUS-MUSCLE
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE AGING; PROTEIN TURNOVER; MUSCLE; LIVER
ID SKELETAL-MUSCLE; DIETARY RESTRICTION; WHOLE-BODY; TURNOVER; GROWTH;
   TISSUES; HEART; INTERVENTION; ACID
AB This study analyses in detail the effects of ageing on gastrocnemius muscle and liver protein synthesis measured in vivo at three ages, 1.5 months (young), 12 months (adult) and 24 months (old) in Sprague-Dawley rats. Comparing adult and old rats, muscle protein synthesis was decreased in old rats when expressed per unit of RNA and per day (translational efficiency), was unchanged when expressed in absolute terms and increased when expressed in fractional terms as a result of protein loss due to muscle atrophy. In the liver, only translational efficiency tended to decrease in old rats compared to adult rats. It is concluded that the decline in protein turnover described in vitro is consistent with a decrease in translational efficiency, but that absolute synthesis rates are maintained during ageing. Muscle atrophy is unlikely to result from alterations in protein synthesis pathways.
RP MOSONI, L (corresponding author), INRA, LAB ETUDE METAB AZOTE, CTR THEIX, F-63122 CEYRAT, FRANCE.
OI Mosoni, Laurent/0000-0002-5409-6760
CR [Anonymous], 1988, SAS STAT USERS GUIDE
   ATTAIX D, 1986, BIOCHIM BIOPHYS ACTA, V882, P389, DOI 10.1016/0304-4165(86)90263-1
   BAILLIE AGS, 1991, J APPL PHYSIOL, V71, P1020, DOI 10.1152/jappl.1991.71.3.1020
   BIGGS RB, 1990, AM J PHYSIOL, V258, pH207, DOI 10.1152/ajpheart.1990.258.1.H207
   BIRCHENALLSPARKS MC, 1985, J NUTR, V115, P944, DOI 10.1093/jn/115.7.944
   BLAZEJOWSKI CA, 1983, MECH AGEING DEV, V21, P345, DOI 10.1016/0047-6374(83)90051-9
   CHEREL Y, 1991, CLIN SCI, V81, P611, DOI 10.1042/cs0810611
   ELHAJ AJ, 1986, COMP BIOCHEM PHYS A, V85, P281, DOI 10.1016/0300-9629(86)90251-3
   FORBES GB, 1976, HUM BIOL, V48, P161
   GARLICK PJ, 1989, AM J PHYSIOL, V257, pE828, DOI 10.1152/ajpendo.1989.257.6.E828
   GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719
   GOLDSPINK DF, 1987, EXP GERONTOL, V22, P67, DOI 10.1016/0531-5565(87)90016-7
   GOLDSPINK DF, 1986, CARDIOVASC RES, V20, P672, DOI 10.1093/cvr/20.9.672
   GOLDSPINK DF, 1984, BIOCHEM J, V217, P507, DOI 10.1042/bj2170507
   HOLLOSZY JO, 1991, MECH AGEING DEV, V60, P199, DOI 10.1016/0047-6374(91)90131-I
   KLITGAARD H, 1989, J APPL PHYSIOL, V67, P1409, DOI 10.1152/jappl.1989.67.4.1409
   LEWIS SEM, 1984, BIOCHEM J, V217, P517, DOI 10.1042/bj2170517
   MANCHESTER KL, 1968, BIOCHEM J, V108, P177, DOI 10.1042/bj1080177
   MASORO EJ, 1980, FED PROC, V39, P3178
   MAYS PK, 1991, MECH AGEING DEV, V59, P229, DOI 10.1016/0047-6374(91)90134-L
   MAZANET R, 1986, MYOLOGY, V1, P285
   MERRY BJ, 1987, MECH AGEING DEV, V39, P189, DOI 10.1016/0047-6374(87)90008-X
   NAKAZAWA T, 1984, MECH AGEING DEV, V26, P241, DOI 10.1016/0047-6374(84)90097-6
   OBLED C, 1991, J NUTR, V121, P1990, DOI 10.1093/jn/121.12.1990
   PLUSKAL MG, 1984, J GERONTOL, V39, P385, DOI 10.1093/geronj/39.4.385
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   WARD WF, 1988, J GERONTOL, V43, pB121, DOI 10.1093/geronj/43.5.B121
   WEBSTER GC, 1982, MECH AGEING DEV, V18, P369, DOI 10.1016/0047-6374(82)90039-2
   WIEDERANDERS B, 1981, ACTA BIOL MED GER, V40, P1243
   YOUNG VR, 1989, NUTR ELDERLY, P65
NR 30
TC 40
Z9 40
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD MAY
PY 1993
VL 68
IS 1-3
BP 209
EP 220
DI 10.1016/0047-6374(93)90152-H
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA LG147
UT WOS:A1993LG14700018
PM 7688841
DA 2024-02-19
ER

PT J
AU Utyro, O
   Perla-Kaján, J
   Jakubowski, H
AF Utyro, Olga
   Perla-Kajan, Joanna
   Jakubowski, Hieronim
TI The Cbs Locus Affects the Expression of Senescence Markers and mtDNA
   Copy Number, but not Telomere Dynamics in Mice
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE cystathionine beta-synthase deficiency; homocysteine; life span; mtDNA;
   senescence markers; telomere dynamics; Tert
ID CYSTATHIONINE BETA-SYNTHASE; MITOCHONDRIAL-DNA MUTATIONS; AGE-RELATED
   DISEASE; METHYLENETETRAHYDROFOLATE REDUCTASE; N-HOMOCYSTEINYLATION;
   CELLULAR SENESCENCE; QUANTITATIVE PCR; ASSOCIATION; GENE; LENGTH
AB Cystathionine beta-synthase (CBS) is a housekeeping enzyme that catalyzes the first step of the homocysteine to cysteine transsulfuration pathway. Homozygous deletion of the Cbs gene in mice causes severe hyperhomocysteinemia and reduces life span. Here, we examined a possible involvement of senescence, mitochondrial DNA, and telomeres in the reduced life span of Cbs(-/-) mice. We found that senescence-related p21, Pai-1, Mcp1, and Il-6 mRNAs were significantly upregulated (2-10-fold) in liver, while p21 was upregulated in the brain of Cbs(-/-) mice (n = 20) compared with control Cbs(+/-) siblings (n = 20) in a sex- and age-dependent manner. Telomere length in blood (n = 80), liver (n = 40), and brain (n = 40) was not affected by the Cbs(-/-) genotype, but varied with sex and/or age. Levels of mitochondrial DNA tended to be reduced in livers, but not brains and blood, of Cbs(-/-) females (n = 20-40). The Cbs(-/-) genotype significantly reduced Tert mRNA expression in brain, but not liver, in a sex- and age-dependent manner. Multiple regression analysis showed that the senescence-related liver (but not brain) mRNAs and liver (but not brain or blood) mitochondrial DNA were associated with the Cbs genotype. In contrast, telomere length in blood, brain, and liver was not associated with the Cbs genotype or hyperhomocysteinemia, but was associated with sex (in brain and liver) and age (in brain and blood). Taken together, these findings suggest that the changes in senescence marker expression and mtDNA levels, but not telomere shortening, could account for the reduced life span of Cbs(-/-) mice.
C1 [Utyro, Olga; Perla-Kajan, Joanna; Jakubowski, Hieronim] Univ Life Sci, Dept Biochem & Biotechnol, PL-60632 Poznan, Poland.
   [Utyro, Olga] Polish Acad Sci, Inst Bioorgan Chem, PL-61704 Poznan, Poland.
   [Utyro, Olga; Jakubowski, Hieronim] Int Ctr Publ Hlth, Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA.
C3 Poznan University of Life Sciences; Polish Academy of Sciences;
   Institute of Bioorganic Chemistry of the Polish Academy of Sciences;
   Rutgers University System; Rutgers University New Brunswick; Rutgers
   University Biomedical & Health Sciences
RP Jakubowski, H (corresponding author), Univ Life Sci, Dept Biochem & Biotechnol, PL-60632 Poznan, Poland.; Jakubowski, H (corresponding author), Int Ctr Publ Hlth, Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA.
EM olga.utyro@gmail.com; kajan@up.poznan.pl; jakubows@rutgers.edu
RI Perla-Kajan, Joanna/F-2965-2010; Jakubowski, Hieronim/A-2510-2017;
   Utyro, Olga/IAR-5259-2023
OI Perla-Kajan, Joanna/0000-0002-0791-5057; Jakubowski,
   Hieronim/0000-0001-5845-4409; Utyro, Olga/0000-0002-9571-6057; righetti,
   giada/0000-0003-0852-8718
FU National Science Center, Poland [2015/17/N/NZ3/03626,
   2014/15/B/NZ2/01079, 2016/23/B/NZ5/00573, 2018/29/B/NZ4/0071,
   2019/33/B/NZ4/01760]; American Heart Association [17GRNT32910002]
FX Supported by grants from the National Science Center, Poland (O.U.:
   2015/17/N/NZ3/03626; J.P.K.: 2014/15/B/NZ2/01079; H.J.:
   2016/23/B/NZ5/00573, 2018/29/B/NZ4/0071, 2019/33/B/NZ4/01760) and the
   American Heart Association (H.J.: 17GRNT32910002).
CR [Anonymous], 2013, CHEM BIOL HOMOCYSTEI
   Baek JH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030247
   Calado RT, 2013, SEMIN HEMATOL, V50, P165, DOI 10.1053/j.seminhematol.2013.03.030
   Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027
   Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7
   Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com
   Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528
   Fries GR, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0048-8
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guillén N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008
   Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033
   Huang TT, 2014, GENESIS, V52, P300, DOI 10.1002/dvg.22761
   Jakubowski H, 2008, ANAL BIOCHEM, V380, P257, DOI 10.1016/j.ab.2008.05.049
   Jakubowski H, 2019, PHYSIOL REV, V99, P555, DOI 10.1152/physrev.00003.2018
   Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086
   Jakubowski H, 2009, FASEB J, V23, P1721, DOI 10.1096/fj.08-127548
   Khan SS, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao1617
   Khayati K, 2017, FASEB J, V31, P598, DOI 10.1096/fj.201600915R
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125
   Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Malik AN, 2016, MITOCHONDRION, V29, P59, DOI 10.1016/j.mito.2016.05.003
   Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001
   Moore AZ, 2018, AGING CELL, V17, DOI 10.1111/acel.12683
   MUDD SH, 1985, AM J HUM GENET, V37, P1
   Perla-Kajan J, 2016, FASEB J, V30, P3810, DOI 10.1096/fj.201600539
   Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008
   Sanders JL, 2012, J GERONTOL A-BIOL, V67, P1439, DOI 10.1093/gerona/gls123
   Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960
   Shay JW, 2019, NAT REV GENET, V20, P299, DOI 10.1038/s41576-019-0099-1
   Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2
   Valle D., 2001, METABOLIC MOL BASES, P2007
   Vaughan DE, 2017, ARTERIOSCL THROM VAS, V37, P1446, DOI 10.1161/ATVBAHA.117.309451
   WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585
   Whittemore K, 2019, P NATL ACAD SCI USA, V116, P15122, DOI 10.1073/pnas.1902452116
   Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514
   Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163
NR 43
TC 2
Z9 2
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2020
VL 21
IS 7
AR 2520
DI 10.3390/ijms21072520
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA LR3DN
UT WOS:000535574200262
PM 32260476
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU UEJIMA, Y
   FUKUCHI, Y
   NAGASE, T
   MATSUSE, T
   YAMAOKA, M
   TABATA, R
   ORIMO, H
AF UEJIMA, Y
   FUKUCHI, Y
   NAGASE, T
   MATSUSE, T
   YAMAOKA, M
   TABATA, R
   ORIMO, H
TI INFLUENCES OF INHALED TOBACCO-SMOKE ON THE SENESCENCE ACCELERATED MOUSE
   (SAM)
SO EUROPEAN RESPIRATORY JOURNAL
LA English
DT Article
DE AGING; BRONCHOALVEOLAR LAVAGE (BAL); GLUTATHIONE (GSH); SENESCENCE
   ACCELERATED MOUSE (SAM); TOBACCO SMOKE
ID AGE-RELATED-CHANGES; ELASTASE; EMPHYSEMA; LUNG; GLUTATHIONE; MECHANISMS;
   INHIBITOR; CATARACT; INJURY; SERUM
AB We studied the influences of inhaled tobacco smoke on lung structure, biochemical changes in bronchoalveolar lavage (BAL) fluid, and glutathione (GSH) content of the lung in the senescence accelerated mouse (SAM), using 30 female SAM-P/8 as the "senescence-prone series", compared with SAM-R/1 as the "senescence-resistant series".  At 18 wks of age, half of each series were housed in Hamburg II machines and exposed to an atmosphere of tobacco smoke for 5 wks, 10 min a day, 5 days a wk.  At 24 wks of age, all of the animals were sacrificed. Blood, lung, liver, kidney and eyes were removed and the contents of GSH and thiol group (-SH) were measured (n = 5).  We also performed BAL, to determine its total protein, albumin, and fibronectin contents, and elastase-like activity, elastase inhibitory capacity (EIC), and trypsin inhibitory capacity (TIC) (n = 5).  Histological changes of the lungs from non-lavaged animals were also examined by light microscopy (n = 5). In SAM-P/8 not exposed to tobacco smoke, the mean linear intercept was longer than that in SAM-R/1.  The exposure of SAM-P/8 to tobacco smoke caused increases in its lung weight and the ratio of albumin to total protein in BAL fluid, a decrease in the EIC/TIC ratio in BAL fluid, and a decrease in the GSH content and the GSH/-SH ratio of the lung, compared with those not exposed.  We also observed focal infiltration of macrophages into alveoli with hyaline membrane and thickened alveolar wall in SAM-P/8 with tobacco exposure.  These changes were not observed in SAM-R/1 except for an increase in lung weight.  These data suggested that SAM-P/8 can be a useful model for the study of age-related changes in the lung.  In addition, the GSH contents and the GSH/-SH ratio of blood, liver, kidney and eyes of SAM-P/8 were also decreased by the exposure to tobacco smoke more extensively than those of SAM-R/1.  These results indicate that SAM-P/8 animals are more sensitive and less protected to inhaled irritant attacks by tobacco smoke than SAM-R/1, and that this characteristic response may be related, at lease in part, to accelerated senescence.
C1 UNIV TOKYO,SCH MED,DEPT GERIATR,TOKYO 113,JAPAN.
C3 University of Tokyo
RP UEJIMA, Y (corresponding author), TEIJIN INST BIOMED RES,BIOCHEM LAB,4-3-2 ASAHIGA OKA,HINO,TOKYO 191,JAPAN.
CR BEATTY K, 1982, J LAB CLIN MED, V100, P186
   BIETH J, 1974, BIOCHEM MED METAB B, V11, P350, DOI 10.1016/0006-2944(74)90134-3
   CARP H, 1978, AM REV RESPIR DIS, V118, P617
   CLARK RA, 1981, J BIOL CHEM, V256, P3348
   Dontenwill W., 1967, BEITR TABAKFORSCH, V4, P45
   DORMANS JAMA, 1989, J TOXICOL ENV HEALTH, V26, P1, DOI 10.1080/15287398909531230
   DUNHILL MS, 1962, THORAX, V19, P320
   ERIKSSON STEN, 1965, ACTA MED SCAND SUPPL, V177, P6
   FRITZ H, 1966, H-S Z PHYSIOL CHEM, V345, P150, DOI 10.1515/bchm2.1966.345.1.150
   GREENBERG DB, 1978, CHEST, V74, P421, DOI 10.1378/chest.74.4.421
   HARMAN D, 1984, AGE, V7, P111, DOI 10.1007/BF02431866
   HAZELTON GA, 1980, BIOCHEM J, V188, P25, DOI 10.1042/bj1880025
   HOCKING WG, 1979, NEW ENGL J MED, V301, P639, DOI 10.1056/NEJM197909203011205
   HOSOKAWA M, 1988, EXP EYE RES, V47, P629, DOI 10.1016/0014-4835(88)90100-5
   HOSOKAWA M, 1984, EXP EYE RES, V38, P105, DOI 10.1016/0014-4835(84)90095-2
   HUNNINGHAKE G, 1980, Chest, V77, P273, DOI 10.1378/chest.77.2_Supplement.273
   JANOFF A, 1983, J APPL PHYSIOL, V55, P285, DOI 10.1152/jappl.1983.55.2.285
   JANOFF A, 1985, ANNU REV MED, V36, P207
   JANOFF A, 1985, AM REV RESPIR DIS, V132, P417
   JANOFF A, 1987, AM REV RESPIR DIS, V136, P1058, DOI 10.1164/ajrccm/136.4.1058
   JOHNSON KJ, 1981, J CLIN INVEST, V67, P983, DOI 10.1172/JCI110149
   KNUDSON RJ, 1977, J APPL PHYSIOL, V43, P1054, DOI 10.1152/jappl.1977.43.6.1054
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARTIN WJ, 1981, J CLIN INVEST, V68, P1277, DOI 10.1172/JCI110374
   MATSUSHITA M, 1986, AM J PATHOL, V125, P276
   MCGOWAN SE, 1987, AM REV RESPIR DIS, V135, P1286
   MIYAMOTO M, 1986, PHYSIOL BEHAV, V38, P399, DOI 10.1016/0031-9384(86)90112-5
   NIEWOEHNER DE, 1977, AM REV RESPIR DIS, V115, P15
   OWENS CWI, 1965, BIOCHEM J, V94, P705, DOI 10.1042/bj0940705
   PRYOR WA, 1987, PULMONARY EMPHYSEMA, P369
   Roscoe J.T., 1969, Fundamental Research Statistics for the Behavioral Sciences
   ROSS D, 1988, PHARMACOL THERAPEUT, V37, P231, DOI 10.1016/0163-7258(88)90027-7
   SWAIM MW, 1988, J LEUKOCYTE BIOL, V43, P365, DOI 10.1002/jlb.43.4.365
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKESHITA S, 1982, MECH AGEING DEV, V20, P13, DOI 10.1016/0047-6374(82)90070-7
NR 35
TC 15
Z9 16
U1 1
U2 2
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0903-1936
J9 EUR RESPIR J
JI Eur. Resp. J.
PD OCT
PY 1990
VL 3
IS 9
BP 1029
EP 1036
PG 8
WC Respiratory System
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Respiratory System
GA ER897
UT WOS:A1990ER89700010
PM 2289550
DA 2024-02-19
ER

PT J
AU Soerensen, M
   Gredilla, R
   Müller-Ohldach, M
   Werner, A
   Bohr, VA
   Osiewacz, HD
   Stevnsner, T
AF Soerensen, Mette
   Gredilla, Ricardo
   Mueller-Ohldach, Mathis
   Werner, Alexandra
   Bohr, Vilhelm A.
   Osiewacz, Heinz D.
   Stevnsner, Tinna
TI A potential impact of DNA repair on ageing and lifespan in the ageing
   model organism <i>Podospora anserina</i>: Decrease in mitochondrial DNA
   repair activity during ageing
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
DE DNA repair; Mitochondria; Ageing; Base excision repair; DNA
   glycosylases; Podospora anserina
ID BASE EXCISION-REPAIR; AGE-ASSOCIATED DAMAGE; OXIDATIVE DAMAGE;
   FILAMENTOUS FUNGUS; ENDO-EXONUCLEASE; MAMMALIAN-CELLS; SKELETAL-MUSCLE;
   NUCLEAR-DNA; MOUSE-LIVER; STRESS
AB The free radical theory of ageing states that ROS play a key role in age-related decrease in mitochondrial function via the damage of mitochondrial DNA (mtDNA), proteins and lipids. In the sexually reproducing ascomycete Podospora anserina ageing is, as in other eukaryotes, associated with mtDNA instability and mitochondrial dysfunction. Part of the mtDNA instabilities may arise due to accumulation of ROS induced mtDNA lesions, which, as previously suggested for mammals, may be caused by an age-related decrease in base excision repair (BER).
   Alignments of known BER protein sequences with the A anserina genome revealed high homology. We report for the first time the presence of BER activities in P. anserina mitochondrial extracts. DNA glycosylase activities decrease with age, suggesting that the increased mtDNA instability with age may be caused by decreased ability to repair mtDNA damage and hence contribute to ageing and lifespan control in this ageing model.
   Additionally, we find low DNA glycosylase activities in the long-lived mutants grisea and Delta PaCox17::ble, which are characterized by low mitochondrial ROS generation.
   Overall, our data identify a potential role of mtDNA repair in controlling ageing and life span in P. anserina, a mechanism possibly regulated in response to ROS levels. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Soerensen, Mette; Gredilla, Ricardo; Stevnsner, Tinna] Univ Aarhus, Danish Ctr Mol Gerontol, DK-8000 Aarhus C, Denmark.
   [Soerensen, Mette; Gredilla, Ricardo; Stevnsner, Tinna] Univ Aarhus, Dept Mol Biol, Aarhus Univ, Danish Aging Res Ctr, DK-8000 Aarhus C, Denmark.
   [Mueller-Ohldach, Mathis; Werner, Alexandra; Osiewacz, Heinz D.] Goethe Univ Frankfurt, Inst Mol Biosci, Fac Biosci & Cluster Excellence Macromol Complexe, D-60438 Frankfurt, Germany.
   [Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA.
C3 Aarhus University; Aarhus University; Goethe University Frankfurt;
   National Institutes of Health (NIH) - USA; NIH National Institute on
   Aging (NIA)
RP Stevnsner, T (corresponding author), Univ Aarhus, Danish Ctr Mol Gerontol, CF Moellers Alle 1130, DK-8000 Aarhus C, Denmark.
EM tvs@mb.au.dk
RI Bohr, Vilhelm/AAP-5931-2020; Osiewacz, Heinz D./D-3454-2011; Soerensen,
   Mette/O-1817-2015
OI Thinggaard, Mette Soerensen/0000-0001-5268-3366; GREDILLA,
   RICARDO/0000-0003-4501-1355
FU European Commission [LSHM-CT-2004-512020]; HDO; Danish Aging Research
   Center [VELUX 95-103-11419]; German Research Foundation (DFG) [OS75/12]
FX This research was supported by a grant from the European Commission
   (LSHM-CT-2004-512020) to TS and HDO, by the Danish Aging Research Center
   (VELUX 95-103-11419) to TS. and the German Research Foundation (DFG,
   OS75/12) to HDO. Professor R. Lill (Philipps-Universitat, Marburg,
   Germany) is thanked for the supply of cytochrome c antibody and Ulla
   Birk Henriksen is thanked for excellent technical assistance.
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312
   BELCOUR L, 1981, CURR GENET, V3, P13, DOI 10.1007/BF00419575
   Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6
   Borghouts C, 1997, P NATL ACAD SCI USA, V94, P10768, DOI 10.1073/pnas.94.20.10768
   Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001
   Bouex P, 2002, BBA-GENE STRUCT EXPR, V1574, P72, DOI 10.1016/S0167-4781(01)00347-5
   Cabelof DC, 2002, CARCINOGENESIS, V23, P1419, DOI 10.1093/carcin/23.9.1419
   Chen DX, 2002, J NEUROCHEM, V81, P1273, DOI 10.1046/j.1471-4159.2002.00916.x
   CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324
   CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927
   CUMMINGS DJ, 1979, MOL GEN GENET, V171, P239, DOI 10.1007/BF00267578
   de Souza-Pinto NC, 2001, FREE RADICAL BIO MED, V30, P916, DOI 10.1016/S0891-5849(01)00483-X
   Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200
   ESSER K, 1976, MOL GEN GENET, V144, P107, DOI 10.1007/BF00277312
   Esser K, 1974, HDB GENETICS, P531, DOI 10.1007/978-1-4899-1710-2_28
   FINETTE BA, 1994, MUTAT RES, V308, P223, DOI 10.1016/0027-5107(94)90157-0
   Foksinski M, 2004, FREE RADICAL BIO MED, V37, P1449, DOI 10.1016/j.freeradbiomed.2004.07.014
   GREDILLA R, 2008, NEUROBIOL AGING
   Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010
   Groebe K, 2007, EXP GERONTOL, V42, P887, DOI 10.1016/j.exger.2007.07.001
   GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z
   Grösch S, 1998, CANCER RES, V58, P4410
   Hamann A, 2008, TRENDS MICROBIOL, V16, P276, DOI 10.1016/j.tim.2008.03.003
   Hamann A, 2007, MOL MICROBIOL, V65, P948, DOI 10.1111/j.1365-2958.2007.05839.x
   Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698
   HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360
   Harman D, 1973, Triangle, V12, P153
   HAYAKAWA M, 1993, MOL CELL BIOCHEM, V119, P95, DOI 10.1007/BF00926859
   Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011
   Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004
   Honda Y, 2002, ANN NY ACAD SCI, V959, P466, DOI 10.1111/j.1749-6632.2002.tb02117.x
   Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200
   Hyun M, 2008, NUCLEIC ACIDS RES, V36, P1380, DOI 10.1093/nar/gkm1161
   Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002
   Karahalil B, 2002, FASEB J, V16, P1895, DOI 10.1096/fj.02-0463com
   Karahalil B, 2003, J BIOL CHEM, V278, P33701, DOI 10.1074/jbc.M301617200
   KATAYAMA M, 1991, BIOCHEM INT, V25, P47
   Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300
   Krause F, 2004, J BIOL CHEM, V279, P26453, DOI 10.1074/jbc.M402756200
   KUCK U, 1981, CURR GENET, V3, P151, DOI 10.1007/BF00365719
   Kuraoka I, 2003, J BIOL CHEM, V278, P7294, DOI 10.1074/jbc.M208102200
   Laquel-Robert P, 2003, BIOCHEM BIOPH RES CO, V303, P713, DOI 10.1016/S0006-291X(03)00410-8
   LINDAHL T, 1993, COLD SPRING HARB SYM, V58, P619, DOI 10.1101/SQB.1993.058.01.068
   LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0
   Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127
   LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4
   LIU F, 2008, J INVEST DERMATOL
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Maas MFPM, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-9
   Madia F, 2007, MECH AGEING DEV, V128, P45, DOI 10.1016/j.mad.2006.11.009
   MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416
   Murakami S, 2006, EXP GERONTOL, V41, P1014, DOI 10.1016/j.exger.2006.06.061
   Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3
   OSIEWACZ HD, 1984, CURR GENET, V8, P299, DOI 10.1007/BF00419728
   OSIEWACZ HD, 1992, AGING-CLIN EXP RES, V4, P273, DOI 10.1007/BF03324108
   Osiewacz HD, 2002, AGEING RES REV, V1, P425, DOI 10.1016/S1568-1637(02)00010-7
   Osiewacz HD, 2004, TOP CURR GENET, V3, P17
   Osiewacz HD, 2002, GENE, V286, P65, DOI 10.1016/S0378-1119(01)00804-6
   Osiewacz HD, 2000, ANN NY ACAD SCI, V908, P31
   Osiewacz HD, 2006, FREE RADICAL RES, V40, P1350, DOI 10.1080/10715760600921153
   PRILLINGER H, 1977, MOL GEN GENET, V156, P333, DOI 10.1007/BF00267190
   RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465
   Rusyn I, 2000, CARCINOGENESIS, V21, P2141, DOI 10.1093/carcin/21.12.2141
   Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524
   Scheckhuber CQ, 2008, MOL GENET GENOMICS, V280, P365, DOI 10.1007/s00438-008-0378-6
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102
   Silar P, 2001, BIOGERONTOLOGY, V2, P1, DOI 10.1023/A:1010000816277
   Souza-Pinto NC, 1999, NUCLEIC ACIDS RES, V27, P1935, DOI 10.1093/nar/27.8.1935
   STAHL U, 1978, MOL GEN GENET, V162, P341, DOI 10.1007/BF00268860
   Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004
   TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B
   Taylor EM, 1998, INT J RADIAT BIOL, V74, P277
   Thiviyanathan V, 2005, CHEM COMMUN, P400, DOI 10.1039/b414474k
   Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517
   Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95
   Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988
   Vijg J, 2005, ANNU REV MED, V56, P193, DOI 10.1146/annurev.med.56.082103.104617
   Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482
   WHITEHEAD I, 1993, J GERONTOL, V48, pB124, DOI 10.1093/geronj/48.4.B124
NR 81
TC 15
Z9 15
U1 0
U2 13
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0047-6374
EI 1872-6216
J9 MECH AGEING DEV
JI Mech. Ageing Dev.
PD AUG
PY 2009
VL 130
IS 8
BP 487
EP 496
DI 10.1016/j.mad.2009.05.003
PG 10
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA 487RH
UT WOS:000269292000003
PM 19486911
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Oyebode, OT
   Giwa, OD
   Olorunsogo, OO
AF Oyebode, Olubukola T.
   Giwa, Olawumi D.
   Olorunsogo, Olufunso O.
TI Comparative effects of galactose-induced aging on mitochondrial
   permeability transition in rat liver and testis
SO TOXICOLOGY MECHANISMS AND METHODS
LA English
DT Article
DE Mitochondrial permeability transition; galactose; aging; liver; testis;
   apoptosis
ID PORE; IMPAIRMENT; HEART; MODEL
AB This study investigated the status and sensitivity of mitochondrial permeability transition (mPT) pore in testis and liver of rats exposed to doses of galactose, an acceptable model used to mimic natural aging. Male albino rats were divided into five groups of eight animals in each group for in vivo studies and administered distilled water, 50,100, 200 and 500 mg galactose/kgbdwt, respectively, for six consecutive weeks. Mitochondria were isolated from liver and testis by differential centrifugation. Mitochondrial permeability transition (mPT) was assessed as mitochondrial swelling and was monitored spectrophotometrically. Mitochondrial lipid peroxidation, ATPase activity, antioxidant enzymes, caspase activation, interleukins, and sperm functional characteristics were also assessed. Administration of galactose (50-500 mg/kg) to male Wistar albino rats had no effect whatsoever on the testicular mPT pore. However, liver mPT pore was significantly opened. Furthermore, the enhancement of mitochondrial ATPase activity and malondialdehyde generation were observed in the liver of galactose-exposed rats. Significant alterations in antioxidant enzymes were observed in post-mitochondrial fraction (PMF) of liver and testis. There were also increases in serum levels of IL-1 beta and 6. In addition, caspases 9 and 3 were significantly elevated in PMF of the liver with evidence of DNA fragmentation. However, there was no significant difference in levels of caspases in PMF of testis in model groups of galactose when compared with control. These results provide evidence that testis mitochondria do not readily undergo permeability transition pore upon exposure to doses of D-galactose that induce the opening of the pore in the liver.
C1 [Oyebode, Olubukola T.; Giwa, Olawumi D.; Olorunsogo, Olufunso O.] Univ Ibadan, Dept Biochem, Labs Biomembrane Res & Biotechnol, Ibadan, Nigeria.
C3 University of Ibadan
RP Oyebode, OT (corresponding author), Univ Ibadan, Dept Biochem, Labs Biomembrane, Ibadan, Oyo State, Nigeria.; Oyebode, OT (corresponding author), Univ Ibadan, Dept Biochem, Biotechnol Unit, Ibadan, Oyo State, Nigeria.
EM bukioyebode@gmail.com
OI Oyebode, Olubukola Titilope/0000-0002-5323-3743; Giwa,
   Olawumi/0000-0002-9779-6708
CR [Anonymous], 1979, MEMBRANE BIOCH LAB M
   [Anonymous], 2018, FRONT CARDIOVASC MED
   [Anonymous], BIOMED RES INT
   [Anonymous], 1976, CARLETONS HISTOLOGIC
   [Anonymous], BIOMED RES INT
   [Anonymous], 1999, WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction
   Aydin S, 2018, JCPSP-J COLL PHYSICI, V28, P501, DOI 10.29271/jcpsp.2018.07.501
   BABABUNMI EA, 1979, BIOCHEM PHARMACOL, V28, P925, DOI 10.1016/0006-2952(79)90377-0
   Bauer TM, 2020, CIRC RES, V126, P280, DOI 10.1161/CIRCRESAHA.119.316306
   Cedikova M, 2016, PHYSIOL RES, V65, pS519, DOI 10.33549/physiolres.933538
   CHEN YT, 1984, PEDIATR RES, V18, P345, DOI 10.1203/00006450-198404000-00008
   Claiborne A., 1985, CRC HDB METHODS OXYG, V147, P283, DOI [10.1037/xge0000366, DOI 10.1007/S11259-005-3684-Z, 10.1201/9781351072922]
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Duan DD, 2017, REJUV RES, V20, P506, DOI 10.1089/rej.2017.1919
   Endlicher Rene, 2009, Acta Medica (Hradec Kralove), V52, P69
   Forges T, 2006, HUM REPROD UPDATE, V12, P573, DOI 10.1093/humupd/dml031
   Franceschi C, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00061
   Gao JQ, 2018, CLIN INTERV AGING, V13, P1859, DOI 10.2147/CIA.S173838
   Goldberg J, 2018, AGING CELL, V17, DOI 10.1111/acel.12715
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018
   HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2
   Hayflick L, 1998, EXP GERONTOL, V33, P639, DOI 10.1016/S0531-5565(98)00023-0
   Johnson D., 1967, Methods Enzymol, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9
   Lane RK, 2015, BBA-BIOENERGETICS, V1847, P1387, DOI 10.1016/j.bbabio.2015.05.021
   LAPIDUS RG, 1992, FEBS LETT, V313, P314, DOI 10.1016/0014-5793(92)81217-A
   Li GW, 2018, BIOMED PHARMACOTHER, V99, P113, DOI 10.1016/j.biopha.2018.01.006
   Li X, 2016, BIOL TRACE ELEM RES, V173, P433, DOI 10.1007/s12011-016-0681-8
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mather M, 2000, BIOCHEM BIOPH RES CO, V273, P603, DOI 10.1006/bbrc.2000.2994
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Mohammadi E, 2018, AVICENNA J PHYTOMEDI, V8, P14
   Müller M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00470
   Oyebode OT, 2020, J FUNCT FOODS, V69, DOI 10.1016/j.jff.2020.103957
   Oyebode OT, 2019, J INTEGR MED-JIM, V17, P446, DOI 10.1016/j.joim.2019.10.001
   Panel M, 2018, AGING CELL, V17, DOI 10.1111/acel.12793
   Qu Z, 2016, PHYSIOL BEHAV, V154, P114, DOI 10.1016/j.physbeh.2015.11.016
   Rottenberg H, 2017, AGING CELL, V16, P943, DOI 10.1111/acel.12650
   Ruan LH, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210831
   Rudzinska M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9020094
   Sahach V F, 2004, Fiziol Zh, V50, P49
   Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043
   Salman TM, 2016, MIDDLE EAST FERTIL S, V21, P82, DOI 10.1016/j.mefs.2015.09.004
   Taba M. Y., 2019, Comparative Clinical Pathology, V28, P997
   VARSHNEY R, 1990, INT J RADIAT BIOL, V58, P733, DOI 10.1080/09553009014552121
   Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010
   Zemjanis R., 1970, DIAGNOSTIC THERAPEUT
NR 48
TC 4
Z9 4
U1 1
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1537-6516
EI 1537-6524
J9 TOXICOL MECH METHOD
JI Toxicol. Mech. Methods
PD JUN 12
PY 2020
VL 30
IS 5
BP 388
EP 396
DI 10.1080/15376516.2020.1755921
PG 9
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA LN0BF
UT WOS:000532610500008
PM 32295448
DA 2024-02-19
ER

PT J
AU MISHRA, RN
   KANUNGO, MS
AF MISHRA, RN
   KANUNGO, MS
TI ALTERATIONS IN HISTONES OF THE LIVER AND OVIDUCT OF JAPANESE-QUAIL
   DURING AGING
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE JAPANESE QUAIL; AGING; HISTONES; HORMONE RESPONSE
ID CHROMOSOMAL-PROTEINS; OLD RATS; CHROMATIN; BRAIN; TRANSCRIPTION;
   MODULATION; DIGESTION; YOUNG; AGES
AB Age-related changes occur in histones of the liver and oviduct of the female quail. In the liver an extra histone band, named HCX, between H2A and H4, is observed that increases with age. In the oviduct, a large complex of histones is seen which is tissue-specific. This complex declines with increasing age. The changes in the histones of the oviduct of adult and old birds in response to estradiol and progesterone are age-related. In the adult, the histone-complex increases after administration of either one of the hormones. In old birds, however, it is seen only after progesterone administration. Thus, the alterations in histones in the birds are not only tissue- and age-related, but also vary in response to steroid hormones.
C1 BANARAS HINDU UNIV, DEPT ZOOL, MOLEC BIOL LAB, VARANASI 221005, UTTAR PRADESH, INDIA.
C3 Banaras Hindu University (BHU)
CR BELLARD M, 1989, METHOD ENZYMOL, V170, P317
   BRADBURY EM, 1992, BIOESSAYS, V14, P9
   CHATURVEDI MM, 1985, BIOCHEM BIOPH RES CO, V127, P604, DOI 10.1016/S0006-291X(85)80203-5
   CHATURVEDI MM, 1985, MOL BIOL REP, V10, P215
   GULATI DP, 1981, POULTRY SCI, V60, P668, DOI 10.3382/ps.0600668
   HEWISH DR, 1973, BIOCHEM BIOPH RES CO, V52, P504, DOI 10.1016/0006-291X(73)90740-7
   KANUNGO MS, 1977, BIOCHEM BIOPH RES CO, V79, P1031, DOI 10.1016/0006-291X(77)91108-1
   KANUNGO MS, 1979, BIOCHEM BIOPH RES CO, V86, P14, DOI 10.1016/0006-291X(79)90375-9
   KANUNGO MS, 1979, J STEROID BIOCHEM, V11, P879, DOI 10.1016/0022-4731(79)90024-4
   KANUNGO MS, 1979, BIOCHEM BIOPH RES CO, V87, P266, DOI 10.1016/0006-291X(79)91675-9
   KANUNGO MS, 1994, GENES AGING
   KUEHL L, 1979, J BIOL CHEM, V254, P7276
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEAVITT WW, 1982, HORMONE ANTAGONISTS, P212
   SOLLNERWEBB B, 1976, CELL, V9, P179, DOI 10.1016/0092-8674(76)90063-5
   SPELSBERG TC, 1979, METHOD ENZYMOL, V31, P263
   VONHOLT C, 1989, METHOD ENZYMOL, V170, P431
NR 17
TC 7
Z9 7
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD JUL
PY 1994
VL 20
IS 1
BP 15
EP 18
DI 10.1007/BF00999850
PG 4
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA PK813
UT WOS:A1994PK81300003
PM 7845393
DA 2024-02-19
ER

PT J
AU Lin, B
   Zhang, F
   Yu, YC
   Jiang, QH
   Zhang, ZF
   Wang, JB
   Li, Y
AF Lin, Bing
   Zhang, Feng
   Yu, Yongchao
   Jiang, Qinghao
   Zhang, Zhaofeng
   Wang, Junbo
   Li, Yong
TI Marine collagen peptides protect against early alcoholic liver injury in
   rats
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Marine collagen peptides; Alcoholic liver injury; Antioxidants; Lipid
   metabolism
ID BLOOD-LIPIDS; EXTRACT PROTECTS; HEPATIC DAMAGE; DISEASE; PATHOGENESIS;
   MECHANISMS; FIBROSIS; ETHANOL
AB Marine collagen peptides (MCP) have been reported to exhibit antioxidative activity, which is the common property of numerous hepatoprotective agents. Previous studies have shown that MCP have biological functions including anti-hypertension, anti-ulcer, anti-skin ageing and extending the life span. However, its role in alcoholic liver injury remains unknown. The present study aimed to investigate the effects of MCP on early alcoholic liver injury in rats. Rats were administered with alcohol at a dose of 6 g/kg body weight intragastrically per d to induce early liver injury, which was then evaluated by serum markers and histopathological examination. Treatment with MCP could reverse the increased level of serum aminotransferase and reduce hepatic histological damage. In addition, MCP attenuated the alteration in serum superoxide dismutase and malondialdehyde levels. MCP also counteracted the increased levels of total cholesterol and TAG. However, no significant difference was observed in the contents of alcohol dehydrogenase both in liver and serum protein of rats. These findings suggest that MCP have a protective effect on early alcoholic liver injury in rats by their antioxidative activity and improving lipid metabolism.
C1 [Lin, Bing; Zhang, Feng; Yu, Yongchao; Jiang, Qinghao; Zhang, Zhaofeng; Wang, Junbo; Li, Yong] Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100191, Peoples R China.
C3 Peking University
RP Li, Y (corresponding author), Peking Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Beijing 100191, Peoples R China.
EM liyongbmu@163.com
FU Foundation from Ministry of Science and Technology of the People's
   Republic of China [2006BAD27B08]
FX This study was supported (grant 2006BAD27B08) by the Foundation from the
   Ministry of Science and Technology of the People's Republic of China.
   The authors gratefully thank the company CF Haishi Biotechnology Limited
   for providing the samples used in the present study. The authors have no
   conflicts of interest to disclose. Y. L. gave the original idea and was
   in charge of the whole trial. B. L. conducted the animal experiment and
   wrote the manuscript. F. Z., Y. Y., Q. J., Z. Z. and J. W. assisted with
   the animal trial and biochemical assays. B. L. and F. Z. were
   responsible for the critical revision of the manuscript.
CR Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004
   Albano E, 2010, GENES NUTR, V5, P141, DOI 10.1007/s12263-009-0151-4
   Allam G, 2007, IMMUNOBIOLOGY, V212, P603, DOI 10.1016/j.imbio.2007.05.006
   Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087
   Bhandarkar MR, 2004, J ETHNOPHARMACOL, V91, P61, DOI 10.1016/j.jep.2003.11.020
   Bunout D, 1999, NUTRITION, V15, P583, DOI 10.1016/S0899-9007(99)00090-8
   CASTELLI WP, 1977, LANCET, V2, P153
   Das SK, 2005, INDIAN J CLIN BIOCHE, V20, P35, DOI 10.1007/BF02893039
   DILUZIO NR, 1967, FED PROC, V26, P1436
   Eaton S, 1997, EUR J CLIN INVEST, V27, P719, DOI 10.1046/j.1365-2362.1997.1780727.x
   Fan JG, 2005, J HEPATOL, V43, P508, DOI 10.1016/j.jhep.2005.02.042
   Guo H, 2009, FOOD CHEM TOXICOL, V47, P2431, DOI 10.1016/j.fct.2009.06.041
   Isayama F, 2003, FREE RADICAL BIO MED, V35, P1568, DOI 10.1016/j.freeradbiomed.2003.09.007
   Jahromi MG, 2010, PEPTIDES, V31, P2114, DOI 10.1016/j.peptides.2010.08.009
   Järveläinen HA, 2001, J HEPATOL, V35, P46, DOI 10.1016/S0168-8278(01)00050-2
   KARSENTY C, 1985, J CLIN INVEST, V75, P976, DOI 10.1172/JCI111799
   Kono H, 2001, FREE RADICAL BIO MED, V30, P403, DOI 10.1016/S0891-5849(00)00490-1
   Li You-Ming, 2004, Hepatobiliary Pancreat Dis Int, V3, P241
   Liang JA, 2010, J MED FOOD, V13, P757, DOI 10.1089/jmf.2009.1279
   LIEBER CS, 1974, LIPIDS, V9, P103, DOI 10.1007/BF02532134
   Lu Zheng-bing, 2004, Yaoxue Xuebao, V39, P17
   Luo QQ, 2009, EUR J PHARMACOL, V607, P226, DOI 10.1016/j.ejphar.2009.02.012
   Mandal P, 2010, WORLD J GASTROENTERO, V16, P1330, DOI 10.3748/wjg.v16.i11.1330
   McKim SE, 2002, ARCH BIOCHEM BIOPHYS, V406, P40, DOI 10.1016/S0003-9861(02)00425-3
   Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074
   Pei XR, 2010, FOOD CHEM, V118, P333, DOI 10.1016/j.foodchem.2009.04.120
   Saito M, 2009, J AGR FOOD CHEM, V57, P10477, DOI 10.1021/jf902355m
   Sancho-Bru P, 2007, GASTROENTEROLOGY, V133, P2019, DOI 10.1053/j.gastro.2007.09.023
   SAUNDERS JB, 1981, BMJ-BRIT MED J, V282, P1140, DOI 10.1136/bmj.282.6270.1140
   Shaheen NJ, 2006, AM J GASTROENTEROL, V101, P2128, DOI 10.1111/j.1572-0241.2006.00723.x
   Shi YL, 2008, J ETHNOPHARMACOL, V117, P415, DOI 10.1016/j.jep.2008.02.023
   Sonoyama T, 2009, FEBS LETT, V583, P2067, DOI 10.1016/j.febslet.2009.05.025
   Tanaka M, 2009, BIOSCI BIOTECH BIOCH, V73, P930, DOI 10.1271/bbb.80649
   Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007
   VEENSTRA J, 1990, ALCOHOL ALCOHOLISM, V25, P371
   Walsh K, 2000, POSTGRAD MED J, V76, P280, DOI 10.1136/pmj.76.895.280
   Wang Guo-Xiang, 2002, Hepatobiliary Pancreat Dis Int, V1, P406
   Wang H, 2009, J ETHNOPHARMACOL, V126, P273, DOI 10.1016/j.jep.2009.08.028
   WANNAMETHEE G, 1992, J EPIDEMIOL COMMUN H, V46, P197, DOI 10.1136/jech.46.3.197
   Yuan GJ, 2007, PHYTOTHER RES, V21, P234, DOI 10.1002/ptr.2054
   Zhang FX, 2009, FOOD CHEM, V117, P387, DOI 10.1016/j.foodchem.2009.04.015
   Zolotarev Iu A, 2006, Bioorg Khim, V32, P192
NR 42
TC 31
Z9 36
U1 5
U2 31
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD APR
PY 2012
VL 107
IS 8
BP 1160
EP 1166
DI 10.1017/S0007114511004211
PG 7
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 944ZR
UT WOS:000304242800008
PM 21899801
OA Bronze
DA 2024-02-19
ER

PT J
AU Kagami, Y
   Kondo, Y
   Handa, S
   Maruyama, N
   Ishigami, A
AF Kagami, Yayoi
   Kondo, Yoshitaka
   Handa, Setsuko
   Maruyama, Naoki
   Ishigami, Akihito
TI Senescence Marker Protein-30/Gluconolactonase Expression in the Mouse
   Ovary during Gestation
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE ascorbic acid; senescence marker protein-30; gluconolactonase; ovary;
   estrogen
ID PROTEIN-30 KNOCKOUT MOUSE; L-ASCORBIC-ACID; CORPUS-LUTEUM; SMP30; LIVER;
   RAT; BIOSYNTHESIS; VITAMIN; MICE
AB Senescence marker protein-30 (SMP30) was first described as a physiologic entity that decreases in the rat liver and kidney with aging. Previously, we established that SMP30 is the lactone-hydrolyzing enzyme gluconolactonase (GNL), which is involved in ascorbic acid (AA) biosynthesis. In the present study, we found SMP30/GNL mRNA expressed in the mouse ovary. To ascertain the reason for ovarian SMP30/GNL expression, we examined mice during gestation. SMP30/GNL mRNA expression was evident at the start of gestation, increased for the next eight days then decreased rapidly. Moreover, L-gulono-gamma-lactone oxidase (Gulo) mRNA, which catalyzes the last step of AA, was found in the ovaries of these mice. The variations of these genes' expression showed an inverse pattern to that of Cypl9a1 (aromatase) mRNA expression. Therefore, the SMP30/GNL and Gulo mRNA expression might be regulated by estrogen levels in the ovary. Since the presence of both SMP30/GNL and Gulo mRNAs could indicate that AA synthesis occurs in the ovary, we quantified AA levels in mouse ovaries during gestation. However, no correlation was found between changes of AA content and SMP30/GNL or Gulo mRNAs expression at this site. Moreover, we compared the changes of AA content during gestation between wild-type and SMP30/GNL knockout mice, which cannot synthesize AA, and found no significant differences between them. These results indicated that, although AA synthesis might occur in the ovaries, the amount of AA which is synthesized in ovaries must be quite low and insufficient to influence the AA content in ovary.
C1 [Kagami, Yayoi; Kondo, Yoshitaka; Handa, Setsuko; Maruyama, Naoki; Ishigami, Akihito] Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
C3 Tokyo Metropolitan Institute of Gerontology
RP Ishigami, A (corresponding author), Tokyo Metropolitan Inst Gerontol, Tokyo 1730015, Japan.
EM ishigami@tmig.or.jp
RI Yoshitaka, Kondo/AFK-7721-2022
OI Yoshitaka, Kondo/0000-0002-0046-9429; Ishigami,
   Akihito/0000-0001-7875-7482
FU JSPS KAKENHI [24380073]; Grants-in-Aid for Scientific Research
   [23790122] Funding Source: KAKEN
FX This study is supported by JSPS KAKENHI Grant Numbers 24380073. The
   authors thank Ms. P. Minick for the excellent English editorial
   assistance. Vitamin C powder was kindly provided by DSM Nutrition Japan.
CR Biskind GR, 1936, J BIOL CHEM, V113, P27
   CHATTERJEE I, 1961, NATURE, V192, P163, DOI 10.1038/192163a0
   DEANE HW, 1952, AM J ANAT, V91, P363, DOI 10.1002/aja.1000910303
   Fayad T, 2004, BIOL REPROD, V70, P523, DOI 10.1095/biolreprod.103.021709
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   GROSSMAN SH, 1974, LIFE SCI, V14, P567, DOI 10.1016/0024-3205(74)90371-3
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigarni A, 2007, GERIATR GERONTOL INT, V7, P316, DOI 10.1111/j.1447-0594.2007.00420.x
   Iwama M, 2011, NUTRITION, V27, P471, DOI 10.1016/j.nut.2010.04.010
   Kondo Y, 2006, P NATL ACAD SCI USA, V103, P5723, DOI 10.1073/pnas.0511225103
   Maia CJB, 2008, MOL CELL BIOCHEM, V311, P81, DOI 10.1007/s11010-007-9697-x
   Mori T, 2004, PATHOL INT, V54, P167, DOI 10.1111/j.1440-1827.2003.01603.x
   NISHIKIMI M, 1991, AM J CLIN NUTR, V54, pS1203, DOI 10.1093/ajcn/54.6.1203s
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Sato Y, 2010, BIOL PHARM BULL, V33, P364, DOI 10.1248/bpb.33.364
   STANSFIELD DA, 1967, J ENDOCRINOL, V39, P27, DOI 10.1677/joe.0.0390027
   Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017
NR 18
TC 6
Z9 11
U1 0
U2 1
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD DEC
PY 2013
VL 36
IS 12
BP 2005
EP 2008
DI 10.1248/bpb.b13-00309
PG 4
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA 260CY
UT WOS:000327573800019
PM 24292059
OA gold
DA 2024-02-19
ER

PT J
AU Ota, K
   Brydun, A
   Itoh-Nakadai, A
   Sun, JY
   Igarashi, K
AF Ota, Kazushige
   Brydun, Andrey
   Itoh-Nakadai, Ari
   Sun, Jiying
   Igarashi, Kazuhiko
TI <i>Bach1</i> Deficiency and Accompanying Overexpression of Heme
   Oxygenase-1 Do Not Influence Aging or Tumorigenesis in Mice
SO OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
LA English
DT Article
ID OXIDATIVE STRESS-RESPONSE; TRANSCRIPTION FACTOR; GENETIC ABLATION;
   MYOCARDIAL PROTECTION; CELLULAR SENESCENCE; SMALL MAF; INDUCTION; P53;
   EXPRESSION; REPRESSOR
AB Oxidative stress contributes to both aging and tumorigenesis. The transcription factor Bach1, a regulator of oxidative stress response, augments oxidative stress by repressing the expression of heme oxygenase-1 (HO-1) gene (Hmox1) and suppresses oxidative stress-induced cellular senescence by restricting the p53 transcriptional activity. Here we investigated the lifelong effects of Bach1 deficiency on mice. Bach1-deficient mice showed longevity similar to wild-type mice. Although HO-1 was upregulated in the cells of Bach1-deficient animals, the levels of ROS in Bach1-deficient HSCs were comparable to those in wild-type cells. Bach1(-/-); p53(-/-) mice succumbed to spontaneous cancers as frequently as p53-deficient mice. Bach1 deficiency significantly altered transcriptome in the liver of the young mice, which surprisingly became similar to that of wild-type mice during the course of aging. The transcriptome adaptation to Bach1 deficiency may reflect how oxidative stress response is tuned upon genetic and environmental perturbations. We concluded that Bach1 deficiency and accompanying overexpression of HO-1 did not influence aging or p53 deficiency-driven tumorigenesis. Our results suggest that it is useful to target Bach1 for acute injury responses without inducing any apparent deteriorative effect.
C1 [Ota, Kazushige; Brydun, Andrey; Itoh-Nakadai, Ari] Tohoku Univ, Dept Biochem, Grad Sch Med, Sendai, Miyagi 9800872, Japan.
   [Ota, Kazushige] Tohoku Univ, Div Nephrol Endocrinol & Vasc Med, Grad Sch Med, Sendai, Miyagi 9800872, Japan.
   [Sun, Jiying] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Cellular Biol, Hiroshima 7348551, Japan.
   [Igarashi, Kazuhiko] Tohoku Univ, Ctr Regulatory Epigenome & Dis, Grad Sch Med, Sendai, Miyagi 9800872, Japan.
C3 Tohoku University; Tohoku University; Hiroshima University; Tohoku
   University
RP Igarashi, K (corresponding author), Tohoku Univ, Dept Biochem, Grad Sch Med, 2-1 Seiryo Machi, Sendai, Miyagi 9800872, Japan.
EM igarashi@med.tohoku.ac.jp
RI Igarashi, Kazuhiko/AGH-9089-2022
OI Igarashi, Kazuhiko/0000-0002-2470-2475
FU Biomedical Research Core of Tohoku University School of Medicine;
   Ministry of Education, Culture, Sports, Science and Technology, Japan;
   Takeda Foundation; Astellas Foundation for Research on Metabolic
   Disorders; Banyu Foundation; Naito Foundation; Grants-in-Aid for
   Scientific Research [26430114] Funding Source: KAKEN
FX The interpretation of the data was enriched by discussions with Dr. M.
   Ono (Tohoku University). Part of this study was supported by Biomedical
   Research Core of Tohoku University School of Medicine. This work was
   supported by Grants-in-aid and the Network Medicine Global-COE Program
   from the Ministry of Education, Culture, Sports, Science and Technology,
   Japan. Critical initiative support was from Takeda Foundation.
   Restoration of laboratory damage from 2011 Tohoku earthquake was
   supported in part by the Astellas Foundation for Research on Metabolic
   Disorders, Banyu Foundation, Naito Foundation, A. Miyazaki, and A. Iida.
CR Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021
   Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071
   ALAM J, 1994, J BIOL CHEM, V269, P1001
   ALAM J, 1995, J BIOL CHEM, V270, P11977, DOI 10.1074/jbc.270.20.11977
   Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159
   Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a
   Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516
   Doi K, 1999, BRIT J CANCER, V80, P1945, DOI 10.1038/sj.bjc.6690624
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0
   Du ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019137
   Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687
   Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363
   Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973
   Giris M, 2006, AM J SURG, V191, P503, DOI 10.1016/j.amjsurg.2005.11.004
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harusato A, 2009, J PHYSIOL PHARMACOL, V60, P149
   Harusato A, 2011, FREE RADICAL RES, V45, P717, DOI 10.3109/10715762.2011.574287
   Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941
   Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107
   Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783
   Igarashi K, 2014, TOHOKU J EXP MED, V232, P229, DOI 10.1620/tjem.232.229
   Iida A, 2009, TOHOKU J EXP MED, V217, P223, DOI 10.1620/tjem.217.223
   Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023
   ITOH K, 1995, MOL CELL BIOL, V15, P4184, DOI 10.1128/mcb.15.8.4184
   JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6
   Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659
   Kuroishi T, 2008, J LEUKOCYTE BIOL, V83, P912, DOI 10.1189/jlb.0607428
   Lee JS, 2012, MECH AGEING DEV, V133, P467, DOI 10.1016/j.mad.2012.05.006
   Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007
   Maines MD, 1996, UROLOGY, V47, P727, DOI 10.1016/S0090-4295(96)00010-6
   Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566
   Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114
   Nakanome A, 2013, ONCOGENE, V32, P3231, DOI 10.1038/onc.2012.336
   Nishizawa H, 2012, CANCER SCI, V103, P897, DOI 10.1111/j.1349-7006.2012.02244.x
   Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835
   Omura S, 2005, GENES CELLS, V10, P277, DOI 10.1111/j.1365-2443.2005.00832.x
   Ota K, 2011, ANTIOXID REDOX SIGN, V14, P2441, DOI 10.1089/ars.2010.3574
   Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9
   Oyake T, 1996, MOL CELL BIOL, V16, P6083
   PATERNITI JR, 1978, ARCH BIOCHEM BIOPHYS, V191, P792, DOI 10.1016/0003-9861(78)90421-6
   Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925
   Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862
   Ryter SW, 2005, ANTIOXID REDOX SIGN, V7, P80, DOI 10.1089/ars.2005.7.80
   Schipper HM, 2000, EXP GERONTOL, V35, P821, DOI 10.1016/S0531-5565(00)00148-0
   Shibahara S, 2002, ANTIOXID REDOX SIGN, V4, P593, DOI 10.1089/15230860260220094
   So AYL, 2012, BLOOD, V120, P2428, DOI 10.1182/blood-2012-04-426247
   Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100
   Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516
   Suttner DM, 1999, AM J PHYSIOL-LUNG C, V276, pL443, DOI 10.1152/ajplung.1999.276.3.L443
   Tanimoto T, 2009, FREE RADICAL BIO MED, V46, P1119, DOI 10.1016/j.freeradbiomed.2009.01.017
   Vulapalli SR, 2002, AM J PHYSIOL-HEART C, V283, pH688, DOI 10.1152/ajpheart.00133.2002
   Wagner CT, 1997, J CLIN INVEST, V100, P589, DOI 10.1172/JCI119569
   Was H, 2011, FREE RADICAL BIO MED, V51, P1717, DOI 10.1016/j.freeradbiomed.2011.07.025
   Yano Y, 2006, GENES CELLS, V11, P791, DOI 10.1111/j.1365-2443.2006.00979.x
   Yun N, 2010, ANTIOXID REDOX SIGN, V13, P1503, DOI 10.1089/ars.2009.2873
NR 56
TC 23
Z9 24
U1 1
U2 4
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1942-0900
EI 1942-0994
J9 OXID MED CELL LONGEV
JI Oxidative Med. Cell. Longev.
PY 2014
VL 2014
AR 757901
DI 10.1155/2014/757901
PG 12
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA AK6QQ
UT WOS:000338552700001
PM 25050144
OA gold, Green Published, Green Submitted
DA 2024-02-19
ER

PT J
AU YOSHINO, K
   KOMURA, S
   OHISHI, N
   KONDO, K
   YAGI, K
AF YOSHINO, K
   KOMURA, S
   OHISHI, N
   KONDO, K
   YAGI, K
TI ENZYME-ACTIVITIES INVOLVED IN THE DEGRADATION OF LIPID PEROXIDES IN THE
   SENESCENCE-ACCELERATED MOUSE
SO JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
LA English
DT Article
DE GLUTATHIONE REDUCTASE; LIPID PEROXIDE LEVEL; SENESCENCE-ACCELERATED MICE
ID GLUTATHIONE-PEROXIDASE; SERUM; LIPOPROTEIN; METABOLISM; AGE; RAT
AB The activities of enzymes involved in the degradation of lipid peroxides, viz., glutathione peroxidase, glutathione S-transferase (GST), glutathione reductase (GR), and glucose-6-phosphate dehydrogenase (G-6-PDH), were measured in the erythrocytes, liver, brain, and heart of male SAM-P/1 mice (accelerated senescence-prone mice) over a period from 1 to 10 months after birth in comparison with those of age-matched male SAM-R/1 mice (accelerated senescence-resistant mice). Among the enzyme activities examined, GR activity in SAM-P/1 mice was markedly lower than that in SAM-R/1 mice in the erythrocytes and all organs tested. GST activity in the liver of the former mice was also lower than that of the latter mice. These results would explain, at least in part, the increased level of lipid peroxides in the former mice as compared with that in the latter. It was noted that G-6-PDH activity increased in the erythrocytes and liver of SAM-P/1 mice.
C1 INST APPL BIOCHEM, YAGI MEM PK, GIFU 50501, JAPAN.
CR AWASTHI YC, 1975, J BIOL CHEM, V250, P5144
   CHOW CK, 1973, J NUTR, V103, P618, DOI 10.1093/jn/103.4.618
   DROR Y, 1970, CLIN CHIM ACTA, V28, P291, DOI 10.1016/0009-8981(70)90093-8
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   HAGIHARA M, 1984, J GERONTOL, V39, P269, DOI 10.1093/geronj/39.3.269
   HAZELTON GA, 1985, MECH AGEING DEV, V29, P71, DOI 10.1016/0047-6374(85)90048-X
   KOMURA S, 1988, J CLIN BIOCHEM NUTR, V5, P255
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   NICHOALDS GE, 1974, CLIN CHEM, V20, P624
   STEINBERG D, 1989, NEW ENGL J MED, V320, P915
   STOHS SJ, 1986, AGE, V9, P65, DOI 10.1007/BF02432270
   SUEMATSU T, 1977, CLIN CHIM ACTA, V79, P267, DOI 10.1016/0009-8981(77)90486-7
   TAKEDA T, 1981, MECH AGEING DEV, V17, P183, DOI 10.1016/0047-6374(81)90084-1
   TAKEUCHI N, 1976, EXP GERONTOL, V11, P179, DOI 10.1016/0531-5565(76)90031-0
   YAGI K, 1985, Journal of Applied Biochemistry, V7, P202
   YAGI K, 1988, ROLE OXYGEN RADICALS, P271
   YAGI K, 1988, J CLIN BIOCHEM NUTR, V5, P22
   ZIGLER JS, 1985, EXP EYE RES, V41, P67, DOI 10.1016/0014-4835(85)90095-8
NR 18
TC 1
Z9 1
U1 0
U2 0
PU JOURNAL CLINICAL BIOCHEMISTRY & NUTRITION
PI KYOTO
PA KYOTO PREFECTURAL UNIV MED, GRAD SCH MEDICAL SCIENCE, DEPT MOLECULAR
   GASTROENTEROLOGY & HEPATOLOGY, KYOTO, 602-8566, JAPAN
SN 0912-0009
EI 1880-5086
J9 J CLIN BIOCHEM NUTR
JI J. Clin. Biochem. Nutr.
PD JAN
PY 1992
VL 12
IS 1
BP 27
EP 34
PG 8
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA HW604
UT WOS:A1992HW60400004
DA 2024-02-19
ER

PT J
AU Kim, KH
   Choi, S
   Zhou, Y
   Kim, EY
   Lee, JM
   Saha, PK
   Anakk, S
   Moore, DD
AF Kim, Kang Ho
   Choi, Sungwoo
   Zhou, Ying
   Kim, Eun Young
   Lee, Jae Man
   Saha, Pradip K.
   Anakk, Sayeepriyadarshini
   Moore, David D.
TI Hepatic FXR/SHP Axis Modulates Systemic Glucose and Fatty Acid
   Homeostasis in Aged Mice
SO HEPATOLOGY
LA English
DT Article
ID FARNESOID-X-RECEPTOR; SMALL HETERODIMER PARTNER; INSULIN-RESISTANCE;
   BILE-ACID; ENERGY-EXPENDITURE; BROWN-ADIPOCYTES; ADIPOSE-TISSUE; LIVER;
   AUTOPHAGY; OBESITY
AB The nuclear receptors farnesoid X receptor (FXR; NR1H4) and small heterodimer partner (SHP; NR0B2) play crucial roles in bile acid homeostasis. Global double knockout of FXR and SHP signaling (DKO) causes severe cholestasis and liver injury at early ages. Here, we report an unexpected beneficial impact on glucose and fatty acid metabolism in aged DKO mice, which show suppressed body weight gain and adiposity when maintained on normal chow. This phenotype was not observed in single Fxr or Shp knockouts. Liver-specific Fxr/Shp double knockout mice fully phenocopied the DKO mice, with lower hepatic triglyceride accumulation, improved glucose/insulin tolerance, and accelerated fatty acid use. In both DKO and liver-specific Fxr/Shp double knockout livers, these metabolic phenotypes were associated with altered expression of fatty acid metabolism and autophagy-machinery genes. Loss of the hepatic FXR/SHP axis reprogrammed white and brown adipose tissue gene expression to boost fatty acid usage. Conclusion: Combined deletion of the hepatic FXR/SHP axis improves glucose/fatty acid homeostasis in aged mice, reversing the aging phenotype of body weight gain, increased adiposity, and glucose/insulin tolerance, suggesting a central role of this axis in whole-body energy homeostasis.
C1 [Kim, Kang Ho; Zhou, Ying; Saha, Pradip K.; Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.
   [Choi, Sungwoo; Moore, David D.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.
   [Zhou, Ying; Moore, David D.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA.
   [Kim, Eun Young; Lee, Jae Man] Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Daegu, South Korea.
   [Anakk, Sayeepriyadarshini] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Kyungpook National University; University of Illinois
   System; University of Illinois Urbana-Champaign
RP Moore, DD (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.
EM moore@bcm.edu
RI Moore, David Dudley/JQI-9927-2023
FU National Institutes of Health [U19 DK062434]
FX Supported by the National Institutes of Health (U19 DK062434).
CR Amir M, 2011, EXPERT REV GASTROENT, V5, P159, DOI [10.1586/EGH.11.4, 10.1586/egh.11.4]
   Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030
   Anakk S, 2011, J CLIN INVEST, V121, P86, DOI 10.1172/JCI42846
   Broeders EPM, 2015, CELL METAB, V22, P418, DOI 10.1016/j.cmet.2015.07.002
   Brolinson A, 2008, ENDOCRINOLOGY, V149, P3158, DOI 10.1210/en.2007-1402
   Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200
   Cavallini G, 2001, EXP GERONTOL, V36, P497, DOI 10.1016/S0531-5565(00)00224-2
   Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017
   Dominguez LJ, 2016, CURR OPIN CLIN NUTR, V19, P5, DOI 10.1097/MCO.0000000000000243
   Fuchs CD, 2016, SEMIN LIVER DIS, V36, P69, DOI 10.1055/s-0036-1571296
   Holloway MG, 2007, ENDOCRINOLOGY, V148, P1977, DOI 10.1210/en.2006-1419
   Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134
   Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632
   Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003
   Jager J, 2016, J BIOL CHEM, V291, P10867, DOI 10.1074/jbc.M116.719120
   Jakobsson A, 2005, AM J PHYSIOL-ENDOC M, V289, pE517, DOI 10.1152/ajpendo.00045.2005
   Ji LJ, 2016, ENDOCRINOLOGY, V157, P91, DOI 10.1210/en.2015-1674
   Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980
   Kim KH, 2014, DIABETES METAB J, V38, P245, DOI 10.4093/dmj.2014.38.4.245
   Kim YC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0835-6
   Kobayashi T, 2012, AM J PHYSIOL-ENDOC M, V302, pE1461, DOI 10.1152/ajpendo.00623.2011
   Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961
   Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604
   Ma YJ, 2013, PHARM RES-DORDR, V30, P1447, DOI 10.1007/s11095-013-0986-7
   Modica Salvatore, 2010, Nucl Recept Signal, V8, pe005, DOI 10.1621/nrs.08005
   Park JH, 2014, AGING CELL, V13, P709, DOI 10.1111/acel.12224
   Park YJ, 2011, J LIPID RES, V52, P2234, DOI 10.1194/jlr.M016048
   Patel R, 2015, MOL ENDOCRINOL, V29, P213, DOI 10.1210/me.2014-1259
   Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478
   Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V
   Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111
   Prawitt J, 2011, DIABETES, V60, P1861, DOI 10.2337/db11-0030
   Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035
   Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3
   Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x
   Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001
   Wang GL, 2015, AM J PATHOL, V185, P3224, DOI 10.1016/j.ajpath.2015.08.002
   Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010
   Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330
   Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203
   Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003
   Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005
   Zadravec D, 2010, FASEB J, V24, P4366, DOI 10.1096/fj.09-152298
   Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851
   Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006
NR 45
TC 71
Z9 85
U1 5
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD AUG
PY 2017
VL 66
IS 2
BP 498
EP 509
DI 10.1002/hep.29199
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA FB0EH
UT WOS:000405817200018
PM 28378930
OA Green Submitted, Green Accepted, Bronze
DA 2024-02-19
ER

PT J
AU Mauriz, JL
   Molpeceres, V
   Garcia-Mediavilla, MV
   González, P
   Barrio, JP
   González-Gallego, J
AF Mauriz, Jose L.
   Molpeceres, Virginia
   Garcia-Mediavilla, Maria V.
   Gonzalez, Paquita
   Barrio, Juan P.
   Gonzalez-Gallego, Javier
TI Melatonin prevents oxidative stress and changes in antioxidant enzyme
   expression and activity in the liver of aging rats
SO JOURNAL OF PINEAL RESEARCH
LA English
DT Article
DE aging; antioxidant enzymes; free radicals; liver; melatonin
ID AGE-RELATED-CHANGES; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION;
   GLUTATHIONE-PEROXIDASE; GENE-EXPRESSION; CYCLOSPORINE-A; MESSENGER-RNA;
   VITAMIN-E; DAMAGE; CATALASE
AB This study compared the effects of melatonin supplementation on markers of oxidative stress, and on the activity and expression of antioxidant enzymes in the liver of young (3-month-old) and aging (24-month-old) rats. Animals were supplemented with melatonin in the drinking water (20 mg/L) for 4 wk. Liver concentration of thiobarbituric-reactive substances (TBARS), as an index of lipid peroxidation, and the oxidized to reduced glutathione ratio significantly increased in aged rats (+ 58%), while values did not significantly differ from the young in aged animals receiving melatonin. Significant decreases in the liver activities of Cu,Zn-superoxide dismutase (SOD) (-25%), cytosolic (-21%) and mitochondrial (-40%) glutathione peroxidase (GPx), and catalase (CAT) (-34%) were found in aged rats. Melatonin abolished these changes and also prevented the reduction of Cu,Zn-SOD (-33%), cytosolic GPx (-30%), and mitochondrial GPx (-47%) liver protein content as measured by Western blot. Reductions in Cu,Zn-SOD mRNA (-39%), and GPx mRNA (-86%) levels induced by aging were also abolished by melatonin. In summary, our data indicate that melatonin treatment abrogates oxidative stress in the liver of aged rats, and that prevention of the decreased activity of CAT and the downregulation of Cu,Zn-SOD and GPx gene expression contribute to this effect.
C1 Univ Leon, Inst Biomed, E-24071 Leon, Spain.
C3 Universidad de Leon
RP González-Gallego, J (corresponding author), Univ Leon, Inst Biomed, E-24071 Leon, Spain.
EM dfijgg@unileon.es
RI Mauriz, Jose L/G-9970-2014; Barrio, Juan Pablo/O-8890-2017;
   Gonzalez-Gallego, Javier/D-8219-2012; Garcia-Mediavilla, María
   Victoria/F-9641-2015
OI Mauriz, Jose L/0000-0003-3160-8599; Barrio, Juan
   Pablo/0000-0002-1039-0175; Gonzalez-Gallego, Javier/0000-0002-4386-9342;
   Garcia-Mediavilla, María Victoria/0000-0002-5722-7500
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   AMSTAD P, 1994, J BIOL CHEM, V269, P1606
   Anisimov VN, 2001, J GERONTOL A-BIOL, V56, pB311, DOI 10.1093/gerona/56.7.B311
   Antolín I, 1997, J PINEAL RES, V23, P182, DOI 10.1111/j.1600-079X.1997.tb00353.x
   Arivazhagan P, 2001, EXP GERONTOL, V37, P81, DOI 10.1016/S0531-5565(01)00147-4
   BARCHAS J, 1967, NATURE, V214, P919, DOI 10.1038/214919a0
   Benot S, 1999, J PINEAL RES, V27, P59, DOI 10.1111/j.1600-079X.1999.tb00597.x
   BURTON GW, 1990, LIPIDS, V25, P199, DOI 10.1007/BF02535748
   Busuttil RA, 2005, CANCER RES, V65, P11271, DOI 10.1158/0008-5472.CAN-05-2980
   CAND F, 1989, FREE RADICAL BIO MED, V7, P59, DOI 10.1016/0891-5849(89)90101-9
   Castillo C, 2005, J PINEAL RES, V38, P240, DOI 10.1111/j.1600-079X.2004.00199.x
   Castillo C, 2005, BIOGERONTOLOGY, V6, P313, DOI 10.1007/s10522-005-4806-2
   CEBALLOSPICOT I, 1992, MUTAT RES, V275, P281, DOI 10.1016/0921-8734(92)90032-K
   Comai Stefano, 2005, Ital J Biochem, V54, P232
   de la Lastra CA, 1999, J PINEAL RES, V26, P101
   DEBUTTE M, 2006, NEUROBIOL AGING, DOI DOI 10.1016/J.NEUROBIOLAG-ING.2005.12.004
   Diaz E, 2000, J REPROD FERTIL, V119, P151, DOI 10.1530/reprod/119.1.151
   El Mohsen MMA, 2005, BIOCHEM BIOPH RES CO, V336, P386, DOI 10.1016/j.bbrc.2005.07.201
   Esparza JL, 2005, J PINEAL RES, V39, P129, DOI 10.1111/j.1600-079X.2005.00225.x
   Esrefoglu M, 2005, J PINEAL RES, V39, P231, DOI 10.1111/j.1600-079X.2005.00235.x
   FAROOQUI MYH, 1987, COMP BIOCHEM PHYS B, V88, P177, DOI 10.1016/0305-0491(87)90097-6
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   Gómez M, 2005, FREE RADICAL BIO MED, V38, P104, DOI 10.1016/j.freeradbiomed.2004.10.009
   Gündüz F, 2004, PHYSIOL RES, V53, P171, DOI 10.33549/physiolres.930384
   HARMAN D, 1992, MUTAT RES, V275, P257, DOI 10.1016/0921-8734(92)90030-S
   HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2
   Hsu CH, 2000, FREE RADICAL BIO MED, V28, P636, DOI 10.1016/S0891-5849(99)00277-4
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   Jones DP, 2002, METHOD ENZYMOL, V348, P93, DOI 10.1016/S0076-6879(02)48630-2
   Jung K, 1996, FREE RADICAL BIO MED, V20, P613, DOI 10.1016/0891-5849(95)02090-X
   Karasek M, 2002, NEUROENDOCRINOL LETT, V23, P118
   León J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Martin R, 2002, EXP GERONTOL, V37, P1481, DOI 10.1016/S0531-5565(02)00168-7
   Mauriz JL, 2001, FREE RADICAL BIO MED, V31, P1236, DOI 10.1016/S0891-5849(01)00716-X
   Mayo JC, 2002, CELL MOL LIFE SCI, V59, P1706, DOI 10.1007/PL00012498
   Mayo JC, 2003, FREE RADICAL RES, V37, P543, DOI 10.1080/1071576031000083206
   MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   Miyoshi N, 2006, P NATL ACAD SCI USA, V103, P1727, DOI 10.1073/pnas.0510346103
   Montilla P, 2001, J PINEAL RES, V31, P138, DOI 10.1034/j.1600-079x.2001.310207.x
   Muñoz-Casares FC, 2006, J PINEAL RES, V40, P195, DOI 10.1111/j.1600-079X.2005.00291.x
   Navarro-Arévalo A, 1998, MECH AGEING DEV, V104, P91, DOI 10.1016/S0047-6374(98)00061-X
   Palomero J, 2001, FREE RADICAL BIO MED, V30, P836, DOI 10.1016/S0891-5849(01)00471-3
   PIGEOLET E, 1990, MECH AGEING DEV, V51, P283, DOI 10.1016/0047-6374(90)90078-T
   Poeggeler B, 2005, ENDOCRINE, V27, P201, DOI 10.1385/ENDO:27:2:201
   POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x
   Pollack M., 1999, Handbook of Oxidants and Antioxidants in Exercise, V30, P881
   Rasmussen DD, 1999, ENDOCRINOLOGY, V140, P1009, DOI 10.1210/en.140.2.1009
   Reiter RJ, 2000, NEWS PHYSIOL SCI, V15, P246
   Reiter RJ, 2000, BIOL SIGNAL RECEPT, V9, P160
   Reiter RJ, 2000, J BIOMED SCI, V7, P444, DOI 10.1007/BF02253360
   Reiter RJ, 2002, ANN NY ACAD SCI, V959, P238, DOI 10.1111/j.1749-6632.2002.tb02096.x
   Reiter RJ, 2002, FREE RADICAL RES, V36, P1323, DOI 10.1080/1071576021000038504
   REITER RJ, 1992, BIOESSAYS, V14, P169, DOI 10.1002/bies.950140307
   Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237
   Rezzani R, 2005, INT IMMUNOPHARMACOL, V5, P1397, DOI 10.1016/j.intimp.2005.03.021
   Rikans LE, 1997, BBA-MOL BASIS DIS, V1362, P116, DOI 10.1016/S0925-4439(97)00067-7
   Sallinen P, 2005, LIFE SCI, V76, P1123, DOI 10.1016/j.lfs.2004.08.016
   Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009
   SEMSEI I, 1989, BIOCHEM BIOPH RES CO, V164, P620, DOI 10.1016/0006-291X(89)91505-2
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Terrón MP, 2005, FREE RADICAL RES, V39, P613, DOI 10.1080/10715760500097831
   Tomás-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x
   WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9
   WILLIS ED, 1985, BIOCH TOXICOLOGY PRA, P407
NR 68
TC 64
Z9 67
U1 1
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0742-3098
EI 1600-079X
J9 J PINEAL RES
JI J. Pineal Res.
PD APR
PY 2007
VL 42
IS 3
BP 222
EP 230
DI 10.1111/j.1600-079X.2006.00409.x
PG 9
WC Endocrinology & Metabolism; Neurosciences; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Neurosciences & Neurology; Physiology
GA 153AX
UT WOS:000245405200002
PM 17349019
DA 2024-02-19
ER

PT S
AU Hoare, M
   Narita, M
AF Hoare, Matthew
   Narita, Masashi
BE Jacks, T
   Sawyers, CL
TI The Power Behind the Throne: Senescence and the Hallmarks of Cancer
SO ANNUAL REVIEW OF CANCER BIOLOGY, VOL 2
SE Annual Review of Cancer Biology-Series
LA English
DT Article; Book Chapter
DE hallmarks; cancer; senescence; microenvironment; tumor suppressor;
   nonautonomous
ID ONCOGENE-INDUCED SENESCENCE; PERSISTENT DNA-DAMAGE; CELL-CYCLE ARREST;
   IN-VIVO; SECRETORY PHENOTYPE; FIBROBLAST SENESCENCE; TRIGGERS
   SENESCENCE; TUMOR-SUPPRESSOR; LIVER-CANCER; P53
AB Cellular senescence is a state of stable proliferative arrest triggered by various stimuli, including oncogenic and other cellular stress. Senescent cells are highly metabolically active and have diverse and profound nonautonomous effects through the senescence-associated secretory phenotype (SASP). It has become increasingly evident that senescent cells can have tumour suppressive or pro-oncogenic effects on adjacent cancer cells and other players in the tumor microenvironment such as the stroma, vasculature, and immune system. Thus, the last decade or so has witnessed a huge leap forward in our understanding of the biology of senescence, promoting it from an autonomous tumor suppressor to a complex, dynamic, and interactive phenotype. It is perhaps not a coincidence that the concept of the "hallmarks of cancer" has also evolved during this period, with the latest iteration (Hanahan & Weinberg 2011) focusing more on the microenvironment. Here, we suggest that cellular senescence could underpin the biology of many of the hallmarks of cancer, making it the true power behind the throne.
C1 [Hoare, Matthew; Narita, Masashi] Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England.
   [Hoare, Matthew] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England.
C3 Cancer Research UK; University of Cambridge; CRUK Cambridge Institute;
   Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's
   Hospital; University of Cambridge
RP Hoare, M (corresponding author), Univ Cambridge, Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England.; Hoare, M (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England.
EM Matthew.Hoare@cruk.cam.ac.uk; masashi.narita@cruk.cam.ac.uk
OI Hoare, Matthew/0000-0001-5990-9604; Narita, Masashi/0000-0001-7764-577X
CR Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038
   Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784
   Aird KM, 2016, J CELL BIOL, V215, P325, DOI 10.1083/jcb.201608026
   Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742
   Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127
   Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031
   Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023
   Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268
   Bavik C, 2006, CANCER RES, V66, P794, DOI 10.1158/0008-5472.CAN-05-1716
   Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035
   Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841
   BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0
   Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010
   Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020
   Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   Coppé JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200
   Coppé JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Coppé JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937
   Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722
   Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241
   Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012
   Denchi LE, 2005, MOL CELL BIOL, V25
   di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440
   di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118
   Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327
   Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638
   Dörr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437
   Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548
   Eggert T, 2016, CANCER CELL, V30, P533, DOI 10.1016/j.ccell.2016.09.003
   Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026
   Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3
   Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69
   Fumagalli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110969
   Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466
   Galbiati A, 2017, AGING CELL, V16, P422, DOI 10.1111/acel.12573
   Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987
   Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Herranz N, 2015, NAT CELL BIOL, V17, P1205, DOI 10.1038/ncb3225
   Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708
   Hoare M, 2016, NAT CELL BIOL, V18, P979, DOI 10.1038/ncb3397
   Jackson JG, 2012, CANCER CELL, V21, P793, DOI 10.1016/j.ccr.2012.04.027
   Johmura Y, 2016, CANCER SCI, V107, P1550, DOI 10.1111/cas.13060
   Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070
   Kanehira M, 2017, STEM CELLS, V35, P739, DOI 10.1002/stem.2499
   Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612
   Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599
   Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154
   Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523
   Kaur A, 2016, NATURE, V532, P250, DOI 10.1038/nature17392
   KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428
   Kirschner K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005053
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698
   Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050
   Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039
   Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195
   LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350
   Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723
   Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008
   Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001
   Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860
   Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020
   Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307
   Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890
   Mosteiro L, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4445
   Muñoz-Espín D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019
   Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920
   Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407
   O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26
   Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052
   Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106
   Oubaha M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9440
   Pagès F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   Parry AJ, 2016, MAMM GENOME, V27, P320, DOI 10.1007/s00335-016-9628-9
   Pérez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054
   Pribluda A, 2013, CANCER CELL, V24, P242, DOI 10.1016/j.ccr.2013.06.005
   Procopio MG, 2015, NAT CELL BIOL, V17, P1193, DOI 10.1038/ncb3228
   Ritschka B, 2017, GENE DEV, V31, P172, DOI 10.1101/gad.290635.116
   Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340
   Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Ruhland MK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11762
   Sadaie M, 2013, GENE DEV, V27, P1800, DOI 10.1101/gad.217281.113
   Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113
   Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1
   Scurr LL, 2010, CELL, V141, P717, DOI 10.1016/j.cell.2010.04.021
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001
   SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2
   Shay JW, 2000, NAT REV MOL CELL BIO, V1, P72, DOI 10.1038/35036093
   Stanton SE, 2016, JAMA ONCOL, V2, P1354, DOI 10.1001/jamaoncol.2016.1061
   Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217
   te Poele RH, 2002, CANCER RES, V62, P1876
   Toso A, 2014, CELL REP, V9, P75, DOI 10.1016/j.celrep.2014.08.044
   Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866
   Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270
   van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0
   Vizioli MG, 2011, ENDOCR-RELAT CANCER, V18, P743, DOI 10.1530/ERC-11-0240
   Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032
   Wajapeyee N, 2010, CELL, V141, P746, DOI 10.1016/j.cell.2010.05.014
   Webster MR, 2015, BBA-REV CANCER, V1856, P244, DOI 10.1016/j.bbcan.2015.10.002
   Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yamakoshi K, 2009, J CELL BIOL, V186, P393, DOI 10.1083/jcb.200904105
   Yevsa T, 2012, ONCOIMMUNOLOGY, V1, P397, DOI 10.4161/onci.19128
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Yoshida A, 2016, CANCER RES, V76, P2990, DOI 10.1158/0008-5472.CAN-15-2931
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709
   Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001
   Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997
   Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344
   Zhuang D, 2008, ONCOGENE, V27, P6623, DOI 10.1038/onc.2008.258
NR 135
TC 20
Z9 24
U1 0
U2 9
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 2472-3428
J9 ANNU REV CANC BIOL
JI Annu. Rev. Canc. Biol.
PY 2018
VL 2
BP 175
EP 194
DI 10.1146/annurev-cancerbio-030617-050352
PG 20
WC Oncology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA BM3UN
UT WOS:000462706100010
OA Green Submitted
DA 2024-02-19
ER

PT J
AU Sheng, KL
   Yang, J
   Xu, YF
   Kong, XW
   Wang, JM
   Wang, YZ
AF Sheng, Kangliang
   Yang, Jian
   Xu, Yifan
   Kong, Xiaowei
   Wang, Jingmin
   Wang, Yongzhong
TI Alleviation effects of grape seed proanthocyanidin extract on
   inflammation and oxidative stress in a d-galactose-induced aging mouse
   model by modulating the gut microbiota
SO FOOD & FUNCTION
LA English
DT Article; Early Access
AB Grape seed proanthocyanidin extract (GSPE) that prevents and alleviates the degenerative changes associated with aging has been receiving extensive attention. In our present work, the ageing model was induced by injection of 500 mg kg(-1)d-galactose daily for a period of eight weeks. The d-galactose-induced ageing mice model was used for evaluating the effect of GSPE on oxidative stress, inflammation levels and gut microbiota composition. d-Galactose induced oxidative damage and inflammation with a significant increase in malondialdehyde contents, myeloperoxidase activities and the levels of TNF-alpha and IL-1 beta, as well as a reduction in the activities of glutathione peroxidase and reduced glutathione. Treatment with different doses of GSPE could significantly improve the antioxidant capacity and inflammation levels in the liver and brain, which is accompanied by increased Lachnospiraceae_NK4A136, Lactobacillus, Bifidobacterium, and Akkermansia, as well as decreased Helicobacter and Alistipes. In addition, the high-dose GSPE group exhibited greater potential to delay the ageing process than the low-dose group. Our results also showed that GSPE administration could downregulate the NLRP3 inflammasome signaling pathway for inhibiting inflammation levels in the brain tissue. This study provided a novel strategy to target the gut microbiota with regard to the effect of GSPE administration on alleviating aging-induced alterations via the gut microbiota-liver axis and gut microbiota-brain axis.
C1 [Sheng, Kangliang; Yang, Jian; Xu, Yifan; Kong, Xiaowei; Wang, Jingmin; Wang, Yongzhong] Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China.
   [Sheng, Kangliang; Yang, Jian; Xu, Yifan; Kong, Xiaowei; Wang, Jingmin; Wang, Yongzhong] Anhui Univ, Key Lab Human Microenvironm & Precis Med, Anhui Higher Educ Inst, Hefei 230601, Anhui, Peoples R China.
   [Sheng, Kangliang; Yang, Jian; Xu, Yifan; Kong, Xiaowei; Wang, Jingmin; Wang, Yongzhong] Anhui Key Lab Modern Biomfg, Hefei 230601, Anhui, Peoples R China.
   [Wang, Yongzhong] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Anhui, Peoples R China.
C3 Anhui University; Anhui University; Anhui University
RP Wang, YZ (corresponding author), Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China.; Wang, YZ (corresponding author), Anhui Univ, Key Lab Human Microenvironm & Precis Med, Anhui Higher Educ Inst, Hefei 230601, Anhui, Peoples R China.; Wang, YZ (corresponding author), Anhui Key Lab Modern Biomfg, Hefei 230601, Anhui, Peoples R China.; Wang, YZ (corresponding author), Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Anhui, Peoples R China.
EM yzwang@ahu.edu.cn
RI Xu, Yifan/ABA-7005-2021
OI Xu, Yifan/0000-0002-8999-2565; Wang, Yongzhong/0000-0002-8231-7153;
   Sheng, Kangliang/0000-0002-3722-6949
FU Natural Science Foundation of Anhui Province [1908085QC120]; National
   Natural Science Foundation of China [31770066, 31470218, 32000081]; Open
   Project Program of State Key Laboratory of Food Science and Technology,
   Jiangnan University [SKLF-KF-201920]; Natural Science Foundation of
   Anhui Higher Education Institutions of China [KJ2019A0040]; Doctoral
   Scientific Research Foundation of Anhui University [J01003316]; Open
   Fund for Discipline Construction, Institute of Physical Science and
   Information Technology of Anhui University; Outstanding Talents Program
   of Anhui University, China
FX This study was supported at least in part by the Natural Science
   Foundation of Anhui Province (K. S., grant no. 1908085QC120), the
   National Natural Science Foundation of China (K. S., grant no.
   32000081), the Open Project Program of State Key Laboratory of Food
   Science and Technology, Jiangnan University (K. S., grant no.
   SKLF-KF-201920), the Natural Science Foundation of Anhui Higher
   Education Institutions of China (K. S., grant no. KJ2019A0040), the
   Doctoral Scientific Research Foundation of Anhui University (K. S.,
   grant no. J01003316), the National Natural Science Foundation of China
   (Y. W., grant no. 31770066 and 31470218), the Open Fund for Discipline
   Construction, Institute of Physical Science and Information Technology
   of Anhui University (Y. W.), and the Outstanding Talents Program of
   Anhui University, China (Y. W.).
CR Ai LY, 2021, GUT, V70, P2261, DOI 10.1136/gutjnl-2020-321094
   Al-Habib A, 2010, J TOXICOL SCI, V35, P357, DOI 10.2131/jts.35.357
   Azm SAN, 2018, APPL PHYSIOL NUTR ME, V43, P718, DOI 10.1139/apnm-2017-0648
   Bárcena C, 2019, NAT MED, V25, P1234, DOI 10.1038/s41591-019-0504-5
   Branca JJV, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100938
   Busch CJ, 2017, BBA-MOL CELL BIOL L, V1862, P398, DOI 10.1016/j.bbalip.2016.06.016
   Caldeira CA, 2021, EXP GERONTOL, V146, DOI 10.1016/j.exger.2021.111226
   de Almeida AJPO, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/1954398
   Du HP, 2021, FOOD FUNCT, V12, P8467, DOI [10.1039/d1fo01361k, 10.1039/D1FO01361K]
   Dulundu E, 2007, J GASTROEN HEPATOL, V22, P885, DOI 10.1111/j.1440-1746.2007.04875.x
   Fernández-Ortiz M, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9121187
   Gallego P, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102148
   Gil-Cardoso K, 2018, J NUTR BIOCHEM, V62, P35, DOI 10.1016/j.jnutbio.2018.07.012
   Grau-Bové C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123647
   Higgins-Chen AT, 2021, SEMIN CELL DEV BIOL, V116, P180, DOI 10.1016/j.semcdb.2021.01.003
   Ionescu-Tucker A, 2021, NEUROBIOL AGING, V107, P86, DOI 10.1016/j.neurobiolaging.2021.07.014
   Jiao JJ, 2017, J FUNCT FOODS, V30, P63, DOI 10.1016/j.jff.2016.12.039
   Komanduri M, 2019, PSYCHOPHARMACOLOGY, V236, P1559, DOI 10.1007/s00213-019-05231-1
   Li HL, 2019, EXP GERONTOL, V120, P88, DOI 10.1016/j.exger.2019.03.002
   Li J, 2019, FOOD FUNCT, V10, P333, DOI 10.1039/c8fo01962b
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Ma JL, 2020, GUT MICROBES, V11, P1450, DOI 10.1080/19490976.2020.1763770
   Miao ZW, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.531117
   Moschen AR, 2016, CELL HOST MICROBE, V19, P455, DOI 10.1016/j.chom.2016.03.007
   Nallathambi R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061623
   Piskovatska Veronika, 2019, Subcell Biochem, V91, P339, DOI 10.1007/978-981-13-3681-2_13
   Rehring JF, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.654259
   Salazar AM, 2018, ISCIENCE, V9, P229, DOI 10.1016/j.isci.2018.10.022
   Sanada F, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00012
   de Medina FS, 2014, INFLAMM BOWEL DIS, V20, P2394, DOI 10.1097/MIB.0000000000000204
   Sehirli Ö, 2008, PHYTOTHER RES, V22, P43, DOI 10.1002/ptr.2256
   Sheng KL, 2020, FOOD FUNCT, V11, P7817, DOI 10.1039/d0fo01418d
   Sheng KL, 2020, FOOD FUNCT, V11, P3964, DOI [10.1039/d0fo00518e, 10.1039/D0FO00518E]
   Shi LG, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00418
   Sierra-Cruz M, 2021, NUTRIENTS, V13, DOI 10.3390/nu13062059
   van der Lugt B, 2019, IMMUN AGEING, V16, DOI 10.1186/s12979-019-0145-z
   Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y
   Wang H, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110449
   Weber HA, 2007, J AGR FOOD CHEM, V55, P148, DOI 10.1021/jf063150n
   Wu GQ, 2020, J AGR FOOD CHEM, V68, P7745, DOI 10.1021/acs.jafc.0c02965
   Wu M, 2021, CRIT REV FOOD SCI, V61, P2175, DOI 10.1080/10408398.2020.1773390
   Xu CM, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1616-2
   Xu ZH, 2018, FISH SHELLFISH IMMUN, V72, P564, DOI 10.1016/j.fsi.2017.11.016
   Zendehdel A, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1157
NR 44
TC 15
Z9 16
U1 9
U2 55
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD 2022 FEB 7
PY 2022
VL 13
IS 3
BP 1348
EP 1359
DI 10.1039/d1fo03396d
EA JAN 2022
PG 12
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA YU3WZ
UT WOS:000744076500001
PM 35043135
DA 2024-02-19
ER

PT J
AU Choi, EK
   Uyeno, S
   Nishida, N
   Okumoto, T
   Fujimura, S
   Aoki, Y
   Nata, M
   Sagisaka, K
   Fukuda, Y
   Nakao, K
   Yoshimoto, T
   Kim, YS
   Ono, T
AF Choi, EK
   Uyeno, S
   Nishida, N
   Okumoto, T
   Fujimura, S
   Aoki, Y
   Nata, M
   Sagisaka, K
   Fukuda, Y
   Nakao, K
   Yoshimoto, T
   Kim, YS
   Ono, T
TI Alterations of c-fos gene methylation in the processes of aging and
   tumorigenesis in human liver
SO MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
LA English
DT Article
DE c-fos; DNA methylation; aging; tumorigenesis; human liver
ID HUMAN HEPATOCELLULAR-CARCINOMA; AGE-ASSOCIATED CHANGES; DNA METHYLATION;
   MYC GENE; MICE; EXPRESSION; CIRRHOSIS; MOUSE
AB The state of DNA methylation in the c-fos gene was examined in human livers of different ages, cirrhosis and hepatocellular carcinoma, The degree of methylation in the intron 1 to exon 4 region increased with age, whereas all of the 10 cirrhosis samples revealed a decrease in methylation when compared to normal livers of similar ages. The 11 hepatocellular carcinomas showed varied alterations suggesting that the alteration of the c-Sos gene methylation is related to aging as well as to early-step of hepatocarcinogenesis.
C1 TOHOKU UNIV, SCH MED, DEPT RADIAT RES, AOBA KU, SENDAI, MIYAGI 98077, JAPAN.
   HALLYM UNIV, INST ENVIRONM & LIFE SCI, CHUNCHON 200702, SOUTH KOREA.
   TOHOKU UNIV, SCH MED, DEPT NEUROSURG, AOBA KU, SENDAI, MIYAGI 98077, JAPAN.
   KYOTO UNIV, GRAD SCH MED, DEPT MED & CLIN SCI, SAKYO KU, KYOTO 606, JAPAN.
   TOHOKU UNIV, SCH MED, DEPT FORENS MED, AOBA KU, SENDAI, MIYAGI 98077, JAPAN.
C3 Tohoku University; Hallym University; Tohoku University; Kyoto
   University; Tohoku University
CR CUTLER RG, 1985, MOL BIOL AGING, P15, DOI DOI 10.2307/2499207
   EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E
   GRAESSMANN A, 1994, MOL CELL BIOL, V14, P2004, DOI 10.1128/MCB.14.3.2004
   ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536
   JOHNSON PJ, 1987, J HEPATOL, V4, P140, DOI 10.1016/S0168-8278(87)80021-1
   KASS SU, 1993, MOL CELL BIOL, V13, P7372, DOI 10.1128/MCB.13.12.7372
   KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560
   KEW MC, 1984, SEMIN LIVER DIS, V4, P136, DOI 10.1055/s-2008-1040653
   KOHN RR, 1971, PRINCIPLES MAMMALIAN, P105
   KOMURA J, 1995, BBA-GENE STRUCT EXPR, V1260, P73, DOI 10.1016/0167-4781(94)00180-B
   LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1
   MACLEOD AR, 1995, J BIOL CHEM, V270, P11327, DOI 10.1074/jbc.270.19.11327
   MACLEOD AR, 1995, J BIOL CHEM, V270, P8037, DOI 10.1074/jbc.270.14.8037
   MIYAMURA Y, 1993, GERONTOLOGY, V39, P3
   NISHIDA N, 1994, INT J ONCOL, V4, P615
   NISHIDA N, 1994, CANCER RES, V54, P3107
   OGATA N, 1991, HEPATOLOGY, V13, P31, DOI 10.1016/0270-9139(91)90212-E
   ONO T, 1993, AGE AGEING, V22, pS34, DOI 10.1093/ageing/22.suppl_1.S34
   ONO T, 1990, MUTAT RES, V237, P239, DOI 10.1016/0921-8734(90)90005-C
   ONO T, 1985, MECH AGEING DEV, V32, P227, DOI 10.1016/0047-6374(85)90082-X
   ONO T, 1989, MUTAT RES, V219, P39, DOI 10.1016/0921-8734(89)90039-8
   Razin A., 1993, Experientia Supplementum (Basel), V64, P343
   SPRUCK CH, 1993, DNA METHYLATION MOL, P487
   STRAATEN F, 1983, P NATL ACAD SCI USA, V80, P3183
   TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501
   UEHARA Y, 1989, ONCOGENE, V4, P1023
   WU JJ, 1993, P NATL ACAD SCI USA, V90, P8891, DOI 10.1073/pnas.90.19.8891
NR 27
TC 40
Z9 43
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-1964
EI 1873-135X
J9 MUTAT RES-FUND MOL M
JI Mutat. Res.-Fundam. Mol. Mech. Mutagen.
PD JUL 5
PY 1996
VL 354
IS 1
BP 123
EP 128
DI 10.1016/0027-5107(96)00056-5
PG 6
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology
GA UY488
UT WOS:A1996UY48800016
PM 8692198
DA 2024-02-19
ER

PT J
AU Martín-Escolano, R
   Vidal-Alcántara, EJ
   Crespo, J
   Ryan, P
   Real, LM
   Lazo-Alvarez, JI
   Cabezas-González, J
   Macías, J
   Arias-Loste, MT
   Cuevas, G
   Virseda-Berdices, A
   Briz, V
   Resino, S
   Jiménez-Sousa, MA
   Fernández-Rodriguez, A
AF Martin-Escolano, Ruben
   Vidal-Alcantara, Erick Joan
   Crespo, Javier
   Ryan, Pablo
   Real, Luis Miguel
   Lazo-Alvarez, Juan Ignacio
   Cabezas-Gonzalez, Joaquin
   Macias, Juan
   Arias-Loste, Maria Teresa
   Cuevas, Guillermo
   Virseda-Berdices, Ana
   Briz, Veronica
   Resino, Salvador
   Jimenez-Sousa, Maria angeles
   Fernandez-Rodriguez, Amanda
TI Immunological and senescence biomarker profiles in patients after
   spontaneous clearance of hepatitis C virus: gender implications for
   long-term health risk
SO IMMUNITY & AGEING
LA English
DT Article
DE Biomarkers; HCV; Immune checkpoint proteins; SASP proteins; Spontaneous
   clearance
ID HUMAN INFECTION MODEL; VACCINE DEVELOPMENT; IMMUNE-RESPONSE; T-CELLS;
   SEX; EXPRESSION; RESOLUTION; CYTOKINES; DRUGS
AB BackgroundAbout 25% of patients with acute hepatitis C virus (HCV) infection show spontaneous clearance within the first six months of infection but may remain at risk of inflammaging, aging, and liver and non-liver disease complications. This study evaluated the differences in the plasma levels of immune checkpoints (ICs) and senescence-associated secretory phenotype (SASP) biomarkers between patients who had spontaneously eliminated HCV infection (SC group) and individuals without evidence of HCV infection (C group).MethodsWe performed a multicenter retrospective study of 56 individuals: 32 in the SC and 24 in the C groups. ICs and SASP proteins were analyzed using a Luminex 200TM analyzer. The statistical analysis used Generalized Linear Models with gamma distribution (log-link) adjusted by significant variables and sex.Results13 ICs (BTLA, CD137(4-1BB), CD27, CD28, CD80, GITR, HVEM, IDO, LAG-3, PD-1, PD-L1, PD-L2, and TIM-3) and 13 SASP proteins (EGF, Eotaxin, IL-1alpha, IL-1RA, IL-8, IL-13, IL-18, IP-10, SDF-1alpha, HGF, beta-NGF, PLGF-1, and SCF) were significantly higher in SC group after approximately more than two years of HCV clearance. After stratifying by sex, differences remained significant for males, which showed higher levels for 13 ICs and 4 SASP proteins in SC. While only PD-L2 was significantly higher in SC women, and no differences in SASP were found.ConclusionsHigher plasma levels of different IC and SASP proteins were found in individuals after more than two years of HCV clearance, mainly in men. Alterations in these molecules might be associated with an increased risk of developing liver and non-hepatic diseases.
C1 [Martin-Escolano, Ruben; Vidal-Alcantara, Erick Joan; Virseda-Berdices, Ana; Resino, Salvador; Jimenez-Sousa, Maria angeles; Fernandez-Rodriguez, Amanda] Inst Salud Carlos III, Unidad Infecc Viral & Inmunidad, Ctr Nacl Microbiol, Campus Majadahonda,Carretera Majadahonda Pozuelo,K, Madrid 28220, Majadahonda, Spain.
   [Crespo, Javier; Cabezas-Gonzalez, Joaquin; Arias-Loste, Maria Teresa] Marques de Valdecilla Univ Hosp, Valdecilla Res Inst IDIVAL, Clin & Traslat Res Digest Dis, Gastroenterol & Hepatol Dept, Santander, Spain.
   [Crespo, Javier; Cabezas-Gonzalez, Joaquin; Arias-Loste, Maria Teresa] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.
   [Ryan, Pablo; Real, Luis Miguel; Macias, Juan; Virseda-Berdices, Ana; Resino, Salvador; Jimenez-Sousa, Maria angeles; Fernandez-Rodriguez, Amanda] Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Infecciosas CIB, Madrid, Spain.
   [Ryan, Pablo; Lazo-Alvarez, Juan Ignacio; Cuevas, Guillermo] Univ Complutense Madrid, Gregorio Maranon Hlth Res Inst, Fac Med, Internal Med Serv,Hosp Univ Infanta Leonor, Madrid, Spain.
   [Real, Luis Miguel; Macias, Juan] Univ Seville, Hosp Univ Virgen de Valme, Inst Biomed Sevilla IBiS, Fac Med, Seville, Spain.
   [Briz, Veronica] Inst Hlth Carlos III, Natl Ctr Microbiol, Lab Reference & Res Viral Hepatitis, Madrid, Majadahonda, Spain.
C3 Instituto de Salud Carlos III; Centro Nacional de Microbiologia (CNM);
   Hospital Universitario Marques de Valdecilla (HUMV); CIBER - Centro de
   Investigacion Biomedica en Red; CIBEREHD; Complutense University of
   Madrid; Hospital Universitario Infanta Leonor; Consejo Superior de
   Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE -
   Instituto de Biomedicina de Sevilla (IBIS); Hospital Valme; Instituto de
   Salud Carlos III; Centro Nacional de Microbiologia (CNM)
RP Jiménez-Sousa, MA; Fernández-Rodriguez, A (corresponding author), Inst Salud Carlos III, Unidad Infecc Viral & Inmunidad, Ctr Nacl Microbiol, Campus Majadahonda,Carretera Majadahonda Pozuelo,K, Madrid 28220, Majadahonda, Spain.; Jiménez-Sousa, MA; Fernández-Rodriguez, A (corresponding author), Inst Salud Carlos III ISCIII, Ctr Invest Biomed Red Enfermedades Infecciosas CIB, Madrid, Spain.
RI Martín-Escolano, Rubén/H-3782-2017; Aguirre-Crespo,
   Francisco/F-8698-2018; Real, Luis M/K-9646-2014
OI Martín-Escolano, Rubén/0000-0002-6262-9344; Real, Luis
   M/0000-0003-4932-7429; Crespo, Javier/0000-0001-8248-0172
FU This study would not have been possible without the collaboration of all
   the patients, medical and nursery staff, and data managers who
   participated in the project. We want to acknowledge the patients in this
   study for their participation.
FX This study would not have been possible without the collaboration of all
   the patients, medical and nursery staff, and data managers who
   participated in the project. We want to acknowledge the patients in this
   study for their participation.
CR Ackermann C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47024-8
   Angel CJL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022928118
   Antonelli A, 2014, IMMUNOL RES, V60, P311, DOI 10.1007/s12026-014-8569-1
   Badeaux MD, 2021, CANCER IMMUNOL RES, V9, P415, DOI 10.1158/2326-6066.CIR-20-0317
   Baden R, 2014, J INFECT DIS, V209, pS81, DOI 10.1093/infdis/jiu057
   Barnes E, 2023, HEPATOLOGY, V77, P1757, DOI 10.1002/hep.32632
   Baz-Martinez M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37007
   Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008
   Bowen DG, 2008, J VIROL, V82, P5109, DOI 10.1128/JVI.00060-08
   Breen EJ, 2015, CYTOKINE, V71, P188, DOI 10.1016/j.cyto.2014.10.030
   Bulteel N, 2016, J HEPATOL, V65, P266, DOI 10.1016/j.jhep.2016.04.030
   Cao WJ, 2009, INT J CANCER, V124, P2886, DOI 10.1002/ijc.24265
   Carvalho F, 2009, ADICCIONES, V21, P99, DOI 10.20882/adicciones.236
   Chan YT, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10112809
   Crespo J, 2020, J VIRAL HEPATITIS, V27, P360, DOI 10.1111/jvh.13238
   Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339
   Feld JJ, 2023, CLIN INFECT DIS, V77, pS262, DOI 10.1093/cid/ciad362
   Ferrari SM, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/5878960
   Friedman H, 2006, FEMS IMMUNOL MED MIC, V47, P330, DOI 10.1111/j.1574-695X.2006.00097.x
   Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960
   Talepoor AG, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.945016
   Giannakoulis VG, 2021, CANCERS, V13, DOI 10.3390/cancers13184732
   Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639
   Hakim MS, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2094
   Hengst J, 2016, J INFECT DIS, V214, P1965, DOI 10.1093/infdis/jiw457
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Horvath S, 2015, J INFECT DIS, V212, P1563, DOI 10.1093/infdis/jiv277
   Kaushik KS, 2011, J MED MICROBIOL, V60, P408, DOI 10.1099/jmm.0.027540-0
   Khera T, 2022, J INFECT DIS, V226, P441, DOI 10.1093/infdis/jiab048
   Koike K, 2015, TRANSPLANTATION, V99, P1447, DOI 10.1097/TP.0000000000000572
   Lian JY, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00986-z
   Liang TJ, 2023, CLIN INFECT DIS, V77, pS215, DOI 10.1093/cid/ciad343
   Martins F, 2019, NAT REV CLIN ONCOL, V16, P563, DOI 10.1038/s41571-019-0218-0
   Muraro E, 2022, CRIT REV ONCOL HEMAT, V175, DOI 10.1016/j.critrevonc.2022.103707
   Ng M, 2022, NEUROBIOL AGING, V120, P88, DOI 10.1016/j.neurobiolaging.2022.08.014
   Oltmanns C, 2023, J HEPATOL, V78, P90, DOI 10.1016/j.jhep.2022.08.042
   Omland LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022476
   Osuch S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12080799
   Osuji FN, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0490-9
   Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947
   Pellegrino TC, 2001, INT IMMUNOPHARMACOL, V1, P665, DOI 10.1016/S1567-5769(00)00051-5
   Larrubia JR, 2014, WORLD J GASTROENTERO, V20, P3418, DOI 10.3748/wjg.v20.i13.3418
   Santoro A, 2021, AGEING RES REV, V71, DOI 10.1016/j.arr.2021.101422
   Shoukry NH, 2021, CURR OPIN VIROL, V51, P80, DOI 10.1016/j.coviro.2021.08.011
   Smits M, 2020, J CLIN INVEST, V130, P998, DOI 10.1172/JCI129642
   de Paula HHS, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0458-6
   Spearman CW, 2019, LANCET, V394, P1451, DOI 10.1016/S0140-6736(19)32320-7
   Tacke F, 2007, J GASTROEN HEPATOL, V22, P1256, DOI 10.1111/j.1440-1746.2006.04621.x
   Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06
   Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509
   Wandrer F, 2018, ALIMENT PHARM THER, V48, P270, DOI 10.1111/apt.14802
   Wang CQ, 2005, AM J PATHOL, V167, P1333, DOI 10.1016/S0002-9440(10)61220-5
   Wang SJ, 2023, TRENDS CANCER, V9, P543, DOI 10.1016/j.trecan.2023.04.002
   Weiss AS, 1999, BIOCHEM EDUC, V27, P237, DOI 10.1016/S0307-4412(99)00044-8
   Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112
   Ye L, 2008, J VIRAL HEPATITIS, V15, P261, DOI 10.1111/j.1365-2893.2007.00940.x
   Ye L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009602
   You CR, 2011, GUT LIVER, V5, P506, DOI 10.5009/gnl.2011.5.4.506
   Zoldan K, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.742061
NR 59
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4933
J9 IMMUN AGEING
JI Immun. Ageing
PD NOV 17
PY 2023
VL 20
IS 1
AR 62
DI 10.1186/s12979-023-00387-z
PG 13
WC Geriatrics & Gerontology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology; Immunology
GA Y2GX8
UT WOS:001103514500002
PM 37978401
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Lin, PH
   Jian, CY
   Chou, JC
   Chen, CW
   Chen, CC
   Soong, C
   Hu, S
   Lieu, FK
   Wang, PS
   Wang, SW
AF Lin, Po-Han
   Jian, Cai-Yun
   Chou, Jou-Chun
   Chen, Chien-Wei
   Chen, Chih-Chieh
   Soong, Christina
   Hu, Sindy
   Lieu, Fu-Kong
   Wang, Paulus S.
   Wang, Shyi-Wu
TI Induction of renal senescence marker protein-30 (SMP30) expression by
   testosterone and its contribution to urinary calcium absorption in male
   rats
SO SCIENTIFIC REPORTS
LA English
DT Article
ID REGUCALCIN MESSENGER-RNA; EPITHELIAL NRK52E CELLS; KIDNEY CORTEX;
   HORMONAL-REGULATION; PROXIMAL TUBULE; GENE-EXPRESSION; APOPTOSIS; LIVER;
   TRANSPORT; MEN
AB The aim of this study was to investigate the involvement of androgen, mainly testosterone, in the expression of renal senescence marker protein-30 (SMP30) in male rats. We found that the renal SMP30 expression was up-regulated by endogenous testosterone stimulation during puberty. Interestingly, androgen-deficient orchidectomized (ORX) rats exhibited lower SMP30 mRNA and protein expression in the kidney, and that was restored by testosterone propionate (TP) replacement. Abrogation of androgen receptor (AR) activity by co-treatment with flutamide abolished testosterone-induced SMP30 expression in the kidney as well as in the NRK52E cells. However, SMP30 expression was unaltered in the liver of ORX rats. We also showed a positive correlation between renal SMP30 expression and plasma testosterone level during the aging process. TP-induced SMP30 expression in ovariectomized (OVX) rats was observed and was an evidence to explain the gender difference of SMP30 levels. Immunofluorescence assay showed that renal SMP30 was specifically expressed in the proximal tubular segments of the kidney. The urinary Ca2+ level was increased in both ORX and male aging rats. Taken together, our results indicate a novel role of testosterone in regulating SMP30 expression specifically in the kidney to contribute to urinary calcium absorption.
C1 [Lin, Po-Han; Jian, Cai-Yun; Chen, Chien-Wei; Chen, Chih-Chieh; Wang, Paulus S.] Natl Yang Ming Univ, Sch Med, Inst & Dept Physiol, Taipei 11221, Taiwan.
   [Chou, Jou-Chun; Wang, Paulus S.] China Med Univ Hosp, Med Ctr Aging Res, Taichung 40402, Taiwan.
   [Soong, Christina; Lieu, Fu-Kong] Cheng Hsin Gen Hosp, Dept Rehabil, Taipei 11212, Taiwan.
   [Hu, Sindy; Wang, Shyi-Wu] Chang Gung Mem Hosp, Dept Dermatol, Aesthet Med Ctr, Taoyuan 33378, Taiwan.
   [Hu, Sindy] Chang Gung Univ, Coll Med, Dept Med, Taoyuan 33302, Taiwan.
   [Wang, Paulus S.] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung 41354, Taiwan.
   [Wang, Paulus S.] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 11217, Taiwan.
   [Wang, Shyi-Wu] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan 33302, Taiwan.
C3 National Yang Ming Chiao Tung University; China Medical University
   Taiwan; China Medical University Hospital - Taiwan; Cheng Hsin General
   Hospital; Chang Gung Memorial Hospital; Chang Gung University; Asia
   University Taiwan; Taipei Veterans General Hospital; Chang Gung
   University
RP Wang, PS (corresponding author), Natl Yang Ming Univ, Sch Med, Inst & Dept Physiol, Taipei 11221, Taiwan.; Wang, PS (corresponding author), China Med Univ Hosp, Med Ctr Aging Res, Taichung 40402, Taiwan.; Lieu, FK (corresponding author), Cheng Hsin Gen Hosp, Dept Rehabil, Taipei 11212, Taiwan.; Wang, SW (corresponding author), Chang Gung Mem Hosp, Dept Dermatol, Aesthet Med Ctr, Taoyuan 33378, Taiwan.; Wang, PS (corresponding author), Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung 41354, Taiwan.; Wang, PS (corresponding author), Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 11217, Taiwan.; Wang, SW (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan 33302, Taiwan.
EM ch2276@chgh.org.tw; pswang3879@gmail.com; swwang@mail.cgu.edu.tw
OI Lin, Po-Han/0000-0003-2099-6258; Soong, Christina/0000-0001-9596-4803
FU Ministry of Science and Technology, Taiwan, ROC [MOST
   103-2320-B-039-034-MY2, MOST 104-2320-B-182-012]; Chang Gung Memorial
   Hospital, Taiwan, ROC [CMRPD3E0301, CMRPG5E0011]
FX This work was supported by the grants from the Ministry of Science and
   Technology (MOST 103-2320-B-039-034-MY2 and MOST 104-2320-B-182-012) and
   Chang Gung Memorial Hospital (CMRPD3E0301 and CMRPG5E0011), Taiwan, ROC.
   The valuable suggestions provided by Dr. Der-Cherng Tarng (National
   Yang-Ming University, Taiwan) are appreciated.
CR BOMSZTYK K, 1984, AM J PHYSIOL, V246, pF600, DOI 10.1152/ajprenal.1984.246.5.F600
   Chang HT, 2014, CHINESE J PHYSIOL, V57, P90, DOI 10.4077/CJP.2014.BAB192
   Cho YM, 2011, INT J ANDROL, V34, P379, DOI 10.1111/j.1365-2605.2010.01091.x
   Couchourel D, 2004, MOL CELL ENDOCRINOL, V222, P71, DOI 10.1016/j.mce.2004.05.001
   Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026
   Fink HA, 2006, J CLIN ENDOCR METAB, V91, P3908, DOI 10.1210/jc.2006-0173
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1132, P297, DOI 10.1016/0167-4781(92)90164-U
   FUJITA T, 1995, BBA-GENE STRUCT EXPR, V1263, P249, DOI 10.1016/0167-4781(95)00120-6
   Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724
   Hsia SM, 2007, EXP BIOL MED, V232, P1181, DOI 10.3181/0612-RM-306
   Hsu YJ, 2010, KIDNEY INT, V77, P601, DOI 10.1038/ki.2009.522
   Inoue H., 1999, CLIN EXP NEPHROL, V3, P261, DOI [10.1007/s101570050045, DOI 10.1007/S101570050045]
   Ishigami A, 2005, CELL TISSUE RES, V320, P243, DOI 10.1007/s00441-004-1073-5
   Ishigami A, 2004, BIOCHEM BIOPH RES CO, V315, P575, DOI 10.1016/j.bbrc.2004.01.091
   Jiang HX, 2005, J BONE MINER RES, V20, P494, DOI 10.1359/JBMR.041133
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Koeppen B, 2013, RENAL PHYSL, P153
   Kurota H, 1997, MOL CELL BIOCHEM, V169, P149, DOI 10.1023/A:1006894332337
   Kurota H, 1996, MOL CELL BIOCHEM, V155, P105
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maia C, 2009, J CELL BIOCHEM, V107, P667, DOI 10.1002/jcb.22158
   Marques R, 2014, CELL MOL LIFE SCI, V71, P93, DOI 10.1007/s00018-013-1323-3
   Misawa H, 2000, INT J MOL MED, V6, P191
   Nakagawa T, 2005, J CELL BIOCHEM, V96, P1274, DOI 10.1002/jcb.20617
   Nakagawa T, 2005, J CELL BIOCHEM, V95, P589, DOI 10.1002/jcb.20422
   Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308
   SHIMOKAWA N, 1993, FEBS LETT, V327, P251, DOI 10.1016/0014-5793(93)80998-A
   Steel R.G.D., 1980, PRINCIPLES PROCEDURE
   Tejwani V, 2013, NUTRIENTS, V5, P1913, DOI 10.3390/nu5061913
   Tsai SC, 1999, AM J PHYSIOL-ENDOC M, V277, pE49, DOI 10.1152/ajpendo.1999.277.1.E49
   Ueoka S, 1998, BIOL PHARM BULL, V21, P405
   Vezzoli G, 2005, KIDNEY INT, V67, P2006, DOI 10.1111/j.1523-1755.2005.00302.x
   Wang KL, 2011, HUM REPROD, V26, P2209, DOI 10.1093/humrep/der165
   White KE, 1997, J GEN PHYSIOL, V109, P217, DOI 10.1085/jgp.109.2.217
   YAMAGUCHI M, 1995, MOL CELL BIOCHEM, V146, P71, DOI 10.1007/BF00926884
   Yamamoto T., 1978, CHEM PHARM BULL, V26, P1915
   Yumura W, 2006, HISTOL HISTOPATHOL, V21, P1151, DOI 10.14670/HH-21.1151
NR 38
TC 9
Z9 9
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 24
PY 2016
VL 6
AR 32085
DI 10.1038/srep32085
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA DT9WR
UT WOS:000381853500001
PM 27553527
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Zhou, D
   Yin, D
   Xiao, F
   Hao, J
AF Zhou, Dan
   Yin, Dan
   Xiao, Fang
   Hao, Jie
TI Expressions of Senescence-Associated β-Galactosidase and Senescence
   Marker Protein-30 are Associated with Lens Epithelial Cell Apoptosis
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Apoptosis; Cataract; Epithelial Cells
ID AGE-RELATED CATARACT; TELOMERE LENGTH; MOUSE-LIVER; REGUCALCIN; NUCLEAR;
   BIOMARKER; TUMORS; DAMAGE; P53
AB Background: To investigate associations of senescence marker protein-30 and senescence-associated beta-galactosidase expression with lens epithelial cells apoptosis among Chinese age-related cataract patients.
   Material/Methods: A total of 145 age-related cataract patients (69 cases with nuclear cataract in 91 eyes and 76 cases of cortical cataract with 102 eyes) were enrolled in our study. An annular tear of the central part of anterior lens capsules was performed for each patient. Immunohistochemical staining and real-time PCR were used to detect the protein and mRNA expression levels, and TUNEL was used to assess lens epithelial cells apoptosis. Comparisons of protein expression levels and lens epithelial cells apoptosis were made between the 2 groups.
   Results: The results showed a higher protein expression level of senescence marker protein-30 in surrounding parts of the anterior lens capsule compared with the central part of the anterior lens capsule; however, the positive rate of senescence-associated beta-galactosidase was remarkably higher in the central part than in the surrounding part. Compared with cortical cataract patients, nuclear cataract patients had elevated senescence marker protein-30 protein and mRNA expression levels, but had a decreased positive rate of senescence-associated beta-galactosidase. TUNEL results showed that the lens epithelial cell apoptosis rate was higher in the central part of the anterior lens capsule than in the surrounding part in both groups. Within either central or surrounding area of anterior lens capsule, cortical cataract patients exhibited a significantly higher lens epithelial cell apoptosis rate in contrast with nuclear cataract patients.
   Conclusions: Our study results suggest that senescence marker protein-30 and senescence-associated beta-galactosidase expressions in both nuclear cataract and cortical cataract patients were associated with lens epithelial cells apoptosis.
C1 [Zhou, Dan; Yin, Dan; Xiao, Fang; Hao, Jie] Harbin Med Univ, Affiliated Hosp 1, Hosp Eye, Harbin, Heilongjiang, Peoples R China.
C3 Harbin Medical University
RP Hao, J (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Hosp Eye, Harbin, Heilongjiang, Peoples R China.
EM haojiehj0815@163.com
CR Arun P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016545
   Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744
   Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600
   Beebe DC, 2010, OPHTHALMIC RES, V44, P155, DOI 10.1159/000316481
   Brennan LA, 2009, EXP EYE RES, V88, P195, DOI 10.1016/j.exer.2008.05.018
   Chakraborti S, 2010, BIOCHEMISTRY-US, V49, P3436, DOI 10.1021/bi9022297
   Chen Y, 2011, J CATARACT REFR SURG, V37, P77, DOI 10.1016/j.jcrs.2010.07.029
   Cheng Y, 2013, CHINESE MED J-PEKING, V126, P1430, DOI 10.3760/cma.j.issn.0366-6999.20123274
   Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Fernández-Menéndez A, 2014, AN PEDIATR, V81, pE62, DOI 10.1016/j.anpedi.2014.01.023
   Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884
   Fujisawa K, 2011, BIOCHEM BIOPH RES CO, V414, P331, DOI 10.1016/j.bbrc.2011.09.067
   Galichanin K, 2012, JOVE-J VIS EXP, DOI 10.3791/4016
   Goldman HB, 2009, GERIATRICS, V64, P19
   Honda S, 2002, BRIT J OPHTHALMOL, V86, P159, DOI 10.1136/bjo.86.2.159
   Huang TT, 2014, GENESIS, V52, P300, DOI 10.1002/dvg.22761
   Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5
   Ishigami A, 2015, GERIATR GERONTOL INT, V15, P804, DOI 10.1111/ggi.12347
   Isik A, 2014, MED SCI MONITOR, V20, P1369, DOI 10.12659/MSM.890804
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Ji YH, 2015, MOL CELL BIOCHEM, V401, P87, DOI 10.1007/s11010-014-2294-x
   Jung KJ, 2004, EXP GERONTOL, V39, P1169, DOI 10.1016/j.exger.2004.04.005
   Kim B, 2012, J CATARACT REFR SURG, V38, P1376, DOI 10.1016/j.jcrs.2012.04.026
   Kim J, 2012, EXP MOL MED, V44, P167, DOI 10.3858/emm.2012.44.2.012
   Lai P, 2011, FEBS LETT, V585, P2291, DOI 10.1016/j.febslet.2011.05.058
   Laurentino SS, 2012, MOL HUM REPROD, V18, P161, DOI 10.1093/molehr/gar075
   Lim SA, 2014, J CATARACT REFR SURG, V40, P1102, DOI 10.1016/j.jcrs.2013.12.015
   Machan CM, 2012, OPTOMETRY VISION SCI, V89, P1165, DOI 10.1097/OPX.0b013e3182644cd1
   Maruyama N, 2010, GERIATR GERONTOL INT, V10, pS88, DOI 10.1111/j.1447-0594.2010.00586.x
   Misaka T, 2013, CARDIOVASC RES, V99, P461, DOI 10.1093/cvr/cvt122
   Miyata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079093
   Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193
   Nischal PM, 2014, NATL MED J INDIA, V27, P56
   Palsamy P, 2014, FREE RADICAL BIO MED, V72, P134, DOI 10.1016/j.freeradbiomed.2014.04.010
   Pradhan Damodar, 2001, Indian Journal of Ophthalmology, V49, P103
   Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002
   Rizvi Saliha, 2014, Curr Aging Sci, V7, P161
   Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008
   Sanders JL, 2011, J GERONTOL A-BIOL, V66, P639, DOI 10.1093/gerona/glr034
   Song E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112054
   Sosinska P, 2014, BIOGERONTOLOGY, V15, P407, DOI 10.1007/s10522-014-9505-4
   Spalton DJ, 2014, J CATARACT REFR SURG, V40, P306, DOI 10.1016/j.jcrs.2013.06.030
   Su S, 2011, INVEST OPHTH VIS SCI, V52, P4182, DOI 10.1167/iovs.10-7094
   Tan W, 2011, MOL VIS, V17, P1553
   Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697
   Wei-xia L, 2014, EXPRESSION STUDY SMP
   Yamaguchi M, 2014, BIOMED REP, V2, P303, DOI 10.3892/br.2014.245
   Zhang Y, 2015, ADV SOC SCI EDUC HUM, V41, P1, DOI 10.1109/VCIP.2015.7457854
   Zheng TY, 2011, CURR EYE RES, V36, P449, DOI 10.3109/02713683.2011.559301
NR 50
TC 13
Z9 15
U1 1
U2 13
PU INT SCIENTIFIC INFORMATION, INC
PI MELVILLE
PA 150 BROADHOLLOW RD, STE 114, MELVILLE, NY 11747 USA
EI 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD NOV 30
PY 2015
VL 21
BP 3728
EP 3735
DI 10.12659/MSM.895596
PG 8
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA CX1DN
UT WOS:000365436600002
PM 26619319
OA Green Published
DA 2024-02-19
ER

PT J
AU Kwan, SY
   Sheel, A
   Song, CQ
   Zhang, XO
   Jiang, TT
   Dang, H
   Cao, YY
   Ozata, DM
   Mou, HW
   Yin, H
   Weng, ZP
   Wang, XW
   Xue, W
AF Kwan, Suet-Yan
   Sheel, Ankur
   Song, Chun-Qing
   Zhang, Xiao-Ou
   Jiang, Tingting
   Dang, Hien
   Cao, Yueying
   Ozata, Deniz M.
   Mou, Haiwei
   Yin, Hao
   Weng, Zhiping
   Wang, Xin Wei
   Xue, Wen
TI Depletion of TRRAP Induces p53-Independent Senescence in Liver Cancer by
   Down-Regulating Mitotic Genes
SO HEPATOLOGY
LA English
DT Article; Early Access
ID HEPATOCELLULAR-CARCINOMA; RNA-SEQ; CHROMOSOME INSTABILITY; COFACTOR;
   TRANSCRIPTION; COMPLEX; ACETYLATION; LANDSCAPE; PROTEIN; MODELS
AB Hepatocellular carcinoma (HCC) is an aggressive subtype of liver cancer with few effective treatments, and the underlying mechanisms that drive HCC pathogenesis remain poorly characterized. Identifying genes and pathways essential for HCC cell growth will aid the development of new targeted therapies for HCC. Using a kinome CRISPR screen in three human HCC cell lines, we identified transformation/transcription domain-associated protein (TRRAP) as an essential gene for HCC cell proliferation. TRRAP has been implicated in oncogenic transformation, but how it functions in cancer cell proliferation is not established. Here, we show that depletion of TRRAP or its co-factor, histone acetyltransferase KAT5, inhibits HCC cell growth through induction of p53-independent and p21-independent senescence. Integrated cancer genomics analyses using patient data and RNA sequencing identified mitotic genes as key TRRAP/KAT5 targets in HCC, and subsequent cell cycle analyses revealed that TRRAP-depleted and KAT5-depleted cells are arrested at the G2/M phase. Depletion of topoisomerase II alpha (TOP2A), a mitotic gene and TRRAP/KAT5 target, was sufficient to recapitulate the senescent phenotype of TRRAP/KAT5 knockdown. Conclusion: Our results uncover a role for TRRAP/KAT5 in promoting HCC cell proliferation by activating mitotic genes. Targeting the TRRAP/KAT5 complex is a potential therapeutic strategy for HCC.
C1 [Kwan, Suet-Yan; Sheel, Ankur; Song, Chun-Qing; Jiang, Tingting; Cao, Yueying; Ozata, Deniz M.; Mou, Haiwei; Xue, Wen] Univ Massachusetts, Med Sch, RNA Therapeut Inst, Worcester, MA USA.
   [Zhang, Xiao-Ou; Weng, Zhiping] Univ Massachusetts, Med Sch, Program Bioinformat & Integrat Biol, Worcester, MA USA.
   [Dang, Hien; Wang, Xin Wei] NCI, Lab Human Carcinogenesis, Ctr Canc Res, Bldg 37, Bethesda, MD 20892 USA.
   [Yin, Hao] Wuhan Univ, Med Res Inst, Wuhan, Hubei, Peoples R China.
   [Weng, Zhiping] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai, Peoples R China.
   [Xue, Wen] Univ Massachusetts, Med Sch, Program Mol Med, Dept Mol Cell & Canc Biol, Worcester, MA USA.
   [Xue, Wen] Univ Massachusetts, Li Weibo Inst Rare Dis Res, Med Sch, Worcester, MA USA.
C3 University of Massachusetts System; University of Massachusetts
   Worcester; University of Massachusetts System; University of
   Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH
   National Cancer Institute (NCI); Wuhan University; Tongji University;
   University of Massachusetts System; University of Massachusetts
   Worcester; University of Massachusetts System; University of
   Massachusetts Worcester
RP Xue, W (corresponding author), Univ Massachusetts, Med Sch, 368 Plantat St,AS4-2043, Worcester, MA 01605 USA.
EM Wen.Xue@umassmed.edu
RI kwan, suet yan/AAH-3974-2020; Wang, Xin Wei/B-6162-2009; MOU,
   Haiwei/AAC-5272-2020; Zhang, Xiao-Ou/J-6229-2014
OI Wang, Xin Wei/0000-0001-9735-606X; Zhang, Xiao-Ou/0000-0002-2027-1313
FU National Institutes of Health [DP2HL137167, P01HL131471, UG3HL147367,
   U24-HG009446]; American Cancer Society [129056-RSG-16-093]; Lung Cancer
   Research Foundation; Hyundai Hope on Wheels; ALS Association; National
   Cancer Institute [F30CA232657]; Intramural Research Program of the
   Center for Cancer Research [Z01-BC 010313, Z01-BC 010876, Z01-BC
   010877]; Young Thousand Talented Program; Wuhan University; NATIONAL
   CANCER INSTITUTE [ZIABC010313] Funding Source: NIH RePORTER
FX Supported by the National Institutes of Health (DP2HL137167,
   P01HL131471, UG3HL147367, and U24-HG009446); American Cancer Society
   (129056-RSG-16-093); Lung Cancer Research Foundation; Hyundai Hope on
   Wheels; ALS Association; National Cancer Institute (F30CA232657);
   Intramural Research Program of the Center for Cancer Research (Z01-BC
   010313, Z01-BC 010876, and Z01-BC 010877); Young Thousand Talented
   Program; and startup funding from Wuhan University.
CR Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108
   Ally A, 2017, CELL, V169, P1327, DOI 10.1016/j.cell.2017.05.046
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480
   Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861
   Chen T, 2015, ONCOGENE, V34, P4019, DOI 10.1038/onc.2014.332
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dominguez-Brauer C, 2015, MOL CELL, V60, P524, DOI 10.1016/j.molcel.2015.11.006
   Fu Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4933-1
   Gao CX, 2014, SCI REP-UK, V4, DOI 10.1038/srep05372
   Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113
   Gire V, 2015, CELL CYCLE, V14, P297, DOI 10.1080/15384101.2014.1000134
   Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024
   Hu HG, 2017, HEPATOLOGY, V65, P515, DOI 10.1002/hep.28887
   Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9
   Jethwat A, 2018, BLOOD, V131, P2789, DOI 10.1182/blood-2017-09-806679
   Kalkat M, 2018, MOL CELL, V72, P836, DOI 10.1016/j.molcel.2018.09.031
   Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377
   Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481
   Lee N, 2015, ONCOTARGET, V6, P30130, DOI 10.18632/oncotarget.4967
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Li H, 2004, EMBO J, V23, P4824, DOI 10.1038/sj.emboj.7600479
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Marquardt JU, 2015, NAT REV CANCER, V15, P653, DOI 10.1038/nrc4017
   Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001
   McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Prieur A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1473
   Ravens S, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0039-z
   Roessler S, 2012, GASTROENTEROLOGY, V142, P957, DOI 10.1053/j.gastro.2011.12.039
   Sawan C, 2013, STEM CELLS, V31, P979, DOI 10.1002/stem.1341
   Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9
   Shukla V, 2011, HEPATOLOGY, V53, P954, DOI 10.1002/hep.24120
   Tapias A, 2014, CELL STEM CELL, V14, P632, DOI 10.1016/j.stem.2014.04.001
   Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263
   Wang XJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03504-5
   Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810
   Weiler SME, 2017, GASTROENTEROLOGY, V152, P2037, DOI 10.1053/j.gastro.2017.02.018
   Wurdak H, 2010, CELL STEM CELL, V6, P37, DOI 10.1016/j.stem.2009.11.002
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Xue W, 2015, HEPAT ONCOL, V2, P315, DOI 10.2217/hep.15.24
   Yang XM, 2018, GASTROENTEROLOGY, V155, P1233, DOI 10.1053/j.gastro.2018.07.010
   Yeh HW, 2017, ONCOTARGET, V8, P77734, DOI 10.18632/oncotarget.20774
   Zucman-Rossi J, 2015, GASTROENTEROLOGY, V149, P1226, DOI 10.1053/j.gastro.2015.05.061
NR 50
TC 41
Z9 48
U1 1
U2 18
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD 2020 JAN
PY 2020
VL 71
IS 1
BP 275
EP 290
DI 10.1002/hep.30807
EA AUG 2019
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA KE5MF
UT WOS:000480563800001
PM 31188495
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Kawakami, K
   Nakamura, A
   Ishigami, A
   Goto, S
   Takahashi, R
AF Kawakami, Kyojiro
   Nakamura, Akihiro
   Ishigami, Akihito
   Goto, Sataro
   Takahashi, Ryoya
TI Age-related difference of site-specific histone modifications in rat
   liver
SO BIOGERONTOLOGY
LA English
DT Article
DE Aging; Histone modification; Acetylation; Methylation; Phosphorylation;
   Epigenetics
ID DNA METHYLATION; CELLULAR SENESCENCE; CHROMATIN; H3; ACETYLATION;
   TRANSCRIPTION; PHOSPHORYLATION; HETEROCHROMATIN; EPIGENETICS; GENE
AB Aging is associated with decrease in activities of the transcription, replication and DNA repair that can result in deterioration of cellular and tissue functions. Changes of chromatin structures with age are likely major underling mechanisms for the functional decline. Chromatin consists of DNA and histones as well as non-histone proteins. While age-associated change of DNA methylation is well documented, little information is available on site-specific histone modifications in aging. We studied here age-related change of selected modifications of rat liver histone, i.e., histone H3 Lys9 acetylation (H3K9ac), H3 Lys9 methylation (H3K9me), H3 Ser10 phosphorylation (H3S10ph) and H3 Lys14 acetylation (H3K14ac). H3K9ac was decreased and H3S10ph was increased with age significantly. In view of reports indicating that decrease in acetylation and increase in phosphorylation of H3 histones can suppress gene activity, our findings suggest that a mechanism of decreased chromatin functions with age is due to such epigenetic changes.
C1 [Goto, Sataro] Juntendo Univ, Grad Sch, Inst Hlth & Sports Sci & Med, Chiba 2701695, Japan.
   [Kawakami, Kyojiro; Ishigami, Akihito; Takahashi, Ryoya] Toho Univ, Dept Biochem, Fac Pharmaceut Sci, Chiba 2748510, Japan.
   [Nakamura, Akihiro] Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan.
C3 Juntendo University; Toho University; Keio University
RP Goto, S (corresponding author), Juntendo Univ, Grad Sch, Inst Hlth & Sports Sci & Med, Hiragagakuendai 1-1, Chiba 2701695, Japan.
EM gotosataro@sakura.juntendo.ac.jp
OI Kawakami, Kyojiro/0000-0002-2822-3252
FU Ministry of Education, Science, and Culture, Japan; Smoking Research
   Foundation, Japan
FX This study is supported by a Grant-in-Aid for Scientific Research and an
   "Open Research Center'' Project from the Ministry of Education, Science,
   and Culture, Japan, and a Grant-in-Aid for Smoking Research Foundation,
   Japan.
CR Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2
   Attwood JT, 2002, CELL MOL LIFE SCI, V59, P241, DOI 10.1007/s00018-002-8420-z
   Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913
   Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017
   COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163
   Edmondson DG, 2002, J BIOL CHEM, V277, P29496, DOI 10.1074/jbc.M200651200
   Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219
   Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008
   Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102
   Funayama R, 2006, J CELL BIOL, V175, P869, DOI 10.1083/jcb.200604005
   Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091
   Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005
   Li Q, 2002, J GERONTOL A-BIOL, V57, pB93, DOI 10.1093/gerona/57.3.B93
   Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101
   Liu L, 2003, MECH AGEING DEV, V124, P989, DOI 10.1016/j.mad.2003.08.001
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005
   Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736
   Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X
   Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007
   Oberdoerffer P, 2007, NAT REV MOL CELL BIO, V8, P692, DOI 10.1038/nrm2238
   OH YH, 1972, LIFE SCI 2-BIOCH GEN, V11, P1207, DOI 10.1016/0024-3205(72)90188-9
   Richardson B, 2003, AGEING RES REV, V2, P245, DOI 10.1016/S1568-1637(03)00010-2
   Roy AK, 2002, AGEING RES REV, V1, P367, DOI 10.1016/S1568-1637(02)00006-5
   Sabbattini P, 2007, EMBO J, V26, P4657, DOI 10.1038/sj.emboj.7601875
   Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200
   Sedivy JM, 2008, EXP CELL RES, V314, P1909, DOI 10.1016/j.yexcr.2008.02.023
   Sharma R, 2006, FREE RADICAL BIO MED, V40, P1179, DOI 10.1016/j.freeradbiomed.2005.11.013
   Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06
   Van Remmen Holly, 1995, P171
   Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031
   Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003
NR 34
TC 65
Z9 72
U1 3
U2 5
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1389-5729
EI 1573-6768
J9 BIOGERONTOLOGY
JI Biogerontology
PD AUG
PY 2009
VL 10
IS 4
BP 415
EP 421
DI 10.1007/s10522-008-9176-0
PG 7
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA 461TC
UT WOS:000267293400004
PM 18814051
DA 2024-02-19
ER

PT J
AU MANCINI, MA
   SONG, CS
   RAO, TR
   CHATTERJEE, B
   ROY, AK
AF MANCINI, MA
   SONG, CS
   RAO, TR
   CHATTERJEE, B
   ROY, AK
TI SPATIOTEMPORAL EXPRESSION OF ESTROGEN SULFOTRANSFERASE WITHIN THE
   HEPATIC LOBULE OF MALE-RATS - IMPLICATION OF INSITU ESTROGEN
   INACTIVATION IN ANDROGEN ACTION
SO ENDOCRINOLOGY
LA English
DT Article
ID HUMAN ENDOMETRIUM; MESSENGER-RNA; STEROID SULFOTRANSFERASES;
   MENSTRUAL-CYCLE; TARGET TISSUE; ALPHA-2U-GLOBULIN; RECEPTOR;
   LOCALIZATION; METABOLISM; INDUCTION
AB Estrogen sulfotransferase (EST) catalyzes transfer of the sulfate group from phosphoadenosine phosphosulfate to estrogenic steroids. Since estrogen sulfates do not bind to the estrogen receptor with high affinity, EST can control the intracellular level of the receptor-active estrogens. Androgen action in the rat liver, as indicated by the androgenic induction of alpha-2u-globulin, is inhibited by low levels of estrogens. Thus, in situ estrogen inactivation by EST is expected to increase hepatic androgen sensitivity. During the lifespan of the animal, rat liver undergoes three distinct phases of androgen sensitivity, i.e. prepubertal androgen insensitivity, androgen sensitivity after approximately 40 days of age, and androgen insensitivity during senescence (>750 days). EST in the liver is expressed only after puberty, when the liver becomes androgen sensitive. Furthermore, localization of EST and its corresponding mRNA within the lobular unit of the liver demonstrates that only androgen-responsive hepatocytes located around the central vein contain immunoreactive EST and its corresponding mRNA. These temporal and spatial correlations of EST expression and hepatic androgen sensitivity support the concept that steroid-inactivating enzymes play important roles in sex hormone action.
C1 UNIV TEXAS, HLTH SCI CTR, DEPT CELLULAR & STRUCT BIOL, SAN ANTONIO, TX 78284 USA.
   UNIV TEXAS, HLTH SCI CTR, INST BIOTECHNOL, SAN ANTONIO, TX 78284 USA.
   UNIV TEXAS, HLTH SCI CTR, DEPT OBSTET & GYNECOL, SAN ANTONIO, TX 78284 USA.
C3 University of Texas System; University of Texas Health Science Center at
   San Antonio; University of Texas System; University of Texas Health
   Science Center at San Antonio; University of Texas System; University of
   Texas Health Science Center at San Antonio
FU NIA NIH HHS [P01-AG-06872, R01-AG-03527] Funding Source: Medline; NIDDK
   NIH HHS [R37-DK-14744] Funding Source: Medline
CR ANTAKLY T, 1982, AM J ANAT, V165, P211, DOI 10.1002/aja.1001650209
   BROOKS SC, 1987, J STEROID BIOCHEM, V26, P285, DOI 10.1016/0022-4731(87)90084-7
   BROOKS SC, 1983, STEROIDS ENDOMETRIAL, P145
   BUIRCHELL BJ, 1975, J STEROID BIOCHEM, V6, P1489, DOI 10.1016/0022-4731(75)90202-2
   DEMYAN WF, 1992, MOL ENDOCRINOL, V6, P589, DOI 10.1210/me.6.4.589
   EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8
   FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584
   GURPIDE E, 1978, J TOXICOL ENV HEALTH, V4, P249, DOI 10.1080/15287397809529660
   HOBKIRK R, 1985, CAN J BIOCHEM CELL B, V63, P1127, DOI 10.1139/o85-141
   HSU SM, 1981, AM J CLIN PATHOL, V75, P734, DOI 10.1093/ajcp/75.5.734
   JACOBY WB, 1990, J BIOL CHEM, V265, P20715
   KOBAYASHI N, 1987, PFLUG ARCH EUR J PHY, V408, P46, DOI 10.1007/BF00581839
   LEINONEN P, 1982, J STEROID BIOCHEM, V16, P277, DOI 10.1016/0022-4731(82)90176-5
   MAHESH VB, 1960, J BIOL CHEM, V235, P356
   MANCINI MA, 1991, J HISTOCHEM CYTOCHEM, V39, P401, DOI 10.1177/39.4.1706374
   MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035
   MOTWANI NM, 1984, J BIOL CHEM, V259, P3653
   POLLOW K, 1977, PROGESTERONE RECEPTO, P313
   ROY AK, 1983, RECENT PROG HORM RES, V39, P425
   ROY AK, 1992, P SOC EXP BIOL MED, V199, P265
   ROY AK, 1975, ENDOCRINOLOGY, V97, P1505
   ROZHIN J, 1977, J BIOL CHEM, V252, P7214
   RUNDLE SE, 1989, ENDOCRINOLOGY, V125, P1700, DOI 10.1210/endo-125-3-1700
   SARKAR FH, 1986, J ENDOCRINOL, V111, P205, DOI 10.1677/joe.0.1110205
   SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349
   TERENGHI G, 1987, P NATL ACAD SCI USA, V84, P7315, DOI 10.1073/pnas.84.20.7315
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TSENG L, 1977, ANN NY ACAD SCI, V286, P190, DOI 10.1111/j.1749-6632.1977.tb29416.x
   TSENG L, 1972, AM J OBSTET GYNECOL, V114, P1002, DOI 10.1016/0002-9378(72)90859-9
NR 29
TC 29
Z9 31
U1 0
U2 3
PU ENDOCRINE SOC
PI CHEVY CHASE
PA 8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD SEP
PY 1992
VL 131
IS 3
BP 1541
EP 1546
DI 10.1210/en.131.3.1541
PG 6
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA JK945
UT WOS:A1992JK94500073
PM 1380444
DA 2024-02-19
ER

PT J
AU Li, BL
   Evivie, SE
   Lu, JJ
   Jiao, YH
   Wang, CF
   Li, ZY
   Liu, F
   Huo, GC
AF Li, Bailiang
   Evivie, Smith Etareri
   Lu, Jingjing
   Jiao, Yuehua
   Wang, Chengfeng
   Li, Ziye
   Liu, Fei
   Huo, Guicheng
TI <i>Lactobacillus helveticus</i> KLDS1.8701 alleviates
   d-galactose-induced aging by regulating Nrf-2 and gut microbiota in mice
SO FOOD & FUNCTION
LA English
DT Article
ID OXIDATIVE STRESS; FREE-RADICALS; IN-VIVO; ANTIOXIDANT; PLANTARUM; LIVER;
   PERSPECTIVE; BACTERIA; DISEASE; OBESITY
AB Aging is commonly associated with chronic oxidative stress and mild inflammation that can cause a variety of degenerative diseases. Lactic acid bacteria (LAB) provide several health benefits to the host including antioxidant activity and immune system regulation. However, there is a lack of information regarding the antioxidant mechanisms of probiotics in vivo. Therefore, the aim of this study was to elucidate the possible mechanisms for the preventive effect of LAB on aging. First, 25 LAB strains were screened for finding potential probiotics with high antioxidant capacity using in vitro methods. Second, d-galactose was administered by subcutaneous injection once daily for 8 weeks to establish an aging mouse model to investigate the protective effects and underlying mechanisms of the potential probiotic strain Lactobacillus helveticus KLDS1.8701, identified from the screening. The results in vitro showed that L. helveticus KLDS1.8701 had a better property with remarkable free radical scavenging activity. In vivo, L. helveticus KLDS1.8701 supplementation significantly ameliorated aging-related changes such as decreased organic index, liver injury and increased endotoxin. L. helveticus KLDS1.8701 supplementation reduced hepatic oxidative stress by modulating the Nrf-2 pathway. Notably, L. helveticus KLDS1.8701 supplementation restored the gut microbiota composition to that of the control group, resulting in increased butyrate production and decreased endotoxin production. These findings indicated that L. helveticus KLDS1.8701 supplementation manipulated gut microbiota and its metabolites could attenuate hepatic oxidative stress via the gut-liver axis.
C1 [Li, Bailiang; Evivie, Smith Etareri; Lu, Jingjing; Wang, Chengfeng; Li, Ziye; Liu, Fei; Huo, Guicheng] Northeast Agr Univ, Minist Educ, Key Lab Dairy Sci, Harbin 150030, Heilongjiang, Peoples R China.
   [Evivie, Smith Etareri] Univ Benin, Fac Agr, Dept Anim Sci, Food Sci & Nutr Unit, PMB 1154, Benin, Nigeria.
   [Jiao, Yuehua] Heilongjiang Univ Chinese Med, Ctr Drug Safety Evaluat, Harbin 150040, Heilongjiang, Peoples R China.
   [Huo, Guicheng] Northeast Agr Univ, Food Coll, Harbin 150030, Heilongjiang, Peoples R China.
C3 Northeast Agricultural University - China; University of Benin;
   Heilongjiang University of Chinese Medicine; Northeast Agricultural
   University - China
RP Liu, F; Huo, GC (corresponding author), Northeast Agr Univ, Minist Educ, Key Lab Dairy Sci, Harbin 150030, Heilongjiang, Peoples R China.; Huo, GC (corresponding author), Northeast Agr Univ, Food Coll, Harbin 150030, Heilongjiang, Peoples R China.
EM liufei@neau.edu.cn; guichenghuo@126.com
RI Liu, Fei/R-9461-2019; Liu, Fei/AAR-2664-2020; li, bai/GRJ-4913-2022; li,
   bz/GVR-7133-2022; Evivie, Smith/AAC-4077-2020
OI Liu, Fei/0000-0001-8827-4409; Evivie, Smith/0000-0002-4209-0978
FU National Key Research and Development Program of China [2017YFD0400303];
   Natural Science Foundation of Heilongjiang Province, China [QC2016039]
FX The present research work was financially supported by the National Key
   Research and Development Program of China (No. 2017YFD0400303) and the
   Natural Science Foundation of Heilongjiang Province, China (QC2016039).
CR Alvarez-Olmos MI, 2001, CLIN INFECT DIS, V32, P1567, DOI 10.1086/320518
   Ames B. N., 2010, ANN NY ACAD SCI, V663, P85
   And M. Y. L., 1999, J AGR FOOD CHEM, V47, P1460
   Azm S. A. N., 2018, APPL PHYSIOL NUTR ME, V43, P1
   Banji OJF, 2014, FOOD CHEM TOXICOL, V74, P51, DOI 10.1016/j.fct.2014.08.020
   Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]
   Butel MJ, 2014, MED MALADIES INFECT, V44, P1, DOI 10.1016/j.medmal.2013.10.002
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Castillo C, 2005, BIOGERONTOLOGY, V6, P313, DOI 10.1007/s10522-005-4806-2
   Chen PC, 2016, FOOD FUNCT, V7, P4576, DOI [10.1039/C6FO00628K, 10.1039/c6fo00628k]
   Dong WP, 2017, J ENDOCRINOL, V232, P71, DOI 10.1530/JOE-16-0322
   Doron Shira, 2006, Expert Rev Anti Infect Ther, V4, P261, DOI 10.1586/14787210.4.2.261
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063388
   Floyd RA, 2002, NEUROBIOL AGING, V23, P795, DOI 10.1016/S0197-4580(02)00019-2
   Gao DW, 2013, FOOD FUNCT, V4, P982, DOI 10.1039/c3fo30316k
   GRICE HC, 1988, FOOD CHEM TOXICOL, V26, P717, DOI 10.1016/0278-6915(88)90072-5
   Gudiña EJ, 2010, LETT APPL MICROBIOL, V50, P419, DOI 10.1111/j.1472-765X.2010.02818.x
   Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247
   Guo LD, 2016, MICROB BIOTECHNOL, V9, P737, DOI 10.1111/1751-7915.12306
   Hamelet J, 2007, J HEPATOL, V46, P151, DOI 10.1016/j.jhep.2006.07.028
   Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   Hsieh HM, 2009, FOOD CHEM TOXICOL, V47, P625, DOI 10.1016/j.fct.2008.12.026
   Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307
   Klaassen CD, 2010, TOXICOL APPL PHARM, V244, P57, DOI 10.1016/j.taap.2010.01.013
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lee J, 2011, INT J FOOD MICROBIOL, V148, P80, DOI 10.1016/j.ijfoodmicro.2011.05.003
   Li SY, 2012, FOOD CHEM, V135, P1914, DOI 10.1016/j.foodchem.2012.06.048
   Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513
   Lin MY, 2000, DIGEST DIS SCI, V45, P1617, DOI 10.1023/A:1005577330695
   Lin XN, 2018, J FOOD SCI, V83, P1990, DOI 10.1111/1750-3841.14200
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Man AL, 2015, CLIN SCI, V129, P515, DOI 10.1042/CS20150046
   Manoharan S, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8590578
   Matafome P, 2011, DIABETES-METAB RES, V27, P54, DOI 10.1002/dmrr.1157
   Mateos R, 2005, J CHROMATOGR B, V827, P76, DOI 10.1016/j.jchromb.2005.06.035
   Mishra V, 2015, J AGR FOOD CHEM, V63, P3615, DOI 10.1021/jf506326t
   Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14
   NOHL H, 1993, BRIT MED BULL, V49, P653, DOI 10.1093/oxfordjournals.bmb.a072638
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   O'Toole Paul W, 2008, Interdiscip Perspect Infect Dis, V2008, P175285, DOI 10.1155/2008/175285
   P Y., 2014, NUCLEIC ACIDS RES, V42, pD643
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Pietraforte D, 2014, ANTIOXID REDOX SIGN, V21, P52, DOI 10.1089/ars.2014.5914
   Plöger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x
   Qiao Y, 2013, APPL MICROBIOL BIOT, V97, P1689, DOI 10.1007/s00253-012-4323-6
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Rajilic-Stojanovic M, 2014, FEMS MICROBIOL REV, V38, P996, DOI 10.1111/1574-6976.12075
   Rowan F, 2010, DIS COLON RECTUM, V53, P1530, DOI 10.1007/DCR.0b013e3181f1e620
   Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072
   Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Shen F, 2017, HEPATOB PANCREAT DIS, V16, P375, DOI 10.1016/S1499-3872(17)60019-5
   Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024
   Stewart CJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0295-1
   Sun MF, 2018, AGEING RES REV, V45, P53, DOI 10.1016/j.arr.2018.04.004
   Tang W, 2016, APPL MICROBIOL BIOT, V100, P7193, DOI 10.1007/s00253-016-7581-x
   Tang W, 2014, WORLD J GASTROENTERO, V20, P13079, DOI 10.3748/wjg.v20.i36.13079
   Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y
   Yang H, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01555
   Yu LL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120783
   Yu XM, 2016, J DAIRY SCI, V99, P903, DOI 10.3168/jds.2015-10265
   Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974
   Zhang J, 2017, J DAIRY SCI, V100, P6025, DOI 10.3168/jds.2016-12480
   Zhang SW, 2011, AFR J MICROBIOL RES, V5, P5194, DOI 10.5897/AJMR11.997
   Zhang X, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]
   Zhao JC, 2018, FOOD FUNCT, V9, P917, DOI [10.1039/c7fo01574g, 10.1039/C7FO01574G]
   Zheng XJ, 2013, METABOLOMICS, V9, P818, DOI 10.1007/s11306-013-0500-6
NR 75
TC 60
Z9 64
U1 7
U2 91
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD DEC 1
PY 2018
VL 9
IS 12
BP 6587
EP 6599
DI 10.1039/c8fo01768a
PG 13
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA HE3HP
UT WOS:000453244900047
PM 30488048
DA 2024-02-19
ER

PT J
AU Tam, CW
   Liu, VWS
   Leung, WY
   Yao, KM
   Shiu, SYW
AF Tam, Chun Wai
   Liu, Vincent Wing Sun
   Leung, Wai Ying
   Yao, Kwok-Ming
   Shiu, Stephen Yuen Wing
TI The autocrine human secreted PDZ domain-containing protein 2 (sPDZD2)
   induces senescence or quiescence of prostate, breast and liver cancer
   cells via transcriptional activation of p53
SO CANCER LETTERS
LA English
DT Article
DE sPDZD2; p53; Prostate; Breast; Liver
ID SMALL-MOLECULE ANTAGONISTS; TUMOR-SUPPRESSOR GENE; NF-KAPPA-B; INDUCED
   APOPTOSIS; EXPRESSION; PATHWAY; GROWTH; MUTATIONS; PROMOTER; ELEMENT
AB Tumor suppressive actions of the autocrine human secreted PDZ domain-containing protein 2 (sPDZD2) have been reported, but the mechanisms remain enigmatic. Here, we showed that sPDZD2 induced senescence of prostate cancer DU145 cells, quiescence of breast cancer MCF-7 and liver cancer Hep-G2 cells, via transcriptional activation of mutant or wild-type p53. Furthermore, sPDZD2 sensitized mutant p53-positive DU145 cells and wild-type p53-positive MCF-7 cells to apoptosis induction through genotoxic stress imposed by sub-lethal concentration of hydrogen peroxide. Together our findings suggest a potential autocrine pathway of p53 activation by transcriptional regulation, and a new approach to reactivate p53 for cancer therapy. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
C1 [Leung, Wai Ying; Yao, Kwok-Ming] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.
   [Tam, Chun Wai; Shiu, Stephen Yuen Wing] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China.
   [Liu, Vincent Wing Sun] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China.
C3 University of Hong Kong; University of Hong Kong; University of Hong
   Kong
RP Yao, KM (corresponding author), Univ Hong Kong, Dept Biochem, Lab Block,Fac Med Bldg,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.
EM kmyao@hkusua.hku.hk; sywshiu@hkucc.hku.hk
RI Leung, Gloria Wai Ying/C-4189-2009; Yao, Kwok Ming/C-4457-2009; Shiu,
   Stephen Yuen Wing/C-4392-2009; Tam, Chun Wai/C-4670-2009
OI Shiu, Stephen Yuen Wing/0000-0003-2208-6135; 
FU University of Hong Kong;  [HKU7474/04M];  [200507176053]; 
   [200611159071];  [HKU7580/05M]
FX We thank Prof. S. Sukumar (Johns Hopkins Oncology Centre, Baltimore,
   Maryland) for the gift of p53 reporter construct -2400-p53-Luc, Dr. E.
   Fearon (University of Michigan School of Medicine, Ann Arbor, Michigan)
   for providing the sequence information of the antisense locked nucleic
   acid (LNA) oligonucleotides and Dr. N. S. Wong (Department of
   Biochemistry, The University of Hong Kong) for providing the human
   caspase-3 cDNA. This work was supported by research grants HKU7474/04M
   (to K.-M.Y.), #200507176053, #200611159071 and HKU7580/05M (to
   S.Y.W.S.). C.W.T. is supported by a postgraduate studentship of The
   University of Hong Kong and the data presented were derived from part of
   his Ph.D. thesis work.
CR Ahmed MM, 2004, CURR CANCER DRUG TAR, V4, P43, DOI 10.2174/1568009043481704
   Bálint É, 2001, BRIT J CANCER, V85, P1813, DOI 10.1054/bjoc.2001.2128
   Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455
   Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068
   Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627
   CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206
   Chaib H, 2001, CANCER RES, V61, P2390
   CHANG C, 1979, J VIROL, V31, P463, DOI 10.1128/JVI.31.2.463-471.1979
   Deguchi M, 2002, J BIOL CHEM, V277, P35778
   Deguchi M, 2000, J BIOL CHEM, V275, P29875, DOI 10.1074/jbc.M005384200
   DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949
   Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116
   Furlong EEM, 1996, MOL CELL BIOL, V16, P5933
   GREENBLATT MS, 1994, CANCER RES, V54, P4855
   Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102
   Gurova KV, 2003, CANCER RES, V63, P2905
   Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615
   He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232
   HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840
   Johansson EM, 2005, MOL ENDOCRINOL, V19, P992, DOI 10.1210/me.2004-0359
   Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100
   Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200
   Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626
   Klein C, 2004, BRIT J CANCER, V91, P1415, DOI 10.1038/sj.bjc.6602164
   KRESS M, 1979, J VIROL, V31, P472, DOI 10.1128/JVI.31.2.472-483.1979
   Lain S, 2003, EUR J CANCER, V39, P1053, DOI 10.1016/S0959-8049(03)00063-7
   LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0
   Li C, 2001, ONCOGENE, V20, P8193, DOI 10.1038/sj.onc.1205046
   LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9
   LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7
   Ma RYM, 2006, INT J BIOCHEM CELL B, V38, P1015, DOI 10.1016/j.biocel.2005.11.012
   Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007
   Nagase T, 1997, DNA Res, V4, P141, DOI 10.1093/dnares/4.2.141
   Nair P, 1997, J BIOL CHEM, V272, P20131, DOI 10.1074/jbc.272.32.20131
   Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3
   NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0
   Noda A, 2000, ONCOGENE, V19, P21, DOI 10.1038/sj.onc.1203230
   OConnor PM, 1997, CANCER RES, V57, P4285
   Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2
   PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613
   Qin CH, 2002, MOL ENDOCRINOL, V16, P1793, DOI 10.1210/me.2002-0006
   Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125
   Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802
   Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314
   Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280
   Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190
   STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x
   Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004
   SUN XG, 1995, MOL CELL BIOL, V15, P4489
   Tam CW, 2006, ENDOCRINOLOGY, V147, P5023, DOI 10.1210/en.2006-0207
   Termini J, 2000, MUTAT RES-FUND MOL M, V450, P107, DOI 10.1016/S0027-5107(00)00019-1
   Thomas MK, 1999, MOL CELL BIOL, V19, P8492
   Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200
   Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012
   TUCK SP, 1989, MOL CELL BIOL, V9, P2163, DOI 10.1128/MCB.9.5.2163
   van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290
   Vassilev LT, 2004, CELL CYCLE, V3, P419
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541
   Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147
   Vousden KH, 2005, CELL, V120, P7, DOI 10.1016/j.cell.2004.12.027
   Wang SL, 2006, CANCER RES, V66, P6982, DOI 10.1158/0008-5472.CAN-06-0511
   Wei XL, 2007, CANCER RES, V67, P1853, DOI 10.1158/0008-5472.CAN-06-3063
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Yan JL, 2007, P NATL ACAD SCI USA, V104, P1841, DOI 10.1073/pnas.0605562104
   Yeung ML, 2003, EMBO REP, V4, P412, DOI 10.1038/sj.embor.embor804
NR 68
TC 19
Z9 24
U1 0
U2 3
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD NOV 18
PY 2008
VL 271
IS 1
BP 64
EP 80
DI 10.1016/j.canlet.2008.05.047
PG 17
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA 373QU
UT WOS:000260987900007
PM 18639375
DA 2024-02-19
ER

PT J
AU Sakai, T
   Sato, R
   Mizuno, H
   Matsuo, H
   Nomura, A
   Koh, S
   Gondo, H
   Wakizaka, A
AF Sakai, T
   Sato, R
   Mizuno, H
   Matsuo, H
   Nomura, A
   Koh, S
   Gondo, H
   Wakizaka, A
TI Influence of aging on the carcinogen-induced protein kinase activity in
   rat liver cell nuclei
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
DE aging; carcinogen; cell nucleus; protein kinase; thioacetamide
ID THIOACETAMIDE; INHIBITORS; INDUCTION; PATHWAYS; YEAST; AGE
AB A carcinogen-induced increase in a protein kinase activity was found in cell nuclei of rat liver. The enzyme was extracted from isolated nuclei with a hypotonic buffer, retained to an anion-exchange column, eluted with 0.15 M NaCl containing solution and to be measured for the activity with casein as the substrate, showing a nature of a casein kinase. The change in the activity during the course of aging was studied with 5-, 10-, and 50-week old Wistar male rats. The activity was highest in 5-week-old rat but decreased in 10- and 50-week-old animal. A hepatocarcinogen, thioacetamide, induced an increase in activity in 10-week old rats but rather decreased in 5- and 50-week-old rats. Aging suppresses the activity of this unique enzyme. Thioacetamide abolishes this suppression resulting in an increase in the activity of the enzyme at a certain stage of aging. (C) 2002 Tohoku University Medical Press.
C1 Kyorin Univ, Sch Med, Dept Biochem, Mitaka, Tokyo 1818611, Japan.
C3 Kyorin University
RP Sakai, T (corresponding author), Kyorin Univ, Sch Med, Dept Biochem, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.
EM wakizaka@kyorin-u.ac.jp
CR ARELLANO M, 1997, INT J BIOCHEM CELL B, V29, P117
   BAKER H, 1995, NEUROBIOL AGING, V16, P119, DOI 10.1016/0197-4580(94)00152-9
   BECKER FF, 1983, J NATL CANCER I, V71, P553
   BEYER HS, 1992, J LAB CLIN MED, V119, P38
   CABISCOL E, 1995, J BIOL CHEM, V270, P14742, DOI 10.1074/jbc.270.24.14742
   CLAWSON GA, 1992, CANCER RES, V52, P1304
   EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567
   FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7
   GERVASI PG, 1989, J CANCER RES CLIN, V115, P29, DOI 10.1007/BF00391596
   GETCHELL ML, 1993, ANN OTO RHINOL LARYN, V102, P368, DOI 10.1177/000348949310200509
   Gitig DM, 2000, METH MOL B, V142, P109
   HERSKOWITZ I, 1995, CELL, V80, P187, DOI 10.1016/0092-8674(95)90402-6
   LEDDACOLUMBANO GM, 1991, AM J PATHOL, V139, P1099
   Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640
   SATO R, 1992, SEIKAGAKU, V65, P1084
   SCHNEIDER HR, 1986, EUR J BIOCHEM, V161, P733, DOI 10.1111/j.1432-1033.1986.tb10501.x
   SOMMERCORN J, 1987, J BIOL CHEM, V262, P3839
   Tuazon P. T., 1991, ADV 2 MESSENGER PHOS, V23, P123
   WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8
   WOHLRAB H, 1988, BIOCHEM BIOPH RES CO, V154, P1130, DOI 10.1016/0006-291X(88)90258-6
NR 20
TC 0
Z9 0
U1 0
U2 0
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD MAR
PY 2002
VL 196
IS 3
BP 131
EP 138
DI 10.1620/tjem.196.131
PG 8
WC Medicine, General & Internal; Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine; Research & Experimental Medicine
GA 540LE
UT WOS:000174929800004
PM 12002269
OA Bronze
DA 2024-02-19
ER

PT J
AU Diao, P
   Wang, XJ
   Jia, FP
   Kimura, T
   Hu, X
   Shirotori, S
   Nakamura, I
   Sato, Y
   Nakayama, J
   Moriya, K
   Koike, K
   Gonzalez, FJ
   Aoyama, T
   Tanaka, N
AF Diao, Pan
   Wang, Xiaojing
   Jia, Fangping
   Kimura, Takefumi
   Hu, Xiao
   Shirotori, Saki
   Nakamura, Ibuki
   Sato, Yoshiko
   Nakayama, Jun
   Moriya, Kyoji
   Koike, Kazuhiko
   Gonzalez, Frank J.
   Aoyama, Toshifumi
   Tanaka, Naoki
TI A saturated fatty acid-rich diet enhances hepatic lipogenesis and
   tumorigenesis in HCV core gene transgenic mice
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Lipogenesis; NF-kappa B; Cydin D1; p62; JNK; HCC
ID ENDOPLASMIC-RETICULUM STRESS; HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE;
   PALMITIC ACID; PROTEIN; ACTIVATION; EXPRESSION; APOPTOSIS; CANCER; RISK
AB Previous studies suggested that high consumption of saturated fatty acid (SFA) is a risk factor for liver cancer. However, it remains unclear how dietary SFA affects liver tumorigenesis. This study aimed to investigate the impact of a SFA-rich diet on hepatic tumorigenesis using hepatitis C virus core gene transgenic (HCVcpTg) mice that spontaneously developed hepatic steatosis and tumors with aging. Male HCVcpTg mice were treated for 15 months with a purified control diet or SFA-rich diet prepared by replacing soybean oil in the control diet with hydrogenated coconut oil, and phenotypic changes were assessed. In this special diet, almost all dietary fatty acids were SFA. Long-term feeding of SFA-rich diet to HCVcpTg mice increased hepatic steatosis, liver dysfunction, and the prevalence of liver tumors, likely due to stimulation of de novo lipogenesis, activation of the pro-inflammatory and pro-oncogenic transcription factor nuclear factor-kappa B (NF-kappa B), enhanced c-Jun N-terminal kinase/activator protein 1 UNK/AP-1) signaling and induction of the oncogenes cyclin D1 and p62/sequestosome 1. The SFA-rich diet did not affect liver fibrosis or autophagy. Collectively, long-term SFA-rich diet consumption promoted hepatic tumorigenesis mainly through activation of lipogenesis, NF-kappa B, and JNK/AP-1 signaling. We therefore propose that HCV-infected patients should avoid excessive intake of SFA-rich foods to prevent liver cancer. (C) 2020 Elsevier Inc. All rights reserved.
C1 [Diao, Pan; Wang, Xiaojing; Jia, Fangping; Hu, Xiao; Shirotori, Saki; Nakamura, Ibuki; Aoyama, Toshifumi; Tanaka, Naoki] Shinshu Univ, Dept Metab Regulat, Sch Med, Matsumoto, Nagano 3908621, Japan.
   [Wang, Xiaojing] Zhejiang Univ, Sch Med, Lishui Hosp, Dept Gastroenterol, Lishui, Zhejiang, Peoples R China.
   [Kimura, Takefumi] Shinshu Univ, Dept Gastroenterol, Sch Med, Matsumoto, Nagano, Japan.
   [Hu, Xiao] Hebei Med Univ, Dept Pathophysiol, Shijiazhuang, Hebei, Peoples R China.
   [Sato, Yoshiko; Nakayama, Jun] Shinshu Univ, Dept Mol Pathol, Sch Med, Matsumoto, Nagano, Japan.
   [Moriya, Kyoji] Univ Tokyo, Dept Infect Control & Prevent, Tokyo, Japan.
   [Koike, Kazuhiko] Univ Tokyo, Dept Gastroenterol, Tokyo, Japan.
   [Gonzalez, Frank J.] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA.
   [Tanaka, Naoki] Shinshu Univ, Res Ctr Social Syst, Matsumoto, Nagano, Japan.
C3 Shinshu University; Zhejiang University; Shinshu University; Hebei
   Medical University; Shinshu University; University of Tokyo; University
   of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer
   Institute (NCI); Shinshu University
RP Tanaka, N (corresponding author), Shinshu Univ, Dept Metab Regulat, Sch Med, Matsumoto, Nagano 3908621, Japan.
EM naopi@shinshu-u.ac.jp
RI Wang, Xiaojing/HNI-4384-2023; Kimura, Takefumi T/D-3412-2011
OI Wang, Xiaojing/0000-0001-6921-3619; Kimura, Takefumi
   T/0000-0002-1481-1029; Tanaka, Naoki/0000-0002-3212-3836; Gonzalez,
   Frank/0000-0002-7990-2140
CR Chen J, 2018, J CELL BIOCHEM, V119, P2368, DOI 10.1002/jcb.26400
   Duarte-Salles T, 2015, INT J CANCER, V137, P2715, DOI 10.1002/ijc.29643
   Fraser NJ, 2020, BIOCHEM SOC T, V48, P281, DOI 10.1042/BST20190707
   Freedman ND, 2010, J NATL CANCER I, V102, P1354, DOI 10.1093/jnci/djq301
   Ganz M, 2011, WORLD J GASTROENTERO, V17, P4772, DOI 10.3748/wjg.v17.i43.4772
   Guo LL, 2005, LIFE SCI, V77, P1869, DOI 10.1016/j.lfs.2005.03.019
   Hao QW, 2014, ONCOL REP, V32, P2471, DOI 10.3892/or.2014.3484
   Hu X, 2020, CARCINOGENESIS, V41, P159, DOI 10.1093/carcin/bgz132
   Hu X, 2017, J NUTR BIOCHEM, V39, P77, DOI 10.1016/j.jnutbio.2016.09.015
   Jia FP, 2020, LIVER CANCER, V9, P529, DOI 10.1159/000508308
   Joo M, 2001, LIVER, V21, P89, DOI 10.1034/j.1600-0676.2001.021002089.x
   Katsuragi Yoshinori, 2016, Current Opinion in Toxicology, V1, P54, DOI 10.1016/j.cotox.2016.09.005
   Kimura T, 2018, WORLD J GASTROENTERO, V24, P1440, DOI 10.3748/wjg.v24.i13.1440
   Kimura T, 2017, HEPATOL RES, V47, P405, DOI 10.1111/hepr.12762
   Lee YJ, 2015, INT J MOL SCI, V16, P26629, DOI 10.3390/ijms161125984
   Li L, 2016, J HEPATOL, V64, P333, DOI 10.1016/j.jhep.2015.10.004
   Li QJ, 2018, J BIOL CHEM, V293, P6434, DOI 10.1074/jbc.RA117.000940
   Liao P, 2017, ELIFE, V6, DOI 10.7554/eLife.22058
   Martínez L, 2015, ONCOTARGET, V6, P41479, DOI 10.18632/oncotarget.6286
   Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341
   Menendez JA, 2010, BBA-MOL CELL BIOL L, V1801, P381, DOI 10.1016/j.bbalip.2009.09.005
   Miyoshi H, 2011, J HEPATOL, V54, P432, DOI 10.1016/j.jhep.2010.07.039
   Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053
   Moriya K, 2001, BIOCHEM BIOPH RES CO, V281, P1207, DOI 10.1006/bbrc.2001.4523
   Moriya K, 2009, AM J PATHOL, V175, P1515, DOI 10.2353/ajpath.2009.090102
   Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441
   Nakajima T, 2017, TOHOKU J EXP MED, V242, P229, DOI 10.1620/tjem.242.229
   Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141
   Rocha DM, 2016, ATHEROSCLEROSIS, V244, P211, DOI 10.1016/j.atherosclerosis.2015.11.015
   Sawada N, 2012, GASTROENTEROLOGY, V142, P1468, DOI 10.1053/j.gastro.2012.02.018
   Suzuki A, 2016, WORLD J GASTROENTERO, V22, P6509, DOI 10.3748/wjg.v22.i28.6509
   Tanaka N, 2008, J CLIN INVEST, V118, P683, DOI 10.1172/JCI33594
   Tanaka N, 2019, WORLD J GASTROENTERO, V25, P163, DOI 10.3748/wjg.v25.i2.163
   Tanaka N, 2017, PHARMACOL THERAPEUT, V179, P142, DOI 10.1016/j.pharmthera.2017.05.011
   Tracz-Gaszewska Z, 2019, CANCERS, V11, DOI 10.3390/cancers11070948
   Trierweiler C, 2016, CELL DEATH DIFFER, V23, P576, DOI 10.1038/cdd.2015.121
   Tsutsumi T, 2002, VIROLOGY, V304, P415, DOI 10.1006/viro.2002.1702
   Umemura A, 2016, CANCER CELL, V29, P935, DOI 10.1016/j.ccell.2016.04.006
   Wang D, 2006, ENDOCRINOLOGY, V147, P943, DOI 10.1210/en.2005-0570
   Wang XJ, 2019, ARCH TOXICOL, V93, P1713, DOI 10.1007/s00204-019-02440-7
   Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005
   Xia H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002391
   Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017
   Yuan M, 2020, ACTA PHARMACOL SIN, V41, P1005, DOI 10.1038/s41401-020-0388-4
   Zácek P, 2019, J NUTR BIOCHEM, V64, P32, DOI 10.1016/j.jnutbio.2018.10.005
NR 45
TC 8
Z9 8
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD NOV
PY 2020
VL 85
AR 108460
DI 10.1016/j.jnutbio.2020.108460
PG 9
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA OH4DF
UT WOS:000582520400006
PM 32992072
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Sun, L
   Yang, H
   He, D
   Chen, J
   Dong, ZQ
   Luo, SX
   Liang, HT
   Cao, Y
   Cai, BC
   Zhang, M
AF Sun, Lei
   Yang, He
   He, Dong
   Chen, Jian
   Dong, Zhiqiang
   Luo, Shaoxiang
   Liang, Huiting
   Cao, Yu
   Cai, Bingcheng
   Zhang, Min
TI Mammalian eIF4E2-GSK3β maintains basal phosphorylation of p53 to resist
   senescence under hypoxia
SO CELL DEATH & DISEASE
LA English
DT Article
ID GLYCOGEN-SYNTHASE KINASE-3; CELLULAR SENESCENCE; POSTTRANSLATIONAL
   MODIFICATIONS; PROTEIN; EXPRESSION; BINDING; TARGET; APOPTOSIS;
   IDENTIFICATION; TRANSCRIPTION
AB Hypoxia modulates senescence, but their physiological link remains unclear. Here, we found that eIF4E2, a hypoxia-activated translation initiation factor, interacted with GSK3 beta to maintain phosphorylation of p53, thus resisting senescence under hypoxia. RNA-binding protein RBM38 interacted with eIF4E to inhibit the translation of p53, but GSK3 beta-mediated Ser195 phosphorylation disrupted the RBM38-eIF4E interaction. Through investigation of RBM38 phosphorylation, we found that the eIF4E2-GSK3 beta pathway specifically regulated proline-directed serine/threonine phosphorylation (S/T-P). Importantly, peptides e2-I or G3-I that blocking eIF4E2-GSK3 beta interaction can inhibit the basal S/T-P phosphorylation of p53 at multiple sites, therby inducing senescence through transcriptional inhibition. Additionally, a nanobody was screened via the domain where eIF4E2 bound to GSK3 beta, and this nanobody inhibited S/T-P phosphorylation to promote senescence. Furthermore, hypoxia inhibited eIF4E2-GSK3 beta pathway by mediating S-Nitrosylation of GSK3 beta. Blocking eIF4E2-GSK3 beta interaction promoted liver senescence under hypoxia, thus leading to liver fibrosis, eventually accelerating N, N-diethylnitrosamine (DEN)-induced tumorigenesis. Interestingly, eIF4E2 isoforms with GSK3 beta-binding motif exclusively exist in mammals, which protect zebrafish heart against hypoxia. Together, this study reveals a mammalian eIF4E2-GSK3 beta pathway that prevents senescence by maintaining basal S/T-P phosphorylation of p53, which underlies hypoxia adaptation of tissues.
C1 [Sun, Lei; Yang, He; He, Dong; Dong, Zhiqiang; Liang, Huiting; Cao, Yu; Cai, Bingcheng; Zhang, Min] Huazhong Agr Univ, Coll Life Sci & Technol, Coll Biomed & Hlth, Wuhan 430070, Peoples R China.
   [Chen, Jian; Liang, Huiting] Hubei Canc Hosp HBCH, Wuhan 430079, Peoples R China.
   [Luo, Shaoxiang] Wuhan Huamei Biotech Co Ltd, Wuhan 430079, Peoples R China.
C3 Huazhong Agricultural University
RP Zhang, M (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Coll Biomed & Hlth, Wuhan 430070, Peoples R China.
EM minzhang@mail.hzau.edu.cn
RI Wang, Yining/JQW-2010-2023; li, wei/IUQ-2973-2023; Li, Ly/JCD-4746-2023
FU National Natural Science Foundation of China [31970682, 81770314,
   31871481]; Natural Science Foundation of Hubei [2017CFB458, 2017CFA064];
   Fundamental Research Funds for the Central Universities [2662017PY110,
   2662016PY091, 2662018PY027]; Applied basic Science and Technology
   Program of Wuhan Science and Technology [2017060201010157]; Health
   Commission of Hubei Province Scientific Research Project [WJ2019H125]
FX We are grateful to Dr. Haiyi Zhao (Wuhan GeneCreate Biological
   Engineering Co., Ltd, Wuhan, China) for technical assistance with the
   iTRAQ LC-MS/MS. This work is supported by the National Natural Science
   Foundation of China (grants 31970682, 81770314, and 31871481), the
   Natural Science Foundation of Hubei (grants 2017CFB458, 2017CFA064),
   Fundamental Research Funds for the Central Universities (program
   2662017PY110, 2662016PY091, and 2662018PY027), Applied basic Science and
   Technology Program of Wuhan Science and Technology (grants
   2017060201010157), and Health Commission of Hubei Province Scientific
   Research Project (grants WJ2019H125).
CR Abat Jasmeet Kaur, 2008, Physiology and Molecular Biology of Plants, V14, P119, DOI 10.1007/s12298-008-0011-5
   Armata HL, 2007, CANCER RES, V67, P11696, DOI 10.1158/0008-5472.CAN-07-1610
   Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016
   Blaszczyk M, 2016, METHODS, V93, P72, DOI 10.1016/j.ymeth.2015.07.004
   Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001
   Chan ASL, 2019, GENE DEV, V33, P127, DOI 10.1101/gad.320937.118
   Chee NT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0968-4
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024
   Chung CI, 2018, ANAL CHEM, V90, P14287, DOI 10.1021/acs.analchem.8b03476
   Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107
   Eom TY, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-14
   Feng X, 2011, EMBO J, V30, P3397, DOI 10.1038/emboj.2011.248
   Flügel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07
   Freemantle SJ, 2002, GENE, V291, P17, DOI 10.1016/S0378-1119(02)00594-2
   Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011
   He L, 2019, P NATL ACAD SCI USA, V116, P19523, DOI 10.1073/pnas.1902397116
   He L, 2018, MOL CELL, V70, P949, DOI 10.1016/j.molcel.2018.04.024
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Jeon Y, 2011, J BIOL CHEM, V286, P5414, DOI 10.1074/jbc.M110.189704
   Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028
   Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126
   Kim YM, 2013, ENDOCRINOL METAB, V28, P297, DOI 10.3803/EnM.2013.28.4.297
   Konermann S, 2018, CELL, V173, P665, DOI 10.1016/j.cell.2018.02.033
   Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448
   Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001
   Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y
   Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2
   Leontieva OV, 2012, P NATL ACAD SCI USA, V109, P13314, DOI 10.1073/pnas.1205690109
   Leroy A, 2010, J BIOL CHEM, V285, P33435, DOI 10.1074/jbc.M110.149419
   Li FM, 2020, NAT CELL BIOL, V22, P728, DOI 10.1038/s41556-020-0511-2
   Liu SY, 2008, P NATL ACAD SCI USA, V105, P5248, DOI 10.1073/pnas.0704242105
   Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047
   McMahon C, 2018, NAT STRUCT MOL BIOL, V25, P289, DOI 10.1038/s41594-018-0028-6
   Melanson G, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6098107
   Midgley CA, 1997, ONCOGENE, V15, P1179, DOI 10.1038/sj.onc.1201459
   Ouzhuluobu, 2020, NATL SCI REV, V7, P391, DOI 10.1093/nsr/nwz160
   Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804
   Ramirez CCA, 2018, NUCLEIC ACIDS RES, V46, P5792, DOI 10.1093/nar/gky198
   Roh MS, 2005, BIOL PSYCHIAT, V57, P278, DOI 10.1016/j.biopsych.2004.10.039
   Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640
   Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200
   Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146
   Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x
   Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200
   Shin M, 2018, NAT BIOMED ENG, V2, P304, DOI 10.1038/s41551-018-0227-9
   Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744
   Uniacke J, 2014, CANCER RES, V74, P1379, DOI 10.1158/0008-5472.CAN-13-2278
   Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055
   Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037
   Wang HC, 2017, CANCER IMMUNOL RES, V5, P885, DOI 10.1158/2326-6066.CIR-16-0295
   Wang SB, 2018, CIRC RES, V122, P1517, DOI 10.1161/CIRCRESAHA.118.312789
   WANG YX, 1995, BRIT J PHARMACOL, V114, P1454, DOI 10.1111/j.1476-5381.1995.tb13369.x
   Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024
   Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000
   Wei G, 2003, FEBS LETT, V543, P16, DOI 10.1016/S0014-5793(03)00369-7
   Welford SM, 2011, MOL CANCER RES, V9, P538, DOI 10.1158/1541-7786.MCR-11-0065
   Xing JY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04453-9
   Yang M, 2017, CELL PHYSIOL BIOCHEM, V44, P293, DOI 10.1159/000484885
   Yeo EJ, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0233-3
   Young JJ, 2010, BIOCHEM BIOPH RES CO, V392, P363, DOI 10.1016/j.bbrc.2010.01.026
   Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200
   Zhang B, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0316-y
   Zhang H, 2002, J BIOL CHEM, V277, P43648, DOI 10.1074/jbc.M203214200
   Zhang HL, 2019, MOL CELL, V76, P110, DOI 10.1016/j.molcel.2019.08.005
   Zhang J, 2011, GENE DEV, V25, P1528, DOI 10.1101/gad.2069311
   Zhang M, 2018, CELL DEATH DIFFER, V25, P1118, DOI 10.1038/s41418-017-0029-8
   Zhang M, 2013, GENE DEV, V27, P2246, DOI 10.1101/gad.221739.113
   Zhang Q, 2018, MOL CELL, V69, P347, DOI 10.1016/j.molcel.2018.01.008
   Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116
   Zhou HJ, 2013, NAT PROTOC, V8, P461, DOI 10.1038/nprot.2013.010
NR 71
TC 0
Z9 0
U1 1
U2 18
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD MAY 14
PY 2022
VL 13
IS 5
AR 459
DI 10.1038/s41419-022-04897-4
PG 13
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 1G7ZD
UT WOS:000796068300005
PM 35568694
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Zhu, Y
   Han, YP
   Wang, WY
   Liang, GM
   Qi, J
AF Zhu, Yan
   Han, Yaping
   Wang, Wuyang
   Liang, Guangming
   Qi, Jin
TI Mulberry leaves attenuate D-galactose-induced aging<i> in</i><i>
   vivo</i> and<i> in</i><i> vitro</i>
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article; Early Access
DE Mulberry leaf extract; Aging; Antioxidant; In vivo; In vitro
ID EXTRACT; INHIBITION; IMPAIRMENT; ACTIVATION; PATHWAY; LIVER; AMPK
AB Ethnopharmacological relevance: Mulberry leaves contain many bioactive compounds and have been widely used in traditional medicines and functional foods for prevention and treatment of age-related diseases, such as diabetes, cognitive impairment and obesity-mediated liver cancer. Aging has an irreversible negative impact on human health for many years, even decades, before death, which is a social and economic burden on society. Aim of the study: The objective of this study was to investigate the antioxidant and anti-aging effects of mulberry leaf extract (MLE) in vivo and in vitro. Materials and methods: The Caenorhabditis elegans (C. elegans) was used as a model organism to observe the effects of different concentrations of MLE (1, 2, 4, 8 mg/mL) on nematodes' healthy lifespan, reproductive capacity, locomotion, stress resistance, and antioxidation. In addition, D-galactose (D-gal) induced liver aging in mice and L-02 cells were established. The antioxidant and anti-aging effects of MLE were evaluated by body weight, organ indexes, malondialdehyde (MDA), total superoxide dismutase (T-SOD), total antioxidant capacity (T-AOC), aspartate and alanine aminotransferases (AST and ALT), reactive oxygen species (ROS), mitochondrial membrane potential (MMP), hematoxylin and eosin (H&E), senescence-associated 8-galactosidase (SA-8-Gal). Besides, the expressions of AMPK/SIRT1/PGC-1 alpha and Nrf2-Keap1 were detected by Western blotting. Results: MLE could significantly prolonged nematodes' average life span and improved most physiological indicators related to aging of C. elegans. Moreover, Treatment with MLE ameliorated the decreased body weight and organ index (weight of organ/body weight) in model mice, and protected against oxidative stress in mice and liver cells, in a dose-dependent manner, up-regulating T-SOD and T-AOC, while reducing ROS and MDA levels. MLE decreased both liver and cell levels of AST and ALT, and enhanced the mitochondrial membrane potential. MLE activated the AMPK/SIRT1/PGC-1 alpha pathways, participated in mitochondrial biosynthesis and oxidative metabolism and delayed D-gal-induced aging. MLE promoted the accumulation of Nrf2 in the nucleus, indicating that the improved oxidative stress response was mediated by the Nrf2-Keap1 pathway in vivo and in vitro. Conclusion: MLE appeared to have great potential for stimulating the oxidative stress response and attenuating the aging process of in vivo and in vitro, and provide a novel health-promoting resource against aging and agingrelated diseases.
C1 [Zhu, Yan; Han, Yaping; Wang, Wuyang; Liang, Guangming; Qi, Jin] China Pharmaceut Univ, Sch Tradit Chinese Pharm, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing 211198, Peoples R China.
C3 China Pharmaceutical University
RP Qi, J (corresponding author), China Pharmaceut Univ, Sch Tradit Chinese Pharm, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing 211198, Peoples R China.
EM qijin2006@163.com
RI Liu, Yilin/JWP-9153-2024; Zhang, Miao/JXY-8985-2024; wang,
   yitian/JFA-6804-2023
OI Liu, Yilin/0000-0002-7581-3933; 
FU National Natural Sciences Foundation [81673555]
FX This work was supported by the National Natural Sciences Foundation
   (No.81673555) .
CR Barzilai N, 2016, CELL METAB, V23, P1060, DOI 10.1016/j.cmet.2016.05.011
   Bellezza I, 2018, BBA-MOL CELL RES, V1865, P721, DOI 10.1016/j.bbamcr.2018.02.010
   Collins JJ, 2006, EXP GERONTOL, V41, P1032, DOI 10.1016/j.exger.2006.06.038
   da Costa JP, 2016, AGEING RES REV, V29, P90, DOI 10.1016/j.arr.2016.06.005
   Deshmukh Prashant, 2017, Biophys Rev, V9, P41, DOI 10.1007/s12551-016-0244-4
   Du ZD, 2020, NEUROCHEM INT, V133, DOI 10.1016/j.neuint.2019.104649
   Effros Rita B, 2005, Immun Ageing, V2, P7, DOI 10.1186/1742-4933-2-7
   Fanibunda SE, 2019, P NATL ACAD SCI USA, V116, P11028, DOI 10.1073/pnas.1821332116
   Ferreira-Gonzalez S, 2021, SEMIN LIVER DIS, V41, P50, DOI 10.1055/s-0040-1722262
   Ghosh-Choudhary SK, 2021, FASEB J, V35, DOI 10.1096/fj.202101462R
   HARMAN D, 1993, DRUG AGING, V3, P60, DOI 10.2165/00002512-199303010-00006
   Hastings J, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00002
   He XR, 2018, FOOD CHEM, V245, P899, DOI 10.1016/j.foodchem.2017.11.084
   Hu Q, 2021, J ETHNOPHARMACOL, V279, DOI 10.1016/j.jep.2021.114398
   Kamal NSM, 2020, EUR J CELL BIOL, V99, DOI 10.1016/j.ejcb.2020.151108
   Kelly DP, 2011, NATURE, V470, P342, DOI 10.1038/nature09896
   Kobayashi Y., 2015, J PHARM NAT PROD, V2, P1, DOI [10.4172/2472-0992.1000113, DOI 10.4172/2472-0992.1000113]
   Koh YH, 2000, FREE RADICAL RES, V33, P739, DOI 10.1080/10715760000301261
   Kou XJ, 2017, BIOMED PHARMACOTHER, V90, P311, DOI 10.1016/j.biopha.2017.03.070
   KRUK PA, 1995, P NATL ACAD SCI USA, V92, P258, DOI 10.1073/pnas.92.1.258
   Kubben N, 2016, CELL, V165, P1361, DOI 10.1016/j.cell.2016.05.017
   Lee YJ, 2017, FOOD FUNCT, V8, P397, DOI 10.1039/c6fo01539e
   Liang HW, 2021, INT J MED SCI, V18, P53, DOI 10.7150/ijms.50174
   Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386
   Liu HM, 2022, INT J BIOL MACROMOL, V202, P286, DOI 10.1016/j.ijbiomac.2022.01.071
   Liu QP, 2016, MOLECULES, V21, DOI 10.3390/molecules21030279
   Liu XL, 2021, FOOD FUNCT, V12, P12142, DOI [10.1039/d1fo01349a, 10.1039/D1FO01349A]
   Liu Y, 2022, CHEMOSPHERE, V286, DOI 10.1016/j.chemosphere.2021.131830
   Ma Q, 2022, FOOD FUNCT, V13, P3465, DOI [10.1039/d1fo03452a, 10.1039/D1FO03452A]
   Mahboubi M, 2019, PHARMACOL RES, V146, DOI 10.1016/j.phrs.2019.104341
   Mohajeri MH, 2015, NUTRITION, V31, P261, DOI 10.1016/j.nut.2014.06.016
   Ngoi NYL, 2021, REDOX BIOL, V45, DOI 10.1016/j.redox.2021.102032
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200
   Russo GL, 2020, BIOCHEM PHARMACOL, V173, DOI 10.1016/j.bcp.2019.113719
   Salminen A, 2016, AGEING RES REV, V28, P15, DOI 10.1016/j.arr.2016.04.003
   Shen N, 2021, FOOD FUNCT, V12, P12395, DOI [10.1039/d1fo02823e, 10.1039/D1FO02823E]
   Son HG, 2019, AGING CELL, V18, DOI 10.1111/acel.12853
   Suliman HB, 2016, PHARMACOL REV, V68, P20, DOI 10.1124/pr.115.011502
   Tsuduki T, 2009, J AGR FOOD CHEM, V57, P11024, DOI 10.1021/jf903132r
   Turgut NH, 2016, PHARM BIOL, V54, P1052, DOI 10.3109/13880209.2015.1101476
   Minh Doan V, 2015, FOOD FUNCT, V6, P1712, DOI [10.1039/C5FO00238A, 10.1039/c5fo00238a]
   Wen LR, 2020, FOOD CHEM, V315, DOI 10.1016/j.foodchem.2020.126236
   Yang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11671-2
   Zhang C, 2017, TOXICOL IN VITRO, V44, P349, DOI 10.1016/j.tiv.2017.07.027
   Zhang YM, 2014, FREE RADICAL BIO MED, V71, P208, DOI 10.1016/j.freeradbiomed.2014.03.018
   Zhao X, 2019, J CELL PHYSIOL, V234, P16619, DOI 10.1002/jcp.28337
   Zheng SQ, 2014, AGE, V36, DOI 10.1007/s11357-014-9719-z
   Zhou CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163571
NR 49
TC 1
Z9 2
U1 16
U2 29
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD 2023 JUL 15
PY 2023
VL 311
AR 116286
DI 10.1016/j.jep.2023.116286
EA APR 2023
PG 12
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA D7UZ5
UT WOS:000970755000001
PM 36965545
DA 2024-02-19
ER

PT J
AU Hamelin, M
   Mary, J
   Vostry, M
   Friguet, B
   Bakala, H
AF Hamelin, Maud
   Mary, Jean
   Vostry, Michal
   Friguet, Bertrand
   Bakala, Hilaire
TI Glycation damage targets glutamate dehydrogenase in the rat liver
   mitochondrial matrix during aging
SO FEBS JOURNAL
LA English
DT Article
DE aging; glycation; liver mitochondria; proteomics; urea cycle enzymes
ID ADENINE-NUCLEOTIDE TRANSLOCASE; PROTEIN OXIDATION; METHYLGLYOXAL; AGE;
   N-EPSILON-(CARBOXYETHYL)LYSINE; ACETYLCYSTEINE; ACCUMULATION;
   EXPRESSION; COMPLEXES; CATALASE
AB Aging is accompanied by gradual cellular dysfunction associated with an accumulation of damaged proteins, particularly via oxidative processes. This cellular dysfunction has been attributed, at least in part, to impairment of mitochondrial function as this organelle is both a major source of oxidants and a target for their damaging effects, which can result in a reduction of energy production, thereby compromising cell function. In the present study, we observed a significant decrease in the respiratory activity of rat liver mitochondria with aging, and an increase in the advanced glycation endproduct-modified protein level in the mitochondrial matrix. Western blot analysis of the glycated protein pattern after 2D electrophoresis revealed that only a restricted set of proteins was modified. Within this set, we identified, by mass spectrometry, proteins connected with the urea cycle, and especially glutamate dehydrogenase, which is markedly modified in older animals. Moreover, mitochondrial matrix extracts exhibited a significant decrease in glutamate dehydrogenase activity and altered allosteric regulation with age. Therefore, the effect of the glycating agent methylglyoxal on glutamate dehydrogenase activity and its allosteric regulation was analyzed. The treated enzyme showed inactivation with time by altering both catalytic properties and allosteric regulation. Altogether, these results showed that advanced glycation endproduct modifications selectively affect mitochondrial matrix proteins, particularly glutamate dehydrogenase, a crucial enzyme at the interface between tricarboxylic acid and urea cycles. Thus, it is proposed that glycated glutamate dehydrogenase could be used as a biomarker of cellular aging. Furthermore, these results suggest a role for such intracellular glycation in age-related dysfunction of mitochondria.
C1 Univ Paris 07, Lab Biol & Biochim Cellulaire Viellissement, F-75251 Paris, France.
C3 Universite Paris Cite
RP Bakala, H (corresponding author), Univ Paris 07, Lab Biol & Biochim Cellulaire Viellissement, EA3106-IFR117,Denis Diderot,2 Pl, F-75251 Paris, France.
EM bakala@paris7.jussieu.fr
RI Mary, Jean/H-2344-2011
OI Mary, Jean/0000-0002-2438-8383; Friguet, Bertrand/0000-0001-8085-1961
CR Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565
   Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200
   Ahn JY, 1999, BIOCHIMIE, V81, P1123, DOI 10.1016/S0300-9084(99)00349-1
   AMES BN, 1992, ANN NY ACAD SCI, V663, P85, DOI 10.1111/j.1749-6632.1992.tb38652.x
   APRILLE JR, 1980, ARCH BIOCHEM BIOPHYS, V201, P564, DOI 10.1016/0003-9861(80)90546-9
   Bakala H, 2003, EUR J BIOCHEM, V270, P2295, DOI 10.1046/j.1432-1033.2003.03598.x
   Banerjee S, 2003, BIOCHEMISTRY-US, V42, P3446, DOI 10.1021/bi0206917
   Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313
   Broca C, 2003, FEBS LETT, V545, P167, DOI 10.1016/S0014-5793(03)00526-X
   CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527
   CORMAN B, 1987, AM J PHYSIOL, V253, pR555, DOI 10.1152/ajpregu.1987.253.4.R555
   Fang J, 2002, BIOCHEM J, V363, P81, DOI 10.1042/0264-6021:3630081
   Fountoulakis M, 2002, ELECTROPHORESIS, V23, P311, DOI 10.1002/1522-2683(200202)23:2<311::AID-ELPS311>3.0.CO;2-0
   Giardino I, 1996, J CLIN INVEST, V97, P1422, DOI 10.1172/JCI118563
   Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263
   Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064
   Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550
   Kang YB, 1996, LEUKEMIA RES, V20, P397, DOI 10.1016/0145-2126(95)00162-X
   Koito W, 2004, J BIOCHEM, V136, P831, DOI 10.1093/jb/mvh193
   Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495
   Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x
   LO TWC, 1994, J BIOL CHEM, V269, P32299
   Martinez M, 1996, BRAIN RES, V731, P246, DOI 10.1016/S0006-8993(96)00708-1
   MIQUEL J, 1995, EUR J PHARM-ENVIRON, V292, P333, DOI 10.1016/0926-6917(95)90041-1
   Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121
   Pamplona R, 1998, EUR J BIOCHEM, V255, P685, DOI 10.1046/j.1432-1327.1998.2550685.x
   RADI R, 1991, J BIOL CHEM, V266, P22028
   Rosca MG, 2002, AM J PHYSIOL-RENAL, V283, pF52, DOI 10.1152/ajprenal.00302.2001
   Salvi M, 2007, J BIOL CHEM, V282, P24407, DOI 10.1074/jbc.M701589200
   Sastre J, 1996, HEPATOLOGY, V24, P1199, DOI 10.1002/hep.510240536
   SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771
   Smith RAJ, 2003, BIOCHEM SOC T, V31, P1295
   Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499
   SOHAL RS, 1994, MECH AGEING DEV, V74, P121, DOI 10.1016/0047-6374(94)90104-X
   SORBI S, 1989, ACTA NEUROL SCAND, V80, P103, DOI 10.1111/j.1600-0404.1989.tb03849.x
   Speer O, 2003, J BIOL CHEM, V278, P34757, DOI 10.1074/jbc.M301990200
   Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142
   Suh JH, 2003, FREE RADICAL BIO MED, V35, P1064, DOI 10.1016/S0891-5849(03)00468-4
   Thornalley PJ, 1996, CLIN SCI, V91, P575, DOI 10.1042/cs0910575
   WellsKnecht KJ, 1996, NEPHROL DIAL TRANSPL, V11, P41
   Winlove CP, 1996, DIABETOLOGIA, V39, P1131, DOI 10.1007/BF02658498
   Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896
   YAN LJ, 1997, BIOCHEMISTRY-US, V94, P11168
NR 43
TC 24
Z9 26
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD NOV
PY 2007
VL 274
IS 22
BP 5949
EP 5961
DI 10.1111/j.1742-4658.2007.06118.x
PG 13
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 226JY
UT WOS:000250586500018
PM 17949437
DA 2024-02-19
ER

PT J
AU Zhang, LK
   Wang, HM
   Yang, RC
   Liu, MM
   Ban, Q
   Chen, WY
   Zhao, MY
   You, R
   Jin, Y
   Guan, YQ
AF Zhang, Ling-Kun
   Wang, Huimin
   Yang, Runcai
   Liu, Mingmin
   Ban, Qing
   Chen, Wuya
   Zhao, Mengyang
   You, Rong
   Jin, Ying
   Guan, Yan-Qing
TI Bone marrow stem cells combined with polycaprolactone-polylactic
   acid-polypropylene amine scaffolds for the treatment of acute liver
   failure
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Liver tissue engineering; Cell senescence; Electrical material; Acute
   liver failure; Liver repair
ID IN-VITRO; HYDROGEL SYNTHESIS; TISSUE; DIFFERENTIATION; BIOMATERIALS;
   HEPATOCYTES; GELATIN; DESIGN; GROWTH; P53
AB Physical elasticity is a major mechanical property of several tissue types, and enormous efforts have been invested into the development of elastomeric biomaterials that mimic properties of native tissue. In the present study, a polycaprolactone-polylactic acid scaffold was photografted with polyacrylamide, tumor necrosis factor-alpha, and insulin-like growth factor 1 to construct a novel scaffold, which was named the polycaprolactone-polylactic acid-polypropylene amine-insulin-like growth factor 1/tumor necrosis factor-alpha (PCL-PLA-PAAm-IGF-1/TNF-alpha) scaffold. Its inhibitory effect on cell senescence of bone marrow mesenchymal stem cells was studied. When the PCL-PLA-PAAm-IGF-1/TNF-alpha scaffolds were transplanted into a rat model of acute hepatic failure, we found that the scaffolds clearly contributed to liver repair. The simple method presented here may be useful for the preparation of cell-scaffold complexes for liver tissue engineering.
C1 [Zhang, Ling-Kun; Wang, Huimin; Liu, Mingmin; Ban, Qing; Chen, Wuya; Zhao, Mengyang; You, Rong; Guan, Yan-Qing] South China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China.
   [Zhang, Ling-Kun; Wang, Huimin; Liu, Mingmin; Ban, Qing; Chen, Wuya; Zhao, Mengyang; You, Rong; Guan, Yan-Qing] South China Normal Univ, Inst Adv Mat, Guangzhou 510006, Guangdong, Peoples R China.
   [Zhang, Ling-Kun; Wang, Huimin; Liu, Mingmin; Ban, Qing; Chen, Wuya; Zhao, Mengyang; You, Rong; Guan, Yan-Qing] South China Normal Univ, Guangdong Prov Key Lab Quantum Engn & Quantum Mat, South China Acad Adv Optoelect, Guangzhou 510006, Guangdong, Peoples R China.
   [Yang, Runcai] Sun Yet Sen Univ, Zhongshan Ophthalm Ctr, Key Lab Ophthalmol & Visual Sci, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China.
   [Jin, Ying] South China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China.
   [Jin, Ying] South China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou 510631, Guangdong, Peoples R China.
C3 South China Normal University; South China Normal University; South
   China Normal University; Sun Yat Sen University; South China Normal
   University; South China Normal University
RP Guan, YQ (corresponding author), South China Normal Univ, Sch Life Sci, Guangzhou 510631, Guangdong, Peoples R China.
EM guanyq@scnu.edu.cn
RI Chen, Wu-Ya/M-5498-2017; Zhang, Ling-Kun/M-5972-2019; wang,
   hui/HSG-6135-2023; Zhang, Ling-Kun/GYJ-3942-2022; Zhao,
   Mengyang/HJY-6991-2023; Wang, Hui/HMU-9512-2023; wang,
   huimin/HDM-8421-2022; wang, hui/GRS-4730-2022
OI Chen, Wu-Ya/0000-0002-6290-9178; Zhang, Ling-Kun/0000-0001-8717-4334;
   Zhang, Ling-Kun/0000-0001-8717-4334; Yang, RunCai/0000-0001-9567-4777
FU National Natural Science Foundation of China [31370967, 31170919];
   Guangdong Province Universities and Colleges Pearl River Scholar Funded
   Scheme, China; Science and Technology Planning Project of Guangdong
   Province, China [2015A020212033]; Science and Technology Project of
   Guangzhou, China [201805010002]
FX The expenses of this work were supported by the National Natural Science
   Foundation of China (31370967, 31170919), the Guangdong Province
   Universities and Colleges Pearl River Scholar Funded Scheme (2014),
   China, the Science and Technology Planning Project of Guangdong Province
   (2015A020212033), China, the Science and Technology Project of Guangzhou
   (201805010002), China.
CR Alpern D, 2014, ELIFE, V3, DOI 10.7554/eLife.03613
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Ben-Zvi D, 2015, CELL, V161, P12, DOI 10.1016/j.cell.2015.02.039
   Bernal W, 2015, LANCET, V386, P1576, DOI 10.1016/S0140-6736(15)00309-8
   Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7
   Bracaglia LG, 2017, ACTA BIOMATER, V56, P3, DOI 10.1016/j.actbio.2017.03.030
   Brown JH, 2018, ACTA BIOMATER, V73, P217, DOI 10.1016/j.actbio.2018.02.009
   Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582
   Chen YX, 2012, HEPATOLOGY, V55, P563, DOI 10.1002/hep.24712
   Chun YS, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-231
   Chung SI, 2016, J HEPATOL, V64, P618, DOI 10.1016/j.jhep.2015.10.007
   Daniele MA, 2014, BIOMATERIALS, V35, P1845, DOI 10.1016/j.biomaterials.2013.11.009
   Dong YJ, 2012, GASTROENTEROLOGY, V142, pS185
   Du C, 2014, BIOMATERIALS, V35, P6006, DOI 10.1016/j.biomaterials.2014.04.011
   Guan YQ, 2012, BIOMATERIALS, V33, P6162, DOI 10.1016/j.biomaterials.2012.05.037
   Guan YQ, 2011, INT BIODETER BIODEGR, V65, P389, DOI 10.1016/j.ibiod.2011.01.001
   Guan YQ, 2010, BIOMATERIALS, V31, P9074, DOI 10.1016/j.biomaterials.2010.08.044
   Guo L, 2008, BIOMATERIALS, V29, P23, DOI 10.1016/j.biomaterials.2007.08.043
   Hamazaki T, 2001, FEBS LETT, V497, P15, DOI 10.1016/S0014-5793(01)02423-1
   Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4
   Jiang WC, 2014, BIOMATERIALS, V35, P3607, DOI 10.1016/j.biomaterials.2014.01.024
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469
   Li X, 2010, BIOMATERIALS, V31, P1894, DOI 10.1016/j.biomaterials.2009.11.031
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Lou PJ, 2010, BIOMATERIALS, V31, P1568, DOI 10.1016/j.biomaterials.2009.11.048
   Ng SLJ, 2011, BIOMATERIALS, V32, P7571, DOI 10.1016/j.biomaterials.2011.06.065
   Ng SS, 2018, BIOMATERIALS, V182, P299, DOI 10.1016/j.biomaterials.2018.07.043
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   No DY, 2014, BIOMATERIALS, V35, P8983, DOI 10.1016/j.biomaterials.2014.07.009
   Oommen OP, 2013, ADV FUNCT MATER, V23, P1273, DOI 10.1002/adfm.201201698
   Ren X, 2014, PFLUG ARCH EUR J PHY, V466, P1847, DOI 10.1007/s00424-014-1504-4
   Schmitt R, 2017, KIDNEY INT, V92, P569, DOI 10.1016/j.kint.2017.02.036
   Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050
   Takebe T, 2014, NAT PROTOC, V9, P396, DOI 10.1038/nprot.2014.020
   Toepke MW, 2013, MACROMOL MATER ENG, V298, P699, DOI 10.1002/mame.201200119
   Tseng JH, 2011, J SURG RES, V166, P77, DOI 10.1016/j.jss.2009.06.043
   Tunca U, 2013, MACROMOL RAPID COMM, V34, P38, DOI 10.1002/marc.201200656
   van Paassen J, 2012, LANCET INFECT DIS, V12, P635, DOI 10.1016/S1473-3099(12)70018-X
   Vinken M, 2011, ARCH TOXICOL, V85, P1589, DOI 10.1007/s00204-011-0703-4
   Wong SF, 2011, BIOMATERIALS, V32, P8087, DOI 10.1016/j.biomaterials.2011.07.028
   Yang RC, 2016, ACS APPL MATER INTER, V8, P26638, DOI 10.1021/acsami.6b10377
   Zhang XQ, 2017, ACTA BIOMATER, V54, P81, DOI 10.1016/j.actbio.2017.02.041
NR 44
TC 5
Z9 5
U1 0
U2 59
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD MAR 15
PY 2019
VL 360
BP 1564
EP 1576
DI 10.1016/j.cej.2018.10.230
PG 13
WC Engineering, Environmental; Engineering, Chemical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering
GA HO5KD
UT WOS:000460964000153
DA 2024-02-19
ER

PT J
AU Barrientos, RM
   Thompson, VM
   Arnold, TH
   Frank, MG
   Watkins, LR
   Maier, SF
AF Barrientos, Ruth M.
   Thompson, Vanessa M.
   Arnold, T. Hayes
   Frank, Matthew G.
   Watkins, Linda R.
   Maier, Steven F.
TI The role of hepatic and splenic macrophages in <i>E</i>.
   <i>coli</i>-induced memory impairments in aged rats
SO BRAIN BEHAVIOR AND IMMUNITY
LA English
DT Article
DE Clodronate liposomes; Hippocampus; Macrophage depletion; Contextual fear
   conditioning; Cognitive decline; Proinflammatory cytokines; Aging
ID PERIPHERAL INFECTION; AGING INTERACT; BRAIN; CONSOLIDATION; PROPAMIDINE;
   CLODRONATE; CHALLENGE; IL-1-BETA; CONTEXT; YOUNG
AB Bi-directional communication between the peripheral and central nervous systems has been extensively demonstrated. Aged rats exhibit a prolonged proinflammatory response in the hippocampus region of the brain following a peripheral bacterial infection, and this response in turn causes robust memory declines. Here we aimed to determine whether hepatic or splenic macrophages play a role in the maintenance of this central response. Proinflammatory cytokines measured in liver and spleen four days following an Escherichia colt infection revealed a potentiated proinflammatory response in liver, and to a lesser extent in spleen, in aged relative to young rats. To determine whether this potentiated response was caused by impaired bacterial clearance in these organs, E. coli colony forming units in liver and spleen were measured 4 days after infection, and there were no difference between young and aged rats in either organ. No E. coli was detected in the hippocampus, eliminating the possibility that the aged blood brain barrier allowed E. coli to enter the brain. Depletion of hepatic and splenic macrophages with clodronate-encapsulated liposomes effectively eliminated the proinflammatory response to E. coli at four days in both organs. However, this treatment failed to reduce the proinflammatory response in the hippocampus. Moreover, depletion of peripheral macrophages from liver and spleen did not prevent E. coil-induced memory impairment. These data strongly suggest that hepatic and splenic macrophages do not play a major role in the long-lasting maintenance of the proinflammatory response in the hippocampus of aged rats following a bacterial infection, or the memory declines that this response produces. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Barrientos, Ruth M.; Thompson, Vanessa M.; Arnold, T. Hayes; Frank, Matthew G.; Watkins, Linda R.; Maier, Steven F.] Univ Colorado, Dept Psychol & Neurosci, Ctr Neurosci, Boulder, CO 80309 USA.
C3 University of Colorado System; University of Colorado Boulder
RP Barrientos, RM (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Campus Box 345, Boulder, CO 80309 USA.
EM ruth.barrientos@colorado.edu
RI Barrientos, Ruth/P-4734-2019
OI Barrientos, Ruth/0000-0001-7224-4109
FU National Institute on Aging [R01AG028271]
FX This work was supported by grants from the National Institute on Aging
   R01AG028271 to R.M.B., M.G.F., L.R.W., & S.F.M.
CR Barrientos RM, 2006, NEUROBIOL AGING, V27, P723, DOI 10.1016/j.neurobiolaging.2005.03.010
   Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1
   Barrientos RM, 2011, J NEUROSCI, V31, P11578, DOI 10.1523/JNEUROSCI.2266-11.2011
   Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P450, DOI 10.1016/j.bbi.2009.01.016
   Barrientos RM, 2009, BRAIN BEHAV IMMUN, V23, P46, DOI 10.1016/j.bbi.2008.07.002
   Blatteis CM, 2004, FRONT BIOSCI-LANDMRK, V9, P915, DOI 10.2741/1297
   Campbell SJ, 2008, NEUROPHARMACOLOGY, V55, P780, DOI 10.1016/j.neuropharm.2008.06.074
   Campbell SJ, 2007, J NEUROCHEM, V103, P2245, DOI 10.1111/j.1471-4159.2007.04928.x
   Chapman TR, 2010, J NEUROSCI, V30, P7598, DOI 10.1523/JNEUROSCI.5172-09.2010
   DERIJK RH, 1993, AM J PHYSIOL, V265, pR1179, DOI 10.1152/ajpregu.1993.265.5.R1179
   Frank MG, 2010, J NEUROIMMUNOL, V226, P181, DOI 10.1016/j.jneuroim.2010.05.022
   Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P254, DOI 10.1016/j.bbi.2009.10.005
   Frank MG, 2006, NEUROBIOL AGING, V27, P717, DOI 10.1016/j.neurobiolaging.2005.03.013
   Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002
   HORAN MA, 1991, MECH AGEING DEV, V57, P145, DOI 10.1016/0047-6374(91)90031-T
   KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183
   Maier SF, 2003, BRAIN BEHAV IMMUN, V17, P69, DOI 10.1016/S0889-1591(03)00032-1
   Rudy JW, 2002, BEHAV NEUROSCI, V116, P530, DOI 10.1037//0735-7044.116.4.530
   vanRooijen N, 1996, J IMMUNOL METHODS, V193, P93, DOI 10.1016/0022-1759(96)00056-7
   VanRooijen N, 1996, HEPATOLOGY, V23, P1239
   WYDE PR, 1989, J GERONTOL, V44, pB118, DOI 10.1093/geronj/44.5.B118
NR 21
TC 5
Z9 5
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0889-1591
EI 1090-2139
J9 BRAIN BEHAV IMMUN
JI Brain Behav. Immun.
PD JAN
PY 2015
VL 43
BP 60
EP 67
DI 10.1016/j.bbi.2014.07.004
PG 8
WC Immunology; Neurosciences; Psychiatry
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Neurosciences & Neurology; Psychiatry
GA CQ4RQ
UT WOS:000360592700010
PM 25043992
OA Green Accepted
DA 2024-02-19
ER

PT J
AU Cook, JJ
   Wei, MDLE
   Segovia, B
   Cosio-Lima, L
   Simpson, J
   Taylor, S
   Koh, Y
   Kim, S
   Lee, YG
AF Cook, Joshua J.
   Wei, Madeline
   Segovia, Benny
   Cosio-Lima, Ludmila
   Simpson, Jeffrey
   Taylor, Scott
   Koh, Yunsuk
   Kim, Sangho
   Lee, Youngil
TI Endurance exercise-mediated metabolic reshuffle attenuates high-caloric
   diet-induced non-alcoholic fatty liver disease
SO ANNALS OF HEPATOLOGY
LA English
DT Article; Early Access
DE Endurance exercise; Non-alcoholic fatty liver disease; Mitochondria;
   Oxidative stress; Senescence
ID MITOCHONDRIAL BIOGENESIS; HEPATIC STEATOSIS; PATHWAY; GLUCONEOGENESIS;
   STEATOHEPATITIS; AUTOPHAGY; TURNOVER; DGAT1
AB Introduction and aim: Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases in the United States. Metabolic distress (obese diabetes) is the main causative element of NAFLD. While there is no cure for NAFLD, endurance exercise (EEx) has emerged as a therapeutic strategy against NAFLD. However, mechanisms of EXE-induced hepatic protection especially in female subjects remain unidentified. Thus, the aim of the study is to examine molecular mechanisms of EXE-induced hepatic protection against diet-induced NAFLD in female mice. Material and methods: Nine-week-old female C57BL/6J mice were randomly divided into three groups: normal-diet control group (CON, n=11); high-fat diet/high-fructose group (HFD/HF, n=11); and HFD/HF+EEx group (HFD/HF+EEx, n=11). The mice assigned to HFD/HF and HFD/HF+EEx groups were fed with HFD/HF for 12 weeks, after which the mice assigned to the EEx group began treadmill exercise for 12 weeks, with HFD/HF continued. Results: EEx attenuated hepatic steatosis, reduced de novo lipogenesis (reduction in ATP -Citrate-Lyase and diacylglycerol-O-acyltransferase 1), and enhanced mitochondrial biogenesis and fatty-acid activation (oxidative phosphorylation enzymes and Acyl-CoA synthetase1). Also, EEx prevented upregulation of gluconeogenic proteins (glyceraldehyde-3-phosphate dehydrogenase, glucose-6-phosphatase, and phosphoenolpyruvate-carboxykinase1), premature senescence (suppression of p53, p22, and p16, tumor-necrosis-factor-alpha, and interleukin-1 beta, and oxidative stress), and autophagy deficiency. Furthermore, EXE reversed apoptosis arrest (cleaved cysteine-dependent-aspartate-directed protease3 and Poly-(ADP-ribose)-polymerase1). Conclusion: EEx-mediated reparations of metabolic and redox imbalance (utilization of pentose phosphate pathway), and autophagy deficiency caused by metabolic distress critically contribute to preventing/delaying severe progression of NAFLD. Also, EEx-induced anti-senescence and cell turnover are crucial protective mechanisms against NAFLD. (C) 2022 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana, S.L.U.
C1 [Cook, Joshua J.; Wei, Madeline; Segovia, Benny; Cosio-Lima, Ludmila; Simpson, Jeffrey; Lee, Youngil] Univ West Florida, MD Coll Hlth, Dept Movement Sci & Hlth, Mol & Cellular Exercise Physiol Lab, Pensacola, FL 32514 USA.
   [Taylor, Scott] Univ West Florida, Hal Marcus Coll Sci & Engn, Dept Biol, Pensacola, FL 32514 USA.
   [Koh, Yunsuk] Baylor Univ, Robbins Coll Human Sci, Dept Hlth Human Performance & Recreat, Waco, TX 76798 USA.
   [Kim, Sangho] Korea Univ, Coll Culture & Sports, Sch Global Sport Studies, Dept Sport Sci, Sejong 30019, South Korea.
   [Lee, Youngil] Univ West Florida, MD Coll Hlth, Dept Movement Sci & Hlth, Usha Kundu, 11000 Univ Pkwy, Pensacola, FL 32514 USA.
C3 State University System of Florida; University of West Florida; State
   University System of Florida; University of West Florida; Baylor
   University; Korea University; State University System of Florida;
   University of West Florida
RP Lee, YG (corresponding author), Univ West Florida, MD Coll Hlth, Dept Movement Sci & Hlth, Usha Kundu, 11000 Univ Pkwy, Pensacola, FL 32514 USA.
EM ylee1@uwf.edu
OI Taylor, Scott/0000-0002-5823-5043; Cook, Joshua/0000-0003-3508-7065
FU University of West Florida Kugelman Honors Program; Office of
   Undergraduate Research; Usha Kundu Research Endowment
FX This project was funded by awards from the University of West Florida
   Kugelman Honors Program (Joshua J. Cook), Office of Undergraduate
   Research (Joshua J. Cook), and Usha Kundu Research Endowment (Youngil
   Lee).
CR Aharoni-Simon M, 2011, LAB INVEST, V91, P1018, DOI 10.1038/labinvest.2011.55
   Alex S, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0026-1
   Bhargava P, 2017, NAT REV NEPHROL, V13, P629, DOI 10.1038/nrneph.2017.107
   Brooks SPJ, 1999, CONTEMP TOP LAB ANIM, V38, P19
   Chang CC, 2020, CHINESE J PHYSIOL, V63, P149, DOI 10.4103/CJP.CJP_43_20
   Cho Jinkyung, 2014, J Exerc Nutrition Biochem, V18, P339, DOI 10.5717/jenb.2014.18.4.339
   Del Ben M, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-81
   Durand M, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/9986299
   Fealy CE, 2012, J APPL PHYSIOL, V113, P1, DOI 10.1152/japplphysiol.00127.2012
   Fernández-Tussy P, 2019, MOL METAB, V29, P40, DOI 10.1016/j.molmet.2019.08.008
   Fletcher JA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127737
   Fukushima H, 2018, HEPATOL RES, V48, P757, DOI 10.1111/hepr.13071
   García-Ruiz I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23664
   Gluchowski NL, 2019, HEPATOLOGY, V70, P1972, DOI 10.1002/hep.30765
   Gonçalves IO, 2014, INT J BIOCHEM CELL B, V54, P163, DOI 10.1016/j.biocel.2014.07.011
   Gonçalves IO, 2014, MITOCHONDRION, V15, P40, DOI 10.1016/j.mito.2014.03.012
   Guo F, 2013, J LIPID RES, V54, P2109, DOI 10.1194/jlr.M035519
   Guo L, 2019, J BIOL CHEM, V294, P11805, DOI 10.1074/jbc.RA119.008708
   Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073
   Hazari Y, 2020, J HEPATOL, V72, P183, DOI 10.1016/j.jhep.2019.08.026
   Jang Y, 2019, MED SCI SPORT EXER, V51, P2012, DOI 10.1249/MSS.0000000000002011
   Jin ES, 2018, AM J PHYSIOL-ENDOC M, V314, pE543, DOI 10.1152/ajpendo.00342.2017
   Keating SE, 2015, J HEPATOL, V63, P174, DOI 10.1016/j.jhep.2015.02.022
   Ko Jinho, 2013, J Exerc Nutrition Biochem, V17, P181, DOI 10.5717/jenb.2013.17.4.181
   Kwon I, 2020, ANN HEPATOL, V19, P69, DOI 10.1016/j.aohep.2019.08.010
   Lehnig AC, 2019, ISCIENCE, V11, P425, DOI 10.1016/j.isci.2018.12.033
   Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z
   Liou CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050447
   Manley S, 2013, EXP BIOL MED, V238, P525, DOI 10.1177/1535370213489446
   Nadal-Casellas A, 2010, CELL PHYSIOL BIOCHEM, V26, P291, DOI 10.1159/000320552
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Peng Q, 2019, AGING-US, V11, P11520, DOI 10.18632/aging.102552
   Pino-de la Fuente F, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158519
   Schefer V, 1996, EXP GERONTOL, V31, P387, DOI 10.1016/0531-5565(95)02032-2
   Sharma R, 2009, ATHEROSCLEROSIS, V203, P291, DOI 10.1016/j.atherosclerosis.2008.06.016
   Simoes ICM, 2020, ANTIOXIDANTS-BASEL, P9
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Song ZY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101383
   Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004
   Tuohetahuntila M, 2016, J LIPID RES, V57, P1162, DOI 10.1194/jlr.M066415
   Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980
   Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774
   Yang P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61473-6
   Ye LY, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02769-7
   Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251
   Yun HY, 2020, J MED FOOD, V23, P281, DOI 10.1089/jmf.2019.4651
   Zhang Q, 2021, LIFE SCI, V270, DOI 10.1016/j.lfs.2021.119071
   Zhang XY, 2012, AM J PHYSIOL-GASTR L, V302, pG558, DOI 10.1152/ajpgi.00032.2011
   Zheng F, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-018-0933-z
NR 49
TC 2
Z9 2
U1 2
U2 8
PU ELSEVIER ESPANA
PI MADRID
PA CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN
SN 1665-2681
J9 ANN HEPATOL
JI Ann. Hepatol.
PD 2022 JUL-AUG
PY 2022
VL 27
IS 4
AR 100709
DI 10.1016/j.aohep.2022.100709
EA MAY 2022
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 2E6JI
UT WOS:000812332800002
PM 35489641
OA gold
DA 2024-02-19
ER

PT J
AU Weisel, KC
   Bautz, F
   Seitz, G
   Yildirim, S
   Kanz, L
   Möhle, R
AF Weisel, Katja C.
   Bautz, Frank
   Seitz, Gabriele
   Yildirim, Sedat
   Kanz, Lothar
   Moehle, Robert
TI Modulation of CXC Chemokine Receptor Expression and Function in Human
   Neutrophils during Aging In Vitro Suggests a Role in Their Clearance
   from Circulation
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID PROGRAMMED CELL-DEATH; TRANSENDOTHELIAL MIGRATION; BONE-MARROW;
   APOPTOSIS; CD34(+); LIVER
AB In mice, differential regulation of CXC chemokine receptor expression in circulating polymorphonuclear neutrophils (PMNs) undergoing senescence results in homing to the bone marrow. However, the role of this compartment and of the chemokine receptor CXCR4 is still under discussion, and only scarce data exist about CXCR4 function in human PMN. In our study, we provide evidence that also in human neutrophils, expression (cell surface and mRNA), chemotactic and signaling functions of the homing-related chemokine receptor CXCR4 are upregulated during aging in vitro, independent of addition of stimulatory cytokines (TNF, IL-1, IL-8, G-CSF). In contrast, interleukin-8 receptors are downmodulated (CXCR2) or remain unchanged (CXCR1), suggesting that human PMNs undergoing senescence acquire a phenotype that impairs inflammatory extravasation and favors homing to the bone marrow or other tissues involved in sequestration. Partially retained responsiveness to interleukin-8 may be important for neutrophil function when senescence occurs after extravasation in inflamed tissues. Copyright (c) 2009 Katja C. Weisel et al.
C1 [Weisel, Katja C.; Bautz, Frank; Seitz, Gabriele; Yildirim, Sedat; Kanz, Lothar; Moehle, Robert] Univ Tubingen, Dept Med 2, D-72076 Tubingen, Germany.
C3 Eberhard Karls University of Tubingen
RP Möhle, R (corresponding author), Univ Tubingen, Dept Med 2, Otfried Muller St 10, D-72076 Tubingen, Germany.
EM robert.moehle@med.uni-tuebingen.de
RI yildirim, sedat/AAF-4610-2019
OI yildirim, sedat/0000-0002-5735-4315
FU University of Tubingen [fortune 506]; Deutsche Forschungsgemeinschaft
   [DFG, SFB 510/A4]
FX This work was supported by grants from the University of Tubingen
   (fortune 506) and Deutsche Forschungsgemeinschaft (DFG, SFB 510/A4). The
   authors thank Petra Mayer and Tina Wiesner for excellent technical
   assistance.
CR Benestad H B, 1989, Curr Top Pathol, V79, P7
   BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   CHUNTHARAPAI A, 1995, J IMMUNOL, V155, P2587
   Crazzolara R, 2001, BRIT J HAEMATOL, V115, P545, DOI 10.1046/j.1365-2141.2001.03164.x
   Dallegri F, 1997, INFLAMM RES, V46, P382, DOI 10.1007/s000110050208
   DRANSFIELD I, 1995, BLOOD, V85, P3264, DOI 10.1182/blood.V85.11.3264.bloodjournal85113264
   Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423
   Gupta SK, 2001, J LEUKOCYTE BIOL, V70, P431
   Hii CS, 2004, J BIOL CHEM, V279, P49825, DOI 10.1074/jbc.M406892200
   Homburg C H, 1996, Curr Opin Hematol, V3, P94
   Knudsen E, 2004, EUR J HAEMATOL, V73, P109, DOI 10.1111/j.1600-0609.2004.00263.x
   Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4
   Lehman JA, 2001, AM J PHYSIOL-CELL PH, V280, pC183, DOI 10.1152/ajpcell.2001.280.1.C183
   Lum JJ, 2005, J IMMUNOL, V175, P1232, DOI 10.4049/jimmunol.175.2.1232
   Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2
   Mohle R, 1997, BLOOD, V89, P72, DOI 10.1182/blood.V89.1.72.72_72_80
   Möhle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530
   Mollinedo F, 1999, IMMUNOL TODAY, V20, P535, DOI 10.1016/S0167-5699(99)01500-5
   Murphy PM, 1997, SEMIN HEMATOL, V34, P311
   Patel L, 2001, CYTOKINE, V14, P27, DOI 10.1006/cyto.2000.0851
   PAYNE CM, 1994, MICROSC RES TECHNIQ, V28, P327, DOI 10.1002/jemt.1070280408
   Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845
   Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375
   SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970
   Shi JL, 2001, BLOOD, V98, P1226, DOI 10.1182/blood.V98.4.1226
   Suratt BT, 2004, BLOOD, V104, P565, DOI 10.1182/blood-2003-10-3638
   Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913
   Weinmann P, 2003, BLOOD, V101, P739, DOI 10.1182/blood-2002-01-0239
   White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095
   WHYTE MKB, 1993, J IMMUNOL, V150, P5124
NR 31
TC 36
Z9 43
U1 0
U2 2
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PY 2009
VL 2009
AR 790174
DI 10.1155/2009/790174
PG 8
WC Cell Biology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Immunology
GA 443PK
UT WOS:000265922100001
PM 19390584
OA Green Submitted, Green Published, gold
DA 2024-02-19
ER

PT J
AU Kang, JH
   Splinter, PL
   Trussoni, CE
   Pirius, NE
   Gores, GJ
   LaRusso, NF
   O'Hara, SP
AF Kang, Jeong-Han
   Splinter, Patrick L.
   Trussoni, Christy E.
   Pirius, Nicholas E.
   Gores, Gregory J.
   LaRusso, Nicholas F.
   O'Hara, Steven P.
TI The Epigenetic Reader, Bromodomain Containing 2, Mediates Cholangiocyte
   Senescence via Interaction With ETS Proto-Oncogene 1
SO GASTROENTEROLOGY
LA English
DT Article
DE Primary Sclerosing Cholangitis (PSC); Senescence; BET Proteins;
   Epigenetics
ID PRIMARY SCLEROSING CHOLANGITIS; SUPPRESSES CELL-GROWTH; SECRETORY
   PHENOTYPE; APOPTOSIS; BRD4; INHIBITION; FIBROBLASTS; RESISTANCE;
   LYMPHOMA; INVASION
AB BACKGROUND & AIMS: We reported that cholangiocyte senescence, regulated by the transcription factor ETS protooncogene 1 (ETS1), is a pathogenic feature of primary sclerosing cholangitis (PSC). Furthermore, histone 3 lysine 27 is acetylated at senescence-associated loci. The epigenetic readers, bromodomain and extra-terminal domain (BET) proteins, bind acetylated histones, recruit transcription factors, and drive gene expression. Thus, we tested the hypothesis that BET proteins interact with ETS1 to drive gene expression and cholangiocyte senescence. METHODS: We performed immunofluorescence for BET proteins (BRD2 and 4) in liver tissue from liver tissue from PSC patients and a mouse PSC model. Using normal human cholangiocytes (NHCs), NHCs experimentally induced to senescence (NHCsen), and PSC patient-derived cholangiocytes (PSCDCs), we assessed senescence, fibroinflammatory secretome, and apoptosis after BET inhibition or RNA interference depletion. We assessed BET interaction with ETS1 in NHCsen and tissues from PSC patient, and the effects of BET inhibitors on liver fibrosis, senescence, and inflammatory gene expression in mouse models. RESULTS: Tissue from patients with PSC and a mouse PSC model exhibited increased cholangiocyte BRD2 and 4 protein (similar to 5x) compared with controls without disease. NHCsen exhibited increased BRD2 and 4 (similar to 2x), whereas PSCDCs exhibited increased BRD2 protein (similar to 2x) relative to NHC. BET inhibition in NHCsen and PSCDCs reduced senescence markers and inhibited the fibroin-flammatory secretome. ETS1 interacted with BRD2 in NHCsen, and BRD2 depletion diminished NHCsen p21 expression. BET inhibitors reduced senescence, fibroin-flammatory gene expression, and fibrosis in the 3,5diethoxycarbonyl-1,4-dihydrocollidine-fed and Mdr2-/- mouse models. CONCLUSION: Our data suggest that BRD2 is an essential mediator of the senescent cholangiocyte phenotype and is a potential therapeutic target for patients with PSC.
C1 [Kang, Jeong-Han; Splinter, Patrick L.; Trussoni, Christy E.; Pirius, Nicholas E.; Gores, Gregory J.; LaRusso, Nicholas F.; O'Hara, Steven P.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA.
   [O'Hara, Steven P.] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St Southwest, Rochester, MN 55905 USA.
C3 Mayo Clinic; Mayo Clinic
RP O'Hara, SP (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, 200 First St Southwest, Rochester, MN 55905 USA.
EM ohara.steven@mayo.edu
FU National Institutes of Health, National Institute of Diabetes and
   Digestive and Kidney Diseases [P30 DK084567, R01 DK057993, R01
   DK0124182]; PSC Partners Seeking a Cure; Endowment in PSC
FX Funding was received from National Institutes of Health, National
   Institute of Diabetes and Digestive and Kidney Diseases grants P30
   DK084567 and R01 DK057993 to Nicholas F. LaRusso and R01 DK0124182 to
   Gregory J. Gores. PSC Partners Seeking a Cure provided support to Steven
   P. O'Hara. Support was received from the Chris M. Carlos and Catharine
   Nicole Jockisch Carlos Endowment in PSC.
CR Alabraba E, 2009, LIVER TRANSPLANT, V15, P330, DOI 10.1002/lt.21679
   Azad AI, 2020, HEPATOLOGY, V72, P1013, DOI 10.1002/hep.31211
   Bambha K, 2003, GASTROENTEROLOGY, V125, P1364, DOI 10.1016/j.gastro.2003.07.011
   Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1
   Coppé JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144
   Cummin TEC, 2020, BLOOD ADV, V4, P3316, DOI 10.1182/bloodadvances.2020002231
   Faivre EJ, 2020, NATURE, V578, P306, DOI 10.1038/s41586-020-1930-8
   Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504
   Gadd MS, 2017, NAT CHEM BIOL, V13, P514, DOI [10.1038/nchembio.2329, 10.1038/NCHEMBIO.2329]
   Gilan O, 2020, SCIENCE, V368, P387, DOI 10.1126/science.aaz8455
   Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.e04-05-0392
   Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001
   Hogg SJ, 2016, MOL CANCER THER, V15, P2030, DOI 10.1158/1535-7163.MCT-15-0924
   Karlsen TH, 2017, J HEPATOL, V67, P1298, DOI 10.1016/j.jhep.2017.07.022
   Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141
   Lazaridis KN, 2016, NEW ENGL J MED, V375, P2501
   Li Y, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.555591
   Lu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41390
   Mohammad HP, 2019, NAT MED, V25, P403, DOI 10.1038/s41591-019-0376-8
   Moncsek A, 2018, HEPATOLOGY, V67, P247, DOI 10.1002/hep.29464
   O'Hara SP, 2019, J BIOL CHEM, V294, P18698, DOI 10.1074/jbc.RA119.010176
   O'Hara SP, 2017, J BIOL CHEM, V292, P4833, DOI 10.1074/jbc.M117.777409
   Sturmlechner I, 2021, SCIENCE, V374, DOI 10.1126/science.abb3420
   Tabibian JH, 2014, LAB INVEST, V94, P1126, DOI 10.1038/labinvest.2014.94
   Tabibian JH, 2014, HEPATOLOGY, V59, P2263, DOI 10.1002/hep.26993
   Tasdemir N, 2016, CANCER DISCOV, V6, P612, DOI 10.1158/2159-8290.CD-16-0217
   Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098
   Wakita M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15719-6
   WANG E, 1995, CANCER RES, V55, P2284
   Wang LM, 2017, BIOL RES, V50, DOI 10.1186/s40659-017-0124-9
   Wang LM, 2016, ONCOL REP, V36, P1989, DOI 10.3892/or.2016.5037
   Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433
   Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200
   Wyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072967
   Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9
NR 35
TC 1
Z9 1
U1 1
U2 1
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD JUL
PY 2023
VL 165
IS 1
BP 228
EP +
DI 10.1053/j.gastro.2023.03.235
EA JUN 2023
PG 18
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA N3BO9
UT WOS:001035810700001
PM 37059338
DA 2024-02-19
ER

PT J
AU Zhang, XL
   Han, X
   Yin, LH
   Xu, L
   Qi, Y
   Xu, YW
   Sun, HJ
   Lin, Y
   Liu, KX
   Peng, JY
AF Zhang, Xiaoling
   Han, Xu
   Yin, Lianhong
   Xu, Lina
   Qi, Yan
   Xu, Youwei
   Sun, Huijun
   Lin, Yuan
   Liu, Kexin
   Peng, Jinyong
TI Potent effects of dioscin against liver fibrosis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HEPATIC STELLATE CELLS; LAEVIGATA MICHX FRUIT; GROWTH-FACTOR-BETA;
   SIGNALING PATHWAYS; HERBAL MEDICINE; TGF-BETA; APOPTOSIS; ACTIVATION;
   RAT; FIBROGENESIS
AB We previously reported the promising effects of dioscin against liver injury, but its effect on liver fibrosis remains unknown. The present work investigated the activities of dioscin against liver fibrosis and the underlying molecular mechanisms. Dioscin effectively inhibited the cell viabilities of HSC-T6, LX-2 and primary rat hepatic stellate cells (HSCs), but not hepatocytes. Furthermore, dioscin markedly increased peroxisome proliferator activated receptor-gamma (PPAR-gamma) expression and significantly reduced a-smooth muscle actin (alpha-SMA), transforming growth factor-beta 1 (TGF-beta 1), collagen alpha 1 (I) (COL1A1) and collagen alpha 1 (III) (COL3A1) levels in vitro. Notably, dioscin inhibited HSCs activation and induced apoptosis in activated HSCs. In vivo, dioscin significantly improved body weight and hydroxylproline, laminin, alpha-SMA, TGF-beta 1, COL1A1 and COL3A1 levels, which were confirmed by histopathological assays. Dioscin facilitated matrix degradation, and exhibited hepatoprotective effects through the attenuation of oxidative stress and inflammation, in addition to exerting anti-fibrotic effects through the modulation of the TGF-beta 1/Smad, Wnt/beta-catenin, mitogen-activated protein kinase (MAPK) and mitochondrial signaling pathways, which triggered the senescence of activated HSCs. In conclusion, dioscin exhibited potent effects against liver fibrosis through the modulation of multiple targets and signaling pathways and should be developed as a novel candidate for the treatment of liver fibrosis in the future.
C1 [Zhang, Xiaoling; Han, Xu; Yin, Lianhong; Xu, Lina; Qi, Yan; Xu, Youwei; Sun, Huijun; Lin, Yuan; Liu, Kexin; Peng, Jinyong] Dalian Med Univ, Coll Pharm, Dalian 116044, Peoples R China.
C3 Dalian Medical University
RP Peng, JY (corresponding author), Dalian Med Univ, Coll Pharm, Western 9 Lvshunnan Rd, Dalian 116044, Peoples R China.
EM jinyongpeng2008@126.com
RI Peng, Jin/HZH-6965-2023; Liu, Kexin/GQH-0970-2022
OI Zhang, Xiaoling/0000-0003-1157-0976
FU National Natural Science Foundation of China [81274195]; Program for
   Liaoning Innovative Research Team in University [LT2013019]; Program for
   New Century Excellent Talents in University [NCET-11-1007]
FX This work was financially supported by National Natural Science
   Foundation of China (No. 81274195), the Program for Liaoning Innovative
   Research Team in University (LT2013019) and the Program for New Century
   Excellent Talents in University (NCET-11-1007).
CR Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012
   Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558
   Bataller R, 2011, BEST PRACT RES CL GA, V25, P231, DOI 10.1016/j.bpg.2011.02.010
   Brautbar N, 2002, INT J HYG ENVIR HEAL, V205, P479, DOI 10.1078/1438-4639-00175
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007
   Dong DS, 2013, FOOD CHEM TOXICOL, V62, P120, DOI 10.1016/j.fct.2013.08.050
   Dong H, 2012, CHIN J INTEGR MED, V18, P152, DOI 10.1007/s11655-012-0993-2
   Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288
   Fox ES, 1997, J SURG RES, V72, P129, DOI 10.1006/jsre.1997.5172
   Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Han YP, 2004, J BIOL CHEM, V279, P4820, DOI 10.1074/jbc.M310999200
   Hsieh MJ, 2013, ARCH TOXICOL, V87, P1927, DOI 10.1007/s00204-013-1047-z
   Hu MM, 2013, J APPL TOXICOL, V33, P712, DOI 10.1002/jat.2715
   Huang QF, 2013, TOXICOL LETT, V217, P102, DOI 10.1016/j.toxlet.2012.12.014
   IKEJIMA K, 1995, BIOCHEM BIOPH RES CO, V214, P440, DOI 10.1006/bbrc.1995.2306
   Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690
   Kaskiw MJ, 2009, BIOORGAN MED CHEM, V17, P7670, DOI 10.1016/j.bmc.2009.09.046
   Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049
   Li XM, 2013, FREE RADICAL BIO MED, V60, P168, DOI 10.1016/j.freeradbiomed.2013.02.027
   Liu YQ, 2011, J HEPATOL, V55, P612, DOI 10.1016/j.jhep.2010.11.035
   Liu YQ, 2009, LAB INVEST, V89, P209, DOI 10.1038/labinvest.2008.127
   Lu BN, 2011, PLANTA MED, V77, P407, DOI 10.1055/s-0030-1250461
   Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062
   Mehal WZ, 2011, NAT MED, V17, P552, DOI 10.1038/nm0511-552
   Muddu AK, 2007, INT J BIOCHEM CELL B, V39, P695, DOI 10.1016/j.biocel.2006.10.006
   Myung SJ, 2007, FEBS LETT, V581, P2954, DOI 10.1016/j.febslet.2007.05.050
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   Novo E, 2006, GUT, V55, P1174, DOI 10.1136/gut.2005.082701
   Park JK, 2010, HEPATOLOGY, V51, P1766, DOI 10.1002/hep.23499
   Parola M, 2008, MOL ASPECTS MED, V29, P58, DOI 10.1016/j.mam.2007.09.002
   Pitrak DL, 1996, J CLIN INVEST, V98, P2714, DOI 10.1172/JCI119096
   Poli G, 1997, FREE RADICAL BIO MED, V22, P287, DOI 10.1016/S0891-5849(96)00327-9
   Sautour M, 2004, CHEM PHARM BULL, V52, P1353, DOI 10.1248/cpb.52.1353
   Shimizu I, 1999, HEPATOLOGY, V29, P149, DOI 10.1002/hep.510290108
   Soh YJ, 2000, MOL PHARMACOL, V58, P535, DOI 10.1124/mol.58.3.535
   Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337
   Su JL, 2005, CARCINOGENESIS, V26, P1, DOI 10.1093/carcin/bgh220
   Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820
   Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056
   Vogel S, 2000, J LIPID RES, V41, P882
   Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040
   Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027
   Weiskirchen R, 2005, METH MOLEC MED, V117, P99
   Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188
   Xi LA, 2011, HEPATOLOGY, V53, P127, DOI 10.1002/hep.24011
   Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127
   Xu LN, 2014, RSC ADV, V4, P30704, DOI 10.1039/c4ra03948c
   Xu TT, 2014, ARCH TOXICOL, V88, P739, DOI 10.1007/s00204-013-1148-8
   Yin LH, 2010, CHROMATOGRAPHIA, V71, P15, DOI 10.1365/s10337-009-1407-2
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Yu J, 2008, BIOCHEM BIOPH RES CO, V372, P571, DOI 10.1016/j.bbrc.2008.05.069
   Zhang S, 2013, FOOD CHEM, V141, P2108, DOI 10.1016/j.foodchem.2013.05.019
   Zhao XM, 2012, TOXICOL LETT, V214, P69, DOI 10.1016/j.toxlet.2012.08.005
NR 55
TC 75
Z9 85
U1 3
U2 41
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 8
PY 2015
VL 5
AR 9713
DI 10.1038/srep09713
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA CF1WP
UT WOS:000352338900001
PM 25853178
OA Green Published, gold
DA 2024-02-19
ER

PT S
AU Celton-Morizur, S
   Desdouets, C
AF Celton-Morizur, Severine
   Desdouets, Chantal
BE Poon, RYC
TI Polyploidization of Liver Cells
SO POLYPLOIDIZATION AND CANCER
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID FLOW-CYTOMETRIC ANALYSIS; DANS LE FOIE; RAT-LIVER; HEPATOCYTE PLOIDY;
   DNA-PLOIDY; PARTIAL-HEPATECTOMY; CENTROSOME DEFECTS; THYROID-HORMONE;
   DIPLOID GROWTH; BINUCLEATION
AB Eukaryotic organisms usually contain a diploid complement of chromosomes. However, there are a number of exceptions. Organisms containing an increase in DNA content by whole number multiples of the entire set of chromosomes are defined as polyploid. Cells that contain more than two sets of chromosomes were first observed in plants about a century ago and it is now recognized that polyploidy cells form in many eukaryotes under a wide variety of circumstance. Although it is less common in mammals, some tissues, including the liver, show a high percentage of polyploid cells. Thus, during postnatal growth, the liver parenchyma undergoes dramatic changes characterized by gradual polyploidization during which hepatocytes of several ploidy classes emerge as a result of modified cell-division cycles. This process generates the successive appearance of tetraploid and octoploid cell classes with one or two nuclei (mononucleated or binucleated). Liver cells polyploidy is generally considered to indicate terminal differentiation and senescence and to lead both to the progressive loss of cell pluripotency and a markedly decreased replication capacity. In adults, liver polyploidization is differentially regulated upon loss of liver mass and liver damage. Interestingly, partial hepatectomy induces marked cell proliferation followed by an increase in liver ploidy. In contrast, during hepatocarcinoma (HCC), growth shifts to a nonpolyploidizing pattern and expansion of the diploid hepatocytes population is observed in neoplastic nodules. Here we review the current state of understanding about how polyploidization is regulated during normal and pathological liver growth and detail by which mechanisms hepatocytes become polyploid.
C1 [Desdouets, Chantal] Univ Paris 05, CNRS, INSERM,UMR 8104, Inst Cochin,UNR 8104,U567,Dept Genet & Dev, F-75014 Paris, France.
C3 Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); Institut National de la Sante et de la
   Recherche Medicale (Inserm); Universite Paris Cite
RP Desdouets, C (corresponding author), Univ Paris 05, CNRS, INSERM,UMR 8104, Inst Cochin,UNR 8104,U567,Dept Genet & Dev, 24 Rue Faubourg St Jacques, F-75014 Paris, France.
EM desdouets@cochin.inserm.fr
RI CELTON-MORIZUR, SEVERINE/AAJ-7127-2021; Desdouets, Chantal/M-3430-2017;
   Celton-Morizur, Severine/P-5282-2017
OI CELTON-MORIZUR, SEVERINE/0000-0001-5622-9777; 
CR ALFERT M, 1958, EXP CELL RES, V15, P230, DOI 10.1016/0014-4827(58)90079-X
   An CST, 1997, HEPATOLOGY, V26, P1224
   ANATSKAYA OV, 1994, J THEOR BIOL, V168, P191, DOI 10.1006/jtbi.1994.1098
   ANTI M, 1994, CANCER, V73, P281, DOI 10.1002/1097-0142(19940115)73:2<281::AID-CNCR2820730208>3.0.CO;2-6
   Asahina K, 2006, BIOCHEM BIOPH RES CO, V342, P1160, DOI 10.1016/j.bbrc.2006.02.076
   Brodsky W Y, 1977, Int Rev Cytol, V50, P275
   Carriere R, 1969, Int Rev Cytol, V25, P201, DOI 10.1016/S0074-7696(08)60204-1
   CARRIERE R, 1967, EXP CELL RES, V46, P533, DOI 10.1016/0014-4827(67)90379-5
   Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476
   DESCHENES J, 1981, CELL BIOPHYS, V3, P321, DOI 10.1007/BF02785117
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8
   Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425
   ENESCO HE, 1983, EXP GERONTOL, V18, P79, DOI 10.1016/0531-5565(83)90054-2
   ENESCO HE, 1991, MECH AGEING DEV, V59, P69, DOI 10.1016/0047-6374(91)90074-A
   EPSTEIN CJ, 1967, P NATL ACAD SCI USA, V57, P327, DOI 10.1073/pnas.57.2.327
   Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969
   Gandillet A, 2003, COMP BIOCHEM PHYS A, V134, P665, DOI 10.1016/S1095-6433(02)00374-4
   GERLYNG P, 1993, CELL PROLIFERAT, V26, P557, DOI 10.1111/j.1365-2184.1993.tb00033.x
   GERLYNG P, 1992, CARCINOGENESIS, V13, P1795, DOI 10.1093/carcin/13.10.1795
   GERMAIN L, 1988, CANCER RES, V48, P4909
   GESCHWIND II, 1960, BIOL BULL, V118, P66, DOI 10.2307/1539056
   GOMEZLECHON MJ, 1981, CELL MOL BIOL, V27, P695
   Gorla GR, 2001, J CELL SCI, V114, P2943
   Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200
   Gustafson LM, 2000, LARYNGOSCOPE, V110, P1798
   Hasmall SC, 1997, TOXICOL APPL PHARM, V144, P287, DOI 10.1006/taap.1997.8133
   Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627
   HOSO M, 1991, VIRCHOWS ARCH A, V418, P401, DOI 10.1007/BF01605925
   Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143
   KATO J, 1993, JPN J CANCER RES, V84, P219, DOI 10.1111/j.1349-7006.1993.tb02859.x
   Kondorosi E, 2000, CURR OPIN PLANT BIOL, V3, P488, DOI 10.1016/S1369-5266(00)00118-7
   KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139
   Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7
   Lingle WL, 1998, P NATL ACAD SCI USA, V95, P2950, DOI 10.1073/pnas.95.6.2950
   MACDONALD R, 1961, ARCH INTERN MED, V107, P335, DOI 10.1001/archinte.1961.03620030023003
   MADRA S, 1995, CARCINOGENESIS, V16, P719, DOI 10.1093/carcin/16.4.719
   Malhi H, 2002, P NATL ACAD SCI USA, V99, P13114, DOI 10.1073/pnas.192365499
   Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907
   Martin NC, 2002, J CELL PHYSIOL, V191, P138, DOI 10.1002/jcp.10057
   Martin NC, 2001, TOXICOL LETT, V119, P109, DOI 10.1016/S0378-4274(00)00299-X
   MELCHIORRI C, 1993, CARCINOGENESIS, V14, P1825, DOI 10.1093/carcin/14.9.1825
   MELCHIORRI C, 1994, CANCER, V74, P1713, DOI 10.1002/1097-0142(19940915)74:6<1713::AID-CNCR2820740612>3.0.CO;2-O
   MENDECKI J, 1978, P SOC EXP BIOL MED, V158, P63
   Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60
   Miller RT, 1996, TOXICOL APPL PHARM, V138, P317, DOI 10.1006/taap.1996.0130
   Minamishima YA, 2002, CANCER RES, V62, P995
   MORTIMER RK, 1958, RADIAT RES, V9, P312, DOI 10.2307/3570795
   MOSSIN L, 1994, EXP CELL RES, V214, P551, DOI 10.1006/excr.1994.1293
   Muramatsu Y, 2000, RES COMMUN MOL PATH, V107, P129
   MURAMATSU Y, 1994, GASTROENTEROLOGY, V107, P1189, DOI 10.1016/0016-5085(94)90247-X
   NADAL C, 1966, EXP CELL RES, V42, P117, DOI 10.1016/0014-4827(66)90325-9
   NADAL C, 1966, EXP CELL RES, V42, P99, DOI 10.1016/0014-4827(66)90324-7
   NADAL C, 1967, EXP CELL RES, V48, P518, DOI 10.1016/0014-4827(67)90318-7
   Nakatani T, 1997, EXP CELL RES, V236, P137, DOI 10.1006/excr.1997.3715
   Núñez F, 2000, FASEB J, V14, P1073, DOI 10.1096/fasebj.14.9.1073
   Pihan GA, 2001, CANCER RES, V61, P2212
   Pihan GA, 1998, CANCER RES, V58, P3974
   Ravid K, 2002, J CELL PHYSIOL, V190, P7, DOI 10.1002/jcp.10035
   SAETER G, 1989, BRIT J CANCER, V59, P198, DOI 10.1038/bjc.1989.41
   SAETER G, 1988, CARCINOGENESIS, V9, P939, DOI 10.1093/carcin/9.6.939
   SAXEMA R, 2003, HEPATHOLOGY TXB LIVE, P43
   SCHILSKY ML, 1994, AM J PHYSIOL, V266, pG907, DOI 10.1152/ajpgi.1994.266.5.G907
   SCHMUCKER DL, 1990, J ELECTRON MICR TECH, V14, P106, DOI 10.1002/jemt.1060140205
   SCHWARZE PE, 1986, CANCER RES, V46, P4732
   SCHWARZE PE, 1991, CARCINOGENESIS, V12, P325, DOI 10.1093/carcin/12.2.325
   SCHWARZE PE, 1984, CARCINOGENESIS, V5, P1267, DOI 10.1093/carcin/5.10.1267
   Seglen PO, 1997, CELL BIOL TOXICOL, V13, P301, DOI 10.1023/A:1007487425047
   SEVERIN E, 1984, CELL TISSUE RES, V238, P649, DOI 10.1007/BF00219884
   SHIOJIRI N, 1991, CANCER RES, V51, P2611
   SIGAL SH, 1995, DIFFERENTIATION, V59, P35, DOI 10.1046/j.1432-0436.1995.5910035.x
   Sigal SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1260, DOI 10.1152/ajpgi.1999.276.5.G1260
   Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276
   SWARTZ F, 1960, EXP CELL RES, V20, P438, DOI 10.1016/0014-4827(60)90172-5
   SWARTZ FJ, 1960, P SOC EXP BIOL MED, V104, P756
   SWARTZ FJ, 1961, ANAT REC, V141, P219, DOI 10.1002/ar.1091410306
   Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489
   Taylor MV, 2002, CURR BIOL, V12, pR224, DOI 10.1016/S0960-9822(02)00757-1
   Terada K, 1999, PEDIATR INT, V41, P414, DOI 10.1046/j.1442-200x.1999.01089.x
   Torres S, 1999, AM J PHYSIOL-GASTR L, V276, pG155, DOI 10.1152/ajpgi.1999.276.1.G155
   Toyoda H, 2005, GUT, V54, P297, DOI 10.1136/gut.2004.043893
   Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x
   VIOLAMAGNI MP, 1972, J MICROSC-OXFORD, V96, P191, DOI 10.1111/j.1365-2818.1972.tb04656.x
   WATANABE T, 1982, VIRCHOWS ARCH B, V39, P9, DOI 10.1007/BF02892832
   Weber RG, 1998, CYTOGENET CELL GENET, V83, P266, DOI 10.1159/000015168
   WHEATLEY DN, 1972, EXP CELL RES, V74, P455, DOI 10.1016/0014-4827(72)90401-6
   Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245
   Yamada T, 1998, RES COMMUN MOL PATH, V99, P283
   Yin L, 1998, HEPATOLOGY, V27, P73, DOI 10.1002/hep.510270113
NR 89
TC 88
Z9 99
U1 0
U2 20
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
BN 978-1-4419-6198-3
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2010
VL 676
BP 123
EP 135
D2 10.1007/978-1-4419-6199-0
PG 13
WC Oncology; Medicine, Research & Experimental
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Research & Experimental Medicine
GA BPB53
UT WOS:000278447400008
PM 20687473
DA 2024-02-19
ER

PT J
AU FRY, M
   SILBER, J
   LOEB, LA
   MARTIN, GM
AF FRY, M
   SILBER, J
   LOEB, LA
   MARTIN, GM
TI DELAYED AND REDUCED CELL REPLICATION AND DIMINISHING LEVELS OF DNA
   POLYMERASE-ALPHA IN REGENERATING LIVER OF AGING MICE
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Article
C1 TECHNION ISRAEL INST TECHNOL, FAC MED, BIOCHEM UNIT, HAIFA, ISRAEL.
   UNIV WASHINGTON, DEPT PATHOL, GOTTSTEIN MEM CANC RES LAB, SEATTLE, WA 98195 USA.
   UNIV WASHINGTON, DEPT PATHOL, DIV GENET PATHOL, SEATTLE, WA 98195 USA.
C3 Technion Israel Institute of Technology; Rappaport Faculty of Medicine;
   University of Washington; University of Washington Seattle; University
   of Washington; University of Washington Seattle
FU NCI NIH HHS [CA-24845] Funding Source: Medline; NIA NIH HHS [AG-01751,
   AG-00057] Funding Source: Medline
CR Adelman RC, 1972, MECH AGEING DEV, V1, P49, DOI 10.1016/0047-6374(72)90052-8
   ALBRIGHT JW, 1976, J EXP MED, V144, P1204, DOI 10.1084/jem.144.5.1204
   BATTULA N, 1974, J BIOL CHEM, V249, P4086
   BROWN M, 1981, P NATL ACAD SCI-BIOL, V78, P3049, DOI 10.1073/pnas.78.5.3049
   BUCHER NLR, 1950, CANCER RES, V10, P324
   BUCHER NLR, 1978, CIBA F S
   BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315
   BYRNES JJ, 1974, NATURE, V248, P187
   Daniel C. W., 1972, ADV GERONTOL RES, V4, P167
   DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53
   FANSLER B, 1972, EXP CELL RES, V75, P433, DOI 10.1016/0014-4827(72)90450-8
   FARRAR JJ, 1974, J IMMUNOL, V112, P1244
   FOSTER DN, 1976, J BIOL CHEM, V251, P7893
   FOX AM, 1980, DEV BIOL, V80, P79, DOI 10.1016/0012-1606(80)90500-X
   FRY M, 1981, J CELL PHYSIOL, V106, P435, DOI 10.1002/jcp.1041060313
   FRY M, 1983, ENZYMES NUCLEIC ACID, V1, P39
   HARRISON DE, 1973, P NATL ACAD SCI USA, V70, P3184, DOI 10.1073/pnas.70.11.3184
   HARRISON DE, 1977, J IMMUNOL, V118, P1223
   HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526
   Hay RJ, 1967, EXP GERONTOL, V2, P123, DOI 10.1016/0531-5565(67)90029-0
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6
   HAYFLICK L, 1973, AM J MED SCI, V265, P432, DOI 10.1097/00000441-197306000-00001
   HERRICK G, 1976, P NATL ACAD SCI USA, V73, P1136, DOI 10.1073/pnas.73.4.1136
   HOBART PM, 1980, BIOCHIM BIOPHYS ACTA, V607, P256, DOI 10.1016/0005-2787(80)90078-7
   HOSHINO K, 1967, NATURE, V213, P193, DOI 10.1038/213193a0
   JOHNSON HA, 1969, AM J PATHOL, V57, P1
   KNOPF KW, 1977, BIOCHEMISTRY-US, V16, P3190, DOI 10.1021/bi00633a023
   KRAUSS SW, 1982, BIOCHEMISTRY-US, V21, P1002, DOI 10.1021/bi00534a027
   KROHN P. L., 1966, P125
   KROHN PL, 1962, PROC R SOC SER B-BIO, V157, P128, DOI 10.1098/rspb.1962.0066
   LOEB LA, 1969, J BIOL CHEM, V244, P1672
   LOEB LA, 1970, BIOCHIM BIOPHYS ACTA, V217, P50, DOI 10.1016/0005-2787(70)90121-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LYNCH WE, 1975, J BIOL CHEM, V250, P8179
   MARTIN GM, 1977, AM J PATHOL, V89, P484
   MARTIN GM, 1970, LAB INVEST, V23, P86
   MOOLTEN FL, 1967, SCIENCE, V158, P272, DOI 10.1126/science.158.3798.272
   OGDEN DA, 1976, TRANSPLANTATION, V22, P287, DOI 10.1097/00007890-197609000-00010
   PENDERGRASS WR, 1982, J CELL PHYSIOL, V113, P141, DOI 10.1002/jcp.1041130123
   PRICE GB, 1972, J IMMUNOL, V108, P413
   REDDY GPV, 1980, P NATL ACAD SCI-BIOL, V77, P3312
   RUHNKE M, 1981, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V125, P526
   SCHAPIRO H, 1982, EXPERIENTIA, V15, P1075
   SIMONS JWI, 1967, EXP CELL RES, V45, P336, DOI 10.1016/0014-4827(67)90184-X
   STARZL TE, 1978, CIBA F S, V55, P111
   TARRAGOLITVAK L, 1979, EUR J BIOCHEM, V93, P271, DOI 10.1111/j.1432-1033.1979.tb12820.x
   WEISMANSHOMER P, 1979, J CELL PHYSIOL, V101, P219, DOI 10.1002/jcp.1041010204
   WOLF NS, 1982, MECH AGEING DEV, V20, P127, DOI 10.1016/0047-6374(82)90064-1
   YOUNG LJT, 1971, EXP GERONTOL, V6, P49, DOI 10.1016/0531-5565(71)90048-9
NR 50
TC 71
Z9 75
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PY 1984
VL 118
IS 3
BP 225
EP 232
DI 10.1002/jcp.1041180302
PG 8
WC Cell Biology; Physiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Physiology
GA SG218
UT WOS:A1984SG21800001
PM 6699097
DA 2024-02-19
ER

PT J
AU Fu, ZD
   Csanaky, IL
   Klaassen, CD
AF Fu, Zidong Donna
   Csanaky, Ivan L.
   Klaassen, Curtis D.
TI Gender-Divergent Profile of Bile Acid Homeostasis during Aging of Mice
SO PLOS ONE
LA English
DT Article
ID AGE-RELATED-CHANGES; LIFE-SPAN; CHOLESTEROL; LIVER; METABOLISM;
   RECEPTOR; TRANSPORTERS; EXPRESSION; CLONING; SERUM
AB Aging is a physiological process with a progressive decline of adaptation and functional capacity of the body. Bile acids (BAs) have been recognized as signaling molecules regulating the homeostasis of glucose, lipid, and energy. The current study characterizes the age-related changes of individual BA concentrations by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) in serum and liver of male and female C57BL/6 mice from 3 to 27 months of age. Total BA concentrations in serum increased 340% from 3 to 27 months in female mice, whereas they remained relatively constant with age in male mice. During aging, male and female mice shared the following changes: (1) BA concentrations in liver remained relatively constant; (2) the proportions of beta-muricholic acid (beta MCA) increased and deoxycholic acid (DCA) decreased between 3 and 27 months in serum and liver; and (3) total BAs in serum and liver became more hydrophilic between 3 and 27 months. In female mice, (1) the mRNAs of hepatic BA uptake transporters, the Na+/taurocholate cotransporting polypeptide (Ntcp) and the organic anion transporting polypeptide 1b2 (Oatp1b2), decreased after 12 months, and similar trends were observed for their proteins; (2) the mRNA of the rate-limiting enzyme for BA synthesis, cholesterol 7 alpha-hydroxylase (Cyp7a1), increased from 3 to 9 months and remained high thereafter. However, in male mice, Ntcp, Oatp1b2, and Cyp7a1 mRNAs remained relatively constant with age. In summary, the current study shows gender-divergent profiles of BA concentrations and composition in serum and liver of mice during aging, which is likely due to the gender-divergent expression of BA transporters Ntcp and Oatp1b2 as well as the synthetic enzyme Cyp7a1.
C1 [Fu, Zidong Donna; Csanaky, Ivan L.; Klaassen, Curtis D.] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.
C3 University of Kansas; University of Kansas Medical Center
RP Fu, ZD (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.
EM cklaasse@kumc.edu
RI Fu, Zidong/A-2703-2017
FU National Institutes of Health [ES-009649, ES-019487, DK-081461]
FX This study was supported by National Institutes of Health grants
   ES-009649, ES-019487, and DK-081461. The funder had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akare S, 2006, INT J CANCER, V119, P2958, DOI 10.1002/ijc.22231
   Amador-Noguez D, 2007, AGING CELL, V6, P453, DOI 10.1111/j.1474-9726.2007.00300.x
   Anwer MS, 2004, HEPATOLOGY, V39, P581, DOI 10.1002/hep.20090
   Ballatori N, 2008, AM J PHYSIOL-GASTR L, V295, pG179, DOI 10.1152/ajpgi.90319.2008
   Bertolotti M, 2007, EUR J CLIN INVEST, V37, P501, DOI 10.1111/j.1365-2362.2007.01808.x
   BERTOLOTTI M, 1993, J LIPID RES, V34, P1001
   CALI JJ, 1991, J BIOL CHEM, V266, P7774
   Cheng X, 2007, BIOCHEM PHARMACOL, V74, P1665, DOI 10.1016/j.bcp.2007.08.014
   Chiang JYL, 2003, AM J PHYSIOL-GASTR L, V284, pG349, DOI 10.1152/ajpgi.00417.2002
   CHIANG JYL, 1998, FRONT BIOSCI, V3, P176
   Csanaky IL, 2011, HEPATOLOGY, V53, P272, DOI 10.1002/hep.23984
   Csanaky IL, 2009, AM J PHYSIOL-GASTR L, V297, pG419, DOI 10.1152/ajpgi.90728.2008
   EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501
   Falany CN, 1997, J LIPID RES, V38, P1139
   Frith J, 2009, AGE AGEING, V38, P11, DOI 10.1093/ageing/afn242
   Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046
   GOODRICK CL, 1975, J GERONTOL, V30, P257, DOI 10.1093/geronj/30.3.257
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   HEUMAN DM, 1989, J LIPID RES, V30, P719
   Hofmann AF, 2009, FRONT BIOSCI-LANDMRK, V14, P2584, DOI 10.2741/3399
   Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001
   Kim I, 2007, J LIPID RES, V48, P2664, DOI 10.1194/jlr.M700330-JLR200
   Li TG, 2012, J LIPIDS, V2012, DOI 10.1155/2012/754067
   Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200
   Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153
   SALEMANS JMJI, 1993, EUR J CLIN INVEST, V23, P192, DOI 10.1111/j.1365-2362.1993.tb00761.x
   SHNEIDER BL, 1995, J CLIN INVEST, V95, P745, DOI 10.1172/JCI117722
   Simon FR, 1999, AM J PHYSIOL-GASTR L, V276, pG556, DOI 10.1152/ajpgi.1999.276.2.G556
   Song PZ, 2011, TOXICOL SCI, V123, P359, DOI 10.1093/toxsci/kfr177
   UCHIDA K, 1990, ARCH GERONTOL GERIAT, V10, P37, DOI 10.1016/0167-4943(90)90042-5
   UCHIDA K, 1978, J LIPID RES, V19, P544
   Vina Jose, 2005, Sci Aging Knowledge Environ, V2005, ppe17, DOI 10.1126/sageke.2005.23.pe17
   Wang DQH, 2003, AM J PHYSIOL-GASTR L, V285, pG494, DOI 10.1152/ajpgi.00156.2003
   Zhang YC, 2010, J LIPID RES, V51, P3230, DOI 10.1194/jlr.M007641
   Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683
NR 37
TC 50
Z9 57
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 5
PY 2012
VL 7
IS 3
AR e32551
DI 10.1371/journal.pone.0032551
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 928WA
UT WOS:000303017700071
PM 22403674
OA Green Published, Green Submitted, gold
DA 2024-02-19
ER

PT J
AU Barazzoni, R
   Short, KR
   Nair, KS
AF Barazzoni, R
   Short, KR
   Nair, KS
TI Effects of aging on mitochondrial DNA copy number and cytochrome
   <i>c</i> oxidase gene expression in rat skeletal muscle, liver, and
   heart
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SENESCENT RATS; ENCODED GENES; AGE; TRANSCRIPTION; ADAPTATION; PROTEIN;
   GROWTH; DAMAGE
AB Mitochondrial DNA (mtDNA) deletions and mutations have been reported to occur with aging in various tissues. To determine the functional impact of these changes, we measured mtDNA copy number, mitochondria-encoded cytochrome c oxidase (COX) subunit I and III transcript levels, and COX enzyme activity in skeletal muscles (medial and lateral gastrocnemius and soleus), liver, and heart in 6- and 27-month-old rats. Substantial age-related reductions of mtDNA copy number occurred in skeletal muscle groups (-23-40%, p < 0.03) and liver (-50%, p < 0.01) but not in the heart. The decline in mtDNA was not associated with reduced COX transcript levels in tissues with high oxidative capacities such as red soleus muscle or liver, while transcript levels were reduced with aging in the less oxidative mixed fiber gastrocnemius muscle (-17-22%, p < 0.06), Consistent with transcript levels, COX activity also remained unchanged in aging liver and heart but declined with age in the lateral gastrocnemius (-32%, p < 0.05). Thus, the effects of aging on mitochondrial gene expression are tissue-specific. A substantial age-related decline in mtDNA copy number proportional to tissue oxidative capacities is demonstrated in skeletal muscle and liver. mtDNA levels are in contrast preserved in the aging heart muscle, presumably due to its incessant aerobic activity. Reduced mtDNA copy number has no major effects on mitochondrial encoded transcript levels and enzyme activities in various tissues under these baseline study conditions. In contrast, maintenance of mitochondrial transcript levels that may be linked to oxidative metabolism and energy demand appears to be the main determinant of mitochondrial oxidative capacity in aging tissues.
C1 Mayo Clin & Mayo Fdn, Endocrine Res Unit, Rochester, MN 55905 USA.
C3 Mayo Clinic
RP Nair, KS (corresponding author), Mayo Clin & Mayo Fdn, Endocrine Res Unit, Joseph 5-194, Rochester, MN 55905 USA.
RI Short, Kevin R/AAC-2553-2020
OI Short, Kevin R/0000-0001-6704-9587
FU NCRR NIH HHS [RR 00585] Funding Source: Medline; NIA NIH HHS [R0 AG
   09531] Funding Source: Medline
CR ADLER CP, 1986, J MOL CELL CARDIOL, V18, P39, DOI 10.1016/S0022-2828(86)80981-6
   ALONI Y, 1971, P NATL ACAD SCI USA, V68, P1757, DOI 10.1073/pnas.68.8.1757
   [Anonymous], 1989, MOL CLONING LAB MANU
   ANTONETTI DA, 1995, J CLIN INVEST, V95, P1383, DOI 10.1172/JCI117790
   ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303
   Barrientos A, 1997, BIOCHEM MOL MED, V62, P165, DOI 10.1006/bmme.1997.2647
   BOHMAN R, 1985, J EXP ZOOL, V233, P385, DOI 10.1002/jez.1402330307
   CASTELLUCCIO C, 1994, MECH AGEING DEV, V76, P73, DOI 10.1016/0047-6374(94)91583-0
   CLAYTON DA, 1974, P NATL ACAD SCI USA, V71, P2777, DOI 10.1073/pnas.71.7.2777
   Delp MD, 1998, J APPL PHYSIOL, V85, P1813, DOI 10.1152/jappl.1998.85.5.1813
   Dutta C, 1997, MUSCLE NERVE       S, V20, P5
   DUTTA C, 1996, J GERONTOL A-BIOL, V50, P1
   Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023
   GADALETA MN, 1990, EUR J BIOCHEM, V187, P501, DOI 10.1111/j.1432-1033.1990.tb15331.x
   GADALETA MN, 1992, MUTAT RES, V275, P181, DOI 10.1016/0921-8734(92)90022-H
   GENOVA ML, 1995, BIOCHEM J, V311, P105, DOI 10.1042/bj3110105
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831
   HSINCHEN L, 1994, BIOCHIM BIOPHYS ACTA, V1226, P37
   JI LL, 1990, AM J PHYSIOL, V258, pR918, DOI 10.1152/ajpregu.1990.258.4.R918
   JI LL, 1991, AM J PHYSIOL, V261, pR386, DOI 10.1152/ajpregu.1991.261.2.R386
   LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413
   MARINGARCIA J, 1994, J MOL CELL CARDIOL, V26, P1029, DOI 10.1006/jmcc.1994.1123
   MEERSON FZ, 1972, J MOL CELL CARDIOL, V4, P571, DOI 10.1016/0022-2828(72)90113-7
   MURAKAMI T, 1994, AM J PHYSIOL, V267, pE388, DOI 10.1152/ajpendo.1994.267.3.E388
   Newsholme E.A., 1973, REGULATION METABOLIS
   OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0
   RAJAMANICKAM C, 1979, CIRC RES, V45, P505, DOI 10.1161/01.RES.45.4.505
   Rooyackers OE, 1996, P NATL ACAD SCI USA, V93, P15364, DOI 10.1073/pnas.93.26.15364
   SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A
   SCOTTO AW, 1983, ARCH BIOCHEM BIOPHYS, V222, P150, DOI 10.1016/0003-9861(83)90512-X
   SOHAL RS, 1994, MECH AGEING DEV, V76, P215, DOI 10.1016/0047-6374(94)91595-4
   STOCCO DM, 1978, J GERONTOL, V33, P802, DOI 10.1093/geronj/33.6.802
   TAKASAWA M, 1993, EXP GERONTOL, V28, P269, DOI 10.1016/0531-5565(93)90034-B
   TOMANEK RJ, 1973, J ULTRA MOL STRUCT R, V42, P201, DOI 10.1016/S0022-5320(73)90050-6
   TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0
   Welle S, 1996, AM J PHYSIOL-ENDOC M, V270, pE224, DOI 10.1152/ajpendo.1996.270.2.E224
   WILLIAMS RS, 1986, J BIOL CHEM, V261, P2390
   WILLIAMS RS, 1987, J BIOL CHEM, V262, P2764
   WILSON PD, 1975, BIOCHEM SOC T, V3, P126, DOI 10.1042/bst0030126
NR 40
TC 285
Z9 330
U1 0
U2 25
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 4
PY 2000
VL 275
IS 5
BP 3343
EP 3347
DI 10.1074/jbc.275.5.3343
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 281FD
UT WOS:000085146500045
PM 10652323
OA hybrid
DA 2024-02-19
ER

PT J
AU Muñoz, VR
   Gaspar, RC
   Mancini, MCS
   de Lima, RD
   Vieira, RFL
   Crisol, BM
   Antunes, GC
   Trombeta, JCS
   Bonfante, ILP
   Simabuco, FM
   da Silva, ASR
   Cavaglieri, CR
   Ropelle, ER
   Cintra, DE
   Pauli, JR
AF Munoz, V. R.
   Gaspar, R. C.
   Mancini, M. C. S.
   de Lima, R. D.
   Vieira, R. F. L.
   Crisol, B. M.
   Antunes, G. C.
   Trombeta, J. C. S.
   Bonfante, I. L. P.
   Simabuco, F. M.
   da Silva, A. S. R.
   Cavaglieri, C. R.
   Ropelle, E. R.
   Cintra, D. E.
   Pauli, J. R.
TI Short-term physical exercise controls age-related hyperinsulinemia and
   improves hepatic metabolism in aged rodents
SO JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
LA English
DT Article; Early Access
DE Aging; Physical exercise; Liver; Hyperinsulinemia
ID INSULIN-RESISTANCE; SECRETION; INFLAMMATION; HUMANS; DIET
AB Purpose Aging is associated with changes in glucose homeostasis related to both decreased insulin secretion and/or impaired insulin action, contributing to the high prevalence of type 2 diabetes (T2D) in the elderly population. Additionally, studies are showing that chronically high levels of circulating insulin can also lead to insulin resistance. In contrast, physical exercise has been a strategy used to improve insulin sensitivity and metabolic health. However, the molecular alterations resulting from the effects of physical exercise in the liver on age-related hyperinsulinemia conditions are not yet fully established. This study aimed to investigate the effects of 7 days of aerobic exercise on hepatic metabolism in aged hyperinsulinemic rats (i.e., Wistar and F344) and in Slc2a4(+/-) mice (hyperglycemic and hyperinsulinemic mice). Results Both aged models showed alterations in insulin and glucose tolerance, which were associated with essential changes in hepatic fat metabolism (lipogenesis, gluconeogenesis, and inflammation). In contrast, 7 days of physical exercise was efficient in improving whole-body glucose and insulin sensitivity, and hepatic metabolism. The Slc2a4(+/-) mice presented significant metabolic impairments (insulin resistance and hepatic fat accumulation) that were improved by short-term exercise training. In this scenario, high circulating insulin may be an important contributor to age-related insulin resistance and hepatic disarrangements in some specific conditions. Conclusion In conclusion, our data demonstrated that short-term aerobic exercise was able to control mechanisms related to hepatic fat accumulation and insulin sensitivity in aged rodents. These effects could contribute to late-life metabolic health and prevent the development/progression of age-related T2D.
C1 [Munoz, V. R.; Gaspar, R. C.; de Lima, R. D.; Vieira, R. F. L.; Crisol, B. M.; Antunes, G. C.; Ropelle, E. R.; Pauli, J. R.] Univ Estadual Campinas, UNICAMP, Lab Mol Biol Exercise, Limeira, SP, Brazil.
   [Mancini, M. C. S.; Simabuco, F. M.] Univ Estadual Campinas, UNICAMP, Sch Appl Sci FCA, Multidisciplinary Lab Food & Hlth LabMAS, Limeira, SP, Brazil.
   [Trombeta, J. C. S.; Bonfante, I. L. P.; Cavaglieri, C. R.] Univ Estadual Campinas, UNICAMP, Fac Phys Educ, Exercise Physiol Lab FISEX, Campinas, Brazil.
   [da Silva, A. S. R.] Univ Sao Paulo, Ribeirao Preto Med Sch, Postgrad Program Rehabil & Funct Performance, Ribeirao Preto, SP, Brazil.
   [da Silva, A. S. R.] Univ Sao Paulo, Sch Phys Educ & Sport Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [Ropelle, E. R.; Cintra, D. E.; Pauli, J. R.] Univ Estadual Campinas, UNICAMP, OCRC Obes & Comorbid Res Ctr, Campinas, SP, Brazil.
   [Ropelle, E. R.; Pauli, J. R.] Univ Estadual Campinas, UNICAMP, Natl Inst Sci & Technol Obes & Diabet, Campinas, SP, Brazil.
   [Cintra, D. E.] Univ Estadual Campinas, UNICAMP, Lab Nutr Genom, Limeira, SP, Brazil.
C3 Universidade Estadual de Campinas; Universidade Estadual de Campinas;
   Universidade Estadual de Campinas; Universidade de Sao Paulo;
   Universidade de Sao Paulo; Universidade Estadual de Campinas;
   Universidade Estadual de Campinas; Universidade Estadual de Campinas
RP Pauli, JR (corresponding author), Univ Estadual Campinas, UNICAMP, Lab Mol Biol Exercise, Limeira, SP, Brazil.; Pauli, JR (corresponding author), Univ Estadual Campinas, UNICAMP, OCRC Obes & Comorbid Res Ctr, Campinas, SP, Brazil.; Pauli, JR (corresponding author), Univ Estadual Campinas, UNICAMP, Natl Inst Sci & Technol Obes & Diabet, Campinas, SP, Brazil.
EM rodrigopaulifca@gmail.com
RI Gaspar, Rafael/N-4771-2015; Pauli, José Rdrigo/AAD-2763-2021; Cintra,
   Dennys E/N-7758-2017; Ropelle, Eduardo R/C-3977-2012; Crisol,
   Barbara/IAQ-0653-2023; Cavaglieri, Cláudia Regina/C-4291-2012; Bonfante,
   Ivan Luiz Padilha/AAN-3544-2020
OI Gaspar, Rafael/0000-0002-2208-3527; Pauli, José
   Rdrigo/0000-0002-6129-1521; Cintra, Dennys E/0000-0002-7954-5630;
   Ropelle, Eduardo R/0000-0003-1655-9557; Cavaglieri, Cláudia
   Regina/0000-0002-7795-6575; Bonfante, Ivan Luiz
   Padilha/0000-0001-6278-4611; Lima, Robson/0000-0003-2056-8384; Crisol,
   Barbara/0000-0003-2026-2844
FU FAEPEX; National Council for Scientific and Technological Development
   (CNPq) [303571/2018-7, 140285/2016-4, 442542/2014-3, 306535/2017-3];
   Coordination for the Improvement of Higher Education Personnel (CAPES)
   [001]; Sao Paulo Research Foundation (FAPESP) [2015/26000-2,
   2016/18488-8, 2018/20872-6, 2019/11820-5, 2020/13443-1, 2021/08692-5]
FX This work was supported by FAEPEX, the National Council for Scientific
   and Technological Development (CNPq; case numbers 303571/2018-7;
   140285/2016-4; 442542/2014-3 and 306535/2017-3), the Coordination for
   the Improvement of Higher Education Personnel (CAPES; finance code 001),
   and the Sao Paulo Research Foundation (FAPESP; case numbers
   2015/26000-2, 2016/18488-8, 2018/20872-6, 2019/11820-5, 2020/13443-1 and
   2021/08692-5).
CR Ardigò D, 2005, METABOLISM, V54, P1566, DOI 10.1016/j.metabol.2005.05.027
   Baboota RK, 2022, MOL METAB, V64, DOI 10.1016/j.molmet.2022.101558
   Barzilai N, 2012, J GERONTOL A-BIOL, V67, P1329, DOI 10.1093/gerona/gls145
   Batista TM, 2021, DIABETOLOGIA, V64, P994, DOI 10.1007/s00125-021-05415-5
   Braga RR, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82352-8
   Cen HH, 2022, FASEB J, V36, DOI 10.1096/fj.202100497RR
   Chang AM, 2003, AM J PHYSIOL-ENDOC M, V284, pE7, DOI 10.1152/ajpendo.00366.2002
   Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483
   Dankner R, 2012, DIABETES-METAB RES, V28, P618, DOI 10.1002/dmrr.2322
   Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006
   Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608
   Dutta S, 2016, LIFE SCI, V152, P244, DOI 10.1016/j.lfs.2015.10.025
   Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628
   FINK RI, 1985, DIABETES, V34, P275, DOI 10.2337/diabetes.34.3.275
   Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fredrickson G, 2021, MOL METAB, V53, DOI 10.1016/j.molmet.2021.101270
   Geloneze B, 2014, METABOLISM, V63, P922, DOI 10.1016/j.metabol.2014.04.004
   GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549
   Gustafson B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10688-x
   Hoene M, 2021, MOL METAB, V54, DOI 10.1016/j.molmet.2021.101359
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Janssen JAMJL, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22157797
   Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3
   Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593
   Kurauti MA, 2019, J CELL PHYSIOL, V234, P9802, DOI 10.1002/jcp.27667
   Lee Joon Hyoek, 1998, Korean Journal of Internal Medicine, V13, P10
   Li Q, 2021, NAT MED, V27, P1941, DOI 10.1038/s41591-021-01501-8
   MARANGOU AG, 1986, DIABETES, V35, P1383, DOI 10.2337/diabetes.35.12.1383
   Marmentini C, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.679492
   Maude H, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.681356
   Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019
   Mehta SR, 2012, J CLIN ENDOCR METAB, V97, P2151, DOI 10.1210/jc.2011-2430
   Meijnikman AS, 2022, DIABETES, V71, P1929, DOI 10.2337/db21-1076
   Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1
   Muñoz VR, 2018, J CELL BIOCHEM, V119, P5885, DOI 10.1002/jcb.26780
   Muñoz VR, 2018, J CELL PHYSIOL, V233, P4791, DOI 10.1002/jcp.26278
   Muñoz VR, 2020, J GERONTOL A-BIOL, V75, P432, DOI 10.1093/gerona/gly293
   Muñoz VR, 2018, J PHYSIOL SCI, V68, P493, DOI 10.1007/s12576-017-0559-3
   Ogrodnik M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15691
   Park MH, 2014, ARCH PHARM RES, V37, P1507, DOI 10.1007/s12272-014-0474-6
   Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004
   REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175
   REAVEN E, 1983, J CLIN INVEST, V71, P345, DOI 10.1172/JCI110775
   Rhee EJ, 2011, AM J MED, V124, P69, DOI 10.1016/j.amjmed.2010.08.012
   Roden M, 2019, NATURE, V576, P51, DOI 10.1038/s41586-019-1797-8
   Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002
   Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Smith HJ, 2020, DEV CELL, V54, P196, DOI 10.1016/j.devcel.2020.06.011
   Spinelli R, 2020, J ENDOCRINOL INVEST, V43, P1373, DOI 10.1007/s40618-020-01255-z
   Spinelli R, 2022, AGING CELL, V21, DOI 10.1111/acel.13557
   Thomas DD, 2019, J ENDOCR SOC, V3, P1727, DOI 10.1210/js.2019-00065
   Thyfault JP, 2020, DIABETES, V69, P517, DOI 10.2337/dbi18-0043
   Tricò D, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124912
   WARD GM, 1990, DIABETES, V39, P501, DOI 10.2337/diabetes.39.4.501
   Yang J, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020501
NR 57
TC 3
Z9 4
U1 2
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0391-4097
EI 1720-8386
J9 J ENDOCRINOL INVEST
JI J. Endocrinol. Invest.
PD 2023 APR
PY 2023
VL 46
IS 4
BP 815
EP 827
DI 10.1007/s40618-022-01947-8
EA NOV 2022
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA A3DG5
UT WOS:000877413800001
PM 36318449
DA 2024-02-19
ER

PT J
AU Wiesenthal, AA
   Legroux, TM
   Richter, C
   Junker, BH
   Hecksteden, A
   Kessler, SM
   Hoppstädter, J
   Kiemer, AK
AF Wiesenthal, Amanda M.
   Legroux, Thierry
   Richter, Chris
   Junker, Bjoern H.
   Hecksteden, Anne M.
   Kessler, Sonja
   Hoppstaedter, Jessica K.
   Kiemer, Alexandra
TI Endotoxin Tolerance Acquisition and Altered Hepatic Fatty Acid Profile
   in Aged Mice
SO BIOLOGY-BASEL
LA English
DT Article
DE LPS tolerance; hepatic fatty acids; immune response; immunosuppression;
   inflammation; fatty acid elongation; liver and lung tissue
ID INDUCED LEUCINE-ZIPPER; INFLAMMATION; ELONGATION; SIGNATURE; LIVER
AB Simple Summary Diseases that are characterized by inflammation such as sepsis, fatty liver or severe COVID-19 are more critical in the elderly population. Endotoxin tolerance is a tolerance towards pathogen components like lipopolysaccharides from bacterial cell walls. Tolerance is developed by the host to avoid strong inflammatory responses when repeatedly being in contact with these endotoxins. We hypothesized that aging is linked to a loss of this tolerance and to elevated fat content in the liver, potentially contributing to an increased risk of inflammatory diseases in the elderly. In this study, mice underwent a treatment protocol that allowed us to study the markers of tolerance in the blood and in the tissues. Based on the markers found in the blood serum and the lung tissue, the old mice showed a clear potential for endotoxin tolerance. They also showed a different fat composition in their liver compared to the young mice. Thus, we conclude that endotoxin tolerance is not necessarily affected by advanced age, but that changes in metabolic tissue homeostasis may lead to an altered immune response in old individuals. An understanding of how the immune response changes with advanced age and changed fat metabolism is important in order to understand age-related inflammatory diseases, which will help in the development of therapies for these diseases. (1) Background: Aging is linked to an altered immune response and metabolism. Inflammatory conditions, such as sepsis, COVID-19, and steatohepatitis are more prevalent in the elderly and steatosis is linked both to severe COVID-19 and sepsis. We hypothesized that aging is linked to a loss of endotoxin tolerance, which normally protects the host from excessive inflammation, and that this is accompanied by elevated levels of hepatic lipids. (2) Methods: An in vivo lipopolysaccharide (LPS) tolerance model in young and old mice was used and the cytokine serum levels were measured by ELISA. Cytokine and toll-like receptor gene expression was determined by qPCR in the lungs and the liver; hepatic fatty acid composition was assessed by GC-MS. (3) Results: The old mice showed a distinct potential for endotoxin tolerance as suggested by the serum cytokine levels and gene expression in the lung tissue. Endotoxin tolerance was less pronounced in the livers of the aged mice. However, the fatty acid composition strongly differed in the liver tissues of the young and old mice with a distinct change in the ratio of C18 to C16 fatty acids. (4) Conclusions: Endotoxin tolerance is maintained in advanced age, but changes in the metabolic tissue homeostasis may lead to an altered immune response in old individuals.
C1 [Wiesenthal, Amanda M.; Legroux, Thierry; Hoppstaedter, Jessica K.; Kiemer, Alexandra] Saarland Univ, Dept Pharm, Pharmaceut Biol, Campus C2-3, D-66123 Saarbrucken, Germany.
   [Wiesenthal, Amanda M.] Univ Rostock, Inst Biol Sci, Marine Biol, D-18059 Rostock, Germany.
   [Richter, Chris; Junker, Bjoern H.] Martin Luther Univ Halle Wittenberg, Inst Pharm, Biosynth Act Subst, D-06120 Halle, Germany.
   [Hecksteden, Anne M.] Saarland Univ, Inst Sports & Prevent Med, D-66123 Saarbrucken, Germany.
   [Kessler, Sonja] Martin Luther Univ Halle Wittenberg, Inst Pharm, Expt Pharmacol Nat Sci, D-06120 Halle, Germany.
C3 Saarland University; University of Rostock; Martin Luther University
   Halle Wittenberg; Saarland University; Martin Luther University Halle
   Wittenberg
RP Kiemer, AK (corresponding author), Saarland Univ, Dept Pharm, Pharmaceut Biol, Campus C2-3, D-66123 Saarbrucken, Germany.
EM pharm.bio.kiemer@mx.uni-saarland.de
RI ; Kiemer, Alexandra K./I-9300-2012
OI Hecksteden, Anne/0000-0003-3390-9619; Legroux, Thierry
   Maxime/0009-0009-0859-7773; Wiesenthal, Amanda
   Alice/0000-0002-4374-9607; Kiemer, Alexandra K./0000-0002-7224-9900
CR Avendaño-Ortiz J, 2021, J IMMUNOL, V207, P162, DOI 10.4049/jimmunol.2001449
   Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009
   Chung HY, 2019, AGING DIS, V10, P367, DOI 10.14336/AD.2018.0324
   Dembek A, 2017, IMMUNOBIOLOGY, V222, P786, DOI 10.1016/j.imbio.2017.01.003
   Draisma A, 2009, INNATE IMMUN-LONDON, V15, P360, DOI 10.1177/1753425909105548
   Draisma A, 2009, CRIT CARE MED, V37, P1261, DOI 10.1097/CCM.0b013e31819c3c67
   DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041
   Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997
   Frith J, 2009, GERONTOLOGY, V55, P607, DOI 10.1159/000235677
   Ghoneim Sara, 2020, Metabol Open, V8, P100057, DOI 10.1016/j.metop.2020.100057
   Glynn JR, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00668-y
   HOLM S, 1979, SCAND J STAT, V6, P65
   Hoppstädter J, 2020, FASEB J, V34, P4684, DOI 10.1096/fj.201902557RRR
   Hoppstädter J, 2015, ONCOTARGET, V6, P38446, DOI 10.18632/oncotarget.6197
   Hoppstädter J, 2015, J IMMUNOL, V194, P6057, DOI 10.4049/jimmunol.1403207
   Hou JC, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI135197
   Huh Y, 2013, ANTIMICROB AGENTS CH, V57, P6171, DOI 10.1128/AAC.01497-13
   Janssens JP, 2005, CURR OPIN PULM MED, V11, P226
   Kessler SM, 2014, INT J MOL SCI, V15, P5762, DOI 10.3390/ijms15045762
   Kessoku T, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.770986
   Kiemer AK, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103086
   Kinoshita M, 2017, J INNATE IMMUN, V9, P493, DOI 10.1159/000475931
   Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1
   Kohman RA, 2010, BRAIN BEHAV IMMUN, V24, P486, DOI 10.1016/j.bbi.2009.12.004
   Kröhler T, 2019, CANCERS, V11, DOI 10.3390/cancers11111754
   Kruglikov IL, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009306
   Laggai S, 2014, J LIPID RES, V55, P1087, DOI 10.1194/jlr.M045500
   Lehrskov LL, 2019, SEMIN IMMUNOPATHOL, V41, P491, DOI 10.1007/s00281-019-00747-2
   Li L, 2015, CELL DEATH DIFFER, V22, P1081, DOI 10.1038/cdd.2014.212
   Liberale L, 2020, EUR HEART J, V41, P2974, DOI 10.1093/eurheartj/ehz961
   Liu D, 2019, J CELL BIOCHEM, V120, P56, DOI 10.1002/jcb.27547
   Mahamid M, 2021, EUR J GASTROEN HEPAT, V33, P1578, DOI 10.1097/MEG.0000000000001902
   MARTIN CE, 1981, BIOCHIM BIOPHYS ACTA, V665, P399, DOI 10.1016/0005-2760(81)90252-6
   Martin TR, 2020, EBIOMEDICINE, V57, DOI 10.1016/j.ebiom.2020.102836
   Matsuzaka T, 2021, DIABETOL INT, V12, P68, DOI 10.1007/s13340-020-00481-3
   Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932
   Medeiros AK, 2020, ABDOM RADIOL, V45, P2748, DOI 10.1007/s00261-020-02648-7
   Minciullo PL, 2016, ARCH IMMUNOL THER EX, V64, P111, DOI 10.1007/s00005-015-0377-3
   Natarajan S, 2010, SHOCK, V33, P162, DOI 10.1097/SHK.0b013e3181aa9690
   Neves J, 2020, FEBS J, V287, P43, DOI 10.1111/febs.15061
   Nier A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030699
   Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18
   Pararasa C, 2016, AGING CELL, V15, P128, DOI 10.1111/acel.12416
   Pena OM, 2014, EBIOMEDICINE, V1, P64, DOI 10.1016/j.ebiom.2014.10.003
   Prasad S, 2012, PREV MED, V54, pS29, DOI 10.1016/j.ypmed.2011.11.011
   Puri P, 2009, HEPATOLOGY, V50, P1827, DOI 10.1002/hep.23229
   Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467
   Remy KE, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140329
   Roca-Fernández A, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.636637
   Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae
   Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039224
   Szabo PA, 2021, IMMUNITY, V54, P797, DOI 10.1016/j.immuni.2021.03.005
   Perez JVV, 2020, AGING CELL, V19, DOI 10.1111/acel.13156
   van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687
   Venet F, 2021, ANN NY ACAD SCI, V1499, P3, DOI 10.1111/nyas.14333
   Vergadi E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02705
   Wang LQ, 2020, LIPIDS HEALTH DIS, V19, DOI 10.1186/s12944-020-01346-z
   WOOD CB, 1985, EUR J SURG ONCOL, V11, P347
   Yamada K, 2015, LIVER INT, V35, P582, DOI 10.1111/liv.12685
   Zhang ZJ, 2018, MOL MED REP, V17, P3845, DOI 10.3892/mmr.2018.8370
NR 60
TC 1
Z9 1
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD APR
PY 2023
VL 12
IS 4
AR 530
DI 10.3390/biology12040530
PG 12
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA E6EF3
UT WOS:000976445300001
PM 37106731
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU Mancinelli, R
   Ceci, L
   Kennedy, L
   Francis, H
   Meadows, V
   Chen, LX
   Carpino, G
   Kyritsi, K
   Wu, N
   Zhou, TH
   Sato, K
   Pannarale, L
   Glaser, S
   Chakraborty, S
   Alpini, G
   Gaudio, E
   Onori, P
   Franchitto, A
AF Mancinelli, Romina
   Ceci, Ludovica
   Kennedy, Lindsey
   Francis, Heather
   Meadows, Vik
   Chen, Lixian
   Carpino, Guido
   Kyritsi, Konstantina
   Wu, Nan
   Zhou, Tianhao
   Sato, Keisaku
   Pannarale, Luigi
   Glaser, Shannon
   Chakraborty, Sanjukta
   Alpini, Gianfranco
   Gaudio, Eugenio
   Onori, Paolo
   Franchitto, Antonio
TI The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are
   Mediated by Calcitonin-Gene-Related Peptide Signaling
SO CELLS
LA English
DT Article
DE bile acid; cAMP; biliary senescence; sensory innervation
ID REDUCES CHOLANGIOCYTE PROLIFERATION; BILE-ACIDS; CELLS; KNOCKOUT;
   GROWTH; RATS; SECRETION; HEPATITIS; CIRRHOSIS; VEGF
AB Background & aims: Cholangiocytes are the target cells of liver diseases that are characterized by biliary senescence (evidenced by enhanced levels of senescence-associated secretory phenotype, SASP, e.g., TGF-beta 1), and liver inflammation and fibrosis accompanied by altered bile acid (BA) homeostasis. Taurocholic acid (TC) stimulates biliary hyperplasia by activation of 3 ',5 '-cyclic cyclic adenosine monophosphate (cAMP) signaling, thereby preventing biliary damage (caused by cholinergic/adrenergic denervation) through enhanced liver angiogenesis. Also: (i) alpha-calcitonin gene-related peptide (alpha-CGRP, which activates the calcitonin receptor-like receptor, CRLR), stimulates biliary proliferation/senescence and liver fibrosis by enhanced biliary secretion of SASPs; and (ii) knock-out of alpha-CGRP reduces these phenotypes by decreased cAMP levels in cholestatic models. We aimed to demonstrate that TC effects on liver phenotypes are dependent on changes in the alpha-CGRP/CALCRL/cAMP/PKA/ERK1/2/TGF-beta 1/VEGF axis. Methods: Wild-type and alpha-CGRP(-/-) mice were fed with a control (BAC) or TC diet for 1 or 2 wk. We measured: (i) CGRP levels by both ELISA kits in serum and by qPCR in isolated cholangiocytes (CALCA gene for alpha-CGRP); (ii) CALCRL immunoreactivity by immunohistochemistry (IHC) in liver sections; (iii) liver histology, intrahepatic biliary mass, biliary senescence (by beta-GAL staining and double immunofluorescence (IF) for p16/CK19), and liver fibrosis (by Red Sirius staining and double IF for collagen/CK19 in liver sections), as well as by qPCR for senescence markers in isolated cholangiocytes; and (iv) phosphorylation of PKA/ERK1/2, immunoreactivity of TGF-beta 1/TGF- beta RI and angiogenic factors by IHC/immunofluorescence in liver sections and qPCR in isolated cholangiocytes. We measured changes in BA composition in total liver by liquid chromatography/mass spectrometry. Results: TC feeding increased CALCA expression, biliary damage, and liver inflammation and fibrosis, as well as phenotypes that were associated with enhanced immunoreactivity of the PKA/ERK1/2/TGF-beta 1/TGF-beta RI/VEGF axis compared to BAC-fed mice and phenotypes that were reversed in alpha-CGRP(-/-) mice fed TC coupled with changes in hepatic BA composition. Conclusion: Modulation of the TC/ alpha-CGRP/CALCRL/PKA/ERK1/2/TGF-beta 1/VEGF axis may be important in the management of cholangiopathies characterized by BA accumulation.
C1 [Mancinelli, Romina; Pannarale, Luigi; Gaudio, Eugenio; Onori, Paolo; Franchitto, Antonio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, I-00161 Rome, Italy.
   [Ceci, Ludovica; Kennedy, Lindsey; Francis, Heather; Meadows, Vik; Chen, Lixian; Kyritsi, Konstantina; Wu, Nan; Zhou, Tianhao; Sato, Keisaku; Alpini, Gianfranco] Indiana Univ Sch Med, Dept Med, Div Gastroenterol & Hepatol, Indianapolis, IN 46202 USA.
   [Kennedy, Lindsey; Francis, Heather; Alpini, Gianfranco] Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA.
   [Carpino, Guido] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, I-00135 Rome, Italy.
   [Glaser, Shannon; Chakraborty, Sanjukta] Texas A&M Univ, Dept Med Physiol, Bryan, TX 77807 USA.
C3 Sapienza University Rome; Indiana University System; Indiana University
   Bloomington; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Richard L. Roudebush VA Medical Center; Foro
   Italico University of Rome; Texas A&M University System; Texas A&M
   University College Station
RP Franchitto, A (corresponding author), Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, I-00161 Rome, Italy.
EM romina.mancinelli@uniroma1.it; lceci@iu.edu; linkenn@iu.edu;
   heafranc@iu.edu; vikmead@iu.edu; chenlix@iu.edu;
   guido.carpino@uniroma4.it; kkyritsi@iu.edu; nawu@iu.edu; zhouv@iu.edu;
   keisato@iu.edu; luigi.pannarale@uniroma1.it; sglaser@tamu.edu;
   schakraborty@tamu.edu; galpini@iu.du; eugenio.gaudio@uniroma1.it;
   paolo.onori@uniroma1.it; antonio.franchitto@uniroma1.it
RI Carpino, Guido/AAB-9692-2019; Mancinelli, Romina/Y-4540-2018
OI CARPINO, Guido/0000-0001-8570-2519; Chakraborty,
   Sanjukta/0000-0002-4869-3198; Mancinelli, Romina/0000-0003-2040-0581
FU Hickam Endowed Chair, Gastroenterology, Medicine, Indiana University;
   Indiana University Health-Indiana University School of Medicine
   Strategic Research Initiative; United States Department of Veteran's
   Affairs, Biomedical Laboratory Research and Development Service
   [1I01BX003031, 1IK2BX005306, 5I01BX000574]; NIH [DK108959, DK119421,
   DK054811, DK115184, DK076898, DK107310, DK110035, DK062975, AA028711];
   CPRIT [RP210213]; PSC Partners Seeking a Cure; Sapienza University
   [RM12117A7AF3C286, RM12117A76FD45EB]; University of Rome "La Sapienza";
   Central Texas Veterans Health Care System, Temple, TX, USA; Richard L.
   Roudebush VA Medical Center, Indianapolis, IN, USA; Medical Physiology,
   Medical Research Building, Temple, TX
FX This work was supported by the Hickam Endowed Chair, Gastroenterology,
   Medicine, Indiana University; the Indiana University Health-Indiana
   University School of Medicine Strategic Research Initiative; the SRCS
   and VA Merit award to GA (5I01BX000574); the RCS and VA Merit award to
   HF (1I01BX003031) and VA CDA-2 Award to LK (1IK2BX005306) from the
   United States Department of Veteran's Affairs, Biomedical Laboratory
   Research and Development Service and NIH grants DK108959 and DK119421
   (HF), DK054811, DK115184, DK076898, DK107310, DK110035, DK062975 and
   AA028711 (GA and SG), CPRIT RP210213 to SC and the PSC Partners Seeking
   a Cure (GA) and by Sapienza University funds #RM12117A7AF3C286 and
   #RM12117A76FD45EB and the Development Service by University of Rome "La
   Sapienza" to PO. This material is the result of work supported by
   resources at the Central Texas Veterans Health Care System, Temple, TX,
   USA, Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA, and
   Medical Physiology, Medical Research Building, Temple, TX. The views
   expressed in this article are those of the authors and do not
   necessarily represent the views of the Department of Veterans Affairs.
CR Abenavoli L, 2020, DISEASES-BASEL, V8, DOI 10.3390/diseases8020020
   Alpini G, 1997, AM J PHYSIOL-GASTR L, V273, pG518, DOI 10.1152/ajpgi.1997.273.2.G518
   Alpini G, 2002, GASTROENTEROLOGY, V123, P1226, DOI 10.1053/gast.2002.36055
   ALPINI G, 1988, J CLIN INVEST, V81, P569, DOI 10.1172/JCI113355
   Alpini G, 1999, GASTROENTEROLOGY, V116, P179, DOI 10.1016/S0016-5085(99)70242-8
   Alpini GP, 2001, HEPATOLOGY, V34, P868, DOI 10.1053/jhep.2001.28884
   Basilio-de-Oliveira RP, 2015, WORLD J GASTROENTERO, V21, P6924, DOI 10.3748/wjg.v21.i22.6924
   Bijvelds MJC, 2005, AM J PHYSIOL-GASTR L, V289, pG870, DOI 10.1152/ajpgi.00226.2005
   Chen LX, 2021, HEPATOLOGY, V74, P1845, DOI 10.1002/hep.31871
   Cho JG, 2015, STEM CELLS, V33, P792, DOI 10.1002/stem.1901
   Conner AC, 2006, J BIOL CHEM, V281, P1644, DOI 10.1074/jbc.M510064200
   DiPette J.D., 2012, PRIMER AUTONOMIC NER, V3rd, P127
   Etherington RE, 2019, FASEB BIOADV, V1, P332, DOI 10.1096/fba.2018-00046
   Francis H, 2004, J HEPATOL, V41, P528, DOI 10.1016/j.jhep.2004.06.009
   Francis H, 2007, LAB INVEST, V87, P473, DOI 10.1038/labinvest.3700533
   García-Cañaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803
   Gaudio E., 2005, Italian Journal of Anatomy and Embryology, V110, P71
   Gaudio E, 2006, GASTROENTEROLOGY, V130, P1270, DOI 10.1053/j.gastro.2005.12.034
   Gaudio E, 1996, GASTROENTEROLOGY, V111, P1118, DOI 10.1016/S0016-5085(96)70081-1
   GILTAY JC, 1989, BLOOD, V73, P1235
   Glaser S, 2014, GASTROENTEROLOGY, V146, P1795, DOI 10.1053/j.gastro.2014.02.030
   Glaser S, 2011, AM J PHYSIOL-GASTR L, V301, pG297, DOI 10.1152/ajpgi.00418.2010
   Glaser S, 2010, DIGEST LIVER DIS, V42, P709, DOI 10.1016/j.dld.2010.02.008
   Glaser SS, 2007, LAB INVEST, V87, P914, DOI 10.1038/labinvest.3700602
   Guicciardi ME, 2020, HEPATOLOGY, V71, P741, DOI 10.1002/hep.31067
   ISHII M, 1989, GASTROENTEROLOGY, V97, P1236, DOI 10.1016/0016-5085(89)91695-8
   Kakiyama G, 2014, J LIPID RES, V55, P978, DOI 10.1194/jlr.D047506
   Kanno N, 2001, AM J PHYSIOL-GASTR L, V281, pG612, DOI 10.1152/ajpgi.2001.281.3.G612
   Kennedy L, 2019, FASEB J, V33, P10269, DOI 10.1096/fj.201802606R
   Laschinger M, 2020, FASEB J, V34, P8125, DOI 10.1096/fj.201903200R
   Li WQ, 2019, EUR J PHARMACOL, V843, P96, DOI 10.1016/j.ejphar.2018.10.023
   Li XJY, 2017, HEPATOLOGY, V66, P869, DOI 10.1002/hep.29145
   Lleo A, 2020, LANCET, V396, P1915, DOI 10.1016/S0140-6736(20)31607-X
   Mancinelli R, 2009, EXP BIOL MED, V234, P462, DOI 10.3181/0808-RM-255
   Meng FY, 2018, LAB INVEST, V98, P1465, DOI 10.1038/s41374-018-0101-0
   Mishima T, 2011, AM J PHYSIOL-HEART C, V300, pH431, DOI 10.1152/ajpheart.00466.2010
   Permpoonputtana K, 2016, LIFE SCI, V144, P19, DOI 10.1016/j.lfs.2015.11.015
   Nguyen PT, 2020, J CANCER RES CLIN, V146, P3255, DOI 10.1007/s00432-020-03374-9
   POYNER DR, 1992, PHARMACOL THERAPEUT, V56, P23, DOI 10.1016/0163-7258(92)90036-Y
   ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0
   Sasaki M, 2017, DIGEST DIS, V35, P210, DOI 10.1159/000450913
   Sato K, 2019, HEPATOLOGY, V69, P420, DOI 10.1002/hep.30150
   Sugata K, 1996, J GASTROEN HEPATOL, V11, P451, DOI 10.1111/j.1440-1746.1996.tb00290.x
   Thakare R, 2018, J APPL TOXICOL, V38, P1323, DOI 10.1002/jat.3644
   Tiegs G, 1999, J NEUROIMMUNOL, V96, P131, DOI 10.1016/S0165-5728(99)00014-4
   Ueno Y, 2007, EXP BIOL MED, V232, P942
   VANMOURIK JA, 1985, J BIOL CHEM, V260, P1300
   Wan Y, 2019, LAB INVEST, V99, P764, DOI 10.1038/s41374-018-0178-5
   Wang XN, 2016, J PROTEOME RES, V15, P1126, DOI 10.1021/acs.jproteome.5b00217
   Ye HL, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117175
   Yin PY, 2009, MOL BIOSYST, V5, P868, DOI 10.1039/b820224a
   Yoon SP, 2018, CELL BIOL TOXICOL, V34, P251, DOI 10.1007/s10565-017-9399-4
   Zhang LP, 2001, PAIN, V89, P265, DOI 10.1016/S0304-3959(00)00378-X
   Zheng SA, 2010, AM J PHYSIOL-CELL PH, V299, pC1485, DOI 10.1152/ajpcell.00173.2010
   Zhou TH, 2018, LAB INVEST, V98, P1449, DOI 10.1038/s41374-018-0093-9
NR 55
TC 4
Z9 4
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAY
PY 2022
VL 11
IS 9
AR 1591
DI 10.3390/cells11091591
PG 21
WC Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology
GA 1E8XP
UT WOS:000794764400001
PM 35563897
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU SPENCER, RP
   NEGRIN, JA
   ANTAR, MA
   LEVINE, GM
   CROTTY, JM
AF SPENCER, RP
   NEGRIN, JA
   ANTAR, MA
   LEVINE, GM
   CROTTY, JM
TI NUCLEAR-MEDICINE STUDIES OF AGING .10. RELATIONSHIP OF LIVER AND SPLEEN
   LENGTHS AT AGE 65 YEARS AND OLDER
SO NUCLEAR MEDICINE AND BIOLOGY
LA English
DT Article
C1 VET ADM MED CTR, NEWINGTON, CT 06111 USA.
   UNCAS ON THAMES HOSP, NORWICH, CT 06360 USA.
C3 US Department of Veterans Affairs; Veterans Health Administration (VHA);
   VA Connecticut Healthcare System
RP SPENCER, RP (corresponding author), UNIV CONNECTICUT, CTR HLTH, DEPT NUCL MED, FARMINGTON, CT 06032 USA.
CR INOUE T, 1987, ACTA PATHOL JAPON, V37, P343
   LAND FH, 1970, RADIOLOGY, V97, P589
   MARCHESINI G, 1988, HEPATOLOGY, V8, P1079, DOI 10.1002/hep.1840080516
   WOODHOUSE KW, 1988, CLIN PHARMACOKINET, V15, P287, DOI 10.2165/00003088-198815050-00002
   WYNNE HA, 1989, HEPATOLOGY, V9, P297, DOI 10.1002/hep.1840090222
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0969-8051
EI 1872-9614
J9 NUCL MED BIOL
JI Nucl. Med. Biol.
PY 1990
VL 17
IS 3
BP 295
EP 296
PG 2
WC Radiology, Nuclear Medicine & Medical Imaging
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Radiology, Nuclear Medicine & Medical Imaging
GA CY736
UT WOS:A1990CY73600007
DA 2024-02-19
ER

PT J
AU Bai, X
   Wang, S
   Tomiyama-Miyaji, C
   Shen, J
   Taniguchi, T
   Izumi, N
   Li, C
   Bakir, HY
   Nagura, T
   Takahashi, S
   Kawamura, T
   Iiai, T
   Okamoto, H
   Hatakeyama, K
   Abo, T
AF Bai, X
   Wang, S
   Tomiyama-Miyaji, C
   Shen, J
   Taniguchi, T
   Izumi, N
   Li, C
   Bakir, HY
   Nagura, T
   Takahashi, S
   Kawamura, T
   Iiai, T
   Okamoto, H
   Hatakeyama, K
   Abo, T
TI Transient appearance of hepatic natural killer cells with high
   cytotoxicity and unique phenotype in very young mice
SO SCANDINAVIAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID LARGE GRANULAR LYMPHOCYTES; EXTRATHYMIC T-CELLS; LIVER; ACTIVATION
AB There were few natural killer (NK) cells in the liver in very young mice at the age of 1-2 weeks. This was because the cell yield from the liver of young mice was low. The percentage of NK cells in the liver of young mice, however, was almost comparable with that in the liver of adult mice. Lymphocytes were isolated from the liver and spleen of C57BL/6 (B6) mice, and NK cytotoxicity and phenotype were herein examined in this study. NK cytotoxicity was extremely high in the liver of very young mice. This phenomenon was seen in the liver of various normal mouse strains. In contrast, the appearance of high cytotoxicity was not seen in NK cells of the spleen, irrespective Of Mouse strains. The quality of NK cells in the liver of young mice was different from that in adult mice. NK cells in the liver of young mice were mainly CD69(+)Mac-1(-) Fas ligand(+), whereas those in the liver of adult mice were CD69(-)Mac-1(+) Fas ligand(-). These results revealed that the quality of hepatic NK cells changes in the process of ageing. Namely, liver NK cells in very young mice temporarily show the highest NK cytotoxicity and a unique activated phenotype. Physiological meaning of the present phenomenon was discussed.
C1 Niigata Univ, Sch Med, Dept Immunol, Niigata 9518510, Japan.
   Niigata Univ, Sch Med, Dept Surg 1, Niigata 9518510, Japan.
   Niigata Univ, Fac Med, Sch Hlth Sci, Niigata, Japan.
C3 Niigata University; Niigata University; Niigata University
RP Abo, T (corresponding author), Niigata Univ, Sch Med, Dept Immunol, Niigata 9518510, Japan.
EM immunol2@med.niigata-u.ac.jp
CR Abo T, 1995, NAT IMMUN, V14, P173
   Abo T, 2000, IMMUNOL REV, V174, P135, DOI 10.1034/j.1600-0528.2002.017415.x
   ABO T, 1986, J IMMUNOL, V136, P3189
   HERBERMAN RB, 1975, INT J CANCER, V16, P216, DOI 10.1002/ijc.2910160204
   ITOH H, 1988, J IMMUNOL, V141, P315
   ITOH K, 1982, J IMMUNOL, V129, P395
   KANEDA K, 1984, HEPATOLOGY, V4, P955, DOI 10.1002/hep.1840040529
   KANEDA K, 1983, BIOMED RES-TOKYO, V4, P567, DOI 10.2220/biomedres.4.567
   Kawamura T, 1997, HEPATOLOGY, V26, P1567
   Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796
   Minagawa M, 2000, HEPATOLOGY, V31, P907, DOI 10.1053/he.2000.5850
   Tsukahara A, 1997, HEPATOLOGY, V26, P301, DOI 10.1002/hep.510260208
   Watanabe H, 1996, J EXP MED, V184, P687, DOI 10.1084/jem.184.2.687
   WATANABE H, 1995, J IMMUNOL, V155, P2972
   WERFEL T, 1991, J IMMUNOL, V147, P2423
   WILTROUT RH, 1984, J EXP MED, V160, P1431, DOI 10.1084/jem.160.5.1431
   ZIEGLER SF, 1994, J IMMUNOL, V152, P1228
NR 17
TC 11
Z9 13
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0300-9475
EI 1365-3083
J9 SCAND J IMMUNOL
JI Scand. J. Immunol.
PD APR
PY 2006
VL 63
IS 4
BP 275
EP 281
DI 10.1111/j.1365-3083.2006.01738.x
PG 7
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 038EP
UT WOS:000237201900004
PM 16623927
OA Bronze
DA 2024-02-19
ER

PT J
AU Wiemann, SU
   Satyanarayana, A
   Buer, J
   Kamino, K
   Manns, MP
   Rudolph, KL
AF Wiemann, SU
   Satyanarayana, A
   Buer, J
   Kamino, K
   Manns, MP
   Rudolph, KL
TI Contrasting effects of telomere shortening on organ homeostasis, tumor
   suppression, and survival during chronic liver damage
SO ONCOGENE
LA English
DT Article
DE telomere shortening; tumor suppression; regeneration; aging; chronic
   disease
ID HEPATOCYTE PROLIFERATIVE ACTIVITY; DYSFUNCTION; MICE; CARCINOMA;
   REGENERATION; CIRRHOSIS; CANCER
AB Telomere shortening limits the regenerative capacity of cells during aging and chronic disease but at the same time inhibits tumor progression, and it has yet to be determined which of these mechanisms is dominantly affecting organismal survival. Here we show that telomere shortening in telomerase knockout (mTERC(-/-)) mice in combination with chronic liver damage significantly reduced organismal survival even though telomere shortening strongly inhibited liver tumor formation. Decreased survival induced by telomere shortening correlated with an imbalance between liver cell proliferation and liver cell apoptosis. Specific changes in gene expression were associated with telomere shortening and chronic liver damage and these gene expression changes were partially reversed by adenovirus mediated telomerase gene delivery. This study gives experimental evidence that the negative impact of telomere shortening on organ homeostasis and organismal survival can surpass the beneficial effects of telomere shortening on suppression of tumor growth in the setting of chronic organ damage.
C1 Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany.
   Hannover Med Sch, Inst Med Microbiol, D-3000 Hannover, Germany.
   Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany.
C3 Hannover Medical School; Hannover Medical School; Hannover Medical
   School
RP Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-3000 Hannover, Germany.
EM rudolph.lenhard@mh-hannover.de
OI Rudolph, Karl Lenhard/0000-0002-4839-2862; Buer, Jan/0000-0002-7602-1698
CR Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311
   ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114
   Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592
   Blasco MA, 1998, CIBA F SYMP, V211, P160
   BRISCIOLI V, 1995, AM J MED GENET, V58, P21, DOI 10.1002/ajmg.1320580106
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8
   CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909
   Delhaye M, 1996, HEPATOLOGY, V23, P1003, DOI 10.1002/hep.510230510
   Delhaye M, 1999, J HEPATOL, V30, P461, DOI 10.1016/S0168-8278(99)80106-8
   Djojosubroto MW, 2003, MOL CELLS, V15, P164
   Edwards JE, 1942, J NATL CANCER I, V3, P19
   ESCHENBRENNER AB, 1946, J NATL CANCER I, V6, P325
   Farazi PA, 2003, CANCER RES, V63, P5021
   González-Suárez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089
   Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Ly DH, 2000, SCIENCE, V287, P2486, DOI 10.1126/science.287.5462.2486
   Minamishima YA, 2002, CANCER RES, V62, P995
   Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271
   Plentz RR, 2003, GUT, V52, P1304, DOI 10.1136/gut.52.9.1304
   Ramírez R, 2003, J BIOL CHEM, V278, P836, DOI 10.1074/jbc.M206818200
   Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871
   Satyanarayana A, 2004, HEPATOLOGY, V40, P276, DOI 10.1002/hep.20308
   Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367
   Stewart SA, 2000, SEMIN CANCER BIOL, V10, P399, DOI 10.1006/scbi.2000.0339
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232
   Wright WE, 1996, DEV GENET, V18, P173
NR 33
TC 17
Z9 20
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
EI 1476-5594
J9 ONCOGENE
JI Oncogene
PD FEB 24
PY 2005
VL 24
IS 9
BP 1501
EP 1509
DI 10.1038/sj.onc.1208308
PG 9
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 900ME
UT WOS:000227218200003
PM 15608677
DA 2024-02-19
ER

PT J
AU DONDA, A
   LEMARCHANDBERAUD, T
AF DONDA, A
   LEMARCHANDBERAUD, T
TI AGING ALTERS THE ACTIVITY OF 5'-DEIODINASE IN THE ADENOHYPOPHYSIS,
   THYROID-GLAND, AND LIVER OF THE MALE-RAT
SO ENDOCRINOLOGY
LA English
DT Article
C1 CHU VAUDOIS,DEPT INTERNAL MED,DIV ENDOCRINOL & CLIN BIOCHEM,CH-1011 LAUSANNE,SWITZERLAND.
C3 University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   CHEN HJ, 1984, EXP GERONTOL, V19, P1, DOI 10.1016/0531-5565(84)90025-1
   CHERON RG, 1980, ENDOCRINOLOGY, V106, P1405, DOI 10.1210/endo-106-5-1405
   CRANTZ FR, 1982, ENDOCRINOLOGY, V110, P367, DOI 10.1210/endo-110-2-367
   DONDA A, 1987, MOL CELL ENDOCRINOL, V54, P29, DOI 10.1016/0303-7207(87)90136-5
   DONDA A, IN PRESS NEUROENDOCR
   ELZAHERI MM, 1980, ENDOCRINOLOGY, V106, P1735, DOI 10.1210/endo-106-6-1735
   ERICKSON VJ, 1981, ENDOCRINOLOGY, V108, P1257, DOI 10.1210/endo-108-4-1257
   FROLKIS VV, 1973, EXP GERONTOL, V8, P285, DOI 10.1016/0531-5565(73)90041-7
   GAMBERT SR, 1981, ENDOCRINOLOGY, V108, P27, DOI 10.1210/endo-108-1-27
   GAVIN LA, 1983, METABOLISM, V32, P543, DOI 10.1016/0026-0495(83)90023-9
   GAVIN LA, 1987, ENDOCRINOLOGY, V121, P858, DOI 10.1210/endo-121-3-858
   HUANG HH, 1980, EXP AGING RES, V6, P3, DOI 10.1080/03610738008258342
   KAISER CA, 1986, ENDOCRINOLOGY, V119, P762, DOI 10.1210/endo-119-2-762
   KAPLAN MM, 1984, NEUROENDOCRINOLOGY, V38, P254, DOI 10.1159/000123900
   KLUG TL, 1979, ENDOCRINOLOGY, V104, P1136, DOI 10.1210/endo-104-4-1136
   LARSEN PR, 1981, ENDOCR REV, V2, P87, DOI 10.1210/edrv-2-1-87
   LARSEN PR, 1979, J CLIN INVEST, V64, P117, DOI 10.1172/JCI109430
   LAURBERG P, 1982, ENDOCRINOLOGY, V110, P2124, DOI 10.1210/endo-110-6-2124
   LEONARD JL, 1980, ENDOCRINOLOGY, V107, P1376, DOI 10.1210/endo-107-5-1376
   MARGARITY M, 1985, MECH AGEING DEV, V29, P181, DOI 10.1016/0047-6374(85)90017-X
   MCCANN UD, 1984, ENDOCRINOLOGY, V114, P1513, DOI 10.1210/endo-114-5-1513
   NAITO K, 1981, ENDOCRINOL JAPON, V28, P793
   OBREGON MJ, 1980, ENDOCRINOLOGY, V106, P1827, DOI 10.1210/endo-106-6-1827
   OBREGON MJ, 1979, ENDOCRINOLOGY, V104, P1467, DOI 10.1210/endo-104-5-1467
   PEKARY AE, 1987, J GERONTOL, V42, P447, DOI 10.1093/geronj/42.4.447
   SCHWARTZ HL, 1979, ENDOCRINOLOGY, V105, P41, DOI 10.1210/endo-105-1-41
   SILVA JE, 1986, AM J PHYSIOL, V251, pE639, DOI 10.1152/ajpendo.1986.251.6.E639
   SILVA JE, 1985, ENDOCRINOLOGY, V116, P1627, DOI 10.1210/endo-116-4-1627
   SILVA JE, 1978, ENDOCRINOLOGY, V103, P1196, DOI 10.1210/endo-103-4-1196
   STGERMAIN DL, 1985, ENDOCRINOLOGY, V117, P55
   TANAKA K, 1987, NEUROENDOCRINOLOGY, V46, P494, DOI 10.1159/000124871
   TANAKA K, 1987, ENDOCRINOLOGY, V121, P74, DOI 10.1210/endo-121-1-74
   VALUEVA GV, 1977, EXP GERONTOL, V12, P97, DOI 10.1016/0531-5565(77)90016-X
   VANDOORN J, 1982, ACTA ENDOCRINOL-COP, V101, P386, DOI 10.1530/acta.0.1010386
   VANDOORN J, 1983, J CLIN INVEST, V72, P1778, DOI 10.1172/JCI111138
   VISSER TJ, 1983, J CLIN INVEST, V71, P992, DOI 10.1172/JCI110854
   [No title captured]
NR 38
TC 53
Z9 58
U1 0
U2 0
PU ENDOCRINE SOC
PI BETHESDA
PA 4350 EAST WEST HIGHWAY SUITE 500, BETHESDA, MD 20814-4110
SN 0013-7227
J9 ENDOCRINOLOGY
JI Endocrinology
PD MAR
PY 1989
VL 124
IS 3
BP 1305
EP 1309
DI 10.1210/endo-124-3-1305
PG 5
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA T5204
UT WOS:A1989T520400030
PM 2917513
DA 2024-02-19
ER

PT J
AU Luchese, C
   Barth, A
   da Costa, GP
   Alves, D
   Novo, DL
   Mesko, MF
   Wilhelm, EA
AF Luchese, Cristiane
   Barth, Anelise
   da Costa, Gabriel Pereira
   Alves, Diego
   Novo, Diogo La Rosa
   Mesko, Marcia Foster
   Wilhelm, Ethel Antunes
TI Role of 7-chloro-4-(phenylselanyl) quinoline as an anti-aging drug
   fighting oxidative damage in different tissues of aged rats
SO EXPERIMENTAL GERONTOLOGY
LA English
DT Article
DE Aging; Quinoline; Selenium; Oxidative stress; Antioxidant
ID FREE-RADICAL THEORY; COGNITIVE DEFICIT; STRESS; ACID; SELENIUM; OXYGEN;
   4-PHENYLSELENYL-7-CHLOROQUINOLINE; ORGANOSELENIUM; DEHYDRATASE
AB This study investigated whether subacute treatment with 7-chloro-4-(phenylselanyl) quinoline (4-PSQ) presented antioxidant action in oxidative stress associated with aging in different rat tissues. We also investigated whether plasma selenium levels were altered by aging, as well as the contribution of 4-PSQ administration to these levels. Aged Wistar male rats (23 month old) were intragastrically treated with 4-PSQ (5 mg/kg) for seven days. On the 14th day of the experimental protocol, plasma was collected to determine selenium levels and biochemical markers of renal and hepatic damage. Furthermore, liver, kidney, spleen and cerebral cortex were removed to determine thiobarbituric acid reactive species (TBARS), non-protein thiols (NPSH), glutathione S-transferase (GST), catalase (CAT) and delta-aminolevulinate dehydratase (ALA-D). Our results showed that one or more parameters changed markedly in the liver, kidney, spleen and cerebral cortex of aged rats. Moreover, biochemical markers of renal and hepatic damage and selenium levels are changed in the plasma of aged rats. Treatment with 4-PSQ repaired redox homeostasis in tissues of aged rats, as well as plasma biochemical markers of renal and hepatic damage and selenium levels. In conclusion, 4-PSQ presented an antioxidant effect in tissues of aged rats, restoring selenium levels, and contributing to the restoration of the damage caused by aging. Thus, 4-PSQ could be a potential candidate for the management of age-related oxidative damage, acting as an anti-aging drug.
C1 [Luchese, Cristiane; Barth, Anelise; Wilhelm, Ethel Antunes] Univ Fed Pelotas, Lab Pesquisa Farmacol Bioquim LaFarBio, Grp Pesquisa Neurobiotecnol, Programa Posgrad Bioquim & Bioprospeccao, BR-96010900 Pelotas, RS, Brazil.
   [da Costa, Gabriel Pereira; Alves, Diego] Univ Fed Pelotas, Lab Sintese Organ Limpa LASOL, Programa Posgrad Quim, BR-96010900 Pelotas, RS, Brazil.
   [Novo, Diogo La Rosa; Mesko, Marcia Foster] Lab Controle Contaminantes Biomat LCCBio, Programa Posgrad Quim & Programa Posgrad Bioquim, BR-96010900 Pelotas, RS, Brazil.
C3 Universidade Federal de Pelotas; Universidade Federal de Pelotas
RP Luchese, C; Wilhelm, EA (corresponding author), Univ Fed Pelotas, CCQFA, Campus Capao de Leao, BR-96010900 Pelotas, RS, Brazil.
EM cristiane_luchese@yahoo.com.br; ethelwilhelm@yahoo.com.br
RI Novo, Diogo/GPS-5167-2022; Wilhelm, Ethel A/C-3219-2014; Pereira da
   Costa, Gabriel/GWC-0606-2022; La Rosa Novo, Diogo/U-6519-2019; Alves,
   Diego/G-5273-2012; MESKO, MARCIA FOSTER/L-3245-2018; Luchese,
   Cristiane/L-6677-2013
OI Novo, Diogo/0000-0002-3668-3494; Pereira da Costa,
   Gabriel/0000-0003-4107-9619; La Rosa Novo, Diogo/0000-0002-3668-3494;
   Alves, Diego/0000-0002-1074-0294; MESKO, MARCIA
   FOSTER/0000-0002-7399-446X; Luchese, Cristiane/0000-0001-6001-0532
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   [UNIVERSAL 408874/2016-3]; Fundacao de Amparo a Pesquisa do Estado do
   Rio Grande do Sul (FAPERGS) [PRONEM 16/2551-0000240-1, PRONUPEQ 16/2551-
   0000526-5, PqG 17/2551-0001013-2]; CNPq; L'OREAL-UNESCO-ABC for Women in
   Science
FX We are grateful for the financial support and scholarships from the
   Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) (UNIVERSAL 408874/2016-3), Fundacao de Amparo a
   Pesquisa do Estado do Rio Grande do Sul (FAPERGS) (PRONEM
   16/2551-0000240-1, PRONUPEQ 16/2551- 0000526-5, PqG 17/2551-0001013-2).
   CNPq is also acknowledged for the fellowship to D.A., M.F.M, E.A.W. and
   C. L. The authors also thank L'OREAL-UNESCO-ABC for Women in Science for
   their financial assistance.
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Amraoui W, 2018, TOXICOL RES-GER, V34, P231, DOI 10.5487/TR.2018.34.3.231
   Andrès E, 2007, EUR J INTERN MED, V18, P456, DOI 10.1016/j.ejim.2007.02.013
   Bai KK, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0324-z
   Barth A, 2019, MOL NEUROBIOL, V56, P6398, DOI 10.1007/s12035-019-1530-5
   Beard JR, 2016, LANCET, V387, P2145, DOI 10.1016/S0140-6736(15)00516-4
   Ben Amara I, 2009, INT J DEV NEUROSCI, V27, P719, DOI 10.1016/j.ijdevneu.2009.07.002
   Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613
   Bizzi CA, 2011, SPECTROCHIM ACTA B, V66, P394, DOI 10.1016/j.sab.2011.04.013
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buford TW, 2016, AGEING RES REV, V26, P96, DOI 10.1016/j.arr.2016.01.007
   Cai ZL, 2019, AGING CLIN EXP RES, V31, P1035, DOI 10.1007/s40520-018-1086-7
   Cenini G, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2105607
   Chard S, 2017, J GERONTOL B-PSYCHOL, V72, P319, DOI 10.1093/geronb/gbw119
   Chen YY, 2019, FREE RADICAL BIO MED, V141, P141, DOI 10.1016/j.freeradbiomed.2019.06.012
   Coles E. H., 1986, VET CLIN PATHOL, P486
   Coutoa SD, 2019, J TRACE ELEM MED BIO, V54, P232, DOI 10.1016/j.jtemb.2018.10.015
   Duarte LFB, 2017, TETRAHEDRON LETT, V58, P3319, DOI 10.1016/j.tetlet.2017.07.039
   Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Folmer V, 2003, J NUTR, V133, P2165, DOI 10.1093/jn/133.7.2165
   Gunes S, 2018, BIOL TRACE ELEM RES, V185, P116, DOI 10.1007/s12011-017-1231-8
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Kaur K, 2010, EUR J MED CHEM, V45, P3245, DOI 10.1016/j.ejmech.2010.04.011
   Kitada M, 2016, AGING-US, V8, P2290, DOI 10.18632/aging.101068
   Kumar P, 2011, NEUROSCI LETT, V502, P56, DOI 10.1016/j.neulet.2011.07.024
   Legrain Y, 2014, J BIOL CHEM, V289, P6299, DOI 10.1074/jbc.M113.526863
   Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6
   Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513
   Liochev SI, 2013, FREE RADICAL BIO MED, V60, P1, DOI 10.1016/j.freeradbiomed.2013.02.011
   Liu ZW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2525967
   López-Otín C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039
   Maciel JV, 2014, FOOD CHEM, V145, P927, DOI 10.1016/j.foodchem.2013.08.119
   Martinez de Toda I., 2019, OXID MED CELL LONGEV, V1, P11
   Mo ZZ, 2017, REJUV RES, V20, P231, DOI 10.1089/rej.2016.1870
   Müller WE, 2010, MOL NEUROBIOL, V41, P159, DOI 10.1007/s12035-010-8141-5
   National Research Council, 1996, GUIDE CARE USE LAB A
   Nogueira CW, 2004, CHEM REV, V104, P6255, DOI 10.1021/cr0406559
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ohwada K, 2008, J CLIN BIOCHEM NUTR, V42, P29, DOI 10.3164/jcbn.2008005
   Oliveira CS, 2016, EXP GERONTOL, V75, P16, DOI 10.1016/j.exger.2016.01.001
   Olukiran OS, 2018, ANIM MODEL EXP MED, V1, P295, DOI 10.1002/ame2.12035
   Pande M, 2002, TOXICOLOGY, V177, P187, DOI 10.1016/S0300-483X(02)00223-8
   Soares MSP, 2017, AMINO ACIDS, V49, P129, DOI 10.1007/s00726-016-2340-y
   Perkin E., 2003, SCIEX ELAN VERSION 3
   Piñeiro-Carrero VM, 2004, PEDIATRICS, V113, P1097
   Pinz M, 2016, EUR J PHARMACOL, V780, P122, DOI 10.1016/j.ejphar.2016.03.039
   Pinz MP, 2018, BIOMED PHARMACOTHER, V105, P1006, DOI 10.1016/j.biopha.2018.06.049
   Rao KS, 2009, INDIAN J BIOCHEM BIO, V46, P9
   Reis AS, 2017, J PSYCHIATR RES, V84, P191, DOI 10.1016/j.jpsychires.2016.10.007
   Rodier F, 2018, AGING-US, V10, P2233, DOI 10.18632/aging.101546
   Sagoo MK, 2018, FREE RADICAL BIO MED, V116, P50, DOI 10.1016/j.freeradbiomed.2017.12.040
   Saio V., 2016, REDOX REP, V1, P9
   Saraiva MT, 2016, J BRAZIL CHEM SOC, V27, P41, DOI 10.5935/0103-5053.20150239
   SASSA S, 1982, ENZYME, V28, P133, DOI 10.1159/000459097
   Savegnago L, 2013, TETRAHEDRON LETT, V54, P40, DOI 10.1016/j.tetlet.2012.10.067
   Silva VDG, 2017, FUND CLIN PHARMACOL, V31, P513, DOI 10.1111/fcp.12295
   Solomon VR, 2011, CURR MED CHEM, V18, P1488
   Stevens LA, 2005, MED CLIN N AM, V89, P457, DOI 10.1016/j.mcna.2004.11.009
   Valentini J, 2008, BIOMED PHARMACOTHER, V62, P378, DOI 10.1016/j.biopha.2007.10.017
   Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528
   Viña J, 2013, ANTIOXID REDOX SIGN, V19, P779, DOI 10.1089/ars.2012.5111
   Vogt AG, 2018, CHEM-BIOL INTERACT, V282, P7, DOI 10.1016/j.cbi.2018.01.003
   Voss GT, 2018, MAT SCI ENG C-MATER, V84, P90, DOI 10.1016/j.msec.2017.11.026
   Wang Z, 2018, MINERAL MET MAT SER, P3, DOI 10.1007/978-3-319-72138-5_1
   Wright TI, 2006, J AM ACAD DERMATOL, V54, P933, DOI 10.1016/j.jaad.2005.08.062
   Xu JQ, 2009, EUR NEUROPSYCHOPHARM, V19, P851, DOI 10.1016/j.euroneuro.2009.07.006
   Zoidis E, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7050066
   Zuo L, 2015, ACTA PHYSIOL, V214, P329, DOI 10.1111/apha.12515
NR 69
TC 13
Z9 14
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0531-5565
EI 1873-6815
J9 EXP GERONTOL
JI Exp. Gerontol.
PD FEB
PY 2020
VL 130
SI SI
AR 110804
DI 10.1016/j.exger.2019.110804
PG 8
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KA4MN
UT WOS:000505771100019
PM 31811892
DA 2024-02-19
ER

PT J
AU FERLAND, G
   PEREA, A
   AUDET, M
   TUCHWEBER, B
AF FERLAND, G
   PEREA, A
   AUDET, M
   TUCHWEBER, B
TI CHARACTERIZATION OF LIVER LYSOSOMAL-ENZYME ACTIVITY IN HEPATOCYTES,
   KUPFFER AND ENDOTHELIAL-CELLS DURING AGING - EFFECT OF DIETARY
   RESTRICTION
SO MECHANISMS OF AGEING AND DEVELOPMENT
LA English
DT Article
C1 UNIV MONTREAL,DEPT NUTR,POB 6128,STN A,MONTREAL H3C 3J7,QUEBEC,CANADA.
C3 Universite de Montreal
CR ASANO S, 1979, MECH AGEING DEV, V10, P81, DOI 10.1016/0047-6374(79)90072-1
   BIRCHENALLSPARKS MC, 1985, J NUTR, V115, P944, DOI 10.1093/jn/115.7.944
   BROUWER A, 1983, MECH AGEING DEV, V21, P205, DOI 10.1016/0047-6374(83)90042-8
   COMOLLI R, 1971, EXP GERONTOL, V6, P219, DOI 10.1016/0531-5565(71)90034-9
   DE AK, 1983, MECH AGEING DEV, V21, P37, DOI 10.1016/0047-6374(83)90014-3
   DEPRIESTER W, 1984, MECH AGEING DEV, V26, P205, DOI 10.1016/0047-6374(84)90094-0
   ELENS A, 1969, EXP GERONTOL, V4, P131, DOI 10.1016/0531-5565(69)90036-9
   FERLAND G, 1989, LIPIDS, V24, P842, DOI 10.1007/BF02535757
   FINCH CE, 1972, EXP GERONTOL, V7, P53, DOI 10.1016/0531-5565(72)90035-6
   GERVAIS F, 1988, J GERONTOL, V43, pB152, DOI 10.1093/geronj/43.6.B152
   GOTO S, 1969, J GERONTOL, V24, P305, DOI 10.1093/geronj/24.3.305
   HEIDRICK ML, 1972, GERONTOLOGIST, V12, P28
   HOCHSCHILD R, 1971, EXP GERONTOL, V6, P153, DOI 10.1016/S0531-5565(71)80014-1
   HOLEHAN AM, 1986, BIOL REV, V61, P329, DOI 10.1111/j.1469-185X.1986.tb00658.x
   KNOOK DL, 1976, MECH AGEING DEV, V5, P389, DOI 10.1016/0047-6374(76)90036-1
   KNOOK DL, 1976, EXP CELL RES, V99, P444, DOI 10.1016/0014-4827(76)90605-4
   KNOOK DL, 1980, BIOCHEM BIOPH RES CO, V96, P250, DOI 10.1016/0006-291X(80)91207-3
   KNOOK DL, 1978, LIVER AGING, P241
   KOIZUMI A, 1987, J NUTR, V117, P361, DOI 10.1093/jn/117.2.361
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKLE RA, 1986, P SOC EXP BIOL MED, V183, P169
   MASORO EJ, 1985, J NUTR, V115, P842, DOI 10.1093/jn/115.7.842
   MASORO EJ, 1988, J GERONTOL, V43, pB59, DOI 10.1093/geronj/43.3.B59
   MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405
   MEIHUIZEN SP, 1980, MECH AGEING DEV, V13, P111, DOI 10.1016/0047-6374(80)90054-8
   NAKAMURA Y, 1989, NEUROSCI LETT, V97, P215, DOI 10.1016/0304-3940(89)90166-3
   ROBINSON D, 1969, BIOCHIM BIOPHYS ACTA, V191, P181
   SALAS M, 1980, PATHOL RES PRACT, V167, P217, DOI 10.1016/S0344-0338(80)80052-5
   SCHMUCKER DL, 1978, LIVER AGING 1978, P21
   SLEYSTER EC, 1980, MECH AGEING DEV, V14, P443, DOI 10.1016/0047-6374(80)90015-9
   SOLOMON C, 1984, MECH AGEING DEV, V24, P9, DOI 10.1016/0047-6374(84)90173-8
   VANBEZOOIJEN CFA, 1977, MECH AGEING DEV, V6, P293, DOI 10.1016/0047-6374(77)90031-8
   VANHOOF F, 1968, EUR J BIOCHEM, V7, P34
   WARD WF, 1988, J GERONTOL, V43, pB50, DOI 10.1093/geronj/43.2.B50
   WILSON PD, 1973, GERONTOLOGY, V19, P79, DOI 10.1159/000211964
   WORWOOD M, 1973, BIOCHEM J, V134, P183, DOI 10.1042/bj1340183
   ZAHLTEN RN, 1978, GASTROENTEROLOGY, V75, P80
NR 37
TC 22
Z9 22
U1 0
U2 2
PU ELSEVIER SCI IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0047-6374
J9 MECH AGEING DEV
JI Mech. Ageing. Dev.
PD NOV
PY 1990
VL 56
IS 2
BP 143
EP 154
DI 10.1016/0047-6374(90)90005-Z
PG 12
WC Cell Biology; Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Cell Biology; Geriatrics & Gerontology
GA EL181
UT WOS:A1990EL18100005
PM 2290353
DA 2024-02-19
ER

PT J
AU GORDILLO, E
   AYALA, A
   FLOBATO, M
   BAUTISTA, J
   MACHADO, A
AF GORDILLO, E
   AYALA, A
   FLOBATO, M
   BAUTISTA, J
   MACHADO, A
TI POSSIBLE INVOLVEMENT OF HISTIDINE-RESIDUES IN THE LOSS OF
   ENZYMATIC-ACTIVITY OF RAT-LIVER MALIC ENZYME DURING AGING
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
C1 UNIV SEVILLE,FAC FARM,DEPT BIOQUIM,SEVILLE,SPAIN.
C3 University of Sevilla
RI Palomas, Juan D Bautista/L-2343-2014; Lobato, Maria
   Fernandez/F-1338-2016; IBIS, ENVEJECIMIENTO/O-9381-2015
OI Palomas, Juan D Bautista/0000-0001-9567-5390; Lobato, Maria
   Fernandez/0000-0003-0778-7443; 
CR AYALA A, 1986, FEBS LETT, V202, P102, DOI 10.1016/0014-5793(86)80657-3
   BRAVO R, 1984, 2 DIMENSIONAL GEL EL
   BRAY RC, 1974, BIOCHEM J, V139, P43, DOI 10.1042/bj1390043
   CHANG GG, 1980, BIOCHIM BIOPHYS ACTA, V611, P217, DOI 10.1016/0005-2744(80)90058-3
   DICE JF, 1982, J BIOL CHEM, V257, P4624
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521
   GAFNI A, 1981, BIOCHEMISTRY-US, V20, P6035, DOI 10.1021/bi00524a018
   GOLDSTEIN S, 1976, MECH AGEING DEV, V5, P221, DOI 10.1016/0047-6374(76)90020-8
   Gross E., 1967, Methods Enzymol, V11, P238, DOI [10.1016/S0076-6879(67)11029-X, DOI 10.1016/S0076-6879(67)11029-X]
   GUPTA SK, 1976, ARCH BIOCHEM BIOPHYS, V174, P324
   HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124
   HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010
   LAVIE L, 1982, BIOCHEM J, V202, P47, DOI 10.1042/bj2020047
   LEVINE RL, 1983, J BIOL CHEM, V258, P1828
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACHADO A, 1983, CARDIOLOGY AGING, P65
   Miles E W, 1977, Methods Enzymol, V47, P431
   NOHL H, 1978, EUR J BIOCHEM, V82, P563, DOI 10.1111/j.1432-1033.1978.tb12051.x
   OCHOA S, 1947, J BIOL CHEM, V167, P871
   OLIVER CN, 1987, J AM GERIATR SOC, V35, P947, DOI 10.1111/j.1532-5415.1987.tb02297.x
   OLIVER CN, 1987, J BIOL CHEM, V262, P5486
   REDDY VA, 1983, BIOCHIM BIOPHYS ACTA, V743, P268, DOI 10.1016/0167-4838(83)90224-8
   REISS U, 1976, EUR J BIOCHEM, V63, P617, DOI 10.1111/j.1432-1033.1976.tb10266.x
   REZNICK AZ, 1979, MECH AGEING DEV, V11, P403, DOI 10.1016/0047-6374(79)90016-2
   REZNICK AZ, 1985, MODIFICATION PROTEIN, P69
   ROTHSTEIN M, 1982, BIOCH APPROACHES AGI, P213
   SHARMA HK, 1980, J BIOL CHEM, V255, P5043
   SHARMA HK, 1979, ARCH BIOCHEM BIOPHYS, V194, P275, DOI 10.1016/0003-9861(79)90619-2
   SHARMA HK, 1978, BIOCHEMISTRY-US, V17, P2869, DOI 10.1021/bi00607a027
   STADTMAN ER, 1986, TRENDS BIOCHEM SCI, V11, P11, DOI 10.1016/0968-0004(86)90221-5
   STARKE PE, 1987, FASEB J, V1, P36, DOI 10.1096/fasebj.1.1.2886388
   TOPHAM CM, 1986, EUR J BIOCHEM, V155, P87, DOI 10.1111/j.1432-1033.1986.tb09461.x
   TUENGLER P, 1977, BIOCHIM BIOPHYS ACTA, V484, P1, DOI 10.1016/0005-2744(77)90108-5
   V Maizel Jr J., 1971, Methods in Virology, V5, P179
   VERNON CM, 1983, ARCH BIOCHEM BIOPHYS, V225, P296, DOI 10.1016/0003-9861(83)90033-4
   VITORICA J, 1981, ENZYME, V26, P144
   YAMASAKI RB, 1981, ANAL BIOCHEM, V111, P220, DOI 10.1016/0003-2697(81)90557-1
NR 38
TC 36
Z9 37
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814
SN 0021-9258
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 15
PY 1988
VL 263
IS 17
BP 8053
EP 8057
PG 5
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA N7766
UT WOS:A1988N776600024
PM 3131338
DA 2024-02-19
ER

PT J
AU Xu, JJ
   Li, YY
   Regenstein, J
   Su, XR
AF Xu, Jiajie
   Li, Yanyan
   Regenstein, Joe
   Su, Xiurong
TI <i>In vitro</i> and <i>in vivo</i> anti-oxidation and anti-fatigue
   effect of monkfish liver hydrolysate
SO FOOD BIOSCIENCE
LA English
DT Article
DE Antioxidant activity; Hydrolysate; Functional food; Amino acid; Seafood
ID FREE AMINO-ACIDS; PROTEIN HYDROLYSATE; SWIMMING ENDURANCE; PEPTIDE
   FRACTIONS; LOPHIUS-LITULON; WHEY-PROTEIN; TUNA LIVER; SUPPLEMENTATION;
   CAPACITY; MUSCLE
AB Monkfish liver, which is rich in protein, has high nutritious and medicinal value. Moreover, in recent studies, properties of bioactive peptides hydrolysates that make potential ingredients of health functional foods. In this study, monkfish liver hydrolysates (MLH) produced commercially enzyme. The in vivo and in vitro antioxidant activity and anti-fatigue activity of MLH were determined. The test of climbing endurance of mice were performance after one and half months of MLH administration in the anti-fatigue activity. After six weeks of MLH administration, mice were then sacrificed and assessed for biochemical parameters, SOD activity and MDA content in hepatic and kidney homogenates. Results showed that MLH contained the amino acids and peptides, which were expected to contribute to its antioxidant and anti-fatigue activities. The climbing period of experimental groups was increased compared with that of Control group. And execution with MLH could significantly increase SOD activity in hepatic and kidney. MDA contents of hepatic and kidney homogenate in the Aging Model had a higher level. MLH could significantly alleviate fatigue of the mice and had an anti-oxidative effect on aging mice. Conclusively, monkfish liver hydrolysates may be a beneficial ingredient to use in functional foods, indicating that monkfish liver is valuable for further study.
C1 [Xu, Jiajie; Li, Yanyan; Su, Xiurong] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.
   [Xu, Jiajie] China Agr Univ, Coll Engn, Beijing 100083, Peoples R China.
   [Li, Yanyan; Regenstein, Joe] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.
C3 Ningbo University; China Agricultural University; Cornell University
RP Su, XR (corresponding author), Fenghua Rd, Ningbo 315211, Zhejiang, Peoples R China.
EM suxiurong@nbu.edu.cn
RI xu, jiajie/AFO-0140-2022; Yan, Jun/IXD-7801-2023
OI Xu, Jiajie/0000-0002-3931-4766
FU Zhejiang Science and Technology Department [2009C03017-1]; K.C. Wong
   Magna Fund at Ningbo University
FX This work was financially supported by major projects by Zhejiang
   Science and Technology Department (No. 2009C03017-1) and also Sponsored
   by K.C. Wong Magna Fund at Ningbo University.
CR ADLERNISSEN J, 1979, J AGR FOOD CHEM, V27, P1256, DOI 10.1021/jf60226a042
   Ahn CB, 2010, INT J FOOD SCI TECH, V45, P562, DOI 10.1111/j.1365-2621.2009.02166.x
   Anand K. V., 2012, GERIATRICS GERONTOLO
   Bartoszek M, 2012, FOOD CHEM, V132, P2089, DOI 10.1016/j.foodchem.2011.12.060
   Bogwald J, 1996, FISH SHELLFISH IMMUN, V6, P3, DOI 10.1006/fsim.1996.0002
   Chaouch MA, 2016, INT J FOOD SCI TECH, V51, P929, DOI 10.1111/ijfs.13055
   Chen LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119427
   Choi JY, 2011, J GINSENG RES, V35, P331, DOI 10.5142/jgr.2011.35.3.331
   Choi J, 2012, INT J DAIRY TECHNOL, V65, P1, DOI 10.1111/j.1471-0307.2011.00725.x
   Choueiri L, 2012, FOOD CHEM, V133, P1039, DOI 10.1016/j.foodchem.2012.01.057
   Ding JF, 2011, FOOD HYDROCOLLOID, V25, P1350, DOI 10.1016/j.foodhyd.2010.12.013
   Elias RJ, 2008, CRIT REV FOOD SCI, V48, P430, DOI 10.1080/10408390701425615
   Fariña AC, 2008, ICES J MAR SCI, V65, P1272, DOI 10.1093/icesjms/fsn140
   Farvin KHS, 2016, FOOD CHEM, V204, P409, DOI 10.1016/j.foodchem.2016.02.145
   Freeman MA, 2011, J FISH DIS, V34, P445, DOI 10.1111/j.1365-2761.2011.01255.x
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Hathwar SC, 2011, APPL BIOCHEM BIOTECH, V164, P115, DOI 10.1007/s12010-010-9119-5
   Herpandi NH, 2011, COMPR REV FOOD SCI F, V10, P195, DOI 10.1111/j.1541-4337.2011.00155.x
   Ho SC, 2003, BIOGERONTOLOGY, V4, P15, DOI 10.1023/A:1022417102206
   박삼국, 2016, [journal of korean foot and ankle society, 대한족부족관절학회지], V20, P88
   Inal ME, 2001, CLIN CHIM ACTA, V305, P75, DOI 10.1016/S0009-8981(00)00422-8
   Je JY, 2009, FOOD RES INT, V42, P1266, DOI 10.1016/j.foodres.2009.06.013
   Jin XS, 2010, DEEP-SEA RES PT II, V57, P996, DOI 10.1016/j.dsr2.2010.02.001
   Kannan A, 2011, J SCI FOOD AGR, V91, P1920, DOI 10.1002/jsfa.4464
   Khalil OAK, 2012, FOOD CHEM, V133, P1001, DOI 10.1016/j.foodchem.2012.02.009
   Kim NH, 2012, AM J CHINESE MED, V40, P111, DOI 10.1142/S0192415X12500097
   Klompong V, 2008, INT J FOOD SCI TECH, V43, P1019, DOI 10.1111/j.1365-2621.2007.01555.x
   Lan Z., 2012, J ETHNOPHARMACOLOG
   Liao WC, 2012, INT J FOOD SCI TECH, V47, P2009, DOI 10.1111/j.1365-2621.2012.03064.x
   Lin SJ, 2012, INT J FOOD SCI TECH, V47, P2045, DOI 10.1111/j.1365-2621.2012.03068.x
   Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212
   Masisi K, 2016, FOOD CHEM, V196, P90, DOI 10.1016/j.foodchem.2015.09.021
   Mendis E, 2005, J AGR FOOD CHEM, V53, P581, DOI 10.1021/jf048877v
   Naqash SY, 2010, J AQUAT FOOD PROD T, V19, P180, DOI 10.1080/10498850.2010.506256
   Nazeer RA, 2012, INT J FOOD SCI TECH, V47, P274, DOI 10.1111/j.1365-2621.2011.02836.x
   Pan DD, 2011, J FOOD BIOCHEM, V35, P1130, DOI 10.1111/j.1745-4514.2010.00440.x
   Peng XY, 2009, FOOD CHEM, V113, P196, DOI 10.1016/j.foodchem.2008.07.068
   Power-Grant O, 2016, INT J FOOD SCI NUTR, V67, P325, DOI 10.3109/09637486.2016.1153607
   Ren JY, 2011, NUTRITION, V27, P789, DOI 10.1016/j.nut.2010.08.020
   Rustad T, 2011, INT J FOOD SCI TECH, V46, P2001, DOI 10.1111/j.1365-2621.2011.02736.x
   Song X, 1999, MECH AGEING DEV, V108, P239, DOI 10.1016/S0047-6374(99)00022-6
   Sookvanichsilp N, 2002, PHYTOTHER RES, V16, P732, DOI 10.1002/ptr.1048
   Sözmen EY, 2001, CLIN EXP MED, V1, P195
   Spellman D, 2003, INT DAIRY J, V13, P447, DOI 10.1016/S0958-6946(03)00053-0
   Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2
   Terpinc P, 2012, IND CROP PROD, V39, P210, DOI 10.1016/j.indcrop.2012.02.023
   Tharakan B, 2005, PHYTOTHER RES, V19, P669, DOI 10.1002/ptr.1725
   van Loon LJC, 2000, AM J CLIN NUTR, V72, P106
   Wang L, 2008, PEPTIDES, V29, P1176, DOI 10.1016/j.peptides.2008.03.004
   Wilson J, 2011, FOOD CHEM, V129, P235, DOI 10.1016/j.foodchem.2011.04.081
   Wu DM, 2008, NEUROBIOL LEARN MEM, V90, P19, DOI 10.1016/j.nlm.2008.01.010
   Wu HC, 2003, FOOD RES INT, V36, P949, DOI 10.1016/S0963-9969(03)00104-2
   Xu Z, 2016, CARBOHYD POLYM, V144, P122, DOI 10.1016/j.carbpol.2016.02.041
   Yoneda M, 2002, FISHERIES SCI, V68, P310, DOI 10.2331/fishsci.68.sup1_310
   You LJ, 2011, FOOD CHEM, V124, P188, DOI 10.1016/j.foodchem.2010.06.007
   Yu B, 2008, EUR FOOD RES TECHNOL, V226, P415, DOI 10.1007/s00217-006-0552-1
   Zhang XX, 2016, FOOD FUNCT, V7, P1429, DOI 10.1039/c5fo01183c
   Zhang YH, 2015, INT J FOOD SCI TECH, V50, P2175, DOI 10.1111/ijfs.12856
   Zhong SY, 2011, FOOD CHEM, V126, P1636, DOI 10.1016/j.foodchem.2010.12.046
NR 59
TC 34
Z9 38
U1 3
U2 21
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-4292
EI 2212-4306
J9 FOOD BIOSCI
JI Food Biosci.
PD JUN
PY 2017
VL 18
BP 9
EP 14
DI 10.1016/j.fbio.2017.03.002
PG 6
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA EW8DL
UT WOS:000402748400002
DA 2024-02-19
ER

PT J
AU Wang, WH
   Peng, HH
   Zeng, MH
   Liu, J
   Liang, GB
   He, ZH
AF Wang, Wenhua
   Peng, Huaihuai
   Zeng, Menghao
   Liu, Jie
   Liang, Guibin
   He, Zhihui
TI Endothelial progenitor cells systemic administration alleviates
   multi-organ senescence by down-regulating USP7/p300 pathway in chronic
   obstructive pulmonary disease
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Article
DE COPD; Senescence; EPCs; Systemic administration; USP7; p300
ID ANIMAL-MODELS; COPD; TRANSPLANTATION; MECHANISMS; EMPHYSEMA; PROMOTES
AB BackgroundChronic obstructive pulmonary disease (COPD) has impacted approximately 390 million people worldwide and the morbidity is increasing every year. However, due to the poor treatment efficacy of COPD, exploring novel treatment has become the hotpot of study on COPD. Endothelial progenitor cells (EPCs) aging is a possible molecular way for COPD development. We aimed to explore the effector whether intravenous administration of EPCs has therapeutic effects in COPD mice.MethodsCOPD mice model was induced by cigarette smoke exposure and EPCs were injected intravenously to investigate their effects on COPD mice. At day 127, heart, liver, spleen, lung and kidney tissues of mice were harvested. The histological effects of EPCs intervention on multiple organs of COPD mice were detected by morphology assay. Quantitative real-time PCR and Western blotting were used to detect the effect of EPCs intervention on the expression of multi-organ senescence-related indicators. And we explored the effect of EPCs systematically intervening on senescence-related USP7/p300 pathway.ResultsCompared with COPD group, senescence-associated beta-galactosidase activity was decreased, protein and mRNA expression of p16 was down-regulated, while protein and mRNA expression of cyclin D1 and TERT were up-regulated of multiple organs, including lung, heart, liver, spleen and kidney in COPD mice after EPCs system intervention. But the morphological alterations of the tissues described above in COPD mice failed to be reversed. Mechanistically, EPCs systemic administration inhibited the expression of mRNA and protein of USP7 and p300 in multiple organs of COPD mice, exerting therapeutic effects.ConclusionsEPCs administration significantly inhibited the senescence of multiple organs in COPD mice via down-regulating USP7/p300 pathway, which presents a possibility of EPCs therapy for COPD.
C1 [Wang, Wenhua; Zeng, Menghao; Liu, Jie; Liang, Guibin; He, Zhihui] Cent South Univ, Xiangya Hosp 3, Dept Intens Care Unit, Changsha, Hunan, Peoples R China.
   [Peng, Huaihuai] Hunan Prov Directly Affiliated Tradit Chinese Med, Dept Intens Care Unit, Zhuzhou, Hunan, Peoples R China.
C3 Central South University
RP He, ZH (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Intens Care Unit, Changsha, Hunan, Peoples R China.
EM hzh703@csu.edu.cn
FU National Natural Science Foundation of China [81870040]
FX This study was funded by the National Natural Science Foundation of
   China (NO: 81870040).
CR Adeloye D, 2022, LANCET RESP MED, V10, P447, DOI 10.1016/S2213-2600(21)00511-7
   Araya J, 2019, AUTOPHAGY, V15, P510, DOI 10.1080/15548627.2018.1532259
   Barnes PJ, 2017, ANNU REV PHYSIOL, V79, P517, DOI 10.1146/annurev-physiol-022516-034314
   Beck DB, 2022, NAT REV RHEUMATOL, V18, P435, DOI 10.1038/s41584-022-00778-4
   Cai YS, 2022, SCI CHINA LIFE SCI, V65, P2354, DOI 10.1007/s11427-022-2161-3
   Childs BG, 2015, NAT MED, V21, P1424, DOI 10.1038/nm.4000
   Cui L, 2020, AGING-US, V12, P23082, DOI 10.18632/aging.104067
   Decramer M, 2013, LANCET RESP MED, V1, P73, DOI 10.1016/S2213-2600(12)70060-7
   Di Micco R, 2021, NAT REV MOL CELL BIO, V22, P75, DOI 10.1038/s41580-020-00314-w
   Dratwa M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.589929
   Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337
   Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919
   Festing MFW, 2014, ILAR J, V55, P399, DOI 10.1093/ilar/ilu036
   Fricker M, 2014, EXPERT OPIN DRUG DIS, V9, P629, DOI 10.1517/17460441.2014.909805
   Gaschler Gordon J., 2007, V14, P126, DOI 10.1159/000107059
   Gasek NS, 2021, NATURE AGING, V1, P870, DOI 10.1038/s43587-021-00121-8
   Glassberg MK, 2021, CHEST, V160, P1271, DOI 10.1016/j.chest.2021.04.020
   He YH, 2020, AGING CELL, V19, DOI 10.1111/acel.13117
   He ZH, 2016, EXP BIOL MED, V241, P131, DOI 10.1177/1535370215598402
   Hu R, 2021, PIGM CELL MELANOMA R, V34, P1131, DOI 10.1111/pcmr.12996
   Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419
   Janssen WJ, 2014, COPD, V11, P277, DOI 10.3109/15412555.2013.841668
   Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397
   Kaur M, 2022, INFLAMM RES, V71, P797, DOI 10.1007/s00011-022-01594-y
   Kaushik K, 2019, CYTOTHERAPY, V21, P1137, DOI 10.1016/j.jcyt.2019.09.002
   Kawasaki T, 2015, AM J RESP CELL MOL, V53, P500, DOI 10.1165/rcmb.2014-0185OC
   Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026
   Lee J, 2011, CURR OPIN PULM MED, V17, P90, DOI 10.1097/MCP.0b013e328341cead
   Liang GB, 2019, CHINESE MED J-PEKING, V132, P2465, DOI 10.1097/CM9.0000000000000469
   Liang GB, 2022, TOB INDUC DIS, V20, P1, DOI 10.18332/tid/143853
   Liu AR, 2020, EXPERT OPIN BIOL TH, V20, P125, DOI 10.1080/14712598.2020.1689954
   Liu B, 2016, EUR J PHARMACOL, V775, P67, DOI 10.1016/j.ejphar.2016.02.022
   Liu P, 2016, THORAC CARDIOV SURG, V64, P323, DOI 10.1055/s-0034-1389261
   LUKAS J, 1995, CANCER RES, V55, P4818
   Martínez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025
   Patschan D, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-02149-1
   Polverino F, 2021, AM J RESP CRIT CARE, V204, P651, DOI 10.1164/rccm.202012-4510OC
   Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC
   Shafei AE, 2017, J GENE MED, V19, DOI 10.1002/jgm.2995
   Shi ZH, 2017, INT J CHRONIC OBSTR, V12, P947, DOI 10.2147/COPD.S110781
   Sin TK, 2015, J PHYSIOL-LONDON, V593, P1887, DOI 10.1113/jphysiol.2014.270101
   Tian YE, 2023, NAT MED, V29, P1221, DOI 10.1038/s41591-023-02296-6
   Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007
   Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC
   Ungvari Z, 2020, J AM COLL CARDIOL, V75, P931, DOI 10.1016/j.jacc.2019.11.061
   Uyar B, 2020, AGEING RES REV, V64, DOI 10.1016/j.arr.2020.101156
   Vij N, 2018, AM J PHYSIOL-CELL PH, V314, pC73, DOI 10.1152/ajpcell.00110.2016
   Vogelmeier CF, 2020, RESP MED, V166, DOI 10.1016/j.rmed.2020.105938
   Wang LH, 2020, CELL METAB, V32, P860, DOI 10.1016/j.cmet.2020.10.004
   Weiss Daniel J, 2013, Ann Am Thorac Soc, V10, pS45, DOI 10.1513/AnnalsATS.201304-090AW
   Yang Y, 2013, CHINESE MED J-PEKING, V126, P3222, DOI 10.3760/cma.j.issn.0366-6999.20122633
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Yousefzadeh MJ, 2021, NATURE, V594, P100, DOI 10.1038/s41586-021-03547-7
   Zafari Z, 2021, CHEST, V159, P1400, DOI 10.1016/j.chest.2020.09.255
   Zeng MH, 2022, TOXICOL LETT, V359, P31, DOI 10.1016/j.toxlet.2022.01.017
   Zengin E, 2006, DEVELOPMENT, V133, P1543, DOI 10.1242/dev.02315
   Zhang HB, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143420
   Zhang Q, 2022, SCI CHINA LIFE SCI, V65, P1198, DOI 10.1007/s11427-021-1982-8
NR 58
TC 0
Z9 0
U1 8
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD DEC 6
PY 2023
VL 21
IS 1
AR 881
DI 10.1186/s12967-023-04735-x
PG 19
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA Z9ST4
UT WOS:001115412200005
PM 38057857
OA gold
DA 2024-02-19
ER

PT J
AU Turunen, M
   Dallner, G
AF Turunen, M
   Dallner, G
TI Elevation of ubiquinone content by peroxisomal inducers in rat liver
   during aging
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE aging; peroxisomal proliferators; ubiquinone
ID COENZYME-Q; BIOSYNTHESIS
AB The effect of di(2-ethylhexyl)phthalate (DEHP) on the induction of peroxisomes and the content of ubiquinone in the liver was studied in rats between 25 and 496 days of age. During this period, peroxisomal beta-oxidation of fatty acids was greatly decreased but it could be induced many-fold in all ages. The ubiquinone (UQ) content was increased upon induction 6-fold in the first weeks of life, but the extent of this elevation continuously narrowed and no induction could be observed in the oldest animals, even after prolonged treatment with the plasticizer. In contrast, the treatment decreased the amount of liver cholesterol in all age groups. Treatment with this peroxisomal inducer increased the biosynthesis of UQ while the breakdown rate was found to be unaffected, as the half-life of this lipid was 103 and 106 h in control and treated rats, respectively. These results indicate that treatment with peroxisomal inducers increases the liver UQ content by increasing the rate of biosynthesis and that this effect is not apparent in aged rats. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
C1 Univ Stockholm, Dept Biochem, S-10691 Stockholm, Sweden.
C3 Stockholm University
RP Turunen, M (corresponding author), Univ Stockholm, Dept Biochem, S-10691 Stockholm, Sweden.
CR ABERG F, 1994, CHEM-BIOL INTERACT, V91, P1, DOI 10.1016/0009-2797(94)90002-7
   Aberg F, 1996, CHEM-BIOL INTERACT, V99, P205, DOI 10.1016/0009-2797(95)03670-9
   BERGMEYER HU, 1955, BIOCHEM Z, V327, P255
   BEYER RE, 1987, CHEM SCRIPTA, V27, P145
   BIERI F, 1993, BIOCHIMIE, V75, P263, DOI 10.1016/0300-9084(93)90086-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Ericsson Johan, 1993, V21, P229
   ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3
   ERNSTER L, 1993, ACTIVE OXYGENS, LIPID PEROXIDES, AND ANTIOXIDANTS, P1
   FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879
   GANNING AE, 1989, TOXICOL LETT, V48, P185, DOI 10.1016/0378-4274(89)90173-2
   GRUNLER J, 1994, BBA-LIPID LIPID MET, V1212, P259, DOI 10.1016/0005-2760(94)90200-3
   Kagan VE., 1996, HDB ANTIOXIDANTS, P157
   KALCKAR HM, 1947, J BIOL CHEM, V167, P429
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072
   KELLER RK, 1986, J BIOL CHEM, V261, P2053
   KVANNES J, 1991, J BIOCHEM BIOPH METH, V23, P135, DOI 10.1016/0165-022X(91)90061-Z
   LEMBERGER T, 1994, J BIOL CHEM, V269, P24527
   MORTENSEN SA, 1993, CLIN INVESTIGATOR, V71, pS116
   OMURA T, 1969, P 4 INT C PHARM, P94
   OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z
   QUILES JL, 1994, MOL ASPECTS MED, V15, P89
   RAO MS, 1992, ENV HLTH PERSPECT, V93, P205
   REDDY JK, 1987, PEROXISOMES BIOL MED, P254
   TECLEBRHAN H, 1995, BBA-LIPID LIPID MET, V1256, P157, DOI 10.1016/0005-2760(95)00016-6
   TECLEBRHAN H, 1993, J BIOL CHEM, V268, P23081
   Zhang YY, 1996, J NUTR, V126, P2089, DOI 10.1093/jn/126.9.2089
NR 27
TC 9
Z9 9
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD NOV 6
PY 1998
VL 116
IS 1-2
BP 79
EP 91
DI 10.1016/S0009-2797(98)00082-9
PG 13
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA 174RH
UT WOS:000079048300006
PM 9877202
DA 2024-02-19
ER

PT J
AU Amelina, H
   Cristobal, S
AF Amelina, Hanna
   Cristobal, Susana
TI Proteomic study on gender differences in aging kidney of mice
SO PROTEOME SCIENCE
LA English
DT Article
ID MITOCHONDRIAL DYSFUNCTION; PROTEIN EXPRESSION; OXIDATIVE DAMAGE; CALORIC
   RESTRICTION; TELOMERE LENGTH; LIFE-SPAN; SENESCENCE; STRESS; LIVER;
   METABOLISM
AB Background: This study aims to analyze sex differences in mice aging kidney. We applied a proteomic technique based on subfractionation, and liquid chromatography coupled with 2-DE. Samples from male and female CD1-Swiss outbred mice from 28 weeks, 52 weeks, and 76 weeks were analysed by 2-DE, and selected proteins were identified by matrix assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS).
   Results: This proteomic analysis detected age-related changes in protein expression in 55 protein-spots, corresponding to 22 spots in males and 33 spots in females. We found a protein expression signature (PES) of aging composed by 8 spots, common for both genders. The identified proteins indicated increases in oxidative and proteolytic proteins and decreases in glycolytic proteins, and antioxidant enzymes.
   Conclusion: Our results provide insights into the gender differences associated to the decline of kidney function in aging. Thus, we show that proteomics can provide valuable information on age-related changes in expression levels of proteins and related modifications. This pilot study is still far from providing candidates for aging-biomarkers. However, we suggest that the analysis of these proteins could suggest mechanisms of cellular aging in kidney, and improve the kidney selection for transplantation.
C1 [Amelina, Hanna; Cristobal, Susana] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.
C3 Stockholm University
RP Cristobal, S (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.
EM Hanna.Amelina@dbb.su.se; Susana.Cristobal@dbb.su.se
OI Cristobal, Susana/0000-0002-3894-2218; Amelina,
   Hanna/0000-0002-9006-9217
FU Swedish Research Council; VR; Magnus Bergvalls Stiftelse; Stiftelsen
   Langmanska kulturfonden; Lars Hiertas Minne; Helge Ax:son Johnsons
   Stifelse; Carl Trygger Stiftelse; Stiftelse Oscar; Lilli Lamms Minne;
   CBR; SSF; VINNOVA; Wallenberg foundation
FX This project was supported by grants from the Swedish Research Council,
   VR, Magnus Bergvalls Stiftelse, Stiftelsen Langmanska kulturfonden, Lars
   Hiertas Minne, Helge Ax:son Johnsons Stifelse, Carl Trygger Stiftelse,
   Stiftelse Oscar and Lilli Lamms Minne, the CBR funding, SSF, VINNOVA and
   Wallenberg foundation. We also thank to Prof. Ana Navarro and her team
   from Cadiz University, Spain for providing the tissues from CD1-mice and
   Stockholm University Proteomic Facility (SUPF).
CR Amelina H, 2007, J PROTEOME RES, V6, P2094, DOI 10.1021/pr060689s
   Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578
   Arantes-Oliveira N, 2003, SCIENCE, V302, P611, DOI 10.1126/science.1089169
   Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S
   Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x
   Bliznakov EG, 1999, BIOCHIMIE, V81, P1131
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chakravarti B, 2009, PROTEOMICS, V9, P580, DOI 10.1002/pmic.200700208
   Chang JS, 2003, MECH AGEING DEV, V124, P33, DOI 10.1016/S0047-6374(02)00167-7
   Cheng XR, 2007, NEUROBIOL AGING, V28, P497, DOI 10.1016/j.neurobiolaging.2006.02.004
   Chevalier S, 2000, EUR J BIOCHEM, V267, P4624, DOI 10.1046/j.1432-1327.2000.01487.x
   Cho YM, 2003, PROTEOMICS, V3, P1883, DOI 10.1002/pmic.200300562
   DAS M, 1994, GERONTOLOGY, V40, P70, DOI 10.1159/000213580
   DEJONG G, 1990, CLIN CHIM ACTA, V190, P1, DOI 10.1016/0009-8981(90)90278-Z
   Drahos Kate L, 2005, J Biomol Tech, V16, P347
   Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200
   Fountoulakis M, 2000, ELECTROPHORESIS, V21, P673, DOI 10.1002/(SICI)1522-2683(20000201)21:3<673::AID-ELPS673>3.0.CO;2-Y
   Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9
   Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515
   Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X
   Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2
   Kil IS, 2006, FREE RADICAL BIO MED, V40, P110, DOI 10.1016/j.freeradbiomed.2005.08.021
   Kim CH, 2004, EXP GERONTOL, V39, P1155, DOI 10.1016/j.exger.2004.04.003
   Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429
   Kiri Ajay N, 2005, J Biomol Tech, V16, P371
   Kondoh H, 2005, CANCER RES, V65, P177
   Konova E, 2004, EXP GERONTOL, V39, P249, DOI 10.1016/j.exger.2003.10.003
   Lee JH, 2006, PROTEOMICS, V6, P1351, DOI 10.1002/pmic.200500287
   Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8
   Legakis JE, 2002, MOL BIOL CELL, V13, P4243, DOI 10.1091/mbc.E02-06-0322
   Li DY, 2004, BIOCHEM BIOPH RES CO, V318, P253, DOI 10.1016/j.bbrc.2004.04.022
   Melov S, 2000, ANN NY ACAD SCI, V908, P219
   Mi J, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-19
   Mi J, 2007, PROTEOMICS, V7, P1916, DOI 10.1002/pmic.200600638
   Moore SL, 2002, SCIENCE, V297, P2015, DOI 10.1126/science.1074196
   Navarro A, 2008, AM J PHYSIOL-REG I, V294, pR501, DOI 10.1152/ajpregu.00492.2007
   Navarro A, 2007, FRONT BIOSCI-LANDMRK, V12, P1154, DOI 10.2741/2133
   Odera K, 2007, BIOGERONTOLOGY, V8, P505, DOI 10.1007/s10522-007-9093-7
   Ottinger MA, 2005, MECH AGEING DEV, V126, P967, DOI 10.1016/j.mad.2005.03.017
   Piec I, 2005, FASEB J, V19, P1143, DOI 10.1096/fj.04-3084fje
   Poon HF, 2006, NEUROBIOL AGING, V27, P1020, DOI 10.1016/j.neurobiolaging.2005.05.014
   Poon HF, 2006, NEUROBIOL AGING, V27, P1010, DOI 10.1016/j.neurobiolaging.2005.05.006
   Rabilloud T, 1998, ELECTROPHORESIS, V19, P758, DOI 10.1002/elps.1150190526
   Robinson LJ, 2003, J PROTEOME RES, V2, P556, DOI 10.1021/pr034035k
   Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427
   Rubin H, 1997, MECH AGEING DEV, V98, P1, DOI 10.1016/S0047-6374(97)00067-5
   Song JW, 2001, NAT CELL BIOL, V3, P276, DOI 10.1038/35060068
   Sultana R, 2006, NEUROBIOL AGING, V27, P1564, DOI 10.1016/j.neurobiolaging.2005.09.021
   Tan JC, 2009, J AM SOC NEPHROL, V20, P181, DOI 10.1681/ASN.2008030306
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Tomás-Zapico C, 2006, CAN J PHYSIOL PHARM, V84, P213, DOI 10.1139/Y05-111
   VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105
   Wang H, 2003, EXP GERONTOL, V38, P507, DOI 10.1016/S0531-5565(03)00036-6
   Yang S, 2008, NEUROSCIENCE, V154, P1107, DOI 10.1016/j.neuroscience.2008.04.012
NR 54
TC 17
Z9 19
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1477-5956
J9 PROTEOME SCI
JI Proteome Sci.
PD APR 9
PY 2009
VL 7
AR 16
DI 10.1186/1477-5956-7-16
PG 12
WC Biochemical Research Methods
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 450TP
UT WOS:000266424100001
PM 19358702
OA Green Published, gold, Green Submitted
DA 2024-02-19
ER

PT J
AU WANG, YJ
   HO, YS
   LO, MJ
   LIN, JK
AF WANG, YJ
   HO, YS
   LO, MJ
   LIN, JK
TI OXIDATIVE MODIFICATION OF DNA BASES IN RAT-LIVER AND LUNG DURING
   CHEMICAL CARCINOGENESIS AND AGING
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE MODIFIED BASES; LIVER; LUNG; CARCINOGENESIS; AGING
ID CHROMATOGRAPHY MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; OXYGEN RADICALS;
   DEOXYRIBONUCLEIC-ACID; GAMMA-IRRADIATION; ESCHERICHIA-COLI; THYMINE
   GLYCOL; DAMAGE; CANCER; N-NITROSO-N-2-FLUORENYLACETAMIDE
AB The extent of DNA modification in cancerous rat liver and lung tissues was investigated and compared to their respective normal tissues. Liver tumors were induced by 2-fluorenyl-acetamide (2-FAA) or N-nitroso-N-2-fluorenylacetamide (N-NO-2-FAA), and lung tumors were induced by sodium nitrite plus trimethylamine. In the DNA samples isolated from these tissues, two pyrimidine-derived and four purine-derived modified DNA bases were identified and quantified by gas chromatography/mass spectrometry with selected-ion monitoring. These compounds were characterized as 5-hydroxyuracil (5-OHUra), thymine glycol (TG), 4,6-diamino-5-formamidopyrimidine (FapyAde), 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyGua), 8-hydroxyadenine (8-OHAde), and 8-hydroxyguanine (8-OHGua). Elevated amounts of modified DNA bases were found in most cancerous tissues when compared to the controls. Chemicals used for tumor induction were responsible for inducing DNA lesions that could be promutagenic in vivo and could lead to various types of mutations. When endogenous oxidative damage to DNA during aging was examined, a roughly 2-fold increase of thymine glycol, 8-OHAde and 8-OHGua was found in aged (12 months) rat liver tissues compared to young tissues (1 month). The same results were also found in lung tissues, except that the amount of thymine glycol exhibited more than a IO-fold increase in aged tissues when compared to young tissues. The association of the modified bases with the processes of aging and carcinogenesis deserves further investigation.
C1 NATL TAIWAN UNIV,COLL MED,INST BIOCHEM,TAIPEI,TAIWAN.
C3 National Taiwan University
CR ADELMAN R, 1988, P NATL ACAD SCI USA, V85, P2706, DOI 10.1073/pnas.85.8.2706
   AMES BN, 1983, SCIENCE, V221, P1256, DOI 10.1126/science.6351251
   AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6
   AMES BN, 1989, FREE RADICAL RES COM, V7, P121, DOI 10.3109/10715768909087933
   BLAKELY WF, 1990, RADIAT RES, V121, P338, DOI 10.2307/3577785
   CATHCART R, 1984, P NATL ACAD SCI-BIOL, V81, P5633, DOI 10.1073/pnas.81.18.5633
   CAVALIERI LF, 1950, J AM CHEM SOC, V72, P2587, DOI 10.1021/ja01162a067
   CHENG KC, 1992, J BIOL CHEM, V267, P166
   CIFONE MA, 1981, P NATL ACAD SCI-BIOL, V78, P6949, DOI 10.1073/pnas.78.11.6949
   CROSS CE, 1987, ANN INTERN MED, V107, P526, DOI 10.7326/0003-4819-107-4-526
   DIZDAROGLU M, 1985, ANAL BIOCHEM, V144, P593, DOI 10.1016/0003-2697(85)90158-7
   DIZDAROGLU M, 1986, ANAL BIOCHEM, V156, P182, DOI 10.1016/0003-2697(86)90171-5
   DIZDAROGLU M, 1991, FREE RADICAL BIO MED, V10, P225, DOI 10.1016/0891-5849(91)90080-M
   DJURIC Z, 1991, CHEM RES TOXICOL, V4, P687, DOI 10.1021/tx00024a014
   DODD GD, 1991, CANCER, V68, P2493, DOI 10.1002/1097-0142(19911201)68:11+<2493::AID-CNCR2820681502>3.0.CO;2-N
   DOETSCH PW, 1987, MOL CELL BIOL, V7, P26, DOI 10.1128/MCB.7.1.26
   FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533
   FREEMAN BA, 1982, LAB INVEST, V47, P412
   FRENKEL K, 1981, BIOCHEMISTRY-US, V20, P750, DOI 10.1021/bi00507a014
   FRENKEL K, 1989, ENVIRON HEALTH PERSP, V81, P45, DOI 10.2307/3430803
   FUCIARELLI AF, 1989, RADIAT RES, V119, P219, DOI 10.2307/3577615
   GUPTA RC, 1984, P NATL ACAD SCI-BIOL, V81, P6943, DOI 10.1073/pnas.81.22.6943
   HALIWELL B, 1989, FEBS LETT
   HALIWELL B, 1991, FEBS LETT, V281, P9
   KUO ML, 1989, MUTAT RES, V212, P231, DOI 10.1016/0027-5107(89)90074-2
   LESKO SA, 1985, MUTAT RES, V149, P119, DOI 10.1016/0027-5107(85)90016-8
   LIN JK, 1988, MUTAT RES, V201, P117, DOI 10.1016/0027-5107(88)90118-2
   MALINS DC, 1993, CANCER-AM CANCER SOC, V71, P3036, DOI 10.1002/1097-0142(19930515)71:10<3036::AID-CNCR2820711025>3.0.CO;2-P
   MALINS DC, 1993, J TOXICOL ENV HEALTH, V40, P247, DOI 10.1080/15287399309531792
   MALINS DC, 1991, CANCER RES, V51, P5430
   MALINS DC, 1990, BIOCHEM BIOPH RES CO, V173, P614, DOI 10.1016/S0006-291X(05)80079-8
   MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y
   OLINSKI R, 1992, FEBS LETT, V309, P193, DOI 10.1016/0014-5793(92)81093-2
   PERCHELLET JP, 1989, FREE RADICAL BIO MED, V7, P377, DOI 10.1016/0891-5849(89)90124-X
   SIES H, 1984, METHOD ENZYMOL, V105, P445
   SRINIVASAN S, 1990, CARCINOGENESIS, V11, P2021, DOI 10.1093/carcin/11.11.2021
   STEENKEN S, 1989, CHEM REV, V89, P503, DOI 10.1021/cr00093a003
   SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D
   TROLL W, 1985, ANNU REV PHARMACOL, V25, P509, DOI 10.1146/annurev.pharmtox.25.1.509
   WILLIAMS GM, 1991, TOXICOLOGY BASIC SCI, P152
   YRUSH MA, 1991, FREE RADICAL BIO MED, V10, P201
NR 41
TC 52
Z9 58
U1 0
U2 5
PU ELSEVIER SCI PUBL IRELAND LTD
PI CLARE
PA CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND
SN 0009-2797
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD FEB
PY 1995
VL 94
IS 2
BP 135
EP 145
DI 10.1016/0009-2797(94)03327-5
PG 11
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA QF443
UT WOS:A1995QF44300004
PM 7828220
DA 2024-02-19
ER

PT J
AU Torgersen, J
   So-Armah, K
   Freiberg, MS
   Goetz, MB
   Budofl, MJ
   Lim, JK
   Taddei, T
   Butt, AA
   Rodriguez-Barradas, MC
   Justice, AC
   Kostman, JR
   Lo Re, V
AF Torgersen, Jessie
   So-Armah, Kaku
   Freiberg, Matthew S.
   Goetz, Matthew B.
   Budofl, Matthew J.
   Lim, Joseph K.
   Taddei, Tamar
   Butt, Adeel A.
   Rodriguez-Barradas, Maria C.
   Justice, Amy C.
   Kostman, Jay R.
   Lo Re, Vincent, III
TI Comparison of the prevalence, severity, and risk factors for hepatic
   steatosis in HIV-infected and uninfected people
SO BMC GASTROENTEROLOGY
LA English
DT Article
DE Hepatic steatosis; HIV; Liver fibrosis
ID NONALCOHOLIC FATTY LIVER; C VIRUS; ANTIRETROVIRAL THERAPY; SAMPLING
   VARIABILITY; DISEASE; FIBROSIS; OBESITY; BIOPSY; ADULTS; CIRRHOSIS
AB Background: Hepatic steatosis is prevalent in Western countries, but few studies have evaluated whether the frequency and severity of steatosis are greater in the setting of HIV infection. We compared the prevalence and severity of hepatic steatosis between HIV-infected (HIV+) and uninfected persons and identified factors associated with greater steatosis severity within both groups.
   Methods: We performed a cross-sectional study among participants without cardiovascular disease who participated in a substudy of the Veterans Aging Cohort Study. Hepatic steatosis was defined by noncontrast computed tomography (CT) liver-to-spleen (L/S) attenuation ratio < 1.0. Multivariable linear regression was used to: 1) evaluate the association between HIV infection and severity of hepatic steatosis, as measured by absolute liver attenuation, and 2) identify factors associated with greater severity of steatosis, by HIV status.
   Results: Among 268 participants (median age, 55 years; 99% male; 79% black; 23% obese; 64% HIV+ [91% on antiretroviral therapy]), the overall prevalence of steatosis was 7.8% and was similar between HIV+ and uninfected individuals (13 [7.6%] versus 8 [8.2%], respectively; p=0.85). Participants with HIV, the majority of whom received antiretroviral therapy, had a higher mean absolute liver attenuation (mean difference, 5.68 Hounsfield units; p<0.001), correlating with lesser hepatic steatosis severity, compared to uninfected participants. After adjusting for covariates, only advanced hepatic fibrosis was associated with greater severity of steatosis in HIV+ persons (p=0.03) and uninfected individuals (p<0.001).
   Conclusions: In this sample of participants without cardiovascular disease, the prevalence of hepatic steatosis by noncontrast abdominal CT was not different by HIV status. Increasing severity of steatosis was independently associated with advanced hepatic fibrosis in both groups.
C1 [Torgersen, Jessie] Univ Penn, Dept Med, Perelman Sch Med, 3910 Powelton Ave 4nd Floor,Ste 411F, Philadelphia, PA 19104 USA.
   [So-Armah, Kaku] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.
   [Freiberg, Matthew S.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.
   [Goetz, Matthew B.; Budofl, Matthew J.] UCLA, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.
   [Goetz, Matthew B.] VA Greater Los Angeles Healthcare Syst, Los Angeles, CA USA.
   [Lim, Joseph K.; Taddei, Tamar; Justice, Amy C.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA.
   [Taddei, Tamar; Justice, Amy C.] VA Connecticut Healthcare, West Haven, CT USA.
   [Butt, Adeel A.] Weill Cornell Med Coll, Dept Med, Ar Rayyan, Qatar.
   [Rodriguez-Barradas, Maria C.] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA.
   [Kostman, Jay R.] Philadelphia FIGHT, John Bell Hlth Ctr, Houston, TX USA.
   [Lo Re, Vincent, III] Univ Penn, Dept Med & Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Boston University; Vanderbilt University;
   University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Greater Los Angeles Healthcare System; Yale
   University; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); VA Connecticut Healthcare System; Qatar Foundation
   (QF); Weill Cornell Medical College Qatar; Baylor College of Medicine;
   University of Pennsylvania
RP Torgersen, J (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, 3910 Powelton Ave 4nd Floor,Ste 411F, Philadelphia, PA 19104 USA.
EM jessie.torgersen@uphs.upenn.edu
RI Goetz, Matthew Bidwell/GPX-4090-2022; Freiberg, Matthew/IYJ-5456-2023;
   Budoff, Matthew/ABD-5175-2021
OI Budoff, Matthew/0000-0002-9616-1946; Goetz, Matthew/0000-0003-4542-992X;
   So-Armah, Kaku/0000-0003-1505-6384
FU National Cancer Institute [R01CA206465]; National Institutes on Alcohol
   Abuse and Alcoholism [U01AA013566]
FX This study was funded, in part, by the National Cancer Institute
   (R01CA206465). The Veterans Aging Cohort Study is supported by a
   research grant from National Institutes on Alcohol Abuse and Alcoholism
   (U01AA013566). The funding agencies had no involvement in the analysis,
   interpretation of results, or development of this manuscript.
CR Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557
   Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501
   Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5
   Borghi V, 2013, INFECTION, V41, P425, DOI 10.1007/s15010-012-0378-7
   Bradley KA, 2006, AM J MANAG CARE, V12, P597
   Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af
   Caldwell SH, 2009, ANN HEPATOL, V8, P346, DOI 10.1016/S1665-2681(19)31748-X
   Castéra L, 2007, ALIMENT PHARM THER, V26, P1489, DOI 10.1111/j.1365-2036.2007.03533.x
   Crum-Cianflone NF, 2011, HIV MED, V12, P463, DOI 10.1111/j.1468-1293.2010.00904.x
   Crum-Cianflone N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010106
   FREEDMAN VA, 1995, DEMOGRAPHY, V32, P459, DOI 10.2307/2061691
   Gaslightwala I, 2006, J HEPATOL, V44, P1026, DOI 10.1016/j.jhep.2006.02.009
   Halfon P, 2009, ALIMENT PHARM THER, V30, P61, DOI 10.1111/j.1365-2036.2009.03995.x
   Haufe S, 2011, HEPATOLOGY, V53, P1504, DOI 10.1002/hep.24242
   Hoffmann CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117813
   Justice AC, 2006, MED CARE, V44, pS13, DOI 10.1097/01.mlr.0000223741.02074.66
   Kanwal F, 2016, CLIN GASTROENTEROL H, V14, P301, DOI 10.1016/j.cgh.2015.08.010
   Kinner S, 2016, DIGEST DIS SCI, V61, P1337, DOI 10.1007/s10620-016-4037-1
   Kodama Y, 2007, AM J ROENTGENOL, V188, P1307, DOI 10.2214/AJR.06.0992
   Koethe JR, 2016, AIDS RES HUM RETROV, V32, P50, DOI 10.1089/aid.2015.0147
   Lemoine M, 2012, CURR OPIN INFECT DIS, V25, P10, DOI 10.1097/QCO.0b013e32834ef599
   Lui G, 2016, ALIMENT PHARM THER, V44, P411, DOI 10.1111/apt.13702
   Mangili A, 2006, CLIN INFECT DIS, V42, P836, DOI 10.1086/500398
   McGinnis KA, 2016, DRUG ALCOHOL DEPEN, V168, P196, DOI 10.1016/j.drugalcdep.2016.09.015
   Mellinger JL, 2015, J HEPATOL, V63, P470, DOI 10.1016/j.jhep.2015.02.045
   Monto A, 2005, HEPATOLOGY, V42, P310, DOI 10.1002/hep.20805
   Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5
   Park BJ, 2008, J GASTROEN HEPATOL, V23, P900, DOI 10.1111/j.1440-1746.2007.05212.x
   Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361
   Park YS, 2011, RADIOLOGY, V258, P760, DOI 10.1148/radiol.10101233
   Price JC, 2017, HEPATOLOGY, V65, P853, DOI 10.1002/hep.28968
   Price JC, 2014, AM J GASTROENTEROL, V109, P695, DOI 10.1038/ajg.2014.32
   Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084
   Rinella ME, 2015, JAMA-J AM MED ASSOC, V313, P2263, DOI 10.1001/jama.2015.5370
   Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742
   Saag MS, 2018, JAMA-J AM MED ASSOC, V320, P379, DOI 10.1001/jama.2018.8431
   Shores NJ, 2011, DIGEST DIS SCI, V56, P2145, DOI 10.1007/s10620-011-1602-5
   Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8
   Solomon SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147879
   Soriano V, 2013, AIDS REV, V15, P25
   Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178
   Tate T, 2012, ANTIVIR THER, V17, P1281, DOI 10.3851/IMP2348
   Vecchi VL, 2013, ANN HEPATOL, V12, P740, DOI 10.1016/S1665-2681(19)31315-8
   Vuppalanchi R, 2009, CLIN GASTROENTEROL H, V7, P481, DOI 10.1016/j.cgh.2008.12.015
   Xiao GQ, 2017, HEPATOLOGY, V66, P1486, DOI 10.1002/hep.29302
   Zeb I, 2016, J AM COLL CARDIOL, V67, P1965, DOI 10.1016/j.jacc.2016.01.070
   Zeb I, 2012, ACAD RADIOL, V19, P811, DOI 10.1016/j.acra.2012.02.022
NR 47
TC 7
Z9 7
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-230X
J9 BMC GASTROENTEROL
JI BMC Gastroenterol.
PD APR 15
PY 2019
VL 19
AR 52
DI 10.1186/s12876-019-0969-1
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA HT8RV
UT WOS:000464833200001
PM 30987601
OA Green Published, gold
DA 2024-02-19
ER

PT J
AU Dobrzynska, I
   Sniecinska, A
   Skrzydlewska, E
   Figaszewski, Z
AF Dobrzynska, I
   Sniecinska, A
   Skrzydlewska, E
   Figaszewski, Z
TI Green tea modulation of the biochemical and electric properties of rat
   liver cells that were affected by ethanol and aging
SO CELLULAR & MOLECULAR BIOLOGY LETTERS
LA English
DT Article
DE ethanol; green tea; lipid peroxidation; liver; surface charge density
ID INDUCED LIPID-PEROXIDATION; LOW-DENSITY-LIPOPROTEIN; MEMBRANE-FLUIDITY;
   XANTHINE-OXIDASE; OXYGEN RADICALS; ANTIOXIDANT; ACETALDEHYDE;
   POLYPHENOLS; CATECHINS; PLASMA
AB The oxidative stress induced by chronic ethanol consumption, particularly in concert with the aging process, has been implicated in changes in the structure and functions of liver cell components including membrane phospholipids. To counteract such changes, particularly those resulting from lipid peroxidation, antioxidants may be applied. Green tea contains large amounts of polyphenols, mainly catechins, which possess antioxidant properties. The aim of this study was to estimate the efficacy of green tea's influence on the physicochemical and biochemical properties of the rat liver as affected by the aging process and/or chronic ethanol intoxication. Several methods were used to evaluate this effect. Antioxidant properties were evaluated by vitamin E and antioxidant status determination. The liver trigliceride and cholesterol levels were also estimated. The extent of lipid peroxidation was determined by measuring the level of lipid peroxidation products as thiobarbituric reactive substances (TBARS). The surface charge density of the rat liver cells was measured using electrophoresis. The concentration of the marker enzymes of liver damage (alanine aminotransferase and aspartate aminotransferase) in the blood serum was also evaluated. Relative to the controls, aging was found to cause a decrease in the liver's antioxidant abilities and provoke an increase in the level of lipid peroxidation; it also increased the surface charge density of the rat liver cell membrane. Ethanol significantly aggravated these changes. This might have resulted in the liver cell membrane damage visible as a leak of alanine aminotransferase and aspartate aminotransferase into the blood. The ingestion of green tea with ethanol partially prevented these aging and/or ethanol-induced changes. Long-term drinking of green tea partially prevents the changes in the structure and function of the cell membrane caused by chronic ethanol intoxication.
C1 Med Acad Bialystok, Dept Analyt Chem, PL-15230 Bialystok, Poland.
   Univ Bialystok, Inst Chem, PL-15443 Bialystok, Poland.
   Univ Warsaw, Lab Interfac Electrochem, Fac Chem, Warsaw, Poland.
C3 University of Bialystok; University of Warsaw
RP Skrzydlewska, E (corresponding author), Med Acad Bialystok, Dept Analyt Chem, Ul Mickiewicza 2, PL-15230 Bialystok, Poland.
EM skrzydle@amb.edu.pl
OI Skrzydlewska, Elzbieta/0000-0001-5397-7139
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Arora A, 2000, ARCH BIOCHEM BIOPHYS, V373, P102, DOI 10.1006/abbi.1999.1525
   Aucamp J, 1997, ANTICANCER RES, V17, P4381
   BARROW GM, 1996, PHYSL CHEM
   BENGA G, 1984, PROG BIOPHYS MOL BIO, V43, P195, DOI 10.1016/0079-6107(84)90014-2
   BOX HC, 1995, RADIAT RES, V141, P91, DOI 10.2307/3579095
   BUNKER VW, 1992, MED LAB SCI, V49, P299
   Chen LJ, 2002, TOXICOL SCI, V69, P149, DOI 10.1093/toxsci/69.1.149
   CHIU D, 1989, SEMIN HEMATOL, V26, P257
   DIX TA, 1993, CHEM RES TOXICOL, V6, P2, DOI 10.1021/tx00031a001
   DOLOWY K, 1984, PROG SURF SCI, V15, P245, DOI 10.1016/0079-6816(84)90013-3
   ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6
   Gennis R., 1989, BIOMEMBRANE MOL STRU
   Guo QN, 1996, BBA-LIPID LIPID MET, V1304, P210, DOI 10.1016/S0005-2760(96)00122-1
   Halliwell B., 2001, FREE RADICALS BIOL M
   JAIN SK, 1985, J CLIN INVEST, V76, P281, DOI 10.1172/JCI111958
   JOVANOVIC SV, 1995, J AM CHEM SOC, V117, P9881, DOI 10.1021/ja00144a014
   KATO S, 1990, GASTROENTEROLOGY, V98, P203, DOI 10.1016/0016-5085(90)91311-S
   KHAN SG, 1992, CANCER RES, V52, P4050
   KLEMM WR, 1990, ALCOHOL, V7, P49, DOI 10.1016/0741-8329(90)90060-P
   KLEMM WR, 1992, DRUG ALCOHOL ABUSE R, V3, P169
   KRYSINSKI P, 1986, PROG SURF SCI, V23, P317
   Lee MJ, 2000, ANAL BIOCHEM, V279, P164, DOI 10.1006/abio.2000.4487
   LIEBER CS, 1970, J BIOL CHEM, V245, P2505
   Lieber CS, 1997, CLIN CHIM ACTA, V257, P59, DOI 10.1016/S0009-8981(96)06434-0
   Luczaj W, 2004, J TOXICOL ENV HEAL A, V67, P595, DOI 10.1080/15287390490425579
   Maiani G, 1997, J CHROMATOGR B, V692, P311, DOI 10.1016/S0378-4347(97)00009-1
   MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407
   NAEIM F, 1985, HDB BIOL AGING
   Nagata N, 1998, ALCOHOL CLIN EXP RES, V22, p150S, DOI 10.1111/acer.1998.22.s3_part1.150s
   Natsume M, 2003, FREE RADICAL BIO MED, V34, P840, DOI 10.1016/S0891-5849(02)01434-X
   Niemelä O, 1998, ALCOHOL CLIN EXP RES, V22, P2118, DOI 10.1097/00000374-199812000-00032
   Okushio K, 1999, DRUG METAB DISPOS, V27, P309
   Ostrowska J, 2004, ALCOHOL, V32, P25, DOI 10.1016/j.alcohol.2003.11.001
   Périchon R, 1998, CELL MOL LIFE SCI, V54, P641, DOI 10.1007/s000180050192
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   ROUACH H, 1990, BIOCHEM PHARMACOL, V39, P1095, DOI 10.1016/0006-2952(90)90289-W
   SALARIS SC, 1988, J PHARM METHOD, V20, P325
   SCOTT JA, 1988, FREE RADICAL BIO MED, V5, P237, DOI 10.1016/0891-5849(88)90017-2
   SEPPI C, 1991, MECH AGEING DEV, V57, P247, DOI 10.1016/0047-6374(91)90050-A
   Skrzydlewska E, 2002, ADDICT BIOL, V7, P307, DOI 10.1080/13556210220139523
   SLATER SJ, 1993, BIOCHEMISTRY-US, V32, P3714, DOI 10.1021/bi00065a025
   Tsuchiya H, 1999, PHARMACOLOGY, V59, P34, DOI 10.1159/000028303
   TUMA DJ, 1987, ALCOHOL CLIN EXP RES, V11, P579, DOI 10.1111/j.1530-0277.1987.tb00178.x
   TUMA DJ, 1984, ARCH BIOCHEM BIOPHYS, V234, P377, DOI 10.1016/0003-9861(84)90283-2
   VARGA M, 1990, EXP MOL PATHOL, V52, P249, DOI 10.1016/0014-4800(90)90010-B
   VARGA M, 1989, PHARMACOL BIOCHEM BE, V33, P523, DOI 10.1016/0091-3057(89)90380-8
   ZHAO BL, 1989, CELL BIOPHYS, V14, P175, DOI 10.1007/BF02797132
   Zhu QY, 1999, J AGR FOOD CHEM, V47, P2020, DOI 10.1021/jf9809941
NR 49
TC 28
Z9 29
U1 0
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1425-8153
EI 1689-1392
J9 CELL MOL BIOL LETT
JI Cell. Mol. Biol. Lett.
PY 2004
VL 9
IS 4A
BP 709
EP 721
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology
GA 884TR
UT WOS:000226109800012
PM 15647793
DA 2024-02-19
ER

PT J
AU Tsuduki, T
   Honma, T
   Nakagawa, K
   Ikeda, I
   Miyazawa, T
AF Tsuduki, Tsuyoshi
   Honma, Taro
   Nakagawa, Kiyotaka
   Ikeda, Ikuo
   Miyazawa, Teruo
TI Long-term intake of fish oil increases oxidative stress and decreases
   lifespan in senescence-accelerated mice
SO NUTRITION
LA English
DT Article
DE Fish oil; Lifespan; omega-3 Polyunsaturated fatty; omega-3 Fatty acid;
   SAMP8; Senescence-accelerated mice
ID POLYUNSATURATED FATTY-ACIDS; CONJUGATED LINOLENIC ACID;
   ALPHA-ELEOSTEARIC-ACID; LIPID-PEROXIDATION; DOCOSAHEXAENOIC ACID; TRIENE
   SYSTEM; TUMOR-GROWTH; MOUSE; SUPPRESSION; ISOMER
AB Objective: The effects of fish oil including omega-3 polyunsaturated fatty acids on aging and lifespan are not well understood. In this study, the influence of long-term ingestion of fish oil on lifespan was examined in senescence-accelerated (SAMP8) mice.
   Methods: We investigated the effects of dietary fish oil on lifespan and on lipid composition and oxidative stress in plasma and liver in SAMP8 mice. Male mice were fed a fish oil diet (5% fish oil and 5% safflower oil) or a safflower oil diet (10% safflower oil) from 12 wk of age.
   Results: The SAMP8 mice fed fish oil did not have a longer maximum lifespan and had a shorter average lifespan than mice fed safflower oil. To examine the mechanism underlying these results, the effects on oxidative stress of long-term ingestion of fish oil were also examined. SAMP8 mice fed fish oil for 28 wk showed strong oxidative stress that caused hyperoxidation of membrane phospholipids and a diminished antioxidant defense system due to a decrease in tocopherol compared with mice fed safflower oil.
   Conclusion: These findings suggest that intake of fish oil increases oxidative stress, decreases cellular function, and causes organ dysfunction in SAMP8 mice, thereby promoting aging and shortening the lifespan of the mice. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Tsuduki, Tsuyoshi; Honma, Taro; Ikeda, Ikuo] Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Sendai, Miyagi 980, Japan.
   [Nakagawa, Kiyotaka; Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr, Food & Biodynam Chem Lab, Sendai, Miyagi 980, Japan.
C3 Tohoku University; Tohoku University
RP Tsuduki, T (corresponding author), Tohoku Univ, Grad Sch Agr, Lab Food & Biomol Sci, Sendai, Miyagi 980, Japan.
EM tsuzukit@biochem.tohoku.ac.jp
RI Tsuduki, Tsuyoshi/C-2254-2016; Tsuduki, Tsuyoshi/T-2697-2019; Tsuduki,
   Tsuyoshi/E-4717-2012
OI Tsuduki, Tsuyoshi/0000-0001-7810-0528; 
FU JSPS, Japan [20157639]
FX This study was supported by KAKENHI (20157639) of JSPS, Japan.
CR BARTLETT GR, 1957, J BIOL CHEM, V226, P497
   BEGIN ME, 1988, J NATL CANCER I, V80, P188, DOI 10.1093/jnci/80.3.188
   Butterfield DA, 2005, EXP GERONTOL, V40, P774, DOI 10.1016/j.exger.2005.05.007
   Calviello G, 2009, NUTR CANCER, V61, P287, DOI 10.1080/01635580802582777
   GARRIDO A, 1989, LIPIDS, V24, P833, DOI 10.1007/BF02544593
   Hung MC, 2001, BRIT J NUTR, V86, P163, DOI 10.1079/BJN2001391
   KAASGAARD SG, 1992, LIPIDS, V27, P740, DOI 10.1007/BF02535843
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kawakami Y, 2007, BIOSCI BIOTECH BIOCH, V71, P464, DOI 10.1271/bbb.60524
   Lavie CJ, 2009, J AM COLL CARDIOL, V54, P585, DOI 10.1016/j.jacc.2009.02.084
   Matsugo S, 2000, NEUROSCI LETT, V278, P105, DOI 10.1016/S0304-3940(99)00907-6
   MEYDANI M, 1991, J NUTR, V121, P484, DOI 10.1093/jn/121.4.484
   Milte CM, 2008, BRIT J NUTR, V99, P1083, DOI 10.1017/S000711450785344X
   MIYASHITA K, 1986, J AM OIL CHEM SOC, V63, P1380, DOI 10.1007/BF02679607
   Mori TA, 2001, CURR OPIN LIPIDOL, V12, P11, DOI 10.1097/00041433-200102000-00003
   Rebrin I, 2005, FREE RADICAL BIO MED, V39, P549, DOI 10.1016/j.freeradbiomed.2005.04.008
   Sirtori CR, 2002, BIOMED PHARMACOTHER, V56, P397, DOI 10.1016/S0753-3322(02)00255-X
   Spencer L, 2009, EUR J CANCER, V45, P2077, DOI 10.1016/j.ejca.2009.04.026
   TAKEDA T, 1991, J AM GERIATR SOC, V39, P911, DOI 10.1111/j.1532-5415.1991.tb04460.x
   Tsuzuki T, 2004, LIPIDS, V39, P475, DOI 10.1007/s11745-004-1253-z
   Tsuzuki T, 2004, J NUTR, V134, P1162, DOI 10.1093/jn/134.5.1162
   Tsuzuki T, 2004, CARCINOGENESIS, V25, P1417, DOI 10.1093/carcin/bgh109
   Tsuzuki T, 2003, J NUTR SCI VITAMINOL, V49, P195, DOI 10.3177/jnsv.49.195
   Tsuzuki T, 2008, CARCINOGENESIS, V29, P797, DOI 10.1093/carcin/bgm298
   Tsuzuki T, 2006, J NUTR BIOCHEM, V17, P518, DOI 10.1016/j.jnutbio.2005.09.006
   Tsuzuki T, 2006, J NUTR, V136, P2153, DOI 10.1093/jn/136.8.2153
   Umezawa M, 2000, J NUTR, V130, P221, DOI 10.1093/jn/130.2.221
NR 27
TC 66
Z9 72
U1 2
U2 23
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0899-9007
J9 NUTRITION
JI Nutrition
PD MAR
PY 2011
VL 27
IS 3
BP 334
EP 337
DI 10.1016/j.nut.2010.05.017
PG 4
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 725ZF
UT WOS:000287684700013
PM 20621447
DA 2024-02-19
ER

PT J
AU Zhang, YJ
   Zhang, YY
   Xiao, YY
   Zhong, CG
   Xiao, F
AF Zhang, Yujing
   Zhang, Yiyuan
   Xiao, Yuanyuan
   Zhong, Caigao
   Xiao, Fang
TI Expression of Clusterin suppresses Cr(VI)-induced premature senescence
   through activation of PI3K/AKT pathway
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Hexavalent chromium [Cr(VI)]; Clusterin (CLU); Premature senescence;
   Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (AKT); L-02
   hepatocytes
ID ENDOTHELIAL PROGENITOR CELLS; CELLULAR SENESCENCE; METASTASIS; SURVIVAL
AB Our group found that long-term low-dose exposure to hexavalent chromium [Cr(VI)] in L-02 hepatocytes resulted in premature senescence, which accompanied by the increased expression of Clusterin (CLU), but the functional role of CLU in premature senescence has never been explored. In the present study, the CLU over-expressed or silenced L-02 hepatocytes were established by lentiviral vector transfection. Cell viability assay, cell cycle analysis, western blotting, plate clone formation assay, and confocal microcopy were performed. The results indicated that Cr(VI)-induced premature senescence was associated with phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) pathway inhibition, and high expression of CLU in the senescent cells exerted its functional role of promoting cell proliferation. CLU could complex with eukaryotic translation initiation factor 3 subunit I (EIF3I) and prevent its degradation, leading to the increase of AKT activity in Cr(VI)-exposed senescent hepatocytes. Blockage of the PI3K/AKT pathway with its inhibitor LY294002 eliminated the inhibitory effect of CLU on Cr(VI)-induced premature senescence. We concluded that high expression of CLU suppressed Cr(VI)-induced premature senescence through activation of PI3K/AKT pathway, which will provide the experimental basis for the study of Cr(VI)-induced liver cancer, especially for the elucidation of the mechanism of liver cancer cells escaping from senescence.
C1 [Zhang, Yujing; Zhang, Yiyuan; Xiao, Yuanyuan; Zhong, Caigao; Xiao, Fang] Cent South Univ, Xiangya Sch Publ Hlth, Dept Hlth Toxicol, Changsha 410078, Hunan, Peoples R China.
C3 Central South University
RP Xiao, F (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Hlth Toxicol, Changsha 410078, Hunan, Peoples R China.
EM fangxiao@csu.edu.cn
RI wu, jun/ISB-8607-2023; Li, Nan/IXD-8260-2023; Li, Fan/JRY-4017-2023;
   Xiao, Fang/S-9283-2018; yan, wang/JRW-9981-2023; Zhang, Y
   J/HLG-1022-2023; zhang, yu/HNS-5948-2023
FU National Natural Science Foundation of China [81773478]; Natural Science
   Foundation of Hunan Province, China [2019JJ40402]
FX We thank all of the individuals in this laboratory for their valuable
   suggestions. The current work was supported by National Natural Science
   Foundation of China (NO. 81773478) and Natural Science Foundation of
   Hunan Province, China (NO. 2019JJ40402).
CR Abreu PL, 2018, BIOMETALS, V31, P477, DOI 10.1007/s10534-018-0093-7
   Ammar H, 2008, J BIOL CHEM, V283, P12851, DOI 10.1074/jbc.M800403200
   de Jesus BB, 2012, CIRC RES, V111, P97, DOI 10.1161/CIRCRESAHA.111.247866
   Bononi Angela, 2011, Enzyme Res, V2011, P329098, DOI 10.4061/2011/329098
   Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653
   Chen DH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.334
   Chikara S, 2017, NUTR CANCER, V69, P652, DOI 10.1080/01635581.2017.1296169
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Jiang LL, 2015, ONCOTARGET, V6, P8286, DOI 10.18632/oncotarget.3221
   Jiang YN, 2015, ONCOTARGET, V6, P40719, DOI 10.18632/oncotarget.5825
   Joo Kwan ng, 2011, The World Journal of Men's Health, V29, P43
   Kohsaka S, 2011, BIOCHEM BIOPH RES CO, V410, P878, DOI 10.1016/j.bbrc.2011.06.082
   Li J, 2013, MOL MED REP, V7, P598, DOI 10.3892/mmr.2012.1180
   Linos A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-50
   Lukin DJ, 2015, MOL CANCER RES, V13, P16, DOI 10.1158/1541-7786.MCR-14-0177
   Luo X., 2014, PLOS ONE, V9
   Luo XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099983
   Ma JC, 2010, J SURG RES, V160, P90, DOI 10.1016/j.jss.2008.08.016
   Matukumalli SR, 2017, SCI REP-UK, V7, DOI 10.1038/srep41235
   Muñoz-Espín D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823
   Pan CH, 2018, J EXPO SCI ENV EPID, V28, P76, DOI 10.1038/jes.2016.85
   Pérez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Qi L., 2018, L 02 HEPATOCYTES, V7
   Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316
   Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094
   Rohne Philipp, 2016, BioMolecular Concepts, V7, P1, DOI 10.1515/bmc-2015-0026
   Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982
   Thill M, 2011, MOL VIS, V17, P85
   Vargas A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182389
   Vishnu VY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166369
   Wang C, 2015, ONCOTARGET, V6, P2903, DOI 10.18632/oncotarget.3093
   Wang R, 2017, AGING CELL, V16, P564, DOI 10.1111/acel.12587
   Wang YF, 2018, INT J MOL MED, V41, P233, DOI 10.3892/ijmm.2017.3219
   Wang YW, 2013, HEPATOLOGY, V58, P239, DOI 10.1002/hep.26352
   Xiao YY, 2019, TOXICOL RES-UK, V8, P15, DOI 10.1039/c8tx00231b
   Xiu P, 2015, WORLD J GASTROENTERO, V21, P8262, DOI 10.3748/wjg.v21.i27.8262
   Xu M, 2015, INT J CLIN EXP MED, V8, P12476
   Xu WT, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0795-2
   Zhang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34578
   Zou Y., 2016, PLOS ONE, V11
NR 40
TC 18
Z9 19
U1 1
U2 27
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD NOV 15
PY 2019
VL 183
AR 109465
DI 10.1016/j.ecoenv.2019.109465
PG 10
WC Environmental Sciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Toxicology
GA IZ6FU
UT WOS:000487178000047
PM 31376806
DA 2024-02-19
ER

PT J
AU Apelo, SIA
   Lin, A
   Brinkman, JA
   Meyer, E
   Morrison, M
   Tomasiewicz, JL
   Pumper, CP
   Baar, EL
   Richardson, NE
   Alotaibi, M
   Lamming, DW
AF Apelo, Sebastian I. Arriola
   Lin, Amy
   Brinkman, Jacqueline A.
   Meyer, Emma
   Morrison, Mark
   Tomasiewicz, Jay L.
   Pumper, Cassidy P.
   Baar, Emma L.
   Richardson, Nicole E.
   Alotaibi, Mohammed
   Lamming, Dudley W.
TI Ovariectomy uncouples lifespan from metabolic health and reveals a
   sex-hormone-dependent role of hepatic mTORC2 in aging
SO ELIFE
LA English
DT Article
ID GLUCOSE-HOMEOSTASIS; CALORIE-RESTRICTION; MECHANISTIC TARGET;
   INSULIN-RESISTANCE; RAPAMYCIN; TOR; EXTENSION; MICE; INHIBITION;
   CASTRATION
AB Inhibition of mTOR (mechanistic Target Of Rapamycin) signaling by rapamycin promotes healthspan and longevity more strongly in females than males, perhaps because inhibition of hepatic mTORC2 (mTOR Complex 2) specifically reduces the lifespan of males. Here, we demonstrate using gonadectomy that the sex-specific impact of reduced hepatic mTORC2 is not reversed by depletion of sex hormones. Intriguingly, we find that ovariectomy uncouples lifespan from metabolic health, with ovariectomized females having improved survival despite paradoxically having increased adiposity and decreased control of blood glucose levels. Further, ovariectomy unexpectedly promotes midlife survival of female mice lacking hepatic mTORC2, significantly increasing the survival of those mice that do not develop cancer. In addition to identifying a sex hormone-dependent role for hepatic mTORC2 in female longevity, our results demonstrate that metabolic health is not inextricably linked to lifespan in mammals, and highlight the importance of evaluating healthspan in mammalian longevity studies.
C1 [Apelo, Sebastian I. Arriola; Lin, Amy; Meyer, Emma] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.
   [Apelo, Sebastian I. Arriola; Lin, Amy; Brinkman, Jacqueline A.; Meyer, Emma; Morrison, Mark; Tomasiewicz, Jay L.; Pumper, Cassidy P.; Baar, Emma L.; Richardson, Nicole E.; Alotaibi, Mohammed; Lamming, Dudley W.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.
   [Apelo, Sebastian I. Arriola; Lin, Amy; Brinkman, Jacqueline A.; Meyer, Emma; Morrison, Mark; Pumper, Cassidy P.; Baar, Emma L.; Richardson, Nicole E.; Alotaibi, Mohammed; Lamming, Dudley W.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA.
   [Richardson, Nicole E.; Alotaibi, Mohammed; Lamming, Dudley W.] Univ Wisconsin, Endocrinol & Reprod Physiol Grad Training Program, Madison, WI 53706 USA.
   [Lamming, Dudley W.] Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI 53706 USA.
C3 University of Wisconsin System; University of Wisconsin Madison; US
   Department of Veterans Affairs; Veterans Health Administration (VHA);
   William S Middleton Memorial Veterans Hospital; University of Wisconsin
   System; University of Wisconsin Madison; University of Wisconsin System;
   University of Wisconsin Madison; University of Wisconsin System;
   University of Wisconsin Madison
RP Lamming, DW (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.; Lamming, DW (corresponding author), Univ Wisconsin, Dept Med, Madison, WI 53706 USA.; Lamming, DW (corresponding author), Univ Wisconsin, Endocrinol & Reprod Physiol Grad Training Program, Madison, WI 53706 USA.; Lamming, DW (corresponding author), Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI 53706 USA.
EM dlamming@medicine.wisc.edu
RI Lamming, Dudley/O-7191-2015; Alotaibi, Mohammed I./AAC-9697-2022
OI Lamming, Dudley/0000-0002-0079-4467; Alotaibi, Mohammed
   I./0000-0002-1841-4039; Lin, Amy/0000-0003-3747-2477
FU American Federation for Aging Research; National Institute on Aging
   [AG041765, AG050135, AG051974, AG056771, AG062328, AG000213]; American
   Diabetes Association [1-16-PMF-001]; National Center for Advancing
   Translational Sciences [UL1TR002373]; Glenn Foundation for Medical
   Research; U.S. Department of Veterans Affairs [I01-BX004031]; School of
   Medicine and Public Health, University of Wisconsin-Madison
FX American Federation for Aging Research Dudley W Lamming; National
   Institute on Aging AG041765 Nicole E Richardson Dudley W Lamming;
   American Diabetes Association 1-16-PMF-001 Sebastian I Arriola Apelo;
   National Center for Advancing Translational Sciences UL1TR002373 Dudley
   W Lamming; Glenn Foundation for Medical Research Dudley W Lamming; U.S.
   Department of Veterans Affairs I01-BX004031 Dudley W Lamming; National
   Institute on Aging AG050135 Nicole E Richardson Dudley W Lamming;
   National Institute on Aging AG051974 Nicole E Richardson Dudley W
   Lamming; National Institute on Aging AG056771 Nicole E Richardson Dudley
   W Lamming; National Institute on Aging AG062328 Nicole E Richardson
   Dudley W Lamming; National Institute on Aging AG000213 Nicole E
   Richardson; School of Medicine and Public Health, University of
   Wisconsin-Madison Dudley W Lamming; The funders had no role in study
   design, data collection and interpretation, or the decision to submit
   the work for publication.
CR Apelo SIA, 2016, J GERONTOL A-BIOL, V71, P876, DOI 10.1093/gerona/glw064
   Apelo SIA, 2016, AGING CELL, V15, P28, DOI 10.1111/acel.12405
   Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768
   ASDELL SA, 1967, J REPROD FERTIL, V14, P113, DOI 10.1530/jrf.0.0140113
   BAILEY CJ, 1980, DIABETOLOGIA, V19, P475, DOI 10.1007/BF00281829
   Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112
   Bellantuono I, 2020, NAT PROTOC, V15, P540, DOI 10.1038/s41596-019-0256-1
   Benedusi V, 2015, ONCOTARGET, V6, P10801, DOI 10.18632/oncotarget.2984
   Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039
   Bitto A, 2016, ELIFE, V5, DOI 10.7554/eLife.16351
   Brayton CF, 2012, VET PATHOL, V49, P85, DOI 10.1177/0300985811430696
   Chang K, 2020, AUTOPHAGY, V16, P1807, DOI 10.1080/15548627.2019.1704117
   Chellappa K, 2019, AGING CELL, V18, DOI 10.1111/acel.13014
   Comhaire F, 2016, ANDROLOGIA, V48, P65, DOI 10.1111/and.12419
   DRORI D, 1976, EXP GERONTOL, V11, P25, DOI 10.1016/0531-5565(76)90007-3
   Dumas SN, 2020, J GERONTOL A-BIOL, V75, P14, DOI 10.1093/gerona/glz056
   Garratt M, 2018, AGING CELL, V17, DOI 10.1111/acel.12786
   Garratt M, 2017, AGING CELL, V16, P1256, DOI 10.1111/acel.12656
   Harada N, 2016, SCI REP-UK, V6, DOI 10.1038/srep23001
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Hatle JD, 2013, EXP GERONTOL, V48, P966, DOI 10.1016/j.exger.2013.06.006
   Inoue T, 2010, PROSTATE, V70, P1628, DOI 10.1002/pros.21198
   Iwasa T, 2018, HORM BEHAV, V97, P25, DOI 10.1016/j.yhbeh.2017.10.005
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kaeberlein M, 2018, GEROSCIENCE, V40, P361, DOI 10.1007/s11357-018-0036-9
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kennedy BK, 2016, CELL METAB, V23, P990, DOI 10.1016/j.cmet.2016.05.009
   Kennedy BK, 2014, CELL, V159, P708, DOI 10.1016/j.cell.2014.10.039
   Kleinert M, 2017, J PHYSIOL-LONDON, V595, P4845, DOI 10.1113/JP274203
   Kleinert M, 2014, MOL METAB, V3, P630, DOI 10.1016/j.molmet.2014.06.004
   Lamming DW, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-735
   Lamming DW, 2014, AGING CELL, V13, P911, DOI 10.1111/acel.12256
   Lamming DW, 2014, FASEB J, V28, P300, DOI 10.1096/fj.13-237743
   Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135
   Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191
   Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261
   Miller RA, 2014, AGING CELL, V13, P468, DOI 10.1111/acel.12194
   Min KJ, 2012, CURR BIOL, V22, pR792, DOI 10.1016/j.cub.2012.06.036
   Mizunuma M, 2014, AGING CELL, V13, P869, DOI 10.1111/acel.12248
   Nadon NL, 2008, AGE, V30, P187, DOI 10.1007/s11357-008-9048-1
   Pirimoglu ZM, 2011, CLIMACTERIC, V14, P453, DOI 10.3109/13697137.2010.539723
   Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Schreiber KH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11174-0
   Schreiber KH, 2015, AGING CELL, V14, P265, DOI 10.1111/acel.12313
   Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409
   Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Yu DY, 2019, CELL REP, V29, P236, DOI 10.1016/j.celrep.2019.08.084
   Yuan Tao, 2015, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V37, P269, DOI 10.3881/j.issn.1000-503X.2015.03.004
NR 52
TC 20
Z9 20
U1 1
U2 6
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD JUL 28
PY 2020
VL 9
AR e56177
DI 10.7554/eLife.56177
PG 17
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA MW9ZB
UT WOS:000557388000001
PM 32720643
OA gold, Green Published
DA 2024-02-19
ER

PT J
AU An, HJ
   Lee, B
   Kim, SM
   Kim, DH
   Chung, KW
   Ha, SG
   Park, KC
   Park, YJ
   Kim, SJ
   Yun, HY
   Chun, P
   Yu, BP
   Moon, HR
   Chung, HY
AF An, Hye Jin
   Lee, Bonggi
   Kim, Seong Min
   Kim, Dae Hyun
   Chung, Ki Wung
   Ha, Su Gyeong
   Park, Kyung Chul
   Park, Yeo Jin
   Kim, Seong Jin
   Yun, Hwi Young
   Chun, Pusoon
   Yu, Byung Pal
   Moon, Hyung Ryong
   Chung, Hae Young
TI A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid
   Accumulation by Promoting Fatty Acid Oxidation and Suppressing
   Inflammation
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE aging; nonalcoholic fatty liver disease; MHY2013; peroxisome
   proliferator-activated receptor (PPAR) pan agonist; lipid oxidation
ID PROLIFERATOR-ACTIVATED RECEPTORS; NF-KAPPA-B; LIVER-DISEASE; METABOLISM;
   ALPHA; GENE; MANAGEMENT; STRATEGY; GAMMA
AB Nonalcoholic fatty liver disease (NAFLD) is frequently observed in obese and aged individuals. Peroxisome proliferator-activated receptors (PPARs) play a role in regulating hepatic lipid accumulation, a hallmark of NAFLD development. A PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013) has been shown to prevent fatty liver formation and insulin resistance in obese mice (db/db) model. However, the beneficial effects of MHY2013 in aged model remain unknown. In this study, we investigated whether MHY2013 alleviates hepatic lipid accumulation in aged Sprague-Dawley (SD) rats. We confirmed that MHY2013 increased the activities of three PPAR subtypes in HepG2 cells using luciferase assay. When administered orally in aged SD rats, MHY2013 markedly decreased the hepatic triglyceride levels without changes in body weight. Regarding underlying mechanisms, MHY2013 increased the mRNA levels of lipid oxidation-related genes, including carnitine palmitoyltransferase 1 (CPTI) and peroxisomal acyl-CoA oxidase 1 (ACOX1), without apparent change in the mRNA expression of lipogenesis-related genes. Furthermore, MHY2013 significantly increased systemic fibroblast growth factor 21 (FGF21) and adiponectin levels and suppressed inflammatory mRNA expression in the liver. In conclusion, MHY2013 alleviated age-related hepatic lipid accumulation, in part by upregulating beta-oxidation signaling and suppressing inflammation in the liver. Therefore, MHY2013 is a potential pharmaceutical agent for treating age-related hepatic lipid accumulation.
C1 [An, Hye Jin; Lee, Bonggi; Kim, Seong Min; Kim, Dae Hyun; Chung, Ki Wung; Ha, Su Gyeong; Park, Kyung Chul; Park, Yeo Jin; Kim, Seong Jin; Yun, Hwi Young; Moon, Hyung Ryong; Chung, Hae Young] Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea.
   [Lee, Bonggi] KIOM, Korean Med KM Applicat Ctr, Daegu 41062, South Korea.
   [Chun, Pusoon] Inje Univ, Coll Pharm, Gyeongsangnam Do 50834, South Korea.
   [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.
C3 Pusan National University; Korea Institute of Oriental Medicine (KIOM);
   Inje University; University of Texas System; University of Texas Health
   Science Center at San Antonio
RP Moon, HR; Chung, HY (corresponding author), Pusan Natl Univ, Coll Pharm, Busan 46241, South Korea.
EM mhr108@pusan.ac.kr; hyjung@pusan.ac.kr
FU National Research Foundation of Korea (NRF) Grants - Korean government
   (MSIP) [2009-0083538, 2015R1A2A2A01004137, 2013M3A9B6076431]
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grants funded by the Korean government (MSIP) (No. 2009-0083538,
   No. 2015R1A2A2A01004137, No. 2013M3A9B6076431). We thank the Korean
   Aging Tissue Bank for providing the research materials.
CR An HJ, 2017, ONCOTARGET, V8, P16912, DOI 10.18632/oncotarget.14818
   Barberá MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200
   Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018
   Bertolotti M, 2014, WORLD J GASTROENTERO, V20, P14185, DOI 10.3748/wjg.v20.i39.14185
   Bouskila M, 2005, INT J OBESITY, V29, pS17, DOI 10.1038/sj.ijo.0802908
   Chen LH, 2014, PPAR RES, V2014, DOI 10.1155/2014/832606
   Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265
   Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2
   Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453
   Ghadir MR, 2010, HEPAT MON, V10, P285
   Kuhla A, 2011, J GERONTOL A-BIOL, V66, P1192, DOI 10.1093/gerona/glr124
   Liu J, 2015, METABOLISM, V64, P380, DOI 10.1016/j.metabol.2014.11.009
   Lundåsen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068
   Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826
   Okamoto H, 2005, CLIN EXP RHEUMATOL, V23, P323
   Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889
   Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379
   Sanguino E, 2004, EXP GERONTOL, V39, P1295, DOI 10.1016/j.exger.2004.06.007
   Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5
   Schoonjans K, 1996, J LIPID RES, V37, P907
   Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128
   Slawik M, 2006, AGEING RES REV, V5, P144, DOI 10.1016/j.arr.2006.03.004
   Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181
   Vernia S, 2014, CELL METAB, V20, P512, DOI 10.1016/j.cmet.2014.06.010
   Vikram A, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/679754
   Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506
   Yang CF, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-67
   Zámbó V, 2013, WORLD J HEPATOL, V5, P550, DOI 10.4254/wjh.v5.i10.550
NR 28
TC 18
Z9 19
U1 1
U2 14
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD JAN
PY 2018
VL 41
IS 1
BP 29
EP 35
DI 10.1248/bpb.b17-00371
PG 7
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA FS3EV
UT WOS:000419663100005
PM 29311481
OA gold
DA 2024-02-19
ER

PT J
AU Yuan, XY
   Tian, GG
   Pei, XY
   Hu, XP
   Wu, J
AF Yuan, Xiaoyan
   Tian, Geng G.
   Pei, Xiuying
   Hu, Xiaopeng
   Wu, Ji
TI Spermidine induces cytoprotective autophagy of female germline stem
   cells in vitro and ameliorates aging caused by oxidative stress through
   upregulated sequestosome-1/p62 expression
SO CELL AND BIOSCIENCE
LA English
DT Article
DE Spermidine; Autophagy; Female germline stem cells; Anti-aging; Anti-
   oxidative stress; p62
ID LIFE-SPAN; CELLULAR SENESCENCE; MICE; OOCYTES; GENES; BLOOD; LIVER
AB Background Autophagy is required for oogenesis and plays a critical role in response to aging caused by oxidative stress. However, there have been no reports on regulation of cytoprotective autophagy in female germline stem cells (FGSCs) in response to aging caused by oxidative stress. Results We found that Spermidine (SPD) significantly increased protein expression of autophagy markers microtubule-associated protein 1 light chain 3 beta-II (MAP1LC3B-II/LC3B-II) and sequestosome-1/p62 (SQSTM1/p62), and evoked autophagic flux in FGSCs. Moreover, SPD increased the number and viability of FGSCs in vitro. Further, we found that SPD significantly reduced basal or hydrogen peroxide (H2O2)-induced up-regulated protein expression of the aging markers, cyclin dependent kinase inhibitor 2A (p16/CDKN2A) and tumor protein 53 (p53). After knockdown of p62 in FGSCs, p16 protein levels were significant higher compared with controls. However, protein p16 levels were not significantly changed in p62 knockdown FGSCs with SPD treatment compared with without SPD. Moreover, SPD significantly changed the expression of autophagy-related genes and pathways in FGSCs, as shown by bioinformatics analysis of RNA sequencing data. Additionally, SPD significantly inhibited AKT/mTOR phosphorylation. Conclusions SPD induces cytoprotective autophagy in FGSCs in vitro and ameliorates cellular senescence of FGSCs induced by H2O2. Furthermore, SPD can ameliorate cellular senescence of FGSCs through p62. SPD might induce autophagy in FGSCs via the PI3K/Akt pathway. Our findings could be helpful for delaying aging of female germ cells due to oxidative stress and preserving female fertility.
C1 [Yuan, Xiaoyan; Pei, Xiuying; Wu, Ji] Ningxia Med Univ, Key Lab Fertil Preservat & Maintenance, Minist Educ, Yinchuan, Ningxia, Peoples R China.
   [Tian, Geng G.; Hu, Xiaopeng; Wu, Ji] Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai, Peoples R China.
   [Yuan, Xiaoyan] Gongli Hosp, Dept Emergency Med, Pudong New Area, Shanghai, Peoples R China.
C3 Ningxia Medical University; Shanghai Jiao Tong University
RP Wu, J (corresponding author), Ningxia Med Univ, Key Lab Fertil Preservat & Maintenance, Minist Educ, Yinchuan, Ningxia, Peoples R China.; Hu, XP; Wu, J (corresponding author), Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai, Peoples R China.
EM huxiaopeng2017@sjtu.edu.cn; jiwu@sjtu.edu.cn
RI Hu, Xiao/GQI-0007-2022; wu, ji/IAR-8520-2023; Yuan,
   Xiaoyan/AAN-1485-2020; Hu, Xiaopeng/GZA-7341-2022
OI Hu, Xiao/0000-0003-1128-4099; Hu, Xiaopeng/0000-0001-8179-8752
FU National Basic Research Program of China (973 Program) [2018YFC1003501,
   2017YFA0504201]; National Nature Science Foundation of China
   [81720108017]; National Natural Science Foundation of China [61827814];
   National Major Scientific Instruments and Equipment Development Project
FX This work was supported by National Basic Research Program of China (973
   Program) (2018YFC1003501, 2017YFA0504201), National Nature Science
   Foundation of China (81720108017), the National Major Scientific
   Instruments and Equipment Development Project, National Natural Science
   Foundation of China (61827814).
CR Chen P, 2021, GENE, V766, DOI 10.1016/j.gene.2020.145150
   de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031
   Ding XB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28218
   Eisenberg T, 2017, AUTOPHAGY, V13, P767, DOI 10.1080/15548627.2017.1280225
   Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222
   García-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187
   Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005
   Guo K, 2016, MOL HUM REPROD, V22, P316, DOI 10.1093/molehr/gaw015
   Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512
   He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015
   Hou L, 2018, CELL TRANSPLANT, V27, P1195, DOI 10.1177/0963689718784878
   Khosravi-Farsani S, 2015, CELL J, V16, P406
   Kumsta C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13540-4
   Li B, 2019, MOL THER-NUCL ACIDS, V17, P436, DOI 10.1016/j.omtn.2019.06.012
   Li XY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060606
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu ZY, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2749461
   Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788
   Maruzs T, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00140
   Miao HM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11716
   Muñoz-Lorente MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12664-x
   Nakamura S, 2018, MOL CELLS, V41, P65, DOI 10.14348/molcells.2018.2333
   Park ES, 2015, MOL HUM REPROD, V21, P58, DOI 10.1093/molehr/gau071
   Pucciarelli S, 2012, REJUV RES, V15, P590, DOI 10.1089/rej.2012.1349
   Shirakabe A, 2016, CIRC RES, V118, P1563, DOI 10.1161/CIRCRESAHA.116.307474
   Song D, 2019, ECOTOX ENVIRON SAFE, V183, DOI 10.1016/j.ecoenv.2019.109492
   Sun HD, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0890-5
   Varghese N, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9100932
   Vellai T, 2009, CELL DEATH DIFFER, V16, P94, DOI 10.1038/cdd.2008.126
   Wang JW, 2018, AUTOPHAGY, V14, P2007, DOI 10.1080/15548627.2018.1501133
   Weichhart T, 2018, GERONTOLOGY, V64, P127, DOI 10.1159/000484629
   Wong SQ, 2020, HUM GENET, V139, P277, DOI 10.1007/s00439-019-02031-7
   Xiong JQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139824
   Xu LZ, 2017, ONCOGENE, V36, P304, DOI 10.1038/onc.2016.202
   Yang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11671-2
   Yao XR, 2019, ANIM SCI J, V90, P1417, DOI 10.1111/asj.13280
   Yousefzadeh MJ, 2020, AGING CELL, V19, DOI 10.1111/acel.13094
   Yue F, 2017, CANCER RES, V77, P2938, DOI 10.1158/0008-5472.CAN-16-3462
   Zhang C, 2016, MOL HUM REPROD, V22, P457, DOI 10.1093/molehr/gaw030
   Zhang Y, 2011, J MOL CELL BIOL, V3, P132, DOI 10.1093/jmcb/mjq043
   Zhang Y, 2019, AGING-US, V11, P2241, DOI 10.18632/aging.101911
   Zou K, 2011, STEM CELLS DEV, V20, P2197, DOI 10.1089/scd.2011.0091
   Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869
NR 43
TC 22
Z9 25
U1 3
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2045-3701
J9 CELL BIOSCI
JI Cell Biosci.
PD JUN 7
PY 2021
VL 11
IS 1
AR 107
DI 10.1186/s13578-021-00614-4
PG 14
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA ST8KY
UT WOS:000662688000002
PM 34099041
OA gold, Green Published
DA 2024-02-19
ER

EF